data_2l4c_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l4c _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.471 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.0 pt-20 . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.536 0.207 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 35.9 Cg_endo -65.46 145.27 82.29 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.617 2.211 . . . . 0.0 112.706 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 m -62.27 154.14 28.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.912 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -97.42 92.82 6.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.811 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 24' ' ' ALA . 42.9 mt -91.84 71.23 5.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.513 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.2 p -72.93 -0.8 14.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.103 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -139.7 147.28 40.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 111.488 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 45.2 t -56.81 -49.93 91.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.518 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.05 -45.44 31.97 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.926 1.751 . . . . 0.0 111.786 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.29 80.12 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.195 0.521 . . . . 0.0 110.19 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.561 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -63.77 -59.83 4.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.063 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.3 mtm -60.59 -25.54 66.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.144 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 21.8 mt-10 -71.6 -51.22 24.41 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.495 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -61.06 -30.21 70.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.466 HD11 HD13 ' A' ' 36' ' ' ILE . 48.6 mt -75.79 -36.96 34.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.965 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.36 -19.48 59.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.248 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.14 28.1 2.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.1 t -171.16 153.15 3.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.46 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.465 ' HG3' HG13 ' A' ' 87' ' ' VAL . 23.3 tt0 -65.36 -65.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.773 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.442 HG12 HD13 ' A' ' 83' ' ' LEU . 18.1 t -106.1 137.82 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.638 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.3 125.92 17.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.524 HG22 HG12 ' A' ' 111' ' ' ILE . 53.9 t -114.56 128.75 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.641 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.466 HD13 HD11 ' A' ' 28' ' ' ILE . 29.9 mt -134.49 137.89 50.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.523 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.11 97.79 1.72 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.427 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.453 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.8 m-85 -83.27 91.85 7.37 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.1 m-85 -111.45 143.3 42.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.469 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.459 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 48.6 mt-30 -90.46 -6.22 55.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.452 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.0 t70 -151.95 121.86 7.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.614 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.507 ' HG ' HG22 ' A' ' 66' ' ' THR . 94.7 mt -90.51 45.76 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.999 0.428 . . . . 0.0 111.515 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 36.9 mt-10 -136.59 8.98 3.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.094 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.681 HG13 HG23 ' A' ' 47' ' ' VAL . 2.8 pt -90.66 156.86 44.75 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.162 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.444 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 79.6 Cg_exo -51.0 -27.75 22.2 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.837 2.358 . . . . 0.0 112.923 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.57 91.67 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.681 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -60.46 -56.7 32.66 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.802 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -59.39 -40.88 63.46 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.671 1.581 . . . . 0.0 111.441 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.607 HG22 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -61.82 -35.59 68.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.145 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.533 ' O ' ' HG3' ' A' ' 53' ' ' MET . 48.4 tp -74.65 -52.56 11.37 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -54.83 -24.27 22.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.071 0.463 . . . . 0.0 109.977 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 m -83.03 -45.27 14.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.623 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.533 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -60.59 -26.28 66.85 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.2 0.524 . . . . 0.0 109.619 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -51.25 -47.71 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.226 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -77.43 -12.97 60.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.913 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -91.23 -17.52 25.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.171 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.562 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 47.8 m-85 -137.99 62.64 34.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.567 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.84 -42.58 65.34 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.677 2.251 . . . . 0.0 111.661 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.93 -37.79 80.84 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.381 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.7 t -70.34 144.34 13.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.551 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 46.7 t -82.26 98.46 8.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.948 0.404 . . . . 0.0 111.094 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.448 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -65.21 127.37 31.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.066 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.27 160.44 28.18 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.159 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 tt -160.37 144.16 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.453 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 37.3 t -148.48 159.11 44.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.5 . . . . 0.0 111.768 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.507 HG22 ' HG ' ' A' ' 42' ' ' LEU . 67.8 p -140.99 4.82 1.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.656 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -74.43 141.56 45.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.672 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.2 t -64.32 -51.11 65.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.448 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -49.88 -41.94 46.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.61 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.52 ' HA ' HG23 ' A' ' 21' ' ' VAL . 56.5 t -72.08 -53.99 18.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.831 0.348 . . . . 0.0 110.762 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -58.78 -14.69 9.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.091 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.0 m -90.54 -42.45 10.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.093 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -59.73 -37.76 79.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.356 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -93.67 12.01 26.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.807 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.9 m120 55.7 23.75 6.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.64 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.609 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.3 mm -59.78 121.59 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.221 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.4 p -142.48 58.7 1.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.011 0.434 . . . . 0.0 111.05 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.04 43.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.658 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 14.2 m120 52.07 43.23 30.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.296 0.569 . . . . 0.0 110.448 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.609 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.2 m -68.61 151.86 46.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.741 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.523 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.1 mt -118.43 116.63 51.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.025 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.529 ' HG ' HD12 ' A' ' 76' ' ' ILE . 72.0 m -105.28 130.3 53.44 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.577 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.5 tp -107.8 103.51 12.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.771 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.0 t80 -97.51 124.37 41.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.529 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.5 HH12 HD12 ' A' ' 116' ' ' LEU . 4.5 mtm180 -106.8 82.85 1.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.967 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 85' ' ' ARG . 6.0 tp -24.99 -60.04 0.06 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.087 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.465 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.52 -70.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.134 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.03 2.08 50.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.05 0.452 . . . . 0.0 110.959 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 m120 53.76 34.85 19.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.632 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 11.8 mm-40 -81.17 163.93 22.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.746 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.09 98.58 2.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.824 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.577 HD21 ' HG ' ' A' ' 83' ' ' LEU . 1.8 mm? -88.37 117.08 27.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.784 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -97.85 94.08 6.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.483 HD23 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -77.65 77.42 4.17 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.406 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.4 mt-10 -78.4 -164.49 0.57 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.492 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 16.3 t70 -51.27 -39.02 55.86 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.096 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.26 -14.67 1.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.103 0.477 . . . . 0.0 110.346 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -129.22 -13.85 4.4 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.674 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 22.4 mm -90.29 -31.0 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.607 0.242 . . . . 0.0 111.563 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -55.21 -39.37 69.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.19 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.8 p -128.03 37.07 4.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.506 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.483 HD13 HD23 ' A' ' 94' ' ' LEU . 6.6 tp -62.77 142.78 16.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.423 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.527 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.1 m-20 -137.34 150.53 47.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.642 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.607 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -48.42 -36.2 14.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.036 0.446 . . . . 0.0 110.367 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.8 m -63.29 -48.7 77.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.398 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -59.08 -58.59 7.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.281 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.597 HD11 HG23 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.49 -56.22 12.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.883 0.373 . . . . 0.0 110.227 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.7 m -58.39 -29.65 66.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.792 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.476 ' HD3' HD12 ' A' ' 113' ' ' ILE . 4.0 tmt_? -71.24 -66.39 0.62 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.094 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -42.57 -42.45 3.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.146 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.524 HG12 HG22 ' A' ' 35' ' ' VAL . 96.3 mt -64.12 -56.27 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.562 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -53.43 -19.87 4.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.328 0.585 . . . . 0.0 110.267 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.476 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.22 -37.04 10.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.915 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.435 ' OD1' ' HG ' ' A' ' 92' ' ' LEU . 16.7 m120 -123.3 30.95 6.12 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.0 p -83.35 41.7 0.78 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.02 0.438 . . . . 0.0 110.169 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.5 HD12 HH12 ' A' ' 85' ' ' ARG . 64.6 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.249 -0.882 . . . . 0.0 111.374 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.51 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.5 pt-20 . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 110.651 -0.129 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 37.2 Cg_endo -66.16 143.9 73.18 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.464 2.109 . . . . 0.0 112.668 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 m -62.0 154.41 26.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.422 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -98.99 90.13 4.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.068 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.562 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.7 mt -86.8 74.14 9.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.312 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.8 p -74.05 -5.28 40.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.971 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -137.56 147.2 44.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.888 0.375 . . . . 0.0 111.555 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.591 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.2 t -56.76 -50.03 90.35 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.448 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.8 Cg_endo -57.56 -44.08 45.09 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.911 1.741 . . . . 0.0 111.83 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.36 83.9 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.172 0.51 . . . . 0.0 110.228 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.52 -58.73 6.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.169 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 64.5 mtp -60.36 -26.37 66.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.148 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -71.45 -51.34 24.36 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.672 0.273 . . . . 0.0 110.569 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -60.37 -32.86 71.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.909 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.441 HD11 HD13 ' A' ' 36' ' ' ILE . 54.7 mt -73.71 -38.75 51.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.108 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.98 -19.86 60.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.055 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.8 25.57 3.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.0 t -168.85 152.2 5.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.514 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.409 ' HG3' HG11 ' A' ' 87' ' ' VAL . 21.9 tt0 -63.82 -74.04 0.11 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.744 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.489 HG13 HD12 ' A' ' 83' ' ' LEU . 17.9 t -98.25 136.32 29.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.452 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.84 125.37 19.19 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.507 HG21 HG12 ' A' ' 111' ' ' ILE . 56.0 t -115.15 131.13 68.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.688 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 21.5 mt -136.58 138.51 46.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.561 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.74 97.02 1.55 Allowed Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.583 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 11.5 m-85 -83.32 89.8 7.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -109.48 137.92 46.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.455 -178.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.44 ' HG2' HD23 ' A' ' 71' ' ' LEU . 24.7 mt-30 -83.85 -6.21 59.38 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.433 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 37.5 t70 -151.69 124.96 8.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.605 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.494 ' HG ' HG22 ' A' ' 66' ' ' THR . 91.7 mt -93.67 47.14 1.21 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.175 0.512 . . . . 0.0 111.246 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.433 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 6.8 mm-40 -138.81 10.77 2.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.98 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.669 HG13 HG23 ' A' ' 47' ' ' VAL . 1.4 pt -94.08 156.67 38.84 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.06 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.461 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 77.8 Cg_exo -50.6 -29.15 24.21 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.774 2.316 . . . . 0.0 113.064 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.438 ' HB1' HD12 ' A' ' 44' ' ' ILE . . . -62.4 -36.65 82.97 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.669 HG23 HG13 ' A' ' 44' ' ' ILE . 2.5 t -63.09 -57.19 22.17 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.72 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.3 Cg_exo -59.64 -36.1 93.2 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.776 1.651 . . . . 0.0 111.284 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.65 HG22 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -66.04 -36.31 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.034 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.514 ' O ' ' HG3' ' A' ' 53' ' ' MET . 40.5 tp -72.96 -52.19 15.47 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -55.19 -23.03 19.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.892 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.3 t -84.27 -44.17 14.12 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.364 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.514 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.57 -25.39 67.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.21 0.529 . . . . 0.0 109.613 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -52.91 -51.18 39.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.171 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -74.31 -10.6 59.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.662 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -93.88 -18.94 21.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.186 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.604 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 56.7 m-85 -135.38 61.99 47.64 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.55 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.94 -41.69 62.19 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.687 2.258 . . . . 0.0 111.653 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.12 96.51 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.59 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.8 t -65.76 144.87 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.579 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 48.2 t -82.4 97.49 8.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.167 0.508 . . . . 0.0 110.81 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.8 p90 -65.21 126.5 28.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.105 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.98 161.59 28.29 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.139 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -157.92 140.33 5.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.831 0.348 . . . . 0.0 110.082 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.3 t -141.03 155.22 46.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.499 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.494 HG22 ' HG ' ' A' ' 42' ' ' LEU . 77.1 p -141.31 -7.19 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.753 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.63 143.57 56.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.709 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 m -62.71 -50.82 69.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.26 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -48.19 -48.56 34.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.687 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.514 ' HA ' HG21 ' A' ' 21' ' ' VAL . 84.2 t -68.1 -53.4 29.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.82 0.343 . . . . 0.0 110.986 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.44 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -57.78 -14.76 6.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.43 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.9 m -91.24 -42.85 10.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.417 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -59.37 -43.65 92.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.644 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -87.61 12.98 11.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.803 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 54.45 26.9 7.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.536 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.663 HG22 ' HB ' ' A' ' 80' ' ' THR . 38.6 mm -61.08 123.33 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.842 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.6 p -143.57 60.43 1.39 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.935 0.398 . . . . 0.0 111.448 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.82 44.14 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.512 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 12.1 m120 52.54 43.19 31.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.269 0.557 . . . . 0.0 110.337 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.663 ' HB ' HG22 ' A' ' 76' ' ' ILE . 96.1 m -69.01 153.09 44.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.701 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.561 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.4 mt -119.58 117.68 54.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.792 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.8 m -106.93 134.12 50.55 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.589 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.9 tp -110.13 105.03 13.97 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.138 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.9 t80 -98.53 122.07 41.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.546 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 6.1 mtm180 -104.45 82.12 1.88 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.71 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tp -24.47 -62.0 0.05 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.409 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.87 -63.49 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.97 2.33 55.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.082 0.468 . . . . 0.0 110.713 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.3 m120 53.48 25.28 4.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.667 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.546 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 14.2 mm-40 -68.94 158.09 35.36 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.81 0.338 . . . . 0.0 110.806 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -143.07 90.42 2.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.742 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.589 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -79.92 141.41 36.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.48 96.14 4.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.518 HD21 HD11 ' A' ' 102' ' ' ILE . 4.5 tt -82.0 77.77 8.78 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.5 mt-10 -79.13 -165.25 0.73 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -176.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 13.8 t70 -50.9 -37.63 44.93 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.836 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -55.6 -14.74 2.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.044 0.449 . . . . 0.0 110.406 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -129.93 -14.0 4.03 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.356 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.507 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 21.4 mm -90.03 -23.0 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.899 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.56 -51.72 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.658 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 83.2 p -121.21 38.57 4.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.258 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.518 HD11 HD21 ' A' ' 94' ' ' LEU . 6.6 tp -59.41 142.78 14.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.529 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.531 ' HA ' HD13 ' A' ' 49' ' ' ILE . 25.2 m-20 -137.24 150.29 47.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.647 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.65 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -47.87 -37.11 13.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 110.447 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -63.27 -47.96 80.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.374 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -59.08 -59.67 5.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.113 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.636 HD13 HG23 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -49.76 -55.31 14.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.094 0.474 . . . . 0.0 110.152 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.7 m -59.08 -28.72 66.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.781 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.452 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -72.11 -65.77 0.73 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.012 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -42.86 -43.79 4.22 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.03 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.507 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -63.23 -56.62 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.585 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -52.56 -20.97 3.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.201 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.452 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -86.15 -39.03 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.953 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.57 HD21 ' HG ' ' A' ' 92' ' ' LEU . 90.2 m-20 -121.03 29.59 7.28 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 111' ' ' ILE . 80.4 p -82.78 49.49 1.51 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.021 0.439 . . . . 0.0 110.246 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.47 HD11 HH12 ' A' ' 85' ' ' ARG . 72.6 mt . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.29 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.7 pt-20 . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.406 0.146 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 31.6 Cg_endo -64.73 142.48 76.84 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.666 2.244 . . . . 0.0 112.398 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.3 m -57.68 152.86 14.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.612 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -99.55 94.22 6.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.962 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 24' ' ' ALA . 42.6 mt -90.37 72.92 7.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.366 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 76.4 p -70.06 -8.04 46.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.185 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.452 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 3.7 m-20 -138.55 147.45 43.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.153 0.502 . . . . 0.0 111.729 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.598 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.8 t -54.32 -49.5 90.16 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.861 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.59 -45.31 34.57 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.018 1.812 . . . . 0.0 112.059 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.96 -36.5 84.18 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.233 0.539 . . . . 0.0 110.295 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.557 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -62.53 -58.71 6.6 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.106 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 69.6 mtp -60.15 -27.57 67.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.18 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 25.0 mt-10 -71.25 -50.34 33.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.803 0.335 . . . . 0.0 110.671 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -59.98 -32.63 71.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.042 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.431 HD13 HD13 ' A' ' 36' ' ' ILE . 44.0 mt -74.84 -38.81 44.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.047 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.45 -19.61 61.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.158 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.53 25.96 4.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.379 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.0 t -170.09 151.14 3.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.387 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.472 ' HG3' HG12 ' A' ' 87' ' ' VAL . 21.7 tt0 -62.0 -72.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.774 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 83' ' ' LEU . 20.7 t -100.78 138.12 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.812 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.16 128.41 20.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.675 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.464 HG23 HG12 ' A' ' 111' ' ' ILE . 47.6 t -116.69 128.74 73.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.701 178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 22.4 mt -134.09 135.9 54.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.615 -177.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.533 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.9 99.41 2.05 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.255 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.8 m-85 -84.77 92.73 8.3 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.0 m-85 -112.14 139.26 47.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.431 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.452 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 74.4 mt-30 -85.81 -8.0 58.38 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.45 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.6 t70 -149.96 123.28 8.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.656 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.487 ' HG ' HG22 ' A' ' 66' ' ' THR . 98.7 mt -92.28 46.97 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.134 0.492 . . . . 0.0 111.321 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.425 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 40.7 mt-10 -137.75 9.18 2.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.981 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.652 HG13 HG21 ' A' ' 47' ' ' VAL . 1.7 pt -92.84 156.54 40.63 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.271 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.462 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 83.2 Cg_exo -50.54 -28.93 23.19 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.836 2.358 . . . . 0.0 113.162 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.417 ' HB2' HD12 ' A' ' 44' ' ' ILE . . . -62.07 -38.65 89.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.652 HG21 HG13 ' A' ' 44' ' ' ILE . 2.2 t -61.53 -56.69 30.82 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.76 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -59.34 -37.9 87.81 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.746 1.631 . . . . 0.0 111.322 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.625 HG23 HD13 ' A' ' 107' ' ' LEU . 5.5 mt -64.42 -35.25 73.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.992 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.525 ' O ' HG22 ' A' ' 54' ' ' VAL . 46.8 tp -73.6 -52.77 12.29 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -54.21 -24.72 19.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.07 0.462 . . . . 0.0 109.795 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 t -82.85 -44.37 15.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.631 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.521 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.42 -25.95 67.54 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.244 0.545 . . . . 0.0 109.653 179.261 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 50' ' ' LEU . 56.3 t -52.15 -50.01 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.848 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -74.43 -12.62 60.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.816 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -91.93 -18.41 23.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.294 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 45.1 m-85 -135.92 62.47 46.89 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.496 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.07 -45.46 38.84 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.82 2.347 . . . . 0.0 111.61 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.07 -41.81 79.09 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.476 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.5 t -65.97 144.22 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.466 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 37.6 t -82.41 98.03 8.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.916 0.389 . . . . 0.0 110.896 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.484 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 7.9 p90 -62.65 129.38 40.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.781 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.37 160.66 28.43 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.14 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.4 HD11 HG13 ' A' ' 47' ' ' VAL . 4.6 tt -159.38 141.7 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.8 t -145.19 151.71 38.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.104 0.478 . . . . 0.0 111.686 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.487 HG22 ' HG ' ' A' ' 42' ' ' LEU . 81.1 p -135.59 -4.89 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.515 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.41 146.22 55.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.791 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.8 t -66.84 -52.12 47.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.474 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -49.71 -43.56 47.66 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.551 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.469 ' HA ' HG23 ' A' ' 21' ' ' VAL . 77.3 t -70.58 -54.07 19.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.91 0.386 . . . . 0.0 110.695 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.448 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -58.75 -14.67 9.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.357 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.4 m -92.29 -39.96 11.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.316 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -61.95 -39.29 91.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.398 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -91.12 10.76 25.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.8 m120 57.53 25.0 10.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.502 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.641 HG21 ' HB ' ' A' ' 80' ' ' THR . 36.0 mm -60.52 121.44 8.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.055 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.2 p -141.86 59.16 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.36 45.27 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.666 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 15.3 m120 52.17 42.89 30.92 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.282 0.563 . . . . 0.0 110.557 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.641 ' HB ' HG21 ' A' ' 76' ' ' ILE . 93.1 m -69.28 152.6 44.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.681 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.533 HG12 ' HA2' ' A' ' 37' ' ' GLY . 68.2 mt -119.45 118.8 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.095 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 83.9 m -107.79 133.55 52.02 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.586 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -108.29 104.24 13.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.778 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.2 t80 -97.76 123.41 41.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.479 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.493 HH12 HD13 ' A' ' 116' ' ' LEU . 5.7 mtm180 -106.83 82.91 1.76 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.957 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 tp -26.01 -59.1 0.08 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.04 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.472 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.55 -70.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 O-C-N 123.413 0.446 . . . . 0.0 112.069 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -87.52 2.51 50.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.739 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 52.07 37.88 22.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.17 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 8.4 mm-40 -82.36 158.19 23.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.618 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -140.11 91.95 2.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.86 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.586 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -81.62 133.81 35.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.491 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.06 116.11 28.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.334 0.588 . . . . 0.0 112.317 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.475 HD21 HD12 ' A' ' 102' ' ' ILE . 3.7 tt -102.39 77.19 1.62 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.455 ' HG2' ' HG1' ' A' ' 80' ' ' THR . 27.5 mt-10 -79.64 -164.84 0.7 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -176.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.494 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 21.2 t70 -50.52 -36.59 34.82 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.101 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -56.67 -14.51 3.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.151 0.501 . . . . 0.0 110.311 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -131.07 -13.93 3.49 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.593 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.531 HG22 ' HB2' ' A' ' 79' ' ' ASN . 25.7 mm -90.07 -30.97 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.774 0.321 . . . . 0.0 111.246 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -54.47 -41.58 69.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.511 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.1 m -126.82 38.64 4.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.569 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.9 tp -64.31 142.44 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.608 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.518 ' HA ' HD12 ' A' ' 49' ' ' ILE . 19.1 m-20 -136.55 149.47 48.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.321 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.621 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -47.41 -35.92 9.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.092 0.472 . . . . 0.0 110.416 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.8 m -62.7 -49.11 76.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.413 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -59.1 -58.28 9.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.411 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.625 HD13 HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.67 -56.69 10.72 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.107 0.479 . . . . 0.0 110.027 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.6 m -58.06 -28.68 64.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.746 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.471 ' HD3' HD12 ' A' ' 113' ' ' ILE . 4.1 tmt_? -71.96 -65.58 0.75 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.062 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -43.05 -42.78 4.04 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.084 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.464 HG12 HG23 ' A' ' 35' ' ' VAL . 96.1 mt -64.46 -55.44 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.551 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.79 -17.21 3.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.232 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.471 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -90.77 -37.01 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.0 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.559 HD21 ' HG ' ' A' ' 92' ' ' LEU . 93.3 m-20 -124.47 29.95 6.16 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.6 p -81.95 47.07 1.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.074 0.464 . . . . 0.0 110.197 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.493 HD13 HH12 ' A' ' 85' ' ' ARG . 51.2 mt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.171 -0.919 . . . . 0.0 111.353 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 . . . . . 0 CA--C 1.532 0.254 0 CA-C-O 120.431 0.157 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 32.2 Cg_endo -65.51 144.91 81.0 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.653 2.236 . . . . 0.0 112.538 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.7 m -62.23 154.13 28.45 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.359 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -99.69 95.57 7.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.136 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 24' ' ' ALA . 44.7 mt -93.13 71.3 4.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.327 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.4 p -71.75 -0.07 10.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.289 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -141.37 147.62 38.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.939 0.4 . . . . 0.0 111.592 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.586 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 23.2 t -57.28 -49.73 92.2 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.499 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.0 Cg_endo -58.71 -42.5 52.97 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.975 1.784 . . . . 0.0 111.879 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.91 -34.91 78.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.195 0.521 . . . . 0.0 110.533 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.573 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -65.06 -57.01 9.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.184 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 61.0 mtm -62.87 -28.6 70.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.075 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 9.9 mt-10 -69.88 -47.77 61.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.718 0.294 . . . . 0.0 110.5 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.08 -42.35 94.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.427 HD11 HD11 ' A' ' 36' ' ' ILE . 51.0 mt -65.36 -40.12 87.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.23 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.61 -15.52 61.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.786 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.45 24.86 6.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.13 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.5 t -171.69 155.02 3.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.515 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.487 ' HG3' HG12 ' A' ' 87' ' ' VAL . 20.7 tt0 -64.76 -79.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.876 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.456 HG11 HD13 ' A' ' 83' ' ' LEU . 17.0 t -93.5 135.14 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.411 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.96 125.51 20.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.026 0.441 . . . . 0.0 112.138 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.498 HG22 HG12 ' A' ' 111' ' ' ILE . 52.4 t -114.48 127.66 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.799 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 23.7 mt -133.18 137.2 53.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.401 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.54 98.61 1.88 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.455 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 6.1 m-85 -83.83 90.22 7.32 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.0 m-85 -109.32 139.09 44.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.377 -178.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -86.06 -8.57 57.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.4 t70 -149.84 121.7 8.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.623 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.499 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.3 mt -89.55 44.85 1.23 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.066 0.46 . . . . 0.0 111.35 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.405 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.7 mt-10 -135.94 10.52 3.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.028 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.658 HG13 HG22 ' A' ' 47' ' ' VAL . 2.1 pt -94.34 156.77 38.39 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.288 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.452 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 73.4 Cg_exo -51.19 -28.58 26.21 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.794 2.33 . . . . 0.0 112.899 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.89 90.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.315 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.658 HG22 HG13 ' A' ' 44' ' ' ILE . 2.4 t -60.97 -57.28 27.5 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.681 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -58.98 -40.27 72.88 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.767 1.644 . . . . 0.0 111.387 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -61.77 -35.77 69.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.007 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.533 ' O ' ' HG3' ' A' ' 53' ' ' MET . 42.1 tp -73.52 -53.11 11.35 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -53.58 -24.44 13.73 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.1 m -82.49 -46.18 13.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.621 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.533 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.7 -26.1 65.33 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 50' ' ' LEU . 58.7 t -53.08 -47.28 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.942 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -77.46 -10.5 59.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.647 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -94.1 -19.68 20.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.16 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.554 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 64.4 m-85 -136.44 62.66 44.57 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.525 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.26 -42.37 60.46 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.653 2.235 . . . . 0.0 111.624 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.72 -39.39 91.17 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.32 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.3 t -67.67 144.11 14.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.547 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 33.7 t -81.89 98.8 8.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 111.015 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.559 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 8.3 p90 -64.88 128.64 36.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.905 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -147.74 160.87 28.44 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.987 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.418 HD13 HG11 ' A' ' 47' ' ' VAL . 4.8 tt -160.75 141.82 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.1 t -146.94 155.87 42.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.952 0.406 . . . . 0.0 111.769 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.498 HG23 ' HG ' ' A' ' 42' ' ' LEU . 82.5 p -137.64 -8.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.681 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.77 141.8 56.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.669 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.4 m -64.68 -49.53 70.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.126 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -50.19 -44.48 53.02 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.411 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.464 ' HA ' HG23 ' A' ' 21' ' ' VAL . 77.2 t -70.53 -53.78 21.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.831 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.38 -14.63 8.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.261 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.4 m -91.73 -40.63 11.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.205 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -61.87 -36.17 80.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.486 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -94.16 10.67 32.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.73 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 57.51 23.66 9.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.64 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.605 HG21 ' HB ' ' A' ' 80' ' ' THR . 35.2 mm -59.89 120.05 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.245 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.9 p -139.39 55.85 1.68 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.174 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.19 45.7 0.02 OUTLIER Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.634 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.538 ' HB2' HG22 ' A' ' 99' ' ' ILE . 21.8 m-80 51.28 43.27 29.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.252 0.549 . . . . 0.0 110.504 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.605 ' HB ' HG21 ' A' ' 76' ' ' ILE . 98.0 m -69.17 151.27 46.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.569 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.546 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.3 mt -117.45 118.95 60.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.223 -0.898 . . . . 0.0 108.821 178.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.517 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.4 m -107.26 133.23 52.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.583 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.5 tp -109.41 103.38 12.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.966 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.9 t80 -96.34 120.88 37.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.56 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.495 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.2 mtm180 -104.06 80.63 1.75 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.808 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 85' ' ' ARG . 8.6 tp -25.18 -58.2 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.028 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.487 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.84 -62.88 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.314 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -95.05 15.45 18.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.783 0.325 . . . . 0.0 111.301 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 44.7 27.94 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.104 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.495 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.4 mm-40 -75.98 156.78 33.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.834 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.404 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.8 OUTLIER -144.26 90.68 2.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.774 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.583 HD21 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -77.52 142.19 39.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.4 91.99 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.495 HD21 HD12 ' A' ' 102' ' ' ILE . 4.6 tt -78.34 79.36 4.78 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -79.5 -165.49 0.8 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.509 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.8 t70 -50.37 -39.86 47.86 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.48 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.14 -15.12 1.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.167 0.508 . . . . 0.0 110.295 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -127.95 -13.79 5.11 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.461 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.557 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 24.4 mm -90.16 -33.45 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.543 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -50.11 -53.64 26.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 110.544 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.6 m -114.97 38.55 3.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.436 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.557 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.3 tp -62.0 142.88 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 111.448 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.539 ' HA ' HD12 ' A' ' 49' ' ' ILE . 24.0 m-20 -137.96 149.57 46.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.848 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.631 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -47.92 -35.89 11.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.034 0.445 . . . . 0.0 110.36 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 95.6 m -62.97 -47.83 81.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.293 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -60.2 -60.29 4.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.126 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.61 HD13 HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.06 -56.02 10.31 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.995 0.426 . . . . 0.0 110.131 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.0 m -58.23 -30.76 66.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.999 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.49 ' HD3' HD11 ' A' ' 113' ' ' ILE . 1.7 tmt_? -69.85 -66.02 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.052 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -42.86 -43.83 4.23 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.218 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.498 HG12 HG22 ' A' ' 35' ' ' VAL . 95.3 mt -62.92 -54.89 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -54.57 -18.68 4.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.267 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.49 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.79 -35.24 7.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.944 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.572 HD21 ' HG ' ' A' ' 92' ' ' LEU . 87.6 m-20 -126.03 30.91 5.55 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.2 p -83.44 38.32 0.61 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.995 0.426 . . . . 0.0 110.423 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.494 HD13 HH12 ' A' ' 85' ' ' ARG . 72.0 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.386 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.47 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.4 pt-20 . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 30.8 Cg_endo -64.26 145.77 89.2 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.536 2.158 . . . . 0.0 112.518 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.2 m -61.05 153.92 24.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.581 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -99.97 89.61 4.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.709 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 24' ' ' ALA . 35.4 mt -87.72 76.8 8.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.56 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.0 p -74.6 -4.95 40.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.049 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -141.48 148.31 39.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.952 0.406 . . . . 0.0 111.821 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.588 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 12.6 t -54.63 -49.97 88.25 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.583 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.0 Cg_endo -57.81 -44.15 43.2 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.005 1.804 . . . . 0.0 112.127 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.98 -37.54 87.81 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.206 0.527 . . . . 0.0 110.263 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.649 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -62.69 -56.54 16.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.016 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.6 mtm -61.86 -26.76 68.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.056 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -71.72 -50.59 28.9 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.642 0.258 . . . . 0.0 110.602 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -60.83 -32.17 71.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.105 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.479 HD12 HD13 ' A' ' 36' ' ' ILE . 53.4 mt -75.29 -39.06 41.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.03 0.443 . . . . 0.0 110.075 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.51 -18.46 61.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.143 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.1 25.39 4.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.261 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 t -169.57 154.24 5.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.689 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.496 ' HG3' HG11 ' A' ' 87' ' ' VAL . 18.9 tt0 -65.13 -72.58 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.878 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.449 HG12 HD11 ' A' ' 83' ' ' LEU . 15.7 t -99.45 137.13 27.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.672 0.272 . . . . 0.0 110.657 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.545 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.58 125.35 16.97 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.024 0.44 . . . . 0.0 112.019 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.466 HG21 HG12 ' A' ' 111' ' ' ILE . 56.0 t -114.88 129.64 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.902 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.479 HD13 HD12 ' A' ' 28' ' ' ILE . 21.6 mt -135.21 136.8 51.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.468 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.552 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.0 99.78 2.1 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.543 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 6.4 m-85 -85.4 93.93 8.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.4 m-85 -113.38 143.37 44.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -92.64 -1.16 57.1 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.496 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.3 t70 -156.89 115.53 3.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.479 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.486 ' HG ' HG23 ' A' ' 66' ' ' THR . 95.2 mt -85.47 44.14 1.08 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.11 0.481 . . . . 0.0 111.233 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.416 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 17.5 mm-40 -135.29 12.74 3.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.46 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.675 HG13 HG21 ' A' ' 47' ' ' VAL . 1.8 pt -96.57 156.37 36.79 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.176 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.44 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 87.6 Cg_exo -50.95 -27.24 20.41 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.837 2.358 . . . . 0.0 113.048 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.15 -37.12 86.31 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.675 HG21 HG13 ' A' ' 44' ' ' ILE . 2.7 t -62.13 -56.1 34.47 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.939 -0.305 . . . . 0.0 111.682 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.8 Cg_exo -59.79 -40.25 65.4 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.735 1.623 . . . . 0.0 111.461 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.614 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -61.83 -37.2 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.086 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.523 ' O ' ' HG3' ' A' ' 53' ' ' MET . 37.6 tp -72.13 -53.19 13.5 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -54.92 -21.02 10.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.085 0.469 . . . . 0.0 109.815 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.7 t -85.38 -44.87 12.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.496 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.523 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.28 -26.55 67.85 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 50' ' ' LEU . 54.5 t -51.89 -50.0 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.069 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -74.54 -13.41 60.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.685 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -91.13 -18.7 24.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.288 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.638 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 48.8 m-85 -135.4 62.06 47.84 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.436 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.18 -36.77 78.62 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.494 2.129 . . . . 0.0 111.493 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.44 -39.77 98.09 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.518 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.5 t -67.72 145.23 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.545 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 36.9 t -82.7 96.28 8.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.099 0.476 . . . . 0.0 110.795 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.449 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 6.8 p90 -64.05 130.83 45.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.187 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -149.87 162.3 29.11 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.008 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.5 tt -160.47 147.1 5.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.9 t -153.11 157.55 40.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.17 0.509 . . . . 0.0 111.697 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.486 HG23 ' HG ' ' A' ' 42' ' ' LEU . 69.9 p -138.03 -3.39 1.8 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.444 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -63.95 143.36 57.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.679 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.0 p -66.22 -52.08 51.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.53 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -50.2 -43.46 52.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.592 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 21' ' ' VAL . 60.4 t -70.53 -52.5 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.934 0.397 . . . . 0.0 110.563 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.96 -14.52 16.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.47 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.6 m -92.13 -41.53 10.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.204 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -60.1 -41.3 92.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.451 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -89.02 11.98 16.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.81 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 55.95 28.81 13.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.483 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.618 HG22 ' HB ' ' A' ' 80' ' ' THR . 34.9 mm -65.5 118.65 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.079 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.7 p -139.75 51.96 1.72 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.193 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.87 44.42 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.567 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.565 ' HB2' HG23 ' A' ' 99' ' ' ILE . 39.2 m-20 51.42 42.29 29.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.364 0.602 . . . . 0.0 110.137 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.618 ' HB ' HG22 ' A' ' 76' ' ' ILE . 93.4 m -68.55 153.36 43.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.93 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.552 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.3 mt -119.93 118.06 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.867 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.2 m -106.75 132.8 52.31 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.578 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -110.42 104.72 13.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.039 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.0 t80 -97.54 123.94 41.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.447 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.504 HH12 HD13 ' A' ' 116' ' ' LEU . 4.8 mtm180 -106.12 81.08 1.58 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.708 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ARG . 8.9 tp -24.28 -59.86 0.05 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.113 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.496 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.8 -63.3 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -93.77 2.57 56.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.995 0.426 . . . . 0.0 111.077 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 54.12 30.7 12.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.718 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.9 mm-40 -78.32 164.07 25.17 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.706 0.288 . . . . 0.0 110.648 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.99 98.74 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.578 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -86.81 115.37 24.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.742 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -96.67 93.61 6.83 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.495 HD22 HD12 ' A' ' 102' ' ' ILE . 4.1 tt -78.67 78.92 5.11 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -80.51 -165.44 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.467 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.17 -50.35 11.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.675 -179.316 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -47.59 -16.5 0.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.941 0.4 . . . . 0.0 111.209 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 96' ' ' ASP . 19.3 m-20 -127.27 -13.73 5.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.467 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.565 HG23 ' HB2' ' A' ' 79' ' ' ASN . 25.2 mm -91.36 -40.73 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -50.35 -37.36 36.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.349 . . . . 0.0 111.076 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.2 p -127.11 38.58 4.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.48 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.5 tp -67.11 143.76 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.616 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.543 ' HA ' HD12 ' A' ' 49' ' ' ILE . 13.3 m-20 -137.93 148.39 45.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.32 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.614 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.8 -36.48 7.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.026 0.441 . . . . 0.0 110.445 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.3 m -62.57 -49.4 75.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.413 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -58.2 -59.07 5.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.365 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.602 HD11 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.64 -55.67 15.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.015 0.436 . . . . 0.0 110.146 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 65.5 m -58.42 -28.76 65.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.763 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.524 ' HD3' HD12 ' A' ' 113' ' ' ILE . 3.9 tmt_? -72.12 -67.21 0.56 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.094 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -42.85 -40.23 2.82 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.34 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.466 HG12 HG21 ' A' ' 35' ' ' VAL . 96.6 mt -66.45 -54.97 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -53.96 -18.84 3.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.324 0.583 . . . . 0.0 110.285 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.524 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.5 mp -90.1 -38.6 11.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.899 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.476 ' OD1' HG22 ' A' ' 113' ' ' ILE . 28.2 m120 -118.36 28.13 8.53 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -82.39 47.63 1.18 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 110.08 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.504 HD13 HH12 ' A' ' 85' ' ' ARG . 52.1 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.252 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.9 pt-20 . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 120.543 0.211 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 47.4 Cg_endo -68.66 150.59 74.65 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.855 2.37 . . . . 0.0 112.592 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.409 HG21 ' N ' ' A' ' 17' ' ' TRP . 8.4 m -73.18 154.23 40.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.38 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.409 ' N ' HG21 ' A' ' 16' ' ' THR . 7.0 m-90 -97.53 91.16 5.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.166 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.564 HD22 ' HA ' ' A' ' 24' ' ' ALA . 30.7 mt -85.02 73.14 10.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.237 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.9 p -68.85 -6.72 28.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.421 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -138.25 147.4 43.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.931 0.396 . . . . 0.0 111.937 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.594 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 33.2 t -54.0 -49.68 88.39 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.685 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.7 Cg_endo -58.05 -46.15 27.48 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.962 1.775 . . . . 0.0 112.131 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.55 -35.33 80.13 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.115 0.483 . . . . 0.0 110.409 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.564 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.17 -59.64 4.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.006 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.9 mtm -61.51 -24.91 66.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.025 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 17.8 mt-10 -71.68 -50.33 31.47 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.749 0.309 . . . . 0.0 110.169 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -60.04 -33.24 71.76 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.444 HD11 HD13 ' A' ' 36' ' ' ILE . 50.0 mt -72.49 -38.98 61.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.038 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.22 -18.33 60.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.239 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.75 27.18 3.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.288 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.6 t -170.8 150.77 3.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.426 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.472 ' HG3' HG12 ' A' ' 87' ' ' VAL . 22.0 tt0 -62.67 -63.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.953 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.46 HG13 HD11 ' A' ' 83' ' ' LEU . 21.8 t -108.18 138.32 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.591 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.517 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.37 125.75 18.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.993 0.425 . . . . 0.0 111.991 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.484 HG23 HG12 ' A' ' 111' ' ' ILE . 51.4 t -114.38 129.79 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.444 HD13 HD11 ' A' ' 28' ' ' ILE . 39.3 mt -135.45 138.12 48.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.524 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.07 96.84 1.5 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.478 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.455 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 37.1 m-85 -83.04 90.45 7.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.607 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 13.6 m-85 -108.51 142.04 39.52 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -87.93 -5.97 58.28 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.461 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.8 t70 -154.49 123.48 6.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.747 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.544 ' HG ' HG23 ' A' ' 66' ' ' THR . 92.3 mt -91.22 46.33 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.13 0.49 . . . . 0.0 111.293 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 32.5 mt-10 -137.57 11.4 2.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.972 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.673 HG13 HG22 ' A' ' 47' ' ' VAL . 1.6 pt -95.61 156.42 37.46 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.158 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 82.0 Cg_exo -50.18 -28.47 19.97 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.848 2.365 . . . . 0.0 113.145 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.458 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.03 -37.05 85.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.673 HG22 HG13 ' A' ' 44' ' ' ILE . 2.6 t -62.39 -56.31 31.69 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.66 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.7 Cg_exo -60.04 -37.25 85.92 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 121.923 1.749 . . . . 0.0 111.49 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.631 HG23 HD13 ' A' ' 107' ' ' LEU . 6.7 mt -65.65 -35.9 76.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.112 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.535 ' O ' ' HG3' ' A' ' 53' ' ' MET . 45.9 tp -73.23 -50.46 22.28 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -54.95 -26.12 34.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.124 0.487 . . . . 0.0 109.78 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.3 t -81.13 -46.97 14.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.625 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.535 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.28 -26.53 65.03 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 50' ' ' LEU . 47.0 t -52.19 -48.15 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.225 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -77.06 -11.89 59.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 28.8 mtpp -92.17 -18.47 23.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.176 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.576 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 56.5 m-85 -136.13 62.45 45.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.439 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.43 -43.09 56.94 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.701 2.267 . . . . 0.0 111.842 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.79 -39.44 91.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.57 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.8 t -67.35 145.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 23.9 t -83.04 97.7 8.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.104 0.478 . . . . 0.0 110.826 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.51 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 5.0 p90 -64.73 125.17 23.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.965 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.56 162.42 27.67 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.146 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -163.08 142.77 2.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.455 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 42.5 t -149.56 156.3 41.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.12 0.486 . . . . 0.0 111.711 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.544 HG23 ' HG ' ' A' ' 42' ' ' LEU . 75.8 p -136.55 -1.54 2.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.459 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -68.08 139.97 56.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.72 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.7 p -62.34 -48.95 77.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.461 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -49.44 -47.38 48.22 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.574 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HA ' HG23 ' A' ' 21' ' ' VAL . 71.5 t -69.01 -53.96 22.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.985 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.86 -14.88 6.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.134 0.492 . . . . 0.0 110.225 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.5 m -90.49 -41.6 11.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.32 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -60.77 -37.87 83.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.475 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -92.88 10.11 32.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.815 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 56.76 25.97 10.86 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.51 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.629 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.3 mm -61.31 123.88 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.353 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.1 p -143.08 60.01 1.41 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.174 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.15 44.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.733 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.607 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 24.0 m-80 51.87 43.99 29.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.23 0.538 . . . . 0.0 110.506 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.629 ' HB ' HG23 ' A' ' 76' ' ' ILE . 90.1 m -69.32 150.94 46.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.744 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.524 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.2 mt -117.23 115.81 49.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.202 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.428 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 71.0 m -104.04 133.16 49.45 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.589 ' HG ' HD21 ' A' ' 92' ' ' LEU . 3.0 tp -108.87 101.3 10.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.028 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.9 t80 -95.32 121.26 36.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.555 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.438 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 4.3 mtm180 -104.56 84.12 2.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.752 0.311 . . . . 0.0 110.897 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tp -26.26 -59.02 0.08 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.472 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.39 -72.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 O-C-N 123.428 0.455 . . . . 0.0 112.009 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.85 3.6 40.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.152 0.501 . . . . 0.0 110.655 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.5 t30 52.72 31.94 11.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.344 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.438 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 16.7 mm-40 -75.11 158.78 32.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.582 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.9 OUTLIER -140.48 90.77 2.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.589 HD21 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -77.52 142.92 38.81 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -124.39 108.86 12.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.167 0.508 . . . . 0.0 112.343 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.484 HD22 HD12 ' A' ' 102' ' ' ILE . 3.9 tt -96.54 77.86 2.95 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.406 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.6 mt-10 -79.0 -165.21 0.71 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.504 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.3 t70 -51.17 -36.6 41.93 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.02 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.15 -14.77 2.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.061 0.458 . . . . 0.0 110.437 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -130.88 -14.17 3.55 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.639 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.521 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 24.0 mm -89.07 -29.49 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.705 0.288 . . . . 0.0 111.271 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -55.7 -47.94 75.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.659 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.9 t -118.81 36.06 4.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.514 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.521 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.9 tp -62.2 142.76 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.513 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.529 ' HA ' HD11 ' A' ' 49' ' ' ILE . 24.0 m-20 -137.87 149.07 45.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.57 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.622 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -47.1 -37.24 9.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.013 0.435 . . . . 0.0 110.441 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -62.87 -48.45 78.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.256 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.09 -57.85 11.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.29 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.631 HD13 HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.96 -56.22 13.45 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.052 0.453 . . . . 0.0 110.275 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.8 m -58.15 -29.47 65.6 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.887 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.434 ' HD3' HD12 ' A' ' 113' ' ' ILE . 4.3 tmt_? -71.58 -64.68 0.88 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.331 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -43.03 -45.8 5.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.932 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.484 HG12 HG23 ' A' ' 35' ' ' VAL . 96.4 mt -61.2 -55.75 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.506 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -54.34 -18.07 3.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.39 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.434 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.25 -37.23 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.04 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.547 HD21 ' HG ' ' A' ' 92' ' ' LEU . 90.5 m-20 -124.81 30.35 5.95 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.5 p -83.13 48.98 1.45 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.049 0.452 . . . . 0.0 110.139 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 61.2 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.357 -179.26 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.2 pt-20 . . . . . 0 CA--C 1.531 0.232 0 CA-C-O 120.511 0.196 . . . . 0.0 110.775 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 36.7 Cg_endo -67.22 143.8 66.13 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.512 2.142 . . . . 0.0 112.578 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.407 HG21 ' N ' ' A' ' 17' ' ' TRP . 18.2 m -61.09 154.43 22.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.457 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.407 ' N ' HG21 ' A' ' 16' ' ' THR . 75.1 m95 -100.56 88.51 3.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.886 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.566 HD21 ' HA ' ' A' ' 24' ' ' ALA . 59.8 mt -83.19 71.99 10.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.414 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.5 p -70.56 -1.51 11.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.377 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -143.27 147.03 34.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.986 0.422 . . . . 0.0 111.829 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.596 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.0 t -54.75 -49.17 93.04 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.561 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.57 -47.46 18.92 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.835 1.69 . . . . 0.0 111.84 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.29 -32.57 73.31 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.182 0.515 . . . . 0.0 110.174 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.566 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -64.85 -61.38 2.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.027 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.4 mmt -59.73 -25.04 64.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.302 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.8 mt-10 -73.1 -52.19 15.2 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.669 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -58.74 -32.55 69.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.433 HD11 HD12 ' A' ' 36' ' ' ILE . 50.8 mt -74.76 -41.13 47.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.287 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.66 -15.27 62.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.14 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.85 26.81 4.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.132 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.417 HG23 ' HB2' ' A' ' 61' ' ' SER . 7.6 t -172.11 154.77 3.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.644 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.434 ' HG3' HG12 ' A' ' 87' ' ' VAL . 10.9 tt0 -64.13 -76.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.842 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.457 HG11 HD13 ' A' ' 83' ' ' LEU . 16.9 t -96.6 136.1 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.59 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.527 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.68 125.67 19.77 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.511 HG23 HG12 ' A' ' 111' ' ' ILE . 52.6 t -115.32 131.67 66.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.755 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.433 HD12 HD11 ' A' ' 28' ' ' ILE . 20.6 mt -137.04 139.97 43.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.385 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.553 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.96 97.99 1.67 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.592 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.473 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 44.5 m-85 -84.6 93.12 8.31 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.1 m-85 -113.15 141.22 47.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.477 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 95.2 mt-30 -86.53 -8.84 57.21 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.481 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.0 t70 -149.82 123.17 9.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.813 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.512 ' HG ' HG23 ' A' ' 66' ' ' THR . 93.5 mt -91.89 46.36 1.27 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.062 0.458 . . . . 0.0 111.326 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -135.18 9.62 3.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.848 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.678 HG13 HG21 ' A' ' 47' ' ' VAL . 3.0 pt -91.98 158.01 40.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.343 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.431 ' O ' HD12 ' A' ' 49' ' ' ILE . 76.5 Cg_exo -53.24 -24.91 28.23 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.961 2.441 . . . . 0.0 113.015 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.1 -37.22 85.22 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.678 HG21 HG13 ' A' ' 44' ' ' ILE . 2.9 t -61.02 -55.2 46.86 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.616 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.655 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.2 Cg_exo -60.88 -42.41 37.92 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.035 1.824 . . . . 0.0 111.565 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.623 HG22 HD11 ' A' ' 107' ' ' LEU . 6.6 mt -61.15 -35.28 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.251 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.525 ' O ' ' HG3' ' A' ' 53' ' ' MET . 51.9 tp -74.15 -51.63 14.98 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -54.09 -26.75 28.68 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.9 m -80.84 -46.62 15.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.565 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.75 -25.28 64.74 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.195 0.521 . . . . 0.0 109.7 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 50' ' ' LEU . 49.5 t -53.12 -46.52 55.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.937 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -79.16 -9.16 59.49 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.808 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -94.61 -19.08 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.225 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.563 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 52.4 m-85 -136.95 63.02 43.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.419 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.68 -44.55 46.85 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.744 2.296 . . . . 0.0 111.71 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.33 -40.67 77.19 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.523 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.7 t -66.93 143.12 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 22.1 t -80.92 96.31 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.403 . . . . 0.0 111.054 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.473 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.7 p90 -65.58 125.46 25.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.912 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -144.71 163.82 27.88 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.01 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 tt -161.81 144.11 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.44 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.9 t -150.1 157.38 43.06 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.041 0.448 . . . . 0.0 111.498 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.512 HG23 ' HG ' ' A' ' 42' ' ' LEU . 75.2 p -138.1 -2.99 1.81 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.644 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -64.06 142.2 58.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.631 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.2 t -65.29 -51.17 62.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.447 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -50.26 -41.97 51.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.5 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.483 ' HA ' HG22 ' A' ' 21' ' ' VAL . 65.4 t -71.91 -53.99 18.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 0.0 110.763 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp -59.07 -14.54 10.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.169 0.509 . . . . 0.0 110.21 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.9 m -92.49 -39.22 11.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.302 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -62.31 -40.95 98.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.445 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.403 ' HB2' HG12 ' A' ' 76' ' ' ILE . 90.5 m-85 -89.17 11.9 17.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.591 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 57.4 24.23 9.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.567 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.645 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.9 mm -61.0 119.9 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.9 p -138.23 52.66 1.83 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.421 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.95 48.15 0.01 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.799 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 12.6 m120 49.71 43.69 24.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.119 0.485 . . . . 0.0 110.477 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.645 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.5 m -69.55 153.3 43.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.838 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.553 HG12 ' HA2' ' A' ' 37' ' ' GLY . 56.0 mt -118.83 119.41 60.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.84 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.473 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 75.5 m -108.2 135.4 49.59 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.557 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.4 tp -112.85 105.65 13.8 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.196 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.9 t80 -98.33 122.06 41.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.315 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.456 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.4 mtm180 -104.29 81.12 1.78 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.757 0.313 . . . . 0.0 110.894 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 85' ' ' ARG . 9.4 tp -25.18 -56.72 0.06 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.809 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.58 -68.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.991 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -91.16 13.63 16.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.057 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.6 p30 43.99 30.88 0.45 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.161 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.456 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 7.6 mm-40 -78.02 160.8 27.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.323 . . . . 0.0 110.674 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.81 95.14 2.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.974 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.557 HD21 ' HG ' ' A' ' 83' ' ' LEU . 1.8 mm? -83.02 143.2 30.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -123.82 93.68 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.529 HD22 HD13 ' A' ' 102' ' ' ILE . 4.9 tt -76.91 77.86 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.5 mt-10 -78.55 -165.7 0.75 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.521 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 19.0 t70 -51.2 -35.44 36.47 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.695 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.29 -17.4 4.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.237 0.541 . . . . 0.0 110.24 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -128.73 -13.87 4.65 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.668 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.543 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.4 mm -88.69 -32.08 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 120.593 0.235 . . . . 0.0 111.591 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.6 -36.23 64.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.103 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.6 m -132.41 38.56 3.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.465 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.529 HD13 HD22 ' A' ' 94' ' ' LEU . 7.0 tp -63.05 142.48 16.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.687 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.546 ' HA ' HD13 ' A' ' 49' ' ' ILE . 18.4 m-20 -136.12 149.03 48.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.349 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -47.36 -37.54 11.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.982 0.42 . . . . 0.0 110.641 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.4 m -61.74 -47.17 86.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.363 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -59.95 -60.46 3.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.27 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.623 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.72 -56.04 9.72 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.03 0.443 . . . . 0.0 110.303 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.7 m -58.28 -30.97 67.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.914 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.478 ' HD3' HD12 ' A' ' 113' ' ' ILE . 3.7 tmt_? -69.95 -65.8 0.68 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.235 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -42.87 -45.02 4.77 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.164 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.511 HG12 HG23 ' A' ' 35' ' ' VAL . 96.5 mt -61.55 -55.03 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -54.79 -18.62 4.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.395 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.478 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.88 -36.47 8.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.875 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -124.88 30.43 5.91 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.4 p -83.21 42.05 0.79 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.972 0.415 . . . . 0.0 110.286 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.452 HD13 ' NH1' ' A' ' 85' ' ' ARG . 81.5 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.382 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.0 pt-20 . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.546 0.212 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.461 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 35.0 Cg_endo -66.09 143.53 72.16 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.7 2.267 . . . . 0.0 112.504 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.0 m -58.38 149.49 24.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.65 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -97.34 85.76 3.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.627 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.573 HD23 ' HA ' ' A' ' 24' ' ' ALA . 39.0 mt -82.14 73.22 9.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.546 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.5 p -71.77 -2.06 16.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.339 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -141.5 147.35 37.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 111.696 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.588 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 58.6 t -55.37 -49.92 89.73 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.602 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.7 Cg_endo -57.85 -45.26 33.89 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.849 1.699 . . . . 0.0 112.066 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.54 78.4 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.132 0.491 . . . . 0.0 110.416 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.573 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -64.6 -59.24 4.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.98 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 60.4 mtp -60.99 -26.54 67.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.04 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 18.7 mt-10 -71.25 -49.27 44.91 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.657 0.265 . . . . 0.0 110.333 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.34 -34.27 73.59 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 36' ' ' ILE . 51.4 mt -72.96 -38.31 55.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.292 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.17 -17.9 60.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.09 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.86 27.27 4.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.287 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.3 t -169.49 152.37 4.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.453 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.523 ' HG3' HG11 ' A' ' 87' ' ' VAL . 21.5 tt0 -64.65 -64.97 0.74 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.912 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.495 HG11 HD11 ' A' ' 83' ' ' LEU . 21.8 t -108.33 137.4 40.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.491 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.87 126.99 21.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.945 0.403 . . . . 0.0 112.031 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.5 HG21 HG12 ' A' ' 111' ' ' ILE . 42.9 t -115.47 127.58 73.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.593 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 28' ' ' ILE . 32.2 mt -134.15 138.78 49.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.572 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.53 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.49 98.42 1.69 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.562 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.439 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.0 m-85 -84.98 92.77 8.41 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.4 m-85 -111.56 147.48 35.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.541 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.525 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 23.9 mt-30 -94.51 -9.89 33.94 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.509 ' O ' HG12 ' A' ' 44' ' ' ILE . 37.5 t70 -147.17 117.41 7.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.397 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.508 ' HG ' HG21 ' A' ' 66' ' ' THR . 95.3 mt -87.35 45.26 1.25 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.127 0.489 . . . . 0.0 111.506 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.1 mt-10 -136.13 10.88 3.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.114 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.67 HG13 HG23 ' A' ' 47' ' ' VAL . 1.5 pt -94.29 155.04 40.27 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.132 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.456 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 88.2 Cg_exo -48.88 -28.51 13.32 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.936 2.424 . . . . 0.0 113.091 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.411 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -62.9 -37.9 88.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.67 HG23 HG13 ' A' ' 44' ' ' ILE . 2.9 t -61.38 -56.35 34.52 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.604 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.2 Cg_exo -60.86 -41.87 42.14 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.822 1.682 . . . . 0.0 111.416 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.613 HG21 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -60.4 -34.94 59.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.038 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.538 ' O ' ' HG3' ' A' ' 53' ' ' MET . 48.8 tp -73.92 -52.39 13.06 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -52.79 -27.1 16.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.065 0.46 . . . . 0.0 109.772 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.6 m -80.12 -46.84 15.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.722 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.538 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.11 -26.04 64.34 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.194 0.521 . . . . 0.0 109.639 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.524 HG21 ' O ' ' A' ' 50' ' ' LEU . 53.2 t -52.83 -51.12 39.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.89 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -75.24 -10.42 59.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.75 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -93.51 -18.25 22.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.253 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.589 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 55.3 m-85 -136.81 62.53 41.5 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.488 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.65 -41.14 70.82 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.592 2.195 . . . . 0.0 111.627 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.72 -39.44 93.59 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.321 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -69.12 144.25 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.519 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 41.3 t -81.96 98.29 8.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.985 0.421 . . . . 0.0 111.013 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.461 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 6.2 p90 -63.53 128.92 37.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.854 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.446 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.15 161.36 28.46 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.261 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.9 tt -162.6 145.12 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.439 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.0 t -152.46 157.72 41.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.195 0.522 . . . . 0.0 111.787 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.508 HG21 ' HG ' ' A' ' 42' ' ' LEU . 67.5 p -138.03 -3.39 1.8 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.626 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.4 139.73 58.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.415 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.4 m -63.69 -49.09 74.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.54 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -50.57 -41.14 53.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.489 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.531 ' HA ' HG22 ' A' ' 21' ' ' VAL . 56.6 t -73.49 -54.98 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 110.685 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp -57.66 -14.52 5.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.367 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 83.2 m -92.44 -42.33 9.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.286 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -60.53 -34.76 74.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.59 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.403 ' HB2' HG12 ' A' ' 76' ' ' ILE . 96.7 m-85 -95.88 10.17 38.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.693 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.0 m120 56.63 27.43 12.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.755 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.624 HG21 ' HB ' ' A' ' 80' ' ' THR . 40.6 mm -63.87 122.23 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.867 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.5 p -141.72 54.77 1.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.911 0.386 . . . . 0.0 111.322 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.49 44.03 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.753 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 12.4 m120 51.79 41.97 29.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.338 0.589 . . . . 0.0 110.251 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.624 ' HB ' HG21 ' A' ' 76' ' ' ILE . 92.8 m -67.64 151.55 47.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.703 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.53 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.3 mt -118.28 116.22 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.869 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 73.0 m -104.14 129.94 51.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.576 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.2 tp -107.01 100.34 9.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.507 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.6 t80 -94.67 122.81 37.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.529 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.7 mtm180 -107.13 92.78 4.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.363 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 tp -37.81 -53.52 1.28 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.009 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.523 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.59 -58.22 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -102.84 9.64 38.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.002 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 85' ' ' ARG . 16.0 t-20 47.2 34.44 3.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.423 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.529 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 15.8 mm-40 -77.48 159.46 29.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -141.87 91.21 2.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.914 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.576 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.5 mm? -81.97 115.27 21.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.847 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -99.81 98.63 9.41 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.468 HD21 HD12 ' A' ' 102' ' ' ILE . 4.3 tt -83.77 77.63 9.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.434 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.3 mt-10 -77.87 -165.64 0.67 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.524 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 20.6 t70 -51.21 -37.89 49.28 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.117 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -55.55 -15.18 2.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.059 0.457 . . . . 0.0 110.437 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -128.38 -14.2 4.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.394 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 23.7 mm -90.18 -29.26 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.889 0.376 . . . . 0.0 111.321 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -56.13 -38.05 70.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 85.4 p -129.98 36.07 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.582 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.2 tp -62.05 141.98 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.597 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.51 ' HA ' HD12 ' A' ' 49' ' ' ILE . 22.7 m-20 -136.89 150.34 48.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.533 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.613 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -47.74 -37.72 13.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.903 0.382 . . . . 0.0 110.584 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -62.73 -47.94 81.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.303 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -58.8 -60.27 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.199 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.612 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.13 -56.58 8.72 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.965 0.412 . . . . 0.0 110.191 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.7 m -58.07 -28.87 64.95 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.947 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HD3' HD12 ' A' ' 113' ' ' ILE . 4.2 tmt_? -72.42 -67.0 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.077 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -42.37 -41.36 2.83 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.103 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.5 HG12 HG21 ' A' ' 35' ' ' VAL . 96.6 mt -65.49 -55.68 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -53.27 -18.68 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.187 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.586 HG23 ' ND2' ' A' ' 114' ' ' ASN . 1.5 mp -89.99 -39.38 12.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.918 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.586 ' ND2' HG23 ' A' ' 113' ' ' ILE . 49.4 m-80 -116.39 26.77 9.66 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 78.7 p -81.56 52.59 1.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.174 0.511 . . . . 0.0 110.216 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.422 HD13 ' NH1' ' A' ' 85' ' ' ARG . 70.8 mt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.032 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 . . . . . 0 CA--C 1.532 0.251 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 53.6 Cg_endo -69.46 136.34 33.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.365 2.044 . . . . 0.0 112.685 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.9 m -60.7 152.43 26.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.676 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -94.01 98.54 11.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.94 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 24' ' ' ALA . 49.1 mt -93.05 70.71 4.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.265 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.9 p -70.54 -2.15 13.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.165 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -139.7 146.87 40.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.021 0.439 . . . . 0.0 111.64 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 43.4 t -56.82 -50.08 90.1 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.396 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.41 -43.89 42.46 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.945 1.763 . . . . 0.0 111.878 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.28 -36.99 85.91 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.223 0.535 . . . . 0.0 110.305 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.555 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -62.84 -57.07 12.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.04 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 62.1 mtp -62.59 -26.74 68.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.117 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.4 mt-10 -70.32 -50.76 35.91 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.726 0.298 . . . . 0.0 110.464 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -61.46 -32.54 72.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.464 HD13 HD13 ' A' ' 36' ' ' ILE . 47.7 mt -72.9 -36.86 52.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.836 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.7 -20.33 59.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.022 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.94 28.33 1.86 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.162 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' 61' ' ' SER . 9.8 t -172.3 154.63 3.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.475 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.486 ' HG3' HG13 ' A' ' 87' ' ' VAL . 30.1 tt0 -68.0 -59.9 2.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.012 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.448 HG13 HD11 ' A' ' 83' ' ' LEU . 20.6 t -110.26 138.26 38.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.495 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.78 127.16 17.73 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.475 HG23 HG12 ' A' ' 111' ' ' ILE . 48.6 t -116.05 130.3 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.586 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.464 HD13 HD13 ' A' ' 28' ' ' ILE . 25.4 mt -135.94 137.59 48.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.456 -177.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.555 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.94 99.43 2.05 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.443 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.521 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 10.8 m-85 -85.67 93.99 8.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.4 m-85 -115.09 141.48 47.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.43 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 48.5 mt-30 -88.95 -2.24 58.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.449 ' O ' HG12 ' A' ' 44' ' ' ILE . 25.1 t70 -155.81 123.06 5.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.636 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.508 ' HG ' HG21 ' A' ' 66' ' ' THR . 92.6 mt -92.62 46.15 1.23 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.136 0.493 . . . . 0.0 111.475 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.416 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 38.3 mt-10 -135.19 8.06 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.921 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.664 HG13 HG22 ' A' ' 47' ' ' VAL . 3.0 pt -90.82 155.51 45.32 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.186 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.447 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 77.2 Cg_exo -50.75 -27.12 19.17 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.87 2.38 . . . . 0.0 112.942 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.6 -37.86 88.94 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.664 HG22 HG13 ' A' ' 44' ' ' ILE . 2.2 t -61.88 -56.0 36.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.773 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.5 Cg_exo -60.47 -37.01 84.08 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 121.9 1.733 . . . . 0.0 111.435 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.627 HG21 HD12 ' A' ' 107' ' ' LEU . 6.1 mt -65.75 -35.43 75.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.941 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.516 ' O ' ' HG3' ' A' ' 53' ' ' MET . 43.4 tp -74.31 -51.85 13.98 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -55.86 -22.21 24.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.979 0.419 . . . . 0.0 109.922 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.6 t -85.59 -44.63 12.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.372 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.516 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.24 -26.03 67.47 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.226 0.536 . . . . 0.0 109.593 179.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 50' ' ' LEU . 44.9 t -51.61 -48.98 35.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.009 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -74.44 -14.84 60.9 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.566 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -90.35 -17.71 26.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.357 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.566 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 65.6 m-85 -137.14 61.82 35.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.699 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.47 -43.52 56.85 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.645 2.23 . . . . 0.0 111.611 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.58 -42.29 90.2 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.422 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.1 t -65.97 141.71 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 41.2 t -78.37 97.71 5.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.081 0.467 . . . . 0.0 110.816 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.43 ' CD2' HG11 ' A' ' 54' ' ' VAL . 2.5 p90 -67.9 124.64 23.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.914 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.43 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -143.51 164.13 27.41 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.041 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.7 tt -161.2 142.14 3.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 t -147.23 153.35 39.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.161 0.505 . . . . 0.0 111.794 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.508 HG21 ' HG ' ' A' ' 42' ' ' LEU . 77.8 p -135.05 2.73 3.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.432 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.84 140.67 49.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.705 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.0 t -64.03 -49.97 70.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.531 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -50.76 -44.46 58.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.602 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.522 ' HA ' HG21 ' A' ' 21' ' ' VAL . 54.5 t -70.24 -52.1 33.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.891 0.377 . . . . 0.0 110.598 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.52 -15.08 15.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.253 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.1 m -90.93 -41.23 11.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.32 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -61.63 -37.84 85.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.389 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -92.08 11.69 24.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.805 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 56.02 23.03 6.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.689 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.648 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.7 mm -57.94 117.28 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.83 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.1 p -136.51 56.4 1.81 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.387 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.28 46.32 0.02 OUTLIER Glycine 0 C--N 1.329 0.174 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.628 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.533 ' HB2' HG22 ' A' ' 99' ' ' ILE . 11.3 m120 51.43 43.62 29.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.162 0.506 . . . . 0.0 110.277 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.648 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.3 m -69.08 154.75 41.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.675 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.555 HG12 ' HA2' ' A' ' 37' ' ' GLY . 52.9 mt -120.65 117.55 53.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.817 178.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.521 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.2 m -106.7 135.9 47.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.59 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.6 tp -112.85 101.64 9.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.064 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.6 t80 -95.05 125.18 39.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.772 0.32 . . . . 0.0 110.334 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.494 HH12 HD13 ' A' ' 116' ' ' LEU . 5.3 mtm180 -107.75 83.65 1.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.825 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 85' ' ' ARG . 9.0 tp -24.67 -59.15 0.06 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.789 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.486 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.85 -77.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 O-C-N 123.5 0.5 . . . . 0.0 112.127 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.55 4.32 21.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.636 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.2 m120 53.8 31.43 13.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.522 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.489 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.1 mm-40 -74.46 161.49 29.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -145.94 86.91 1.73 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.862 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.59 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -74.25 144.84 44.47 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -128.25 98.28 5.03 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.507 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -84.64 78.28 9.88 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.0 mt-10 -79.02 -165.61 0.78 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.494 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.8 t70 -50.23 -38.62 41.43 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.03 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -55.06 -14.9 1.74 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.119 0.485 . . . . 0.0 110.492 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -130.1 -13.94 3.96 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.664 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.533 HG22 ' HB2' ' A' ' 79' ' ' ASN . 23.5 mm -88.49 -31.86 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.636 0.255 . . . . 0.0 111.614 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -56.43 -35.29 67.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.952 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.5 m -130.31 39.77 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.558 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.507 HD13 HD21 ' A' ' 94' ' ' LEU . 7.2 tp -68.25 142.08 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.754 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.557 ' HA ' HD13 ' A' ' 49' ' ' ILE . 10.0 m-20 -136.04 149.69 48.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.391 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.605 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.63 -35.87 10.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.127 0.489 . . . . 0.0 110.445 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.8 m -62.59 -48.61 78.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.42 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -59.4 -59.76 4.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.256 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.627 HD12 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.34 -55.48 12.72 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 110.301 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.5 m -58.92 -30.59 67.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.999 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.482 ' NH1' HD11 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -70.83 -66.25 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.138 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -43.15 -43.58 4.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.119 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.475 HG12 HG23 ' A' ' 35' ' ' VAL . 96.8 mt -63.8 -55.43 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -54.12 -17.59 2.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.129 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.482 HD11 ' NH1' ' A' ' 109' ' ' ARG . 1.3 mp -90.69 -37.22 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.01 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -122.63 29.96 6.67 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 98.7 p -83.26 40.55 0.72 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.091 0.472 . . . . 0.0 110.1 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.494 HD13 HH12 ' A' ' 85' ' ' ARG . 58.2 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.422 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.595 0.236 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.558 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 45.0 Cg_endo -69.7 148.15 64.8 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.773 2.315 . . . . 0.0 112.756 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 m -66.25 150.13 49.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.527 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -96.51 90.64 5.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.999 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 24' ' ' ALA . 37.1 mt -86.12 71.49 10.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.567 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.8 p -70.68 -1.96 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.081 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -141.57 147.07 37.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.919 0.39 . . . . 0.0 111.7 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 59.3 t -55.79 -49.85 90.52 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.491 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.4 Cg_endo -57.55 -44.91 37.65 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.89 1.727 . . . . 0.0 111.937 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.84 -34.46 78.43 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.226 0.536 . . . . 0.0 110.353 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -64.46 -59.41 4.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.174 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.1 mtm -61.48 -26.96 68.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.049 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -70.77 -49.26 48.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.638 0.256 . . . . 0.0 110.51 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -61.48 -32.88 72.91 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.401 HD13 HD11 ' A' ' 36' ' ' ILE . 42.8 mt -72.08 -37.99 61.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.828 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.76 -23.62 61.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.837 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.93 32.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.138 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -173.47 151.31 1.94 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.346 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.487 ' HG3' HG13 ' A' ' 87' ' ' VAL . 30.0 tt0 -68.31 -53.45 24.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.749 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.447 HG13 HD12 ' A' ' 83' ' ' LEU . 21.5 t -116.58 139.83 41.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.413 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.15 126.78 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.549 HG23 HG12 ' A' ' 111' ' ' ILE . 43.7 t -115.61 125.99 73.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.404 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 28.2 mt -131.39 136.26 57.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -177.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.555 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.08 98.33 1.88 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.267 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.5 m-85 -84.12 93.27 8.1 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -113.62 142.88 45.45 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -90.47 -9.25 48.08 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.496 ' O ' HG12 ' A' ' 44' ' ' ILE . 30.2 t70 -147.72 119.28 7.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.55 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.495 ' HA ' HG23 ' A' ' 47' ' ' VAL . 94.3 mt -88.9 45.49 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.096 0.474 . . . . 0.0 111.413 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.433 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.9 mt-10 -135.65 7.94 3.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.107 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.667 HG13 HG21 ' A' ' 47' ' ' VAL . 3.5 pt -89.87 157.03 46.69 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.158 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.434 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 74.0 Cg_exo -51.84 -25.98 22.86 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.792 2.328 . . . . 0.0 112.824 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.87 -39.04 92.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.667 HG21 HG13 ' A' ' 44' ' ' ILE . 2.1 t -60.38 -55.12 48.26 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.4 Cg_exo -60.56 -42.0 43.56 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.879 1.719 . . . . 0.0 111.371 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.638 HG21 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -60.62 -35.45 63.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.046 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.526 ' O ' ' HG3' ' A' ' 53' ' ' MET . 50.9 tp -73.81 -50.09 22.15 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -55.81 -25.27 40.71 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.8 m -81.56 -45.77 15.4 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.595 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.526 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.22 -25.82 67.32 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.114 0.483 . . . . 0.0 109.748 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 50' ' ' LEU . 42.8 t -52.16 -47.77 43.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.084 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -76.94 -14.29 59.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.668 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -90.8 -16.58 28.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.389 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.656 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 34.3 m-85 -136.99 61.42 34.52 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.606 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.39 -39.56 81.25 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.636 2.224 . . . . 0.0 111.592 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.98 -41.16 99.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.519 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.656 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.9 t -67.12 145.23 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.531 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 46.6 t -82.31 96.56 7.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.984 0.421 . . . . 0.0 110.999 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.558 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 4.7 p90 -62.1 128.24 35.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.612 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.2 161.46 28.32 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.826 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.5 tt -164.02 140.73 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.2 t -144.45 159.33 42.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.227 0.537 . . . . 0.0 111.959 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.467 HG23 ' HG ' ' A' ' 42' ' ' LEU . 76.2 p -141.18 -0.0 1.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.314 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -71.28 144.4 50.01 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.602 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.8 p -65.66 -50.96 63.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.392 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -49.96 -41.8 47.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.616 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.537 ' HA ' HG22 ' A' ' 21' ' ' VAL . 70.9 t -72.45 -54.08 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.841 0.353 . . . . 0.0 110.712 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.0 -14.74 10.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.35 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.6 m -91.67 -42.0 10.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.258 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -60.52 -38.97 86.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.356 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -91.15 9.61 30.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.763 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.8 m120 57.24 24.68 10.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.592 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.633 HG21 ' HB ' ' A' ' 80' ' ' THR . 42.0 mm -59.27 125.24 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.9 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.0 p -143.86 60.31 1.37 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.529 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.87 45.51 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.542 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.527 ' HB2' HG22 ' A' ' 99' ' ' ILE . 29.6 m-80 51.63 41.87 29.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.236 0.541 . . . . 0.0 110.385 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.633 ' HB ' HG21 ' A' ' 76' ' ' ILE . 95.2 m -67.65 152.22 45.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.747 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.555 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.1 mt -119.56 116.83 51.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.835 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.503 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 71.2 m -106.31 136.58 45.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.585 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.6 tp -109.73 100.91 9.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.196 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -92.99 119.88 32.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.434 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.473 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.5 mtm180 -104.25 85.21 2.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.973 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 tp -26.97 -61.28 0.09 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.487 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.1 -76.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 O-C-N 123.525 0.516 . . . . 0.0 112.056 -179.42 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.48 3.12 25.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.098 0.475 . . . . 0.0 110.533 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.405 ' ND2' ' O ' ' A' ' 89' ' ' ASN . 12.3 t30 52.65 31.84 10.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.299 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.473 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 19.6 mm-40 -75.28 165.96 24.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.533 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -149.68 87.55 1.5 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.585 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -72.04 147.22 47.04 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.85 105.72 8.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.292 0.568 . . . . 0.0 112.302 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.495 HD23 HD11 ' A' ' 102' ' ' ILE . 3.9 tt -94.05 76.45 4.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -77.61 -165.88 0.68 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.456 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.63 -51.9 11.51 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.524 -179.368 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -47.28 -17.56 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.868 0.366 . . . . 0.0 111.301 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -124.39 -13.92 7.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.423 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.527 HG22 ' HB2' ' A' ' 79' ' ' ASN . 22.8 mm -91.48 -40.25 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -51.71 -30.38 22.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.821 0.343 . . . . 0.0 111.29 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m -134.67 39.98 2.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.079 0.466 . . . . 0.0 110.395 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.495 HD11 HD23 ' A' ' 94' ' ' LEU . 6.9 tp -68.48 143.93 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.712 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.545 ' HA ' HD11 ' A' ' 49' ' ' ILE . 23.7 m-20 -136.32 147.89 47.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.437 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.638 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -46.69 -38.69 10.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.017 0.437 . . . . 0.0 110.542 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.8 m -59.51 -49.32 78.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.323 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.411 ' HD3' ' H ' ' A' ' 103' ' ' ASP . 51.1 mtpt -57.87 -62.6 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.274 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.623 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -46.64 -57.53 4.71 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.945 0.403 . . . . 0.0 110.446 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.9 m -57.74 -29.88 65.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.931 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.477 ' HD3' HD11 ' A' ' 113' ' ' ILE . 3.0 tmt_? -71.4 -65.85 0.7 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.237 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -42.64 -43.61 3.9 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.993 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.549 HG12 HG23 ' A' ' 35' ' ' VAL . 96.5 mt -63.25 -55.98 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.617 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -54.15 -18.36 3.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.362 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.477 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.91 -37.47 10.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.84 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -125.45 31.21 5.6 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 98.2 p -83.9 44.51 1.0 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.122 0.487 . . . . 0.0 110.074 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.435 HD11 HH12 ' A' ' 85' ' ' ARG . 65.4 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.352 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.429 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.2 pt-20 . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.358 0.123 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 36.3 Cg_endo -67.13 140.55 54.34 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.444 2.096 . . . . 0.0 112.494 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.0 m -54.8 152.03 7.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.748 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -98.98 87.11 3.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.079 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' A' ' 24' ' ' ALA . 45.8 mt -84.85 72.57 10.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.344 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.0 p -71.67 0.19 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.445 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -144.67 148.29 34.07 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.752 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.588 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 45.2 t -55.3 -49.57 91.62 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.528 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.28 -46.53 24.38 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.922 1.748 . . . . 0.0 111.9 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.88 -33.06 74.84 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.11 0.481 . . . . 0.0 110.324 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.565 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -65.83 -59.03 4.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.939 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.6 mtm -61.0 -25.39 66.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.054 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.4 mt-10 -72.97 -52.01 16.18 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.684 0.278 . . . . 0.0 110.499 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -58.49 -33.78 70.19 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.464 HD11 HD11 ' A' ' 36' ' ' ILE . 57.9 mt -73.84 -40.76 53.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.261 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.98 -15.22 62.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.174 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.29 23.74 7.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.4 t -169.88 153.68 4.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.737 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.483 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.7 tt0 -63.35 -74.95 0.09 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.816 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.473 HG12 HD11 ' A' ' 83' ' ' LEU . 15.7 t -97.75 135.9 30.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.784 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.91 124.07 16.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.948 0.404 . . . . 0.0 111.904 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.508 HG23 HG12 ' A' ' 111' ' ' ILE . 45.8 t -112.44 130.38 66.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.785 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.464 HD11 HD11 ' A' ' 28' ' ' ILE . 29.1 mt -135.75 138.63 47.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.611 -177.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.517 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.03 98.13 1.77 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.543 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.465 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 35.9 m-85 -83.84 91.63 7.59 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.3 m-85 -111.75 141.08 45.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.3 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -86.08 -10.19 55.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.53 129.35 14.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.561 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.524 ' HG ' HG21 ' A' ' 66' ' ' THR . 90.1 mt -96.97 48.4 1.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.077 0.465 . . . . 0.0 111.475 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -137.9 7.29 2.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.771 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.673 HG13 HG22 ' A' ' 47' ' ' VAL . 3.7 pt -88.58 159.2 47.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.129 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.437 ' O ' HD11 ' A' ' 49' ' ' ILE . 54.4 Cg_exo -54.47 -24.91 37.86 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.864 2.376 . . . . 0.0 112.816 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.9 -39.01 90.22 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.673 HG22 HG13 ' A' ' 44' ' ' ILE . 2.3 t -59.34 -55.08 49.8 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.3 Cg_exo -60.37 -41.84 46.45 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.01 1.807 . . . . 0.0 111.505 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.639 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.5 mt -61.68 -34.42 62.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.103 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.531 ' O ' HG22 ' A' ' 54' ' ' VAL . 52.0 tp -75.09 -51.85 12.49 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -54.32 -24.92 21.15 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -82.08 -46.13 14.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.593 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -60.43 -25.52 66.03 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 50' ' ' LEU . 55.9 t -52.39 -48.18 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.081 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -78.11 -9.96 59.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.83 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -93.9 -19.15 21.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.304 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.592 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 51.3 m-85 -135.83 62.91 49.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.56 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.82 -43.9 48.48 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.829 2.352 . . . . 0.0 111.644 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.08 -40.71 91.86 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.497 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.3 t -67.57 142.51 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.513 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 32.2 t -81.44 97.68 7.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.055 0.455 . . . . 0.0 110.976 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.428 ' CD2' HG13 ' A' ' 54' ' ' VAL . 4.6 p90 -65.03 128.14 34.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.786 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.84 163.0 28.6 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.8 -0.715 . . . . 0.0 111.937 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 tt -161.68 144.26 3.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.465 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 40.7 t -148.52 156.33 42.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.131 0.491 . . . . 0.0 111.581 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.524 HG21 ' HG ' ' A' ' 42' ' ' LEU . 69.6 p -138.24 5.93 2.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.783 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -76.2 141.19 41.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.632 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.9 t -63.77 -50.35 69.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.396 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -49.68 -43.29 47.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.405 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.514 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.0 t -71.14 -54.16 18.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.841 0.353 . . . . 0.0 110.745 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mp -58.23 -14.82 7.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.118 0.485 . . . . 0.0 110.211 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.4 m -91.17 -40.55 11.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.161 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -61.75 -33.02 73.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.149 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -97.35 9.15 43.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.959 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 58.88 22.78 10.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.506 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.617 HG21 ' HB ' ' A' ' 80' ' ' THR . 41.0 mm -59.13 125.61 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.266 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.6 p -144.44 58.69 1.33 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.29 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.57 43.94 0.02 OUTLIER Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.664 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 32.5 m-20 52.37 44.75 29.55 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.285 0.564 . . . . 0.0 110.435 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.617 ' HB ' HG21 ' A' ' 76' ' ' ILE . 89.8 m -69.96 152.31 44.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.913 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.535 HG22 HD23 ' A' ' 107' ' ' LEU . 59.5 mt -117.72 116.99 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-N 115.496 -0.775 . . . . 0.0 108.979 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.432 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 75.7 m -106.22 133.65 50.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.582 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -110.34 105.41 14.42 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.077 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.2 t80 -97.22 122.12 39.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.697 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.49 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.3 mtm180 -105.04 81.94 1.79 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 110.552 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.7 tp -25.71 -58.73 0.07 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.026 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.483 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -44.26 -57.25 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.59 13.52 33.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.592 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 43.8 28.81 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.301 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.49 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 15.9 mm-40 -77.79 156.98 30.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.745 0.307 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -141.83 95.33 2.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.567 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.582 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -84.9 116.14 23.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.959 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.18 108.89 21.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.544 HD22 HD12 ' A' ' 102' ' ' ILE . 4.2 tt -95.01 77.62 3.55 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.4 mt-10 -78.72 -165.09 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 17.2 t70 -50.26 -39.9 46.4 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.249 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -53.91 -15.88 1.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.132 0.492 . . . . 0.0 110.229 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -128.96 -13.68 4.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.58 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.558 HG23 ' HB2' ' A' ' 79' ' ' ASN . 25.5 mm -91.01 -40.04 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -51.55 -33.82 33.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.935 0.398 . . . . 0.0 111.044 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.1 m -131.39 40.0 3.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.372 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.544 HD12 HD22 ' A' ' 94' ' ' LEU . 8.0 tp -68.89 144.91 13.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.658 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.532 ' HA ' HD12 ' A' ' 49' ' ' ILE . 9.8 m-20 -138.59 146.95 42.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.257 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.639 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.09 -36.17 5.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.967 0.413 . . . . 0.0 110.694 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 100.0 m -62.24 -48.18 81.1 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.489 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -59.32 -61.29 2.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.055 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.599 HD13 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.91 -55.88 8.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.974 0.416 . . . . 0.0 110.332 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.9 m -58.44 -30.61 67.04 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.922 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.524 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.7 tmt_? -71.06 -66.08 0.66 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.245 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -42.98 -41.9 3.56 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.243 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.508 HG12 HG23 ' A' ' 35' ' ' VAL . 97.0 mt -65.11 -55.14 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -53.94 -18.85 3.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.14 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.524 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.75 -37.95 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.827 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.472 ' OD1' HG23 ' A' ' 113' ' ' ILE . 31.6 m120 -119.86 28.6 8.02 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.8 p -82.81 48.0 1.28 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.075 0.464 . . . . 0.0 110.484 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.421 HD11 ' NH1' ' A' ' 85' ' ' ARG . 78.1 mt . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.246 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.478 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.48 0.181 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 49.9 Cg_endo -70.37 144.91 52.15 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.664 2.243 . . . . 0.0 112.762 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.3 m -63.46 150.7 43.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.631 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -96.26 97.86 9.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.015 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.568 HD21 ' HA ' ' A' ' 24' ' ' ALA . 54.9 mt -92.93 70.91 4.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.318 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.8 p -71.74 -2.25 16.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.136 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -139.32 146.7 40.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.058 0.456 . . . . 0.0 111.509 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.58 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 13.1 t -56.43 -50.42 87.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.471 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.74 -45.28 34.19 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.831 1.688 . . . . 0.0 111.856 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.31 79.87 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.198 0.523 . . . . 0.0 110.309 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.568 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -64.07 -59.26 4.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.988 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.1 mtm -60.63 -25.39 66.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.202 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 26.3 mt-10 -73.38 -51.39 17.51 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.728 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -60.04 -31.67 70.18 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.458 HD12 HD12 ' A' ' 36' ' ' ILE . 48.8 mt -75.21 -39.85 43.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.127 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.58 -18.14 61.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.266 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.33 24.97 5.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.31 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 t -168.44 152.75 6.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.677 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.459 ' HG3' HG12 ' A' ' 87' ' ' VAL . 16.5 tt0 -62.82 -77.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.895 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.488 HG12 HD13 ' A' ' 83' ' ' LEU . 19.5 t -95.73 135.27 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.397 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.582 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.76 125.77 21.23 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.465 HG22 HG12 ' A' ' 111' ' ' ILE . 49.3 t -115.41 129.73 71.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.789 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.458 HD12 HD12 ' A' ' 28' ' ' ILE . 23.0 mt -135.45 137.19 50.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.446 -177.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.77 96.91 1.63 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.294 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 19.5 m-85 -82.51 89.02 6.61 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -107.44 137.71 44.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.446 ' HG2' HD22 ' A' ' 71' ' ' LEU . 21.9 mt-30 -83.83 -5.0 59.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.427 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 27.0 t70 -155.41 127.71 7.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.529 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 66' ' ' THR . 92.5 mt -95.34 46.91 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 111.68 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.8 mt-10 -135.85 5.08 3.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.612 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.644 HG13 HG21 ' A' ' 47' ' ' VAL . 2.2 pt -88.84 157.39 48.95 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.296 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.454 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 74.6 Cg_exo -52.8 -27.96 36.53 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.914 2.409 . . . . 0.0 112.958 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.27 -37.21 84.6 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.644 HG21 HG13 ' A' ' 44' ' ' ILE . 2.2 t -62.21 -56.94 26.4 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.525 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.8 Cg_exo -58.64 -40.9 69.34 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.758 1.639 . . . . 0.0 111.448 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' A' ' 104' ' ' ALA . 7.8 mt -61.37 -37.16 77.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.524 ' O ' ' HG3' ' A' ' 53' ' ' MET . 37.9 tp -73.46 -53.82 9.74 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -53.1 -23.25 7.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.098 0.475 . . . . 0.0 110.081 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.2 m -83.92 -45.5 13.12 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.467 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.524 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -60.03 -25.2 65.13 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.8 t -52.33 -48.05 45.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.992 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -77.85 -11.17 59.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.797 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -93.08 -17.91 23.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.235 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.569 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 57.0 m-85 -137.57 62.53 36.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.558 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.63 -42.73 60.43 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.612 2.208 . . . . 0.0 111.708 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.76 -40.49 92.93 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.509 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.7 t -66.57 143.9 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.582 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 30.5 t -81.42 97.12 7.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 0.0 110.994 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.433 ' CD2' HG11 ' A' ' 54' ' ' VAL . 3.8 p90 -64.82 127.13 30.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.965 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.09 162.84 28.39 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.029 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -160.96 142.36 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.2 t -145.5 154.04 41.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.983 0.421 . . . . 0.0 111.691 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.51 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.4 p -137.52 -4.41 1.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.884 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.42 142.84 56.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.771 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.2 t -64.5 -50.58 66.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.511 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -49.02 -45.45 42.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.658 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.59 -52.4 29.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.917 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.446 HD22 ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -59.05 -14.85 10.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.122 0.487 . . . . 0.0 110.135 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.1 m -91.17 -41.38 11.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.394 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -60.97 -40.07 92.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.455 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -90.24 11.82 20.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.576 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.6 m120 55.98 24.17 7.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.494 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.614 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.9 mm -60.83 120.08 5.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.4 p -138.68 52.37 1.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.419 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.27 46.49 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.64 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 28.3 m-80 50.77 42.01 27.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.177 0.513 . . . . 0.0 110.29 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.614 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.3 m -68.07 150.38 48.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.68 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.546 HG12 ' HA2' ' A' ' 37' ' ' GLY . 69.4 mt -116.79 116.94 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.984 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.513 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.4 m -106.64 132.14 52.98 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.62 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -109.08 105.37 14.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.979 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.5 t80 -98.62 121.07 40.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.498 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.531 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.1 mtm180 -102.85 80.71 1.91 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.711 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 85' ' ' ARG . 6.1 tp -25.11 -58.46 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.459 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.35 -59.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.199 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -97.11 2.9 51.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.045 0.45 . . . . 0.0 110.82 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 52.77 32.58 12.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.817 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.531 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 13.0 mm-40 -77.93 156.99 29.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.663 0.268 . . . . 0.0 110.805 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.415 HE21 ' HB3' ' A' ' 91' ' ' GLN . 1.1 tm0? -140.18 96.23 3.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.601 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.62 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -88.13 114.47 24.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.804 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -97.65 99.69 11.07 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.525 HD22 HD12 ' A' ' 102' ' ' ILE . 4.4 tt -84.24 77.45 9.97 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -78.11 -165.61 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -176.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.444 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.72 -49.9 14.25 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.548 -179.515 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -48.5 -15.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.929 0.395 . . . . 0.0 111.291 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 96' ' ' ASP . 22.1 m-20 -127.33 -13.9 5.45 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.498 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.538 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 23.9 mm -90.67 -37.24 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -49.04 -49.31 41.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.334 . . . . 0.0 111.127 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.0 m -118.0 35.6 4.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.778 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.538 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 8.1 tp -60.78 145.17 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.46 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.529 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.0 m-20 -138.41 149.22 45.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.48 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.62 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -48.4 -36.22 14.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.035 0.445 . . . . 0.0 110.377 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.0 m -62.06 -49.62 75.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.286 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -58.18 -60.39 3.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.376 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.559 HD13 HG23 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -49.19 -55.99 10.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.964 0.411 . . . . 0.0 110.378 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.6 m -58.57 -28.87 65.94 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.726 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.556 ' HD3' HD12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -72.25 -66.64 0.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.188 179.761 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -43.56 -41.99 4.81 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.065 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.465 HG12 HG22 ' A' ' 35' ' ' VAL . 96.5 mt -64.72 -55.94 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.42 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 43.1 tt0 -52.95 -19.13 2.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.294 0.569 . . . . 0.0 110.265 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.556 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -90.11 -38.56 11.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.062 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.455 ' OD1' HG23 ' A' ' 113' ' ' ILE . 28.9 m120 -117.72 27.12 9.23 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.2 p -81.32 50.12 1.39 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.083 0.468 . . . . 0.0 110.152 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.496 HD13 HH12 ' A' ' 85' ' ' ARG . 56.4 mt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.345 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.483 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 16.6 pt-20 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.521 0.201 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 38.1 Cg_endo -66.65 145.17 75.01 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.635 2.223 . . . . 0.0 112.564 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.443 HG23 ' N ' ' A' ' 17' ' ' TRP . 11.5 m -62.22 155.78 23.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.911 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.443 ' N ' HG23 ' A' ' 16' ' ' THR . 12.1 m-90 -99.53 86.94 3.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.719 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 24' ' ' ALA . 44.1 mt -83.04 73.83 10.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.047 0.451 . . . . 0.0 110.61 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.0 p -72.19 -0.82 12.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.356 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -143.0 148.26 36.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.917 0.389 . . . . 0.0 111.535 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.585 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 32.8 t -56.77 -50.52 87.52 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.434 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.61 -44.76 38.73 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.939 1.76 . . . . 0.0 111.832 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.33 -36.5 83.89 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.334 0.588 . . . . 0.0 110.183 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.541 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -63.91 -59.12 4.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.91 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.6 mtp -60.19 -24.98 65.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.095 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -72.57 -52.52 15.18 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.775 0.321 . . . . 0.0 110.558 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -59.34 -31.41 69.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 36' ' ' ILE . 55.3 mt -74.52 -39.37 47.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.175 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.29 -20.77 61.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.147 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.64 28.69 2.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.032 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.9 t -170.11 152.43 4.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.425 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.475 ' HG3' HG12 ' A' ' 87' ' ' VAL . 26.0 tt0 -66.76 -61.73 1.81 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.462 HG11 HD11 ' A' ' 83' ' ' LEU . 17.2 t -109.33 136.98 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.438 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.91 127.75 20.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.014 0.435 . . . . 0.0 112.116 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.466 HG23 HG12 ' A' ' 111' ' ' ILE . 50.6 t -116.46 131.19 69.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.615 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 28' ' ' ILE . 22.1 mt -136.45 135.34 49.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -177.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.552 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -97.32 98.03 2.06 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.539 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.9 m-85 -84.43 93.48 8.3 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.0 m-85 -114.3 142.14 46.69 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -89.97 -0.94 57.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.438 ' O ' HG12 ' A' ' 44' ' ' ILE . 37.8 t70 -156.26 122.47 5.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.707 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.506 ' HG ' HG21 ' A' ' 66' ' ' THR . 92.1 mt -92.32 46.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.159 0.504 . . . . 0.0 111.293 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.428 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.5 mt-10 -136.91 7.5 2.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.005 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.664 HG13 HG22 ' A' ' 47' ' ' VAL . 2.7 pt -89.46 158.45 45.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.014 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.438 ' O ' HD11 ' A' ' 49' ' ' ILE . 66.1 Cg_exo -53.32 -26.23 33.97 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.781 2.321 . . . . 0.0 112.896 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.92 -37.64 88.32 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.664 HG22 HG13 ' A' ' 44' ' ' ILE . 2.1 t -61.54 -55.66 40.63 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.616 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 36.6 Cg_exo -61.24 -37.82 70.72 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.067 1.845 . . . . 0.0 111.519 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.615 HG21 HD13 ' A' ' 107' ' ' LEU . 5.5 mt -65.24 -34.86 73.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.014 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' A' ' 53' ' ' MET . 45.4 tp -73.27 -52.34 14.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -52.81 -26.31 14.09 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -80.29 -47.59 14.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.7 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -58.8 -25.93 63.61 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.136 0.493 . . . . 0.0 109.684 179.6 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.2 t -53.23 -48.35 55.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.967 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.92 -10.06 59.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.635 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -94.1 -18.88 21.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.212 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 59.9 m-85 -136.82 62.84 43.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.526 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.8 -41.61 68.89 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.748 2.298 . . . . 0.0 111.369 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.61 -39.38 93.25 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.375 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.9 t -68.55 144.33 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.514 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 39.5 t -81.88 98.07 8.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.075 0.464 . . . . 0.0 111.043 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.419 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.3 p90 -65.06 125.55 25.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.028 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.03 162.11 28.12 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.998 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -161.19 145.49 4.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.0 t -151.02 158.08 43.68 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.173 0.511 . . . . 0.0 111.857 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.506 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.3 p -138.53 -0.61 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.375 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.4 ' O ' HD11 ' A' ' 71' ' ' LEU . 28.6 t70 -67.06 143.85 56.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.779 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.6 t -67.49 -50.95 56.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.437 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -50.77 -42.39 57.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.355 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.513 ' HA ' HG21 ' A' ' 21' ' ' VAL . 63.6 t -70.91 -53.85 20.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 120.914 0.387 . . . . 0.0 110.731 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.4 HD11 ' O ' ' A' ' 67' ' ' ASP . 6.4 mp -58.8 -15.42 12.24 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.425 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.0 m -90.4 -40.56 11.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.074 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -60.27 -40.13 89.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.386 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -92.56 14.57 16.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 54.0 25.83 5.82 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.638 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.621 HG22 ' HB ' ' A' ' 80' ' ' THR . 35.6 mm -61.43 120.78 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.175 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.3 p -140.69 56.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.075 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.68 45.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.64 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 29.8 m-80 51.29 43.62 29.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.192 0.52 . . . . 0.0 110.539 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.621 ' HB ' HG22 ' A' ' 76' ' ' ILE . 94.8 m -70.21 152.79 43.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.544 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.552 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.8 mt -119.11 117.88 55.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.529 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 70.7 m -105.56 133.37 50.42 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.537 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.3 tp -109.89 104.77 13.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.905 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.0 t80 -98.4 124.21 42.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.459 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.478 HH12 HD12 ' A' ' 116' ' ' LEU . 4.9 mtm180 -106.32 83.29 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.85 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 tp -25.48 -59.4 0.07 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.024 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.475 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.75 -67.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 123.505 0.503 . . . . 0.0 112.305 -179.324 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.06 4.96 51.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.935 0.398 . . . . 0.0 111.012 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.8 m120 53.78 29.21 9.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.636 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.466 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.7 mm-40 -74.27 159.89 31.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.682 0.277 . . . . 0.0 110.882 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -146.1 95.18 2.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.867 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.595 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.0 mm? -84.35 135.73 34.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.414 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -114.07 96.01 5.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.532 HD23 HD12 ' A' ' 102' ' ' ILE . 4.1 tt -79.44 79.38 5.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.0 mt-10 -82.34 -162.89 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.653 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.556 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 5.1 m-20 -50.62 -39.39 50.17 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.091 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.43 -15.09 0.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.265 0.555 . . . . 0.0 110.112 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.423 ' N ' ' C ' ' A' ' 96' ' ' ASP . 42.9 m-20 -132.11 -13.45 3.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.566 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.556 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 27.7 mm -91.5 -39.41 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -47.52 -42.52 23.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.909 0.385 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.8 t -129.69 44.39 2.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.28 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.532 HD12 HD23 ' A' ' 94' ' ' LEU . 6.7 tp -67.1 144.37 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.584 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.547 ' HA ' HD12 ' A' ' 49' ' ' ILE . 9.5 m-20 -136.98 149.04 47.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.35 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.611 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.88 -34.63 9.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.052 0.453 . . . . 0.0 110.408 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.2 m -63.88 -48.02 78.34 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.537 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -59.73 -57.41 13.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.308 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.615 HD13 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.7 -54.99 22.21 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.039 0.447 . . . . 0.0 110.064 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.0 m -59.5 -28.67 67.25 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.775 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.496 ' HD3' HD11 ' A' ' 113' ' ' ILE . 3.8 tmt_? -72.07 -67.06 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.142 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -43.05 -43.14 4.2 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.196 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.466 HG12 HG23 ' A' ' 35' ' ' VAL . 96.5 mt -63.69 -54.64 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.81 -19.56 6.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.248 0.547 . . . . 0.0 110.301 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.496 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.41 -37.03 9.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.814 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.595 HD21 ' HG ' ' A' ' 92' ' ' LEU . 90.8 m-20 -122.84 29.86 6.66 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 83.6 p -82.95 47.36 1.21 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.14 0.495 . . . . 0.0 109.846 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.478 HD12 HH12 ' A' ' 85' ' ' ARG . 53.2 mt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.265 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.9 pt-20 . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.424 0.154 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 53.6 Cg_endo -70.18 141.14 42.78 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.569 2.179 . . . . 0.0 112.415 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 m -62.33 151.88 35.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.497 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.67 88.8 4.74 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.007 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.573 HD22 ' HA ' ' A' ' 24' ' ' ALA . 44.1 mt -80.73 71.79 7.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.372 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.7 p -69.65 -6.07 28.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.236 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -138.68 147.18 42.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.005 0.431 . . . . 0.0 111.764 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.2 t -54.66 -49.38 91.66 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.561 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.33 -47.31 22.8 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.985 1.79 . . . . 0.0 112.009 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.12 -34.4 77.54 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.24 0.543 . . . . 0.0 110.281 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.573 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.31 -59.48 4.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.207 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.8 mtm -60.67 -26.07 66.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.105 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -70.91 -51.0 28.78 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.771 0.32 . . . . 0.0 110.493 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -60.64 -31.97 71.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.852 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.488 HD12 HD11 ' A' ' 36' ' ' ILE . 49.7 mt -73.96 -36.52 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.037 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.93 -20.94 59.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.815 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.19 30.98 1.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -169.72 151.48 4.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.388 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.549 ' HG3' HG11 ' A' ' 87' ' ' VAL . 31.2 tt0 -72.17 -40.76 67.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.632 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.429 HG11 HD12 ' A' ' 83' ' ' LEU . 20.5 t -129.7 130.96 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.893 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -135.64 128.67 31.54 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.492 HG21 HG12 ' A' ' 111' ' ' ILE . 41.2 t -116.5 128.03 73.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.532 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.488 HD11 HD12 ' A' ' 28' ' ' ILE . 26.2 mt -134.02 137.19 52.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.57 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.33 96.29 1.66 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.638 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.0 m-85 -82.68 89.24 6.72 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.0 m-85 -108.98 140.35 42.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -88.43 -1.91 58.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.439 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.6 t70 -156.85 124.04 5.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.621 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.517 ' HG ' HG23 ' A' ' 66' ' ' THR . 93.7 mt -93.4 47.34 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.152 0.501 . . . . 0.0 111.408 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 37.0 mt-10 -137.07 6.88 2.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.841 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.636 HG13 HG21 ' A' ' 47' ' ' VAL . 1.4 pt -90.24 156.55 46.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.177 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.427 ' O ' HD12 ' A' ' 49' ' ' ILE . 71.2 Cg_exo -51.5 -26.14 21.15 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.858 2.372 . . . . 0.0 113.255 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.01 -35.72 82.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.636 HG21 HG13 ' A' ' 44' ' ' ILE . 2.3 t -64.12 -55.14 34.06 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.66 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.0 Cg_exo -60.93 -37.74 74.72 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.987 1.791 . . . . 0.0 111.321 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.644 HG22 HD11 ' A' ' 107' ' ' LEU . 5.6 mt -65.58 -36.45 77.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.921 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.559 ' O ' ' HG3' ' A' ' 53' ' ' MET . 51.3 tp -71.98 -51.61 21.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -53.89 -24.53 16.38 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.9 t -82.66 -46.63 13.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.641 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.559 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.31 -25.44 64.16 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.403 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 50' ' ' LEU . 55.2 t -52.92 -50.01 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.036 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -76.73 -9.53 58.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.76 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -93.79 -19.28 21.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.121 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 59.5 m-85 -135.66 62.9 50.92 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.511 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.42 -40.42 71.27 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.724 2.283 . . . . 0.0 111.733 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.29 -41.51 98.39 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.539 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.4 t -65.56 147.06 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.531 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 36.0 t -84.27 96.75 9.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.997 0.427 . . . . 0.0 110.839 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.422 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.2 p90 -65.24 121.83 15.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.216 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -141.37 163.32 26.8 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.118 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -161.68 143.3 3.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.5 t -146.97 157.81 43.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.139 0.495 . . . . 0.0 111.753 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.517 HG23 ' HG ' ' A' ' 42' ' ' LEU . 76.8 p -140.67 3.53 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.63 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -74.74 142.36 44.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.593 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.3 t -64.31 -49.05 73.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.45 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -50.66 -45.3 57.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.494 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HA ' HG23 ' A' ' 21' ' ' VAL . 74.3 t -70.15 -53.21 24.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.86 0.362 . . . . 0.0 110.772 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.55 -15.04 9.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.25 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.4 m -91.72 -41.28 10.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.457 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -61.57 -36.23 80.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.579 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -94.2 9.76 36.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.947 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.0 t30 60.28 20.39 9.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.667 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.697 HG21 ' HB ' ' A' ' 80' ' ' THR . 36.7 mm -56.88 123.21 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.097 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.3 p -143.37 60.5 1.4 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.26 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.59 45.9 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.633 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 29.8 m-80 51.41 43.38 29.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.181 0.515 . . . . 0.0 110.403 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.697 ' HB ' HG21 ' A' ' 76' ' ' ILE . 95.7 m -69.55 150.63 46.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.716 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.57 HG12 ' HA2' ' A' ' 37' ' ' GLY . 57.3 mt -117.23 118.28 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.076 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.516 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.4 m -107.94 131.42 54.56 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.547 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.1 tp -107.54 103.47 12.8 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.622 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.3 t80 -97.73 119.27 36.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.872 0.368 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.485 HH12 HD13 ' A' ' 116' ' ' LEU . 4.3 mtm180 -101.44 98.41 8.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.028 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.0 tp -43.28 -52.38 5.77 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.907 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.549 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.59 -62.18 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.548 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -99.3 9.5 43.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.426 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 85' ' ' ARG . 18.5 m120 50.26 32.75 6.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.747 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.478 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.7 mm-40 -78.23 162.98 26.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.718 0.294 . . . . 0.0 111.006 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.96 98.06 2.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.66 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.547 HD22 ' HG ' ' A' ' 83' ' ' LEU . 1.7 mm? -88.14 123.85 33.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.664 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -103.21 98.12 8.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.508 HD23 HD12 ' A' ' 102' ' ' ILE . 4.7 tt -82.05 77.0 8.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.406 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.2 mt-10 -78.04 -165.53 0.67 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.468 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.5 OUTLIER -45.56 -52.43 10.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.279 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -46.01 -18.33 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.874 0.369 . . . . 0.0 111.198 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 96' ' ' ASP . 14.8 m-20 -124.78 -13.94 6.84 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.348 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.515 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 24.1 mm -90.72 -42.39 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -49.74 -33.41 16.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.9 t -129.58 37.81 3.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.492 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.515 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.0 tp -66.61 143.66 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.541 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.528 ' HA ' HD13 ' A' ' 49' ' ' ILE . 14.6 m-20 -138.59 148.5 44.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.32 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.623 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -47.13 -36.75 8.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 110.349 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 100.0 m -62.43 -47.12 85.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.423 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -61.3 -58.44 8.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.4 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.644 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.83 -55.35 17.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.946 0.403 . . . . 0.0 110.169 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.5 m -58.71 -31.23 68.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.975 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.516 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.1 tmt_? -70.57 -66.28 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.267 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -43.29 -43.01 4.7 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.331 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.492 HG12 HG21 ' A' ' 35' ' ' VAL . 96.7 mt -63.1 -55.01 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -53.84 -22.26 9.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.374 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.516 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -85.27 -38.59 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.889 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.493 ' OD1' HG23 ' A' ' 113' ' ' ILE . 30.8 m120 -118.29 27.73 8.78 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.4 p -80.82 46.18 0.87 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.026 0.441 . . . . 0.0 110.278 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.485 HD13 HH12 ' A' ' 85' ' ' ARG . 48.4 mt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.138 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.5 pt-20 . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 120.389 0.138 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 31.5 Cg_endo -64.67 152.0 83.54 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.642 2.228 . . . . 0.0 112.778 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.8 m -68.34 154.24 42.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.605 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -99.44 92.2 5.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.898 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.534 HD11 ' HA ' ' A' ' 24' ' ' ALA . 55.8 mt -91.41 70.98 6.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.702 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.2 p -72.6 -1.4 15.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.908 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -140.71 147.03 38.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 111.782 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.589 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.2 t -56.22 -50.21 88.79 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.567 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.1 Cg_endo -57.98 -45.29 33.17 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.924 1.75 . . . . 0.0 111.802 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.92 -34.11 77.23 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.25 0.547 . . . . 0.0 110.408 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.534 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -64.55 -58.8 5.37 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.947 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.6 mtp -60.14 -27.53 67.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.194 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 27.9 mt-10 -72.08 -51.04 23.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.707 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -59.5 -32.76 70.58 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.452 HD13 HD13 ' A' ' 36' ' ' ILE . 42.4 mt -74.79 -38.85 45.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.97 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.52 -18.91 61.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.215 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.49 27.03 3.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.311 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.4 t -171.86 155.2 3.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.491 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.51 ' HG3' HG11 ' A' ' 87' ' ' VAL . 21.3 tt0 -64.79 -73.81 0.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.471 HG12 HD11 ' A' ' 83' ' ' LEU . 21.1 t -99.23 139.1 21.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.568 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.02 127.96 19.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.498 HG23 HG12 ' A' ' 111' ' ' ILE . 49.9 t -116.68 129.23 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.59 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.452 HD13 HD13 ' A' ' 28' ' ' ILE . 20.7 mt -135.02 137.87 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.466 -177.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.527 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.11 97.17 1.63 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.593 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.469 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 42.0 m-85 -83.13 89.92 7.0 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -108.28 143.13 37.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.351 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -89.87 -6.6 55.65 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.487 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.6 t70 -151.62 119.81 6.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.584 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.5 ' HG ' HG21 ' A' ' 66' ' ' THR . 94.9 mt -88.69 45.39 1.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.218 0.532 . . . . 0.0 111.127 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 10.2 mm-40 -136.33 12.04 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.248 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.646 HG13 HG22 ' A' ' 47' ' ' VAL . 2.1 pt -97.04 157.8 34.4 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.426 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.501 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 79.9 Cg_exo -51.11 -30.8 33.26 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.723 2.282 . . . . 0.0 112.886 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.51 81.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.401 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.654 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.3 t -61.02 -58.02 22.18 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.569 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.654 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 35.8 Cg_exo -58.31 -40.25 77.23 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.784 1.656 . . . . 0.0 111.435 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.658 HG21 ' HA ' ' A' ' 104' ' ' ALA . 9.8 mt -61.7 -35.96 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.503 ' O ' HG22 ' A' ' 54' ' ' VAL . 46.3 tp -73.89 -53.58 9.85 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -54.34 -24.09 17.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.007 0.432 . . . . 0.0 109.915 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.5 t -83.22 -43.78 15.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.558 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.497 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.85 -25.66 67.66 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 50' ' ' LEU . 53.3 t -53.1 -48.53 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.095 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -75.24 -11.65 60.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.58 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -93.44 -18.49 22.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.27 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.606 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 44.9 m-85 -135.99 63.08 49.61 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.643 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.94 -44.21 50.47 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.731 2.287 . . . . 0.0 111.654 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.6 -41.69 89.67 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.473 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 14.3 t -65.64 144.7 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.497 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 36.2 t -82.06 96.26 7.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.02 0.438 . . . . 0.0 111.012 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.501 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 5.6 p90 -62.6 129.3 39.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.735 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.13 161.36 28.58 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.058 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.425 HD12 HG11 ' A' ' 47' ' ' VAL . 5.2 tt -160.84 143.06 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.469 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 32.4 t -150.46 158.25 43.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 111.793 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.5 HG21 ' HG ' ' A' ' 42' ' ' LEU . 82.7 p -138.69 -2.72 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.642 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.412 ' O ' HD13 ' A' ' 71' ' ' LEU . 16.6 t70 -62.64 143.12 57.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.662 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.0 m -67.29 -52.57 39.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.23 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -49.83 -40.71 42.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.409 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.497 ' HA ' HG23 ' A' ' 21' ' ' VAL . 54.9 t -72.54 -55.08 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 67' ' ' ASP . 6.3 mp -57.98 -14.29 6.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.248 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.3 m -92.41 -40.49 10.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.214 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -61.84 -35.04 77.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.224 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -95.12 9.68 38.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.695 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t30 58.6 24.28 11.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.454 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.577 HD13 ' HB ' ' A' ' 80' ' ' THR . 37.2 mm -61.28 124.19 15.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.3 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.1 p -143.68 59.49 1.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.195 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.78 44.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.706 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.599 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 26.3 m-80 52.31 44.63 29.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.188 0.518 . . . . 0.0 110.639 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.577 ' HB ' HD13 ' A' ' 76' ' ' ILE . 95.3 m -69.55 152.14 45.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.63 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.574 HG22 HD22 ' A' ' 107' ' ' LEU . 60.5 mt -118.46 115.58 48.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.07 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.449 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 77.4 m -103.4 133.25 48.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.605 ' HG ' HD22 ' A' ' 92' ' ' LEU . 3.0 tp -108.71 101.54 10.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.853 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.2 t80 -95.31 121.86 37.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.568 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.459 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 4.6 mtm180 -106.6 82.04 1.67 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.908 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 87' ' ' VAL . 4.8 tp -25.46 -61.78 0.07 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.51 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.76 -54.84 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -103.84 3.97 34.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.92 0.391 . . . . 0.0 111.21 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 51.57 31.31 7.5 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.57 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 9.7 mm-40 -77.83 157.62 29.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.491 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.13 95.89 2.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.997 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.605 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -84.31 112.3 20.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.586 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.47 ' H ' ' ND2' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -95.8 96.05 8.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.536 HD22 HD12 ' A' ' 102' ' ' ILE . 3.8 tt -81.73 78.93 8.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.4 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.5 mt-10 -79.8 -165.01 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.504 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.6 t70 -50.66 -37.41 40.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.988 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -55.25 -14.79 1.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.204 0.526 . . . . 0.0 110.428 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -130.74 -13.94 3.64 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.546 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.548 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 23.8 mm -89.5 -29.01 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.709 0.29 . . . . 0.0 111.413 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -52.93 -52.34 58.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.811 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.2 m -117.51 37.25 3.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.488 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.548 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.8 tp -61.36 147.56 10.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.596 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.564 ' HA ' HD11 ' A' ' 49' ' ' ILE . 4.3 t70 -140.83 161.08 38.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.621 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.658 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -58.95 -35.04 72.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.091 0.472 . . . . 0.0 110.17 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 94.0 m -65.34 -46.71 79.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.407 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -59.96 -57.15 14.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.983 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.593 HD13 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.81 -54.87 24.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.117 0.484 . . . . 0.0 110.109 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.7 m -59.18 -29.3 67.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.704 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.467 ' HD3' HD12 ' A' ' 113' ' ' ILE . 3.6 tmt_? -71.97 -66.21 0.67 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.213 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -42.86 -43.85 4.24 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.154 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.498 HG12 HG23 ' A' ' 35' ' ' VAL . 82.8 mt -63.06 -55.05 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.465 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -54.76 -17.93 4.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.14 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.467 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.96 -35.26 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.923 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.593 HD21 ' HG ' ' A' ' 92' ' ' LEU . 88.0 m-20 -125.44 30.31 5.81 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 95.5 p -84.03 51.49 2.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.066 0.46 . . . . 0.0 110.25 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.442 HD13 ' NH1' ' A' ' 85' ' ' ARG . 82.0 mt . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.421 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.491 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.0 pt-20 . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.402 0.144 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 37.1 Cg_endo -65.81 143.09 72.33 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.574 2.182 . . . . 0.0 112.672 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.5 m -63.53 153.22 36.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.676 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -96.97 93.0 6.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.012 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.559 HD11 ' HA ' ' A' ' 24' ' ' ALA . 39.4 mt -87.34 70.84 10.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.128 0.49 . . . . 0.0 110.234 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.4 p -69.9 -3.12 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.161 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -139.01 147.43 42.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.909 0.385 . . . . 0.0 111.65 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.591 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 42.1 t -56.43 -49.95 90.5 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.485 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.64 -46.0 29.87 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.974 1.783 . . . . 0.0 111.867 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.85 81.64 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.178 0.513 . . . . 0.0 110.112 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.559 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -62.54 -60.13 3.96 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.002 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 44.7 mtm -60.36 -25.82 66.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.278 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -70.92 -51.66 24.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.704 0.288 . . . . 0.0 110.418 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -60.6 -30.79 70.04 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.471 HD12 HD12 ' A' ' 36' ' ' ILE . 53.2 mt -74.38 -37.52 45.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.023 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.93 -19.67 60.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.16 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.53 30.96 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.079 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.401 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.2 t -172.35 152.97 2.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.426 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.472 ' HG3' HG12 ' A' ' 87' ' ' VAL . 26.8 tt0 -68.88 -47.07 66.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.77 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.4 HG11 HD12 ' A' ' 83' ' ' LEU . 18.5 t -122.22 139.48 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.432 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -143.13 125.95 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.575 HG21 HG12 ' A' ' 111' ' ' ILE . 49.5 t -114.39 128.77 71.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.424 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.471 HD12 HD12 ' A' ' 28' ' ' ILE . 29.2 mt -134.88 137.57 50.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.421 -177.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.533 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.23 96.41 1.6 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.587 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.436 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.7 m-85 -82.89 91.27 7.08 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.586 ' HB3' HD21 ' A' ' 79' ' ' ASN . 11.5 m-85 -111.03 144.35 40.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.453 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.499 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 45.8 mt-30 -92.98 -2.55 55.66 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 44' ' ' ILE . 28.6 t70 -155.97 117.13 3.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.582 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.494 ' HG ' HG23 ' A' ' 66' ' ' THR . 92.2 mt -87.31 45.5 1.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.116 0.484 . . . . 0.0 111.604 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.405 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 38.6 mt-10 -134.59 10.76 3.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.037 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.656 HG13 HG21 ' A' ' 47' ' ' VAL . 7.2 pt -92.31 161.33 33.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.293 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.443 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 50.1 Cg_exo -56.81 -26.52 66.97 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.739 2.293 . . . . 0.0 112.369 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.78 88.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.482 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.656 HG21 HG13 ' A' ' 44' ' ' ILE . 2.2 t -61.23 -56.66 32.04 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.642 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.87 -38.61 78.4 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.864 1.709 . . . . 0.0 111.423 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.651 HG21 HD11 ' A' ' 107' ' ' LEU . 5.6 mt -64.12 -35.09 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.869 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.538 ' O ' ' HG3' ' A' ' 53' ' ' MET . 49.7 tp -74.03 -52.47 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -55.53 -23.2 25.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.036 0.446 . . . . 0.0 109.853 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.6 t -83.78 -44.73 14.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.445 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.538 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.6 -25.77 67.55 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -52.79 -49.5 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.036 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -74.41 -11.67 60.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.7 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -93.38 -19.04 21.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.305 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 54.8 m-85 -137.16 61.99 36.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.399 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.73 -42.16 68.46 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.684 2.256 . . . . 0.0 111.615 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.86 -39.84 88.84 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.212 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.5 t -67.71 143.37 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.524 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 47.1 t -80.14 98.37 7.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.022 0.439 . . . . 0.0 110.967 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.452 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.3 p90 -65.99 124.73 23.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.968 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -143.71 162.01 27.73 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.171 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -161.8 142.73 3.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.436 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 41.0 t -149.04 156.51 42.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.194 0.521 . . . . 0.0 111.809 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.494 HG23 ' HG ' ' A' ' 42' ' ' LEU . 68.2 p -137.15 3.05 2.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.481 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.419 ' O ' HD13 ' A' ' 71' ' ' LEU . 17.7 t70 -69.92 142.97 52.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.685 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.9 m -67.34 -50.92 58.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.351 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -51.11 -40.94 59.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.364 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.497 ' HA ' HG21 ' A' ' 21' ' ' VAL . 53.7 t -72.48 -54.68 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.358 . . . . 0.0 110.539 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.419 HD13 ' O ' ' A' ' 67' ' ' ASP . 6.6 mp -58.41 -14.64 8.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.099 0.476 . . . . 0.0 110.255 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.5 m -91.78 -40.35 11.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.239 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -62.08 -34.36 76.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.267 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -96.63 10.88 37.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.72 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 56.01 26.65 10.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.867 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.621 HG22 ' HB ' ' A' ' 80' ' ' THR . 40.1 mm -62.7 122.19 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.4 p -141.8 59.16 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 111.259 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.52 44.65 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.521 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.586 HD21 ' HB3' ' A' ' 39' ' ' PHE . 13.8 m120 51.48 44.18 29.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.141 0.496 . . . . 0.0 110.635 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.621 ' HB ' HG22 ' A' ' 76' ' ' ILE . 93.0 m -69.72 151.67 45.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.836 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.533 HG12 ' HA2' ' A' ' 37' ' ' GLY . 55.8 mt -117.6 116.74 52.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.813 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 74.8 m -104.28 132.79 50.14 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.608 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -109.63 101.98 10.85 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.866 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -96.38 122.78 39.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.538 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.472 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.0 mtm180 -106.31 86.37 2.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.857 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.1 tp -27.05 -60.54 0.09 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.472 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.91 -73.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 123.434 0.459 . . . . 0.0 112.149 -179.273 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -83.51 2.89 34.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.014 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.9 m120 53.75 30.07 10.6 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.42 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 8.0 mm-40 -74.46 159.25 32.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.805 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -144.16 93.31 2.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.823 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.608 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -80.91 141.83 34.16 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -122.85 92.81 3.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.516 HD23 HD11 ' A' ' 102' ' ' ILE . 4.0 tt -76.99 77.43 3.54 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.419 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.2 mt-10 -79.08 -164.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.48 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 23.7 t70 -51.66 -36.38 46.08 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.915 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.68 -14.65 3.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.282 0.563 . . . . 0.0 110.244 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -130.65 -13.83 3.7 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.694 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.493 HD12 HG13 ' A' ' 81' ' ' ILE . 23.1 mm -89.94 -30.0 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.727 0.298 . . . . 0.0 111.294 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -52.12 -48.52 64.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.746 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.9 t -123.78 42.08 3.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.414 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.516 HD11 HD23 ' A' ' 94' ' ' LEU . 7.9 tp -63.46 143.14 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.545 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.543 ' HA ' HD13 ' A' ' 49' ' ' ILE . 15.0 m-20 -136.03 150.56 49.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.487 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.601 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.07 -33.85 12.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.034 0.445 . . . . 0.0 110.26 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.3 m -65.35 -47.31 76.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.438 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HB2' HD12 ' A' ' 102' ' ' ILE . 57.3 mtpt -60.05 -56.34 22.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.149 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.651 HD11 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -52.36 -57.14 10.72 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.959 0.409 . . . . 0.0 109.905 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 61.4 m -56.87 -28.91 62.42 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.869 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HD3' HD11 ' A' ' 113' ' ' ILE . 3.7 tmt_? -71.04 -66.88 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.954 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -42.3 -41.17 2.7 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.156 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.575 HG12 HG21 ' A' ' 35' ' ' VAL . 76.8 mt -64.91 -55.77 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -54.24 -18.01 3.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.253 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.475 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.5 mp -92.56 -34.58 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.12 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.606 HD21 ' HG ' ' A' ' 92' ' ' LEU . 85.5 m-20 -128.31 32.69 4.83 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 93.8 p -85.17 41.84 0.9 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.164 0.507 . . . . 0.0 109.918 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 85' ' ' ARG . 49.9 mt . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.527 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 . . . . . 0 CA--C 1.531 0.245 0 CA-C-O 120.631 0.253 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.521 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.7 Cg_endo -68.23 155.38 69.58 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.768 2.312 . . . . 0.0 112.741 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.7 m -70.71 151.61 44.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.416 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -96.79 86.36 4.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.755 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.56 HD11 ' HA ' ' A' ' 24' ' ' ALA . 48.0 mt -83.34 71.52 10.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.619 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 76.8 p -69.21 -6.2 27.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.288 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -140.05 146.97 39.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.993 0.425 . . . . 0.0 111.791 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.604 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.5 t -54.34 -49.74 88.82 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.632 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.8 Cg_endo -56.58 -46.46 29.81 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.984 1.789 . . . . 0.0 112.082 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.23 -34.47 78.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.173 0.511 . . . . 0.0 110.288 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.56 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -63.88 -58.88 5.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.081 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 61.3 mtp -61.39 -27.16 68.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.189 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.5 mt-10 -70.64 -49.89 42.7 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.772 0.32 . . . . 0.0 110.386 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -60.5 -33.14 72.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.846 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.424 HD13 HD13 ' A' ' 36' ' ' ILE . 46.0 mt -73.86 -37.66 48.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.127 178.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.66 -20.75 60.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.128 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.1 29.77 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.059 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.9 t -171.25 150.86 3.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.333 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.497 ' HG3' HG12 ' A' ' 87' ' ' VAL . 25.1 tt0 -64.58 -63.32 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.91 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.438 HG12 HD11 ' A' ' 83' ' ' LEU . 21.4 t -108.04 141.9 22.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.592 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.494 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -144.08 126.52 15.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.021 0.439 . . . . 0.0 112.109 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.531 HG22 HG12 ' A' ' 111' ' ' ILE . 47.8 t -115.47 127.53 73.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.622 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 26.7 mt -133.71 136.4 54.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.728 -177.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.466 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.71 97.69 1.82 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.347 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.441 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 38.8 m-85 -83.49 89.67 7.11 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -108.35 141.3 40.36 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -89.62 -2.69 58.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.498 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.9 t70 -155.37 117.51 4.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.581 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.515 ' HG ' HG23 ' A' ' 66' ' ' THR . 93.3 mt -86.99 43.67 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.054 0.454 . . . . 0.0 111.343 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.412 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.1 mt-10 -134.61 13.14 3.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.121 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.657 HG13 HG21 ' A' ' 47' ' ' VAL . 2.0 pt -96.92 157.62 34.78 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.266 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.474 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 76.4 Cg_exo -51.6 -28.67 29.82 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.834 2.356 . . . . 0.0 112.888 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.95 -37.58 85.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.657 HG21 HG13 ' A' ' 44' ' ' ILE . 2.7 t -61.33 -56.77 30.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.606 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 39.5 Cg_exo -57.52 -42.4 61.37 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 121.742 1.628 . . . . 0.0 111.125 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 104' ' ' ALA . 11.8 mt -60.0 -37.71 73.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.215 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.518 ' O ' ' HG3' ' A' ' 53' ' ' MET . 47.2 tp -73.32 -51.71 16.53 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -54.8 -24.37 22.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.087 0.47 . . . . 0.0 109.858 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.3 m -83.84 -44.59 14.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.585 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.518 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -60.68 -25.91 66.72 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.372 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 50' ' ' LEU . 45.2 t -51.99 -47.0 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.898 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -78.89 -13.47 59.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.712 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -90.89 -17.09 27.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.308 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.593 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 44.0 m-85 -137.95 62.93 35.89 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.558 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.18 -44.4 49.21 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.703 2.269 . . . . 0.0 111.754 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.86 -37.16 76.46 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.515 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 17.2 t -70.18 143.6 14.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 45.6 t -81.37 97.94 7.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 110.886 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.521 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 4.9 p90 -64.18 129.2 39.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.828 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -147.51 161.06 28.46 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.128 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -161.26 145.69 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.1 t -154.06 159.53 41.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.069 0.461 . . . . 0.0 111.727 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.515 HG23 ' HG ' ' A' ' 42' ' ' LEU . 58.3 p -138.84 -7.66 1.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.693 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.06 141.45 55.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.706 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.434 ' HG ' ' H ' ' A' ' 69' ' ' GLU . 79.0 p -64.39 -50.11 68.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.38 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.434 ' H ' ' HG ' ' A' ' 68' ' ' SER . 30.6 mt-10 -49.81 -44.46 49.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.543 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.516 ' HA ' HG21 ' A' ' 21' ' ' VAL . 70.6 t -70.05 -54.61 18.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.956 0.408 . . . . 0.0 110.674 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 mp -58.38 -14.42 7.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.437 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.1 m -91.3 -42.01 10.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.339 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -60.26 -37.38 80.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.367 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -93.72 12.49 25.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.979 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 55.64 26.77 9.63 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.674 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.638 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.0 mm -64.16 123.5 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.174 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.7 p -142.16 58.35 1.47 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.286 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.414 ' HA3' ' OD1' ' A' ' 96' ' ' ASP . . . 152.7 44.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.947 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 27.4 m-80 52.61 42.53 31.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.244 0.545 . . . . 0.0 110.492 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.638 ' HB ' HG23 ' A' ' 76' ' ' ILE . 90.1 m -68.83 151.34 46.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.43 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.556 HG13 HD12 ' A' ' 99' ' ' ILE . 62.2 mt -117.13 116.76 53.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.199 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.441 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 74.2 m -105.45 133.83 49.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.558 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.2 tp -109.59 103.39 12.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.971 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.4 t80 -96.47 124.44 40.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.693 0.283 . . . . 0.0 110.749 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.444 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 3.5 mtm180 -107.95 85.52 2.13 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.11 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 tp -27.13 -60.57 0.09 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.497 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -35.84 -68.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 123.574 0.546 . . . . 0.0 112.289 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -89.77 3.65 52.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.165 0.507 . . . . 0.0 110.715 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.4 t30 51.85 37.37 20.48 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.986 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 11.0 mm-40 -81.84 159.06 23.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.563 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -140.9 90.83 2.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.667 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.558 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.8 mm? -77.75 141.87 39.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.61 116.84 26.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.253 0.549 . . . . 0.0 112.023 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.552 HD22 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -104.32 77.94 1.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.406 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -80.61 -164.27 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.827 -177.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.595 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 7.2 m-20 -49.74 -41.1 43.05 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.294 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -52.17 -15.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.256 0.55 . . . . 0.0 110.143 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.417 ' N ' ' C ' ' A' ' 96' ' ' ASP . 36.2 m-20 -130.86 -13.38 3.64 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.321 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.595 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 26.8 mm -90.96 -42.13 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.488 ' HG3' ' HB3' ' A' ' 96' ' ' ASP . 43.4 mt-10 -48.49 -37.96 18.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.936 0.398 . . . . 0.0 111.055 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.5 p -130.43 45.16 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.375 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.552 HD13 HD22 ' A' ' 94' ' ' LEU . 8.6 tp -71.95 145.17 12.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.785 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.482 ' HA ' HD12 ' A' ' 49' ' ' ILE . 9.2 m-20 -138.61 149.4 45.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.649 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.627 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -48.0 -36.47 12.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.018 0.437 . . . . 0.0 110.609 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.4 m -61.53 -48.61 80.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.202 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.402 ' HD3' ' H ' ' A' ' 103' ' ' ASP . 28.9 mtpp -59.05 -60.68 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.149 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.624 HD13 HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.41 -55.93 9.53 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.953 0.406 . . . . 0.0 110.315 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.8 m -58.08 -30.38 66.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.787 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.477 ' HD3' HD12 ' A' ' 113' ' ' ILE . 4.2 tmt_? -71.03 -65.91 0.68 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.209 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -43.17 -44.06 4.93 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.921 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.531 HG12 HG22 ' A' ' 35' ' ' VAL . 96.4 mt -62.61 -56.41 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.445 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.86 -18.39 3.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.316 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.477 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.95 -37.25 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.925 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -123.64 29.01 6.72 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 98.2 p -83.04 51.6 1.98 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.217 0.532 . . . . 0.0 109.915 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.44 HD13 HH12 ' A' ' 85' ' ' ARG . 68.1 mt . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.397 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.779 0.323 . . . . 0.0 111.339 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 31.8 Cg_endo -66.0 152.79 80.44 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.967 2.444 . . . . 0.0 112.794 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.442 HG22 ' N ' ' A' ' 17' ' ' TRP . 18.8 m -69.36 157.16 37.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.825 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.442 ' N ' HG22 ' A' ' 16' ' ' THR . 8.4 m-90 -99.52 92.91 5.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.962 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.567 HD23 ' HA ' ' A' ' 24' ' ' ALA . 48.0 mt -91.62 72.69 5.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.359 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 p -71.24 -5.38 31.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.334 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -137.46 147.4 45.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.935 0.398 . . . . 0.0 111.72 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 48.9 t -56.05 -50.05 89.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.568 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.8 Cg_endo -57.91 -45.4 32.74 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.896 1.731 . . . . 0.0 112.027 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.52 -36.08 82.59 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.259 0.552 . . . . 0.0 110.439 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.567 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -63.82 -59.32 4.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.952 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.4 mtm -60.05 -25.45 65.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.076 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -72.12 -51.46 21.34 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.39 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -59.75 -30.45 68.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.477 HD11 HD13 ' A' ' 36' ' ' ILE . 49.3 mt -75.78 -40.43 39.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.242 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.51 -21.47 61.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.243 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.76 27.32 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.292 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.476 HG21 ' HB2' ' A' ' 61' ' ' SER . 7.7 t -170.86 155.66 4.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.578 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.438 ' HG3' HG11 ' A' ' 87' ' ' VAL . 25.5 tt0 -68.08 -62.31 1.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.462 HG13 HD12 ' A' ' 83' ' ' LEU . 16.6 t -108.56 137.78 38.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.715 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.13 127.49 18.8 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.497 HG22 HG12 ' A' ' 111' ' ' ILE . 47.6 t -116.39 130.06 71.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.7 178.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.477 HD13 HD11 ' A' ' 28' ' ' ILE . 25.7 mt -136.11 136.91 49.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.56 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.76 99.51 2.08 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.476 -0.783 . . . . 0.0 112.586 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.525 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.6 m-85 -86.07 92.72 8.8 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -112.29 142.01 45.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.435 ' HG2' HD23 ' A' ' 71' ' ' LEU . 46.6 mt-30 -90.61 -0.78 57.8 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.455 ' O ' HG12 ' A' ' 44' ' ' ILE . 30.1 t70 -156.51 121.17 4.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.453 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.475 ' HG ' HG22 ' A' ' 66' ' ' THR . 96.8 mt -92.13 46.49 1.27 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.057 0.456 . . . . 0.0 111.554 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 39.9 mt-10 -136.24 7.21 3.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.952 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.653 HG13 HG23 ' A' ' 47' ' ' VAL . 2.0 pt -89.27 157.07 48.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.164 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.45 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 72.7 Cg_exo -51.72 -27.02 25.05 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.828 2.352 . . . . 0.0 113.034 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.38 87.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.653 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -62.0 -55.96 36.16 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 121.044 -0.263 . . . . 0.0 111.707 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -60.12 -37.93 80.49 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.103 1.868 . . . . 0.0 111.486 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.623 HG21 ' HA ' ' A' ' 104' ' ' ALA . 6.7 mt -65.31 -35.82 76.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.18 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.531 ' O ' ' HG3' ' A' ' 53' ' ' MET . 48.4 tp -73.42 -50.45 21.69 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -54.52 -24.68 21.73 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -82.4 -46.68 13.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.798 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.531 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.15 -26.0 64.37 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 50' ' ' LEU . 48.6 t -52.72 -49.11 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.213 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -77.89 -9.01 58.85 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.571 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -94.7 -18.92 20.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.235 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.589 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 54.3 m-85 -137.57 63.19 39.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.36 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.13 -41.32 72.91 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.713 2.275 . . . . 0.0 111.575 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.43 -42.72 95.91 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.283 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.3 t -64.87 142.94 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.493 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 25.2 t -80.37 96.44 6.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.13 0.49 . . . . 0.0 110.943 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.458 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.1 p90 -65.97 125.87 26.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.912 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.55 163.03 28.26 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.983 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -160.02 141.9 4.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.7 t -145.36 158.87 43.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.117 0.484 . . . . 0.0 111.594 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.475 HG22 ' HG ' ' A' ' 42' ' ' LEU . 69.0 p -141.37 -6.2 1.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.823 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.71 142.21 58.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.686 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.0 t -63.35 -48.45 77.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.665 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -49.7 -47.18 50.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.544 ' HA ' HG21 ' A' ' 21' ' ' VAL . 78.5 t -69.6 -52.66 30.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.779 0.323 . . . . 0.0 110.85 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.435 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.38 -14.71 8.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.084 0.469 . . . . 0.0 110.304 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.5 m -91.0 -42.48 10.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.396 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -60.21 -38.53 83.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.469 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -91.64 9.7 31.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 58.82 21.88 9.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.397 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.595 HG21 ' HB ' ' A' ' 80' ' ' THR . 36.0 mm -57.78 117.91 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.047 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.2 p -137.34 48.68 2.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.467 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 162.69 48.1 0.02 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.426 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 24.2 m-80 49.22 42.38 21.52 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.321 0.582 . . . . 0.0 110.313 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.595 ' HB ' HG21 ' A' ' 76' ' ' ILE . 92.8 m -68.15 152.41 45.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.687 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.56 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.3 mt -119.36 118.82 58.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.979 178.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.525 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 79.7 m -106.97 133.11 52.12 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.586 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.4 tp -109.46 103.44 12.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.8 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.5 t80 -97.51 123.44 41.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.763 0.316 . . . . 0.0 110.713 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.454 ' NH1' HD11 ' A' ' 116' ' ' LEU . 4.1 mtm180 -106.62 84.2 1.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.741 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 85' ' ' ARG . 5.9 tp -24.96 -60.33 0.06 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.95 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.438 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.16 -73.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 O-C-N 123.488 0.493 . . . . 0.0 112.255 -179.277 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -84.13 0.85 46.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.988 0.423 . . . . 0.0 111.053 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.9 m120 54.0 36.68 25.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.566 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 13.2 mm-40 -82.78 158.14 22.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.736 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.4 96.49 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.632 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.616 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.2 mm? -85.15 114.17 22.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.817 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.72 100.41 11.79 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.503 HD23 HD12 ' A' ' 102' ' ' ILE . 4.6 tt -85.24 76.96 10.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.459 ' HA ' ' HG1' ' A' ' 80' ' ' THR . 27.2 mt-10 -77.49 -165.66 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.451 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.91 -51.63 12.88 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.383 -179.363 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -47.49 -17.35 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 96' ' ' ASP . 14.8 m-20 -124.79 -14.16 6.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.506 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.504 HG23 ' HB2' ' A' ' 79' ' ' ASN . 22.8 mm -90.11 -38.37 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -49.05 -46.15 43.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 110.942 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -118.96 39.29 3.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.617 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.503 HD12 HD23 ' A' ' 94' ' ' LEU . 7.8 tp -65.95 143.84 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 111.201 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.539 ' HA ' HD13 ' A' ' 49' ' ' ILE . 15.0 m-20 -139.38 148.4 42.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.557 178.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.623 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -46.99 -37.8 9.71 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 110.372 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.6 m -61.62 -48.79 79.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.262 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -58.41 -60.75 3.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.279 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.603 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.41 -56.74 7.38 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.873 0.368 . . . . 0.0 110.208 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.2 m -57.75 -30.08 65.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.865 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.479 ' HD3' HD12 ' A' ' 113' ' ' ILE . 3.9 tmt_? -71.17 -65.68 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.196 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -43.05 -42.57 3.95 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.014 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.497 HG12 HG22 ' A' ' 35' ' ' VAL . 97.3 mt -63.5 -55.74 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -54.38 -18.55 4.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.32 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.479 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.63 -35.04 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.953 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.616 HD21 ' HG ' ' A' ' 92' ' ' LEU . 88.2 m-20 -126.4 30.98 5.47 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 91.6 p -83.89 42.34 0.85 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.017 0.437 . . . . 0.0 110.267 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.454 HD11 ' NH1' ' A' ' 85' ' ' ARG . 77.5 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.365 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.464 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.2 pt-20 . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 120.476 0.179 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 23.7 Cg_endo -63.71 147.76 92.45 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.552 2.168 . . . . 0.0 112.764 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.406 HG21 ' N ' ' A' ' 17' ' ' TRP . 19.9 m -61.4 155.12 22.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.581 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.406 ' N ' HG21 ' A' ' 16' ' ' THR . 9.1 m-90 -98.48 91.71 5.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.877 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.545 HD23 ' HA ' ' A' ' 24' ' ' ALA . 43.3 mt -92.49 76.49 5.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.005 0.431 . . . . 0.0 110.471 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.8 p -74.71 -6.32 48.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.123 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -139.83 148.46 42.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.005 0.431 . . . . 0.0 111.743 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 19.6 t -54.43 -49.44 90.77 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.832 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.11 -47.31 23.36 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.087 1.858 . . . . 0.0 112.135 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.84 -35.64 80.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.217 0.532 . . . . 0.0 110.211 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.545 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -63.84 -59.6 4.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.105 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 59.0 mtm -60.8 -24.39 65.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.041 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -72.47 -52.22 16.78 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.704 0.288 . . . . 0.0 110.527 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -59.69 -30.35 68.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.464 HD11 HD13 ' A' ' 36' ' ' ILE . 50.0 mt -75.1 -39.01 43.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.18 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.96 -18.89 60.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.161 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.28 28.46 2.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.209 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.407 HG22 ' CB ' ' A' ' 61' ' ' SER . 8.8 t -170.08 152.24 4.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.351 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.483 ' HG3' HG11 ' A' ' 87' ' ' VAL . 23.8 tt0 -68.32 -48.19 65.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 83' ' ' LEU . 15.7 t -121.83 134.96 63.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.523 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.94 127.95 22.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 111.948 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.505 HG21 HG12 ' A' ' 111' ' ' ILE . 51.9 t -116.56 127.68 74.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.725 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 23.5 mt -133.24 137.13 53.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.69 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.555 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.53 99.75 2.05 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.405 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.514 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.6 m-85 -85.38 94.23 8.92 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.8 m-85 -113.89 141.63 47.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -89.35 -3.61 58.4 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.45 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.0 t70 -154.12 121.52 5.78 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.614 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.487 ' HA ' HG23 ' A' ' 47' ' ' VAL . 94.1 mt -90.9 47.28 1.4 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.081 0.467 . . . . 0.0 111.184 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 37.3 mt-10 -138.45 8.42 2.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.113 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.67 HG13 HG21 ' A' ' 47' ' ' VAL . 1.6 pt -91.68 156.45 42.88 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.256 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.445 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 81.4 Cg_exo -50.74 -27.16 19.22 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.781 2.321 . . . . 0.0 113.112 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -64.28 -36.99 85.9 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.67 HG21 HG13 ' A' ' 44' ' ' ILE . 2.6 t -62.47 -55.4 39.82 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.703 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.2 Cg_exo -60.46 -38.63 72.39 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.985 1.79 . . . . 0.0 111.376 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.643 HG21 HD13 ' A' ' 107' ' ' LEU . 6.3 mt -64.93 -35.47 75.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.09 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.529 ' O ' ' HG3' ' A' ' 53' ' ' MET . 43.4 tp -73.17 -51.74 16.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -53.58 -26.7 22.73 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.154 0.502 . . . . 0.0 109.656 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.9 t -80.85 -47.1 14.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.709 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.05 -26.08 64.3 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.186 0.517 . . . . 0.0 109.608 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 50' ' ' LEU . 55.1 t -53.4 -48.26 57.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.034 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -77.88 -8.52 58.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.671 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -95.25 -18.65 20.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.171 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 57.8 m-85 -136.66 63.22 45.85 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.484 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.37 -43.18 55.98 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.699 2.266 . . . . 0.0 111.465 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.0 -40.77 91.79 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.377 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.4 t -66.6 144.5 14.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 33.0 t -83.08 96.28 8.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 110.865 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 7.4 p90 -63.07 130.8 46.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.937 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -149.71 161.33 28.8 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.023 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.4 tt -160.53 143.23 4.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.756 0.313 . . . . 0.0 110.207 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -146.41 160.15 42.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.215 0.531 . . . . 0.0 111.716 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.482 HG22 ' HG ' ' A' ' 42' ' ' LEU . 74.6 p -142.0 -1.95 1.2 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.562 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.03 144.78 52.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -64.9 -50.75 65.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.499 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -48.74 -46.94 41.69 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.588 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.427 ' HA ' HG21 ' A' ' 21' ' ' VAL . 75.1 t -68.84 -53.3 27.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.805 0.336 . . . . 0.0 110.88 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -58.61 -14.5 8.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.289 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.9 m -91.53 -40.56 11.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.19 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -60.91 -39.65 90.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.466 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -92.24 11.62 25.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.809 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 55.34 28.57 11.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.221 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.627 HG23 ' HB ' ' A' ' 80' ' ' THR . 36.1 mm -62.44 119.2 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.076 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.5 p -140.13 58.27 1.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.17 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.31 44.56 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.433 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.523 ' HB2' HG21 ' A' ' 99' ' ' ILE . 26.1 m-80 51.65 43.36 29.91 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.183 0.516 . . . . 0.0 110.304 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.627 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.9 m -68.67 154.03 42.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.657 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.555 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.5 mt -120.94 118.81 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.034 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 81.6 m -107.6 134.62 50.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.616 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -110.69 104.68 13.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.989 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.2 t80 -98.81 122.6 42.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.788 0.328 . . . . 0.0 110.582 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.486 HH12 HD12 ' A' ' 116' ' ' LEU . 3.6 mtm180 -106.05 87.76 2.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.727 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.7 tp -26.93 -59.85 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.439 -0.8 . . . . 0.0 113.059 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.483 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -35.4 -80.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 O-C-N 123.542 0.526 . . . . 0.0 112.331 -179.43 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.406 ' HB2' HH21 ' A' ' 85' ' ' ARG . 2.7 m-20 -78.67 1.6 22.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.787 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 m120 55.91 33.25 21.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.421 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 19.7 mm-40 -77.11 159.69 29.6 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.833 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -144.17 91.61 2.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.757 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.616 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -77.63 143.52 38.17 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -124.92 96.93 5.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.5 HD23 HD12 ' A' ' 102' ' ' ILE . 4.6 tt -83.44 79.17 9.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.401 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.9 mt-10 -80.61 -164.53 0.73 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.446 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.99 -49.69 15.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.604 -179.32 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -48.23 -16.6 0.1 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.773 0.321 . . . . 0.0 111.158 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -127.19 -13.94 5.52 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.556 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.523 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.2 mm -89.81 -33.15 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.729 0.299 . . . . 0.0 111.611 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -55.45 -42.03 73.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.968 0.413 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.4 m -122.53 35.16 4.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.697 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.5 HD12 HD23 ' A' ' 94' ' ' LEU . 7.0 tp -62.97 142.18 17.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.118 0.485 . . . . 0.0 111.496 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.509 ' HA ' HD13 ' A' ' 49' ' ' ILE . 21.4 m-20 -137.45 148.3 46.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.437 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.625 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.02 -36.83 8.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.95 0.405 . . . . 0.0 110.513 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -62.68 -47.14 84.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.286 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.68 -61.47 2.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.11 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.643 HD13 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.82 -55.31 10.0 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.049 0.452 . . . . 0.0 110.201 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 63.5 m -58.88 -30.47 67.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.794 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.463 ' HD3' HD11 ' A' ' 113' ' ' ILE . 4.2 tmt_? -71.3 -66.35 0.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.045 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -42.01 -43.33 3.14 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.141 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.505 HG12 HG21 ' A' ' 35' ' ' VAL . 93.3 mt -63.57 -56.14 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.435 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 41.2 tt0 -53.01 -19.2 2.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.31 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.463 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.24 -38.88 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.902 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.588 HD21 ' HG ' ' A' ' 92' ' ' LEU . 88.7 m-20 -121.24 29.21 7.4 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 82.8 p -82.25 44.95 0.9 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.043 0.449 . . . . 0.0 110.039 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.486 HD12 HH12 ' A' ' 85' ' ' ARG . 55.3 mt . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.245 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 120.496 0.189 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 33.8 Cg_endo -65.5 139.96 61.1 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.532 2.155 . . . . 0.0 112.588 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 17' ' ' TRP . 20.4 m -55.26 155.09 5.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.872 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.407 ' N ' HG22 ' A' ' 16' ' ' THR . 76.1 m95 -100.29 90.58 4.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.866 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.552 HD11 ' HA ' ' A' ' 24' ' ' ALA . 48.5 mt -88.83 73.72 8.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.59 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.5 p -73.56 -0.35 14.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.239 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -143.8 147.73 34.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.98 0.419 . . . . 0.0 111.591 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 31.0 t -55.6 -50.18 88.4 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.573 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.6 Cg_endo -57.83 -44.75 37.87 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.054 1.836 . . . . 0.0 111.886 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.23 -35.63 81.45 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.15 0.5 . . . . 0.0 110.351 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.552 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -63.93 -59.09 4.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.98 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.3 mtm -60.4 -26.73 66.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.173 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 20.2 mt-10 -71.65 -50.31 31.81 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.687 0.279 . . . . 0.0 110.658 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -60.33 -34.27 73.58 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.493 HD13 HD13 ' A' ' 36' ' ' ILE . 47.7 mt -72.97 -38.57 56.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.032 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.97 -17.3 61.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.971 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.84 25.64 5.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.174 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -170.3 152.63 4.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.622 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.506 ' HG3' HG11 ' A' ' 87' ' ' VAL . 15.6 tt0 -61.88 -80.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.595 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.461 HG12 HD12 ' A' ' 83' ' ' LEU . 20.1 t -94.39 136.68 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.619 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.521 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.65 126.25 20.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.053 0.454 . . . . 0.0 111.883 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.538 HG21 HG12 ' A' ' 111' ' ' ILE . 47.1 t -115.07 128.02 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.752 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.493 HD13 HD13 ' A' ' 28' ' ' ILE . 23.1 mt -134.65 137.53 51.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.428 -177.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.499 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.66 98.48 1.85 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.347 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.451 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 37.7 m-85 -83.4 90.82 7.23 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 13.4 m-85 -109.16 141.77 40.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.537 -178.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.48 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 28.4 mt-30 -88.77 -7.58 55.97 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.462 ' O ' HG12 ' A' ' 44' ' ' ILE . 27.7 t70 -151.22 121.79 7.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.641 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.525 ' HG ' HG22 ' A' ' 66' ' ' THR . 95.0 mt -90.49 46.04 1.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.108 0.48 . . . . 0.0 111.393 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 40.0 mt-10 -136.7 11.07 3.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.041 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.661 HG13 HG21 ' A' ' 47' ' ' VAL . 1.7 pt -95.7 155.52 38.42 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.311 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 84.7 Cg_exo -49.75 -28.59 17.91 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.833 2.355 . . . . 0.0 113.089 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.407 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -62.54 -37.24 85.33 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.661 HG21 HG13 ' A' ' 44' ' ' ILE . 2.5 t -62.58 -56.31 31.0 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.615 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.654 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.9 Cg_exo -59.4 -39.87 72.67 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.89 1.727 . . . . 0.0 111.187 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.607 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.5 mt -63.2 -36.07 74.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.064 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.518 ' O ' ' HG3' ' A' ' 53' ' ' MET . 52.0 tp -71.97 -51.42 22.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -54.94 -25.72 31.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 p -80.99 -45.2 16.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.599 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.518 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.95 -25.9 67.87 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.518 HG21 ' O ' ' A' ' 50' ' ' LEU . 55.4 t -53.2 -49.88 49.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.913 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -75.63 -9.18 58.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.716 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -95.26 -18.99 20.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.286 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.546 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 62.4 m-85 -136.1 62.3 44.81 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.566 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.0 -45.82 36.35 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.893 2.395 . . . . 0.0 111.742 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.5 -40.3 69.08 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.403 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.7 t -67.3 143.61 15.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.521 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 39.8 t -81.8 96.55 7.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.948 0.404 . . . . 0.0 110.965 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.434 ' CD2' HG12 ' A' ' 54' ' ' VAL . 6.6 p90 -63.82 129.67 41.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.983 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -149.14 162.3 28.94 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.143 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.7 tt -160.26 145.39 5.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.451 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 30.9 t -151.02 155.55 39.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.229 0.538 . . . . 0.0 111.787 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.525 HG22 ' HG ' ' A' ' 42' ' ' LEU . 66.8 p -135.95 -3.56 2.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.398 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.73 139.74 58.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.505 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.0 m -64.61 -51.95 60.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.258 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -49.53 -41.53 41.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.543 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.513 ' HA ' HG23 ' A' ' 21' ' ' VAL . 59.8 t -71.77 -55.32 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.731 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.27 -14.63 7.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.365 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 79.5 m -91.98 -40.9 10.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.312 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -61.63 -36.46 80.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.326 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -93.87 12.07 27.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.793 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 57.47 22.96 8.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.716 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.62 HG21 ' HB ' ' A' ' 80' ' ' THR . 40.8 mm -60.64 122.3 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.104 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.2 p -141.99 58.58 1.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.205 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.77 44.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.741 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 13.4 m120 52.8 43.16 31.8 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.115 0.483 . . . . 0.0 110.739 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.62 ' HB ' HG21 ' A' ' 76' ' ' ILE . 94.8 m -68.77 151.03 47.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.65 -178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.57 HG22 HD21 ' A' ' 107' ' ' LEU . 67.2 mt -117.32 116.12 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.986 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 76.9 m -104.11 133.65 48.69 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.597 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -109.43 102.55 11.42 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.941 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.4 t80 -97.5 121.76 39.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.771 0.32 . . . . 0.0 110.762 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.498 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 3.0 mtm180 -105.76 91.75 3.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.123 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 tp -38.55 -50.69 1.59 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.611 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.506 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.36 -63.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.796 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.52 8.54 43.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.04 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 m120 51.86 31.97 9.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.615 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.498 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 20.3 mm-40 -78.82 160.82 27.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.809 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.409 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.9 OUTLIER -146.92 91.49 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.911 179.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.597 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -78.42 144.65 35.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.03 99.33 6.07 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.528 HD22 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -85.29 78.31 9.81 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.4 mt-10 -78.46 -165.6 0.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.538 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.7 t70 -51.7 -35.4 42.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.004 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -56.87 -14.92 3.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.248 0.547 . . . . 0.0 110.327 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -129.94 -14.01 4.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.481 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.538 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 25.3 mm -89.48 -32.58 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 120.781 0.324 . . . . 0.0 111.267 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -51.7 -45.19 63.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.2 p -124.56 37.09 4.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.573 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.6 tp -60.6 143.18 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.787 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.547 ' HA ' HD12 ' A' ' 49' ' ' ILE . 24.1 m-20 -137.53 149.51 46.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.523 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.607 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.08 -38.33 11.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 110.593 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.2 m -61.74 -47.78 83.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.488 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -59.02 -59.62 5.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.273 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.599 HD11 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.97 -56.52 10.34 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.08 0.467 . . . . 0.0 110.23 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 55.1 m -57.59 -30.64 65.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.844 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.455 ' HD3' HD12 ' A' ' 113' ' ' ILE . 2.9 tmt_? -70.01 -65.73 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.073 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -42.5 -44.49 4.1 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.034 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.538 HG12 HG21 ' A' ' 35' ' ' VAL . 83.3 mt -61.83 -55.78 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.453 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -54.39 -18.1 3.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.512 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.455 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.48 -36.65 8.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.929 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.591 HD21 ' HG ' ' A' ' 92' ' ' LEU . 90.4 m-20 -125.88 31.47 5.47 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.5 p -83.33 40.55 0.72 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.036 0.446 . . . . 0.0 110.307 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.493 HD13 HH12 ' A' ' 85' ' ' ARG . 59.5 mt . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.266 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.419 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.3 pt-20 . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.571 0.224 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.5 Cg_endo -66.35 146.23 80.0 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.666 2.244 . . . . 0.0 112.463 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.9 m -61.35 153.61 26.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.792 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -100.34 92.57 5.24 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.754 179.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.581 HD21 ' HA ' ' A' ' 24' ' ' ALA . 47.3 mt -91.03 71.15 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.714 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.3 p -72.75 2.26 6.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.044 -179.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -143.75 146.61 33.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.841 0.353 . . . . 0.0 111.559 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.578 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 43.7 t -55.94 -50.2 88.61 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.577 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.1 Cg_endo -58.37 -45.85 28.25 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.873 1.716 . . . . 0.0 111.895 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.06 -34.32 77.34 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 110.29 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.581 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -65.42 -59.24 4.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.044 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.8 mtm -61.08 -24.2 66.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.021 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.5 mt-10 -73.91 -52.19 13.7 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.661 0.267 . . . . 0.0 110.544 179.592 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.83 -31.7 68.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.436 HD12 HD13 ' A' ' 36' ' ' ILE . 49.0 mt -75.05 -40.64 45.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.938 178.074 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.16 -16.9 62.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.096 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.89 24.3 5.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.266 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 t -170.77 153.7 4.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.618 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.464 ' HG3' HG11 ' A' ' 87' ' ' VAL . 16.6 tt0 -63.51 -75.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.469 HG11 HD13 ' A' ' 83' ' ' LEU . 18.2 t -96.97 136.63 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.817 0.341 . . . . 0.0 110.701 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.539 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.96 124.25 16.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.79 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.449 HG23 HG12 ' A' ' 111' ' ' ILE . 51.6 t -112.49 128.87 68.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.796 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 29.3 mt -134.2 137.33 52.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.517 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.62 97.22 1.68 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.199 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.471 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 41.9 m-85 -82.9 90.83 7.01 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.5 m-85 -109.91 140.63 43.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.41 -178.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.474 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 47.8 mt-30 -87.45 -9.3 55.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.458 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 17.7 t70 -148.91 123.43 9.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.53 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.518 ' HA ' HG22 ' A' ' 47' ' ' VAL . 94.8 mt -92.2 47.14 1.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.974 0.416 . . . . 0.0 111.599 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.9 mt-10 -137.94 10.47 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.113 178.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.661 HG13 HG23 ' A' ' 47' ' ' VAL . 4.1 pt -91.84 159.04 38.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.155 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.439 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 75.4 Cg_exo -53.93 -25.41 35.71 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.693 2.262 . . . . 0.0 112.858 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.28 -41.4 94.23 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.661 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -56.67 -55.6 41.4 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.612 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.6 Cg_exo -61.01 -42.23 38.33 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.572 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.613 HG23 HD11 ' A' ' 107' ' ' LEU . 5.8 mt -60.34 -33.65 54.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.097 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.536 ' O ' HG22 ' A' ' 54' ' ' VAL . 46.7 tp -75.36 -52.7 10.17 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -52.57 -27.42 16.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.1 0.476 . . . . 0.0 109.763 178.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -79.76 -49.07 12.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.624 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.522 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -57.08 -26.46 60.43 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.528 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 50' ' ' LEU . 54.6 t -51.67 -49.79 33.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.838 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -74.77 -16.31 60.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.679 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -88.01 -16.18 34.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.246 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.621 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 50.8 m-85 -137.56 62.43 35.99 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.447 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.52 -43.6 53.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.705 2.27 . . . . 0.0 111.671 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.8 -41.49 94.04 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.645 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 13.1 t -65.75 145.07 14.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.539 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 36.8 t -83.64 98.27 9.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 111.016 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.457 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 5.3 p90 -63.86 129.07 38.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.089 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -147.39 161.17 28.46 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.071 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -161.61 144.99 4.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.457 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 37.1 t -149.57 159.14 44.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.121 0.486 . . . . 0.0 111.777 -179.124 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.517 HG23 ' HG ' ' A' ' 42' ' ' LEU . 74.3 p -139.97 -1.87 1.55 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.546 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.59 138.91 55.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.74 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 61.2 m -61.58 -51.61 67.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.672 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -48.21 -44.08 32.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.695 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.512 ' HA ' HG21 ' A' ' 21' ' ' VAL . 76.1 t -70.7 -54.96 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.908 0.385 . . . . 0.0 110.769 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.41 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.2 mp -57.59 -14.57 5.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.2 179.37 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.6 m -91.2 -41.15 11.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.144 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -59.71 -40.22 87.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.455 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -93.33 15.07 16.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.725 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.7 m120 53.87 25.45 5.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.791 179.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.632 HG21 ' HB ' ' A' ' 80' ' ' THR . 40.2 mm -60.33 121.41 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.002 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.9 p -140.97 57.86 1.55 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.491 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.3 44.58 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.637 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 12.5 m120 51.97 44.09 29.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.247 0.546 . . . . 0.0 110.37 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.632 ' HB ' HG21 ' A' ' 76' ' ' ILE . 91.9 m -69.14 152.79 44.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.676 -178.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.517 HG12 ' HA2' ' A' ' 37' ' ' GLY . 66.1 mt -118.89 116.75 52.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.998 177.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.471 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 74.7 m -106.45 133.02 51.79 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.576 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -107.49 103.99 13.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.899 178.405 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -97.05 120.37 37.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.789 0.328 . . . . 0.0 110.694 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.477 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 5.3 mtm180 -104.18 82.22 1.93 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.719 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ARG . 7.2 tp -25.19 -59.66 0.06 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.41 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.464 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.73 -64.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.295 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -93.27 3.83 54.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.922 0.391 . . . . 0.0 110.959 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 49.56 36.59 10.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.526 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 6.3 mm-40 -83.57 157.08 22.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.5 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.18 96.06 3.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.724 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.576 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -84.71 111.55 19.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.048 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.35 115.41 27.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.262 0.553 . . . . 0.0 112.308 -178.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.511 HD22 HD12 ' A' ' 102' ' ' ILE . 3.1 tt -102.61 76.84 1.56 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.409 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 26.5 mt-10 -78.2 -165.08 0.62 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.499 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 22.6 t70 -50.48 -38.89 46.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.174 -179.16 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -54.89 -14.62 1.52 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.142 0.496 . . . . 0.0 110.343 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -130.42 -13.81 3.82 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.721 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.521 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 24.1 mm -90.8 -35.1 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.701 0.286 . . . . 0.0 111.435 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.77 -43.46 65.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.914 0.388 . . . . 0.0 110.758 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.7 m -122.34 40.33 3.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.518 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.521 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.6 tp -67.32 143.43 15.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.687 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.548 ' HA ' HD11 ' A' ' 49' ' ' ILE . 13.0 m-20 -138.37 148.31 44.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.536 178.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.608 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -47.14 -36.8 8.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.984 0.421 . . . . 0.0 110.449 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.2 m -62.07 -49.83 74.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.249 178.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -57.6 -60.96 2.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.227 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.613 HD11 HG23 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.69 -56.52 8.32 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.912 0.387 . . . . 0.0 110.44 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.7 m -58.66 -29.99 66.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.974 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.51 ' HD3' HD11 ' A' ' 113' ' ' ILE . 3.2 tmt_? -71.08 -65.33 0.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.138 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -43.44 -44.58 5.9 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.044 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.449 HG12 HG23 ' A' ' 35' ' ' VAL . 96.8 mt -62.6 -55.39 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.512 178.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.406 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 37.6 tt0 -54.36 -18.73 4.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.266 0.555 . . . . 0.0 110.305 179.392 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.51 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.44 -37.02 9.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.907 -179.136 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.542 HD21 ' HG ' ' A' ' 92' ' ' LEU . 89.6 m-20 -124.48 30.38 6.03 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 97.9 p -83.08 44.29 0.93 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.055 0.455 . . . . 0.0 110.091 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.4 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.33 -179.445 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.487 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.0 pt-20 . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 46.0 Cg_endo -68.51 142.57 54.3 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.531 2.154 . . . . 0.0 112.619 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.6 m -63.33 152.26 38.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.51 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 12.7 m0 -96.53 89.51 5.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.005 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.543 HD12 ' HA ' ' A' ' 24' ' ' ALA . 54.7 mt -83.4 71.28 10.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.056 0.455 . . . . 0.0 110.39 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.6 p -71.07 -1.83 13.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.096 -179.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -141.42 147.28 37.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.892 0.377 . . . . 0.0 111.673 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.1 t -57.33 -49.68 92.51 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.364 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.11 -43.76 45.08 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.939 1.759 . . . . 0.0 111.743 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.23 -34.85 79.34 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.2 0.524 . . . . 0.0 110.361 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.543 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -64.68 -58.65 5.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.954 179.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 59.4 mtm -60.6 -27.64 67.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.135 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -71.36 -50.68 29.81 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.756 0.312 . . . . 0.0 110.677 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -59.47 -34.77 72.96 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.435 HD13 HD13 ' A' ' 36' ' ' ILE . 48.4 mt -73.07 -39.38 57.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.103 178.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.26 -18.85 61.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.081 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.3 24.26 3.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.252 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.0 t -170.78 155.09 4.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.546 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.48 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.8 tt0 -65.53 -73.25 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.478 HG11 HD12 ' A' ' 83' ' ' LEU . 17.9 t -98.66 137.37 26.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.743 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.19 128.07 19.43 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.234 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.486 HG21 HG12 ' A' ' 111' ' ' ILE . 54.6 t -115.37 131.38 67.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.43 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 23.1 mt -136.55 136.17 48.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.543 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.64 98.16 1.89 Allowed Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.505 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.9 m-85 -83.34 89.73 7.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.0 m-85 -109.59 137.88 46.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.497 -178.018 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.441 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 48.8 mt-30 -85.18 -4.49 59.18 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.452 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 12.0 t70 -153.63 126.4 8.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.561 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.505 ' HG ' HG23 ' A' ' 66' ' ' THR . 95.1 mt -95.48 48.21 1.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.112 0.482 . . . . 0.0 111.369 -179.355 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 45.2 mt-10 -137.98 8.65 2.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.808 178.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.655 HG13 HG22 ' A' ' 47' ' ' VAL . 1.8 pt -91.94 157.17 41.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.247 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.427 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 76.3 Cg_exo -52.23 -26.03 25.49 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.915 2.41 . . . . 0.0 113.058 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.19 -36.06 83.0 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.655 HG22 HG13 ' A' ' 44' ' ' ILE . 2.5 t -62.78 -55.75 35.55 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.64 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.0 Cg_exo -60.83 -39.43 62.28 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.03 1.82 . . . . 0.0 111.471 179.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.612 HG21 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -63.45 -36.7 77.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.062 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.519 ' O ' HG21 ' A' ' 54' ' ' VAL . 42.8 tp -71.89 -51.95 19.73 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -53.21 -26.31 17.15 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.6 t -80.01 -47.55 14.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.656 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.17 -26.11 64.5 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.429 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.519 HG21 ' O ' ' A' ' 50' ' ' LEU . 54.7 t -53.11 -49.43 50.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.834 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -76.08 -10.59 59.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.626 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -93.69 -18.94 21.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.374 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.58 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 67.5 m-85 -135.96 62.21 45.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.589 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.9 -41.14 64.87 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.693 2.262 . . . . 0.0 111.568 179.114 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.14 -41.58 96.69 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.293 179.15 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.1 t -66.1 143.77 15.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.465 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 33.3 t -81.5 99.3 8.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.039 0.447 . . . . 0.0 110.844 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.436 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 3.9 p90 -65.61 126.76 29.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.987 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.95 162.73 28.35 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.318 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -160.89 141.34 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.1 t -144.29 151.78 39.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.107 0.48 . . . . 0.0 111.655 -179.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.505 HG23 ' HG ' ' A' ' 42' ' ' LEU . 81.6 p -135.57 -0.5 2.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.772 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.59 145.99 50.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.918 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.0 t -67.66 -50.58 57.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.466 -179.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -50.45 -44.05 55.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.363 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.503 ' HA ' HG23 ' A' ' 21' ' ' VAL . 58.4 t -70.83 -53.45 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.736 0.303 . . . . 0.0 110.604 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.4 -14.72 8.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.147 0.498 . . . . 0.0 110.459 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.0 m -92.56 -40.68 10.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.466 178.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -61.88 -35.33 78.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.497 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -95.55 12.88 28.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.872 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.595 ' N ' HD21 ' A' ' 75' ' ' ASN . 0.8 OUTLIER 56.93 23.65 8.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.691 179.236 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.647 HG21 ' HB ' ' A' ' 80' ' ' THR . 35.2 mm -61.08 121.13 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.092 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.2 p -141.02 57.86 1.55 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.378 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.51 46.49 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.536 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 14.0 m120 51.29 42.94 29.5 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.253 0.549 . . . . 0.0 110.406 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.647 ' HB ' HG21 ' A' ' 76' ' ' ILE . 93.0 m -68.93 152.39 45.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.65 -178.568 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.543 HG12 ' HA2' ' A' ' 37' ' ' GLY . 68.1 mt -119.32 118.53 57.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.241 178.163 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.497 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.9 m -107.34 134.04 50.98 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.599 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.8 tp -107.62 103.05 12.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.716 178.183 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.1 t80 -95.87 120.26 35.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.869 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.527 HH12 HD11 ' A' ' 116' ' ' LEU . 3.9 mtm180 -106.09 82.19 1.73 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.872 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.5 tp -25.11 -58.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.219 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.48 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.08 -60.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.375 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -100.77 4.77 43.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.128 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 54.08 26.01 6.11 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.373 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 13.9 mm-40 -70.61 155.18 41.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.822 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.86 95.06 2.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.445 179.391 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.599 HD21 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -84.36 111.55 19.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.224 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.7 118.08 30.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.37 0.605 . . . . 0.0 112.253 -179.13 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.484 HD23 HD12 ' A' ' 102' ' ' ILE . 4.3 tt -105.56 77.6 1.29 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.131 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.409 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.7 mt-10 -79.69 -163.84 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.905 -176.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.481 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.7 t70 -51.11 -35.71 36.7 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.925 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.402 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 12.9 pt-20 -56.18 -14.57 2.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.091 0.472 . . . . 0.0 110.192 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' OD2' ' HG3' ' A' ' 97' ' ' GLU . 35.5 m-20 -132.46 -14.05 2.94 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.573 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.502 HG23 ' HB2' ' A' ' 79' ' ' ASN . 25.4 mm -89.86 -33.96 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.718 0.294 . . . . 0.0 111.402 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -54.54 -34.23 61.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.753 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.5 p -133.06 40.25 3.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.341 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.6 tp -66.07 143.57 15.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.597 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.538 ' HA ' HD13 ' A' ' 49' ' ' ILE . 9.3 m-20 -138.62 148.56 44.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.5 178.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.612 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -46.91 -35.57 6.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.102 0.477 . . . . 0.0 110.342 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.2 m -63.33 -49.63 73.17 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.358 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -58.61 -59.66 5.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.131 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.605 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.7 -55.92 12.07 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.963 0.411 . . . . 0.0 110.317 179.875 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.2 m -58.66 -28.93 66.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.785 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.538 ' HD3' HD12 ' A' ' 113' ' ' ILE . 3.9 tmt_? -71.58 -65.69 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.169 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -42.91 -43.97 4.35 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.913 179.106 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.486 HG12 HG21 ' A' ' 35' ' ' VAL . 94.6 mt -62.96 -55.93 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.571 178.314 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.31 -17.81 3.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.538 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.83 -36.84 8.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.98 -179.194 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -124.37 30.02 6.16 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 81.2 p -82.38 47.69 1.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.013 0.435 . . . . 0.0 110.315 179.058 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.527 HD11 HH12 ' A' ' 85' ' ' ARG . 63.1 mt . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.297 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.464 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 120.525 0.202 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.0 Cg_endo -67.83 148.25 76.54 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.878 2.385 . . . . 0.0 112.6 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.3 m -64.64 153.99 37.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.54 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -98.84 89.37 4.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.005 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.534 HD11 ' HA ' ' A' ' 24' ' ' ALA . 50.1 mt -86.86 74.14 9.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.603 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.9 p -71.82 -1.25 13.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.266 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -143.52 148.73 36.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.868 0.366 . . . . 0.0 111.863 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.585 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 20.4 t -56.86 -50.66 86.78 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.407 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.52 -43.45 50.97 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.944 1.763 . . . . 0.0 111.884 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.61 -35.47 80.9 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.222 0.534 . . . . 0.0 110.299 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.534 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -64.26 -58.2 7.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.868 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.7 mtm -60.25 -28.56 68.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.005 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 17.0 mt-10 -70.57 -48.9 53.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.794 0.331 . . . . 0.0 110.568 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -60.75 -33.64 73.24 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.999 179.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 36' ' ' ILE . 38.1 mt -73.55 -39.6 54.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.003 178.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.33 -19.16 62.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.177 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.32 26.45 3.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.253 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 t -172.8 154.28 2.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.705 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.49 ' HG3' HG11 ' A' ' 87' ' ' VAL . 22.3 tt0 -63.65 -79.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.711 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.47 HG11 HD12 ' A' ' 83' ' ' LEU . 16.0 t -92.88 139.03 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.661 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.45 122.99 14.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 0.0 111.716 -179.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.577 HG22 HG12 ' A' ' 111' ' ' ILE . 55.1 t -112.03 128.34 68.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.755 178.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 28' ' ' ILE . 38.4 mt -134.08 137.59 51.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.604 -177.015 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.507 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.75 98.26 1.82 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.217 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.457 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 35.8 m-85 -84.17 91.88 7.8 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.575 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.8 m-85 -111.78 143.76 42.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.356 -178.085 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -89.31 -8.07 54.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.431 ' O ' HG12 ' A' ' 44' ' ' ILE . 13.4 t70 -149.79 124.57 9.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.618 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.546 ' HG ' HG21 ' A' ' 66' ' ' THR . 90.6 mt -93.18 46.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.055 0.455 . . . . 0.0 111.511 -179.239 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.412 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 37.1 mt-10 -136.98 8.93 3.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.917 178.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.665 HG13 HG23 ' A' ' 47' ' ' VAL . 2.2 pt -91.81 155.56 43.37 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.4 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.447 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 83.8 Cg_exo -50.42 -26.61 16.53 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.877 2.385 . . . . 0.0 112.964 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.48 -38.52 91.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -179.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.665 HG23 HG13 ' A' ' 44' ' ' ILE . 2.8 t -60.0 -55.91 40.83 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.656 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.7 Cg_exo -60.67 -41.59 45.93 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.081 1.854 . . . . 0.0 111.545 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.617 HG22 HD13 ' A' ' 107' ' ' LEU . 5.8 mt -61.12 -35.17 63.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.973 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.532 ' O ' ' HG3' ' A' ' 53' ' ' MET . 50.4 tp -74.57 -49.47 21.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.06 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -55.14 -25.83 34.63 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -81.84 -47.34 12.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.69 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.532 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -58.48 -26.38 63.35 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.455 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 50' ' ' LEU . 41.9 t -52.82 -48.01 50.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.123 179.395 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -77.97 -11.88 59.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -92.23 -17.86 24.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.312 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.592 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 62.4 m-85 -136.5 62.36 42.52 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.453 -179.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.33 -42.12 62.38 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.79 2.327 . . . . 0.0 111.677 179.137 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.9 -40.59 95.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.443 179.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.4 t -67.22 142.6 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.531 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 28.7 t -81.17 98.46 8.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.049 0.452 . . . . 0.0 110.877 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.491 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 4.6 p90 -66.04 129.44 39.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.015 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -147.32 161.98 28.57 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.003 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -160.93 143.93 4.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.457 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 34.1 t -149.79 158.3 44.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.1 0.476 . . . . 0.0 111.693 -179.165 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.546 HG21 ' HG ' ' A' ' 42' ' ' LEU . 77.5 p -139.86 2.53 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.668 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -72.18 134.51 45.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.428 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.1 t -57.86 -49.29 77.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.435 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -50.21 -43.49 52.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.695 -179.378 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.545 ' HA ' HG21 ' A' ' 21' ' ' VAL . 73.9 t -71.35 -53.2 21.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.967 0.413 . . . . 0.0 110.69 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 76' ' ' ILE . 6.6 mp -59.31 -14.34 11.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.176 179.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.5 m -92.02 -41.24 10.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.251 178.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -60.68 -38.51 85.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.434 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -92.61 10.46 30.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.766 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.9 t30 58.95 23.01 11.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.626 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.625 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.0 mm -60.23 123.34 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.022 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.5 p -143.62 60.05 1.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.028 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.86 43.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.572 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 30.0 m-80 52.09 43.57 30.35 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.109 0.48 . . . . 0.0 110.43 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.625 ' HB ' HG23 ' A' ' 76' ' ' ILE . 88.5 m -68.41 152.67 45.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.655 -178.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.545 HG23 HD23 ' A' ' 107' ' ' LEU . 62.2 mt -118.46 115.53 48.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 78.3 m -103.63 135.14 45.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -177.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.569 ' HG ' HD22 ' A' ' 92' ' ' LEU . 3.0 tp -110.72 105.61 14.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.125 178.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.7 t80 -99.41 118.94 37.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.996 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.442 HH12 HD11 ' A' ' 116' ' ' LEU . 3.3 mtm180 -103.29 80.69 1.86 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.789 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 85' ' ' ARG . 6.6 tp -24.33 -59.65 0.05 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.935 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.49 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.79 -62.48 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.302 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -96.87 3.3 52.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.0 0.428 . . . . 0.0 111.065 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 51.77 32.07 9.01 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.526 179.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.9 mm-40 -80.03 137.5 36.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.614 179.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.02 93.31 4.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.028 0.442 . . . . 0.0 110.86 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.588 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.3 mm? -81.16 141.39 34.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.361 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -121.86 115.18 22.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.322 0.582 . . . . 0.0 112.343 -179.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.496 HD22 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -99.57 74.88 1.91 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -76.38 -166.03 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -176.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.439 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.4 OUTLIER -46.01 -51.7 13.1 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.418 -179.278 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -47.15 -15.83 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.275 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 96' ' ' ASP . 30.5 m-20 -127.02 -14.03 5.6 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.351 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.509 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 22.4 mm -91.59 -40.48 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -46.18 -42.85 14.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 t -124.45 41.36 3.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.491 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.509 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.3 tp -66.86 143.6 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.712 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.525 ' HA ' HD12 ' A' ' 49' ' ' ILE . 15.7 m-20 -137.22 149.54 47.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.486 178.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -48.23 -36.77 14.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.379 . . . . 0.0 110.461 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.5 m -62.27 -48.42 79.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.236 178.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 103' ' ' ASP . 28.8 mtpp -58.86 -59.34 5.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.188 -179.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.617 HD13 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.2 -56.39 11.25 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.05 0.452 . . . . 0.0 110.182 -179.96 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.6 m -58.05 -28.8 64.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.744 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.47 ' HD3' HD12 ' A' ' 113' ' ' ILE . 2.9 tmt_? -71.6 -66.05 0.68 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.967 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -42.13 -45.52 4.03 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.865 179.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.577 HG12 HG22 ' A' ' 35' ' ' VAL . 82.1 mt -61.33 -56.86 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.593 178.521 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -53.82 -18.07 2.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.336 179.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.47 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.43 -37.16 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.215 -179.042 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.588 HD21 ' HG ' ' A' ' 92' ' ' LEU . 82.9 m-20 -124.62 29.63 6.21 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 99.8 p -82.9 49.11 1.45 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.996 0.427 . . . . 0.0 110.316 179.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.442 HD11 HH12 ' A' ' 85' ' ' ARG . 73.7 mt . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.355 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.508 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.9 pt-20 . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.423 0.154 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 31.4 Cg_endo -65.0 139.76 62.89 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.487 2.124 . . . . 0.0 112.526 -179.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.416 HG23 ' N ' ' A' ' 17' ' ' TRP . 19.2 m -57.18 154.34 10.34 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.003 -179.399 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.416 ' N ' HG23 ' A' ' 16' ' ' THR . 10.4 m-90 -98.21 94.11 6.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.902 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.557 HD22 ' HA ' ' A' ' 24' ' ' ALA . 51.3 mt -90.07 70.01 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.27 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.2 p -68.82 -2.6 9.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.246 -178.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -142.61 147.53 35.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.997 0.427 . . . . 0.0 111.645 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.7 t -55.29 -50.01 89.11 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.638 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.6 Cg_endo -57.06 -46.87 25.86 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.958 1.772 . . . . 0.0 111.924 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.8 -34.62 77.66 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.193 0.52 . . . . 0.0 110.113 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.557 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.13 -59.26 4.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.054 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.4 mtp -60.62 -25.19 66.09 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.183 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -72.26 -50.82 24.3 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.571 179.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -61.72 -29.48 70.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.479 HD11 HD13 ' A' ' 36' ' ' ILE . 50.2 mt -76.11 -37.48 33.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.068 178.217 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.79 -19.54 60.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.115 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.41 30.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.197 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.401 HG23 ' HB2' ' A' ' 61' ' ' SER . 9.7 t -170.97 153.53 3.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.314 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.546 ' HG3' HG12 ' A' ' 87' ' ' VAL . 27.5 tt0 -70.18 -46.29 64.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.793 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.46 HG12 HD12 ' A' ' 83' ' ' LEU . 21.1 t -124.53 135.22 64.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.286 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.56 127.47 22.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.163 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.532 HG22 HG12 ' A' ' 111' ' ' ILE . 49.2 t -115.66 128.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.465 178.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.479 HD13 HD11 ' A' ' 28' ' ' ILE . 22.2 mt -134.64 138.41 49.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.556 -177.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.534 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.87 97.06 1.64 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.378 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.464 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 39.3 m-85 -82.95 91.96 7.24 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.0 m-85 -112.0 145.21 40.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.181 0.515 . . . . 0.0 112.378 -178.188 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.443 ' HG2' HD22 ' A' ' 71' ' ' LEU . 46.2 mt-30 -93.17 -0.99 56.75 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.441 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.8 t70 -156.58 123.85 5.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.564 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 66' ' ' THR . 84.0 mt -93.75 47.5 1.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.204 0.526 . . . . 0.0 111.505 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.416 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 45.4 mt-10 -137.38 7.27 2.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.729 178.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.653 HG13 HG21 ' A' ' 47' ' ' VAL . 2.0 pt -89.68 156.55 47.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.027 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.428 ' O ' HD13 ' A' ' 49' ' ' ILE . 72.1 Cg_exo -52.16 -24.19 19.62 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.876 2.384 . . . . 0.0 113.007 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.32 -35.99 80.56 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.653 HG21 HG13 ' A' ' 44' ' ' ILE . 2.6 t -61.9 -54.97 45.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.667 -178.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.641 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.6 Cg_exo -61.44 -40.28 49.48 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.999 1.799 . . . . 0.0 111.445 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.609 HG22 HD11 ' A' ' 107' ' ' LEU . 6.3 mt -63.11 -35.92 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.19 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.529 ' O ' ' HG3' ' A' ' 53' ' ' MET . 48.9 tp -73.06 -50.26 23.99 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -54.82 -25.37 27.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.198 0.523 . . . . 0.0 109.598 178.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.9 t -80.98 -47.23 13.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.547 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.23 -27.17 65.51 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.541 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.524 HG21 ' O ' ' A' ' 50' ' ' LEU . 53.6 t -51.71 -50.91 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.021 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -74.68 -12.35 60.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.722 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -91.81 -17.34 25.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.215 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.6 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.0 m-85 -138.15 63.37 36.23 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.568 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.07 -41.11 74.19 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.652 2.235 . . . . 0.0 111.58 179.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.3 -41.83 97.05 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.35 179.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.6 t -65.76 144.69 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.514 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 47.5 t -82.35 97.23 8.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.026 0.441 . . . . 0.0 111.006 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -64.45 126.64 28.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.724 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.1 161.84 28.33 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.169 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -161.03 143.02 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.464 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 35.6 t -147.25 153.52 39.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.071 0.462 . . . . 0.0 111.805 -179.061 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.51 HG21 ' HG ' ' A' ' 42' ' ' LEU . 64.4 p -135.62 5.73 3.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.371 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.27 140.34 44.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.738 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.8 m -62.94 -52.78 61.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.378 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -47.7 -44.73 27.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.614 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.486 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.0 t -70.05 -55.29 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.832 0.348 . . . . 0.0 110.991 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.443 HD22 ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -57.39 -14.84 5.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.25 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.4 m -90.48 -41.43 11.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.246 178.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -60.1 -39.42 86.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.392 179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -92.93 12.99 21.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.959 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.3 m120 55.15 24.28 6.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.623 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.607 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.4 mm -60.16 120.43 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.97 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.5 p -142.05 55.67 1.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.942 0.401 . . . . 0.0 111.109 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.44 42.37 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.432 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 35.6 m-20 52.24 43.37 30.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.232 0.539 . . . . 0.0 110.364 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.607 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.6 m -68.95 151.11 46.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.87 -178.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.556 HG22 HD23 ' A' ' 107' ' ' LEU . 64.0 mt -117.8 115.47 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.911 177.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.456 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 78.3 m -103.82 132.57 49.95 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.577 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.3 tp -109.07 103.68 12.74 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.803 178.312 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -98.73 122.15 41.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.821 0.343 . . . . 0.0 110.79 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.455 HH21 ' HB2' ' A' ' 88' ' ' ASP . 2.8 mtm180 -105.04 98.72 8.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.036 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.3 tp -41.9 -52.71 4.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.882 -179.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.546 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.7 -71.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.385 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.455 ' HB2' HH21 ' A' ' 85' ' ' ARG . 11.2 m-20 -88.33 6.01 39.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.041 -179.665 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 52.49 35.89 18.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.387 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 7.3 mm-40 -81.46 161.66 23.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.817 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -146.05 92.81 2.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.92 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.585 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.4 mm? -79.39 144.23 34.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.181 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -124.56 95.49 4.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.498 HD22 HD12 ' A' ' 102' ' ' ILE . 3.9 tt -81.0 77.78 7.88 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.639 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.42 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.5 mt-10 -78.8 -165.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.487 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 25.5 t70 -51.01 -36.47 39.57 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.932 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -56.27 -14.61 2.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.183 0.516 . . . . 0.0 110.361 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -130.68 -13.95 3.67 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.592 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.538 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 23.0 mm -89.49 -32.71 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.754 0.311 . . . . 0.0 111.373 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -50.36 -47.98 55.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.728 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -122.05 38.31 4.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.609 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.538 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.0 tp -61.07 143.44 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.653 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.539 ' HA ' HD11 ' A' ' 49' ' ' ILE . 19.1 m-20 -137.12 147.91 46.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.473 178.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.601 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -47.1 -35.26 6.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.99 0.424 . . . . 0.0 110.45 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -63.91 -48.68 75.62 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.423 178.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -58.98 -58.58 8.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.115 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.609 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.49 -55.78 14.47 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.998 0.428 . . . . 0.0 110.134 179.901 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.1 m -58.31 -28.98 65.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.823 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.456 ' HD3' HD11 ' A' ' 113' ' ' ILE . 2.7 tmt_? -72.65 -65.88 0.73 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.222 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -42.92 -42.82 3.86 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.04 179.112 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.532 HG12 HG22 ' A' ' 35' ' ' VAL . 92.2 mt -64.18 -56.63 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.576 178.371 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -52.33 -22.16 4.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.367 0.604 . . . . 0.0 110.211 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.456 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -85.17 -37.88 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.93 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.585 HD21 ' HG ' ' A' ' 92' ' ' LEU . 88.9 m-20 -123.64 30.78 6.1 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.312 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 111' ' ' ILE . 87.4 p -83.5 39.58 0.68 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.18 0.514 . . . . 0.0 110.066 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.7 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.291 -179.453 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.1 pt-20 . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 120.426 0.155 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 35.9 Cg_endo -66.3 140.71 59.53 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.55 2.167 . . . . 0.0 112.465 -179.701 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 m -56.46 150.5 15.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.666 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -96.27 93.36 6.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.98 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 24' ' ' ALA . 54.2 mt -90.7 72.93 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.511 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.7 p -74.96 2.11 11.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.065 -179.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -144.67 147.54 33.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 0.0 111.595 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.581 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 39.7 t -56.48 -50.21 89.08 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.622 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.96 -44.92 35.82 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 121.876 1.717 . . . . 0.0 111.797 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.85 -36.22 83.2 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.169 0.509 . . . . 0.0 110.33 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.551 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -63.21 -59.4 4.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.148 179.377 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 65.8 mtp -60.97 -25.19 66.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.139 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 21.3 mt-10 -72.59 -51.98 17.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.719 0.295 . . . . 0.0 110.648 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -59.94 -31.87 70.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.935 179.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.458 HD13 HD12 ' A' ' 36' ' ' ILE . 50.7 mt -75.27 -38.8 41.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.938 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.61 -19.0 61.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.232 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.76 26.18 3.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.243 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 t -170.62 153.75 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.611 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.491 ' HG3' HG13 ' A' ' 87' ' ' VAL . 18.2 tt0 -64.5 -73.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.491 HG13 HD13 ' A' ' 83' ' ' LEU . 19.7 t -98.13 137.81 24.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.613 179.787 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.517 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.18 125.65 16.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.937 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.518 HG23 HG12 ' A' ' 111' ' ' ILE . 55.0 t -114.07 130.16 68.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.85 178.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 27.0 mt -135.53 137.78 49.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.625 -177.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.24 98.08 1.75 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.587 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.0 m-85 -84.3 91.84 7.85 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.4 m-85 -110.84 143.87 40.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.287 -178.191 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.452 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 49.9 mt-30 -91.51 -3.3 56.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.503 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.6 t70 -154.8 118.46 4.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.596 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.488 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.8 mt -87.96 44.78 1.22 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.01 0.433 . . . . 0.0 111.329 -179.318 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 31.3 mt-10 -135.28 10.11 3.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.128 179.054 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.666 HG13 HG22 ' A' ' 47' ' ' VAL . 3.3 pt -92.77 157.57 39.4 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.477 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.453 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 71.8 Cg_exo -52.22 -27.5 30.43 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.908 2.405 . . . . 0.0 112.898 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.36 -39.95 95.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.666 HG22 HG13 ' A' ' 44' ' ' ILE . 2.2 t -58.57 -56.89 30.92 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -178.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -58.87 -40.29 73.4 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.783 1.655 . . . . 0.0 111.438 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.613 HG22 HD12 ' A' ' 107' ' ' LEU . 6.2 mt -61.85 -35.34 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.936 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.53 ' O ' ' HG3' ' A' ' 53' ' ' MET . 39.7 tp -75.03 -54.67 6.76 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -52.68 -23.69 7.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.0 0.429 . . . . 0.0 109.947 178.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -84.22 -46.08 12.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.557 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.53 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.0 -25.26 63.48 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.318 0.58 . . . . 0.0 109.457 179.433 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 50' ' ' LEU . 54.3 t -51.57 -50.49 29.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.121 179.352 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -76.08 -9.48 58.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.874 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -93.13 -19.74 21.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.998 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.9 m-85 -135.84 63.79 53.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.506 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.61 -43.2 57.05 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.707 2.272 . . . . 0.0 111.576 179.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.42 -42.29 93.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.337 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -65.27 143.77 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 38.2 t -82.28 98.12 8.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 111.092 -179.627 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.439 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.4 p90 -65.37 128.35 35.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.927 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -147.83 161.84 28.62 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.025 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.403 HD13 HG12 ' A' ' 47' ' ' VAL . 4.7 tt -160.18 144.3 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 t -148.48 158.72 44.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.191 0.519 . . . . 0.0 111.865 -178.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.488 HG22 ' HG ' ' A' ' 42' ' ' LEU . 72.5 p -141.49 1.03 1.53 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.585 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.02 144.97 52.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.663 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.4 m -66.67 -53.4 34.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.344 -179.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -48.71 -42.95 36.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.511 -179.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.491 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.8 t -70.56 -56.12 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.051 0.453 . . . . 0.0 110.648 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.49 -15.08 3.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.315 179.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.5 m -90.87 -41.23 11.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.304 178.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -61.33 -31.91 71.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.251 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -100.02 12.39 37.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.274 179.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.7 m120 55.95 22.05 5.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.595 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.66 HG21 ' HB ' ' A' ' 80' ' ' THR . 32.4 mm -58.96 118.99 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.152 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.6 p -142.16 55.81 1.46 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.085 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.82 42.41 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.355 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 14.1 m120 53.17 42.19 32.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.256 0.55 . . . . 0.0 110.203 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.66 ' HB ' HG21 ' A' ' 76' ' ' ILE . 92.9 m -67.93 151.77 46.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.864 -178.497 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.541 HG12 ' HA2' ' A' ' 37' ' ' GLY . 66.4 mt -118.95 115.79 49.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.88 177.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.528 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.4 m -105.34 132.65 51.26 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.611 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.5 tp -108.34 103.91 13.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.925 178.327 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.5 t80 -97.36 123.58 41.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.847 0.356 . . . . 0.0 110.579 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.475 HH12 HD13 ' A' ' 116' ' ' LEU . 4.5 mtm180 -106.36 81.23 1.58 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.705 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 85' ' ' ARG . 4.6 tp -24.13 -59.76 0.05 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.06 -179.537 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.491 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.03 -61.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.064 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.9 4.29 49.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.953 0.406 . . . . 0.0 111.19 -179.428 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.9 m120 53.21 28.24 6.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.81 179.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.0 mm-40 -74.13 159.29 32.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.578 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -144.19 96.8 2.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.827 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.611 HD21 ' HG ' ' A' ' 83' ' ' LEU . 2.1 mm? -85.32 111.57 20.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.058 179.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -93.87 101.36 13.44 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.538 HD23 HD12 ' A' ' 102' ' ' ILE . 3.4 tt -86.72 75.82 9.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.42 ' HG2' ' HG1' ' A' ' 80' ' ' THR . 27.0 mt-10 -77.1 -166.1 0.66 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -176.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.45 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -46.11 -50.67 15.13 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.398 -179.388 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -47.73 -16.3 0.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.976 0.417 . . . . 0.0 111.285 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.41 ' N ' ' C ' ' A' ' 96' ' ' ASP . 43.0 m-20 -126.38 -13.91 5.98 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.465 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.537 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 20.9 mm -91.46 -32.21 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -48.84 -59.31 3.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.962 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.6 p -110.72 36.28 3.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.585 179.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.538 HD12 HD23 ' A' ' 94' ' ' LEU . 8.7 tp -56.91 144.66 8.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.438 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.549 ' HA ' HD13 ' A' ' 49' ' ' ILE . 21.7 m-20 -138.5 148.75 44.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.721 179.072 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.59 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -48.18 -36.72 14.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.029 0.442 . . . . 0.0 110.491 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 96.6 m -61.46 -49.07 78.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.174 178.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.424 ' HD3' ' H ' ' A' ' 103' ' ' ASP . 55.9 mtpt -58.1 -61.45 2.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.148 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.613 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.21 -56.54 7.69 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.903 0.382 . . . . 0.0 110.511 -179.849 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 56.6 m -58.31 -29.85 66.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.918 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.502 ' HD3' HD11 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -71.29 -64.7 0.86 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.252 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -44.52 -43.01 7.64 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.079 179.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.518 HG12 HG23 ' A' ' 35' ' ' VAL . 95.9 mt -63.76 -56.43 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.639 178.464 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -53.23 -19.39 3.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.179 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.502 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.56 -37.75 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.07 -179.075 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -122.4 30.03 6.7 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.6 p -82.35 43.74 0.83 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.123 0.487 . . . . 0.0 110.152 178.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.475 HD13 HH12 ' A' ' 85' ' ' ARG . 49.5 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.408 -179.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.9 pt-20 . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 110.687 -0.116 . . . . 0.0 110.687 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.7 Cg_endo -66.89 141.65 59.58 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.423 2.082 . . . . 0.0 112.173 -179.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.6 m -56.42 152.31 11.67 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.495 -179.547 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -99.79 85.67 3.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.062 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 24' ' ' ALA . 49.7 mt -81.89 74.61 8.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.453 179.84 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.7 p -74.14 -1.96 22.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.98 -178.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -140.11 147.02 39.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.422 . . . . 0.0 111.643 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.579 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 32.2 t -56.09 -50.05 89.62 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.534 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.4 Cg_endo -58.74 -45.33 29.94 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.808 1.672 . . . . 0.0 111.718 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.54 -33.82 76.42 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.25 0.547 . . . . 0.0 110.169 179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.554 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -64.93 -59.11 4.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.006 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.8 mtp -60.6 -26.02 66.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.182 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.3 mt-10 -72.86 -50.97 20.66 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.708 0.289 . . . . 0.0 110.642 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -59.92 -32.2 70.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.854 179.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.441 HD13 HD11 ' A' ' 36' ' ' ILE . 47.6 mt -75.08 -40.5 44.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.08 0.466 . . . . 0.0 110.111 178.312 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -18.7 62.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.207 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.48 25.41 3.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.206 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.7 t -171.0 155.1 4.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.744 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.493 ' HG3' HG11 ' A' ' 87' ' ' VAL . 18.4 tt0 -64.61 -77.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.824 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.524 HG12 HD11 ' A' ' 83' ' ' LEU . 20.2 t -95.93 136.97 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.731 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.527 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.41 126.04 17.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.942 0.401 . . . . 0.0 112.074 -179.124 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.487 HG23 HG12 ' A' ' 111' ' ' ILE . 53.9 t -114.53 131.01 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.836 178.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 27.9 mt -135.97 135.39 50.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.274 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.559 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.58 98.06 1.97 Allowed Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.619 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 10.8 m-85 -84.17 91.73 7.77 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.0 m-85 -112.08 137.98 49.37 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.128 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -83.21 -7.03 59.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.437 ' O ' HG12 ' A' ' 44' ' ' ILE . 7.2 t70 -152.03 125.6 8.89 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.654 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.515 ' HG ' HG22 ' A' ' 66' ' ' THR . 96.0 mt -93.23 43.27 1.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.039 0.447 . . . . 0.0 111.407 -179.645 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -132.55 14.79 4.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.828 178.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.655 HG13 HG22 ' A' ' 47' ' ' VAL . 2.6 pt -99.08 157.77 33.48 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.197 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.444 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 74.1 Cg_exo -52.99 -26.98 33.88 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.9 2.4 . . . . 0.0 112.956 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.77 -38.25 89.86 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.017 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.655 HG22 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.35 -56.4 34.2 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.629 -178.826 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.2 Cg_exo -59.64 -41.23 57.98 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.942 1.762 . . . . 0.0 111.372 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.614 HG21 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -61.16 -35.87 68.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.054 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.525 ' O ' ' HG3' ' A' ' 53' ' ' MET . 48.8 tp -73.68 -52.06 14.58 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 178.784 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -53.58 -25.18 16.2 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.705 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -81.76 -46.82 13.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.505 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.16 -25.81 64.24 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.357 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.7 t -53.06 -47.69 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.948 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -77.99 -11.62 59.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.714 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -92.73 -17.77 23.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.155 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.602 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.3 m-85 -137.14 62.63 39.85 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.605 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.37 -39.46 81.47 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.517 2.145 . . . . 0.0 111.466 178.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.65 -39.42 96.55 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.458 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.1 t -68.58 144.09 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.067 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 35.7 t -81.29 98.08 7.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 110.916 -179.754 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.451 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.2 p90 -65.16 127.52 32.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.77 162.88 28.57 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.212 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -160.68 143.71 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.774 0.321 . . . . 0.0 110.155 179.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.3 t -146.91 154.17 40.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.041 0.448 . . . . 0.0 111.512 -179.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.515 HG22 ' HG ' ' A' ' 42' ' ' LEU . 81.9 p -137.73 -4.75 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.71 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.35 144.49 55.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.831 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -64.35 -51.49 63.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.46 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -48.6 -45.26 37.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.656 -179.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.508 ' HA ' HG21 ' A' ' 21' ' ' VAL . 74.5 t -70.15 -53.47 23.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.829 0.347 . . . . 0.0 110.724 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.71 -14.32 8.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.351 179.416 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.2 m -91.91 -41.68 10.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.274 178.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -60.09 -39.62 86.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.414 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -91.74 11.95 22.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.787 179.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 55.79 26.23 9.32 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.542 179.222 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.625 HG22 ' HB ' ' A' ' 80' ' ' THR . 39.0 mm -61.89 122.06 11.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.226 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.6 p -140.83 58.2 1.55 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.311 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.87 46.77 0.02 OUTLIER Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.89 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 30.2 m-80 50.57 43.0 27.53 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.229 0.538 . . . . 0.0 110.543 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.625 ' HB ' HG22 ' A' ' 76' ' ' ILE . 94.6 m -69.17 152.57 44.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.686 -178.612 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.559 HG12 ' HA2' ' A' ' 37' ' ' GLY . 60.6 mt -118.9 118.34 57.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.107 178.189 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.9 m -107.89 134.07 51.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.599 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -109.53 104.73 13.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.085 178.544 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.4 t80 -97.3 122.61 40.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.464 179.555 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.534 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.6 mtm180 -106.85 82.71 1.74 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.928 0.394 . . . . 0.0 110.835 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tp -25.67 -60.03 0.07 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.127 -179.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.493 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.25 -58.75 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.852 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -98.83 13.28 32.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.758 0.313 . . . . 0.0 111.37 -179.177 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.2 p30 43.55 30.95 0.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.017 178.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.534 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 28.2 mm-40 -77.47 157.16 30.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.835 0.35 . . . . 0.0 110.916 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.429 HE22 ' HB3' ' A' ' 93' ' ' ASN . 1.2 tm0? -142.26 94.48 2.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.676 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.599 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -85.25 121.69 28.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.637 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.484 ' H ' ' ND2' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -105.16 103.77 13.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.767 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.485 HD21 HD11 ' A' ' 102' ' ' ILE . 4.6 tt -89.63 78.67 6.96 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -79.81 -165.87 0.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.458 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.1 -51.06 10.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.7 -179.311 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -46.56 -18.88 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.857 0.361 . . . . 0.0 111.088 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 96' ' ' ASP . 16.2 m-20 -124.73 -13.82 6.89 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.488 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.559 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 24.7 mm -90.59 -40.61 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.363 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -49.08 -40.91 33.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.342 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.3 t -123.68 36.41 4.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.449 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 8.1 tp -63.14 144.68 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.475 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.524 ' HA ' HD13 ' A' ' 49' ' ' ILE . 19.8 m-20 -139.69 147.88 41.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.475 178.756 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.614 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -47.11 -37.84 10.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.984 0.421 . . . . 0.0 110.554 -179.571 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -61.43 -47.55 85.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.311 178.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -60.12 -60.83 3.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.215 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.609 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.0 -55.56 11.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.329 -179.999 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.0 m -58.45 -30.49 66.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.732 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.432 ' C ' ' HD3' ' A' ' 109' ' ' ARG . 2.5 tmt_? -70.4 -66.55 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.128 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -42.62 -45.16 4.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.169 179.454 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.487 HG12 HG23 ' A' ' 35' ' ' VAL . 96.4 mt -62.41 -54.76 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.306 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.409 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 40.8 tt0 -54.6 -18.78 4.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.426 179.397 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.425 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.62 -37.43 10.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.79 -178.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.558 HD21 ' HG ' ' A' ' 92' ' ' LEU . 89.1 m-20 -122.96 29.36 6.82 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.387 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 78.9 p -82.65 50.85 1.75 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.118 0.485 . . . . 0.0 110.092 178.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.496 HD11 HH12 ' A' ' 85' ' ' ARG . 57.0 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.278 -0.867 . . . . 0.0 111.374 -179.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.1 pt-20 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.405 0.145 . . . . 0.0 110.714 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.453 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.7 Cg_endo -65.37 145.21 82.68 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.618 2.212 . . . . 0.0 112.48 -179.569 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.429 HG21 ' N ' ' A' ' 17' ' ' TRP . 21.8 m -61.76 155.36 23.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.74 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.429 ' N ' HG21 ' A' ' 16' ' ' THR . 7.4 m-90 -99.1 91.46 5.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.077 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.556 HD23 ' HA ' ' A' ' 24' ' ' ALA . 49.8 mt -87.97 74.19 8.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.415 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.7 p -73.02 -3.18 24.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.156 -178.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -141.31 148.28 39.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.865 0.364 . . . . 0.0 111.643 -179.721 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.9 t -56.54 -50.28 88.7 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.407 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -57.34 -44.04 46.6 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 121.97 1.78 . . . . 0.0 111.866 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.24 -36.91 85.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.206 0.527 . . . . 0.0 110.184 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.556 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -62.87 -59.05 5.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.026 179.499 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.0 mtp -60.55 -27.19 67.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.212 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 19.8 mt-10 -70.66 -49.29 48.87 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.746 0.308 . . . . 0.0 110.547 179.843 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -61.52 -34.16 75.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.243 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.474 HD12 HD11 ' A' ' 36' ' ' ILE . 50.0 mt -72.99 -37.06 52.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.126 0.488 . . . . 0.0 109.939 178.345 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.01 -19.43 60.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.959 -179.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.61 23.95 4.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.297 -179.651 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.1 t -169.96 153.33 4.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.518 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.492 ' HG3' HG12 ' A' ' 87' ' ' VAL . 21.2 tt0 -63.92 -80.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.669 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.48 HG12 HD11 ' A' ' 83' ' ' LEU . 16.9 t -91.86 134.15 31.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.489 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.43 126.06 22.11 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.195 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.518 HG22 HG12 ' A' ' 111' ' ' ILE . 48.9 t -114.21 129.13 70.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.811 178.546 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.474 HD11 HD12 ' A' ' 28' ' ' ILE . 24.2 mt -135.59 137.17 49.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.439 -177.524 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.493 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.61 98.71 1.89 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.427 179.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.476 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 45.7 m-85 -84.62 93.05 8.3 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.302 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.2 m-85 -112.33 145.86 39.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.351 -177.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -93.81 -4.95 49.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.492 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.1 t70 -152.68 118.39 5.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.599 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.468 ' HG ' HG23 ' A' ' 66' ' ' THR . 92.4 mt -88.15 45.8 1.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 111.336 -179.295 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.438 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 45.4 mt-10 -136.03 9.06 3.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.125 179.161 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.67 HG13 HG23 ' A' ' 47' ' ' VAL . 2.7 pt -92.27 157.52 40.48 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.152 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.452 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 72.3 Cg_exo -52.53 -27.94 34.36 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.855 2.37 . . . . 0.0 112.865 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.47 -37.79 87.29 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.67 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.51 -57.35 25.63 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.654 -178.833 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -59.39 -38.97 80.94 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.794 1.663 . . . . 0.0 111.37 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.618 HG21 HD11 ' A' ' 107' ' ' LEU . 6.4 mt -63.26 -35.19 71.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.89 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.543 ' O ' ' HG3' ' A' ' 53' ' ' MET . 40.7 tp -74.61 -53.35 9.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.73 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -54.64 -21.81 11.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.009 0.433 . . . . 0.0 110.04 178.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 t -85.89 -45.01 11.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.491 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.543 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -60.31 -25.83 66.07 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.296 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 50' ' ' LEU . 53.4 t -52.39 -49.92 40.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.999 179.286 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -74.91 -9.59 58.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.721 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -94.83 -19.35 20.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.09 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.553 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 70.4 m-85 -135.96 63.03 49.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.476 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.4 -43.15 56.36 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.629 2.219 . . . . 0.0 111.632 179.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.89 -42.66 92.43 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.338 179.188 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.8 t -64.47 145.27 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.519 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 29.9 t -83.15 98.94 9.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.033 0.444 . . . . 0.0 111.072 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.453 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.0 p90 -66.47 126.66 29.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.1 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.55 161.34 28.37 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.145 179.645 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.9 tt -159.98 144.01 5.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.461 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 31.1 t -148.05 159.52 43.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.006 0.431 . . . . 0.0 111.705 -179.306 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.468 HG23 ' HG ' ' A' ' 42' ' ' LEU . 50.6 p -140.46 -2.56 1.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.086 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.43 141.11 55.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.744 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.0 m -62.99 -50.91 68.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.553 -179.417 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -48.95 -44.61 40.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.638 -179.37 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.492 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.3 t -70.01 -54.4 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.909 0.385 . . . . 0.0 110.766 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -57.97 -14.51 6.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.303 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 76.4 m -91.62 -40.14 11.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.227 178.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -60.68 -39.67 89.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.38 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -93.09 13.88 19.58 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.444 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 m120 54.8 26.2 7.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.582 179.519 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.611 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.6 mm -61.19 120.7 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.01 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.5 p -140.74 58.28 1.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.323 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.47 44.26 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.643 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 35.2 m-20 51.75 43.49 29.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.284 0.564 . . . . 0.0 110.353 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.611 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.4 m -68.66 152.28 45.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.786 -178.646 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.521 HG22 HD21 ' A' ' 107' ' ' LEU . 67.2 mt -119.21 115.68 48.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.97 177.898 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.476 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 72.5 m -104.11 131.03 51.81 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.722 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.622 ' HG ' HD23 ' A' ' 92' ' ' LEU . 1.9 tp -106.96 102.16 11.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.492 177.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.1 t80 -95.73 119.68 34.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.806 -179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.463 HH12 HD11 ' A' ' 116' ' ' LEU . 4.4 mtm180 -102.97 80.86 1.91 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.673 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 85' ' ' ARG . 4.7 tp -24.87 -59.14 0.06 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.351 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.492 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.13 -62.51 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.088 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -95.35 2.88 54.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.087 0.47 . . . . 0.0 110.797 -179.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 52.42 33.13 12.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.445 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 12.7 mm-40 -79.37 158.2 27.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.84 99.1 3.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.953 0.406 . . . . 0.0 110.885 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.622 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -87.59 107.6 18.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.747 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -90.89 95.12 9.96 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.534 HD21 HD11 ' A' ' 102' ' ' ILE . 4.6 tt -79.6 76.98 6.22 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.407 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.3 mt-10 -78.46 -165.44 0.7 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -176.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.451 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -46.03 -50.02 15.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.484 -179.233 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -47.83 -17.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.963 0.411 . . . . 0.0 110.943 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 96' ' ' ASP . 13.7 m-20 -125.65 -13.67 6.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.392 -179.735 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.538 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.1 mm -91.87 -46.31 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.559 0.219 . . . . 0.0 111.561 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -48.82 -31.05 6.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.913 0.387 . . . . 0.0 110.739 179.783 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 57.0 m -131.25 45.55 2.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.072 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.536 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 8.1 tp -78.61 146.39 8.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.79 -179.452 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.547 ' HA ' HD11 ' A' ' 49' ' ' ILE . 6.1 m-20 -141.37 148.8 40.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.266 178.616 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.58 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.13 -37.36 9.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 110.593 -179.598 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -61.44 -49.2 77.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.401 178.722 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -58.66 -60.47 3.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.151 -179.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.618 HD11 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.93 -55.72 10.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.006 0.432 . . . . 0.0 110.264 -179.954 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.3 m -58.35 -29.57 66.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.819 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.503 ' HD3' HD13 ' A' ' 113' ' ' ILE . 1.7 tmt_? -72.15 -66.56 0.63 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.184 179.713 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -42.05 -44.12 3.46 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.05 179.147 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.518 HG12 HG22 ' A' ' 35' ' ' VAL . 96.7 mt -62.5 -55.02 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.517 178.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -55.25 -17.85 5.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.325 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.579 HG22 ' ND2' ' A' ' 114' ' ' ASN . 1.4 mp -91.01 -36.0 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.856 -179.185 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.579 ' ND2' HG22 ' A' ' 113' ' ' ILE . 61.7 m-80 -119.33 26.4 9.46 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.9 p -79.92 46.12 0.77 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.044 0.449 . . . . 0.0 110.306 178.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.463 HD11 HH12 ' A' ' 85' ' ' ARG . 57.0 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.413 -179.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.464 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.3 pt-20 . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 35.4 Cg_endo -65.48 142.62 72.56 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.421 2.081 . . . . 0.0 112.611 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.5 m -60.76 151.45 29.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.695 -179.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -95.17 92.01 6.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.083 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.553 HD21 ' HA ' ' A' ' 24' ' ' ALA . 65.2 mt -88.72 77.64 7.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.411 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.6 p -77.26 -3.19 38.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.023 -179.113 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -141.69 147.33 37.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.948 0.404 . . . . 0.0 111.774 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 22.1 t -55.22 -50.02 88.98 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.633 179.875 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.89 -45.82 30.17 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.939 1.759 . . . . 0.0 111.793 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.23 -33.99 76.69 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.205 0.526 . . . . 0.0 110.149 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.553 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -64.52 -59.39 4.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.116 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 47.3 mtm -61.1 -26.33 67.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.131 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.9 mt-10 -71.23 -52.07 21.08 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.702 0.286 . . . . 0.0 110.437 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.402 ' O ' HG23 ' A' ' 31' ' ' THR . 7.8 m-85 -59.79 -30.71 69.08 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.122 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.465 HD12 HD11 ' A' ' 36' ' ' ILE . 47.2 mt -74.59 -37.81 44.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.965 178.188 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.6 -18.56 61.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.813 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.89 27.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.057 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.411 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.7 t -169.05 156.65 7.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.328 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HG3' HG11 ' A' ' 87' ' ' VAL . 27.6 tt0 -75.56 -37.2 60.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.657 179.617 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.47 HG11 HD11 ' A' ' 83' ' ' LEU . 18.7 t -132.29 131.45 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.291 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -137.25 128.27 27.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.032 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.519 HG23 HG12 ' A' ' 111' ' ' ILE . 52.7 t -116.03 127.92 73.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.692 178.39 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 20.6 mt -133.79 137.08 53.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.781 -177.251 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.545 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.85 96.29 1.61 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.371 179.726 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.521 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.0 m-85 -81.51 88.55 6.17 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.524 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -108.43 142.57 38.59 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.194 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -90.29 -8.97 49.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 44' ' ' ILE . 15.6 t70 -148.54 119.28 7.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.521 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.458 ' HG ' HG23 ' A' ' 66' ' ' THR . 94.5 mt -89.06 45.17 1.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.131 0.491 . . . . 0.0 111.588 -179.279 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.415 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.5 mt-10 -135.31 8.28 3.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.069 178.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.646 HG13 HG23 ' A' ' 47' ' ' VAL . 1.5 pt -92.19 156.09 42.24 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.169 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 86.3 Cg_exo -49.78 -31.32 25.62 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.794 2.329 . . . . 0.0 112.807 179.684 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.14 -37.38 77.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.29 -178.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.679 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.5 t -62.28 -58.3 18.17 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.578 -178.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.679 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.5 Cg_exo -58.97 -40.94 66.69 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.697 1.598 . . . . 0.0 111.272 179.187 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.66 HG21 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -60.46 -35.5 63.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.738 179.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.52 ' O ' ' HG3' ' A' ' 53' ' ' MET . 49.0 tp -74.3 -53.75 9.06 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -53.83 -24.03 14.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.105 0.479 . . . . 0.0 109.946 178.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.0 m -82.97 -45.11 14.51 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.342 179.551 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.52 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -60.58 -26.41 66.94 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.368 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 50' ' ' LEU . 62.3 t -53.16 -50.7 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.976 179.518 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -73.23 -10.97 60.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.617 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -93.96 -19.42 20.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.295 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 54.2 m-85 -135.88 61.79 43.38 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.472 -179.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.02 -40.5 76.26 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.565 2.176 . . . . 0.0 111.415 179.175 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.17 -43.0 95.56 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.357 178.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.1 t -65.02 146.08 13.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 178.86 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.514 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 37.5 t -83.1 95.73 8.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.053 0.454 . . . . 0.0 111.054 -179.61 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.461 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 5.8 p90 -61.42 128.9 38.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.75 179.49 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.84 160.98 28.58 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.251 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.5 tt -159.47 143.54 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.696 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.4 t -147.28 155.29 41.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.154 0.502 . . . . 0.0 111.833 -178.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.458 HG23 ' HG ' ' A' ' 42' ' ' LEU . 81.4 p -138.77 -0.31 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.587 179.561 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -68.61 141.98 55.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.571 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 t -65.12 -51.34 61.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.411 -179.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -50.91 -42.05 59.05 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.551 -179.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.51 ' HA ' HG23 ' A' ' 21' ' ' VAL . 57.4 t -71.15 -53.39 21.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.92 0.39 . . . . 0.0 110.596 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.05 -15.43 13.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.324 179.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.4 m -91.24 -40.6 11.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.359 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -61.13 -38.22 85.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.345 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -93.25 14.28 18.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.682 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 54.45 23.32 4.41 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.643 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.642 HG22 ' HB ' ' A' ' 80' ' ' THR . 39.6 mm -57.72 120.05 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.961 179.754 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.2 p -139.01 57.36 1.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.492 -179.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.36 49.3 0.02 OUTLIER Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.738 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.536 ' HB2' HG23 ' A' ' 99' ' ' ILE . 34.3 m-20 48.17 43.68 18.79 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.207 0.527 . . . . 0.0 110.292 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.642 ' HB ' HG22 ' A' ' 76' ' ' ILE . 97.2 m -69.34 151.53 46.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.737 -178.373 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.545 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.9 mt -118.27 117.0 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.835 178.12 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.521 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.1 m -106.05 130.93 53.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.824 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.594 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.4 tp -107.23 104.19 13.75 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.525 177.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.2 t80 -98.7 121.1 40.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.798 0.332 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.519 HH12 HD11 ' A' ' 116' ' ' LEU . 3.8 mtm180 -104.38 98.45 8.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.094 179.711 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tp -42.07 -50.46 4.7 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.783 -179.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.539 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.86 -65.21 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.516 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.409 ' HB2' HH21 ' A' ' 85' ' ' ARG . 9.7 m-20 -99.01 10.57 41.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.562 -179.315 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 85' ' ' ARG . 78.1 m-20 49.66 34.27 7.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.509 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 8.2 mm-40 -78.02 157.69 29.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.122 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -142.34 97.2 3.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.808 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.594 HD21 ' HG ' ' A' ' 83' ' ' LEU . 1.9 mm? -88.06 113.52 23.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.767 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -95.84 96.91 9.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.548 HD23 HD13 ' A' ' 102' ' ' ILE . 4.1 tt -80.98 78.76 7.77 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.626 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.406 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.0 mt-10 -80.77 -163.79 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.762 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.475 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 17.4 t70 -50.66 -37.7 42.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.047 -179.2 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -55.34 -14.93 2.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.118 0.485 . . . . 0.0 110.393 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -131.14 -13.76 3.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.605 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.573 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 25.8 mm -89.63 -32.98 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.612 0.244 . . . . 0.0 111.379 -179.376 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -51.51 -49.38 62.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.704 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.3 m -117.79 38.14 3.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.526 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.573 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.2 tp -63.93 147.0 12.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.645 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.558 ' HA ' HD11 ' A' ' 49' ' ' ILE . 11.5 t70 -141.09 165.24 28.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.685 178.574 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.66 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -62.12 -35.57 79.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.144 0.497 . . . . 0.0 109.691 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -64.66 -47.5 78.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.222 178.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -59.31 -59.37 5.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.177 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.579 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.21 -55.62 14.49 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.937 0.399 . . . . 0.0 110.132 179.656 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.5 m -58.85 -28.65 66.29 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.82 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.529 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.9 tmt_? -71.93 -66.45 0.64 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.185 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -42.9 -43.71 4.22 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.166 179.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.519 HG12 HG23 ' A' ' 35' ' ' VAL . 95.4 mt -63.38 -54.69 29.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.551 178.452 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -54.52 -19.36 5.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.23 179.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.529 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -87.89 -37.67 10.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.939 -179.109 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -121.76 29.39 7.16 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.601 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 81.1 p -81.65 44.97 0.85 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.11 0.481 . . . . 0.0 110.232 178.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.519 HD11 HH12 ' A' ' 85' ' ' ARG . 52.6 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.185 -179.398 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.7 pt-20 . . . . . 0 CA--C 1.53 0.201 0 CA-C-O 120.5 0.19 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 38.8 Cg_endo -66.76 142.85 65.07 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.592 2.195 . . . . 0.0 112.389 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.3 m -61.81 152.87 30.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.765 -179.315 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.51 94.91 7.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.866 179.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 24' ' ' ALA . 48.8 mt -90.52 71.48 6.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.373 179.855 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.0 p -70.92 -5.04 27.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.945 -179.23 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -137.53 146.49 44.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.007 0.432 . . . . 0.0 111.656 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.9 t -56.12 -49.17 94.7 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.377 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -58.11 -46.46 25.35 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.936 1.757 . . . . 0.0 111.869 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.68 -34.85 77.96 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.344 0.592 . . . . 0.0 110.251 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.56 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -63.8 -59.84 4.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.113 179.399 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 30.6 mtt -60.7 -25.88 66.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.207 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 31.3 mt-10 -71.27 -51.13 26.2 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.373 179.639 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -60.66 -30.32 69.83 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.159 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.448 HD13 HD13 ' A' ' 36' ' ' ILE . 45.6 mt -76.22 -37.01 31.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.96 178.15 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.02 -23.08 61.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.813 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.13 31.65 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.923 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.425 HG22 ' CB ' ' A' ' 61' ' ' SER . 8.9 t -170.22 151.25 3.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.337 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.476 ' HG3' HG13 ' A' ' 87' ' ' VAL . 23.3 tt0 -70.73 -50.36 37.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.58 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 83' ' ' LEU . 19.1 t -119.7 136.34 57.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.359 179.262 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.494 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.56 128.55 20.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.013 0.435 . . . . 0.0 112.119 -178.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG23 HG12 ' A' ' 111' ' ' ILE . 47.1 t -115.5 128.81 72.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.672 178.469 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 23.8 mt -135.03 136.08 52.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -177.306 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.544 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.48 97.24 1.78 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.455 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.522 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.4 m-85 -83.39 90.98 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.9 m-85 -110.5 142.71 41.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.037 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.449 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 50.8 mt-30 -91.04 -0.96 57.85 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.482 ' O ' HG12 ' A' ' 44' ' ' ILE . 26.6 t70 -157.59 119.39 3.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.571 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.496 ' HG ' HG23 ' A' ' 66' ' ' THR . 94.2 mt -89.15 45.4 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.087 0.47 . . . . 0.0 111.386 -179.262 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.1 mt-10 -134.66 12.04 3.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.01 179.094 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.68 HG13 HG23 ' A' ' 47' ' ' VAL . 3.5 pt -95.53 158.29 34.75 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.483 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.467 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 73.4 Cg_exo -52.73 -28.65 38.84 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.853 2.369 . . . . 0.0 112.721 179.42 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.63 -38.09 86.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.012 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.68 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.05 -57.69 24.48 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.681 -178.724 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.665 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.5 Cg_exo -59.46 -39.49 75.53 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.775 1.65 . . . . 0.0 111.431 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.638 HG21 ' HA ' ' A' ' 104' ' ' ALA . 7.7 mt -62.5 -36.06 73.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.008 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.541 ' O ' ' HG3' ' A' ' 53' ' ' MET . 40.1 tp -74.8 -54.07 7.99 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.852 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -53.45 -23.63 10.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.952 0.406 . . . . 0.0 110.025 178.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 t -84.27 -45.54 12.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.474 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.541 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.33 -25.6 64.31 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.342 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.2 t -51.89 -49.08 38.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.265 179.391 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -76.76 -9.08 58.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.738 -179.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -94.94 -18.71 20.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.156 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.553 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.4 m-85 -136.86 63.21 44.49 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.368 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.55 -46.12 35.46 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.643 2.229 . . . . 0.0 111.643 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.82 -42.87 69.97 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.392 179.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -65.03 144.28 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.781 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 46.8 t -82.35 98.79 9.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.078 0.466 . . . . 0.0 111.159 -179.554 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.435 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.1 p90 -65.35 126.72 29.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.009 179.728 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.73 161.98 28.46 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.187 179.861 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -160.57 143.3 4.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.2 t -146.18 156.67 43.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.183 0.516 . . . . 0.0 111.675 -179.066 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.496 HG23 ' HG ' ' A' ' 42' ' ' LEU . 52.2 p -139.17 -3.63 1.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.589 179.548 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.44 140.46 57.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.401 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.4 t -64.63 -47.64 77.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.68 -179.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -51.77 -43.68 63.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.73 -0.213 . . . . 0.0 111.554 -179.307 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.503 ' HA ' HG21 ' A' ' 21' ' ' VAL . 79.7 t -71.75 -52.37 25.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.722 0.296 . . . . 0.0 110.513 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.428 HD21 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -58.48 -15.0 9.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.24 179.271 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.7 m -92.61 -40.52 10.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.429 178.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -62.41 -33.08 74.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.428 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -97.07 9.81 41.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.864 179.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 75' ' ' ASN . 2.1 t-20 60.1 20.7 9.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.569 178.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.617 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.9 mm -58.36 117.92 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 179.818 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.9 p -138.38 56.78 1.71 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.283 179.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.22 45.45 0.02 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.677 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 12.2 m120 51.26 43.11 29.47 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.243 0.545 . . . . 0.0 110.398 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.617 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.5 m -69.05 151.08 46.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.673 -178.573 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.544 HG12 ' HA2' ' A' ' 37' ' ' GLY . 70.9 mt -118.32 116.8 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.882 178.045 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.522 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.5 m -105.89 130.88 53.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.808 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.552 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -105.37 99.73 9.33 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.389 177.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.1 t80 -92.63 121.85 34.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.583 179.854 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.503 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.0 mtm180 -106.41 85.56 2.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.83 -179.684 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.9 tp -26.51 -60.2 0.08 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.365 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.476 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.94 -71.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 O-C-N 123.448 0.467 . . . . 0.0 112.092 -179.161 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.04 5.32 41.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 110.687 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 51.12 33.44 9.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.148 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.503 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 14.1 mm-40 -75.64 164.77 25.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.727 179.535 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -148.79 89.01 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.836 179.936 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.552 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.6 mm? -76.6 111.71 12.38 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.544 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -94.48 97.53 10.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.488 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.476 HD21 HD12 ' A' ' 102' ' ' ILE . 4.4 tt -82.93 77.29 9.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.593 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.2 mt-10 -78.91 -165.12 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.487 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 19.4 t70 -51.67 -35.42 42.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.686 -179.291 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -56.57 -15.19 3.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.225 0.536 . . . . 0.0 110.24 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -130.33 -13.99 3.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.779 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.502 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.4 mm -89.44 -29.59 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.684 0.278 . . . . 0.0 111.514 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.52 -38.38 69.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.855 0.36 . . . . 0.0 110.961 -179.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.8 t -129.78 38.74 3.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.319 179.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.8 tp -64.02 141.74 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.559 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.551 ' HA ' HD11 ' A' ' 49' ' ' ILE . 21.6 m-20 -137.24 149.81 47.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.531 178.786 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.638 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -47.67 -37.31 12.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.923 0.392 . . . . 0.0 110.337 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -61.88 -49.09 77.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.147 178.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -58.65 -61.31 2.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.23 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.581 HD11 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.18 -57.34 6.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 110.35 179.908 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.3 m -57.06 -30.38 64.23 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.8 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.5 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -70.91 -65.72 0.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.186 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -42.82 -40.91 3.05 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.044 179.277 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.502 HG12 HG23 ' A' ' 35' ' ' VAL . 96.2 mt -65.9 -56.29 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.247 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -53.21 -18.26 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.325 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.573 HG23 ' ND2' ' A' ' 114' ' ' ASN . 1.4 mp -90.31 -39.5 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.87 -179.108 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.573 ' ND2' HG23 ' A' ' 113' ' ' ILE . 67.8 m-80 -118.72 28.73 8.13 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.775 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.3 p -82.22 50.26 1.56 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.023 0.44 . . . . 0.0 110.35 179.224 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.478 HD12 ' NH1' ' A' ' 85' ' ' ARG . 67.2 mt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.265 -179.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.473 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.7 pt-20 . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.495 0.188 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 37.7 Cg_endo -67.78 145.44 69.08 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.739 2.293 . . . . 0.0 112.559 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -64.14 153.35 38.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.554 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -98.13 95.02 7.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.799 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.562 HD21 ' HA ' ' A' ' 24' ' ' ALA . 44.7 mt -91.45 71.91 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.357 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.2 p -70.84 -4.28 23.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.169 -179.157 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -139.46 147.34 41.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.378 . . . . 0.0 111.661 -179.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 35.3 t -55.64 -49.69 91.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.559 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.68 -46.39 27.18 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.917 1.745 . . . . 0.0 112.053 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.79 81.45 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.176 0.513 . . . . 0.0 110.2 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -63.55 -58.84 5.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.121 179.328 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.6 mtp -60.37 -25.54 65.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.157 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -72.61 -51.16 20.82 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.608 179.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -60.63 -30.73 70.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.199 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.454 HD12 HD12 ' A' ' 36' ' ' ILE . 53.4 mt -75.79 -37.96 36.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.052 178.417 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.85 -17.08 60.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.285 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.42 26.62 3.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.078 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.2 t -167.86 153.09 6.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.54 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.529 ' HG3' HG12 ' A' ' 87' ' ' VAL . 25.0 tt0 -66.79 -52.31 45.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.89 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.463 HG11 HD13 ' A' ' 83' ' ' LEU . 22.4 t -119.83 137.39 53.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.322 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.49 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.71 128.55 21.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.193 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.491 HG21 HG12 ' A' ' 111' ' ' ILE . 52.1 t -116.61 131.76 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.572 178.511 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.454 HD12 HD12 ' A' ' 28' ' ' ILE . 21.0 mt -136.62 136.73 48.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.487 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.558 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.34 97.53 1.83 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.549 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.1 m-85 -83.7 92.49 7.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.6 m-85 -112.95 140.44 47.76 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.166 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.451 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 51.7 mt-30 -88.93 0.33 56.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.449 ' O ' HG12 ' A' ' 44' ' ' ILE . 24.8 t70 -157.96 120.72 3.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.66 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.505 ' HG ' HG23 ' A' ' 66' ' ' THR . 91.7 mt -90.62 46.53 1.34 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 111.428 -179.307 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.444 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 36.8 mt-10 -136.95 9.72 3.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 179.122 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.656 HG13 HG21 ' A' ' 47' ' ' VAL . 2.3 pt -92.97 157.01 39.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.313 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.42 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 72.4 Cg_exo -52.01 -25.26 21.75 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.943 2.429 . . . . 0.0 113.022 179.719 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.44 -38.59 90.3 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.656 HG21 HG13 ' A' ' 44' ' ' ILE . 2.3 t -59.95 -55.59 44.01 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.583 -178.776 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.627 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.96 -41.31 54.38 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.928 1.752 . . . . 0.0 111.502 179.218 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.617 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.3 mt -61.57 -34.6 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.208 179.83 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.52 ' O ' ' HG3' ' A' ' 53' ' ' MET . 45.8 tp -73.93 -52.71 12.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -53.03 -26.96 17.39 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.9 m -80.07 -46.45 16.51 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.621 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.52 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.75 -25.99 65.31 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.446 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.8 t -53.1 -49.37 50.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.718 179.368 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -76.23 -9.7 58.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.666 -179.855 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -94.92 -17.8 21.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.116 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.549 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 68.3 m-85 -138.35 63.01 33.56 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.441 -179.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.01 -43.56 56.02 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.623 2.215 . . . . 0.0 111.651 179.145 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.23 -40.83 85.4 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.239 179.041 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.3 t -66.19 142.99 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.49 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 42.1 t -80.79 96.8 7.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.959 0.409 . . . . 0.0 110.957 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.473 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 4.9 p90 -62.59 126.94 29.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.836 179.582 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.16 161.76 28.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.256 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.8 tt -161.24 142.24 3.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -147.59 154.14 40.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.1 0.476 . . . . 0.0 111.803 -178.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.505 HG23 ' HG ' ' A' ' 42' ' ' LEU . 68.4 p -135.57 -2.08 2.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.534 179.529 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.41 ' O ' HD12 ' A' ' 71' ' ' LEU . 23.9 t70 -67.18 142.48 56.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.717 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.1 m -65.95 -49.85 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.664 -179.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -50.47 -43.24 55.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.436 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.471 ' HA ' HG21 ' A' ' 21' ' ' VAL . 76.2 t -71.45 -53.21 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.668 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.421 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -58.52 -14.63 8.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.222 179.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 78.4 m -91.89 -41.2 10.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.252 178.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -61.22 -34.86 75.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.318 179.703 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -96.01 11.91 32.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.854 179.516 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 56.05 22.74 6.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.646 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.638 HG21 ' HB ' ' A' ' 80' ' ' THR . 35.5 mm -59.03 120.21 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.951 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.1 p -140.7 55.2 1.59 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.333 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.75 45.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.458 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.546 ' HB2' HG22 ' A' ' 99' ' ' ILE . 13.1 m120 50.71 43.43 27.92 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.15 0.5 . . . . 0.0 110.44 -179.826 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.638 ' HB ' HG21 ' A' ' 76' ' ' ILE . 98.0 m -69.61 152.31 44.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.77 -178.495 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.581 HG21 HD23 ' A' ' 107' ' ' LEU . 62.8 mt -118.8 118.17 56.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.892 178.075 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.2 m -106.81 134.78 49.44 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.6 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.5 tp -110.79 103.36 11.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.788 178.227 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -96.96 123.0 40.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.525 179.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.522 HH12 HD11 ' A' ' 116' ' ' LEU . 5.5 mtm180 -106.07 96.33 6.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.051 0.453 . . . . 0.0 110.187 179.803 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.4 tp -40.45 -50.2 2.88 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.558 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.529 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -44.66 -68.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.85 0.357 . . . . 0.0 111.908 -179.627 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.409 ' HB2' HH21 ' A' ' 85' ' ' ARG . 17.7 m-20 -92.85 17.76 10.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.442 -179.424 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.9 p30 43.11 31.3 0.34 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.043 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.508 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 13.7 mm-40 -76.59 162.48 27.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.824 0.345 . . . . 0.0 111.14 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -149.01 87.1 1.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.967 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.6 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -76.05 144.64 40.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.304 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -125.35 99.31 6.0 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.074 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.548 HD21 HD12 ' A' ' 102' ' ' ILE . 4.8 tt -84.11 78.01 9.84 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.597 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -79.66 -165.79 0.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.439 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.6 OUTLIER -44.47 -52.58 7.76 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.618 -179.255 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -46.82 -17.06 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.51 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -125.76 -13.98 6.3 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.41 179.723 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 79' ' ' ASN . 24.6 mm -89.73 -35.41 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.112 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -48.25 -55.39 10.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.852 -179.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.1 p -114.08 39.31 2.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.539 179.462 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.548 HD12 HD21 ' A' ' 94' ' ' LEU . 8.2 tp -61.14 142.57 15.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.515 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.585 ' HA ' HD12 ' A' ' 49' ' ' ILE . 18.8 m-20 -134.92 149.76 50.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.572 178.785 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.617 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.32 -32.96 12.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.11 0.481 . . . . 0.0 110.102 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -63.9 -49.08 74.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.352 178.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -59.04 -59.84 4.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.278 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.604 HD13 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.19 -56.19 12.09 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.071 0.462 . . . . 0.0 110.076 179.848 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.3 m -58.21 -28.86 65.21 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.776 179.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.45 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.4 tmt_? -71.35 -67.11 0.54 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.079 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -42.24 -43.34 3.38 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.158 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.491 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -64.35 -55.47 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.702 178.416 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -52.89 -22.9 6.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.481 0.658 . . . . 0.0 110.112 179.259 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.45 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -85.66 -36.96 11.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.009 -179.054 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -124.84 31.87 5.56 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 111' ' ' ILE . 89.1 p -83.6 36.93 0.56 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.189 0.518 . . . . 0.0 110.213 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.522 HD11 HH12 ' A' ' 85' ' ' ARG . 51.7 mt . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.212 -179.517 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.497 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 . . . . . 0 CA--C 1.532 0.259 0 CA-C-O 120.395 0.141 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 29.4 Cg_endo -64.32 154.0 73.63 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.63 2.22 . . . . 0.0 112.525 -179.718 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -67.94 153.06 44.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.42 -179.765 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.99 84.15 2.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.727 179.696 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 24' ' ' ALA . 46.8 mt -81.73 72.21 8.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.633 -179.723 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.1 p -70.63 -2.94 15.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.09 -179.013 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -142.27 147.63 36.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.083 0.468 . . . . 0.0 111.804 -179.603 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.583 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 60.6 t -55.47 -49.99 89.39 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.824 -179.999 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.3 Cg_endo -58.32 -44.84 34.97 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.035 1.823 . . . . 0.0 111.82 -179.899 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.23 -34.55 78.37 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.33 0.586 . . . . 0.0 110.229 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.561 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -63.2 -59.18 5.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.929 179.262 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 34.0 mtt -60.23 -27.82 67.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.244 -179.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -70.21 -49.88 45.72 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 110.603 179.807 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -61.13 -32.95 72.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.892 179.237 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.415 HD13 HD13 ' A' ' 36' ' ' ILE . 48.4 mt -75.0 -37.35 40.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.034 178.478 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.32 -18.27 60.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.131 -179.705 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.2 27.31 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.131 -179.896 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.9 t -174.31 154.91 2.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.602 -179.873 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.441 ' HG3' HG11 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -64.58 -82.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.016 0.436 . . . . 0.0 110.719 179.556 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.513 HG13 HD12 ' A' ' 83' ' ' LEU . 18.1 t -89.6 134.34 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.758 -179.53 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.545 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.46 124.71 20.37 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.061 -179.216 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.577 HG22 HG12 ' A' ' 111' ' ' ILE . 46.4 t -113.61 128.16 70.61 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.921 178.702 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.453 HG12 ' HA3' ' A' ' 63' ' ' GLY . 26.8 mt -133.63 138.48 50.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.457 -177.289 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.528 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.68 95.9 1.41 Allowed Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.381 179.801 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.504 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 36.3 m-85 -81.99 89.33 6.39 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.294 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.584 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 13.6 m-85 -107.59 140.57 40.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.615 -177.769 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -88.9 -5.62 57.87 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.081 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.475 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.3 t70 -154.53 121.73 5.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.656 179.851 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.491 ' HA ' HG22 ' A' ' 47' ' ' VAL . 92.0 mt -90.04 45.29 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.014 0.435 . . . . 0.0 111.449 -179.354 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 11.1 mm-40 -134.83 11.78 3.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.068 179.245 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.684 HG13 HG23 ' A' ' 47' ' ' VAL . 4.0 pt -94.89 158.92 34.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.286 -179.955 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.425 ' O ' HD11 ' A' ' 49' ' ' ILE . 62.4 Cg_exo -54.86 -25.38 43.12 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.843 2.362 . . . . 0.0 112.803 179.497 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.43 -35.64 81.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.705 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.684 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -63.51 -55.87 31.33 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.648 -178.776 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 38.0 Cg_exo -60.84 -34.49 91.29 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.999 1.8 . . . . 0.0 111.598 179.65 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.656 HG23 HD13 ' A' ' 107' ' ' LEU . 6.4 mt -69.38 -35.35 66.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.606 ' O ' ' HG3' ' A' ' 53' ' ' MET . 36.7 tp -73.61 -50.41 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.471 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -55.74 -20.32 14.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.304 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -84.43 -49.67 8.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.567 179.29 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 2.9 ppp? -57.67 -25.36 60.13 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.099 0.476 . . . . 0.0 109.91 179.556 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -52.87 -46.55 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.991 179.51 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -80.05 -9.85 59.73 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.533 -179.848 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 27.8 mtpp -93.55 -19.0 21.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.239 -179.963 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.601 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 70.8 m-85 -137.17 62.57 39.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.468 -179.291 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.64 -36.47 71.98 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.535 2.157 . . . . 0.0 111.366 179.025 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.85 -42.05 99.75 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.818 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.1 t -65.95 144.95 14.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.799 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.545 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 46.7 t -83.24 98.82 9.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.108 0.48 . . . . 0.0 110.974 -179.613 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.502 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 6.4 p90 -64.8 129.05 38.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.025 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.453 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -147.1 161.46 28.46 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.087 179.862 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -162.25 144.07 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.823 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.504 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 44.8 t -149.77 155.61 40.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.144 0.497 . . . . 0.0 111.673 -179.262 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.489 HG22 ' HG ' ' A' ' 42' ' ' LEU . 70.2 p -136.94 0.03 2.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.39 179.281 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -69.53 138.91 53.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.506 179.841 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.4 p -63.14 -48.26 79.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.529 -179.459 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -49.98 -46.78 52.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.615 0.245 . . . . 0.0 111.571 -179.411 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.525 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.4 t -69.02 -53.96 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -58.32 -15.05 8.85 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.258 179.478 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.2 m -91.67 -39.23 11.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.362 179.041 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -62.84 -39.04 93.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.468 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -92.15 12.62 21.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.627 179.312 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 55.86 25.2 8.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.535 179.363 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.637 HG21 ' HB ' ' A' ' 80' ' ' THR . 42.1 mm -60.84 122.68 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.48 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.2 p -142.8 59.68 1.43 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.248 -179.824 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.29 43.46 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.571 179.856 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.584 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 24.6 m-80 52.41 44.26 30.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.177 0.513 . . . . 0.0 110.569 -179.821 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.637 ' HB ' HG21 ' A' ' 76' ' ' ILE . 95.6 m -69.71 151.34 45.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.404 -0.817 . . . . 0.0 112.804 -178.568 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.528 HG12 ' HA2' ' A' ' 37' ' ' GLY . 57.1 mt -116.85 116.6 52.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.132 178.155 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 74.4 m -104.56 135.27 46.29 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.568 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -112.07 102.58 10.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.296 178.822 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.2 t80 -96.03 119.67 34.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.448 179.547 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.493 HH12 HD12 ' A' ' 116' ' ' LEU . 5.6 mtm180 -103.49 81.39 1.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.958 -179.421 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.413 ' HB3' ' HA ' ' A' ' 32' ' ' GLU . 11.6 tp -25.35 -58.73 0.06 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.026 -179.369 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.441 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.42 -72.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.408 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -83.44 3.69 30.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.009 0.433 . . . . 0.0 110.542 179.944 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 52.06 32.7 10.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.639 179.725 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.473 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 7.1 mm-40 -78.26 162.1 26.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.688 179.737 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.8 OUTLIER -146.45 91.67 2.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.026 179.926 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.571 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.3 mm? -79.09 146.06 33.45 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.378 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -127.28 93.21 3.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.018 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.504 HD22 HD13 ' A' ' 102' ' ' ILE . 4.4 tt -79.01 77.69 5.46 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.689 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.6 mt-10 -78.18 -166.24 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.801 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.522 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.8 t70 -51.12 -36.74 42.1 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.86 -179.369 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.419 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 10.3 pt-20 -55.82 -14.75 2.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.193 0.521 . . . . 0.0 110.477 179.551 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.419 ' OD2' ' HG3' ' A' ' 97' ' ' GLU . 23.7 m-20 -130.12 -13.75 3.97 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.537 179.881 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.522 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 19.6 mm -89.27 -29.96 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.316 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -55.16 -45.28 75.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 111.134 -179.804 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.6 m -121.74 37.66 4.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.454 179.774 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.504 HD13 HD22 ' A' ' 94' ' ' LEU . 6.7 tp -62.35 144.69 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.43 -179.842 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.506 ' HA ' HD12 ' A' ' 49' ' ' ILE . 21.6 m-20 -139.9 150.09 44.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.73 178.881 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.577 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -46.56 -39.79 11.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.916 0.389 . . . . 0.0 110.617 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.1 m -61.89 -47.57 84.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.64 178.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -59.03 -57.09 14.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.366 -179.521 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.656 HD13 HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.7 -57.34 9.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.966 0.412 . . . . 0.0 110.011 179.832 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.2 m -56.7 -29.62 62.61 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.98 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -70.69 -65.25 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.189 179.739 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -43.2 -43.61 4.77 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.938 179.167 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.577 HG12 HG22 ' A' ' 35' ' ' VAL . 26.0 mt -62.13 -56.32 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.438 178.249 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -53.87 -19.38 4.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.29 179.401 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.469 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.63 -35.71 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.956 -179.154 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.571 HD21 ' HG ' ' A' ' 92' ' ' LEU . 87.8 m-20 -126.6 31.25 5.38 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.463 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 111' ' ' ILE . 88.6 p -84.56 45.98 1.19 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.242 0.544 . . . . 0.0 110.071 178.848 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.493 HD12 HH12 ' A' ' 85' ' ' ARG . 55.5 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.455 -179.163 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 120.525 0.203 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 38.0 Cg_endo -67.18 142.14 59.86 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.595 2.197 . . . . 0.0 112.473 -179.753 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.0 m -56.28 152.95 10.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.52 -179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -99.84 83.07 2.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.856 179.852 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 24' ' ' ALA . 36.9 mt -80.87 73.24 7.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.527 -179.905 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.0 p -72.8 -4.75 33.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.937 -179.191 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -136.65 147.11 46.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.382 . . . . 0.0 111.65 -179.72 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.591 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 24.1 t -56.33 -49.81 91.22 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.493 -179.985 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.82 -46.04 29.02 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.849 1.699 . . . . 0.0 111.934 179.994 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.37 -35.44 80.42 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.211 0.529 . . . . 0.0 110.277 -179.944 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.584 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -63.49 -58.93 5.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.097 179.562 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 60.3 mtp -59.82 -27.31 66.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.103 -179.986 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 27.1 mt-10 -71.2 -50.44 33.02 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.661 0.267 . . . . 0.0 110.778 179.777 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -60.99 -31.89 71.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.976 179.283 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.477 HD12 HD11 ' A' ' 36' ' ' ILE . 47.2 mt -73.93 -37.26 47.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.883 178.269 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.92 -18.73 60.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.018 -179.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.12 29.61 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.9 t -169.49 152.23 4.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.389 -179.736 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.542 ' HG3' HG11 ' A' ' 87' ' ' VAL . 31.3 tt0 -70.33 -41.45 73.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.765 179.913 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.44 HG13 HD12 ' A' ' 83' ' ' LEU . 19.6 t -128.95 134.11 64.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.182 179.324 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.5 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.11 128.91 26.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 112.154 -179.052 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.505 HG21 HG12 ' A' ' 111' ' ' ILE . 43.3 t -116.92 127.14 74.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.502 178.325 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.477 HD11 HD12 ' A' ' 28' ' ' ILE . 23.4 mt -133.25 136.16 55.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.45 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.563 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.12 97.38 1.83 Allowed Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.562 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.5 m-85 -83.57 91.69 7.48 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.408 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.2 m-85 -111.89 138.32 48.67 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.023 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.472 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 48.3 mt-30 -85.06 -9.5 57.91 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.87 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.448 ' O ' HG12 ' A' ' 44' ' ' ILE . 15.8 t70 -150.4 119.56 6.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.745 179.716 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.494 ' HG ' HG21 ' A' ' 66' ' ' THR . 96.4 mt -87.89 44.06 1.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.023 0.44 . . . . 0.0 111.562 -179.153 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 36.8 mt-10 -131.97 11.52 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.237 0.541 . . . . 0.0 109.972 179.134 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.653 HG13 HG23 ' A' ' 47' ' ' VAL . 8.5 pt -93.96 161.61 29.38 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.517 -179.657 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.435 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 51.6 Cg_exo -57.04 -25.22 62.09 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.843 2.362 . . . . 0.0 112.538 179.202 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.14 -38.77 91.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.478 -178.763 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.653 HG23 HG13 ' A' ' 44' ' ' ILE . 2.1 t -59.81 -55.41 45.96 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -178.717 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.5 Cg_exo -60.88 -41.63 43.85 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.026 1.817 . . . . 0.0 111.567 179.199 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.655 HG21 HD11 ' A' ' 107' ' ' LEU . 6.9 mt -61.72 -34.2 61.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.149 -179.998 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.54 ' O ' ' HG3' ' A' ' 53' ' ' MET . 40.1 tp -74.98 -51.89 12.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.785 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -53.6 -26.0 19.9 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.094 0.473 . . . . 0.0 109.808 178.607 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 t -82.17 -46.39 13.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.642 179.6 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.54 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -58.67 -25.84 63.21 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.358 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 50' ' ' LEU . 52.5 t -52.29 -46.05 44.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.827 179.34 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -80.76 -10.12 59.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.735 -179.795 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -93.55 -17.12 23.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.153 179.837 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.578 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 49.3 m-85 -139.38 63.89 29.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.505 -179.854 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.78 -45.1 42.92 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.719 2.279 . . . . 0.0 111.713 179.052 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.23 -40.76 76.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.293 179.252 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.6 t -66.86 143.97 15.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.69 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 42.2 t -82.42 97.96 8.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.987 0.422 . . . . 0.0 111.045 -179.633 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.427 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -64.2 127.24 30.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.722 179.71 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.82 162.7 28.56 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.133 179.887 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 tt -160.82 145.12 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.913 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 t -149.82 152.82 35.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.004 0.431 . . . . 0.0 111.597 -179.157 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.494 HG21 ' HG ' ' A' ' 42' ' ' LEU . 81.7 p -135.87 -1.45 2.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.622 179.569 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.61 143.32 56.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.77 -179.918 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 81.7 p -65.7 -49.59 67.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.103 -179.556 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -50.79 -45.87 59.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.458 -179.352 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HA ' HG21 ' A' ' 21' ' ' VAL . 62.3 t -69.48 -53.17 26.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.733 0.301 . . . . 0.0 110.737 179.935 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -58.55 -15.17 10.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.283 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.4 m -90.39 -40.97 11.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.223 178.63 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -60.67 -40.49 92.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.45 179.841 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.51 11.44 21.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 179.605 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 55.96 25.1 8.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.482 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.656 HG21 ' HB ' ' A' ' 80' ' ' THR . 38.7 mm -60.67 119.74 5.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 179.797 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.6 p -140.35 57.76 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.242 179.98 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.76 42.97 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.601 179.82 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 14.4 m120 52.67 42.38 31.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.194 0.521 . . . . 0.0 110.255 -179.726 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.656 ' HB ' HG21 ' A' ' 76' ' ' ILE . 93.9 m -68.74 152.83 44.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.806 -178.529 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.563 HG12 ' HA2' ' A' ' 37' ' ' GLY . 71.4 mt -119.76 117.54 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.979 178.206 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.503 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 72.4 m -105.75 130.42 53.75 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.871 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.589 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.5 tp -106.49 101.16 10.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.619 178.036 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.7 t80 -95.89 120.51 36.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.769 0.319 . . . . 0.0 110.706 -179.954 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.52 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.0 mtm180 -103.24 97.95 7.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.045 179.881 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 tp -41.67 -51.79 3.99 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.598 -179.464 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.542 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -44.5 -65.67 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.395 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.426 ' HB2' HH21 ' A' ' 85' ' ' ARG . 7.6 m-20 -95.53 17.31 14.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.69 -178.977 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.4 p30 42.38 32.64 0.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.036 179.227 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 25.3 mm-40 -78.99 161.69 26.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.855 0.36 . . . . 0.0 111.33 -179.876 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -147.23 96.45 2.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.52 179.497 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.603 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.1 mm? -86.66 120.3 27.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.942 179.817 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.95 98.72 9.16 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.679 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.53 HD21 HD12 ' A' ' 102' ' ' ILE . 3.9 tt -83.43 77.71 9.77 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.721 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.6 mt-10 -78.99 -164.7 0.64 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.801 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.497 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.8 t70 -51.39 -36.4 43.25 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.254 -179.175 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -56.95 -14.69 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.148 0.499 . . . . 0.0 110.265 179.558 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -129.64 -13.64 4.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.577 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 21.4 mm -91.24 -29.27 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.519 -179.492 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -51.7 -51.89 52.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 56.0 m -121.27 39.98 3.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.506 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.53 HD12 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -60.67 142.01 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.557 -179.704 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.523 ' HA ' HD13 ' A' ' 49' ' ' ILE . 17.4 m-20 -134.25 150.71 51.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.428 178.752 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.623 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.74 -35.86 23.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.065 0.46 . . . . 0.0 110.4 179.993 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.6 m -62.4 -46.08 90.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.237 178.739 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.57 ' HB3' ' HZ2' ' A' ' 106' ' ' LYS . 8.3 mtpm? -60.97 -60.76 3.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.179 -179.79 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.655 HD11 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.48 -55.45 10.93 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.958 0.409 . . . . 0.0 110.04 179.844 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.9 m -58.51 -30.81 67.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.92 179.715 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.452 ' HD3' HD11 ' A' ' 113' ' ' ILE . 3.9 tmt_? -70.94 -65.71 0.7 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.195 179.677 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -42.91 -43.31 4.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.06 179.303 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.505 HG12 HG21 ' A' ' 35' ' ' VAL . 96.6 mt -63.28 -55.87 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.174 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.13 -18.42 3.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.305 179.259 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.452 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.41 -36.39 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.69 -179.305 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.603 HD21 ' HG ' ' A' ' 92' ' ' LEU . 91.7 m-20 -126.29 32.97 5.11 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.547 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.2 p -84.57 38.35 0.68 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.058 0.456 . . . . 0.0 110.243 178.801 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.431 HD11 HH12 ' A' ' 85' ' ' ARG . 58.6 mt . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.085 -0.959 . . . . 0.0 111.28 -179.445 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.484 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.8 pt-20 . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 42.6 Cg_endo -67.24 147.74 79.11 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.569 2.18 . . . . 0.0 112.628 -179.251 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 17' ' ' TRP . 16.5 m -69.39 154.06 42.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.662 -179.494 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.404 ' N ' HG23 ' A' ' 16' ' ' THR . 5.6 m-90 -97.16 87.73 4.28 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.251 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.575 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.1 mt -81.6 70.05 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.066 179.473 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.6 p -67.85 -0.44 4.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.626 -178.654 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 7.8 m-20 -145.9 147.83 32.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 111.65 -179.887 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.0 t -54.29 -49.83 88.21 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.504 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.6 Cg_endo -56.81 -47.53 22.96 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.07 1.847 . . . . 0.0 112.195 179.94 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.62 78.08 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.202 0.525 . . . . 0.0 110.508 -179.701 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.575 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.17 -58.7 5.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.169 179.355 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 68.3 mtp -60.98 -27.21 68.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.065 -179.861 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 25.0 mt-10 -71.33 -50.48 31.94 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.735 0.303 . . . . 0.0 110.596 179.777 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -59.74 -34.59 73.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.904 179.303 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.443 HD13 HD13 ' A' ' 36' ' ' ILE . 44.3 mt -72.62 -37.78 57.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.946 178.288 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.56 -17.67 61.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.989 -179.768 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.1 26.41 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.222 -179.671 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.0 t -169.88 151.75 4.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.557 -179.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.505 ' HG3' HG11 ' A' ' 87' ' ' VAL . 15.6 tt0 -62.78 -76.42 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.598 179.751 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.432 HG12 HD13 ' A' ' 83' ' ' LEU . 16.0 t -96.49 138.71 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.459 179.538 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.556 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.59 124.11 15.85 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.991 0.424 . . . . 0.0 112.003 -179.26 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 111' ' ' ILE . 50.0 t -112.62 129.85 67.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.435 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.443 HD13 HD13 ' A' ' 28' ' ' ILE . 34.7 mt -135.74 137.13 49.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.041 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.91 96.69 1.66 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.461 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.441 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.1 m-85 -82.97 90.56 7.01 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.233 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.1 m-85 -110.23 145.82 36.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.363 -178.148 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.408 ' HG2' HD23 ' A' ' 71' ' ' LEU . 93.2 mt-30 -92.36 -6.5 50.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.839 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.496 ' O ' HG12 ' A' ' 44' ' ' ILE . 36.6 t70 -151.87 121.93 7.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.555 179.822 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.517 ' HG ' HG22 ' A' ' 66' ' ' THR . 87.9 mt -90.57 46.49 1.34 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.158 0.504 . . . . 0.0 111.331 -179.319 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.439 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 38.9 mt-10 -135.68 7.11 3.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.937 178.977 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.687 HG13 HG23 ' A' ' 47' ' ' VAL . 3.1 pt -89.54 157.64 46.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.26 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.418 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 70.6 Cg_exo -53.4 -26.05 33.99 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.92 2.413 . . . . 0.0 112.911 179.665 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.08 -36.95 85.95 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.977 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.687 HG23 HG13 ' A' ' 44' ' ' ILE . 3.2 t -60.99 -56.65 32.86 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.549 -178.915 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.668 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.2 Cg_exo -59.82 -41.26 56.06 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 121.754 1.636 . . . . 0.0 111.407 179.635 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.614 HG21 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -61.29 -35.6 67.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.027 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.535 ' O ' ' HG3' ' A' ' 53' ' ' MET . 48.1 tp -72.98 -53.78 10.32 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.809 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -53.71 -24.6 15.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.086 0.47 . . . . 0.0 109.848 178.748 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -82.07 -45.57 15.06 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.623 179.615 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.535 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -60.83 -26.18 67.15 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.082 0.468 . . . . 0.0 109.74 179.582 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 50' ' ' LEU . 61.1 t -52.76 -49.65 45.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.843 179.492 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -75.04 -9.41 58.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.637 -179.708 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -95.14 -18.67 20.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.059 179.586 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.569 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 64.3 m-85 -135.92 62.85 48.93 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.285 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.8 -42.51 62.82 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.701 2.267 . . . . 0.0 111.64 179.137 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.25 -37.23 86.26 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.657 179.147 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.2 t -69.89 144.8 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.121 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.556 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 35.4 t -82.53 98.81 9.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.095 0.474 . . . . 0.0 110.932 -179.902 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -65.23 126.29 27.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.205 179.976 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.24 161.23 28.16 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.276 179.809 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -161.64 144.18 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.441 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.8 t -149.47 157.85 43.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.171 0.51 . . . . 0.0 111.845 -179.28 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.517 HG22 ' HG ' ' A' ' 42' ' ' LEU . 57.9 p -138.57 -0.24 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.481 179.488 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.25 137.13 54.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.343 -179.907 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.0 m -61.59 -50.7 71.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.501 -179.341 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -50.28 -40.91 49.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.568 -179.558 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.493 ' HA ' HG23 ' A' ' 21' ' ' VAL . 73.2 t -72.05 -54.93 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.028 0.442 . . . . 0.0 110.73 179.846 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.408 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.2 mp -58.38 -14.64 8.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.291 179.324 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.5 m -91.18 -41.72 10.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.178 178.719 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -59.9 -40.64 89.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.462 179.833 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -90.43 9.15 30.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.794 179.444 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 58.73 24.71 12.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.604 179.429 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.59 HG21 ' HB ' ' A' ' 80' ' ' THR . 37.8 mm -60.97 119.62 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.986 179.53 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.0 p -138.55 56.04 1.72 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.262 -179.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.09 45.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.594 179.849 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.559 ' HB2' HG23 ' A' ' 99' ' ' ILE . 25.7 m-20 50.15 43.44 25.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.162 0.506 . . . . 0.0 110.397 -179.828 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.59 ' HB ' HG21 ' A' ' 76' ' ' ILE . 88.5 m -68.42 151.97 46.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.786 -178.665 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.54 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.9 mt -118.21 115.65 48.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.219 178.032 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 72.1 m -103.85 133.49 48.75 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -177.819 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.586 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.6 tp -109.22 104.6 13.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.979 178.392 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.7 t80 -98.62 121.11 40.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.643 179.8 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.493 HH12 HD12 ' A' ' 116' ' ' LEU . 4.4 mtm180 -103.94 81.34 1.85 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.906 -179.726 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 7.2 tp -25.26 -59.63 0.06 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -179.455 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.505 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.53 -57.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.338 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -98.3 3.42 48.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.636 -179.735 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.2 t30 53.11 21.2 2.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.586 179.654 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 12.6 mm-40 -67.34 154.12 42.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.659 179.596 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.8 OUTLIER -138.05 89.3 2.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.507 179.314 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.586 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -78.0 141.79 38.68 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.378 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.92 109.27 14.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.218 0.532 . . . . 0.0 112.401 -178.929 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.537 HD22 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -94.7 76.43 3.71 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.875 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 99' ' ' ILE . 24.0 mt-10 -77.39 -165.31 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -176.857 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.442 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.3 OUTLIER -46.52 -51.05 16.22 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.575 -179.191 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -48.15 -15.24 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.967 0.413 . . . . 0.0 111.262 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 96' ' ' ASP . 17.0 m-20 -126.98 -13.66 5.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.367 179.792 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.559 HG23 ' HB2' ' A' ' 79' ' ' ASN . 23.5 mm -91.87 -38.97 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.479 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -50.43 -47.42 56.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.967 0.413 . . . . 0.0 110.71 179.74 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.8 m -116.61 38.83 3.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.507 179.89 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.542 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 8.5 tp -67.21 144.86 14.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.593 -179.541 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.553 ' HA ' HD13 ' A' ' 49' ' ' ILE . 13.9 m-20 -139.44 148.83 43.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.321 178.48 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.614 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -47.37 -36.84 10.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.104 0.478 . . . . 0.0 110.444 -179.713 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.9 m -63.05 -47.55 82.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.342 178.977 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -59.81 -58.93 6.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.313 -179.694 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.6 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.23 -55.44 15.29 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.002 0.43 . . . . 0.0 110.117 179.869 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.2 m -58.39 -29.53 66.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.809 179.796 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.481 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -71.3 -66.11 0.66 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.225 179.609 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -42.82 -44.04 4.28 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.122 179.274 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.491 HG12 HG22 ' A' ' 35' ' ' VAL . 96.2 mt -62.92 -55.36 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.529 178.293 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -54.32 -18.41 4.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.374 179.223 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.481 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.0 -36.89 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.862 -179.059 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -125.37 31.03 5.65 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.464 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 97.1 p -82.62 37.76 0.53 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.076 0.465 . . . . 0.0 110.142 178.869 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.493 HD12 HH12 ' A' ' 85' ' ' ARG . 59.0 mt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.188 -179.425 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.473 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.1 pt-20 . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.9 Cg_endo -66.83 145.68 75.62 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.308 2.005 . . . . 0.0 112.756 -179.541 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.4 m -62.54 147.52 48.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.524 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -92.99 84.3 4.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.739 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.535 HD21 ' HA ' ' A' ' 24' ' ' ALA . 48.4 mt -81.77 76.21 8.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.638 -179.913 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.8 p -76.02 -4.17 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.856 -179.255 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -139.37 147.28 41.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.994 0.426 . . . . 0.0 111.61 -179.738 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.589 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 44.2 t -55.76 -50.33 87.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.59 179.891 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.33 -45.11 37.01 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.986 1.791 . . . . 0.0 111.939 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.03 82.73 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.262 0.553 . . . . 0.0 110.285 -179.881 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -63.55 -59.0 5.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.05 179.513 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 59.7 mtm -60.41 -27.02 67.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.148 -179.928 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -70.98 -50.79 30.45 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.72 0.295 . . . . 0.0 110.571 179.594 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -60.26 -31.42 70.2 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.197 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.448 HD12 HD12 ' A' ' 36' ' ' ILE . 47.7 mt -74.18 -39.07 49.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.077 178.196 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.45 -19.71 60.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.071 -179.899 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.25 30.0 1.78 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.414 HG23 ' CB ' ' A' ' 61' ' ' SER . 10.0 t -169.85 154.34 5.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.42 -179.593 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.555 ' HG3' HG12 ' A' ' 87' ' ' VAL . 24.8 tt0 -71.8 -43.46 65.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.683 179.861 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.466 HG13 HD13 ' A' ' 83' ' ' LEU . 19.1 t -127.47 137.4 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.225 179.418 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.67 129.75 22.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.947 0.403 . . . . 0.0 112.062 -179.061 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.476 HG22 HG12 ' A' ' 111' ' ' ILE . 42.3 t -117.45 128.26 74.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.571 178.536 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 22.8 mt -133.66 136.18 54.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.47 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.547 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.81 95.97 1.57 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.517 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.6 m-85 -82.6 89.65 6.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.523 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.7 m-85 -108.55 139.24 43.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.538 -178.181 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -85.94 -4.52 59.19 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.915 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.433 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.4 t70 -153.95 122.05 6.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.619 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.521 ' HG ' HG21 ' A' ' 66' ' ' THR . 97.9 mt -91.17 47.37 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.147 0.499 . . . . 0.0 111.375 -179.331 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.4 mt-10 -138.85 8.67 2.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.941 179.073 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.629 HG13 HG22 ' A' ' 47' ' ' VAL . 1.2 pt -92.91 154.45 41.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.061 179.753 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.469 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 87.0 Cg_exo -48.24 -29.75 13.5 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.004 2.469 . . . . 0.0 113.242 179.82 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.484 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -62.37 -36.7 83.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.911 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.643 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.7 t -63.18 -56.62 26.18 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.747 -178.801 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.3 Cg_exo -59.86 -36.92 89.2 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.789 1.659 . . . . 0.0 111.42 179.534 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.62 HG21 ' HA ' ' A' ' 104' ' ' ALA . 5.6 mt -64.83 -36.52 77.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.909 179.73 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.519 ' O ' ' HG3' ' A' ' 53' ' ' MET . 42.9 tp -72.46 -53.36 12.37 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.749 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -53.86 -22.26 9.45 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.072 0.463 . . . . 0.0 109.824 178.765 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -85.36 -44.83 12.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.555 179.668 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.519 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -60.92 -25.55 66.84 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.369 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.7 t -53.24 -49.41 52.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.988 179.411 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -75.09 -9.41 58.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.686 -179.885 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -95.23 -20.25 19.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.309 179.788 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.581 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 61.1 m-85 -134.69 61.12 46.38 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.508 -179.603 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.74 -40.17 74.83 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.506 2.137 . . . . 0.0 111.45 179.176 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.04 -40.85 96.05 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.764 -0.732 . . . . 0.0 111.449 178.963 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.3 t -67.65 144.58 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.798 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.499 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 38.7 t -81.43 96.5 7.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.085 0.469 . . . . 0.0 111.157 -179.624 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.505 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 5.7 p90 -62.28 129.45 40.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.962 179.732 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.51 161.48 28.65 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.079 179.716 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.409 HD13 HG11 ' A' ' 47' ' ' VAL . 5.2 tt -160.53 143.07 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.813 0.34 . . . . 0.0 110.178 179.862 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.6 t -146.44 157.98 43.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.971 0.415 . . . . 0.0 111.678 -179.035 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.521 HG21 ' HG ' ' A' ' 42' ' ' LEU . 67.5 p -141.07 -8.78 1.01 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.766 179.804 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -64.48 142.79 58.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.789 -179.882 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.6 m -64.03 -47.74 79.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.567 -179.495 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -51.14 -46.09 61.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.514 -179.269 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.53 ' HA ' HG23 ' A' ' 21' ' ' VAL . 72.7 t -70.34 -51.54 37.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.812 0.339 . . . . 0.0 110.73 179.806 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mp -59.3 -14.63 12.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.187 179.371 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.0 m -91.97 -41.17 10.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.297 178.657 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -60.3 -41.99 94.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.657 179.933 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -89.21 11.29 19.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.798 179.587 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 56.41 27.72 12.5 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.597 179.45 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.642 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.4 mm -62.67 124.3 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.961 179.755 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.1 p -142.78 59.31 1.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.444 -179.782 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.83 46.39 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.687 179.697 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 30.1 m-80 51.91 43.15 30.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.059 0.457 . . . . 0.0 110.469 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.642 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.8 m -68.87 152.01 45.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.661 -178.522 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.562 HG23 HD23 ' A' ' 107' ' ' LEU . 61.2 mt -118.97 116.28 50.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.906 177.985 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.516 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 72.8 m -106.15 132.67 51.95 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.83 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.583 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.1 tp -108.64 103.54 12.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.838 178.413 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -97.95 123.94 42.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.823 0.344 . . . . 0.0 110.863 179.992 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.485 HH21 ' HB2' ' A' ' 88' ' ' ASP . 2.3 mtm180 -107.35 100.81 10.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.092 179.833 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.9 tp -44.37 -52.69 7.49 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.687 -179.203 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.555 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.22 -64.33 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.015 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.485 ' HB2' HH21 ' A' ' 85' ' ' ARG . 5.8 m-20 -97.01 17.13 17.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.605 -179.044 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.9 p30 42.37 32.31 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.152 179.128 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.476 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 5.8 mm-40 -79.05 159.85 27.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.944 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.42 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.9 OUTLIER -145.35 92.31 2.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.95 179.656 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.583 HD21 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -78.58 140.24 38.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.453 179.257 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.08 100.79 7.16 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.477 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.468 HD23 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -87.16 77.04 9.15 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.819 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.431 ' HA ' ' HG1' ' A' ' 80' ' ' THR . 27.9 mt-10 -79.0 -164.85 0.66 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -176.93 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.465 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -46.38 -49.62 17.67 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.452 -179.369 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -47.62 -18.25 0.13 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.852 0.358 . . . . 0.0 111.165 179.762 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -125.29 -13.83 6.59 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.574 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.51 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 22.9 mm -90.44 -28.77 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.682 0.277 . . . . 0.0 111.475 -179.451 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -53.96 -48.87 69.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 82.5 p -119.61 36.72 4.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.435 179.783 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.51 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.2 tp -60.55 142.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.425 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.502 ' HA ' HD12 ' A' ' 49' ' ' ILE . 24.6 m-20 -138.55 150.46 46.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.665 178.883 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.62 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -48.2 -37.25 15.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.968 0.413 . . . . 0.0 110.348 -179.632 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.4 m -62.11 -47.72 83.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.437 178.803 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -60.69 -60.78 3.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.169 -179.682 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.607 HD11 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -47.98 -55.84 9.06 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.923 0.392 . . . . 0.0 110.125 179.977 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.8 m -58.49 -31.62 68.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.484 ' HD3' HD12 ' A' ' 113' ' ' ILE . 4.0 tmt_? -70.39 -65.73 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.398 179.847 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -42.93 -43.62 4.22 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.014 179.282 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.476 HG12 HG22 ' A' ' 35' ' ' VAL . 96.1 mt -63.47 -55.84 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.529 178.167 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -53.41 -18.75 2.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.336 179.282 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.484 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.16 -37.84 11.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.833 -179.359 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.401 ' O ' HD22 ' A' ' 83' ' ' LEU . 15.4 m120 -123.55 30.92 6.07 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.821 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 111' ' ' ILE . 90.2 p -84.28 39.46 0.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.078 0.466 . . . . 0.0 110.282 179.013 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.444 HD13 ' NH1' ' A' ' 85' ' ' ARG . 77.3 mt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.146 -0.931 . . . . 0.0 111.29 -179.679 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.488 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.8 pt-20 . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.611 0.243 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 45.7 Cg_endo -69.47 143.74 53.26 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.831 2.354 . . . . 0.0 112.622 -179.701 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.7 m -63.37 151.29 41.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.544 -179.61 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -94.55 94.42 8.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.96 -179.934 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.556 HD21 ' HA ' ' A' ' 24' ' ' ALA . 48.6 mt -88.77 73.89 8.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.299 179.64 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.0 p -72.4 0.51 9.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.306 -178.927 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -145.63 148.56 33.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.928 0.394 . . . . 0.0 111.862 -179.78 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 57.6 t -56.06 -50.26 88.38 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.448 179.815 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.5 Cg_endo -58.23 -45.1 33.4 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.826 1.684 . . . . 0.0 112.035 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.59 81.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.257 0.551 . . . . 0.0 110.35 -179.927 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.556 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -64.09 -59.59 4.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.98 179.391 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.8 mtm -60.48 -25.94 66.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.156 -179.972 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 21.3 mt-10 -71.83 -49.94 34.06 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.695 0.283 . . . . 0.0 110.414 179.657 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -33.37 71.97 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.079 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 36' ' ' ILE . 50.4 mt -72.33 -39.01 62.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.105 178.627 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.05 -21.33 60.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.994 -179.856 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.93 31.87 1.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.939 -179.878 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.423 HG22 ' CB ' ' A' ' 61' ' ' SER . 9.1 t -170.8 151.29 3.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.328 -179.621 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.454 ' HG3' HG13 ' A' ' 87' ' ' VAL . 30.0 tt0 -68.27 -52.76 30.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.598 179.652 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.435 HG11 HD13 ' A' ' 83' ' ' LEU . 19.4 t -118.27 137.61 51.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.174 179.329 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.527 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.9 126.23 18.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.055 0.455 . . . . 0.0 112.191 -179.031 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.559 HG23 HG12 ' A' ' 111' ' ' ILE . 49.2 t -115.22 127.85 72.63 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.521 178.338 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 28' ' ' ILE . 32.6 mt -134.17 138.3 50.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.642 -177.165 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.524 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.4 97.54 1.66 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.45 179.773 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.448 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 39.3 m-85 -83.82 92.43 7.76 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.224 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -112.49 139.32 48.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.485 -178.003 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.431 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 78.6 mt-30 -87.68 -3.22 58.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.691 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 22.2 t70 -153.72 124.39 7.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.511 179.922 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.511 ' HG ' HG23 ' A' ' 66' ' ' THR . 96.0 mt -94.92 47.34 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 0.0 111.528 -179.436 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 33.8 mt-10 -136.33 5.88 3.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.7 178.845 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.644 HG13 HG23 ' A' ' 47' ' ' VAL . 2.1 pt -88.46 156.31 50.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.083 179.884 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.444 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 75.2 Cg_exo -51.78 -27.09 25.76 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.85 2.367 . . . . 0.0 113.078 179.797 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.7 -37.67 88.21 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.78 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.644 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -62.22 -56.15 33.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.752 -178.692 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.5 Cg_exo -60.13 -36.03 90.29 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.804 1.67 . . . . 0.0 111.488 179.65 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.622 HG23 HD13 ' A' ' 107' ' ' LEU . 6.3 mt -67.1 -34.81 71.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.995 -179.937 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.545 ' O ' ' HG3' ' A' ' 53' ' ' MET . 44.6 tp -74.44 -50.98 16.23 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.893 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -55.29 -22.8 20.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.03 0.443 . . . . 0.0 109.994 178.77 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.8 m -84.89 -45.44 12.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.455 179.36 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.545 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.48 -25.62 64.59 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.198 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 50' ' ' LEU . 45.6 t -52.77 -47.75 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.119 179.329 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -78.31 -8.96 59.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.656 -179.855 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -94.51 -19.36 20.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.277 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.585 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 61.0 m-85 -136.03 62.88 48.38 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.623 -179.79 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.2 -43.35 53.91 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.689 2.259 . . . . 0.0 111.634 179.019 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.5 -42.03 93.72 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.413 179.355 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.7 t -65.31 144.53 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 178.876 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 33.9 t -81.94 96.97 7.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.012 0.434 . . . . 0.0 110.95 -179.83 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.49 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 4.8 p90 -64.3 127.34 31.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.785 179.692 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.99 160.67 28.19 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.061 179.807 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.405 HD12 HG13 ' A' ' 47' ' ' VAL . 5.0 tt -160.98 142.59 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.788 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.448 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.9 t -147.78 158.77 44.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.218 0.532 . . . . 0.0 111.646 -179.094 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.511 HG23 ' HG ' ' A' ' 42' ' ' LEU . 76.3 p -139.49 -2.35 1.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.568 179.619 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -66.79 140.52 57.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.703 -179.977 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.6 m -63.98 -49.91 70.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.444 -179.465 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -50.3 -42.7 52.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.605 -179.458 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HA ' HG21 ' A' ' 21' ' ' VAL . 58.9 t -71.92 -54.02 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.344 . . . . 0.0 110.791 179.832 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.416 HD23 ' HG2' ' A' ' 40' ' ' GLN . 5.9 mp -58.29 -14.61 7.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.339 179.331 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.7 m -91.78 -41.51 10.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.333 178.789 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -60.69 -39.64 89.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.496 179.78 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.411 ' HB2' HG12 ' A' ' 76' ' ' ILE . 61.0 m-85 -90.17 9.92 26.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.754 179.567 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.0 m120 57.71 25.28 11.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.672 179.386 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.632 HG22 ' HB ' ' A' ' 80' ' ' THR . 42.1 mm -61.73 121.77 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.149 179.805 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.1 p -140.63 58.42 1.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 0.0 111.184 -179.935 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.65 45.04 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.623 179.791 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 14.4 m120 51.07 44.17 28.74 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.125 0.488 . . . . 0.0 110.476 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.632 ' HB ' HG22 ' A' ' 76' ' ' ILE . 96.7 m -69.53 152.65 44.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.632 -178.688 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.524 HG12 ' HA2' ' A' ' 37' ' ' GLY . 58.9 mt -118.62 116.4 51.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.428 -0.805 . . . . 0.0 108.982 178.04 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.432 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 75.6 m -104.35 132.68 50.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -177.723 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.581 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.4 tp -110.94 102.66 11.13 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.982 178.434 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -96.59 125.25 40.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.7 0.286 . . . . 0.0 110.392 179.723 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.51 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.6 mtm180 -107.63 85.8 2.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.034 -179.536 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.6 tp -27.42 -61.93 0.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.253 -179.286 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.454 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.29 -64.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.154 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -90.99 13.77 15.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.781 0.324 . . . . 0.0 111.32 -179.314 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 43.68 29.1 0.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.086 178.985 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.51 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 20.6 mm-40 -75.94 160.94 29.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.78 179.85 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -147.57 84.68 1.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.695 179.778 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.591 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.7 mm? -71.48 145.08 49.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.565 179.662 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -127.32 93.44 3.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.23 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.509 HD23 HD11 ' A' ' 102' ' ' ILE . 4.2 tt -78.84 78.31 5.28 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.609 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.8 mt-10 -79.63 -164.35 0.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -176.915 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.474 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 22.7 t70 -51.09 -38.36 51.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.093 -179.246 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -55.22 -14.98 1.97 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.202 0.525 . . . . 0.0 110.213 179.552 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -129.82 -13.89 4.1 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.73 -179.716 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' A' ' 79' ' ' ASN . 24.2 mm -90.32 -30.04 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 111.294 -179.652 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.45 -33.73 68.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.6 m -133.68 39.64 3.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 179.816 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 94' ' ' LEU . 7.1 tp -66.64 143.33 15.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.726 -179.676 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.538 ' HA ' HD13 ' A' ' 49' ' ' ILE . 16.1 m-20 -138.33 148.93 45.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.421 178.857 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.605 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -47.71 -36.68 11.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.094 0.473 . . . . 0.0 110.508 -179.719 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.7 m -62.38 -46.79 87.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.27 178.785 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -61.16 -59.38 5.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.224 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.622 HD13 HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.52 -54.4 18.14 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.995 0.426 . . . . 0.0 110.109 179.852 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.9 m -58.88 -31.1 68.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.761 179.765 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.457 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.6 tmt_? -71.0 -65.62 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.297 179.768 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -43.19 -43.57 4.74 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.147 179.34 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 35' ' ' VAL . 85.2 mt -63.22 -55.24 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.259 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -54.84 -18.16 4.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.219 0.533 . . . . 0.0 110.203 179.305 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.457 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.59 -35.15 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.821 -179.302 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.591 HD21 ' HG ' ' A' ' 92' ' ' LEU . 89.6 m-20 -127.03 31.2 5.31 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.369 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 111' ' ' ILE . 89.1 p -84.42 36.48 0.59 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.034 0.445 . . . . 0.0 110.253 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.45 HD11 ' NH1' ' A' ' 85' ' ' ARG . 70.5 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.309 -179.46 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.494 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 14.4 pt-20 . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 35.5 Cg_endo -65.95 144.7 77.54 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.548 2.165 . . . . 0.0 112.798 -179.196 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.6 m -62.9 150.18 42.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.602 -179.602 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -94.31 97.77 10.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.903 179.697 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.548 HD22 ' HA ' ' A' ' 24' ' ' ALA . 59.6 mt -95.44 70.99 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.072 0.463 . . . . 0.0 110.632 179.882 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 p -68.68 -8.18 40.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.225 -178.885 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -137.12 150.28 47.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.979 0.419 . . . . 0.0 111.933 -179.421 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 20.9 t -58.49 -49.78 91.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.617 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -57.81 -43.26 51.14 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.91 1.74 . . . . 0.0 111.873 179.865 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.39 -36.99 85.64 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.196 0.522 . . . . 0.0 110.277 179.921 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.548 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.39 -57.37 11.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.028 179.262 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 65.4 mtp -62.08 -27.22 68.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.253 -179.941 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 20.7 mt-10 -70.28 -51.36 31.07 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.73 0.3 . . . . 0.0 110.381 179.747 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -59.92 -33.18 71.53 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.147 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.442 HD13 HD13 ' A' ' 36' ' ' ILE . 52.9 mt -71.81 -38.24 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.907 178.241 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.06 -18.75 61.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.929 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.24 28.95 3.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.249 -179.824 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -168.58 151.55 5.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 -179.701 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.536 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.7 tt0 -68.86 -49.64 56.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.03 -179.968 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.46 HG13 HD12 ' A' ' 83' ' ' LEU . 23.4 t -122.29 135.19 63.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.12 179.31 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.29 125.85 22.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.996 0.427 . . . . 0.0 112.022 -178.862 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.527 HG23 HG12 ' A' ' 111' ' ' ILE . 48.0 t -114.26 127.15 71.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.558 178.355 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 33.9 mt -132.95 139.36 49.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.735 -177.062 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.482 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.54 100.14 1.94 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.121 179.596 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.463 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 40.1 m-85 -86.84 94.56 9.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.387 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.614 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.4 m-85 -114.06 142.24 46.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.503 -177.898 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -88.32 -6.03 57.98 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.72 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -151.4 125.75 9.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.618 179.606 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.501 ' HG ' HG23 ' A' ' 66' ' ' THR . 93.2 mt -95.24 47.83 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.032 0.444 . . . . 0.0 111.502 -179.526 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -137.72 7.14 2.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.718 178.869 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.648 HG13 HG23 ' A' ' 47' ' ' VAL . 1.2 pt -90.51 155.41 46.12 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.194 179.939 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.433 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 78.3 Cg_exo -50.38 -27.32 18.04 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.881 2.387 . . . . 0.0 113.246 -179.881 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.531 ' HB1' HD12 ' A' ' 44' ' ' ILE . . . -64.56 -37.52 87.84 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.892 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.648 HG23 HG13 ' A' ' 44' ' ' ILE . 3.1 t -61.79 -56.0 36.54 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.572 -178.895 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.648 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.4 Cg_exo -60.16 -39.44 68.97 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.833 1.689 . . . . 0.0 111.533 179.508 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.603 HG22 ' HA ' ' A' ' 104' ' ' ALA . 5.2 mt -62.99 -36.7 76.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.035 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.518 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.2 tp -72.43 -52.68 14.84 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.021 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -54.69 -22.28 13.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.037 0.446 . . . . 0.0 109.943 178.774 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.4 m -85.48 -44.12 12.99 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.494 179.501 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.5 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.52 -24.93 66.94 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.378 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.5 t -51.74 -47.22 39.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.962 179.319 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -77.43 -13.04 60.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.837 -179.776 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -91.45 -18.27 24.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.014 179.897 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.573 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.3 m-85 -137.22 62.74 39.88 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.466 -179.836 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.56 -45.15 43.11 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.643 2.228 . . . . 0.0 111.734 179.231 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.2 -42.86 83.43 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.545 179.148 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.1 t -64.29 144.51 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.667 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 37.7 t -82.3 97.43 8.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.036 0.446 . . . . 0.0 111.137 -179.68 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.445 ' CD2' HG12 ' A' ' 54' ' ' VAL . 3.6 p90 -64.49 128.13 34.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.607 179.579 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.87 160.76 28.32 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.022 179.901 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -159.97 143.29 5.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.423 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 41.6 t -150.09 157.25 42.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.048 0.451 . . . . 0.0 111.558 -179.181 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.501 HG23 ' HG ' ' A' ' 42' ' ' LEU . 82.7 p -137.82 -3.33 1.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.619 179.777 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -65.55 139.72 58.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.627 -179.835 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.2 t -61.58 -50.39 72.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.209 -179.633 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -48.69 -47.77 40.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.665 -179.391 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.535 ' HA ' HG21 ' A' ' 21' ' ' VAL . 64.9 t -67.87 -55.02 18.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.772 0.32 . . . . 0.0 110.73 179.818 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 mp -56.86 -14.8 3.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.351 179.397 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.7 m -91.0 -41.75 10.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.281 178.764 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -60.82 -35.94 77.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.616 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -95.88 14.25 24.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.805 179.621 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 55.49 25.11 7.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.771 179.067 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.636 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.4 mm -62.67 121.82 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.883 0.373 . . . . 0.0 111.243 179.981 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.5 p -142.46 59.28 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.117 179.959 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.28 44.93 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.586 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.614 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 29.2 m-80 51.79 43.83 29.76 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.222 0.534 . . . . 0.0 110.609 -179.944 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.636 ' HB ' HG23 ' A' ' 76' ' ' ILE . 87.5 m -69.31 151.65 45.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.55 -178.642 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.53 HG23 HD22 ' A' ' 107' ' ' LEU . 54.6 mt -117.7 117.54 55.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.158 177.931 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.463 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 71.2 m -108.06 133.2 52.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.566 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.584 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -108.55 104.96 14.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.752 178.268 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -98.95 120.84 40.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.881 0.372 . . . . 0.0 110.892 179.77 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.5 HH12 HD12 ' A' ' 116' ' ' LEU . 3.7 mtm180 -104.43 100.49 10.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.123 179.82 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.6 tp -43.78 -55.11 4.67 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.017 -179.362 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.536 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.3 -62.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.171 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -98.31 8.14 45.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.167 -179.618 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 85' ' ' ARG . 19.7 t-20 48.69 38.03 10.73 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.023 -179.914 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.468 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 7.1 mm-40 -82.25 160.72 22.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.765 179.691 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.2 94.3 2.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 179.462 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.584 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -81.94 139.51 34.56 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.291 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -120.28 114.55 22.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.315 0.578 . . . . 0.0 112.294 -179.385 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.454 HD22 HD12 ' A' ' 102' ' ' ILE . 3.8 tt -100.23 75.75 1.84 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.9 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -76.98 -166.41 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.146 -176.785 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.449 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.4 OUTLIER -45.92 -51.21 13.61 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.249 -179.334 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -46.98 -17.02 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.286 179.653 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.406 ' N ' ' C ' ' A' ' 96' ' ' ASP . 10.8 m-20 -126.22 -14.17 6.01 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.551 -179.999 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.467 HG21 ' HB2' ' A' ' 79' ' ' ASN . 21.7 mm -90.91 -26.19 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.624 -179.322 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -58.18 -35.48 71.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.868 0.366 . . . . 0.0 110.971 -179.81 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.3 m -132.52 39.49 3.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.526 179.964 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.454 HD12 HD22 ' A' ' 94' ' ' LEU . 6.2 tp -64.16 142.07 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.438 -179.86 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.534 ' HA ' HD13 ' A' ' 49' ' ' ILE . 16.3 m-20 -136.74 148.36 47.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.593 178.846 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.603 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -46.39 -35.57 5.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.034 0.445 . . . . 0.0 110.391 179.961 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -63.67 -49.02 74.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.441 178.891 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -59.2 -58.7 7.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.179 -179.88 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.586 HD13 HG23 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.18 -55.84 13.52 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.091 0.472 . . . . 0.0 109.966 179.881 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.0 m -58.39 -29.13 65.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.9 179.726 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.47 ' HD3' HD12 ' A' ' 113' ' ' ILE . 3.8 tmt_? -71.48 -66.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.172 179.588 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -42.59 -42.58 3.45 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.07 179.132 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 35' ' ' VAL . 95.5 mt -64.28 -55.77 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.503 178.346 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.28 -18.62 4.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.319 179.41 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.47 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.32 -37.28 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.934 -179.023 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -122.44 28.75 7.25 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.595 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.1 p -82.3 52.85 2.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.09 0.472 . . . . 0.0 110.184 178.884 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.5 HD12 HH12 ' A' ' 85' ' ' ARG . 67.9 mt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.125 -179.344 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.4 pt-20 . . . . . 0 CA--C 1.53 0.191 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 42.0 Cg_endo -67.77 139.9 49.38 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.492 2.128 . . . . 0.0 112.535 -179.397 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.451 HG23 ' N ' ' A' ' 17' ' ' TRP . 12.5 m -59.35 154.67 16.23 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.831 -179.52 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.451 ' N ' HG23 ' A' ' 16' ' ' THR . 6.2 m-90 -97.11 90.6 5.21 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.023 -179.927 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 24' ' ' ALA . 51.5 mt -88.01 74.53 8.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.233 179.643 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.8 p -75.83 2.62 11.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.214 -179.167 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.414 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 9.7 m-20 -145.2 147.69 32.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 111.612 -179.813 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.594 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.3 t -56.47 -49.29 94.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.516 179.896 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 17.7 Cg_endo -59.39 -43.8 37.74 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.841 1.694 . . . . 0.0 111.975 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.18 -34.95 79.59 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.191 0.519 . . . . 0.0 110.317 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.55 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -63.93 -59.05 4.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.051 179.396 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 46.3 mtm -61.42 -27.17 68.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.16 -179.964 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.0 mt-10 -70.05 -49.77 47.85 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.756 0.312 . . . . 0.0 110.512 179.774 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -61.42 -35.36 77.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.981 179.2 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.428 HD11 HD13 ' A' ' 36' ' ' ILE . 48.7 mt -71.19 -35.98 60.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.213 0.53 . . . . 0.0 109.802 178.324 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.7 -19.36 60.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.927 -179.915 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.17 25.49 4.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.211 -179.736 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.9 t -170.68 153.56 4.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.633 -179.8 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.459 ' HG3' HG11 ' A' ' 87' ' ' VAL . 21.3 tt0 -64.37 -80.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.727 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.504 HG13 HD13 ' A' ' 83' ' ' LEU . 19.6 t -92.14 135.0 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.498 179.693 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.6 126.12 21.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.035 0.445 . . . . 0.0 112.11 -179.107 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.471 HG21 HG12 ' A' ' 111' ' ' ILE . 45.6 t -114.76 130.93 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.71 178.51 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 25.9 mt -135.88 137.54 48.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.544 -177.385 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.39 97.68 1.76 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.519 179.907 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.486 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.5 m-85 -82.85 90.91 6.99 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.632 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.6 m-85 -110.85 138.64 47.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.224 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.466 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 78.6 mt-30 -84.59 -8.69 58.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.824 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.43 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.3 t70 -150.37 125.87 10.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.738 179.794 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.491 ' HG ' HG21 ' A' ' 66' ' ' THR . 94.0 mt -93.41 46.68 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.422 . . . . 0.0 111.325 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.6 mt-10 -137.26 11.37 3.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.929 179.036 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.668 HG13 HG23 ' A' ' 47' ' ' VAL . 2.5 pt -94.03 158.1 36.74 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.014 179.984 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.443 ' O ' HD11 ' A' ' 49' ' ' ILE . 78.0 Cg_exo -53.47 -25.08 30.67 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.709 2.273 . . . . 0.0 112.93 179.951 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.53 -37.68 87.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.758 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.668 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -61.28 -55.45 43.51 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -178.754 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.2 Cg_exo -60.95 -40.41 52.89 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.045 1.83 . . . . 0.0 111.367 179.405 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.63 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -63.0 -33.79 62.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.042 179.973 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.536 ' O ' ' HG3' ' A' ' 53' ' ' MET . 42.9 tp -75.26 -51.85 12.3 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.842 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -53.56 -25.85 18.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.218 0.532 . . . . 0.0 109.837 178.541 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 t -81.88 -47.53 12.66 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.589 179.895 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.536 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -58.14 -26.44 62.68 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.517 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 50' ' ' LEU . 52.6 t -51.68 -47.54 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.016 179.306 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -78.54 -11.88 59.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.681 -179.891 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 28.4 mtpp -92.12 -16.41 26.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.226 179.764 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.579 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 55.4 m-85 -138.71 63.18 31.72 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.478 -179.883 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.8 -44.47 47.92 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.636 2.224 . . . . 0.0 111.643 179.085 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.53 -38.85 82.94 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.542 179.209 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.0 t -68.76 144.28 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.175 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.513 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 23.2 t -82.53 96.5 8.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.106 0.479 . . . . 0.0 110.816 -179.65 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.442 ' CD2' HG12 ' A' ' 54' ' ' VAL . 4.0 p90 -64.07 125.75 25.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.074 179.69 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.66 162.05 28.25 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.16 179.908 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.5 tt -158.16 142.19 6.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.811 0.339 . . . . 0.0 110.223 179.62 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.8 t -142.73 154.69 44.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.136 0.493 . . . . 0.0 111.706 -179.036 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.491 HG21 ' HG ' ' A' ' 42' ' ' LEU . 71.3 p -140.16 1.86 1.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.534 179.503 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -74.24 139.86 44.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.658 -179.786 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.3 m -62.17 -50.77 70.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.296 -179.694 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -49.65 -44.63 47.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.588 -179.449 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.471 ' HA ' HG21 ' A' ' 21' ' ' VAL . 67.6 t -69.8 -53.94 21.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.859 0.361 . . . . 0.0 110.687 179.856 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp -57.95 -15.43 8.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.396 179.385 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 86.4 m -89.81 -42.5 11.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.212 178.748 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -59.72 -36.92 77.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.45 179.694 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -94.86 12.31 28.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.11 179.638 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.7 m120 57.29 20.77 6.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.67 179.063 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.635 HG21 ' HB ' ' A' ' 80' ' ' THR . 35.3 mm -57.49 120.66 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.951 179.637 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.1 p -140.62 53.8 1.61 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.865 0.364 . . . . 0.0 111.312 -179.957 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.43 46.15 0.01 OUTLIER Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.68 179.839 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' A' ' 99' ' ' ILE . 13.6 m120 51.2 42.54 28.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.186 0.517 . . . . 0.0 110.404 -179.85 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.635 ' HB ' HG21 ' A' ' 76' ' ' ILE . 94.3 m -68.35 152.82 44.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.557 -178.658 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.549 HG12 ' HA2' ' A' ' 37' ' ' GLY . 60.7 mt -119.43 118.53 57.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.035 178.195 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.486 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 65.6 m -107.57 137.08 46.24 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.695 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.584 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.9 tp -111.47 103.49 11.85 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.092 178.702 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -96.65 117.96 32.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.664 179.644 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.446 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 4.5 mtm180 -101.94 81.37 2.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.761 -179.863 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 5.6 tp -25.05 -60.98 0.06 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.327 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.459 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.46 -62.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.137 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -94.43 1.07 55.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.011 0.434 . . . . 0.0 111.045 -179.5 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 51.13 38.81 21.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.313 179.684 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 6.3 mm-40 -87.52 157.54 19.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.574 179.658 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.03 101.51 4.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.938 179.735 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.584 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -90.4 115.81 27.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.704 179.319 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.79 111.27 23.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.734 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.471 HD21 HD12 ' A' ' 102' ' ' ILE . 5.4 tt -97.6 77.61 2.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.723 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.469 ' HG2' ' HG1' ' A' ' 80' ' ' THR . 26.4 mt-10 -79.12 -164.74 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -176.786 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.469 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -45.66 -50.97 12.96 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.515 -179.173 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -46.55 -17.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.008 0.432 . . . . 0.0 111.128 179.747 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.414 ' N ' ' C ' ' A' ' 96' ' ' ASP . 17.0 m-20 -126.79 -13.78 5.77 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.484 180.0 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.573 HG21 ' HB2' ' A' ' 79' ' ' ASN . 27.4 mm -91.32 -42.11 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.464 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -51.9 -30.74 25.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.907 0.384 . . . . 0.0 111.052 179.935 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.5 m -131.36 36.09 3.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.277 179.68 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.7 tp -65.66 143.91 15.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.583 -179.818 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.484 ' HA ' HD12 ' A' ' 49' ' ' ILE . 16.2 m-20 -139.2 147.58 41.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.39 178.719 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.63 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.71 -37.11 7.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 110.307 -179.829 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.1 m -61.83 -48.37 80.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.357 178.677 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -59.9 -61.23 2.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.367 -179.842 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.599 HD13 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.85 -55.89 8.75 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 110.386 179.894 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -58.75 -31.75 68.62 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.991 179.909 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.495 ' HD3' HD12 ' A' ' 113' ' ' ILE . 3.3 tmt_? -69.86 -65.32 0.74 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.308 179.777 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -43.59 -44.17 6.06 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.168 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.471 HG12 HG21 ' A' ' 35' ' ' VAL . 96.7 mt -62.29 -55.36 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.197 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.43 -19.04 4.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.522 179.31 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.495 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -87.29 -36.79 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.796 -179.294 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -124.91 29.86 6.05 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.784 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.8 p -82.67 46.73 1.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.121 0.486 . . . . 0.0 110.329 179.166 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 63.1 mt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.316 -179.379 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.445 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.57 0.224 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.455 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.9 Cg_endo -67.91 140.86 51.73 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.654 2.236 . . . . 0.0 112.407 -179.712 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.2 m -55.1 155.0 5.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.892 -179.409 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -100.57 92.26 5.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.876 179.725 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 24' ' ' ALA . 55.4 mt -90.2 73.41 7.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.433 -179.893 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.5 p -74.36 0.85 13.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.288 -178.858 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -143.49 147.17 34.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.729 -179.678 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.577 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 19.9 t -55.2 -51.01 83.3 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.413 179.973 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.02 -44.18 41.91 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.905 1.737 . . . . 0.0 112.012 179.805 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.94 79.21 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.284 0.564 . . . . 0.0 110.35 -179.883 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -65.19 -58.48 5.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.984 179.515 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.7 mtm -61.28 -25.18 66.93 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.88 179.892 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -71.51 -51.68 22.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.357 179.613 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.01 -33.82 72.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.929 179.282 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.503 HD12 HD12 ' A' ' 36' ' ' ILE . 51.6 mt -73.42 -37.99 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.951 178.492 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.17 -18.35 60.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.905 -179.933 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.4 24.73 4.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.19 -179.871 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.9 t -169.71 153.08 4.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.695 -179.792 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.48 ' HG3' HG11 ' A' ' 87' ' ' VAL . 18.2 tt0 -64.12 -77.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.609 179.774 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.471 HG13 HD12 ' A' ' 83' ' ' LEU . 21.5 t -95.53 133.84 35.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.418 179.668 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.557 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -137.47 124.9 21.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.254 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.5 HG21 HG12 ' A' ' 111' ' ' ILE . 55.0 t -114.07 128.32 71.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.723 178.464 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.503 HD12 HD12 ' A' ' 28' ' ' ILE . 27.3 mt -135.05 138.53 48.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.534 -177.345 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.531 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.66 98.79 1.9 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.272 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.439 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 37.1 m-85 -84.23 91.02 7.63 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.291 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -110.72 142.54 42.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.646 -178.065 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -86.63 -8.08 57.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.887 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -151.53 131.11 13.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.605 179.745 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.532 ' HG ' HG22 ' A' ' 66' ' ' THR . 84.4 mt -97.75 47.58 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.109 0.48 . . . . 0.0 111.621 -179.539 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -137.09 5.22 2.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.689 178.773 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.664 HG13 HG21 ' A' ' 47' ' ' VAL . 1.6 pt -88.27 155.72 51.64 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.094 179.766 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.468 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 72.3 Cg_exo -50.95 -29.06 25.94 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.89 2.393 . . . . 0.0 113.126 179.886 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.47 ' HB3' HD13 ' A' ' 44' ' ' ILE . . . -62.04 -37.44 84.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.831 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.678 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 3.2 t -61.9 -57.21 25.48 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.659 -178.787 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.678 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.3 Cg_exo -59.07 -38.57 86.51 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.759 1.639 . . . . 0.0 111.52 179.589 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.604 HG22 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -63.33 -36.48 76.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.047 179.936 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.514 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.5 tp -73.98 -53.23 10.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.77 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -54.2 -22.59 11.86 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.816 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.2 t -85.32 -43.66 13.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.435 179.516 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.508 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.44 -24.85 66.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.253 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -51.97 -46.69 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.89 179.236 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -77.58 -12.6 59.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.905 -179.74 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -92.19 -18.16 23.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.332 -179.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.578 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 52.5 m-85 -137.37 63.31 41.45 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.547 -179.692 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.64 -46.43 33.41 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.71 2.274 . . . . 0.0 111.77 178.939 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.9 -42.08 78.59 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.658 179.328 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.9 t -64.27 146.61 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.87 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.557 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 32.8 t -83.51 97.48 9.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.964 0.411 . . . . 0.0 110.924 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.455 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.2 p90 -66.02 126.17 27.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.32 161.62 28.35 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.195 179.81 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -159.07 144.36 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.993 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.439 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 29.4 t -149.18 155.86 41.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.12 0.486 . . . . 0.0 111.762 -179.214 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.532 HG22 ' HG ' ' A' ' 42' ' ' LEU . 76.6 p -137.09 -0.8 2.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.613 179.387 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.92 136.33 53.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.566 -179.927 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 59.5 m -61.52 -48.66 80.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.577 -179.634 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -51.51 -41.27 60.88 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.51 -179.435 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.424 ' HA ' HG23 ' A' ' 21' ' ' VAL . 55.4 t -72.6 -53.61 18.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.915 0.388 . . . . 0.0 110.439 179.835 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.64 -14.56 8.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.23 179.261 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.2 m -91.84 -42.12 10.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.385 178.85 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -60.39 -39.49 87.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -90.06 11.02 21.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.651 179.595 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.8 m120 58.03 24.97 11.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.52 179.373 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.59 HD11 ' HB ' ' A' ' 80' ' ' THR . 40.9 mm -62.8 124.17 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.875 179.458 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.8 p -142.32 58.95 1.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.437 -179.887 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.09 45.3 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.823 179.854 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 26.8 m-80 52.04 44.03 29.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.174 0.511 . . . . 0.0 110.613 -179.86 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.59 ' HB ' HD11 ' A' ' 76' ' ' ILE . 86.6 m -69.16 154.22 42.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.533 -178.763 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.546 HG21 HD21 ' A' ' 107' ' ' LEU . 60.5 mt -119.72 117.8 55.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.16 178.156 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 72.8 m -106.99 134.68 49.78 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -177.787 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.581 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -110.78 103.79 12.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.663 178.17 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -97.93 118.03 33.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.634 179.909 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.517 HH12 HD13 ' A' ' 116' ' ' LEU . 4.5 mtm180 -101.22 80.08 2.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.462 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' ARG . 5.1 tp -23.91 -60.51 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.36 -0.836 . . . . 0.0 113.249 -179.417 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.48 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.97 -61.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.01 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -95.34 3.31 54.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.41 . . . . 0.0 111.034 -179.506 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 53.19 29.24 8.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.802 179.357 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.5 mm-40 -75.47 153.13 37.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.538 0.209 . . . . 0.0 110.643 179.721 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.409 HE21 ' HB3' ' A' ' 91' ' ' GLN . 1.0 OUTLIER -136.54 95.98 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.718 179.858 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.592 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.0 mm? -87.44 114.53 24.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.976 179.917 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.39 110.53 23.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.087 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 102' ' ' ILE . 4.3 tt -96.16 78.81 3.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.014 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.417 ' O ' HG12 ' A' ' 99' ' ' ILE . 30.6 mt-10 -78.78 -165.17 0.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -176.383 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.501 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 30.2 t70 -51.46 -35.28 39.03 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.951 -179.178 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -56.68 -15.33 4.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.206 0.527 . . . . 0.0 110.261 179.482 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -130.11 -14.09 3.93 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.531 179.923 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.501 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 22.9 mm -90.0 -27.67 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.789 0.328 . . . . 0.0 111.263 -179.517 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -57.13 -37.43 71.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.782 -179.862 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.5 m -131.95 38.17 3.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.562 179.673 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.505 HD11 HD23 ' A' ' 94' ' ' LEU . 7.6 tp -63.61 144.61 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.575 -179.602 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.552 ' HA ' HD13 ' A' ' 49' ' ' ILE . 15.5 m-20 -138.37 149.64 45.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.45 178.603 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.604 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -47.73 -35.0 9.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.111 0.481 . . . . 0.0 110.48 -179.673 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.5 m -63.01 -48.53 78.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.49 178.761 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -59.66 -59.17 5.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.182 -179.703 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.59 HD12 HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.1 -55.45 14.89 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.988 0.423 . . . . 0.0 110.18 -179.994 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.6 m -58.72 -29.48 66.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.714 179.836 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.501 ' HD3' HD12 ' A' ' 113' ' ' ILE . 4.0 tmt_? -71.11 -66.2 0.65 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.068 179.724 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -42.71 -44.73 4.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.057 179.275 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.5 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -62.65 -55.2 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.535 178.387 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -54.37 -18.69 4.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.253 179.357 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.501 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.09 -36.21 8.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.898 -179.137 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.592 HD21 ' HG ' ' A' ' 92' ' ' LEU . 90.2 m-20 -125.35 30.33 5.83 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.3 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.1 p -83.53 48.48 1.42 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.135 0.493 . . . . 0.0 110.145 178.922 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.517 HD13 HH12 ' A' ' 85' ' ' ARG . 60.9 mt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.36 -179.362 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.44 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.1 pt-20 . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 120.625 0.25 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 36.4 Cg_endo -67.08 142.93 63.36 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.934 2.423 . . . . 0.0 112.827 -179.514 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.8 m -59.68 153.77 19.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.624 -179.838 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -98.53 97.5 8.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.129 -179.849 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 24' ' ' ALA . 46.8 mt -95.21 76.46 3.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.361 179.769 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.9 p -75.17 -2.49 28.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.297 -178.736 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -142.16 147.36 36.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.919 0.39 . . . . 0.0 111.727 -179.814 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 36.1 t -54.3 -49.5 90.14 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.663 179.983 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.07 -46.97 22.3 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.949 1.766 . . . . 0.0 112.147 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.92 -34.68 77.94 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.186 0.517 . . . . 0.0 110.388 -179.81 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -63.84 -59.97 3.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.122 179.389 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 67.5 mtp -60.4 -25.98 66.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.215 -179.897 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 25.1 mt-10 -73.07 -51.73 16.97 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 120.652 0.263 . . . . 0.0 110.675 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -58.44 -33.35 69.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.117 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.454 HD12 HD12 ' A' ' 36' ' ' ILE . 45.0 mt -72.35 -40.04 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.901 178.104 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.81 -17.77 62.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.06 179.948 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.64 27.92 2.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.231 -179.828 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.8 t -173.16 155.49 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.579 -179.626 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.508 ' HG3' HG13 ' A' ' 87' ' ' VAL . 19.6 tt0 -65.31 -76.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.681 179.838 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.483 HG13 HD13 ' A' ' 83' ' ' LEU . 21.0 t -95.38 137.98 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.42 179.661 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.546 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.97 125.94 18.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.039 0.447 . . . . 0.0 112.021 -179.142 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.551 HG21 HG12 ' A' ' 111' ' ' ILE . 51.6 t -115.57 129.53 71.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.828 178.526 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 26.5 mt -135.02 135.72 52.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.624 -177.341 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.55 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.4 99.81 2.24 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.335 179.633 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 11.7 m-85 -84.63 92.57 8.19 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.725 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 9.7 m-85 -114.69 142.67 46.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.309 -178.217 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -90.06 -8.64 50.98 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.7 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.48 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.5 t70 -148.12 118.96 7.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.742 179.761 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.513 ' HG ' HG22 ' A' ' 66' ' ' THR . 93.9 mt -88.4 44.85 1.23 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.114 0.483 . . . . 0.0 111.516 -179.268 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.404 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 39.1 mt-10 -133.82 6.96 3.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.124 178.953 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.657 HG13 HG23 ' A' ' 47' ' ' VAL . 5.6 pt -88.14 159.48 47.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.191 179.89 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.457 ' O ' HD11 ' A' ' 49' ' ' ILE . 54.3 Cg_exo -54.91 -26.07 46.95 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.763 2.308 . . . . 0.0 112.689 179.429 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.41 -38.7 91.94 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.883 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.657 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -59.69 -55.58 44.33 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.723 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.64 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.1 Cg_exo -59.75 -41.27 56.59 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.052 1.835 . . . . 0.0 111.403 179.185 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.618 HG22 ' HA ' ' A' ' 104' ' ' ALA . 8.9 mt -61.97 -35.01 65.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.194 -179.906 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.523 ' O ' ' HG3' ' A' ' 53' ' ' MET . 47.2 tp -74.75 -50.93 15.59 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.959 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -54.98 -26.0 33.7 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.398 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -81.42 -46.12 15.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.734 179.859 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.523 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -60.21 -26.15 66.15 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.38 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 50' ' ' LEU . 47.7 t -53.87 -48.44 62.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.162 179.541 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -76.83 -9.35 58.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.588 -179.898 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -94.82 -19.56 20.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 179.719 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.585 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 73.4 m-85 -135.04 62.11 50.43 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.609 -179.548 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.4 -40.35 71.33 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.57 2.18 . . . . 0.0 111.379 178.996 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.42 -42.5 97.54 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.323 179.068 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.9 t -65.49 144.83 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.084 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.546 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 24.1 t -82.65 96.6 8.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.095 0.474 . . . . 0.0 110.967 -179.554 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.528 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 5.2 p90 -64.28 129.39 39.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.106 179.805 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.83 161.98 28.8 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.097 179.667 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -160.99 143.03 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.808 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.1 t -145.67 155.66 43.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.109 0.481 . . . . 0.0 111.917 -178.935 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.513 HG22 ' HG ' ' A' ' 42' ' ' LEU . 78.8 p -138.89 6.16 2.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.655 179.505 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.09 144.42 40.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.706 -179.925 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -65.64 -54.39 28.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.384 -179.547 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -49.04 -40.0 29.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.631 -179.364 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.537 ' HA ' HG21 ' A' ' 21' ' ' VAL . 68.3 t -72.37 -55.27 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.857 0.361 . . . . 0.0 110.603 179.69 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.3 -14.78 8.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.517 179.461 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.6 m -89.22 -48.04 7.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.721 179.101 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -59.03 -33.58 70.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.57 179.837 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -92.82 8.24 40.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.547 179.235 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 57.32 23.69 9.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.632 179.51 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.695 HG21 ' HB ' ' A' ' 80' ' ' THR . 34.3 mm -61.22 120.9 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.012 179.652 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.8 p -141.3 58.43 1.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.308 179.825 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.32 42.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.533 179.815 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.527 ' HB2' HG22 ' A' ' 99' ' ' ILE . 39.9 m-20 52.77 42.43 31.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.267 0.556 . . . . 0.0 110.151 -179.669 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.695 ' HB ' HG21 ' A' ' 76' ' ' ILE . 93.4 m -67.97 154.36 41.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.682 -178.472 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.55 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.5 mt -120.32 116.95 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.271 178.271 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.512 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.7 m -105.93 137.09 44.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.857 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.577 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.4 tp -112.98 105.68 13.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.253 178.671 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.2 t80 -98.18 123.08 42.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.682 0.277 . . . . 0.0 110.415 179.413 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.513 HH12 HD12 ' A' ' 116' ' ' LEU . 5.7 mtm180 -105.59 82.38 1.8 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.801 0.334 . . . . 0.0 110.875 -179.698 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 7.2 tp -26.29 -59.28 0.08 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.432 -0.803 . . . . 0.0 113.103 -179.287 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.508 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.21 -56.27 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.128 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -99.93 13.27 34.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.734 0.302 . . . . 0.0 111.386 -179.353 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 45.2 24.39 0.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.218 179.234 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.51 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 15.9 mm-40 -72.02 157.73 37.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.768 0.318 . . . . 0.0 110.77 179.794 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -143.6 85.44 1.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.67 179.667 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.585 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.7 mm? -72.78 147.96 45.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.947 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.69 114.41 16.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.309 0.576 . . . . 0.0 112.285 -179.562 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 102' ' ' ILE . 4.2 tt -101.83 76.33 1.62 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.93 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.419 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.8 mt-10 -75.82 -166.75 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -176.692 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.532 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.6 t70 -50.91 -38.67 51.47 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.057 -179.093 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -55.51 -14.9 2.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.164 0.506 . . . . 0.0 110.525 179.794 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -128.45 -13.67 4.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.47 -179.988 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 21.2 mm -89.47 -23.79 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.71 -179.33 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -53.65 -66.46 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 110.684 179.807 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.8 t -105.77 34.3 3.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.622 179.782 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.544 HD12 HD23 ' A' ' 94' ' ' LEU . 7.5 tp -53.99 142.04 8.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.224 -179.947 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.537 ' HA ' HD12 ' A' ' 49' ' ' ILE . 24.7 m-20 -135.61 151.06 49.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.676 178.967 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.618 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -49.42 -34.97 17.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.981 0.42 . . . . 0.0 110.446 -179.883 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 95.0 m -63.1 -48.16 79.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.287 178.774 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -59.79 -60.44 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.252 -179.815 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.581 HD12 HG23 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -49.36 -55.62 12.32 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.074 0.464 . . . . 0.0 110.237 179.785 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.2 m -58.32 -30.57 66.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.872 179.735 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.473 ' HD3' HD12 ' A' ' 113' ' ' ILE . 4.0 tmt_? -70.15 -66.19 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.118 179.771 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -43.43 -44.73 5.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.059 179.355 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.551 HG12 HG21 ' A' ' 35' ' ' VAL . 95.5 mt -61.88 -54.63 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.367 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -55.51 -19.15 8.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.4 179.48 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.473 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -87.69 -36.61 9.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.88 -179.009 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.585 HD21 ' HG ' ' A' ' 92' ' ' LEU . 85.1 m-20 -122.15 27.27 8.09 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.44 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.6 p -81.33 51.68 1.68 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.988 0.423 . . . . 0.0 110.362 178.886 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.513 HD12 HH12 ' A' ' 85' ' ' ARG . 71.1 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.401 -179.469 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.504 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.427 0.156 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 30.5 Cg_endo -64.18 143.69 84.59 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.699 2.266 . . . . 0.0 112.603 -179.709 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.0 m -61.71 152.41 31.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.552 -179.776 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -98.18 92.55 5.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.581 HD22 ' HA ' ' A' ' 24' ' ' ALA . 40.2 mt -87.71 72.55 9.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.258 -179.905 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.4 p -69.07 -3.98 15.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.251 -178.922 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -141.39 149.58 41.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.993 0.425 . . . . 0.0 111.792 -179.569 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.594 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 25.3 t -57.03 -49.12 95.81 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.626 179.753 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.7 Cg_endo -58.93 -43.73 41.04 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.956 1.771 . . . . 0.0 111.909 179.865 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.16 -35.3 80.67 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 110.143 179.831 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.581 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.43 -56.97 11.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.091 179.361 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 33.8 mtt -62.53 -27.72 69.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.171 -179.961 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -69.94 -49.61 50.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.686 0.279 . . . . 0.0 110.449 179.723 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.01 -32.56 73.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.84 179.071 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.443 HD12 HD12 ' A' ' 36' ' ' ILE . 54.3 mt -72.47 -37.65 57.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.833 178.161 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 -20.81 60.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.706 -179.958 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.17 28.96 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.153 -179.873 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.454 HG22 ' CB ' ' A' ' 61' ' ' SER . 8.9 t -169.1 155.38 6.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.33 -179.798 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.459 ' HG3' HG11 ' A' ' 87' ' ' VAL . 29.2 tt0 -75.98 -33.91 59.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.254 179.481 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.432 HG12 HD13 ' A' ' 83' ' ' LEU . 17.1 t -133.37 136.3 54.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.125 179.273 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.59 125.24 16.85 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.117 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.537 HG23 HG12 ' A' ' 111' ' ' ILE . 53.4 t -113.18 127.63 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.449 178.234 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.443 HD12 HD12 ' A' ' 28' ' ' ILE . 35.7 mt -133.87 139.41 48.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.62 -176.86 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.528 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.89 97.59 1.53 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.459 179.848 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.484 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 36.9 m-85 -84.84 94.37 8.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.322 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 9.9 m-85 -114.32 146.12 40.91 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.092 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.616 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 52.4 mt-30 -93.77 -6.45 46.01 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.082 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.7 t70 -151.98 113.94 4.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.511 179.855 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.473 ' HG ' HG23 ' A' ' 66' ' ' THR . 89.0 mt -84.19 43.63 0.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.026 0.441 . . . . 0.0 111.549 -179.166 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.444 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.5 mt-10 -132.24 11.38 4.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.999 179.11 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.657 HG13 HG23 ' A' ' 47' ' ' VAL . 9.6 pt -91.78 161.89 32.62 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.336 179.969 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.441 ' O ' HD11 ' A' ' 49' ' ' ILE . 51.3 Cg_exo -57.73 -23.93 60.6 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.737 2.291 . . . . 0.0 112.587 179.047 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.18 88.99 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.812 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.657 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -58.6 -55.1 49.38 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -178.681 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.625 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.8 Cg_exo -61.57 -42.46 33.01 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.971 1.781 . . . . 0.0 111.648 179.287 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.633 HG21 HD12 ' A' ' 107' ' ' LEU . 6.2 mt -60.67 -34.33 58.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.236 -179.991 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.532 ' O ' ' HG3' ' A' ' 53' ' ' MET . 51.3 tp -74.37 -51.67 14.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.138 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -53.55 -25.89 18.94 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.541 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 m -80.56 -49.79 10.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.606 179.686 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.532 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -56.43 -27.17 55.87 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.174 0.511 . . . . 0.0 109.666 179.551 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.2 t -53.27 -49.97 49.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.726 179.481 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -75.17 -8.66 57.2 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.583 -179.76 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -95.81 -19.14 19.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.203 179.613 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.606 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 63.4 m-85 -135.65 62.61 49.4 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.503 -179.796 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.65 -41.44 61.42 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.613 2.209 . . . . 0.0 111.658 179.094 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.37 -41.78 97.13 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.511 179.167 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.0 t -66.03 144.07 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.882 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 47.4 t -82.07 99.32 9.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.08 0.467 . . . . 0.0 111.001 -179.773 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.505 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 5.5 p90 -65.59 127.94 33.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.635 179.688 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.16 161.52 28.32 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.235 -179.944 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 tt -162.21 143.24 3.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.732 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.484 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 44.1 t -150.32 157.24 42.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.127 0.489 . . . . 0.0 111.519 -179.143 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.473 HG23 ' HG ' ' A' ' 42' ' ' LEU . 71.2 p -136.49 -7.66 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.695 179.413 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -60.19 139.69 57.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.605 179.883 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.2 p -63.48 -47.33 82.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.61 -179.356 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -52.48 -43.42 64.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.716 -179.224 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.434 ' HA ' HG23 ' A' ' 21' ' ' VAL . 67.0 t -72.15 -51.04 32.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.849 0.356 . . . . 0.0 110.71 179.832 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.74 -14.84 23.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.088 0.47 . . . . 0.0 110.135 179.449 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.2 m -92.3 -39.46 11.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.418 178.799 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -62.86 -40.66 98.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.423 -179.996 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -88.25 8.2 28.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.467 179.426 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 58.54 27.06 15.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.506 179.539 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.637 HG21 ' HB ' ' A' ' 80' ' ' THR . 38.6 mm -63.2 121.69 12.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.225 179.689 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.0 p -141.12 56.17 1.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.377 -179.965 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.37 44.37 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.579 179.847 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.616 ' ND2' ' H ' ' A' ' 40' ' ' GLN . 6.8 m120 51.31 43.85 29.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.297 0.57 . . . . 0.0 110.379 -179.846 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.637 ' HB ' HG21 ' A' ' 76' ' ' ILE . 93.3 m -69.13 153.28 43.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.076 -178.334 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.528 HG12 ' HA2' ' A' ' 37' ' ' GLY . 55.2 mt -119.14 116.41 50.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.92 177.88 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 72.4 m -104.85 130.1 53.04 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.833 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.586 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.8 tp -107.92 100.74 10.07 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.583 178.102 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -95.16 121.65 37.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.488 179.808 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.543 HH12 HD11 ' A' ' 116' ' ' LEU . 5.0 mtm180 -105.05 88.04 2.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.545 -179.933 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 tp -27.11 -60.28 0.09 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.279 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.459 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.19 -79.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.361 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -78.3 2.57 18.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.818 -179.907 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 54.36 28.84 9.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.54 179.671 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.539 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 27.5 mm-40 -71.32 163.44 27.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.884 0.374 . . . . 0.0 110.882 179.876 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.02 88.48 1.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.668 179.76 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.586 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -78.45 117.79 19.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.897 179.879 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.77 93.55 5.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.882 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.482 HD22 HD13 ' A' ' 102' ' ' ILE . 4.0 tt -78.71 78.6 5.15 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.776 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -79.73 -165.5 0.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.787 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.439 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.7 OUTLIER -44.83 -52.05 8.92 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.374 -179.377 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -46.06 -17.68 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.365 179.786 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 96' ' ' ASP . 28.6 m-20 -125.9 -13.8 6.26 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.523 -179.941 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.538 HG23 ' HB2' ' A' ' 79' ' ' ASN . 23.0 mm -90.85 -35.13 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.338 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.0 -39.0 58.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.362 -179.681 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.7 m -126.48 32.96 5.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.749 179.937 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.9 tp -58.37 143.71 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.681 -179.935 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.515 ' HA ' HD12 ' A' ' 49' ' ' ILE . 23.3 m-20 -138.61 148.78 44.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.475 178.891 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.593 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.88 -37.14 13.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.061 0.458 . . . . 0.0 110.337 -179.888 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.6 m -61.76 -48.0 82.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.237 178.741 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -60.1 -62.38 1.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.26 -179.895 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.633 HD12 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.22 -56.44 6.7 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.013 0.435 . . . . 0.0 110.258 179.982 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.9 m -57.97 -31.25 66.72 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.815 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.466 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -70.32 -66.51 0.59 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.184 179.71 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -42.07 -43.96 3.43 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.295 179.351 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.537 HG12 HG23 ' A' ' 35' ' ' VAL . 95.1 mt -63.42 -55.05 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.381 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -54.01 -18.89 3.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.151 179.234 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.466 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.91 -35.81 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.944 -179.137 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -125.17 31.78 5.53 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.472 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.1 p -83.84 36.54 0.56 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.037 0.446 . . . . 0.0 110.465 178.792 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.543 HD11 HH12 ' A' ' 85' ' ' ARG . 63.7 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.311 -179.565 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.445 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 10.3 pt-20 . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.513 0.197 . . . . 0.0 110.545 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 30.3 Cg_endo -64.26 148.99 91.06 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.584 2.19 . . . . 0.0 112.594 -179.373 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 17' ' ' TRP . 26.0 m -64.13 154.28 35.11 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.161 -179.39 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.401 ' N ' HG22 ' A' ' 16' ' ' THR . 5.6 m-90 -98.09 88.4 4.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.827 179.647 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.555 HD21 ' HA ' ' A' ' 24' ' ' ALA . 60.8 mt -88.33 77.01 8.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.057 0.456 . . . . 0.0 110.379 179.914 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.2 p -75.03 -7.09 52.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.32 -179.076 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -138.8 147.9 43.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.816 -179.576 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.589 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 47.9 t -54.93 -50.32 86.91 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.521 179.794 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.44 -44.49 42.0 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.944 1.762 . . . . 0.0 111.854 -179.956 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.86 -33.98 77.29 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.258 0.552 . . . . 0.0 110.4 -179.988 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.555 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -65.28 -58.55 5.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.127 179.371 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.5 mtp -61.24 -27.02 68.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.981 179.992 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 18.7 mt-10 -71.0 -49.88 40.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.654 0.264 . . . . 0.0 110.342 179.616 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -60.16 -35.24 74.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.002 179.229 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.452 HD13 HD11 ' A' ' 36' ' ' ILE . 49.0 mt -72.28 -38.36 61.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.926 178.526 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.3 -18.65 61.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.04 -179.823 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.08 26.63 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.04 -179.842 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.9 t -173.32 153.72 2.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.541 -179.623 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.464 ' HG3' HG13 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -63.3 -84.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.148 0.499 . . . . 0.0 110.903 179.532 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.464 HG11 HD13 ' A' ' 83' ' ' LEU . 13.0 t -87.7 134.21 28.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.663 -179.808 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.55 125.46 21.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 112.019 -179.162 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.478 HG22 HG12 ' A' ' 111' ' ' ILE . 53.5 t -115.21 127.87 72.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.955 178.544 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.452 HD11 HD13 ' A' ' 28' ' ' ILE . 23.5 mt -133.23 136.15 55.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.513 -177.27 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.559 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.58 98.8 1.99 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.49 179.797 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.487 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 11.7 m-85 -83.81 92.36 7.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.632 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.9 m-85 -113.42 141.59 46.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.451 -178.068 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.401 ' HG2' HD21 ' A' ' 71' ' ' LEU . 25.3 mt-30 -89.41 -6.99 56.07 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.712 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 44' ' ' ILE . 36.4 t70 -150.03 119.06 6.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.82 179.916 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.475 ' HG ' HG23 ' A' ' 66' ' ' THR . 94.7 mt -88.36 44.97 1.24 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.11 0.481 . . . . 0.0 111.165 -179.605 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -135.99 10.85 3.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.21 179.317 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.643 HG13 HG23 ' A' ' 47' ' ' VAL . 1.7 pt -95.13 156.39 37.88 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.098 179.742 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.452 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 76.4 Cg_exo -50.94 -29.79 28.31 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.712 2.274 . . . . 0.0 112.909 179.825 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.11 77.48 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.052 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.648 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.2 t -64.49 -57.66 16.38 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.636 -178.926 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.648 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.9 Cg_exo -58.23 -37.93 93.21 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.712 1.608 . . . . 0.0 111.205 179.279 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.616 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.6 mt -64.34 -37.32 79.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.029 179.822 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.559 ' O ' ' HG3' ' A' ' 53' ' ' MET . 39.7 tp -72.82 -52.92 12.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.905 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -54.8 -25.16 26.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.021 0.438 . . . . 0.0 109.966 178.791 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.7 t -81.71 -44.94 16.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.465 179.588 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.559 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.49 -26.31 67.83 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.159 0.504 . . . . 0.0 109.788 179.497 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 50' ' ' LEU . 53.7 t -53.02 -49.65 48.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.121 179.513 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -74.47 -11.74 60.31 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.564 -179.949 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -93.71 -17.9 22.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.291 179.936 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.543 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 65.2 m-85 -136.49 61.65 38.81 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.551 -179.74 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.61 -42.64 60.88 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.682 2.255 . . . . 0.0 111.67 179.174 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.29 -39.47 90.31 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.368 179.31 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.6 t -67.76 145.09 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.521 -0.34 . . . . 0.0 110.19 178.927 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.542 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 22.6 t -82.71 96.79 8.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.03 0.443 . . . . 0.0 110.899 -179.716 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.459 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 6.9 p90 -63.98 129.53 40.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.05 179.888 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.97 161.57 28.73 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.01 179.697 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -160.12 144.39 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.795 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.8 t -146.82 155.55 42.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.174 0.512 . . . . 0.0 111.733 -179.137 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.475 HG23 ' HG ' ' A' ' 42' ' ' LEU . 77.9 p -139.14 2.08 2.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.618 179.654 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -73.63 143.78 46.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.744 -179.893 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.2 p -64.91 -51.84 59.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.405 -179.578 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -49.23 -42.58 40.94 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.707 -179.472 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.546 ' HA ' HG21 ' A' ' 21' ' ' VAL . 77.7 t -71.77 -54.1 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.936 0.398 . . . . 0.0 110.714 179.973 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.401 HD21 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.63 -14.68 8.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.303 179.368 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.1 m -91.91 -40.95 10.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.261 178.966 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -60.69 -39.34 88.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.403 179.825 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -91.9 10.61 28.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.723 179.398 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 58.26 22.37 9.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.662 179.128 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.633 HG22 ' HB ' ' A' ' 80' ' ' THR . 37.9 mm -57.83 122.21 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.044 179.912 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.0 p -142.3 59.55 1.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.139 -179.912 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.3 44.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.725 179.989 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.554 ' HB2' HG23 ' A' ' 99' ' ' ILE . 42.1 m-20 51.77 42.83 30.21 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.192 0.52 . . . . 0.0 110.532 -179.9 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.633 ' HB ' HG22 ' A' ' 76' ' ' ILE . 93.8 m -69.02 153.83 43.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.677 -178.671 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.559 HG12 ' HA2' ' A' ' 37' ' ' GLY . 62.7 mt -120.83 118.28 55.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.941 178.268 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.487 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.4 m -106.55 134.31 49.88 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.998 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.593 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.7 tp -111.42 105.08 13.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.129 178.716 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.3 t80 -99.31 119.91 38.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.446 179.543 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.443 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 4.6 mtm180 -101.74 79.98 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.809 -179.731 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 85' ' ' ARG . 11.5 tp -23.9 -59.35 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.108 -179.622 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.464 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.21 -63.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.264 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.49 3.72 54.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.061 0.457 . . . . 0.0 111.14 -179.694 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 51.37 30.02 5.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.947 179.422 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 7.0 mm-40 -77.53 153.5 33.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.505 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -135.4 94.98 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.904 179.816 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.593 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -84.71 134.85 34.34 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.003 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.26 101.31 8.33 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.824 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.53 HD23 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -85.93 78.19 9.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.794 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.1 mt-10 -80.4 -164.84 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.891 -176.877 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.493 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 23.7 t70 -51.26 -36.12 40.56 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.831 -179.381 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -55.77 -14.88 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.106 0.479 . . . . 0.0 110.21 179.448 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -131.5 -13.81 3.34 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.623 -179.806 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.577 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 25.8 mm -90.17 -35.45 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.594 0.235 . . . . 0.0 111.406 -179.496 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -49.62 -44.56 47.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.801 -179.98 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.3 m -124.74 41.14 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.358 179.498 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.577 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.8 tp -66.3 143.97 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.8 -179.618 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.525 ' HA ' HD12 ' A' ' 49' ' ' ILE . 17.4 m-20 -138.45 149.59 45.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.581 178.72 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.616 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.61 -37.6 12.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.581 -179.788 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.5 m -61.6 -47.49 85.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.346 178.75 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -59.86 -61.39 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.249 -179.718 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.71 -55.8 10.36 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.924 0.392 . . . . 0.0 110.382 179.98 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.6 m -58.51 -30.18 66.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.88 179.901 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.533 ' HD3' HD11 ' A' ' 113' ' ' ILE . 2.9 tmt_? -70.54 -66.42 0.61 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.101 179.558 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -42.88 -44.4 4.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.274 179.34 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.478 HG12 HG22 ' A' ' 35' ' ' VAL . 96.6 mt -63.19 -54.75 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.287 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.403 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 32.8 tt0 -53.96 -19.66 5.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.224 179.191 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.533 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.7 -36.53 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.771 -179.155 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.59 HD21 ' HG ' ' A' ' 92' ' ' LEU . 88.9 m-20 -123.71 30.01 6.35 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.183 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 96.6 p -82.83 37.13 0.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.165 0.507 . . . . 0.0 110.052 178.797 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.43 HD11 HH12 ' A' ' 85' ' ' ARG . 53.5 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.314 -179.329 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.7 pt-20 . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 110.52 -0.178 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 38.1 Cg_endo -66.43 144.48 73.68 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.53 2.153 . . . . 0.0 112.405 -179.614 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.424 HG23 ' N ' ' A' ' 17' ' ' TRP . 19.6 m -63.41 153.58 34.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.671 -179.536 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.424 ' N ' HG23 ' A' ' 16' ' ' THR . 4.5 m-90 -98.62 92.53 5.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 179.488 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.58 HD13 ' HA ' ' A' ' 24' ' ' ALA . 43.5 mt -86.96 73.65 9.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.326 179.801 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.2 p -72.21 -5.37 35.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.118 -179.167 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -137.06 146.72 45.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.905 0.383 . . . . 0.0 111.604 -179.684 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 59.9 t -55.5 -49.81 90.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.61 179.883 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.8 Cg_endo -57.77 -46.17 28.29 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.923 1.749 . . . . 0.0 112.07 179.877 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.83 81.39 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.346 0.593 . . . . 0.0 110.239 -179.898 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.58 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -63.99 -58.53 6.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.023 179.524 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.41 ' HG3' ' O ' ' A' ' 21' ' ' VAL . 57.7 mtm -60.02 -25.76 65.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.065 179.891 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -71.97 -52.07 18.86 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.621 179.642 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -60.01 -30.2 69.0 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.33 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.473 HD13 HD12 ' A' ' 36' ' ' ILE . 48.0 mt -75.57 -38.69 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.121 178.201 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 -20.66 60.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.018 -179.851 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.78 31.85 1.33 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -179.929 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.491 HG22 ' CB ' ' A' ' 61' ' ' SER . 9.7 t -170.43 151.78 3.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.45 -179.539 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.53 ' HG3' HG11 ' A' ' 87' ' ' VAL . 24.4 tt0 -70.18 -40.55 74.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.558 179.539 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.426 HG11 HD12 ' A' ' 83' ' ' LEU . 19.4 t -129.94 137.35 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.162 179.283 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.93 128.19 19.85 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.134 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.485 HG23 HG12 ' A' ' 111' ' ' ILE . 55.0 t -115.93 130.53 70.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.379 178.338 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.473 HD12 HD13 ' A' ' 28' ' ' ILE . 28.7 mt -136.19 135.92 49.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.305 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.548 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.39 96.86 1.73 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.559 179.722 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.498 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 13.6 m-85 -82.45 89.68 6.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.522 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -109.94 140.56 43.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.057 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -87.28 -6.51 58.51 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.661 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.453 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.9 t70 -151.58 122.42 7.54 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.755 179.837 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.505 ' HG ' HG23 ' A' ' 66' ' ' THR . 97.1 mt -91.34 46.18 1.29 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.131 0.491 . . . . 0.0 111.208 -179.486 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -137.25 11.08 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.0 179.204 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.646 HG13 HG21 ' A' ' 47' ' ' VAL . 2.3 pt -94.21 156.13 39.23 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.133 179.923 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.439 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 75.0 Cg_exo -51.16 -27.08 21.28 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.807 2.338 . . . . 0.0 113.057 179.666 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.67 -38.7 92.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.945 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.646 HG21 HG13 ' A' ' 44' ' ' ILE . 2.2 t -60.21 -56.67 33.15 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.734 -178.849 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.0 Cg_exo -58.42 -40.12 77.76 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.587 1.525 . . . . 0.0 111.37 179.597 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.622 HG21 ' HA ' ' A' ' 104' ' ' ALA . 7.9 mt -62.66 -34.92 67.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.092 179.874 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.2 tp -74.95 -52.77 10.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.845 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -54.26 -23.15 13.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.036 0.446 . . . . 0.0 109.932 178.781 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 75.6 m -84.15 -46.45 11.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.498 179.363 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.519 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -58.75 -26.18 63.72 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.374 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.5 t -51.69 -50.62 30.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.013 179.28 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -75.96 -8.59 57.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.934 -179.558 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -95.0 -19.25 20.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.177 179.581 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.566 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 63.9 m-85 -136.04 63.16 49.62 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.578 -179.734 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.87 -44.46 44.91 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.718 2.278 . . . . 0.0 111.553 178.988 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.24 -40.94 85.76 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.421 179.212 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.3 t -67.27 143.96 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.886 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.491 ' CB ' HG22 ' A' ' 31' ' ' THR . 42.2 t -82.34 99.56 9.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.083 0.468 . . . . 0.0 111.014 -179.591 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.481 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.9 p90 -66.71 123.96 21.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.0 179.787 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -143.74 162.81 27.7 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.063 179.979 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -160.06 142.33 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.936 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.9 t -143.42 153.57 42.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.114 0.483 . . . . 0.0 111.843 -178.888 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.505 HG23 ' HG ' ' A' ' 42' ' ' LEU . 75.3 p -138.34 1.16 2.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.589 179.598 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.402 ' O ' HD12 ' A' ' 71' ' ' LEU . 16.7 t70 -73.38 145.95 45.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.873 -179.936 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.7 t -66.76 -50.83 61.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.385 -179.569 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -50.1 -43.98 51.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.539 -179.392 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.526 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.1 t -71.04 -53.43 21.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.867 0.365 . . . . 0.0 110.799 179.885 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 67' ' ' ASP . 6.7 mp -58.74 -14.74 9.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.263 179.402 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.7 m -91.62 -42.96 9.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.427 179.062 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -60.36 -38.66 84.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.577 179.816 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -91.39 11.17 24.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.697 179.647 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 56.19 24.41 8.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.705 179.289 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.633 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.3 mm -60.93 122.3 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.922 179.648 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.4 p -142.89 60.34 1.42 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.089 -179.959 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.29 45.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.499 179.88 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.564 ' HB2' HG23 ' A' ' 99' ' ' ILE . 30.5 m-20 50.52 43.81 27.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.158 0.504 . . . . 0.0 110.301 -179.773 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.633 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.7 m -69.56 153.61 43.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.653 -178.41 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.548 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.9 mt -120.71 116.61 50.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.004 177.993 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.498 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 71.4 m -106.18 132.57 52.09 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.837 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.574 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.6 tp -108.32 102.6 11.7 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.798 178.291 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -97.39 123.64 41.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.885 0.374 . . . . 0.0 110.68 179.784 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.472 HH12 HD13 ' A' ' 116' ' ' LEU . 3.6 mtm180 -106.17 99.66 9.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.073 179.7 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.0 tp -43.28 -51.1 6.41 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.621 -179.38 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.53 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -42.59 -64.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.334 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.462 ' HB2' HH21 ' A' ' 85' ' ' ARG . 2.9 m-20 -98.29 18.09 17.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.59 -179.13 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.7 p30 43.63 29.49 0.28 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.022 179.207 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.463 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 7.5 mm-40 -75.02 156.38 36.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.37 . . . . 0.0 111.137 -179.946 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.93 89.78 2.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.687 179.574 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.594 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.7 mm? -78.03 142.38 38.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.65 179.574 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.22 111.25 15.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.355 0.598 . . . . 0.0 112.534 -179.108 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.531 HD21 HD12 ' A' ' 102' ' ' ILE . 3.6 tt -98.29 76.39 2.32 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.043 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.7 mt-10 -77.65 -166.29 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -176.697 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.517 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.6 t70 -50.54 -37.71 40.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.914 -179.218 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -56.46 -15.27 3.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.13 0.491 . . . . 0.0 110.461 179.791 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -128.66 -13.67 4.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.395 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.564 HG23 ' HB2' ' A' ' 79' ' ' ASN . 22.9 mm -89.63 -25.13 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.592 -179.31 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -51.9 -61.48 2.23 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.923 0.392 . . . . 0.0 110.653 179.846 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.8 m -112.89 38.94 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.471 179.649 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.531 HD12 HD21 ' A' ' 94' ' ' LEU . 7.7 tp -57.1 143.24 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.427 -179.832 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.553 ' HA ' HD12 ' A' ' 49' ' ' ILE . 20.1 m-20 -136.05 149.81 48.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.823 178.873 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.622 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -48.25 -33.92 9.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.187 179.97 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 97.8 m -62.82 -50.6 70.33 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.245 178.73 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -58.33 -58.42 8.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.278 -179.614 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.604 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.93 -57.27 8.95 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.036 0.446 . . . . 0.0 110.32 179.977 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 64.9 m -57.82 -29.4 64.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.831 179.85 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.463 ' HD3' HD11 ' A' ' 113' ' ' ILE . 3.1 tmt_? -71.38 -64.88 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.239 179.786 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -43.44 -43.38 5.26 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.972 178.976 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.485 HG12 HG23 ' A' ' 35' ' ' VAL . 95.9 mt -63.68 -56.11 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.509 178.408 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.84 -16.7 2.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.283 0.563 . . . . 0.0 110.334 179.337 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.463 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -91.91 -34.99 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.738 -179.231 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.594 HD21 ' HG ' ' A' ' 92' ' ' LEU . 88.4 m-20 -127.5 32.16 5.06 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.306 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 111' ' ' ILE . 91.0 p -83.94 36.08 0.55 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.201 0.524 . . . . 0.0 110.199 178.995 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.472 HD13 HH12 ' A' ' 85' ' ' ARG . 51.9 mt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.174 -179.443 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.491 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.581 0.229 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 40.0 Cg_endo -67.89 142.59 57.7 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.733 2.289 . . . . 0.0 112.533 -179.702 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 m -54.49 152.66 6.41 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.23 -179.977 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -103.11 79.66 1.77 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.066 0.46 . . . . 0.0 111.057 -179.79 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.568 HD23 ' HA ' ' A' ' 24' ' ' ALA . 46.6 mt -71.06 94.45 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.317 179.708 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.4 p -85.45 -12.93 50.72 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.871 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 5.4 m-20 -139.62 151.27 45.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.77 -179.471 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.592 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 30.0 t -52.89 -49.76 85.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.561 179.853 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.6 Cg_endo -57.42 -45.71 32.58 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.97 1.78 . . . . 0.0 112.043 179.912 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.22 -34.79 78.42 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.201 0.524 . . . . 0.0 110.279 -179.852 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.568 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -64.93 -59.46 4.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.147 179.406 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.6 mtm -60.75 -24.26 65.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.041 -179.994 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.4 -51.28 17.85 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.312 179.437 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -59.62 -31.74 69.77 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.141 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.464 HD11 HD12 ' A' ' 36' ' ' ILE . 49.4 mt -75.03 -41.25 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.271 178.444 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.28 -19.04 62.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.162 -179.788 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.59 27.82 2.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.146 -179.845 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.8 t -172.68 154.01 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.769 -179.629 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.501 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.0 tt0 -63.8 -73.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.747 179.911 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.505 HG11 HD11 ' A' ' 83' ' ' LEU . 21.6 t -100.68 137.86 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.656 179.87 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.573 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.94 126.1 18.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.987 0.422 . . . . 0.0 112.058 -179.27 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.493 HG21 HG12 ' A' ' 111' ' ' ILE . 50.0 t -114.7 130.63 68.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.518 178.413 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.464 HD12 HD11 ' A' ' 28' ' ' ILE . 24.0 mt -135.07 136.02 52.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.243 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.51 97.73 1.93 Allowed Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.465 179.787 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.514 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 10.3 m-85 -83.37 92.06 7.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.665 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.7 m-85 -112.92 138.66 49.44 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.093 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.485 ' HG2' HD21 ' A' ' 71' ' ' LEU . 22.9 mt-30 -85.25 -6.48 59.26 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.714 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.436 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.4 t70 -151.54 125.67 9.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.644 179.672 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.498 ' HA ' HG22 ' A' ' 47' ' ' VAL . 94.9 mt -93.83 44.06 1.12 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.004 0.43 . . . . 0.0 111.203 -179.535 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.422 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.3 mt-10 -133.56 9.63 3.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.865 178.962 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.671 HG13 HG23 ' A' ' 47' ' ' VAL . 3.2 pt -91.73 157.69 41.31 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.19 179.942 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.432 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 77.9 Cg_exo -53.22 -26.08 32.51 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.845 2.363 . . . . 0.0 112.956 179.603 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.32 -38.87 92.58 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.916 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.671 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -60.26 -55.41 45.57 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -178.557 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -60.22 -39.47 68.14 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.882 1.721 . . . . 0.0 111.509 179.286 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.629 HG21 ' HA ' ' A' ' 104' ' ' ALA . 6.5 mt -63.88 -34.2 66.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.045 179.984 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.531 ' O ' ' HG3' ' A' ' 53' ' ' MET . 50.1 tp -74.76 -52.27 11.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.823 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -53.44 -27.31 24.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.168 0.508 . . . . 0.0 109.765 178.618 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -80.25 -46.38 16.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.568 179.876 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.531 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.49 -25.8 64.74 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.406 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 50' ' ' LEU . 54.1 t -53.53 -50.39 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.999 179.505 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -73.89 -11.51 60.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.617 179.911 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -93.3 -18.77 22.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.22 -179.863 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.585 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 63.0 m-85 -136.0 61.6 41.52 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.636 -179.682 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.37 -38.28 82.33 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.604 2.203 . . . . 0.0 111.506 179.167 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.16 -41.27 99.42 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.354 179.079 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.1 t -67.07 145.23 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.884 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.573 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 36.0 t -82.41 96.57 8.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.959 0.409 . . . . 0.0 111.114 -179.696 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.439 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.9 p90 -63.87 127.16 30.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.982 179.763 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.54 162.71 28.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.054 179.78 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 tt -160.62 144.71 5.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.986 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 t -145.01 157.05 44.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.98 0.419 . . . . 0.0 111.81 -178.949 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.479 HG22 ' HG ' ' A' ' 42' ' ' LEU . 76.5 p -141.92 1.41 1.47 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.593 179.649 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.7 144.15 45.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.624 179.93 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.5 p -65.28 -51.51 60.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.67 -179.439 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -49.67 -43.03 46.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.64 -179.386 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.433 ' HA ' HG21 ' A' ' 21' ' ' VAL . 73.3 t -71.72 -52.96 22.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.311 . . . . 0.0 110.748 179.981 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.485 HD21 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -59.14 -14.6 10.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.158 0.504 . . . . 0.0 110.273 179.371 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.4 m -91.84 -40.57 11.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.377 178.722 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -61.31 -39.99 92.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.232 179.822 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -90.51 9.73 28.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.626 179.533 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 m120 57.38 25.53 11.39 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.641 179.107 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.631 HG22 ' HB ' ' A' ' 80' ' ' THR . 36.9 mm -60.8 118.13 3.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.997 179.653 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.1 p -136.62 56.28 1.81 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.388 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.25 45.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.728 179.838 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.511 ' HB2' HG23 ' A' ' 99' ' ' ILE . 14.0 m120 51.62 42.54 29.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.196 0.522 . . . . 0.0 110.474 179.93 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.631 ' HB ' HG22 ' A' ' 76' ' ' ILE . 89.3 m -68.24 153.07 44.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.646 -178.607 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.546 HG12 ' HA2' ' A' ' 37' ' ' GLY . 61.7 mt -119.33 118.65 58.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.054 177.988 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 81.5 m -107.62 135.7 48.62 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.787 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.581 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.7 tp -110.41 105.47 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.104 178.552 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.3 t80 -98.9 123.09 42.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.851 0.357 . . . . 0.0 110.666 179.652 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.467 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.5 mtm180 -106.73 91.8 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.205 179.844 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tp -38.25 -50.74 1.46 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.711 -179.824 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.501 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -45.2 -59.78 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.435 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -99.98 17.08 21.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.328 -179.418 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.2 p30 42.83 32.76 0.42 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.948 179.084 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 8.3 mm-40 -81.58 160.59 23.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 111.147 -179.823 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.75 91.45 2.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.362 179.564 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.581 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -80.07 149.22 30.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.875 179.7 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.6 124.62 41.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.315 0.579 . . . . 0.0 112.117 -179.366 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.542 HD23 HD11 ' A' ' 102' ' ' ILE . 3.8 tt -111.24 75.53 0.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.073 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.426 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 25.0 mt-10 -77.51 -165.62 0.63 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.395 -0.821 . . . . 0.0 113.208 -176.736 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.492 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.5 t70 -51.31 -36.74 43.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.968 -179.181 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -56.49 -14.82 3.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.152 0.501 . . . . 0.0 110.266 179.536 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -130.26 -13.94 3.88 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.554 -179.947 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.511 HG23 ' HB2' ' A' ' 79' ' ' ASN . 23.2 mm -90.7 -25.38 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.78 0.324 . . . . 0.0 111.34 -179.364 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.6 -52.2 62.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.691 179.993 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 81.1 p -119.66 36.57 4.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.511 179.811 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.542 HD11 HD23 ' A' ' 94' ' ' LEU . 7.5 tp -57.38 142.24 13.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.487 -179.853 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.544 ' HA ' HD11 ' A' ' 49' ' ' ILE . 25.0 m-20 -135.93 149.76 49.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.757 178.884 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.629 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -48.04 -37.06 14.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.03 0.443 . . . . 0.0 110.446 -179.77 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.8 m -62.52 -47.85 82.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.295 178.71 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.44 ' HD3' ' N ' ' A' ' 103' ' ' ASP . 59.3 mtpt -59.2 -60.23 4.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.087 -179.735 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.58 HD13 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.06 -55.98 10.45 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.931 0.396 . . . . 0.0 110.15 179.847 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.2 m -57.87 -30.19 65.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.814 179.794 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.459 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -70.61 -65.77 0.69 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.088 179.696 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -42.29 -44.78 3.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.076 179.053 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.493 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -62.66 -55.86 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.537 178.495 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -54.13 -18.31 3.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.444 179.326 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.459 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.87 -38.51 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.016 -179.057 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.565 HD21 ' HG ' ' A' ' 92' ' ' LEU . 90.4 m-20 -123.35 29.59 6.61 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.348 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.5 p -82.11 50.32 1.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.116 0.484 . . . . 0.0 110.267 178.9 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 61.3 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.43 -179.44 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.626 0.251 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.582 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.8 Cg_endo -68.67 148.93 73.0 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.7 2.267 . . . . 0.0 112.677 -179.777 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 m -63.16 152.61 36.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.575 -179.668 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -98.8 97.46 8.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.812 179.706 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.566 HD22 ' HA ' ' A' ' 24' ' ' ALA . 38.4 mt -96.37 71.57 2.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.641 179.964 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.9 p -71.39 -3.12 19.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.953 -179.171 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -140.14 147.68 40.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.934 0.397 . . . . 0.0 111.656 -179.991 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.594 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 24.9 t -56.49 -49.46 93.4 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.761 -179.896 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.51 -45.27 35.25 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.931 1.754 . . . . 0.0 111.963 179.954 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.38 -35.89 82.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.267 0.556 . . . . 0.0 110.344 -179.961 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.566 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.95 -57.91 8.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.185 179.427 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 64.4 mtp -61.75 -26.39 68.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.224 -179.952 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.48 -50.79 28.15 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.497 179.598 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -60.24 -33.05 71.74 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.035 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.433 HD12 HD12 ' A' ' 36' ' ' ILE . 57.1 mt -72.72 -39.81 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.024 178.475 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.75 -19.33 62.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.99 -179.869 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.12 29.45 2.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.856 -179.975 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 t -169.31 153.03 5.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.271 -179.722 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.422 ' HG3' HG11 ' A' ' 87' ' ' VAL . 27.1 tt0 -72.4 -46.34 55.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG11 HD11 ' A' ' 83' ' ' LEU . 21.0 t -122.68 133.87 67.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.08 179.296 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.565 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.66 126.29 20.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.012 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.556 HG23 HG12 ' A' ' 111' ' ' ILE . 52.0 t -114.24 127.59 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.766 178.701 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 24.8 mt -133.03 136.73 54.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.391 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.91 96.92 1.7 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.544 179.972 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.536 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.6 m-85 -83.17 90.82 7.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.654 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.4 m-85 -111.56 139.34 47.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.184 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.426 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 89.6 mt-30 -85.42 -7.21 59.05 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.89 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.42 ' O ' HG12 ' A' ' 44' ' ' ILE . 36.6 t70 -150.67 125.68 9.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.667 179.768 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.512 ' HG ' HG23 ' A' ' 66' ' ' THR . 95.2 mt -93.72 46.94 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.112 0.482 . . . . 0.0 111.373 -179.533 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 46.7 mt-10 -138.19 9.99 2.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.948 179.034 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.665 HG13 HG22 ' A' ' 47' ' ' VAL . 1.4 pt -93.06 156.28 40.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.064 179.848 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.445 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 81.4 Cg_exo -50.96 -27.25 20.52 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.818 2.345 . . . . 0.0 113.214 -179.914 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 44' ' ' ILE . . . -64.43 -38.25 90.39 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.916 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.665 HG22 HG13 ' A' ' 44' ' ' ILE . 3.0 t -60.45 -55.96 39.98 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.585 -178.742 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.647 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.6 -41.55 55.37 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.876 1.717 . . . . 0.0 111.4 179.487 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.608 HG21 HD12 ' A' ' 107' ' ' LEU . 7.2 mt -60.94 -35.58 66.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.247 179.983 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.546 ' O ' ' HG3' ' A' ' 53' ' ' MET . 43.2 tp -73.99 -52.28 13.26 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.957 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -54.44 -24.25 19.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.08 0.467 . . . . 0.0 109.824 178.831 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.3 m -82.55 -46.38 13.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.514 179.643 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.546 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.59 -26.41 65.4 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.107 0.48 . . . . 0.0 109.744 179.492 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 50' ' ' LEU . 55.7 t -52.86 -50.02 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.194 179.498 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -75.83 -8.35 56.68 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.631 179.992 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -95.72 -19.04 19.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.133 179.743 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.547 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 71.9 m-85 -136.73 62.36 41.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.509 -179.617 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.87 -41.12 72.78 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.7 2.266 . . . . 0.0 111.538 179.09 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.58 -41.63 95.67 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.428 179.191 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.8 t -66.18 145.72 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.765 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.565 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 40.3 t -83.11 97.34 8.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 111.035 -179.553 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.582 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 8.0 p90 -62.82 129.53 40.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.862 179.646 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.16 159.83 28.15 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.993 179.73 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.9 tt -161.83 140.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.882 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.9 t -145.15 159.2 43.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.146 0.498 . . . . 0.0 111.741 -178.872 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.512 HG23 ' HG ' ' A' ' 42' ' ' LEU . 79.7 p -140.29 -0.77 1.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.396 179.495 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -69.46 141.2 54.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.718 -179.786 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.2 t -64.3 -48.38 75.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.296 -179.78 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -49.96 -46.31 52.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.436 -179.639 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.491 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.5 t -69.44 -53.27 25.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.703 179.846 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.419 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.8 mp -58.27 -14.82 8.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.195 0.521 . . . . 0.0 110.317 179.462 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.2 m -90.66 -42.46 10.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.264 178.615 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -59.79 -40.76 89.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.629 -179.98 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -90.6 11.04 23.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.831 179.602 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 56.8 26.24 11.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.438 179.326 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.644 HG22 ' HB ' ' A' ' 80' ' ' THR . 35.5 mm -61.61 122.96 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.839 179.633 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.1 p -140.9 47.89 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.762 0.315 . . . . 0.0 111.51 -179.891 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.8 47.88 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.742 179.819 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.536 ' HB2' HG21 ' A' ' 99' ' ' ILE . 13.9 m120 50.06 41.45 23.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.257 0.551 . . . . 0.0 110.271 -179.775 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.644 ' HB ' HG22 ' A' ' 76' ' ' ILE . 94.1 m -67.79 151.79 46.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.671 -178.515 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.564 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.3 mt -118.73 115.79 49.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.865 178.059 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.536 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.1 m -105.47 130.92 53.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.779 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.572 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.3 tp -107.66 99.84 9.29 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.843 178.455 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.5 t80 -92.31 122.93 35.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.364 179.633 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.464 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 6.1 mtm180 -105.24 85.66 2.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.867 0.365 . . . . 0.0 110.57 -179.915 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 tp -26.05 -59.61 0.08 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.12 -179.322 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.422 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.86 -71.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.261 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.71 13.41 8.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.333 -179.302 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.29 29.82 0.4 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.131 178.973 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.464 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 10.4 mm-40 -76.41 167.52 21.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.349 . . . . 0.0 110.79 179.825 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -154.26 95.23 1.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.623 179.724 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.572 HD21 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -80.55 110.71 16.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.065 -179.953 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -92.52 92.1 7.9 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.973 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.525 HD23 HD13 ' A' ' 102' ' ' ILE . 3.3 tt -77.92 78.11 4.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.753 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.8 mt-10 -79.05 -164.95 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.865 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.489 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 22.5 t70 -51.18 -37.61 47.56 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.905 -179.252 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -54.91 -14.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.213 0.53 . . . . 0.0 110.352 179.533 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -130.77 -13.99 3.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.753 -179.906 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.538 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 25.1 mm -89.84 -37.11 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.281 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -51.0 -39.77 56.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.885 0.374 . . . . 0.0 111.077 -179.874 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.9 p -126.92 36.03 4.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.645 179.939 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.538 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.9 tp -62.61 143.91 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.701 -179.666 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.521 ' HA ' HD13 ' A' ' 49' ' ' ILE . 18.0 m-20 -137.74 147.34 44.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.364 178.856 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.6 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.85 -35.93 6.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.972 0.415 . . . . 0.0 110.333 -179.735 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 99.6 m -62.29 -48.31 80.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.266 178.646 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -60.0 -59.87 4.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.241 -179.709 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.608 HD12 HG21 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.03 -55.69 13.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.899 0.381 . . . . 0.0 110.275 -179.909 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.2 m -58.19 -29.93 66.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.687 179.702 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.492 ' HD3' HD11 ' A' ' 113' ' ' ILE . 3.6 tmt_? -71.39 -66.14 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.188 179.772 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -42.75 -43.4 3.93 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.12 179.286 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.556 HG12 HG23 ' A' ' 35' ' ' VAL . 90.2 mt -63.89 -55.23 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.549 178.409 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -55.14 -16.82 3.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.281 179.282 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.492 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -92.27 -34.7 6.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.767 -179.272 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.405 ' OD1' HG22 ' A' ' 113' ' ' ILE . 36.1 m120 -123.12 28.1 7.31 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.653 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.1 p -82.35 46.81 1.08 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.067 0.46 . . . . 0.0 110.502 179.278 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.439 HD12 ' NH1' ' A' ' 85' ' ' ARG . 70.2 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.212 -179.62 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 14.3 pt-20 . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 120.497 0.189 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.499 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 42.8 Cg_endo -69.57 144.05 53.77 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.656 2.237 . . . . 0.0 112.574 -179.675 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -59.45 151.32 24.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.346 -179.835 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -96.87 86.85 4.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.938 179.995 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 24' ' ' ALA . 40.4 mt -83.58 74.47 10.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.488 179.929 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.8 p -74.4 0.54 14.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.048 -179.188 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.414 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 4.7 m-20 -143.88 147.44 34.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.996 0.427 . . . . 0.0 111.751 -179.863 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.1 t -55.67 -49.34 93.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.45 179.77 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.1 Cg_endo -58.44 -46.48 24.2 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.039 1.826 . . . . 0.0 111.977 179.799 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.16 -34.57 77.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.232 0.539 . . . . 0.0 110.169 -179.873 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.572 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -64.38 -58.06 7.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.973 179.535 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 33.1 mtt -61.86 -26.01 67.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.239 -179.898 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 26.2 mt-10 -71.89 -51.02 24.33 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 110.552 179.681 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -60.59 -31.2 70.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.06 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.441 HD13 HD11 ' A' ' 36' ' ' ILE . 52.4 mt -75.22 -39.57 42.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.059 178.198 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 -18.59 61.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.109 -179.816 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.45 26.15 2.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.147 -179.947 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.9 t -171.35 155.87 4.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.608 -179.788 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.473 ' HG3' HG12 ' A' ' 87' ' ' VAL . 26.0 tt0 -67.92 -58.78 3.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.717 179.934 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.435 HG12 HD13 ' A' ' 83' ' ' LEU . 13.6 t -111.17 138.33 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.67 127.44 18.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.961 0.41 . . . . 0.0 111.876 -179.526 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.487 HG22 HG12 ' A' ' 111' ' ' ILE . 47.0 t -116.01 128.58 73.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.748 178.732 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 21.5 mt -134.01 136.76 53.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.412 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.558 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.21 97.7 1.78 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.521 179.728 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.4 m-85 -83.43 91.32 7.34 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.482 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -111.57 142.06 44.36 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -177.945 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.474 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 76.6 mt-30 -88.96 -7.33 56.23 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.563 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.445 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.7 t70 -149.38 121.72 8.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.52 179.623 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.47 ' HA ' HG21 ' A' ' 47' ' ' VAL . 98.7 mt -91.7 46.84 1.31 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.18 0.514 . . . . 0.0 111.383 -179.293 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 47.4 mt-10 -137.54 7.09 2.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.002 178.964 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.655 HG13 HG22 ' A' ' 47' ' ' VAL . 1.3 pt -90.13 155.63 46.89 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.949 179.786 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 84.3 Cg_exo -49.95 -29.38 21.09 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.729 2.286 . . . . 0.0 112.984 -179.953 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.48 86.82 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.998 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.655 HG22 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.66 -57.49 24.38 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.569 -178.83 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.06 -38.77 85.4 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.765 1.644 . . . . 0.0 111.453 179.437 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.635 HG21 ' HA ' ' A' ' 104' ' ' ALA . 7.9 mt -63.66 -34.38 67.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.907 179.85 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.539 ' O ' ' HG3' ' A' ' 53' ' ' MET . 46.6 tp -75.57 -53.02 9.29 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.836 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -54.06 -24.18 16.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.115 0.483 . . . . 0.0 109.977 178.876 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.6 t -84.08 -47.0 11.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.607 179.657 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.539 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -58.27 -25.84 62.25 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.504 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 50' ' ' LEU . 49.4 t -52.63 -49.15 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.166 179.483 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -76.61 -9.01 58.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.714 179.989 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -94.46 -19.16 20.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.047 179.601 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.576 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 58.4 m-85 -135.52 63.02 52.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.752 -179.795 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.79 -45.24 39.56 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.77 2.313 . . . . 0.0 111.636 179.206 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.63 -42.32 84.34 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.468 179.133 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.3 t -65.48 143.58 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.947 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.532 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 41.7 t -82.33 97.11 8.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.02 0.438 . . . . 0.0 111.125 -179.627 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.499 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 6.5 p90 -62.85 128.81 37.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.897 179.658 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.69 160.28 28.32 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.106 179.98 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.8 tt -158.83 143.29 6.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.723 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.4 t -146.44 152.69 39.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.003 0.43 . . . . 0.0 111.776 -179.083 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.466 HG23 ' HG ' ' A' ' 42' ' ' LEU . 71.4 p -136.99 -3.95 1.98 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.326 179.5 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.49 142.73 58.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.697 179.986 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.5 m -64.79 -50.44 66.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.428 -179.461 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -50.37 -43.82 54.49 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.671 -179.338 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.467 ' HA ' HG23 ' A' ' 21' ' ' VAL . 69.1 t -71.46 -52.39 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 -179.973 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.39 -15.14 14.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.15 0.5 . . . . 0.0 110.187 179.387 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.7 m -91.59 -40.02 11.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.296 178.795 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -61.32 -42.4 98.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.374 179.948 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -88.51 9.31 24.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.695 179.528 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 58.82 23.27 11.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.538 179.128 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.619 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.2 mm -56.81 120.83 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.975 179.852 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.6 p -140.31 58.71 1.57 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.344 -179.546 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.76 45.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.7 179.606 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.503 ' HB2' HG23 ' A' ' 99' ' ' ILE . 14.5 m120 51.73 43.28 30.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.217 0.532 . . . . 0.0 110.422 -179.914 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.619 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.5 m -69.36 152.08 45.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.735 -178.539 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.558 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.0 mt -119.02 118.04 56.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.964 178.135 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.518 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 79.4 m -105.91 133.21 51.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.907 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.594 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.7 tp -109.02 105.17 14.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.774 178.48 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -98.67 120.11 38.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.683 179.787 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.441 HH12 HD13 ' A' ' 116' ' ' LEU . 4.3 mtm180 -104.74 80.98 1.71 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.611 179.965 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 85' ' ' ARG . 7.1 tp -22.59 -58.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 O-C-N 124.009 0.818 . . . . 0.0 112.856 -179.683 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.473 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.09 -67.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.366 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -93.3 3.26 55.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.388 -179.227 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 50.48 37.7 16.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.68 179.682 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 6.6 mm-40 -86.15 134.09 33.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.709 179.952 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.48 95.04 4.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.998 0.427 . . . . 0.0 110.833 179.954 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.603 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.2 mm? -82.41 109.93 17.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.634 179.506 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -93.87 94.59 8.58 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.439 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.508 HD23 HD12 ' A' ' 102' ' ' ILE . 4.3 tt -78.66 77.61 5.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.438 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.5 mt-10 -78.88 -164.91 0.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.908 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.489 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.6 t70 -50.76 -38.43 47.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.148 -179.145 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.57 -14.69 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.227 0.537 . . . . 0.0 110.33 179.722 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -129.68 -13.83 4.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.63 -179.85 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.525 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 23.6 mm -91.08 -31.27 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 111.438 -179.5 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -53.28 -43.15 67.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.891 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.8 m -124.93 38.53 4.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.419 179.711 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.525 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.3 tp -63.93 142.52 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.67 -179.698 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.539 ' HA ' HD13 ' A' ' 49' ' ' ILE . 21.9 m-20 -137.98 150.91 47.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.604 178.803 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.635 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -48.78 -37.37 18.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.002 0.43 . . . . 0.0 110.443 -179.859 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 94.6 m -61.97 -46.93 87.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.208 178.686 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -60.75 -61.14 2.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.415 -179.819 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.623 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.52 -55.16 11.79 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.979 0.418 . . . . 0.0 110.128 179.906 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.6 m -59.05 -30.98 68.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.912 179.832 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.463 ' HD3' HD12 ' A' ' 113' ' ' ILE . 3.2 tmt_? -70.53 -65.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.097 179.691 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -43.01 -42.7 3.92 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.306 179.411 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.487 HG12 HG22 ' A' ' 35' ' ' VAL . 96.3 mt -64.65 -55.23 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.23 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -54.02 -18.23 3.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.201 179.305 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.463 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -90.06 -38.42 10.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.985 -179.077 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.603 HD21 ' HG ' ' A' ' 92' ' ' LEU . 90.2 m-20 -122.77 30.54 6.4 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.432 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.0 p -83.14 44.03 0.91 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 110.15 178.727 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.441 HD13 HH12 ' A' ' 85' ' ' ARG . 57.7 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.404 -179.328 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.481 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.3 pt-20 . . . . . 0 CA--C 1.53 0.203 0 CA-C-O 120.513 0.197 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 54.0 Cg_endo -69.9 149.65 66.28 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.636 2.224 . . . . 0.0 112.753 -179.686 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 17' ' ' TRP . 13.3 m -71.55 155.89 40.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.509 -179.622 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.426 ' N ' HG22 ' A' ' 16' ' ' THR . 5.7 m-90 -100.05 88.9 3.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.073 179.827 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.592 HD22 ' HA ' ' A' ' 24' ' ' ALA . 35.1 mt -82.73 71.78 9.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.375 179.781 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.5 p -70.21 -5.18 25.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.07 -178.892 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -135.81 147.36 48.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 111.416 -179.76 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.595 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 15.6 t -58.27 -48.99 96.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.367 179.915 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.0 Cg_endo -58.45 -43.83 42.71 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.899 1.733 . . . . 0.0 111.839 179.45 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.5 -37.22 86.79 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.291 0.567 . . . . 0.0 110.261 179.811 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.592 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.03 -54.89 35.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.049 179.45 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 38.3 mtt -62.48 -29.91 70.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.28 -179.928 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 32.8 mt-10 -69.18 -49.01 60.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.658 0.266 . . . . 0.0 110.517 -179.959 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -62.26 -32.82 73.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.851 179.253 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.47 HD13 HD11 ' A' ' 36' ' ' ILE . 48.1 mt -74.16 -36.15 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.156 0.503 . . . . 0.0 109.821 178.05 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.45 -18.57 60.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.21 27.57 2.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.185 -179.823 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.43 HG22 ' HB2' ' A' ' 61' ' ' SER . 8.2 t -171.16 155.95 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.608 -179.761 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.493 ' HG3' HG11 ' A' ' 87' ' ' VAL . 24.4 tt0 -71.26 -46.87 59.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.597 179.755 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.443 HG12 HD13 ' A' ' 83' ' ' LEU . 19.1 t -121.68 137.6 54.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.361 179.555 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.481 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.06 128.45 20.03 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.154 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.47 HG22 HG12 ' A' ' 111' ' ' ILE . 43.5 t -116.22 129.61 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.467 178.463 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.47 HD11 HD13 ' A' ' 28' ' ' ILE . 28.0 mt -136.46 136.15 48.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.226 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.63 96.71 1.77 Allowed Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.482 179.686 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.478 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 40.0 m-85 -82.71 89.67 6.78 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.277 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.1 m-85 -108.44 146.55 32.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.603 -178.031 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -94.48 -1.8 52.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.947 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.6 t70 -156.87 118.16 3.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.582 179.876 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.518 ' HG ' HG22 ' A' ' 66' ' ' THR . 90.9 mt -87.28 44.78 1.21 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.117 0.485 . . . . 0.0 111.291 -179.351 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.1 mt-10 -136.61 13.09 3.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.078 179.255 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.662 HG13 HG23 ' A' ' 47' ' ' VAL . 1.4 pt -96.97 156.23 36.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.19 179.928 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.497 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 86.2 Cg_exo -49.57 -31.36 24.27 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.745 2.297 . . . . 0.0 112.851 179.657 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.38 -37.21 77.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.312 -179.107 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.685 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.9 t -61.89 -58.55 17.29 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.591 -178.917 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.685 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 37.0 Cg_exo -58.38 -40.54 74.23 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.777 1.651 . . . . 0.0 111.291 179.342 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.673 HG23 ' HA ' ' A' ' 104' ' ' ALA . 8.6 mt -61.02 -36.3 71.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.899 179.712 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.528 ' O ' ' HG3' ' A' ' 53' ' ' MET . 47.6 tp -74.01 -52.37 12.96 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.942 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -54.13 -23.06 12.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.061 0.458 . . . . 0.0 109.876 178.824 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.9 m -83.08 -47.57 11.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.357 179.329 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.528 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -58.11 -26.4 62.56 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.272 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 50' ' ' LEU . 53.0 t -51.67 -51.38 27.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.091 179.512 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -74.3 -12.09 60.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.688 -179.852 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 28.7 mtpp -92.46 -17.61 24.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.27 -179.96 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.576 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 52.6 m-85 -137.92 62.91 36.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.535 -179.799 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.67 -43.82 54.53 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.601 2.2 . . . . 0.0 111.618 179.065 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.58 -38.92 83.84 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.417 179.305 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 13.0 t -68.74 144.67 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.861 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 42.3 t -81.68 98.77 8.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.047 0.451 . . . . 0.0 110.79 180.0 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.434 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.6 p90 -66.95 122.42 17.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.016 179.856 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.439 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -141.87 163.91 26.87 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.159 179.997 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -162.12 143.08 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.924 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.478 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 43.8 t -148.54 158.81 44.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 111.777 -179.094 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.518 HG22 ' HG ' ' A' ' 42' ' ' LEU . 64.6 p -138.93 -5.42 1.49 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.898 179.548 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.69 140.02 58.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.722 179.948 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.3 m -63.52 -48.16 78.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.824 -179.308 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -51.23 -44.27 61.64 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.241 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.473 ' HA ' HG22 ' A' ' 21' ' ' VAL . 54.2 t -70.75 -53.47 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.85 0.357 . . . . 0.0 110.726 179.804 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.93 -14.91 10.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.234 179.475 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.9 m -91.74 -39.87 11.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.299 178.848 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.404 ' ND1' HG11 ' A' ' 21' ' ' VAL . 5.2 t60 -61.21 -39.93 92.06 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.329 179.902 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -91.86 12.26 22.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.919 179.557 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 56.67 25.43 10.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.6 179.23 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.662 HG23 ' HB ' ' A' ' 80' ' ' THR . 41.7 mm -61.77 120.51 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.968 179.653 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.5 p -140.95 57.17 1.56 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.272 179.982 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.89 45.08 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.552 179.824 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 26.8 m-20 50.25 43.47 26.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.255 0.55 . . . . 0.0 110.248 -179.817 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.662 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.2 m -68.99 151.25 46.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.785 -178.627 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.54 HG12 ' HA2' ' A' ' 37' ' ' GLY . 72.0 mt -117.76 115.38 48.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.851 177.931 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.474 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 80.1 m -103.76 130.5 51.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.755 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.617 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.4 tp -107.78 101.65 10.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.613 178.231 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.4 t80 -95.86 123.03 39.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.478 179.806 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.487 HH12 HD12 ' A' ' 116' ' ' LEU . 4.8 mtm180 -105.72 87.23 2.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.841 -179.7 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 tp -26.29 -60.68 0.08 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.903 -179.383 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.493 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.76 -79.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.433 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -79.2 3.33 18.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.96 0.409 . . . . 0.0 110.993 -179.891 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 52.21 32.8 11.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.691 179.561 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.4 mm-40 -76.39 161.45 28.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.695 179.83 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.498 HE22 ' HB3' ' A' ' 93' ' ' ASN . 1.1 tm0? -145.03 93.95 2.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.627 179.788 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.617 HD21 ' HG ' ' A' ' 83' ' ' LEU . 2.1 mm? -83.43 118.6 23.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.789 179.74 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.498 ' HB3' HE22 ' A' ' 91' ' ' GLN . 1.3 p-10 -99.86 94.54 6.36 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.756 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.514 HD21 HD13 ' A' ' 102' ' ' ILE . 3.4 tt -79.2 77.93 5.7 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.672 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.417 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.8 mt-10 -79.76 -164.33 0.64 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -176.843 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.495 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.0 t70 -50.78 -37.65 43.54 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.971 -179.379 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.21 -15.92 2.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.226 0.536 . . . . 0.0 110.338 179.76 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -129.63 -14.07 4.17 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.645 -179.92 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.534 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.6 mm -89.89 -24.8 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.77 0.319 . . . . 0.0 111.268 -179.3 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.66 -57.45 11.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.4 p -114.56 35.52 4.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.325 179.661 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.522 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.6 tp -57.78 146.85 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.485 -179.844 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.577 ' HA ' HD11 ' A' ' 49' ' ' ILE . 9.5 t70 -139.3 164.84 28.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.674 178.605 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.673 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -62.49 -35.97 81.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.111 0.481 . . . . 0.0 110.061 -179.616 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 83.4 m -65.42 -44.88 86.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.199 178.743 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -61.06 -58.46 8.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.952 -179.713 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.556 HD11 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.3 -54.32 27.24 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.037 0.446 . . . . 0.0 109.975 179.556 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.4 m -59.02 -29.93 67.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.847 179.795 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.478 ' HD3' HD11 ' A' ' 113' ' ' ILE . 4.0 tmt_? -71.06 -66.03 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.056 179.697 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -43.2 -43.87 4.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.223 179.38 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.47 HG12 HG22 ' A' ' 35' ' ' VAL . 96.4 mt -62.97 -54.23 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.225 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.414 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 33.4 tt0 -54.59 -19.63 6.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.159 179.226 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.478 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.27 -34.5 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.79 -178.985 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.606 HD21 ' HG ' ' A' ' 92' ' ' LEU . 89.4 m-20 -124.86 29.56 6.15 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.329 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 111' ' ' ILE . 88.2 p -83.54 45.25 1.04 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.115 0.483 . . . . 0.0 110.111 178.996 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.487 HD12 HH12 ' A' ' 85' ' ' ARG . 69.9 mt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.35 -179.344 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.497 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.7 pt-20 . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.503 0.192 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 39.2 Cg_endo -67.7 142.72 59.19 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.597 2.198 . . . . 0.0 112.623 -179.901 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.4 m -63.12 153.47 34.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.809 -179.686 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.89 89.91 5.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.167 179.886 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 24' ' ' ALA . 41.2 mt -84.78 72.57 10.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.298 179.613 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.1 p -71.9 -2.02 16.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.176 -179.043 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -139.27 147.42 41.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.987 0.423 . . . . 0.0 111.573 -179.797 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.591 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 29.6 t -57.24 -49.52 93.42 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.449 179.913 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.66 -44.82 33.58 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.901 1.734 . . . . 0.0 111.998 179.723 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.25 83.19 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.332 0.587 . . . . 0.0 110.203 179.824 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.551 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -62.65 -57.51 10.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.157 179.548 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 31.4 mtt -61.89 -26.83 68.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.225 -179.923 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -70.44 -50.38 38.92 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.477 179.786 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.422 ' O ' HG21 ' A' ' 31' ' ' THR . 11.5 m-85 -61.68 -31.17 71.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.182 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.443 HD11 HD12 ' A' ' 36' ' ' ILE . 52.7 mt -74.62 -37.67 43.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.967 178.056 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.41 -17.59 61.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.972 -179.747 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.56 28.69 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.122 -179.929 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.483 HG22 ' HB2' ' A' ' 61' ' ' SER . 9.1 t -168.89 153.89 6.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.572 -179.681 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.505 ' HG3' HG12 ' A' ' 87' ' ' VAL . 20.8 tt0 -70.91 -42.73 69.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.498 179.6 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.442 HG13 HD11 ' A' ' 83' ' ' LEU . 22.1 t -127.0 137.05 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.278 179.414 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.78 128.37 21.46 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.173 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.506 HG22 HG12 ' A' ' 111' ' ' ILE . 46.1 t -116.25 130.53 70.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.496 178.473 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 28' ' ' ILE . 29.3 mt -136.42 136.81 48.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.232 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.557 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.22 99.01 2.05 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.528 179.716 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.7 m-85 -85.35 93.97 8.84 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.657 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 9.1 m-85 -114.38 143.77 44.37 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.125 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -91.17 -3.51 56.96 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.913 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 44' ' ' ILE . 37.1 t70 -154.27 122.33 6.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.689 -1.142 . . . . 0.0 109.465 179.845 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.468 ' HG ' HG22 ' A' ' 66' ' ' THR . 91.6 mt -91.9 47.18 1.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 0.0 111.276 -179.486 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.41 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.9 mt-10 -136.51 11.13 3.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.792 178.977 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.68 HG13 HG22 ' A' ' 47' ' ' VAL . 3.1 pt -93.6 159.06 35.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.437 -179.915 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.427 ' O ' HD12 ' A' ' 49' ' ' ILE . 69.3 Cg_exo -54.59 -23.66 33.26 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.99 2.46 . . . . 0.0 112.925 179.556 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.11 -38.8 86.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.823 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.68 HG22 HG13 ' A' ' 44' ' ' ILE . 2.5 t -59.13 -54.72 53.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -178.787 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.1 Cg_exo -61.29 -43.53 28.19 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.066 1.844 . . . . 0.0 111.499 179.225 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.623 HG22 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -59.89 -34.01 54.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.148 179.981 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.515 ' O ' ' HG3' ' A' ' 53' ' ' MET . 50.1 tp -75.48 -51.5 12.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.167 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -53.96 -25.23 19.66 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.994 0.426 . . . . 0.0 109.936 178.793 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 t -83.09 -47.45 11.64 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.625 179.764 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -57.76 -26.37 61.78 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.376 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 50' ' ' LEU . 51.2 t -51.89 -49.87 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.048 179.451 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -75.45 -12.74 60.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.641 179.952 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -91.5 -17.24 26.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.325 180.0 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.558 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 46.3 m-85 -138.97 63.11 29.66 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.432 -179.877 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.03 -47.67 26.28 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.756 2.304 . . . . 0.0 111.766 179.315 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.71 -41.14 57.17 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.395 179.275 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.6 t -66.23 143.13 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.781 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.483 ' HB2' HG22 ' A' ' 31' ' ' THR . 42.0 t -81.06 97.42 7.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.984 0.421 . . . . 0.0 110.903 -179.786 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.442 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.6 p90 -65.61 123.58 20.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.822 179.699 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -143.09 163.8 27.33 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.109 179.996 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -161.02 141.95 3.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.897 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.2 t -145.33 155.6 43.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.046 0.45 . . . . 0.0 111.708 -178.993 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.468 HG22 ' HG ' ' A' ' 42' ' ' LEU . 57.1 p -137.99 -3.25 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.807 179.652 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.73 139.81 55.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.425 179.976 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -62.24 -47.4 84.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.68 -179.313 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -50.73 -46.94 59.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.486 -179.217 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.483 ' HA ' HG22 ' A' ' 21' ' ' VAL . 75.3 t -69.6 -51.87 37.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.767 0.318 . . . . 0.0 110.756 179.92 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.36 -14.57 12.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.033 0.444 . . . . 0.0 110.219 179.466 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.3 m -92.63 -40.75 10.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.429 178.776 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -62.65 -35.55 79.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 -179.922 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.405 ' HB2' HG12 ' A' ' 76' ' ' ILE . 44.8 m-85 -94.11 10.36 34.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.754 179.544 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 57.27 24.3 9.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.683 179.422 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.625 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.0 mm -61.31 120.2 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.032 179.767 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.5 p -139.94 55.91 1.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 111.397 -179.926 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.9 44.19 0.02 OUTLIER Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.515 179.86 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.545 ' HB2' HG21 ' A' ' 99' ' ' ILE . 30.8 m-80 52.14 41.9 30.32 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.178 0.513 . . . . 0.0 110.437 -179.646 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.625 ' HB ' HG23 ' A' ' 76' ' ' ILE . 88.2 m -67.77 152.68 45.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.628 -178.564 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.557 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.5 mt -119.58 118.57 57.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.951 178.006 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.518 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.3 m -107.5 133.89 51.32 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -177.855 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.558 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.2 tp -109.73 102.55 11.35 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.794 178.262 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -96.93 122.64 40.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.791 0.329 . . . . 0.0 110.77 179.755 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.505 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 4.7 mtm180 -104.61 100.43 10.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.138 0.494 . . . . 0.0 109.971 179.582 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -43.78 -52.01 6.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.872 -179.156 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.505 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -42.82 -65.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.154 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.21 18.95 12.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.652 -179.322 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 p30 42.93 31.1 0.3 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.941 179.332 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.505 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 8.8 mm-40 -75.91 159.5 30.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 0.0 110.974 -179.923 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -146.42 85.44 1.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.65 179.798 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.558 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -75.04 144.84 42.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.224 179.996 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -121.93 124.83 44.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.351 0.596 . . . . 0.0 111.792 -179.643 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.53 HD21 HD11 ' A' ' 102' ' ' ILE . 3.7 tt -112.09 76.03 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.273 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.417 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.0 mt-10 -77.91 -165.41 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.752 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.46 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -46.45 -51.22 15.59 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.556 -179.11 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -47.23 -17.87 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.923 0.392 . . . . 0.0 110.899 179.764 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 96' ' ' ASP . 9.4 m-20 -124.84 -13.94 6.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.414 -179.91 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.545 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.3 mm -92.23 -42.74 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.264 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -50.78 -34.76 28.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.021 179.812 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.5 t -127.66 37.69 4.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.371 179.622 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 8.7 tp -67.6 144.72 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.779 -179.607 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.53 ' HA ' HD13 ' A' ' 49' ' ' ILE . 28.0 m-20 -138.64 147.87 43.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.345 178.542 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.623 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -46.71 -37.44 8.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.962 0.41 . . . . 0.0 110.579 -179.722 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.5 m -62.32 -48.45 79.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.322 178.88 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -58.39 -58.4 8.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.311 -179.677 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.613 HD12 HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.77 -56.59 11.36 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.057 0.456 . . . . 0.0 110.271 179.902 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.4 m -57.71 -29.41 64.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.762 179.796 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.506 ' HD3' HD11 ' A' ' 113' ' ' ILE . 2.2 tmt_? -71.44 -65.65 0.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.247 179.83 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -42.89 -42.77 3.81 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.033 179.231 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.506 HG12 HG22 ' A' ' 35' ' ' VAL . 95.5 mt -63.92 -55.3 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.494 178.377 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -54.96 -17.71 4.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.253 0.549 . . . . 0.0 110.332 179.333 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.506 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.77 -36.81 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.84 -179.29 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -123.64 30.12 6.33 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.527 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.8 p -82.58 51.33 1.84 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.085 0.469 . . . . 0.0 109.959 178.741 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 85' ' ' ARG . 55.3 mt . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.295 -179.208 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.488 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 46.6 Cg_endo -68.71 146.87 68.15 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.348 2.032 . . . . 0.0 112.811 -179.168 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.6 m -67.75 152.4 45.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.443 -179.623 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -95.81 85.88 4.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.813 179.87 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.549 HD11 ' HA ' ' A' ' 24' ' ' ALA . 49.3 mt -81.75 71.24 8.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.63 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.0 p -71.43 0.14 8.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.034 -179.266 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -142.56 147.43 35.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.965 0.412 . . . . 0.0 111.705 -179.701 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.584 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.2 t -56.86 -50.35 88.61 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.443 179.881 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.2 Cg_endo -58.39 -44.48 37.65 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.975 1.783 . . . . 0.0 111.93 179.916 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.26 83.28 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.291 0.567 . . . . 0.0 110.18 179.953 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.549 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -63.69 -57.42 10.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.053 179.435 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.2 mtm -61.39 -26.78 68.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.013 -179.903 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.2 mt-10 -71.47 -50.66 29.44 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.484 179.738 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -60.65 -31.67 70.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.058 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.426 HD13 HD13 ' A' ' 36' ' ' ILE . 49.9 mt -73.17 -38.03 53.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.809 178.236 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.06 -19.7 61.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.998 179.857 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.14 31.01 1.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.471 -179.715 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -171.26 153.25 3.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.333 -179.853 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.535 ' HG3' HG12 ' A' ' 87' ' ' VAL . 27.6 tt0 -71.62 -37.46 70.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.651 179.63 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.468 HG11 HD12 ' A' ' 83' ' ' LEU . 26.9 t -131.53 136.81 56.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.229 179.408 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.02 127.12 19.49 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.252 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.496 HG23 HG12 ' A' ' 111' ' ' ILE . 50.8 t -114.58 130.6 68.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.427 178.304 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 28.2 mt -136.09 135.66 50.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.439 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.538 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.54 99.13 2.12 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.404 179.46 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 13.9 m-85 -85.39 93.28 8.7 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.631 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -112.8 142.06 45.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.492 -177.958 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.427 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 47.7 mt-30 -90.87 1.69 56.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.767 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.446 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.8 t70 -159.36 122.22 3.59 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.585 179.895 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.516 ' HG ' HG23 ' A' ' 66' ' ' THR . 90.1 mt -92.38 47.67 1.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.185 0.517 . . . . 0.0 111.417 -179.32 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.444 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 47.5 mt-10 -138.0 7.47 2.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.913 178.868 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.658 HG13 HG21 ' A' ' 47' ' ' VAL . 1.8 pt -90.93 155.91 44.75 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.159 179.824 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.434 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 86.5 Cg_exo -51.11 -26.71 20.01 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.862 2.374 . . . . 0.0 113.214 179.733 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.51 -36.22 83.48 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.842 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.658 HG21 HG13 ' A' ' 44' ' ' ILE . 2.4 t -62.98 -55.92 33.29 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.494 -178.854 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.631 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.1 Cg_exo -58.75 -39.62 80.31 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.807 1.672 . . . . 0.0 111.407 179.34 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.617 HG21 ' HA ' ' A' ' 104' ' ' ALA . 8.3 mt -63.35 -37.59 79.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.137 179.986 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.518 ' O ' ' HG3' ' A' ' 53' ' ' MET . 41.9 tp -71.87 -51.76 20.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.844 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -55.49 -22.0 19.0 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.507 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -85.09 -44.17 13.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.581 179.494 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.518 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -62.12 -25.56 67.8 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.33 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 50' ' ' LEU . 52.9 t -52.87 -46.97 52.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.928 179.436 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -77.62 -11.65 59.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.705 -179.729 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -93.72 -18.09 22.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.347 -179.85 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.566 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 66.4 m-85 -137.34 62.39 37.29 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.569 -179.775 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.52 -42.53 61.07 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.632 2.221 . . . . 0.0 111.636 179.033 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.95 -40.96 94.02 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.521 179.227 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.2 t -66.93 143.27 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 178.8 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.48 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 48.4 t -80.58 98.08 7.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.134 0.492 . . . . 0.0 110.99 -179.681 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 2.6 p90 -66.11 125.57 25.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.78 179.67 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -144.39 161.91 27.94 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.99 179.902 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.0 tt -159.54 144.17 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.803 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.3 t -150.29 154.37 37.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.218 0.532 . . . . 0.0 111.811 -178.993 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.516 HG23 ' HG ' ' A' ' 42' ' ' LEU . 75.2 p -135.21 -2.64 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.474 179.464 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.05 141.36 57.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.717 -179.875 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.3 p -64.57 -49.93 69.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.509 -179.569 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -49.6 -45.02 47.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.492 -179.371 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.513 ' HA ' HG23 ' A' ' 21' ' ' VAL . 69.0 t -70.52 -53.19 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.877 0.37 . . . . 0.0 110.734 179.853 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.415 HD22 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.25 -14.71 7.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.193 179.406 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.4 m -91.59 -41.85 10.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.333 178.889 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -61.25 -35.48 77.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.449 179.679 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -94.61 9.31 39.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.759 179.452 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.3 t30 57.65 23.19 9.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.671 178.787 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.655 HG22 ' HB ' ' A' ' 80' ' ' THR . 37.6 mm -58.13 120.78 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.157 179.856 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.3 p -139.23 57.34 1.66 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.403 -179.632 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.82 46.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.75 179.754 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.54 ' HB2' HG21 ' A' ' 99' ' ' ILE . 13.1 m120 50.62 42.52 27.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.188 0.518 . . . . 0.0 110.293 -179.868 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.655 ' HB ' HG22 ' A' ' 76' ' ' ILE . 93.4 m -69.0 152.26 45.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.665 -178.352 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.562 HG21 HD22 ' A' ' 107' ' ' LEU . 66.0 mt -119.18 116.42 50.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.952 178.01 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.518 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.4 m -105.34 135.23 47.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.816 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.559 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -109.64 98.78 8.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.916 178.377 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -92.45 120.11 32.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.541 179.816 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.486 HH12 HD12 ' A' ' 116' ' ' LEU . 5.1 mtm180 -103.74 103.84 13.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.399 . . . . 0.0 110.108 179.706 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.5 tp -45.1 -56.32 4.82 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.831 -179.182 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.535 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.03 -76.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.175 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -82.5 5.9 19.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.047 -179.754 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 52.3 36.58 20.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.425 179.779 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.449 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 7.3 mm-40 -81.61 167.19 19.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.959 179.833 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -150.73 89.53 1.56 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.575 179.621 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.569 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.8 mm? -74.49 148.09 41.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.877 179.735 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.5 114.62 18.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.3 0.571 . . . . 0.0 112.165 -179.512 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.492 HD23 HD11 ' A' ' 102' ' ' ILE . 4.5 tt -103.52 77.88 1.54 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.154 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.2 mt-10 -80.55 -164.4 0.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.91 -176.775 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.481 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 17.7 t70 -50.62 -36.25 34.31 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.068 -179.319 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -56.04 -14.7 2.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.313 0.578 . . . . 0.0 110.254 179.63 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -132.33 -13.67 3.03 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.768 -179.909 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.54 HG21 ' HB2' ' A' ' 79' ' ' ASN . 26.2 mm -89.69 -31.54 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.7 0.286 . . . . 0.0 111.269 -179.555 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -53.78 -43.04 68.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.0 110.707 179.815 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.5 p -125.74 38.83 4.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.393 179.738 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.53 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.7 tp -63.56 142.93 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.653 -179.835 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.546 ' HA ' HD13 ' A' ' 49' ' ' ILE . 17.9 m-20 -137.25 148.46 46.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.505 178.836 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.617 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -47.53 -34.89 8.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.193 0.52 . . . . 0.0 110.274 -179.989 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.2 m -63.47 -48.1 79.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.35 178.774 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -60.3 -60.74 3.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.266 -179.71 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.608 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.68 -55.36 11.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.029 0.442 . . . . 0.0 110.239 179.898 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 65.8 m -58.92 -30.86 68.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.87 179.948 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.479 ' HD3' HD11 ' A' ' 113' ' ' ILE . 3.2 tmt_? -70.85 -65.81 0.69 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.146 179.724 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -42.87 -44.23 4.42 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.232 179.355 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.496 HG12 HG23 ' A' ' 35' ' ' VAL . 95.4 mt -62.89 -55.08 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.175 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.44 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 7.8 tp10 -54.1 -17.97 3.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.294 179.178 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.479 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -91.09 -34.9 6.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.031 -179.097 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.569 HD21 ' HG ' ' A' ' 92' ' ' LEU . 83.7 m-20 -124.78 28.79 6.39 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.408 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 94.3 p -82.47 43.88 0.85 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.076 0.465 . . . . 0.0 110.346 179.157 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.486 HD12 HH12 ' A' ' 85' ' ' ARG . 59.2 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.392 -179.279 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.8 pt-20 . . . . . 0 CA--C 1.53 0.19 0 CA-C-O 120.404 0.145 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 32.5 Cg_endo -64.89 139.11 60.64 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.549 2.166 . . . . 0.0 112.502 -179.655 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -54.84 153.49 6.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.824 -179.368 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -98.18 92.18 5.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.976 179.78 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.566 HD22 ' HA ' ' A' ' 24' ' ' ALA . 50.9 mt -92.42 72.07 5.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.448 179.77 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.8 p -73.79 -0.99 17.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.889 -179.299 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -140.51 146.78 38.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.393 . . . . 0.0 111.626 -179.953 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.591 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 48.4 t -56.29 -49.96 90.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.494 179.862 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.4 Cg_endo -57.5 -46.15 29.36 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.896 1.73 . . . . 0.0 111.773 179.842 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.98 76.9 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.269 0.557 . . . . 0.0 110.259 -179.822 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.566 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.87 -58.68 5.55 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.104 179.342 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 46.7 mtm -61.3 -26.3 67.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.209 -179.943 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.0 mt-10 -72.06 -51.42 21.72 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.687 0.28 . . . . 0.0 110.612 179.806 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -59.69 -34.64 73.14 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.106 179.249 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.416 HD13 HD11 ' A' ' 36' ' ' ILE . 49.3 mt -72.89 -38.49 56.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.844 178.293 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.65 -17.46 61.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.005 -179.826 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.61 26.04 5.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.307 -179.9 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -172.78 152.06 2.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.597 -179.77 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.628 ' HG3' HG12 ' A' ' 87' ' ' VAL . 1.2 mp0 -59.67 -90.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.252 0.548 . . . . 0.0 110.948 179.32 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.509 HG11 HD12 ' A' ' 83' ' ' LEU . 11.4 t -85.41 133.12 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.715 -179.321 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.536 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -137.57 124.4 21.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.873 -178.977 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.459 HG22 HG12 ' A' ' 111' ' ' ILE . 52.3 t -112.75 129.71 67.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.845 178.736 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 25.2 mt -134.66 135.56 53.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.646 -177.249 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.556 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.54 98.06 1.97 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.41 179.859 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.532 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.9 m-85 -83.24 90.06 7.06 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.725 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.4 m-85 -110.29 139.74 45.16 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.0 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -87.36 -5.91 58.69 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.764 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.47 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.2 t70 -152.59 120.85 6.28 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.583 -179.924 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.456 ' HG ' HG21 ' A' ' 66' ' ' THR . 99.3 mt -89.81 45.58 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.047 0.451 . . . . 0.0 111.513 -179.187 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.435 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.4 mt-10 -136.85 11.05 3.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.09 178.97 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.671 HG13 HG21 ' A' ' 47' ' ' VAL . 3.2 pt -92.77 157.22 39.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.27 179.815 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.431 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 70.9 Cg_exo -51.67 -25.93 21.61 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.853 2.368 . . . . 0.0 113.004 179.547 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.41 -37.9 88.34 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.853 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.671 HG21 HG13 ' A' ' 44' ' ' ILE . 2.3 t -61.12 -54.92 49.16 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -178.73 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.611 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 35.2 Cg_exo -61.05 -38.81 65.11 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.951 1.767 . . . . 0.0 111.508 179.202 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.633 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -64.76 -34.58 71.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.025 -179.954 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.522 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.1 tp -74.3 -52.13 13.17 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.879 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -53.11 -26.36 16.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.173 0.511 . . . . 0.0 109.681 178.618 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 t -80.93 -47.55 13.55 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.778 179.867 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.521 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -58.72 -26.32 63.81 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.443 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 50' ' ' LEU . 56.0 t -52.36 -49.43 42.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.019 179.624 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -77.57 -11.44 59.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.75 -179.815 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -91.3 -18.74 23.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.01 179.807 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 50.3 m-85 -135.92 63.2 50.6 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.267 -179.818 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.03 -43.86 49.6 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.629 2.219 . . . . 0.0 111.692 179.252 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.6 -40.94 88.8 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.367 179.086 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.1 t -66.45 144.48 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.913 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.536 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 31.0 t -83.73 98.98 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.059 0.457 . . . . 0.0 110.987 -179.581 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.441 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 6.4 p90 -64.39 128.84 37.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.053 179.875 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.62 161.65 28.7 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.137 179.762 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -159.32 141.89 5.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.679 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.1 t -141.73 154.55 45.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.971 0.415 . . . . 0.0 111.489 -178.974 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.456 HG21 ' HG ' ' A' ' 42' ' ' LEU . 68.9 p -139.96 -2.44 1.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.875 179.894 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -72.15 143.06 49.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.754 -179.939 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.8 p -63.19 -49.67 73.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.533 -179.493 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -49.97 -44.37 50.71 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.69 -179.381 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.519 ' HA ' HG21 ' A' ' 21' ' ' VAL . 79.6 t -70.54 -52.83 25.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.925 0.393 . . . . 0.0 110.723 179.797 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.19 -14.55 11.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.223 179.422 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.7 m -91.53 -41.89 10.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.264 178.871 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -59.78 -39.92 86.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.498 179.723 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -92.11 13.75 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.987 179.675 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.4 m120 55.32 24.19 6.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.598 179.433 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.627 HG21 ' HB ' ' A' ' 80' ' ' THR . 40.1 mm -59.73 119.23 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.886 179.747 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -139.51 57.59 1.64 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.199 -179.948 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.2 45.06 0.02 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.515 179.828 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.496 ' HB2' HG21 ' A' ' 99' ' ' ILE . 24.9 m-80 51.42 42.16 28.99 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.292 0.567 . . . . 0.0 110.406 -179.859 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.627 ' HB ' HG21 ' A' ' 76' ' ' ILE . 97.9 m -67.86 152.86 44.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.605 -178.621 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.556 HG12 ' HA2' ' A' ' 37' ' ' GLY . 66.1 mt -119.41 117.26 53.43 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.14 178.161 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.532 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.1 m -106.13 135.99 46.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.837 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.564 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.6 tp -110.64 104.49 13.18 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.132 178.546 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.485 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -97.46 120.1 37.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.76 179.76 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.529 HH12 HD13 ' A' ' 116' ' ' LEU . 5.6 mtm180 -103.39 88.83 3.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.563 -179.739 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tp -38.61 -49.46 1.54 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.637 -179.791 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.628 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -42.48 -52.38 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 111.431 -179.88 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -108.59 9.39 27.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.62 179.821 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 85' ' ' ARG . 17.0 t-20 47.89 35.55 5.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.519 -179.834 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 8.0 mm-40 -83.05 163.8 20.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.648 179.566 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -147.2 94.14 2.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 179.761 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.572 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.3 mm? -80.94 146.16 30.9 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.338 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.75 106.31 9.96 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.927 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.54 HD22 HD11 ' A' ' 102' ' ' ILE . 4.8 tt -91.79 77.42 5.54 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.663 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -79.19 -165.09 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.767 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.439 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -45.25 -51.46 10.75 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.569 -179.331 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -47.04 -17.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.901 0.382 . . . . 0.0 111.215 179.88 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -125.52 -13.85 6.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.575 -179.968 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.496 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.3 mm -90.88 -41.32 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.729 -179.381 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -49.05 -40.41 31.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.4 p -126.03 41.87 3.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.684 179.839 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.54 HD11 HD22 ' A' ' 94' ' ' LEU . 7.5 tp -69.31 142.54 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.663 -179.581 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.523 ' HA ' HD13 ' A' ' 49' ' ' ILE . 16.8 m-20 -135.6 147.76 48.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.237 178.597 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.633 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.45 -36.14 6.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.593 -179.608 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.8 m -63.22 -47.45 82.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.562 178.822 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -59.5 -59.3 5.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.206 -179.743 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.623 HD13 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.02 -54.59 19.13 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.898 0.38 . . . . 0.0 110.22 179.712 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.3 m -59.38 -30.15 68.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.479 ' HD3' HD11 ' A' ' 113' ' ' ILE . 4.1 tmt_? -70.84 -65.59 0.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.191 179.651 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -43.48 -44.23 5.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.908 179.363 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.459 HG12 HG22 ' A' ' 35' ' ' VAL . 96.8 mt -62.34 -54.96 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.437 178.257 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -54.8 -18.9 5.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.213 179.358 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.479 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.91 -35.72 8.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.937 -179.094 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.572 HD21 ' HG ' ' A' ' 92' ' ' LEU . 87.3 m-20 -125.3 29.82 5.97 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.397 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 96.8 p -81.99 38.3 0.52 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.971 0.415 . . . . 0.0 110.487 179.048 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.529 HD13 HH12 ' A' ' 85' ' ' ARG . 58.6 mt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.114 -179.705 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.3 pt-20 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.403 0.144 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.2 Cg_endo -66.25 143.49 70.98 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.532 2.155 . . . . 0.0 112.712 -179.429 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.4 m -59.3 154.17 17.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.427 -179.614 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -102.14 97.06 7.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.935 -179.987 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.562 HD22 ' HA ' ' A' ' 24' ' ' ALA . 39.2 mt -95.17 76.81 3.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.432 179.958 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.0 p -74.09 -4.34 34.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.142 -179.085 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -139.02 147.32 41.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.92 0.39 . . . . 0.0 111.595 -179.669 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.591 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.2 t -55.97 -50.24 88.42 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.36 179.969 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.95 -44.25 41.63 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 121.88 1.72 . . . . 0.0 111.736 179.992 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.76 78.82 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.321 0.582 . . . . 0.0 110.22 179.995 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.51 -58.66 5.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.093 179.483 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.2 mtp -61.7 -25.83 67.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 19.1 mt-10 -71.34 -51.5 23.9 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.738 0.304 . . . . 0.0 110.474 179.591 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -59.27 -35.68 74.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.97 179.317 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.428 HD13 HD11 ' A' ' 36' ' ' ILE . 46.9 mt -71.13 -39.56 74.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.904 178.305 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.98 -17.98 62.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.994 -179.906 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.78 24.95 5.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.186 -179.862 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.3 t -169.95 152.76 4.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.416 -179.92 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.5 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.5 tt0 -61.23 -82.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.898 -179.888 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.496 HG13 HD12 ' A' ' 83' ' ' LEU . 21.9 t -94.63 138.16 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.48 179.964 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.99 126.84 20.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.946 0.403 . . . . 0.0 111.989 -179.173 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.492 HG22 HG12 ' A' ' 111' ' ' ILE . 45.1 t -113.65 128.11 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.789 178.445 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 32.0 mt -133.0 134.68 57.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.658 -177.053 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.503 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.3 100.25 2.31 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.347 179.614 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.519 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 4.4 m-85 -84.76 93.19 8.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.8 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.2 m-85 -114.5 141.45 47.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.103 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.456 ' HG2' HD22 ' A' ' 71' ' ' LEU . 74.0 mt-30 -88.89 -7.8 55.43 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.706 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.44 ' O ' HG12 ' A' ' 44' ' ' ILE . 25.4 t70 -150.2 120.95 7.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.667 -1.152 . . . . 0.0 109.66 179.688 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.6 mt -90.17 45.33 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.006 0.432 . . . . 0.0 111.536 -179.197 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.7 mt-10 -135.42 11.84 3.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.083 178.976 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.652 HG13 HG22 ' A' ' 47' ' ' VAL . 4.9 pt -93.18 158.93 36.43 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.441 ' O ' HD11 ' A' ' 49' ' ' ILE . 68.8 Cg_exo -54.15 -25.66 38.58 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.743 2.295 . . . . 0.0 112.791 179.462 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.33 89.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.456 -178.804 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.652 HG22 HG13 ' A' ' 44' ' ' ILE . 2.1 t -60.34 -56.45 35.24 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.704 -178.788 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.617 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.4 -41.11 61.19 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.812 1.675 . . . . 0.0 111.401 179.561 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.639 HG21 HD13 ' A' ' 107' ' ' LEU . 5.6 mt -61.64 -34.87 63.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.992 179.781 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 53' ' ' MET . 43.7 tp -74.19 -53.39 9.93 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 178.809 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -53.47 -24.52 13.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.004 0.431 . . . . 0.0 109.887 178.911 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.9 m -82.74 -45.93 13.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.499 179.421 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.534 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.25 -25.84 64.39 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.407 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.0 t -52.84 -49.98 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.823 179.312 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -75.73 -11.45 60.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.813 -179.867 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -92.64 -18.26 23.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.145 179.937 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.576 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 68.1 m-85 -135.56 62.34 48.44 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.396 -179.739 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.7 -43.32 51.78 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.727 2.284 . . . . 0.0 111.552 179.0 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.72 -38.11 86.61 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.52 179.294 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.0 t -70.05 144.4 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.955 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.502 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 42.9 t -83.83 99.32 10.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.006 0.431 . . . . 0.0 111.042 -179.672 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.528 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 7.7 p90 -62.57 131.25 48.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.151 179.915 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -150.06 161.69 28.97 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.121 179.712 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -162.85 142.63 2.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.995 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.8 t -144.37 155.97 44.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.041 0.448 . . . . 0.0 111.652 -179.059 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.457 HG22 ' HG ' ' A' ' 42' ' ' LEU . 67.7 p -139.03 3.1 2.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.842 179.666 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.75 143.11 44.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.784 -179.972 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.9 t -64.48 -50.47 67.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.496 -179.426 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.76 -43.57 48.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.514 -179.413 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.507 ' HA ' HG21 ' A' ' 21' ' ' VAL . 78.1 t -71.51 -53.02 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.811 0.339 . . . . 0.0 110.756 179.987 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.456 HD22 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -58.86 -14.51 9.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.233 179.315 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 76.1 m -91.48 -40.98 11.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.294 178.641 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -60.49 -40.22 90.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.45 179.847 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -91.45 11.86 22.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.853 179.644 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 56.04 25.74 9.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.596 179.551 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.637 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.0 mm -59.78 119.42 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.839 179.597 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.4 p -138.49 58.88 1.65 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.235 -179.549 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.11 48.22 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.709 179.664 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.535 ' HB2' HG23 ' A' ' 99' ' ' ILE . 36.3 m-20 49.52 43.4 23.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.103 0.478 . . . . 0.0 110.461 -179.945 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.637 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.1 m -68.62 152.63 45.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.621 -178.677 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.503 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.4 mt -118.81 119.14 60.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.07 178.065 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.519 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 83.6 m -108.55 134.62 51.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.038 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.56 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.5 tp -106.71 103.99 13.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.608 178.438 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -97.33 119.72 36.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.867 0.365 . . . . 0.0 111.199 -179.886 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.464 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 3.2 mtm180 -105.24 95.93 6.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.407 -179.95 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tp -43.19 -54.55 4.43 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.782 -179.622 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.5 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.1 -59.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.03 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -97.86 3.62 49.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.446 -179.346 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 85' ' ' ARG . 38.2 t30 51.58 47.08 25.5 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.259 0.552 . . . . 0.0 110.834 -179.818 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.464 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 10.2 mm-40 -97.23 158.67 15.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.715 -179.894 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -140.96 92.34 2.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.934 179.809 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.56 HD21 ' HG ' ' A' ' 83' ' ' LEU . 2.5 mm? -80.8 143.42 32.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.258 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -120.97 123.06 41.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.281 0.562 . . . . 0.0 112.439 -179.363 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.489 HD23 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -111.09 76.34 0.97 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.126 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.416 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.3 mt-10 -78.13 -164.58 0.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.364 -0.834 . . . . 0.0 113.137 -176.669 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.506 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 12.5 t70 -50.94 -37.2 42.83 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.98 -179.113 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.74 -14.98 2.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.106 0.479 . . . . 0.0 110.304 179.639 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -130.6 -13.8 3.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.585 179.776 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.535 HG23 ' HB2' ' A' ' 79' ' ' ASN . 25.7 mm -90.48 -24.95 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.76 0.314 . . . . 0.0 111.195 -179.538 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -57.18 -52.02 66.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.993 0.425 . . . . 0.0 110.611 179.843 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.5 m -117.73 35.6 4.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.348 179.537 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.9 tp -58.09 140.6 16.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.437 -179.619 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.514 ' HA ' HD12 ' A' ' 49' ' ' ILE . 20.9 m-20 -135.69 149.97 49.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.424 178.644 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.631 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.02 -34.55 9.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.019 0.437 . . . . 0.0 110.479 -179.844 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.9 m -64.79 -48.24 75.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.452 178.844 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -59.99 -57.33 13.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.226 -179.794 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.639 HD13 HG21 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -51.75 -55.89 17.08 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.132 0.491 . . . . 0.0 110.001 179.662 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.9 m -58.0 -30.24 65.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.917 179.866 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.423 ' HD3' HD12 ' A' ' 113' ' ' ILE . 2.8 tmt_? -70.37 -65.81 0.68 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.275 179.66 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -42.98 -43.9 4.39 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.141 179.277 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.492 HG12 HG22 ' A' ' 35' ' ' VAL . 88.8 mt -62.29 -55.55 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.208 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -54.6 -18.33 4.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.451 179.319 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.423 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.74 -36.64 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.079 -178.873 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -124.22 28.79 6.6 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.574 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.9 p -81.04 42.84 0.67 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.928 0.394 . . . . 0.0 110.462 179.21 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.429 HD11 ' NH1' ' A' ' 85' ' ' ARG . 62.3 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.189 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.761 0.315 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.56 133.19 59.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.161 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -136.7 -3.0 2.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.87 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -103.27 -164.26 1.06 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.995 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.9 p -57.14 164.3 1.76 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.4 m 55.28 76.89 0.24 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.957 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -87.43 -20.99 25.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.796 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.32 153.66 9.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.548 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.85 130.4 32.8 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.54 2.16 . . . . 0.0 112.266 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.54 98.8 2.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.618 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -169.1 -75.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.688 0.28 . . . . 0.0 110.697 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.73 -80.4 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.52 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.535 ' HG3' HG13 ' A' ' 54' ' ' VAL . 11.2 pt20 -164.23 142.61 7.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.882 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.471 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.0 pt-20 -129.83 158.15 74.59 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.76 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 35.9 Cg_endo -65.46 145.27 82.29 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.617 2.211 . . . . 0.0 112.706 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 m -62.27 154.14 28.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.912 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -97.42 92.82 6.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.811 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 24' ' ' ALA . 42.9 mt -91.84 71.23 5.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.513 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.2 p -72.93 -0.8 14.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.103 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -139.7 147.28 40.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 111.488 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 45.2 t -56.81 -49.93 91.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.518 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.05 -45.44 31.97 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.926 1.751 . . . . 0.0 111.786 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.29 80.12 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.195 0.521 . . . . 0.0 110.19 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.561 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -63.77 -59.83 4.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.063 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.3 mtm -60.59 -25.54 66.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.144 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 21.8 mt-10 -71.6 -51.22 24.41 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.495 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -61.06 -30.21 70.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.466 HD11 HD13 ' A' ' 36' ' ' ILE . 48.6 mt -75.79 -36.96 34.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.965 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.36 -19.48 59.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.248 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.14 28.1 2.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.1 t -171.16 153.15 3.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.46 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.465 ' HG3' HG13 ' A' ' 87' ' ' VAL . 23.3 tt0 -65.36 -65.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.773 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.442 HG12 HD13 ' A' ' 83' ' ' LEU . 18.1 t -106.1 137.82 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.638 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.3 125.92 17.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.524 HG22 HG12 ' A' ' 111' ' ' ILE . 53.9 t -114.56 128.75 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.641 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.466 HD13 HD11 ' A' ' 28' ' ' ILE . 29.9 mt -134.49 137.89 50.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.523 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.11 97.79 1.72 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.427 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.453 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.8 m-85 -83.27 91.85 7.37 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.1 m-85 -111.45 143.3 42.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.469 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.459 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 48.6 mt-30 -90.46 -6.22 55.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.452 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.0 t70 -151.95 121.86 7.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.614 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.507 ' HG ' HG22 ' A' ' 66' ' ' THR . 94.7 mt -90.51 45.76 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.999 0.428 . . . . 0.0 111.515 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 36.9 mt-10 -136.59 8.98 3.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.094 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.681 HG13 HG23 ' A' ' 47' ' ' VAL . 2.8 pt -90.66 156.86 44.75 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.162 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.444 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 79.6 Cg_exo -51.0 -27.75 22.2 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.837 2.358 . . . . 0.0 112.923 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.57 91.67 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.681 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -60.46 -56.7 32.66 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.802 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -59.39 -40.88 63.46 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.671 1.581 . . . . 0.0 111.441 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.607 HG22 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -61.82 -35.59 68.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.145 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.533 ' O ' ' HG3' ' A' ' 53' ' ' MET . 48.4 tp -74.65 -52.56 11.37 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -54.83 -24.27 22.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.071 0.463 . . . . 0.0 109.977 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 m -83.03 -45.27 14.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.623 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.533 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -60.59 -26.28 66.85 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.2 0.524 . . . . 0.0 109.619 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.535 HG13 ' HG3' ' A' ' 13' ' ' GLN . 55.0 t -51.25 -47.71 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.226 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -77.43 -12.97 60.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.913 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -91.23 -17.52 25.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.171 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.562 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 47.8 m-85 -137.99 62.64 34.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.567 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.84 -42.58 65.34 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.677 2.251 . . . . 0.0 111.661 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.93 -37.79 80.84 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.381 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.7 t -70.34 144.34 13.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.551 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 46.7 t -82.26 98.46 8.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.948 0.404 . . . . 0.0 111.094 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.448 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -65.21 127.37 31.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.066 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.27 160.44 28.18 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.159 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 tt -160.37 144.16 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.453 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 37.3 t -148.48 159.11 44.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.5 . . . . 0.0 111.768 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.507 HG22 ' HG ' ' A' ' 42' ' ' LEU . 67.8 p -140.99 4.82 1.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.656 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -74.43 141.56 45.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.672 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.2 t -64.32 -51.11 65.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.448 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -49.88 -41.94 46.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.61 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.52 ' HA ' HG23 ' A' ' 21' ' ' VAL . 56.5 t -72.08 -53.99 18.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.831 0.348 . . . . 0.0 110.762 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -58.78 -14.69 9.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.091 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.0 m -90.54 -42.45 10.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.093 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -59.73 -37.76 79.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.356 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -93.67 12.01 26.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.807 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.9 m120 55.7 23.75 6.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.64 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.609 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.3 mm -59.78 121.59 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.221 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.4 p -142.48 58.7 1.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.011 0.434 . . . . 0.0 111.05 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.04 43.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.658 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 14.2 m120 52.07 43.23 30.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.296 0.569 . . . . 0.0 110.448 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.609 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.2 m -68.61 151.86 46.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.741 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.523 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.1 mt -118.43 116.63 51.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.025 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.529 ' HG ' HD12 ' A' ' 76' ' ' ILE . 72.0 m -105.28 130.3 53.44 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.577 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.5 tp -107.8 103.51 12.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.771 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.0 t80 -97.51 124.37 41.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.529 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.5 HH12 HD12 ' A' ' 116' ' ' LEU . 4.5 mtm180 -106.8 82.85 1.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.967 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 85' ' ' ARG . 6.0 tp -24.99 -60.04 0.06 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.087 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.465 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.52 -70.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.134 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.03 2.08 50.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.05 0.452 . . . . 0.0 110.959 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 m120 53.76 34.85 19.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.632 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 11.8 mm-40 -81.17 163.93 22.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.746 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.09 98.58 2.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.824 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.577 HD21 ' HG ' ' A' ' 83' ' ' LEU . 1.8 mm? -88.37 117.08 27.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.784 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -97.85 94.08 6.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.483 HD23 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -77.65 77.42 4.17 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.4 mt-10 -78.4 -164.49 0.57 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.492 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 16.3 t70 -51.27 -39.02 55.86 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.096 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.26 -14.67 1.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.103 0.477 . . . . 0.0 110.346 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -129.22 -13.85 4.4 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.674 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 22.4 mm -90.29 -31.0 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.607 0.242 . . . . 0.0 111.563 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -55.21 -39.37 69.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.19 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.8 p -128.03 37.07 4.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.506 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.483 HD13 HD23 ' A' ' 94' ' ' LEU . 6.6 tp -62.77 142.78 16.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.423 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.527 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.1 m-20 -137.34 150.53 47.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.642 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.607 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -48.42 -36.2 14.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.036 0.446 . . . . 0.0 110.367 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.8 m -63.29 -48.7 77.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.398 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -59.08 -58.59 7.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.281 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.597 HD11 HG23 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.49 -56.22 12.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.883 0.373 . . . . 0.0 110.227 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.7 m -58.39 -29.65 66.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.792 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.476 ' HD3' HD12 ' A' ' 113' ' ' ILE . 4.0 tmt_? -71.24 -66.39 0.62 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.094 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -42.57 -42.45 3.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.146 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.524 HG12 HG22 ' A' ' 35' ' ' VAL . 96.3 mt -64.12 -56.27 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.562 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -53.43 -19.87 4.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.328 0.585 . . . . 0.0 110.267 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.476 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.22 -37.04 10.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.915 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.435 ' OD1' ' HG ' ' A' ' 92' ' ' LEU . 16.7 m120 -123.3 30.95 6.12 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.0 p -83.35 41.7 0.78 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.02 0.438 . . . . 0.0 110.169 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.5 HD12 HH12 ' A' ' 85' ' ' ARG . 64.6 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.249 -0.882 . . . . 0.0 111.374 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.737 0.303 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.4 t 57.3 84.04 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -155.69 -41.47 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.989 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -125.43 18.48 8.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.6 m -101.43 25.11 8.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.947 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.2 m -98.56 -10.17 23.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.921 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.85 101.72 8.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.979 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.59 -160.87 9.29 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.473 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.08 -70.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.548 2.165 . . . . 0.0 112.24 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.95 -130.21 43.22 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.645 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -169.87 -59.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.67 0.272 . . . . 0.0 110.77 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.423 ' HB2' ' OE1' ' A' ' 55' ' ' GLN . . . 59.64 104.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.371 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.581 ' HG3' HG13 ' A' ' 54' ' ' VAL . 4.2 pt20 -55.96 154.19 7.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.222 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.51 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.5 pt-20 -126.57 160.23 59.43 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.651 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 37.2 Cg_endo -66.16 143.9 73.18 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.464 2.109 . . . . 0.0 112.668 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 m -62.0 154.41 26.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.422 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -98.99 90.13 4.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.068 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.562 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.7 mt -86.8 74.14 9.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.312 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.8 p -74.05 -5.28 40.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.971 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -137.56 147.2 44.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.888 0.375 . . . . 0.0 111.555 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.591 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.2 t -56.76 -50.03 90.35 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.448 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.8 Cg_endo -57.56 -44.08 45.09 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.911 1.741 . . . . 0.0 111.83 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.36 83.9 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.172 0.51 . . . . 0.0 110.228 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.52 -58.73 6.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.169 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 64.5 mtp -60.36 -26.37 66.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.148 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -71.45 -51.34 24.36 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.672 0.273 . . . . 0.0 110.569 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -60.37 -32.86 71.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.909 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.441 HD11 HD13 ' A' ' 36' ' ' ILE . 54.7 mt -73.71 -38.75 51.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.108 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.98 -19.86 60.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.055 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.8 25.57 3.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.0 t -168.85 152.2 5.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.514 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.409 ' HG3' HG11 ' A' ' 87' ' ' VAL . 21.9 tt0 -63.82 -74.04 0.11 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.744 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.489 HG13 HD12 ' A' ' 83' ' ' LEU . 17.9 t -98.25 136.32 29.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.452 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.84 125.37 19.19 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.507 HG21 HG12 ' A' ' 111' ' ' ILE . 56.0 t -115.15 131.13 68.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.688 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 21.5 mt -136.58 138.51 46.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.561 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.74 97.02 1.55 Allowed Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.583 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 11.5 m-85 -83.32 89.8 7.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -109.48 137.92 46.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.455 -178.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.44 ' HG2' HD23 ' A' ' 71' ' ' LEU . 24.7 mt-30 -83.85 -6.21 59.38 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.433 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 37.5 t70 -151.69 124.96 8.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.605 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.494 ' HG ' HG22 ' A' ' 66' ' ' THR . 91.7 mt -93.67 47.14 1.21 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.175 0.512 . . . . 0.0 111.246 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.433 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 6.8 mm-40 -138.81 10.77 2.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.98 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.669 HG13 HG23 ' A' ' 47' ' ' VAL . 1.4 pt -94.08 156.67 38.84 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.06 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.461 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 77.8 Cg_exo -50.6 -29.15 24.21 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.774 2.316 . . . . 0.0 113.064 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.438 ' HB1' HD12 ' A' ' 44' ' ' ILE . . . -62.4 -36.65 82.97 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.669 HG23 HG13 ' A' ' 44' ' ' ILE . 2.5 t -63.09 -57.19 22.17 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.72 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.3 Cg_exo -59.64 -36.1 93.2 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.776 1.651 . . . . 0.0 111.284 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.65 HG22 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -66.04 -36.31 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.034 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.514 ' O ' ' HG3' ' A' ' 53' ' ' MET . 40.5 tp -72.96 -52.19 15.47 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -55.19 -23.03 19.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.892 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.3 t -84.27 -44.17 14.12 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.364 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.514 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.57 -25.39 67.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.21 0.529 . . . . 0.0 109.613 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.581 HG13 ' HG3' ' A' ' 13' ' ' GLN . 55.0 t -52.91 -51.18 39.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.171 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.423 ' OE1' ' HB2' ' A' ' 12' ' ' ALA . 7.4 mt-30 -74.31 -10.6 59.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.662 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -93.88 -18.94 21.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.186 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.604 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 56.7 m-85 -135.38 61.99 47.64 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.55 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.94 -41.69 62.19 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.687 2.258 . . . . 0.0 111.653 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.12 96.51 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.59 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.8 t -65.76 144.87 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.579 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 48.2 t -82.4 97.49 8.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.167 0.508 . . . . 0.0 110.81 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.8 p90 -65.21 126.5 28.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.105 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.98 161.59 28.29 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.139 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -157.92 140.33 5.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.831 0.348 . . . . 0.0 110.082 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.3 t -141.03 155.22 46.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.499 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.494 HG22 ' HG ' ' A' ' 42' ' ' LEU . 77.1 p -141.31 -7.19 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.753 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.63 143.57 56.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.709 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 m -62.71 -50.82 69.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.26 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -48.19 -48.56 34.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.687 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.514 ' HA ' HG21 ' A' ' 21' ' ' VAL . 84.2 t -68.1 -53.4 29.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.82 0.343 . . . . 0.0 110.986 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.44 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -57.78 -14.76 6.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.43 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.9 m -91.24 -42.85 10.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.417 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -59.37 -43.65 92.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.644 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -87.61 12.98 11.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.803 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 54.45 26.9 7.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.536 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.663 HG22 ' HB ' ' A' ' 80' ' ' THR . 38.6 mm -61.08 123.33 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.842 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.6 p -143.57 60.43 1.39 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.935 0.398 . . . . 0.0 111.448 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.82 44.14 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.512 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 12.1 m120 52.54 43.19 31.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.269 0.557 . . . . 0.0 110.337 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.663 ' HB ' HG22 ' A' ' 76' ' ' ILE . 96.1 m -69.01 153.09 44.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.701 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.561 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.4 mt -119.58 117.68 54.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.792 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.8 m -106.93 134.12 50.55 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.589 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.9 tp -110.13 105.03 13.97 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.138 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.9 t80 -98.53 122.07 41.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.546 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 6.1 mtm180 -104.45 82.12 1.88 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.71 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tp -24.47 -62.0 0.05 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.409 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.87 -63.49 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.97 2.33 55.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.082 0.468 . . . . 0.0 110.713 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.3 m120 53.48 25.28 4.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.667 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.546 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 14.2 mm-40 -68.94 158.09 35.36 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.81 0.338 . . . . 0.0 110.806 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -143.07 90.42 2.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.742 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.589 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -79.92 141.41 36.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.48 96.14 4.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.518 HD21 HD11 ' A' ' 102' ' ' ILE . 4.5 tt -82.0 77.77 8.78 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.5 mt-10 -79.13 -165.25 0.73 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -176.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 13.8 t70 -50.9 -37.63 44.93 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.836 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -55.6 -14.74 2.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.044 0.449 . . . . 0.0 110.406 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -129.93 -14.0 4.03 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.356 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.507 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 21.4 mm -90.03 -23.0 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.899 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.56 -51.72 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.658 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 83.2 p -121.21 38.57 4.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.258 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.518 HD11 HD21 ' A' ' 94' ' ' LEU . 6.6 tp -59.41 142.78 14.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.529 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.531 ' HA ' HD13 ' A' ' 49' ' ' ILE . 25.2 m-20 -137.24 150.29 47.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.647 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.65 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -47.87 -37.11 13.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 110.447 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -63.27 -47.96 80.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.374 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -59.08 -59.67 5.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.113 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.636 HD13 HG23 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -49.76 -55.31 14.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.094 0.474 . . . . 0.0 110.152 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.7 m -59.08 -28.72 66.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.781 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.452 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -72.11 -65.77 0.73 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.012 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -42.86 -43.79 4.22 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.03 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.507 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -63.23 -56.62 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.585 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -52.56 -20.97 3.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.201 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.452 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -86.15 -39.03 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.953 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.57 HD21 ' HG ' ' A' ' 92' ' ' LEU . 90.2 m-20 -121.03 29.59 7.28 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 111' ' ' ILE . 80.4 p -82.78 49.49 1.51 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.021 0.439 . . . . 0.0 110.246 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.47 HD11 HH12 ' A' ' 85' ' ' ARG . 72.6 mt . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.29 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.811 0.339 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.6 m -105.7 -40.36 5.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.343 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 51.66 85.66 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -94.66 -57.61 2.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.102 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.7 t -93.61 30.75 1.69 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.952 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.3 m 56.41 71.41 0.57 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.085 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -84.68 6.82 22.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.695 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.28 -171.2 27.12 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.623 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -61.85 -33.62 84.12 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.511 2.141 . . . . 0.0 112.396 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.99 56.35 0.21 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.323 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.73 -49.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 0.0 110.516 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 64.19 -78.17 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.689 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.536 ' HG3' HG13 ' A' ' 54' ' ' VAL . 12.9 pt20 -156.15 131.61 9.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.877 0.37 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.7 pt-20 -114.21 156.44 44.24 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.787 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 31.6 Cg_endo -64.73 142.48 76.84 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.666 2.244 . . . . 0.0 112.398 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.3 m -57.68 152.86 14.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.612 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -99.55 94.22 6.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.962 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 24' ' ' ALA . 42.6 mt -90.37 72.92 7.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.366 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 76.4 p -70.06 -8.04 46.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.185 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.452 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 3.7 m-20 -138.55 147.45 43.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.153 0.502 . . . . 0.0 111.729 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.598 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.8 t -54.32 -49.5 90.16 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.861 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.59 -45.31 34.57 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.018 1.812 . . . . 0.0 112.059 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.96 -36.5 84.18 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.233 0.539 . . . . 0.0 110.295 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.557 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -62.53 -58.71 6.6 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.106 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 69.6 mtp -60.15 -27.57 67.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.18 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 25.0 mt-10 -71.25 -50.34 33.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.803 0.335 . . . . 0.0 110.671 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -59.98 -32.63 71.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.042 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.431 HD13 HD13 ' A' ' 36' ' ' ILE . 44.0 mt -74.84 -38.81 44.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.047 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.45 -19.61 61.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.158 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.53 25.96 4.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.379 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.0 t -170.09 151.14 3.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.387 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.472 ' HG3' HG12 ' A' ' 87' ' ' VAL . 21.7 tt0 -62.0 -72.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.774 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 83' ' ' LEU . 20.7 t -100.78 138.12 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.812 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.16 128.41 20.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.675 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.464 HG23 HG12 ' A' ' 111' ' ' ILE . 47.6 t -116.69 128.74 73.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.701 178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 22.4 mt -134.09 135.9 54.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.615 -177.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.533 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.9 99.41 2.05 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.255 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.8 m-85 -84.77 92.73 8.3 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.0 m-85 -112.14 139.26 47.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.431 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.452 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 74.4 mt-30 -85.81 -8.0 58.38 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.45 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.6 t70 -149.96 123.28 8.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.656 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.487 ' HG ' HG22 ' A' ' 66' ' ' THR . 98.7 mt -92.28 46.97 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.134 0.492 . . . . 0.0 111.321 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.425 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 40.7 mt-10 -137.75 9.18 2.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.981 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.652 HG13 HG21 ' A' ' 47' ' ' VAL . 1.7 pt -92.84 156.54 40.63 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.271 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.462 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 83.2 Cg_exo -50.54 -28.93 23.19 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.836 2.358 . . . . 0.0 113.162 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.417 ' HB2' HD12 ' A' ' 44' ' ' ILE . . . -62.07 -38.65 89.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.652 HG21 HG13 ' A' ' 44' ' ' ILE . 2.2 t -61.53 -56.69 30.82 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.76 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -59.34 -37.9 87.81 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.746 1.631 . . . . 0.0 111.322 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.625 HG23 HD13 ' A' ' 107' ' ' LEU . 5.5 mt -64.42 -35.25 73.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.992 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.525 ' O ' HG22 ' A' ' 54' ' ' VAL . 46.8 tp -73.6 -52.77 12.29 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -54.21 -24.72 19.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.07 0.462 . . . . 0.0 109.795 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 t -82.85 -44.37 15.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.631 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.521 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.42 -25.95 67.54 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.244 0.545 . . . . 0.0 109.653 179.261 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.536 HG13 ' HG3' ' A' ' 13' ' ' GLN . 56.3 t -52.15 -50.01 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.848 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.444 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 8.6 mt-30 -74.43 -12.62 60.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.816 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -91.93 -18.41 23.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.294 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 45.1 m-85 -135.92 62.47 46.89 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.496 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.07 -45.46 38.84 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.82 2.347 . . . . 0.0 111.61 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.07 -41.81 79.09 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.476 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.5 t -65.97 144.22 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.466 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 37.6 t -82.41 98.03 8.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.916 0.389 . . . . 0.0 110.896 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.484 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 7.9 p90 -62.65 129.38 40.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.781 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.37 160.66 28.43 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.14 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.4 HD11 HG13 ' A' ' 47' ' ' VAL . 4.6 tt -159.38 141.7 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.8 t -145.19 151.71 38.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.104 0.478 . . . . 0.0 111.686 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.487 HG22 ' HG ' ' A' ' 42' ' ' LEU . 81.1 p -135.59 -4.89 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.515 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.41 146.22 55.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.791 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.8 t -66.84 -52.12 47.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.474 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -49.71 -43.56 47.66 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.551 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.469 ' HA ' HG23 ' A' ' 21' ' ' VAL . 77.3 t -70.58 -54.07 19.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.91 0.386 . . . . 0.0 110.695 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.448 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -58.75 -14.67 9.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.357 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.4 m -92.29 -39.96 11.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.316 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -61.95 -39.29 91.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.398 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -91.12 10.76 25.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.8 m120 57.53 25.0 10.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.502 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.641 HG21 ' HB ' ' A' ' 80' ' ' THR . 36.0 mm -60.52 121.44 8.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.055 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.2 p -141.86 59.16 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.36 45.27 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.666 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 15.3 m120 52.17 42.89 30.92 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.282 0.563 . . . . 0.0 110.557 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.641 ' HB ' HG21 ' A' ' 76' ' ' ILE . 93.1 m -69.28 152.6 44.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.681 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.533 HG12 ' HA2' ' A' ' 37' ' ' GLY . 68.2 mt -119.45 118.8 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.095 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 83.9 m -107.79 133.55 52.02 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.586 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -108.29 104.24 13.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.778 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.2 t80 -97.76 123.41 41.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.479 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.493 HH12 HD13 ' A' ' 116' ' ' LEU . 5.7 mtm180 -106.83 82.91 1.76 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.957 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 tp -26.01 -59.1 0.08 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.04 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.472 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.55 -70.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 O-C-N 123.413 0.446 . . . . 0.0 112.069 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -87.52 2.51 50.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.739 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 52.07 37.88 22.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.17 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 8.4 mm-40 -82.36 158.19 23.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.618 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -140.11 91.95 2.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.86 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.586 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -81.62 133.81 35.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.491 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.06 116.11 28.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.334 0.588 . . . . 0.0 112.317 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.475 HD21 HD12 ' A' ' 102' ' ' ILE . 3.7 tt -102.39 77.19 1.62 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.455 ' HG2' ' HG1' ' A' ' 80' ' ' THR . 27.5 mt-10 -79.64 -164.84 0.7 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -176.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.494 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 21.2 t70 -50.52 -36.59 34.82 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.101 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -56.67 -14.51 3.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.151 0.501 . . . . 0.0 110.311 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -131.07 -13.93 3.49 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.593 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.531 HG22 ' HB2' ' A' ' 79' ' ' ASN . 25.7 mm -90.07 -30.97 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.774 0.321 . . . . 0.0 111.246 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -54.47 -41.58 69.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.511 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.1 m -126.82 38.64 4.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.569 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.9 tp -64.31 142.44 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.608 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.518 ' HA ' HD12 ' A' ' 49' ' ' ILE . 19.1 m-20 -136.55 149.47 48.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.321 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.621 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -47.41 -35.92 9.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.092 0.472 . . . . 0.0 110.416 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.8 m -62.7 -49.11 76.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.413 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -59.1 -58.28 9.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.411 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.625 HD13 HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.67 -56.69 10.72 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.107 0.479 . . . . 0.0 110.027 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.6 m -58.06 -28.68 64.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.746 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.471 ' HD3' HD12 ' A' ' 113' ' ' ILE . 4.1 tmt_? -71.96 -65.58 0.75 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.062 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -43.05 -42.78 4.04 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.084 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.464 HG12 HG23 ' A' ' 35' ' ' VAL . 96.1 mt -64.46 -55.44 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.551 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.79 -17.21 3.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.232 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.471 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -90.77 -37.01 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.0 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.559 HD21 ' HG ' ' A' ' 92' ' ' LEU . 93.3 m-20 -124.47 29.95 6.16 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.6 p -81.95 47.07 1.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.074 0.464 . . . . 0.0 110.197 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.493 HD13 HH12 ' A' ' 85' ' ' ARG . 51.2 mt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.171 -0.919 . . . . 0.0 111.353 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.838 0.351 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.9 t 58.45 87.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.268 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -85.04 -63.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.999 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -131.33 -71.83 0.56 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.091 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.0 m -154.77 -177.58 6.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.229 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 p -85.84 -61.72 1.69 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.656 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.7 t70 56.31 82.2 0.11 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.111 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.99 -165.92 36.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.632 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.98 -39.69 59.3 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.741 2.294 . . . . 0.0 112.53 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.89 171.85 22.11 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.636 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.92 -62.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.8 0.333 . . . . 0.0 110.429 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.537 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . . . 60.45 106.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.586 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.541 ' HG3' HG12 ' A' ' 54' ' ' VAL . 16.4 pt20 -50.52 155.63 1.04 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.264 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 -128.1 159.3 67.66 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 32.2 Cg_endo -65.51 144.91 81.0 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.653 2.236 . . . . 0.0 112.538 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.7 m -62.23 154.13 28.45 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.359 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -99.69 95.57 7.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.136 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 24' ' ' ALA . 44.7 mt -93.13 71.3 4.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.327 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.4 p -71.75 -0.07 10.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.289 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -141.37 147.62 38.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.939 0.4 . . . . 0.0 111.592 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.586 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 23.2 t -57.28 -49.73 92.2 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.499 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.0 Cg_endo -58.71 -42.5 52.97 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.975 1.784 . . . . 0.0 111.879 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.91 -34.91 78.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.195 0.521 . . . . 0.0 110.533 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.573 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -65.06 -57.01 9.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.184 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 61.0 mtm -62.87 -28.6 70.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.075 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 9.9 mt-10 -69.88 -47.77 61.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.718 0.294 . . . . 0.0 110.5 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.08 -42.35 94.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.427 HD11 HD11 ' A' ' 36' ' ' ILE . 51.0 mt -65.36 -40.12 87.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.23 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.61 -15.52 61.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.786 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.45 24.86 6.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.13 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.5 t -171.69 155.02 3.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.515 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.487 ' HG3' HG12 ' A' ' 87' ' ' VAL . 20.7 tt0 -64.76 -79.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.876 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.456 HG11 HD13 ' A' ' 83' ' ' LEU . 17.0 t -93.5 135.14 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.411 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.96 125.51 20.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.026 0.441 . . . . 0.0 112.138 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.498 HG22 HG12 ' A' ' 111' ' ' ILE . 52.4 t -114.48 127.66 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.799 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 23.7 mt -133.18 137.2 53.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.401 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.54 98.61 1.88 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.455 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 6.1 m-85 -83.83 90.22 7.32 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.0 m-85 -109.32 139.09 44.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.377 -178.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -86.06 -8.57 57.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.4 t70 -149.84 121.7 8.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.623 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.499 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.3 mt -89.55 44.85 1.23 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.066 0.46 . . . . 0.0 111.35 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.405 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.7 mt-10 -135.94 10.52 3.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.028 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.658 HG13 HG22 ' A' ' 47' ' ' VAL . 2.1 pt -94.34 156.77 38.39 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.288 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.452 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 73.4 Cg_exo -51.19 -28.58 26.21 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.794 2.33 . . . . 0.0 112.899 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.89 90.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.315 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.658 HG22 HG13 ' A' ' 44' ' ' ILE . 2.4 t -60.97 -57.28 27.5 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.681 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -58.98 -40.27 72.88 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.767 1.644 . . . . 0.0 111.387 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -61.77 -35.77 69.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.007 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.533 ' O ' ' HG3' ' A' ' 53' ' ' MET . 42.1 tp -73.52 -53.11 11.35 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -53.58 -24.44 13.73 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.1 m -82.49 -46.18 13.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.621 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.533 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.7 -26.1 65.33 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.541 HG12 ' HG3' ' A' ' 13' ' ' GLN . 58.7 t -53.08 -47.28 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.942 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.537 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 22.6 mt-30 -77.46 -10.5 59.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.647 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -94.1 -19.68 20.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.16 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.554 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 64.4 m-85 -136.44 62.66 44.57 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.525 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.26 -42.37 60.46 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.653 2.235 . . . . 0.0 111.624 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.72 -39.39 91.17 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.32 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.3 t -67.67 144.11 14.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.547 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 33.7 t -81.89 98.8 8.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 111.015 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.559 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 8.3 p90 -64.88 128.64 36.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.905 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -147.74 160.87 28.44 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.987 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.418 HD13 HG11 ' A' ' 47' ' ' VAL . 4.8 tt -160.75 141.82 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.1 t -146.94 155.87 42.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.952 0.406 . . . . 0.0 111.769 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.498 HG23 ' HG ' ' A' ' 42' ' ' LEU . 82.5 p -137.64 -8.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.681 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.77 141.8 56.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.669 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.4 m -64.68 -49.53 70.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.126 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -50.19 -44.48 53.02 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.411 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.464 ' HA ' HG23 ' A' ' 21' ' ' VAL . 77.2 t -70.53 -53.78 21.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.831 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.38 -14.63 8.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.261 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.4 m -91.73 -40.63 11.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.205 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -61.87 -36.17 80.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.486 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -94.16 10.67 32.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.73 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 57.51 23.66 9.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.64 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.605 HG21 ' HB ' ' A' ' 80' ' ' THR . 35.2 mm -59.89 120.05 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.245 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.9 p -139.39 55.85 1.68 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.174 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.19 45.7 0.02 OUTLIER Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.634 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.538 ' HB2' HG22 ' A' ' 99' ' ' ILE . 21.8 m-80 51.28 43.27 29.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.252 0.549 . . . . 0.0 110.504 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.605 ' HB ' HG21 ' A' ' 76' ' ' ILE . 98.0 m -69.17 151.27 46.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.569 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.546 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.3 mt -117.45 118.95 60.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.223 -0.898 . . . . 0.0 108.821 178.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.517 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.4 m -107.26 133.23 52.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.583 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.5 tp -109.41 103.38 12.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.966 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.9 t80 -96.34 120.88 37.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.56 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.495 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.2 mtm180 -104.06 80.63 1.75 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.808 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 85' ' ' ARG . 8.6 tp -25.18 -58.2 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.028 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.487 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.84 -62.88 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.314 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -95.05 15.45 18.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.783 0.325 . . . . 0.0 111.301 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 44.7 27.94 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.104 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.495 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.4 mm-40 -75.98 156.78 33.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.834 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.404 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.8 OUTLIER -144.26 90.68 2.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.774 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.583 HD21 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -77.52 142.19 39.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.4 91.99 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.495 HD21 HD12 ' A' ' 102' ' ' ILE . 4.6 tt -78.34 79.36 4.78 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -79.5 -165.49 0.8 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.509 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.8 t70 -50.37 -39.86 47.86 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.48 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.14 -15.12 1.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.167 0.508 . . . . 0.0 110.295 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -127.95 -13.79 5.11 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.461 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.557 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 24.4 mm -90.16 -33.45 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.543 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -50.11 -53.64 26.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 110.544 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.6 m -114.97 38.55 3.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.436 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.557 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.3 tp -62.0 142.88 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 111.448 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.539 ' HA ' HD12 ' A' ' 49' ' ' ILE . 24.0 m-20 -137.96 149.57 46.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.848 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.631 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -47.92 -35.89 11.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.034 0.445 . . . . 0.0 110.36 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 95.6 m -62.97 -47.83 81.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.293 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -60.2 -60.29 4.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.126 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.61 HD13 HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.06 -56.02 10.31 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.995 0.426 . . . . 0.0 110.131 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.0 m -58.23 -30.76 66.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.999 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.49 ' HD3' HD11 ' A' ' 113' ' ' ILE . 1.7 tmt_? -69.85 -66.02 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.052 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -42.86 -43.83 4.23 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.218 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.498 HG12 HG22 ' A' ' 35' ' ' VAL . 95.3 mt -62.92 -54.89 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -54.57 -18.68 4.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.267 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.49 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.79 -35.24 7.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.944 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.572 HD21 ' HG ' ' A' ' 92' ' ' LEU . 87.6 m-20 -126.03 30.91 5.55 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.2 p -83.44 38.32 0.61 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.995 0.426 . . . . 0.0 110.423 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.494 HD13 HH12 ' A' ' 85' ' ' ARG . 72.0 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.386 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.721 0.296 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.13 133.89 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.895 0.379 . . . . 0.0 111.198 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.08 -175.71 3.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.599 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -60.46 -78.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.703 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.6 p 45.41 62.83 2.0 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.38 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.8 p -142.77 -19.46 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.067 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.72 174.68 7.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.01 175.28 15.15 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.545 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.27 119.16 5.69 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.622 2.215 . . . . 0.0 112.454 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.08 147.15 3.73 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.638 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.42 -23.53 0.24 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.91 0.386 . . . . 0.0 110.289 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.24 95.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.467 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.609 ' HG3' HG11 ' A' ' 54' ' ' VAL . 12.1 pt20 -50.17 152.97 1.56 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.362 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.47 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.4 pt-20 -122.6 158.77 55.59 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.579 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 30.8 Cg_endo -64.26 145.77 89.2 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.536 2.158 . . . . 0.0 112.518 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.2 m -61.05 153.92 24.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.581 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -99.97 89.61 4.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.709 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 24' ' ' ALA . 35.4 mt -87.72 76.8 8.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.56 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.0 p -74.6 -4.95 40.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.049 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -141.48 148.31 39.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.952 0.406 . . . . 0.0 111.821 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.588 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 12.6 t -54.63 -49.97 88.25 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.583 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.0 Cg_endo -57.81 -44.15 43.2 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.005 1.804 . . . . 0.0 112.127 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.98 -37.54 87.81 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.206 0.527 . . . . 0.0 110.263 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.649 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -62.69 -56.54 16.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.016 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.6 mtm -61.86 -26.76 68.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.056 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -71.72 -50.59 28.9 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.642 0.258 . . . . 0.0 110.602 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -60.83 -32.17 71.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.105 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.479 HD12 HD13 ' A' ' 36' ' ' ILE . 53.4 mt -75.29 -39.06 41.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.03 0.443 . . . . 0.0 110.075 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.51 -18.46 61.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.143 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.1 25.39 4.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.261 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 t -169.57 154.24 5.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.689 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.496 ' HG3' HG11 ' A' ' 87' ' ' VAL . 18.9 tt0 -65.13 -72.58 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.878 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.449 HG12 HD11 ' A' ' 83' ' ' LEU . 15.7 t -99.45 137.13 27.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.672 0.272 . . . . 0.0 110.657 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.545 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.58 125.35 16.97 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.024 0.44 . . . . 0.0 112.019 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.466 HG21 HG12 ' A' ' 111' ' ' ILE . 56.0 t -114.88 129.64 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.902 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.479 HD13 HD12 ' A' ' 28' ' ' ILE . 21.6 mt -135.21 136.8 51.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.468 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.552 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.0 99.78 2.1 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.543 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 6.4 m-85 -85.4 93.93 8.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.4 m-85 -113.38 143.37 44.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -92.64 -1.16 57.1 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.496 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.3 t70 -156.89 115.53 3.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.479 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.486 ' HG ' HG23 ' A' ' 66' ' ' THR . 95.2 mt -85.47 44.14 1.08 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.11 0.481 . . . . 0.0 111.233 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.416 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 17.5 mm-40 -135.29 12.74 3.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.46 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.675 HG13 HG21 ' A' ' 47' ' ' VAL . 1.8 pt -96.57 156.37 36.79 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.176 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.44 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 87.6 Cg_exo -50.95 -27.24 20.41 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.837 2.358 . . . . 0.0 113.048 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.15 -37.12 86.31 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.675 HG21 HG13 ' A' ' 44' ' ' ILE . 2.7 t -62.13 -56.1 34.47 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.939 -0.305 . . . . 0.0 111.682 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.8 Cg_exo -59.79 -40.25 65.4 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.735 1.623 . . . . 0.0 111.461 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.614 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -61.83 -37.2 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.086 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.523 ' O ' ' HG3' ' A' ' 53' ' ' MET . 37.6 tp -72.13 -53.19 13.5 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -54.92 -21.02 10.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.085 0.469 . . . . 0.0 109.815 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.7 t -85.38 -44.87 12.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.496 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.523 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.28 -26.55 67.85 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.609 HG11 ' HG3' ' A' ' 13' ' ' GLN . 54.5 t -51.89 -50.0 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.069 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -74.54 -13.41 60.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.685 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -91.13 -18.7 24.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.288 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.638 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 48.8 m-85 -135.4 62.06 47.84 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.436 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.18 -36.77 78.62 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.494 2.129 . . . . 0.0 111.493 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.44 -39.77 98.09 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.518 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.5 t -67.72 145.23 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.545 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 36.9 t -82.7 96.28 8.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.099 0.476 . . . . 0.0 110.795 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.449 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 6.8 p90 -64.05 130.83 45.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.187 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -149.87 162.3 29.11 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.008 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.5 tt -160.47 147.1 5.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.9 t -153.11 157.55 40.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.17 0.509 . . . . 0.0 111.697 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.486 HG23 ' HG ' ' A' ' 42' ' ' LEU . 69.9 p -138.03 -3.39 1.8 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.444 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -63.95 143.36 57.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.679 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.0 p -66.22 -52.08 51.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.53 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -50.2 -43.46 52.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.592 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 21' ' ' VAL . 60.4 t -70.53 -52.5 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.934 0.397 . . . . 0.0 110.563 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.96 -14.52 16.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.47 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.6 m -92.13 -41.53 10.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.204 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -60.1 -41.3 92.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.451 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -89.02 11.98 16.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.81 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 55.95 28.81 13.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.483 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.618 HG22 ' HB ' ' A' ' 80' ' ' THR . 34.9 mm -65.5 118.65 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.079 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.7 p -139.75 51.96 1.72 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.193 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.87 44.42 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.567 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.565 ' HB2' HG23 ' A' ' 99' ' ' ILE . 39.2 m-20 51.42 42.29 29.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.364 0.602 . . . . 0.0 110.137 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.618 ' HB ' HG22 ' A' ' 76' ' ' ILE . 93.4 m -68.55 153.36 43.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.93 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.552 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.3 mt -119.93 118.06 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.867 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.2 m -106.75 132.8 52.31 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.578 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -110.42 104.72 13.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.039 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.0 t80 -97.54 123.94 41.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.447 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.504 HH12 HD13 ' A' ' 116' ' ' LEU . 4.8 mtm180 -106.12 81.08 1.58 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.708 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ARG . 8.9 tp -24.28 -59.86 0.05 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.113 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.496 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.8 -63.3 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -93.77 2.57 56.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.995 0.426 . . . . 0.0 111.077 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 54.12 30.7 12.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.718 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.9 mm-40 -78.32 164.07 25.17 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.706 0.288 . . . . 0.0 110.648 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.99 98.74 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.578 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -86.81 115.37 24.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.742 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -96.67 93.61 6.83 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.495 HD22 HD12 ' A' ' 102' ' ' ILE . 4.1 tt -78.67 78.92 5.11 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -80.51 -165.44 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.467 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.17 -50.35 11.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.675 -179.316 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -47.59 -16.5 0.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.941 0.4 . . . . 0.0 111.209 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 96' ' ' ASP . 19.3 m-20 -127.27 -13.73 5.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.467 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.565 HG23 ' HB2' ' A' ' 79' ' ' ASN . 25.2 mm -91.36 -40.73 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -50.35 -37.36 36.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.349 . . . . 0.0 111.076 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.2 p -127.11 38.58 4.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.48 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.5 tp -67.11 143.76 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.616 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.543 ' HA ' HD12 ' A' ' 49' ' ' ILE . 13.3 m-20 -137.93 148.39 45.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.32 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.614 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.8 -36.48 7.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.026 0.441 . . . . 0.0 110.445 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.3 m -62.57 -49.4 75.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.413 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -58.2 -59.07 5.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.365 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.602 HD11 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.64 -55.67 15.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.015 0.436 . . . . 0.0 110.146 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 65.5 m -58.42 -28.76 65.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.763 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.524 ' HD3' HD12 ' A' ' 113' ' ' ILE . 3.9 tmt_? -72.12 -67.21 0.56 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.094 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -42.85 -40.23 2.82 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.34 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.466 HG12 HG21 ' A' ' 35' ' ' VAL . 96.6 mt -66.45 -54.97 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -53.96 -18.84 3.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.324 0.583 . . . . 0.0 110.285 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.524 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.5 mp -90.1 -38.6 11.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.899 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.476 ' OD1' HG22 ' A' ' 113' ' ' ILE . 28.2 m120 -118.36 28.13 8.53 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -82.39 47.63 1.18 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 110.08 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.504 HD13 HH12 ' A' ' 85' ' ' ARG . 52.1 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.252 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.874 0.369 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.5 m -122.43 149.4 25.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.269 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -135.73 -72.4 0.46 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.023 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -66.84 98.78 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.893 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.6 p -73.15 124.31 25.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.8 m -75.19 -48.75 22.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -146.98 -61.37 0.29 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 124.36 -72.84 0.42 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.748 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.93 127.63 26.9 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.595 2.197 . . . . 0.0 112.478 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.28 108.76 0.41 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.602 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.536 ' HB3' HE21 ' A' ' 13' ' ' GLN . . . -168.98 -77.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.749 0.309 . . . . 0.0 110.793 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.75 96.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.662 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.536 HE21 ' HB3' ' A' ' 11' ' ' ALA . 8.5 pt20 -171.22 177.33 3.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.9 pt-20 -126.59 157.97 69.2 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.128 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 47.4 Cg_endo -68.66 150.59 74.65 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.855 2.37 . . . . 0.0 112.592 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.409 HG21 ' N ' ' A' ' 17' ' ' TRP . 8.4 m -73.18 154.23 40.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.38 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.409 ' N ' HG21 ' A' ' 16' ' ' THR . 7.0 m-90 -97.53 91.16 5.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.166 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.564 HD22 ' HA ' ' A' ' 24' ' ' ALA . 30.7 mt -85.02 73.14 10.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.237 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.9 p -68.85 -6.72 28.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.421 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -138.25 147.4 43.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.931 0.396 . . . . 0.0 111.937 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.594 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 33.2 t -54.0 -49.68 88.39 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.685 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.7 Cg_endo -58.05 -46.15 27.48 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.962 1.775 . . . . 0.0 112.131 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.55 -35.33 80.13 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.115 0.483 . . . . 0.0 110.409 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.564 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.17 -59.64 4.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.006 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.9 mtm -61.51 -24.91 66.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.025 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 17.8 mt-10 -71.68 -50.33 31.47 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.749 0.309 . . . . 0.0 110.169 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -60.04 -33.24 71.76 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.444 HD11 HD13 ' A' ' 36' ' ' ILE . 50.0 mt -72.49 -38.98 61.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.038 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.22 -18.33 60.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.239 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.75 27.18 3.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.288 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.6 t -170.8 150.77 3.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.426 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.472 ' HG3' HG12 ' A' ' 87' ' ' VAL . 22.0 tt0 -62.67 -63.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.953 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.46 HG13 HD11 ' A' ' 83' ' ' LEU . 21.8 t -108.18 138.32 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.591 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.517 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.37 125.75 18.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.993 0.425 . . . . 0.0 111.991 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.484 HG23 HG12 ' A' ' 111' ' ' ILE . 51.4 t -114.38 129.79 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.444 HD13 HD11 ' A' ' 28' ' ' ILE . 39.3 mt -135.45 138.12 48.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.524 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.07 96.84 1.5 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.478 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.455 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 37.1 m-85 -83.04 90.45 7.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.607 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 13.6 m-85 -108.51 142.04 39.52 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -87.93 -5.97 58.28 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.461 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.8 t70 -154.49 123.48 6.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.747 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.544 ' HG ' HG23 ' A' ' 66' ' ' THR . 92.3 mt -91.22 46.33 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.13 0.49 . . . . 0.0 111.293 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 32.5 mt-10 -137.57 11.4 2.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.972 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.673 HG13 HG22 ' A' ' 47' ' ' VAL . 1.6 pt -95.61 156.42 37.46 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.158 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 82.0 Cg_exo -50.18 -28.47 19.97 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.848 2.365 . . . . 0.0 113.145 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.458 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.03 -37.05 85.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.673 HG22 HG13 ' A' ' 44' ' ' ILE . 2.6 t -62.39 -56.31 31.69 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.66 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.7 Cg_exo -60.04 -37.25 85.92 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 121.923 1.749 . . . . 0.0 111.49 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.631 HG23 HD13 ' A' ' 107' ' ' LEU . 6.7 mt -65.65 -35.9 76.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.112 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.535 ' O ' ' HG3' ' A' ' 53' ' ' MET . 45.9 tp -73.23 -50.46 22.28 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -54.95 -26.12 34.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.124 0.487 . . . . 0.0 109.78 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.3 t -81.13 -46.97 14.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.625 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.535 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.28 -26.53 65.03 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.505 ' CG1' ' HG3' ' A' ' 13' ' ' GLN . 47.0 t -52.19 -48.15 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.225 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -77.06 -11.89 59.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 28.8 mtpp -92.17 -18.47 23.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.176 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.576 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 56.5 m-85 -136.13 62.45 45.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.439 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.43 -43.09 56.94 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.701 2.267 . . . . 0.0 111.842 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.79 -39.44 91.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.57 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.8 t -67.35 145.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 23.9 t -83.04 97.7 8.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.104 0.478 . . . . 0.0 110.826 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.51 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 5.0 p90 -64.73 125.17 23.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.965 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.56 162.42 27.67 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.146 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -163.08 142.77 2.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.455 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 42.5 t -149.56 156.3 41.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.12 0.486 . . . . 0.0 111.711 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.544 HG23 ' HG ' ' A' ' 42' ' ' LEU . 75.8 p -136.55 -1.54 2.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.459 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -68.08 139.97 56.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.72 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.7 p -62.34 -48.95 77.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.461 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -49.44 -47.38 48.22 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.574 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HA ' HG23 ' A' ' 21' ' ' VAL . 71.5 t -69.01 -53.96 22.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.985 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.86 -14.88 6.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.134 0.492 . . . . 0.0 110.225 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.5 m -90.49 -41.6 11.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.32 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -60.77 -37.87 83.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.475 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -92.88 10.11 32.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.815 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 56.76 25.97 10.86 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.51 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.629 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.3 mm -61.31 123.88 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.353 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.1 p -143.08 60.01 1.41 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.174 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.15 44.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.733 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.607 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 24.0 m-80 51.87 43.99 29.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.23 0.538 . . . . 0.0 110.506 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.629 ' HB ' HG23 ' A' ' 76' ' ' ILE . 90.1 m -69.32 150.94 46.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.744 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.524 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.2 mt -117.23 115.81 49.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.202 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.428 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 71.0 m -104.04 133.16 49.45 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.589 ' HG ' HD21 ' A' ' 92' ' ' LEU . 3.0 tp -108.87 101.3 10.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.028 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.9 t80 -95.32 121.26 36.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.555 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.438 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 4.3 mtm180 -104.56 84.12 2.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.752 0.311 . . . . 0.0 110.897 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tp -26.26 -59.02 0.08 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.472 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.39 -72.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 O-C-N 123.428 0.455 . . . . 0.0 112.009 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.85 3.6 40.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.152 0.501 . . . . 0.0 110.655 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.5 t30 52.72 31.94 11.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.344 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.438 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 16.7 mm-40 -75.11 158.78 32.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.582 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.9 OUTLIER -140.48 90.77 2.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.589 HD21 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -77.52 142.92 38.81 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -124.39 108.86 12.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.167 0.508 . . . . 0.0 112.343 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.484 HD22 HD12 ' A' ' 102' ' ' ILE . 3.9 tt -96.54 77.86 2.95 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.6 mt-10 -79.0 -165.21 0.71 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.504 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.3 t70 -51.17 -36.6 41.93 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.02 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.15 -14.77 2.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.061 0.458 . . . . 0.0 110.437 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -130.88 -14.17 3.55 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.639 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.521 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 24.0 mm -89.07 -29.49 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.705 0.288 . . . . 0.0 111.271 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -55.7 -47.94 75.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.659 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.9 t -118.81 36.06 4.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.514 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.521 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.9 tp -62.2 142.76 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.513 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.529 ' HA ' HD11 ' A' ' 49' ' ' ILE . 24.0 m-20 -137.87 149.07 45.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.57 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.622 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -47.1 -37.24 9.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.013 0.435 . . . . 0.0 110.441 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -62.87 -48.45 78.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.256 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.09 -57.85 11.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.29 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.631 HD13 HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.96 -56.22 13.45 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.052 0.453 . . . . 0.0 110.275 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.8 m -58.15 -29.47 65.6 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.887 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.434 ' HD3' HD12 ' A' ' 113' ' ' ILE . 4.3 tmt_? -71.58 -64.68 0.88 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.331 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -43.03 -45.8 5.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.932 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.484 HG12 HG23 ' A' ' 35' ' ' VAL . 96.4 mt -61.2 -55.75 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.506 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -54.34 -18.07 3.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.39 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.434 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.25 -37.23 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.04 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.547 HD21 ' HG ' ' A' ' 92' ' ' LEU . 90.5 m-20 -124.81 30.35 5.95 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.5 p -83.13 48.98 1.45 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.049 0.452 . . . . 0.0 110.139 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 61.2 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.357 -179.26 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.823 0.345 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -100.54 165.99 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.858 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -136.17 126.36 26.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.978 0.418 . . . . 0.0 111.13 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -63.73 -45.0 91.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.584 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 85.3 p 45.47 60.92 2.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.338 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.3 t -105.45 82.01 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.817 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -133.1 111.72 11.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.51 -94.53 0.17 Allowed Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.471 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.78 103.32 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.401 2.068 . . . . 0.0 112.269 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.49 -115.21 0.32 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.528 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.48 -47.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.446 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.04 -84.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.558 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.532 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.8 pt20 -133.11 143.85 49.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.368 . . . . 0.0 110.871 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.2 pt-20 -129.63 158.15 74.36 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.775 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 36.7 Cg_endo -67.22 143.8 66.13 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.512 2.142 . . . . 0.0 112.578 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.407 HG21 ' N ' ' A' ' 17' ' ' TRP . 18.2 m -61.09 154.43 22.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.457 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.407 ' N ' HG21 ' A' ' 16' ' ' THR . 75.1 m95 -100.56 88.51 3.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.886 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.566 HD21 ' HA ' ' A' ' 24' ' ' ALA . 59.8 mt -83.19 71.99 10.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.414 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.5 p -70.56 -1.51 11.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.377 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -143.27 147.03 34.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.986 0.422 . . . . 0.0 111.829 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.596 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.0 t -54.75 -49.17 93.04 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.561 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.57 -47.46 18.92 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.835 1.69 . . . . 0.0 111.84 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.29 -32.57 73.31 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.182 0.515 . . . . 0.0 110.174 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.566 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -64.85 -61.38 2.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.027 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.4 mmt -59.73 -25.04 64.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.302 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.8 mt-10 -73.1 -52.19 15.2 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.669 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -58.74 -32.55 69.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.433 HD11 HD12 ' A' ' 36' ' ' ILE . 50.8 mt -74.76 -41.13 47.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.287 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.66 -15.27 62.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.14 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.85 26.81 4.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.132 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.417 HG23 ' HB2' ' A' ' 61' ' ' SER . 7.6 t -172.11 154.77 3.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.644 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.434 ' HG3' HG12 ' A' ' 87' ' ' VAL . 10.9 tt0 -64.13 -76.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.842 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.457 HG11 HD13 ' A' ' 83' ' ' LEU . 16.9 t -96.6 136.1 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.59 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.527 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.68 125.67 19.77 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.511 HG23 HG12 ' A' ' 111' ' ' ILE . 52.6 t -115.32 131.67 66.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.755 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.433 HD12 HD11 ' A' ' 28' ' ' ILE . 20.6 mt -137.04 139.97 43.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.385 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.553 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.96 97.99 1.67 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.592 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.473 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 44.5 m-85 -84.6 93.12 8.31 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.1 m-85 -113.15 141.22 47.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.477 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 95.2 mt-30 -86.53 -8.84 57.21 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.481 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.0 t70 -149.82 123.17 9.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.813 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.512 ' HG ' HG23 ' A' ' 66' ' ' THR . 93.5 mt -91.89 46.36 1.27 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.062 0.458 . . . . 0.0 111.326 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -135.18 9.62 3.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.848 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.678 HG13 HG21 ' A' ' 47' ' ' VAL . 3.0 pt -91.98 158.01 40.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.343 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.431 ' O ' HD12 ' A' ' 49' ' ' ILE . 76.5 Cg_exo -53.24 -24.91 28.23 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.961 2.441 . . . . 0.0 113.015 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.1 -37.22 85.22 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.678 HG21 HG13 ' A' ' 44' ' ' ILE . 2.9 t -61.02 -55.2 46.86 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.616 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.655 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.2 Cg_exo -60.88 -42.41 37.92 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.035 1.824 . . . . 0.0 111.565 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.623 HG22 HD11 ' A' ' 107' ' ' LEU . 6.6 mt -61.15 -35.28 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.251 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.525 ' O ' ' HG3' ' A' ' 53' ' ' MET . 51.9 tp -74.15 -51.63 14.98 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -54.09 -26.75 28.68 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.9 m -80.84 -46.62 15.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.565 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.75 -25.28 64.74 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.195 0.521 . . . . 0.0 109.7 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.532 HG12 ' HG3' ' A' ' 13' ' ' GLN . 49.5 t -53.12 -46.52 55.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.937 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -79.16 -9.16 59.49 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.808 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -94.61 -19.08 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.225 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.563 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 52.4 m-85 -136.95 63.02 43.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.419 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.68 -44.55 46.85 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.744 2.296 . . . . 0.0 111.71 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.33 -40.67 77.19 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.523 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.7 t -66.93 143.12 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 22.1 t -80.92 96.31 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.403 . . . . 0.0 111.054 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.473 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.7 p90 -65.58 125.46 25.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.912 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -144.71 163.82 27.88 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.01 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 tt -161.81 144.11 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.44 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.9 t -150.1 157.38 43.06 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.041 0.448 . . . . 0.0 111.498 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.512 HG23 ' HG ' ' A' ' 42' ' ' LEU . 75.2 p -138.1 -2.99 1.81 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.644 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -64.06 142.2 58.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.631 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.2 t -65.29 -51.17 62.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.447 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -50.26 -41.97 51.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.5 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.483 ' HA ' HG22 ' A' ' 21' ' ' VAL . 65.4 t -71.91 -53.99 18.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 0.0 110.763 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp -59.07 -14.54 10.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.169 0.509 . . . . 0.0 110.21 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.9 m -92.49 -39.22 11.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.302 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -62.31 -40.95 98.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.445 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.403 ' HB2' HG12 ' A' ' 76' ' ' ILE . 90.5 m-85 -89.17 11.9 17.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.591 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 57.4 24.23 9.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.567 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.645 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.9 mm -61.0 119.9 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.9 p -138.23 52.66 1.83 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.421 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.95 48.15 0.01 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.799 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 12.6 m120 49.71 43.69 24.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.119 0.485 . . . . 0.0 110.477 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.645 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.5 m -69.55 153.3 43.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.838 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.553 HG12 ' HA2' ' A' ' 37' ' ' GLY . 56.0 mt -118.83 119.41 60.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.84 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.473 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 75.5 m -108.2 135.4 49.59 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.557 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.4 tp -112.85 105.65 13.8 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.196 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.9 t80 -98.33 122.06 41.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.315 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.456 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.4 mtm180 -104.29 81.12 1.78 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.757 0.313 . . . . 0.0 110.894 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 85' ' ' ARG . 9.4 tp -25.18 -56.72 0.06 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.809 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.58 -68.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.991 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -91.16 13.63 16.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.057 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.6 p30 43.99 30.88 0.45 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.161 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.456 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 7.6 mm-40 -78.02 160.8 27.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.323 . . . . 0.0 110.674 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.81 95.14 2.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.974 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.557 HD21 ' HG ' ' A' ' 83' ' ' LEU . 1.8 mm? -83.02 143.2 30.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -123.82 93.68 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.529 HD22 HD13 ' A' ' 102' ' ' ILE . 4.9 tt -76.91 77.86 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.5 mt-10 -78.55 -165.7 0.75 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.521 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 19.0 t70 -51.2 -35.44 36.47 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.695 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.29 -17.4 4.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.237 0.541 . . . . 0.0 110.24 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -128.73 -13.87 4.65 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.668 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.543 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.4 mm -88.69 -32.08 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 120.593 0.235 . . . . 0.0 111.591 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.6 -36.23 64.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.103 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.6 m -132.41 38.56 3.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.465 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.529 HD13 HD22 ' A' ' 94' ' ' LEU . 7.0 tp -63.05 142.48 16.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.687 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.546 ' HA ' HD13 ' A' ' 49' ' ' ILE . 18.4 m-20 -136.12 149.03 48.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.349 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -47.36 -37.54 11.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.982 0.42 . . . . 0.0 110.641 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.4 m -61.74 -47.17 86.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.363 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -59.95 -60.46 3.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.27 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.623 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.72 -56.04 9.72 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.03 0.443 . . . . 0.0 110.303 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.7 m -58.28 -30.97 67.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.914 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.478 ' HD3' HD12 ' A' ' 113' ' ' ILE . 3.7 tmt_? -69.95 -65.8 0.68 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.235 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -42.87 -45.02 4.77 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.164 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.511 HG12 HG23 ' A' ' 35' ' ' VAL . 96.5 mt -61.55 -55.03 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -54.79 -18.62 4.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.395 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.478 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.88 -36.47 8.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.875 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -124.88 30.43 5.91 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.4 p -83.21 42.05 0.79 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.972 0.415 . . . . 0.0 110.286 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.452 HD13 ' NH1' ' A' ' 85' ' ' ARG . 81.5 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.382 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.743 0.306 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.29 17.85 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.321 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 55.55 46.86 22.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.129 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 55.91 84.24 0.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.075 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.4 p -60.09 124.81 21.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.78 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.0 t -98.58 104.3 16.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.987 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -109.49 -11.76 14.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.845 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.05 154.32 9.28 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.475 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.2 -33.14 95.07 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.642 2.228 . . . . 0.0 112.41 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.91 -136.97 4.34 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.49 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.3 -51.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.791 0.329 . . . . 0.0 110.653 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.3 -83.8 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.534 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.567 HE21 HG11 ' A' ' 54' ' ' VAL . 13.7 pt20 -129.81 142.7 50.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.351 . . . . 0.0 110.891 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.0 pt-20 -125.09 157.76 65.86 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.984 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.461 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 35.0 Cg_endo -66.09 143.53 72.16 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.7 2.267 . . . . 0.0 112.504 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.0 m -58.38 149.49 24.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.65 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -97.34 85.76 3.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.627 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.573 HD23 ' HA ' ' A' ' 24' ' ' ALA . 39.0 mt -82.14 73.22 9.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.546 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.5 p -71.77 -2.06 16.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.339 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -141.5 147.35 37.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 111.696 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.588 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 58.6 t -55.37 -49.92 89.73 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.602 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.7 Cg_endo -57.85 -45.26 33.89 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.849 1.699 . . . . 0.0 112.066 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.54 78.4 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.132 0.491 . . . . 0.0 110.416 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.573 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -64.6 -59.24 4.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.98 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 60.4 mtp -60.99 -26.54 67.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.04 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 18.7 mt-10 -71.25 -49.27 44.91 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.657 0.265 . . . . 0.0 110.333 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.34 -34.27 73.59 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 36' ' ' ILE . 51.4 mt -72.96 -38.31 55.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.292 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.17 -17.9 60.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.09 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.86 27.27 4.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.287 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.3 t -169.49 152.37 4.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.453 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.523 ' HG3' HG11 ' A' ' 87' ' ' VAL . 21.5 tt0 -64.65 -64.97 0.74 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.912 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.495 HG11 HD11 ' A' ' 83' ' ' LEU . 21.8 t -108.33 137.4 40.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.491 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.87 126.99 21.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.945 0.403 . . . . 0.0 112.031 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.5 HG21 HG12 ' A' ' 111' ' ' ILE . 42.9 t -115.47 127.58 73.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.593 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 28' ' ' ILE . 32.2 mt -134.15 138.78 49.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.572 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.53 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.49 98.42 1.69 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.562 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.439 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.0 m-85 -84.98 92.77 8.41 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.4 m-85 -111.56 147.48 35.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.541 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.525 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 23.9 mt-30 -94.51 -9.89 33.94 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.509 ' O ' HG12 ' A' ' 44' ' ' ILE . 37.5 t70 -147.17 117.41 7.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.397 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.508 ' HG ' HG21 ' A' ' 66' ' ' THR . 95.3 mt -87.35 45.26 1.25 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.127 0.489 . . . . 0.0 111.506 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.1 mt-10 -136.13 10.88 3.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.114 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.67 HG13 HG23 ' A' ' 47' ' ' VAL . 1.5 pt -94.29 155.04 40.27 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.132 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.456 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 88.2 Cg_exo -48.88 -28.51 13.32 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.936 2.424 . . . . 0.0 113.091 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.411 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -62.9 -37.9 88.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.67 HG23 HG13 ' A' ' 44' ' ' ILE . 2.9 t -61.38 -56.35 34.52 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.604 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.2 Cg_exo -60.86 -41.87 42.14 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.822 1.682 . . . . 0.0 111.416 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.613 HG21 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -60.4 -34.94 59.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.038 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.538 ' O ' ' HG3' ' A' ' 53' ' ' MET . 48.8 tp -73.92 -52.39 13.06 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -52.79 -27.1 16.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.065 0.46 . . . . 0.0 109.772 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.6 m -80.12 -46.84 15.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.722 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.538 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.11 -26.04 64.34 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.194 0.521 . . . . 0.0 109.639 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.567 HG11 HE21 ' A' ' 13' ' ' GLN . 53.2 t -52.83 -51.12 39.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.89 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -75.24 -10.42 59.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.75 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -93.51 -18.25 22.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.253 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.589 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 55.3 m-85 -136.81 62.53 41.5 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.488 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.65 -41.14 70.82 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.592 2.195 . . . . 0.0 111.627 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.72 -39.44 93.59 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.321 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -69.12 144.25 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.519 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 41.3 t -81.96 98.29 8.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.985 0.421 . . . . 0.0 111.013 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.461 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 6.2 p90 -63.53 128.92 37.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.854 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.446 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.15 161.36 28.46 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.261 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.9 tt -162.6 145.12 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.439 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.0 t -152.46 157.72 41.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.195 0.522 . . . . 0.0 111.787 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.508 HG21 ' HG ' ' A' ' 42' ' ' LEU . 67.5 p -138.03 -3.39 1.8 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.626 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.4 139.73 58.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.415 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.4 m -63.69 -49.09 74.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.54 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -50.57 -41.14 53.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.489 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.531 ' HA ' HG22 ' A' ' 21' ' ' VAL . 56.6 t -73.49 -54.98 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 110.685 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp -57.66 -14.52 5.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.367 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 83.2 m -92.44 -42.33 9.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.286 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -60.53 -34.76 74.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.59 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.403 ' HB2' HG12 ' A' ' 76' ' ' ILE . 96.7 m-85 -95.88 10.17 38.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.693 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.0 m120 56.63 27.43 12.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.755 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.624 HG21 ' HB ' ' A' ' 80' ' ' THR . 40.6 mm -63.87 122.23 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.867 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.5 p -141.72 54.77 1.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.911 0.386 . . . . 0.0 111.322 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.49 44.03 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.753 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 12.4 m120 51.79 41.97 29.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.338 0.589 . . . . 0.0 110.251 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.624 ' HB ' HG21 ' A' ' 76' ' ' ILE . 92.8 m -67.64 151.55 47.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.703 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.53 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.3 mt -118.28 116.22 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.869 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 73.0 m -104.14 129.94 51.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.576 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.2 tp -107.01 100.34 9.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.507 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.6 t80 -94.67 122.81 37.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.529 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.7 mtm180 -107.13 92.78 4.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.363 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 tp -37.81 -53.52 1.28 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.009 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.523 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.59 -58.22 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -102.84 9.64 38.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.002 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 85' ' ' ARG . 16.0 t-20 47.2 34.44 3.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.423 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.529 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 15.8 mm-40 -77.48 159.46 29.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -141.87 91.21 2.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.914 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.576 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.5 mm? -81.97 115.27 21.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.847 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -99.81 98.63 9.41 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.468 HD21 HD12 ' A' ' 102' ' ' ILE . 4.3 tt -83.77 77.63 9.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.434 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.3 mt-10 -77.87 -165.64 0.67 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.524 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 20.6 t70 -51.21 -37.89 49.28 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.117 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -55.55 -15.18 2.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.059 0.457 . . . . 0.0 110.437 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -128.38 -14.2 4.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.394 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 23.7 mm -90.18 -29.26 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.889 0.376 . . . . 0.0 111.321 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -56.13 -38.05 70.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 85.4 p -129.98 36.07 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.582 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.2 tp -62.05 141.98 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.597 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.51 ' HA ' HD12 ' A' ' 49' ' ' ILE . 22.7 m-20 -136.89 150.34 48.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.533 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.613 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -47.74 -37.72 13.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.903 0.382 . . . . 0.0 110.584 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -62.73 -47.94 81.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.303 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -58.8 -60.27 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.199 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.612 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.13 -56.58 8.72 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.965 0.412 . . . . 0.0 110.191 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.7 m -58.07 -28.87 64.95 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.947 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HD3' HD12 ' A' ' 113' ' ' ILE . 4.2 tmt_? -72.42 -67.0 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.077 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -42.37 -41.36 2.83 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.103 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.5 HG12 HG21 ' A' ' 35' ' ' VAL . 96.6 mt -65.49 -55.68 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -53.27 -18.68 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.187 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.586 HG23 ' ND2' ' A' ' 114' ' ' ASN . 1.5 mp -89.99 -39.38 12.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.918 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.586 ' ND2' HG23 ' A' ' 113' ' ' ILE . 49.4 m-80 -116.39 26.77 9.66 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 78.7 p -81.56 52.59 1.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.174 0.511 . . . . 0.0 110.216 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.422 HD13 ' NH1' ' A' ' 85' ' ' ARG . 70.8 mt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.032 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.777 0.322 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -155.24 -30.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -93.79 130.82 39.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.763 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 4' ' ' LYS . 13.8 mptt -94.5 162.8 13.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.0 p -139.91 17.97 2.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.0 p -89.8 -43.83 10.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.98 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -148.48 89.14 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.011 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -107.19 -163.08 21.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.487 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.47 98.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.587 2.191 . . . . 0.0 112.33 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.32 79.02 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.462 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.75 -65.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.81 53.07 11.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.271 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.498 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.7 pt20 47.37 173.26 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.846 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 -165.54 159.4 13.67 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.488 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 53.6 Cg_endo -69.46 136.34 33.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.365 2.044 . . . . 0.0 112.685 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.9 m -60.7 152.43 26.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.676 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -94.01 98.54 11.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.94 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 24' ' ' ALA . 49.1 mt -93.05 70.71 4.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.265 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.9 p -70.54 -2.15 13.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.165 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -139.7 146.87 40.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.021 0.439 . . . . 0.0 111.64 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 43.4 t -56.82 -50.08 90.1 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.396 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.41 -43.89 42.46 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.945 1.763 . . . . 0.0 111.878 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.28 -36.99 85.91 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.223 0.535 . . . . 0.0 110.305 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.555 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -62.84 -57.07 12.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.04 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 62.1 mtp -62.59 -26.74 68.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.117 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.4 mt-10 -70.32 -50.76 35.91 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.726 0.298 . . . . 0.0 110.464 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -61.46 -32.54 72.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.464 HD13 HD13 ' A' ' 36' ' ' ILE . 47.7 mt -72.9 -36.86 52.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.836 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.7 -20.33 59.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.022 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.94 28.33 1.86 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.162 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' 61' ' ' SER . 9.8 t -172.3 154.63 3.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.475 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.486 ' HG3' HG13 ' A' ' 87' ' ' VAL . 30.1 tt0 -68.0 -59.9 2.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.012 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.448 HG13 HD11 ' A' ' 83' ' ' LEU . 20.6 t -110.26 138.26 38.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.495 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.78 127.16 17.73 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.475 HG23 HG12 ' A' ' 111' ' ' ILE . 48.6 t -116.05 130.3 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.586 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.464 HD13 HD13 ' A' ' 28' ' ' ILE . 25.4 mt -135.94 137.59 48.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.456 -177.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.555 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.94 99.43 2.05 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.443 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.521 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 10.8 m-85 -85.67 93.99 8.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.4 m-85 -115.09 141.48 47.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.43 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 48.5 mt-30 -88.95 -2.24 58.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.449 ' O ' HG12 ' A' ' 44' ' ' ILE . 25.1 t70 -155.81 123.06 5.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.636 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.508 ' HG ' HG21 ' A' ' 66' ' ' THR . 92.6 mt -92.62 46.15 1.23 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.136 0.493 . . . . 0.0 111.475 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.416 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 38.3 mt-10 -135.19 8.06 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.921 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.664 HG13 HG22 ' A' ' 47' ' ' VAL . 3.0 pt -90.82 155.51 45.32 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.186 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.447 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 77.2 Cg_exo -50.75 -27.12 19.17 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.87 2.38 . . . . 0.0 112.942 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.6 -37.86 88.94 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.664 HG22 HG13 ' A' ' 44' ' ' ILE . 2.2 t -61.88 -56.0 36.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.773 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.5 Cg_exo -60.47 -37.01 84.08 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 121.9 1.733 . . . . 0.0 111.435 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.627 HG21 HD12 ' A' ' 107' ' ' LEU . 6.1 mt -65.75 -35.43 75.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.941 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.516 ' O ' ' HG3' ' A' ' 53' ' ' MET . 43.4 tp -74.31 -51.85 13.98 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -55.86 -22.21 24.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.979 0.419 . . . . 0.0 109.922 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.6 t -85.59 -44.63 12.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.372 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.516 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.24 -26.03 67.47 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.226 0.536 . . . . 0.0 109.593 179.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 50' ' ' LEU . 44.9 t -51.61 -48.98 35.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.009 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -74.44 -14.84 60.9 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.566 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -90.35 -17.71 26.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.357 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.566 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 65.6 m-85 -137.14 61.82 35.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.699 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.47 -43.52 56.85 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.645 2.23 . . . . 0.0 111.611 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.58 -42.29 90.2 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.422 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.1 t -65.97 141.71 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 41.2 t -78.37 97.71 5.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.081 0.467 . . . . 0.0 110.816 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.43 ' CD2' HG11 ' A' ' 54' ' ' VAL . 2.5 p90 -67.9 124.64 23.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.914 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.43 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -143.51 164.13 27.41 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.041 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.7 tt -161.2 142.14 3.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 t -147.23 153.35 39.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.161 0.505 . . . . 0.0 111.794 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.508 HG21 ' HG ' ' A' ' 42' ' ' LEU . 77.8 p -135.05 2.73 3.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.432 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.84 140.67 49.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.705 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.0 t -64.03 -49.97 70.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.531 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -50.76 -44.46 58.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.602 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.522 ' HA ' HG21 ' A' ' 21' ' ' VAL . 54.5 t -70.24 -52.1 33.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.891 0.377 . . . . 0.0 110.598 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.52 -15.08 15.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.253 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.1 m -90.93 -41.23 11.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.32 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -61.63 -37.84 85.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.389 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -92.08 11.69 24.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.805 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 56.02 23.03 6.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.689 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.648 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.7 mm -57.94 117.28 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.83 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.1 p -136.51 56.4 1.81 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.387 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.28 46.32 0.02 OUTLIER Glycine 0 C--N 1.329 0.174 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.628 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.533 ' HB2' HG22 ' A' ' 99' ' ' ILE . 11.3 m120 51.43 43.62 29.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.162 0.506 . . . . 0.0 110.277 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.648 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.3 m -69.08 154.75 41.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.675 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.555 HG12 ' HA2' ' A' ' 37' ' ' GLY . 52.9 mt -120.65 117.55 53.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.817 178.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.521 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.2 m -106.7 135.9 47.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.59 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.6 tp -112.85 101.64 9.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.064 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.6 t80 -95.05 125.18 39.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.772 0.32 . . . . 0.0 110.334 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.494 HH12 HD13 ' A' ' 116' ' ' LEU . 5.3 mtm180 -107.75 83.65 1.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.825 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 85' ' ' ARG . 9.0 tp -24.67 -59.15 0.06 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.789 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.486 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.85 -77.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 O-C-N 123.5 0.5 . . . . 0.0 112.127 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.55 4.32 21.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.636 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.2 m120 53.8 31.43 13.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.522 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.489 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.1 mm-40 -74.46 161.49 29.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -145.94 86.91 1.73 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.862 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.59 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -74.25 144.84 44.47 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -128.25 98.28 5.03 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.507 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -84.64 78.28 9.88 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.0 mt-10 -79.02 -165.61 0.78 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.494 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.8 t70 -50.23 -38.62 41.43 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.03 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -55.06 -14.9 1.74 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.119 0.485 . . . . 0.0 110.492 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -130.1 -13.94 3.96 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.664 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.533 HG22 ' HB2' ' A' ' 79' ' ' ASN . 23.5 mm -88.49 -31.86 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.636 0.255 . . . . 0.0 111.614 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -56.43 -35.29 67.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.952 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.5 m -130.31 39.77 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.558 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.507 HD13 HD21 ' A' ' 94' ' ' LEU . 7.2 tp -68.25 142.08 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.754 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.557 ' HA ' HD13 ' A' ' 49' ' ' ILE . 10.0 m-20 -136.04 149.69 48.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.391 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.605 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.63 -35.87 10.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.127 0.489 . . . . 0.0 110.445 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.8 m -62.59 -48.61 78.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.42 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -59.4 -59.76 4.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.256 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.627 HD12 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.34 -55.48 12.72 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 110.301 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.5 m -58.92 -30.59 67.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.999 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.482 ' NH1' HD11 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -70.83 -66.25 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.138 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -43.15 -43.58 4.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.119 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.475 HG12 HG23 ' A' ' 35' ' ' VAL . 96.8 mt -63.8 -55.43 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -54.12 -17.59 2.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.129 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.482 HD11 ' NH1' ' A' ' 109' ' ' ARG . 1.3 mp -90.69 -37.22 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.01 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -122.63 29.96 6.67 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 98.7 p -83.26 40.55 0.72 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.091 0.472 . . . . 0.0 110.1 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.494 HD13 HH12 ' A' ' 85' ' ' ARG . 58.2 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.422 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.821 0.344 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.0 p -155.94 143.6 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.93 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -124.37 103.71 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.993 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -135.32 127.37 29.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.735 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.4 m -75.14 87.84 2.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.9 p -162.42 37.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.21 -57.59 3.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.802 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -113.72 177.44 17.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.578 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.07 -58.78 1.02 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.584 2.19 . . . . 0.0 112.253 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.66 -118.37 0.54 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.374 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.479 ' HB2' HE21 ' A' ' 13' ' ' GLN . . . -167.98 -68.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.638 0.256 . . . . 0.0 110.787 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.428 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . . . 59.35 100.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.315 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.504 ' HG3' ' CG1' ' A' ' 54' ' ' VAL . 9.0 pt20 -168.98 172.28 7.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.977 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 -118.29 158.45 46.55 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.084 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.558 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 45.0 Cg_endo -69.7 148.15 64.8 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.773 2.315 . . . . 0.0 112.756 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 m -66.25 150.13 49.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.527 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -96.51 90.64 5.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.999 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 24' ' ' ALA . 37.1 mt -86.12 71.49 10.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.567 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.8 p -70.68 -1.96 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.081 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -141.57 147.07 37.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.919 0.39 . . . . 0.0 111.7 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 59.3 t -55.79 -49.85 90.52 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.491 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.4 Cg_endo -57.55 -44.91 37.65 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.89 1.727 . . . . 0.0 111.937 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.84 -34.46 78.43 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.226 0.536 . . . . 0.0 110.353 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -64.46 -59.41 4.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.174 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.1 mtm -61.48 -26.96 68.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.049 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -70.77 -49.26 48.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.638 0.256 . . . . 0.0 110.51 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -61.48 -32.88 72.91 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.401 HD13 HD11 ' A' ' 36' ' ' ILE . 42.8 mt -72.08 -37.99 61.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.828 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.76 -23.62 61.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.837 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.93 32.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.138 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -173.47 151.31 1.94 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.346 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.487 ' HG3' HG13 ' A' ' 87' ' ' VAL . 30.0 tt0 -68.31 -53.45 24.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.749 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.447 HG13 HD12 ' A' ' 83' ' ' LEU . 21.5 t -116.58 139.83 41.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.413 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.15 126.78 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.549 HG23 HG12 ' A' ' 111' ' ' ILE . 43.7 t -115.61 125.99 73.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.404 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 28.2 mt -131.39 136.26 57.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -177.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.555 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.08 98.33 1.88 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.267 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.5 m-85 -84.12 93.27 8.1 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -113.62 142.88 45.45 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -90.47 -9.25 48.08 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.496 ' O ' HG12 ' A' ' 44' ' ' ILE . 30.2 t70 -147.72 119.28 7.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.55 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.495 ' HA ' HG23 ' A' ' 47' ' ' VAL . 94.3 mt -88.9 45.49 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.096 0.474 . . . . 0.0 111.413 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.433 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.9 mt-10 -135.65 7.94 3.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.107 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.667 HG13 HG21 ' A' ' 47' ' ' VAL . 3.5 pt -89.87 157.03 46.69 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.158 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.434 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 74.0 Cg_exo -51.84 -25.98 22.86 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.792 2.328 . . . . 0.0 112.824 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.87 -39.04 92.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.667 HG21 HG13 ' A' ' 44' ' ' ILE . 2.1 t -60.38 -55.12 48.26 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.4 Cg_exo -60.56 -42.0 43.56 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.879 1.719 . . . . 0.0 111.371 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.638 HG21 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -60.62 -35.45 63.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.046 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.526 ' O ' ' HG3' ' A' ' 53' ' ' MET . 50.9 tp -73.81 -50.09 22.15 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -55.81 -25.27 40.71 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.8 m -81.56 -45.77 15.4 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.595 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.526 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.22 -25.82 67.32 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.114 0.483 . . . . 0.0 109.748 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.504 ' CG1' ' HG3' ' A' ' 13' ' ' GLN . 42.8 t -52.16 -47.77 43.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.084 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.428 ' NE2' ' HA ' ' A' ' 12' ' ' ALA . 36.5 mt-30 -76.94 -14.29 59.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.668 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -90.8 -16.58 28.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.389 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.656 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 34.3 m-85 -136.99 61.42 34.52 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.606 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.39 -39.56 81.25 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.636 2.224 . . . . 0.0 111.592 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.98 -41.16 99.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.519 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.656 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.9 t -67.12 145.23 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.531 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 46.6 t -82.31 96.56 7.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.984 0.421 . . . . 0.0 110.999 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.558 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 4.7 p90 -62.1 128.24 35.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.612 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.2 161.46 28.32 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.826 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.5 tt -164.02 140.73 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.2 t -144.45 159.33 42.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.227 0.537 . . . . 0.0 111.959 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.467 HG23 ' HG ' ' A' ' 42' ' ' LEU . 76.2 p -141.18 -0.0 1.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.314 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -71.28 144.4 50.01 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.602 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.8 p -65.66 -50.96 63.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.392 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -49.96 -41.8 47.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.616 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.537 ' HA ' HG22 ' A' ' 21' ' ' VAL . 70.9 t -72.45 -54.08 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.841 0.353 . . . . 0.0 110.712 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.0 -14.74 10.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.35 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.6 m -91.67 -42.0 10.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.258 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -60.52 -38.97 86.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.356 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -91.15 9.61 30.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.763 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.8 m120 57.24 24.68 10.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.592 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.633 HG21 ' HB ' ' A' ' 80' ' ' THR . 42.0 mm -59.27 125.24 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.9 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.0 p -143.86 60.31 1.37 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.529 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.87 45.51 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.542 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.527 ' HB2' HG22 ' A' ' 99' ' ' ILE . 29.6 m-80 51.63 41.87 29.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.236 0.541 . . . . 0.0 110.385 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.633 ' HB ' HG21 ' A' ' 76' ' ' ILE . 95.2 m -67.65 152.22 45.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.747 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.555 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.1 mt -119.56 116.83 51.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.835 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.503 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 71.2 m -106.31 136.58 45.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.585 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.6 tp -109.73 100.91 9.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.196 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -92.99 119.88 32.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.434 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.473 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.5 mtm180 -104.25 85.21 2.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.973 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 tp -26.97 -61.28 0.09 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.487 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.1 -76.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 O-C-N 123.525 0.516 . . . . 0.0 112.056 -179.42 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.48 3.12 25.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.098 0.475 . . . . 0.0 110.533 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.405 ' ND2' ' O ' ' A' ' 89' ' ' ASN . 12.3 t30 52.65 31.84 10.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.299 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.473 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 19.6 mm-40 -75.28 165.96 24.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.533 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -149.68 87.55 1.5 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.585 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -72.04 147.22 47.04 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.85 105.72 8.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.292 0.568 . . . . 0.0 112.302 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.495 HD23 HD11 ' A' ' 102' ' ' ILE . 3.9 tt -94.05 76.45 4.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -77.61 -165.88 0.68 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.456 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.63 -51.9 11.51 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.524 -179.368 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -47.28 -17.56 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.868 0.366 . . . . 0.0 111.301 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -124.39 -13.92 7.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.423 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.527 HG22 ' HB2' ' A' ' 79' ' ' ASN . 22.8 mm -91.48 -40.25 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -51.71 -30.38 22.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.821 0.343 . . . . 0.0 111.29 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m -134.67 39.98 2.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.079 0.466 . . . . 0.0 110.395 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.495 HD11 HD23 ' A' ' 94' ' ' LEU . 6.9 tp -68.48 143.93 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.712 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.545 ' HA ' HD11 ' A' ' 49' ' ' ILE . 23.7 m-20 -136.32 147.89 47.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.437 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.638 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -46.69 -38.69 10.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.017 0.437 . . . . 0.0 110.542 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.8 m -59.51 -49.32 78.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.323 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.411 ' HD3' ' H ' ' A' ' 103' ' ' ASP . 51.1 mtpt -57.87 -62.6 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.274 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.623 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -46.64 -57.53 4.71 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.945 0.403 . . . . 0.0 110.446 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.9 m -57.74 -29.88 65.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.931 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.477 ' HD3' HD11 ' A' ' 113' ' ' ILE . 3.0 tmt_? -71.4 -65.85 0.7 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.237 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -42.64 -43.61 3.9 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.993 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.549 HG12 HG23 ' A' ' 35' ' ' VAL . 96.5 mt -63.25 -55.98 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.617 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -54.15 -18.36 3.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.362 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.477 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.91 -37.47 10.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.84 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -125.45 31.21 5.6 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 98.2 p -83.9 44.51 1.0 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.122 0.487 . . . . 0.0 110.074 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.435 HD11 HH12 ' A' ' 85' ' ' ARG . 65.4 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.352 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.701 0.286 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p -141.78 133.66 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.187 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -105.31 -9.59 17.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.846 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -78.49 152.98 31.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.976 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -95.54 120.23 35.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.4 m -146.01 122.2 10.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.101 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -120.62 96.64 5.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.776 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 110.06 -94.19 0.79 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.362 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.72 134.09 52.04 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.451 2.101 . . . . 0.0 112.239 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.34 -78.36 0.18 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.701 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.42 -41.9 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.864 0.364 . . . . 0.0 110.35 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.53 -83.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.72 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.512 ' HG3' HG11 ' A' ' 54' ' ' VAL . 4.7 pt20 -139.9 142.37 36.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.863 0.363 . . . . 0.0 110.963 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.429 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.2 pt-20 -128.09 157.87 72.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.798 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 36.3 Cg_endo -67.13 140.55 54.34 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.444 2.096 . . . . 0.0 112.494 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.0 m -54.8 152.03 7.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.748 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -98.98 87.11 3.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.079 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' A' ' 24' ' ' ALA . 45.8 mt -84.85 72.57 10.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.344 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.0 p -71.67 0.19 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.445 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -144.67 148.29 34.07 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.752 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.588 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 45.2 t -55.3 -49.57 91.62 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.528 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.28 -46.53 24.38 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.922 1.748 . . . . 0.0 111.9 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.88 -33.06 74.84 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.11 0.481 . . . . 0.0 110.324 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.565 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -65.83 -59.03 4.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.939 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.6 mtm -61.0 -25.39 66.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.054 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.4 mt-10 -72.97 -52.01 16.18 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.684 0.278 . . . . 0.0 110.499 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -58.49 -33.78 70.19 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.464 HD11 HD11 ' A' ' 36' ' ' ILE . 57.9 mt -73.84 -40.76 53.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.261 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.98 -15.22 62.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.174 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.29 23.74 7.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.4 t -169.88 153.68 4.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.737 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.483 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.7 tt0 -63.35 -74.95 0.09 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.816 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.473 HG12 HD11 ' A' ' 83' ' ' LEU . 15.7 t -97.75 135.9 30.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.784 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.91 124.07 16.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.948 0.404 . . . . 0.0 111.904 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.508 HG23 HG12 ' A' ' 111' ' ' ILE . 45.8 t -112.44 130.38 66.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.785 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.464 HD11 HD11 ' A' ' 28' ' ' ILE . 29.1 mt -135.75 138.63 47.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.611 -177.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.517 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.03 98.13 1.77 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.543 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.465 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 35.9 m-85 -83.84 91.63 7.59 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.3 m-85 -111.75 141.08 45.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.3 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -86.08 -10.19 55.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.53 129.35 14.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.561 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.524 ' HG ' HG21 ' A' ' 66' ' ' THR . 90.1 mt -96.97 48.4 1.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.077 0.465 . . . . 0.0 111.475 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -137.9 7.29 2.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.771 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.673 HG13 HG22 ' A' ' 47' ' ' VAL . 3.7 pt -88.58 159.2 47.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.129 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.437 ' O ' HD11 ' A' ' 49' ' ' ILE . 54.4 Cg_exo -54.47 -24.91 37.86 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.864 2.376 . . . . 0.0 112.816 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.9 -39.01 90.22 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.673 HG22 HG13 ' A' ' 44' ' ' ILE . 2.3 t -59.34 -55.08 49.8 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.3 Cg_exo -60.37 -41.84 46.45 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.01 1.807 . . . . 0.0 111.505 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.639 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.5 mt -61.68 -34.42 62.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.103 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.531 ' O ' HG22 ' A' ' 54' ' ' VAL . 52.0 tp -75.09 -51.85 12.49 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -54.32 -24.92 21.15 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -82.08 -46.13 14.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.593 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -60.43 -25.52 66.03 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 50' ' ' LEU . 55.9 t -52.39 -48.18 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.081 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -78.11 -9.96 59.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.83 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -93.9 -19.15 21.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.304 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.592 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 51.3 m-85 -135.83 62.91 49.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.56 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.82 -43.9 48.48 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.829 2.352 . . . . 0.0 111.644 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.08 -40.71 91.86 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.497 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.3 t -67.57 142.51 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.513 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 32.2 t -81.44 97.68 7.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.055 0.455 . . . . 0.0 110.976 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.428 ' CD2' HG13 ' A' ' 54' ' ' VAL . 4.6 p90 -65.03 128.14 34.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.786 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.84 163.0 28.6 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.8 -0.715 . . . . 0.0 111.937 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 tt -161.68 144.26 3.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.465 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 40.7 t -148.52 156.33 42.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.131 0.491 . . . . 0.0 111.581 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.524 HG21 ' HG ' ' A' ' 42' ' ' LEU . 69.6 p -138.24 5.93 2.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.783 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -76.2 141.19 41.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.632 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.9 t -63.77 -50.35 69.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.396 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -49.68 -43.29 47.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.405 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.514 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.0 t -71.14 -54.16 18.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.841 0.353 . . . . 0.0 110.745 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mp -58.23 -14.82 7.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.118 0.485 . . . . 0.0 110.211 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.4 m -91.17 -40.55 11.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.161 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -61.75 -33.02 73.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.149 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -97.35 9.15 43.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.959 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 58.88 22.78 10.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.506 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.617 HG21 ' HB ' ' A' ' 80' ' ' THR . 41.0 mm -59.13 125.61 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.266 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.6 p -144.44 58.69 1.33 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.29 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.57 43.94 0.02 OUTLIER Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.664 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 32.5 m-20 52.37 44.75 29.55 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.285 0.564 . . . . 0.0 110.435 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.617 ' HB ' HG21 ' A' ' 76' ' ' ILE . 89.8 m -69.96 152.31 44.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.913 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.535 HG22 HD23 ' A' ' 107' ' ' LEU . 59.5 mt -117.72 116.99 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-N 115.496 -0.775 . . . . 0.0 108.979 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.432 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 75.7 m -106.22 133.65 50.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.582 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -110.34 105.41 14.42 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.077 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.2 t80 -97.22 122.12 39.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.697 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.49 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.3 mtm180 -105.04 81.94 1.79 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 110.552 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.7 tp -25.71 -58.73 0.07 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.026 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.483 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -44.26 -57.25 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.59 13.52 33.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.592 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 43.8 28.81 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.301 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.49 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 15.9 mm-40 -77.79 156.98 30.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.745 0.307 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -141.83 95.33 2.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.567 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.582 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -84.9 116.14 23.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.959 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.18 108.89 21.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.544 HD22 HD12 ' A' ' 102' ' ' ILE . 4.2 tt -95.01 77.62 3.55 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.4 mt-10 -78.72 -165.09 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 17.2 t70 -50.26 -39.9 46.4 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.249 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -53.91 -15.88 1.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.132 0.492 . . . . 0.0 110.229 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -128.96 -13.68 4.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.58 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.558 HG23 ' HB2' ' A' ' 79' ' ' ASN . 25.5 mm -91.01 -40.04 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -51.55 -33.82 33.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.935 0.398 . . . . 0.0 111.044 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.1 m -131.39 40.0 3.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.372 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.544 HD12 HD22 ' A' ' 94' ' ' LEU . 8.0 tp -68.89 144.91 13.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.658 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.532 ' HA ' HD12 ' A' ' 49' ' ' ILE . 9.8 m-20 -138.59 146.95 42.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.257 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.639 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.09 -36.17 5.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.967 0.413 . . . . 0.0 110.694 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 100.0 m -62.24 -48.18 81.1 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.489 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -59.32 -61.29 2.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.055 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.599 HD13 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.91 -55.88 8.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.974 0.416 . . . . 0.0 110.332 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.9 m -58.44 -30.61 67.04 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.922 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.524 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.7 tmt_? -71.06 -66.08 0.66 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.245 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -42.98 -41.9 3.56 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.243 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.508 HG12 HG23 ' A' ' 35' ' ' VAL . 97.0 mt -65.11 -55.14 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -53.94 -18.85 3.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.14 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.524 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.75 -37.95 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.827 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.472 ' OD1' HG23 ' A' ' 113' ' ' ILE . 31.6 m120 -119.86 28.6 8.02 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.8 p -82.81 48.0 1.28 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.075 0.464 . . . . 0.0 110.484 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.421 HD11 ' NH1' ' A' ' 85' ' ' ARG . 78.1 mt . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.246 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.747 0.308 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.84 151.76 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.151 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 56.8 84.2 0.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -157.98 139.66 13.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.6 m -96.68 46.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.717 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.7 m -139.39 -46.41 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -100.49 97.36 8.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.94 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.07 -173.04 27.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.455 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.25 104.75 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.527 2.151 . . . . 0.0 112.175 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.87 55.02 0.58 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.437 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.73 -46.82 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.976 0.417 . . . . 0.0 110.571 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.37 -83.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.673 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.51 ' HG3' HG12 ' A' ' 54' ' ' VAL . 10.5 pt20 -139.72 154.63 47.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.478 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 -140.88 159.28 62.8 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 49.9 Cg_endo -70.37 144.91 52.15 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.664 2.243 . . . . 0.0 112.762 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.3 m -63.46 150.7 43.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.631 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -96.26 97.86 9.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.015 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.568 HD21 ' HA ' ' A' ' 24' ' ' ALA . 54.9 mt -92.93 70.91 4.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.318 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.8 p -71.74 -2.25 16.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.136 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -139.32 146.7 40.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.058 0.456 . . . . 0.0 111.509 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.58 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 13.1 t -56.43 -50.42 87.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.471 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.74 -45.28 34.19 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.831 1.688 . . . . 0.0 111.856 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.31 79.87 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.198 0.523 . . . . 0.0 110.309 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.568 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -64.07 -59.26 4.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.988 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.1 mtm -60.63 -25.39 66.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.202 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 26.3 mt-10 -73.38 -51.39 17.51 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.728 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -60.04 -31.67 70.18 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.458 HD12 HD12 ' A' ' 36' ' ' ILE . 48.8 mt -75.21 -39.85 43.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.127 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.58 -18.14 61.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.266 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.33 24.97 5.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.31 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 t -168.44 152.75 6.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.677 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.459 ' HG3' HG12 ' A' ' 87' ' ' VAL . 16.5 tt0 -62.82 -77.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.895 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.488 HG12 HD13 ' A' ' 83' ' ' LEU . 19.5 t -95.73 135.27 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.397 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.582 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.76 125.77 21.23 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.465 HG22 HG12 ' A' ' 111' ' ' ILE . 49.3 t -115.41 129.73 71.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.789 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.458 HD12 HD12 ' A' ' 28' ' ' ILE . 23.0 mt -135.45 137.19 50.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.446 -177.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.77 96.91 1.63 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.294 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 19.5 m-85 -82.51 89.02 6.61 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -107.44 137.71 44.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.446 ' HG2' HD22 ' A' ' 71' ' ' LEU . 21.9 mt-30 -83.83 -5.0 59.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.427 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 27.0 t70 -155.41 127.71 7.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.529 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 66' ' ' THR . 92.5 mt -95.34 46.91 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 111.68 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.8 mt-10 -135.85 5.08 3.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.612 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.644 HG13 HG21 ' A' ' 47' ' ' VAL . 2.2 pt -88.84 157.39 48.95 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.296 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.454 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 74.6 Cg_exo -52.8 -27.96 36.53 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.914 2.409 . . . . 0.0 112.958 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.27 -37.21 84.6 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.644 HG21 HG13 ' A' ' 44' ' ' ILE . 2.2 t -62.21 -56.94 26.4 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.525 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.8 Cg_exo -58.64 -40.9 69.34 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.758 1.639 . . . . 0.0 111.448 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' A' ' 104' ' ' ALA . 7.8 mt -61.37 -37.16 77.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.524 ' O ' ' HG3' ' A' ' 53' ' ' MET . 37.9 tp -73.46 -53.82 9.74 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -53.1 -23.25 7.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.098 0.475 . . . . 0.0 110.081 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.2 m -83.92 -45.5 13.12 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.467 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.524 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -60.03 -25.2 65.13 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.8 t -52.33 -48.05 45.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.992 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -77.85 -11.17 59.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.797 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -93.08 -17.91 23.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.235 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.569 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 57.0 m-85 -137.57 62.53 36.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.558 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.63 -42.73 60.43 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.612 2.208 . . . . 0.0 111.708 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.76 -40.49 92.93 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.509 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.7 t -66.57 143.9 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.582 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 30.5 t -81.42 97.12 7.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 0.0 110.994 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.433 ' CD2' HG11 ' A' ' 54' ' ' VAL . 3.8 p90 -64.82 127.13 30.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.965 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.09 162.84 28.39 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.029 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -160.96 142.36 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.2 t -145.5 154.04 41.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.983 0.421 . . . . 0.0 111.691 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.51 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.4 p -137.52 -4.41 1.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.884 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.42 142.84 56.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.771 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.2 t -64.5 -50.58 66.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.511 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -49.02 -45.45 42.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.658 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.59 -52.4 29.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.917 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.446 HD22 ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -59.05 -14.85 10.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.122 0.487 . . . . 0.0 110.135 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.1 m -91.17 -41.38 11.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.394 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -60.97 -40.07 92.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.455 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -90.24 11.82 20.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.576 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.6 m120 55.98 24.17 7.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.494 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.614 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.9 mm -60.83 120.08 5.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.4 p -138.68 52.37 1.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.419 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.27 46.49 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.64 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 28.3 m-80 50.77 42.01 27.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.177 0.513 . . . . 0.0 110.29 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.614 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.3 m -68.07 150.38 48.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.68 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.546 HG12 ' HA2' ' A' ' 37' ' ' GLY . 69.4 mt -116.79 116.94 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.984 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.513 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.4 m -106.64 132.14 52.98 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.62 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -109.08 105.37 14.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.979 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.5 t80 -98.62 121.07 40.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.498 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.531 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.1 mtm180 -102.85 80.71 1.91 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.711 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 85' ' ' ARG . 6.1 tp -25.11 -58.46 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.459 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.35 -59.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.199 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -97.11 2.9 51.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.045 0.45 . . . . 0.0 110.82 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 52.77 32.58 12.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.817 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.531 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 13.0 mm-40 -77.93 156.99 29.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.663 0.268 . . . . 0.0 110.805 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.415 HE21 ' HB3' ' A' ' 91' ' ' GLN . 1.1 tm0? -140.18 96.23 3.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.601 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.62 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -88.13 114.47 24.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.804 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -97.65 99.69 11.07 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.525 HD22 HD12 ' A' ' 102' ' ' ILE . 4.4 tt -84.24 77.45 9.97 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -78.11 -165.61 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -176.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.444 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.72 -49.9 14.25 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.548 -179.515 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -48.5 -15.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.929 0.395 . . . . 0.0 111.291 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 96' ' ' ASP . 22.1 m-20 -127.33 -13.9 5.45 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.498 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.538 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 23.9 mm -90.67 -37.24 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -49.04 -49.31 41.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.334 . . . . 0.0 111.127 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.0 m -118.0 35.6 4.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.778 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.538 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 8.1 tp -60.78 145.17 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.46 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.529 ' HA ' HD11 ' A' ' 49' ' ' ILE . 18.0 m-20 -138.41 149.22 45.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.48 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.62 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -48.4 -36.22 14.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.035 0.445 . . . . 0.0 110.377 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.0 m -62.06 -49.62 75.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.286 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -58.18 -60.39 3.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.376 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.559 HD13 HG23 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -49.19 -55.99 10.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.964 0.411 . . . . 0.0 110.378 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.6 m -58.57 -28.87 65.94 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.726 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.556 ' HD3' HD12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -72.25 -66.64 0.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.188 179.761 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -43.56 -41.99 4.81 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.065 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.465 HG12 HG22 ' A' ' 35' ' ' VAL . 96.5 mt -64.72 -55.94 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.42 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 43.1 tt0 -52.95 -19.13 2.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.294 0.569 . . . . 0.0 110.265 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.556 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -90.11 -38.56 11.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.062 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.455 ' OD1' HG23 ' A' ' 113' ' ' ILE . 28.9 m120 -117.72 27.12 9.23 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.2 p -81.32 50.12 1.39 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.083 0.468 . . . . 0.0 110.152 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.496 HD13 HH12 ' A' ' 85' ' ' ARG . 56.4 mt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.345 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.714 0.292 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.8 p -144.77 139.72 23.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.105 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -107.48 154.85 20.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.601 ' HB3' ' HZ2' ' A' ' 4' ' ' LYS . 5.7 ttpm? 59.06 95.43 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.938 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.6 p -62.61 146.3 52.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.063 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.6 m -87.41 87.41 7.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.7 t70 62.07 -83.11 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.12 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.79 172.03 45.09 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.603 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.56 -176.75 0.26 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.739 2.293 . . . . 0.0 112.372 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.34 -119.5 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.509 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.25 -72.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.709 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.51 -81.58 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.527 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.523 ' HG3' HG12 ' A' ' 54' ' ' VAL . 16.5 pt20 -155.97 142.57 18.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.632 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.483 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 16.6 pt-20 -134.27 158.56 74.98 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.96 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 38.1 Cg_endo -66.65 145.17 75.01 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.635 2.223 . . . . 0.0 112.564 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.443 HG23 ' N ' ' A' ' 17' ' ' TRP . 11.5 m -62.22 155.78 23.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.911 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.443 ' N ' HG23 ' A' ' 16' ' ' THR . 12.1 m-90 -99.53 86.94 3.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.719 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 24' ' ' ALA . 44.1 mt -83.04 73.83 10.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.047 0.451 . . . . 0.0 110.61 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.0 p -72.19 -0.82 12.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.356 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -143.0 148.26 36.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.917 0.389 . . . . 0.0 111.535 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.585 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 32.8 t -56.77 -50.52 87.52 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.434 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.61 -44.76 38.73 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.939 1.76 . . . . 0.0 111.832 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.33 -36.5 83.89 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.334 0.588 . . . . 0.0 110.183 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.541 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -63.91 -59.12 4.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.91 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.6 mtp -60.19 -24.98 65.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.095 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -72.57 -52.52 15.18 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.775 0.321 . . . . 0.0 110.558 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -59.34 -31.41 69.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 36' ' ' ILE . 55.3 mt -74.52 -39.37 47.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.175 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.29 -20.77 61.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.147 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.64 28.69 2.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.032 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.9 t -170.11 152.43 4.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.425 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.475 ' HG3' HG12 ' A' ' 87' ' ' VAL . 26.0 tt0 -66.76 -61.73 1.81 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.462 HG11 HD11 ' A' ' 83' ' ' LEU . 17.2 t -109.33 136.98 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.438 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.91 127.75 20.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.014 0.435 . . . . 0.0 112.116 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.466 HG23 HG12 ' A' ' 111' ' ' ILE . 50.6 t -116.46 131.19 69.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.615 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 28' ' ' ILE . 22.1 mt -136.45 135.34 49.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -177.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.552 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -97.32 98.03 2.06 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.539 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.9 m-85 -84.43 93.48 8.3 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.0 m-85 -114.3 142.14 46.69 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -89.97 -0.94 57.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.438 ' O ' HG12 ' A' ' 44' ' ' ILE . 37.8 t70 -156.26 122.47 5.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.707 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.506 ' HG ' HG21 ' A' ' 66' ' ' THR . 92.1 mt -92.32 46.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.159 0.504 . . . . 0.0 111.293 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.428 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.5 mt-10 -136.91 7.5 2.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.005 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.664 HG13 HG22 ' A' ' 47' ' ' VAL . 2.7 pt -89.46 158.45 45.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.014 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.438 ' O ' HD11 ' A' ' 49' ' ' ILE . 66.1 Cg_exo -53.32 -26.23 33.97 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.781 2.321 . . . . 0.0 112.896 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.92 -37.64 88.32 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.664 HG22 HG13 ' A' ' 44' ' ' ILE . 2.1 t -61.54 -55.66 40.63 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.616 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 36.6 Cg_exo -61.24 -37.82 70.72 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.067 1.845 . . . . 0.0 111.519 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.615 HG21 HD13 ' A' ' 107' ' ' LEU . 5.5 mt -65.24 -34.86 73.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.014 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' A' ' 53' ' ' MET . 45.4 tp -73.27 -52.34 14.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -52.81 -26.31 14.09 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -80.29 -47.59 14.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.7 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -58.8 -25.93 63.61 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.136 0.493 . . . . 0.0 109.684 179.6 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.523 HG12 ' HG3' ' A' ' 13' ' ' GLN . 54.2 t -53.23 -48.35 55.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.967 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.92 -10.06 59.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.635 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -94.1 -18.88 21.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.212 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 59.9 m-85 -136.82 62.84 43.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.526 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.8 -41.61 68.89 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.748 2.298 . . . . 0.0 111.369 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.61 -39.38 93.25 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.375 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.9 t -68.55 144.33 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.514 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 39.5 t -81.88 98.07 8.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.075 0.464 . . . . 0.0 111.043 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.419 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.3 p90 -65.06 125.55 25.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.028 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.03 162.11 28.12 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.998 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -161.19 145.49 4.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.0 t -151.02 158.08 43.68 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.173 0.511 . . . . 0.0 111.857 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.506 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.3 p -138.53 -0.61 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.375 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.4 ' O ' HD11 ' A' ' 71' ' ' LEU . 28.6 t70 -67.06 143.85 56.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.779 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.6 t -67.49 -50.95 56.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.437 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -50.77 -42.39 57.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.355 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.513 ' HA ' HG21 ' A' ' 21' ' ' VAL . 63.6 t -70.91 -53.85 20.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 120.914 0.387 . . . . 0.0 110.731 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.4 HD11 ' O ' ' A' ' 67' ' ' ASP . 6.4 mp -58.8 -15.42 12.24 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.425 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.0 m -90.4 -40.56 11.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.074 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -60.27 -40.13 89.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.386 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -92.56 14.57 16.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 54.0 25.83 5.82 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.638 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.621 HG22 ' HB ' ' A' ' 80' ' ' THR . 35.6 mm -61.43 120.78 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.175 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.3 p -140.69 56.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.075 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.68 45.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.64 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 29.8 m-80 51.29 43.62 29.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.192 0.52 . . . . 0.0 110.539 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.621 ' HB ' HG22 ' A' ' 76' ' ' ILE . 94.8 m -70.21 152.79 43.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.544 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.552 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.8 mt -119.11 117.88 55.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.529 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 70.7 m -105.56 133.37 50.42 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.537 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.3 tp -109.89 104.77 13.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.905 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.0 t80 -98.4 124.21 42.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.459 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.478 HH12 HD12 ' A' ' 116' ' ' LEU . 4.9 mtm180 -106.32 83.29 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.85 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 tp -25.48 -59.4 0.07 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.024 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.475 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.75 -67.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 123.505 0.503 . . . . 0.0 112.305 -179.324 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.06 4.96 51.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.935 0.398 . . . . 0.0 111.012 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.8 m120 53.78 29.21 9.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.636 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.466 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.7 mm-40 -74.27 159.89 31.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.682 0.277 . . . . 0.0 110.882 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -146.1 95.18 2.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.867 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.595 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.0 mm? -84.35 135.73 34.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.414 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -114.07 96.01 5.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.532 HD23 HD12 ' A' ' 102' ' ' ILE . 4.1 tt -79.44 79.38 5.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.0 mt-10 -82.34 -162.89 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.653 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.556 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 5.1 m-20 -50.62 -39.39 50.17 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.091 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.43 -15.09 0.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.265 0.555 . . . . 0.0 110.112 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.423 ' N ' ' C ' ' A' ' 96' ' ' ASP . 42.9 m-20 -132.11 -13.45 3.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.566 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.556 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 27.7 mm -91.5 -39.41 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -47.52 -42.52 23.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.909 0.385 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.8 t -129.69 44.39 2.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.28 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.532 HD12 HD23 ' A' ' 94' ' ' LEU . 6.7 tp -67.1 144.37 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.584 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.547 ' HA ' HD12 ' A' ' 49' ' ' ILE . 9.5 m-20 -136.98 149.04 47.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.35 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.611 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.88 -34.63 9.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.052 0.453 . . . . 0.0 110.408 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.2 m -63.88 -48.02 78.34 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.537 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -59.73 -57.41 13.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.308 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.615 HD13 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.7 -54.99 22.21 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.039 0.447 . . . . 0.0 110.064 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.0 m -59.5 -28.67 67.25 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.775 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.496 ' HD3' HD11 ' A' ' 113' ' ' ILE . 3.8 tmt_? -72.07 -67.06 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.142 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -43.05 -43.14 4.2 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.196 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.466 HG12 HG23 ' A' ' 35' ' ' VAL . 96.5 mt -63.69 -54.64 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.81 -19.56 6.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.248 0.547 . . . . 0.0 110.301 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.496 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.41 -37.03 9.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.814 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.595 HD21 ' HG ' ' A' ' 92' ' ' LEU . 90.8 m-20 -122.84 29.86 6.66 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 83.6 p -82.95 47.36 1.21 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.14 0.495 . . . . 0.0 109.846 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.478 HD12 HH12 ' A' ' 85' ' ' ARG . 53.2 mt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.265 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.901 0.381 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.8 p -156.99 142.95 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.165 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -133.6 127.94 34.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -80.55 121.99 26.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.3 p -163.73 156.65 18.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.024 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.5 t -147.93 -4.84 0.48 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.811 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -165.62 131.82 2.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.789 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.93 -87.57 1.71 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.522 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.87 99.34 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.492 2.128 . . . . 0.0 112.371 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.82 75.51 0.2 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.475 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.71 -71.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.664 0.269 . . . . 0.0 110.636 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.43 -81.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.57 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.527 ' HG3' HG12 ' A' ' 54' ' ' VAL . 9.9 pt20 -130.52 159.68 36.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.908 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.9 pt-20 -143.85 157.35 58.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.083 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 53.6 Cg_endo -70.18 141.14 42.78 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.569 2.179 . . . . 0.0 112.415 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 m -62.33 151.88 35.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.497 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.67 88.8 4.74 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.007 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.573 HD22 ' HA ' ' A' ' 24' ' ' ALA . 44.1 mt -80.73 71.79 7.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.372 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.7 p -69.65 -6.07 28.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.236 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -138.68 147.18 42.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.005 0.431 . . . . 0.0 111.764 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.2 t -54.66 -49.38 91.66 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.561 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.33 -47.31 22.8 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.985 1.79 . . . . 0.0 112.009 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.12 -34.4 77.54 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.24 0.543 . . . . 0.0 110.281 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.573 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.31 -59.48 4.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.207 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.8 mtm -60.67 -26.07 66.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.105 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -70.91 -51.0 28.78 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.771 0.32 . . . . 0.0 110.493 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -60.64 -31.97 71.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.852 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.488 HD12 HD11 ' A' ' 36' ' ' ILE . 49.7 mt -73.96 -36.52 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.037 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.93 -20.94 59.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.815 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.19 30.98 1.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -169.72 151.48 4.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.388 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.549 ' HG3' HG11 ' A' ' 87' ' ' VAL . 31.2 tt0 -72.17 -40.76 67.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.632 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.429 HG11 HD12 ' A' ' 83' ' ' LEU . 20.5 t -129.7 130.96 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.893 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -135.64 128.67 31.54 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.492 HG21 HG12 ' A' ' 111' ' ' ILE . 41.2 t -116.5 128.03 73.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.532 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.488 HD11 HD12 ' A' ' 28' ' ' ILE . 26.2 mt -134.02 137.19 52.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.57 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.33 96.29 1.66 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.638 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.0 m-85 -82.68 89.24 6.72 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.0 m-85 -108.98 140.35 42.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -88.43 -1.91 58.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.439 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.6 t70 -156.85 124.04 5.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.621 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.517 ' HG ' HG23 ' A' ' 66' ' ' THR . 93.7 mt -93.4 47.34 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.152 0.501 . . . . 0.0 111.408 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 37.0 mt-10 -137.07 6.88 2.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.841 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.636 HG13 HG21 ' A' ' 47' ' ' VAL . 1.4 pt -90.24 156.55 46.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.177 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.427 ' O ' HD12 ' A' ' 49' ' ' ILE . 71.2 Cg_exo -51.5 -26.14 21.15 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.858 2.372 . . . . 0.0 113.255 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.01 -35.72 82.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.636 HG21 HG13 ' A' ' 44' ' ' ILE . 2.3 t -64.12 -55.14 34.06 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.66 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.0 Cg_exo -60.93 -37.74 74.72 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.987 1.791 . . . . 0.0 111.321 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.644 HG22 HD11 ' A' ' 107' ' ' LEU . 5.6 mt -65.58 -36.45 77.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.921 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.559 ' O ' ' HG3' ' A' ' 53' ' ' MET . 51.3 tp -71.98 -51.61 21.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -53.89 -24.53 16.38 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.9 t -82.66 -46.63 13.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.641 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.559 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.31 -25.44 64.16 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.403 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 50' ' ' LEU . 55.2 t -52.92 -50.01 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.036 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -76.73 -9.53 58.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.76 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -93.79 -19.28 21.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.121 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 59.5 m-85 -135.66 62.9 50.92 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.511 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.42 -40.42 71.27 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.724 2.283 . . . . 0.0 111.733 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.29 -41.51 98.39 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.539 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.4 t -65.56 147.06 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.531 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 36.0 t -84.27 96.75 9.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.997 0.427 . . . . 0.0 110.839 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.422 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.2 p90 -65.24 121.83 15.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.216 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -141.37 163.32 26.8 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.118 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -161.68 143.3 3.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.5 t -146.97 157.81 43.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.139 0.495 . . . . 0.0 111.753 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.517 HG23 ' HG ' ' A' ' 42' ' ' LEU . 76.8 p -140.67 3.53 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.63 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -74.74 142.36 44.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.593 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.3 t -64.31 -49.05 73.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.45 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -50.66 -45.3 57.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.494 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HA ' HG23 ' A' ' 21' ' ' VAL . 74.3 t -70.15 -53.21 24.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.86 0.362 . . . . 0.0 110.772 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.55 -15.04 9.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.25 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.4 m -91.72 -41.28 10.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.457 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -61.57 -36.23 80.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.579 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -94.2 9.76 36.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.947 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.0 t30 60.28 20.39 9.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.667 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.697 HG21 ' HB ' ' A' ' 80' ' ' THR . 36.7 mm -56.88 123.21 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.097 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.3 p -143.37 60.5 1.4 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.26 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.59 45.9 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.633 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 29.8 m-80 51.41 43.38 29.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.181 0.515 . . . . 0.0 110.403 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.697 ' HB ' HG21 ' A' ' 76' ' ' ILE . 95.7 m -69.55 150.63 46.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.716 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.57 HG12 ' HA2' ' A' ' 37' ' ' GLY . 57.3 mt -117.23 118.28 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.076 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.516 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.4 m -107.94 131.42 54.56 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.547 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.1 tp -107.54 103.47 12.8 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.622 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.3 t80 -97.73 119.27 36.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.872 0.368 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.485 HH12 HD13 ' A' ' 116' ' ' LEU . 4.3 mtm180 -101.44 98.41 8.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.028 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.0 tp -43.28 -52.38 5.77 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.907 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.549 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.59 -62.18 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.548 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -99.3 9.5 43.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.426 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 85' ' ' ARG . 18.5 m120 50.26 32.75 6.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.747 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.478 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.7 mm-40 -78.23 162.98 26.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.718 0.294 . . . . 0.0 111.006 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.96 98.06 2.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.66 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.547 HD22 ' HG ' ' A' ' 83' ' ' LEU . 1.7 mm? -88.14 123.85 33.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.664 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -103.21 98.12 8.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.508 HD23 HD12 ' A' ' 102' ' ' ILE . 4.7 tt -82.05 77.0 8.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.2 mt-10 -78.04 -165.53 0.67 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.468 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.5 OUTLIER -45.56 -52.43 10.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.279 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -46.01 -18.33 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.874 0.369 . . . . 0.0 111.198 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 96' ' ' ASP . 14.8 m-20 -124.78 -13.94 6.84 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.348 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.515 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 24.1 mm -90.72 -42.39 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -49.74 -33.41 16.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.9 t -129.58 37.81 3.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.492 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.515 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.0 tp -66.61 143.66 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.541 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.528 ' HA ' HD13 ' A' ' 49' ' ' ILE . 14.6 m-20 -138.59 148.5 44.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.32 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.623 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -47.13 -36.75 8.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 110.349 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 100.0 m -62.43 -47.12 85.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.423 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -61.3 -58.44 8.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.4 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.644 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.83 -55.35 17.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.946 0.403 . . . . 0.0 110.169 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.5 m -58.71 -31.23 68.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.975 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.516 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.1 tmt_? -70.57 -66.28 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.267 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -43.29 -43.01 4.7 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.331 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.492 HG12 HG21 ' A' ' 35' ' ' VAL . 96.7 mt -63.1 -55.01 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -53.84 -22.26 9.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.374 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.516 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -85.27 -38.59 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.889 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.493 ' OD1' HG23 ' A' ' 113' ' ' ILE . 30.8 m120 -118.29 27.73 8.78 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.4 p -80.82 46.18 0.87 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.026 0.441 . . . . 0.0 110.278 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.485 HD13 HH12 ' A' ' 85' ' ' ARG . 48.4 mt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.138 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.873 0.368 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.482 HG22 ' HG3' ' A' ' 3' ' ' GLU . 24.3 m -103.32 -15.82 7.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.09 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.482 ' HG3' HG22 ' A' ' 2' ' ' VAL . 40.9 mt-10 -137.53 -66.32 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.762 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm 64.14 144.31 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.242 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.2 t 61.98 176.09 0.13 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.161 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.4 t -66.24 -71.91 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -145.14 147.37 32.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.851 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.91 -83.87 0.05 OUTLIER Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.57 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.17 118.15 4.98 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.543 2.162 . . . . 0.0 112.388 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.73 162.45 10.83 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.547 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.95 -72.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.709 0.29 . . . . 0.0 110.618 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.504 ' HB3' ' NE2' ' A' ' 55' ' ' GLN . . . 59.1 106.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.75 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.548 HE21 HG11 ' A' ' 54' ' ' VAL . 11.6 pt20 -59.5 165.85 2.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.099 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.5 pt-20 -133.21 157.9 77.09 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.761 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 31.5 Cg_endo -64.67 152.0 83.54 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.642 2.228 . . . . 0.0 112.778 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.8 m -68.34 154.24 42.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.605 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -99.44 92.2 5.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.898 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.534 HD11 ' HA ' ' A' ' 24' ' ' ALA . 55.8 mt -91.41 70.98 6.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.702 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.2 p -72.6 -1.4 15.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.908 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -140.71 147.03 38.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 111.782 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.589 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.2 t -56.22 -50.21 88.79 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.567 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.1 Cg_endo -57.98 -45.29 33.17 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.924 1.75 . . . . 0.0 111.802 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.92 -34.11 77.23 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.25 0.547 . . . . 0.0 110.408 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.534 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -64.55 -58.8 5.37 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.947 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.6 mtp -60.14 -27.53 67.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.194 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 27.9 mt-10 -72.08 -51.04 23.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.707 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -59.5 -32.76 70.58 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.452 HD13 HD13 ' A' ' 36' ' ' ILE . 42.4 mt -74.79 -38.85 45.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.97 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.52 -18.91 61.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.215 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.49 27.03 3.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.311 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.4 t -171.86 155.2 3.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.491 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.51 ' HG3' HG11 ' A' ' 87' ' ' VAL . 21.3 tt0 -64.79 -73.81 0.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.471 HG12 HD11 ' A' ' 83' ' ' LEU . 21.1 t -99.23 139.1 21.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.568 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.02 127.96 19.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.498 HG23 HG12 ' A' ' 111' ' ' ILE . 49.9 t -116.68 129.23 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.59 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.452 HD13 HD13 ' A' ' 28' ' ' ILE . 20.7 mt -135.02 137.87 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.466 -177.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.527 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.11 97.17 1.63 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.593 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.469 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 42.0 m-85 -83.13 89.92 7.0 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -108.28 143.13 37.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.351 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -89.87 -6.6 55.65 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.487 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.6 t70 -151.62 119.81 6.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.584 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.5 ' HG ' HG21 ' A' ' 66' ' ' THR . 94.9 mt -88.69 45.39 1.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.218 0.532 . . . . 0.0 111.127 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 10.2 mm-40 -136.33 12.04 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.248 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.646 HG13 HG22 ' A' ' 47' ' ' VAL . 2.1 pt -97.04 157.8 34.4 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.426 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.501 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 79.9 Cg_exo -51.11 -30.8 33.26 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.723 2.282 . . . . 0.0 112.886 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.51 81.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.401 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.654 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.3 t -61.02 -58.02 22.18 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.569 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.654 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 35.8 Cg_exo -58.31 -40.25 77.23 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.784 1.656 . . . . 0.0 111.435 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.658 HG21 ' HA ' ' A' ' 104' ' ' ALA . 9.8 mt -61.7 -35.96 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.503 ' O ' HG22 ' A' ' 54' ' ' VAL . 46.3 tp -73.89 -53.58 9.85 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -54.34 -24.09 17.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.007 0.432 . . . . 0.0 109.915 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.5 t -83.22 -43.78 15.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.558 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.497 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.85 -25.66 67.66 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.548 HG11 HE21 ' A' ' 13' ' ' GLN . 53.3 t -53.1 -48.53 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.095 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.504 ' NE2' ' HB3' ' A' ' 12' ' ' ALA . 29.3 mt-30 -75.24 -11.65 60.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.58 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -93.44 -18.49 22.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.27 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.606 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 44.9 m-85 -135.99 63.08 49.61 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.643 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.94 -44.21 50.47 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.731 2.287 . . . . 0.0 111.654 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.6 -41.69 89.67 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.473 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 14.3 t -65.64 144.7 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.497 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 36.2 t -82.06 96.26 7.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.02 0.438 . . . . 0.0 111.012 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.501 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 5.6 p90 -62.6 129.3 39.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.735 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.13 161.36 28.58 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.058 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.425 HD12 HG11 ' A' ' 47' ' ' VAL . 5.2 tt -160.84 143.06 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.469 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 32.4 t -150.46 158.25 43.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 111.793 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.5 HG21 ' HG ' ' A' ' 42' ' ' LEU . 82.7 p -138.69 -2.72 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.642 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.412 ' O ' HD13 ' A' ' 71' ' ' LEU . 16.6 t70 -62.64 143.12 57.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.662 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.0 m -67.29 -52.57 39.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.23 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -49.83 -40.71 42.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.409 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.497 ' HA ' HG23 ' A' ' 21' ' ' VAL . 54.9 t -72.54 -55.08 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 67' ' ' ASP . 6.3 mp -57.98 -14.29 6.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.248 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.3 m -92.41 -40.49 10.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.214 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -61.84 -35.04 77.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.224 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -95.12 9.68 38.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.695 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t30 58.6 24.28 11.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.454 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.577 HD13 ' HB ' ' A' ' 80' ' ' THR . 37.2 mm -61.28 124.19 15.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.3 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.1 p -143.68 59.49 1.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.195 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.78 44.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.706 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.599 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 26.3 m-80 52.31 44.63 29.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.188 0.518 . . . . 0.0 110.639 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.577 ' HB ' HD13 ' A' ' 76' ' ' ILE . 95.3 m -69.55 152.14 45.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.63 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.574 HG22 HD22 ' A' ' 107' ' ' LEU . 60.5 mt -118.46 115.58 48.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.07 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.449 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 77.4 m -103.4 133.25 48.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.605 ' HG ' HD22 ' A' ' 92' ' ' LEU . 3.0 tp -108.71 101.54 10.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.853 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.2 t80 -95.31 121.86 37.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.568 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.459 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 4.6 mtm180 -106.6 82.04 1.67 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.908 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 87' ' ' VAL . 4.8 tp -25.46 -61.78 0.07 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.51 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.76 -54.84 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -103.84 3.97 34.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.92 0.391 . . . . 0.0 111.21 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 51.57 31.31 7.5 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.57 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 9.7 mm-40 -77.83 157.62 29.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.491 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.13 95.89 2.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.997 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.605 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -84.31 112.3 20.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.586 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.47 ' H ' ' ND2' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -95.8 96.05 8.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.536 HD22 HD12 ' A' ' 102' ' ' ILE . 3.8 tt -81.73 78.93 8.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.4 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.5 mt-10 -79.8 -165.01 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.504 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.6 t70 -50.66 -37.41 40.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.988 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -55.25 -14.79 1.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.204 0.526 . . . . 0.0 110.428 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -130.74 -13.94 3.64 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.546 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.548 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 23.8 mm -89.5 -29.01 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.709 0.29 . . . . 0.0 111.413 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -52.93 -52.34 58.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.811 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.2 m -117.51 37.25 3.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.488 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.548 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.8 tp -61.36 147.56 10.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.596 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.564 ' HA ' HD11 ' A' ' 49' ' ' ILE . 4.3 t70 -140.83 161.08 38.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.621 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.658 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -58.95 -35.04 72.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.091 0.472 . . . . 0.0 110.17 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 94.0 m -65.34 -46.71 79.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.407 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -59.96 -57.15 14.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.983 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.593 HD13 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.81 -54.87 24.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.117 0.484 . . . . 0.0 110.109 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.7 m -59.18 -29.3 67.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.704 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.467 ' HD3' HD12 ' A' ' 113' ' ' ILE . 3.6 tmt_? -71.97 -66.21 0.67 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.213 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -42.86 -43.85 4.24 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.154 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.498 HG12 HG23 ' A' ' 35' ' ' VAL . 82.8 mt -63.06 -55.05 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.465 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -54.76 -17.93 4.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.14 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.467 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.96 -35.26 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.923 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.593 HD21 ' HG ' ' A' ' 92' ' ' LEU . 88.0 m-20 -125.44 30.31 5.81 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 95.5 p -84.03 51.49 2.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.066 0.46 . . . . 0.0 110.25 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.442 HD13 ' NH1' ' A' ' 85' ' ' ARG . 82.0 mt . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.421 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.764 0.316 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p -81.75 -23.68 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 110.946 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.02 -46.14 78.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.959 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -137.35 118.74 14.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.842 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.0 p -143.7 136.99 27.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.9 m -127.56 -38.98 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -116.48 -64.16 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.73 -173.75 45.56 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.437 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.95 115.58 2.23 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.688 2.259 . . . . 0.0 112.467 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.36 164.41 40.25 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.681 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.02 -63.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.75 0.309 . . . . 0.0 110.509 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.21 -82.08 0.02 OUTLIER 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.712 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.451 ' HG3' HG12 ' A' ' 54' ' ' VAL . 29.8 pt20 -140.16 147.19 39.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.117 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.491 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.0 pt-20 -131.74 159.36 72.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.638 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 37.1 Cg_endo -65.81 143.09 72.33 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.574 2.182 . . . . 0.0 112.672 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.5 m -63.53 153.22 36.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.676 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -96.97 93.0 6.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.012 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.559 HD11 ' HA ' ' A' ' 24' ' ' ALA . 39.4 mt -87.34 70.84 10.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.128 0.49 . . . . 0.0 110.234 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.4 p -69.9 -3.12 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.161 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -139.01 147.43 42.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.909 0.385 . . . . 0.0 111.65 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.591 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 42.1 t -56.43 -49.95 90.5 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.485 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.64 -46.0 29.87 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.974 1.783 . . . . 0.0 111.867 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.85 81.64 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.178 0.513 . . . . 0.0 110.112 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.559 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -62.54 -60.13 3.96 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.002 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 44.7 mtm -60.36 -25.82 66.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.278 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -70.92 -51.66 24.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.704 0.288 . . . . 0.0 110.418 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -60.6 -30.79 70.04 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.471 HD12 HD12 ' A' ' 36' ' ' ILE . 53.2 mt -74.38 -37.52 45.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.023 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.93 -19.67 60.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.16 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.53 30.96 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.079 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.401 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.2 t -172.35 152.97 2.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.426 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.472 ' HG3' HG12 ' A' ' 87' ' ' VAL . 26.8 tt0 -68.88 -47.07 66.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.77 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.4 HG11 HD12 ' A' ' 83' ' ' LEU . 18.5 t -122.22 139.48 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.432 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -143.13 125.95 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.575 HG21 HG12 ' A' ' 111' ' ' ILE . 49.5 t -114.39 128.77 71.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.424 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.471 HD12 HD12 ' A' ' 28' ' ' ILE . 29.2 mt -134.88 137.57 50.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.421 -177.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.533 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.23 96.41 1.6 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.587 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.436 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.7 m-85 -82.89 91.27 7.08 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.586 ' HB3' HD21 ' A' ' 79' ' ' ASN . 11.5 m-85 -111.03 144.35 40.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.453 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.499 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 45.8 mt-30 -92.98 -2.55 55.66 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 44' ' ' ILE . 28.6 t70 -155.97 117.13 3.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.582 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.494 ' HG ' HG23 ' A' ' 66' ' ' THR . 92.2 mt -87.31 45.5 1.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.116 0.484 . . . . 0.0 111.604 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.405 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 38.6 mt-10 -134.59 10.76 3.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.037 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.656 HG13 HG21 ' A' ' 47' ' ' VAL . 7.2 pt -92.31 161.33 33.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.293 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.443 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 50.1 Cg_exo -56.81 -26.52 66.97 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.739 2.293 . . . . 0.0 112.369 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.78 88.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.482 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.656 HG21 HG13 ' A' ' 44' ' ' ILE . 2.2 t -61.23 -56.66 32.04 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.642 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.87 -38.61 78.4 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.864 1.709 . . . . 0.0 111.423 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.651 HG21 HD11 ' A' ' 107' ' ' LEU . 5.6 mt -64.12 -35.09 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.869 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.538 ' O ' ' HG3' ' A' ' 53' ' ' MET . 49.7 tp -74.03 -52.47 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -55.53 -23.2 25.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.036 0.446 . . . . 0.0 109.853 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.6 t -83.78 -44.73 14.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.445 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.538 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.6 -25.77 67.55 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -52.79 -49.5 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.036 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -74.41 -11.67 60.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.7 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -93.38 -19.04 21.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.305 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 54.8 m-85 -137.16 61.99 36.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.399 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.73 -42.16 68.46 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.684 2.256 . . . . 0.0 111.615 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.86 -39.84 88.84 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.212 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.5 t -67.71 143.37 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.524 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 47.1 t -80.14 98.37 7.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.022 0.439 . . . . 0.0 110.967 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.452 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.3 p90 -65.99 124.73 23.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.968 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -143.71 162.01 27.73 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.171 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -161.8 142.73 3.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.436 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 41.0 t -149.04 156.51 42.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.194 0.521 . . . . 0.0 111.809 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.494 HG23 ' HG ' ' A' ' 42' ' ' LEU . 68.2 p -137.15 3.05 2.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.481 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.419 ' O ' HD13 ' A' ' 71' ' ' LEU . 17.7 t70 -69.92 142.97 52.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.685 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.9 m -67.34 -50.92 58.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.351 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -51.11 -40.94 59.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.364 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.497 ' HA ' HG21 ' A' ' 21' ' ' VAL . 53.7 t -72.48 -54.68 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.358 . . . . 0.0 110.539 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.419 HD13 ' O ' ' A' ' 67' ' ' ASP . 6.6 mp -58.41 -14.64 8.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.099 0.476 . . . . 0.0 110.255 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.5 m -91.78 -40.35 11.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.239 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -62.08 -34.36 76.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.267 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -96.63 10.88 37.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.72 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 56.01 26.65 10.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.867 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.621 HG22 ' HB ' ' A' ' 80' ' ' THR . 40.1 mm -62.7 122.19 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.4 p -141.8 59.16 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 111.259 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.52 44.65 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.521 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.586 HD21 ' HB3' ' A' ' 39' ' ' PHE . 13.8 m120 51.48 44.18 29.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.141 0.496 . . . . 0.0 110.635 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.621 ' HB ' HG22 ' A' ' 76' ' ' ILE . 93.0 m -69.72 151.67 45.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.836 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.533 HG12 ' HA2' ' A' ' 37' ' ' GLY . 55.8 mt -117.6 116.74 52.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.813 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 74.8 m -104.28 132.79 50.14 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.608 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -109.63 101.98 10.85 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.866 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -96.38 122.78 39.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.538 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.472 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.0 mtm180 -106.31 86.37 2.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.857 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.1 tp -27.05 -60.54 0.09 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.472 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.91 -73.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 123.434 0.459 . . . . 0.0 112.149 -179.273 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -83.51 2.89 34.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.014 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.9 m120 53.75 30.07 10.6 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.42 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 8.0 mm-40 -74.46 159.25 32.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.805 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -144.16 93.31 2.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.823 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.608 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -80.91 141.83 34.16 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -122.85 92.81 3.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.516 HD23 HD11 ' A' ' 102' ' ' ILE . 4.0 tt -76.99 77.43 3.54 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.419 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.2 mt-10 -79.08 -164.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.48 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 23.7 t70 -51.66 -36.38 46.08 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.915 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.68 -14.65 3.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.282 0.563 . . . . 0.0 110.244 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -130.65 -13.83 3.7 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.694 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.493 HD12 HG13 ' A' ' 81' ' ' ILE . 23.1 mm -89.94 -30.0 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.727 0.298 . . . . 0.0 111.294 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -52.12 -48.52 64.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.746 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.9 t -123.78 42.08 3.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.414 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.516 HD11 HD23 ' A' ' 94' ' ' LEU . 7.9 tp -63.46 143.14 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.545 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.543 ' HA ' HD13 ' A' ' 49' ' ' ILE . 15.0 m-20 -136.03 150.56 49.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.487 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.601 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.07 -33.85 12.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.034 0.445 . . . . 0.0 110.26 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.3 m -65.35 -47.31 76.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.438 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HB2' HD12 ' A' ' 102' ' ' ILE . 57.3 mtpt -60.05 -56.34 22.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.149 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.651 HD11 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -52.36 -57.14 10.72 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.959 0.409 . . . . 0.0 109.905 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 61.4 m -56.87 -28.91 62.42 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.869 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HD3' HD11 ' A' ' 113' ' ' ILE . 3.7 tmt_? -71.04 -66.88 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.954 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -42.3 -41.17 2.7 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.156 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.575 HG12 HG21 ' A' ' 35' ' ' VAL . 76.8 mt -64.91 -55.77 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -54.24 -18.01 3.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.253 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.475 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.5 mp -92.56 -34.58 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.12 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.606 HD21 ' HG ' ' A' ' 92' ' ' LEU . 85.5 m-20 -128.31 32.69 4.83 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 93.8 p -85.17 41.84 0.9 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.164 0.507 . . . . 0.0 109.918 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 85' ' ' ARG . 49.9 mt . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.527 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.7 m -118.17 20.83 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.167 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 58.55 34.2 23.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.153 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt 60.51 -85.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.284 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.9 p 47.48 80.05 0.06 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.27 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.1 m -99.37 31.12 3.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.964 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.44 -47.46 17.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.39 -104.57 0.26 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.603 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.11 -67.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.489 2.126 . . . . 0.0 112.315 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.13 81.01 0.13 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.504 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.42 -67.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.345 . . . . 0.0 110.647 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.519 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . . . 59.42 94.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.454 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.507 ' HG3' ' CG1' ' A' ' 54' ' ' VAL . 1.3 pt20 -170.48 166.74 8.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.627 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 -114.63 158.5 40.11 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.249 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.521 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.7 Cg_endo -68.23 155.38 69.58 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.768 2.312 . . . . 0.0 112.741 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.7 m -70.71 151.61 44.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.416 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -96.79 86.36 4.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.755 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.56 HD11 ' HA ' ' A' ' 24' ' ' ALA . 48.0 mt -83.34 71.52 10.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.619 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 76.8 p -69.21 -6.2 27.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.288 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -140.05 146.97 39.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.993 0.425 . . . . 0.0 111.791 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.604 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.5 t -54.34 -49.74 88.82 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.632 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.8 Cg_endo -56.58 -46.46 29.81 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.984 1.789 . . . . 0.0 112.082 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.23 -34.47 78.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.173 0.511 . . . . 0.0 110.288 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.56 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -63.88 -58.88 5.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.081 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 61.3 mtp -61.39 -27.16 68.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.189 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.5 mt-10 -70.64 -49.89 42.7 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.772 0.32 . . . . 0.0 110.386 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -60.5 -33.14 72.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.846 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.424 HD13 HD13 ' A' ' 36' ' ' ILE . 46.0 mt -73.86 -37.66 48.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.127 178.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.66 -20.75 60.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.128 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.1 29.77 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.059 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.9 t -171.25 150.86 3.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.333 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.497 ' HG3' HG12 ' A' ' 87' ' ' VAL . 25.1 tt0 -64.58 -63.32 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.91 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.438 HG12 HD11 ' A' ' 83' ' ' LEU . 21.4 t -108.04 141.9 22.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.592 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.494 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -144.08 126.52 15.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.021 0.439 . . . . 0.0 112.109 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.531 HG22 HG12 ' A' ' 111' ' ' ILE . 47.8 t -115.47 127.53 73.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.622 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 26.7 mt -133.71 136.4 54.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.728 -177.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.466 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.71 97.69 1.82 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.347 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.441 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 38.8 m-85 -83.49 89.67 7.11 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -108.35 141.3 40.36 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -89.62 -2.69 58.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.498 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.9 t70 -155.37 117.51 4.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.581 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.515 ' HG ' HG23 ' A' ' 66' ' ' THR . 93.3 mt -86.99 43.67 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.054 0.454 . . . . 0.0 111.343 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.412 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.1 mt-10 -134.61 13.14 3.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.121 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.657 HG13 HG21 ' A' ' 47' ' ' VAL . 2.0 pt -96.92 157.62 34.78 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.266 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.474 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 76.4 Cg_exo -51.6 -28.67 29.82 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.834 2.356 . . . . 0.0 112.888 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.95 -37.58 85.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.657 HG21 HG13 ' A' ' 44' ' ' ILE . 2.7 t -61.33 -56.77 30.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.606 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 39.5 Cg_exo -57.52 -42.4 61.37 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 121.742 1.628 . . . . 0.0 111.125 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 104' ' ' ALA . 11.8 mt -60.0 -37.71 73.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.215 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.518 ' O ' ' HG3' ' A' ' 53' ' ' MET . 47.2 tp -73.32 -51.71 16.53 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -54.8 -24.37 22.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.087 0.47 . . . . 0.0 109.858 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.3 m -83.84 -44.59 14.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.585 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.518 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -60.68 -25.91 66.72 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.372 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.507 ' CG1' ' HG3' ' A' ' 13' ' ' GLN . 45.2 t -51.99 -47.0 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.898 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.519 ' NE2' ' HA ' ' A' ' 12' ' ' ALA . 30.7 mt-30 -78.89 -13.47 59.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.712 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -90.89 -17.09 27.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.308 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.593 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 44.0 m-85 -137.95 62.93 35.89 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.558 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.18 -44.4 49.21 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.703 2.269 . . . . 0.0 111.754 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.86 -37.16 76.46 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.515 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 17.2 t -70.18 143.6 14.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 45.6 t -81.37 97.94 7.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 110.886 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.521 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 4.9 p90 -64.18 129.2 39.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.828 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -147.51 161.06 28.46 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.128 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -161.26 145.69 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.1 t -154.06 159.53 41.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.069 0.461 . . . . 0.0 111.727 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.515 HG23 ' HG ' ' A' ' 42' ' ' LEU . 58.3 p -138.84 -7.66 1.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.693 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.06 141.45 55.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.706 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.434 ' HG ' ' H ' ' A' ' 69' ' ' GLU . 79.0 p -64.39 -50.11 68.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.38 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.434 ' H ' ' HG ' ' A' ' 68' ' ' SER . 30.6 mt-10 -49.81 -44.46 49.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.543 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.516 ' HA ' HG21 ' A' ' 21' ' ' VAL . 70.6 t -70.05 -54.61 18.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.956 0.408 . . . . 0.0 110.674 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 mp -58.38 -14.42 7.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.437 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.1 m -91.3 -42.01 10.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.339 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -60.26 -37.38 80.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.367 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -93.72 12.49 25.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.979 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 55.64 26.77 9.63 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.674 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.638 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.0 mm -64.16 123.5 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.174 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.7 p -142.16 58.35 1.47 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.286 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.414 ' HA3' ' OD1' ' A' ' 96' ' ' ASP . . . 152.7 44.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.947 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 27.4 m-80 52.61 42.53 31.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.244 0.545 . . . . 0.0 110.492 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.638 ' HB ' HG23 ' A' ' 76' ' ' ILE . 90.1 m -68.83 151.34 46.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.43 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.556 HG13 HD12 ' A' ' 99' ' ' ILE . 62.2 mt -117.13 116.76 53.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.199 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.441 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 74.2 m -105.45 133.83 49.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.558 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.2 tp -109.59 103.39 12.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.971 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.4 t80 -96.47 124.44 40.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.693 0.283 . . . . 0.0 110.749 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.444 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 3.5 mtm180 -107.95 85.52 2.13 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.11 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 tp -27.13 -60.57 0.09 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.497 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -35.84 -68.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 123.574 0.546 . . . . 0.0 112.289 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -89.77 3.65 52.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.165 0.507 . . . . 0.0 110.715 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.4 t30 51.85 37.37 20.48 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.986 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 11.0 mm-40 -81.84 159.06 23.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.563 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -140.9 90.83 2.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.667 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.558 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.8 mm? -77.75 141.87 39.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.61 116.84 26.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.253 0.549 . . . . 0.0 112.023 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.552 HD22 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -104.32 77.94 1.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -80.61 -164.27 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.827 -177.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.595 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 7.2 m-20 -49.74 -41.1 43.05 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.294 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -52.17 -15.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.256 0.55 . . . . 0.0 110.143 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.417 ' N ' ' C ' ' A' ' 96' ' ' ASP . 36.2 m-20 -130.86 -13.38 3.64 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.321 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.595 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 26.8 mm -90.96 -42.13 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.488 ' HG3' ' HB3' ' A' ' 96' ' ' ASP . 43.4 mt-10 -48.49 -37.96 18.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.936 0.398 . . . . 0.0 111.055 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.5 p -130.43 45.16 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.375 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.552 HD13 HD22 ' A' ' 94' ' ' LEU . 8.6 tp -71.95 145.17 12.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.785 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.482 ' HA ' HD12 ' A' ' 49' ' ' ILE . 9.2 m-20 -138.61 149.4 45.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.649 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.627 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -48.0 -36.47 12.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.018 0.437 . . . . 0.0 110.609 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.4 m -61.53 -48.61 80.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.202 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.402 ' HD3' ' H ' ' A' ' 103' ' ' ASP . 28.9 mtpp -59.05 -60.68 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.149 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.624 HD13 HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.41 -55.93 9.53 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.953 0.406 . . . . 0.0 110.315 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.8 m -58.08 -30.38 66.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.787 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.477 ' HD3' HD12 ' A' ' 113' ' ' ILE . 4.2 tmt_? -71.03 -65.91 0.68 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.209 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -43.17 -44.06 4.93 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.921 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.531 HG12 HG22 ' A' ' 35' ' ' VAL . 96.4 mt -62.61 -56.41 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.445 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.86 -18.39 3.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.316 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.477 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.95 -37.25 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.925 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -123.64 29.01 6.72 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 98.2 p -83.04 51.6 1.98 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.217 0.532 . . . . 0.0 109.915 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.44 HD13 HH12 ' A' ' 85' ' ' ARG . 68.1 mt . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.397 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.431 ' HG3' HG11 ' A' ' 2' ' ' VAL . 11.2 pt-20 . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.721 0.296 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.431 HG11 ' HG3' ' A' ' 1' ' ' GLU . 14.8 m -110.65 11.66 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.371 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -89.04 -59.67 2.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.503 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -128.25 21.8 6.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.612 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.2 m 59.4 33.84 22.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.852 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.4 m -84.94 138.42 32.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -138.96 -27.99 0.81 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.961 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.46 -170.86 45.95 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.716 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -52.0 106.32 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.675 2.25 . . . . 0.0 112.491 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.76 -171.29 35.94 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.64 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 55' ' ' GLN . . . -170.85 -61.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 110.516 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.84 93.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.519 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.455 ' HG3' ' CG1' ' A' ' 54' ' ' VAL . 3.7 pt20 -171.44 165.52 6.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.554 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 -116.03 157.71 44.32 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-O 120.779 0.323 . . . . 0.0 111.339 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 31.8 Cg_endo -66.0 152.79 80.44 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.967 2.444 . . . . 0.0 112.794 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.442 HG22 ' N ' ' A' ' 17' ' ' TRP . 18.8 m -69.36 157.16 37.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.825 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.442 ' N ' HG22 ' A' ' 16' ' ' THR . 8.4 m-90 -99.52 92.91 5.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.962 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.567 HD23 ' HA ' ' A' ' 24' ' ' ALA . 48.0 mt -91.62 72.69 5.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.359 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 p -71.24 -5.38 31.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.334 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -137.46 147.4 45.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.935 0.398 . . . . 0.0 111.72 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 48.9 t -56.05 -50.05 89.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.568 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.8 Cg_endo -57.91 -45.4 32.74 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.896 1.731 . . . . 0.0 112.027 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.52 -36.08 82.59 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.259 0.552 . . . . 0.0 110.439 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.567 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -63.82 -59.32 4.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.952 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.4 mtm -60.05 -25.45 65.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.076 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -72.12 -51.46 21.34 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.39 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -59.75 -30.45 68.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.477 HD11 HD13 ' A' ' 36' ' ' ILE . 49.3 mt -75.78 -40.43 39.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.242 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.51 -21.47 61.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.243 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.76 27.32 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.292 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.476 HG21 ' HB2' ' A' ' 61' ' ' SER . 7.7 t -170.86 155.66 4.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.578 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.438 ' HG3' HG11 ' A' ' 87' ' ' VAL . 25.5 tt0 -68.08 -62.31 1.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.462 HG13 HD12 ' A' ' 83' ' ' LEU . 16.6 t -108.56 137.78 38.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.715 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.13 127.49 18.8 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.497 HG22 HG12 ' A' ' 111' ' ' ILE . 47.6 t -116.39 130.06 71.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.7 178.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.477 HD13 HD11 ' A' ' 28' ' ' ILE . 25.7 mt -136.11 136.91 49.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.56 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.76 99.51 2.08 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.476 -0.783 . . . . 0.0 112.586 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.525 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.6 m-85 -86.07 92.72 8.8 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -112.29 142.01 45.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.435 ' HG2' HD23 ' A' ' 71' ' ' LEU . 46.6 mt-30 -90.61 -0.78 57.8 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.455 ' O ' HG12 ' A' ' 44' ' ' ILE . 30.1 t70 -156.51 121.17 4.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.453 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.475 ' HG ' HG22 ' A' ' 66' ' ' THR . 96.8 mt -92.13 46.49 1.27 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.057 0.456 . . . . 0.0 111.554 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 39.9 mt-10 -136.24 7.21 3.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.952 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.653 HG13 HG23 ' A' ' 47' ' ' VAL . 2.0 pt -89.27 157.07 48.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.164 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.45 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 72.7 Cg_exo -51.72 -27.02 25.05 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.828 2.352 . . . . 0.0 113.034 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.38 87.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.653 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -62.0 -55.96 36.16 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 121.044 -0.263 . . . . 0.0 111.707 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -60.12 -37.93 80.49 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.103 1.868 . . . . 0.0 111.486 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.623 HG21 ' HA ' ' A' ' 104' ' ' ALA . 6.7 mt -65.31 -35.82 76.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.18 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.531 ' O ' ' HG3' ' A' ' 53' ' ' MET . 48.4 tp -73.42 -50.45 21.69 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -54.52 -24.68 21.73 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -82.4 -46.68 13.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.798 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.531 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.15 -26.0 64.37 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 50' ' ' LEU . 48.6 t -52.72 -49.11 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.213 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 11' ' ' ALA . 7.4 mt-30 -77.89 -9.01 58.85 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.571 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -94.7 -18.92 20.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.235 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.589 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 54.3 m-85 -137.57 63.19 39.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.36 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.13 -41.32 72.91 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.713 2.275 . . . . 0.0 111.575 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.43 -42.72 95.91 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.283 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.3 t -64.87 142.94 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.493 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 25.2 t -80.37 96.44 6.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.13 0.49 . . . . 0.0 110.943 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.458 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.1 p90 -65.97 125.87 26.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.912 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.55 163.03 28.26 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.983 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -160.02 141.9 4.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.7 t -145.36 158.87 43.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.117 0.484 . . . . 0.0 111.594 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.475 HG22 ' HG ' ' A' ' 42' ' ' LEU . 69.0 p -141.37 -6.2 1.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.823 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.71 142.21 58.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.686 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.0 t -63.35 -48.45 77.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.665 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -49.7 -47.18 50.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.544 ' HA ' HG21 ' A' ' 21' ' ' VAL . 78.5 t -69.6 -52.66 30.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.779 0.323 . . . . 0.0 110.85 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.435 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.38 -14.71 8.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.084 0.469 . . . . 0.0 110.304 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.5 m -91.0 -42.48 10.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.396 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -60.21 -38.53 83.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.469 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -91.64 9.7 31.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 58.82 21.88 9.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.397 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.595 HG21 ' HB ' ' A' ' 80' ' ' THR . 36.0 mm -57.78 117.91 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.047 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.2 p -137.34 48.68 2.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.467 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 162.69 48.1 0.02 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.426 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 24.2 m-80 49.22 42.38 21.52 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.321 0.582 . . . . 0.0 110.313 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.595 ' HB ' HG21 ' A' ' 76' ' ' ILE . 92.8 m -68.15 152.41 45.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.687 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.56 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.3 mt -119.36 118.82 58.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.979 178.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.525 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 79.7 m -106.97 133.11 52.12 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.586 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.4 tp -109.46 103.44 12.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.8 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.5 t80 -97.51 123.44 41.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.763 0.316 . . . . 0.0 110.713 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.454 ' NH1' HD11 ' A' ' 116' ' ' LEU . 4.1 mtm180 -106.62 84.2 1.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.741 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 85' ' ' ARG . 5.9 tp -24.96 -60.33 0.06 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.95 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.438 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.16 -73.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 O-C-N 123.488 0.493 . . . . 0.0 112.255 -179.277 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -84.13 0.85 46.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.988 0.423 . . . . 0.0 111.053 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.9 m120 54.0 36.68 25.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.566 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 13.2 mm-40 -82.78 158.14 22.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.736 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.4 96.49 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.632 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.616 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.2 mm? -85.15 114.17 22.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.817 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.72 100.41 11.79 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.503 HD23 HD12 ' A' ' 102' ' ' ILE . 4.6 tt -85.24 76.96 10.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.459 ' HA ' ' HG1' ' A' ' 80' ' ' THR . 27.2 mt-10 -77.49 -165.66 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.451 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.91 -51.63 12.88 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.383 -179.363 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -47.49 -17.35 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 96' ' ' ASP . 14.8 m-20 -124.79 -14.16 6.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.506 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.504 HG23 ' HB2' ' A' ' 79' ' ' ASN . 22.8 mm -90.11 -38.37 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -49.05 -46.15 43.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 110.942 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -118.96 39.29 3.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.617 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.503 HD12 HD23 ' A' ' 94' ' ' LEU . 7.8 tp -65.95 143.84 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 111.201 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.539 ' HA ' HD13 ' A' ' 49' ' ' ILE . 15.0 m-20 -139.38 148.4 42.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.557 178.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.623 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -46.99 -37.8 9.71 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 110.372 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.6 m -61.62 -48.79 79.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.262 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -58.41 -60.75 3.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.279 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.603 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.41 -56.74 7.38 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.873 0.368 . . . . 0.0 110.208 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.2 m -57.75 -30.08 65.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.865 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.479 ' HD3' HD12 ' A' ' 113' ' ' ILE . 3.9 tmt_? -71.17 -65.68 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.196 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -43.05 -42.57 3.95 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.014 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.497 HG12 HG22 ' A' ' 35' ' ' VAL . 97.3 mt -63.5 -55.74 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -54.38 -18.55 4.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.32 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.479 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.63 -35.04 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.953 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.616 HD21 ' HG ' ' A' ' 92' ' ' LEU . 88.2 m-20 -126.4 30.98 5.47 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 91.6 p -83.89 42.34 0.85 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.017 0.437 . . . . 0.0 110.267 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.454 HD11 ' NH1' ' A' ' 85' ' ' ARG . 77.5 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.365 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.762 0.315 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.561 HG21 ' HG3' ' A' ' 3' ' ' GLU . 12.6 p -99.46 148.66 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.058 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.561 ' HG3' HG21 ' A' ' 2' ' ' VAL . 46.2 mt-10 56.48 78.6 0.2 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.106 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -103.37 -32.36 9.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.709 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.3 p -113.3 23.16 13.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.7 t -142.25 40.57 1.62 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -147.24 146.12 29.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -132.25 -173.99 13.49 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.408 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.14 -56.32 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.517 2.145 . . . . 0.0 112.283 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.8 82.5 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.334 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.35 -68.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 110.576 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.61 -80.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.45 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.446 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.4 pt20 -141.78 163.25 33.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.464 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.2 pt-20 -141.93 158.24 62.56 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.803 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 23.7 Cg_endo -63.71 147.76 92.45 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.552 2.168 . . . . 0.0 112.764 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.406 HG21 ' N ' ' A' ' 17' ' ' TRP . 19.9 m -61.4 155.12 22.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.581 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.406 ' N ' HG21 ' A' ' 16' ' ' THR . 9.1 m-90 -98.48 91.71 5.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.877 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.545 HD23 ' HA ' ' A' ' 24' ' ' ALA . 43.3 mt -92.49 76.49 5.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.005 0.431 . . . . 0.0 110.471 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.8 p -74.71 -6.32 48.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.123 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -139.83 148.46 42.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.005 0.431 . . . . 0.0 111.743 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 19.6 t -54.43 -49.44 90.77 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.832 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.11 -47.31 23.36 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.087 1.858 . . . . 0.0 112.135 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.84 -35.64 80.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.217 0.532 . . . . 0.0 110.211 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.545 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -63.84 -59.6 4.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.105 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 59.0 mtm -60.8 -24.39 65.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.041 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -72.47 -52.22 16.78 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.704 0.288 . . . . 0.0 110.527 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -59.69 -30.35 68.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.464 HD11 HD13 ' A' ' 36' ' ' ILE . 50.0 mt -75.1 -39.01 43.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.18 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.96 -18.89 60.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.161 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.28 28.46 2.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.209 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.407 HG22 ' CB ' ' A' ' 61' ' ' SER . 8.8 t -170.08 152.24 4.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.351 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.483 ' HG3' HG11 ' A' ' 87' ' ' VAL . 23.8 tt0 -68.32 -48.19 65.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 83' ' ' LEU . 15.7 t -121.83 134.96 63.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.523 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.94 127.95 22.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 111.948 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.505 HG21 HG12 ' A' ' 111' ' ' ILE . 51.9 t -116.56 127.68 74.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.725 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 23.5 mt -133.24 137.13 53.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.69 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.555 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.53 99.75 2.05 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.405 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.514 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.6 m-85 -85.38 94.23 8.92 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.8 m-85 -113.89 141.63 47.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -89.35 -3.61 58.4 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.45 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.0 t70 -154.12 121.52 5.78 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.614 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.487 ' HA ' HG23 ' A' ' 47' ' ' VAL . 94.1 mt -90.9 47.28 1.4 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.081 0.467 . . . . 0.0 111.184 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 37.3 mt-10 -138.45 8.42 2.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.113 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.67 HG13 HG21 ' A' ' 47' ' ' VAL . 1.6 pt -91.68 156.45 42.88 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.256 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.445 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 81.4 Cg_exo -50.74 -27.16 19.22 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.781 2.321 . . . . 0.0 113.112 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -64.28 -36.99 85.9 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.67 HG21 HG13 ' A' ' 44' ' ' ILE . 2.6 t -62.47 -55.4 39.82 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.703 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.2 Cg_exo -60.46 -38.63 72.39 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.985 1.79 . . . . 0.0 111.376 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.643 HG21 HD13 ' A' ' 107' ' ' LEU . 6.3 mt -64.93 -35.47 75.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.09 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.529 ' O ' ' HG3' ' A' ' 53' ' ' MET . 43.4 tp -73.17 -51.74 16.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -53.58 -26.7 22.73 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.154 0.502 . . . . 0.0 109.656 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.9 t -80.85 -47.1 14.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.709 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.05 -26.08 64.3 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.186 0.517 . . . . 0.0 109.608 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 50' ' ' LEU . 55.1 t -53.4 -48.26 57.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.034 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -77.88 -8.52 58.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.671 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -95.25 -18.65 20.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.171 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 57.8 m-85 -136.66 63.22 45.85 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.484 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.37 -43.18 55.98 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.699 2.266 . . . . 0.0 111.465 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.0 -40.77 91.79 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.377 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.4 t -66.6 144.5 14.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 33.0 t -83.08 96.28 8.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 110.865 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 7.4 p90 -63.07 130.8 46.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.937 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -149.71 161.33 28.8 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.023 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.4 tt -160.53 143.23 4.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.756 0.313 . . . . 0.0 110.207 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -146.41 160.15 42.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.215 0.531 . . . . 0.0 111.716 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.482 HG22 ' HG ' ' A' ' 42' ' ' LEU . 74.6 p -142.0 -1.95 1.2 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.562 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.03 144.78 52.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -64.9 -50.75 65.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.499 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -48.74 -46.94 41.69 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.588 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.427 ' HA ' HG21 ' A' ' 21' ' ' VAL . 75.1 t -68.84 -53.3 27.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.805 0.336 . . . . 0.0 110.88 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -58.61 -14.5 8.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.289 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.9 m -91.53 -40.56 11.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.19 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -60.91 -39.65 90.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.466 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -92.24 11.62 25.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.809 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 55.34 28.57 11.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.221 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.627 HG23 ' HB ' ' A' ' 80' ' ' THR . 36.1 mm -62.44 119.2 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.076 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.5 p -140.13 58.27 1.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.17 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.31 44.56 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.433 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.523 ' HB2' HG21 ' A' ' 99' ' ' ILE . 26.1 m-80 51.65 43.36 29.91 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.183 0.516 . . . . 0.0 110.304 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.627 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.9 m -68.67 154.03 42.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.657 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.555 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.5 mt -120.94 118.81 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.034 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 81.6 m -107.6 134.62 50.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.616 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -110.69 104.68 13.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.989 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.2 t80 -98.81 122.6 42.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.788 0.328 . . . . 0.0 110.582 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.486 HH12 HD12 ' A' ' 116' ' ' LEU . 3.6 mtm180 -106.05 87.76 2.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.727 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.7 tp -26.93 -59.85 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.439 -0.8 . . . . 0.0 113.059 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.483 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -35.4 -80.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 O-C-N 123.542 0.526 . . . . 0.0 112.331 -179.43 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.406 ' HB2' HH21 ' A' ' 85' ' ' ARG . 2.7 m-20 -78.67 1.6 22.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.787 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 m120 55.91 33.25 21.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.421 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 19.7 mm-40 -77.11 159.69 29.6 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.833 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -144.17 91.61 2.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.757 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.616 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -77.63 143.52 38.17 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -124.92 96.93 5.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.5 HD23 HD12 ' A' ' 102' ' ' ILE . 4.6 tt -83.44 79.17 9.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.401 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.9 mt-10 -80.61 -164.53 0.73 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.446 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.99 -49.69 15.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.604 -179.32 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -48.23 -16.6 0.1 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.773 0.321 . . . . 0.0 111.158 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -127.19 -13.94 5.52 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.556 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.523 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.2 mm -89.81 -33.15 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.729 0.299 . . . . 0.0 111.611 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -55.45 -42.03 73.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.968 0.413 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.4 m -122.53 35.16 4.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.697 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.5 HD12 HD23 ' A' ' 94' ' ' LEU . 7.0 tp -62.97 142.18 17.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.118 0.485 . . . . 0.0 111.496 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.509 ' HA ' HD13 ' A' ' 49' ' ' ILE . 21.4 m-20 -137.45 148.3 46.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.437 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.625 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.02 -36.83 8.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.95 0.405 . . . . 0.0 110.513 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -62.68 -47.14 84.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.286 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.68 -61.47 2.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.11 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.643 HD13 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.82 -55.31 10.0 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.049 0.452 . . . . 0.0 110.201 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 63.5 m -58.88 -30.47 67.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.794 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.463 ' HD3' HD11 ' A' ' 113' ' ' ILE . 4.2 tmt_? -71.3 -66.35 0.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.045 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -42.01 -43.33 3.14 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.141 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.505 HG12 HG21 ' A' ' 35' ' ' VAL . 93.3 mt -63.57 -56.14 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.435 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 41.2 tt0 -53.01 -19.2 2.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.31 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.463 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.24 -38.88 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.902 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.588 HD21 ' HG ' ' A' ' 92' ' ' LEU . 88.7 m-20 -121.24 29.21 7.4 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 82.8 p -82.25 44.95 0.9 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.043 0.449 . . . . 0.0 110.039 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.486 HD12 HH12 ' A' ' 85' ' ' ARG . 55.3 mt . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.245 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.936 0.398 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.5 p -90.13 -36.58 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.265 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 52.15 82.84 0.06 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.905 0.383 . . . . 0.0 110.839 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -79.59 -19.54 49.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.235 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.6 p -148.42 97.27 2.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.125 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.5 m -75.45 122.33 23.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.615 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -91.33 -7.6 50.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.044 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.43 98.98 2.58 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.492 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.87 142.86 90.17 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.471 2.114 . . . . 0.0 112.142 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.36 64.03 0.24 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.637 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.05 -65.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.722 0.296 . . . . 0.0 110.711 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.2 -82.61 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.48 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.507 ' HG3' HG13 ' A' ' 54' ' ' VAL . 4.2 pt20 -148.99 146.99 28.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.832 0.349 . . . . 0.0 111.101 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 -133.06 158.34 76.07 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.542 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 33.8 Cg_endo -65.5 139.96 61.1 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.532 2.155 . . . . 0.0 112.588 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 17' ' ' TRP . 20.4 m -55.26 155.09 5.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.872 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.407 ' N ' HG22 ' A' ' 16' ' ' THR . 76.1 m95 -100.29 90.58 4.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.866 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.552 HD11 ' HA ' ' A' ' 24' ' ' ALA . 48.5 mt -88.83 73.72 8.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.59 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.5 p -73.56 -0.35 14.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.239 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -143.8 147.73 34.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.98 0.419 . . . . 0.0 111.591 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 31.0 t -55.6 -50.18 88.4 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.573 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.6 Cg_endo -57.83 -44.75 37.87 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.054 1.836 . . . . 0.0 111.886 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.23 -35.63 81.45 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.15 0.5 . . . . 0.0 110.351 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.552 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -63.93 -59.09 4.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.98 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.3 mtm -60.4 -26.73 66.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.173 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 20.2 mt-10 -71.65 -50.31 31.81 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.687 0.279 . . . . 0.0 110.658 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -60.33 -34.27 73.58 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.493 HD13 HD13 ' A' ' 36' ' ' ILE . 47.7 mt -72.97 -38.57 56.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.032 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.97 -17.3 61.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.971 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.84 25.64 5.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.174 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -170.3 152.63 4.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.622 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.506 ' HG3' HG11 ' A' ' 87' ' ' VAL . 15.6 tt0 -61.88 -80.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.595 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.461 HG12 HD12 ' A' ' 83' ' ' LEU . 20.1 t -94.39 136.68 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.619 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.521 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.65 126.25 20.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.053 0.454 . . . . 0.0 111.883 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.538 HG21 HG12 ' A' ' 111' ' ' ILE . 47.1 t -115.07 128.02 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.752 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.493 HD13 HD13 ' A' ' 28' ' ' ILE . 23.1 mt -134.65 137.53 51.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.428 -177.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.499 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.66 98.48 1.85 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.347 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.451 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 37.7 m-85 -83.4 90.82 7.23 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 13.4 m-85 -109.16 141.77 40.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.537 -178.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.48 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 28.4 mt-30 -88.77 -7.58 55.97 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.462 ' O ' HG12 ' A' ' 44' ' ' ILE . 27.7 t70 -151.22 121.79 7.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.641 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.525 ' HG ' HG22 ' A' ' 66' ' ' THR . 95.0 mt -90.49 46.04 1.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.108 0.48 . . . . 0.0 111.393 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 40.0 mt-10 -136.7 11.07 3.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.041 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.661 HG13 HG21 ' A' ' 47' ' ' VAL . 1.7 pt -95.7 155.52 38.42 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.311 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 84.7 Cg_exo -49.75 -28.59 17.91 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.833 2.355 . . . . 0.0 113.089 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.407 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -62.54 -37.24 85.33 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.661 HG21 HG13 ' A' ' 44' ' ' ILE . 2.5 t -62.58 -56.31 31.0 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.615 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.654 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.9 Cg_exo -59.4 -39.87 72.67 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.89 1.727 . . . . 0.0 111.187 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.607 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.5 mt -63.2 -36.07 74.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.064 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.518 ' O ' ' HG3' ' A' ' 53' ' ' MET . 52.0 tp -71.97 -51.42 22.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -54.94 -25.72 31.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 p -80.99 -45.2 16.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.599 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.518 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.95 -25.9 67.87 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.518 HG21 ' O ' ' A' ' 50' ' ' LEU . 55.4 t -53.2 -49.88 49.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.913 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -75.63 -9.18 58.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.716 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -95.26 -18.99 20.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.286 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.546 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 62.4 m-85 -136.1 62.3 44.81 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.566 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.0 -45.82 36.35 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.893 2.395 . . . . 0.0 111.742 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.5 -40.3 69.08 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.403 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.7 t -67.3 143.61 15.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.521 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 39.8 t -81.8 96.55 7.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.948 0.404 . . . . 0.0 110.965 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.434 ' CD2' HG12 ' A' ' 54' ' ' VAL . 6.6 p90 -63.82 129.67 41.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.983 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -149.14 162.3 28.94 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.143 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.7 tt -160.26 145.39 5.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.451 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 30.9 t -151.02 155.55 39.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.229 0.538 . . . . 0.0 111.787 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.525 HG22 ' HG ' ' A' ' 42' ' ' LEU . 66.8 p -135.95 -3.56 2.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.398 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.73 139.74 58.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.505 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.0 m -64.61 -51.95 60.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.258 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -49.53 -41.53 41.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.543 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.513 ' HA ' HG23 ' A' ' 21' ' ' VAL . 59.8 t -71.77 -55.32 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.731 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.27 -14.63 7.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.365 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 79.5 m -91.98 -40.9 10.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.312 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -61.63 -36.46 80.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.326 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -93.87 12.07 27.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.793 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 57.47 22.96 8.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.716 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.62 HG21 ' HB ' ' A' ' 80' ' ' THR . 40.8 mm -60.64 122.3 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.104 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.2 p -141.99 58.58 1.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.205 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.77 44.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.741 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 13.4 m120 52.8 43.16 31.8 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.115 0.483 . . . . 0.0 110.739 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.62 ' HB ' HG21 ' A' ' 76' ' ' ILE . 94.8 m -68.77 151.03 47.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.65 -178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.57 HG22 HD21 ' A' ' 107' ' ' LEU . 67.2 mt -117.32 116.12 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.986 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 76.9 m -104.11 133.65 48.69 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.597 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -109.43 102.55 11.42 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.941 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.4 t80 -97.5 121.76 39.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.771 0.32 . . . . 0.0 110.762 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.498 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 3.0 mtm180 -105.76 91.75 3.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.123 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 tp -38.55 -50.69 1.59 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.611 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.506 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.36 -63.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.796 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.52 8.54 43.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.04 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 m120 51.86 31.97 9.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.615 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.498 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 20.3 mm-40 -78.82 160.82 27.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.809 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.409 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.9 OUTLIER -146.92 91.49 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.911 179.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.597 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -78.42 144.65 35.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.03 99.33 6.07 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.528 HD22 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -85.29 78.31 9.81 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.4 mt-10 -78.46 -165.6 0.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.538 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.7 t70 -51.7 -35.4 42.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.004 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -56.87 -14.92 3.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.248 0.547 . . . . 0.0 110.327 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -129.94 -14.01 4.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.481 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.538 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 25.3 mm -89.48 -32.58 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 120.781 0.324 . . . . 0.0 111.267 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -51.7 -45.19 63.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.2 p -124.56 37.09 4.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.573 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.6 tp -60.6 143.18 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.787 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.547 ' HA ' HD12 ' A' ' 49' ' ' ILE . 24.1 m-20 -137.53 149.51 46.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.523 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.607 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.08 -38.33 11.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 110.593 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.2 m -61.74 -47.78 83.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.488 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -59.02 -59.62 5.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.273 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.599 HD11 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.97 -56.52 10.34 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.08 0.467 . . . . 0.0 110.23 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 55.1 m -57.59 -30.64 65.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.844 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.455 ' HD3' HD12 ' A' ' 113' ' ' ILE . 2.9 tmt_? -70.01 -65.73 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.073 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -42.5 -44.49 4.1 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.034 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.538 HG12 HG21 ' A' ' 35' ' ' VAL . 83.3 mt -61.83 -55.78 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.453 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -54.39 -18.1 3.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.512 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.455 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.48 -36.65 8.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.929 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.591 HD21 ' HG ' ' A' ' 92' ' ' LEU . 90.4 m-20 -125.88 31.47 5.47 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.5 p -83.33 40.55 0.72 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.036 0.446 . . . . 0.0 110.307 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.493 HD13 HH12 ' A' ' 85' ' ' ARG . 59.5 mt . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.266 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 120.744 0.307 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -144.13 -22.63 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.987 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -60.38 -62.46 1.85 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.964 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -94.3 55.66 2.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.828 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -75.35 84.19 2.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.8 m -150.32 25.78 0.79 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 57.85 72.74 0.5 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.015 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.29 92.33 0.54 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.543 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.92 147.4 89.23 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.762 2.308 . . . . 0.0 112.226 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.32 102.22 0.46 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.488 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.93 -21.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.824 0.345 . . . . 0.0 110.857 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -39.98 98.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.655 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.57 ' HG3' HG12 ' A' ' 54' ' ' VAL . 10.5 pt20 -47.88 140.87 6.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.229 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.419 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.3 pt-20 -110.42 157.2 38.85 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.733 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.5 Cg_endo -66.35 146.23 80.0 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.666 2.244 . . . . 0.0 112.463 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.9 m -61.35 153.61 26.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.792 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -100.34 92.57 5.24 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.754 179.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.581 HD21 ' HA ' ' A' ' 24' ' ' ALA . 47.3 mt -91.03 71.15 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.714 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.3 p -72.75 2.26 6.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.044 -179.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -143.75 146.61 33.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.841 0.353 . . . . 0.0 111.559 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.578 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 43.7 t -55.94 -50.2 88.61 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.577 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.1 Cg_endo -58.37 -45.85 28.25 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.873 1.716 . . . . 0.0 111.895 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.06 -34.32 77.34 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 110.29 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.581 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -65.42 -59.24 4.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.044 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.8 mtm -61.08 -24.2 66.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.021 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.5 mt-10 -73.91 -52.19 13.7 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.661 0.267 . . . . 0.0 110.544 179.592 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.83 -31.7 68.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.436 HD12 HD13 ' A' ' 36' ' ' ILE . 49.0 mt -75.05 -40.64 45.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.938 178.074 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.16 -16.9 62.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.096 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.89 24.3 5.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.266 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 t -170.77 153.7 4.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.618 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.464 ' HG3' HG11 ' A' ' 87' ' ' VAL . 16.6 tt0 -63.51 -75.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.469 HG11 HD13 ' A' ' 83' ' ' LEU . 18.2 t -96.97 136.63 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.817 0.341 . . . . 0.0 110.701 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.539 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.96 124.25 16.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.79 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.449 HG23 HG12 ' A' ' 111' ' ' ILE . 51.6 t -112.49 128.87 68.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.796 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 29.3 mt -134.2 137.33 52.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.517 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.62 97.22 1.68 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.199 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.471 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 41.9 m-85 -82.9 90.83 7.01 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.5 m-85 -109.91 140.63 43.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.41 -178.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.474 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 47.8 mt-30 -87.45 -9.3 55.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.458 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 17.7 t70 -148.91 123.43 9.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.53 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.518 ' HA ' HG22 ' A' ' 47' ' ' VAL . 94.8 mt -92.2 47.14 1.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.974 0.416 . . . . 0.0 111.599 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.9 mt-10 -137.94 10.47 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.113 178.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.661 HG13 HG23 ' A' ' 47' ' ' VAL . 4.1 pt -91.84 159.04 38.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.155 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.439 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 75.4 Cg_exo -53.93 -25.41 35.71 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.693 2.262 . . . . 0.0 112.858 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.28 -41.4 94.23 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.661 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -56.67 -55.6 41.4 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.612 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.6 Cg_exo -61.01 -42.23 38.33 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.572 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.613 HG23 HD11 ' A' ' 107' ' ' LEU . 5.8 mt -60.34 -33.65 54.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.097 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.536 ' O ' HG22 ' A' ' 54' ' ' VAL . 46.7 tp -75.36 -52.7 10.17 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -52.57 -27.42 16.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.1 0.476 . . . . 0.0 109.763 178.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -79.76 -49.07 12.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.624 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.522 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -57.08 -26.46 60.43 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.528 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.57 HG12 ' HG3' ' A' ' 13' ' ' GLN . 54.6 t -51.67 -49.79 33.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.838 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -74.77 -16.31 60.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.679 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -88.01 -16.18 34.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.246 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.621 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 50.8 m-85 -137.56 62.43 35.99 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.447 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.52 -43.6 53.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.705 2.27 . . . . 0.0 111.671 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.8 -41.49 94.04 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.645 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 13.1 t -65.75 145.07 14.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.539 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 36.8 t -83.64 98.27 9.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 111.016 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.457 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 5.3 p90 -63.86 129.07 38.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.089 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -147.39 161.17 28.46 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.071 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -161.61 144.99 4.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.457 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 37.1 t -149.57 159.14 44.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.121 0.486 . . . . 0.0 111.777 -179.124 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.517 HG23 ' HG ' ' A' ' 42' ' ' LEU . 74.3 p -139.97 -1.87 1.55 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.546 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.59 138.91 55.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.74 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 61.2 m -61.58 -51.61 67.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.672 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -48.21 -44.08 32.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.695 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.512 ' HA ' HG21 ' A' ' 21' ' ' VAL . 76.1 t -70.7 -54.96 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.908 0.385 . . . . 0.0 110.769 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.41 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.2 mp -57.59 -14.57 5.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.2 179.37 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.6 m -91.2 -41.15 11.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.144 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -59.71 -40.22 87.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.455 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -93.33 15.07 16.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.725 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.7 m120 53.87 25.45 5.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.791 179.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.632 HG21 ' HB ' ' A' ' 80' ' ' THR . 40.2 mm -60.33 121.41 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.002 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.9 p -140.97 57.86 1.55 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.491 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.3 44.58 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.637 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 12.5 m120 51.97 44.09 29.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.247 0.546 . . . . 0.0 110.37 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.632 ' HB ' HG21 ' A' ' 76' ' ' ILE . 91.9 m -69.14 152.79 44.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.676 -178.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.517 HG12 ' HA2' ' A' ' 37' ' ' GLY . 66.1 mt -118.89 116.75 52.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.998 177.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.471 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 74.7 m -106.45 133.02 51.79 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.576 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -107.49 103.99 13.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.899 178.405 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -97.05 120.37 37.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.789 0.328 . . . . 0.0 110.694 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.477 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 5.3 mtm180 -104.18 82.22 1.93 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.719 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ARG . 7.2 tp -25.19 -59.66 0.06 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.41 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.464 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.73 -64.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.295 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -93.27 3.83 54.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.922 0.391 . . . . 0.0 110.959 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 49.56 36.59 10.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.526 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 6.3 mm-40 -83.57 157.08 22.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.5 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.18 96.06 3.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.724 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.576 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -84.71 111.55 19.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.048 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.35 115.41 27.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.262 0.553 . . . . 0.0 112.308 -178.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.511 HD22 HD12 ' A' ' 102' ' ' ILE . 3.1 tt -102.61 76.84 1.56 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.409 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 26.5 mt-10 -78.2 -165.08 0.62 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.499 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 22.6 t70 -50.48 -38.89 46.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.174 -179.16 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -54.89 -14.62 1.52 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.142 0.496 . . . . 0.0 110.343 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -130.42 -13.81 3.82 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.721 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.521 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 24.1 mm -90.8 -35.1 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.701 0.286 . . . . 0.0 111.435 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.77 -43.46 65.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.914 0.388 . . . . 0.0 110.758 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.7 m -122.34 40.33 3.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.518 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.521 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.6 tp -67.32 143.43 15.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.687 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.548 ' HA ' HD11 ' A' ' 49' ' ' ILE . 13.0 m-20 -138.37 148.31 44.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.536 178.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.608 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -47.14 -36.8 8.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.984 0.421 . . . . 0.0 110.449 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.2 m -62.07 -49.83 74.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.249 178.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -57.6 -60.96 2.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.227 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.613 HD11 HG23 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.69 -56.52 8.32 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.912 0.387 . . . . 0.0 110.44 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.7 m -58.66 -29.99 66.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.974 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.51 ' HD3' HD11 ' A' ' 113' ' ' ILE . 3.2 tmt_? -71.08 -65.33 0.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.138 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -43.44 -44.58 5.9 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.044 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.449 HG12 HG23 ' A' ' 35' ' ' VAL . 96.8 mt -62.6 -55.39 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.512 178.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.406 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 37.6 tt0 -54.36 -18.73 4.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.266 0.555 . . . . 0.0 110.305 179.392 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.51 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.44 -37.02 9.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.907 -179.136 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.542 HD21 ' HG ' ' A' ' 92' ' ' LEU . 89.6 m-20 -124.48 30.38 6.03 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 97.9 p -83.08 44.29 0.93 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.055 0.455 . . . . 0.0 110.091 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.4 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.33 -179.445 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.859 0.361 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.6 m -115.85 -12.57 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.332 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.23 173.81 8.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.19 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.8 tttm 62.2 -83.16 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.121 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.6 t -158.44 -81.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.771 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.0 m 52.41 83.93 0.06 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.199 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -81.28 -84.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.959 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.04 137.8 0.12 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.692 179.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.35 107.48 0.42 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.507 2.138 . . . . 0.0 112.25 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.21 -169.87 32.68 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.458 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.2 -71.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.781 0.325 . . . . 0.0 110.781 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.11 107.33 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.502 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.606 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.3 pt20 -62.04 160.08 13.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.394 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.487 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.0 pt-20 -128.98 159.57 68.01 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.621 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 46.0 Cg_endo -68.51 142.57 54.3 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.531 2.154 . . . . 0.0 112.619 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.6 m -63.33 152.26 38.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.51 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 12.7 m0 -96.53 89.51 5.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.005 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.543 HD12 ' HA ' ' A' ' 24' ' ' ALA . 54.7 mt -83.4 71.28 10.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.056 0.455 . . . . 0.0 110.39 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.6 p -71.07 -1.83 13.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.096 -179.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -141.42 147.28 37.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.892 0.377 . . . . 0.0 111.673 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.1 t -57.33 -49.68 92.51 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.364 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.11 -43.76 45.08 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.939 1.759 . . . . 0.0 111.743 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.23 -34.85 79.34 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.2 0.524 . . . . 0.0 110.361 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.543 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -64.68 -58.65 5.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.954 179.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 59.4 mtm -60.6 -27.64 67.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.135 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -71.36 -50.68 29.81 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.756 0.312 . . . . 0.0 110.677 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -59.47 -34.77 72.96 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.435 HD13 HD13 ' A' ' 36' ' ' ILE . 48.4 mt -73.07 -39.38 57.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.103 178.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.26 -18.85 61.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.081 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.3 24.26 3.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.252 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.0 t -170.78 155.09 4.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.546 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.48 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.8 tt0 -65.53 -73.25 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.478 HG11 HD12 ' A' ' 83' ' ' LEU . 17.9 t -98.66 137.37 26.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.743 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.19 128.07 19.43 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.234 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.486 HG21 HG12 ' A' ' 111' ' ' ILE . 54.6 t -115.37 131.38 67.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.43 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 23.1 mt -136.55 136.17 48.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.543 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.64 98.16 1.89 Allowed Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.505 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.9 m-85 -83.34 89.73 7.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.0 m-85 -109.59 137.88 46.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.497 -178.018 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.441 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 48.8 mt-30 -85.18 -4.49 59.18 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.452 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 12.0 t70 -153.63 126.4 8.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.561 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.505 ' HG ' HG23 ' A' ' 66' ' ' THR . 95.1 mt -95.48 48.21 1.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.112 0.482 . . . . 0.0 111.369 -179.355 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 45.2 mt-10 -137.98 8.65 2.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.808 178.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.655 HG13 HG22 ' A' ' 47' ' ' VAL . 1.8 pt -91.94 157.17 41.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.247 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.427 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 76.3 Cg_exo -52.23 -26.03 25.49 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.915 2.41 . . . . 0.0 113.058 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.19 -36.06 83.0 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.655 HG22 HG13 ' A' ' 44' ' ' ILE . 2.5 t -62.78 -55.75 35.55 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.64 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.0 Cg_exo -60.83 -39.43 62.28 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.03 1.82 . . . . 0.0 111.471 179.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.612 HG21 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -63.45 -36.7 77.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.062 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.519 ' O ' HG21 ' A' ' 54' ' ' VAL . 42.8 tp -71.89 -51.95 19.73 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -53.21 -26.31 17.15 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.6 t -80.01 -47.55 14.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.656 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.17 -26.11 64.5 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.429 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.606 HG12 ' HG3' ' A' ' 13' ' ' GLN . 54.7 t -53.11 -49.43 50.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.834 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -76.08 -10.59 59.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.626 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -93.69 -18.94 21.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.374 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.58 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 67.5 m-85 -135.96 62.21 45.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.589 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.9 -41.14 64.87 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.693 2.262 . . . . 0.0 111.568 179.114 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.14 -41.58 96.69 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.293 179.15 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.1 t -66.1 143.77 15.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.465 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 33.3 t -81.5 99.3 8.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.039 0.447 . . . . 0.0 110.844 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.436 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 3.9 p90 -65.61 126.76 29.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.987 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.95 162.73 28.35 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.318 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -160.89 141.34 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.1 t -144.29 151.78 39.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.107 0.48 . . . . 0.0 111.655 -179.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.505 HG23 ' HG ' ' A' ' 42' ' ' LEU . 81.6 p -135.57 -0.5 2.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.772 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.59 145.99 50.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.918 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.0 t -67.66 -50.58 57.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.466 -179.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -50.45 -44.05 55.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.363 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.503 ' HA ' HG23 ' A' ' 21' ' ' VAL . 58.4 t -70.83 -53.45 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.736 0.303 . . . . 0.0 110.604 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.4 -14.72 8.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.147 0.498 . . . . 0.0 110.459 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.0 m -92.56 -40.68 10.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.466 178.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -61.88 -35.33 78.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.497 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -95.55 12.88 28.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.872 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.595 ' N ' HD21 ' A' ' 75' ' ' ASN . 0.8 OUTLIER 56.93 23.65 8.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.691 179.236 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.647 HG21 ' HB ' ' A' ' 80' ' ' THR . 35.2 mm -61.08 121.13 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.092 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.2 p -141.02 57.86 1.55 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.378 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.51 46.49 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.536 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 14.0 m120 51.29 42.94 29.5 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.253 0.549 . . . . 0.0 110.406 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.647 ' HB ' HG21 ' A' ' 76' ' ' ILE . 93.0 m -68.93 152.39 45.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.65 -178.568 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.543 HG12 ' HA2' ' A' ' 37' ' ' GLY . 68.1 mt -119.32 118.53 57.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.241 178.163 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.497 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.9 m -107.34 134.04 50.98 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.599 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.8 tp -107.62 103.05 12.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.716 178.183 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.1 t80 -95.87 120.26 35.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.869 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.527 HH12 HD11 ' A' ' 116' ' ' LEU . 3.9 mtm180 -106.09 82.19 1.73 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.872 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.5 tp -25.11 -58.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.219 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.48 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.08 -60.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.375 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -100.77 4.77 43.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.128 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 54.08 26.01 6.11 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.373 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 13.9 mm-40 -70.61 155.18 41.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.822 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.86 95.06 2.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.445 179.391 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.599 HD21 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -84.36 111.55 19.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.224 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.7 118.08 30.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.37 0.605 . . . . 0.0 112.253 -179.13 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.484 HD23 HD12 ' A' ' 102' ' ' ILE . 4.3 tt -105.56 77.6 1.29 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.131 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.409 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.7 mt-10 -79.69 -163.84 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.905 -176.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.481 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.7 t70 -51.11 -35.71 36.7 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.925 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.402 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 12.9 pt-20 -56.18 -14.57 2.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.091 0.472 . . . . 0.0 110.192 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' OD2' ' HG3' ' A' ' 97' ' ' GLU . 35.5 m-20 -132.46 -14.05 2.94 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.573 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.502 HG23 ' HB2' ' A' ' 79' ' ' ASN . 25.4 mm -89.86 -33.96 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.718 0.294 . . . . 0.0 111.402 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -54.54 -34.23 61.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.753 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.5 p -133.06 40.25 3.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.341 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.6 tp -66.07 143.57 15.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.597 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.538 ' HA ' HD13 ' A' ' 49' ' ' ILE . 9.3 m-20 -138.62 148.56 44.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.5 178.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.612 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -46.91 -35.57 6.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.102 0.477 . . . . 0.0 110.342 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.2 m -63.33 -49.63 73.17 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.358 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -58.61 -59.66 5.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.131 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.605 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.7 -55.92 12.07 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.963 0.411 . . . . 0.0 110.317 179.875 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.2 m -58.66 -28.93 66.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.785 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.538 ' HD3' HD12 ' A' ' 113' ' ' ILE . 3.9 tmt_? -71.58 -65.69 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.169 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -42.91 -43.97 4.35 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.913 179.106 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.486 HG12 HG21 ' A' ' 35' ' ' VAL . 94.6 mt -62.96 -55.93 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.571 178.314 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.31 -17.81 3.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.538 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.83 -36.84 8.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.98 -179.194 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -124.37 30.02 6.16 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 81.2 p -82.38 47.69 1.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.013 0.435 . . . . 0.0 110.315 179.058 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.527 HD11 HH12 ' A' ' 85' ' ' ARG . 63.1 mt . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.297 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.775 0.321 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.406 HG22 ' HG3' ' A' ' 3' ' ' GLU . 22.6 m -97.74 -2.41 10.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.406 ' HG3' HG22 ' A' ' 2' ' ' VAL . 44.5 mt-10 -139.52 29.24 2.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.821 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -137.64 -56.31 0.68 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.748 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.7 m -117.91 136.9 53.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.686 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.3 m -111.2 -48.62 3.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -122.88 10.55 9.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.046 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.17 97.6 0.33 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -61.89 120.0 7.39 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.579 2.186 . . . . 0.0 112.163 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.88 -130.18 2.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.617 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.651 ' HB2' HE21 ' A' ' 13' ' ' GLN . . . -162.57 -72.36 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.739 0.304 . . . . 0.0 110.715 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.424 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . . . 57.69 96.89 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.673 179.341 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.651 HE21 ' HB2' ' A' ' 11' ' ' ALA . 7.6 pt20 -172.83 170.28 4.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.964 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.464 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 -117.26 157.96 45.78 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.0 Cg_endo -67.83 148.25 76.54 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.878 2.385 . . . . 0.0 112.6 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.3 m -64.64 153.99 37.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.54 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -98.84 89.37 4.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.005 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.534 HD11 ' HA ' ' A' ' 24' ' ' ALA . 50.1 mt -86.86 74.14 9.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.603 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.9 p -71.82 -1.25 13.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.266 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -143.52 148.73 36.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.868 0.366 . . . . 0.0 111.863 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.585 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 20.4 t -56.86 -50.66 86.78 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.407 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.52 -43.45 50.97 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.944 1.763 . . . . 0.0 111.884 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.61 -35.47 80.9 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.222 0.534 . . . . 0.0 110.299 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.534 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -64.26 -58.2 7.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.868 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.7 mtm -60.25 -28.56 68.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.005 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 17.0 mt-10 -70.57 -48.9 53.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.794 0.331 . . . . 0.0 110.568 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -60.75 -33.64 73.24 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.999 179.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 36' ' ' ILE . 38.1 mt -73.55 -39.6 54.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.003 178.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.33 -19.16 62.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.177 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.32 26.45 3.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.253 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 t -172.8 154.28 2.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.705 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.49 ' HG3' HG11 ' A' ' 87' ' ' VAL . 22.3 tt0 -63.65 -79.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.711 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.47 HG11 HD12 ' A' ' 83' ' ' LEU . 16.0 t -92.88 139.03 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.661 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.45 122.99 14.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 0.0 111.716 -179.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.577 HG22 HG12 ' A' ' 111' ' ' ILE . 55.1 t -112.03 128.34 68.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.755 178.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 28' ' ' ILE . 38.4 mt -134.08 137.59 51.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.604 -177.015 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.507 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.75 98.26 1.82 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.217 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.457 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 35.8 m-85 -84.17 91.88 7.8 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.575 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.8 m-85 -111.78 143.76 42.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.356 -178.085 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -89.31 -8.07 54.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.431 ' O ' HG12 ' A' ' 44' ' ' ILE . 13.4 t70 -149.79 124.57 9.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.618 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.546 ' HG ' HG21 ' A' ' 66' ' ' THR . 90.6 mt -93.18 46.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.055 0.455 . . . . 0.0 111.511 -179.239 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.412 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 37.1 mt-10 -136.98 8.93 3.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.917 178.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.665 HG13 HG23 ' A' ' 47' ' ' VAL . 2.2 pt -91.81 155.56 43.37 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.4 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.447 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 83.8 Cg_exo -50.42 -26.61 16.53 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.877 2.385 . . . . 0.0 112.964 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.48 -38.52 91.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -179.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.665 HG23 HG13 ' A' ' 44' ' ' ILE . 2.8 t -60.0 -55.91 40.83 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.656 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.7 Cg_exo -60.67 -41.59 45.93 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.081 1.854 . . . . 0.0 111.545 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.617 HG22 HD13 ' A' ' 107' ' ' LEU . 5.8 mt -61.12 -35.17 63.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.973 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.532 ' O ' ' HG3' ' A' ' 53' ' ' MET . 50.4 tp -74.57 -49.47 21.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.06 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -55.14 -25.83 34.63 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -81.84 -47.34 12.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.69 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.532 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -58.48 -26.38 63.35 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.455 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 50' ' ' LEU . 41.9 t -52.82 -48.01 50.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.123 179.395 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.424 ' NE2' ' HA ' ' A' ' 12' ' ' ALA . 38.5 mt-30 -77.97 -11.88 59.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -92.23 -17.86 24.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.312 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.592 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 62.4 m-85 -136.5 62.36 42.52 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.453 -179.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.33 -42.12 62.38 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.79 2.327 . . . . 0.0 111.677 179.137 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.9 -40.59 95.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.443 179.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.4 t -67.22 142.6 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.531 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 28.7 t -81.17 98.46 8.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.049 0.452 . . . . 0.0 110.877 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.491 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 4.6 p90 -66.04 129.44 39.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.015 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -147.32 161.98 28.57 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.003 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -160.93 143.93 4.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.457 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 34.1 t -149.79 158.3 44.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.1 0.476 . . . . 0.0 111.693 -179.165 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.546 HG21 ' HG ' ' A' ' 42' ' ' LEU . 77.5 p -139.86 2.53 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.668 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -72.18 134.51 45.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.428 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.1 t -57.86 -49.29 77.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.435 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -50.21 -43.49 52.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.695 -179.378 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.545 ' HA ' HG21 ' A' ' 21' ' ' VAL . 73.9 t -71.35 -53.2 21.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.967 0.413 . . . . 0.0 110.69 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 76' ' ' ILE . 6.6 mp -59.31 -14.34 11.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.176 179.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.5 m -92.02 -41.24 10.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.251 178.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -60.68 -38.51 85.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.434 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -92.61 10.46 30.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.766 179.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.9 t30 58.95 23.01 11.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.626 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.625 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.0 mm -60.23 123.34 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.022 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.5 p -143.62 60.05 1.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.028 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.86 43.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.572 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 30.0 m-80 52.09 43.57 30.35 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.109 0.48 . . . . 0.0 110.43 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.625 ' HB ' HG23 ' A' ' 76' ' ' ILE . 88.5 m -68.41 152.67 45.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.655 -178.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.545 HG23 HD23 ' A' ' 107' ' ' LEU . 62.2 mt -118.46 115.53 48.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 78.3 m -103.63 135.14 45.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -177.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.569 ' HG ' HD22 ' A' ' 92' ' ' LEU . 3.0 tp -110.72 105.61 14.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.125 178.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.7 t80 -99.41 118.94 37.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.996 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.442 HH12 HD11 ' A' ' 116' ' ' LEU . 3.3 mtm180 -103.29 80.69 1.86 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.789 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 85' ' ' ARG . 6.6 tp -24.33 -59.65 0.05 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.935 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.49 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.79 -62.48 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.302 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -96.87 3.3 52.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.0 0.428 . . . . 0.0 111.065 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 51.77 32.07 9.01 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.526 179.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.9 mm-40 -80.03 137.5 36.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.614 179.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.02 93.31 4.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.028 0.442 . . . . 0.0 110.86 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.588 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.3 mm? -81.16 141.39 34.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.361 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -121.86 115.18 22.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.322 0.582 . . . . 0.0 112.343 -179.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.496 HD22 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -99.57 74.88 1.91 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -76.38 -166.03 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -176.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.439 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.4 OUTLIER -46.01 -51.7 13.1 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.418 -179.278 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -47.15 -15.83 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.275 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 96' ' ' ASP . 30.5 m-20 -127.02 -14.03 5.6 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.351 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.509 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 22.4 mm -91.59 -40.48 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -46.18 -42.85 14.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 t -124.45 41.36 3.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.491 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.509 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.3 tp -66.86 143.6 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.712 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.525 ' HA ' HD12 ' A' ' 49' ' ' ILE . 15.7 m-20 -137.22 149.54 47.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.486 178.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -48.23 -36.77 14.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.379 . . . . 0.0 110.461 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.5 m -62.27 -48.42 79.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.236 178.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 103' ' ' ASP . 28.8 mtpp -58.86 -59.34 5.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.188 -179.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.617 HD13 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.2 -56.39 11.25 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.05 0.452 . . . . 0.0 110.182 -179.96 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.6 m -58.05 -28.8 64.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.744 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.47 ' HD3' HD12 ' A' ' 113' ' ' ILE . 2.9 tmt_? -71.6 -66.05 0.68 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.967 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -42.13 -45.52 4.03 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.865 179.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.577 HG12 HG22 ' A' ' 35' ' ' VAL . 82.1 mt -61.33 -56.86 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.593 178.521 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -53.82 -18.07 2.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.336 179.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.47 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.43 -37.16 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.215 -179.042 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.588 HD21 ' HG ' ' A' ' 92' ' ' LEU . 82.9 m-20 -124.62 29.63 6.21 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 99.8 p -82.9 49.11 1.45 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.996 0.427 . . . . 0.0 110.316 179.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.442 HD11 HH12 ' A' ' 85' ' ' ARG . 73.7 mt . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.355 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.861 0.362 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.2 m -99.44 -43.37 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.093 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -172.51 92.17 0.11 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.777 179.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.8 tttt 55.71 90.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.094 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 85.3 p -161.19 114.0 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.004 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.4 m -130.98 24.75 4.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.995 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -110.54 -40.43 4.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.846 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.93 152.78 6.02 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.48 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.84 107.34 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.546 2.164 . . . . 0.0 112.13 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.76 165.62 25.87 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.612 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.07 -61.74 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.74 0.305 . . . . 0.0 110.676 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.473 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . . . 53.89 83.26 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.102 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.505 ' HG3' HG13 ' A' ' 54' ' ' VAL . 3.5 pt20 48.27 117.29 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.919 0.762 . . . . 0.0 112.287 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.508 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.9 pt-20 -114.25 159.54 36.14 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.649 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 31.4 Cg_endo -65.0 139.76 62.89 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.487 2.124 . . . . 0.0 112.526 -179.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.416 HG23 ' N ' ' A' ' 17' ' ' TRP . 19.2 m -57.18 154.34 10.34 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.003 -179.399 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.416 ' N ' HG23 ' A' ' 16' ' ' THR . 10.4 m-90 -98.21 94.11 6.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.902 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.557 HD22 ' HA ' ' A' ' 24' ' ' ALA . 51.3 mt -90.07 70.01 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.27 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.2 p -68.82 -2.6 9.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.246 -178.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -142.61 147.53 35.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.997 0.427 . . . . 0.0 111.645 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.7 t -55.29 -50.01 89.11 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.638 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.6 Cg_endo -57.06 -46.87 25.86 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.958 1.772 . . . . 0.0 111.924 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.8 -34.62 77.66 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.193 0.52 . . . . 0.0 110.113 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.557 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.13 -59.26 4.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.054 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.4 mtp -60.62 -25.19 66.09 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.183 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -72.26 -50.82 24.3 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.571 179.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -61.72 -29.48 70.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.479 HD11 HD13 ' A' ' 36' ' ' ILE . 50.2 mt -76.11 -37.48 33.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.068 178.217 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.79 -19.54 60.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.115 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.41 30.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.197 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.401 HG23 ' HB2' ' A' ' 61' ' ' SER . 9.7 t -170.97 153.53 3.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.314 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.546 ' HG3' HG12 ' A' ' 87' ' ' VAL . 27.5 tt0 -70.18 -46.29 64.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.793 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.46 HG12 HD12 ' A' ' 83' ' ' LEU . 21.1 t -124.53 135.22 64.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.286 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.56 127.47 22.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.163 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.532 HG22 HG12 ' A' ' 111' ' ' ILE . 49.2 t -115.66 128.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.465 178.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.479 HD13 HD11 ' A' ' 28' ' ' ILE . 22.2 mt -134.64 138.41 49.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.556 -177.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.534 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.87 97.06 1.64 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.378 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.464 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 39.3 m-85 -82.95 91.96 7.24 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.0 m-85 -112.0 145.21 40.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.181 0.515 . . . . 0.0 112.378 -178.188 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.443 ' HG2' HD22 ' A' ' 71' ' ' LEU . 46.2 mt-30 -93.17 -0.99 56.75 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.441 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.8 t70 -156.58 123.85 5.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.564 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 66' ' ' THR . 84.0 mt -93.75 47.5 1.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.204 0.526 . . . . 0.0 111.505 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.416 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 45.4 mt-10 -137.38 7.27 2.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.729 178.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.653 HG13 HG21 ' A' ' 47' ' ' VAL . 2.0 pt -89.68 156.55 47.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.027 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.428 ' O ' HD13 ' A' ' 49' ' ' ILE . 72.1 Cg_exo -52.16 -24.19 19.62 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.876 2.384 . . . . 0.0 113.007 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.32 -35.99 80.56 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.653 HG21 HG13 ' A' ' 44' ' ' ILE . 2.6 t -61.9 -54.97 45.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.667 -178.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.641 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.6 Cg_exo -61.44 -40.28 49.48 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.999 1.799 . . . . 0.0 111.445 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.609 HG22 HD11 ' A' ' 107' ' ' LEU . 6.3 mt -63.11 -35.92 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.19 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.529 ' O ' ' HG3' ' A' ' 53' ' ' MET . 48.9 tp -73.06 -50.26 23.99 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -54.82 -25.37 27.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.198 0.523 . . . . 0.0 109.598 178.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.9 t -80.98 -47.23 13.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.547 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.23 -27.17 65.51 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.541 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.524 HG21 ' O ' ' A' ' 50' ' ' LEU . 53.6 t -51.71 -50.91 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.021 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.473 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 36.0 mt-30 -74.68 -12.35 60.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.722 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -91.81 -17.34 25.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.215 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.6 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.0 m-85 -138.15 63.37 36.23 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.568 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.07 -41.11 74.19 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.652 2.235 . . . . 0.0 111.58 179.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.3 -41.83 97.05 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.35 179.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.6 t -65.76 144.69 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.514 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 47.5 t -82.35 97.23 8.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.026 0.441 . . . . 0.0 111.006 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -64.45 126.64 28.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.724 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.1 161.84 28.33 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.169 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -161.03 143.02 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.464 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 35.6 t -147.25 153.52 39.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.071 0.462 . . . . 0.0 111.805 -179.061 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.51 HG21 ' HG ' ' A' ' 42' ' ' LEU . 64.4 p -135.62 5.73 3.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.371 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.27 140.34 44.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.738 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.8 m -62.94 -52.78 61.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.378 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -47.7 -44.73 27.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.614 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.486 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.0 t -70.05 -55.29 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.832 0.348 . . . . 0.0 110.991 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.443 HD22 ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -57.39 -14.84 5.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.25 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.4 m -90.48 -41.43 11.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.246 178.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -60.1 -39.42 86.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.392 179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -92.93 12.99 21.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.959 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.3 m120 55.15 24.28 6.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.623 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.607 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.4 mm -60.16 120.43 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.97 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.5 p -142.05 55.67 1.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.942 0.401 . . . . 0.0 111.109 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.44 42.37 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.432 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 35.6 m-20 52.24 43.37 30.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.232 0.539 . . . . 0.0 110.364 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.607 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.6 m -68.95 151.11 46.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.87 -178.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.556 HG22 HD23 ' A' ' 107' ' ' LEU . 64.0 mt -117.8 115.47 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.911 177.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.456 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 78.3 m -103.82 132.57 49.95 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.577 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.3 tp -109.07 103.68 12.74 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.803 178.312 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -98.73 122.15 41.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.821 0.343 . . . . 0.0 110.79 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.455 HH21 ' HB2' ' A' ' 88' ' ' ASP . 2.8 mtm180 -105.04 98.72 8.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.036 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.3 tp -41.9 -52.71 4.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.882 -179.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.546 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.7 -71.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.385 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.455 ' HB2' HH21 ' A' ' 85' ' ' ARG . 11.2 m-20 -88.33 6.01 39.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.041 -179.665 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 52.49 35.89 18.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.387 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 7.3 mm-40 -81.46 161.66 23.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.817 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -146.05 92.81 2.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.92 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.585 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.4 mm? -79.39 144.23 34.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.181 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -124.56 95.49 4.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.498 HD22 HD12 ' A' ' 102' ' ' ILE . 3.9 tt -81.0 77.78 7.88 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.639 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.5 mt-10 -78.8 -165.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.487 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 25.5 t70 -51.01 -36.47 39.57 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.932 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -56.27 -14.61 2.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.183 0.516 . . . . 0.0 110.361 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -130.68 -13.95 3.67 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.592 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.538 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 23.0 mm -89.49 -32.71 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.754 0.311 . . . . 0.0 111.373 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -50.36 -47.98 55.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.728 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -122.05 38.31 4.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.609 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.538 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.0 tp -61.07 143.44 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.653 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.539 ' HA ' HD11 ' A' ' 49' ' ' ILE . 19.1 m-20 -137.12 147.91 46.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.473 178.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.601 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -47.1 -35.26 6.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.99 0.424 . . . . 0.0 110.45 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -63.91 -48.68 75.62 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.423 178.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -58.98 -58.58 8.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.115 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.609 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.49 -55.78 14.47 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.998 0.428 . . . . 0.0 110.134 179.901 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.1 m -58.31 -28.98 65.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.823 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.456 ' HD3' HD11 ' A' ' 113' ' ' ILE . 2.7 tmt_? -72.65 -65.88 0.73 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.222 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -42.92 -42.82 3.86 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.04 179.112 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.532 HG12 HG22 ' A' ' 35' ' ' VAL . 92.2 mt -64.18 -56.63 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.576 178.371 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -52.33 -22.16 4.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.367 0.604 . . . . 0.0 110.211 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.456 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -85.17 -37.88 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.93 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.585 HD21 ' HG ' ' A' ' 92' ' ' LEU . 88.9 m-20 -123.64 30.78 6.1 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.312 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 111' ' ' ILE . 87.4 p -83.5 39.58 0.68 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.18 0.514 . . . . 0.0 110.066 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.7 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.291 -179.453 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.518 0.199 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.5 m 34.94 61.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.09 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.07 -27.77 65.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.978 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -63.79 144.24 57.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.5 m -141.75 -26.61 0.67 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.792 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 56.5 m -153.86 107.22 2.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -110.55 108.44 18.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -129.86 -176.06 14.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.384 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.26 130.86 42.44 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.555 2.17 . . . . 0.0 112.426 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.62 59.56 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.462 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.9 -51.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.823 0.344 . . . . 0.0 110.447 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.52 -82.28 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.632 179.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.54 ' HG3' HG12 ' A' ' 54' ' ' VAL . 11.1 pt20 -161.66 139.94 9.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.89 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.1 pt-20 -121.68 158.3 54.58 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.739 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 35.9 Cg_endo -66.3 140.71 59.53 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.55 2.167 . . . . 0.0 112.465 -179.701 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 m -56.46 150.5 15.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.666 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -96.27 93.36 6.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.98 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 24' ' ' ALA . 54.2 mt -90.7 72.93 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.511 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.7 p -74.96 2.11 11.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.065 -179.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -144.67 147.54 33.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 0.0 111.595 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.581 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 39.7 t -56.48 -50.21 89.08 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.622 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.96 -44.92 35.82 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 121.876 1.717 . . . . 0.0 111.797 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.85 -36.22 83.2 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.169 0.509 . . . . 0.0 110.33 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.551 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -63.21 -59.4 4.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.148 179.377 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 65.8 mtp -60.97 -25.19 66.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.139 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 21.3 mt-10 -72.59 -51.98 17.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.719 0.295 . . . . 0.0 110.648 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -59.94 -31.87 70.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.935 179.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.458 HD13 HD12 ' A' ' 36' ' ' ILE . 50.7 mt -75.27 -38.8 41.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.938 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.61 -19.0 61.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.232 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.76 26.18 3.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.243 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 t -170.62 153.75 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.611 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.491 ' HG3' HG13 ' A' ' 87' ' ' VAL . 18.2 tt0 -64.5 -73.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.491 HG13 HD13 ' A' ' 83' ' ' LEU . 19.7 t -98.13 137.81 24.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.613 179.787 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.517 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.18 125.65 16.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.937 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.518 HG23 HG12 ' A' ' 111' ' ' ILE . 55.0 t -114.07 130.16 68.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.85 178.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 27.0 mt -135.53 137.78 49.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.625 -177.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.24 98.08 1.75 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.587 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.0 m-85 -84.3 91.84 7.85 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.4 m-85 -110.84 143.87 40.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.287 -178.191 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.452 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 49.9 mt-30 -91.51 -3.3 56.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.503 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.6 t70 -154.8 118.46 4.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.596 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.488 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.8 mt -87.96 44.78 1.22 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.01 0.433 . . . . 0.0 111.329 -179.318 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 31.3 mt-10 -135.28 10.11 3.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.128 179.054 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.666 HG13 HG22 ' A' ' 47' ' ' VAL . 3.3 pt -92.77 157.57 39.4 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.477 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.453 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 71.8 Cg_exo -52.22 -27.5 30.43 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.908 2.405 . . . . 0.0 112.898 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.36 -39.95 95.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.666 HG22 HG13 ' A' ' 44' ' ' ILE . 2.2 t -58.57 -56.89 30.92 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -178.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -58.87 -40.29 73.4 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.783 1.655 . . . . 0.0 111.438 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.613 HG22 HD12 ' A' ' 107' ' ' LEU . 6.2 mt -61.85 -35.34 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.936 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.53 ' O ' ' HG3' ' A' ' 53' ' ' MET . 39.7 tp -75.03 -54.67 6.76 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -52.68 -23.69 7.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.0 0.429 . . . . 0.0 109.947 178.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -84.22 -46.08 12.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.557 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.53 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.0 -25.26 63.48 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.318 0.58 . . . . 0.0 109.457 179.433 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.54 HG12 ' HG3' ' A' ' 13' ' ' GLN . 54.3 t -51.57 -50.49 29.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.121 179.352 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -76.08 -9.48 58.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.874 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -93.13 -19.74 21.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.998 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.9 m-85 -135.84 63.79 53.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.506 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.61 -43.2 57.05 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.707 2.272 . . . . 0.0 111.576 179.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.42 -42.29 93.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.337 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -65.27 143.77 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 38.2 t -82.28 98.12 8.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 111.092 -179.627 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.439 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.4 p90 -65.37 128.35 35.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.927 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -147.83 161.84 28.62 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.025 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.403 HD13 HG12 ' A' ' 47' ' ' VAL . 4.7 tt -160.18 144.3 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 t -148.48 158.72 44.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.191 0.519 . . . . 0.0 111.865 -178.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.488 HG22 ' HG ' ' A' ' 42' ' ' LEU . 72.5 p -141.49 1.03 1.53 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.585 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.02 144.97 52.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.663 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.4 m -66.67 -53.4 34.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.344 -179.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -48.71 -42.95 36.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.511 -179.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.491 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.8 t -70.56 -56.12 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.051 0.453 . . . . 0.0 110.648 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.49 -15.08 3.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.315 179.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.5 m -90.87 -41.23 11.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.304 178.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -61.33 -31.91 71.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.251 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -100.02 12.39 37.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.274 179.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.7 m120 55.95 22.05 5.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.595 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.66 HG21 ' HB ' ' A' ' 80' ' ' THR . 32.4 mm -58.96 118.99 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.152 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.6 p -142.16 55.81 1.46 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.085 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.82 42.41 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.355 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 14.1 m120 53.17 42.19 32.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.256 0.55 . . . . 0.0 110.203 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.66 ' HB ' HG21 ' A' ' 76' ' ' ILE . 92.9 m -67.93 151.77 46.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.864 -178.497 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.541 HG12 ' HA2' ' A' ' 37' ' ' GLY . 66.4 mt -118.95 115.79 49.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.88 177.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.528 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.4 m -105.34 132.65 51.26 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.611 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.5 tp -108.34 103.91 13.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.925 178.327 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.5 t80 -97.36 123.58 41.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.847 0.356 . . . . 0.0 110.579 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.475 HH12 HD13 ' A' ' 116' ' ' LEU . 4.5 mtm180 -106.36 81.23 1.58 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.705 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 85' ' ' ARG . 4.6 tp -24.13 -59.76 0.05 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.06 -179.537 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.491 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.03 -61.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.064 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.9 4.29 49.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.953 0.406 . . . . 0.0 111.19 -179.428 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.9 m120 53.21 28.24 6.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.81 179.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.0 mm-40 -74.13 159.29 32.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.578 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -144.19 96.8 2.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.827 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.611 HD21 ' HG ' ' A' ' 83' ' ' LEU . 2.1 mm? -85.32 111.57 20.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.058 179.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -93.87 101.36 13.44 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.538 HD23 HD12 ' A' ' 102' ' ' ILE . 3.4 tt -86.72 75.82 9.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' HG2' ' HG1' ' A' ' 80' ' ' THR . 27.0 mt-10 -77.1 -166.1 0.66 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -176.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.45 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -46.11 -50.67 15.13 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.398 -179.388 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -47.73 -16.3 0.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.976 0.417 . . . . 0.0 111.285 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.41 ' N ' ' C ' ' A' ' 96' ' ' ASP . 43.0 m-20 -126.38 -13.91 5.98 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.465 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.537 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 20.9 mm -91.46 -32.21 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -48.84 -59.31 3.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.962 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.6 p -110.72 36.28 3.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.585 179.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.538 HD12 HD23 ' A' ' 94' ' ' LEU . 8.7 tp -56.91 144.66 8.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.438 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.549 ' HA ' HD13 ' A' ' 49' ' ' ILE . 21.7 m-20 -138.5 148.75 44.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.721 179.072 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.59 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -48.18 -36.72 14.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.029 0.442 . . . . 0.0 110.491 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 96.6 m -61.46 -49.07 78.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.174 178.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.424 ' HD3' ' H ' ' A' ' 103' ' ' ASP . 55.9 mtpt -58.1 -61.45 2.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.148 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.613 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.21 -56.54 7.69 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.903 0.382 . . . . 0.0 110.511 -179.849 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 56.6 m -58.31 -29.85 66.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.918 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.502 ' HD3' HD11 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -71.29 -64.7 0.86 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.252 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -44.52 -43.01 7.64 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.079 179.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.518 HG12 HG23 ' A' ' 35' ' ' VAL . 95.9 mt -63.76 -56.43 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.639 178.464 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -53.23 -19.39 3.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.179 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.502 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.56 -37.75 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.07 -179.075 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -122.4 30.03 6.7 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.6 p -82.35 43.74 0.83 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.123 0.487 . . . . 0.0 110.152 178.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.475 HD13 HH12 ' A' ' 85' ' ' ARG . 49.5 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.408 -179.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.82 0.343 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.2 m -89.62 3.11 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.472 -179.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.09 136.23 57.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.967 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.6 mttp 58.64 -169.42 0.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.422 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.5 m -65.11 -26.21 68.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.264 -179.682 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.8 t 67.71 -75.21 0.06 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.162 -179.768 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.8 t70 63.47 107.24 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.99 0.424 . . . . 0.0 111.272 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.56 179.09 40.7 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.36 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -57.23 98.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.59 2.193 . . . . 0.0 112.186 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.89 58.66 0.51 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.706 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.39 -69.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.779 0.324 . . . . 0.0 110.795 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 13' ' ' GLN . . . 55.15 81.12 0.12 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.156 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.492 ' HG3' HG11 ' A' ' 54' ' ' VAL . 4.2 pt20 46.02 115.89 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 O-C-N 123.905 0.753 . . . . 0.0 112.66 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.9 pt-20 -111.46 157.84 38.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.687 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.7 Cg_endo -66.89 141.65 59.58 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.423 2.082 . . . . 0.0 112.173 -179.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.6 m -56.42 152.31 11.67 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.495 -179.547 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -99.79 85.67 3.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.062 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 24' ' ' ALA . 49.7 mt -81.89 74.61 8.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.453 179.84 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.7 p -74.14 -1.96 22.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.98 -178.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -140.11 147.02 39.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.422 . . . . 0.0 111.643 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.579 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 32.2 t -56.09 -50.05 89.62 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.534 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.4 Cg_endo -58.74 -45.33 29.94 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.808 1.672 . . . . 0.0 111.718 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.54 -33.82 76.42 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.25 0.547 . . . . 0.0 110.169 179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.554 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -64.93 -59.11 4.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.006 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.8 mtp -60.6 -26.02 66.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.182 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.3 mt-10 -72.86 -50.97 20.66 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.708 0.289 . . . . 0.0 110.642 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -59.92 -32.2 70.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.854 179.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.441 HD13 HD11 ' A' ' 36' ' ' ILE . 47.6 mt -75.08 -40.5 44.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.08 0.466 . . . . 0.0 110.111 178.312 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -18.7 62.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.207 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.48 25.41 3.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.206 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.7 t -171.0 155.1 4.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.744 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.493 ' HG3' HG11 ' A' ' 87' ' ' VAL . 18.4 tt0 -64.61 -77.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.824 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.524 HG12 HD11 ' A' ' 83' ' ' LEU . 20.2 t -95.93 136.97 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.731 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.527 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.41 126.04 17.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.942 0.401 . . . . 0.0 112.074 -179.124 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.487 HG23 HG12 ' A' ' 111' ' ' ILE . 53.9 t -114.53 131.01 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.836 178.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 27.9 mt -135.97 135.39 50.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.274 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.559 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.58 98.06 1.97 Allowed Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.619 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 10.8 m-85 -84.17 91.73 7.77 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.0 m-85 -112.08 137.98 49.37 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.128 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -83.21 -7.03 59.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.437 ' O ' HG12 ' A' ' 44' ' ' ILE . 7.2 t70 -152.03 125.6 8.89 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.654 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.515 ' HG ' HG22 ' A' ' 66' ' ' THR . 96.0 mt -93.23 43.27 1.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.039 0.447 . . . . 0.0 111.407 -179.645 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -132.55 14.79 4.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.828 178.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.655 HG13 HG22 ' A' ' 47' ' ' VAL . 2.6 pt -99.08 157.77 33.48 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.197 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.444 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 74.1 Cg_exo -52.99 -26.98 33.88 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.9 2.4 . . . . 0.0 112.956 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.77 -38.25 89.86 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.017 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.655 HG22 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.35 -56.4 34.2 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.629 -178.826 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.2 Cg_exo -59.64 -41.23 57.98 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.942 1.762 . . . . 0.0 111.372 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.614 HG21 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -61.16 -35.87 68.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.054 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.525 ' O ' ' HG3' ' A' ' 53' ' ' MET . 48.8 tp -73.68 -52.06 14.58 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 178.784 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -53.58 -25.18 16.2 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.705 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -81.76 -46.82 13.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.505 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.16 -25.81 64.24 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.357 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.7 t -53.06 -47.69 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.948 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.402 ' HA ' ' OE1' ' A' ' 13' ' ' GLN . 8.9 mt-30 -77.99 -11.62 59.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.714 -179.802 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -92.73 -17.77 23.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.155 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.602 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.3 m-85 -137.14 62.63 39.85 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.605 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.37 -39.46 81.47 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.517 2.145 . . . . 0.0 111.466 178.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.65 -39.42 96.55 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.458 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.1 t -68.58 144.09 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.067 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 35.7 t -81.29 98.08 7.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 110.916 -179.754 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.451 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.2 p90 -65.16 127.52 32.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.77 162.88 28.57 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.212 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -160.68 143.71 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.774 0.321 . . . . 0.0 110.155 179.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.3 t -146.91 154.17 40.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.041 0.448 . . . . 0.0 111.512 -179.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.515 HG22 ' HG ' ' A' ' 42' ' ' LEU . 81.9 p -137.73 -4.75 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.71 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.35 144.49 55.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.831 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -64.35 -51.49 63.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.46 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -48.6 -45.26 37.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.656 -179.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.508 ' HA ' HG21 ' A' ' 21' ' ' VAL . 74.5 t -70.15 -53.47 23.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.829 0.347 . . . . 0.0 110.724 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.71 -14.32 8.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.351 179.416 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.2 m -91.91 -41.68 10.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.274 178.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -60.09 -39.62 86.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.414 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -91.74 11.95 22.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.787 179.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 55.79 26.23 9.32 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.542 179.222 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.625 HG22 ' HB ' ' A' ' 80' ' ' THR . 39.0 mm -61.89 122.06 11.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.226 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.6 p -140.83 58.2 1.55 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.311 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.87 46.77 0.02 OUTLIER Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.89 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 30.2 m-80 50.57 43.0 27.53 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.229 0.538 . . . . 0.0 110.543 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.625 ' HB ' HG22 ' A' ' 76' ' ' ILE . 94.6 m -69.17 152.57 44.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.686 -178.612 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.559 HG12 ' HA2' ' A' ' 37' ' ' GLY . 60.6 mt -118.9 118.34 57.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.107 178.189 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.9 m -107.89 134.07 51.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.599 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -109.53 104.73 13.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.085 178.544 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.4 t80 -97.3 122.61 40.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.464 179.555 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.534 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.6 mtm180 -106.85 82.71 1.74 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.928 0.394 . . . . 0.0 110.835 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tp -25.67 -60.03 0.07 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.127 -179.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.493 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.25 -58.75 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.852 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -98.83 13.28 32.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.758 0.313 . . . . 0.0 111.37 -179.177 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.2 p30 43.55 30.95 0.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.017 178.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.534 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 28.2 mm-40 -77.47 157.16 30.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.835 0.35 . . . . 0.0 110.916 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.429 HE22 ' HB3' ' A' ' 93' ' ' ASN . 1.2 tm0? -142.26 94.48 2.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.676 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.599 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -85.25 121.69 28.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.637 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.484 ' H ' ' ND2' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -105.16 103.77 13.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.767 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.485 HD21 HD11 ' A' ' 102' ' ' ILE . 4.6 tt -89.63 78.67 6.96 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -79.81 -165.87 0.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.458 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.1 -51.06 10.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.7 -179.311 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -46.56 -18.88 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.857 0.361 . . . . 0.0 111.088 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 96' ' ' ASP . 16.2 m-20 -124.73 -13.82 6.89 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.488 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.559 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 24.7 mm -90.59 -40.61 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.363 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -49.08 -40.91 33.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.342 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.3 t -123.68 36.41 4.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.449 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 8.1 tp -63.14 144.68 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.475 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.524 ' HA ' HD13 ' A' ' 49' ' ' ILE . 19.8 m-20 -139.69 147.88 41.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.475 178.756 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.614 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -47.11 -37.84 10.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.984 0.421 . . . . 0.0 110.554 -179.571 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -61.43 -47.55 85.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.311 178.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -60.12 -60.83 3.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.215 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.609 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.0 -55.56 11.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.329 -179.999 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.0 m -58.45 -30.49 66.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.732 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.432 ' C ' ' HD3' ' A' ' 109' ' ' ARG . 2.5 tmt_? -70.4 -66.55 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.128 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -42.62 -45.16 4.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.169 179.454 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.487 HG12 HG23 ' A' ' 35' ' ' VAL . 96.4 mt -62.41 -54.76 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.306 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.409 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 40.8 tt0 -54.6 -18.78 4.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.426 179.397 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.425 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.62 -37.43 10.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.79 -178.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.558 HD21 ' HG ' ' A' ' 92' ' ' LEU . 89.1 m-20 -122.96 29.36 6.82 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.387 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 78.9 p -82.65 50.85 1.75 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.118 0.485 . . . . 0.0 110.092 178.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.496 HD11 HH12 ' A' ' 85' ' ' ARG . 57.0 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.278 -0.867 . . . . 0.0 111.374 -179.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.91 0.386 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.5 m -86.21 174.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.867 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 57.63 93.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.979 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -81.12 -71.27 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.998 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.2 t -105.63 130.81 53.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.052 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.8 t -126.27 146.04 50.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.698 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -106.88 101.42 10.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.067 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.22 -160.5 54.06 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.54 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.82 -39.42 91.22 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.64 2.226 . . . . 0.0 112.413 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.25 -83.46 0.35 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.426 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.99 -45.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.87 0.367 . . . . 0.0 110.445 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.65 -83.59 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.695 179.388 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.477 ' HG3' HG13 ' A' ' 54' ' ' VAL . 28.4 pt20 -140.65 146.83 38.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 111.034 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.1 pt-20 -131.78 157.77 77.28 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.714 179.902 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.453 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.7 Cg_endo -65.37 145.21 82.68 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.618 2.212 . . . . 0.0 112.48 -179.569 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.429 HG21 ' N ' ' A' ' 17' ' ' TRP . 21.8 m -61.76 155.36 23.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.74 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.429 ' N ' HG21 ' A' ' 16' ' ' THR . 7.4 m-90 -99.1 91.46 5.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.077 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.556 HD23 ' HA ' ' A' ' 24' ' ' ALA . 49.8 mt -87.97 74.19 8.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.415 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.7 p -73.02 -3.18 24.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.156 -178.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -141.31 148.28 39.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.865 0.364 . . . . 0.0 111.643 -179.721 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.9 t -56.54 -50.28 88.7 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.407 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -57.34 -44.04 46.6 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 121.97 1.78 . . . . 0.0 111.866 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.24 -36.91 85.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.206 0.527 . . . . 0.0 110.184 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.556 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -62.87 -59.05 5.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.026 179.499 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.0 mtp -60.55 -27.19 67.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.212 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 19.8 mt-10 -70.66 -49.29 48.87 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.746 0.308 . . . . 0.0 110.547 179.843 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -61.52 -34.16 75.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.243 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.474 HD12 HD11 ' A' ' 36' ' ' ILE . 50.0 mt -72.99 -37.06 52.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.126 0.488 . . . . 0.0 109.939 178.345 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.01 -19.43 60.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.959 -179.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.61 23.95 4.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.297 -179.651 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.1 t -169.96 153.33 4.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.518 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.492 ' HG3' HG12 ' A' ' 87' ' ' VAL . 21.2 tt0 -63.92 -80.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.669 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.48 HG12 HD11 ' A' ' 83' ' ' LEU . 16.9 t -91.86 134.15 31.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.489 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.43 126.06 22.11 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.195 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.518 HG22 HG12 ' A' ' 111' ' ' ILE . 48.9 t -114.21 129.13 70.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.811 178.546 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.474 HD11 HD12 ' A' ' 28' ' ' ILE . 24.2 mt -135.59 137.17 49.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.439 -177.524 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.493 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.61 98.71 1.89 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.427 179.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.476 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 45.7 m-85 -84.62 93.05 8.3 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.302 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.2 m-85 -112.33 145.86 39.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.351 -177.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -93.81 -4.95 49.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.492 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.1 t70 -152.68 118.39 5.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.599 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.468 ' HG ' HG23 ' A' ' 66' ' ' THR . 92.4 mt -88.15 45.8 1.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 111.336 -179.295 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.438 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 45.4 mt-10 -136.03 9.06 3.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.125 179.161 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.67 HG13 HG23 ' A' ' 47' ' ' VAL . 2.7 pt -92.27 157.52 40.48 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.152 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.452 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 72.3 Cg_exo -52.53 -27.94 34.36 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.855 2.37 . . . . 0.0 112.865 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.47 -37.79 87.29 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.67 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.51 -57.35 25.63 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.654 -178.833 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -59.39 -38.97 80.94 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.794 1.663 . . . . 0.0 111.37 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.618 HG21 HD11 ' A' ' 107' ' ' LEU . 6.4 mt -63.26 -35.19 71.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.89 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.543 ' O ' ' HG3' ' A' ' 53' ' ' MET . 40.7 tp -74.61 -53.35 9.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.73 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -54.64 -21.81 11.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.009 0.433 . . . . 0.0 110.04 178.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 t -85.89 -45.01 11.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.491 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.543 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -60.31 -25.83 66.07 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.296 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 50' ' ' LEU . 53.4 t -52.39 -49.92 40.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.999 179.286 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.446 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 31.3 mt-30 -74.91 -9.59 58.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.721 -179.877 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -94.83 -19.35 20.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.09 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.553 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 70.4 m-85 -135.96 63.03 49.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.476 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.4 -43.15 56.36 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.629 2.219 . . . . 0.0 111.632 179.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.89 -42.66 92.43 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.338 179.188 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.8 t -64.47 145.27 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.519 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 29.9 t -83.15 98.94 9.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.033 0.444 . . . . 0.0 111.072 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.453 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.0 p90 -66.47 126.66 29.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.1 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.55 161.34 28.37 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.145 179.645 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.9 tt -159.98 144.01 5.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.461 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 31.1 t -148.05 159.52 43.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.006 0.431 . . . . 0.0 111.705 -179.306 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.468 HG23 ' HG ' ' A' ' 42' ' ' LEU . 50.6 p -140.46 -2.56 1.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.086 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.43 141.11 55.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.744 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.0 m -62.99 -50.91 68.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.553 -179.417 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -48.95 -44.61 40.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.638 -179.37 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.492 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.3 t -70.01 -54.4 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.909 0.385 . . . . 0.0 110.766 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -57.97 -14.51 6.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.303 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 76.4 m -91.62 -40.14 11.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.227 178.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -60.68 -39.67 89.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.38 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -93.09 13.88 19.58 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.444 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 m120 54.8 26.2 7.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.582 179.519 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.611 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.6 mm -61.19 120.7 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.01 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.5 p -140.74 58.28 1.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.323 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.47 44.26 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.643 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 35.2 m-20 51.75 43.49 29.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.284 0.564 . . . . 0.0 110.353 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.611 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.4 m -68.66 152.28 45.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.786 -178.646 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.521 HG22 HD21 ' A' ' 107' ' ' LEU . 67.2 mt -119.21 115.68 48.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.97 177.898 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.476 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 72.5 m -104.11 131.03 51.81 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.722 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.622 ' HG ' HD23 ' A' ' 92' ' ' LEU . 1.9 tp -106.96 102.16 11.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.492 177.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.1 t80 -95.73 119.68 34.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.806 -179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.463 HH12 HD11 ' A' ' 116' ' ' LEU . 4.4 mtm180 -102.97 80.86 1.91 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.673 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 85' ' ' ARG . 4.7 tp -24.87 -59.14 0.06 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.351 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.492 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.13 -62.51 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.088 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -95.35 2.88 54.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.087 0.47 . . . . 0.0 110.797 -179.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 52.42 33.13 12.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.445 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 12.7 mm-40 -79.37 158.2 27.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.84 99.1 3.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.953 0.406 . . . . 0.0 110.885 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.622 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -87.59 107.6 18.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.747 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -90.89 95.12 9.96 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.534 HD21 HD11 ' A' ' 102' ' ' ILE . 4.6 tt -79.6 76.98 6.22 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.407 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.3 mt-10 -78.46 -165.44 0.7 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -176.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.451 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -46.03 -50.02 15.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.484 -179.233 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -47.83 -17.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.963 0.411 . . . . 0.0 110.943 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 96' ' ' ASP . 13.7 m-20 -125.65 -13.67 6.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.392 -179.735 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.538 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.1 mm -91.87 -46.31 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.559 0.219 . . . . 0.0 111.561 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -48.82 -31.05 6.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.913 0.387 . . . . 0.0 110.739 179.783 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 57.0 m -131.25 45.55 2.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.072 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.536 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 8.1 tp -78.61 146.39 8.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.79 -179.452 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.547 ' HA ' HD11 ' A' ' 49' ' ' ILE . 6.1 m-20 -141.37 148.8 40.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.266 178.616 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.58 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.13 -37.36 9.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 110.593 -179.598 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -61.44 -49.2 77.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.401 178.722 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -58.66 -60.47 3.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.151 -179.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.618 HD11 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.93 -55.72 10.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.006 0.432 . . . . 0.0 110.264 -179.954 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.3 m -58.35 -29.57 66.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.819 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.503 ' HD3' HD13 ' A' ' 113' ' ' ILE . 1.7 tmt_? -72.15 -66.56 0.63 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.184 179.713 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -42.05 -44.12 3.46 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.05 179.147 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.518 HG12 HG22 ' A' ' 35' ' ' VAL . 96.7 mt -62.5 -55.02 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.517 178.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -55.25 -17.85 5.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.325 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.579 HG22 ' ND2' ' A' ' 114' ' ' ASN . 1.4 mp -91.01 -36.0 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.856 -179.185 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.579 ' ND2' HG22 ' A' ' 113' ' ' ILE . 61.7 m-80 -119.33 26.4 9.46 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.9 p -79.92 46.12 0.77 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.044 0.449 . . . . 0.0 110.306 178.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.463 HD11 HH12 ' A' ' 85' ' ' ARG . 57.0 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.413 -179.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.777 0.322 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.607 HG23 ' HG2' ' A' ' 3' ' ' GLU . 11.5 p -87.84 141.28 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.051 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.607 ' HG2' HG23 ' A' ' 2' ' ' VAL . 15.8 mm-40 60.6 -84.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.354 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.49 ' HE3' ' HA ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -88.34 -174.2 4.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.185 -179.687 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.3 m -83.81 -165.51 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 t -64.56 -61.75 2.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -149.24 -36.87 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.141 179.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.45 -163.89 24.14 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.644 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.65 143.92 98.12 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.665 2.243 . . . . 0.0 112.318 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.24 110.78 3.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.598 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.87 -24.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.924 0.392 . . . . 0.0 110.592 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.491 ' HB3' ' NE2' ' A' ' 55' ' ' GLN . . . -53.66 92.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.31 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.602 ' HG3' HG11 ' A' ' 54' ' ' VAL . 3.6 pt20 -50.31 155.88 0.94 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.537 179.893 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.464 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.3 pt-20 -124.67 158.63 61.49 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.369 179.641 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 35.4 Cg_endo -65.48 142.62 72.56 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.421 2.081 . . . . 0.0 112.611 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.5 m -60.76 151.45 29.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.695 -179.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -95.17 92.01 6.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.083 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.553 HD21 ' HA ' ' A' ' 24' ' ' ALA . 65.2 mt -88.72 77.64 7.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.411 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.6 p -77.26 -3.19 38.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.023 -179.113 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -141.69 147.33 37.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.948 0.404 . . . . 0.0 111.774 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 22.1 t -55.22 -50.02 88.98 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.633 179.875 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.89 -45.82 30.17 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.939 1.759 . . . . 0.0 111.793 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.23 -33.99 76.69 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.205 0.526 . . . . 0.0 110.149 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.553 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -64.52 -59.39 4.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.116 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 47.3 mtm -61.1 -26.33 67.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.131 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.9 mt-10 -71.23 -52.07 21.08 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.702 0.286 . . . . 0.0 110.437 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.402 ' O ' HG23 ' A' ' 31' ' ' THR . 7.8 m-85 -59.79 -30.71 69.08 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.122 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.465 HD12 HD11 ' A' ' 36' ' ' ILE . 47.2 mt -74.59 -37.81 44.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.965 178.188 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.6 -18.56 61.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.813 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.89 27.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.057 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.411 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.7 t -169.05 156.65 7.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.328 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HG3' HG11 ' A' ' 87' ' ' VAL . 27.6 tt0 -75.56 -37.2 60.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.657 179.617 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.47 HG11 HD11 ' A' ' 83' ' ' LEU . 18.7 t -132.29 131.45 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.291 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -137.25 128.27 27.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.032 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.519 HG23 HG12 ' A' ' 111' ' ' ILE . 52.7 t -116.03 127.92 73.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.692 178.39 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 20.6 mt -133.79 137.08 53.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.781 -177.251 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.545 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.85 96.29 1.61 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.371 179.726 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.521 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.0 m-85 -81.51 88.55 6.17 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.524 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -108.43 142.57 38.59 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.194 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -90.29 -8.97 49.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 44' ' ' ILE . 15.6 t70 -148.54 119.28 7.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.521 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.458 ' HG ' HG23 ' A' ' 66' ' ' THR . 94.5 mt -89.06 45.17 1.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.131 0.491 . . . . 0.0 111.588 -179.279 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.415 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.5 mt-10 -135.31 8.28 3.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.069 178.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.646 HG13 HG23 ' A' ' 47' ' ' VAL . 1.5 pt -92.19 156.09 42.24 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.169 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 86.3 Cg_exo -49.78 -31.32 25.62 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.794 2.329 . . . . 0.0 112.807 179.684 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.14 -37.38 77.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.29 -178.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.679 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.5 t -62.28 -58.3 18.17 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.578 -178.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.679 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.5 Cg_exo -58.97 -40.94 66.69 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.697 1.598 . . . . 0.0 111.272 179.187 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.66 HG21 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -60.46 -35.5 63.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.738 179.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.52 ' O ' ' HG3' ' A' ' 53' ' ' MET . 49.0 tp -74.3 -53.75 9.06 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -53.83 -24.03 14.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.105 0.479 . . . . 0.0 109.946 178.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.0 m -82.97 -45.11 14.51 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.342 179.551 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.52 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -60.58 -26.41 66.94 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.368 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.602 HG11 ' HG3' ' A' ' 13' ' ' GLN . 62.3 t -53.16 -50.7 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.976 179.518 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.491 ' NE2' ' HB3' ' A' ' 12' ' ' ALA . 34.5 mt-30 -73.23 -10.97 60.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.617 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -93.96 -19.42 20.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.295 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 54.2 m-85 -135.88 61.79 43.38 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.472 -179.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.02 -40.5 76.26 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.565 2.176 . . . . 0.0 111.415 179.175 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.17 -43.0 95.56 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.357 178.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.1 t -65.02 146.08 13.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 178.86 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.514 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 37.5 t -83.1 95.73 8.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.053 0.454 . . . . 0.0 111.054 -179.61 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.461 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 5.8 p90 -61.42 128.9 38.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.75 179.49 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.84 160.98 28.58 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.251 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.5 tt -159.47 143.54 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.696 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.4 t -147.28 155.29 41.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.154 0.502 . . . . 0.0 111.833 -178.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.458 HG23 ' HG ' ' A' ' 42' ' ' LEU . 81.4 p -138.77 -0.31 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.587 179.561 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -68.61 141.98 55.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.571 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 t -65.12 -51.34 61.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.411 -179.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -50.91 -42.05 59.05 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.551 -179.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.51 ' HA ' HG23 ' A' ' 21' ' ' VAL . 57.4 t -71.15 -53.39 21.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.92 0.39 . . . . 0.0 110.596 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.05 -15.43 13.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.324 179.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.4 m -91.24 -40.6 11.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.359 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -61.13 -38.22 85.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.345 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -93.25 14.28 18.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.682 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 54.45 23.32 4.41 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.643 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.642 HG22 ' HB ' ' A' ' 80' ' ' THR . 39.6 mm -57.72 120.05 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.961 179.754 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.2 p -139.01 57.36 1.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.492 -179.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.36 49.3 0.02 OUTLIER Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.738 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.536 ' HB2' HG23 ' A' ' 99' ' ' ILE . 34.3 m-20 48.17 43.68 18.79 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.207 0.527 . . . . 0.0 110.292 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.642 ' HB ' HG22 ' A' ' 76' ' ' ILE . 97.2 m -69.34 151.53 46.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.737 -178.373 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.545 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.9 mt -118.27 117.0 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.835 178.12 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.521 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.1 m -106.05 130.93 53.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.824 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.594 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.4 tp -107.23 104.19 13.75 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.525 177.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.2 t80 -98.7 121.1 40.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.798 0.332 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.519 HH12 HD11 ' A' ' 116' ' ' LEU . 3.8 mtm180 -104.38 98.45 8.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.094 179.711 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tp -42.07 -50.46 4.7 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.783 -179.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.539 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.86 -65.21 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.516 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.409 ' HB2' HH21 ' A' ' 85' ' ' ARG . 9.7 m-20 -99.01 10.57 41.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.562 -179.315 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 85' ' ' ARG . 78.1 m-20 49.66 34.27 7.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.509 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 8.2 mm-40 -78.02 157.69 29.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.122 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -142.34 97.2 3.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.808 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.594 HD21 ' HG ' ' A' ' 83' ' ' LEU . 1.9 mm? -88.06 113.52 23.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.767 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -95.84 96.91 9.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.548 HD23 HD13 ' A' ' 102' ' ' ILE . 4.1 tt -80.98 78.76 7.77 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.626 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.0 mt-10 -80.77 -163.79 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.762 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.475 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 17.4 t70 -50.66 -37.7 42.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.047 -179.2 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -55.34 -14.93 2.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.118 0.485 . . . . 0.0 110.393 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -131.14 -13.76 3.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.605 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.573 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 25.8 mm -89.63 -32.98 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.612 0.244 . . . . 0.0 111.379 -179.376 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -51.51 -49.38 62.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.704 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.3 m -117.79 38.14 3.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.526 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.573 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.2 tp -63.93 147.0 12.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.645 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.558 ' HA ' HD11 ' A' ' 49' ' ' ILE . 11.5 t70 -141.09 165.24 28.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.685 178.574 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.66 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -62.12 -35.57 79.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.144 0.497 . . . . 0.0 109.691 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -64.66 -47.5 78.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.222 178.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -59.31 -59.37 5.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.177 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.579 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.21 -55.62 14.49 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.937 0.399 . . . . 0.0 110.132 179.656 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.5 m -58.85 -28.65 66.29 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.82 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.529 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.9 tmt_? -71.93 -66.45 0.64 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.185 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -42.9 -43.71 4.22 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.166 179.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.519 HG12 HG23 ' A' ' 35' ' ' VAL . 95.4 mt -63.38 -54.69 29.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.551 178.452 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -54.52 -19.36 5.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.23 179.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.529 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -87.89 -37.67 10.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.939 -179.109 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -121.76 29.39 7.16 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.601 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 81.1 p -81.65 44.97 0.85 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.11 0.481 . . . . 0.0 110.232 178.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.519 HD11 HH12 ' A' ' 85' ' ' ARG . 52.6 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.185 -179.398 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.775 0.321 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.8 m -101.38 19.14 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.219 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -99.33 124.53 44.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.96 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.556 ' HA ' ' HE2' ' A' ' 4' ' ' LYS . 11.4 mmpt? 55.72 42.85 28.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.992 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.1 t -149.05 30.23 0.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.687 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.6 m -146.81 87.67 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.995 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -121.13 -172.33 2.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.86 -152.82 33.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.279 -179.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -56.93 104.36 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.508 2.139 . . . . 0.0 112.062 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.33 110.2 3.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.546 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.78 -74.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.621 0.248 . . . . 0.0 110.779 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.0 -80.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.269 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.488 ' HG3' HG12 ' A' ' 54' ' ' VAL . 27.7 pt20 -167.23 148.0 5.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.7 pt-20 -131.87 158.4 75.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.985 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 38.8 Cg_endo -66.76 142.85 65.07 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.592 2.195 . . . . 0.0 112.389 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.3 m -61.81 152.87 30.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.765 -179.315 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.51 94.91 7.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.866 179.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 24' ' ' ALA . 48.8 mt -90.52 71.48 6.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.373 179.855 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.0 p -70.92 -5.04 27.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.945 -179.23 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -137.53 146.49 44.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.007 0.432 . . . . 0.0 111.656 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.9 t -56.12 -49.17 94.7 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.377 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -58.11 -46.46 25.35 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.936 1.757 . . . . 0.0 111.869 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.68 -34.85 77.96 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.344 0.592 . . . . 0.0 110.251 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.56 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -63.8 -59.84 4.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.113 179.399 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 30.6 mtt -60.7 -25.88 66.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.207 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 31.3 mt-10 -71.27 -51.13 26.2 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.373 179.639 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -60.66 -30.32 69.83 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.159 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.448 HD13 HD13 ' A' ' 36' ' ' ILE . 45.6 mt -76.22 -37.01 31.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.96 178.15 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.02 -23.08 61.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.813 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.13 31.65 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.923 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.425 HG22 ' CB ' ' A' ' 61' ' ' SER . 8.9 t -170.22 151.25 3.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.337 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.476 ' HG3' HG13 ' A' ' 87' ' ' VAL . 23.3 tt0 -70.73 -50.36 37.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.58 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 83' ' ' LEU . 19.1 t -119.7 136.34 57.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.359 179.262 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.494 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.56 128.55 20.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.013 0.435 . . . . 0.0 112.119 -178.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG23 HG12 ' A' ' 111' ' ' ILE . 47.1 t -115.5 128.81 72.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.672 178.469 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 23.8 mt -135.03 136.08 52.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -177.306 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.544 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.48 97.24 1.78 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.455 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.522 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.4 m-85 -83.39 90.98 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.9 m-85 -110.5 142.71 41.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.037 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.449 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 50.8 mt-30 -91.04 -0.96 57.85 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.482 ' O ' HG12 ' A' ' 44' ' ' ILE . 26.6 t70 -157.59 119.39 3.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.571 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.496 ' HG ' HG23 ' A' ' 66' ' ' THR . 94.2 mt -89.15 45.4 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.087 0.47 . . . . 0.0 111.386 -179.262 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.1 mt-10 -134.66 12.04 3.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.01 179.094 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.68 HG13 HG23 ' A' ' 47' ' ' VAL . 3.5 pt -95.53 158.29 34.75 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.483 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.467 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 73.4 Cg_exo -52.73 -28.65 38.84 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.853 2.369 . . . . 0.0 112.721 179.42 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.63 -38.09 86.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.012 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.68 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.05 -57.69 24.48 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.681 -178.724 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.665 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.5 Cg_exo -59.46 -39.49 75.53 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.775 1.65 . . . . 0.0 111.431 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.638 HG21 ' HA ' ' A' ' 104' ' ' ALA . 7.7 mt -62.5 -36.06 73.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.008 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.541 ' O ' ' HG3' ' A' ' 53' ' ' MET . 40.1 tp -74.8 -54.07 7.99 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.852 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -53.45 -23.63 10.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.952 0.406 . . . . 0.0 110.025 178.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 t -84.27 -45.54 12.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.474 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.541 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.33 -25.6 64.31 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.342 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.2 t -51.89 -49.08 38.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.265 179.391 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.468 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 38.1 mt-30 -76.76 -9.08 58.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.738 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -94.94 -18.71 20.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.156 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.553 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.4 m-85 -136.86 63.21 44.49 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.368 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.55 -46.12 35.46 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.643 2.229 . . . . 0.0 111.643 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.82 -42.87 69.97 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.392 179.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -65.03 144.28 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.781 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 46.8 t -82.35 98.79 9.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.078 0.466 . . . . 0.0 111.159 -179.554 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.435 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.1 p90 -65.35 126.72 29.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.009 179.728 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.73 161.98 28.46 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.187 179.861 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -160.57 143.3 4.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.2 t -146.18 156.67 43.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.183 0.516 . . . . 0.0 111.675 -179.066 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.496 HG23 ' HG ' ' A' ' 42' ' ' LEU . 52.2 p -139.17 -3.63 1.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.589 179.548 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.44 140.46 57.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.401 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.4 t -64.63 -47.64 77.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.68 -179.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -51.77 -43.68 63.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.73 -0.213 . . . . 0.0 111.554 -179.307 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.503 ' HA ' HG21 ' A' ' 21' ' ' VAL . 79.7 t -71.75 -52.37 25.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.722 0.296 . . . . 0.0 110.513 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.428 HD21 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -58.48 -15.0 9.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.24 179.271 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.7 m -92.61 -40.52 10.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.429 178.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -62.41 -33.08 74.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.428 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -97.07 9.81 41.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.864 179.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 75' ' ' ASN . 2.1 t-20 60.1 20.7 9.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.569 178.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.617 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.9 mm -58.36 117.92 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 179.818 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.9 p -138.38 56.78 1.71 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.283 179.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.22 45.45 0.02 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.677 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 12.2 m120 51.26 43.11 29.47 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.243 0.545 . . . . 0.0 110.398 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.617 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.5 m -69.05 151.08 46.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.673 -178.573 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.544 HG12 ' HA2' ' A' ' 37' ' ' GLY . 70.9 mt -118.32 116.8 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.882 178.045 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.522 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.5 m -105.89 130.88 53.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.808 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.552 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -105.37 99.73 9.33 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.389 177.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.1 t80 -92.63 121.85 34.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.583 179.854 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.503 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.0 mtm180 -106.41 85.56 2.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.83 -179.684 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.9 tp -26.51 -60.2 0.08 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.365 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.476 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.94 -71.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 O-C-N 123.448 0.467 . . . . 0.0 112.092 -179.161 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.04 5.32 41.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 110.687 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 51.12 33.44 9.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.148 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.503 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 14.1 mm-40 -75.64 164.77 25.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.727 179.535 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -148.79 89.01 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.836 179.936 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.552 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.6 mm? -76.6 111.71 12.38 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.544 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -94.48 97.53 10.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.488 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.476 HD21 HD12 ' A' ' 102' ' ' ILE . 4.4 tt -82.93 77.29 9.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.593 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.2 mt-10 -78.91 -165.12 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.487 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 19.4 t70 -51.67 -35.42 42.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.686 -179.291 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -56.57 -15.19 3.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.225 0.536 . . . . 0.0 110.24 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -130.33 -13.99 3.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.779 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.502 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.4 mm -89.44 -29.59 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.684 0.278 . . . . 0.0 111.514 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.52 -38.38 69.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.855 0.36 . . . . 0.0 110.961 -179.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.8 t -129.78 38.74 3.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.319 179.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.8 tp -64.02 141.74 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.559 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.551 ' HA ' HD11 ' A' ' 49' ' ' ILE . 21.6 m-20 -137.24 149.81 47.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.531 178.786 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.638 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -47.67 -37.31 12.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.923 0.392 . . . . 0.0 110.337 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -61.88 -49.09 77.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.147 178.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -58.65 -61.31 2.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.23 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.581 HD11 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.18 -57.34 6.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 110.35 179.908 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.3 m -57.06 -30.38 64.23 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.8 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.5 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -70.91 -65.72 0.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.186 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -42.82 -40.91 3.05 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.044 179.277 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.502 HG12 HG23 ' A' ' 35' ' ' VAL . 96.2 mt -65.9 -56.29 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.247 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -53.21 -18.26 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.325 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.573 HG23 ' ND2' ' A' ' 114' ' ' ASN . 1.4 mp -90.31 -39.5 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.87 -179.108 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.573 ' ND2' HG23 ' A' ' 113' ' ' ILE . 67.8 m-80 -118.72 28.73 8.13 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.775 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.3 p -82.22 50.26 1.56 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.023 0.44 . . . . 0.0 110.35 179.224 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.478 HD12 ' NH1' ' A' ' 85' ' ' ARG . 67.2 mt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.265 -179.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.906 0.384 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.478 HG23 ' HG3' ' A' ' 3' ' ' GLU . 27.5 m -104.99 -10.33 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.178 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.478 ' HG3' HG23 ' A' ' 2' ' ' VAL . 46.2 mt-10 -120.67 146.69 46.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.0 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -135.12 16.94 3.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.718 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 t -126.51 117.93 23.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.967 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.5 m -69.07 103.86 1.98 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.821 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -65.22 147.0 54.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.96 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.56 -75.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.516 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.16 130.36 32.06 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.671 2.248 . . . . 0.0 112.353 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.0 158.36 19.59 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.282 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.27 -32.39 0.05 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.951 0.405 . . . . 0.0 110.782 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.406 ' HB1' ' NE2' ' A' ' 55' ' ' GLN . . . -56.17 -30.69 62.57 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.996 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.495 ' HG3' HG11 ' A' ' 54' ' ' VAL . 11.5 pt20 -173.45 145.91 1.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.687 -179.848 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.473 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.7 pt-20 -133.05 158.7 75.16 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.062 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 37.7 Cg_endo -67.78 145.44 69.08 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.739 2.293 . . . . 0.0 112.559 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -64.14 153.35 38.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.554 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -98.13 95.02 7.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.799 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.562 HD21 ' HA ' ' A' ' 24' ' ' ALA . 44.7 mt -91.45 71.91 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.357 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.2 p -70.84 -4.28 23.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.169 -179.157 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -139.46 147.34 41.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.378 . . . . 0.0 111.661 -179.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 35.3 t -55.64 -49.69 91.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.559 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.68 -46.39 27.18 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.917 1.745 . . . . 0.0 112.053 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.79 81.45 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.176 0.513 . . . . 0.0 110.2 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -63.55 -58.84 5.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.121 179.328 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.6 mtp -60.37 -25.54 65.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.157 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -72.61 -51.16 20.82 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.608 179.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -60.63 -30.73 70.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.199 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.454 HD12 HD12 ' A' ' 36' ' ' ILE . 53.4 mt -75.79 -37.96 36.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.052 178.417 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.85 -17.08 60.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.285 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.42 26.62 3.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.078 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.2 t -167.86 153.09 6.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.54 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.529 ' HG3' HG12 ' A' ' 87' ' ' VAL . 25.0 tt0 -66.79 -52.31 45.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.89 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.463 HG11 HD13 ' A' ' 83' ' ' LEU . 22.4 t -119.83 137.39 53.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.322 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.49 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.71 128.55 21.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.193 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.491 HG21 HG12 ' A' ' 111' ' ' ILE . 52.1 t -116.61 131.76 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.572 178.511 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.454 HD12 HD12 ' A' ' 28' ' ' ILE . 21.0 mt -136.62 136.73 48.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.487 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.558 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.34 97.53 1.83 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.549 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.1 m-85 -83.7 92.49 7.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.6 m-85 -112.95 140.44 47.76 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.166 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.451 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 51.7 mt-30 -88.93 0.33 56.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.449 ' O ' HG12 ' A' ' 44' ' ' ILE . 24.8 t70 -157.96 120.72 3.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.66 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.505 ' HG ' HG23 ' A' ' 66' ' ' THR . 91.7 mt -90.62 46.53 1.34 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 111.428 -179.307 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.444 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 36.8 mt-10 -136.95 9.72 3.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 179.122 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.656 HG13 HG21 ' A' ' 47' ' ' VAL . 2.3 pt -92.97 157.01 39.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.313 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.42 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 72.4 Cg_exo -52.01 -25.26 21.75 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.943 2.429 . . . . 0.0 113.022 179.719 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.44 -38.59 90.3 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.656 HG21 HG13 ' A' ' 44' ' ' ILE . 2.3 t -59.95 -55.59 44.01 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.583 -178.776 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.627 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.96 -41.31 54.38 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.928 1.752 . . . . 0.0 111.502 179.218 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.617 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.3 mt -61.57 -34.6 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.208 179.83 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.52 ' O ' ' HG3' ' A' ' 53' ' ' MET . 45.8 tp -73.93 -52.71 12.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -53.03 -26.96 17.39 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.9 m -80.07 -46.45 16.51 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.621 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.52 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.75 -25.99 65.31 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.446 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.8 t -53.1 -49.37 50.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.718 179.368 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.406 ' NE2' ' HB1' ' A' ' 12' ' ' ALA . 40.9 mt-30 -76.23 -9.7 58.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.666 -179.855 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -94.92 -17.8 21.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.116 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.549 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 68.3 m-85 -138.35 63.01 33.56 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.441 -179.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.01 -43.56 56.02 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.623 2.215 . . . . 0.0 111.651 179.145 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.23 -40.83 85.4 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.239 179.041 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.3 t -66.19 142.99 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.49 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 42.1 t -80.79 96.8 7.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.959 0.409 . . . . 0.0 110.957 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.473 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 4.9 p90 -62.59 126.94 29.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.836 179.582 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.16 161.76 28.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.256 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.8 tt -161.24 142.24 3.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -147.59 154.14 40.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.1 0.476 . . . . 0.0 111.803 -178.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.505 HG23 ' HG ' ' A' ' 42' ' ' LEU . 68.4 p -135.57 -2.08 2.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.534 179.529 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' O ' HD12 ' A' ' 71' ' ' LEU . 23.9 t70 -67.18 142.48 56.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.717 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.1 m -65.95 -49.85 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.664 -179.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -50.47 -43.24 55.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.436 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.471 ' HA ' HG21 ' A' ' 21' ' ' VAL . 76.2 t -71.45 -53.21 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.668 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.421 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -58.52 -14.63 8.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.222 179.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 78.4 m -91.89 -41.2 10.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.252 178.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -61.22 -34.86 75.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.318 179.703 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -96.01 11.91 32.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.854 179.516 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 56.05 22.74 6.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.646 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.638 HG21 ' HB ' ' A' ' 80' ' ' THR . 35.5 mm -59.03 120.21 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.951 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.1 p -140.7 55.2 1.59 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.333 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.75 45.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.458 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.546 ' HB2' HG22 ' A' ' 99' ' ' ILE . 13.1 m120 50.71 43.43 27.92 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.15 0.5 . . . . 0.0 110.44 -179.826 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.638 ' HB ' HG21 ' A' ' 76' ' ' ILE . 98.0 m -69.61 152.31 44.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.77 -178.495 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.581 HG21 HD23 ' A' ' 107' ' ' LEU . 62.8 mt -118.8 118.17 56.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.892 178.075 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.2 m -106.81 134.78 49.44 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.6 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.5 tp -110.79 103.36 11.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.788 178.227 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -96.96 123.0 40.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.525 179.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.522 HH12 HD11 ' A' ' 116' ' ' LEU . 5.5 mtm180 -106.07 96.33 6.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.051 0.453 . . . . 0.0 110.187 179.803 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.4 tp -40.45 -50.2 2.88 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.558 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.529 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -44.66 -68.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.85 0.357 . . . . 0.0 111.908 -179.627 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.409 ' HB2' HH21 ' A' ' 85' ' ' ARG . 17.7 m-20 -92.85 17.76 10.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.442 -179.424 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.9 p30 43.11 31.3 0.34 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.043 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.508 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 13.7 mm-40 -76.59 162.48 27.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.824 0.345 . . . . 0.0 111.14 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -149.01 87.1 1.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.967 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.6 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -76.05 144.64 40.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.304 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -125.35 99.31 6.0 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.074 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.548 HD21 HD12 ' A' ' 102' ' ' ILE . 4.8 tt -84.11 78.01 9.84 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.597 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -79.66 -165.79 0.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.439 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.6 OUTLIER -44.47 -52.58 7.76 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.618 -179.255 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -46.82 -17.06 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.51 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -125.76 -13.98 6.3 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.41 179.723 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 79' ' ' ASN . 24.6 mm -89.73 -35.41 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.112 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -48.25 -55.39 10.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.852 -179.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.1 p -114.08 39.31 2.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.539 179.462 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.548 HD12 HD21 ' A' ' 94' ' ' LEU . 8.2 tp -61.14 142.57 15.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.515 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.585 ' HA ' HD12 ' A' ' 49' ' ' ILE . 18.8 m-20 -134.92 149.76 50.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.572 178.785 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.617 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.32 -32.96 12.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.11 0.481 . . . . 0.0 110.102 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -63.9 -49.08 74.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.352 178.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -59.04 -59.84 4.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.278 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.604 HD13 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.19 -56.19 12.09 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.071 0.462 . . . . 0.0 110.076 179.848 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.3 m -58.21 -28.86 65.21 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.776 179.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.45 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.4 tmt_? -71.35 -67.11 0.54 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.079 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -42.24 -43.34 3.38 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.158 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.491 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -64.35 -55.47 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.702 178.416 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -52.89 -22.9 6.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.481 0.658 . . . . 0.0 110.112 179.259 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.45 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -85.66 -36.96 11.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.009 -179.054 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -124.84 31.87 5.56 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 111' ' ' ILE . 89.1 p -83.6 36.93 0.56 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.189 0.518 . . . . 0.0 110.213 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.522 HD11 HH12 ' A' ' 85' ' ' ARG . 51.7 mt . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.212 -179.517 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.6 m -90.84 148.16 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.093 -179.926 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -136.75 -42.49 0.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.974 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -76.42 -68.21 0.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.697 179.946 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.5 p -109.26 162.02 14.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.825 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.2 t -121.64 120.32 34.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.177 -179.702 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.9 t70 55.21 84.78 0.07 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.124 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -107.99 158.51 14.83 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.457 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.97 96.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.53 2.153 . . . . 0.0 112.409 179.992 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.87 -87.07 0.11 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.299 179.827 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.04 -81.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.571 0.224 . . . . 0.0 110.59 179.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.417 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . . . 56.16 104.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.507 179.678 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.607 ' HG3' HG13 ' A' ' 54' ' ' VAL . 24.9 pt20 -51.47 139.24 20.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.076 -179.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.497 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 -111.19 159.67 31.93 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.859 -179.958 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 29.4 Cg_endo -64.32 154.0 73.63 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.63 2.22 . . . . 0.0 112.525 -179.718 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -67.94 153.06 44.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.42 -179.765 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.99 84.15 2.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.727 179.696 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 24' ' ' ALA . 46.8 mt -81.73 72.21 8.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.633 -179.723 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.1 p -70.63 -2.94 15.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.09 -179.013 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -142.27 147.63 36.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.083 0.468 . . . . 0.0 111.804 -179.603 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.583 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 60.6 t -55.47 -49.99 89.39 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.824 -179.999 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.3 Cg_endo -58.32 -44.84 34.97 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.035 1.823 . . . . 0.0 111.82 -179.899 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.23 -34.55 78.37 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.33 0.586 . . . . 0.0 110.229 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.561 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -63.2 -59.18 5.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.929 179.262 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 34.0 mtt -60.23 -27.82 67.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.244 -179.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -70.21 -49.88 45.72 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 110.603 179.807 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -61.13 -32.95 72.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.892 179.237 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.415 HD13 HD13 ' A' ' 36' ' ' ILE . 48.4 mt -75.0 -37.35 40.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.034 178.478 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.32 -18.27 60.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.131 -179.705 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.2 27.31 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.131 -179.896 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.9 t -174.31 154.91 2.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.602 -179.873 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.441 ' HG3' HG11 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -64.58 -82.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.016 0.436 . . . . 0.0 110.719 179.556 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.513 HG13 HD12 ' A' ' 83' ' ' LEU . 18.1 t -89.6 134.34 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.758 -179.53 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.545 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.46 124.71 20.37 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.061 -179.216 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.577 HG22 HG12 ' A' ' 111' ' ' ILE . 46.4 t -113.61 128.16 70.61 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.921 178.702 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.453 HG12 ' HA3' ' A' ' 63' ' ' GLY . 26.8 mt -133.63 138.48 50.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.457 -177.289 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.528 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.68 95.9 1.41 Allowed Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.381 179.801 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.504 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 36.3 m-85 -81.99 89.33 6.39 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.294 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.584 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 13.6 m-85 -107.59 140.57 40.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.615 -177.769 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -88.9 -5.62 57.87 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.081 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.475 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.3 t70 -154.53 121.73 5.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.656 179.851 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.491 ' HA ' HG22 ' A' ' 47' ' ' VAL . 92.0 mt -90.04 45.29 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.014 0.435 . . . . 0.0 111.449 -179.354 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 11.1 mm-40 -134.83 11.78 3.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.068 179.245 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.684 HG13 HG23 ' A' ' 47' ' ' VAL . 4.0 pt -94.89 158.92 34.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.286 -179.955 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' O ' HD11 ' A' ' 49' ' ' ILE . 62.4 Cg_exo -54.86 -25.38 43.12 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.843 2.362 . . . . 0.0 112.803 179.497 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.43 -35.64 81.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.705 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.684 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -63.51 -55.87 31.33 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.648 -178.776 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 38.0 Cg_exo -60.84 -34.49 91.29 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.999 1.8 . . . . 0.0 111.598 179.65 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.656 HG23 HD13 ' A' ' 107' ' ' LEU . 6.4 mt -69.38 -35.35 66.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.606 ' O ' ' HG3' ' A' ' 53' ' ' MET . 36.7 tp -73.61 -50.41 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.471 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -55.74 -20.32 14.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.304 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -84.43 -49.67 8.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.567 179.29 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 2.9 ppp? -57.67 -25.36 60.13 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.099 0.476 . . . . 0.0 109.91 179.556 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.607 HG13 ' HG3' ' A' ' 13' ' ' GLN . 55.0 t -52.87 -46.55 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.991 179.51 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.417 ' OE1' ' HB3' ' A' ' 12' ' ' ALA . 6.7 mt-30 -80.05 -9.85 59.73 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.533 -179.848 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 27.8 mtpp -93.55 -19.0 21.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.239 -179.963 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.601 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 70.8 m-85 -137.17 62.57 39.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.468 -179.291 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.64 -36.47 71.98 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.535 2.157 . . . . 0.0 111.366 179.025 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.85 -42.05 99.75 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.818 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.1 t -65.95 144.95 14.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.799 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.545 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 46.7 t -83.24 98.82 9.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.108 0.48 . . . . 0.0 110.974 -179.613 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.502 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 6.4 p90 -64.8 129.05 38.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.025 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.453 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -147.1 161.46 28.46 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.087 179.862 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -162.25 144.07 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.823 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.504 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 44.8 t -149.77 155.61 40.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.144 0.497 . . . . 0.0 111.673 -179.262 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.489 HG22 ' HG ' ' A' ' 42' ' ' LEU . 70.2 p -136.94 0.03 2.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.39 179.281 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -69.53 138.91 53.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.506 179.841 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.4 p -63.14 -48.26 79.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.529 -179.459 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -49.98 -46.78 52.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.615 0.245 . . . . 0.0 111.571 -179.411 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.525 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.4 t -69.02 -53.96 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -58.32 -15.05 8.85 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.258 179.478 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.2 m -91.67 -39.23 11.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.362 179.041 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -62.84 -39.04 93.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.468 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -92.15 12.62 21.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.627 179.312 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 55.86 25.2 8.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.535 179.363 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.637 HG21 ' HB ' ' A' ' 80' ' ' THR . 42.1 mm -60.84 122.68 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.48 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.2 p -142.8 59.68 1.43 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.248 -179.824 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.29 43.46 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.571 179.856 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.584 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 24.6 m-80 52.41 44.26 30.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.177 0.513 . . . . 0.0 110.569 -179.821 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.637 ' HB ' HG21 ' A' ' 76' ' ' ILE . 95.6 m -69.71 151.34 45.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.404 -0.817 . . . . 0.0 112.804 -178.568 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.528 HG12 ' HA2' ' A' ' 37' ' ' GLY . 57.1 mt -116.85 116.6 52.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.132 178.155 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 74.4 m -104.56 135.27 46.29 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.568 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -112.07 102.58 10.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.296 178.822 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.2 t80 -96.03 119.67 34.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.448 179.547 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.493 HH12 HD12 ' A' ' 116' ' ' LEU . 5.6 mtm180 -103.49 81.39 1.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.958 -179.421 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.413 ' HB3' ' HA ' ' A' ' 32' ' ' GLU . 11.6 tp -25.35 -58.73 0.06 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.026 -179.369 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.441 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.42 -72.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.408 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -83.44 3.69 30.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.009 0.433 . . . . 0.0 110.542 179.944 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 52.06 32.7 10.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.639 179.725 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.473 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 7.1 mm-40 -78.26 162.1 26.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.688 179.737 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.8 OUTLIER -146.45 91.67 2.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.026 179.926 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.571 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.3 mm? -79.09 146.06 33.45 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.378 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -127.28 93.21 3.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.018 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.504 HD22 HD13 ' A' ' 102' ' ' ILE . 4.4 tt -79.01 77.69 5.46 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.689 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.6 mt-10 -78.18 -166.24 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.801 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.522 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.8 t70 -51.12 -36.74 42.1 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.86 -179.369 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.419 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 10.3 pt-20 -55.82 -14.75 2.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.193 0.521 . . . . 0.0 110.477 179.551 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.419 ' OD2' ' HG3' ' A' ' 97' ' ' GLU . 23.7 m-20 -130.12 -13.75 3.97 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.537 179.881 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.522 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 19.6 mm -89.27 -29.96 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.316 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -55.16 -45.28 75.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 111.134 -179.804 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.6 m -121.74 37.66 4.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.454 179.774 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.504 HD13 HD22 ' A' ' 94' ' ' LEU . 6.7 tp -62.35 144.69 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.43 -179.842 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.506 ' HA ' HD12 ' A' ' 49' ' ' ILE . 21.6 m-20 -139.9 150.09 44.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.73 178.881 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.577 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -46.56 -39.79 11.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.916 0.389 . . . . 0.0 110.617 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.1 m -61.89 -47.57 84.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.64 178.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -59.03 -57.09 14.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.366 -179.521 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.656 HD13 HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.7 -57.34 9.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.966 0.412 . . . . 0.0 110.011 179.832 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.2 m -56.7 -29.62 62.61 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.98 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -70.69 -65.25 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.189 179.739 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -43.2 -43.61 4.77 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.938 179.167 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.577 HG12 HG22 ' A' ' 35' ' ' VAL . 26.0 mt -62.13 -56.32 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.438 178.249 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -53.87 -19.38 4.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.29 179.401 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.469 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.63 -35.71 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.956 -179.154 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.571 HD21 ' HG ' ' A' ' 92' ' ' LEU . 87.8 m-20 -126.6 31.25 5.38 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.463 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 111' ' ' ILE . 88.6 p -84.56 45.98 1.19 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.242 0.544 . . . . 0.0 110.071 178.848 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.493 HD12 HH12 ' A' ' 85' ' ' ARG . 55.5 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.455 -179.163 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 p -61.92 145.89 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.046 179.868 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -153.18 92.78 1.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.926 179.911 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -96.0 20.11 10.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.593 179.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.7 t 61.61 -86.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.264 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.0 t -146.43 141.29 26.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.85 0.357 . . . . 0.0 110.801 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.03 63.02 6.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.948 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.17 95.5 0.24 Allowed Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.414 179.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.38 142.97 92.83 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.639 2.226 . . . . 0.0 112.233 -179.836 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.85 51.58 1.63 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.591 179.972 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.0 -60.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 0.0 110.673 179.926 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.15 -81.77 0.02 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.489 179.655 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.511 ' HG3' HG13 ' A' ' 54' ' ' VAL . 26.2 pt20 -143.18 135.99 27.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 111.049 179.889 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 -121.78 158.45 54.42 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.81 -179.723 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 38.0 Cg_endo -67.18 142.14 59.86 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.595 2.197 . . . . 0.0 112.473 -179.753 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.0 m -56.28 152.95 10.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.52 -179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -99.84 83.07 2.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.856 179.852 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 24' ' ' ALA . 36.9 mt -80.87 73.24 7.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.527 -179.905 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.0 p -72.8 -4.75 33.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.937 -179.191 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -136.65 147.11 46.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.382 . . . . 0.0 111.65 -179.72 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.591 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 24.1 t -56.33 -49.81 91.22 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.493 -179.985 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.82 -46.04 29.02 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.849 1.699 . . . . 0.0 111.934 179.994 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.37 -35.44 80.42 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.211 0.529 . . . . 0.0 110.277 -179.944 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.584 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -63.49 -58.93 5.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.097 179.562 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 60.3 mtp -59.82 -27.31 66.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.103 -179.986 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 27.1 mt-10 -71.2 -50.44 33.02 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.661 0.267 . . . . 0.0 110.778 179.777 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -60.99 -31.89 71.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.976 179.283 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.477 HD12 HD11 ' A' ' 36' ' ' ILE . 47.2 mt -73.93 -37.26 47.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.883 178.269 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.92 -18.73 60.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.018 -179.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.12 29.61 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.9 t -169.49 152.23 4.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.389 -179.736 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.542 ' HG3' HG11 ' A' ' 87' ' ' VAL . 31.3 tt0 -70.33 -41.45 73.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.765 179.913 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.44 HG13 HD12 ' A' ' 83' ' ' LEU . 19.6 t -128.95 134.11 64.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.182 179.324 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.5 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.11 128.91 26.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 112.154 -179.052 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.505 HG21 HG12 ' A' ' 111' ' ' ILE . 43.3 t -116.92 127.14 74.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.502 178.325 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.477 HD11 HD12 ' A' ' 28' ' ' ILE . 23.4 mt -133.25 136.16 55.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.45 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.563 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.12 97.38 1.83 Allowed Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.562 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.5 m-85 -83.57 91.69 7.48 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.408 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.2 m-85 -111.89 138.32 48.67 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.023 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.472 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 48.3 mt-30 -85.06 -9.5 57.91 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.87 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.448 ' O ' HG12 ' A' ' 44' ' ' ILE . 15.8 t70 -150.4 119.56 6.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.745 179.716 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.494 ' HG ' HG21 ' A' ' 66' ' ' THR . 96.4 mt -87.89 44.06 1.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.023 0.44 . . . . 0.0 111.562 -179.153 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 36.8 mt-10 -131.97 11.52 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.237 0.541 . . . . 0.0 109.972 179.134 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.653 HG13 HG23 ' A' ' 47' ' ' VAL . 8.5 pt -93.96 161.61 29.38 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.517 -179.657 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.435 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 51.6 Cg_exo -57.04 -25.22 62.09 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.843 2.362 . . . . 0.0 112.538 179.202 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.14 -38.77 91.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.478 -178.763 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.653 HG23 HG13 ' A' ' 44' ' ' ILE . 2.1 t -59.81 -55.41 45.96 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -178.717 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.5 Cg_exo -60.88 -41.63 43.85 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.026 1.817 . . . . 0.0 111.567 179.199 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.655 HG21 HD11 ' A' ' 107' ' ' LEU . 6.9 mt -61.72 -34.2 61.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.149 -179.998 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.54 ' O ' ' HG3' ' A' ' 53' ' ' MET . 40.1 tp -74.98 -51.89 12.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.785 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -53.6 -26.0 19.9 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.094 0.473 . . . . 0.0 109.808 178.607 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 t -82.17 -46.39 13.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.642 179.6 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.54 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -58.67 -25.84 63.21 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.358 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 50' ' ' LEU . 52.5 t -52.29 -46.05 44.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.827 179.34 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.442 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 29.5 mt-30 -80.76 -10.12 59.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.735 -179.795 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -93.55 -17.12 23.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.153 179.837 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.578 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 49.3 m-85 -139.38 63.89 29.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.505 -179.854 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.78 -45.1 42.92 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.719 2.279 . . . . 0.0 111.713 179.052 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.23 -40.76 76.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.293 179.252 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.6 t -66.86 143.97 15.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.69 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 42.2 t -82.42 97.96 8.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.987 0.422 . . . . 0.0 111.045 -179.633 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.427 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -64.2 127.24 30.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.722 179.71 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.82 162.7 28.56 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.133 179.887 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 tt -160.82 145.12 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.913 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 t -149.82 152.82 35.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.004 0.431 . . . . 0.0 111.597 -179.157 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.494 HG21 ' HG ' ' A' ' 42' ' ' LEU . 81.7 p -135.87 -1.45 2.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.622 179.569 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.61 143.32 56.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.77 -179.918 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 81.7 p -65.7 -49.59 67.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.103 -179.556 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -50.79 -45.87 59.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.458 -179.352 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HA ' HG21 ' A' ' 21' ' ' VAL . 62.3 t -69.48 -53.17 26.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.733 0.301 . . . . 0.0 110.737 179.935 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -58.55 -15.17 10.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.283 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.4 m -90.39 -40.97 11.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.223 178.63 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -60.67 -40.49 92.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.45 179.841 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.51 11.44 21.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 179.605 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 55.96 25.1 8.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.482 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.656 HG21 ' HB ' ' A' ' 80' ' ' THR . 38.7 mm -60.67 119.74 5.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 179.797 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.6 p -140.35 57.76 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.242 179.98 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.76 42.97 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.601 179.82 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 14.4 m120 52.67 42.38 31.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.194 0.521 . . . . 0.0 110.255 -179.726 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.656 ' HB ' HG21 ' A' ' 76' ' ' ILE . 93.9 m -68.74 152.83 44.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.806 -178.529 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.563 HG12 ' HA2' ' A' ' 37' ' ' GLY . 71.4 mt -119.76 117.54 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.979 178.206 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.503 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 72.4 m -105.75 130.42 53.75 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.871 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.589 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.5 tp -106.49 101.16 10.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.619 178.036 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.7 t80 -95.89 120.51 36.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.769 0.319 . . . . 0.0 110.706 -179.954 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.52 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.0 mtm180 -103.24 97.95 7.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.045 179.881 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 tp -41.67 -51.79 3.99 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.598 -179.464 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.542 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -44.5 -65.67 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.395 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.426 ' HB2' HH21 ' A' ' 85' ' ' ARG . 7.6 m-20 -95.53 17.31 14.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.69 -178.977 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.4 p30 42.38 32.64 0.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.036 179.227 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 25.3 mm-40 -78.99 161.69 26.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.855 0.36 . . . . 0.0 111.33 -179.876 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -147.23 96.45 2.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.52 179.497 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.603 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.1 mm? -86.66 120.3 27.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.942 179.817 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.95 98.72 9.16 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.679 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.53 HD21 HD12 ' A' ' 102' ' ' ILE . 3.9 tt -83.43 77.71 9.77 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.721 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.6 mt-10 -78.99 -164.7 0.64 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.801 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.497 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.8 t70 -51.39 -36.4 43.25 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.254 -179.175 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -56.95 -14.69 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.148 0.499 . . . . 0.0 110.265 179.558 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -129.64 -13.64 4.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.577 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 21.4 mm -91.24 -29.27 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.519 -179.492 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -51.7 -51.89 52.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 56.0 m -121.27 39.98 3.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.506 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.53 HD12 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -60.67 142.01 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.557 -179.704 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.523 ' HA ' HD13 ' A' ' 49' ' ' ILE . 17.4 m-20 -134.25 150.71 51.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.428 178.752 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.623 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.74 -35.86 23.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.065 0.46 . . . . 0.0 110.4 179.993 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.6 m -62.4 -46.08 90.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.237 178.739 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.57 ' HB3' ' HZ2' ' A' ' 106' ' ' LYS . 8.3 mtpm? -60.97 -60.76 3.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.179 -179.79 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.655 HD11 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.48 -55.45 10.93 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.958 0.409 . . . . 0.0 110.04 179.844 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.9 m -58.51 -30.81 67.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.92 179.715 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.452 ' HD3' HD11 ' A' ' 113' ' ' ILE . 3.9 tmt_? -70.94 -65.71 0.7 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.195 179.677 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -42.91 -43.31 4.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.06 179.303 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.505 HG12 HG21 ' A' ' 35' ' ' VAL . 96.6 mt -63.28 -55.87 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.174 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.13 -18.42 3.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.305 179.259 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.452 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.41 -36.39 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.69 -179.305 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.603 HD21 ' HG ' ' A' ' 92' ' ' LEU . 91.7 m-20 -126.29 32.97 5.11 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.547 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.2 p -84.57 38.35 0.68 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.058 0.456 . . . . 0.0 110.243 178.801 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.431 HD11 HH12 ' A' ' 85' ' ' ARG . 58.6 mt . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.085 -0.959 . . . . 0.0 111.28 -179.445 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.5 p -108.0 142.45 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.191 -179.956 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -154.56 -31.7 0.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.004 179.842 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -57.38 130.51 46.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.091 -179.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 85.1 p 47.99 83.24 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.447 179.914 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.0 m -90.67 52.5 2.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 179.883 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -135.44 39.79 2.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.28 113.5 0.56 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.341 -179.969 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -56.13 101.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.419 2.079 . . . . 0.0 112.437 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.91 -133.66 11.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.693 179.802 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.01 -59.36 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 110.608 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.52 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . . . 60.43 106.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.542 179.673 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.576 ' HG3' HG11 ' A' ' 54' ' ' VAL . 8.3 pt20 -54.38 163.97 0.77 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.525 179.95 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.484 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.8 pt-20 -138.98 159.08 68.4 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.476 179.79 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 42.6 Cg_endo -67.24 147.74 79.11 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.569 2.18 . . . . 0.0 112.628 -179.251 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 17' ' ' TRP . 16.5 m -69.39 154.06 42.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.662 -179.494 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.404 ' N ' HG23 ' A' ' 16' ' ' THR . 5.6 m-90 -97.16 87.73 4.28 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.251 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.575 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.1 mt -81.6 70.05 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.066 179.473 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.6 p -67.85 -0.44 4.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.626 -178.654 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 7.8 m-20 -145.9 147.83 32.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 111.65 -179.887 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.0 t -54.29 -49.83 88.21 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.504 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.6 Cg_endo -56.81 -47.53 22.96 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.07 1.847 . . . . 0.0 112.195 179.94 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.62 78.08 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.202 0.525 . . . . 0.0 110.508 -179.701 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.575 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.17 -58.7 5.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.169 179.355 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 68.3 mtp -60.98 -27.21 68.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.065 -179.861 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 25.0 mt-10 -71.33 -50.48 31.94 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.735 0.303 . . . . 0.0 110.596 179.777 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -59.74 -34.59 73.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.904 179.303 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.443 HD13 HD13 ' A' ' 36' ' ' ILE . 44.3 mt -72.62 -37.78 57.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.946 178.288 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.56 -17.67 61.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.989 -179.768 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.1 26.41 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.222 -179.671 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.0 t -169.88 151.75 4.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.557 -179.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.505 ' HG3' HG11 ' A' ' 87' ' ' VAL . 15.6 tt0 -62.78 -76.42 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.598 179.751 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.432 HG12 HD13 ' A' ' 83' ' ' LEU . 16.0 t -96.49 138.71 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.459 179.538 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.556 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.59 124.11 15.85 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.991 0.424 . . . . 0.0 112.003 -179.26 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 111' ' ' ILE . 50.0 t -112.62 129.85 67.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.435 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.443 HD13 HD13 ' A' ' 28' ' ' ILE . 34.7 mt -135.74 137.13 49.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.041 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.91 96.69 1.66 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.461 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.441 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.1 m-85 -82.97 90.56 7.01 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.233 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.1 m-85 -110.23 145.82 36.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.363 -178.148 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.408 ' HG2' HD23 ' A' ' 71' ' ' LEU . 93.2 mt-30 -92.36 -6.5 50.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.839 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.496 ' O ' HG12 ' A' ' 44' ' ' ILE . 36.6 t70 -151.87 121.93 7.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.555 179.822 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.517 ' HG ' HG22 ' A' ' 66' ' ' THR . 87.9 mt -90.57 46.49 1.34 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.158 0.504 . . . . 0.0 111.331 -179.319 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.439 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 38.9 mt-10 -135.68 7.11 3.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.937 178.977 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.687 HG13 HG23 ' A' ' 47' ' ' VAL . 3.1 pt -89.54 157.64 46.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.26 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.418 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 70.6 Cg_exo -53.4 -26.05 33.99 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.92 2.413 . . . . 0.0 112.911 179.665 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.08 -36.95 85.95 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.977 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.687 HG23 HG13 ' A' ' 44' ' ' ILE . 3.2 t -60.99 -56.65 32.86 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.549 -178.915 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.668 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.2 Cg_exo -59.82 -41.26 56.06 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 121.754 1.636 . . . . 0.0 111.407 179.635 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.614 HG21 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -61.29 -35.6 67.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.027 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.535 ' O ' ' HG3' ' A' ' 53' ' ' MET . 48.1 tp -72.98 -53.78 10.32 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.809 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -53.71 -24.6 15.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.086 0.47 . . . . 0.0 109.848 178.748 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -82.07 -45.57 15.06 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.623 179.615 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.535 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -60.83 -26.18 67.15 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.082 0.468 . . . . 0.0 109.74 179.582 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.576 HG11 ' HG3' ' A' ' 13' ' ' GLN . 61.1 t -52.76 -49.65 45.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.843 179.492 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.52 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 33.3 mt-30 -75.04 -9.41 58.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.637 -179.708 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -95.14 -18.67 20.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.059 179.586 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.569 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 64.3 m-85 -135.92 62.85 48.93 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.285 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.8 -42.51 62.82 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.701 2.267 . . . . 0.0 111.64 179.137 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.25 -37.23 86.26 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.657 179.147 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.2 t -69.89 144.8 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.121 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.556 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 35.4 t -82.53 98.81 9.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.095 0.474 . . . . 0.0 110.932 -179.902 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -65.23 126.29 27.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.205 179.976 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.24 161.23 28.16 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.276 179.809 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -161.64 144.18 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.441 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.8 t -149.47 157.85 43.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.171 0.51 . . . . 0.0 111.845 -179.28 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.517 HG22 ' HG ' ' A' ' 42' ' ' LEU . 57.9 p -138.57 -0.24 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.481 179.488 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.25 137.13 54.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.343 -179.907 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.0 m -61.59 -50.7 71.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.501 -179.341 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -50.28 -40.91 49.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.568 -179.558 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.493 ' HA ' HG23 ' A' ' 21' ' ' VAL . 73.2 t -72.05 -54.93 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.028 0.442 . . . . 0.0 110.73 179.846 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.408 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.2 mp -58.38 -14.64 8.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.291 179.324 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.5 m -91.18 -41.72 10.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.178 178.719 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -59.9 -40.64 89.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.462 179.833 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -90.43 9.15 30.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.794 179.444 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 58.73 24.71 12.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.604 179.429 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.59 HG21 ' HB ' ' A' ' 80' ' ' THR . 37.8 mm -60.97 119.62 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.986 179.53 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.0 p -138.55 56.04 1.72 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.262 -179.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.09 45.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.594 179.849 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.559 ' HB2' HG23 ' A' ' 99' ' ' ILE . 25.7 m-20 50.15 43.44 25.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.162 0.506 . . . . 0.0 110.397 -179.828 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.59 ' HB ' HG21 ' A' ' 76' ' ' ILE . 88.5 m -68.42 151.97 46.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.786 -178.665 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.54 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.9 mt -118.21 115.65 48.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.219 178.032 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 72.1 m -103.85 133.49 48.75 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -177.819 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.586 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.6 tp -109.22 104.6 13.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.979 178.392 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.7 t80 -98.62 121.11 40.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.643 179.8 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.493 HH12 HD12 ' A' ' 116' ' ' LEU . 4.4 mtm180 -103.94 81.34 1.85 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.906 -179.726 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 7.2 tp -25.26 -59.63 0.06 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -179.455 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.505 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.53 -57.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.338 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -98.3 3.42 48.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.636 -179.735 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.2 t30 53.11 21.2 2.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.586 179.654 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 12.6 mm-40 -67.34 154.12 42.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.659 179.596 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.8 OUTLIER -138.05 89.3 2.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.507 179.314 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.586 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -78.0 141.79 38.68 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.378 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.92 109.27 14.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.218 0.532 . . . . 0.0 112.401 -178.929 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.537 HD22 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -94.7 76.43 3.71 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.875 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 99' ' ' ILE . 24.0 mt-10 -77.39 -165.31 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -176.857 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.442 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.3 OUTLIER -46.52 -51.05 16.22 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.575 -179.191 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -48.15 -15.24 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.967 0.413 . . . . 0.0 111.262 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 96' ' ' ASP . 17.0 m-20 -126.98 -13.66 5.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.367 179.792 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.559 HG23 ' HB2' ' A' ' 79' ' ' ASN . 23.5 mm -91.87 -38.97 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.479 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -50.43 -47.42 56.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.967 0.413 . . . . 0.0 110.71 179.74 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.8 m -116.61 38.83 3.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.507 179.89 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.542 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 8.5 tp -67.21 144.86 14.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.593 -179.541 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.553 ' HA ' HD13 ' A' ' 49' ' ' ILE . 13.9 m-20 -139.44 148.83 43.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.321 178.48 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.614 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -47.37 -36.84 10.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.104 0.478 . . . . 0.0 110.444 -179.713 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.9 m -63.05 -47.55 82.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.342 178.977 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -59.81 -58.93 6.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.313 -179.694 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.6 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.23 -55.44 15.29 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.002 0.43 . . . . 0.0 110.117 179.869 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.2 m -58.39 -29.53 66.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.809 179.796 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.481 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -71.3 -66.11 0.66 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.225 179.609 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -42.82 -44.04 4.28 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.122 179.274 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.491 HG12 HG22 ' A' ' 35' ' ' VAL . 96.2 mt -62.92 -55.36 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.529 178.293 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -54.32 -18.41 4.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.374 179.223 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.481 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.0 -36.89 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.862 -179.059 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -125.37 31.03 5.65 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.464 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 97.1 p -82.62 37.76 0.53 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.076 0.465 . . . . 0.0 110.142 178.869 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.493 HD12 HH12 ' A' ' 85' ' ' ARG . 59.0 mt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.188 -179.425 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.516 ' HG3' HG11 ' A' ' 2' ' ' VAL . 13.5 tp10 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.804 0.335 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.516 HG11 ' HG3' ' A' ' 1' ' ' GLU . 7.2 p -170.33 -41.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.191 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 51.25 70.72 0.5 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.986 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -160.59 101.55 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 -179.782 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.1 p -130.12 143.19 50.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.778 179.827 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.9 m -137.53 -63.05 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.035 -179.935 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 57.39 76.91 0.3 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.022 -179.893 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.75 -72.05 0.83 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.462 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -59.81 141.33 96.57 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.462 2.108 . . . . 0.0 112.196 179.704 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.86 49.29 3.58 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.579 -179.96 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.55 -75.9 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.92 107.7 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.357 179.748 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.551 ' HG3' HG13 ' A' ' 54' ' ' VAL . 3.9 pt20 -58.81 164.45 2.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.503 -179.712 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.473 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.1 pt-20 -134.91 159.55 71.69 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.109 179.789 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.9 Cg_endo -66.83 145.68 75.62 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.308 2.005 . . . . 0.0 112.756 -179.541 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.4 m -62.54 147.52 48.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.524 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -92.99 84.3 4.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.739 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.535 HD21 ' HA ' ' A' ' 24' ' ' ALA . 48.4 mt -81.77 76.21 8.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.638 -179.913 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.8 p -76.02 -4.17 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.856 -179.255 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -139.37 147.28 41.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.994 0.426 . . . . 0.0 111.61 -179.738 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.589 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 44.2 t -55.76 -50.33 87.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.59 179.891 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.33 -45.11 37.01 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.986 1.791 . . . . 0.0 111.939 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.03 82.73 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.262 0.553 . . . . 0.0 110.285 -179.881 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -63.55 -59.0 5.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.05 179.513 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 59.7 mtm -60.41 -27.02 67.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.148 -179.928 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -70.98 -50.79 30.45 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.72 0.295 . . . . 0.0 110.571 179.594 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -60.26 -31.42 70.2 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.197 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.448 HD12 HD12 ' A' ' 36' ' ' ILE . 47.7 mt -74.18 -39.07 49.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.077 178.196 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.45 -19.71 60.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.071 -179.899 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.25 30.0 1.78 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.414 HG23 ' CB ' ' A' ' 61' ' ' SER . 10.0 t -169.85 154.34 5.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.42 -179.593 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.555 ' HG3' HG12 ' A' ' 87' ' ' VAL . 24.8 tt0 -71.8 -43.46 65.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.683 179.861 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.466 HG13 HD13 ' A' ' 83' ' ' LEU . 19.1 t -127.47 137.4 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.225 179.418 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.67 129.75 22.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.947 0.403 . . . . 0.0 112.062 -179.061 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.476 HG22 HG12 ' A' ' 111' ' ' ILE . 42.3 t -117.45 128.26 74.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.571 178.536 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 22.8 mt -133.66 136.18 54.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.47 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.547 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.81 95.97 1.57 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.517 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.6 m-85 -82.6 89.65 6.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.523 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.7 m-85 -108.55 139.24 43.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.538 -178.181 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -85.94 -4.52 59.19 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.915 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.433 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.4 t70 -153.95 122.05 6.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.619 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.521 ' HG ' HG21 ' A' ' 66' ' ' THR . 97.9 mt -91.17 47.37 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.147 0.499 . . . . 0.0 111.375 -179.331 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.4 mt-10 -138.85 8.67 2.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.941 179.073 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.629 HG13 HG22 ' A' ' 47' ' ' VAL . 1.2 pt -92.91 154.45 41.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.061 179.753 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.469 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 87.0 Cg_exo -48.24 -29.75 13.5 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.004 2.469 . . . . 0.0 113.242 179.82 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.484 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -62.37 -36.7 83.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.911 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.643 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.7 t -63.18 -56.62 26.18 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.747 -178.801 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.3 Cg_exo -59.86 -36.92 89.2 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.789 1.659 . . . . 0.0 111.42 179.534 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.62 HG21 ' HA ' ' A' ' 104' ' ' ALA . 5.6 mt -64.83 -36.52 77.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.909 179.73 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.519 ' O ' ' HG3' ' A' ' 53' ' ' MET . 42.9 tp -72.46 -53.36 12.37 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.749 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -53.86 -22.26 9.45 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.072 0.463 . . . . 0.0 109.824 178.765 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -85.36 -44.83 12.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.555 179.668 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.519 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -60.92 -25.55 66.84 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.369 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.551 HG13 ' HG3' ' A' ' 13' ' ' GLN . 55.7 t -53.24 -49.41 52.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.988 179.411 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -75.09 -9.41 58.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.686 -179.885 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -95.23 -20.25 19.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.309 179.788 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.581 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 61.1 m-85 -134.69 61.12 46.38 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.508 -179.603 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.74 -40.17 74.83 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.506 2.137 . . . . 0.0 111.45 179.176 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.04 -40.85 96.05 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.764 -0.732 . . . . 0.0 111.449 178.963 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.3 t -67.65 144.58 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.798 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.499 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 38.7 t -81.43 96.5 7.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.085 0.469 . . . . 0.0 111.157 -179.624 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.505 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 5.7 p90 -62.28 129.45 40.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.962 179.732 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.51 161.48 28.65 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.079 179.716 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.409 HD13 HG11 ' A' ' 47' ' ' VAL . 5.2 tt -160.53 143.07 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.813 0.34 . . . . 0.0 110.178 179.862 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.6 t -146.44 157.98 43.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.971 0.415 . . . . 0.0 111.678 -179.035 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.521 HG21 ' HG ' ' A' ' 42' ' ' LEU . 67.5 p -141.07 -8.78 1.01 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.766 179.804 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -64.48 142.79 58.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.789 -179.882 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.6 m -64.03 -47.74 79.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.567 -179.495 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -51.14 -46.09 61.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.514 -179.269 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.53 ' HA ' HG23 ' A' ' 21' ' ' VAL . 72.7 t -70.34 -51.54 37.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.812 0.339 . . . . 0.0 110.73 179.806 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mp -59.3 -14.63 12.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.187 179.371 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.0 m -91.97 -41.17 10.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.297 178.657 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -60.3 -41.99 94.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.657 179.933 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -89.21 11.29 19.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.798 179.587 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 56.41 27.72 12.5 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.597 179.45 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.642 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.4 mm -62.67 124.3 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.961 179.755 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.1 p -142.78 59.31 1.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.444 -179.782 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.83 46.39 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.687 179.697 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 30.1 m-80 51.91 43.15 30.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.059 0.457 . . . . 0.0 110.469 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.642 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.8 m -68.87 152.01 45.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.661 -178.522 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.562 HG23 HD23 ' A' ' 107' ' ' LEU . 61.2 mt -118.97 116.28 50.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.906 177.985 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.516 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 72.8 m -106.15 132.67 51.95 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.83 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.583 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.1 tp -108.64 103.54 12.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.838 178.413 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -97.95 123.94 42.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.823 0.344 . . . . 0.0 110.863 179.992 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.485 HH21 ' HB2' ' A' ' 88' ' ' ASP . 2.3 mtm180 -107.35 100.81 10.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.092 179.833 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.9 tp -44.37 -52.69 7.49 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.687 -179.203 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.555 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.22 -64.33 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.015 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.485 ' HB2' HH21 ' A' ' 85' ' ' ARG . 5.8 m-20 -97.01 17.13 17.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.605 -179.044 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.9 p30 42.37 32.31 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.152 179.128 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.476 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 5.8 mm-40 -79.05 159.85 27.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.944 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.42 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.9 OUTLIER -145.35 92.31 2.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.95 179.656 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.583 HD21 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -78.58 140.24 38.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.453 179.257 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.08 100.79 7.16 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.477 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.468 HD23 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -87.16 77.04 9.15 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.819 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' HA ' ' HG1' ' A' ' 80' ' ' THR . 27.9 mt-10 -79.0 -164.85 0.66 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -176.93 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.465 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -46.38 -49.62 17.67 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.452 -179.369 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -47.62 -18.25 0.13 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.852 0.358 . . . . 0.0 111.165 179.762 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -125.29 -13.83 6.59 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.574 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.51 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 22.9 mm -90.44 -28.77 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.682 0.277 . . . . 0.0 111.475 -179.451 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -53.96 -48.87 69.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 82.5 p -119.61 36.72 4.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.435 179.783 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.51 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.2 tp -60.55 142.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.425 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.502 ' HA ' HD12 ' A' ' 49' ' ' ILE . 24.6 m-20 -138.55 150.46 46.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.665 178.883 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.62 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -48.2 -37.25 15.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.968 0.413 . . . . 0.0 110.348 -179.632 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.4 m -62.11 -47.72 83.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.437 178.803 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -60.69 -60.78 3.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.169 -179.682 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.607 HD11 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -47.98 -55.84 9.06 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.923 0.392 . . . . 0.0 110.125 179.977 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.8 m -58.49 -31.62 68.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.484 ' HD3' HD12 ' A' ' 113' ' ' ILE . 4.0 tmt_? -70.39 -65.73 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.398 179.847 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -42.93 -43.62 4.22 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.014 179.282 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.476 HG12 HG22 ' A' ' 35' ' ' VAL . 96.1 mt -63.47 -55.84 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.529 178.167 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -53.41 -18.75 2.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.336 179.282 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.484 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.16 -37.84 11.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.833 -179.359 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.401 ' O ' HD22 ' A' ' 83' ' ' LEU . 15.4 m120 -123.55 30.92 6.07 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.821 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 111' ' ' ILE . 90.2 p -84.28 39.46 0.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.078 0.466 . . . . 0.0 110.282 179.013 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.444 HD13 ' NH1' ' A' ' 85' ' ' ARG . 77.3 mt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.146 -0.931 . . . . 0.0 111.29 -179.679 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.862 0.363 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.4 m -92.82 5.68 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.421 -179.807 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.574 ' HG2' ' HG3' ' A' ' 4' ' ' LYS . 38.8 tt0 -126.96 149.7 49.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.699 179.874 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.574 ' HG3' ' HG2' ' A' ' 3' ' ' GLU . 54.5 mtpt 58.71 34.44 23.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 -179.763 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.3 t -139.4 83.23 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.013 -179.837 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.2 t -115.1 -3.77 12.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 179.987 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -87.44 -52.54 5.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.975 -179.975 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.57 163.58 19.25 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.477 -179.898 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.35 172.35 1.95 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.725 2.283 . . . . 0.0 112.385 179.952 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.83 148.21 9.54 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.644 179.94 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.96 -67.12 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.682 0.277 . . . . 0.0 110.836 179.906 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.483 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . . . 59.88 105.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.58 179.429 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.496 ' HG3' ' CG1' ' A' ' 54' ' ' VAL . 1.1 pt20 -169.68 172.78 6.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.883 -179.727 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.488 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.8 pt-20 -121.76 158.81 53.38 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.176 -179.371 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 45.7 Cg_endo -69.47 143.74 53.26 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.831 2.354 . . . . 0.0 112.622 -179.701 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.7 m -63.37 151.29 41.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.544 -179.61 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -94.55 94.42 8.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.96 -179.934 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.556 HD21 ' HA ' ' A' ' 24' ' ' ALA . 48.6 mt -88.77 73.89 8.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.299 179.64 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.0 p -72.4 0.51 9.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.306 -178.927 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -145.63 148.56 33.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.928 0.394 . . . . 0.0 111.862 -179.78 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 57.6 t -56.06 -50.26 88.38 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.448 179.815 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.5 Cg_endo -58.23 -45.1 33.4 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.826 1.684 . . . . 0.0 112.035 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.59 81.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.257 0.551 . . . . 0.0 110.35 -179.927 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.556 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -64.09 -59.59 4.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.98 179.391 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.8 mtm -60.48 -25.94 66.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.156 -179.972 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 21.3 mt-10 -71.83 -49.94 34.06 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.695 0.283 . . . . 0.0 110.414 179.657 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -33.37 71.97 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.079 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 36' ' ' ILE . 50.4 mt -72.33 -39.01 62.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.105 178.627 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.05 -21.33 60.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.994 -179.856 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.93 31.87 1.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.939 -179.878 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.423 HG22 ' CB ' ' A' ' 61' ' ' SER . 9.1 t -170.8 151.29 3.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.328 -179.621 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.454 ' HG3' HG13 ' A' ' 87' ' ' VAL . 30.0 tt0 -68.27 -52.76 30.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.598 179.652 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.435 HG11 HD13 ' A' ' 83' ' ' LEU . 19.4 t -118.27 137.61 51.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.174 179.329 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.527 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.9 126.23 18.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.055 0.455 . . . . 0.0 112.191 -179.031 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.559 HG23 HG12 ' A' ' 111' ' ' ILE . 49.2 t -115.22 127.85 72.63 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.521 178.338 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 28' ' ' ILE . 32.6 mt -134.17 138.3 50.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.642 -177.165 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.524 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.4 97.54 1.66 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.45 179.773 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.448 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 39.3 m-85 -83.82 92.43 7.76 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.224 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -112.49 139.32 48.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.485 -178.003 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.431 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 78.6 mt-30 -87.68 -3.22 58.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.691 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 22.2 t70 -153.72 124.39 7.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.511 179.922 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.511 ' HG ' HG23 ' A' ' 66' ' ' THR . 96.0 mt -94.92 47.34 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 0.0 111.528 -179.436 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 33.8 mt-10 -136.33 5.88 3.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.7 178.845 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.644 HG13 HG23 ' A' ' 47' ' ' VAL . 2.1 pt -88.46 156.31 50.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.083 179.884 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.444 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 75.2 Cg_exo -51.78 -27.09 25.76 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.85 2.367 . . . . 0.0 113.078 179.797 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.7 -37.67 88.21 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.78 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.644 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -62.22 -56.15 33.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.752 -178.692 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.5 Cg_exo -60.13 -36.03 90.29 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.804 1.67 . . . . 0.0 111.488 179.65 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.622 HG23 HD13 ' A' ' 107' ' ' LEU . 6.3 mt -67.1 -34.81 71.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.995 -179.937 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.545 ' O ' ' HG3' ' A' ' 53' ' ' MET . 44.6 tp -74.44 -50.98 16.23 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.893 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -55.29 -22.8 20.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.03 0.443 . . . . 0.0 109.994 178.77 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.8 m -84.89 -45.44 12.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.455 179.36 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.545 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.48 -25.62 64.59 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.198 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.496 ' CG1' ' HG3' ' A' ' 13' ' ' GLN . 45.6 t -52.77 -47.75 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.119 179.329 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 12' ' ' ALA . 35.9 mt-30 -78.31 -8.96 59.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.656 -179.855 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -94.51 -19.36 20.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.277 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.585 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 61.0 m-85 -136.03 62.88 48.38 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.623 -179.79 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.2 -43.35 53.91 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.689 2.259 . . . . 0.0 111.634 179.019 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.5 -42.03 93.72 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.413 179.355 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.7 t -65.31 144.53 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 178.876 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 33.9 t -81.94 96.97 7.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.012 0.434 . . . . 0.0 110.95 -179.83 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.49 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 4.8 p90 -64.3 127.34 31.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.785 179.692 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.99 160.67 28.19 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.061 179.807 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.405 HD12 HG13 ' A' ' 47' ' ' VAL . 5.0 tt -160.98 142.59 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.788 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.448 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.9 t -147.78 158.77 44.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.218 0.532 . . . . 0.0 111.646 -179.094 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.511 HG23 ' HG ' ' A' ' 42' ' ' LEU . 76.3 p -139.49 -2.35 1.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.568 179.619 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -66.79 140.52 57.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.703 -179.977 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.6 m -63.98 -49.91 70.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.444 -179.465 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -50.3 -42.7 52.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.605 -179.458 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HA ' HG21 ' A' ' 21' ' ' VAL . 58.9 t -71.92 -54.02 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.344 . . . . 0.0 110.791 179.832 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.416 HD23 ' HG2' ' A' ' 40' ' ' GLN . 5.9 mp -58.29 -14.61 7.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.339 179.331 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.7 m -91.78 -41.51 10.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.333 178.789 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -60.69 -39.64 89.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.496 179.78 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.411 ' HB2' HG12 ' A' ' 76' ' ' ILE . 61.0 m-85 -90.17 9.92 26.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.754 179.567 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.0 m120 57.71 25.28 11.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.672 179.386 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.632 HG22 ' HB ' ' A' ' 80' ' ' THR . 42.1 mm -61.73 121.77 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.149 179.805 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.1 p -140.63 58.42 1.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 0.0 111.184 -179.935 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.65 45.04 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.623 179.791 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 14.4 m120 51.07 44.17 28.74 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.125 0.488 . . . . 0.0 110.476 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.632 ' HB ' HG22 ' A' ' 76' ' ' ILE . 96.7 m -69.53 152.65 44.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.632 -178.688 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.524 HG12 ' HA2' ' A' ' 37' ' ' GLY . 58.9 mt -118.62 116.4 51.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.428 -0.805 . . . . 0.0 108.982 178.04 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.432 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 75.6 m -104.35 132.68 50.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -177.723 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.581 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.4 tp -110.94 102.66 11.13 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.982 178.434 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -96.59 125.25 40.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.7 0.286 . . . . 0.0 110.392 179.723 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.51 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.6 mtm180 -107.63 85.8 2.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.034 -179.536 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.6 tp -27.42 -61.93 0.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.253 -179.286 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.454 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.29 -64.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.154 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -90.99 13.77 15.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.781 0.324 . . . . 0.0 111.32 -179.314 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 43.68 29.1 0.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.086 178.985 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.51 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 20.6 mm-40 -75.94 160.94 29.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.78 179.85 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -147.57 84.68 1.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.695 179.778 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.591 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.7 mm? -71.48 145.08 49.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.565 179.662 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -127.32 93.44 3.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.23 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.509 HD23 HD11 ' A' ' 102' ' ' ILE . 4.2 tt -78.84 78.31 5.28 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.609 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.8 mt-10 -79.63 -164.35 0.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -176.915 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.474 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 22.7 t70 -51.09 -38.36 51.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.093 -179.246 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -55.22 -14.98 1.97 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.202 0.525 . . . . 0.0 110.213 179.552 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -129.82 -13.89 4.1 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.73 -179.716 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' A' ' 79' ' ' ASN . 24.2 mm -90.32 -30.04 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 111.294 -179.652 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.45 -33.73 68.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.6 m -133.68 39.64 3.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 179.816 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 94' ' ' LEU . 7.1 tp -66.64 143.33 15.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.726 -179.676 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.538 ' HA ' HD13 ' A' ' 49' ' ' ILE . 16.1 m-20 -138.33 148.93 45.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.421 178.857 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.605 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -47.71 -36.68 11.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.094 0.473 . . . . 0.0 110.508 -179.719 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.7 m -62.38 -46.79 87.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.27 178.785 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -61.16 -59.38 5.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.224 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.622 HD13 HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.52 -54.4 18.14 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.995 0.426 . . . . 0.0 110.109 179.852 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.9 m -58.88 -31.1 68.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.761 179.765 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.457 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.6 tmt_? -71.0 -65.62 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.297 179.768 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -43.19 -43.57 4.74 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.147 179.34 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 35' ' ' VAL . 85.2 mt -63.22 -55.24 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.259 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -54.84 -18.16 4.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.219 0.533 . . . . 0.0 110.203 179.305 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.457 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.59 -35.15 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.821 -179.302 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.591 HD21 ' HG ' ' A' ' 92' ' ' LEU . 89.6 m-20 -127.03 31.2 5.31 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.369 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 111' ' ' ILE . 89.1 p -84.42 36.48 0.59 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.034 0.445 . . . . 0.0 110.253 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.45 HD11 ' NH1' ' A' ' 85' ' ' ARG . 70.5 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.309 -179.46 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.69 0.281 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.503 HG23 ' HG2' ' A' ' 3' ' ' GLU . 35.1 m -133.52 -18.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 179.967 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.503 ' HG2' HG23 ' A' ' 2' ' ' VAL . 7.1 pt-20 -149.07 99.31 2.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.039 0.447 . . . . 0.0 111.088 179.886 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -164.36 -42.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.757 179.856 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 93.5 p 51.23 -166.76 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.193 -179.953 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.3 t 58.98 34.2 23.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.847 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -108.32 -42.81 4.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.827 179.772 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.15 -165.06 13.66 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.314 179.937 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.24 179.83 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.506 2.137 . . . . 0.0 112.287 179.989 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.88 -105.34 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.482 179.946 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -174.42 -44.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.929 0.395 . . . . 0.0 110.257 179.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.11 -80.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.841 179.431 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.548 ' HG3' HG13 ' A' ' 54' ' ' VAL . 11.2 pt20 -140.29 141.91 35.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.874 0.369 . . . . 0.0 110.981 179.937 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.494 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 14.4 pt-20 -127.94 159.53 66.12 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.421 179.858 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 35.5 Cg_endo -65.95 144.7 77.54 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.548 2.165 . . . . 0.0 112.798 -179.196 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.6 m -62.9 150.18 42.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.602 -179.602 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -94.31 97.77 10.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.903 179.697 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.548 HD22 ' HA ' ' A' ' 24' ' ' ALA . 59.6 mt -95.44 70.99 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.072 0.463 . . . . 0.0 110.632 179.882 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 p -68.68 -8.18 40.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.225 -178.885 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -137.12 150.28 47.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.979 0.419 . . . . 0.0 111.933 -179.421 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 20.9 t -58.49 -49.78 91.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.617 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -57.81 -43.26 51.14 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.91 1.74 . . . . 0.0 111.873 179.865 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.39 -36.99 85.64 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.196 0.522 . . . . 0.0 110.277 179.921 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.548 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.39 -57.37 11.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.028 179.262 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 65.4 mtp -62.08 -27.22 68.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.253 -179.941 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 20.7 mt-10 -70.28 -51.36 31.07 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.73 0.3 . . . . 0.0 110.381 179.747 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -59.92 -33.18 71.53 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.147 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.442 HD13 HD13 ' A' ' 36' ' ' ILE . 52.9 mt -71.81 -38.24 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.907 178.241 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.06 -18.75 61.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.929 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.24 28.95 3.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.249 -179.824 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -168.58 151.55 5.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 -179.701 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.536 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.7 tt0 -68.86 -49.64 56.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.03 -179.968 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.46 HG13 HD12 ' A' ' 83' ' ' LEU . 23.4 t -122.29 135.19 63.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.12 179.31 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.29 125.85 22.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.996 0.427 . . . . 0.0 112.022 -178.862 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.527 HG23 HG12 ' A' ' 111' ' ' ILE . 48.0 t -114.26 127.15 71.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.558 178.355 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 33.9 mt -132.95 139.36 49.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.735 -177.062 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.482 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.54 100.14 1.94 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.121 179.596 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.463 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 40.1 m-85 -86.84 94.56 9.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.387 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.614 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.4 m-85 -114.06 142.24 46.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.503 -177.898 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -88.32 -6.03 57.98 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.72 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -151.4 125.75 9.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.618 179.606 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.501 ' HG ' HG23 ' A' ' 66' ' ' THR . 93.2 mt -95.24 47.83 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.032 0.444 . . . . 0.0 111.502 -179.526 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -137.72 7.14 2.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.718 178.869 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.648 HG13 HG23 ' A' ' 47' ' ' VAL . 1.2 pt -90.51 155.41 46.12 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.194 179.939 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.433 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 78.3 Cg_exo -50.38 -27.32 18.04 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.881 2.387 . . . . 0.0 113.246 -179.881 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.531 ' HB1' HD12 ' A' ' 44' ' ' ILE . . . -64.56 -37.52 87.84 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.892 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.648 HG23 HG13 ' A' ' 44' ' ' ILE . 3.1 t -61.79 -56.0 36.54 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.572 -178.895 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.648 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.4 Cg_exo -60.16 -39.44 68.97 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.833 1.689 . . . . 0.0 111.533 179.508 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.603 HG22 ' HA ' ' A' ' 104' ' ' ALA . 5.2 mt -62.99 -36.7 76.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.035 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.518 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.2 tp -72.43 -52.68 14.84 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.021 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -54.69 -22.28 13.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.037 0.446 . . . . 0.0 109.943 178.774 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.4 m -85.48 -44.12 12.99 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.494 179.501 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.5 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.52 -24.93 66.94 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.378 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.548 HG13 ' HG3' ' A' ' 13' ' ' GLN . 54.5 t -51.74 -47.22 39.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.962 179.319 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -77.43 -13.04 60.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.837 -179.776 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -91.45 -18.27 24.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.014 179.897 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.573 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.3 m-85 -137.22 62.74 39.88 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.466 -179.836 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.56 -45.15 43.11 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.643 2.228 . . . . 0.0 111.734 179.231 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.2 -42.86 83.43 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.545 179.148 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.1 t -64.29 144.51 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.667 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 37.7 t -82.3 97.43 8.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.036 0.446 . . . . 0.0 111.137 -179.68 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.445 ' CD2' HG12 ' A' ' 54' ' ' VAL . 3.6 p90 -64.49 128.13 34.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.607 179.579 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.87 160.76 28.32 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.022 179.901 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -159.97 143.29 5.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.423 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 41.6 t -150.09 157.25 42.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.048 0.451 . . . . 0.0 111.558 -179.181 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.501 HG23 ' HG ' ' A' ' 42' ' ' LEU . 82.7 p -137.82 -3.33 1.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.619 179.777 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -65.55 139.72 58.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.627 -179.835 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.2 t -61.58 -50.39 72.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.209 -179.633 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -48.69 -47.77 40.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.665 -179.391 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.535 ' HA ' HG21 ' A' ' 21' ' ' VAL . 64.9 t -67.87 -55.02 18.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.772 0.32 . . . . 0.0 110.73 179.818 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 mp -56.86 -14.8 3.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.351 179.397 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.7 m -91.0 -41.75 10.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.281 178.764 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -60.82 -35.94 77.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.616 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -95.88 14.25 24.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.805 179.621 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 55.49 25.11 7.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.771 179.067 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.636 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.4 mm -62.67 121.82 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.883 0.373 . . . . 0.0 111.243 179.981 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.5 p -142.46 59.28 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.117 179.959 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.28 44.93 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.586 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.614 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 29.2 m-80 51.79 43.83 29.76 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.222 0.534 . . . . 0.0 110.609 -179.944 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.636 ' HB ' HG23 ' A' ' 76' ' ' ILE . 87.5 m -69.31 151.65 45.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.55 -178.642 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.53 HG23 HD22 ' A' ' 107' ' ' LEU . 54.6 mt -117.7 117.54 55.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.158 177.931 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.463 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 71.2 m -108.06 133.2 52.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.566 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.584 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -108.55 104.96 14.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.752 178.268 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -98.95 120.84 40.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.881 0.372 . . . . 0.0 110.892 179.77 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.5 HH12 HD12 ' A' ' 116' ' ' LEU . 3.7 mtm180 -104.43 100.49 10.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.123 179.82 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.6 tp -43.78 -55.11 4.67 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.017 -179.362 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.536 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.3 -62.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.171 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -98.31 8.14 45.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.167 -179.618 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 85' ' ' ARG . 19.7 t-20 48.69 38.03 10.73 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.023 -179.914 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.468 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 7.1 mm-40 -82.25 160.72 22.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.765 179.691 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.2 94.3 2.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 179.462 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.584 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -81.94 139.51 34.56 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.291 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -120.28 114.55 22.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.315 0.578 . . . . 0.0 112.294 -179.385 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.454 HD22 HD12 ' A' ' 102' ' ' ILE . 3.8 tt -100.23 75.75 1.84 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.9 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -76.98 -166.41 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.146 -176.785 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.449 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.4 OUTLIER -45.92 -51.21 13.61 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.249 -179.334 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -46.98 -17.02 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.286 179.653 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.406 ' N ' ' C ' ' A' ' 96' ' ' ASP . 10.8 m-20 -126.22 -14.17 6.01 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.551 -179.999 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.467 HG21 ' HB2' ' A' ' 79' ' ' ASN . 21.7 mm -90.91 -26.19 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.624 -179.322 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -58.18 -35.48 71.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.868 0.366 . . . . 0.0 110.971 -179.81 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.3 m -132.52 39.49 3.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.526 179.964 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.454 HD12 HD22 ' A' ' 94' ' ' LEU . 6.2 tp -64.16 142.07 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.438 -179.86 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.534 ' HA ' HD13 ' A' ' 49' ' ' ILE . 16.3 m-20 -136.74 148.36 47.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.593 178.846 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.603 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -46.39 -35.57 5.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.034 0.445 . . . . 0.0 110.391 179.961 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -63.67 -49.02 74.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.441 178.891 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -59.2 -58.7 7.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.179 -179.88 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.586 HD13 HG23 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.18 -55.84 13.52 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.091 0.472 . . . . 0.0 109.966 179.881 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.0 m -58.39 -29.13 65.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.9 179.726 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.47 ' HD3' HD12 ' A' ' 113' ' ' ILE . 3.8 tmt_? -71.48 -66.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.172 179.588 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -42.59 -42.58 3.45 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.07 179.132 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 35' ' ' VAL . 95.5 mt -64.28 -55.77 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.503 178.346 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.28 -18.62 4.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.319 179.41 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.47 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.32 -37.28 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.934 -179.023 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -122.44 28.75 7.25 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.595 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.1 p -82.3 52.85 2.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.09 0.472 . . . . 0.0 110.184 178.884 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.5 HD12 HH12 ' A' ' 85' ' ' ARG . 67.9 mt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.125 -179.344 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.783 0.325 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.439 HG21 ' HG2' ' A' ' 3' ' ' GLU . 20.3 m -137.5 -23.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' HG2' HG21 ' A' ' 2' ' ' VAL . 21.8 mm-40 -124.96 27.14 6.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.064 179.946 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -131.14 54.14 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.799 179.875 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.6 m -143.6 20.14 1.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.971 179.976 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.9 m -148.0 -56.91 0.23 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.858 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.95 134.85 54.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.071 -179.888 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.73 -162.13 13.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.348 -179.912 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -51.66 111.91 0.7 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.631 2.221 . . . . 0.0 112.348 179.781 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.13 -160.63 36.71 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.548 -179.761 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.22 -24.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.028 0.442 . . . . 0.0 110.593 -179.917 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.78 -30.06 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.35 179.986 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.519 ' HG3' HG13 ' A' ' 54' ' ' VAL . 10.3 pt20 -168.36 153.19 6.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.204 -179.735 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.4 pt-20 -143.93 158.28 56.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.476 179.949 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 42.0 Cg_endo -67.77 139.9 49.38 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.492 2.128 . . . . 0.0 112.535 -179.397 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.451 HG23 ' N ' ' A' ' 17' ' ' TRP . 12.5 m -59.35 154.67 16.23 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.831 -179.52 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.451 ' N ' HG23 ' A' ' 16' ' ' THR . 6.2 m-90 -97.11 90.6 5.21 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.023 -179.927 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 24' ' ' ALA . 51.5 mt -88.01 74.53 8.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.233 179.643 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.8 p -75.83 2.62 11.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.214 -179.167 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.414 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 9.7 m-20 -145.2 147.69 32.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 111.612 -179.813 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.594 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.3 t -56.47 -49.29 94.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.516 179.896 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 17.7 Cg_endo -59.39 -43.8 37.74 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.841 1.694 . . . . 0.0 111.975 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.18 -34.95 79.59 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.191 0.519 . . . . 0.0 110.317 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.55 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -63.93 -59.05 4.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.051 179.396 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 46.3 mtm -61.42 -27.17 68.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.16 -179.964 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.0 mt-10 -70.05 -49.77 47.85 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.756 0.312 . . . . 0.0 110.512 179.774 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -61.42 -35.36 77.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.981 179.2 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.428 HD11 HD13 ' A' ' 36' ' ' ILE . 48.7 mt -71.19 -35.98 60.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.213 0.53 . . . . 0.0 109.802 178.324 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.7 -19.36 60.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.927 -179.915 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.17 25.49 4.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.211 -179.736 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.9 t -170.68 153.56 4.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.633 -179.8 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.459 ' HG3' HG11 ' A' ' 87' ' ' VAL . 21.3 tt0 -64.37 -80.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.727 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.504 HG13 HD13 ' A' ' 83' ' ' LEU . 19.6 t -92.14 135.0 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.498 179.693 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.6 126.12 21.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.035 0.445 . . . . 0.0 112.11 -179.107 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.471 HG21 HG12 ' A' ' 111' ' ' ILE . 45.6 t -114.76 130.93 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.71 178.51 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 25.9 mt -135.88 137.54 48.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.544 -177.385 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.39 97.68 1.76 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.519 179.907 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.486 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.5 m-85 -82.85 90.91 6.99 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.632 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.6 m-85 -110.85 138.64 47.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.224 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.466 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 78.6 mt-30 -84.59 -8.69 58.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.824 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.43 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.3 t70 -150.37 125.87 10.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.738 179.794 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.491 ' HG ' HG21 ' A' ' 66' ' ' THR . 94.0 mt -93.41 46.68 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.422 . . . . 0.0 111.325 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.6 mt-10 -137.26 11.37 3.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.929 179.036 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.668 HG13 HG23 ' A' ' 47' ' ' VAL . 2.5 pt -94.03 158.1 36.74 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.014 179.984 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.443 ' O ' HD11 ' A' ' 49' ' ' ILE . 78.0 Cg_exo -53.47 -25.08 30.67 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.709 2.273 . . . . 0.0 112.93 179.951 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.53 -37.68 87.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.758 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.668 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -61.28 -55.45 43.51 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -178.754 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.2 Cg_exo -60.95 -40.41 52.89 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.045 1.83 . . . . 0.0 111.367 179.405 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.63 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -63.0 -33.79 62.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.042 179.973 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.536 ' O ' ' HG3' ' A' ' 53' ' ' MET . 42.9 tp -75.26 -51.85 12.3 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.842 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -53.56 -25.85 18.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.218 0.532 . . . . 0.0 109.837 178.541 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 t -81.88 -47.53 12.66 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.589 179.895 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.536 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -58.14 -26.44 62.68 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.517 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.519 HG13 ' HG3' ' A' ' 13' ' ' GLN . 52.6 t -51.68 -47.54 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.016 179.306 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -78.54 -11.88 59.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.681 -179.891 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 28.4 mtpp -92.12 -16.41 26.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.226 179.764 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.579 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 55.4 m-85 -138.71 63.18 31.72 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.478 -179.883 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.8 -44.47 47.92 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.636 2.224 . . . . 0.0 111.643 179.085 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.53 -38.85 82.94 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.542 179.209 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.0 t -68.76 144.28 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.175 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.513 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 23.2 t -82.53 96.5 8.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.106 0.479 . . . . 0.0 110.816 -179.65 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.442 ' CD2' HG12 ' A' ' 54' ' ' VAL . 4.0 p90 -64.07 125.75 25.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.074 179.69 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.66 162.05 28.25 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.16 179.908 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.5 tt -158.16 142.19 6.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.811 0.339 . . . . 0.0 110.223 179.62 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.8 t -142.73 154.69 44.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.136 0.493 . . . . 0.0 111.706 -179.036 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.491 HG21 ' HG ' ' A' ' 42' ' ' LEU . 71.3 p -140.16 1.86 1.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.534 179.503 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -74.24 139.86 44.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.658 -179.786 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.3 m -62.17 -50.77 70.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.296 -179.694 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -49.65 -44.63 47.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.588 -179.449 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.471 ' HA ' HG21 ' A' ' 21' ' ' VAL . 67.6 t -69.8 -53.94 21.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.859 0.361 . . . . 0.0 110.687 179.856 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp -57.95 -15.43 8.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.396 179.385 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 86.4 m -89.81 -42.5 11.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.212 178.748 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -59.72 -36.92 77.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.45 179.694 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -94.86 12.31 28.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.11 179.638 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.7 m120 57.29 20.77 6.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.67 179.063 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.635 HG21 ' HB ' ' A' ' 80' ' ' THR . 35.3 mm -57.49 120.66 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.951 179.637 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.1 p -140.62 53.8 1.61 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.865 0.364 . . . . 0.0 111.312 -179.957 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.43 46.15 0.01 OUTLIER Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.68 179.839 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.573 ' HB2' HG21 ' A' ' 99' ' ' ILE . 13.6 m120 51.2 42.54 28.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.186 0.517 . . . . 0.0 110.404 -179.85 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.635 ' HB ' HG21 ' A' ' 76' ' ' ILE . 94.3 m -68.35 152.82 44.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.557 -178.658 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.549 HG12 ' HA2' ' A' ' 37' ' ' GLY . 60.7 mt -119.43 118.53 57.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.035 178.195 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.486 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 65.6 m -107.57 137.08 46.24 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.695 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.584 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.9 tp -111.47 103.49 11.85 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.092 178.702 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -96.65 117.96 32.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.664 179.644 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.446 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 4.5 mtm180 -101.94 81.37 2.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.761 -179.863 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 5.6 tp -25.05 -60.98 0.06 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.327 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.459 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.46 -62.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.137 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -94.43 1.07 55.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.011 0.434 . . . . 0.0 111.045 -179.5 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 51.13 38.81 21.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.313 179.684 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 6.3 mm-40 -87.52 157.54 19.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.574 179.658 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.03 101.51 4.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.938 179.735 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.584 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -90.4 115.81 27.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.704 179.319 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.79 111.27 23.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.734 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.471 HD21 HD12 ' A' ' 102' ' ' ILE . 5.4 tt -97.6 77.61 2.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.723 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.469 ' HG2' ' HG1' ' A' ' 80' ' ' THR . 26.4 mt-10 -79.12 -164.74 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -176.786 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.469 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -45.66 -50.97 12.96 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.515 -179.173 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -46.55 -17.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.008 0.432 . . . . 0.0 111.128 179.747 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.414 ' N ' ' C ' ' A' ' 96' ' ' ASP . 17.0 m-20 -126.79 -13.78 5.77 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.484 180.0 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.573 HG21 ' HB2' ' A' ' 79' ' ' ASN . 27.4 mm -91.32 -42.11 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.464 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -51.9 -30.74 25.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.907 0.384 . . . . 0.0 111.052 179.935 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.5 m -131.36 36.09 3.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.277 179.68 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.7 tp -65.66 143.91 15.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.583 -179.818 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.484 ' HA ' HD12 ' A' ' 49' ' ' ILE . 16.2 m-20 -139.2 147.58 41.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.39 178.719 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.63 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.71 -37.11 7.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 110.307 -179.829 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.1 m -61.83 -48.37 80.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.357 178.677 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -59.9 -61.23 2.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.367 -179.842 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.599 HD13 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.85 -55.89 8.75 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 110.386 179.894 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -58.75 -31.75 68.62 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.991 179.909 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.495 ' HD3' HD12 ' A' ' 113' ' ' ILE . 3.3 tmt_? -69.86 -65.32 0.74 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.308 179.777 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -43.59 -44.17 6.06 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.168 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.471 HG12 HG21 ' A' ' 35' ' ' VAL . 96.7 mt -62.29 -55.36 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.197 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.43 -19.04 4.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.522 179.31 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.495 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -87.29 -36.79 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.796 -179.294 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -124.91 29.86 6.05 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.784 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.8 p -82.67 46.73 1.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.121 0.486 . . . . 0.0 110.329 179.166 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 63.1 mt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.316 -179.379 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.809 0.337 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.9 m -80.01 162.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.305 -179.925 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -131.33 110.27 10.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.803 -179.912 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.459 ' N ' ' HD3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER 56.47 68.64 0.83 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 -179.76 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.8 t -118.03 39.86 3.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.867 -179.829 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.3 t 56.73 62.48 2.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.917 -179.954 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -88.15 -21.2 24.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.822 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.89 169.92 24.23 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.339 179.944 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.7 121.85 10.27 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.64 2.227 . . . . 0.0 112.229 179.942 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.94 28.4 1.42 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.578 -179.832 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.59 -24.94 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.026 0.441 . . . . 0.0 110.514 179.774 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 13' ' ' GLN . . . -62.89 84.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.024 179.811 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.498 ' NE2' ' HA ' ' A' ' 55' ' ' GLN . 30.0 pt20 44.84 114.62 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.85 0.719 . . . . 0.0 112.63 -179.872 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.445 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 -110.35 158.03 36.47 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.798 -179.748 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.455 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.9 Cg_endo -67.91 140.86 51.73 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.654 2.236 . . . . 0.0 112.407 -179.712 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.2 m -55.1 155.0 5.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.892 -179.409 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -100.57 92.26 5.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.876 179.725 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 24' ' ' ALA . 55.4 mt -90.2 73.41 7.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.433 -179.893 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.5 p -74.36 0.85 13.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.288 -178.858 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -143.49 147.17 34.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.729 -179.678 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.577 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 19.9 t -55.2 -51.01 83.3 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.413 179.973 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.02 -44.18 41.91 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.905 1.737 . . . . 0.0 112.012 179.805 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.94 79.21 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.284 0.564 . . . . 0.0 110.35 -179.883 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -65.19 -58.48 5.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.984 179.515 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.7 mtm -61.28 -25.18 66.93 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.88 179.892 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -71.51 -51.68 22.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.357 179.613 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.01 -33.82 72.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.929 179.282 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.503 HD12 HD12 ' A' ' 36' ' ' ILE . 51.6 mt -73.42 -37.99 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.951 178.492 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.17 -18.35 60.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.905 -179.933 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.4 24.73 4.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.19 -179.871 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.9 t -169.71 153.08 4.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.695 -179.792 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.48 ' HG3' HG11 ' A' ' 87' ' ' VAL . 18.2 tt0 -64.12 -77.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.609 179.774 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.471 HG13 HD12 ' A' ' 83' ' ' LEU . 21.5 t -95.53 133.84 35.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.418 179.668 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.557 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -137.47 124.9 21.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.254 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.5 HG21 HG12 ' A' ' 111' ' ' ILE . 55.0 t -114.07 128.32 71.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.723 178.464 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.503 HD12 HD12 ' A' ' 28' ' ' ILE . 27.3 mt -135.05 138.53 48.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.534 -177.345 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.531 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.66 98.79 1.9 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.272 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.439 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 37.1 m-85 -84.23 91.02 7.63 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.291 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -110.72 142.54 42.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.646 -178.065 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -86.63 -8.08 57.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.887 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -151.53 131.11 13.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.605 179.745 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.532 ' HG ' HG22 ' A' ' 66' ' ' THR . 84.4 mt -97.75 47.58 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.109 0.48 . . . . 0.0 111.621 -179.539 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -137.09 5.22 2.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.689 178.773 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.664 HG13 HG21 ' A' ' 47' ' ' VAL . 1.6 pt -88.27 155.72 51.64 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.094 179.766 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.468 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 72.3 Cg_exo -50.95 -29.06 25.94 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.89 2.393 . . . . 0.0 113.126 179.886 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.47 ' HB3' HD13 ' A' ' 44' ' ' ILE . . . -62.04 -37.44 84.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.831 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.678 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 3.2 t -61.9 -57.21 25.48 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.659 -178.787 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.678 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.3 Cg_exo -59.07 -38.57 86.51 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.759 1.639 . . . . 0.0 111.52 179.589 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.604 HG22 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -63.33 -36.48 76.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.047 179.936 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.514 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.5 tp -73.98 -53.23 10.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.77 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -54.2 -22.59 11.86 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.816 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.2 t -85.32 -43.66 13.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.435 179.516 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.508 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.44 -24.85 66.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.253 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -51.97 -46.69 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.89 179.236 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.498 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 9.3 mt-30 -77.58 -12.6 59.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.905 -179.74 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -92.19 -18.16 23.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.332 -179.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.578 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 52.5 m-85 -137.37 63.31 41.45 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.547 -179.692 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.64 -46.43 33.41 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.71 2.274 . . . . 0.0 111.77 178.939 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.9 -42.08 78.59 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.658 179.328 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.9 t -64.27 146.61 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.87 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.557 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 32.8 t -83.51 97.48 9.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.964 0.411 . . . . 0.0 110.924 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.455 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.2 p90 -66.02 126.17 27.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.32 161.62 28.35 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.195 179.81 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -159.07 144.36 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.993 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.439 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 29.4 t -149.18 155.86 41.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.12 0.486 . . . . 0.0 111.762 -179.214 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.532 HG22 ' HG ' ' A' ' 42' ' ' LEU . 76.6 p -137.09 -0.8 2.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.613 179.387 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.92 136.33 53.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.566 -179.927 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 59.5 m -61.52 -48.66 80.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.577 -179.634 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -51.51 -41.27 60.88 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.51 -179.435 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.424 ' HA ' HG23 ' A' ' 21' ' ' VAL . 55.4 t -72.6 -53.61 18.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.915 0.388 . . . . 0.0 110.439 179.835 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.64 -14.56 8.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.23 179.261 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.2 m -91.84 -42.12 10.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.385 178.85 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -60.39 -39.49 87.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -90.06 11.02 21.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.651 179.595 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.8 m120 58.03 24.97 11.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.52 179.373 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.59 HD11 ' HB ' ' A' ' 80' ' ' THR . 40.9 mm -62.8 124.17 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.875 179.458 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.8 p -142.32 58.95 1.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.437 -179.887 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.09 45.3 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.823 179.854 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 26.8 m-80 52.04 44.03 29.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.174 0.511 . . . . 0.0 110.613 -179.86 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.59 ' HB ' HD11 ' A' ' 76' ' ' ILE . 86.6 m -69.16 154.22 42.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.533 -178.763 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.546 HG21 HD21 ' A' ' 107' ' ' LEU . 60.5 mt -119.72 117.8 55.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.16 178.156 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 72.8 m -106.99 134.68 49.78 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -177.787 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.581 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -110.78 103.79 12.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.663 178.17 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -97.93 118.03 33.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.634 179.909 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.517 HH12 HD13 ' A' ' 116' ' ' LEU . 4.5 mtm180 -101.22 80.08 2.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.462 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' ARG . 5.1 tp -23.91 -60.51 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.36 -0.836 . . . . 0.0 113.249 -179.417 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.48 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.97 -61.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.01 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -95.34 3.31 54.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.41 . . . . 0.0 111.034 -179.506 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 53.19 29.24 8.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.802 179.357 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.5 mm-40 -75.47 153.13 37.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.538 0.209 . . . . 0.0 110.643 179.721 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.409 HE21 ' HB3' ' A' ' 91' ' ' GLN . 1.0 OUTLIER -136.54 95.98 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.718 179.858 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.592 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.0 mm? -87.44 114.53 24.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.976 179.917 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.39 110.53 23.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.087 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 102' ' ' ILE . 4.3 tt -96.16 78.81 3.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.014 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.417 ' O ' HG12 ' A' ' 99' ' ' ILE . 30.6 mt-10 -78.78 -165.17 0.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -176.383 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.501 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 30.2 t70 -51.46 -35.28 39.03 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.951 -179.178 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -56.68 -15.33 4.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.206 0.527 . . . . 0.0 110.261 179.482 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -130.11 -14.09 3.93 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.531 179.923 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.501 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 22.9 mm -90.0 -27.67 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.789 0.328 . . . . 0.0 111.263 -179.517 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -57.13 -37.43 71.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.782 -179.862 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.5 m -131.95 38.17 3.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.562 179.673 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.505 HD11 HD23 ' A' ' 94' ' ' LEU . 7.6 tp -63.61 144.61 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.575 -179.602 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.552 ' HA ' HD13 ' A' ' 49' ' ' ILE . 15.5 m-20 -138.37 149.64 45.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.45 178.603 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.604 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -47.73 -35.0 9.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.111 0.481 . . . . 0.0 110.48 -179.673 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.5 m -63.01 -48.53 78.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.49 178.761 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -59.66 -59.17 5.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.182 -179.703 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.59 HD12 HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.1 -55.45 14.89 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.988 0.423 . . . . 0.0 110.18 -179.994 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.6 m -58.72 -29.48 66.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.714 179.836 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.501 ' HD3' HD12 ' A' ' 113' ' ' ILE . 4.0 tmt_? -71.11 -66.2 0.65 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.068 179.724 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -42.71 -44.73 4.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.057 179.275 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.5 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -62.65 -55.2 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.535 178.387 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -54.37 -18.69 4.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.253 179.357 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.501 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.09 -36.21 8.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.898 -179.137 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.592 HD21 ' HG ' ' A' ' 92' ' ' LEU . 90.2 m-20 -125.35 30.33 5.83 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.3 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.1 p -83.53 48.48 1.42 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.135 0.493 . . . . 0.0 110.145 178.922 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.517 HD13 HH12 ' A' ' 85' ' ' ARG . 60.9 mt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.36 -179.362 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.785 0.326 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.48 131.75 70.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.038 -179.995 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -171.73 164.93 6.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.833 -179.896 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -89.29 50.58 1.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.83 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.1 m -156.74 130.03 8.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.922 -179.987 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 t -139.01 125.28 20.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.804 -179.982 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -142.37 26.73 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 -179.968 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.24 -166.02 29.97 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.572 -179.866 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.92 -173.55 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.647 2.231 . . . . 0.0 112.473 -179.939 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.54 -122.8 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.682 -179.931 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.04 -69.2 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.683 0.277 . . . . 0.0 110.6 -179.811 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.46 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . . . 57.32 99.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.367 179.687 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.5 ' HG3' HG11 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -167.31 -179.93 4.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.825 -179.366 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.44 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.1 pt-20 -128.92 157.01 77.0 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.135 -179.542 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 36.4 Cg_endo -67.08 142.93 63.36 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.934 2.423 . . . . 0.0 112.827 -179.514 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.8 m -59.68 153.77 19.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.624 -179.838 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -98.53 97.5 8.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.129 -179.849 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 24' ' ' ALA . 46.8 mt -95.21 76.46 3.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.361 179.769 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.9 p -75.17 -2.49 28.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.297 -178.736 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -142.16 147.36 36.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.919 0.39 . . . . 0.0 111.727 -179.814 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 36.1 t -54.3 -49.5 90.14 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.663 179.983 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.07 -46.97 22.3 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.949 1.766 . . . . 0.0 112.147 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.92 -34.68 77.94 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.186 0.517 . . . . 0.0 110.388 -179.81 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -63.84 -59.97 3.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.122 179.389 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 67.5 mtp -60.4 -25.98 66.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.215 -179.897 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 25.1 mt-10 -73.07 -51.73 16.97 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 120.652 0.263 . . . . 0.0 110.675 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -58.44 -33.35 69.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.117 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.454 HD12 HD12 ' A' ' 36' ' ' ILE . 45.0 mt -72.35 -40.04 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.901 178.104 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.81 -17.77 62.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.06 179.948 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.64 27.92 2.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.231 -179.828 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.8 t -173.16 155.49 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.579 -179.626 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.508 ' HG3' HG13 ' A' ' 87' ' ' VAL . 19.6 tt0 -65.31 -76.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.681 179.838 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.483 HG13 HD13 ' A' ' 83' ' ' LEU . 21.0 t -95.38 137.98 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.42 179.661 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.546 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.97 125.94 18.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.039 0.447 . . . . 0.0 112.021 -179.142 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.551 HG21 HG12 ' A' ' 111' ' ' ILE . 51.6 t -115.57 129.53 71.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.828 178.526 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 26.5 mt -135.02 135.72 52.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.624 -177.341 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.55 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.4 99.81 2.24 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.335 179.633 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 11.7 m-85 -84.63 92.57 8.19 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.725 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 9.7 m-85 -114.69 142.67 46.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.309 -178.217 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -90.06 -8.64 50.98 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.7 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.48 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.5 t70 -148.12 118.96 7.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.742 179.761 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.513 ' HG ' HG22 ' A' ' 66' ' ' THR . 93.9 mt -88.4 44.85 1.23 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.114 0.483 . . . . 0.0 111.516 -179.268 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.404 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 39.1 mt-10 -133.82 6.96 3.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.124 178.953 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.657 HG13 HG23 ' A' ' 47' ' ' VAL . 5.6 pt -88.14 159.48 47.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.191 179.89 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.457 ' O ' HD11 ' A' ' 49' ' ' ILE . 54.3 Cg_exo -54.91 -26.07 46.95 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.763 2.308 . . . . 0.0 112.689 179.429 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.41 -38.7 91.94 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.883 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.657 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -59.69 -55.58 44.33 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.723 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.64 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.1 Cg_exo -59.75 -41.27 56.59 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.052 1.835 . . . . 0.0 111.403 179.185 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.618 HG22 ' HA ' ' A' ' 104' ' ' ALA . 8.9 mt -61.97 -35.01 65.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.194 -179.906 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.523 ' O ' ' HG3' ' A' ' 53' ' ' MET . 47.2 tp -74.75 -50.93 15.59 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.959 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -54.98 -26.0 33.7 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.398 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -81.42 -46.12 15.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.734 179.859 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.523 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -60.21 -26.15 66.15 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.38 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.5 HG11 ' HG3' ' A' ' 13' ' ' GLN . 47.7 t -53.87 -48.44 62.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.162 179.541 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 12' ' ' ALA . 34.0 mt-30 -76.83 -9.35 58.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.588 -179.898 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -94.82 -19.56 20.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 179.719 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.585 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 73.4 m-85 -135.04 62.11 50.43 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.609 -179.548 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.4 -40.35 71.33 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.57 2.18 . . . . 0.0 111.379 178.996 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.42 -42.5 97.54 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.323 179.068 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.9 t -65.49 144.83 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.084 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.546 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 24.1 t -82.65 96.6 8.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.095 0.474 . . . . 0.0 110.967 -179.554 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.528 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 5.2 p90 -64.28 129.39 39.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.106 179.805 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.83 161.98 28.8 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.097 179.667 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -160.99 143.03 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.808 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.1 t -145.67 155.66 43.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.109 0.481 . . . . 0.0 111.917 -178.935 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.513 HG22 ' HG ' ' A' ' 42' ' ' LEU . 78.8 p -138.89 6.16 2.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.655 179.505 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.09 144.42 40.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.706 -179.925 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -65.64 -54.39 28.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.384 -179.547 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -49.04 -40.0 29.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.631 -179.364 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.537 ' HA ' HG21 ' A' ' 21' ' ' VAL . 68.3 t -72.37 -55.27 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.857 0.361 . . . . 0.0 110.603 179.69 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.3 -14.78 8.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.517 179.461 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.6 m -89.22 -48.04 7.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.721 179.101 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -59.03 -33.58 70.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.57 179.837 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -92.82 8.24 40.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.547 179.235 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 57.32 23.69 9.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.632 179.51 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.695 HG21 ' HB ' ' A' ' 80' ' ' THR . 34.3 mm -61.22 120.9 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.012 179.652 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.8 p -141.3 58.43 1.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.308 179.825 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.32 42.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.533 179.815 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.527 ' HB2' HG22 ' A' ' 99' ' ' ILE . 39.9 m-20 52.77 42.43 31.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.267 0.556 . . . . 0.0 110.151 -179.669 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.695 ' HB ' HG21 ' A' ' 76' ' ' ILE . 93.4 m -67.97 154.36 41.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.682 -178.472 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.55 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.5 mt -120.32 116.95 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.271 178.271 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.512 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.7 m -105.93 137.09 44.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.857 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.577 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.4 tp -112.98 105.68 13.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.253 178.671 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.2 t80 -98.18 123.08 42.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.682 0.277 . . . . 0.0 110.415 179.413 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.513 HH12 HD12 ' A' ' 116' ' ' LEU . 5.7 mtm180 -105.59 82.38 1.8 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.801 0.334 . . . . 0.0 110.875 -179.698 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 7.2 tp -26.29 -59.28 0.08 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.432 -0.803 . . . . 0.0 113.103 -179.287 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.508 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.21 -56.27 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.128 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -99.93 13.27 34.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.734 0.302 . . . . 0.0 111.386 -179.353 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 45.2 24.39 0.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.218 179.234 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.51 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 15.9 mm-40 -72.02 157.73 37.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.768 0.318 . . . . 0.0 110.77 179.794 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -143.6 85.44 1.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.67 179.667 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.585 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.7 mm? -72.78 147.96 45.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.947 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.69 114.41 16.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.309 0.576 . . . . 0.0 112.285 -179.562 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 102' ' ' ILE . 4.2 tt -101.83 76.33 1.62 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.93 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.419 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.8 mt-10 -75.82 -166.75 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -176.692 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.532 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.6 t70 -50.91 -38.67 51.47 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.057 -179.093 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -55.51 -14.9 2.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.164 0.506 . . . . 0.0 110.525 179.794 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -128.45 -13.67 4.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.47 -179.988 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 21.2 mm -89.47 -23.79 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.71 -179.33 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -53.65 -66.46 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 110.684 179.807 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.8 t -105.77 34.3 3.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.622 179.782 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.544 HD12 HD23 ' A' ' 94' ' ' LEU . 7.5 tp -53.99 142.04 8.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.224 -179.947 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.537 ' HA ' HD12 ' A' ' 49' ' ' ILE . 24.7 m-20 -135.61 151.06 49.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.676 178.967 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.618 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -49.42 -34.97 17.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.981 0.42 . . . . 0.0 110.446 -179.883 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 95.0 m -63.1 -48.16 79.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.287 178.774 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -59.79 -60.44 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.252 -179.815 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.581 HD12 HG23 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -49.36 -55.62 12.32 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.074 0.464 . . . . 0.0 110.237 179.785 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.2 m -58.32 -30.57 66.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.872 179.735 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.473 ' HD3' HD12 ' A' ' 113' ' ' ILE . 4.0 tmt_? -70.15 -66.19 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.118 179.771 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -43.43 -44.73 5.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.059 179.355 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.551 HG12 HG21 ' A' ' 35' ' ' VAL . 95.5 mt -61.88 -54.63 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.367 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -55.51 -19.15 8.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.4 179.48 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.473 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -87.69 -36.61 9.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.88 -179.009 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.585 HD21 ' HG ' ' A' ' 92' ' ' LEU . 85.1 m-20 -122.15 27.27 8.09 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.44 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.6 p -81.33 51.68 1.68 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.988 0.423 . . . . 0.0 110.362 178.886 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.513 HD12 HH12 ' A' ' 85' ' ' ARG . 71.1 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.401 -179.469 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.775 0.321 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.75 164.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.098 179.986 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -146.12 148.8 32.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 179.924 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -107.0 126.02 51.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.946 -179.952 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -148.09 92.92 2.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 179.91 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.1 p -110.4 137.23 48.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.027 -179.848 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -108.66 144.2 36.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.738 179.867 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.12 179.08 35.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.547 -179.831 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.09 135.81 64.96 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.666 2.244 . . . . 0.0 112.317 179.939 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.19 147.09 2.52 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.528 -179.927 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.05 -70.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.733 0.301 . . . . 0.0 110.729 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.497 ' HB3' ' NE2' ' A' ' 55' ' ' GLN . . . 60.2 106.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.212 179.836 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.549 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.7 pt20 -51.25 148.35 4.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.265 -179.788 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.504 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 -122.77 159.5 53.11 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.735 -179.748 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 30.5 Cg_endo -64.18 143.69 84.59 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.699 2.266 . . . . 0.0 112.603 -179.709 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.0 m -61.71 152.41 31.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.552 -179.776 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -98.18 92.55 5.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.581 HD22 ' HA ' ' A' ' 24' ' ' ALA . 40.2 mt -87.71 72.55 9.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.258 -179.905 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.4 p -69.07 -3.98 15.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.251 -178.922 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -141.39 149.58 41.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.993 0.425 . . . . 0.0 111.792 -179.569 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.594 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 25.3 t -57.03 -49.12 95.81 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.626 179.753 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.7 Cg_endo -58.93 -43.73 41.04 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.956 1.771 . . . . 0.0 111.909 179.865 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.16 -35.3 80.67 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 110.143 179.831 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.581 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.43 -56.97 11.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.091 179.361 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 33.8 mtt -62.53 -27.72 69.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.171 -179.961 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -69.94 -49.61 50.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.686 0.279 . . . . 0.0 110.449 179.723 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.01 -32.56 73.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.84 179.071 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.443 HD12 HD12 ' A' ' 36' ' ' ILE . 54.3 mt -72.47 -37.65 57.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.833 178.161 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 -20.81 60.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.706 -179.958 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.17 28.96 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.153 -179.873 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.454 HG22 ' CB ' ' A' ' 61' ' ' SER . 8.9 t -169.1 155.38 6.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.33 -179.798 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.459 ' HG3' HG11 ' A' ' 87' ' ' VAL . 29.2 tt0 -75.98 -33.91 59.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.254 179.481 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.432 HG12 HD13 ' A' ' 83' ' ' LEU . 17.1 t -133.37 136.3 54.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.125 179.273 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.59 125.24 16.85 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.117 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.537 HG23 HG12 ' A' ' 111' ' ' ILE . 53.4 t -113.18 127.63 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.449 178.234 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.443 HD12 HD12 ' A' ' 28' ' ' ILE . 35.7 mt -133.87 139.41 48.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.62 -176.86 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.528 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.89 97.59 1.53 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.459 179.848 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.484 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 36.9 m-85 -84.84 94.37 8.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.322 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 9.9 m-85 -114.32 146.12 40.91 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.092 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.616 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 52.4 mt-30 -93.77 -6.45 46.01 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.082 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.7 t70 -151.98 113.94 4.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.511 179.855 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.473 ' HG ' HG23 ' A' ' 66' ' ' THR . 89.0 mt -84.19 43.63 0.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.026 0.441 . . . . 0.0 111.549 -179.166 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.444 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.5 mt-10 -132.24 11.38 4.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.999 179.11 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.657 HG13 HG23 ' A' ' 47' ' ' VAL . 9.6 pt -91.78 161.89 32.62 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.336 179.969 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.441 ' O ' HD11 ' A' ' 49' ' ' ILE . 51.3 Cg_exo -57.73 -23.93 60.6 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.737 2.291 . . . . 0.0 112.587 179.047 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.18 88.99 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.812 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.657 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -58.6 -55.1 49.38 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -178.681 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.625 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.8 Cg_exo -61.57 -42.46 33.01 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.971 1.781 . . . . 0.0 111.648 179.287 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.633 HG21 HD12 ' A' ' 107' ' ' LEU . 6.2 mt -60.67 -34.33 58.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.236 -179.991 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.532 ' O ' ' HG3' ' A' ' 53' ' ' MET . 51.3 tp -74.37 -51.67 14.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.138 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -53.55 -25.89 18.94 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.541 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 m -80.56 -49.79 10.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.606 179.686 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.532 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -56.43 -27.17 55.87 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.174 0.511 . . . . 0.0 109.666 179.551 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.549 HG12 ' HG3' ' A' ' 13' ' ' GLN . 54.2 t -53.27 -49.97 49.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.726 179.481 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 12' ' ' ALA . 27.2 mt-30 -75.17 -8.66 57.2 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.583 -179.76 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -95.81 -19.14 19.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.203 179.613 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.606 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 63.4 m-85 -135.65 62.61 49.4 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.503 -179.796 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.65 -41.44 61.42 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.613 2.209 . . . . 0.0 111.658 179.094 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.37 -41.78 97.13 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.511 179.167 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.0 t -66.03 144.07 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.882 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 47.4 t -82.07 99.32 9.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.08 0.467 . . . . 0.0 111.001 -179.773 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.505 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 5.5 p90 -65.59 127.94 33.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.635 179.688 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.16 161.52 28.32 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.235 -179.944 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 tt -162.21 143.24 3.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.732 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.484 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 44.1 t -150.32 157.24 42.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.127 0.489 . . . . 0.0 111.519 -179.143 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.473 HG23 ' HG ' ' A' ' 42' ' ' LEU . 71.2 p -136.49 -7.66 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.695 179.413 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -60.19 139.69 57.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.605 179.883 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.2 p -63.48 -47.33 82.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.61 -179.356 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -52.48 -43.42 64.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.716 -179.224 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.434 ' HA ' HG23 ' A' ' 21' ' ' VAL . 67.0 t -72.15 -51.04 32.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.849 0.356 . . . . 0.0 110.71 179.832 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.74 -14.84 23.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.088 0.47 . . . . 0.0 110.135 179.449 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.2 m -92.3 -39.46 11.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.418 178.799 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -62.86 -40.66 98.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.423 -179.996 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -88.25 8.2 28.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.467 179.426 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 58.54 27.06 15.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.506 179.539 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.637 HG21 ' HB ' ' A' ' 80' ' ' THR . 38.6 mm -63.2 121.69 12.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.225 179.689 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.0 p -141.12 56.17 1.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.377 -179.965 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.37 44.37 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.579 179.847 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.616 ' ND2' ' H ' ' A' ' 40' ' ' GLN . 6.8 m120 51.31 43.85 29.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.297 0.57 . . . . 0.0 110.379 -179.846 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.637 ' HB ' HG21 ' A' ' 76' ' ' ILE . 93.3 m -69.13 153.28 43.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.076 -178.334 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.528 HG12 ' HA2' ' A' ' 37' ' ' GLY . 55.2 mt -119.14 116.41 50.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.92 177.88 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 72.4 m -104.85 130.1 53.04 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.833 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.586 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.8 tp -107.92 100.74 10.07 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.583 178.102 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -95.16 121.65 37.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.488 179.808 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.543 HH12 HD11 ' A' ' 116' ' ' LEU . 5.0 mtm180 -105.05 88.04 2.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.545 -179.933 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 tp -27.11 -60.28 0.09 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.279 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.459 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.19 -79.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.361 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -78.3 2.57 18.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.818 -179.907 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 54.36 28.84 9.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.54 179.671 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.539 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 27.5 mm-40 -71.32 163.44 27.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.884 0.374 . . . . 0.0 110.882 179.876 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.02 88.48 1.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.668 179.76 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.586 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -78.45 117.79 19.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.897 179.879 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.77 93.55 5.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.882 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.482 HD22 HD13 ' A' ' 102' ' ' ILE . 4.0 tt -78.71 78.6 5.15 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.776 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -79.73 -165.5 0.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.787 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.439 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.7 OUTLIER -44.83 -52.05 8.92 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.374 -179.377 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -46.06 -17.68 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.365 179.786 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 96' ' ' ASP . 28.6 m-20 -125.9 -13.8 6.26 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.523 -179.941 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.538 HG23 ' HB2' ' A' ' 79' ' ' ASN . 23.0 mm -90.85 -35.13 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.338 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.0 -39.0 58.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.362 -179.681 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.7 m -126.48 32.96 5.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.749 179.937 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.9 tp -58.37 143.71 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.681 -179.935 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.515 ' HA ' HD12 ' A' ' 49' ' ' ILE . 23.3 m-20 -138.61 148.78 44.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.475 178.891 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.593 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.88 -37.14 13.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.061 0.458 . . . . 0.0 110.337 -179.888 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.6 m -61.76 -48.0 82.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.237 178.741 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -60.1 -62.38 1.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.26 -179.895 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.633 HD12 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.22 -56.44 6.7 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.013 0.435 . . . . 0.0 110.258 179.982 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.9 m -57.97 -31.25 66.72 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.815 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.466 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -70.32 -66.51 0.59 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.184 179.71 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -42.07 -43.96 3.43 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.295 179.351 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.537 HG12 HG23 ' A' ' 35' ' ' VAL . 95.1 mt -63.42 -55.05 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.381 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -54.01 -18.89 3.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.151 179.234 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.466 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.91 -35.81 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.944 -179.137 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -125.17 31.78 5.53 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.472 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.1 p -83.84 36.54 0.56 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.037 0.446 . . . . 0.0 110.465 178.792 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.543 HD11 HH12 ' A' ' 85' ' ' ARG . 63.7 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.311 -179.565 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.735 0.302 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.36 -21.86 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.311 -179.839 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -94.84 149.28 21.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.803 179.846 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -126.87 25.17 6.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.947 -179.841 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 t -75.84 136.87 40.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.776 179.915 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.2 m -134.65 -60.62 0.78 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.123 -179.805 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.29 100.26 2.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.114 -179.839 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.37 177.93 41.21 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.425 179.831 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.57 -41.27 66.19 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.419 2.079 . . . . 0.0 112.134 179.903 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.69 -97.1 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.295 179.866 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.22 -65.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.707 0.289 . . . . 0.0 110.74 -179.955 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.497 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . . . 60.55 104.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.48 179.699 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.533 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.5 pt20 -56.59 164.97 1.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.297 179.947 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.445 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 10.3 pt-20 -134.94 157.4 77.14 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.545 179.919 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 30.3 Cg_endo -64.26 148.99 91.06 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.584 2.19 . . . . 0.0 112.594 -179.373 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 17' ' ' TRP . 26.0 m -64.13 154.28 35.11 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.161 -179.39 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.401 ' N ' HG22 ' A' ' 16' ' ' THR . 5.6 m-90 -98.09 88.4 4.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.827 179.647 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.555 HD21 ' HA ' ' A' ' 24' ' ' ALA . 60.8 mt -88.33 77.01 8.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.057 0.456 . . . . 0.0 110.379 179.914 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.2 p -75.03 -7.09 52.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.32 -179.076 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -138.8 147.9 43.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.816 -179.576 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.589 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 47.9 t -54.93 -50.32 86.91 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.521 179.794 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.44 -44.49 42.0 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.944 1.762 . . . . 0.0 111.854 -179.956 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.86 -33.98 77.29 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.258 0.552 . . . . 0.0 110.4 -179.988 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.555 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -65.28 -58.55 5.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.127 179.371 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.5 mtp -61.24 -27.02 68.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.981 179.992 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 18.7 mt-10 -71.0 -49.88 40.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.654 0.264 . . . . 0.0 110.342 179.616 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -60.16 -35.24 74.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.002 179.229 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.452 HD13 HD11 ' A' ' 36' ' ' ILE . 49.0 mt -72.28 -38.36 61.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.926 178.526 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.3 -18.65 61.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.04 -179.823 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.08 26.63 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.04 -179.842 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.9 t -173.32 153.72 2.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.541 -179.623 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.464 ' HG3' HG13 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -63.3 -84.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.148 0.499 . . . . 0.0 110.903 179.532 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.464 HG11 HD13 ' A' ' 83' ' ' LEU . 13.0 t -87.7 134.21 28.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.663 -179.808 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.55 125.46 21.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 112.019 -179.162 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.478 HG22 HG12 ' A' ' 111' ' ' ILE . 53.5 t -115.21 127.87 72.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.955 178.544 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.452 HD11 HD13 ' A' ' 28' ' ' ILE . 23.5 mt -133.23 136.15 55.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.513 -177.27 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.559 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.58 98.8 1.99 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.49 179.797 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.487 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 11.7 m-85 -83.81 92.36 7.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.632 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.9 m-85 -113.42 141.59 46.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.451 -178.068 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.401 ' HG2' HD21 ' A' ' 71' ' ' LEU . 25.3 mt-30 -89.41 -6.99 56.07 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.712 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 44' ' ' ILE . 36.4 t70 -150.03 119.06 6.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.82 179.916 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.475 ' HG ' HG23 ' A' ' 66' ' ' THR . 94.7 mt -88.36 44.97 1.24 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.11 0.481 . . . . 0.0 111.165 -179.605 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -135.99 10.85 3.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.21 179.317 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.643 HG13 HG23 ' A' ' 47' ' ' VAL . 1.7 pt -95.13 156.39 37.88 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.098 179.742 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.452 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 76.4 Cg_exo -50.94 -29.79 28.31 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.712 2.274 . . . . 0.0 112.909 179.825 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.11 77.48 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.052 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.648 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.2 t -64.49 -57.66 16.38 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.636 -178.926 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.648 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.9 Cg_exo -58.23 -37.93 93.21 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.712 1.608 . . . . 0.0 111.205 179.279 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.616 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.6 mt -64.34 -37.32 79.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.029 179.822 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.559 ' O ' ' HG3' ' A' ' 53' ' ' MET . 39.7 tp -72.82 -52.92 12.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.905 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -54.8 -25.16 26.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.021 0.438 . . . . 0.0 109.966 178.791 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.7 t -81.71 -44.94 16.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.465 179.588 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.559 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -61.49 -26.31 67.83 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.159 0.504 . . . . 0.0 109.788 179.497 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.533 HG12 ' HG3' ' A' ' 13' ' ' GLN . 53.7 t -53.02 -49.65 48.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.121 179.513 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.497 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 29.0 mt-30 -74.47 -11.74 60.31 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.564 -179.949 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -93.71 -17.9 22.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.291 179.936 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.543 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 65.2 m-85 -136.49 61.65 38.81 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.551 -179.74 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.61 -42.64 60.88 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.682 2.255 . . . . 0.0 111.67 179.174 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.29 -39.47 90.31 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.368 179.31 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.6 t -67.76 145.09 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.521 -0.34 . . . . 0.0 110.19 178.927 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.542 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 22.6 t -82.71 96.79 8.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.03 0.443 . . . . 0.0 110.899 -179.716 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.459 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 6.9 p90 -63.98 129.53 40.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.05 179.888 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.97 161.57 28.73 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.01 179.697 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -160.12 144.39 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.795 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.8 t -146.82 155.55 42.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.174 0.512 . . . . 0.0 111.733 -179.137 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.475 HG23 ' HG ' ' A' ' 42' ' ' LEU . 77.9 p -139.14 2.08 2.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.618 179.654 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -73.63 143.78 46.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.744 -179.893 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.2 p -64.91 -51.84 59.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.405 -179.578 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -49.23 -42.58 40.94 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.707 -179.472 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.546 ' HA ' HG21 ' A' ' 21' ' ' VAL . 77.7 t -71.77 -54.1 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.936 0.398 . . . . 0.0 110.714 179.973 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.401 HD21 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.63 -14.68 8.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.303 179.368 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.1 m -91.91 -40.95 10.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.261 178.966 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -60.69 -39.34 88.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.403 179.825 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -91.9 10.61 28.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.723 179.398 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 58.26 22.37 9.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.662 179.128 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.633 HG22 ' HB ' ' A' ' 80' ' ' THR . 37.9 mm -57.83 122.21 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.044 179.912 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.0 p -142.3 59.55 1.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.139 -179.912 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.3 44.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.725 179.989 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.554 ' HB2' HG23 ' A' ' 99' ' ' ILE . 42.1 m-20 51.77 42.83 30.21 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.192 0.52 . . . . 0.0 110.532 -179.9 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.633 ' HB ' HG22 ' A' ' 76' ' ' ILE . 93.8 m -69.02 153.83 43.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.677 -178.671 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.559 HG12 ' HA2' ' A' ' 37' ' ' GLY . 62.7 mt -120.83 118.28 55.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.941 178.268 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.487 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.4 m -106.55 134.31 49.88 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.998 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.593 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.7 tp -111.42 105.08 13.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.129 178.716 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.3 t80 -99.31 119.91 38.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.446 179.543 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.443 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 4.6 mtm180 -101.74 79.98 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.809 -179.731 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 85' ' ' ARG . 11.5 tp -23.9 -59.35 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.108 -179.622 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.464 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.21 -63.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.264 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.49 3.72 54.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.061 0.457 . . . . 0.0 111.14 -179.694 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 51.37 30.02 5.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.947 179.422 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 7.0 mm-40 -77.53 153.5 33.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.505 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -135.4 94.98 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.904 179.816 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.593 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -84.71 134.85 34.34 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.003 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.26 101.31 8.33 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.824 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.53 HD23 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -85.93 78.19 9.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.794 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.1 mt-10 -80.4 -164.84 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.891 -176.877 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.493 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 23.7 t70 -51.26 -36.12 40.56 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.831 -179.381 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -55.77 -14.88 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.106 0.479 . . . . 0.0 110.21 179.448 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -131.5 -13.81 3.34 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.623 -179.806 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.577 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 25.8 mm -90.17 -35.45 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.594 0.235 . . . . 0.0 111.406 -179.496 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -49.62 -44.56 47.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.801 -179.98 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.3 m -124.74 41.14 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.358 179.498 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.577 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.8 tp -66.3 143.97 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.8 -179.618 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.525 ' HA ' HD12 ' A' ' 49' ' ' ILE . 17.4 m-20 -138.45 149.59 45.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.581 178.72 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.616 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.61 -37.6 12.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.581 -179.788 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.5 m -61.6 -47.49 85.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.346 178.75 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -59.86 -61.39 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.249 -179.718 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.71 -55.8 10.36 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.924 0.392 . . . . 0.0 110.382 179.98 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.6 m -58.51 -30.18 66.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.88 179.901 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.533 ' HD3' HD11 ' A' ' 113' ' ' ILE . 2.9 tmt_? -70.54 -66.42 0.61 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.101 179.558 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -42.88 -44.4 4.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.274 179.34 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.478 HG12 HG22 ' A' ' 35' ' ' VAL . 96.6 mt -63.19 -54.75 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.287 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.403 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 32.8 tt0 -53.96 -19.66 5.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.224 179.191 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.533 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.7 -36.53 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.771 -179.155 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.59 HD21 ' HG ' ' A' ' 92' ' ' LEU . 88.9 m-20 -123.71 30.01 6.35 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.183 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 96.6 p -82.83 37.13 0.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.165 0.507 . . . . 0.0 110.052 178.797 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.43 HD11 HH12 ' A' ' 85' ' ' ARG . 53.5 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.314 -179.329 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.841 0.353 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.2 p -130.43 135.61 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 -179.939 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -79.54 -179.75 7.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.773 179.963 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -57.24 -74.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.826 179.994 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.3 m 52.02 40.43 28.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.192 179.679 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.9 p -168.88 153.81 5.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.911 0.386 . . . . 0.0 110.949 179.953 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -155.32 130.2 9.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.859 179.766 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.74 -165.3 25.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.474 -179.924 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.27 -37.76 81.09 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.591 2.194 . . . . 0.0 112.449 -179.996 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.09 23.11 0.49 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.464 179.985 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.11 -66.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.85 0.357 . . . . 0.0 110.286 -179.946 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 13' ' ' GLN . . . 52.24 54.27 11.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.748 179.232 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.534 ' HG3' HG11 ' A' ' 54' ' ' VAL . 20.6 pt20 45.82 117.43 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.707 0.803 . . . . 0.0 112.844 179.727 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.7 pt-20 -116.25 158.15 43.57 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.52 179.774 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 38.1 Cg_endo -66.43 144.48 73.68 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.53 2.153 . . . . 0.0 112.405 -179.614 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.424 HG23 ' N ' ' A' ' 17' ' ' TRP . 19.6 m -63.41 153.58 34.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.671 -179.536 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.424 ' N ' HG23 ' A' ' 16' ' ' THR . 4.5 m-90 -98.62 92.53 5.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 179.488 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.58 HD13 ' HA ' ' A' ' 24' ' ' ALA . 43.5 mt -86.96 73.65 9.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.326 179.801 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.2 p -72.21 -5.37 35.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.118 -179.167 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -137.06 146.72 45.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.905 0.383 . . . . 0.0 111.604 -179.684 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 59.9 t -55.5 -49.81 90.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.61 179.883 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.8 Cg_endo -57.77 -46.17 28.29 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.923 1.749 . . . . 0.0 112.07 179.877 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.83 81.39 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.346 0.593 . . . . 0.0 110.239 -179.898 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.58 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -63.99 -58.53 6.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.023 179.524 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.41 ' HG3' ' O ' ' A' ' 21' ' ' VAL . 57.7 mtm -60.02 -25.76 65.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.065 179.891 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -71.97 -52.07 18.86 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.621 179.642 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -60.01 -30.2 69.0 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.33 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.473 HD13 HD12 ' A' ' 36' ' ' ILE . 48.0 mt -75.57 -38.69 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.121 178.201 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 -20.66 60.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.018 -179.851 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.78 31.85 1.33 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -179.929 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.491 HG22 ' CB ' ' A' ' 61' ' ' SER . 9.7 t -170.43 151.78 3.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.45 -179.539 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.53 ' HG3' HG11 ' A' ' 87' ' ' VAL . 24.4 tt0 -70.18 -40.55 74.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.558 179.539 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.426 HG11 HD12 ' A' ' 83' ' ' LEU . 19.4 t -129.94 137.35 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.162 179.283 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.93 128.19 19.85 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.134 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.485 HG23 HG12 ' A' ' 111' ' ' ILE . 55.0 t -115.93 130.53 70.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.379 178.338 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.473 HD12 HD13 ' A' ' 28' ' ' ILE . 28.7 mt -136.19 135.92 49.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.305 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.548 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.39 96.86 1.73 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.559 179.722 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.498 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 13.6 m-85 -82.45 89.68 6.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.522 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -109.94 140.56 43.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.057 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -87.28 -6.51 58.51 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.661 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.453 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.9 t70 -151.58 122.42 7.54 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.755 179.837 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.505 ' HG ' HG23 ' A' ' 66' ' ' THR . 97.1 mt -91.34 46.18 1.29 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.131 0.491 . . . . 0.0 111.208 -179.486 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -137.25 11.08 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.0 179.204 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.646 HG13 HG21 ' A' ' 47' ' ' VAL . 2.3 pt -94.21 156.13 39.23 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.133 179.923 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.439 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 75.0 Cg_exo -51.16 -27.08 21.28 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.807 2.338 . . . . 0.0 113.057 179.666 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.67 -38.7 92.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.945 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.646 HG21 HG13 ' A' ' 44' ' ' ILE . 2.2 t -60.21 -56.67 33.15 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.734 -178.849 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.0 Cg_exo -58.42 -40.12 77.76 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.587 1.525 . . . . 0.0 111.37 179.597 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.622 HG21 ' HA ' ' A' ' 104' ' ' ALA . 7.9 mt -62.66 -34.92 67.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.092 179.874 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.2 tp -74.95 -52.77 10.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.845 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -54.26 -23.15 13.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.036 0.446 . . . . 0.0 109.932 178.781 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 75.6 m -84.15 -46.45 11.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.498 179.363 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.519 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -58.75 -26.18 63.72 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.374 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.534 HG11 ' HG3' ' A' ' 13' ' ' GLN . 53.5 t -51.69 -50.62 30.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.013 179.28 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -75.96 -8.59 57.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.934 -179.558 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -95.0 -19.25 20.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.177 179.581 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.566 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 63.9 m-85 -136.04 63.16 49.62 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.578 -179.734 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.87 -44.46 44.91 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.718 2.278 . . . . 0.0 111.553 178.988 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.24 -40.94 85.76 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.421 179.212 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.3 t -67.27 143.96 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.886 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.491 ' CB ' HG22 ' A' ' 31' ' ' THR . 42.2 t -82.34 99.56 9.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.083 0.468 . . . . 0.0 111.014 -179.591 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.481 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.9 p90 -66.71 123.96 21.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.0 179.787 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -143.74 162.81 27.7 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.063 179.979 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -160.06 142.33 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.936 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.9 t -143.42 153.57 42.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.114 0.483 . . . . 0.0 111.843 -178.888 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.505 HG23 ' HG ' ' A' ' 42' ' ' LEU . 75.3 p -138.34 1.16 2.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.589 179.598 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.402 ' O ' HD12 ' A' ' 71' ' ' LEU . 16.7 t70 -73.38 145.95 45.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.873 -179.936 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.7 t -66.76 -50.83 61.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.385 -179.569 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -50.1 -43.98 51.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.539 -179.392 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.526 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.1 t -71.04 -53.43 21.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.867 0.365 . . . . 0.0 110.799 179.885 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 67' ' ' ASP . 6.7 mp -58.74 -14.74 9.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.263 179.402 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.7 m -91.62 -42.96 9.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.427 179.062 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -60.36 -38.66 84.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.577 179.816 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -91.39 11.17 24.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.697 179.647 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 56.19 24.41 8.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.705 179.289 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.633 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.3 mm -60.93 122.3 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.922 179.648 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.4 p -142.89 60.34 1.42 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.089 -179.959 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.29 45.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.499 179.88 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.564 ' HB2' HG23 ' A' ' 99' ' ' ILE . 30.5 m-20 50.52 43.81 27.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.158 0.504 . . . . 0.0 110.301 -179.773 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.633 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.7 m -69.56 153.61 43.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.653 -178.41 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.548 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.9 mt -120.71 116.61 50.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.004 177.993 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.498 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 71.4 m -106.18 132.57 52.09 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.837 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.574 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.6 tp -108.32 102.6 11.7 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.798 178.291 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -97.39 123.64 41.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.885 0.374 . . . . 0.0 110.68 179.784 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.472 HH12 HD13 ' A' ' 116' ' ' LEU . 3.6 mtm180 -106.17 99.66 9.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.073 179.7 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.0 tp -43.28 -51.1 6.41 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.621 -179.38 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.53 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -42.59 -64.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.334 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.462 ' HB2' HH21 ' A' ' 85' ' ' ARG . 2.9 m-20 -98.29 18.09 17.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.59 -179.13 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.7 p30 43.63 29.49 0.28 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.022 179.207 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.463 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 7.5 mm-40 -75.02 156.38 36.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.37 . . . . 0.0 111.137 -179.946 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.93 89.78 2.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.687 179.574 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.594 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.7 mm? -78.03 142.38 38.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.65 179.574 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.22 111.25 15.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.355 0.598 . . . . 0.0 112.534 -179.108 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.531 HD21 HD12 ' A' ' 102' ' ' ILE . 3.6 tt -98.29 76.39 2.32 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.043 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.7 mt-10 -77.65 -166.29 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -176.697 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.517 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.6 t70 -50.54 -37.71 40.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.914 -179.218 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -56.46 -15.27 3.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.13 0.491 . . . . 0.0 110.461 179.791 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -128.66 -13.67 4.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.395 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.564 HG23 ' HB2' ' A' ' 79' ' ' ASN . 22.9 mm -89.63 -25.13 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.592 -179.31 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -51.9 -61.48 2.23 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.923 0.392 . . . . 0.0 110.653 179.846 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.8 m -112.89 38.94 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.471 179.649 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.531 HD12 HD21 ' A' ' 94' ' ' LEU . 7.7 tp -57.1 143.24 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.427 -179.832 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.553 ' HA ' HD12 ' A' ' 49' ' ' ILE . 20.1 m-20 -136.05 149.81 48.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.823 178.873 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.622 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -48.25 -33.92 9.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.187 179.97 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 97.8 m -62.82 -50.6 70.33 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.245 178.73 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -58.33 -58.42 8.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.278 -179.614 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.604 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.93 -57.27 8.95 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.036 0.446 . . . . 0.0 110.32 179.977 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 64.9 m -57.82 -29.4 64.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.831 179.85 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.463 ' HD3' HD11 ' A' ' 113' ' ' ILE . 3.1 tmt_? -71.38 -64.88 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.239 179.786 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -43.44 -43.38 5.26 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.972 178.976 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.485 HG12 HG23 ' A' ' 35' ' ' VAL . 95.9 mt -63.68 -56.11 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.509 178.408 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.84 -16.7 2.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.283 0.563 . . . . 0.0 110.334 179.337 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.463 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -91.91 -34.99 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.738 -179.231 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.594 HD21 ' HG ' ' A' ' 92' ' ' LEU . 88.4 m-20 -127.5 32.16 5.06 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.306 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 111' ' ' ILE . 91.0 p -83.94 36.08 0.55 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.201 0.524 . . . . 0.0 110.199 178.995 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.472 HD13 HH12 ' A' ' 85' ' ' ARG . 51.9 mt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.174 -179.443 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.891 0.376 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.441 HG11 ' HG3' ' A' ' 3' ' ' GLU . 8.4 p -137.92 -31.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.15 -179.911 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.441 ' HG3' HG11 ' A' ' 2' ' ' VAL . 47.8 mt-10 -137.56 -68.41 0.47 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.074 -179.796 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -155.2 153.59 30.94 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.927 -179.741 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.1 t 61.79 173.54 0.12 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.109 179.944 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.2 m -144.51 90.44 2.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.932 179.943 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 58.42 89.41 0.05 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.096 -179.94 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.34 159.38 27.71 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.503 179.977 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.35 100.45 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.541 2.161 . . . . 0.0 112.28 179.932 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.37 132.04 0.43 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.632 179.923 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.5 -24.56 0.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.843 0.354 . . . . 0.0 110.585 179.944 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.92 94.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.113 179.856 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.603 ' HG3' HG13 ' A' ' 54' ' ' VAL . 4.3 pt20 -44.03 136.46 3.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.213 179.931 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.491 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 -108.85 159.21 31.87 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.146 -179.548 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 40.0 Cg_endo -67.89 142.59 57.7 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.733 2.289 . . . . 0.0 112.533 -179.702 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 m -54.49 152.66 6.41 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.23 -179.977 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -103.11 79.66 1.77 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.066 0.46 . . . . 0.0 111.057 -179.79 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.568 HD23 ' HA ' ' A' ' 24' ' ' ALA . 46.6 mt -71.06 94.45 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.317 179.708 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.4 p -85.45 -12.93 50.72 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.871 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 5.4 m-20 -139.62 151.27 45.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.77 -179.471 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.592 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 30.0 t -52.89 -49.76 85.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.561 179.853 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.6 Cg_endo -57.42 -45.71 32.58 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.97 1.78 . . . . 0.0 112.043 179.912 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.22 -34.79 78.42 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.201 0.524 . . . . 0.0 110.279 -179.852 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.568 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -64.93 -59.46 4.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.147 179.406 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.6 mtm -60.75 -24.26 65.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.041 -179.994 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.4 -51.28 17.85 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.312 179.437 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -59.62 -31.74 69.77 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.141 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.464 HD11 HD12 ' A' ' 36' ' ' ILE . 49.4 mt -75.03 -41.25 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.271 178.444 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.28 -19.04 62.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.162 -179.788 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.59 27.82 2.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.146 -179.845 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.8 t -172.68 154.01 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.769 -179.629 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.501 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.0 tt0 -63.8 -73.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.747 179.911 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.505 HG11 HD11 ' A' ' 83' ' ' LEU . 21.6 t -100.68 137.86 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.656 179.87 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.573 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.94 126.1 18.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.987 0.422 . . . . 0.0 112.058 -179.27 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.493 HG21 HG12 ' A' ' 111' ' ' ILE . 50.0 t -114.7 130.63 68.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.518 178.413 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.464 HD12 HD11 ' A' ' 28' ' ' ILE . 24.0 mt -135.07 136.02 52.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.243 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.51 97.73 1.93 Allowed Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.465 179.787 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.514 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 10.3 m-85 -83.37 92.06 7.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.665 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.7 m-85 -112.92 138.66 49.44 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.093 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.485 ' HG2' HD21 ' A' ' 71' ' ' LEU . 22.9 mt-30 -85.25 -6.48 59.26 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.714 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.436 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.4 t70 -151.54 125.67 9.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.644 179.672 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.498 ' HA ' HG22 ' A' ' 47' ' ' VAL . 94.9 mt -93.83 44.06 1.12 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.004 0.43 . . . . 0.0 111.203 -179.535 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.422 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.3 mt-10 -133.56 9.63 3.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.865 178.962 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.671 HG13 HG23 ' A' ' 47' ' ' VAL . 3.2 pt -91.73 157.69 41.31 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.19 179.942 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.432 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 77.9 Cg_exo -53.22 -26.08 32.51 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.845 2.363 . . . . 0.0 112.956 179.603 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.32 -38.87 92.58 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.916 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.671 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -60.26 -55.41 45.57 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -178.557 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -60.22 -39.47 68.14 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.882 1.721 . . . . 0.0 111.509 179.286 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.629 HG21 ' HA ' ' A' ' 104' ' ' ALA . 6.5 mt -63.88 -34.2 66.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.045 179.984 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.531 ' O ' ' HG3' ' A' ' 53' ' ' MET . 50.1 tp -74.76 -52.27 11.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.823 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -53.44 -27.31 24.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.168 0.508 . . . . 0.0 109.765 178.618 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -80.25 -46.38 16.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.568 179.876 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.531 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.49 -25.8 64.74 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.406 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.603 HG13 ' HG3' ' A' ' 13' ' ' GLN . 54.1 t -53.53 -50.39 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.999 179.505 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -73.89 -11.51 60.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.617 179.911 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -93.3 -18.77 22.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.22 -179.863 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.585 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 63.0 m-85 -136.0 61.6 41.52 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.636 -179.682 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.37 -38.28 82.33 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.604 2.203 . . . . 0.0 111.506 179.167 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.16 -41.27 99.42 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.354 179.079 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.1 t -67.07 145.23 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.884 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.573 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 36.0 t -82.41 96.57 8.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.959 0.409 . . . . 0.0 111.114 -179.696 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.439 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.9 p90 -63.87 127.16 30.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.982 179.763 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.54 162.71 28.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.054 179.78 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 tt -160.62 144.71 5.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.986 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 t -145.01 157.05 44.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.98 0.419 . . . . 0.0 111.81 -178.949 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.479 HG22 ' HG ' ' A' ' 42' ' ' LEU . 76.5 p -141.92 1.41 1.47 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.593 179.649 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.7 144.15 45.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.624 179.93 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.5 p -65.28 -51.51 60.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.67 -179.439 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -49.67 -43.03 46.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.64 -179.386 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.433 ' HA ' HG21 ' A' ' 21' ' ' VAL . 73.3 t -71.72 -52.96 22.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.311 . . . . 0.0 110.748 179.981 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.485 HD21 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -59.14 -14.6 10.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.158 0.504 . . . . 0.0 110.273 179.371 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.4 m -91.84 -40.57 11.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.377 178.722 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -61.31 -39.99 92.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.232 179.822 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -90.51 9.73 28.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.626 179.533 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 m120 57.38 25.53 11.39 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.641 179.107 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.631 HG22 ' HB ' ' A' ' 80' ' ' THR . 36.9 mm -60.8 118.13 3.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.997 179.653 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.1 p -136.62 56.28 1.81 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.388 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.25 45.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.728 179.838 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.511 ' HB2' HG23 ' A' ' 99' ' ' ILE . 14.0 m120 51.62 42.54 29.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.196 0.522 . . . . 0.0 110.474 179.93 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.631 ' HB ' HG22 ' A' ' 76' ' ' ILE . 89.3 m -68.24 153.07 44.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.646 -178.607 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.546 HG12 ' HA2' ' A' ' 37' ' ' GLY . 61.7 mt -119.33 118.65 58.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.054 177.988 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 81.5 m -107.62 135.7 48.62 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.787 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.581 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.7 tp -110.41 105.47 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.104 178.552 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.3 t80 -98.9 123.09 42.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.851 0.357 . . . . 0.0 110.666 179.652 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.467 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.5 mtm180 -106.73 91.8 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.205 179.844 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tp -38.25 -50.74 1.46 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.711 -179.824 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.501 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -45.2 -59.78 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.435 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -99.98 17.08 21.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.328 -179.418 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.2 p30 42.83 32.76 0.42 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.948 179.084 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 8.3 mm-40 -81.58 160.59 23.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 111.147 -179.823 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.75 91.45 2.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.362 179.564 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.581 HD22 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -80.07 149.22 30.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.875 179.7 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.6 124.62 41.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.315 0.579 . . . . 0.0 112.117 -179.366 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.542 HD23 HD11 ' A' ' 102' ' ' ILE . 3.8 tt -111.24 75.53 0.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.073 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' HA ' ' OG1' ' A' ' 80' ' ' THR . 25.0 mt-10 -77.51 -165.62 0.63 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.395 -0.821 . . . . 0.0 113.208 -176.736 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.492 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.5 t70 -51.31 -36.74 43.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.968 -179.181 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -56.49 -14.82 3.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.152 0.501 . . . . 0.0 110.266 179.536 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -130.26 -13.94 3.88 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.554 -179.947 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.511 HG23 ' HB2' ' A' ' 79' ' ' ASN . 23.2 mm -90.7 -25.38 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.78 0.324 . . . . 0.0 111.34 -179.364 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.6 -52.2 62.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.691 179.993 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 81.1 p -119.66 36.57 4.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.511 179.811 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.542 HD11 HD23 ' A' ' 94' ' ' LEU . 7.5 tp -57.38 142.24 13.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.487 -179.853 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.544 ' HA ' HD11 ' A' ' 49' ' ' ILE . 25.0 m-20 -135.93 149.76 49.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.757 178.884 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.629 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -48.04 -37.06 14.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.03 0.443 . . . . 0.0 110.446 -179.77 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.8 m -62.52 -47.85 82.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.295 178.71 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.44 ' HD3' ' N ' ' A' ' 103' ' ' ASP . 59.3 mtpt -59.2 -60.23 4.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.087 -179.735 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.58 HD13 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.06 -55.98 10.45 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.931 0.396 . . . . 0.0 110.15 179.847 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.2 m -57.87 -30.19 65.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.814 179.794 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.459 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -70.61 -65.77 0.69 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.088 179.696 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -42.29 -44.78 3.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.076 179.053 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.493 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -62.66 -55.86 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.537 178.495 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -54.13 -18.31 3.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.444 179.326 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.459 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.87 -38.51 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.016 -179.057 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.565 HD21 ' HG ' ' A' ' 92' ' ' LEU . 90.4 m-20 -123.35 29.59 6.61 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.348 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.5 p -82.11 50.32 1.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.116 0.484 . . . . 0.0 110.267 178.9 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 61.3 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.43 -179.44 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.406 ' HG3' HG23 ' A' ' 2' ' ' VAL . 10.6 tp10 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.654 0.264 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.406 HG23 ' HG3' ' A' ' 1' ' ' GLU . 48.8 t 61.77 -83.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.544 179.96 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 58.71 94.22 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.855 -179.95 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -92.73 11.84 25.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.243 -179.748 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.4 m -68.95 129.74 40.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.67 179.767 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.8 p -85.76 -20.07 29.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.122 -179.836 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -126.38 103.57 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.88 0.372 . . . . 0.0 110.985 179.904 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.99 148.98 48.71 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.458 -179.948 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.94 -39.86 88.36 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.494 2.129 . . . . 0.0 112.361 -179.863 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.1 -177.75 16.81 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.729 179.757 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.1 -73.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.638 0.256 . . . . 0.0 110.73 179.951 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.53 93.9 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.407 179.506 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.522 ' HG3' HG13 ' A' ' 54' ' ' VAL . 7.3 pt20 -170.09 161.02 8.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.817 -179.793 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 -107.74 158.37 33.58 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.04 -179.622 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.582 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.8 Cg_endo -68.67 148.93 73.0 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.7 2.267 . . . . 0.0 112.677 -179.777 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 m -63.16 152.61 36.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.575 -179.668 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -98.8 97.46 8.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.812 179.706 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.566 HD22 ' HA ' ' A' ' 24' ' ' ALA . 38.4 mt -96.37 71.57 2.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.641 179.964 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.9 p -71.39 -3.12 19.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.953 -179.171 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -140.14 147.68 40.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.934 0.397 . . . . 0.0 111.656 -179.991 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.594 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 24.9 t -56.49 -49.46 93.4 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.761 -179.896 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.51 -45.27 35.25 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.931 1.754 . . . . 0.0 111.963 179.954 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.38 -35.89 82.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.267 0.556 . . . . 0.0 110.344 -179.961 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.566 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.95 -57.91 8.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.185 179.427 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 64.4 mtp -61.75 -26.39 68.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.224 -179.952 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.48 -50.79 28.15 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.497 179.598 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -60.24 -33.05 71.74 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.035 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.433 HD12 HD12 ' A' ' 36' ' ' ILE . 57.1 mt -72.72 -39.81 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.024 178.475 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.75 -19.33 62.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.99 -179.869 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.12 29.45 2.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.856 -179.975 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 t -169.31 153.03 5.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.271 -179.722 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.422 ' HG3' HG11 ' A' ' 87' ' ' VAL . 27.1 tt0 -72.4 -46.34 55.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG11 HD11 ' A' ' 83' ' ' LEU . 21.0 t -122.68 133.87 67.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.08 179.296 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.565 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.66 126.29 20.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.012 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.556 HG23 HG12 ' A' ' 111' ' ' ILE . 52.0 t -114.24 127.59 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.766 178.701 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 24.8 mt -133.03 136.73 54.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.391 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.91 96.92 1.7 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.544 179.972 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.536 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.6 m-85 -83.17 90.82 7.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.654 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.4 m-85 -111.56 139.34 47.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.184 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.426 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 89.6 mt-30 -85.42 -7.21 59.05 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.89 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' O ' HG12 ' A' ' 44' ' ' ILE . 36.6 t70 -150.67 125.68 9.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.667 179.768 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.512 ' HG ' HG23 ' A' ' 66' ' ' THR . 95.2 mt -93.72 46.94 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.112 0.482 . . . . 0.0 111.373 -179.533 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 46.7 mt-10 -138.19 9.99 2.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.948 179.034 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.665 HG13 HG22 ' A' ' 47' ' ' VAL . 1.4 pt -93.06 156.28 40.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.064 179.848 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.445 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 81.4 Cg_exo -50.96 -27.25 20.52 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.818 2.345 . . . . 0.0 113.214 -179.914 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 44' ' ' ILE . . . -64.43 -38.25 90.39 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.916 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.665 HG22 HG13 ' A' ' 44' ' ' ILE . 3.0 t -60.45 -55.96 39.98 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.585 -178.742 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.647 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.6 -41.55 55.37 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.876 1.717 . . . . 0.0 111.4 179.487 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.608 HG21 HD12 ' A' ' 107' ' ' LEU . 7.2 mt -60.94 -35.58 66.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.247 179.983 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.546 ' O ' ' HG3' ' A' ' 53' ' ' MET . 43.2 tp -73.99 -52.28 13.26 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.957 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -54.44 -24.25 19.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.08 0.467 . . . . 0.0 109.824 178.831 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.3 m -82.55 -46.38 13.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.514 179.643 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.546 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.59 -26.41 65.4 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.107 0.48 . . . . 0.0 109.744 179.492 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.522 HG13 ' HG3' ' A' ' 13' ' ' GLN . 55.7 t -52.86 -50.02 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.194 179.498 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -75.83 -8.35 56.68 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.631 179.992 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -95.72 -19.04 19.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.133 179.743 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.547 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 71.9 m-85 -136.73 62.36 41.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.509 -179.617 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.87 -41.12 72.78 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.7 2.266 . . . . 0.0 111.538 179.09 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.58 -41.63 95.67 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.428 179.191 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.8 t -66.18 145.72 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.765 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.565 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 40.3 t -83.11 97.34 8.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 111.035 -179.553 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.582 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 8.0 p90 -62.82 129.53 40.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.862 179.646 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.16 159.83 28.15 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.993 179.73 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.9 tt -161.83 140.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.882 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.9 t -145.15 159.2 43.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.146 0.498 . . . . 0.0 111.741 -178.872 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.512 HG23 ' HG ' ' A' ' 42' ' ' LEU . 79.7 p -140.29 -0.77 1.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.396 179.495 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -69.46 141.2 54.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.718 -179.786 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.2 t -64.3 -48.38 75.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.296 -179.78 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -49.96 -46.31 52.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.436 -179.639 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.491 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.5 t -69.44 -53.27 25.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.703 179.846 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.419 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.8 mp -58.27 -14.82 8.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.195 0.521 . . . . 0.0 110.317 179.462 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.2 m -90.66 -42.46 10.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.264 178.615 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -59.79 -40.76 89.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.629 -179.98 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -90.6 11.04 23.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.831 179.602 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 56.8 26.24 11.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.438 179.326 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.644 HG22 ' HB ' ' A' ' 80' ' ' THR . 35.5 mm -61.61 122.96 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.839 179.633 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.1 p -140.9 47.89 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.762 0.315 . . . . 0.0 111.51 -179.891 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.8 47.88 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.742 179.819 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.536 ' HB2' HG21 ' A' ' 99' ' ' ILE . 13.9 m120 50.06 41.45 23.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.257 0.551 . . . . 0.0 110.271 -179.775 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.644 ' HB ' HG22 ' A' ' 76' ' ' ILE . 94.1 m -67.79 151.79 46.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.671 -178.515 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.564 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.3 mt -118.73 115.79 49.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.865 178.059 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.536 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.1 m -105.47 130.92 53.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.779 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.572 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.3 tp -107.66 99.84 9.29 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.843 178.455 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.5 t80 -92.31 122.93 35.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.364 179.633 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.464 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 6.1 mtm180 -105.24 85.66 2.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.867 0.365 . . . . 0.0 110.57 -179.915 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 tp -26.05 -59.61 0.08 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.12 -179.322 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.422 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.86 -71.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.261 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.71 13.41 8.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.333 -179.302 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.29 29.82 0.4 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.131 178.973 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.464 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 10.4 mm-40 -76.41 167.52 21.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.349 . . . . 0.0 110.79 179.825 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -154.26 95.23 1.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.623 179.724 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.572 HD21 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -80.55 110.71 16.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.065 -179.953 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -92.52 92.1 7.9 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.973 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.525 HD23 HD13 ' A' ' 102' ' ' ILE . 3.3 tt -77.92 78.11 4.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.753 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.8 mt-10 -79.05 -164.95 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.865 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.489 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 22.5 t70 -51.18 -37.61 47.56 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.905 -179.252 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -54.91 -14.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.213 0.53 . . . . 0.0 110.352 179.533 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -130.77 -13.99 3.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.753 -179.906 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.538 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 25.1 mm -89.84 -37.11 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.281 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -51.0 -39.77 56.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.885 0.374 . . . . 0.0 111.077 -179.874 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.9 p -126.92 36.03 4.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.645 179.939 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.538 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.9 tp -62.61 143.91 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.701 -179.666 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.521 ' HA ' HD13 ' A' ' 49' ' ' ILE . 18.0 m-20 -137.74 147.34 44.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.364 178.856 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.6 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.85 -35.93 6.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.972 0.415 . . . . 0.0 110.333 -179.735 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 99.6 m -62.29 -48.31 80.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.266 178.646 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -60.0 -59.87 4.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.241 -179.709 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.608 HD12 HG21 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.03 -55.69 13.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.899 0.381 . . . . 0.0 110.275 -179.909 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.2 m -58.19 -29.93 66.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.687 179.702 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.492 ' HD3' HD11 ' A' ' 113' ' ' ILE . 3.6 tmt_? -71.39 -66.14 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.188 179.772 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -42.75 -43.4 3.93 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.12 179.286 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.556 HG12 HG23 ' A' ' 35' ' ' VAL . 90.2 mt -63.89 -55.23 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.549 178.409 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -55.14 -16.82 3.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.281 179.282 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.492 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -92.27 -34.7 6.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.767 -179.272 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.405 ' OD1' HG22 ' A' ' 113' ' ' ILE . 36.1 m120 -123.12 28.1 7.31 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.653 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.1 p -82.35 46.81 1.08 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.067 0.46 . . . . 0.0 110.502 179.278 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.439 HD12 ' NH1' ' A' ' 85' ' ' ARG . 70.2 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.212 -179.62 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.807 0.337 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.4 m -116.78 20.05 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.853 179.757 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -88.94 10.62 20.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.758 179.98 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -137.96 -173.8 3.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.164 -179.758 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.6 m 55.66 38.95 30.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.104 179.934 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.0 m -135.28 -65.66 0.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 57.2 89.35 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -101.93 -79.94 1.44 Allowed Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.7 -179.918 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.72 118.18 4.91 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.569 2.179 . . . . 0.0 112.353 -179.994 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.9 154.34 16.69 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.485 -179.995 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.16 -71.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.757 0.313 . . . . 0.0 110.575 -180.0 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.91 95.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.485 179.543 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.511 ' HG3' HG13 ' A' ' 54' ' ' VAL . 1.2 pt20 -170.08 161.51 8.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.62 -179.707 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 14.3 pt-20 -110.12 157.81 36.9 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.984 -179.458 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.499 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 42.8 Cg_endo -69.57 144.05 53.77 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.656 2.237 . . . . 0.0 112.574 -179.675 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -59.45 151.32 24.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.346 -179.835 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -96.87 86.85 4.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.938 179.995 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 24' ' ' ALA . 40.4 mt -83.58 74.47 10.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.488 179.929 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.8 p -74.4 0.54 14.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.048 -179.188 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.414 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 4.7 m-20 -143.88 147.44 34.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.996 0.427 . . . . 0.0 111.751 -179.863 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.1 t -55.67 -49.34 93.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.45 179.77 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.1 Cg_endo -58.44 -46.48 24.2 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.039 1.826 . . . . 0.0 111.977 179.799 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.16 -34.57 77.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.232 0.539 . . . . 0.0 110.169 -179.873 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.572 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -64.38 -58.06 7.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.973 179.535 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 33.1 mtt -61.86 -26.01 67.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.239 -179.898 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 26.2 mt-10 -71.89 -51.02 24.33 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 110.552 179.681 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -60.59 -31.2 70.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.06 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.441 HD13 HD11 ' A' ' 36' ' ' ILE . 52.4 mt -75.22 -39.57 42.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.059 178.198 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 -18.59 61.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.109 -179.816 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.45 26.15 2.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.147 -179.947 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.9 t -171.35 155.87 4.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.608 -179.788 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.473 ' HG3' HG12 ' A' ' 87' ' ' VAL . 26.0 tt0 -67.92 -58.78 3.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.717 179.934 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.435 HG12 HD13 ' A' ' 83' ' ' LEU . 13.6 t -111.17 138.33 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.67 127.44 18.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.961 0.41 . . . . 0.0 111.876 -179.526 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.487 HG22 HG12 ' A' ' 111' ' ' ILE . 47.0 t -116.01 128.58 73.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.748 178.732 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 21.5 mt -134.01 136.76 53.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.412 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.558 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.21 97.7 1.78 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.521 179.728 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.4 m-85 -83.43 91.32 7.34 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.482 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -111.57 142.06 44.36 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -177.945 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.474 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 76.6 mt-30 -88.96 -7.33 56.23 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.563 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.445 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.7 t70 -149.38 121.72 8.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.52 179.623 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.47 ' HA ' HG21 ' A' ' 47' ' ' VAL . 98.7 mt -91.7 46.84 1.31 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.18 0.514 . . . . 0.0 111.383 -179.293 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 47.4 mt-10 -137.54 7.09 2.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.002 178.964 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.655 HG13 HG22 ' A' ' 47' ' ' VAL . 1.3 pt -90.13 155.63 46.89 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.949 179.786 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 84.3 Cg_exo -49.95 -29.38 21.09 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.729 2.286 . . . . 0.0 112.984 -179.953 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.48 86.82 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.998 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.655 HG22 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.66 -57.49 24.38 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.569 -178.83 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.06 -38.77 85.4 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.765 1.644 . . . . 0.0 111.453 179.437 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.635 HG21 ' HA ' ' A' ' 104' ' ' ALA . 7.9 mt -63.66 -34.38 67.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.907 179.85 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.539 ' O ' ' HG3' ' A' ' 53' ' ' MET . 46.6 tp -75.57 -53.02 9.29 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.836 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -54.06 -24.18 16.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.115 0.483 . . . . 0.0 109.977 178.876 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.6 t -84.08 -47.0 11.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.607 179.657 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.539 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -58.27 -25.84 62.25 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.504 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.511 HG13 ' HG3' ' A' ' 13' ' ' GLN . 49.4 t -52.63 -49.15 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.166 179.483 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -76.61 -9.01 58.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.714 179.989 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -94.46 -19.16 20.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.047 179.601 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.576 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 58.4 m-85 -135.52 63.02 52.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.752 -179.795 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.79 -45.24 39.56 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.77 2.313 . . . . 0.0 111.636 179.206 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.63 -42.32 84.34 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.468 179.133 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.3 t -65.48 143.58 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.947 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.532 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 41.7 t -82.33 97.11 8.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.02 0.438 . . . . 0.0 111.125 -179.627 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.499 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 6.5 p90 -62.85 128.81 37.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.897 179.658 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.69 160.28 28.32 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.106 179.98 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.8 tt -158.83 143.29 6.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.723 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.4 t -146.44 152.69 39.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.003 0.43 . . . . 0.0 111.776 -179.083 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.466 HG23 ' HG ' ' A' ' 42' ' ' LEU . 71.4 p -136.99 -3.95 1.98 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.326 179.5 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.49 142.73 58.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.697 179.986 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.5 m -64.79 -50.44 66.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.428 -179.461 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -50.37 -43.82 54.49 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.671 -179.338 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.467 ' HA ' HG23 ' A' ' 21' ' ' VAL . 69.1 t -71.46 -52.39 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 -179.973 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.39 -15.14 14.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.15 0.5 . . . . 0.0 110.187 179.387 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.7 m -91.59 -40.02 11.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.296 178.795 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -61.32 -42.4 98.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.374 179.948 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -88.51 9.31 24.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.695 179.528 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 58.82 23.27 11.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.538 179.128 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.619 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.2 mm -56.81 120.83 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.975 179.852 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.6 p -140.31 58.71 1.57 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.344 -179.546 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.76 45.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.7 179.606 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.503 ' HB2' HG23 ' A' ' 99' ' ' ILE . 14.5 m120 51.73 43.28 30.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.217 0.532 . . . . 0.0 110.422 -179.914 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.619 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.5 m -69.36 152.08 45.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.735 -178.539 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.558 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.0 mt -119.02 118.04 56.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.964 178.135 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.518 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 79.4 m -105.91 133.21 51.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.907 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.594 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.7 tp -109.02 105.17 14.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.774 178.48 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -98.67 120.11 38.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.683 179.787 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.441 HH12 HD13 ' A' ' 116' ' ' LEU . 4.3 mtm180 -104.74 80.98 1.71 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.611 179.965 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 85' ' ' ARG . 7.1 tp -22.59 -58.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 O-C-N 124.009 0.818 . . . . 0.0 112.856 -179.683 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.473 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.09 -67.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.366 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -93.3 3.26 55.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.388 -179.227 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 50.48 37.7 16.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.68 179.682 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 6.6 mm-40 -86.15 134.09 33.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.709 179.952 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.48 95.04 4.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.998 0.427 . . . . 0.0 110.833 179.954 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.603 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.2 mm? -82.41 109.93 17.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.634 179.506 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -93.87 94.59 8.58 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.439 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.508 HD23 HD12 ' A' ' 102' ' ' ILE . 4.3 tt -78.66 77.61 5.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.438 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.5 mt-10 -78.88 -164.91 0.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.908 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.489 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.6 t70 -50.76 -38.43 47.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.148 -179.145 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.57 -14.69 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.227 0.537 . . . . 0.0 110.33 179.722 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -129.68 -13.83 4.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.63 -179.85 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.525 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 23.6 mm -91.08 -31.27 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 111.438 -179.5 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -53.28 -43.15 67.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.891 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.8 m -124.93 38.53 4.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.419 179.711 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.525 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.3 tp -63.93 142.52 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.67 -179.698 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.539 ' HA ' HD13 ' A' ' 49' ' ' ILE . 21.9 m-20 -137.98 150.91 47.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.604 178.803 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.635 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -48.78 -37.37 18.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.002 0.43 . . . . 0.0 110.443 -179.859 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 94.6 m -61.97 -46.93 87.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.208 178.686 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -60.75 -61.14 2.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.415 -179.819 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.623 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.52 -55.16 11.79 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.979 0.418 . . . . 0.0 110.128 179.906 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.6 m -59.05 -30.98 68.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.912 179.832 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.463 ' HD3' HD12 ' A' ' 113' ' ' ILE . 3.2 tmt_? -70.53 -65.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.097 179.691 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -43.01 -42.7 3.92 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.306 179.411 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.487 HG12 HG22 ' A' ' 35' ' ' VAL . 96.3 mt -64.65 -55.23 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.23 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -54.02 -18.23 3.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.201 179.305 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.463 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -90.06 -38.42 10.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.985 -179.077 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.603 HD21 ' HG ' ' A' ' 92' ' ' LEU . 90.2 m-20 -122.77 30.54 6.4 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.432 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.0 p -83.14 44.03 0.91 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 110.15 178.727 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.441 HD13 HH12 ' A' ' 85' ' ' ARG . 57.7 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.404 -179.328 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.8 0.333 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 t 55.72 72.72 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.175 -179.945 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -145.27 138.26 26.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.851 -179.967 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 80.1 tttt 55.9 47.46 20.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.727 -179.887 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.0 t -120.69 2.51 10.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.91 -179.996 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.3 p -96.36 2.91 53.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.043 -179.93 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.7 t70 57.64 88.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.196 179.88 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.41 ' HA2' ' HD3' ' A' ' 9' ' ' PRO . . . -157.77 135.82 4.53 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.284 179.804 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.41 ' HD3' ' HA2' ' A' ' 8' ' ' GLY . 28.6 Cg_exo -62.03 -20.59 70.16 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.4 2.066 . . . . 0.0 112.28 -179.865 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.61 119.02 4.96 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.444 179.972 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.31 -70.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 0.0 110.653 -179.982 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.05 -82.02 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.642 179.751 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.508 ' HG3' HG13 ' A' ' 54' ' ' VAL . 3.3 pt20 -151.39 170.64 19.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.043 -179.637 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.481 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.3 pt-20 -147.33 159.44 42.02 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 -179.775 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 54.0 Cg_endo -69.9 149.65 66.28 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.636 2.224 . . . . 0.0 112.753 -179.686 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 17' ' ' TRP . 13.3 m -71.55 155.89 40.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.509 -179.622 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.426 ' N ' HG22 ' A' ' 16' ' ' THR . 5.7 m-90 -100.05 88.9 3.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.073 179.827 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.592 HD22 ' HA ' ' A' ' 24' ' ' ALA . 35.1 mt -82.73 71.78 9.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.375 179.781 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.5 p -70.21 -5.18 25.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.07 -178.892 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -135.81 147.36 48.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 111.416 -179.76 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.595 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 15.6 t -58.27 -48.99 96.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.367 179.915 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.0 Cg_endo -58.45 -43.83 42.71 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.899 1.733 . . . . 0.0 111.839 179.45 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.5 -37.22 86.79 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.291 0.567 . . . . 0.0 110.261 179.811 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.592 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.03 -54.89 35.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.049 179.45 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 38.3 mtt -62.48 -29.91 70.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.28 -179.928 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 32.8 mt-10 -69.18 -49.01 60.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.658 0.266 . . . . 0.0 110.517 -179.959 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -62.26 -32.82 73.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.851 179.253 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.47 HD13 HD11 ' A' ' 36' ' ' ILE . 48.1 mt -74.16 -36.15 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.156 0.503 . . . . 0.0 109.821 178.05 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.45 -18.57 60.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.21 27.57 2.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.185 -179.823 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.43 HG22 ' HB2' ' A' ' 61' ' ' SER . 8.2 t -171.16 155.95 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.608 -179.761 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.493 ' HG3' HG11 ' A' ' 87' ' ' VAL . 24.4 tt0 -71.26 -46.87 59.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.597 179.755 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.443 HG12 HD13 ' A' ' 83' ' ' LEU . 19.1 t -121.68 137.6 54.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.361 179.555 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.481 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.06 128.45 20.03 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.154 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.47 HG22 HG12 ' A' ' 111' ' ' ILE . 43.5 t -116.22 129.61 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.467 178.463 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.47 HD11 HD13 ' A' ' 28' ' ' ILE . 28.0 mt -136.46 136.15 48.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.226 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.63 96.71 1.77 Allowed Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.482 179.686 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.478 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 40.0 m-85 -82.71 89.67 6.78 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.277 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.1 m-85 -108.44 146.55 32.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.603 -178.031 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -94.48 -1.8 52.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.947 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.6 t70 -156.87 118.16 3.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.582 179.876 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.518 ' HG ' HG22 ' A' ' 66' ' ' THR . 90.9 mt -87.28 44.78 1.21 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.117 0.485 . . . . 0.0 111.291 -179.351 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.1 mt-10 -136.61 13.09 3.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.078 179.255 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.662 HG13 HG23 ' A' ' 47' ' ' VAL . 1.4 pt -96.97 156.23 36.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.19 179.928 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.497 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 86.2 Cg_exo -49.57 -31.36 24.27 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.745 2.297 . . . . 0.0 112.851 179.657 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.38 -37.21 77.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.312 -179.107 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.685 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.9 t -61.89 -58.55 17.29 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.591 -178.917 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.685 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 37.0 Cg_exo -58.38 -40.54 74.23 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.777 1.651 . . . . 0.0 111.291 179.342 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.673 HG23 ' HA ' ' A' ' 104' ' ' ALA . 8.6 mt -61.02 -36.3 71.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.899 179.712 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.528 ' O ' ' HG3' ' A' ' 53' ' ' MET . 47.6 tp -74.01 -52.37 12.96 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.942 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -54.13 -23.06 12.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.061 0.458 . . . . 0.0 109.876 178.824 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.9 m -83.08 -47.57 11.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.357 179.329 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.528 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -58.11 -26.4 62.56 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.272 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 50' ' ' LEU . 53.0 t -51.67 -51.38 27.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.091 179.512 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -74.3 -12.09 60.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.688 -179.852 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 28.7 mtpp -92.46 -17.61 24.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.27 -179.96 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.576 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 52.6 m-85 -137.92 62.91 36.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.535 -179.799 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.67 -43.82 54.53 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.601 2.2 . . . . 0.0 111.618 179.065 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.58 -38.92 83.84 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.417 179.305 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 13.0 t -68.74 144.67 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.861 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 42.3 t -81.68 98.77 8.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.047 0.451 . . . . 0.0 110.79 180.0 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.434 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.6 p90 -66.95 122.42 17.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.016 179.856 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.439 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -141.87 163.91 26.87 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.159 179.997 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -162.12 143.08 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.924 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.478 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 43.8 t -148.54 158.81 44.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 111.777 -179.094 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.518 HG22 ' HG ' ' A' ' 42' ' ' LEU . 64.6 p -138.93 -5.42 1.49 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.898 179.548 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.69 140.02 58.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.722 179.948 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.3 m -63.52 -48.16 78.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.824 -179.308 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -51.23 -44.27 61.64 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.241 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.473 ' HA ' HG22 ' A' ' 21' ' ' VAL . 54.2 t -70.75 -53.47 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.85 0.357 . . . . 0.0 110.726 179.804 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.93 -14.91 10.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.234 179.475 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.9 m -91.74 -39.87 11.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.299 178.848 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.404 ' ND1' HG11 ' A' ' 21' ' ' VAL . 5.2 t60 -61.21 -39.93 92.06 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.329 179.902 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -91.86 12.26 22.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.919 179.557 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 56.67 25.43 10.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.6 179.23 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.662 HG23 ' HB ' ' A' ' 80' ' ' THR . 41.7 mm -61.77 120.51 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.968 179.653 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.5 p -140.95 57.17 1.56 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.272 179.982 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.89 45.08 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.552 179.824 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 26.8 m-20 50.25 43.47 26.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.255 0.55 . . . . 0.0 110.248 -179.817 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.662 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.2 m -68.99 151.25 46.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.785 -178.627 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.54 HG12 ' HA2' ' A' ' 37' ' ' GLY . 72.0 mt -117.76 115.38 48.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.851 177.931 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.474 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 80.1 m -103.76 130.5 51.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.755 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.617 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.4 tp -107.78 101.65 10.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.613 178.231 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.4 t80 -95.86 123.03 39.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.478 179.806 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.487 HH12 HD12 ' A' ' 116' ' ' LEU . 4.8 mtm180 -105.72 87.23 2.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.841 -179.7 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 tp -26.29 -60.68 0.08 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.903 -179.383 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.493 HG11 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.76 -79.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.433 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -79.2 3.33 18.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.96 0.409 . . . . 0.0 110.993 -179.891 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 52.21 32.8 11.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.691 179.561 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.4 mm-40 -76.39 161.45 28.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.695 179.83 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.498 HE22 ' HB3' ' A' ' 93' ' ' ASN . 1.1 tm0? -145.03 93.95 2.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.627 179.788 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.617 HD21 ' HG ' ' A' ' 83' ' ' LEU . 2.1 mm? -83.43 118.6 23.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.789 179.74 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.498 ' HB3' HE22 ' A' ' 91' ' ' GLN . 1.3 p-10 -99.86 94.54 6.36 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.756 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.514 HD21 HD13 ' A' ' 102' ' ' ILE . 3.4 tt -79.2 77.93 5.7 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.672 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.417 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.8 mt-10 -79.76 -164.33 0.64 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -176.843 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.495 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.0 t70 -50.78 -37.65 43.54 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.971 -179.379 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.21 -15.92 2.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.226 0.536 . . . . 0.0 110.338 179.76 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -129.63 -14.07 4.17 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.645 -179.92 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.534 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.6 mm -89.89 -24.8 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.77 0.319 . . . . 0.0 111.268 -179.3 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.66 -57.45 11.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.4 p -114.56 35.52 4.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.325 179.661 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.522 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.6 tp -57.78 146.85 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.485 -179.844 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.577 ' HA ' HD11 ' A' ' 49' ' ' ILE . 9.5 t70 -139.3 164.84 28.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.674 178.605 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.673 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -62.49 -35.97 81.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.111 0.481 . . . . 0.0 110.061 -179.616 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 83.4 m -65.42 -44.88 86.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.199 178.743 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -61.06 -58.46 8.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.952 -179.713 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.556 HD11 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.3 -54.32 27.24 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.037 0.446 . . . . 0.0 109.975 179.556 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.4 m -59.02 -29.93 67.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.847 179.795 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.478 ' HD3' HD11 ' A' ' 113' ' ' ILE . 4.0 tmt_? -71.06 -66.03 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.056 179.697 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -43.2 -43.87 4.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.223 179.38 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.47 HG12 HG22 ' A' ' 35' ' ' VAL . 96.4 mt -62.97 -54.23 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.225 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.414 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 33.4 tt0 -54.59 -19.63 6.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.159 179.226 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.478 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.27 -34.5 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.79 -178.985 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.606 HD21 ' HG ' ' A' ' 92' ' ' LEU . 89.4 m-20 -124.86 29.56 6.15 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.329 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 111' ' ' ILE . 88.2 p -83.54 45.25 1.04 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.115 0.483 . . . . 0.0 110.111 178.996 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.487 HD12 HH12 ' A' ' 85' ' ' ARG . 69.9 mt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.35 -179.344 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.879 0.371 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.7 p -159.84 -30.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.226 -179.965 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.83 9.14 28.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.872 179.963 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -113.62 13.82 18.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.984 -179.873 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.1 p -90.74 106.81 18.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.936 -179.759 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 t -83.17 85.15 7.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.765 179.918 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.09 -59.04 2.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.74 116.98 0.06 OUTLIER Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.627 179.902 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.28 108.37 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.47 2.114 . . . . 0.0 112.19 179.861 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.57 -96.28 0.16 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.452 -179.953 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.88 -72.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.534 0.207 . . . . 0.0 110.828 179.882 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.3 103.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.596 179.848 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.616 ' HG3' HG11 ' A' ' 54' ' ' VAL . 4.2 pt20 -53.37 141.06 25.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.092 -179.913 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.497 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.7 pt-20 -113.98 160.33 32.71 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.939 -179.784 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 39.2 Cg_endo -67.7 142.72 59.19 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.597 2.198 . . . . 0.0 112.623 -179.901 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.4 m -63.12 153.47 34.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.809 -179.686 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.89 89.91 5.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.167 179.886 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 24' ' ' ALA . 41.2 mt -84.78 72.57 10.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.298 179.613 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.1 p -71.9 -2.02 16.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.176 -179.043 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -139.27 147.42 41.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.987 0.423 . . . . 0.0 111.573 -179.797 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.591 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 29.6 t -57.24 -49.52 93.42 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.449 179.913 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.66 -44.82 33.58 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.901 1.734 . . . . 0.0 111.998 179.723 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.25 83.19 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.332 0.587 . . . . 0.0 110.203 179.824 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.551 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -62.65 -57.51 10.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.157 179.548 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 31.4 mtt -61.89 -26.83 68.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.225 -179.923 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -70.44 -50.38 38.92 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.477 179.786 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.422 ' O ' HG21 ' A' ' 31' ' ' THR . 11.5 m-85 -61.68 -31.17 71.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.182 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.443 HD11 HD12 ' A' ' 36' ' ' ILE . 52.7 mt -74.62 -37.67 43.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.967 178.056 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.41 -17.59 61.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.972 -179.747 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.56 28.69 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.122 -179.929 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.483 HG22 ' HB2' ' A' ' 61' ' ' SER . 9.1 t -168.89 153.89 6.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.572 -179.681 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.505 ' HG3' HG12 ' A' ' 87' ' ' VAL . 20.8 tt0 -70.91 -42.73 69.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.498 179.6 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.442 HG13 HD11 ' A' ' 83' ' ' LEU . 22.1 t -127.0 137.05 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.278 179.414 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.78 128.37 21.46 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.173 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.506 HG22 HG12 ' A' ' 111' ' ' ILE . 46.1 t -116.25 130.53 70.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.496 178.473 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 28' ' ' ILE . 29.3 mt -136.42 136.81 48.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.232 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.557 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.22 99.01 2.05 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.528 179.716 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.7 m-85 -85.35 93.97 8.84 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.657 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 9.1 m-85 -114.38 143.77 44.37 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.125 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -91.17 -3.51 56.96 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.913 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 44' ' ' ILE . 37.1 t70 -154.27 122.33 6.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.689 -1.142 . . . . 0.0 109.465 179.845 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.468 ' HG ' HG22 ' A' ' 66' ' ' THR . 91.6 mt -91.9 47.18 1.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 0.0 111.276 -179.486 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.41 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.9 mt-10 -136.51 11.13 3.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.792 178.977 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.68 HG13 HG22 ' A' ' 47' ' ' VAL . 3.1 pt -93.6 159.06 35.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.437 -179.915 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.427 ' O ' HD12 ' A' ' 49' ' ' ILE . 69.3 Cg_exo -54.59 -23.66 33.26 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.99 2.46 . . . . 0.0 112.925 179.556 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.11 -38.8 86.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.823 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.68 HG22 HG13 ' A' ' 44' ' ' ILE . 2.5 t -59.13 -54.72 53.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -178.787 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.1 Cg_exo -61.29 -43.53 28.19 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.066 1.844 . . . . 0.0 111.499 179.225 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.623 HG22 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -59.89 -34.01 54.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.148 179.981 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.515 ' O ' ' HG3' ' A' ' 53' ' ' MET . 50.1 tp -75.48 -51.5 12.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.167 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -53.96 -25.23 19.66 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.994 0.426 . . . . 0.0 109.936 178.793 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 t -83.09 -47.45 11.64 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.625 179.764 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -57.76 -26.37 61.78 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.376 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.616 HG11 ' HG3' ' A' ' 13' ' ' GLN . 51.2 t -51.89 -49.87 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.048 179.451 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -75.45 -12.74 60.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.641 179.952 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -91.5 -17.24 26.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.325 180.0 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.558 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 46.3 m-85 -138.97 63.11 29.66 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.432 -179.877 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.03 -47.67 26.28 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.756 2.304 . . . . 0.0 111.766 179.315 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.71 -41.14 57.17 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.395 179.275 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.6 t -66.23 143.13 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.781 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.483 ' HB2' HG22 ' A' ' 31' ' ' THR . 42.0 t -81.06 97.42 7.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.984 0.421 . . . . 0.0 110.903 -179.786 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.442 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.6 p90 -65.61 123.58 20.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.822 179.699 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -143.09 163.8 27.33 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.109 179.996 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -161.02 141.95 3.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.897 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.2 t -145.33 155.6 43.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.046 0.45 . . . . 0.0 111.708 -178.993 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.468 HG22 ' HG ' ' A' ' 42' ' ' LEU . 57.1 p -137.99 -3.25 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.807 179.652 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.73 139.81 55.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.425 179.976 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -62.24 -47.4 84.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.68 -179.313 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -50.73 -46.94 59.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.486 -179.217 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.483 ' HA ' HG22 ' A' ' 21' ' ' VAL . 75.3 t -69.6 -51.87 37.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.767 0.318 . . . . 0.0 110.756 179.92 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.36 -14.57 12.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.033 0.444 . . . . 0.0 110.219 179.466 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.3 m -92.63 -40.75 10.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.429 178.776 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -62.65 -35.55 79.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 -179.922 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.405 ' HB2' HG12 ' A' ' 76' ' ' ILE . 44.8 m-85 -94.11 10.36 34.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.754 179.544 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 57.27 24.3 9.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.683 179.422 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.625 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.0 mm -61.31 120.2 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.032 179.767 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.5 p -139.94 55.91 1.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 111.397 -179.926 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.9 44.19 0.02 OUTLIER Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.515 179.86 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.545 ' HB2' HG21 ' A' ' 99' ' ' ILE . 30.8 m-80 52.14 41.9 30.32 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.178 0.513 . . . . 0.0 110.437 -179.646 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.625 ' HB ' HG23 ' A' ' 76' ' ' ILE . 88.2 m -67.77 152.68 45.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.628 -178.564 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.557 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.5 mt -119.58 118.57 57.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.951 178.006 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.518 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.3 m -107.5 133.89 51.32 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -177.855 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.558 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.2 tp -109.73 102.55 11.35 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.794 178.262 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -96.93 122.64 40.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.791 0.329 . . . . 0.0 110.77 179.755 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.505 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 4.7 mtm180 -104.61 100.43 10.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.138 0.494 . . . . 0.0 109.971 179.582 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -43.78 -52.01 6.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.872 -179.156 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.505 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -42.82 -65.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.154 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.21 18.95 12.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.652 -179.322 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 p30 42.93 31.1 0.3 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.941 179.332 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.505 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 8.8 mm-40 -75.91 159.5 30.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 0.0 110.974 -179.923 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -146.42 85.44 1.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.65 179.798 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.558 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -75.04 144.84 42.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.224 179.996 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -121.93 124.83 44.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.351 0.596 . . . . 0.0 111.792 -179.643 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.53 HD21 HD11 ' A' ' 102' ' ' ILE . 3.7 tt -112.09 76.03 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.273 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.417 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.0 mt-10 -77.91 -165.41 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.752 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.46 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -46.45 -51.22 15.59 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.556 -179.11 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -47.23 -17.87 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.923 0.392 . . . . 0.0 110.899 179.764 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 96' ' ' ASP . 9.4 m-20 -124.84 -13.94 6.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.414 -179.91 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.545 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.3 mm -92.23 -42.74 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.264 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -50.78 -34.76 28.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.021 179.812 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.5 t -127.66 37.69 4.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.371 179.622 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 8.7 tp -67.6 144.72 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.779 -179.607 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.53 ' HA ' HD13 ' A' ' 49' ' ' ILE . 28.0 m-20 -138.64 147.87 43.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.345 178.542 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.623 ' HA ' HG22 ' A' ' 49' ' ' ILE . . . -46.71 -37.44 8.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.962 0.41 . . . . 0.0 110.579 -179.722 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.5 m -62.32 -48.45 79.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.322 178.88 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -58.39 -58.4 8.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.311 -179.677 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.613 HD12 HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.77 -56.59 11.36 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.057 0.456 . . . . 0.0 110.271 179.902 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.4 m -57.71 -29.41 64.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.762 179.796 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.506 ' HD3' HD11 ' A' ' 113' ' ' ILE . 2.2 tmt_? -71.44 -65.65 0.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.247 179.83 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -42.89 -42.77 3.81 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.033 179.231 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.506 HG12 HG22 ' A' ' 35' ' ' VAL . 95.5 mt -63.92 -55.3 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.494 178.377 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -54.96 -17.71 4.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.253 0.549 . . . . 0.0 110.332 179.333 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.506 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.77 -36.81 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.84 -179.29 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -123.64 30.12 6.33 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.527 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.8 p -82.58 51.33 1.84 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.085 0.469 . . . . 0.0 109.959 178.741 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 85' ' ' ARG . 55.3 mt . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.295 -179.208 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.681 0.277 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.8 t 55.4 77.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 -179.937 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -121.06 72.14 0.97 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.012 -179.872 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -88.22 -25.1 23.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 179.91 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.0 t -166.62 43.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.927 179.889 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.0 t -143.36 115.99 8.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.843 179.939 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -82.1 -20.03 38.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.855 -179.875 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.37 165.22 28.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.625 -179.988 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.16 -45.33 19.63 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.623 2.215 . . . . 0.0 112.192 179.856 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.37 160.12 13.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.646 -179.883 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.56 -63.63 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.83 0.347 . . . . 0.0 110.56 -179.957 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.442 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . . . 55.39 89.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.75 179.62 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 55' ' ' GLN . 4.8 pt20 48.14 170.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.961 179.689 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.488 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 -164.14 160.17 16.54 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.2 -179.862 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 46.6 Cg_endo -68.71 146.87 68.15 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.348 2.032 . . . . 0.0 112.811 -179.168 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.6 m -67.75 152.4 45.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.443 -179.623 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -95.81 85.88 4.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.813 179.87 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.549 HD11 ' HA ' ' A' ' 24' ' ' ALA . 49.3 mt -81.75 71.24 8.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.63 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.0 p -71.43 0.14 8.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.034 -179.266 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -142.56 147.43 35.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.965 0.412 . . . . 0.0 111.705 -179.701 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.584 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.2 t -56.86 -50.35 88.61 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.443 179.881 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.2 Cg_endo -58.39 -44.48 37.65 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.975 1.783 . . . . 0.0 111.93 179.916 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.26 83.28 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.291 0.567 . . . . 0.0 110.18 179.953 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.549 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -63.69 -57.42 10.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.053 179.435 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.2 mtm -61.39 -26.78 68.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.013 -179.903 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.2 mt-10 -71.47 -50.66 29.44 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.484 179.738 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -60.65 -31.67 70.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.058 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.426 HD13 HD13 ' A' ' 36' ' ' ILE . 49.9 mt -73.17 -38.03 53.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.809 178.236 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.06 -19.7 61.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.998 179.857 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.14 31.01 1.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.471 -179.715 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -171.26 153.25 3.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.333 -179.853 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.535 ' HG3' HG12 ' A' ' 87' ' ' VAL . 27.6 tt0 -71.62 -37.46 70.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.651 179.63 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.468 HG11 HD12 ' A' ' 83' ' ' LEU . 26.9 t -131.53 136.81 56.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.229 179.408 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.02 127.12 19.49 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.252 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.496 HG23 HG12 ' A' ' 111' ' ' ILE . 50.8 t -114.58 130.6 68.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.427 178.304 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 28.2 mt -136.09 135.66 50.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.439 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.538 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.54 99.13 2.12 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.404 179.46 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 13.9 m-85 -85.39 93.28 8.7 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.631 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -112.8 142.06 45.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.492 -177.958 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.427 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 47.7 mt-30 -90.87 1.69 56.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.767 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.446 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.8 t70 -159.36 122.22 3.59 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.585 179.895 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.516 ' HG ' HG23 ' A' ' 66' ' ' THR . 90.1 mt -92.38 47.67 1.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.185 0.517 . . . . 0.0 111.417 -179.32 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.444 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 47.5 mt-10 -138.0 7.47 2.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.913 178.868 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.658 HG13 HG21 ' A' ' 47' ' ' VAL . 1.8 pt -90.93 155.91 44.75 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.159 179.824 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.434 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 86.5 Cg_exo -51.11 -26.71 20.01 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.862 2.374 . . . . 0.0 113.214 179.733 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.51 -36.22 83.48 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.842 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.658 HG21 HG13 ' A' ' 44' ' ' ILE . 2.4 t -62.98 -55.92 33.29 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.494 -178.854 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.631 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.1 Cg_exo -58.75 -39.62 80.31 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.807 1.672 . . . . 0.0 111.407 179.34 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.617 HG21 ' HA ' ' A' ' 104' ' ' ALA . 8.3 mt -63.35 -37.59 79.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.137 179.986 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.518 ' O ' ' HG3' ' A' ' 53' ' ' MET . 41.9 tp -71.87 -51.76 20.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.844 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -55.49 -22.0 19.0 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.507 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -85.09 -44.17 13.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.581 179.494 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.518 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -62.12 -25.56 67.8 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.33 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 50' ' ' LEU . 52.9 t -52.87 -46.97 52.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.928 179.436 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.442 ' OE1' ' HB3' ' A' ' 12' ' ' ALA . 3.8 mt-30 -77.62 -11.65 59.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.705 -179.729 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -93.72 -18.09 22.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.347 -179.85 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.566 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 66.4 m-85 -137.34 62.39 37.29 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.569 -179.775 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.52 -42.53 61.07 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.632 2.221 . . . . 0.0 111.636 179.033 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.95 -40.96 94.02 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.521 179.227 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.2 t -66.93 143.27 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 178.8 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.48 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 48.4 t -80.58 98.08 7.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.134 0.492 . . . . 0.0 110.99 -179.681 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 2.6 p90 -66.11 125.57 25.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.78 179.67 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -144.39 161.91 27.94 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.99 179.902 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.0 tt -159.54 144.17 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.803 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.3 t -150.29 154.37 37.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.218 0.532 . . . . 0.0 111.811 -178.993 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.516 HG23 ' HG ' ' A' ' 42' ' ' LEU . 75.2 p -135.21 -2.64 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.474 179.464 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.05 141.36 57.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.717 -179.875 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.3 p -64.57 -49.93 69.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.509 -179.569 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -49.6 -45.02 47.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.492 -179.371 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.513 ' HA ' HG23 ' A' ' 21' ' ' VAL . 69.0 t -70.52 -53.19 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.877 0.37 . . . . 0.0 110.734 179.853 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.415 HD22 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.25 -14.71 7.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.193 179.406 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.4 m -91.59 -41.85 10.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.333 178.889 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -61.25 -35.48 77.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.449 179.679 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -94.61 9.31 39.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.759 179.452 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.3 t30 57.65 23.19 9.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.671 178.787 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.655 HG22 ' HB ' ' A' ' 80' ' ' THR . 37.6 mm -58.13 120.78 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.157 179.856 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.3 p -139.23 57.34 1.66 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.403 -179.632 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.82 46.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.75 179.754 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.54 ' HB2' HG21 ' A' ' 99' ' ' ILE . 13.1 m120 50.62 42.52 27.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.188 0.518 . . . . 0.0 110.293 -179.868 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.655 ' HB ' HG22 ' A' ' 76' ' ' ILE . 93.4 m -69.0 152.26 45.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.665 -178.352 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.562 HG21 HD22 ' A' ' 107' ' ' LEU . 66.0 mt -119.18 116.42 50.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.952 178.01 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.518 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.4 m -105.34 135.23 47.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.816 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.559 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -109.64 98.78 8.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.916 178.377 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -92.45 120.11 32.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.541 179.816 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.486 HH12 HD12 ' A' ' 116' ' ' LEU . 5.1 mtm180 -103.74 103.84 13.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.399 . . . . 0.0 110.108 179.706 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.5 tp -45.1 -56.32 4.82 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.831 -179.182 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.535 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.03 -76.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.175 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -82.5 5.9 19.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.047 -179.754 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 52.3 36.58 20.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.425 179.779 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.449 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 7.3 mm-40 -81.61 167.19 19.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.959 179.833 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -150.73 89.53 1.56 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.575 179.621 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.569 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.8 mm? -74.49 148.09 41.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.877 179.735 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.5 114.62 18.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.3 0.571 . . . . 0.0 112.165 -179.512 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.492 HD23 HD11 ' A' ' 102' ' ' ILE . 4.5 tt -103.52 77.88 1.54 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.154 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.2 mt-10 -80.55 -164.4 0.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.91 -176.775 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.481 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 17.7 t70 -50.62 -36.25 34.31 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.068 -179.319 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -56.04 -14.7 2.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.313 0.578 . . . . 0.0 110.254 179.63 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -132.33 -13.67 3.03 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.768 -179.909 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.54 HG21 ' HB2' ' A' ' 79' ' ' ASN . 26.2 mm -89.69 -31.54 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.7 0.286 . . . . 0.0 111.269 -179.555 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -53.78 -43.04 68.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.0 110.707 179.815 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.5 p -125.74 38.83 4.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.393 179.738 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.53 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.7 tp -63.56 142.93 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.653 -179.835 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.546 ' HA ' HD13 ' A' ' 49' ' ' ILE . 17.9 m-20 -137.25 148.46 46.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.505 178.836 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.617 ' HA ' HG21 ' A' ' 49' ' ' ILE . . . -47.53 -34.89 8.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.193 0.52 . . . . 0.0 110.274 -179.989 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.2 m -63.47 -48.1 79.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.35 178.774 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -60.3 -60.74 3.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.266 -179.71 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.608 HD11 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.68 -55.36 11.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.029 0.442 . . . . 0.0 110.239 179.898 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 65.8 m -58.92 -30.86 68.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.87 179.948 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.479 ' HD3' HD11 ' A' ' 113' ' ' ILE . 3.2 tmt_? -70.85 -65.81 0.69 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.146 179.724 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -42.87 -44.23 4.42 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.232 179.355 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.496 HG12 HG23 ' A' ' 35' ' ' VAL . 95.4 mt -62.89 -55.08 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.175 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.44 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 7.8 tp10 -54.1 -17.97 3.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.294 179.178 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.479 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -91.09 -34.9 6.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.031 -179.097 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.569 HD21 ' HG ' ' A' ' 92' ' ' LEU . 83.7 m-20 -124.78 28.79 6.39 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.408 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 94.3 p -82.47 43.88 0.85 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.076 0.465 . . . . 0.0 110.346 179.157 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.486 HD12 HH12 ' A' ' 85' ' ' ARG . 59.2 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.392 -179.279 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.867 0.365 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.3 m -107.26 158.37 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.087 -179.891 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -135.52 -65.44 0.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.731 -179.913 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 63.85 151.53 0.04 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.362 179.709 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.4 t -78.4 95.97 5.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.033 -179.915 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.6 m -136.91 -55.79 0.72 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -68.78 164.26 22.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.911 179.996 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.61 -161.66 28.41 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.56 -179.93 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.19 131.26 37.98 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.582 2.188 . . . . 0.0 112.314 179.839 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.47 -77.67 0.24 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.613 179.976 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.73 -45.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.001 0.429 . . . . 0.0 110.429 -179.945 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.35 -84.04 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.954 179.093 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.523 ' HG3' HG12 ' A' ' 54' ' ' VAL . 11.5 pt20 -133.16 138.12 46.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.106 -179.929 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.8 pt-20 -122.15 156.29 60.31 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.62 179.905 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 32.5 Cg_endo -64.89 139.11 60.64 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.549 2.166 . . . . 0.0 112.502 -179.655 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -54.84 153.49 6.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.824 -179.368 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -98.18 92.18 5.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.976 179.78 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.566 HD22 ' HA ' ' A' ' 24' ' ' ALA . 50.9 mt -92.42 72.07 5.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.448 179.77 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.8 p -73.79 -0.99 17.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.889 -179.299 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -140.51 146.78 38.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.393 . . . . 0.0 111.626 -179.953 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.591 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 48.4 t -56.29 -49.96 90.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.494 179.862 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.4 Cg_endo -57.5 -46.15 29.36 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.896 1.73 . . . . 0.0 111.773 179.842 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.98 76.9 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.269 0.557 . . . . 0.0 110.259 -179.822 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.566 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.87 -58.68 5.55 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.104 179.342 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 46.7 mtm -61.3 -26.3 67.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.209 -179.943 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.0 mt-10 -72.06 -51.42 21.72 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.687 0.28 . . . . 0.0 110.612 179.806 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -59.69 -34.64 73.14 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.106 179.249 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.416 HD13 HD11 ' A' ' 36' ' ' ILE . 49.3 mt -72.89 -38.49 56.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.844 178.293 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.65 -17.46 61.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.005 -179.826 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.61 26.04 5.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.307 -179.9 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -172.78 152.06 2.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.597 -179.77 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.628 ' HG3' HG12 ' A' ' 87' ' ' VAL . 1.2 mp0 -59.67 -90.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.252 0.548 . . . . 0.0 110.948 179.32 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.509 HG11 HD12 ' A' ' 83' ' ' LEU . 11.4 t -85.41 133.12 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.715 -179.321 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.536 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -137.57 124.4 21.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.873 -178.977 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG22 HG12 ' A' ' 111' ' ' ILE . 52.3 t -112.75 129.71 67.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.845 178.736 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 25.2 mt -134.66 135.56 53.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.646 -177.249 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.556 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.54 98.06 1.97 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.41 179.859 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.532 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.9 m-85 -83.24 90.06 7.06 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.725 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.4 m-85 -110.29 139.74 45.16 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.0 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -87.36 -5.91 58.69 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.764 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.47 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.2 t70 -152.59 120.85 6.28 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.583 -179.924 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.456 ' HG ' HG21 ' A' ' 66' ' ' THR . 99.3 mt -89.81 45.58 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.047 0.451 . . . . 0.0 111.513 -179.187 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.435 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.4 mt-10 -136.85 11.05 3.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.09 178.97 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.671 HG13 HG21 ' A' ' 47' ' ' VAL . 3.2 pt -92.77 157.22 39.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.27 179.815 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.431 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 70.9 Cg_exo -51.67 -25.93 21.61 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.853 2.368 . . . . 0.0 113.004 179.547 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.41 -37.9 88.34 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.853 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.671 HG21 HG13 ' A' ' 44' ' ' ILE . 2.3 t -61.12 -54.92 49.16 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -178.73 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.611 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 35.2 Cg_exo -61.05 -38.81 65.11 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.951 1.767 . . . . 0.0 111.508 179.202 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.633 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -64.76 -34.58 71.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.025 -179.954 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.522 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.1 tp -74.3 -52.13 13.17 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.879 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -53.11 -26.36 16.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.173 0.511 . . . . 0.0 109.681 178.618 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 t -80.93 -47.55 13.55 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.778 179.867 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.521 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -58.72 -26.32 63.81 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.443 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.523 HG12 ' HG3' ' A' ' 13' ' ' GLN . 56.0 t -52.36 -49.43 42.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.019 179.624 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -77.57 -11.44 59.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.75 -179.815 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -91.3 -18.74 23.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.01 179.807 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 50.3 m-85 -135.92 63.2 50.6 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.267 -179.818 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.03 -43.86 49.6 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.629 2.219 . . . . 0.0 111.692 179.252 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.6 -40.94 88.8 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.367 179.086 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.1 t -66.45 144.48 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.913 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.536 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 31.0 t -83.73 98.98 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.059 0.457 . . . . 0.0 110.987 -179.581 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.441 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 6.4 p90 -64.39 128.84 37.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.053 179.875 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.62 161.65 28.7 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.137 179.762 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -159.32 141.89 5.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.679 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.1 t -141.73 154.55 45.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.971 0.415 . . . . 0.0 111.489 -178.974 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.456 HG21 ' HG ' ' A' ' 42' ' ' LEU . 68.9 p -139.96 -2.44 1.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.875 179.894 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -72.15 143.06 49.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.754 -179.939 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.8 p -63.19 -49.67 73.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.533 -179.493 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -49.97 -44.37 50.71 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.69 -179.381 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.519 ' HA ' HG21 ' A' ' 21' ' ' VAL . 79.6 t -70.54 -52.83 25.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.925 0.393 . . . . 0.0 110.723 179.797 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.19 -14.55 11.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.223 179.422 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.7 m -91.53 -41.89 10.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.264 178.871 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -59.78 -39.92 86.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.498 179.723 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -92.11 13.75 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.987 179.675 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.4 m120 55.32 24.19 6.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.598 179.433 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.627 HG21 ' HB ' ' A' ' 80' ' ' THR . 40.1 mm -59.73 119.23 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.886 179.747 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -139.51 57.59 1.64 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.199 -179.948 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.2 45.06 0.02 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.515 179.828 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.496 ' HB2' HG21 ' A' ' 99' ' ' ILE . 24.9 m-80 51.42 42.16 28.99 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.292 0.567 . . . . 0.0 110.406 -179.859 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.627 ' HB ' HG21 ' A' ' 76' ' ' ILE . 97.9 m -67.86 152.86 44.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.605 -178.621 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.556 HG12 ' HA2' ' A' ' 37' ' ' GLY . 66.1 mt -119.41 117.26 53.43 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.14 178.161 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.532 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.1 m -106.13 135.99 46.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.837 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.564 ' HG ' HD22 ' A' ' 92' ' ' LEU . 2.6 tp -110.64 104.49 13.18 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.132 178.546 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.485 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -97.46 120.1 37.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.76 179.76 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.529 HH12 HD13 ' A' ' 116' ' ' LEU . 5.6 mtm180 -103.39 88.83 3.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.563 -179.739 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tp -38.61 -49.46 1.54 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.637 -179.791 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.628 HG12 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -42.48 -52.38 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 111.431 -179.88 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -108.59 9.39 27.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.62 179.821 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 85' ' ' ARG . 17.0 t-20 47.89 35.55 5.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.519 -179.834 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 8.0 mm-40 -83.05 163.8 20.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.648 179.566 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -147.2 94.14 2.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 179.761 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.572 ' HG ' HD21 ' A' ' 114' ' ' ASN . 2.3 mm? -80.94 146.16 30.9 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.338 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.75 106.31 9.96 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.927 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.54 HD22 HD11 ' A' ' 102' ' ' ILE . 4.8 tt -91.79 77.42 5.54 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.663 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -79.19 -165.09 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.767 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.439 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -45.25 -51.46 10.75 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.569 -179.331 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -47.04 -17.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.901 0.382 . . . . 0.0 111.215 179.88 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -125.52 -13.85 6.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.575 -179.968 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.496 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.3 mm -90.88 -41.32 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.729 -179.381 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -49.05 -40.41 31.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.4 p -126.03 41.87 3.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.684 179.839 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.54 HD11 HD22 ' A' ' 94' ' ' LEU . 7.5 tp -69.31 142.54 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.663 -179.581 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.523 ' HA ' HD13 ' A' ' 49' ' ' ILE . 16.8 m-20 -135.6 147.76 48.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.237 178.597 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.633 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.45 -36.14 6.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.593 -179.608 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.8 m -63.22 -47.45 82.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.562 178.822 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -59.5 -59.3 5.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.206 -179.743 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.623 HD13 HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.02 -54.59 19.13 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.898 0.38 . . . . 0.0 110.22 179.712 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.3 m -59.38 -30.15 68.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.479 ' HD3' HD11 ' A' ' 113' ' ' ILE . 4.1 tmt_? -70.84 -65.59 0.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.191 179.651 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -43.48 -44.23 5.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.908 179.363 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.459 HG12 HG22 ' A' ' 35' ' ' VAL . 96.8 mt -62.34 -54.96 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.437 178.257 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -54.8 -18.9 5.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.213 179.358 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.479 HD11 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.91 -35.72 8.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.937 -179.094 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.572 HD21 ' HG ' ' A' ' 92' ' ' LEU . 87.3 m-20 -125.3 29.82 5.97 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.397 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 96.8 p -81.99 38.3 0.52 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.971 0.415 . . . . 0.0 110.487 179.048 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.529 HD13 HH12 ' A' ' 85' ' ' ARG . 58.6 mt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.114 -179.705 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.763 0.316 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.3 m -66.77 140.78 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.121 -179.934 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -74.16 89.63 2.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.917 -179.861 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -163.72 32.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.561 179.862 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.2 m 64.56 127.58 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.279 -179.969 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -134.94 81.9 1.93 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.986 -179.953 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 61.63 -84.35 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.271 179.778 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.37 -161.38 10.68 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.669 -179.81 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.32 148.96 84.05 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.762 2.308 . . . . 0.0 112.507 -179.806 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.72 148.67 17.08 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.434 179.928 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.33 -54.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.786 0.326 . . . . 0.0 110.681 -179.9 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.62 -84.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.67 179.527 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.524 ' HG3' HG11 ' A' ' 54' ' ' VAL . 28.1 pt20 -162.35 135.16 5.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.859 0.361 . . . . 0.0 111.31 -179.985 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.3 pt-20 -120.13 157.71 52.43 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.625 179.895 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.2 Cg_endo -66.25 143.49 70.98 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.532 2.155 . . . . 0.0 112.712 -179.429 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.4 m -59.3 154.17 17.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.427 -179.614 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -102.14 97.06 7.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.935 -179.987 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.562 HD22 ' HA ' ' A' ' 24' ' ' ALA . 39.2 mt -95.17 76.81 3.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.432 179.958 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.0 p -74.09 -4.34 34.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.142 -179.085 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -139.02 147.32 41.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.92 0.39 . . . . 0.0 111.595 -179.669 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.591 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.2 t -55.97 -50.24 88.42 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.36 179.969 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.95 -44.25 41.63 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 121.88 1.72 . . . . 0.0 111.736 179.992 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.76 78.82 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.321 0.582 . . . . 0.0 110.22 179.995 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.51 -58.66 5.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.093 179.483 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.2 mtp -61.7 -25.83 67.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 19.1 mt-10 -71.34 -51.5 23.9 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.738 0.304 . . . . 0.0 110.474 179.591 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -59.27 -35.68 74.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.97 179.317 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.428 HD13 HD11 ' A' ' 36' ' ' ILE . 46.9 mt -71.13 -39.56 74.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.904 178.305 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.98 -17.98 62.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.994 -179.906 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.78 24.95 5.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.186 -179.862 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.3 t -169.95 152.76 4.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.416 -179.92 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.5 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.5 tt0 -61.23 -82.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.898 -179.888 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.496 HG13 HD12 ' A' ' 83' ' ' LEU . 21.9 t -94.63 138.16 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.48 179.964 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.99 126.84 20.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.946 0.403 . . . . 0.0 111.989 -179.173 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.492 HG22 HG12 ' A' ' 111' ' ' ILE . 45.1 t -113.65 128.11 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.789 178.445 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 32.0 mt -133.0 134.68 57.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.658 -177.053 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.503 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.3 100.25 2.31 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.347 179.614 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.519 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 4.4 m-85 -84.76 93.19 8.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.8 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.2 m-85 -114.5 141.45 47.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.103 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.456 ' HG2' HD22 ' A' ' 71' ' ' LEU . 74.0 mt-30 -88.89 -7.8 55.43 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.706 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.44 ' O ' HG12 ' A' ' 44' ' ' ILE . 25.4 t70 -150.2 120.95 7.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.667 -1.152 . . . . 0.0 109.66 179.688 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.6 mt -90.17 45.33 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.006 0.432 . . . . 0.0 111.536 -179.197 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.7 mt-10 -135.42 11.84 3.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.083 178.976 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.652 HG13 HG22 ' A' ' 47' ' ' VAL . 4.9 pt -93.18 158.93 36.43 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.441 ' O ' HD11 ' A' ' 49' ' ' ILE . 68.8 Cg_exo -54.15 -25.66 38.58 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.743 2.295 . . . . 0.0 112.791 179.462 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.33 89.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.456 -178.804 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.652 HG22 HG13 ' A' ' 44' ' ' ILE . 2.1 t -60.34 -56.45 35.24 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.704 -178.788 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.617 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.4 -41.11 61.19 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.812 1.675 . . . . 0.0 111.401 179.561 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.639 HG21 HD13 ' A' ' 107' ' ' LEU . 5.6 mt -61.64 -34.87 63.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.992 179.781 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 53' ' ' MET . 43.7 tp -74.19 -53.39 9.93 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 178.809 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -53.47 -24.52 13.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.004 0.431 . . . . 0.0 109.887 178.911 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.9 m -82.74 -45.93 13.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.499 179.421 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.534 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -59.25 -25.84 64.39 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.407 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.524 HG11 ' HG3' ' A' ' 13' ' ' GLN . 53.0 t -52.84 -49.98 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.823 179.312 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.466 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 7.6 mt-30 -75.73 -11.45 60.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.813 -179.867 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -92.64 -18.26 23.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.145 179.937 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.576 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 68.1 m-85 -135.56 62.34 48.44 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.396 -179.739 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.7 -43.32 51.78 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.727 2.284 . . . . 0.0 111.552 179.0 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.72 -38.11 86.61 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.52 179.294 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.0 t -70.05 144.4 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.955 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.502 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 42.9 t -83.83 99.32 10.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.006 0.431 . . . . 0.0 111.042 -179.672 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.528 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 7.7 p90 -62.57 131.25 48.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.151 179.915 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -150.06 161.69 28.97 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.121 179.712 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -162.85 142.63 2.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.995 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.8 t -144.37 155.97 44.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.041 0.448 . . . . 0.0 111.652 -179.059 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.457 HG22 ' HG ' ' A' ' 42' ' ' LEU . 67.7 p -139.03 3.1 2.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.842 179.666 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.75 143.11 44.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.784 -179.972 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.9 t -64.48 -50.47 67.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.496 -179.426 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.76 -43.57 48.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.514 -179.413 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.507 ' HA ' HG21 ' A' ' 21' ' ' VAL . 78.1 t -71.51 -53.02 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.811 0.339 . . . . 0.0 110.756 179.987 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.456 HD22 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -58.86 -14.51 9.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.233 179.315 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 76.1 m -91.48 -40.98 11.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.294 178.641 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -60.49 -40.22 90.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.45 179.847 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -91.45 11.86 22.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.853 179.644 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 56.04 25.74 9.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.596 179.551 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.637 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.0 mm -59.78 119.42 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.839 179.597 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.4 p -138.49 58.88 1.65 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.235 -179.549 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.11 48.22 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.709 179.664 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.535 ' HB2' HG23 ' A' ' 99' ' ' ILE . 36.3 m-20 49.52 43.4 23.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.103 0.478 . . . . 0.0 110.461 -179.945 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.637 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.1 m -68.62 152.63 45.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.621 -178.677 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.503 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.4 mt -118.81 119.14 60.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.07 178.065 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.519 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 83.6 m -108.55 134.62 51.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.038 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.56 ' HG ' HD21 ' A' ' 92' ' ' LEU . 2.5 tp -106.71 103.99 13.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.608 178.438 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -97.33 119.72 36.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.867 0.365 . . . . 0.0 111.199 -179.886 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.464 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 3.2 mtm180 -105.24 95.93 6.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.407 -179.95 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tp -43.19 -54.55 4.43 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.782 -179.622 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.5 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.1 -59.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.03 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -97.86 3.62 49.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.446 -179.346 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 85' ' ' ARG . 38.2 t30 51.58 47.08 25.5 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.259 0.552 . . . . 0.0 110.834 -179.818 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.464 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 10.2 mm-40 -97.23 158.67 15.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.715 -179.894 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -140.96 92.34 2.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.934 179.809 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.56 HD21 ' HG ' ' A' ' 83' ' ' LEU . 2.5 mm? -80.8 143.42 32.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.258 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -120.97 123.06 41.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.281 0.562 . . . . 0.0 112.439 -179.363 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.489 HD23 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -111.09 76.34 0.97 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.126 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.416 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.3 mt-10 -78.13 -164.58 0.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.364 -0.834 . . . . 0.0 113.137 -176.669 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.506 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 12.5 t70 -50.94 -37.2 42.83 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.98 -179.113 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.74 -14.98 2.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.106 0.479 . . . . 0.0 110.304 179.639 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -130.6 -13.8 3.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.585 179.776 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.535 HG23 ' HB2' ' A' ' 79' ' ' ASN . 25.7 mm -90.48 -24.95 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.76 0.314 . . . . 0.0 111.195 -179.538 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -57.18 -52.02 66.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.993 0.425 . . . . 0.0 110.611 179.843 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.5 m -117.73 35.6 4.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.348 179.537 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.9 tp -58.09 140.6 16.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.437 -179.619 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.514 ' HA ' HD12 ' A' ' 49' ' ' ILE . 20.9 m-20 -135.69 149.97 49.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.424 178.644 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.631 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.02 -34.55 9.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.019 0.437 . . . . 0.0 110.479 -179.844 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.9 m -64.79 -48.24 75.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.452 178.844 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -59.99 -57.33 13.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.226 -179.794 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.639 HD13 HG21 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -51.75 -55.89 17.08 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.132 0.491 . . . . 0.0 110.001 179.662 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.9 m -58.0 -30.24 65.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.917 179.866 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.423 ' HD3' HD12 ' A' ' 113' ' ' ILE . 2.8 tmt_? -70.37 -65.81 0.68 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.275 179.66 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -42.98 -43.9 4.39 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.141 179.277 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.492 HG12 HG22 ' A' ' 35' ' ' VAL . 88.8 mt -62.29 -55.55 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.208 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -54.6 -18.33 4.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.451 179.319 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.423 HD12 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.74 -36.64 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.079 -178.873 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -124.22 28.79 6.6 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.574 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.9 p -81.04 42.84 0.67 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.928 0.394 . . . . 0.0 110.462 179.21 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.429 HD11 ' NH1' ' A' ' 85' ' ' ARG . 62.3 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.189 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.483 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.0 pt-20 . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.536 0.207 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.506 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.9 Cg_endo -65.46 145.27 82.29 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.617 2.211 . . . . 0.0 112.706 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 m -62.27 154.14 28.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.912 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -97.42 92.82 6.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.811 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.596 HD22 ' HA ' ' A' ' 24' ' ' ALA . 42.9 mt -91.84 71.23 5.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.513 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.2 p -72.93 -0.8 14.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.103 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -139.7 147.28 40.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 111.488 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 45.2 t -56.81 -49.93 91.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.518 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.05 -45.44 31.97 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.926 1.751 . . . . 0.0 111.786 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.29 80.12 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.195 0.521 . . . . 0.0 110.19 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.596 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.77 -59.83 4.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.063 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.3 mtm -60.59 -25.54 66.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.144 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 21.8 mt-10 -71.6 -51.22 24.41 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.495 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.498 ' O ' HG22 ' A' ' 31' ' ' THR . 10.4 m-85 -61.06 -30.21 70.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.575 HD11 HD12 ' A' ' 36' ' ' ILE . 48.6 mt -75.79 -36.96 34.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.965 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.36 -19.48 59.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.248 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.14 28.1 2.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.655 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.1 t -171.16 153.15 3.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.46 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.503 ' HG3' HG13 ' A' ' 87' ' ' VAL . 23.3 tt0 -65.36 -65.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.773 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.509 HG13 HD11 ' A' ' 83' ' ' LEU . 18.1 t -106.1 137.82 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.638 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.536 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.3 125.92 17.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.476 HG21 HG12 ' A' ' 111' ' ' ILE . 53.9 t -114.56 128.75 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.641 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.575 HD12 HD11 ' A' ' 28' ' ' ILE . 29.9 mt -134.49 137.89 50.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.558 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.11 97.79 1.72 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.427 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.469 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.8 m-85 -83.27 91.85 7.37 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.1 m-85 -111.45 143.3 42.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.469 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -90.46 -6.22 55.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.0 t70 -151.95 121.86 7.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.614 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.514 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.7 mt -90.51 45.76 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.999 0.428 . . . . 0.0 111.515 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 36.9 mt-10 -136.59 8.98 3.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.094 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.741 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.8 pt -90.66 156.86 44.75 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.162 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.487 ' O ' HD12 ' A' ' 49' ' ' ILE . 79.6 Cg_exo -51.0 -27.75 22.2 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.837 2.358 . . . . 0.0 112.923 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.741 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.46 -38.57 91.67 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.703 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -60.46 -56.7 32.66 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.802 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.644 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -59.39 -40.88 63.46 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.671 1.581 . . . . 0.0 111.441 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -61.82 -35.59 68.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.145 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.603 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.4 tp -74.65 -52.56 11.37 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -54.83 -24.27 22.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.071 0.463 . . . . 0.0 109.977 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 m -83.03 -45.27 14.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.623 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.614 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.59 -26.28 66.85 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.2 0.524 . . . . 0.0 109.619 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -51.25 -47.71 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.226 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -77.43 -12.97 60.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.913 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -91.23 -17.52 25.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.171 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.576 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 47.8 m-85 -137.99 62.64 34.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.567 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.84 -42.58 65.34 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.677 2.251 . . . . 0.0 111.661 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.93 -37.79 80.84 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.381 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.7 t -70.34 144.34 13.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.655 ' HB2' HG21 ' A' ' 31' ' ' THR . 46.7 t -82.26 98.46 8.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.948 0.404 . . . . 0.0 111.094 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.506 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -65.21 127.37 31.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.066 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.27 160.44 28.18 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.159 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 tt -160.37 144.16 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.469 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 37.3 t -148.48 159.11 44.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.5 . . . . 0.0 111.768 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.468 HG21 ' HG ' ' A' ' 42' ' ' LEU . 67.8 p -140.99 4.82 1.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.656 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -74.43 141.56 45.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.672 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.2 t -64.32 -51.11 65.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.448 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -49.88 -41.94 46.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.61 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.543 ' HA ' HG22 ' A' ' 21' ' ' VAL . 56.5 t -72.08 -53.99 18.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.831 0.348 . . . . 0.0 110.762 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -58.78 -14.69 9.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.091 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.0 m -90.54 -42.45 10.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.093 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -59.73 -37.76 79.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.356 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.431 ' HB2' HG12 ' A' ' 76' ' ' ILE . 79.6 m-85 -93.67 12.01 26.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.807 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 55.7 23.75 6.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.64 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.703 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.3 mm -59.78 121.59 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.221 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.4 p -142.48 58.7 1.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.011 0.434 . . . . 0.0 111.05 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.04 43.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.658 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.556 ' HB2' HG21 ' A' ' 99' ' ' ILE . 24.2 m-80 52.07 43.23 30.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.296 0.569 . . . . 0.0 110.448 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.703 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.2 m -68.61 151.86 46.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.741 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.558 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.1 mt -118.43 116.63 51.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.025 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 72.0 m -105.28 130.3 53.44 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.606 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -107.8 103.51 12.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.771 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.0 t80 -97.51 124.37 41.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.529 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.534 HH12 HD12 ' A' ' 116' ' ' LEU . 4.5 mtm180 -106.8 82.85 1.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.967 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 85' ' ' ARG . 6.0 tp -24.99 -60.04 0.06 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.087 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.503 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.52 -70.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.134 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.03 2.08 50.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.05 0.452 . . . . 0.0 110.959 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 m120 53.76 34.85 19.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.632 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 11.8 mm-40 -81.17 163.93 22.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.746 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.09 98.58 2.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.824 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.606 HD23 ' HG ' ' A' ' 83' ' ' LEU . 1.8 mm? -88.37 117.08 27.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.784 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -97.85 94.08 6.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.545 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -77.65 77.42 4.17 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.4 mt-10 -78.4 -164.49 0.57 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.516 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 16.3 t70 -51.27 -39.02 55.86 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.096 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.26 -14.67 1.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.103 0.477 . . . . 0.0 110.346 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -129.22 -13.85 4.4 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.674 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.556 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.4 mm -90.29 -31.0 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.607 0.242 . . . . 0.0 111.563 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -55.21 -39.37 69.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.19 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.8 p -128.03 37.07 4.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.506 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.545 HD13 HD21 ' A' ' 94' ' ' LEU . 6.6 tp -62.77 142.78 16.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.423 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -137.34 150.53 47.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.642 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.881 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.42 -36.2 14.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.036 0.446 . . . . 0.0 110.367 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.8 m -63.29 -48.7 77.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.398 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -59.08 -58.59 7.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.281 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.49 -56.22 12.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.883 0.373 . . . . 0.0 110.227 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.7 m -58.39 -29.65 66.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.792 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.493 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -71.24 -66.39 0.62 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.094 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -42.57 -42.45 3.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.146 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.476 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -64.12 -56.27 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.562 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -53.43 -19.87 4.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.328 0.585 . . . . 0.0 110.267 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.493 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.22 -37.04 10.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.915 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.435 ' OD1' ' HG ' ' A' ' 92' ' ' LEU . 16.7 m120 -123.3 30.95 6.12 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.0 p -83.35 41.7 0.78 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.02 0.438 . . . . 0.0 110.169 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.534 HD12 HH12 ' A' ' 85' ' ' ARG . 64.6 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.249 -0.882 . . . . 0.0 111.374 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.515 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.5 pt-20 . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 110.651 -0.129 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 37.2 Cg_endo -66.16 143.9 73.18 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.464 2.109 . . . . 0.0 112.668 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 m -62.0 154.41 26.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.422 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -98.99 90.13 4.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.068 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.633 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.7 mt -86.8 74.14 9.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.312 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.8 p -74.05 -5.28 40.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.971 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -137.56 147.2 44.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.888 0.375 . . . . 0.0 111.555 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.2 t -56.76 -50.03 90.35 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.448 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.8 Cg_endo -57.56 -44.08 45.09 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.911 1.741 . . . . 0.0 111.83 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.36 83.9 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.172 0.51 . . . . 0.0 110.228 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.633 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.52 -58.73 6.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.169 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 64.5 mtp -60.36 -26.37 66.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.148 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -71.45 -51.34 24.36 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.672 0.273 . . . . 0.0 110.569 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.546 ' O ' HG22 ' A' ' 31' ' ' THR . 10.9 m-85 -60.37 -32.86 71.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.909 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.49 HD11 ' CD1' ' A' ' 36' ' ' ILE . 54.7 mt -73.71 -38.75 51.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.108 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.98 -19.86 60.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.055 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.8 25.57 3.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.638 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.0 t -168.85 152.2 5.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.514 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HG2' HG22 ' A' ' 87' ' ' VAL . 21.9 tt0 -63.82 -74.04 0.11 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.744 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.549 HG13 HD11 ' A' ' 83' ' ' LEU . 17.9 t -98.25 136.32 29.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.452 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.84 125.37 19.19 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.437 HG21 HG12 ' A' ' 111' ' ' ILE . 56.0 t -115.15 131.13 68.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.688 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 21.5 mt -136.58 138.51 46.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.604 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.74 97.02 1.55 Allowed Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.583 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 11.5 m-85 -83.32 89.8 7.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -109.48 137.92 46.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.455 -178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.481 ' HG2' HD23 ' A' ' 71' ' ' LEU . 94.2 mt-30 -83.85 -6.21 59.38 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.442 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 37.5 t70 -151.69 124.96 8.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.605 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.564 ' HA ' HG21 ' A' ' 47' ' ' VAL . 91.7 mt -93.67 47.14 1.21 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.175 0.512 . . . . 0.0 111.246 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.442 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 6.8 mm-40 -138.81 10.77 2.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.98 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.819 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.4 pt -94.08 156.67 38.84 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.06 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.503 ' O ' HD12 ' A' ' 49' ' ' ILE . 77.8 Cg_exo -50.6 -29.15 24.21 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.774 2.316 . . . . 0.0 113.064 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.819 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.4 -36.65 82.97 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.656 HG23 HG13 ' A' ' 44' ' ' ILE . 2.5 t -63.09 -57.19 22.17 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.72 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.653 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.3 Cg_exo -59.64 -36.1 93.2 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.776 1.651 . . . . 0.0 111.284 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -66.04 -36.31 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.034 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.595 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.5 tp -72.96 -52.19 15.47 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -55.19 -23.03 19.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.892 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.3 t -84.27 -44.17 14.12 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.364 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.576 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.57 -25.39 67.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.21 0.529 . . . . 0.0 109.613 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -52.91 -51.18 39.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.171 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -74.31 -10.6 59.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.662 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.1 mtpp -93.88 -18.94 21.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.186 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.623 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 56.7 m-85 -135.38 61.99 47.64 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.55 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.94 -41.69 62.19 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.687 2.258 . . . . 0.0 111.653 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.12 96.51 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.59 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.623 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.8 t -65.76 144.87 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.638 ' HB2' HG21 ' A' ' 31' ' ' THR . 48.2 t -82.4 97.49 8.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.167 0.508 . . . . 0.0 110.81 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.499 ' HB3' HG22 ' A' ' 54' ' ' VAL . 4.8 p90 -65.21 126.5 28.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.105 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.507 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.98 161.59 28.29 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.139 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -157.92 140.33 5.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.831 0.348 . . . . 0.0 110.082 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.3 t -141.03 155.22 46.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.499 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 39' ' ' PHE . 77.1 p -141.31 -7.19 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.753 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.63 143.57 56.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.709 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 m -62.71 -50.82 69.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.26 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -48.19 -48.56 34.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.687 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HA ' HG22 ' A' ' 21' ' ' VAL . 84.2 t -68.1 -53.4 29.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.82 0.343 . . . . 0.0 110.986 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.481 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -57.78 -14.76 6.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.43 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.9 m -91.24 -42.85 10.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.417 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -59.37 -43.65 92.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.644 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -87.61 12.98 11.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.803 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 54.45 26.9 7.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.536 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.699 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.6 mm -61.08 123.33 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.842 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.6 p -143.57 60.43 1.39 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.935 0.398 . . . . 0.0 111.448 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.82 44.14 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.512 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.594 ' HB2' HG21 ' A' ' 99' ' ' ILE . 19.0 m-80 52.54 43.19 31.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.269 0.557 . . . . 0.0 110.337 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.699 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.1 m -69.01 153.09 44.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.701 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.604 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.4 mt -119.58 117.68 54.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.792 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.506 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.8 m -106.93 134.12 50.55 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.662 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -110.13 105.03 13.97 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.138 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.9 t80 -98.53 122.07 41.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 6.1 mtm180 -104.45 82.12 1.88 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.71 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tp -24.47 -62.0 0.05 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.415 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.87 -63.49 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.97 2.33 55.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.082 0.468 . . . . 0.0 110.713 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.3 m120 53.48 25.28 4.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.667 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.549 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 14.2 mm-40 -68.94 158.09 35.36 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.81 0.338 . . . . 0.0 110.806 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -143.07 90.42 2.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.742 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.662 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -79.92 141.41 36.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.48 96.14 4.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.524 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -82.0 77.77 8.78 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.451 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.5 mt-10 -79.13 -165.25 0.73 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.525 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 13.8 t70 -50.9 -37.63 44.93 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.836 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -55.6 -14.74 2.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.044 0.449 . . . . 0.0 110.406 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -129.93 -14.0 4.03 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.356 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.594 HG21 ' HB2' ' A' ' 79' ' ' ASN . 21.4 mm -90.03 -23.0 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.899 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.56 -51.72 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.658 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 83.2 p -121.21 38.57 4.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.258 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.524 HD13 HD21 ' A' ' 94' ' ' LEU . 6.6 tp -59.41 142.78 14.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.529 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -137.24 150.29 47.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.647 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.89 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.87 -37.11 13.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 110.447 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -63.27 -47.96 80.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.374 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -59.08 -59.67 5.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.113 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.752 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -49.76 -55.31 14.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.094 0.474 . . . . 0.0 110.152 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.7 m -59.08 -28.72 66.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.781 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.474 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -72.11 -65.77 0.73 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.012 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -42.86 -43.79 4.22 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.03 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.437 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -63.23 -56.62 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.585 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -52.56 -20.97 3.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.201 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.474 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -86.15 -39.03 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.953 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.419 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.6 m120 -121.03 29.59 7.28 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 111' ' ' ILE . 80.4 p -82.78 49.49 1.51 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.021 0.439 . . . . 0.0 110.246 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.526 HD12 HH12 ' A' ' 85' ' ' ARG . 72.6 mt . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.29 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.427 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.7 pt-20 . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.406 0.146 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 31.6 Cg_endo -64.73 142.48 76.84 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.666 2.244 . . . . 0.0 112.398 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.3 m -57.68 152.86 14.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.612 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -99.55 94.22 6.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.962 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.65 HD22 ' HA ' ' A' ' 24' ' ' ALA . 42.6 mt -90.37 72.92 7.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.366 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 76.4 p -70.06 -8.04 46.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.185 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 3.7 m-20 -138.55 147.45 43.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.153 0.502 . . . . 0.0 111.729 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.608 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.8 t -54.32 -49.5 90.16 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.861 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.59 -45.31 34.57 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.018 1.812 . . . . 0.0 112.059 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.96 -36.5 84.18 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.233 0.539 . . . . 0.0 110.295 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.65 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.53 -58.71 6.6 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.106 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 69.6 mtp -60.15 -27.57 67.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.18 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 25.0 mt-10 -71.25 -50.34 33.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.803 0.335 . . . . 0.0 110.671 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.53 ' O ' HG22 ' A' ' 31' ' ' THR . 7.2 m-85 -59.98 -32.63 71.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.042 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 36' ' ' ILE . 44.0 mt -74.84 -38.81 44.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.047 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.45 -19.61 61.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.158 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.53 25.96 4.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.379 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.656 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.0 t -170.09 151.14 3.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.387 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.515 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.7 tt0 -62.0 -72.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.774 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.525 HG13 HD11 ' A' ' 83' ' ' LEU . 20.7 t -100.78 138.12 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.812 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.16 128.41 20.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.675 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG21 HG12 ' A' ' 111' ' ' ILE . 47.6 t -116.69 128.74 73.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.701 178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.521 HD12 HD11 ' A' ' 28' ' ' ILE . 22.4 mt -134.09 135.9 54.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.615 -177.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.9 99.41 2.05 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.255 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.495 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.8 m-85 -84.77 92.73 8.3 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.575 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.0 m-85 -112.14 139.26 47.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.431 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.491 ' HG2' HD23 ' A' ' 71' ' ' LEU . 74.4 mt-30 -85.81 -8.0 58.38 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.6 t70 -149.96 123.28 8.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.656 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.551 ' HA ' HG21 ' A' ' 47' ' ' VAL . 98.7 mt -92.28 46.97 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.134 0.492 . . . . 0.0 111.321 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 40.7 mt-10 -137.75 9.18 2.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.981 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.81 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.7 pt -92.84 156.54 40.63 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.271 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.489 ' O ' HD12 ' A' ' 49' ' ' ILE . 83.2 Cg_exo -50.54 -28.93 23.19 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.836 2.358 . . . . 0.0 113.162 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.81 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.07 -38.65 89.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.642 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -61.53 -56.69 30.82 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.76 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -59.34 -37.9 87.81 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.746 1.631 . . . . 0.0 111.322 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.869 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.5 mt -64.42 -35.25 73.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.992 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.602 ' O ' HG23 ' A' ' 54' ' ' VAL . 46.8 tp -73.6 -52.77 12.29 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -54.21 -24.72 19.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.07 0.462 . . . . 0.0 109.795 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 t -82.85 -44.37 15.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.631 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.598 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.42 -25.95 67.54 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.244 0.545 . . . . 0.0 109.653 179.261 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 50' ' ' LEU . 56.3 t -52.15 -50.01 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.848 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -74.43 -12.62 60.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.816 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -91.93 -18.41 23.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.294 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.612 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 45.1 m-85 -135.92 62.47 46.89 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.496 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.07 -45.46 38.84 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.82 2.347 . . . . 0.0 111.61 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.07 -41.81 79.09 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.476 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.612 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.5 t -65.97 144.22 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.656 ' HB2' HG21 ' A' ' 31' ' ' THR . 37.6 t -82.41 98.03 8.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.916 0.389 . . . . 0.0 110.896 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.501 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 7.9 p90 -62.65 129.38 40.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.781 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.37 160.66 28.43 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.14 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.417 HD11 HG13 ' A' ' 47' ' ' VAL . 4.6 tt -159.38 141.7 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.8 t -145.19 151.71 38.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.104 0.478 . . . . 0.0 111.686 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 39' ' ' PHE . 81.1 p -135.59 -4.89 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.515 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.41 146.22 55.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.791 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.8 t -66.84 -52.12 47.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.474 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -49.71 -43.56 47.66 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.551 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.502 ' HA ' HG22 ' A' ' 21' ' ' VAL . 77.3 t -70.58 -54.07 19.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.91 0.386 . . . . 0.0 110.695 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.491 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -58.75 -14.67 9.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.357 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.4 m -92.29 -39.96 11.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.316 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -61.95 -39.29 91.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.398 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.411 ' HB2' HG12 ' A' ' 76' ' ' ILE . 41.2 m-85 -91.12 10.76 25.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 57.53 25.0 10.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.502 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.668 HG23 ' HB ' ' A' ' 80' ' ' THR . 36.0 mm -60.52 121.44 8.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.055 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.2 p -141.86 59.16 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.36 45.27 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.666 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.615 ' HB2' HG21 ' A' ' 99' ' ' ILE . 28.4 m-80 52.17 42.89 30.92 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.282 0.563 . . . . 0.0 110.557 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.668 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.1 m -69.28 152.6 44.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.681 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.565 HG12 ' HA2' ' A' ' 37' ' ' GLY . 68.2 mt -119.45 118.8 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.095 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.495 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 83.9 m -107.79 133.55 52.02 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.651 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -108.29 104.24 13.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.778 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.2 t80 -97.76 123.41 41.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.479 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.531 HH12 HD12 ' A' ' 116' ' ' LEU . 5.7 mtm180 -106.83 82.91 1.76 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.957 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 tp -26.01 -59.1 0.08 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.04 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.515 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.55 -70.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 O-C-N 123.413 0.446 . . . . 0.0 112.069 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -87.52 2.51 50.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.739 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 52.07 37.88 22.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.17 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.493 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 8.4 mm-40 -82.36 158.19 23.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.618 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -140.11 91.95 2.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.86 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.651 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -81.62 133.81 35.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.491 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.06 116.11 28.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.334 0.588 . . . . 0.0 112.317 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.553 HD21 HD13 ' A' ' 102' ' ' ILE . 3.7 tt -102.39 77.19 1.62 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -79.64 -164.84 0.7 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -176.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.518 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 21.2 t70 -50.52 -36.59 34.82 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.101 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -56.67 -14.51 3.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.151 0.501 . . . . 0.0 110.311 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -131.07 -13.93 3.49 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.593 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.615 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.7 mm -90.07 -30.97 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.774 0.321 . . . . 0.0 111.246 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -54.47 -41.58 69.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.511 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.1 m -126.82 38.64 4.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.569 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.553 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -64.31 142.44 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.608 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -136.55 149.47 48.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.321 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.869 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.41 -35.92 9.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.092 0.472 . . . . 0.0 110.416 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 98.8 m -62.7 -49.11 76.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.413 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -59.1 -58.28 9.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.411 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.746 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.67 -56.69 10.72 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.107 0.479 . . . . 0.0 110.027 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.6 m -58.06 -28.68 64.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.746 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.483 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.1 tmt_? -71.96 -65.58 0.75 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.062 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -43.05 -42.78 4.04 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.084 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.422 HG12 HG21 ' A' ' 35' ' ' VAL . 96.1 mt -64.46 -55.44 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.551 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.79 -17.21 3.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.232 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.483 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -90.77 -37.01 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.0 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.409 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.7 m120 -124.47 29.95 6.16 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.6 p -81.95 47.07 1.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.074 0.464 . . . . 0.0 110.197 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.531 HD12 HH12 ' A' ' 85' ' ' ARG . 51.2 mt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.171 -0.919 . . . . 0.0 111.353 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.497 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 . . . . . 0 CA--C 1.532 0.254 0 CA-C-O 120.431 0.157 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 32.2 Cg_endo -65.51 144.91 81.0 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.653 2.236 . . . . 0.0 112.538 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.7 m -62.23 154.13 28.45 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.359 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -99.69 95.57 7.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.136 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 24' ' ' ALA . 44.7 mt -93.13 71.3 4.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.327 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.4 p -71.75 -0.07 10.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.289 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -141.37 147.62 38.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.939 0.4 . . . . 0.0 111.592 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 23.2 t -57.28 -49.73 92.2 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.499 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.0 Cg_endo -58.71 -42.5 52.97 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.975 1.784 . . . . 0.0 111.879 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.91 -34.91 78.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.195 0.521 . . . . 0.0 110.533 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.602 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -65.06 -57.01 9.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.184 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 61.0 mtm -62.87 -28.6 70.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.075 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 9.9 mt-10 -69.88 -47.77 61.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.718 0.294 . . . . 0.0 110.5 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.567 ' O ' HG22 ' A' ' 31' ' ' THR . 0.4 OUTLIER -60.08 -42.35 94.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.346 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.539 HD11 HD12 ' A' ' 36' ' ' ILE . 51.0 mt -65.36 -40.12 87.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.23 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.61 -15.52 61.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.786 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.45 24.86 6.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.13 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.629 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.5 t -171.69 155.02 3.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.515 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.53 ' HG3' HG13 ' A' ' 87' ' ' VAL . 20.7 tt0 -64.76 -79.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.876 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.519 HG13 HD11 ' A' ' 83' ' ' LEU . 17.0 t -93.5 135.14 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.411 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.96 125.51 20.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.026 0.441 . . . . 0.0 112.138 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.459 HG21 HG12 ' A' ' 111' ' ' ILE . 52.4 t -114.48 127.66 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.799 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.539 HD12 HD11 ' A' ' 28' ' ' ILE . 23.7 mt -133.18 137.2 53.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.401 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.54 98.61 1.88 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.455 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 6.1 m-85 -83.83 90.22 7.32 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.0 m-85 -109.32 139.09 44.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.377 -178.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.426 ' HG2' HD23 ' A' ' 71' ' ' LEU . 54.1 mt-30 -86.06 -8.57 57.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.485 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.4 t70 -149.84 121.7 8.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.623 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.567 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.3 mt -89.55 44.85 1.23 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.066 0.46 . . . . 0.0 111.35 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.408 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.7 mt-10 -135.94 10.52 3.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.028 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.1 pt -94.34 156.77 38.39 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.288 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.486 ' O ' HD12 ' A' ' 49' ' ' ILE . 73.4 Cg_exo -51.19 -28.58 26.21 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.794 2.33 . . . . 0.0 112.899 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.795 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -61.89 -38.89 90.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.315 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.678 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -60.97 -57.28 27.5 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.681 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.66 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -58.98 -40.27 72.88 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.767 1.644 . . . . 0.0 111.387 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.892 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -61.77 -35.77 69.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.007 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.596 ' O ' HG23 ' A' ' 54' ' ' VAL . 42.1 tp -73.52 -53.11 11.35 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 14.7 m-70 -53.58 -24.44 13.73 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.1 m -82.49 -46.18 13.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.621 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.585 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.7 -26.1 65.33 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 50' ' ' LEU . 58.7 t -53.08 -47.28 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.942 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -77.46 -10.5 59.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.647 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -94.1 -19.68 20.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.16 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.57 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 64.4 m-85 -136.44 62.66 44.57 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.525 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.26 -42.37 60.46 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.653 2.235 . . . . 0.0 111.624 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.72 -39.39 91.17 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.32 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.3 t -67.67 144.11 14.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.629 ' HB2' HG21 ' A' ' 31' ' ' THR . 33.7 t -81.89 98.8 8.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 111.015 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.493 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 8.3 p90 -64.88 128.64 36.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.905 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.74 160.87 28.44 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.987 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.43 HD11 HG13 ' A' ' 47' ' ' VAL . 4.8 tt -160.75 141.82 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.1 t -146.94 155.87 42.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.952 0.406 . . . . 0.0 111.769 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 39' ' ' PHE . 82.5 p -137.64 -8.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.681 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.77 141.8 56.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.669 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.4 m -64.68 -49.53 70.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.126 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -50.19 -44.48 53.02 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.411 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.486 ' HA ' HG22 ' A' ' 21' ' ' VAL . 77.2 t -70.53 -53.78 21.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.831 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.426 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.0 mp -58.38 -14.63 8.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.261 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.4 m -91.73 -40.63 11.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.205 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -61.87 -36.17 80.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.486 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.43 ' HB2' HG12 ' A' ' 76' ' ' ILE . 32.4 m-85 -94.16 10.67 32.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.73 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 57.51 23.66 9.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.64 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.665 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.2 mm -59.89 120.05 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.245 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.9 p -139.39 55.85 1.68 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.174 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.19 45.7 0.02 OUTLIER Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.634 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.624 ' HB2' HG21 ' A' ' 99' ' ' ILE . 21.8 m-80 51.28 43.27 29.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.252 0.549 . . . . 0.0 110.504 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.665 ' HB ' HG23 ' A' ' 76' ' ' ILE . 98.0 m -69.17 151.27 46.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.569 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.581 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.3 mt -117.45 118.95 60.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.223 -0.898 . . . . 0.0 108.821 178.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.513 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.4 m -107.26 133.23 52.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.654 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -109.41 103.38 12.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.966 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.9 t80 -96.34 120.88 37.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.56 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.504 HH12 HD12 ' A' ' 116' ' ' LEU . 5.2 mtm180 -104.06 80.63 1.75 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.808 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 8.6 tp -25.18 -58.2 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.028 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.53 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.84 -62.88 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.314 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -95.05 15.45 18.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.783 0.325 . . . . 0.0 111.301 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 44.7 27.94 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.104 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.495 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.4 mm-40 -75.98 156.78 33.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.834 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.7 tm0? -144.26 90.68 2.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.774 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.654 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -77.52 142.19 39.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.4 91.99 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.573 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -78.34 79.36 4.78 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -79.5 -165.49 0.8 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.8 t70 -50.37 -39.86 47.86 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.48 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.14 -15.12 1.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.167 0.508 . . . . 0.0 110.295 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -127.95 -13.79 5.11 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.461 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.624 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.4 mm -90.16 -33.45 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.543 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -50.11 -53.64 26.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 110.544 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.6 m -114.97 38.55 3.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.436 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.579 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.3 tp -62.0 142.88 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 111.448 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -137.96 149.57 46.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.848 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.892 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.92 -35.89 11.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.034 0.445 . . . . 0.0 110.36 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 95.6 m -62.97 -47.83 81.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.293 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -60.2 -60.29 4.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.126 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.738 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.06 -56.02 10.31 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.995 0.426 . . . . 0.0 110.131 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.0 m -58.23 -30.76 66.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.999 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.5 ' HD3' HD13 ' A' ' 113' ' ' ILE . 1.7 tmt_? -69.85 -66.02 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.052 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -42.86 -43.83 4.23 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.218 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.459 HG12 HG21 ' A' ' 35' ' ' VAL . 95.3 mt -62.92 -54.89 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -54.57 -18.68 4.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.267 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.5 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.79 -35.24 7.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.944 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.472 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.3 m120 -126.03 30.91 5.55 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.2 p -83.44 38.32 0.61 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.995 0.426 . . . . 0.0 110.423 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.504 HD12 HH12 ' A' ' 85' ' ' ARG . 72.0 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.386 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.48 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.4 pt-20 . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 30.8 Cg_endo -64.26 145.77 89.2 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.536 2.158 . . . . 0.0 112.518 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.2 m -61.05 153.92 24.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.581 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -99.97 89.61 4.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.709 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 35.4 mt -87.72 76.8 8.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.56 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.0 p -74.6 -4.95 40.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.049 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -141.48 148.31 39.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.952 0.406 . . . . 0.0 111.821 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 12.6 t -54.63 -49.97 88.25 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.583 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.0 Cg_endo -57.81 -44.15 43.2 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.005 1.804 . . . . 0.0 112.127 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.98 -37.54 87.81 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.206 0.527 . . . . 0.0 110.263 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.69 -56.54 16.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.016 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.6 mtm -61.86 -26.76 68.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.056 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -71.72 -50.59 28.9 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.642 0.258 . . . . 0.0 110.602 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.539 ' O ' HG22 ' A' ' 31' ' ' THR . 11.4 m-85 -60.83 -32.17 71.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.105 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.527 HD11 HD12 ' A' ' 36' ' ' ILE . 53.4 mt -75.29 -39.06 41.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.03 0.443 . . . . 0.0 110.075 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.51 -18.46 61.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.143 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.1 25.39 4.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.261 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.628 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.0 t -169.57 154.24 5.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.689 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.545 ' HG3' HG13 ' A' ' 87' ' ' VAL . 18.9 tt0 -65.13 -72.58 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.878 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.524 HG13 HD11 ' A' ' 83' ' ' LEU . 15.7 t -99.45 137.13 27.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.672 0.272 . . . . 0.0 110.657 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.58 125.35 16.97 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.024 0.44 . . . . 0.0 112.019 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.467 HG22 ' HB2' ' A' ' 83' ' ' LEU . 56.0 t -114.88 129.64 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.902 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.527 HD12 HD11 ' A' ' 28' ' ' ILE . 21.6 mt -135.21 136.8 51.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.468 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.0 99.78 2.1 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.543 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 6.4 m-85 -85.4 93.93 8.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.4 m-85 -113.38 143.37 44.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -92.64 -1.16 57.1 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.52 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.3 t70 -156.89 115.53 3.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.479 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.592 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.2 mt -85.47 44.14 1.08 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.11 0.481 . . . . 0.0 111.233 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.425 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 17.5 mm-40 -135.29 12.74 3.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.46 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.797 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.8 pt -96.57 156.37 36.79 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.176 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.492 ' O ' HD12 ' A' ' 49' ' ' ILE . 87.6 Cg_exo -50.95 -27.24 20.41 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.837 2.358 . . . . 0.0 113.048 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.797 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.15 -37.12 86.31 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.672 HG23 HG13 ' A' ' 44' ' ' ILE . 2.7 t -62.13 -56.1 34.47 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.939 -0.305 . . . . 0.0 111.682 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.8 Cg_exo -59.79 -40.25 65.4 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.735 1.623 . . . . 0.0 111.461 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.869 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -61.83 -37.2 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.086 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.579 ' O ' HG23 ' A' ' 54' ' ' VAL . 37.6 tp -72.13 -53.19 13.5 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -54.92 -21.02 10.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.085 0.469 . . . . 0.0 109.815 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.7 t -85.38 -44.87 12.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.496 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.582 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.28 -26.55 67.85 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.5 t -51.89 -50.0 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.069 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -74.54 -13.41 60.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.685 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -91.13 -18.7 24.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.288 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.654 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 48.8 m-85 -135.4 62.06 47.84 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.436 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.18 -36.77 78.62 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.494 2.129 . . . . 0.0 111.493 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.44 -39.77 98.09 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.518 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.654 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.5 t -67.72 145.23 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.628 ' HB2' HG21 ' A' ' 31' ' ' THR . 36.9 t -82.7 96.28 8.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.099 0.476 . . . . 0.0 110.795 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.504 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.8 p90 -64.05 130.83 45.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.187 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.494 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -149.87 162.3 29.11 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.008 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.5 tt -160.47 147.1 5.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.9 t -153.11 157.55 40.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.17 0.509 . . . . 0.0 111.697 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.436 HG21 ' HG ' ' A' ' 42' ' ' LEU . 69.9 p -138.03 -3.39 1.8 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.444 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -63.95 143.36 57.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.679 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.0 p -66.22 -52.08 51.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.53 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -50.2 -43.46 52.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.592 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.477 HG22 ' HA ' ' A' ' 21' ' ' VAL . 60.4 t -70.53 -52.5 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.934 0.397 . . . . 0.0 110.563 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.96 -14.52 16.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.47 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.6 m -92.13 -41.53 10.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.204 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -60.1 -41.3 92.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.451 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.401 ' HB2' HG12 ' A' ' 76' ' ' ILE . 36.3 m-85 -89.02 11.98 16.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.81 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 55.95 28.81 13.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.483 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.68 HG23 ' HB ' ' A' ' 80' ' ' THR . 34.9 mm -65.5 118.65 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.079 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.7 p -139.75 51.96 1.72 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.193 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.87 44.42 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.567 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.643 ' HB2' HG21 ' A' ' 99' ' ' ILE . 39.2 m-20 51.42 42.29 29.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.364 0.602 . . . . 0.0 110.137 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.68 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.4 m -68.55 153.36 43.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.93 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.591 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.3 mt -119.93 118.06 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.867 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.2 m -106.75 132.8 52.31 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.624 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -110.42 104.72 13.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.039 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.0 t80 -97.54 123.94 41.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.447 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.533 HH12 HD12 ' A' ' 116' ' ' LEU . 4.8 mtm180 -106.12 81.08 1.58 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.708 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ARG . 8.9 tp -24.28 -59.86 0.05 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.113 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.545 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.8 -63.3 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -93.77 2.57 56.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.995 0.426 . . . . 0.0 111.077 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 54.12 30.7 12.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.718 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.9 mm-40 -78.32 164.07 25.17 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.706 0.288 . . . . 0.0 110.648 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.99 98.74 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.624 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -86.81 115.37 24.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.742 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -96.67 93.61 6.83 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.563 HD21 HD13 ' A' ' 102' ' ' ILE . 4.1 tt -78.67 78.92 5.11 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -80.51 -165.44 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.501 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.17 -50.35 11.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.675 -179.316 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -47.59 -16.5 0.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.941 0.4 . . . . 0.0 111.209 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 96' ' ' ASP . 19.3 m-20 -127.27 -13.73 5.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.467 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.643 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.2 mm -91.36 -40.73 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -50.35 -37.36 36.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.349 . . . . 0.0 111.076 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.2 p -127.11 38.58 4.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.48 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.563 HD13 HD21 ' A' ' 94' ' ' LEU . 7.5 tp -67.11 143.76 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.616 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -137.93 148.39 45.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.32 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.869 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.8 -36.48 7.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.026 0.441 . . . . 0.0 110.445 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.3 m -62.57 -49.4 75.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.413 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -58.2 -59.07 5.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.365 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.732 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.64 -55.67 15.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.015 0.436 . . . . 0.0 110.146 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 65.5 m -58.42 -28.76 65.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.763 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.556 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -72.12 -67.21 0.56 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.094 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -42.85 -40.23 2.82 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.34 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.416 HG12 HG21 ' A' ' 35' ' ' VAL . 96.6 mt -66.45 -54.97 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -53.96 -18.84 3.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.324 0.583 . . . . 0.0 110.285 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.556 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.5 mp -90.1 -38.6 11.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.899 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.493 ' OD1' HG22 ' A' ' 113' ' ' ILE . 28.2 m120 -118.36 28.13 8.53 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -82.39 47.63 1.18 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 110.08 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.533 HD12 HH12 ' A' ' 85' ' ' ARG . 52.1 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.252 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.472 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.9 pt-20 . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 120.543 0.211 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.511 ' HD3' HG21 ' A' ' 54' ' ' VAL . 47.4 Cg_endo -68.66 150.59 74.65 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.855 2.37 . . . . 0.0 112.592 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.423 HG21 ' CZ ' ' A' ' 27' ' ' PHE . 8.4 m -73.18 154.23 40.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.38 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -97.53 91.16 5.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.166 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.591 HD13 ' HA ' ' A' ' 24' ' ' ALA . 30.7 mt -85.02 73.14 10.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.237 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.9 p -68.85 -6.72 28.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.421 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -138.25 147.4 43.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.931 0.396 . . . . 0.0 111.937 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 33.2 t -54.0 -49.68 88.39 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.685 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.7 Cg_endo -58.05 -46.15 27.48 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.962 1.775 . . . . 0.0 112.131 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.55 -35.33 80.13 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.115 0.483 . . . . 0.0 110.409 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.591 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -64.17 -59.64 4.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.006 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.9 mtm -61.51 -24.91 66.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.025 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 17.8 mt-10 -71.68 -50.33 31.47 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.749 0.309 . . . . 0.0 110.169 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.511 ' O ' HG22 ' A' ' 31' ' ' THR . 6.3 m-85 -60.04 -33.24 71.76 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.569 HD11 HD12 ' A' ' 36' ' ' ILE . 50.0 mt -72.49 -38.98 61.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.038 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.22 -18.33 60.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.239 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.75 27.18 3.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.288 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.762 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.6 t -170.8 150.77 3.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.426 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.505 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.0 tt0 -62.67 -63.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.953 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.504 HG13 HD11 ' A' ' 83' ' ' LEU . 21.8 t -108.18 138.32 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.591 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.37 125.75 18.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.993 0.425 . . . . 0.0 111.991 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.442 HG21 HG12 ' A' ' 111' ' ' ILE . 51.4 t -114.38 129.79 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 28' ' ' ILE . 39.3 mt -135.45 138.12 48.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.56 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.07 96.84 1.5 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.478 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.463 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 37.1 m-85 -83.04 90.45 7.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.646 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 13.6 m-85 -108.51 142.04 39.52 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -87.93 -5.97 58.28 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.477 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.8 t70 -154.49 123.48 6.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.747 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.554 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.3 mt -91.22 46.33 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.13 0.49 . . . . 0.0 111.293 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 32.5 mt-10 -137.57 11.4 2.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.972 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.813 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.6 pt -95.61 156.42 37.46 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.158 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.475 ' O ' HD12 ' A' ' 49' ' ' ILE . 82.0 Cg_exo -50.18 -28.47 19.97 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.848 2.365 . . . . 0.0 113.145 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.813 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.03 -37.05 85.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.67 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.6 t -62.39 -56.31 31.69 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.67 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.7 Cg_exo -60.04 -37.25 85.92 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 121.923 1.749 . . . . 0.0 111.49 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.7 mt -65.65 -35.9 76.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.112 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 54' ' ' VAL . 45.9 tp -73.23 -50.46 22.28 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -54.95 -26.12 34.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.124 0.487 . . . . 0.0 109.78 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.3 t -81.13 -46.97 14.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.625 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.585 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.28 -26.53 65.03 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.52 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 50' ' ' LEU . 47.0 t -52.19 -48.15 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.225 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -77.06 -11.89 59.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 28.8 mtpp -92.17 -18.47 23.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.176 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.59 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 56.5 m-85 -136.13 62.45 45.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.439 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.43 -43.09 56.94 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.701 2.267 . . . . 0.0 111.842 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.79 -39.44 91.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.57 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.8 t -67.35 145.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.762 ' HB2' HG21 ' A' ' 31' ' ' THR . 23.9 t -83.04 97.7 8.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.104 0.478 . . . . 0.0 110.826 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.502 ' HB3' HG22 ' A' ' 54' ' ' VAL . 5.0 p90 -64.73 125.17 23.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.965 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -143.56 162.42 27.67 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.146 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -163.08 142.77 2.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.463 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 42.5 t -149.56 156.3 41.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.12 0.486 . . . . 0.0 111.711 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.52 HG21 ' HG ' ' A' ' 42' ' ' LEU . 75.8 p -136.55 -1.54 2.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.459 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -68.08 139.97 56.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.72 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.7 p -62.34 -48.95 77.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.461 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -49.44 -47.38 48.22 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.574 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.498 ' HA ' HG22 ' A' ' 21' ' ' VAL . 71.5 t -69.01 -53.96 22.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.985 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.86 -14.88 6.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.134 0.492 . . . . 0.0 110.225 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.5 m -90.49 -41.6 11.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.32 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -60.77 -37.87 83.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.475 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.431 ' HB2' HG12 ' A' ' 76' ' ' ILE . 60.0 m-85 -92.88 10.11 32.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.815 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 56.76 25.97 10.86 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.51 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.705 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.3 mm -61.31 123.88 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.353 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.1 p -143.08 60.01 1.41 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.174 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.15 44.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.733 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.646 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 24.0 m-80 51.87 43.99 29.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.23 0.538 . . . . 0.0 110.506 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.705 ' HB ' HG23 ' A' ' 76' ' ' ILE . 90.1 m -69.32 150.94 46.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.744 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.56 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.2 mt -117.23 115.81 49.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.202 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.427 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 71.0 m -104.04 133.16 49.45 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.663 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -108.87 101.3 10.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.028 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.9 t80 -95.32 121.26 36.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.555 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.455 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 4.3 mtm180 -104.56 84.12 2.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.752 0.311 . . . . 0.0 110.897 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tp -26.26 -59.02 0.08 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.505 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.39 -72.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 O-C-N 123.428 0.455 . . . . 0.0 112.009 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.85 3.6 40.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.152 0.501 . . . . 0.0 110.655 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.5 t30 52.72 31.94 11.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.344 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 16.7 mm-40 -75.11 158.78 32.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.582 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -140.48 90.77 2.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.663 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -77.52 142.92 38.81 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -124.39 108.86 12.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.167 0.508 . . . . 0.0 112.343 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.553 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -96.54 77.86 2.95 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.6 mt-10 -79.0 -165.21 0.71 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.528 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.3 t70 -51.17 -36.6 41.93 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.02 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.15 -14.77 2.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.061 0.458 . . . . 0.0 110.437 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -130.88 -14.17 3.55 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.639 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.588 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.0 mm -89.07 -29.49 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.705 0.288 . . . . 0.0 111.271 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -55.7 -47.94 75.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.659 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.9 t -118.81 36.06 4.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.514 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.553 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -62.2 142.76 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.513 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -137.87 149.07 45.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.57 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.1 -37.24 9.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.013 0.435 . . . . 0.0 110.441 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 98.9 m -62.87 -48.45 78.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.256 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.09 -57.85 11.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.29 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.779 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.96 -56.22 13.45 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.052 0.453 . . . . 0.0 110.275 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.8 m -58.15 -29.47 65.6 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.887 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.501 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.3 tmt_? -71.58 -64.68 0.88 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.331 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -43.03 -45.8 5.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.932 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.442 HG12 HG21 ' A' ' 35' ' ' VAL . 96.4 mt -61.2 -55.75 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.506 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -54.34 -18.07 3.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.39 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.501 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.25 -37.23 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.04 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.448 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.5 m120 -124.81 30.35 5.95 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.5 p -83.13 48.98 1.45 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.049 0.452 . . . . 0.0 110.139 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.409 HD12 ' NH1' ' A' ' 85' ' ' ARG . 61.2 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.357 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.2 pt-20 . . . . . 0 CA--C 1.531 0.232 0 CA-C-O 120.511 0.196 . . . . 0.0 110.775 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 36.7 Cg_endo -67.22 143.8 66.13 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.512 2.142 . . . . 0.0 112.578 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 m -61.09 154.43 22.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.457 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -100.56 88.51 3.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.886 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 24' ' ' ALA . 59.8 mt -83.19 71.99 10.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.414 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.5 p -70.56 -1.51 11.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.377 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -143.27 147.03 34.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.986 0.422 . . . . 0.0 111.829 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.0 t -54.75 -49.17 93.04 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.561 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.57 -47.46 18.92 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.835 1.69 . . . . 0.0 111.84 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.29 -32.57 73.31 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.182 0.515 . . . . 0.0 110.174 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.611 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.85 -61.38 2.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.027 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.4 mmt -59.73 -25.04 64.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.302 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -73.1 -52.19 15.2 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.669 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.46 ' O ' HG22 ' A' ' 31' ' ' THR . 5.6 m-85 -58.74 -32.55 69.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.523 HD11 ' CD1' ' A' ' 36' ' ' ILE . 50.8 mt -74.76 -41.13 47.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.287 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.66 -15.27 62.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.14 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.85 26.81 4.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.132 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.674 HG21 ' HB2' ' A' ' 61' ' ' SER . 7.6 t -172.11 154.77 3.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.644 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HG2' HG22 ' A' ' 87' ' ' VAL . 10.9 tt0 -64.13 -76.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.842 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.551 HG13 HD11 ' A' ' 83' ' ' LEU . 16.9 t -96.6 136.1 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.59 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.68 125.67 19.77 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.472 HG21 HG12 ' A' ' 111' ' ' ILE . 52.6 t -115.32 131.67 66.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.755 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.523 ' CD1' HD11 ' A' ' 28' ' ' ILE . 20.6 mt -137.04 139.97 43.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.385 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.59 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.96 97.99 1.67 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.592 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.472 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 44.5 m-85 -84.6 93.12 8.31 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.613 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.1 m-85 -113.15 141.22 47.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -86.53 -8.84 57.21 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.494 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.0 t70 -149.82 123.17 9.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.813 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.554 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.5 mt -91.89 46.36 1.27 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.062 0.458 . . . . 0.0 111.326 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -135.18 9.62 3.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.848 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.723 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.0 pt -91.98 158.01 40.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.343 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' HD12 ' A' ' 49' ' ' ILE . 76.5 Cg_exo -53.24 -24.91 28.23 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.961 2.441 . . . . 0.0 113.015 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.723 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -66.1 -37.22 85.22 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.705 HG23 HG13 ' A' ' 44' ' ' ILE . 2.9 t -61.02 -55.2 46.86 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.616 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.658 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.2 Cg_exo -60.88 -42.41 37.92 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.035 1.824 . . . . 0.0 111.565 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.891 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -61.15 -35.28 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.251 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.61 ' O ' HG23 ' A' ' 54' ' ' VAL . 51.9 tp -74.15 -51.63 14.98 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -54.09 -26.75 28.68 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.9 m -80.84 -46.62 15.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.565 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.634 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.75 -25.28 64.74 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.195 0.521 . . . . 0.0 109.7 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 50' ' ' LEU . 49.5 t -53.12 -46.52 55.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.937 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -79.16 -9.16 59.49 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.808 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -94.61 -19.08 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.225 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.579 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 52.4 m-85 -136.95 63.02 43.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.419 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.68 -44.55 46.85 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.744 2.296 . . . . 0.0 111.71 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.33 -40.67 77.19 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.523 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.7 t -66.93 143.12 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.674 ' HB2' HG21 ' A' ' 31' ' ' THR . 22.1 t -80.92 96.31 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.403 . . . . 0.0 111.054 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.526 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.7 p90 -65.58 125.46 25.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.912 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -144.71 163.82 27.88 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.01 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 tt -161.81 144.11 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.452 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.9 t -150.1 157.38 43.06 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.041 0.448 . . . . 0.0 111.498 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.462 HG21 ' HG ' ' A' ' 42' ' ' LEU . 75.2 p -138.1 -2.99 1.81 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.644 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -64.06 142.2 58.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.631 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.2 t -65.29 -51.17 62.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.447 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -50.26 -41.97 51.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.5 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.508 ' HA ' HG22 ' A' ' 21' ' ' VAL . 65.4 t -71.91 -53.99 18.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 0.0 110.763 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp -59.07 -14.54 10.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.169 0.509 . . . . 0.0 110.21 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.9 m -92.49 -39.22 11.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.302 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -62.31 -40.95 98.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.445 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.433 ' HB2' HG12 ' A' ' 76' ' ' ILE . 90.5 m-85 -89.17 11.9 17.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.591 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 57.4 24.23 9.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.567 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.689 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.9 mm -61.0 119.9 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.9 p -138.23 52.66 1.83 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.421 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.95 48.15 0.01 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.799 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.624 ' HB2' HG21 ' A' ' 99' ' ' ILE . 21.4 m-80 49.71 43.69 24.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.119 0.485 . . . . 0.0 110.477 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.689 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.5 m -69.55 153.3 43.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.838 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.59 HG12 ' HA2' ' A' ' 37' ' ' GLY . 56.0 mt -118.83 119.41 60.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.84 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.472 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 75.5 m -108.2 135.4 49.59 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.595 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -112.85 105.65 13.8 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.196 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.9 t80 -98.33 122.06 41.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.315 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.472 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 5.4 mtm180 -104.29 81.12 1.78 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.757 0.313 . . . . 0.0 110.894 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 85' ' ' ARG . 9.4 tp -25.18 -56.72 0.06 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.809 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.507 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.58 -68.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.991 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -91.16 13.63 16.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.057 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 43.99 30.88 0.45 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.161 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 7.6 mm-40 -78.02 160.8 27.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.323 . . . . 0.0 110.674 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.81 95.14 2.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.974 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.595 HD23 ' HG ' ' A' ' 83' ' ' LEU . 1.8 mm? -83.02 143.2 30.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -123.82 93.68 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.548 HD21 HD13 ' A' ' 102' ' ' ILE . 4.9 tt -76.91 77.86 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.5 mt-10 -78.55 -165.7 0.75 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 19.0 t70 -51.2 -35.44 36.47 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.695 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.29 -17.4 4.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.237 0.541 . . . . 0.0 110.24 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -128.73 -13.87 4.65 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.668 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.624 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.4 mm -88.69 -32.08 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 120.593 0.235 . . . . 0.0 111.591 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.6 -36.23 64.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.103 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.6 m -132.41 38.56 3.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.465 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.548 HD13 HD21 ' A' ' 94' ' ' LEU . 7.0 tp -63.05 142.48 16.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.687 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -136.12 149.03 48.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.349 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.891 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.36 -37.54 11.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.982 0.42 . . . . 0.0 110.641 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.4 m -61.74 -47.17 86.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.363 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -59.95 -60.46 3.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.27 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.767 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.72 -56.04 9.72 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.03 0.443 . . . . 0.0 110.303 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.7 m -58.28 -30.97 67.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.914 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.501 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.7 tmt_? -69.95 -65.8 0.68 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.235 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -42.87 -45.02 4.77 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.164 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.472 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -61.55 -55.03 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -54.79 -18.62 4.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.395 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.501 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.88 -36.47 8.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.875 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.443 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.2 m120 -124.88 30.43 5.91 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.4 p -83.21 42.05 0.79 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.972 0.415 . . . . 0.0 110.286 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.461 HD12 ' NH1' ' A' ' 85' ' ' ARG . 81.5 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.382 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.0 pt-20 . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.546 0.212 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.0 Cg_endo -66.09 143.53 72.16 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.7 2.267 . . . . 0.0 112.504 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.0 m -58.38 149.49 24.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.65 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -97.34 85.76 3.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.627 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.621 HD22 ' HA ' ' A' ' 24' ' ' ALA . 39.0 mt -82.14 73.22 9.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.546 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.5 p -71.77 -2.06 16.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.339 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -141.5 147.35 37.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 111.696 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.598 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 58.6 t -55.37 -49.92 89.73 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.602 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.7 Cg_endo -57.85 -45.26 33.89 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.849 1.699 . . . . 0.0 112.066 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.54 78.4 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.132 0.491 . . . . 0.0 110.416 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.621 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.6 -59.24 4.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.98 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 60.4 mtp -60.99 -26.54 67.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.04 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 18.7 mt-10 -71.25 -49.27 44.91 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.657 0.265 . . . . 0.0 110.333 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.549 ' O ' HG22 ' A' ' 31' ' ' THR . 4.3 m-85 -60.34 -34.27 73.59 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.584 HD11 HD12 ' A' ' 36' ' ' ILE . 51.4 mt -72.96 -38.31 55.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.292 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.17 -17.9 60.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.09 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.86 27.27 4.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.287 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.62 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.3 t -169.49 152.37 4.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.453 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.598 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.5 tt0 -64.65 -64.97 0.74 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.912 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.527 HG13 HD11 ' A' ' 83' ' ' LEU . 21.8 t -108.33 137.4 40.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.491 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.87 126.99 21.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.945 0.403 . . . . 0.0 112.031 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.458 HG21 HG12 ' A' ' 111' ' ' ILE . 42.9 t -115.47 127.58 73.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.593 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.584 HD12 HD11 ' A' ' 28' ' ' ILE . 32.2 mt -134.15 138.78 49.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.572 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.568 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.49 98.42 1.69 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.562 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.446 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.0 m-85 -84.98 92.77 8.41 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.4 m-85 -111.56 147.48 35.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.541 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.417 ' HG2' HD23 ' A' ' 71' ' ' LEU . 89.0 mt-30 -94.51 -9.89 33.94 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.531 ' O ' HG12 ' A' ' 44' ' ' ILE . 37.5 t70 -147.17 117.41 7.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.397 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.572 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.3 mt -87.35 45.26 1.25 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.127 0.489 . . . . 0.0 111.506 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.1 mt-10 -136.13 10.88 3.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.114 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.806 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.5 pt -94.29 155.04 40.27 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.132 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.484 ' O ' HD12 ' A' ' 49' ' ' ILE . 88.2 Cg_exo -48.88 -28.51 13.32 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.936 2.424 . . . . 0.0 113.091 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.806 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.9 -37.9 88.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.677 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.9 t -61.38 -56.35 34.52 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.604 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.677 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.2 Cg_exo -60.86 -41.87 42.14 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.822 1.682 . . . . 0.0 111.416 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.884 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -60.4 -34.94 59.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.038 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.61 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.8 tp -73.92 -52.39 13.06 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -52.79 -27.1 16.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.065 0.46 . . . . 0.0 109.772 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.6 m -80.12 -46.84 15.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.722 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.575 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.11 -26.04 64.34 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.194 0.521 . . . . 0.0 109.639 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.2 t -52.83 -51.12 39.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.89 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -75.24 -10.42 59.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.75 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.2 mtpp -93.51 -18.25 22.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.253 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.607 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 55.3 m-85 -136.81 62.53 41.5 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.488 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.65 -41.14 70.82 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.592 2.195 . . . . 0.0 111.627 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.72 -39.44 93.59 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.321 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.607 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -69.12 144.25 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.62 ' HB2' HG21 ' A' ' 31' ' ' THR . 41.3 t -81.96 98.29 8.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.985 0.421 . . . . 0.0 111.013 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.479 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.2 p90 -63.53 128.92 37.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.854 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.509 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.15 161.36 28.46 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.261 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.9 tt -162.6 145.12 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.446 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.0 t -152.46 157.72 41.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.195 0.522 . . . . 0.0 111.787 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.457 HG21 ' HG ' ' A' ' 42' ' ' LEU . 67.5 p -138.03 -3.39 1.8 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.626 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.4 139.73 58.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.415 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.4 m -63.69 -49.09 74.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.54 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -50.57 -41.14 53.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.489 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.582 ' HA ' HG22 ' A' ' 21' ' ' VAL . 56.6 t -73.49 -54.98 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 110.685 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.417 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.0 mp -57.66 -14.52 5.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.367 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 83.2 m -92.44 -42.33 9.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.286 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -60.53 -34.76 74.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.59 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.437 ' HB2' HG12 ' A' ' 76' ' ' ILE . 96.7 m-85 -95.88 10.17 38.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.693 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.0 m120 56.63 27.43 12.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.755 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.711 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.6 mm -63.87 122.23 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.867 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.5 p -141.72 54.77 1.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.911 0.386 . . . . 0.0 111.322 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.49 44.03 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.753 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.593 ' HB2' HG21 ' A' ' 99' ' ' ILE . 19.8 m-80 51.79 41.97 29.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.338 0.589 . . . . 0.0 110.251 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.711 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.8 m -67.64 151.55 47.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.703 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.568 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.3 mt -118.28 116.22 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.869 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 73.0 m -104.14 129.94 51.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.644 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.2 tp -107.01 100.34 9.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.507 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.6 t80 -94.67 122.81 37.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.532 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.7 mtm180 -107.13 92.78 4.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.363 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 tp -37.81 -53.52 1.28 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.009 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.598 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.59 -58.22 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -102.84 9.64 38.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.002 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 85' ' ' ARG . 16.0 t-20 47.2 34.44 3.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.423 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.532 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 15.8 mm-40 -77.48 159.46 29.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.87 91.21 2.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.914 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.644 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.5 mm? -81.97 115.27 21.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.847 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.81 98.63 9.41 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.499 HD21 HD13 ' A' ' 102' ' ' ILE . 4.3 tt -83.77 77.63 9.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.461 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.3 mt-10 -77.87 -165.64 0.67 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.548 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 20.6 t70 -51.21 -37.89 49.28 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.117 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -55.55 -15.18 2.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.059 0.457 . . . . 0.0 110.437 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -128.38 -14.2 4.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.394 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.593 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.7 mm -90.18 -29.26 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.889 0.376 . . . . 0.0 111.321 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -56.13 -38.05 70.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 85.4 p -129.98 36.07 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.582 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.2 tp -62.05 141.98 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.597 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -136.89 150.34 48.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.533 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.884 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.74 -37.72 13.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.903 0.382 . . . . 0.0 110.584 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -62.73 -47.94 81.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.303 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -58.8 -60.27 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.199 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.765 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.13 -56.58 8.72 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.965 0.412 . . . . 0.0 110.191 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.7 m -58.07 -28.87 64.95 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.947 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.51 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.2 tmt_? -72.42 -67.0 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.077 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -42.37 -41.36 2.83 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.103 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 35' ' ' VAL . 96.6 mt -65.49 -55.68 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -53.27 -18.68 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.187 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.51 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.5 mp -89.99 -39.38 12.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.918 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.449 ' OD1' HG22 ' A' ' 113' ' ' ILE . 26.3 m120 -116.39 26.77 9.66 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 78.7 p -81.56 52.59 1.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.174 0.511 . . . . 0.0 110.216 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.447 HD12 HH12 ' A' ' 85' ' ' ARG . 70.8 mt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.032 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.483 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 . . . . . 0 CA--C 1.532 0.251 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 53.6 Cg_endo -69.46 136.34 33.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.365 2.044 . . . . 0.0 112.685 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.9 m -60.7 152.43 26.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.676 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -94.01 98.54 11.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.94 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.1 mt -93.05 70.71 4.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.265 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.9 p -70.54 -2.15 13.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.165 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -139.7 146.87 40.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.021 0.439 . . . . 0.0 111.64 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 43.4 t -56.82 -50.08 90.1 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.396 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.41 -43.89 42.46 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.945 1.763 . . . . 0.0 111.878 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.28 -36.99 85.91 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.223 0.535 . . . . 0.0 110.305 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.602 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.84 -57.07 12.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.04 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 62.1 mtp -62.59 -26.74 68.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.117 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.32 -50.76 35.91 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.726 0.298 . . . . 0.0 110.464 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.478 ' O ' HG22 ' A' ' 31' ' ' THR . 12.2 m-85 -61.46 -32.54 72.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.513 HD11 HD12 ' A' ' 36' ' ' ILE . 47.7 mt -72.9 -36.86 52.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.836 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.7 -20.33 59.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.022 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.94 28.33 1.86 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.162 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.75 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.8 t -172.3 154.63 3.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.475 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.545 ' HG3' HG13 ' A' ' 87' ' ' VAL . 30.1 tt0 -68.0 -59.9 2.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.012 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.529 HG13 HD11 ' A' ' 83' ' ' LEU . 20.6 t -110.26 138.26 38.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.495 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.78 127.16 17.73 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.453 HG21 HG12 ' A' ' 111' ' ' ILE . 48.6 t -116.05 130.3 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.586 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.513 HD12 HD11 ' A' ' 28' ' ' ILE . 25.4 mt -135.94 137.59 48.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.456 -177.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.94 99.43 2.05 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.443 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 10.8 m-85 -85.67 93.99 8.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.4 m-85 -115.09 141.48 47.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -88.95 -2.24 58.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.465 ' O ' HG12 ' A' ' 44' ' ' ILE . 25.1 t70 -155.81 123.06 5.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.636 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.55 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.6 mt -92.62 46.15 1.23 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.136 0.493 . . . . 0.0 111.475 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.417 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 38.3 mt-10 -135.19 8.06 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.921 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.755 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.0 pt -90.82 155.51 45.32 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.186 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.506 ' O ' HD12 ' A' ' 49' ' ' ILE . 77.2 Cg_exo -50.75 -27.12 19.17 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.87 2.38 . . . . 0.0 112.942 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.755 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.6 -37.86 88.94 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.673 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -61.88 -56.0 36.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.773 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.5 Cg_exo -60.47 -37.01 84.08 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 121.9 1.733 . . . . 0.0 111.435 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.875 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -65.75 -35.43 75.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.941 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.4 tp -74.31 -51.85 13.98 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -55.86 -22.21 24.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.979 0.419 . . . . 0.0 109.922 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.6 t -85.59 -44.63 12.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.372 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.615 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.24 -26.03 67.47 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.226 0.536 . . . . 0.0 109.593 179.337 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 50' ' ' LEU . 44.9 t -51.61 -48.98 35.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.009 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -74.44 -14.84 60.9 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.566 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -90.35 -17.71 26.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.357 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.583 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 65.6 m-85 -137.14 61.82 35.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.699 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.47 -43.52 56.85 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.645 2.23 . . . . 0.0 111.611 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.58 -42.29 90.2 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.422 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.583 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.1 t -65.97 141.71 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.75 ' HB2' HG21 ' A' ' 31' ' ' THR . 41.2 t -78.37 97.71 5.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.081 0.467 . . . . 0.0 110.816 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.496 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.5 p90 -67.9 124.64 23.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.914 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.459 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -143.51 164.13 27.41 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.041 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.7 tt -161.2 142.14 3.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 t -147.23 153.35 39.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.161 0.505 . . . . 0.0 111.794 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.457 HG21 ' HG ' ' A' ' 42' ' ' LEU . 77.8 p -135.05 2.73 3.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.432 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.84 140.67 49.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.705 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.0 t -64.03 -49.97 70.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.531 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -50.76 -44.46 58.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.602 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.556 ' HA ' HG22 ' A' ' 21' ' ' VAL . 54.5 t -70.24 -52.1 33.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.891 0.377 . . . . 0.0 110.598 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.52 -15.08 15.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.253 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.1 m -90.93 -41.23 11.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.32 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -61.63 -37.84 85.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.389 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.41 ' HB2' HG12 ' A' ' 76' ' ' ILE . 45.3 m-85 -92.08 11.69 24.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.805 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 56.02 23.03 6.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.689 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.671 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.7 mm -57.94 117.28 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.83 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.1 p -136.51 56.4 1.81 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.387 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.28 46.32 0.02 OUTLIER Glycine 0 C--N 1.329 0.174 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.628 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.595 ' HB2' HG21 ' A' ' 99' ' ' ILE . 16.4 m-80 51.43 43.62 29.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.162 0.506 . . . . 0.0 110.277 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.671 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.3 m -69.08 154.75 41.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.675 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.592 HG12 ' HA2' ' A' ' 37' ' ' GLY . 52.9 mt -120.65 117.55 53.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.817 178.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.513 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.2 m -106.7 135.9 47.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.674 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -112.85 101.64 9.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.064 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.6 t80 -95.05 125.18 39.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.772 0.32 . . . . 0.0 110.334 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.519 HH12 HD12 ' A' ' 116' ' ' LEU . 5.3 mtm180 -107.75 83.65 1.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.825 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 85' ' ' ARG . 9.0 tp -24.67 -59.15 0.06 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.789 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.545 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.85 -77.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 O-C-N 123.5 0.5 . . . . 0.0 112.127 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.55 4.32 21.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.636 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.2 m120 53.8 31.43 13.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.522 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.1 mm-40 -74.46 161.49 29.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -145.94 86.91 1.73 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.862 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.674 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -74.25 144.84 44.47 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -128.25 98.28 5.03 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.528 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -84.64 78.28 9.88 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.0 mt-10 -79.02 -165.61 0.78 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.518 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.8 t70 -50.23 -38.62 41.43 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.03 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -55.06 -14.9 1.74 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.119 0.485 . . . . 0.0 110.492 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -130.1 -13.94 3.96 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.664 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.595 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.5 mm -88.49 -31.86 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.636 0.255 . . . . 0.0 111.614 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -56.43 -35.29 67.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.952 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.5 m -130.31 39.77 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.558 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.528 HD13 HD21 ' A' ' 94' ' ' LEU . 7.2 tp -68.25 142.08 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.754 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -136.04 149.69 48.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.391 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.875 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.63 -35.87 10.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.127 0.489 . . . . 0.0 110.445 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.8 m -62.59 -48.61 78.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.42 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -59.4 -59.76 4.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.256 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.775 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.34 -55.48 12.72 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 110.301 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.5 m -58.92 -30.59 67.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.999 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.494 ' HD3' HD13 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -70.83 -66.25 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.138 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -43.15 -43.58 4.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.119 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.453 HG12 HG21 ' A' ' 35' ' ' VAL . 96.8 mt -63.8 -55.43 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -54.12 -17.59 2.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.129 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.494 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -90.69 -37.22 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.01 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.448 ' O ' HD21 ' A' ' 83' ' ' LEU . 14.9 m120 -122.63 29.96 6.67 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 98.7 p -83.26 40.55 0.72 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.091 0.472 . . . . 0.0 110.1 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.519 HD12 HH12 ' A' ' 85' ' ' ARG . 58.2 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.422 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.595 0.236 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 45.0 Cg_endo -69.7 148.15 64.8 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.773 2.315 . . . . 0.0 112.756 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 m -66.25 150.13 49.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.527 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -96.51 90.64 5.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.999 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 37.1 mt -86.12 71.49 10.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.567 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.8 p -70.68 -1.96 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.081 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -141.57 147.07 37.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.919 0.39 . . . . 0.0 111.7 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 59.3 t -55.79 -49.85 90.52 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.491 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.4 Cg_endo -57.55 -44.91 37.65 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.89 1.727 . . . . 0.0 111.937 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.84 -34.46 78.43 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.226 0.536 . . . . 0.0 110.353 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.46 -59.41 4.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.174 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.1 mtm -61.48 -26.96 68.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.049 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -70.77 -49.26 48.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.638 0.256 . . . . 0.0 110.51 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.465 ' O ' HG22 ' A' ' 31' ' ' THR . 6.2 m-85 -61.48 -32.88 72.91 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.49 HD11 ' CD1' ' A' ' 36' ' ' ILE . 42.8 mt -72.08 -37.99 61.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.828 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.76 -23.62 61.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.837 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.93 32.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.138 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.615 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.8 t -173.47 151.31 1.94 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.346 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.521 ' HG3' HG13 ' A' ' 87' ' ' VAL . 30.0 tt0 -68.31 -53.45 24.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.749 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.509 HG13 HD11 ' A' ' 83' ' ' LEU . 21.5 t -116.58 139.83 41.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.413 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.15 126.78 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.488 HG21 HG12 ' A' ' 111' ' ' ILE . 43.7 t -115.61 125.99 73.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.404 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.49 ' CD1' HD11 ' A' ' 28' ' ' ILE . 28.2 mt -131.39 136.26 57.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -177.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.597 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.08 98.33 1.88 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.267 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.5 m-85 -84.12 93.27 8.1 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -113.62 142.88 45.45 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.42 ' HG2' HD23 ' A' ' 71' ' ' LEU . 74.0 mt-30 -90.47 -9.25 48.08 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.514 ' O ' HG12 ' A' ' 44' ' ' ILE . 30.2 t70 -147.72 119.28 7.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.55 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.536 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.3 mt -88.9 45.49 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.096 0.474 . . . . 0.0 111.413 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.433 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.9 mt-10 -135.65 7.94 3.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.107 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.731 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.5 pt -89.87 157.03 46.69 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.158 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' HD12 ' A' ' 49' ' ' ILE . 74.0 Cg_exo -51.84 -25.98 22.86 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.792 2.328 . . . . 0.0 112.824 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.731 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.87 -39.04 92.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 44' ' ' ILE . 2.1 t -60.38 -55.12 48.26 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.608 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.4 Cg_exo -60.56 -42.0 43.56 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.879 1.719 . . . . 0.0 111.371 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.898 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -60.62 -35.45 63.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.046 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.605 ' O ' HG23 ' A' ' 54' ' ' VAL . 50.9 tp -73.81 -50.09 22.15 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -55.81 -25.27 40.71 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.8 m -81.56 -45.77 15.4 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.595 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.609 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.22 -25.82 67.32 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.114 0.483 . . . . 0.0 109.748 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 50' ' ' LEU . 42.8 t -52.16 -47.77 43.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.084 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -76.94 -14.29 59.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.668 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -90.8 -16.58 28.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.389 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.671 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 34.3 m-85 -136.99 61.42 34.52 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.606 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.39 -39.56 81.25 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.636 2.224 . . . . 0.0 111.592 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.98 -41.16 99.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.519 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.9 t -67.12 145.23 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.615 ' CB ' HG21 ' A' ' 31' ' ' THR . 46.6 t -82.31 96.56 7.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.984 0.421 . . . . 0.0 110.999 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.496 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 4.7 p90 -62.1 128.24 35.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.612 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.5 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.2 161.46 28.32 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.826 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.407 HD11 HG13 ' A' ' 47' ' ' VAL . 5.5 tt -164.02 140.73 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.2 t -144.45 159.33 42.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.227 0.537 . . . . 0.0 111.959 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 39' ' ' PHE . 76.2 p -141.18 -0.0 1.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.314 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -71.28 144.4 50.01 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.602 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.8 p -65.66 -50.96 63.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.392 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -49.96 -41.8 47.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.616 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.563 ' HA ' HG22 ' A' ' 21' ' ' VAL . 70.9 t -72.45 -54.08 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.841 0.353 . . . . 0.0 110.712 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.42 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.3 mp -59.0 -14.74 10.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.35 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.6 m -91.67 -42.0 10.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.258 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -60.52 -38.97 86.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.356 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.413 ' HB2' HG12 ' A' ' 76' ' ' ILE . 43.6 m-85 -91.15 9.61 30.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.763 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.8 m120 57.24 24.68 10.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.592 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.673 HG23 ' HB ' ' A' ' 80' ' ' THR . 42.0 mm -59.27 125.24 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.9 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.0 p -143.86 60.31 1.37 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.529 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.87 45.51 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.542 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.616 ' HB2' HG21 ' A' ' 99' ' ' ILE . 29.6 m-80 51.63 41.87 29.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.236 0.541 . . . . 0.0 110.385 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.673 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.2 m -67.65 152.22 45.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.747 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.597 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.1 mt -119.56 116.83 51.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.835 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.497 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 71.2 m -106.31 136.58 45.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.655 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -109.73 100.91 9.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.196 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.5 t80 -92.99 119.88 32.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.434 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.471 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.5 mtm180 -104.25 85.21 2.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.973 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 tp -26.97 -61.28 0.09 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.521 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.1 -76.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 O-C-N 123.525 0.516 . . . . 0.0 112.056 -179.42 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.48 3.12 25.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.098 0.475 . . . . 0.0 110.533 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.405 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 12.3 t30 52.65 31.84 10.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.299 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 19.6 mm-40 -75.28 165.96 24.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.533 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -149.68 87.55 1.5 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.655 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -72.04 147.22 47.04 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.85 105.72 8.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.292 0.568 . . . . 0.0 112.302 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.561 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -94.05 76.45 4.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.0 mt-10 -77.61 -165.88 0.68 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.492 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.63 -51.9 11.51 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.524 -179.368 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -47.28 -17.56 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.868 0.366 . . . . 0.0 111.301 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -124.39 -13.92 7.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.423 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.616 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.8 mm -91.48 -40.25 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -51.71 -30.38 22.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.821 0.343 . . . . 0.0 111.29 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m -134.67 39.98 2.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.079 0.466 . . . . 0.0 110.395 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.561 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -68.48 143.93 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.712 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.409 ' H ' ' HD3' ' A' ' 106' ' ' LYS . 23.7 m-20 -136.32 147.89 47.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.437 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.898 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.69 -38.69 10.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.017 0.437 . . . . 0.0 110.542 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 98.8 m -59.51 -49.32 78.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.323 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 103' ' ' ASP . 51.1 mtpt -57.87 -62.6 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.274 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.76 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -46.64 -57.53 4.71 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.945 0.403 . . . . 0.0 110.446 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.9 m -57.74 -29.88 65.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.931 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.509 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.0 tmt_? -71.4 -65.85 0.7 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.237 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -42.64 -43.61 3.9 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.993 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.488 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -63.25 -55.98 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.617 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -54.15 -18.36 3.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.362 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.509 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.91 -37.47 10.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.84 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.478 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.6 m120 -125.45 31.21 5.6 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 98.2 p -83.9 44.51 1.0 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.122 0.487 . . . . 0.0 110.074 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.443 HD12 HH12 ' A' ' 85' ' ' ARG . 65.4 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.352 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.2 pt-20 . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.358 0.123 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.484 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 36.3 Cg_endo -67.13 140.55 54.34 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.444 2.096 . . . . 0.0 112.494 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.0 m -54.8 152.03 7.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.748 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -98.98 87.11 3.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.079 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.618 HD22 ' HA ' ' A' ' 24' ' ' ALA . 45.8 mt -84.85 72.57 10.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.344 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.0 p -71.67 0.19 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.445 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -144.67 148.29 34.07 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.752 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 45.2 t -55.3 -49.57 91.62 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.528 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.28 -46.53 24.38 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.922 1.748 . . . . 0.0 111.9 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.88 -33.06 74.84 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.11 0.481 . . . . 0.0 110.324 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.618 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -65.83 -59.03 4.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.939 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.6 mtm -61.0 -25.39 66.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.054 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.4 mt-10 -72.97 -52.01 16.18 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.684 0.278 . . . . 0.0 110.499 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.502 ' O ' HG22 ' A' ' 31' ' ' THR . 4.0 m-85 -58.49 -33.78 70.19 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.558 HD11 HD12 ' A' ' 36' ' ' ILE . 57.9 mt -73.84 -40.76 53.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.261 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.98 -15.22 62.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.174 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.29 23.74 7.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.643 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.4 t -169.88 153.68 4.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.737 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.7 tt0 -63.35 -74.95 0.09 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.816 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.548 HG13 HD11 ' A' ' 83' ' ' LEU . 15.7 t -97.75 135.9 30.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.784 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.512 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.91 124.07 16.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.948 0.404 . . . . 0.0 111.904 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 111' ' ' ILE . 45.8 t -112.44 130.38 66.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.785 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 28' ' ' ILE . 29.1 mt -135.75 138.63 47.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.611 -177.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.551 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.03 98.13 1.77 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.543 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.476 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 35.9 m-85 -83.84 91.63 7.59 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.3 m-85 -111.75 141.08 45.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.3 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.429 ' HG2' HD23 ' A' ' 71' ' ' LEU . 88.2 mt-30 -86.08 -10.19 55.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 44' ' ' ILE . 9.8 t70 -148.53 129.35 14.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.561 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.501 ' HA ' HG21 ' A' ' 47' ' ' VAL . 90.1 mt -96.97 48.4 1.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.077 0.465 . . . . 0.0 111.475 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -137.9 7.29 2.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.771 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.713 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.7 pt -88.58 159.2 47.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.129 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.481 ' O ' HD12 ' A' ' 49' ' ' ILE . 54.4 Cg_exo -54.47 -24.91 37.86 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.864 2.376 . . . . 0.0 112.816 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.713 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.9 -39.01 90.22 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.702 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -59.34 -55.08 49.8 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.3 Cg_exo -60.37 -41.84 46.45 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.01 1.807 . . . . 0.0 111.505 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.892 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.5 mt -61.68 -34.42 62.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.103 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.614 ' O ' HG23 ' A' ' 54' ' ' VAL . 52.0 tp -75.09 -51.85 12.49 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -54.32 -24.92 21.15 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -82.08 -46.13 14.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.593 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.609 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.43 -25.52 66.03 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.9 t -52.39 -48.18 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.081 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -78.11 -9.96 59.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.83 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -93.9 -19.15 21.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.304 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.608 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 51.3 m-85 -135.83 62.91 49.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.56 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.82 -43.9 48.48 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.829 2.352 . . . . 0.0 111.644 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.08 -40.71 91.86 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.497 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.3 t -67.57 142.51 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.643 ' HB2' HG21 ' A' ' 31' ' ' THR . 32.2 t -81.44 97.68 7.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.055 0.455 . . . . 0.0 110.976 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.484 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.6 p90 -65.03 128.14 34.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.786 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.84 163.0 28.6 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.8 -0.715 . . . . 0.0 111.937 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 tt -161.68 144.26 3.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.476 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 40.7 t -148.52 156.33 42.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.131 0.491 . . . . 0.0 111.581 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.471 HG21 ' HG ' ' A' ' 42' ' ' LEU . 69.6 p -138.24 5.93 2.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.783 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -76.2 141.19 41.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.632 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.9 t -63.77 -50.35 69.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.396 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -49.68 -43.29 47.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.405 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.544 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.0 t -71.14 -54.16 18.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.841 0.353 . . . . 0.0 110.745 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.429 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -58.23 -14.82 7.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.118 0.485 . . . . 0.0 110.211 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.4 m -91.17 -40.55 11.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.161 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -61.75 -33.02 73.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.149 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.432 ' HB2' HG12 ' A' ' 76' ' ' ILE . 68.2 m-85 -97.35 9.15 43.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.959 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 58.88 22.78 10.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.506 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.709 HD12 ' HB ' ' A' ' 80' ' ' THR . 41.0 mm -59.13 125.61 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.266 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.6 p -144.44 58.69 1.33 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.29 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.57 43.94 0.02 OUTLIER Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.664 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.617 ' HB2' HG21 ' A' ' 99' ' ' ILE . 32.5 m-20 52.37 44.75 29.55 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.285 0.564 . . . . 0.0 110.435 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.709 ' HB ' HD12 ' A' ' 76' ' ' ILE . 89.8 m -69.96 152.31 44.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.913 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.551 HG12 ' HA2' ' A' ' 37' ' ' GLY . 59.5 mt -117.72 116.99 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-N 115.496 -0.775 . . . . 0.0 108.979 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.436 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 75.7 m -106.22 133.65 50.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.631 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -110.34 105.41 14.42 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.077 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.2 t80 -97.22 122.12 39.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.697 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.491 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.3 mtm180 -105.04 81.94 1.79 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 110.552 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.7 tp -25.71 -58.73 0.07 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.026 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.539 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -44.26 -57.25 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.136 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.59 13.52 33.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.592 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 43.8 28.81 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.301 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 15.9 mm-40 -77.79 156.98 30.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.745 0.307 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.83 95.33 2.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.567 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.631 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -84.9 116.14 23.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.959 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.18 108.89 21.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.586 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -95.01 77.62 3.55 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.436 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.4 mt-10 -78.72 -165.09 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.531 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 17.2 t70 -50.26 -39.9 46.4 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.249 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -53.91 -15.88 1.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.132 0.492 . . . . 0.0 110.229 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -128.96 -13.68 4.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.58 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.617 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.5 mm -91.01 -40.04 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -51.55 -33.82 33.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.935 0.398 . . . . 0.0 111.044 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.1 m -131.39 40.0 3.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.372 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.586 HD13 HD21 ' A' ' 94' ' ' LEU . 8.0 tp -68.89 144.91 13.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.658 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -138.59 146.95 42.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.257 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.892 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.09 -36.17 5.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.967 0.413 . . . . 0.0 110.694 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 100.0 m -62.24 -48.18 81.1 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.489 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -59.32 -61.29 2.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.055 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.752 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.91 -55.88 8.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.974 0.416 . . . . 0.0 110.332 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.9 m -58.44 -30.61 67.04 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.922 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.536 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.7 tmt_? -71.06 -66.08 0.66 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.245 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -42.98 -41.9 3.56 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.243 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.475 HG12 HG21 ' A' ' 35' ' ' VAL . 97.0 mt -65.11 -55.14 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -53.94 -18.85 3.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.14 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.536 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.75 -37.95 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.827 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.485 ' OD1' HG22 ' A' ' 113' ' ' ILE . 31.6 m120 -119.86 28.6 8.02 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.8 p -82.81 48.0 1.28 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.075 0.464 . . . . 0.0 110.484 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.43 HD12 ' NH1' ' A' ' 85' ' ' ARG . 78.1 mt . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.246 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.485 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.48 0.181 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 49.9 Cg_endo -70.37 144.91 52.15 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.664 2.243 . . . . 0.0 112.762 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.3 m -63.46 150.7 43.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.631 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -96.26 97.86 9.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.015 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 54.9 mt -92.93 70.91 4.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.318 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.8 p -71.74 -2.25 16.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.136 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -139.32 146.7 40.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.058 0.456 . . . . 0.0 111.509 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 13.1 t -56.43 -50.42 87.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.471 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.74 -45.28 34.19 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.831 1.688 . . . . 0.0 111.856 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.31 79.87 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.198 0.523 . . . . 0.0 110.309 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.07 -59.26 4.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.988 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.1 mtm -60.63 -25.39 66.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.202 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 26.3 mt-10 -73.38 -51.39 17.51 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.728 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.546 ' O ' HG22 ' A' ' 31' ' ' THR . 9.1 m-85 -60.04 -31.67 70.18 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.561 HD11 HD12 ' A' ' 36' ' ' ILE . 48.8 mt -75.21 -39.85 43.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.127 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.58 -18.14 61.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.266 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.33 24.97 5.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.31 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.631 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.2 t -168.44 152.75 6.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.677 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.533 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.5 tt0 -62.82 -77.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.895 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.561 HG13 HD11 ' A' ' 83' ' ' LEU . 19.5 t -95.73 135.27 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.397 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.565 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.76 125.77 21.23 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.457 HG22 ' HB2' ' A' ' 83' ' ' LEU . 49.3 t -115.41 129.73 71.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.789 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.561 HD12 HD11 ' A' ' 28' ' ' ILE . 23.0 mt -135.45 137.19 50.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.446 -177.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.77 96.91 1.63 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.294 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.508 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 19.5 m-85 -82.51 89.02 6.61 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -107.44 137.71 44.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.473 ' HG2' HD23 ' A' ' 71' ' ' LEU . 90.8 mt-30 -83.83 -5.0 59.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.432 ' O ' HG12 ' A' ' 44' ' ' ILE . 27.0 t70 -155.41 127.71 7.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.529 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.562 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.5 mt -95.34 46.91 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 111.68 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.425 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.8 mt-10 -135.85 5.08 3.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.612 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.809 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.2 pt -88.84 157.39 48.95 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.296 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' HD12 ' A' ' 49' ' ' ILE . 74.6 Cg_exo -52.8 -27.96 36.53 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.914 2.409 . . . . 0.0 112.958 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.809 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.27 -37.21 84.6 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.654 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.2 t -62.21 -56.94 26.4 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.525 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.654 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.8 Cg_exo -58.64 -40.9 69.34 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.758 1.639 . . . . 0.0 111.448 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.888 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.8 mt -61.37 -37.16 77.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.572 ' O ' HG23 ' A' ' 54' ' ' VAL . 37.9 tp -73.46 -53.82 9.74 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -53.1 -23.25 7.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.098 0.475 . . . . 0.0 110.081 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.2 m -83.92 -45.5 13.12 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.467 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.596 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.03 -25.2 65.13 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.8 t -52.33 -48.05 45.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.992 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -77.85 -11.17 59.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.797 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -93.08 -17.91 23.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.235 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.587 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 57.0 m-85 -137.57 62.53 36.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.558 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.63 -42.73 60.43 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.612 2.208 . . . . 0.0 111.708 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.76 -40.49 92.93 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.509 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.587 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.7 t -66.57 143.9 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.631 ' HB2' HG21 ' A' ' 31' ' ' THR . 30.5 t -81.42 97.12 7.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 0.0 110.994 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.472 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.8 p90 -64.82 127.13 30.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.965 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.481 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.09 162.84 28.39 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.029 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.415 HD11 HG13 ' A' ' 47' ' ' VAL . 4.6 tt -160.96 142.36 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.2 t -145.5 154.04 41.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.983 0.421 . . . . 0.0 111.691 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.452 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.4 p -137.52 -4.41 1.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.884 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.42 142.84 56.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.771 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.2 t -64.5 -50.58 66.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.511 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -49.02 -45.45 42.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.658 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 21' ' ' VAL . 77.8 t -70.59 -52.4 29.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.917 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.473 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -59.05 -14.85 10.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.122 0.487 . . . . 0.0 110.135 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.1 m -91.17 -41.38 11.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.394 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -60.97 -40.07 92.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.455 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.415 ' HB2' HG12 ' A' ' 76' ' ' ILE . 64.3 m-85 -90.24 11.82 20.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.576 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.6 m120 55.98 24.17 7.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.494 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.675 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.9 mm -60.83 120.08 5.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.4 p -138.68 52.37 1.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.419 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.27 46.49 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.64 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.605 ' HB2' HG21 ' A' ' 99' ' ' ILE . 28.3 m-80 50.77 42.01 27.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.177 0.513 . . . . 0.0 110.29 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.675 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.3 m -68.07 150.38 48.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.68 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.584 HG12 ' HA2' ' A' ' 37' ' ' GLY . 69.4 mt -116.79 116.94 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.984 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.508 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.4 m -106.64 132.14 52.98 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.652 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -109.08 105.37 14.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.979 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.5 t80 -98.62 121.07 40.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.498 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.532 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.1 mtm180 -102.85 80.71 1.91 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.711 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 6.1 tp -25.11 -58.46 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.533 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.35 -59.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.199 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -97.11 2.9 51.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.045 0.45 . . . . 0.0 110.82 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 52.77 32.58 12.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.817 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 13.0 mm-40 -77.93 156.99 29.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.663 0.268 . . . . 0.0 110.805 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 91' ' ' GLN . 1.1 tm0? -140.18 96.23 3.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.601 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.652 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -88.13 114.47 24.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.804 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -97.65 99.69 11.07 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.605 HD21 HD13 ' A' ' 102' ' ' ILE . 4.4 tt -84.24 77.45 9.97 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.2 mt-10 -78.11 -165.61 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -176.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.72 -49.9 14.25 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.548 -179.515 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -48.5 -15.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.929 0.395 . . . . 0.0 111.291 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 96' ' ' ASP . 22.1 m-20 -127.33 -13.9 5.45 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.498 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.605 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.9 mm -90.67 -37.24 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -49.04 -49.31 41.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.334 . . . . 0.0 111.127 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.0 m -118.0 35.6 4.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.778 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.605 HD13 HD21 ' A' ' 94' ' ' LEU . 8.1 tp -60.78 145.17 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.46 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -138.41 149.22 45.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.48 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.888 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.4 -36.22 14.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.035 0.445 . . . . 0.0 110.377 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.0 m -62.06 -49.62 75.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.286 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -58.18 -60.39 3.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.376 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.709 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -49.19 -55.99 10.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.964 0.411 . . . . 0.0 110.378 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.6 m -58.57 -28.87 65.94 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.726 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.527 ' NH1' HD11 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -72.25 -66.64 0.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.188 179.761 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -43.56 -41.99 4.81 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.065 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.407 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -64.72 -55.94 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.423 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 43.1 tt0 -52.95 -19.13 2.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.294 0.569 . . . . 0.0 110.265 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.527 HD11 ' NH1' ' A' ' 109' ' ' ARG . 1.4 mp -90.11 -38.56 11.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.062 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.486 ' OD1' HG22 ' A' ' 113' ' ' ILE . 28.9 m120 -117.72 27.12 9.23 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.2 p -81.32 50.12 1.39 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.083 0.468 . . . . 0.0 110.152 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.507 HD12 HH12 ' A' ' 85' ' ' ARG . 56.4 mt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.345 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.49 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 16.6 pt-20 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.521 0.201 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 38.1 Cg_endo -66.65 145.17 75.01 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.635 2.223 . . . . 0.0 112.564 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 17' ' ' TRP . 11.5 m -62.22 155.78 23.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.911 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.408 ' N ' HG22 ' A' ' 16' ' ' THR . 12.1 m-90 -99.53 86.94 3.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.719 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 24' ' ' ALA . 44.1 mt -83.04 73.83 10.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.047 0.451 . . . . 0.0 110.61 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.0 p -72.19 -0.82 12.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.356 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -143.0 148.26 36.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.917 0.389 . . . . 0.0 111.535 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.594 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 32.8 t -56.77 -50.52 87.52 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.434 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.61 -44.76 38.73 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.939 1.76 . . . . 0.0 111.832 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.33 -36.5 83.89 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.334 0.588 . . . . 0.0 110.183 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.609 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.91 -59.12 4.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.91 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.6 mtp -60.19 -24.98 65.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.095 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -72.57 -52.52 15.18 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.775 0.321 . . . . 0.0 110.558 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.479 ' O ' HG22 ' A' ' 31' ' ' THR . 13.0 m-85 -59.34 -31.41 69.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.519 HD11 HD12 ' A' ' 36' ' ' ILE . 55.3 mt -74.52 -39.37 47.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.175 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.29 -20.77 61.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.147 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.64 28.69 2.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.032 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.635 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.9 t -170.11 152.43 4.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.425 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.551 ' HG3' HG13 ' A' ' 87' ' ' VAL . 26.0 tt0 -66.76 -61.73 1.81 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.526 HG13 HD11 ' A' ' 83' ' ' LEU . 17.2 t -109.33 136.98 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.438 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.506 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.91 127.75 20.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.014 0.435 . . . . 0.0 112.116 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.435 ' C ' HG13 ' A' ' 36' ' ' ILE . 50.6 t -116.46 131.19 69.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.615 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.519 HD12 HD11 ' A' ' 28' ' ' ILE . 22.1 mt -136.45 135.34 49.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -177.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -97.32 98.03 2.06 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.539 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.524 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.9 m-85 -84.43 93.48 8.3 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.0 m-85 -114.3 142.14 46.69 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -89.97 -0.94 57.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' O ' HG12 ' A' ' 44' ' ' ILE . 37.8 t70 -156.26 122.47 5.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.707 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.52 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.1 mt -92.32 46.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.159 0.504 . . . . 0.0 111.293 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.435 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.5 mt-10 -136.91 7.5 2.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.005 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.779 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.7 pt -89.46 158.45 45.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.014 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.519 ' O ' HD12 ' A' ' 49' ' ' ILE . 66.1 Cg_exo -53.32 -26.23 33.97 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.781 2.321 . . . . 0.0 112.896 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.779 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.92 -37.64 88.32 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 44' ' ' ILE . 2.1 t -61.54 -55.66 40.63 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.616 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 36.6 Cg_exo -61.24 -37.82 70.72 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.067 1.845 . . . . 0.0 111.519 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.878 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.5 mt -65.24 -34.86 73.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.014 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.59 ' O ' HG23 ' A' ' 54' ' ' VAL . 45.4 tp -73.27 -52.34 14.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -52.81 -26.31 14.09 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -80.29 -47.59 14.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.7 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.566 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.8 -25.93 63.61 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.136 0.493 . . . . 0.0 109.684 179.6 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.2 t -53.23 -48.35 55.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.967 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -76.92 -10.06 59.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.635 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -94.1 -18.88 21.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.212 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.608 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 59.9 m-85 -136.82 62.84 43.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.526 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.8 -41.61 68.89 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.748 2.298 . . . . 0.0 111.369 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.61 -39.38 93.25 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.375 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.9 t -68.55 144.33 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.635 ' HB2' HG21 ' A' ' 31' ' ' THR . 39.5 t -81.88 98.07 8.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.075 0.464 . . . . 0.0 111.043 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.5 ' HB3' HG22 ' A' ' 54' ' ' VAL . 5.3 p90 -65.06 125.55 25.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.028 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.03 162.11 28.12 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.998 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.415 HD11 HG13 ' A' ' 47' ' ' VAL . 4.4 tt -161.19 145.49 4.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.0 t -151.02 158.08 43.68 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.173 0.511 . . . . 0.0 111.857 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.462 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.3 p -138.53 -0.61 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.375 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.06 143.85 56.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.779 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.6 t -67.49 -50.95 56.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.437 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 2.4 mp0 -50.77 -42.39 57.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.355 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HA ' HG22 ' A' ' 21' ' ' VAL . 63.6 t -70.91 -53.85 20.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 120.914 0.387 . . . . 0.0 110.731 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 mp -58.8 -15.42 12.24 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.425 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.0 m -90.4 -40.56 11.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.074 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -60.27 -40.13 89.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.386 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -92.56 14.57 16.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 54.0 25.83 5.82 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.638 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.693 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.6 mm -61.43 120.78 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.175 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.3 p -140.69 56.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.075 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.68 45.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.64 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 29.8 m-80 51.29 43.62 29.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.192 0.52 . . . . 0.0 110.539 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.693 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.8 m -70.21 152.79 43.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.544 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.582 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.8 mt -119.11 117.88 55.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.524 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 70.7 m -105.56 133.37 50.42 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.592 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.3 tp -109.89 104.77 13.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.905 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.0 t80 -98.4 124.21 42.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.459 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.516 HH12 HD12 ' A' ' 116' ' ' LEU . 4.9 mtm180 -106.32 83.29 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.85 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 tp -25.48 -59.4 0.07 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.024 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.551 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.75 -67.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 123.505 0.503 . . . . 0.0 112.305 -179.324 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.06 4.96 51.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.935 0.398 . . . . 0.0 111.012 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.8 m120 53.78 29.21 9.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.636 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.469 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.7 mm-40 -74.27 159.89 31.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.682 0.277 . . . . 0.0 110.882 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.1 95.18 2.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.867 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.592 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -84.35 135.73 34.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.414 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -114.07 96.01 5.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.628 HD21 HD13 ' A' ' 102' ' ' ILE . 4.1 tt -79.44 79.38 5.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.451 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.0 mt-10 -82.34 -162.89 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.653 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.587 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 5.1 m-20 -50.62 -39.39 50.17 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.091 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.43 -15.09 0.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.265 0.555 . . . . 0.0 110.112 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.423 ' N ' ' C ' ' A' ' 96' ' ' ASP . 42.9 m-20 -132.11 -13.45 3.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.566 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.587 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 27.7 mm -91.5 -39.41 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -47.52 -42.52 23.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.909 0.385 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.8 t -129.69 44.39 2.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.28 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.628 HD13 HD21 ' A' ' 94' ' ' LEU . 6.7 tp -67.1 144.37 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.584 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.414 ' N ' HG13 ' A' ' 102' ' ' ILE . 9.5 m-20 -136.98 149.04 47.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.35 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.878 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.88 -34.63 9.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.052 0.453 . . . . 0.0 110.408 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.2 m -63.88 -48.02 78.34 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.537 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -59.73 -57.41 13.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.308 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.723 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.7 -54.99 22.21 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.039 0.447 . . . . 0.0 110.064 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.0 m -59.5 -28.67 67.25 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.775 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.511 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -72.07 -67.06 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.142 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -43.05 -43.14 4.2 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.196 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.431 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -63.69 -54.64 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.81 -19.56 6.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.248 0.547 . . . . 0.0 110.301 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.511 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.41 -37.03 9.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.814 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.404 ' O ' HD21 ' A' ' 83' ' ' LEU . 17.2 m120 -122.84 29.86 6.66 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 83.6 p -82.95 47.36 1.21 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.14 0.495 . . . . 0.0 109.846 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.516 HD12 HH12 ' A' ' 85' ' ' ARG . 53.2 mt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.265 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.9 pt-20 . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.424 0.154 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.466 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 53.6 Cg_endo -70.18 141.14 42.78 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.569 2.179 . . . . 0.0 112.415 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 m -62.33 151.88 35.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.497 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.67 88.8 4.74 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.007 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.606 HD22 ' HA ' ' A' ' 24' ' ' ALA . 44.1 mt -80.73 71.79 7.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.372 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.7 p -69.65 -6.07 28.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.236 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -138.68 147.18 42.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.005 0.431 . . . . 0.0 111.764 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.613 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.2 t -54.66 -49.38 91.66 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.561 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.33 -47.31 22.8 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.985 1.79 . . . . 0.0 112.009 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.12 -34.4 77.54 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.24 0.543 . . . . 0.0 110.281 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.31 -59.48 4.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.207 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.8 mtm -60.67 -26.07 66.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.105 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -70.91 -51.0 28.78 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.771 0.32 . . . . 0.0 110.493 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.412 ' O ' HG22 ' A' ' 31' ' ' THR . 7.9 m-85 -60.64 -31.97 71.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.852 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.528 HD11 HD12 ' A' ' 36' ' ' ILE . 49.7 mt -73.96 -36.52 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.037 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.93 -20.94 59.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.815 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.19 30.98 1.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.579 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.8 t -169.72 151.48 4.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.388 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.644 ' HG3' HG13 ' A' ' 87' ' ' VAL . 31.2 tt0 -72.17 -40.76 67.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.632 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 83' ' ' LEU . 20.5 t -129.7 130.96 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.893 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -135.64 128.67 31.54 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 83' ' ' LEU . 41.2 t -116.5 128.03 73.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.532 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.528 HD12 HD11 ' A' ' 28' ' ' ILE . 26.2 mt -134.02 137.19 52.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.607 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.33 96.29 1.66 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.638 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.0 m-85 -82.68 89.24 6.72 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.0 m-85 -108.98 140.35 42.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -88.43 -1.91 58.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.6 t70 -156.85 124.04 5.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.621 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.7 mt -93.4 47.34 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.152 0.501 . . . . 0.0 111.408 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 37.0 mt-10 -137.07 6.88 2.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.841 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.832 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.4 pt -90.24 156.55 46.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.177 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.516 ' O ' HD12 ' A' ' 49' ' ' ILE . 71.2 Cg_exo -51.5 -26.14 21.15 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.858 2.372 . . . . 0.0 113.255 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.832 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.01 -35.72 82.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.626 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.3 t -64.12 -55.14 34.06 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.66 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.0 Cg_exo -60.93 -37.74 74.72 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.987 1.791 . . . . 0.0 111.321 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.88 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.6 mt -65.58 -36.45 77.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.921 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.626 ' O ' HG23 ' A' ' 54' ' ' VAL . 51.3 tp -71.98 -51.61 21.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -53.89 -24.53 16.38 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.9 t -82.66 -46.63 13.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.641 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.576 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.31 -25.44 64.16 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.403 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.2 t -52.92 -50.01 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.036 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -76.73 -9.53 58.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.76 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.3 mtpp -93.79 -19.28 21.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.121 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.621 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 59.5 m-85 -135.66 62.9 50.92 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.511 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.42 -40.42 71.27 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.724 2.283 . . . . 0.0 111.733 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.29 -41.51 98.39 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.539 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.4 t -65.56 147.06 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.579 ' CB ' HG21 ' A' ' 31' ' ' THR . 36.0 t -84.27 96.75 9.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.997 0.427 . . . . 0.0 110.839 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.466 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.2 p90 -65.24 121.83 15.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.216 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.458 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -141.37 163.32 26.8 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.118 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -161.68 143.3 3.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.5 t -146.97 157.81 43.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.139 0.495 . . . . 0.0 111.753 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.461 HG21 ' HG ' ' A' ' 42' ' ' LEU . 76.8 p -140.67 3.53 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.63 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -74.74 142.36 44.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.593 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.3 t -64.31 -49.05 73.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.45 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -50.66 -45.3 57.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.494 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.502 ' HA ' HG22 ' A' ' 21' ' ' VAL . 74.3 t -70.15 -53.21 24.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.86 0.362 . . . . 0.0 110.772 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.55 -15.04 9.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.25 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.4 m -91.72 -41.28 10.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.457 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -61.57 -36.23 80.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.579 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -94.2 9.76 36.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.947 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.0 t30 60.28 20.39 9.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.667 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.701 HG23 ' HB ' ' A' ' 80' ' ' THR . 36.7 mm -56.88 123.21 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.097 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.3 p -143.37 60.5 1.4 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.26 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.59 45.9 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.633 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 29.8 m-80 51.41 43.38 29.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.181 0.515 . . . . 0.0 110.403 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.701 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.7 m -69.55 150.63 46.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.716 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.607 HG12 ' HA2' ' A' ' 37' ' ' GLY . 57.3 mt -117.23 118.28 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.076 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.4 m -107.94 131.42 54.56 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.571 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.1 tp -107.54 103.47 12.8 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.622 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.3 t80 -97.73 119.27 36.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.872 0.368 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.511 HH12 HD12 ' A' ' 116' ' ' LEU . 4.3 mtm180 -101.44 98.41 8.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.028 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.0 tp -43.28 -52.38 5.77 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.907 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.644 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.59 -62.18 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.548 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.427 ' HB2' HH21 ' A' ' 85' ' ' ARG . 6.2 m-20 -99.3 9.5 43.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.426 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 85' ' ' ARG . 85.7 m-20 50.26 32.75 6.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.747 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.491 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 11.7 mm-40 -78.23 162.98 26.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.718 0.294 . . . . 0.0 111.006 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.96 98.06 2.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.66 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.571 HD23 ' HG ' ' A' ' 83' ' ' LEU . 1.7 mm? -88.14 123.85 33.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.664 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -103.21 98.12 8.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 102' ' ' ILE . 4.7 tt -82.05 77.0 8.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.2 mt-10 -78.04 -165.53 0.67 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.5 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.5 OUTLIER -45.56 -52.43 10.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.279 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -46.01 -18.33 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.874 0.369 . . . . 0.0 111.198 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 96' ' ' ASP . 14.8 m-20 -124.78 -13.94 6.84 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.348 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.576 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.1 mm -90.72 -42.39 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -49.74 -33.41 16.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.9 t -129.58 37.81 3.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.492 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.541 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.0 tp -66.61 143.66 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.541 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -138.59 148.5 44.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.32 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.88 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.13 -36.75 8.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 110.349 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 100.0 m -62.43 -47.12 85.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.423 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -61.3 -58.44 8.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.4 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.773 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.83 -55.35 17.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.946 0.403 . . . . 0.0 110.169 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.5 m -58.71 -31.23 68.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.975 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.552 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.1 tmt_? -70.57 -66.28 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.267 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -43.29 -43.01 4.7 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.331 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.45 HG12 HG21 ' A' ' 35' ' ' VAL . 96.7 mt -63.1 -55.01 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -53.84 -22.26 9.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.374 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.552 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -85.27 -38.59 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.889 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.502 ' OD1' HG22 ' A' ' 113' ' ' ILE . 30.8 m120 -118.29 27.73 8.78 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.4 p -80.82 46.18 0.87 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.026 0.441 . . . . 0.0 110.278 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.511 HD12 HH12 ' A' ' 85' ' ' ARG . 48.4 mt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.138 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.5 pt-20 . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 120.389 0.138 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 31.5 Cg_endo -64.67 152.0 83.54 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.642 2.228 . . . . 0.0 112.778 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 17' ' ' TRP . 39.8 m -68.34 154.24 42.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.605 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.41 ' N ' HG22 ' A' ' 16' ' ' THR . 92.8 m95 -99.44 92.2 5.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.898 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.606 HD22 ' HA ' ' A' ' 24' ' ' ALA . 55.8 mt -91.41 70.98 6.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.702 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.2 p -72.6 -1.4 15.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.908 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -140.71 147.03 38.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 111.782 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.2 t -56.22 -50.21 88.79 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.567 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.1 Cg_endo -57.98 -45.29 33.17 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.924 1.75 . . . . 0.0 111.802 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.92 -34.11 77.23 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.25 0.547 . . . . 0.0 110.408 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.55 -58.8 5.37 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.947 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.6 mtp -60.14 -27.53 67.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.194 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 27.9 mt-10 -72.08 -51.04 23.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.707 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.498 ' O ' HG22 ' A' ' 31' ' ' THR . 6.0 m-85 -59.5 -32.76 70.58 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.544 HD11 HD12 ' A' ' 36' ' ' ILE . 42.4 mt -74.79 -38.85 45.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.97 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.52 -18.91 61.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.215 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.49 27.03 3.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.311 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.722 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.4 t -171.86 155.2 3.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.491 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.572 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.3 tt0 -64.79 -73.81 0.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.531 HG13 HD11 ' A' ' 83' ' ' LEU . 21.1 t -99.23 139.1 21.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.568 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.02 127.96 19.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 111' ' ' ILE . 49.9 t -116.68 129.23 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.59 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.544 HD12 HD11 ' A' ' 28' ' ' ILE . 20.7 mt -135.02 137.87 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.466 -177.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.11 97.17 1.63 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.593 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.479 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 42.0 m-85 -83.13 89.92 7.0 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -108.28 143.13 37.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.351 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -89.87 -6.6 55.65 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.507 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.6 t70 -151.62 119.81 6.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.584 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.493 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.9 mt -88.69 45.39 1.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.218 0.532 . . . . 0.0 111.127 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 10.2 mm-40 -136.33 12.04 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.248 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.823 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.1 pt -97.04 157.8 34.4 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.426 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.502 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 79.9 Cg_exo -51.11 -30.8 33.26 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.723 2.282 . . . . 0.0 112.886 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.823 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -59.59 -38.51 81.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.401 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.669 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.3 t -61.02 -58.02 22.18 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.569 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.669 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 35.8 Cg_exo -58.31 -40.25 77.23 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.784 1.656 . . . . 0.0 111.435 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.979 HG23 ' HA ' ' A' ' 104' ' ' ALA . 9.8 mt -61.7 -35.96 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 54' ' ' VAL . 46.3 tp -73.89 -53.58 9.85 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -54.34 -24.09 17.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.007 0.432 . . . . 0.0 109.915 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.5 t -83.22 -43.78 15.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.558 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.59 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.85 -25.66 67.66 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.3 t -53.1 -48.53 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.095 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -75.24 -11.65 60.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.58 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -93.44 -18.49 22.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.27 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.622 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 44.9 m-85 -135.99 63.08 49.61 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.643 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.94 -44.21 50.47 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.731 2.287 . . . . 0.0 111.654 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.6 -41.69 89.67 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.473 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 14.3 t -65.64 144.7 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.722 ' HB2' HG21 ' A' ' 31' ' ' THR . 36.2 t -82.06 96.26 7.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.02 0.438 . . . . 0.0 111.012 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.485 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.6 p90 -62.6 129.3 39.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.735 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.522 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -148.13 161.36 28.58 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.058 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.438 HD11 HG13 ' A' ' 47' ' ' VAL . 5.2 tt -160.84 143.06 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.479 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 32.4 t -150.46 158.25 43.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 111.793 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.46 HG21 ' HG ' ' A' ' 42' ' ' LEU . 82.7 p -138.69 -2.72 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.642 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.402 ' O ' HD13 ' A' ' 71' ' ' LEU . 16.6 t70 -62.64 143.12 57.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.662 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.0 m -67.29 -52.57 39.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.23 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 2.6 mp0 -49.83 -40.71 42.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.409 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.523 ' HA ' HG22 ' A' ' 21' ' ' VAL . 54.9 t -72.54 -55.08 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 67' ' ' ASP . 6.3 mp -57.98 -14.29 6.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.248 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.3 m -92.41 -40.49 10.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.214 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -61.84 -35.04 77.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.224 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.43 ' HB2' HG12 ' A' ' 76' ' ' ILE . 86.9 m-85 -95.12 9.68 38.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.695 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t30 58.6 24.28 11.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.454 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.719 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.2 mm -61.28 124.19 15.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.3 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.1 p -143.68 59.49 1.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.195 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.78 44.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.706 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.632 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 26.3 m-80 52.31 44.63 29.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.188 0.518 . . . . 0.0 110.639 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.719 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.3 m -69.55 152.14 45.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.63 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.571 HG21 HD21 ' A' ' 107' ' ' LEU . 60.5 mt -118.46 115.58 48.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.07 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 77.4 m -103.4 133.25 48.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.663 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -108.71 101.54 10.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.853 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.2 t80 -95.31 121.86 37.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.568 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.478 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 4.6 mtm180 -106.6 82.04 1.67 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.908 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.422 ' HG ' ' N ' ' A' ' 87' ' ' VAL . 4.8 tp -25.46 -61.78 0.07 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.572 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.76 -54.84 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -103.84 3.97 34.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.92 0.391 . . . . 0.0 111.21 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 51.57 31.31 7.5 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.57 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 9.7 mm-40 -77.83 157.62 29.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.491 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.13 95.89 2.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.997 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.663 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -84.31 112.3 20.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.586 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -95.8 96.05 8.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.589 HD21 HD13 ' A' ' 102' ' ' ILE . 3.8 tt -81.73 78.93 8.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.5 mt-10 -79.8 -165.01 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.527 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.6 t70 -50.66 -37.41 40.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.988 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -55.25 -14.79 1.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.204 0.526 . . . . 0.0 110.428 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -130.74 -13.94 3.64 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.546 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.571 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 23.8 mm -89.5 -29.01 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.709 0.29 . . . . 0.0 111.413 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -52.93 -52.34 58.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.811 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.2 m -117.51 37.25 3.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.488 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.589 HD13 HD21 ' A' ' 94' ' ' LEU . 7.8 tp -61.36 147.56 10.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.596 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.449 ' HA ' ' CD1' ' A' ' 49' ' ' ILE . 4.3 t70 -140.83 161.08 38.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.621 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.979 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -58.95 -35.04 72.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.091 0.472 . . . . 0.0 110.17 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 94.0 m -65.34 -46.71 79.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.407 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -59.96 -57.15 14.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.983 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.78 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.81 -54.87 24.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.117 0.484 . . . . 0.0 110.109 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.7 m -59.18 -29.3 67.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.704 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.483 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.6 tmt_? -71.97 -66.21 0.67 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.213 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -42.86 -43.85 4.24 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.154 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.475 HG12 HG21 ' A' ' 35' ' ' VAL . 82.8 mt -63.06 -55.05 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.465 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -54.76 -17.93 4.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.14 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.483 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.96 -35.26 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.923 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.442 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.4 m120 -125.44 30.31 5.81 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 95.5 p -84.03 51.49 2.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.066 0.46 . . . . 0.0 110.25 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.448 HD12 ' NH1' ' A' ' 85' ' ' ARG . 82.0 mt . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.421 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.504 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.0 pt-20 . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.402 0.144 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.1 Cg_endo -65.81 143.09 72.33 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.574 2.182 . . . . 0.0 112.672 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.5 m -63.53 153.22 36.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.676 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -96.97 93.0 6.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.012 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.603 HD13 ' HA ' ' A' ' 24' ' ' ALA . 39.4 mt -87.34 70.84 10.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.128 0.49 . . . . 0.0 110.234 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.4 p -69.9 -3.12 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.161 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -139.01 147.43 42.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.909 0.385 . . . . 0.0 111.65 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 42.1 t -56.43 -49.95 90.5 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.485 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.64 -46.0 29.87 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.974 1.783 . . . . 0.0 111.867 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.85 81.64 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.178 0.513 . . . . 0.0 110.112 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -62.54 -60.13 3.96 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.002 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 44.7 mtm -60.36 -25.82 66.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.278 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -70.92 -51.66 24.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.704 0.288 . . . . 0.0 110.418 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.407 ' O ' HG22 ' A' ' 31' ' ' THR . 13.9 m-85 -60.6 -30.79 70.04 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.526 HD11 HD12 ' A' ' 36' ' ' ILE . 53.2 mt -74.38 -37.52 45.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.023 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.93 -19.67 60.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.16 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.53 30.96 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.079 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.694 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.2 t -172.35 152.97 2.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.426 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.511 ' HG3' HG13 ' A' ' 87' ' ' VAL . 26.8 tt0 -68.88 -47.07 66.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.77 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.494 HG13 HD11 ' A' ' 83' ' ' LEU . 18.5 t -122.22 139.48 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.432 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.512 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -143.13 125.95 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.529 HG21 HG12 ' A' ' 111' ' ' ILE . 49.5 t -114.39 128.77 71.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.424 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 28' ' ' ILE . 29.2 mt -134.88 137.57 50.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.421 -177.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.23 96.41 1.6 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.587 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.449 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.7 m-85 -82.89 91.27 7.08 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -111.03 144.35 40.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.453 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.453 ' HG2' HD23 ' A' ' 71' ' ' LEU . 45.8 mt-30 -92.98 -2.55 55.66 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.484 ' O ' HG12 ' A' ' 44' ' ' ILE . 28.6 t70 -155.97 117.13 3.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.582 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.484 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.2 mt -87.31 45.5 1.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.116 0.484 . . . . 0.0 111.604 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.403 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 38.6 mt-10 -134.59 10.76 3.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.037 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.688 HG13 HG23 ' A' ' 47' ' ' VAL . 7.2 pt -92.31 161.33 33.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.293 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.498 ' O ' HD12 ' A' ' 49' ' ' ILE . 50.1 Cg_exo -56.81 -26.52 66.97 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.739 2.293 . . . . 0.0 112.369 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.673 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.67 -37.78 88.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.482 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.688 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -61.23 -56.66 32.04 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.642 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.87 -38.61 78.4 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.864 1.709 . . . . 0.0 111.423 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.864 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.6 mt -64.12 -35.09 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.869 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 54' ' ' VAL . 49.7 tp -74.03 -52.47 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -55.53 -23.2 25.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.036 0.446 . . . . 0.0 109.853 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.6 t -83.78 -44.73 14.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.445 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.614 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.6 -25.77 67.55 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -52.79 -49.5 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.036 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -74.41 -11.67 60.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.7 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -93.38 -19.04 21.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.305 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.555 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 54.8 m-85 -137.16 61.99 36.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.399 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.73 -42.16 68.46 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.684 2.256 . . . . 0.0 111.615 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.86 -39.84 88.84 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.212 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.555 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.5 t -67.71 143.37 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.694 ' HB2' HG21 ' A' ' 31' ' ' THR . 47.1 t -80.14 98.37 7.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.022 0.439 . . . . 0.0 110.967 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.51 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.3 p90 -65.99 124.73 23.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.968 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.47 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -143.71 162.01 27.73 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.171 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -161.8 142.73 3.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.449 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 41.0 t -149.04 156.51 42.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.194 0.521 . . . . 0.0 111.809 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 68.2 p -137.15 3.05 2.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.481 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.413 ' O ' HD13 ' A' ' 71' ' ' LEU . 17.7 t70 -69.92 142.97 52.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.685 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.9 m -67.34 -50.92 58.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.351 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -51.11 -40.94 59.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.364 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.531 ' HA ' HG22 ' A' ' 21' ' ' VAL . 53.7 t -72.48 -54.68 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.358 . . . . 0.0 110.539 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -58.41 -14.64 8.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.099 0.476 . . . . 0.0 110.255 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.5 m -91.78 -40.35 11.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.239 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -62.08 -34.36 76.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.267 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.415 ' HB2' HG12 ' A' ' 76' ' ' ILE . 84.9 m-85 -96.63 10.88 37.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.72 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 56.01 26.65 10.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.867 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.716 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.1 mm -62.7 122.19 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.4 p -141.8 59.16 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 111.259 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.52 44.65 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.521 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.609 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 23.2 m-80 51.48 44.18 29.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.141 0.496 . . . . 0.0 110.635 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.716 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.0 m -69.72 151.67 45.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.836 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.565 HG12 ' HA2' ' A' ' 37' ' ' GLY . 55.8 mt -117.6 116.74 52.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.813 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 74.8 m -104.28 132.79 50.14 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.643 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -109.63 101.98 10.85 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.866 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -96.38 122.78 39.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.538 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.479 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 4.0 mtm180 -106.31 86.37 2.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.857 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.1 tp -27.05 -60.54 0.09 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.511 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.91 -73.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 123.434 0.459 . . . . 0.0 112.149 -179.273 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -83.51 2.89 34.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.014 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.9 m120 53.75 30.07 10.6 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.42 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.479 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 8.0 mm-40 -74.46 159.25 32.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.805 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -144.16 93.31 2.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.823 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.643 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -80.91 141.83 34.16 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -122.85 92.81 3.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.643 HD21 HD13 ' A' ' 102' ' ' ILE . 4.0 tt -76.99 77.43 3.54 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.444 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.2 mt-10 -79.08 -164.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.508 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 23.7 t70 -51.66 -36.38 46.08 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.915 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.68 -14.65 3.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.282 0.563 . . . . 0.0 110.244 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -130.65 -13.83 3.7 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.694 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.578 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.1 mm -89.94 -30.0 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.727 0.298 . . . . 0.0 111.294 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -52.12 -48.52 64.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.746 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.9 t -123.78 42.08 3.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.414 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.643 HD13 HD21 ' A' ' 94' ' ' LEU . 7.9 tp -63.46 143.14 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.545 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -136.03 150.56 49.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.487 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.864 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.07 -33.85 12.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.034 0.445 . . . . 0.0 110.26 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.3 m -65.35 -47.31 76.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.438 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -60.05 -56.34 22.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.149 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.793 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -52.36 -57.14 10.72 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.959 0.409 . . . . 0.0 109.905 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 61.4 m -56.87 -28.91 62.42 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.869 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.474 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.7 tmt_? -71.04 -66.88 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.954 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -42.3 -41.17 2.7 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.156 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.529 HG12 HG21 ' A' ' 35' ' ' VAL . 76.8 mt -64.91 -55.77 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -54.24 -18.01 3.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.253 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.474 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.5 mp -92.56 -34.58 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.12 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.486 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.0 m120 -128.31 32.69 4.83 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 93.8 p -85.17 41.84 0.9 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.164 0.507 . . . . 0.0 109.918 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 85' ' ' ARG . 49.9 mt . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.527 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 . . . . . 0 CA--C 1.531 0.245 0 CA-C-O 120.631 0.253 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.48 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.7 Cg_endo -68.23 155.38 69.58 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.768 2.312 . . . . 0.0 112.741 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.7 m -70.71 151.61 44.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.416 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -96.79 86.36 4.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.755 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.0 mt -83.34 71.52 10.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.619 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 76.8 p -69.21 -6.2 27.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.288 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -140.05 146.97 39.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.993 0.425 . . . . 0.0 111.791 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.615 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.5 t -54.34 -49.74 88.82 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.632 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.8 Cg_endo -56.58 -46.46 29.81 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.984 1.789 . . . . 0.0 112.082 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.23 -34.47 78.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.173 0.511 . . . . 0.0 110.288 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.61 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.88 -58.88 5.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.081 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 61.3 mtp -61.39 -27.16 68.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.189 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.5 mt-10 -70.64 -49.89 42.7 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.772 0.32 . . . . 0.0 110.386 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 31' ' ' THR . 5.9 m-85 -60.5 -33.14 72.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.846 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.527 HD11 ' CD1' ' A' ' 36' ' ' ILE . 46.0 mt -73.86 -37.66 48.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.127 178.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.66 -20.75 60.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.128 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.1 29.77 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.059 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.638 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.9 t -171.25 150.86 3.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.333 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.527 ' HG3' HG13 ' A' ' 87' ' ' VAL . 25.1 tt0 -64.58 -63.32 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.91 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.484 HG13 HD11 ' A' ' 83' ' ' LEU . 21.4 t -108.04 141.9 22.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.592 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -144.08 126.52 15.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.021 0.439 . . . . 0.0 112.109 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.468 HG21 HG12 ' A' ' 111' ' ' ILE . 47.8 t -115.47 127.53 73.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.622 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.527 ' CD1' HD11 ' A' ' 28' ' ' ILE . 26.7 mt -133.71 136.4 54.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.728 -177.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.498 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.71 97.69 1.82 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.347 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.443 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 38.8 m-85 -83.49 89.67 7.11 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -108.35 141.3 40.36 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.448 ' HG2' HD23 ' A' ' 71' ' ' LEU . 77.0 mt-30 -89.62 -2.69 58.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.522 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.9 t70 -155.37 117.51 4.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.581 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.512 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.3 mt -86.99 43.67 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.054 0.454 . . . . 0.0 111.343 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.1 mt-10 -134.61 13.14 3.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.121 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.825 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.0 pt -96.92 157.62 34.78 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.266 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.473 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 76.4 Cg_exo -51.6 -28.67 29.82 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.834 2.356 . . . . 0.0 112.888 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.825 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -61.95 -37.58 85.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.668 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.7 t -61.33 -56.77 30.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.606 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.668 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 39.5 Cg_exo -57.52 -42.4 61.37 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 121.742 1.628 . . . . 0.0 111.125 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.908 HG23 ' HA ' ' A' ' 104' ' ' ALA . 11.8 mt -60.0 -37.71 73.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.215 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.596 ' O ' HG23 ' A' ' 54' ' ' VAL . 47.2 tp -73.32 -51.71 16.53 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -54.8 -24.37 22.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.087 0.47 . . . . 0.0 109.858 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.3 m -83.84 -44.59 14.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.585 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.591 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.68 -25.91 66.72 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.372 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 50' ' ' LEU . 45.2 t -51.99 -47.0 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.898 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -78.89 -13.47 59.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.712 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -90.89 -17.09 27.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.308 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.61 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 44.0 m-85 -137.95 62.93 35.89 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.558 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.18 -44.4 49.21 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.703 2.269 . . . . 0.0 111.754 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.86 -37.16 76.46 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.515 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.61 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 17.2 t -70.18 143.6 14.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.638 ' HB2' HG21 ' A' ' 31' ' ' THR . 45.6 t -81.37 97.94 7.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 110.886 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.481 ' HB3' HG22 ' A' ' 54' ' ' VAL . 4.9 p90 -64.18 129.2 39.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.828 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.538 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.51 161.06 28.46 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.128 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -161.26 145.69 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.407 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 40.1 t -154.06 159.53 41.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.069 0.461 . . . . 0.0 111.727 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.481 HG21 ' HG ' ' A' ' 42' ' ' LEU . 58.3 p -138.84 -7.66 1.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.693 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.06 141.45 55.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.706 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.0 p -64.39 -50.11 68.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.38 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -49.81 -44.46 49.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.543 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.539 ' HA ' HG22 ' A' ' 21' ' ' VAL . 70.6 t -70.05 -54.61 18.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.956 0.408 . . . . 0.0 110.674 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.448 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.1 mp -58.38 -14.42 7.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.437 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.1 m -91.3 -42.01 10.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.339 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -60.26 -37.38 80.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.367 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.424 ' HB2' HG12 ' A' ' 76' ' ' ILE . 83.0 m-85 -93.72 12.49 25.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.979 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 55.64 26.77 9.63 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.674 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.692 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.0 mm -64.16 123.5 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.174 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.7 p -142.16 58.35 1.47 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.286 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.42 ' HA3' ' OD1' ' A' ' 96' ' ' ASP . . . 152.7 44.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.947 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 27.4 m-80 52.61 42.53 31.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.244 0.545 . . . . 0.0 110.492 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.692 ' HB ' HG23 ' A' ' 76' ' ' ILE . 90.1 m -68.83 151.34 46.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.43 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.542 HG21 HD21 ' A' ' 107' ' ' LEU . 62.2 mt -117.13 116.76 53.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.199 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.443 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 74.2 m -105.45 133.83 49.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.611 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.2 tp -109.59 103.39 12.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.971 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.4 t80 -96.47 124.44 40.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.693 0.283 . . . . 0.0 110.749 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.466 ' NH1' HD12 ' A' ' 116' ' ' LEU . 3.5 mtm180 -107.95 85.52 2.13 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.11 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 tp -27.13 -60.57 0.09 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.527 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -35.84 -68.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 123.574 0.546 . . . . 0.0 112.289 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -89.77 3.65 52.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.165 0.507 . . . . 0.0 110.715 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.4 t30 51.85 37.37 20.48 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.986 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 11.0 mm-40 -81.84 159.06 23.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.563 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -140.9 90.83 2.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.667 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.611 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.8 mm? -77.75 141.87 39.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.61 116.84 26.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.253 0.549 . . . . 0.0 112.023 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.626 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -104.32 77.94 1.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -80.61 -164.27 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.827 -177.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.621 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 7.2 m-20 -49.74 -41.1 43.05 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.294 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -52.17 -15.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.256 0.55 . . . . 0.0 110.143 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.417 ' N ' ' C ' ' A' ' 96' ' ' ASP . 36.2 m-20 -130.86 -13.38 3.64 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.321 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.621 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 26.8 mm -90.96 -42.13 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.488 ' HG3' ' HB3' ' A' ' 96' ' ' ASP . 43.4 mt-10 -48.49 -37.96 18.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.936 0.398 . . . . 0.0 111.055 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.5 p -130.43 45.16 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.375 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.626 HD13 HD21 ' A' ' 94' ' ' LEU . 8.6 tp -71.95 145.17 12.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.785 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -138.61 149.4 45.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.649 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.908 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.0 -36.47 12.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.018 0.437 . . . . 0.0 110.609 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.4 m -61.53 -48.61 80.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.202 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 102' ' ' ILE . 28.9 mtpp -59.05 -60.68 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.149 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.779 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.41 -55.93 9.53 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.953 0.406 . . . . 0.0 110.315 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.8 m -58.08 -30.38 66.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.787 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.502 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.2 tmt_? -71.03 -65.91 0.68 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.209 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -43.17 -44.06 4.93 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.921 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.468 HG12 HG21 ' A' ' 35' ' ' VAL . 96.4 mt -62.61 -56.41 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.445 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.86 -18.39 3.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.316 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.502 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.95 -37.25 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.925 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -123.64 29.01 6.72 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 98.2 p -83.04 51.6 1.98 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.217 0.532 . . . . 0.0 109.915 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.466 HD12 ' NH1' ' A' ' 85' ' ' ARG . 68.1 mt . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.397 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.474 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.779 0.323 . . . . 0.0 111.339 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 31.8 Cg_endo -66.0 152.79 80.44 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.967 2.444 . . . . 0.0 112.794 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.44 HG22 ' N ' ' A' ' 17' ' ' TRP . 18.8 m -69.36 157.16 37.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.825 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.44 ' N ' HG22 ' A' ' 16' ' ' THR . 8.4 m-90 -99.52 92.91 5.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.962 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.0 mt -91.62 72.69 5.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.359 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 p -71.24 -5.38 31.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.334 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -137.46 147.4 45.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.935 0.398 . . . . 0.0 111.72 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.598 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 48.9 t -56.05 -50.05 89.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.568 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.8 Cg_endo -57.91 -45.4 32.74 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.896 1.731 . . . . 0.0 112.027 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.52 -36.08 82.59 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.259 0.552 . . . . 0.0 110.439 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.608 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.82 -59.32 4.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.952 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.4 mtm -60.05 -25.45 65.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.076 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -72.12 -51.46 21.34 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.39 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 31' ' ' THR . 9.0 m-85 -59.75 -30.45 68.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.555 HD11 HD12 ' A' ' 36' ' ' ILE . 49.3 mt -75.78 -40.43 39.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.242 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.51 -21.47 61.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.243 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.76 27.32 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.292 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.677 HG21 ' HB2' ' A' ' 61' ' ' SER . 7.7 t -170.86 155.66 4.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.578 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.462 ' HG3' HG13 ' A' ' 87' ' ' VAL . 25.5 tt0 -68.08 -62.31 1.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.51 HG13 HD11 ' A' ' 83' ' ' LEU . 16.6 t -108.56 137.78 38.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.715 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.13 127.49 18.8 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.468 HG21 HG12 ' A' ' 111' ' ' ILE . 47.6 t -116.39 130.06 71.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.7 178.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.555 HD12 HD11 ' A' ' 28' ' ' ILE . 25.7 mt -136.11 136.91 49.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.597 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.76 99.51 2.08 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.476 -0.783 . . . . 0.0 112.586 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.519 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.6 m-85 -86.07 92.72 8.8 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -112.29 142.01 45.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.47 ' HG2' HD23 ' A' ' 71' ' ' LEU . 46.6 mt-30 -90.61 -0.78 57.8 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 44' ' ' ILE . 30.1 t70 -156.51 121.17 4.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.453 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.535 ' HA ' HG21 ' A' ' 47' ' ' VAL . 96.8 mt -92.13 46.49 1.27 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.057 0.456 . . . . 0.0 111.554 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 39.9 mt-10 -136.24 7.21 3.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.952 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.797 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.0 pt -89.27 157.07 48.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.164 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.501 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.7 Cg_exo -51.72 -27.02 25.05 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.828 2.352 . . . . 0.0 113.034 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.797 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.75 -37.38 87.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.668 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -62.0 -55.96 36.16 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 121.044 -0.263 . . . . 0.0 111.707 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.644 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -60.12 -37.93 80.49 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.103 1.868 . . . . 0.0 111.486 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.88 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.7 mt -65.31 -35.82 76.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.18 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.585 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.4 tp -73.42 -50.45 21.69 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -54.52 -24.68 21.73 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -82.4 -46.68 13.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.798 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.581 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.15 -26.0 64.37 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 50' ' ' LEU . 48.6 t -52.72 -49.11 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.213 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -77.89 -9.01 58.85 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.571 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.3 mtpp -94.7 -18.92 20.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.235 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.606 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 54.3 m-85 -137.57 63.19 39.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.36 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.13 -41.32 72.91 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.713 2.275 . . . . 0.0 111.575 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.43 -42.72 95.91 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.283 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.3 t -64.87 142.94 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.677 ' HB2' HG21 ' A' ' 31' ' ' THR . 25.2 t -80.37 96.44 6.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.13 0.49 . . . . 0.0 110.943 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.52 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.1 p90 -65.97 125.87 26.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.912 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.55 163.03 28.26 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.983 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -160.02 141.9 4.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.7 t -145.36 158.87 43.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.117 0.484 . . . . 0.0 111.594 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 39' ' ' PHE . 69.0 p -141.37 -6.2 1.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.823 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.71 142.21 58.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.686 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.0 t -63.35 -48.45 77.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.665 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -49.7 -47.18 50.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.577 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.5 t -69.6 -52.66 30.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.779 0.323 . . . . 0.0 110.85 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.47 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.38 -14.71 8.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.084 0.469 . . . . 0.0 110.304 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.5 m -91.0 -42.48 10.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.396 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -60.21 -38.53 83.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.469 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -91.64 9.7 31.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.7 t30 58.82 21.88 9.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.397 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.668 HD12 ' HB ' ' A' ' 80' ' ' THR . 36.0 mm -57.78 117.91 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.047 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.2 p -137.34 48.68 2.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.467 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 162.69 48.1 0.02 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.426 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 24.2 m-80 49.22 42.38 21.52 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.321 0.582 . . . . 0.0 110.313 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.668 ' HB ' HD12 ' A' ' 76' ' ' ILE . 92.8 m -68.15 152.41 45.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.687 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.597 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.3 mt -119.36 118.82 58.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.979 178.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.519 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 79.7 m -106.97 133.11 52.12 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.663 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -109.46 103.44 12.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.8 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.5 t80 -97.51 123.44 41.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.763 0.316 . . . . 0.0 110.713 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.463 ' NH1' HD12 ' A' ' 116' ' ' LEU . 4.1 mtm180 -106.62 84.2 1.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.741 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 85' ' ' ARG . 5.9 tp -24.96 -60.33 0.06 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.95 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.462 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.16 -73.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 O-C-N 123.488 0.493 . . . . 0.0 112.255 -179.277 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -84.13 0.85 46.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.988 0.423 . . . . 0.0 111.053 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.9 m120 54.0 36.68 25.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.566 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 13.2 mm-40 -82.78 158.14 22.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.736 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.4 96.49 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.632 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.663 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -85.15 114.17 22.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.817 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.72 100.41 11.79 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -85.24 76.96 10.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.413 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.2 mt-10 -77.49 -165.66 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.485 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.91 -51.63 12.88 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.383 -179.363 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -47.49 -17.35 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 96' ' ' ASP . 14.8 m-20 -124.79 -14.16 6.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.506 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.577 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.8 mm -90.11 -38.37 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -49.05 -46.15 43.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 110.942 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -118.96 39.29 3.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.617 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.54 HD13 HD21 ' A' ' 94' ' ' LEU . 7.8 tp -65.95 143.84 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 111.201 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -139.38 148.4 42.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.557 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.88 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.99 -37.8 9.71 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 110.372 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.6 m -61.62 -48.79 79.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.262 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -58.41 -60.75 3.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.279 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.744 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.41 -56.74 7.38 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.873 0.368 . . . . 0.0 110.208 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.2 m -57.75 -30.08 65.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.865 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.503 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -71.17 -65.68 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.196 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -43.05 -42.57 3.95 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.014 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.468 HG12 HG21 ' A' ' 35' ' ' VAL . 97.3 mt -63.5 -55.74 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -54.38 -18.55 4.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.32 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.503 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.63 -35.04 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.953 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.44 ' O ' HD21 ' A' ' 83' ' ' LEU . 17.8 m120 -126.4 30.98 5.47 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 91.6 p -83.89 42.34 0.85 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.017 0.437 . . . . 0.0 110.267 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.463 HD12 ' NH1' ' A' ' 85' ' ' ARG . 77.5 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.365 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.473 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.2 pt-20 . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 120.476 0.179 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.523 ' HD3' HG21 ' A' ' 54' ' ' VAL . 23.7 Cg_endo -63.71 147.76 92.45 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.552 2.168 . . . . 0.0 112.764 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 17' ' ' TRP . 19.9 m -61.4 155.12 22.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.581 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.406 ' N ' HG22 ' A' ' 16' ' ' THR . 9.1 m-90 -98.48 91.71 5.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.877 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 24' ' ' ALA . 43.3 mt -92.49 76.49 5.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.005 0.431 . . . . 0.0 110.471 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.8 p -74.71 -6.32 48.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.123 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -139.83 148.46 42.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.005 0.431 . . . . 0.0 111.743 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.61 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 19.6 t -54.43 -49.44 90.77 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.832 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.11 -47.31 23.36 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.087 1.858 . . . . 0.0 112.135 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.84 -35.64 80.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.217 0.532 . . . . 0.0 110.211 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.84 -59.6 4.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.105 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 59.0 mtm -60.8 -24.39 65.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.041 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -72.47 -52.22 16.78 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.704 0.288 . . . . 0.0 110.527 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.404 ' O ' HG22 ' A' ' 31' ' ' THR . 10.5 m-85 -59.69 -30.35 68.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 36' ' ' ILE . 50.0 mt -75.1 -39.01 43.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.18 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.96 -18.89 60.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.161 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.28 28.46 2.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.209 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.651 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.8 t -170.08 152.24 4.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.351 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.524 ' HG3' HG13 ' A' ' 87' ' ' VAL . 23.8 tt0 -68.32 -48.19 65.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.516 HG13 HD11 ' A' ' 83' ' ' LEU . 15.7 t -121.83 134.96 63.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.523 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.94 127.95 22.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 111.948 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.456 HG21 HG12 ' A' ' 111' ' ' ILE . 51.9 t -116.56 127.68 74.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.725 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.532 HD12 HD11 ' A' ' 28' ' ' ILE . 23.5 mt -133.24 137.13 53.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.69 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.53 99.75 2.05 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.405 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.6 m-85 -85.38 94.23 8.92 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.8 m-85 -113.89 141.63 47.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -89.35 -3.61 58.4 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.471 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.0 t70 -154.12 121.52 5.78 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.614 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.565 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.1 mt -90.9 47.28 1.4 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.081 0.467 . . . . 0.0 111.184 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 37.3 mt-10 -138.45 8.42 2.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.113 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.821 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.6 pt -91.68 156.45 42.88 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.256 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.481 ' O ' HD12 ' A' ' 49' ' ' ILE . 81.4 Cg_exo -50.74 -27.16 19.22 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.781 2.321 . . . . 0.0 113.112 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.821 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.28 -36.99 85.9 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.671 HG23 HG13 ' A' ' 44' ' ' ILE . 2.6 t -62.47 -55.4 39.82 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.703 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.2 Cg_exo -60.46 -38.63 72.39 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.985 1.79 . . . . 0.0 111.376 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.864 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.3 mt -64.93 -35.47 75.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.09 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.4 tp -73.17 -51.74 16.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 16.1 m80 -53.58 -26.7 22.73 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.154 0.502 . . . . 0.0 109.656 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.9 t -80.85 -47.1 14.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.709 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.58 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.05 -26.08 64.3 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.186 0.517 . . . . 0.0 109.608 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.1 t -53.4 -48.26 57.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.034 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -77.88 -8.52 58.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.671 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -95.25 -18.65 20.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.171 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.595 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 57.8 m-85 -136.66 63.22 45.85 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.484 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.37 -43.18 55.98 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.699 2.266 . . . . 0.0 111.465 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.0 -40.77 91.79 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.377 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.4 t -66.6 144.5 14.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.651 ' HB2' HG21 ' A' ' 31' ' ' THR . 33.0 t -83.08 96.28 8.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 110.865 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.475 ' HB3' HG22 ' A' ' 54' ' ' VAL . 7.4 p90 -63.07 130.8 46.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.937 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -149.71 161.33 28.8 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.023 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.4 tt -160.53 143.23 4.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.756 0.313 . . . . 0.0 110.207 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -146.41 160.15 42.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.215 0.531 . . . . 0.0 111.716 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.434 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.6 p -142.0 -1.95 1.2 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.562 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.03 144.78 52.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -64.9 -50.75 65.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.499 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -48.74 -46.94 41.69 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.588 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.455 ' HA ' HG22 ' A' ' 21' ' ' VAL . 75.1 t -68.84 -53.3 27.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.805 0.336 . . . . 0.0 110.88 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -58.61 -14.5 8.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.289 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.9 m -91.53 -40.56 11.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.19 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -60.91 -39.65 90.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.466 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.417 ' HB2' HG12 ' A' ' 76' ' ' ILE . 42.3 m-85 -92.24 11.62 25.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.809 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 55.34 28.57 11.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.221 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.646 HG23 ' HB ' ' A' ' 80' ' ' THR . 36.1 mm -62.44 119.2 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.076 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.5 p -140.13 58.27 1.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.17 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.31 44.56 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.433 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.583 ' HB2' HG21 ' A' ' 99' ' ' ILE . 26.1 m-80 51.65 43.36 29.91 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.183 0.516 . . . . 0.0 110.304 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.646 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.9 m -68.67 154.03 42.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.657 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.592 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.5 mt -120.94 118.81 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.034 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.509 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 81.6 m -107.6 134.62 50.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.658 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -110.69 104.68 13.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.989 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.2 t80 -98.81 122.6 42.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.788 0.328 . . . . 0.0 110.582 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.526 HH12 HD12 ' A' ' 116' ' ' LEU . 3.6 mtm180 -106.05 87.76 2.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.727 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.41 ' HB3' ' HA ' ' A' ' 32' ' ' GLU . 8.7 tp -26.93 -59.85 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.439 -0.8 . . . . 0.0 113.059 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.524 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -35.4 -80.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 O-C-N 123.542 0.526 . . . . 0.0 112.331 -179.43 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.436 ' HB2' HH21 ' A' ' 85' ' ' ARG . 2.7 m-20 -78.67 1.6 22.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.787 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 m120 55.91 33.25 21.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.421 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 19.7 mm-40 -77.11 159.69 29.6 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.833 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.17 91.61 2.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.757 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.658 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -77.63 143.52 38.17 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -124.92 96.93 5.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.536 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -83.44 79.17 9.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.9 mt-10 -80.61 -164.53 0.73 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.479 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.99 -49.69 15.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.604 -179.32 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -48.23 -16.6 0.1 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.773 0.321 . . . . 0.0 111.158 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -127.19 -13.94 5.52 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.556 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.583 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.2 mm -89.81 -33.15 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.729 0.299 . . . . 0.0 111.611 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -55.45 -42.03 73.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.968 0.413 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.4 m -122.53 35.16 4.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.697 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.536 HD13 HD21 ' A' ' 94' ' ' LEU . 7.0 tp -62.97 142.18 17.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.118 0.485 . . . . 0.0 111.496 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -137.45 148.3 46.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.437 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.864 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.02 -36.83 8.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.95 0.405 . . . . 0.0 110.513 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -62.68 -47.14 84.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.286 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.68 -61.47 2.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.11 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.82 -55.31 10.0 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.049 0.452 . . . . 0.0 110.201 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 63.5 m -58.88 -30.47 67.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.794 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.2 tmt_? -71.3 -66.35 0.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.045 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -42.01 -43.33 3.14 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.141 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.456 HG12 HG21 ' A' ' 35' ' ' VAL . 93.3 mt -63.57 -56.14 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.439 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 41.2 tt0 -53.01 -19.2 2.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.31 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.482 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.24 -38.88 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.902 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.416 ' O ' HD21 ' A' ' 83' ' ' LEU . 17.1 m120 -121.24 29.21 7.4 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 82.8 p -82.25 44.95 0.9 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.043 0.449 . . . . 0.0 110.039 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.526 HD12 HH12 ' A' ' 85' ' ' ARG . 55.3 mt . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.245 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 120.496 0.189 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.484 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 33.8 Cg_endo -65.5 139.96 61.1 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.532 2.155 . . . . 0.0 112.588 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 17' ' ' TRP . 20.4 m -55.26 155.09 5.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.872 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.401 ' N ' HG22 ' A' ' 16' ' ' THR . 76.1 m95 -100.29 90.58 4.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.866 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.606 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.5 mt -88.83 73.72 8.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.59 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.5 p -73.56 -0.35 14.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.239 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -143.8 147.73 34.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.98 0.419 . . . . 0.0 111.591 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 31.0 t -55.6 -50.18 88.4 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.573 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.6 Cg_endo -57.83 -44.75 37.87 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.054 1.836 . . . . 0.0 111.886 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.23 -35.63 81.45 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.15 0.5 . . . . 0.0 110.351 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.93 -59.09 4.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.98 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.3 mtm -60.4 -26.73 66.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.173 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 20.2 mt-10 -71.65 -50.31 31.81 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.687 0.279 . . . . 0.0 110.658 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.569 ' O ' HG22 ' A' ' 31' ' ' THR . 9.9 m-85 -60.33 -34.27 73.58 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.564 HD11 HD12 ' A' ' 36' ' ' ILE . 47.7 mt -72.97 -38.57 56.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.032 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.97 -17.3 61.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.971 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.84 25.64 5.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.174 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.605 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.8 t -170.3 152.63 4.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.622 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.595 ' HG3' HG13 ' A' ' 87' ' ' VAL . 15.6 tt0 -61.88 -80.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.595 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.534 HG13 HD11 ' A' ' 83' ' ' LEU . 20.1 t -94.39 136.68 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.619 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.65 126.25 20.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.053 0.454 . . . . 0.0 111.883 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.501 HG21 HG12 ' A' ' 111' ' ' ILE . 47.1 t -115.07 128.02 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.752 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.564 HD12 HD11 ' A' ' 28' ' ' ILE . 23.1 mt -134.65 137.53 51.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.428 -177.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.538 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.66 98.48 1.85 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.347 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.465 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 37.7 m-85 -83.4 90.82 7.23 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.614 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 13.4 m-85 -109.16 141.77 40.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.537 -178.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -88.77 -7.58 55.97 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.479 ' O ' HG12 ' A' ' 44' ' ' ILE . 27.7 t70 -151.22 121.79 7.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.641 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.549 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.0 mt -90.49 46.04 1.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.108 0.48 . . . . 0.0 111.393 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 40.0 mt-10 -136.7 11.07 3.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.041 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.817 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.7 pt -95.7 155.52 38.42 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.311 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.472 ' O ' HD12 ' A' ' 49' ' ' ILE . 84.7 Cg_exo -49.75 -28.59 17.91 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.833 2.355 . . . . 0.0 113.089 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.817 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.54 -37.24 85.33 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.664 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.5 t -62.58 -56.31 31.0 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.615 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.9 Cg_exo -59.4 -39.87 72.67 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.89 1.727 . . . . 0.0 111.187 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.927 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.5 mt -63.2 -36.07 74.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.064 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.623 ' O ' HG23 ' A' ' 54' ' ' VAL . 52.0 tp -71.97 -51.42 22.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -54.94 -25.72 31.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 p -80.99 -45.2 16.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.599 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.605 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.95 -25.9 67.87 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.4 t -53.2 -49.88 49.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.913 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -75.63 -9.18 58.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.716 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -95.26 -18.99 20.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.286 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.563 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 62.4 m-85 -136.1 62.3 44.81 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.566 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.0 -45.82 36.35 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.893 2.395 . . . . 0.0 111.742 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.5 -40.3 69.08 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.403 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.7 t -67.3 143.61 15.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.605 ' HB2' HG21 ' A' ' 31' ' ' THR . 39.8 t -81.8 96.55 7.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.948 0.404 . . . . 0.0 110.965 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.484 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.6 p90 -63.82 129.67 41.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.983 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -149.14 162.3 28.94 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.143 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 15' ' ' PRO . 4.7 tt -160.26 145.39 5.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.465 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 30.9 t -151.02 155.55 39.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.229 0.538 . . . . 0.0 111.787 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.476 HG21 ' HG ' ' A' ' 42' ' ' LEU . 66.8 p -135.95 -3.56 2.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.398 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.73 139.74 58.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.505 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.0 m -64.61 -51.95 60.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.258 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -49.53 -41.53 41.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.543 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.541 ' HA ' HG22 ' A' ' 21' ' ' VAL . 59.8 t -71.77 -55.32 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.731 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.27 -14.63 7.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.365 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 79.5 m -91.98 -40.9 10.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.312 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -61.63 -36.46 80.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.326 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.432 ' HB2' HG12 ' A' ' 76' ' ' ILE . 90.1 m-85 -93.87 12.07 27.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.793 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 57.47 22.96 8.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.716 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.709 HD12 ' HB ' ' A' ' 80' ' ' THR . 40.8 mm -60.64 122.3 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.104 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.2 p -141.99 58.58 1.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.205 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.77 44.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.741 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.631 ' HB2' HG21 ' A' ' 99' ' ' ILE . 21.2 m-80 52.8 43.16 31.8 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.115 0.483 . . . . 0.0 110.739 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.709 ' HB ' HD12 ' A' ' 76' ' ' ILE . 94.8 m -68.77 151.03 47.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.65 -178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.591 HG21 HD21 ' A' ' 107' ' ' LEU . 67.2 mt -117.32 116.12 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.986 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 76.9 m -104.11 133.65 48.69 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.665 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -109.43 102.55 11.42 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.941 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.4 t80 -97.5 121.76 39.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.771 0.32 . . . . 0.0 110.762 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.516 HH12 HD12 ' A' ' 116' ' ' LEU . 3.0 mtm180 -105.76 91.75 3.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.123 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 tp -38.55 -50.69 1.59 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.611 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.595 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.36 -63.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.796 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.412 ' HB2' HH21 ' A' ' 85' ' ' ARG . 9.2 m-20 -96.52 8.54 43.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.04 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 m120 51.86 31.97 9.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.615 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 20.3 mm-40 -78.82 160.82 27.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.809 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -146.92 91.49 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.911 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.665 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -78.42 144.65 35.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.03 99.33 6.07 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.598 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -85.29 78.31 9.81 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.454 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.4 mt-10 -78.46 -165.6 0.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.564 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.7 t70 -51.7 -35.4 42.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.004 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -56.87 -14.92 3.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.248 0.547 . . . . 0.0 110.327 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -129.94 -14.01 4.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.481 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.631 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.3 mm -89.48 -32.58 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 120.781 0.324 . . . . 0.0 111.267 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -51.7 -45.19 63.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.2 p -124.56 37.09 4.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.573 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.598 HD13 HD21 ' A' ' 94' ' ' LEU . 7.6 tp -60.6 143.18 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.787 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -137.53 149.51 46.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.523 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.927 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.08 -38.33 11.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 110.593 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.2 m -61.74 -47.78 83.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.488 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -59.02 -59.62 5.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.273 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.727 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.97 -56.52 10.34 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.08 0.467 . . . . 0.0 110.23 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 55.1 m -57.59 -30.64 65.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.844 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.9 tmt_? -70.01 -65.73 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.073 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -42.5 -44.49 4.1 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.034 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.501 HG12 HG21 ' A' ' 35' ' ' VAL . 83.3 mt -61.83 -55.78 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.453 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -54.39 -18.1 3.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.512 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.475 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.48 -36.65 8.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.929 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.472 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.2 m120 -125.88 31.47 5.47 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.5 p -83.33 40.55 0.72 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.036 0.446 . . . . 0.0 110.307 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.516 HD12 HH12 ' A' ' 85' ' ' ARG . 59.5 mt . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.266 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.3 pt-20 . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.571 0.224 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.516 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.5 Cg_endo -66.35 146.23 80.0 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.666 2.244 . . . . 0.0 112.463 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.9 m -61.35 153.61 26.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.792 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -100.34 92.57 5.24 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.754 179.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' ' 24' ' ' ALA . 47.3 mt -91.03 71.15 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.714 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.3 p -72.75 2.26 6.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.044 -179.209 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -143.75 146.61 33.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.841 0.353 . . . . 0.0 111.559 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 43.7 t -55.94 -50.2 88.61 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.577 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.1 Cg_endo -58.37 -45.85 28.25 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.873 1.716 . . . . 0.0 111.895 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.06 -34.32 77.34 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 110.29 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.642 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -65.42 -59.24 4.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.044 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.8 mtm -61.08 -24.2 66.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.021 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.5 mt-10 -73.91 -52.19 13.7 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.661 0.267 . . . . 0.0 110.544 179.592 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.497 ' O ' HG22 ' A' ' 31' ' ' THR . 8.2 m-85 -58.83 -31.7 68.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.558 HD11 HD12 ' A' ' 36' ' ' ILE . 49.0 mt -75.05 -40.64 45.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.938 178.074 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.16 -16.9 62.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.096 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.89 24.3 5.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.266 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.599 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.0 t -170.77 153.7 4.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.618 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.502 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.6 tt0 -63.51 -75.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.552 HG13 HD11 ' A' ' 83' ' ' LEU . 18.2 t -96.97 136.63 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.817 0.341 . . . . 0.0 110.701 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.96 124.25 16.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.79 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.489 HG11 HD11 ' A' ' 111' ' ' ILE . 51.6 t -112.49 128.87 68.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.796 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 28' ' ' ILE . 29.3 mt -134.2 137.33 52.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.21 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.554 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.62 97.22 1.68 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.199 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.473 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 41.9 m-85 -82.9 90.83 7.01 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.5 m-85 -109.91 140.63 43.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.41 -178.106 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.453 ' HG2' HD23 ' A' ' 71' ' ' LEU . 47.8 mt-30 -87.45 -9.3 55.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.459 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 17.7 t70 -148.91 123.43 9.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.53 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.499 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.8 mt -92.2 47.14 1.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.974 0.416 . . . . 0.0 111.599 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.9 mt-10 -137.94 10.47 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.113 178.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.72 HG13 HG23 ' A' ' 47' ' ' VAL . 4.1 pt -91.84 159.04 38.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.155 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.496 ' O ' HD12 ' A' ' 49' ' ' ILE . 75.4 Cg_exo -53.93 -25.41 35.71 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.693 2.262 . . . . 0.0 112.858 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.677 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.28 -41.4 94.23 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.913 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.72 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -56.67 -55.6 41.4 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.64 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.6 Cg_exo -61.01 -42.23 38.33 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.572 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.874 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.8 mt -60.34 -33.65 54.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.097 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.61 ' O ' HG23 ' A' ' 54' ' ' VAL . 46.7 tp -75.36 -52.7 10.17 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -52.57 -27.42 16.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.1 0.476 . . . . 0.0 109.763 178.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -79.76 -49.07 12.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.624 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.593 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -57.08 -26.46 60.43 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.528 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.6 t -51.67 -49.79 33.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.838 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -74.77 -16.31 60.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.679 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -88.01 -16.18 34.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.246 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.635 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 50.8 m-85 -137.56 62.43 35.99 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.447 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.52 -43.6 53.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.705 2.27 . . . . 0.0 111.671 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.8 -41.49 94.04 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.645 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.635 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 13.1 t -65.75 145.07 14.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.599 ' HB2' HG21 ' A' ' 31' ' ' THR . 36.8 t -83.64 98.27 9.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 111.016 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.516 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.3 p90 -63.86 129.07 38.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.089 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.469 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -147.39 161.17 28.46 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.071 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -161.61 144.99 4.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.473 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 37.1 t -149.57 159.14 44.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.121 0.486 . . . . 0.0 111.777 -179.124 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.465 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.3 p -139.97 -1.87 1.55 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.546 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.59 138.91 55.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.74 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 61.2 m -61.58 -51.61 67.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.672 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -48.21 -44.08 32.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.695 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.545 ' HA ' HG22 ' A' ' 21' ' ' VAL . 76.1 t -70.7 -54.96 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.908 0.385 . . . . 0.0 110.769 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.2 mp -57.59 -14.57 5.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.2 179.37 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.6 m -91.2 -41.15 11.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.144 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -59.71 -40.22 87.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.455 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.42 ' HB2' HG12 ' A' ' 76' ' ' ILE . 97.5 m-85 -93.33 15.07 16.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.725 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.7 m120 53.87 25.45 5.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.791 179.142 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.694 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.2 mm -60.33 121.41 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.002 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.9 p -140.97 57.86 1.55 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.491 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.3 44.58 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.637 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.617 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 19.5 m-80 51.97 44.09 29.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.247 0.546 . . . . 0.0 110.37 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.694 ' HB ' HG23 ' A' ' 76' ' ' ILE . 91.9 m -69.14 152.79 44.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.676 -178.624 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.554 HG12 ' HA2' ' A' ' 37' ' ' GLY . 66.1 mt -118.89 116.75 52.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.998 177.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.472 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 74.7 m -106.45 133.02 51.79 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.628 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -107.49 103.99 13.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.899 178.405 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -97.05 120.37 37.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.789 0.328 . . . . 0.0 110.694 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.496 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 5.3 mtm180 -104.18 82.22 1.93 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.719 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ARG . 7.2 tp -25.19 -59.66 0.06 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.41 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.502 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.73 -64.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.295 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -93.27 3.83 54.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.922 0.391 . . . . 0.0 110.959 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 49.56 36.59 10.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.526 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 6.3 mm-40 -83.57 157.08 22.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.5 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.18 96.06 3.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.724 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.628 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -84.71 111.55 19.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.048 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.35 115.41 27.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.262 0.553 . . . . 0.0 112.308 -178.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.581 HD21 HD13 ' A' ' 102' ' ' ILE . 3.1 tt -102.61 76.84 1.56 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.156 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.5 mt-10 -78.2 -165.08 0.62 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.621 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.524 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 22.6 t70 -50.48 -38.89 46.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.174 -179.16 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -54.89 -14.62 1.52 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.142 0.496 . . . . 0.0 110.343 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -130.42 -13.81 3.82 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.721 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.563 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.1 mm -90.8 -35.1 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.701 0.286 . . . . 0.0 111.435 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.77 -43.46 65.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.914 0.388 . . . . 0.0 110.758 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.7 m -122.34 40.33 3.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.518 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.581 HD13 HD21 ' A' ' 94' ' ' LEU . 7.6 tp -67.32 143.43 15.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.687 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -138.37 148.31 44.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.536 178.568 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.874 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.14 -36.8 8.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.984 0.421 . . . . 0.0 110.449 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.2 m -62.07 -49.83 74.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.249 178.669 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -57.6 -60.96 2.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.227 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.761 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.69 -56.52 8.32 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.912 0.387 . . . . 0.0 110.44 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.7 m -58.66 -29.99 66.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.974 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.553 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.2 tmt_? -71.08 -65.33 0.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.138 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -43.44 -44.58 5.9 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.044 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.489 HD11 HG11 ' A' ' 35' ' ' VAL . 96.8 mt -62.6 -55.39 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.512 178.365 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.41 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 37.6 tt0 -54.36 -18.73 4.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.266 0.555 . . . . 0.0 110.305 179.392 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.553 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.44 -37.02 9.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.907 -179.136 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.48 ' O ' HD21 ' A' ' 83' ' ' LEU . 17.7 m120 -124.48 30.38 6.03 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 97.9 p -83.08 44.29 0.93 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.055 0.455 . . . . 0.0 110.091 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.418 HD12 HH12 ' A' ' 85' ' ' ARG . 44.4 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.33 -179.445 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.497 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.0 pt-20 . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 46.0 Cg_endo -68.51 142.57 54.3 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.531 2.154 . . . . 0.0 112.619 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.6 m -63.33 152.26 38.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.51 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 12.7 m0 -96.53 89.51 5.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.005 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 24' ' ' ALA . 54.7 mt -83.4 71.28 10.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.056 0.455 . . . . 0.0 110.39 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.6 p -71.07 -1.83 13.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.096 -179.099 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -141.42 147.28 37.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.892 0.377 . . . . 0.0 111.673 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.1 t -57.33 -49.68 92.51 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.364 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.11 -43.76 45.08 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.939 1.759 . . . . 0.0 111.743 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.23 -34.85 79.34 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.2 0.524 . . . . 0.0 110.361 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.624 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.68 -58.65 5.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.954 179.286 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 59.4 mtm -60.6 -27.64 67.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.135 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -71.36 -50.68 29.81 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.756 0.312 . . . . 0.0 110.677 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.534 ' O ' HG22 ' A' ' 31' ' ' THR . 4.0 m-85 -59.47 -34.77 72.96 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.246 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.555 HD11 HD12 ' A' ' 36' ' ' ILE . 48.4 mt -73.07 -39.38 57.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.103 178.519 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.26 -18.85 61.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.081 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.3 24.26 3.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.252 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.709 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.0 t -170.78 155.09 4.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.546 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.547 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.8 tt0 -65.53 -73.25 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG13 HD11 ' A' ' 83' ' ' LEU . 17.9 t -98.66 137.37 26.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.743 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.455 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.19 128.07 19.43 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.234 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.444 HG21 HG12 ' A' ' 111' ' ' ILE . 54.6 t -115.37 131.38 67.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.43 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.555 HD12 HD11 ' A' ' 28' ' ' ILE . 23.1 mt -136.55 136.17 48.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.377 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.64 98.16 1.89 Allowed Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.505 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.49 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.9 m-85 -83.34 89.73 7.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.0 m-85 -109.59 137.88 46.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.497 -178.018 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.449 ' HG2' HD23 ' A' ' 71' ' ' LEU . 48.8 mt-30 -85.18 -4.49 59.18 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.449 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 12.0 t70 -153.63 126.4 8.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.561 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.543 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.1 mt -95.48 48.21 1.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.112 0.482 . . . . 0.0 111.369 -179.355 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.449 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 45.2 mt-10 -137.98 8.65 2.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.808 178.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.812 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.8 pt -91.94 157.17 41.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.247 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.503 ' O ' HD12 ' A' ' 49' ' ' ILE . 76.3 Cg_exo -52.23 -26.03 25.49 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.915 2.41 . . . . 0.0 113.058 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.812 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.19 -36.06 83.0 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.655 HG23 HG13 ' A' ' 44' ' ' ILE . 2.5 t -62.78 -55.75 35.55 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.741 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.644 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.0 Cg_exo -60.83 -39.43 62.28 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.03 1.82 . . . . 0.0 111.471 179.381 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -63.45 -36.7 77.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.062 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.6 ' O ' HG23 ' A' ' 54' ' ' VAL . 42.8 tp -71.89 -51.95 19.73 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -53.21 -26.31 17.15 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.338 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.6 t -80.01 -47.55 14.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.656 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.562 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.17 -26.11 64.5 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.429 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.7 t -53.11 -49.43 50.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.834 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -76.08 -10.59 59.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.626 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -93.69 -18.94 21.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.374 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 67.5 m-85 -135.96 62.21 45.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.589 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.9 -41.14 64.87 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.693 2.262 . . . . 0.0 111.568 179.114 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.14 -41.58 96.69 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.293 179.15 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.1 t -66.1 143.77 15.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.709 ' HB2' HG21 ' A' ' 31' ' ' THR . 33.3 t -81.5 99.3 8.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.039 0.447 . . . . 0.0 110.844 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.479 ' HB3' HG22 ' A' ' 54' ' ' VAL . 3.9 p90 -65.61 126.76 29.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.987 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.491 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.95 162.73 28.35 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.318 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -160.89 141.34 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.1 t -144.29 151.78 39.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.107 0.48 . . . . 0.0 111.655 -179.044 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.432 HG21 ' HG ' ' A' ' 42' ' ' LEU . 81.6 p -135.57 -0.5 2.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.772 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.59 145.99 50.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.918 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.0 t -67.66 -50.58 57.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.466 -179.424 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -50.45 -44.05 55.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.363 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.536 ' HA ' HG22 ' A' ' 21' ' ' VAL . 58.4 t -70.83 -53.45 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.736 0.303 . . . . 0.0 110.604 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.449 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.4 -14.72 8.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.147 0.498 . . . . 0.0 110.459 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.0 m -92.56 -40.68 10.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.466 178.675 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -61.88 -35.33 78.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.497 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.421 ' HB2' HG12 ' A' ' 76' ' ' ILE . 41.9 m-85 -95.55 12.88 28.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.872 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 56.93 23.65 8.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.691 179.236 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.681 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.2 mm -61.08 121.13 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.092 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.2 p -141.02 57.86 1.55 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.378 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.51 46.49 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.536 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.585 ' HB2' HG21 ' A' ' 99' ' ' ILE . 23.3 m-80 51.29 42.94 29.5 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.253 0.549 . . . . 0.0 110.406 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.681 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.0 m -68.93 152.39 45.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.65 -178.568 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.578 HG12 ' HA2' ' A' ' 37' ' ' GLY . 68.1 mt -119.32 118.53 57.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.241 178.163 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.49 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.9 m -107.34 134.04 50.98 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.658 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -107.62 103.05 12.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.716 178.183 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.1 t80 -95.87 120.26 35.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.869 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.567 HH12 HD12 ' A' ' 116' ' ' LEU . 3.9 mtm180 -106.09 82.19 1.73 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.872 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.5 tp -25.11 -58.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.219 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.547 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.08 -60.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.375 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -100.77 4.77 43.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.128 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 54.08 26.01 6.11 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.373 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 13.9 mm-40 -70.61 155.18 41.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.822 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.86 95.06 2.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.445 179.391 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.658 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -84.36 111.55 19.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.224 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.7 118.08 30.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.37 0.605 . . . . 0.0 112.253 -179.13 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.515 HD21 HD13 ' A' ' 102' ' ' ILE . 4.3 tt -105.56 77.6 1.29 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.131 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.7 mt-10 -79.69 -163.84 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.905 -176.543 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.7 t70 -51.11 -35.71 36.7 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.925 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.415 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 12.9 pt-20 -56.18 -14.57 2.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.091 0.472 . . . . 0.0 110.192 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.415 ' OD2' ' HG3' ' A' ' 97' ' ' GLU . 35.5 m-20 -132.46 -14.05 2.94 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.573 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.4 mm -89.86 -33.96 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.718 0.294 . . . . 0.0 111.402 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -54.54 -34.23 61.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.753 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.5 p -133.06 40.25 3.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.341 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.517 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.6 tp -66.07 143.57 15.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.597 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.404 ' N ' HG13 ' A' ' 102' ' ' ILE . 9.3 m-20 -138.62 148.56 44.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.5 178.591 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.91 -35.57 6.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.102 0.477 . . . . 0.0 110.342 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.2 m -63.33 -49.63 73.17 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.358 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -58.61 -59.66 5.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.131 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.7 -55.92 12.07 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.963 0.411 . . . . 0.0 110.317 179.875 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.2 m -58.66 -28.93 66.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.785 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.555 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -71.58 -65.69 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.169 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -42.91 -43.97 4.35 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.913 179.106 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.444 HG12 HG21 ' A' ' 35' ' ' VAL . 94.6 mt -62.96 -55.93 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.571 178.314 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.31 -17.81 3.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.555 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.83 -36.84 8.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.98 -179.194 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.413 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.3 m120 -124.37 30.02 6.16 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 81.2 p -82.38 47.69 1.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.013 0.435 . . . . 0.0 110.315 179.058 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.567 HD12 HH12 ' A' ' 85' ' ' ARG . 63.1 mt . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.297 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.47 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 120.525 0.202 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.0 Cg_endo -67.83 148.25 76.54 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.878 2.385 . . . . 0.0 112.6 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.3 m -64.64 153.99 37.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.54 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -98.84 89.37 4.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.005 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 24' ' ' ALA . 50.1 mt -86.86 74.14 9.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.603 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.9 p -71.82 -1.25 13.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.266 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -143.52 148.73 36.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.868 0.366 . . . . 0.0 111.863 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.592 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 20.4 t -56.86 -50.66 86.78 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.407 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.52 -43.45 50.97 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.944 1.763 . . . . 0.0 111.884 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.61 -35.47 80.9 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.222 0.534 . . . . 0.0 110.299 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.61 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.26 -58.2 7.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.868 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.7 mtm -60.25 -28.56 68.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.005 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -70.57 -48.9 53.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.794 0.331 . . . . 0.0 110.568 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 31' ' ' THR . 4.5 m-85 -60.75 -33.64 73.24 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.999 179.311 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.6 HD11 HD12 ' A' ' 36' ' ' ILE . 38.1 mt -73.55 -39.6 54.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.003 178.568 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.33 -19.16 62.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.177 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.32 26.45 3.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.253 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.648 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.0 t -172.8 154.28 2.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.705 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.526 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.3 tt0 -63.65 -79.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.711 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.53 HG13 HD11 ' A' ' 83' ' ' LEU . 16.0 t -92.88 139.03 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.661 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.45 122.99 14.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 0.0 111.716 -179.45 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.554 HG21 HG12 ' A' ' 111' ' ' ILE . 55.1 t -112.03 128.34 68.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.755 178.449 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.6 HD12 HD11 ' A' ' 28' ' ' ILE . 38.4 mt -134.08 137.59 51.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.604 -177.015 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.544 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.75 98.26 1.82 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.217 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.467 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 35.8 m-85 -84.17 91.88 7.8 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.8 m-85 -111.78 143.76 42.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.356 -178.085 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -89.31 -8.07 54.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.447 ' O ' HG12 ' A' ' 44' ' ' ILE . 13.4 t70 -149.79 124.57 9.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.618 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.547 ' HA ' HG21 ' A' ' 47' ' ' VAL . 90.6 mt -93.18 46.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.055 0.455 . . . . 0.0 111.511 -179.239 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 37.1 mt-10 -136.98 8.93 3.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.917 178.851 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.78 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.2 pt -91.81 155.56 43.37 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.4 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.489 ' O ' HD12 ' A' ' 49' ' ' ILE . 83.8 Cg_exo -50.42 -26.61 16.53 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.877 2.385 . . . . 0.0 112.964 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.78 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.48 -38.52 91.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -179.028 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.691 HG23 HG13 ' A' ' 44' ' ' ILE . 2.8 t -60.0 -55.91 40.83 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.817 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.663 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.7 Cg_exo -60.67 -41.59 45.93 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.081 1.854 . . . . 0.0 111.545 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.871 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.8 mt -61.12 -35.17 63.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.973 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.614 ' O ' HG23 ' A' ' 54' ' ' VAL . 50.4 tp -74.57 -49.47 21.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.06 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -55.14 -25.83 34.63 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.635 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -81.84 -47.34 12.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.69 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.584 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.48 -26.38 63.35 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.455 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 50' ' ' LEU . 41.9 t -52.82 -48.01 50.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.123 179.395 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -77.97 -11.88 59.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.4 mtpp -92.23 -17.86 24.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.312 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.608 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 62.4 m-85 -136.5 62.36 42.52 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.453 -179.651 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.33 -42.12 62.38 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.79 2.327 . . . . 0.0 111.677 179.137 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.9 -40.59 95.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.443 179.233 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.4 t -67.22 142.6 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.648 ' HB2' HG21 ' A' ' 31' ' ' THR . 28.7 t -81.17 98.46 8.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.049 0.452 . . . . 0.0 110.877 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.521 ' HB3' HG22 ' A' ' 54' ' ' VAL . 4.6 p90 -66.04 129.44 39.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.015 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.32 161.98 28.57 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.003 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -160.93 143.93 4.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.467 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 34.1 t -149.79 158.3 44.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.1 0.476 . . . . 0.0 111.693 -179.165 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.518 HG21 ' HG ' ' A' ' 42' ' ' LEU . 77.5 p -139.86 2.53 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.668 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -72.18 134.51 45.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.428 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.1 t -57.86 -49.29 77.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.435 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -50.21 -43.49 52.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.695 -179.378 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.57 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.9 t -71.35 -53.2 21.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.967 0.413 . . . . 0.0 110.69 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 76' ' ' ILE . 6.6 mp -59.31 -14.34 11.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.176 179.362 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.5 m -92.02 -41.24 10.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.251 178.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -60.68 -38.51 85.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.434 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.41 ' HB2' HG12 ' A' ' 76' ' ' ILE . 60.1 m-85 -92.61 10.46 30.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.766 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.9 t30 58.95 23.01 11.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.626 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.718 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.0 mm -60.23 123.34 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.022 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.5 p -143.62 60.05 1.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.028 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.86 43.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.572 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.612 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 30.0 m-80 52.09 43.57 30.35 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.109 0.48 . . . . 0.0 110.43 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.718 ' HB ' HG23 ' A' ' 76' ' ' ILE . 88.5 m -68.41 152.67 45.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.655 -178.636 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.579 HG21 HD21 ' A' ' 107' ' ' LEU . 62.2 mt -118.46 115.53 48.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 78.3 m -103.63 135.14 45.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -177.742 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.631 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -110.72 105.61 14.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.125 178.519 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.7 t80 -99.41 118.94 37.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.996 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.456 HH12 HD12 ' A' ' 116' ' ' LEU . 3.3 mtm180 -103.29 80.69 1.86 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.789 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 85' ' ' ARG . 6.6 tp -24.33 -59.65 0.05 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.935 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.526 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.79 -62.48 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.302 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -96.87 3.3 52.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.0 0.428 . . . . 0.0 111.065 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 51.77 32.07 9.01 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.526 179.471 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.9 mm-40 -80.03 137.5 36.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.614 179.656 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.02 93.31 4.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.028 0.442 . . . . 0.0 110.86 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.631 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -81.16 141.39 34.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.361 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -121.86 115.18 22.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.322 0.582 . . . . 0.0 112.343 -179.425 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.533 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -99.57 74.88 1.91 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.42 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.5 mt-10 -76.38 -166.03 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -176.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.474 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.4 OUTLIER -46.01 -51.7 13.1 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.418 -179.278 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -47.15 -15.83 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.275 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 96' ' ' ASP . 30.5 m-20 -127.02 -14.03 5.6 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.351 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.546 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.4 mm -91.59 -40.48 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -46.18 -42.85 14.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 t -124.45 41.36 3.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.491 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.533 HD13 HD21 ' A' ' 94' ' ' LEU . 7.3 tp -66.86 143.6 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.712 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -137.22 149.54 47.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.486 178.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.871 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.23 -36.77 14.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.379 . . . . 0.0 110.461 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 99.5 m -62.27 -48.42 79.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.236 178.711 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -58.86 -59.34 5.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.188 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.2 -56.39 11.25 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.05 0.452 . . . . 0.0 110.182 -179.96 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.6 m -58.05 -28.8 64.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.744 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.498 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.9 tmt_? -71.6 -66.05 0.68 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.967 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -42.13 -45.52 4.03 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.865 179.105 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.554 HG12 HG21 ' A' ' 35' ' ' VAL . 82.1 mt -61.33 -56.86 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.593 178.521 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -53.82 -18.07 2.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.336 179.393 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.498 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.43 -37.16 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.215 -179.042 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.458 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.6 m120 -124.62 29.63 6.21 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 99.8 p -82.9 49.11 1.45 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.996 0.427 . . . . 0.0 110.316 179.055 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.456 HD12 HH12 ' A' ' 85' ' ' ARG . 73.7 mt . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.355 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.519 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.9 pt-20 . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.423 0.154 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 31.4 Cg_endo -65.0 139.76 62.89 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.487 2.124 . . . . 0.0 112.526 -179.534 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 17' ' ' TRP . 19.2 m -57.18 154.34 10.34 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.003 -179.399 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.401 ' N ' HG22 ' A' ' 16' ' ' THR . 10.4 m-90 -98.21 94.11 6.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.902 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.617 HD13 ' HA ' ' A' ' 24' ' ' ALA . 51.3 mt -90.07 70.01 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.27 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.2 p -68.82 -2.6 9.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.246 -178.91 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -142.61 147.53 35.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.997 0.427 . . . . 0.0 111.645 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.7 t -55.29 -50.01 89.11 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.638 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.6 Cg_endo -57.06 -46.87 25.86 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.958 1.772 . . . . 0.0 111.924 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.8 -34.62 77.66 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.193 0.52 . . . . 0.0 110.113 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -64.13 -59.26 4.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.054 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.4 mtp -60.62 -25.19 66.09 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.183 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -72.26 -50.82 24.3 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.571 179.601 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 31' ' ' THR . 12.0 m-85 -61.72 -29.48 70.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.047 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.516 HD11 HD12 ' A' ' 36' ' ' ILE . 50.2 mt -76.11 -37.48 33.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.068 178.217 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.79 -19.54 60.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.115 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.41 30.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.197 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.613 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.7 t -170.97 153.53 3.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.314 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.615 ' HG3' HG13 ' A' ' 87' ' ' VAL . 27.5 tt0 -70.18 -46.29 64.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.793 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.508 HG13 HD11 ' A' ' 83' ' ' LEU . 21.1 t -124.53 135.22 64.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.286 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.507 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.56 127.47 22.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.163 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.503 HG21 HG12 ' A' ' 111' ' ' ILE . 49.2 t -115.66 128.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.465 178.511 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.516 HD12 HD11 ' A' ' 28' ' ' ILE . 22.2 mt -134.64 138.41 49.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.556 -177.322 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.575 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.87 97.06 1.64 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.378 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.477 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 39.3 m-85 -82.95 91.96 7.24 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.0 m-85 -112.0 145.21 40.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.181 0.515 . . . . 0.0 112.378 -178.188 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.479 ' HG2' HD23 ' A' ' 71' ' ' LEU . 46.2 mt-30 -93.17 -0.99 56.75 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.8 t70 -156.58 123.85 5.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.564 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.549 ' HA ' HG21 ' A' ' 47' ' ' VAL . 84.0 mt -93.75 47.5 1.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.204 0.526 . . . . 0.0 111.505 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 45.4 mt-10 -137.38 7.27 2.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.729 178.892 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.808 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.0 pt -89.68 156.55 47.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.027 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.509 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.1 Cg_exo -52.16 -24.19 19.62 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.876 2.384 . . . . 0.0 113.007 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.808 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -67.32 -35.99 80.56 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.706 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.673 HG23 HG13 ' A' ' 44' ' ' ILE . 2.6 t -61.9 -54.97 45.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.667 -178.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.6 Cg_exo -61.44 -40.28 49.48 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.999 1.799 . . . . 0.0 111.445 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.868 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.3 mt -63.11 -35.92 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.19 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.624 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.9 tp -73.06 -50.26 23.99 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.865 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -54.82 -25.37 27.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.198 0.523 . . . . 0.0 109.598 178.459 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.9 t -80.98 -47.23 13.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.547 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.556 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.23 -27.17 65.51 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.541 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.6 t -51.71 -50.91 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.021 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -74.68 -12.35 60.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.722 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -91.81 -17.34 25.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.215 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.619 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.0 m-85 -138.15 63.37 36.23 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.568 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.07 -41.11 74.19 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.652 2.235 . . . . 0.0 111.58 179.021 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.3 -41.83 97.05 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.35 179.124 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.6 t -65.76 144.69 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.613 ' HB2' HG21 ' A' ' 31' ' ' THR . 47.5 t -82.35 97.23 8.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.026 0.441 . . . . 0.0 111.006 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.493 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -64.45 126.64 28.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.724 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.476 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.1 161.84 28.33 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.169 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' A' ' 15' ' ' PRO . 4.3 tt -161.03 143.02 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.477 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 35.6 t -147.25 153.52 39.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.071 0.462 . . . . 0.0 111.805 -179.061 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.483 HG21 ' HG ' ' A' ' 42' ' ' LEU . 64.4 p -135.62 5.73 3.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.371 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.27 140.34 44.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.738 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.8 m -62.94 -52.78 61.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.378 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -47.7 -44.73 27.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.614 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.509 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.0 t -70.05 -55.29 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.832 0.348 . . . . 0.0 110.991 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.479 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -57.39 -14.84 5.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.25 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.4 m -90.48 -41.43 11.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.246 178.768 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -60.1 -39.42 86.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.392 179.804 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -92.93 12.99 21.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.959 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.3 m120 55.15 24.28 6.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.623 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.709 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.4 mm -60.16 120.43 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.97 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.5 p -142.05 55.67 1.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.942 0.401 . . . . 0.0 111.109 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.44 42.37 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.432 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.625 ' HB2' HG21 ' A' ' 99' ' ' ILE . 35.6 m-20 52.24 43.37 30.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.232 0.539 . . . . 0.0 110.364 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.709 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.6 m -68.95 151.11 46.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.87 -178.427 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.575 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.0 mt -117.8 115.47 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.911 177.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.458 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 78.3 m -103.82 132.57 49.95 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.865 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.665 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.3 tp -109.07 103.68 12.74 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.803 178.312 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.6 t80 -98.73 122.15 41.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.821 0.343 . . . . 0.0 110.79 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.481 HH21 ' HB2' ' A' ' 88' ' ' ASP . 2.8 mtm180 -105.04 98.72 8.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.036 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.3 tp -41.9 -52.71 4.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.882 -179.533 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.615 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.7 -71.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.385 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.481 ' HB2' HH21 ' A' ' 85' ' ' ARG . 11.2 m-20 -88.33 6.01 39.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.041 -179.665 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 52.49 35.89 18.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.387 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 7.3 mm-40 -81.46 161.66 23.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.817 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -146.05 92.81 2.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.92 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.665 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -79.39 144.23 34.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.181 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -124.56 95.49 4.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.025 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.579 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -81.0 77.78 7.88 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.639 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.5 mt-10 -78.8 -165.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.514 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 25.5 t70 -51.01 -36.47 39.57 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.932 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -56.27 -14.61 2.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.183 0.516 . . . . 0.0 110.361 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -130.68 -13.95 3.67 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.592 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.625 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.0 mm -89.49 -32.71 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.754 0.311 . . . . 0.0 111.373 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -50.36 -47.98 55.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.728 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -122.05 38.31 4.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.609 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.579 HD13 HD21 ' A' ' 94' ' ' LEU . 7.0 tp -61.07 143.44 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.653 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.404 ' N ' HG13 ' A' ' 102' ' ' ILE . 19.1 m-20 -137.12 147.91 46.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.473 178.605 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.868 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.1 -35.26 6.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.99 0.424 . . . . 0.0 110.45 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -63.91 -48.68 75.62 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.423 178.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -58.98 -58.58 8.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.115 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.733 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.49 -55.78 14.47 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.998 0.428 . . . . 0.0 110.134 179.901 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.1 m -58.31 -28.98 65.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.823 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.7 tmt_? -72.65 -65.88 0.73 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.222 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -42.92 -42.82 3.86 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.04 179.112 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.503 HG12 HG21 ' A' ' 35' ' ' VAL . 92.2 mt -64.18 -56.63 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.576 178.371 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -52.33 -22.16 4.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.367 0.604 . . . . 0.0 110.211 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.475 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -85.17 -37.88 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.93 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.436 ' O ' HD21 ' A' ' 83' ' ' LEU . 17.7 m120 -123.64 30.78 6.1 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.312 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 111' ' ' ILE . 87.4 p -83.5 39.58 0.68 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.18 0.514 . . . . 0.0 110.066 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.7 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.291 -179.453 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.1 pt-20 . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 120.426 0.155 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.495 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.9 Cg_endo -66.3 140.71 59.53 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.55 2.167 . . . . 0.0 112.465 -179.701 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 m -56.46 150.5 15.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.666 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -96.27 93.36 6.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.98 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 24' ' ' ALA . 54.2 mt -90.7 72.93 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.511 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.7 p -74.96 2.11 11.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.065 -179.21 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -144.67 147.54 33.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 0.0 111.595 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.589 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 39.7 t -56.48 -50.21 89.08 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.622 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.96 -44.92 35.82 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 121.876 1.717 . . . . 0.0 111.797 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.85 -36.22 83.2 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.169 0.509 . . . . 0.0 110.33 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.61 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.21 -59.4 4.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.148 179.377 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 65.8 mtp -60.97 -25.19 66.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.139 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 21.3 mt-10 -72.59 -51.98 17.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.719 0.295 . . . . 0.0 110.648 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.507 ' O ' HG22 ' A' ' 31' ' ' THR . 12.5 m-85 -59.94 -31.87 70.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.935 179.368 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.572 HD11 HD12 ' A' ' 36' ' ' ILE . 50.7 mt -75.27 -38.8 41.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.938 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.61 -19.0 61.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.232 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.76 26.18 3.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.243 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.0 t -170.62 153.75 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.611 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.529 ' HG3' HG13 ' A' ' 87' ' ' VAL . 18.2 tt0 -64.5 -73.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.574 HG13 HD11 ' A' ' 83' ' ' LEU . 19.7 t -98.13 137.81 24.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.613 179.787 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.18 125.65 16.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.937 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 111' ' ' ILE . 55.0 t -114.07 130.16 68.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.85 178.558 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.572 HD12 HD11 ' A' ' 28' ' ' ILE . 27.0 mt -135.53 137.78 49.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.625 -177.264 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.24 98.08 1.75 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.587 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.523 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.0 m-85 -84.3 91.84 7.85 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.4 m-85 -110.84 143.87 40.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.287 -178.191 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -91.51 -3.3 56.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.762 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.522 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.6 t70 -154.8 118.46 4.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.596 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.494 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.8 mt -87.96 44.78 1.22 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.01 0.433 . . . . 0.0 111.329 -179.318 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 31.3 mt-10 -135.28 10.11 3.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.128 179.054 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.73 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.3 pt -92.77 157.57 39.4 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.477 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.462 ' O ' HD12 ' A' ' 49' ' ' ILE . 71.8 Cg_exo -52.22 -27.5 30.43 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.908 2.405 . . . . 0.0 112.898 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.73 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.36 -39.95 95.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.701 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -58.57 -56.89 30.92 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -178.633 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -58.87 -40.29 73.4 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.783 1.655 . . . . 0.0 111.438 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.874 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -61.85 -35.34 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.936 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.586 ' O ' HG23 ' A' ' 54' ' ' VAL . 39.7 tp -75.03 -54.67 6.76 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -52.68 -23.69 7.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.0 0.429 . . . . 0.0 109.947 178.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -84.22 -46.08 12.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.557 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.606 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.0 -25.26 63.48 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.318 0.58 . . . . 0.0 109.457 179.433 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.3 t -51.57 -50.49 29.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.121 179.352 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -76.08 -9.48 58.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.874 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -93.13 -19.74 21.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.998 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.9 m-85 -135.84 63.79 53.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.506 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.61 -43.2 57.05 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.707 2.272 . . . . 0.0 111.576 179.229 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.42 -42.29 93.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.337 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -65.27 143.77 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.67 ' HB2' HG21 ' A' ' 31' ' ' THR . 38.2 t -82.28 98.12 8.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 111.092 -179.627 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.495 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.4 p90 -65.37 128.35 35.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.927 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.485 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.83 161.84 28.62 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.025 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.419 HD11 HG13 ' A' ' 47' ' ' VAL . 4.7 tt -160.18 144.3 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 t -148.48 158.72 44.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.191 0.519 . . . . 0.0 111.865 -178.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 39' ' ' PHE . 72.5 p -141.49 1.03 1.53 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.585 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.02 144.97 52.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.663 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.4 m -66.67 -53.4 34.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.344 -179.522 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 2.2 mp0 -48.71 -42.95 36.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.511 -179.684 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.522 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.8 t -70.56 -56.12 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.051 0.453 . . . . 0.0 110.648 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.49 -15.08 3.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.315 179.477 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.5 m -90.87 -41.23 11.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.304 178.745 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -61.33 -31.91 71.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.251 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -100.02 12.39 37.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.274 179.63 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.7 m120 55.95 22.05 5.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.595 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.666 HG23 ' HB ' ' A' ' 80' ' ' THR . 32.4 mm -58.96 118.99 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.152 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.6 p -142.16 55.81 1.46 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.085 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.82 42.41 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.355 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.591 ' HB2' HG21 ' A' ' 99' ' ' ILE . 23.8 m-80 53.17 42.19 32.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.256 0.55 . . . . 0.0 110.203 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.666 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.9 m -67.93 151.77 46.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.864 -178.497 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.581 HG12 ' HA2' ' A' ' 37' ' ' GLY . 66.4 mt -118.95 115.79 49.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.88 177.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.523 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.4 m -105.34 132.65 51.26 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.656 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -108.34 103.91 13.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.925 178.327 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.5 t80 -97.36 123.58 41.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.847 0.356 . . . . 0.0 110.579 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.487 HH12 HD12 ' A' ' 116' ' ' LEU . 4.5 mtm180 -106.36 81.23 1.58 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.705 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 85' ' ' ARG . 4.6 tp -24.13 -59.76 0.05 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.06 -179.537 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.529 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.03 -61.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.064 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.9 4.29 49.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.953 0.406 . . . . 0.0 111.19 -179.428 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.9 m120 53.21 28.24 6.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.81 179.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.0 mm-40 -74.13 159.29 32.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.578 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -144.19 96.8 2.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.827 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.656 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.1 mm? -85.32 111.57 20.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.058 179.635 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -93.87 101.36 13.44 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.77 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.634 HD21 HD13 ' A' ' 102' ' ' ILE . 3.4 tt -86.72 75.82 9.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.656 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.0 mt-10 -77.1 -166.1 0.66 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -176.805 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.48 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -46.11 -50.67 15.13 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.398 -179.388 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -47.73 -16.3 0.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.976 0.417 . . . . 0.0 111.285 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.41 ' N ' ' C ' ' A' ' 96' ' ' ASP . 43.0 m-20 -126.38 -13.91 5.98 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.465 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.591 HG21 ' HB2' ' A' ' 79' ' ' ASN . 20.9 mm -91.46 -32.21 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -48.84 -59.31 3.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.962 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.6 p -110.72 36.28 3.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.585 179.623 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.634 HD13 HD21 ' A' ' 94' ' ' LEU . 8.7 tp -56.91 144.66 8.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.438 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.413 ' H ' ' HD3' ' A' ' 106' ' ' LYS . 21.7 m-20 -138.5 148.75 44.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.721 179.072 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.874 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.18 -36.72 14.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.029 0.442 . . . . 0.0 110.491 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 96.6 m -61.46 -49.07 78.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.174 178.724 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.413 ' HD3' ' H ' ' A' ' 103' ' ' ASP . 55.9 mtpt -58.1 -61.45 2.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.148 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.79 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.21 -56.54 7.69 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.903 0.382 . . . . 0.0 110.511 -179.849 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 56.6 m -58.31 -29.85 66.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.918 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.508 ' NH1' HD11 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -71.29 -64.7 0.86 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.252 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -44.52 -43.01 7.64 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.079 179.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.475 HG12 HG21 ' A' ' 35' ' ' VAL . 95.9 mt -63.76 -56.43 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.639 178.464 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -53.23 -19.39 3.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.179 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.508 HD11 ' NH1' ' A' ' 109' ' ' ARG . 1.3 mp -88.56 -37.75 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.07 -179.075 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.429 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.6 m120 -122.4 30.03 6.7 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.6 p -82.35 43.74 0.83 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.123 0.487 . . . . 0.0 110.152 178.697 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.487 HD12 HH12 ' A' ' 85' ' ' ARG . 49.5 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.408 -179.224 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.9 pt-20 . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 110.687 -0.116 . . . . 0.0 110.687 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.503 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.7 Cg_endo -66.89 141.65 59.58 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.423 2.082 . . . . 0.0 112.173 -179.792 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.6 m -56.42 152.31 11.67 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.495 -179.547 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -99.79 85.67 3.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.062 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.603 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.7 mt -81.89 74.61 8.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.453 179.84 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.7 p -74.14 -1.96 22.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.98 -178.959 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -140.11 147.02 39.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.422 . . . . 0.0 111.643 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 32.2 t -56.09 -50.05 89.62 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.534 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.4 Cg_endo -58.74 -45.33 29.94 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.808 1.672 . . . . 0.0 111.718 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.54 -33.82 76.42 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.25 0.547 . . . . 0.0 110.169 179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.93 -59.11 4.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.006 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.8 mtp -60.6 -26.02 66.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.182 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.3 mt-10 -72.86 -50.97 20.66 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.708 0.289 . . . . 0.0 110.642 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.486 ' O ' HG22 ' A' ' 31' ' ' THR . 7.8 m-85 -59.92 -32.2 70.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.854 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 36' ' ' ILE . 47.6 mt -75.08 -40.5 44.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.08 0.466 . . . . 0.0 110.111 178.312 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -18.7 62.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.207 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.48 25.41 3.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.206 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.635 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.7 t -171.0 155.1 4.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.744 -179.788 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.522 ' HG3' HG13 ' A' ' 87' ' ' VAL . 18.4 tt0 -64.61 -77.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.824 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.584 HG13 HD11 ' A' ' 83' ' ' LEU . 20.2 t -95.93 136.97 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.731 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.516 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.41 126.04 17.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.942 0.401 . . . . 0.0 112.074 -179.124 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.421 HG21 HG12 ' A' ' 111' ' ' ILE . 53.9 t -114.53 131.01 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.836 178.539 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.559 HD12 HD11 ' A' ' 28' ' ' ILE . 27.9 mt -135.97 135.39 50.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.274 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.593 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.58 98.06 1.97 Allowed Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.619 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 10.8 m-85 -84.17 91.73 7.77 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.606 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.0 m-85 -112.08 137.98 49.37 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.128 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -83.21 -7.03 59.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.942 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.459 ' O ' HG12 ' A' ' 44' ' ' ILE . 7.2 t70 -152.03 125.6 8.89 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.654 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.551 ' HA ' HG21 ' A' ' 47' ' ' VAL . 96.0 mt -93.23 43.27 1.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.039 0.447 . . . . 0.0 111.407 -179.645 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -132.55 14.79 4.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.828 178.932 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.6 pt -99.08 157.77 33.48 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.197 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.477 ' O ' HD12 ' A' ' 49' ' ' ILE . 74.1 Cg_exo -52.99 -26.98 33.88 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.9 2.4 . . . . 0.0 112.956 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.781 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.77 -38.25 89.86 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.017 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.672 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.35 -56.4 34.2 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.629 -178.826 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.2 Cg_exo -59.64 -41.23 57.98 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.942 1.762 . . . . 0.0 111.372 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -61.16 -35.87 68.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.054 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.594 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.8 tp -73.68 -52.06 14.58 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 178.784 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -53.58 -25.18 16.2 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.705 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -81.76 -46.82 13.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.505 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.558 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.16 -25.81 64.24 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.357 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.7 t -53.06 -47.69 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.948 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -77.99 -11.62 59.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.714 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -92.73 -17.77 23.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.155 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.618 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.3 m-85 -137.14 62.63 39.85 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.605 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.37 -39.46 81.47 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.517 2.145 . . . . 0.0 111.466 178.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.65 -39.42 96.55 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.458 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.1 t -68.58 144.09 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.067 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.635 ' HB2' HG21 ' A' ' 31' ' ' THR . 35.7 t -81.29 98.08 7.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 110.916 -179.754 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.503 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.2 p90 -65.16 127.52 32.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.77 162.88 28.57 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.212 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -160.68 143.71 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.774 0.321 . . . . 0.0 110.155 179.889 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.3 t -146.91 154.17 40.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.041 0.448 . . . . 0.0 111.512 -179.255 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.457 HG21 ' HG ' ' A' ' 42' ' ' LEU . 81.9 p -137.73 -4.75 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.71 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.35 144.49 55.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.831 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -64.35 -51.49 63.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.46 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -48.6 -45.26 37.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.656 -179.517 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.533 ' HA ' HG22 ' A' ' 21' ' ' VAL . 74.5 t -70.15 -53.47 23.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.829 0.347 . . . . 0.0 110.724 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.71 -14.32 8.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.351 179.416 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.2 m -91.91 -41.68 10.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.274 178.717 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -60.09 -39.62 86.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.414 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.42 ' HB2' HG12 ' A' ' 76' ' ' ILE . 59.0 m-85 -91.74 11.95 22.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.787 179.606 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 55.79 26.23 9.32 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.542 179.222 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.682 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.0 mm -61.89 122.06 11.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.226 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.6 p -140.83 58.2 1.55 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.311 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.87 46.77 0.02 OUTLIER Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.89 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.626 ' HB2' HG21 ' A' ' 99' ' ' ILE . 30.2 m-80 50.57 43.0 27.53 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.229 0.538 . . . . 0.0 110.543 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.682 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.6 m -69.17 152.57 44.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.686 -178.612 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.593 HG12 ' HA2' ' A' ' 37' ' ' GLY . 60.6 mt -118.9 118.34 57.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.107 178.189 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.9 m -107.89 134.07 51.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.941 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.651 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -109.53 104.73 13.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.085 178.544 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.4 t80 -97.3 122.61 40.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.464 179.555 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.583 HH12 HD12 ' A' ' 116' ' ' LEU . 5.6 mtm180 -106.85 82.71 1.74 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.928 0.394 . . . . 0.0 110.835 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tp -25.67 -60.03 0.07 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.127 -179.404 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.522 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.25 -58.75 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.852 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -98.83 13.28 32.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.758 0.313 . . . . 0.0 111.37 -179.177 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.2 p30 43.55 30.95 0.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.017 178.996 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.536 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 28.2 mm-40 -77.47 157.16 30.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.835 0.35 . . . . 0.0 110.916 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -142.26 94.48 2.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.676 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.651 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -85.25 121.69 28.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.637 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -105.16 103.77 13.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.767 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.555 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -89.63 78.67 6.96 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.817 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.1 mt-10 -79.81 -165.87 0.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.81 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.491 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.1 -51.06 10.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.7 -179.311 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -46.56 -18.88 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.857 0.361 . . . . 0.0 111.088 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 96' ' ' ASP . 16.2 m-20 -124.73 -13.82 6.89 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.488 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.626 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.7 mm -90.59 -40.61 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.363 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -49.08 -40.91 33.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.342 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.3 t -123.68 36.41 4.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.449 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.58 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 8.1 tp -63.14 144.68 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.475 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -139.69 147.88 41.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.475 178.756 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.11 -37.84 10.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.984 0.421 . . . . 0.0 110.554 -179.571 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -61.43 -47.55 85.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.311 178.647 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -60.12 -60.83 3.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.215 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.763 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.0 -55.56 11.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.329 -179.999 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.0 m -58.45 -30.49 66.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.732 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.443 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.5 tmt_? -70.4 -66.55 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.128 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -42.62 -45.16 4.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.169 179.454 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.421 HG12 HG21 ' A' ' 35' ' ' VAL . 96.4 mt -62.41 -54.76 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.306 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.41 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 40.8 tt0 -54.6 -18.78 4.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.426 179.397 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.443 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.62 -37.43 10.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.79 -178.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.419 ' O ' HD21 ' A' ' 83' ' ' LEU . 19.9 m120 -122.96 29.36 6.82 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.387 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 78.9 p -82.65 50.85 1.75 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.118 0.485 . . . . 0.0 110.092 178.824 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.583 HD12 HH12 ' A' ' 85' ' ' ARG . 57.0 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.278 -0.867 . . . . 0.0 111.374 -179.251 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.1 pt-20 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.405 0.145 . . . . 0.0 110.714 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.7 Cg_endo -65.37 145.21 82.68 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.618 2.212 . . . . 0.0 112.48 -179.569 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 17' ' ' TRP . 21.8 m -61.76 155.36 23.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.74 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.414 ' N ' HG22 ' A' ' 16' ' ' THR . 7.4 m-90 -99.1 91.46 5.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.077 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.628 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.8 mt -87.97 74.19 8.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.415 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.7 p -73.02 -3.18 24.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.156 -178.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -141.31 148.28 39.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.865 0.364 . . . . 0.0 111.643 -179.721 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.609 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.9 t -56.54 -50.28 88.7 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.407 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -57.34 -44.04 46.6 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 121.97 1.78 . . . . 0.0 111.866 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.24 -36.91 85.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.206 0.527 . . . . 0.0 110.184 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.628 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.87 -59.05 5.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.026 179.499 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.0 mtp -60.55 -27.19 67.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.212 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 19.8 mt-10 -70.66 -49.29 48.87 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.746 0.308 . . . . 0.0 110.547 179.843 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.57 ' O ' HG22 ' A' ' 31' ' ' THR . 9.5 m-85 -61.52 -34.16 75.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.243 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 36' ' ' ILE . 50.0 mt -72.99 -37.06 52.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.126 0.488 . . . . 0.0 109.939 178.345 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.01 -19.43 60.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.959 -179.849 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.61 23.95 4.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.297 -179.651 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.674 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.1 t -169.96 153.33 4.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.518 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.542 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.2 tt0 -63.92 -80.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.669 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.544 HG13 HD11 ' A' ' 83' ' ' LEU . 16.9 t -91.86 134.15 31.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.489 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.43 126.06 22.11 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.195 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.474 HG21 HG12 ' A' ' 111' ' ' ILE . 48.9 t -114.21 129.13 70.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.811 178.546 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.559 HD12 HD11 ' A' ' 28' ' ' ILE . 24.2 mt -135.59 137.17 49.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.439 -177.524 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.527 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.61 98.71 1.89 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.427 179.734 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.48 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 45.7 m-85 -84.62 93.05 8.3 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.302 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.2 m-85 -112.33 145.86 39.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.351 -177.986 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -93.81 -4.95 49.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.951 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.516 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.1 t70 -152.68 118.39 5.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.599 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.518 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.4 mt -88.15 45.8 1.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 111.336 -179.295 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 45.4 mt-10 -136.03 9.06 3.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.125 179.161 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.779 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.7 pt -92.27 157.52 40.48 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.152 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.49 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.3 Cg_exo -52.53 -27.94 34.36 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.855 2.37 . . . . 0.0 112.865 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.779 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.47 -37.79 87.29 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.936 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.684 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.51 -57.35 25.63 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.654 -178.833 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.659 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -59.39 -38.97 80.94 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.794 1.663 . . . . 0.0 111.37 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -63.26 -35.19 71.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.89 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.7 tp -74.61 -53.35 9.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.73 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -54.64 -21.81 11.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.009 0.433 . . . . 0.0 110.04 178.874 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 t -85.89 -45.01 11.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.491 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.583 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.31 -25.83 66.07 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.296 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.4 t -52.39 -49.92 40.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.999 179.286 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -74.91 -9.59 58.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.721 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.1 mtpp -94.83 -19.35 20.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.09 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.569 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 70.4 m-85 -135.96 63.03 49.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.476 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.4 -43.15 56.36 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.629 2.219 . . . . 0.0 111.632 179.145 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.89 -42.66 92.43 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.338 179.188 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.8 t -64.47 145.27 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.815 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.674 ' HB2' HG21 ' A' ' 31' ' ' THR . 29.9 t -83.15 98.94 9.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.033 0.444 . . . . 0.0 111.072 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.52 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.0 p90 -66.47 126.66 29.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.1 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.55 161.34 28.37 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.145 179.645 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.416 HD11 HG13 ' A' ' 47' ' ' VAL . 4.9 tt -159.98 144.01 5.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.474 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 31.1 t -148.05 159.52 43.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.006 0.431 . . . . 0.0 111.705 -179.306 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 50.6 p -140.46 -2.56 1.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.086 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.43 141.11 55.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.744 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.0 m -62.99 -50.91 68.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.553 -179.417 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -48.95 -44.61 40.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.638 -179.37 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.517 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.3 t -70.01 -54.4 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.909 0.385 . . . . 0.0 110.766 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -57.97 -14.51 6.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.303 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 76.4 m -91.62 -40.14 11.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.227 178.659 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -60.68 -39.67 89.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.38 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.411 ' HB2' HG12 ' A' ' 76' ' ' ILE . 93.0 m-85 -93.09 13.88 19.58 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.444 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 m120 54.8 26.2 7.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.582 179.519 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.717 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.6 mm -61.19 120.7 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.01 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.5 p -140.74 58.28 1.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.323 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.47 44.26 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.643 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.603 ' HB2' HG21 ' A' ' 99' ' ' ILE . 35.2 m-20 51.75 43.49 29.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.284 0.564 . . . . 0.0 110.353 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.717 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.4 m -68.66 152.28 45.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.786 -178.646 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.527 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.2 mt -119.21 115.68 48.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.97 177.898 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.48 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 72.5 m -104.11 131.03 51.81 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.722 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.658 ' HG ' HD23 ' A' ' 92' ' ' LEU . 1.9 tp -106.96 102.16 11.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.492 177.906 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.1 t80 -95.73 119.68 34.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.806 -179.883 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.475 HH12 HD12 ' A' ' 116' ' ' LEU . 4.4 mtm180 -102.97 80.86 1.91 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.673 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 85' ' ' ARG . 4.7 tp -24.87 -59.14 0.06 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.351 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.542 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.13 -62.51 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.088 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -95.35 2.88 54.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.087 0.47 . . . . 0.0 110.797 -179.677 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 52.42 33.13 12.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.445 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 12.7 mm-40 -79.37 158.2 27.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.84 99.1 3.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.953 0.406 . . . . 0.0 110.885 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.658 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -87.59 107.6 18.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.747 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -90.89 95.12 9.96 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.572 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.572 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -79.6 76.98 6.22 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.594 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.3 mt-10 -78.46 -165.44 0.7 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -176.811 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.483 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -46.03 -50.02 15.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.484 -179.233 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -47.83 -17.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.963 0.411 . . . . 0.0 110.943 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 96' ' ' ASP . 13.7 m-20 -125.65 -13.67 6.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.392 -179.735 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.603 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.1 mm -91.87 -46.31 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.559 0.219 . . . . 0.0 111.561 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -48.82 -31.05 6.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.913 0.387 . . . . 0.0 110.739 179.783 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 57.0 m -131.25 45.55 2.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.072 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.572 HD13 HD21 ' A' ' 94' ' ' LEU . 8.1 tp -78.61 146.39 8.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.79 -179.452 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.427 ' N ' HG13 ' A' ' 102' ' ' ILE . 6.1 m-20 -141.37 148.8 40.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.266 178.616 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.13 -37.36 9.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 110.593 -179.598 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -61.44 -49.2 77.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.401 178.722 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -58.66 -60.47 3.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.151 -179.685 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.802 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.93 -55.72 10.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.006 0.432 . . . . 0.0 110.264 -179.954 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.3 m -58.35 -29.57 66.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.819 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.515 ' HD3' HD13 ' A' ' 113' ' ' ILE . 1.7 tmt_? -72.15 -66.56 0.63 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.184 179.713 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -42.05 -44.12 3.46 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.05 179.147 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.474 HG12 HG21 ' A' ' 35' ' ' VAL . 96.7 mt -62.5 -55.02 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.517 178.386 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -55.25 -17.85 5.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.325 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.515 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -91.01 -36.0 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.856 -179.185 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.449 ' OD1' HG22 ' A' ' 113' ' ' ILE . 30.4 m120 -119.33 26.4 9.46 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.9 p -79.92 46.12 0.77 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.044 0.449 . . . . 0.0 110.306 178.949 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.475 HD12 HH12 ' A' ' 85' ' ' ARG . 57.0 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.413 -179.336 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.47 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.3 pt-20 . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.482 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.4 Cg_endo -65.48 142.62 72.56 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.421 2.081 . . . . 0.0 112.611 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.5 m -60.76 151.45 29.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.695 -179.595 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -95.17 92.01 6.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.083 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.631 HD22 ' HA ' ' A' ' 24' ' ' ALA . 65.2 mt -88.72 77.64 7.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.411 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.6 p -77.26 -3.19 38.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.023 -179.113 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -141.69 147.33 37.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.948 0.404 . . . . 0.0 111.774 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 22.1 t -55.22 -50.02 88.98 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.633 179.875 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.89 -45.82 30.17 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.939 1.759 . . . . 0.0 111.793 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.23 -33.99 76.69 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.205 0.526 . . . . 0.0 110.149 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.631 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.52 -59.39 4.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.116 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 47.3 mtm -61.1 -26.33 67.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.131 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.9 mt-10 -71.23 -52.07 21.08 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.702 0.286 . . . . 0.0 110.437 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -59.79 -30.71 69.08 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.122 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.504 HD11 HD12 ' A' ' 36' ' ' ILE . 47.2 mt -74.59 -37.81 44.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.965 178.188 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.6 -18.56 61.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.813 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.89 27.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.057 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.617 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.7 t -169.05 156.65 7.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.328 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.623 ' HG3' HG13 ' A' ' 87' ' ' VAL . 27.6 tt0 -75.56 -37.2 60.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.657 179.617 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.545 HG13 HD11 ' A' ' 83' ' ' LEU . 18.7 t -132.29 131.45 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.291 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -137.25 128.27 27.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.032 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.471 HG21 HG12 ' A' ' 111' ' ' ILE . 52.7 t -116.03 127.92 73.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.692 178.39 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.504 HD12 HD11 ' A' ' 28' ' ' ILE . 20.6 mt -133.79 137.08 53.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.781 -177.251 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.85 96.29 1.61 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.371 179.726 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.0 m-85 -81.51 88.55 6.17 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.524 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -108.43 142.57 38.59 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.194 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -90.29 -8.97 49.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.804 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.497 ' O ' HG12 ' A' ' 44' ' ' ILE . 15.6 t70 -148.54 119.28 7.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.521 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.555 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.5 mt -89.06 45.17 1.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.131 0.491 . . . . 0.0 111.588 -179.279 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.5 mt-10 -135.31 8.28 3.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.069 178.939 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.841 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.5 pt -92.19 156.09 42.24 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.169 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.518 ' O ' HD12 ' A' ' 49' ' ' ILE . 86.3 Cg_exo -49.78 -31.32 25.62 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.794 2.329 . . . . 0.0 112.807 179.684 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.841 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -59.14 -37.38 77.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.29 -178.914 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.696 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.5 t -62.28 -58.3 18.17 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.578 -178.912 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.696 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.5 Cg_exo -58.97 -40.94 66.69 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.697 1.598 . . . . 0.0 111.272 179.187 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.947 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -60.46 -35.5 63.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.738 179.66 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.583 ' O ' HG23 ' A' ' 54' ' ' VAL . 49.0 tp -74.3 -53.75 9.06 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -53.83 -24.03 14.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.105 0.479 . . . . 0.0 109.946 178.823 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.0 m -82.97 -45.11 14.51 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.342 179.551 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.61 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.58 -26.41 66.94 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.368 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 50' ' ' LEU . 62.3 t -53.16 -50.7 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.976 179.518 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -73.23 -10.97 60.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.617 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -93.96 -19.42 20.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.295 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.592 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 54.2 m-85 -135.88 61.79 43.38 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.472 -179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.02 -40.5 76.26 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.565 2.176 . . . . 0.0 111.415 179.175 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.17 -43.0 95.56 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.357 178.964 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.1 t -65.02 146.08 13.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 178.86 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.617 ' HB2' HG21 ' A' ' 31' ' ' THR . 37.5 t -83.1 95.73 8.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.053 0.454 . . . . 0.0 111.054 -179.61 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.482 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.8 p90 -61.42 128.9 38.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.75 179.49 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.496 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -148.84 160.98 28.58 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.251 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.5 tt -159.47 143.54 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.696 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.4 t -147.28 155.29 41.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.154 0.502 . . . . 0.0 111.833 -178.93 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 39' ' ' PHE . 81.4 p -138.77 -0.31 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.587 179.561 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -68.61 141.98 55.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.571 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 t -65.12 -51.34 61.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.411 -179.494 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -50.91 -42.05 59.05 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.551 -179.377 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HA ' HG22 ' A' ' 21' ' ' VAL . 57.4 t -71.15 -53.39 21.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.92 0.39 . . . . 0.0 110.596 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.05 -15.43 13.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.324 179.429 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.4 m -91.24 -40.6 11.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.359 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -61.13 -38.22 85.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.345 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -93.25 14.28 18.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.682 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 54.45 23.32 4.41 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.643 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.707 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.6 mm -57.72 120.05 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.961 179.754 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.2 p -139.01 57.36 1.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.492 -179.618 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.36 49.3 0.02 OUTLIER Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.738 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.598 ' HB2' HG21 ' A' ' 99' ' ' ILE . 34.3 m-20 48.17 43.68 18.79 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.207 0.527 . . . . 0.0 110.292 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.707 ' HB ' HG23 ' A' ' 76' ' ' ILE . 97.2 m -69.34 151.53 46.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.737 -178.373 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.581 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.9 mt -118.27 117.0 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.835 178.12 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.516 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.1 m -106.05 130.93 53.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.824 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.634 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -107.23 104.19 13.75 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.525 177.952 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.2 t80 -98.7 121.1 40.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.798 0.332 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.538 HH12 HD12 ' A' ' 116' ' ' LEU . 3.8 mtm180 -104.38 98.45 8.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.094 179.711 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tp -42.07 -50.46 4.7 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.783 -179.389 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.623 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.86 -65.21 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.516 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.442 ' HB2' HH21 ' A' ' 85' ' ' ARG . 9.7 m-20 -99.01 10.57 41.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.562 -179.315 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 85' ' ' ARG . 78.1 m-20 49.66 34.27 7.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.509 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 8.2 mm-40 -78.02 157.69 29.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.122 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -142.34 97.2 3.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.808 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.634 HD23 ' HG ' ' A' ' 83' ' ' LEU . 1.9 mm? -88.06 113.52 23.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.767 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -95.84 96.91 9.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.817 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.572 HD21 HD13 ' A' ' 102' ' ' ILE . 4.1 tt -80.98 78.76 7.77 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.626 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.0 mt-10 -80.77 -163.79 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.762 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.497 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 17.4 t70 -50.66 -37.7 42.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.047 -179.2 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -55.34 -14.93 2.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.118 0.485 . . . . 0.0 110.393 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -131.14 -13.76 3.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.605 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.598 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.8 mm -89.63 -32.98 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.612 0.244 . . . . 0.0 111.379 -179.376 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -51.51 -49.38 62.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.704 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.3 m -117.79 38.14 3.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.526 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.592 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.2 tp -63.93 147.0 12.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.645 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.465 ' N ' HG13 ' A' ' 102' ' ' ILE . 11.5 t70 -141.09 165.24 28.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.685 178.574 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.947 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -62.12 -35.57 79.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.144 0.497 . . . . 0.0 109.691 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -64.66 -47.5 78.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.222 178.705 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -59.31 -59.37 5.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.177 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.76 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.21 -55.62 14.49 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.937 0.399 . . . . 0.0 110.132 179.656 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.5 m -58.85 -28.65 66.29 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.82 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.549 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.9 tmt_? -71.93 -66.45 0.64 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.185 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -42.9 -43.71 4.22 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.166 179.177 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.471 HG12 HG21 ' A' ' 35' ' ' VAL . 95.4 mt -63.38 -54.69 29.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.551 178.452 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -54.52 -19.36 5.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.23 179.261 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.549 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -87.89 -37.67 10.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.939 -179.109 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -121.76 29.39 7.16 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.601 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 81.1 p -81.65 44.97 0.85 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.11 0.481 . . . . 0.0 110.232 178.959 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.538 HD12 HH12 ' A' ' 85' ' ' ARG . 52.6 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.185 -179.398 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.482 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.7 pt-20 . . . . . 0 CA--C 1.53 0.201 0 CA-C-O 120.5 0.19 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.499 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 38.8 Cg_endo -66.76 142.85 65.07 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.592 2.195 . . . . 0.0 112.389 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.3 m -61.81 152.87 30.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.765 -179.315 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.51 94.91 7.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.866 179.699 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.621 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.8 mt -90.52 71.48 6.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.373 179.855 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.0 p -70.92 -5.04 27.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.945 -179.23 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -137.53 146.49 44.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.007 0.432 . . . . 0.0 111.656 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.615 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.9 t -56.12 -49.17 94.7 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.377 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -58.11 -46.46 25.35 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.936 1.757 . . . . 0.0 111.869 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.68 -34.85 77.96 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.344 0.592 . . . . 0.0 110.251 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.621 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.8 -59.84 4.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.113 179.399 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 30.6 mtt -60.7 -25.88 66.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.207 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 31.3 mt-10 -71.27 -51.13 26.2 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.373 179.639 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -60.66 -30.32 69.83 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.159 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.517 HD11 HD12 ' A' ' 36' ' ' ILE . 45.6 mt -76.22 -37.01 31.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.96 178.15 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.02 -23.08 61.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.813 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.13 31.65 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.923 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.506 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.9 t -170.22 151.25 3.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.337 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.522 ' HG3' HG13 ' A' ' 87' ' ' VAL . 23.3 tt0 -70.73 -50.36 37.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.58 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.528 HG13 HD11 ' A' ' 83' ' ' LEU . 19.1 t -119.7 136.34 57.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.359 179.262 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.56 128.55 20.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.013 0.435 . . . . 0.0 112.119 -178.931 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.459 HG21 HG12 ' A' ' 111' ' ' ILE . 47.1 t -115.5 128.81 72.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.672 178.469 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.517 HD12 HD11 ' A' ' 28' ' ' ILE . 23.8 mt -135.03 136.08 52.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -177.306 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.58 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.48 97.24 1.78 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.455 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.4 m-85 -83.39 90.98 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.9 m-85 -110.5 142.71 41.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.037 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.456 ' HG2' HD23 ' A' ' 71' ' ' LEU . 50.8 mt-30 -91.04 -0.96 57.85 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.803 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.498 ' O ' HG12 ' A' ' 44' ' ' ILE . 26.6 t70 -157.59 119.39 3.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.571 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.495 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.2 mt -89.15 45.4 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.087 0.47 . . . . 0.0 111.386 -179.262 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.1 mt-10 -134.66 12.04 3.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.01 179.094 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.741 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.5 pt -95.53 158.29 34.75 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.483 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.487 ' O ' HD12 ' A' ' 49' ' ' ILE . 73.4 Cg_exo -52.73 -28.65 38.84 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.853 2.369 . . . . 0.0 112.721 179.42 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.741 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -61.63 -38.09 86.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.012 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.692 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.05 -57.69 24.48 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.681 -178.724 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.675 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.5 Cg_exo -59.46 -39.49 75.53 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.775 1.65 . . . . 0.0 111.431 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.7 mt -62.5 -36.06 73.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.008 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.586 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.1 tp -74.8 -54.07 7.99 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.852 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -53.45 -23.63 10.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.952 0.406 . . . . 0.0 110.025 178.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 t -84.27 -45.54 12.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.474 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.605 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.33 -25.6 64.31 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.342 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.2 t -51.89 -49.08 38.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.265 179.391 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -76.76 -9.08 58.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.738 -179.82 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -94.94 -18.71 20.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.156 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.569 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.4 m-85 -136.86 63.21 44.49 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.368 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.55 -46.12 35.46 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.643 2.229 . . . . 0.0 111.643 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.82 -42.87 69.97 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.392 179.038 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -65.03 144.28 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.781 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.506 ' CB ' HG21 ' A' ' 31' ' ' THR . 46.8 t -82.35 98.79 9.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.078 0.466 . . . . 0.0 111.159 -179.554 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.499 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.1 p90 -65.35 126.72 29.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.009 179.728 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.504 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.73 161.98 28.46 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.187 179.861 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -160.57 143.3 4.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.2 t -146.18 156.67 43.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.183 0.516 . . . . 0.0 111.675 -179.066 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.449 HG21 ' HG ' ' A' ' 42' ' ' LEU . 52.2 p -139.17 -3.63 1.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.589 179.548 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.44 140.46 57.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.401 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.4 t -64.63 -47.64 77.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.68 -179.31 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -51.77 -43.68 63.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.73 -0.213 . . . . 0.0 111.554 -179.307 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.527 ' HA ' HG22 ' A' ' 21' ' ' VAL . 79.7 t -71.75 -52.37 25.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.722 0.296 . . . . 0.0 110.513 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.456 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -58.48 -15.0 9.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.24 179.271 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.7 m -92.61 -40.52 10.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.429 178.789 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -62.41 -33.08 74.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.428 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.414 ' HB2' HG12 ' A' ' 76' ' ' ILE . 28.7 m-85 -97.07 9.81 41.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.864 179.507 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.6 t30 60.1 20.7 9.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.569 178.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.674 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.9 mm -58.36 117.92 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 179.818 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.9 p -138.38 56.78 1.71 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.283 179.951 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.22 45.45 0.02 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.677 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 17.6 m-80 51.26 43.11 29.47 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.243 0.545 . . . . 0.0 110.398 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.674 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.5 m -69.05 151.08 46.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.673 -178.573 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.58 HG12 ' HA2' ' A' ' 37' ' ' GLY . 70.9 mt -118.32 116.8 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.882 178.045 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.5 m -105.89 130.88 53.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.808 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.612 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -105.37 99.73 9.33 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.389 177.981 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.1 t80 -92.63 121.85 34.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.583 179.854 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.504 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.0 mtm180 -106.41 85.56 2.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.83 -179.684 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.9 tp -26.51 -60.2 0.08 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.365 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.522 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.94 -71.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 O-C-N 123.448 0.467 . . . . 0.0 112.092 -179.161 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.04 5.32 41.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 110.687 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 51.12 33.44 9.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.148 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.504 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 14.1 mm-40 -75.64 164.77 25.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.727 179.535 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.79 89.01 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.836 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.612 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.6 mm? -76.6 111.71 12.38 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.544 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -94.48 97.53 10.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.488 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.548 HD21 HD13 ' A' ' 102' ' ' ILE . 4.4 tt -82.93 77.29 9.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.593 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.448 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.2 mt-10 -78.91 -165.12 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.785 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.512 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 19.4 t70 -51.67 -35.42 42.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.686 -179.291 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -56.57 -15.19 3.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.225 0.536 . . . . 0.0 110.24 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -130.33 -13.99 3.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.779 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.57 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.4 mm -89.44 -29.59 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.684 0.278 . . . . 0.0 111.514 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.52 -38.38 69.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.855 0.36 . . . . 0.0 110.961 -179.801 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.8 t -129.78 38.74 3.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.319 179.685 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.548 HD13 HD21 ' A' ' 94' ' ' LEU . 6.8 tp -64.02 141.74 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.559 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -137.24 149.81 47.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.531 178.786 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.889 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.67 -37.31 12.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.923 0.392 . . . . 0.0 110.337 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -61.88 -49.09 77.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.147 178.69 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -58.65 -61.31 2.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.23 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.73 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.18 -57.34 6.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 110.35 179.908 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.3 m -57.06 -30.38 64.23 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.8 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.506 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -70.91 -65.72 0.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.186 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -42.82 -40.91 3.05 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.044 179.277 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.459 HG12 HG21 ' A' ' 35' ' ' VAL . 96.2 mt -65.9 -56.29 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.247 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -53.21 -18.26 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.325 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.506 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -90.31 -39.5 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.87 -179.108 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.454 ' OD1' HG22 ' A' ' 113' ' ' ILE . 33.0 m120 -118.72 28.73 8.13 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.775 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.3 p -82.22 50.26 1.56 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.023 0.44 . . . . 0.0 110.35 179.224 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.495 HD12 HH12 ' A' ' 85' ' ' ARG . 67.2 mt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.265 -179.618 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.7 pt-20 . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.495 0.188 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 37.7 Cg_endo -67.78 145.44 69.08 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.739 2.293 . . . . 0.0 112.559 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -64.14 153.35 38.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.554 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -98.13 95.02 7.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.799 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 24' ' ' ALA . 44.7 mt -91.45 71.91 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.357 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.2 p -70.84 -4.28 23.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.169 -179.157 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -139.46 147.34 41.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.378 . . . . 0.0 111.661 -179.717 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 35.3 t -55.64 -49.69 91.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.559 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.68 -46.39 27.18 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.917 1.745 . . . . 0.0 112.053 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.79 81.45 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.176 0.513 . . . . 0.0 110.2 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.608 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.55 -58.84 5.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.121 179.328 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.6 mtp -60.37 -25.54 65.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.157 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -72.61 -51.16 20.82 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.608 179.637 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.4 ' O ' HG22 ' A' ' 31' ' ' THR . 8.5 m-85 -60.63 -30.73 70.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.199 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.511 HD11 HD12 ' A' ' 36' ' ' ILE . 53.4 mt -75.79 -37.96 36.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.052 178.417 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.85 -17.08 60.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.285 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.42 26.62 3.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.078 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.7 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.2 t -167.86 153.09 6.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.54 -179.652 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.592 ' HG3' HG13 ' A' ' 87' ' ' VAL . 25.0 tt0 -66.79 -52.31 45.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.89 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.539 HG13 HD11 ' A' ' 83' ' ' LEU . 22.4 t -119.83 137.39 53.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.322 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.71 128.55 21.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.193 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.459 HG21 HG12 ' A' ' 111' ' ' ILE . 52.1 t -116.61 131.76 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.572 178.511 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.511 HD12 HD11 ' A' ' 28' ' ' ILE . 21.0 mt -136.62 136.73 48.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.487 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.593 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.34 97.53 1.83 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.549 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.1 m-85 -83.7 92.49 7.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.6 m-85 -112.95 140.44 47.76 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.166 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.457 ' HG2' HD23 ' A' ' 71' ' ' LEU . 51.7 mt-30 -88.93 0.33 56.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.718 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 44' ' ' ILE . 24.8 t70 -157.96 120.72 3.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.66 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.499 ' HA ' HG21 ' A' ' 47' ' ' VAL . 91.7 mt -90.62 46.53 1.34 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 111.428 -179.307 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.447 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 36.8 mt-10 -136.95 9.72 3.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 179.122 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.779 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.3 pt -92.97 157.01 39.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.313 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.471 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.4 Cg_exo -52.01 -25.26 21.75 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.943 2.429 . . . . 0.0 113.022 179.719 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.779 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.44 -38.59 90.3 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.669 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -59.95 -55.59 44.01 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.583 -178.776 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.632 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.96 -41.31 54.38 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.928 1.752 . . . . 0.0 111.502 179.218 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.3 mt -61.57 -34.6 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.208 179.83 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 54' ' ' VAL . 45.8 tp -73.93 -52.71 12.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.968 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -53.03 -26.96 17.39 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.576 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.9 m -80.07 -46.45 16.51 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.621 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.565 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.75 -25.99 65.31 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.446 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.8 t -53.1 -49.37 50.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.718 179.368 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -76.23 -9.7 58.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.666 -179.855 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -94.92 -17.8 21.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.116 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.566 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 68.3 m-85 -138.35 63.01 33.56 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.441 -179.845 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.01 -43.56 56.02 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.623 2.215 . . . . 0.0 111.651 179.145 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.23 -40.83 85.4 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.239 179.041 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.3 t -66.19 142.99 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.845 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.7 ' HB2' HG21 ' A' ' 31' ' ' THR . 42.1 t -80.79 96.8 7.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.959 0.409 . . . . 0.0 110.957 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.475 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.9 p90 -62.59 126.94 29.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.836 179.582 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.495 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.16 161.76 28.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.256 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.8 tt -161.24 142.24 3.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.749 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -147.59 154.14 40.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.1 0.476 . . . . 0.0 111.803 -178.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.454 HG21 ' HG ' ' A' ' 42' ' ' LEU . 68.4 p -135.57 -2.08 2.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.534 179.529 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.408 ' O ' HD13 ' A' ' 71' ' ' LEU . 23.9 t70 -67.18 142.48 56.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.717 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.1 m -65.95 -49.85 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.664 -179.461 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -50.47 -43.24 55.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.436 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.496 ' HA ' HG22 ' A' ' 21' ' ' VAL . 76.2 t -71.45 -53.21 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.668 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.457 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -58.52 -14.63 8.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.222 179.371 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 78.4 m -91.89 -41.2 10.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.252 178.749 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -61.22 -34.86 75.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.318 179.703 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 76' ' ' ILE . 47.7 m-85 -96.01 11.91 32.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.854 179.516 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 56.05 22.74 6.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.646 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.674 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.5 mm -59.03 120.21 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.951 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.1 p -140.7 55.2 1.59 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.333 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.75 45.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.458 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.618 ' HB2' HG21 ' A' ' 99' ' ' ILE . 22.2 m-80 50.71 43.43 27.92 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.15 0.5 . . . . 0.0 110.44 -179.826 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.674 ' HB ' HG23 ' A' ' 76' ' ' ILE . 98.0 m -69.61 152.31 44.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.77 -178.495 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.625 HG21 HD21 ' A' ' 107' ' ' LEU . 62.8 mt -118.8 118.17 56.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.892 178.075 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.2 m -106.81 134.78 49.44 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.894 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.634 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -110.79 103.36 11.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.788 178.227 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -96.96 123.0 40.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.525 179.802 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.539 HH12 HD12 ' A' ' 116' ' ' LEU . 5.5 mtm180 -106.07 96.33 6.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.051 0.453 . . . . 0.0 110.187 179.803 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.4 tp -40.45 -50.2 2.88 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.558 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.592 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -44.66 -68.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.85 0.357 . . . . 0.0 111.908 -179.627 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.447 ' HB2' HH21 ' A' ' 85' ' ' ARG . 17.7 m-20 -92.85 17.76 10.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.442 -179.424 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.9 p30 43.11 31.3 0.34 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.043 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.511 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 13.7 mm-40 -76.59 162.48 27.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.824 0.345 . . . . 0.0 111.14 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.01 87.1 1.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.967 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.634 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -76.05 144.64 40.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.304 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -125.35 99.31 6.0 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.074 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.617 HD21 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -84.11 78.01 9.84 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.597 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.421 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.3 mt-10 -79.66 -165.79 0.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.787 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.476 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.6 OUTLIER -44.47 -52.58 7.76 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.618 -179.255 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.402 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 12.8 pt-20 -46.82 -17.06 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.51 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' OD2' ' HG3' ' A' ' 97' ' ' GLU . 36.5 m-20 -125.76 -13.98 6.3 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.41 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.618 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.6 mm -89.73 -35.41 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.112 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -48.25 -55.39 10.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.852 -179.833 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.1 p -114.08 39.31 2.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.539 179.462 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.617 HD13 HD21 ' A' ' 94' ' ' LEU . 8.2 tp -61.14 142.57 15.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.515 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -134.92 149.76 50.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.572 178.785 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.89 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.32 -32.96 12.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.11 0.481 . . . . 0.0 110.102 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -63.9 -49.08 74.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.352 178.691 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 102' ' ' ILE . 29.7 mtpp -59.04 -59.84 4.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.278 -179.806 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.755 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.19 -56.19 12.09 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.071 0.462 . . . . 0.0 110.076 179.848 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.3 m -58.21 -28.86 65.21 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.776 179.769 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.459 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.4 tmt_? -71.35 -67.11 0.54 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.079 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -42.24 -43.34 3.38 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.158 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.459 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -64.35 -55.47 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.702 178.416 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -52.89 -22.9 6.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.481 0.658 . . . . 0.0 110.112 179.259 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.459 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -85.66 -36.96 11.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.009 -179.054 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.473 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.7 m120 -124.84 31.87 5.56 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.054 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 111' ' ' ILE . 89.1 p -83.6 36.93 0.56 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.189 0.518 . . . . 0.0 110.213 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.539 HD12 HH12 ' A' ' 85' ' ' ARG . 51.7 mt . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.212 -179.517 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.508 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 . . . . . 0 CA--C 1.532 0.259 0 CA-C-O 120.395 0.141 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 29.4 Cg_endo -64.32 154.0 73.63 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.63 2.22 . . . . 0.0 112.525 -179.718 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -67.94 153.06 44.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.42 -179.765 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.99 84.15 2.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.727 179.696 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 46.8 mt -81.73 72.21 8.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.633 -179.723 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.1 p -70.63 -2.94 15.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.09 -179.013 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -142.27 147.63 36.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.083 0.468 . . . . 0.0 111.804 -179.603 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 60.6 t -55.47 -49.99 89.39 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.824 -179.999 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.3 Cg_endo -58.32 -44.84 34.97 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.035 1.823 . . . . 0.0 111.82 -179.899 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.23 -34.55 78.37 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.33 0.586 . . . . 0.0 110.229 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.2 -59.18 5.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.929 179.262 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 34.0 mtt -60.23 -27.82 67.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.244 -179.967 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -70.21 -49.88 45.72 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 110.603 179.807 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.531 ' O ' HG22 ' A' ' 31' ' ' THR . 6.6 m-85 -61.13 -32.95 72.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.892 179.237 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.526 HD11 ' CD1' ' A' ' 36' ' ' ILE . 48.4 mt -75.0 -37.35 40.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.034 178.478 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.32 -18.27 60.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.131 -179.705 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.2 27.31 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.131 -179.896 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.718 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.9 t -174.31 154.91 2.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.602 -179.873 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.492 ' HG3' HG13 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -64.58 -82.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.016 0.436 . . . . 0.0 110.719 179.556 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.561 HG13 HD11 ' A' ' 83' ' ' LEU . 18.1 t -89.6 134.34 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.758 -179.53 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.46 124.71 20.37 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.061 -179.216 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.524 HG21 HG12 ' A' ' 111' ' ' ILE . 46.4 t -113.61 128.16 70.61 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.921 178.702 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.526 ' CD1' HD11 ' A' ' 28' ' ' ILE . 26.8 mt -133.63 138.48 50.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.457 -177.289 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.68 95.9 1.41 Allowed Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.381 179.801 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.519 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 36.3 m-85 -81.99 89.33 6.39 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.294 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 13.6 m-85 -107.59 140.57 40.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.615 -177.769 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -88.9 -5.62 57.87 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.081 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.486 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.3 t70 -154.53 121.73 5.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.656 179.851 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.522 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.0 mt -90.04 45.29 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.014 0.435 . . . . 0.0 111.449 -179.354 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.441 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 11.1 mm-40 -134.83 11.78 3.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.068 179.245 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.734 HD12 ' HB3' ' A' ' 46' ' ' ALA . 4.0 pt -94.89 158.92 34.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.286 -179.955 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.511 ' O ' HD12 ' A' ' 49' ' ' ILE . 62.4 Cg_exo -54.86 -25.38 43.12 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.843 2.362 . . . . 0.0 112.803 179.497 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.734 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.43 -35.64 81.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.705 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.707 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -63.51 -55.87 31.33 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.648 -178.776 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 38.0 Cg_exo -60.84 -34.49 91.29 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.999 1.8 . . . . 0.0 111.598 179.65 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.843 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -69.38 -35.35 66.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.635 ' O ' HG23 ' A' ' 54' ' ' VAL . 36.7 tp -73.61 -50.41 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.471 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -55.74 -20.32 14.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.304 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -84.43 -49.67 8.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.567 179.29 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.699 ' HG2' HD13 ' A' ' 107' ' ' LEU . 2.9 ppp? -57.67 -25.36 60.13 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.099 0.476 . . . . 0.0 109.91 179.556 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -52.87 -46.55 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.991 179.51 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -80.05 -9.85 59.73 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.533 -179.848 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.495 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 27.8 mtpp -93.55 -19.0 21.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.239 -179.963 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.618 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 70.8 m-85 -137.17 62.57 39.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.468 -179.291 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.64 -36.47 71.98 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.535 2.157 . . . . 0.0 111.366 179.025 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.85 -42.05 99.75 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.818 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.1 t -65.95 144.95 14.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.799 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.718 ' HB2' HG21 ' A' ' 31' ' ' THR . 46.7 t -83.24 98.82 9.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.108 0.48 . . . . 0.0 110.974 -179.613 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.496 ' HB3' HG22 ' A' ' 54' ' ' VAL . 6.4 p90 -64.8 129.05 38.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.025 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.502 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.1 161.46 28.46 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.087 179.862 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -162.25 144.07 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.823 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.519 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 44.8 t -149.77 155.61 40.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.144 0.497 . . . . 0.0 111.673 -179.262 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 70.2 p -136.94 0.03 2.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.39 179.281 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -69.53 138.91 53.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.506 179.841 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.4 p -63.14 -48.26 79.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.529 -179.459 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -49.98 -46.78 52.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.615 0.245 . . . . 0.0 111.571 -179.411 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.571 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.4 t -69.02 -53.96 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -58.32 -15.05 8.85 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.258 179.478 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.2 m -91.67 -39.23 11.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.362 179.041 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -62.84 -39.04 93.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.468 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -92.15 12.62 21.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.627 179.312 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 55.86 25.2 8.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.535 179.363 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.697 HG23 ' HB ' ' A' ' 80' ' ' THR . 42.1 mm -60.84 122.68 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.48 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.2 p -142.8 59.68 1.43 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.248 -179.824 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.29 43.46 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.571 179.856 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 24.6 m-80 52.41 44.26 30.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.177 0.513 . . . . 0.0 110.569 -179.821 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.697 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.6 m -69.71 151.34 45.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.404 -0.817 . . . . 0.0 112.804 -178.568 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.565 HG12 ' HA2' ' A' ' 37' ' ' GLY . 57.1 mt -116.85 116.6 52.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.132 178.155 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 74.4 m -104.56 135.27 46.29 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.95 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.626 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -112.07 102.58 10.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.296 178.822 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.2 t80 -96.03 119.67 34.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.448 179.547 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.514 HH12 HD12 ' A' ' 116' ' ' LEU . 5.6 mtm180 -103.49 81.39 1.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.958 -179.421 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 32' ' ' GLU . 11.6 tp -25.35 -58.73 0.06 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.026 -179.369 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.492 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.42 -72.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.408 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -83.44 3.69 30.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.009 0.433 . . . . 0.0 110.542 179.944 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 52.06 32.7 10.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.639 179.725 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.474 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 7.1 mm-40 -78.26 162.1 26.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.688 179.737 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -146.45 91.67 2.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.026 179.926 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.626 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -79.09 146.06 33.45 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.378 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -127.28 93.21 3.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.018 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.49 HD21 HD13 ' A' ' 102' ' ' ILE . 4.4 tt -79.01 77.69 5.46 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.689 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.6 mt-10 -78.18 -166.24 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.801 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.54 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.8 t70 -51.12 -36.74 42.1 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.86 -179.369 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.428 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 10.3 pt-20 -55.82 -14.75 2.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.193 0.521 . . . . 0.0 110.477 179.551 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.428 ' OD2' ' HG3' ' A' ' 97' ' ' GLU . 23.7 m-20 -130.12 -13.75 3.97 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.537 179.881 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 79' ' ' ASN . 19.6 mm -89.27 -29.96 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.316 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -55.16 -45.28 75.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 111.134 -179.804 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.6 m -121.74 37.66 4.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.454 179.774 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.7 tp -62.35 144.69 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.43 -179.842 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.422 ' N ' HG13 ' A' ' 102' ' ' ILE . 21.6 m-20 -139.9 150.09 44.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.73 178.881 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.843 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.56 -39.79 11.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.916 0.389 . . . . 0.0 110.617 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.1 m -61.89 -47.57 84.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.64 178.846 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -59.03 -57.09 14.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.366 -179.521 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.813 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.7 -57.34 9.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.966 0.412 . . . . 0.0 110.011 179.832 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.2 m -56.7 -29.62 62.61 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.98 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.488 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -70.69 -65.25 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.189 179.739 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -43.2 -43.61 4.77 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.938 179.167 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.556 HD11 HD22 ' A' ' 107' ' ' LEU . 26.0 mt -62.13 -56.32 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.438 178.249 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -53.87 -19.38 4.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.29 179.401 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.488 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.63 -35.71 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.956 -179.154 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.457 ' O ' HD21 ' A' ' 83' ' ' LEU . 17.2 m120 -126.6 31.25 5.38 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.463 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 111' ' ' ILE . 88.6 p -84.56 45.98 1.19 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.242 0.544 . . . . 0.0 110.071 178.848 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.514 HD12 HH12 ' A' ' 85' ' ' ARG . 55.5 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.455 -179.163 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 120.525 0.203 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 38.0 Cg_endo -67.18 142.14 59.86 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.595 2.197 . . . . 0.0 112.473 -179.753 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.0 m -56.28 152.95 10.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.52 -179.874 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -99.84 83.07 2.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.856 179.852 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 24' ' ' ALA . 36.9 mt -80.87 73.24 7.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.527 -179.905 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.0 p -72.8 -4.75 33.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.937 -179.191 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -136.65 147.11 46.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.382 . . . . 0.0 111.65 -179.72 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 24.1 t -56.33 -49.81 91.22 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.493 -179.985 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.82 -46.04 29.02 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.849 1.699 . . . . 0.0 111.934 179.994 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.37 -35.44 80.42 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.211 0.529 . . . . 0.0 110.277 -179.944 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.595 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -63.49 -58.93 5.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.097 179.562 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 60.3 mtp -59.82 -27.31 66.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.103 -179.986 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -71.2 -50.44 33.02 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.661 0.267 . . . . 0.0 110.778 179.777 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -60.99 -31.89 71.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.976 179.283 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.526 HD11 HD12 ' A' ' 36' ' ' ILE . 47.2 mt -73.93 -37.26 47.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.883 178.269 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.92 -18.73 60.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.018 -179.882 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.12 29.61 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.642 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.9 t -169.49 152.23 4.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.389 -179.736 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.632 ' HG3' HG13 ' A' ' 87' ' ' VAL . 31.3 tt0 -70.33 -41.45 73.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.765 179.913 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.515 HG13 HD11 ' A' ' 83' ' ' LEU . 19.6 t -128.95 134.11 64.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.182 179.324 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.11 128.91 26.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 112.154 -179.052 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.448 HG21 HG12 ' A' ' 111' ' ' ILE . 43.3 t -116.92 127.14 74.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.502 178.325 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 28' ' ' ILE . 23.4 mt -133.25 136.16 55.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.45 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.603 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.12 97.38 1.83 Allowed Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.562 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.5 m-85 -83.57 91.69 7.48 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.408 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.2 m-85 -111.89 138.32 48.67 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.023 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -85.06 -9.5 57.91 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.87 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.463 ' O ' HG12 ' A' ' 44' ' ' ILE . 15.8 t70 -150.4 119.56 6.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.745 179.716 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.506 ' HA ' HG21 ' A' ' 47' ' ' VAL . 96.4 mt -87.89 44.06 1.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.023 0.44 . . . . 0.0 111.562 -179.153 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.417 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 36.8 mt-10 -131.97 11.52 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.237 0.541 . . . . 0.0 109.972 179.134 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.682 HG13 HG23 ' A' ' 47' ' ' VAL . 8.5 pt -93.96 161.61 29.38 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.517 -179.657 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.482 ' O ' HD12 ' A' ' 49' ' ' ILE . 51.6 Cg_exo -57.04 -25.22 62.09 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.843 2.362 . . . . 0.0 112.538 179.202 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.628 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.14 -38.77 91.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.478 -178.763 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 44' ' ' ILE . 2.1 t -59.81 -55.41 45.96 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -178.717 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.5 Cg_exo -60.88 -41.63 43.85 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.026 1.817 . . . . 0.0 111.567 179.199 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.879 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -61.72 -34.2 61.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.149 -179.998 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.1 tp -74.98 -51.89 12.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.785 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -53.6 -26.0 19.9 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.094 0.473 . . . . 0.0 109.808 178.607 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 t -82.17 -46.39 13.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.642 179.6 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.578 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.67 -25.84 63.21 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.358 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 50' ' ' LEU . 52.5 t -52.29 -46.05 44.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.827 179.34 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -80.76 -10.12 59.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.735 -179.795 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -93.55 -17.12 23.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.153 179.837 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 49.3 m-85 -139.38 63.89 29.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.505 -179.854 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.78 -45.1 42.92 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.719 2.279 . . . . 0.0 111.713 179.052 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.23 -40.76 76.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.293 179.252 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.6 t -66.86 143.97 15.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.69 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.642 ' CB ' HG21 ' A' ' 31' ' ' THR . 42.2 t -82.42 97.96 8.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.987 0.422 . . . . 0.0 111.045 -179.633 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.483 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -64.2 127.24 30.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.722 179.71 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.501 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.82 162.7 28.56 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.133 179.887 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 tt -160.82 145.12 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.913 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 t -149.82 152.82 35.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.004 0.431 . . . . 0.0 111.597 -179.157 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 39' ' ' PHE . 81.7 p -135.87 -1.45 2.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.622 179.569 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.61 143.32 56.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.77 -179.918 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 81.7 p -65.7 -49.59 67.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.103 -179.556 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -50.79 -45.87 59.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.458 -179.352 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.496 ' HA ' HG22 ' A' ' 21' ' ' VAL . 62.3 t -69.48 -53.17 26.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.733 0.301 . . . . 0.0 110.737 179.935 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -58.55 -15.17 10.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.283 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.4 m -90.39 -40.97 11.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.223 178.63 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -60.67 -40.49 92.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.45 179.841 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.407 ' HB2' HG12 ' A' ' 76' ' ' ILE . 46.1 m-85 -90.51 11.44 21.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 179.605 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 55.96 25.1 8.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.482 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.672 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.7 mm -60.67 119.74 5.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 179.797 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.6 p -140.35 57.76 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.242 179.98 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.76 42.97 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.601 179.82 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.578 ' HB2' HG21 ' A' ' 99' ' ' ILE . 25.9 m-80 52.67 42.38 31.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.194 0.521 . . . . 0.0 110.255 -179.726 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.672 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.9 m -68.74 152.83 44.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.806 -178.529 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.603 HG12 ' HA2' ' A' ' 37' ' ' GLY . 71.4 mt -119.76 117.54 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.979 178.206 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.5 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 72.4 m -105.75 130.42 53.75 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.871 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.642 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -106.49 101.16 10.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.619 178.036 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.7 t80 -95.89 120.51 36.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.769 0.319 . . . . 0.0 110.706 -179.954 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.6 HH12 HD12 ' A' ' 116' ' ' LEU . 5.0 mtm180 -103.24 97.95 7.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.045 179.881 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 tp -41.67 -51.79 3.99 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.598 -179.464 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.632 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -44.5 -65.67 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.395 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.46 ' HB2' HH21 ' A' ' 85' ' ' ARG . 7.6 m-20 -95.53 17.31 14.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.69 -178.977 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.4 p30 42.38 32.64 0.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.036 179.227 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 25.3 mm-40 -78.99 161.69 26.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.855 0.36 . . . . 0.0 111.33 -179.876 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -147.23 96.45 2.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.52 179.497 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.642 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.1 mm? -86.66 120.3 27.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.942 179.817 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.95 98.72 9.16 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.679 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.573 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -83.43 77.71 9.77 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.721 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.6 mt-10 -78.99 -164.7 0.64 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.801 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.526 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.8 t70 -51.39 -36.4 43.25 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.254 -179.175 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -56.95 -14.69 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.148 0.499 . . . . 0.0 110.265 179.558 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -129.64 -13.64 4.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.577 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.578 HG21 ' HB2' ' A' ' 79' ' ' ASN . 21.4 mm -91.24 -29.27 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.519 -179.492 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -51.7 -51.89 52.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 56.0 m -121.27 39.98 3.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.506 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.573 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -60.67 142.01 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.557 -179.704 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.445 ' H ' ' HD3' ' A' ' 106' ' ' LYS . 17.4 m-20 -134.25 150.71 51.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.428 178.752 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.879 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.74 -35.86 23.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.065 0.46 . . . . 0.0 110.4 179.993 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.6 m -62.4 -46.08 90.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.237 178.739 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.51 ' HZ3' HD12 ' A' ' 102' ' ' ILE . 8.3 mtpm? -60.97 -60.76 3.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.179 -179.79 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.79 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.48 -55.45 10.93 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.958 0.409 . . . . 0.0 110.04 179.844 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.9 m -58.51 -30.81 67.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.92 179.715 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -70.94 -65.71 0.7 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.195 179.677 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -42.91 -43.31 4.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.06 179.303 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.448 HG12 HG21 ' A' ' 35' ' ' VAL . 96.6 mt -63.28 -55.87 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.174 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.13 -18.42 3.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.305 179.259 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.469 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.41 -36.39 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.69 -179.305 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.475 ' O ' HD21 ' A' ' 83' ' ' LEU . 18.3 m120 -126.29 32.97 5.11 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.547 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.2 p -84.57 38.35 0.68 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.058 0.456 . . . . 0.0 110.243 178.801 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.6 HD12 HH12 ' A' ' 85' ' ' ARG . 58.6 mt . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.085 -0.959 . . . . 0.0 111.28 -179.445 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.491 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.8 pt-20 . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 42.6 Cg_endo -67.24 147.74 79.11 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.569 2.18 . . . . 0.0 112.628 -179.251 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.5 m -69.39 154.06 42.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.662 -179.494 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -97.16 87.73 4.28 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.251 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.1 mt -81.6 70.05 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.066 179.473 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.6 p -67.85 -0.44 4.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.626 -178.654 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 7.8 m-20 -145.9 147.83 32.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 111.65 -179.887 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.608 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.0 t -54.29 -49.83 88.21 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.504 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.6 Cg_endo -56.81 -47.53 22.96 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.07 1.847 . . . . 0.0 112.195 179.94 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.62 78.08 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.202 0.525 . . . . 0.0 110.508 -179.701 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.17 -58.7 5.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.169 179.355 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 68.3 mtp -60.98 -27.21 68.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.065 -179.861 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 25.0 mt-10 -71.33 -50.48 31.94 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.735 0.303 . . . . 0.0 110.596 179.777 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.564 ' O ' HG22 ' A' ' 31' ' ' THR . 7.5 m-85 -59.74 -34.59 73.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.904 179.303 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.576 HD11 HD12 ' A' ' 36' ' ' ILE . 44.3 mt -72.62 -37.78 57.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.946 178.288 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.56 -17.67 61.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.989 -179.768 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.1 26.41 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.222 -179.671 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.613 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.0 t -169.88 151.75 4.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.557 -179.881 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.564 ' HG3' HG13 ' A' ' 87' ' ' VAL . 15.6 tt0 -62.78 -76.42 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.598 179.751 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG13 HD11 ' A' ' 83' ' ' LEU . 16.0 t -96.49 138.71 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.459 179.538 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.59 124.11 15.85 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.991 0.424 . . . . 0.0 112.003 -179.26 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.431 HG11 HD11 ' A' ' 111' ' ' ILE . 50.0 t -112.62 129.85 67.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.435 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 28' ' ' ILE . 34.7 mt -135.74 137.13 49.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.041 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.91 96.69 1.66 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.461 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.451 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.1 m-85 -82.97 90.56 7.01 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.233 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.1 m-85 -110.23 145.82 36.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.363 -178.148 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.444 ' HG2' HD23 ' A' ' 71' ' ' LEU . 93.2 mt-30 -92.36 -6.5 50.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.839 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.514 ' O ' HG12 ' A' ' 44' ' ' ILE . 36.6 t70 -151.87 121.93 7.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.555 179.822 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.584 ' HA ' HG21 ' A' ' 47' ' ' VAL . 87.9 mt -90.57 46.49 1.34 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.158 0.504 . . . . 0.0 111.331 -179.319 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.438 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 38.9 mt-10 -135.68 7.11 3.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.937 178.977 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.754 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.1 pt -89.54 157.64 46.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.26 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.484 ' O ' HD12 ' A' ' 49' ' ' ILE . 70.6 Cg_exo -53.4 -26.05 33.99 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.92 2.413 . . . . 0.0 112.911 179.665 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.754 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.08 -36.95 85.95 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.977 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.72 HG23 HG13 ' A' ' 44' ' ' ILE . 3.2 t -60.99 -56.65 32.86 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.549 -178.915 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.68 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.2 Cg_exo -59.82 -41.26 56.06 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 121.754 1.636 . . . . 0.0 111.407 179.635 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -61.29 -35.6 67.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.027 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.1 tp -72.98 -53.78 10.32 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.809 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -53.71 -24.6 15.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.086 0.47 . . . . 0.0 109.848 178.748 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -82.07 -45.57 15.06 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.623 179.615 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.605 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.83 -26.18 67.15 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.082 0.468 . . . . 0.0 109.74 179.582 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 50' ' ' LEU . 61.1 t -52.76 -49.65 45.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.843 179.492 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -75.04 -9.41 58.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.637 -179.708 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -95.14 -18.67 20.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.059 179.586 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.586 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 64.3 m-85 -135.92 62.85 48.93 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.285 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.8 -42.51 62.82 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.701 2.267 . . . . 0.0 111.64 179.137 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.25 -37.23 86.26 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.657 179.147 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.2 t -69.89 144.8 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.121 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.613 ' CB ' HG21 ' A' ' 31' ' ' THR . 35.4 t -82.53 98.81 9.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.095 0.474 . . . . 0.0 110.932 -179.902 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.493 ' HB3' HG22 ' A' ' 54' ' ' VAL . 5.4 p90 -65.23 126.29 27.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.205 179.976 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.479 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.24 161.23 28.16 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.276 179.809 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -161.64 144.18 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.451 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.8 t -149.47 157.85 43.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.171 0.51 . . . . 0.0 111.845 -179.28 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.501 HG21 ' HG ' ' A' ' 42' ' ' LEU . 57.9 p -138.57 -0.24 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.481 179.488 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.25 137.13 54.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.343 -179.907 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.0 m -61.59 -50.7 71.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.501 -179.341 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -50.28 -40.91 49.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.568 -179.558 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.512 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.2 t -72.05 -54.93 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.028 0.442 . . . . 0.0 110.73 179.846 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.444 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.2 mp -58.38 -14.64 8.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.291 179.324 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.5 m -91.18 -41.72 10.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.178 178.719 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -59.9 -40.64 89.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.462 179.833 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 76' ' ' ILE . 89.9 m-85 -90.43 9.15 30.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.794 179.444 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 58.73 24.71 12.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.604 179.429 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.748 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.8 mm -60.97 119.62 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.986 179.53 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.0 p -138.55 56.04 1.72 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.262 -179.941 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.09 45.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.594 179.849 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.636 ' HB2' HG21 ' A' ' 99' ' ' ILE . 25.7 m-20 50.15 43.44 25.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.162 0.506 . . . . 0.0 110.397 -179.828 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.748 ' HB ' HG23 ' A' ' 76' ' ' ILE . 88.5 m -68.42 151.97 46.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.786 -178.665 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.581 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.9 mt -118.21 115.65 48.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.219 178.032 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 72.1 m -103.85 133.49 48.75 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -177.819 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.657 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -109.22 104.6 13.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.979 178.392 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.7 t80 -98.62 121.11 40.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.643 179.8 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.503 HH12 HD12 ' A' ' 116' ' ' LEU . 4.4 mtm180 -103.94 81.34 1.85 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.906 -179.726 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 7.2 tp -25.26 -59.63 0.06 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -179.455 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.564 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.53 -57.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.338 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -98.3 3.42 48.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.636 -179.735 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.2 t30 53.11 21.2 2.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.586 179.654 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 12.6 mm-40 -67.34 154.12 42.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.659 179.596 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -138.05 89.3 2.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.507 179.314 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.657 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -78.0 141.79 38.68 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.378 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.92 109.27 14.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.218 0.532 . . . . 0.0 112.401 -178.929 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.606 HD21 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -94.7 76.43 3.71 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.875 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 99' ' ' ILE . 24.0 mt-10 -77.39 -165.31 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -176.857 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.473 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.3 OUTLIER -46.52 -51.05 16.22 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.575 -179.191 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -48.15 -15.24 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.967 0.413 . . . . 0.0 111.262 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.413 ' N ' ' C ' ' A' ' 96' ' ' ASP . 17.0 m-20 -126.98 -13.66 5.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.367 179.792 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.636 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.5 mm -91.87 -38.97 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.479 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -50.43 -47.42 56.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.967 0.413 . . . . 0.0 110.71 179.74 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.8 m -116.61 38.83 3.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.507 179.89 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.606 HD13 HD21 ' A' ' 94' ' ' LEU . 8.5 tp -67.21 144.86 14.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.593 -179.541 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -139.44 148.83 43.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.321 178.48 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.887 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.37 -36.84 10.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.104 0.478 . . . . 0.0 110.444 -179.713 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.9 m -63.05 -47.55 82.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.342 178.977 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -59.81 -58.93 6.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.313 -179.694 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.764 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.23 -55.44 15.29 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.002 0.43 . . . . 0.0 110.117 179.869 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.2 m -58.39 -29.53 66.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.809 179.796 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.499 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -71.3 -66.11 0.66 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.225 179.609 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -42.82 -44.04 4.28 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.122 179.274 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.431 HD11 HG11 ' A' ' 35' ' ' VAL . 96.2 mt -62.92 -55.36 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.529 178.293 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -54.32 -18.41 4.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.374 179.223 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.499 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.0 -36.89 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.862 -179.059 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.5 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.0 m120 -125.37 31.03 5.65 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.464 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 97.1 p -82.62 37.76 0.53 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.076 0.465 . . . . 0.0 110.142 178.869 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.503 HD12 HH12 ' A' ' 85' ' ' ARG . 59.0 mt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.188 -179.425 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.48 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.1 pt-20 . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 37.9 Cg_endo -66.83 145.68 75.62 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.308 2.005 . . . . 0.0 112.756 -179.541 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.4 m -62.54 147.52 48.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.524 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -92.99 84.3 4.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.739 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.62 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.4 mt -81.77 76.21 8.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.638 -179.913 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.8 p -76.02 -4.17 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.856 -179.255 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -139.37 147.28 41.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.994 0.426 . . . . 0.0 111.61 -179.738 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 44.2 t -55.76 -50.33 87.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.59 179.891 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.33 -45.11 37.01 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.986 1.791 . . . . 0.0 111.939 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.03 82.73 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.262 0.553 . . . . 0.0 110.285 -179.881 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.62 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.55 -59.0 5.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.05 179.513 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 59.7 mtm -60.41 -27.02 67.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.148 -179.928 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -70.98 -50.79 30.45 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.72 0.295 . . . . 0.0 110.571 179.594 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.415 ' O ' HG22 ' A' ' 31' ' ' THR . 9.9 m-85 -60.26 -31.42 70.2 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.197 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 36' ' ' ILE . 47.7 mt -74.18 -39.07 49.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.077 178.196 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.45 -19.71 60.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.071 -179.899 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.25 30.0 1.78 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.576 HG21 ' CB ' ' A' ' 61' ' ' SER . 10.0 t -169.85 154.34 5.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.42 -179.593 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.631 ' HG3' HG13 ' A' ' 87' ' ' VAL . 24.8 tt0 -71.8 -43.46 65.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.683 179.861 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG13 HD11 ' A' ' 83' ' ' LEU . 19.1 t -127.47 137.4 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.225 179.418 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.67 129.75 22.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.947 0.403 . . . . 0.0 112.062 -179.061 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.431 HG11 HD11 ' A' ' 111' ' ' ILE . 42.3 t -117.45 128.26 74.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.571 178.536 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.541 HD12 HD11 ' A' ' 28' ' ' ILE . 22.8 mt -133.66 136.18 54.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.47 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.585 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.81 95.97 1.57 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.517 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.6 m-85 -82.6 89.65 6.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.523 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.7 m-85 -108.55 139.24 43.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.538 -178.181 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.432 ' HG2' HD23 ' A' ' 71' ' ' LEU . 47.4 mt-30 -85.94 -4.52 59.19 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.915 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.4 t70 -153.95 122.05 6.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.619 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.632 ' HA ' HG21 ' A' ' 47' ' ' VAL . 97.9 mt -91.17 47.37 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.147 0.499 . . . . 0.0 111.375 -179.331 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.423 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.4 mt-10 -138.85 8.67 2.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.941 179.073 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.841 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.2 pt -92.91 154.45 41.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.061 179.753 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.504 ' O ' HD12 ' A' ' 49' ' ' ILE . 87.0 Cg_exo -48.24 -29.75 13.5 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.004 2.469 . . . . 0.0 113.242 179.82 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.841 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.37 -36.7 83.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.911 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.665 HG23 HG13 ' A' ' 44' ' ' ILE . 2.7 t -63.18 -56.62 26.18 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.747 -178.801 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.656 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.3 Cg_exo -59.86 -36.92 89.2 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.789 1.659 . . . . 0.0 111.42 179.534 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.6 mt -64.83 -36.52 77.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.909 179.73 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.593 ' O ' HG23 ' A' ' 54' ' ' VAL . 42.9 tp -72.46 -53.36 12.37 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.749 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -53.86 -22.26 9.45 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.072 0.463 . . . . 0.0 109.824 178.765 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -85.36 -44.83 12.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.555 179.668 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.593 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.92 -25.55 66.84 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.369 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.7 t -53.24 -49.41 52.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.988 179.411 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -75.09 -9.41 58.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.686 -179.885 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -95.23 -20.25 19.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.309 179.788 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.599 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 61.1 m-85 -134.69 61.12 46.38 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.508 -179.603 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.74 -40.17 74.83 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.506 2.137 . . . . 0.0 111.45 179.176 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.04 -40.85 96.05 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.764 -0.732 . . . . 0.0 111.449 178.963 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.3 t -67.65 144.58 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.798 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.576 ' CB ' HG21 ' A' ' 31' ' ' THR . 38.7 t -81.43 96.5 7.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.085 0.469 . . . . 0.0 111.157 -179.624 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.455 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.7 p90 -62.28 129.45 40.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.962 179.732 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.514 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -148.51 161.48 28.65 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.079 179.716 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.431 HD11 HG13 ' A' ' 47' ' ' VAL . 5.2 tt -160.53 143.07 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.813 0.34 . . . . 0.0 110.178 179.862 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.6 t -146.44 157.98 43.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.971 0.415 . . . . 0.0 111.678 -179.035 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.457 HG21 ' HG ' ' A' ' 42' ' ' LEU . 67.5 p -141.07 -8.78 1.01 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.766 179.804 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -64.48 142.79 58.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.789 -179.882 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.6 m -64.03 -47.74 79.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.567 -179.495 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -51.14 -46.09 61.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.514 -179.269 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.556 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.7 t -70.34 -51.54 37.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.812 0.339 . . . . 0.0 110.73 179.806 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.432 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -59.3 -14.63 12.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.187 179.371 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.0 m -91.97 -41.17 10.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.297 178.657 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -60.3 -41.99 94.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.657 179.933 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.417 ' HB2' HG12 ' A' ' 76' ' ' ILE . 51.2 m-85 -89.21 11.29 19.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.798 179.587 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 56.41 27.72 12.5 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.597 179.45 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.683 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.4 mm -62.67 124.3 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.961 179.755 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.1 p -142.78 59.31 1.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.444 -179.782 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.83 46.39 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.687 179.697 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 30.1 m-80 51.91 43.15 30.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.059 0.457 . . . . 0.0 110.469 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.683 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.8 m -68.87 152.01 45.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.661 -178.522 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.585 HG12 ' HA2' ' A' ' 37' ' ' GLY . 61.2 mt -118.97 116.28 50.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.906 177.985 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.509 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 72.8 m -106.15 132.67 51.95 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.83 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.668 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.1 tp -108.64 103.54 12.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.838 178.413 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -97.95 123.94 42.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.823 0.344 . . . . 0.0 110.863 179.992 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.51 HH21 ' HB2' ' A' ' 88' ' ' ASP . 2.3 mtm180 -107.35 100.81 10.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.092 179.833 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.9 tp -44.37 -52.69 7.49 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.687 -179.203 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.631 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.22 -64.33 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.015 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' HB2' HH21 ' A' ' 85' ' ' ARG . 5.8 m-20 -97.01 17.13 17.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.605 -179.044 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 42.37 32.31 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.152 179.128 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.493 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 5.8 mm-40 -79.05 159.85 27.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.944 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.35 92.31 2.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.95 179.656 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.668 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -78.58 140.24 38.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.453 179.257 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.08 100.79 7.16 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.477 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.537 HD21 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -87.16 77.04 9.15 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.819 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.9 mt-10 -79.0 -164.85 0.66 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -176.93 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.496 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -46.38 -49.62 17.67 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.452 -179.369 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -47.62 -18.25 0.13 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.852 0.358 . . . . 0.0 111.165 179.762 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -125.29 -13.83 6.59 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.574 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.567 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.9 mm -90.44 -28.77 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.682 0.277 . . . . 0.0 111.475 -179.451 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -53.96 -48.87 69.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 82.5 p -119.61 36.72 4.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.435 179.783 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.537 HD13 HD21 ' A' ' 94' ' ' LEU . 6.2 tp -60.55 142.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.425 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.412 ' N ' HG13 ' A' ' 102' ' ' ILE . 24.6 m-20 -138.55 150.46 46.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.665 178.883 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.889 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.2 -37.25 15.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.968 0.413 . . . . 0.0 110.348 -179.632 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.4 m -62.11 -47.72 83.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.437 178.803 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -60.69 -60.78 3.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.169 -179.682 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.743 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -47.98 -55.84 9.06 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.923 0.392 . . . . 0.0 110.125 179.977 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.8 m -58.49 -31.62 68.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.523 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -70.39 -65.73 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.398 179.847 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -42.93 -43.62 4.22 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.014 179.282 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.431 HD11 HG11 ' A' ' 35' ' ' VAL . 96.1 mt -63.47 -55.84 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.529 178.167 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -53.41 -18.75 2.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.336 179.282 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.523 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.16 -37.84 11.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.833 -179.359 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.478 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.4 m120 -123.55 30.92 6.07 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.821 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 111' ' ' ILE . 90.2 p -84.28 39.46 0.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.078 0.466 . . . . 0.0 110.282 179.013 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.481 HD12 ' NH1' ' A' ' 85' ' ' ARG . 77.3 mt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.146 -0.931 . . . . 0.0 111.29 -179.679 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.498 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.8 pt-20 . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.611 0.243 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 45.7 Cg_endo -69.47 143.74 53.26 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.831 2.354 . . . . 0.0 112.622 -179.701 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.7 m -63.37 151.29 41.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.544 -179.61 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -94.55 94.42 8.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.96 -179.934 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.647 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.6 mt -88.77 73.89 8.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.299 179.64 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.0 p -72.4 0.51 9.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.306 -178.927 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -145.63 148.56 33.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.928 0.394 . . . . 0.0 111.862 -179.78 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 57.6 t -56.06 -50.26 88.38 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.448 179.815 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.5 Cg_endo -58.23 -45.1 33.4 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.826 1.684 . . . . 0.0 112.035 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.59 81.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.257 0.551 . . . . 0.0 110.35 -179.927 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.647 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.09 -59.59 4.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.98 179.391 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.8 mtm -60.48 -25.94 66.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.156 -179.972 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 21.3 mt-10 -71.83 -49.94 34.06 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.695 0.283 . . . . 0.0 110.414 179.657 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.455 ' O ' HG22 ' A' ' 31' ' ' THR . 0.2 OUTLIER -60.06 -33.37 71.97 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.079 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.558 HD11 HD12 ' A' ' 36' ' ' ILE . 50.4 mt -72.33 -39.01 62.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.105 178.627 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.05 -21.33 60.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.994 -179.856 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.93 31.87 1.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.939 -179.878 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.566 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.1 t -170.8 151.29 3.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.328 -179.621 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.476 ' HG3' HG13 ' A' ' 87' ' ' VAL . 30.0 tt0 -68.27 -52.76 30.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.598 179.652 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.479 HG13 HD11 ' A' ' 83' ' ' LEU . 19.4 t -118.27 137.61 51.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.174 179.329 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.9 126.23 18.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.055 0.455 . . . . 0.0 112.191 -179.031 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.527 HG21 HG12 ' A' ' 111' ' ' ILE . 49.2 t -115.22 127.85 72.63 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.521 178.338 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 28' ' ' ILE . 32.6 mt -134.17 138.3 50.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.642 -177.165 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.555 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.4 97.54 1.66 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.45 179.773 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.463 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 39.3 m-85 -83.82 92.43 7.76 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.224 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -112.49 139.32 48.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.485 -178.003 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.459 ' HG2' HD23 ' A' ' 71' ' ' LEU . 78.6 mt-30 -87.68 -3.22 58.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.691 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.431 ' O ' HG12 ' A' ' 44' ' ' ILE . 22.2 t70 -153.72 124.39 7.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.511 179.922 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.572 ' HA ' HG21 ' A' ' 47' ' ' VAL . 96.0 mt -94.92 47.34 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 0.0 111.528 -179.436 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 33.8 mt-10 -136.33 5.88 3.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.7 178.845 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.809 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.1 pt -88.46 156.31 50.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.083 179.884 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.507 ' O ' HD12 ' A' ' 49' ' ' ILE . 75.2 Cg_exo -51.78 -27.09 25.76 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.85 2.367 . . . . 0.0 113.078 179.797 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.809 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.7 -37.67 88.21 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.78 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.66 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -62.22 -56.15 33.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.752 -178.692 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.5 Cg_exo -60.13 -36.03 90.29 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.804 1.67 . . . . 0.0 111.488 179.65 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.876 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.3 mt -67.1 -34.81 71.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.995 -179.937 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.58 ' O ' HG23 ' A' ' 54' ' ' VAL . 44.6 tp -74.44 -50.98 16.23 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.893 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -55.29 -22.8 20.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.03 0.443 . . . . 0.0 109.994 178.77 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.8 m -84.89 -45.44 12.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.455 179.36 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.583 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.48 -25.62 64.59 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.198 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 50' ' ' LEU . 45.6 t -52.77 -47.75 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.119 179.329 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -78.31 -8.96 59.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.656 -179.855 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -94.51 -19.36 20.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.277 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.604 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 61.0 m-85 -136.03 62.88 48.38 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.623 -179.79 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.2 -43.35 53.91 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.689 2.259 . . . . 0.0 111.634 179.019 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.5 -42.03 93.72 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.413 179.355 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.7 t -65.31 144.53 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 178.876 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.566 ' CB ' HG21 ' A' ' 31' ' ' THR . 33.9 t -81.94 96.97 7.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.012 0.434 . . . . 0.0 110.95 -179.83 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.488 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.8 p90 -64.3 127.34 31.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.785 179.692 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.478 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.99 160.67 28.19 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.061 179.807 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.434 HD11 HG13 ' A' ' 47' ' ' VAL . 5.0 tt -160.98 142.59 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.788 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.463 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.9 t -147.78 158.77 44.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.218 0.532 . . . . 0.0 111.646 -179.094 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.446 HG21 ' HG ' ' A' ' 42' ' ' LEU . 76.3 p -139.49 -2.35 1.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.568 179.619 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -66.79 140.52 57.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.703 -179.977 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.6 m -63.98 -49.91 70.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.444 -179.465 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -50.3 -42.7 52.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.605 -179.458 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.584 ' HA ' HG22 ' A' ' 21' ' ' VAL . 58.9 t -71.92 -54.02 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.344 . . . . 0.0 110.791 179.832 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.459 HD23 ' HG2' ' A' ' 40' ' ' GLN . 5.9 mp -58.29 -14.61 7.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.339 179.331 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.7 m -91.78 -41.51 10.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.333 178.789 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -60.69 -39.64 89.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.496 179.78 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.445 ' HB2' HG12 ' A' ' 76' ' ' ILE . 61.0 m-85 -90.17 9.92 26.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.754 179.567 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.0 m120 57.71 25.28 11.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.672 179.386 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.69 HG23 ' HB ' ' A' ' 80' ' ' THR . 42.1 mm -61.73 121.77 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.149 179.805 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.1 p -140.63 58.42 1.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 0.0 111.184 -179.935 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.65 45.04 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.623 179.791 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.571 ' HB2' HG21 ' A' ' 99' ' ' ILE . 25.9 m-80 51.07 44.17 28.74 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.125 0.488 . . . . 0.0 110.476 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.69 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.7 m -69.53 152.65 44.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.632 -178.688 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.555 HG12 ' HA2' ' A' ' 37' ' ' GLY . 58.9 mt -118.62 116.4 51.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.428 -0.805 . . . . 0.0 108.982 178.04 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.434 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 75.6 m -104.35 132.68 50.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -177.723 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.669 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -110.94 102.66 11.13 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.982 178.434 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.2 t80 -96.59 125.25 40.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.7 0.286 . . . . 0.0 110.392 179.723 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.6 mtm180 -107.63 85.8 2.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.034 -179.536 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.6 tp -27.42 -61.93 0.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.253 -179.286 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.476 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.29 -64.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.154 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -90.99 13.77 15.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.781 0.324 . . . . 0.0 111.32 -179.314 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 43.68 29.1 0.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.086 178.985 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.513 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 20.6 mm-40 -75.94 160.94 29.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.78 179.85 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.57 84.68 1.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.695 179.778 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.669 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -71.48 145.08 49.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.565 179.662 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -127.32 93.44 3.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.23 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.568 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -78.84 78.31 5.28 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.609 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.8 mt-10 -79.63 -164.35 0.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -176.915 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.504 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 22.7 t70 -51.09 -38.36 51.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.093 -179.246 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -55.22 -14.98 1.97 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.202 0.525 . . . . 0.0 110.213 179.552 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -129.82 -13.89 4.1 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.73 -179.716 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.571 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.2 mm -90.32 -30.04 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 111.294 -179.652 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.45 -33.73 68.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.6 m -133.68 39.64 3.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 179.816 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.568 HD13 HD21 ' A' ' 94' ' ' LEU . 7.1 tp -66.64 143.33 15.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.726 -179.676 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -138.33 148.93 45.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.421 178.857 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.876 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.71 -36.68 11.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.094 0.473 . . . . 0.0 110.508 -179.719 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.7 m -62.38 -46.79 87.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.27 178.785 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -61.16 -59.38 5.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.224 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.772 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.52 -54.4 18.14 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.995 0.426 . . . . 0.0 110.109 179.852 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.9 m -58.88 -31.1 68.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.761 179.765 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.468 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.6 tmt_? -71.0 -65.62 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.297 179.768 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -43.19 -43.57 4.74 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.147 179.34 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.527 HG12 HG21 ' A' ' 35' ' ' VAL . 85.2 mt -63.22 -55.24 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.259 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -54.84 -18.16 4.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.219 0.533 . . . . 0.0 110.203 179.305 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.468 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.59 -35.15 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.821 -179.302 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.471 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.5 m120 -127.03 31.2 5.31 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.369 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 111' ' ' ILE . 89.1 p -84.42 36.48 0.59 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.034 0.445 . . . . 0.0 110.253 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.464 HD12 ' NH1' ' A' ' 85' ' ' ARG . 70.5 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.309 -179.46 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 14.4 pt-20 . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 35.5 Cg_endo -65.95 144.7 77.54 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.548 2.165 . . . . 0.0 112.798 -179.196 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.6 m -62.9 150.18 42.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.602 -179.602 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -94.31 97.77 10.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.903 179.697 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.616 HD22 ' HA ' ' A' ' 24' ' ' ALA . 59.6 mt -95.44 70.99 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.072 0.463 . . . . 0.0 110.632 179.882 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 p -68.68 -8.18 40.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.225 -178.885 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -137.12 150.28 47.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.979 0.419 . . . . 0.0 111.933 -179.421 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 20.9 t -58.49 -49.78 91.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.617 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -57.81 -43.26 51.14 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.91 1.74 . . . . 0.0 111.873 179.865 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.39 -36.99 85.64 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.196 0.522 . . . . 0.0 110.277 179.921 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.39 -57.37 11.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.028 179.262 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 65.4 mtp -62.08 -27.22 68.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.253 -179.941 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -70.28 -51.36 31.07 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.73 0.3 . . . . 0.0 110.381 179.747 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.446 ' O ' HG22 ' A' ' 31' ' ' THR . 8.4 m-85 -59.92 -33.18 71.53 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.147 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.51 HD11 HD12 ' A' ' 36' ' ' ILE . 52.9 mt -71.81 -38.24 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.907 178.241 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.06 -18.75 61.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.929 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.24 28.95 3.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.249 -179.824 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.589 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.8 t -168.58 151.55 5.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 -179.701 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.607 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.7 tt0 -68.86 -49.64 56.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.03 -179.968 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 83' ' ' LEU . 23.4 t -122.29 135.19 63.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.12 179.31 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.29 125.85 22.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.996 0.427 . . . . 0.0 112.022 -178.862 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.489 HG21 HG12 ' A' ' 111' ' ' ILE . 48.0 t -114.26 127.15 71.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.558 178.355 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.51 HD12 HD11 ' A' ' 28' ' ' ILE . 33.9 mt -132.95 139.36 49.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.735 -177.062 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.513 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.54 100.14 1.94 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.121 179.596 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.461 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 40.1 m-85 -86.84 94.56 9.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.387 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.4 m-85 -114.06 142.24 46.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.503 -177.898 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -88.32 -6.03 57.98 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.72 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' O ' HG12 ' A' ' 44' ' ' ILE . 9.6 t70 -151.4 125.75 9.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.618 179.606 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.647 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.2 mt -95.24 47.83 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.032 0.444 . . . . 0.0 111.502 -179.526 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -137.72 7.14 2.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.718 178.869 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.813 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.2 pt -90.51 155.41 46.12 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.194 179.939 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.494 ' O ' HD12 ' A' ' 49' ' ' ILE . 78.3 Cg_exo -50.38 -27.32 18.04 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.881 2.387 . . . . 0.0 113.246 -179.881 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.813 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.56 -37.52 87.84 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.892 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.708 HG23 HG13 ' A' ' 44' ' ' ILE . 3.1 t -61.79 -56.0 36.54 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.572 -178.895 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.663 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.4 Cg_exo -60.16 -39.44 68.97 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.833 1.689 . . . . 0.0 111.533 179.508 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.2 mt -62.99 -36.7 76.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.035 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.2 tp -72.43 -52.68 14.84 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.021 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -54.69 -22.28 13.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.037 0.446 . . . . 0.0 109.943 178.774 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.4 m -85.48 -44.12 12.99 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.494 179.501 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.609 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.52 -24.93 66.94 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.378 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.5 t -51.74 -47.22 39.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.962 179.319 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -77.43 -13.04 60.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.837 -179.776 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -91.45 -18.27 24.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.014 179.897 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.589 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.3 m-85 -137.22 62.74 39.88 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.466 -179.836 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.56 -45.15 43.11 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.643 2.228 . . . . 0.0 111.734 179.231 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.2 -42.86 83.43 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.545 179.148 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.1 t -64.29 144.51 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.667 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.589 ' CB ' HG21 ' A' ' 31' ' ' THR . 37.7 t -82.3 97.43 8.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.036 0.446 . . . . 0.0 111.137 -179.68 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.487 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.6 p90 -64.49 128.13 34.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.607 179.579 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.87 160.76 28.32 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.022 179.901 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -159.97 143.29 5.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.428 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 41.6 t -150.09 157.25 42.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.048 0.451 . . . . 0.0 111.558 -179.181 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.458 HG21 ' HG ' ' A' ' 42' ' ' LEU . 82.7 p -137.82 -3.33 1.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.619 179.777 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -65.55 139.72 58.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.627 -179.835 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.2 t -61.58 -50.39 72.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.209 -179.633 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -48.69 -47.77 40.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.665 -179.391 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.558 ' HA ' HG22 ' A' ' 21' ' ' VAL . 64.9 t -67.87 -55.02 18.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.772 0.32 . . . . 0.0 110.73 179.818 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 mp -56.86 -14.8 3.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.351 179.397 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.7 m -91.0 -41.75 10.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.281 178.764 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -60.82 -35.94 77.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.616 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.409 ' HB2' HG12 ' A' ' 76' ' ' ILE . 84.7 m-85 -95.88 14.25 24.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.805 179.621 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 55.49 25.11 7.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.771 179.067 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.685 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.4 mm -62.67 121.82 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.883 0.373 . . . . 0.0 111.243 179.981 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.5 p -142.46 59.28 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.117 179.959 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.28 44.93 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.586 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.645 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 29.2 m-80 51.79 43.83 29.76 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.222 0.534 . . . . 0.0 110.609 -179.944 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.685 ' HB ' HG23 ' A' ' 76' ' ' ILE . 87.5 m -69.31 151.65 45.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.55 -178.642 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.57 HG21 HD21 ' A' ' 107' ' ' LEU . 54.6 mt -117.7 117.54 55.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.158 177.931 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.461 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 71.2 m -108.06 133.2 52.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.566 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.649 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -108.55 104.96 14.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.752 178.268 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -98.95 120.84 40.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.881 0.372 . . . . 0.0 110.892 179.77 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.519 HH12 HD12 ' A' ' 116' ' ' LEU . 3.7 mtm180 -104.43 100.49 10.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.123 179.82 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.6 tp -43.78 -55.11 4.67 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.017 -179.362 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.607 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.3 -62.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.171 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -98.31 8.14 45.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.167 -179.618 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 85' ' ' ARG . 19.7 t-20 48.69 38.03 10.73 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.023 -179.914 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 7.1 mm-40 -82.25 160.72 22.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.765 179.691 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.2 94.3 2.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 179.462 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.649 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -81.94 139.51 34.56 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.291 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -120.28 114.55 22.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.315 0.578 . . . . 0.0 112.294 -179.385 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.483 HD21 HD13 ' A' ' 102' ' ' ILE . 3.8 tt -100.23 75.75 1.84 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.9 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.421 ' O ' HG12 ' A' ' 99' ' ' ILE . 22.5 mt-10 -76.98 -166.41 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.146 -176.785 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.483 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.4 OUTLIER -45.92 -51.21 13.61 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.249 -179.334 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -46.98 -17.02 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.286 179.653 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.406 ' N ' ' C ' ' A' ' 96' ' ' ASP . 10.8 m-20 -126.22 -14.17 6.01 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.551 -179.999 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.552 HG21 ' HB2' ' A' ' 79' ' ' ASN . 21.7 mm -90.91 -26.19 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.624 -179.322 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -58.18 -35.48 71.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.868 0.366 . . . . 0.0 110.971 -179.81 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.3 m -132.52 39.49 3.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.526 179.964 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.519 HG21 ' HB2' ' A' ' 46' ' ' ALA . 6.2 tp -64.16 142.07 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.438 -179.86 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -136.74 148.36 47.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.593 178.846 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.89 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.39 -35.57 5.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.034 0.445 . . . . 0.0 110.391 179.961 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -63.67 -49.02 74.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.441 178.891 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -59.2 -58.7 7.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.179 -179.88 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.721 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.18 -55.84 13.52 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.091 0.472 . . . . 0.0 109.966 179.881 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.0 m -58.39 -29.13 65.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.9 179.726 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.489 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -71.48 -66.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.172 179.588 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -42.59 -42.58 3.45 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.07 179.132 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.489 HG12 HG21 ' A' ' 35' ' ' VAL . 95.5 mt -64.28 -55.77 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.503 178.346 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.28 -18.62 4.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.319 179.41 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.489 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.32 -37.28 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.934 -179.023 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.404 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.1 m120 -122.44 28.75 7.25 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.595 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.1 p -82.3 52.85 2.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.09 0.472 . . . . 0.0 110.184 178.884 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.519 HD12 HH12 ' A' ' 85' ' ' ARG . 67.9 mt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.125 -179.344 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.467 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.4 pt-20 . . . . . 0 CA--C 1.53 0.191 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HD3' HG21 ' A' ' 54' ' ' VAL . 42.0 Cg_endo -67.77 139.9 49.38 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.492 2.128 . . . . 0.0 112.535 -179.397 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.5 m -59.35 154.67 16.23 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.831 -179.52 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -97.11 90.6 5.21 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.023 -179.927 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 24' ' ' ALA . 51.5 mt -88.01 74.53 8.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.233 179.643 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.8 p -75.83 2.62 11.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.214 -179.167 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 9.7 m-20 -145.2 147.69 32.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 111.612 -179.813 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.3 t -56.47 -49.29 94.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.516 179.896 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 17.7 Cg_endo -59.39 -43.8 37.74 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.841 1.694 . . . . 0.0 111.975 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.18 -34.95 79.59 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.191 0.519 . . . . 0.0 110.317 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.619 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.93 -59.05 4.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.051 179.396 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 46.3 mtm -61.42 -27.17 68.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.16 -179.964 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.0 mt-10 -70.05 -49.77 47.85 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.756 0.312 . . . . 0.0 110.512 179.774 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.597 ' O ' HG22 ' A' ' 31' ' ' THR . 6.6 m-85 -61.42 -35.36 77.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.981 179.2 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.512 HD11 HD12 ' A' ' 36' ' ' ILE . 48.7 mt -71.19 -35.98 60.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.213 0.53 . . . . 0.0 109.802 178.324 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.7 -19.36 60.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.927 -179.915 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.17 25.49 4.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.211 -179.736 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.644 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.9 t -170.68 153.56 4.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.633 -179.8 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.514 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.3 tt0 -64.37 -80.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.727 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.571 HG13 HD11 ' A' ' 83' ' ' LEU . 19.6 t -92.14 135.0 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.498 179.693 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.6 126.12 21.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.035 0.445 . . . . 0.0 112.11 -179.107 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.431 HG21 HG12 ' A' ' 111' ' ' ILE . 45.6 t -114.76 130.93 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.71 178.51 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.512 HD12 HD11 ' A' ' 28' ' ' ILE . 25.9 mt -135.88 137.54 48.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.544 -177.385 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.585 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.39 97.68 1.76 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.519 179.907 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.5 m-85 -82.85 90.91 6.99 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.632 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.6 m-85 -110.85 138.64 47.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.224 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -84.59 -8.69 58.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.824 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.3 t70 -150.37 125.87 10.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.738 179.794 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.515 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.0 mt -93.41 46.68 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.422 . . . . 0.0 111.325 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.6 mt-10 -137.26 11.37 3.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.929 179.036 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.767 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.5 pt -94.03 158.1 36.74 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.014 179.984 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.505 ' O ' HD12 ' A' ' 49' ' ' ILE . 78.0 Cg_exo -53.47 -25.08 30.67 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.709 2.273 . . . . 0.0 112.93 179.951 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.767 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.53 -37.68 87.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.758 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.683 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -61.28 -55.45 43.51 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -178.754 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.2 Cg_exo -60.95 -40.41 52.89 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.045 1.83 . . . . 0.0 111.367 179.405 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.877 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -63.0 -33.79 62.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.042 179.973 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.62 ' O ' HG23 ' A' ' 54' ' ' VAL . 42.9 tp -75.26 -51.85 12.3 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.842 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -53.56 -25.85 18.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.218 0.532 . . . . 0.0 109.837 178.541 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 t -81.88 -47.53 12.66 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.589 179.895 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.613 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.14 -26.44 62.68 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.517 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 50' ' ' LEU . 52.6 t -51.68 -47.54 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.016 179.306 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -78.54 -11.88 59.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.681 -179.891 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 28.4 mtpp -92.12 -16.41 26.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.226 179.764 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.598 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 55.4 m-85 -138.71 63.18 31.72 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.478 -179.883 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.8 -44.47 47.92 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.636 2.224 . . . . 0.0 111.643 179.085 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.53 -38.85 82.94 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.542 179.209 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.0 t -68.76 144.28 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.175 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.644 ' HB2' HG21 ' A' ' 31' ' ' THR . 23.2 t -82.53 96.5 8.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.106 0.479 . . . . 0.0 110.816 -179.65 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.501 ' HB3' HG22 ' A' ' 54' ' ' VAL . 4.0 p90 -64.07 125.75 25.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.074 179.69 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.66 162.05 28.25 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.16 179.908 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.5 tt -158.16 142.19 6.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.811 0.339 . . . . 0.0 110.223 179.62 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.8 t -142.73 154.69 44.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.136 0.493 . . . . 0.0 111.706 -179.036 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.442 HG21 ' HG ' ' A' ' 42' ' ' LEU . 71.3 p -140.16 1.86 1.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.534 179.503 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -74.24 139.86 44.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.658 -179.786 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.3 m -62.17 -50.77 70.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.296 -179.694 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -49.65 -44.63 47.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.588 -179.449 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.498 ' HA ' HG22 ' A' ' 21' ' ' VAL . 67.6 t -69.8 -53.94 21.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.859 0.361 . . . . 0.0 110.687 179.856 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp -57.95 -15.43 8.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.396 179.385 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 86.4 m -89.81 -42.5 11.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.212 178.748 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -59.72 -36.92 77.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.45 179.694 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.412 ' HB2' HG12 ' A' ' 76' ' ' ILE . 65.4 m-85 -94.86 12.31 28.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.11 179.638 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.7 m120 57.29 20.77 6.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.67 179.063 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.654 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.3 mm -57.49 120.66 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.951 179.637 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.1 p -140.62 53.8 1.61 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.865 0.364 . . . . 0.0 111.312 -179.957 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.43 46.15 0.01 OUTLIER Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.68 179.839 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.62 ' HB2' HG21 ' A' ' 99' ' ' ILE . 23.3 m-80 51.2 42.54 28.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.186 0.517 . . . . 0.0 110.404 -179.85 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.654 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.3 m -68.35 152.82 44.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.557 -178.658 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.585 HG12 ' HA2' ' A' ' 37' ' ' GLY . 60.7 mt -119.43 118.53 57.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.035 178.195 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.477 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 65.6 m -107.57 137.08 46.24 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.695 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.643 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -111.47 103.49 11.85 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.092 178.702 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -96.65 117.96 32.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.664 179.644 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.467 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 4.5 mtm180 -101.94 81.37 2.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.761 -179.863 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 5.6 tp -25.05 -60.98 0.06 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.327 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.514 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.46 -62.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.137 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -94.43 1.07 55.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.011 0.434 . . . . 0.0 111.045 -179.5 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 51.13 38.81 21.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.313 179.684 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 6.3 mm-40 -87.52 157.54 19.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.574 179.658 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.03 101.51 4.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.938 179.735 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.643 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -90.4 115.81 27.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.704 179.319 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.79 111.27 23.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.734 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.554 HD21 HD13 ' A' ' 102' ' ' ILE . 5.4 tt -97.6 77.61 2.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.723 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.4 mt-10 -79.12 -164.74 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -176.786 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -45.66 -50.97 12.96 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.515 -179.173 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -46.55 -17.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.008 0.432 . . . . 0.0 111.128 179.747 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.414 ' N ' ' C ' ' A' ' 96' ' ' ASP . 17.0 m-20 -126.79 -13.78 5.77 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.484 180.0 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.62 HG21 ' HB2' ' A' ' 79' ' ' ASN . 27.4 mm -91.32 -42.11 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.464 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -51.9 -30.74 25.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.907 0.384 . . . . 0.0 111.052 179.935 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.5 m -131.36 36.09 3.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.277 179.68 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.7 tp -65.66 143.91 15.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.583 -179.818 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.411 ' N ' HG13 ' A' ' 102' ' ' ILE . 16.2 m-20 -139.2 147.58 41.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.39 178.719 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.877 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.71 -37.11 7.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 110.307 -179.829 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.1 m -61.83 -48.37 80.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.357 178.677 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -59.9 -61.23 2.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.367 -179.842 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.736 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.85 -55.89 8.75 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 110.386 179.894 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -58.75 -31.75 68.62 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.991 179.909 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.535 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.3 tmt_? -69.86 -65.32 0.74 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.308 179.777 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -43.59 -44.17 6.06 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.168 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.431 HG12 HG21 ' A' ' 35' ' ' VAL . 96.7 mt -62.29 -55.36 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.197 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.43 -19.04 4.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.522 179.31 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.535 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -87.29 -36.79 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.796 -179.294 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.446 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.9 m120 -124.91 29.86 6.05 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.784 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.8 p -82.67 46.73 1.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.121 0.486 . . . . 0.0 110.329 179.166 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 63.1 mt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.316 -179.379 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.57 0.224 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.9 Cg_endo -67.91 140.86 51.73 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.654 2.236 . . . . 0.0 112.407 -179.712 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 17' ' ' TRP . 23.2 m -55.1 155.0 5.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.892 -179.409 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.4 ' N ' HG22 ' A' ' 16' ' ' THR . 91.4 m95 -100.57 92.26 5.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.876 179.725 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.609 HD13 ' HA ' ' A' ' 24' ' ' ALA . 55.4 mt -90.2 73.41 7.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.433 -179.893 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.5 p -74.36 0.85 13.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.288 -178.858 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -143.49 147.17 34.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.729 -179.678 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.586 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 19.9 t -55.2 -51.01 83.3 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.413 179.973 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.02 -44.18 41.91 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.905 1.737 . . . . 0.0 112.012 179.805 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.94 79.21 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.284 0.564 . . . . 0.0 110.35 -179.883 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.609 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -65.19 -58.48 5.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.984 179.515 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.7 mtm -61.28 -25.18 66.93 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.88 179.892 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -71.51 -51.68 22.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.357 179.613 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.574 ' O ' HG22 ' A' ' 31' ' ' THR . 0.3 OUTLIER -60.01 -33.82 72.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.929 179.282 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.533 HD11 HD12 ' A' ' 36' ' ' ILE . 51.6 mt -73.42 -37.99 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.951 178.492 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.17 -18.35 60.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.905 -179.933 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.4 24.73 4.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.19 -179.871 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.656 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.9 t -169.71 153.08 4.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.695 -179.792 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.528 ' HG3' HG13 ' A' ' 87' ' ' VAL . 18.2 tt0 -64.12 -77.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.609 179.774 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 83' ' ' LEU . 21.5 t -95.53 133.84 35.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.418 179.668 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.559 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -137.47 124.9 21.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.254 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.438 HG11 HD11 ' A' ' 111' ' ' ILE . 55.0 t -114.07 128.32 71.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.723 178.464 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.533 HD12 HD11 ' A' ' 28' ' ' ILE . 27.3 mt -135.05 138.53 48.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.534 -177.345 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.57 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.66 98.79 1.9 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.272 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.451 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 37.1 m-85 -84.23 91.02 7.63 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.291 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -110.72 142.54 42.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.646 -178.065 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -86.63 -8.08 57.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.887 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -151.53 131.11 13.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.605 179.745 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.636 ' HA ' HG21 ' A' ' 47' ' ' VAL . 84.4 mt -97.75 47.58 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.109 0.48 . . . . 0.0 111.621 -179.539 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -137.09 5.22 2.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.689 178.773 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.811 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.6 pt -88.27 155.72 51.64 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.094 179.766 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.488 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.3 Cg_exo -50.95 -29.06 25.94 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.89 2.393 . . . . 0.0 113.126 179.886 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.811 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.04 -37.44 84.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.831 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.709 HG23 HG13 ' A' ' 44' ' ' ILE . 3.2 t -61.9 -57.21 25.48 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.659 -178.787 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.693 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.3 Cg_exo -59.07 -38.57 86.51 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.759 1.639 . . . . 0.0 111.52 179.589 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -63.33 -36.48 76.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.047 179.936 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.5 tp -73.98 -53.23 10.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.77 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -54.2 -22.59 11.86 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.816 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.2 t -85.32 -43.66 13.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.435 179.516 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.585 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.44 -24.85 66.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.253 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -51.97 -46.69 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.89 179.236 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -77.58 -12.6 59.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.905 -179.74 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -92.19 -18.16 23.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.332 -179.978 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 52.5 m-85 -137.37 63.31 41.45 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.547 -179.692 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.64 -46.43 33.41 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.71 2.274 . . . . 0.0 111.77 178.939 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.9 -42.08 78.59 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.658 179.328 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.9 t -64.27 146.61 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.87 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.656 ' HB2' HG21 ' A' ' 31' ' ' THR . 32.8 t -83.51 97.48 9.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.964 0.411 . . . . 0.0 110.924 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.51 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.2 p90 -66.02 126.17 27.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.49 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.32 161.62 28.35 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.195 179.81 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -159.07 144.36 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.993 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.451 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 29.4 t -149.18 155.86 41.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.12 0.486 . . . . 0.0 111.762 -179.214 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.513 HG21 ' HG ' ' A' ' 42' ' ' LEU . 76.6 p -137.09 -0.8 2.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.613 179.387 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.92 136.33 53.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.566 -179.927 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 59.5 m -61.52 -48.66 80.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.577 -179.634 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -51.51 -41.27 60.88 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.51 -179.435 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.45 ' HA ' HG22 ' A' ' 21' ' ' VAL . 55.4 t -72.6 -53.61 18.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.915 0.388 . . . . 0.0 110.439 179.835 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.64 -14.56 8.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.23 179.261 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.2 m -91.84 -42.12 10.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.385 178.85 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -60.39 -39.49 87.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.422 ' HB2' HG12 ' A' ' 76' ' ' ILE . 88.5 m-85 -90.06 11.02 21.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.651 179.595 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.8 m120 58.03 24.97 11.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.52 179.373 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.747 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.9 mm -62.8 124.17 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.875 179.458 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.8 p -142.32 58.95 1.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.437 -179.887 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.09 45.3 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.823 179.854 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 26.8 m-80 52.04 44.03 29.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.174 0.511 . . . . 0.0 110.613 -179.86 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.747 ' HB ' HG23 ' A' ' 76' ' ' ILE . 86.6 m -69.16 154.22 42.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.533 -178.763 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.609 HG21 HD21 ' A' ' 107' ' ' LEU . 60.5 mt -119.72 117.8 55.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.16 178.156 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 72.8 m -106.99 134.68 49.78 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -177.787 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.635 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -110.78 103.79 12.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.663 178.17 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -97.93 118.03 33.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.634 179.909 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.543 HH12 HD12 ' A' ' 116' ' ' LEU . 4.5 mtm180 -101.22 80.08 2.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.462 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' ARG . 5.1 tp -23.91 -60.51 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.36 -0.836 . . . . 0.0 113.249 -179.417 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.528 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.97 -61.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.01 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -95.34 3.31 54.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.41 . . . . 0.0 111.034 -179.506 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 53.19 29.24 8.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.802 179.357 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.5 mm-40 -75.47 153.13 37.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.538 0.209 . . . . 0.0 110.643 179.721 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.54 95.98 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.718 179.858 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.635 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -87.44 114.53 24.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.976 179.917 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.39 110.53 23.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.087 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.566 HD21 HD13 ' A' ' 102' ' ' ILE . 4.3 tt -96.16 78.81 3.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.014 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.441 ' O ' HG12 ' A' ' 99' ' ' ILE . 30.6 mt-10 -78.78 -165.17 0.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -176.383 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.526 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 30.2 t70 -51.46 -35.28 39.03 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.951 -179.178 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -56.68 -15.33 4.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.206 0.527 . . . . 0.0 110.261 179.482 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -130.11 -14.09 3.93 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.531 179.923 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.572 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.9 mm -90.0 -27.67 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.789 0.328 . . . . 0.0 111.263 -179.517 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -57.13 -37.43 71.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.782 -179.862 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.5 m -131.95 38.17 3.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.562 179.673 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.566 HD13 HD21 ' A' ' 94' ' ' LEU . 7.6 tp -63.61 144.61 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.575 -179.602 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -138.37 149.64 45.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.45 178.603 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.887 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.73 -35.0 9.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.111 0.481 . . . . 0.0 110.48 -179.673 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.5 m -63.01 -48.53 78.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.49 178.761 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 102' ' ' ILE . 54.3 mtpt -59.66 -59.17 5.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.182 -179.703 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.739 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.1 -55.45 14.89 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.988 0.423 . . . . 0.0 110.18 -179.994 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.6 m -58.72 -29.48 66.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.714 179.836 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.519 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -71.11 -66.2 0.65 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.068 179.724 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -42.71 -44.73 4.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.057 179.275 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.438 HD11 HG11 ' A' ' 35' ' ' VAL . 96.5 mt -62.65 -55.2 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.535 178.387 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -54.37 -18.69 4.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.253 179.357 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.519 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.09 -36.21 8.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.898 -179.137 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.431 ' O ' HD21 ' A' ' 83' ' ' LEU . 19.0 m120 -125.35 30.33 5.83 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.3 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.1 p -83.53 48.48 1.42 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.135 0.493 . . . . 0.0 110.145 178.922 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.543 HD12 HH12 ' A' ' 85' ' ' ARG . 60.9 mt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.36 -179.362 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.1 pt-20 . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 120.625 0.25 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 36.4 Cg_endo -67.08 142.93 63.36 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.934 2.423 . . . . 0.0 112.827 -179.514 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.8 m -59.68 153.77 19.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.624 -179.838 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -98.53 97.5 8.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.129 -179.849 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 24' ' ' ALA . 46.8 mt -95.21 76.46 3.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.361 179.769 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.9 p -75.17 -2.49 28.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.297 -178.736 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -142.16 147.36 36.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.919 0.39 . . . . 0.0 111.727 -179.814 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 36.1 t -54.3 -49.5 90.14 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.663 179.983 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.07 -46.97 22.3 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.949 1.766 . . . . 0.0 112.147 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.92 -34.68 77.94 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.186 0.517 . . . . 0.0 110.388 -179.81 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.619 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.84 -59.97 3.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.122 179.389 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 67.5 mtp -60.4 -25.98 66.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.215 -179.897 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 25.1 mt-10 -73.07 -51.73 16.97 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 120.652 0.263 . . . . 0.0 110.675 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.499 ' O ' HG22 ' A' ' 31' ' ' THR . 7.0 m-85 -58.44 -33.35 69.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.117 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.556 HD11 HD12 ' A' ' 36' ' ' ILE . 45.0 mt -72.35 -40.04 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.901 178.104 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.81 -17.77 62.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.06 179.948 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.64 27.92 2.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.231 -179.828 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.639 HG21 ' HB2' ' A' ' 61' ' ' SER . 7.8 t -173.16 155.49 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.579 -179.626 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.551 ' HG3' HG13 ' A' ' 87' ' ' VAL . 19.6 tt0 -65.31 -76.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.681 179.838 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.537 HG13 HD11 ' A' ' 83' ' ' LEU . 21.0 t -95.38 137.98 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.42 179.661 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.545 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.97 125.94 18.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.039 0.447 . . . . 0.0 112.021 -179.142 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.504 HG21 HG12 ' A' ' 111' ' ' ILE . 51.6 t -115.57 129.53 71.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.828 178.526 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.556 HD12 HD11 ' A' ' 28' ' ' ILE . 26.5 mt -135.02 135.72 52.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.624 -177.341 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.4 99.81 2.24 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.335 179.633 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 11.7 m-85 -84.63 92.57 8.19 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.725 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 9.7 m-85 -114.69 142.67 46.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.309 -178.217 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -90.06 -8.64 50.98 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.7 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.494 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.5 t70 -148.12 118.96 7.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.742 179.761 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.501 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.9 mt -88.4 44.85 1.23 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.114 0.483 . . . . 0.0 111.516 -179.268 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.408 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 39.1 mt-10 -133.82 6.96 3.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.124 178.953 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.694 HG13 HG23 ' A' ' 47' ' ' VAL . 5.6 pt -88.14 159.48 47.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.191 179.89 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' HD12 ' A' ' 49' ' ' ILE . 54.3 Cg_exo -54.91 -26.07 46.95 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.763 2.308 . . . . 0.0 112.689 179.429 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.656 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.41 -38.7 91.94 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.883 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.694 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -59.69 -55.58 44.33 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.723 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.647 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.1 Cg_exo -59.75 -41.27 56.59 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.052 1.835 . . . . 0.0 111.403 179.185 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.905 HG23 ' HA ' ' A' ' 104' ' ' ALA . 8.9 mt -61.97 -35.01 65.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.194 -179.906 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 54' ' ' VAL . 47.2 tp -74.75 -50.93 15.59 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.959 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -54.98 -26.0 33.7 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.398 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -81.42 -46.12 15.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.734 179.859 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.58 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.21 -26.15 66.15 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.38 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 50' ' ' LEU . 47.7 t -53.87 -48.44 62.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.162 179.541 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -76.83 -9.35 58.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.588 -179.898 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -94.82 -19.56 20.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 179.719 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.599 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 73.4 m-85 -135.04 62.11 50.43 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.609 -179.548 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.4 -40.35 71.33 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.57 2.18 . . . . 0.0 111.379 178.996 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.42 -42.5 97.54 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.323 179.068 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.9 t -65.49 144.83 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.084 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.639 ' HB2' HG21 ' A' ' 31' ' ' THR . 24.1 t -82.65 96.6 8.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.095 0.474 . . . . 0.0 110.967 -179.554 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.54 ' HB3' HG22 ' A' ' 54' ' ' VAL . 5.2 p90 -64.28 129.39 39.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.106 179.805 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.83 161.98 28.8 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.097 179.667 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -160.99 143.03 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.808 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.1 t -145.67 155.66 43.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.109 0.481 . . . . 0.0 111.917 -178.935 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 78.8 p -138.89 6.16 2.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.655 179.505 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.09 144.42 40.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.706 -179.925 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -65.64 -54.39 28.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.384 -179.547 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -49.04 -40.0 29.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.631 -179.364 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.576 ' HA ' HG22 ' A' ' 21' ' ' VAL . 68.3 t -72.37 -55.27 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.857 0.361 . . . . 0.0 110.603 179.69 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.3 -14.78 8.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.517 179.461 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.6 m -89.22 -48.04 7.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.721 179.101 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -59.03 -33.58 70.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.57 179.837 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 76' ' ' ILE . 40.7 m-85 -92.82 8.24 40.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.547 179.235 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 57.32 23.69 9.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.632 179.51 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.697 HG23 ' HB ' ' A' ' 80' ' ' THR . 34.3 mm -61.22 120.9 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.012 179.652 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.8 p -141.3 58.43 1.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.308 179.825 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.32 42.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.533 179.815 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.601 ' HB2' HG21 ' A' ' 99' ' ' ILE . 39.9 m-20 52.77 42.43 31.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.267 0.556 . . . . 0.0 110.151 -179.669 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.697 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.4 m -67.97 154.36 41.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.682 -178.472 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.588 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.5 mt -120.32 116.95 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.271 178.271 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.7 m -105.93 137.09 44.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.857 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.668 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -112.98 105.68 13.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.253 178.671 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.2 t80 -98.18 123.08 42.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.682 0.277 . . . . 0.0 110.415 179.413 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.552 HH12 HD12 ' A' ' 116' ' ' LEU . 5.7 mtm180 -105.59 82.38 1.8 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.801 0.334 . . . . 0.0 110.875 -179.698 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 7.2 tp -26.29 -59.28 0.08 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.432 -0.803 . . . . 0.0 113.103 -179.287 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.551 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.21 -56.27 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.128 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -99.93 13.27 34.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.734 0.302 . . . . 0.0 111.386 -179.353 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 45.2 24.39 0.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.218 179.234 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.516 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 15.9 mm-40 -72.02 157.73 37.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.768 0.318 . . . . 0.0 110.77 179.794 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -143.6 85.44 1.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.67 179.667 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.668 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -72.78 147.96 45.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.947 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.69 114.41 16.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.309 0.576 . . . . 0.0 112.285 -179.562 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.617 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -101.83 76.33 1.62 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.93 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.444 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.8 mt-10 -75.82 -166.75 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -176.692 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.554 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.6 t70 -50.91 -38.67 51.47 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.057 -179.093 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -55.51 -14.9 2.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.164 0.506 . . . . 0.0 110.525 179.794 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -128.45 -13.67 4.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.47 -179.988 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.601 HG21 ' HB2' ' A' ' 79' ' ' ASN . 21.2 mm -89.47 -23.79 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.71 -179.33 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -53.65 -66.46 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 110.684 179.807 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.8 t -105.77 34.3 3.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.622 179.782 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.617 HD13 HD21 ' A' ' 94' ' ' LEU . 7.5 tp -53.99 142.04 8.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.224 -179.947 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -135.61 151.06 49.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.676 178.967 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.905 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.42 -34.97 17.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.981 0.42 . . . . 0.0 110.446 -179.883 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 95.0 m -63.1 -48.16 79.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.287 178.774 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -59.79 -60.44 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.252 -179.815 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.767 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -49.36 -55.62 12.32 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.074 0.464 . . . . 0.0 110.237 179.785 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.2 m -58.32 -30.57 66.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.872 179.735 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.516 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -70.15 -66.19 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.118 179.771 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -43.43 -44.73 5.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.059 179.355 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.504 HG12 HG21 ' A' ' 35' ' ' VAL . 95.5 mt -61.88 -54.63 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.367 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -55.51 -19.15 8.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.4 179.48 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.516 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -87.69 -36.61 9.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.88 -179.009 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -122.15 27.27 8.09 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.44 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.6 p -81.33 51.68 1.68 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.988 0.423 . . . . 0.0 110.362 178.886 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.552 HD12 HH12 ' A' ' 85' ' ' ARG . 71.1 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.401 -179.469 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.516 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.427 0.156 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 30.5 Cg_endo -64.18 143.69 84.59 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.699 2.266 . . . . 0.0 112.603 -179.709 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.0 m -61.71 152.41 31.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.552 -179.776 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -98.18 92.55 5.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 40.2 mt -87.71 72.55 9.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.258 -179.905 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.4 p -69.07 -3.98 15.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.251 -178.922 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -141.39 149.58 41.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.993 0.425 . . . . 0.0 111.792 -179.569 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 25.3 t -57.03 -49.12 95.81 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.626 179.753 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.7 Cg_endo -58.93 -43.73 41.04 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.956 1.771 . . . . 0.0 111.909 179.865 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.16 -35.3 80.67 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 110.143 179.831 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.43 -56.97 11.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.091 179.361 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 33.8 mtt -62.53 -27.72 69.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.171 -179.961 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -69.94 -49.61 50.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.686 0.279 . . . . 0.0 110.449 179.723 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.01 -32.56 73.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.84 179.071 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.526 HD11 HD12 ' A' ' 36' ' ' ILE . 54.3 mt -72.47 -37.65 57.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.833 178.161 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 -20.81 60.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.706 -179.958 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.17 28.96 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.153 -179.873 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.557 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.9 t -169.1 155.38 6.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.33 -179.798 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.526 ' HG3' HG13 ' A' ' 87' ' ' VAL . 29.2 tt0 -75.98 -33.91 59.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.254 179.481 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.474 HG13 HD11 ' A' ' 83' ' ' LEU . 17.1 t -133.37 136.3 54.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.125 179.273 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.59 125.24 16.85 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.117 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.486 HG21 HG12 ' A' ' 111' ' ' ILE . 53.4 t -113.18 127.63 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.449 178.234 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 28' ' ' ILE . 35.7 mt -133.87 139.41 48.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.62 -176.86 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.89 97.59 1.53 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.459 179.848 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.494 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 36.9 m-85 -84.84 94.37 8.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.322 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.576 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 9.9 m-85 -114.32 146.12 40.91 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.092 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -93.77 -6.45 46.01 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.082 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.476 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.7 t70 -151.98 113.94 4.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.511 179.855 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.498 ' HA ' HG21 ' A' ' 47' ' ' VAL . 89.0 mt -84.19 43.63 0.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.026 0.441 . . . . 0.0 111.549 -179.166 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.446 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.5 mt-10 -132.24 11.38 4.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.999 179.11 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.677 HG13 HG23 ' A' ' 47' ' ' VAL . 9.6 pt -91.78 161.89 32.62 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.336 179.969 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.501 ' O ' HD12 ' A' ' 49' ' ' ILE . 51.3 Cg_exo -57.73 -23.93 60.6 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.737 2.291 . . . . 0.0 112.587 179.047 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.604 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -66.36 -39.18 88.99 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.812 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.677 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -58.6 -55.1 49.38 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -178.681 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.8 Cg_exo -61.57 -42.46 33.01 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.971 1.781 . . . . 0.0 111.648 179.287 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.868 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -60.67 -34.33 58.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.236 -179.991 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.623 ' O ' HG23 ' A' ' 54' ' ' VAL . 51.3 tp -74.37 -51.67 14.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.138 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -53.55 -25.89 18.94 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.541 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 m -80.56 -49.79 10.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.606 179.686 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.578 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -56.43 -27.17 55.87 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.174 0.511 . . . . 0.0 109.666 179.551 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.2 t -53.27 -49.97 49.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.726 179.481 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -75.17 -8.66 57.2 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.583 -179.76 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -95.81 -19.14 19.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.203 179.613 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.624 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 63.4 m-85 -135.65 62.61 49.4 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.503 -179.796 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.65 -41.44 61.42 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.613 2.209 . . . . 0.0 111.658 179.094 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.37 -41.78 97.13 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.511 179.167 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.0 t -66.03 144.07 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.882 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.557 ' CB ' HG21 ' A' ' 31' ' ' THR . 47.4 t -82.07 99.32 9.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.08 0.467 . . . . 0.0 111.001 -179.773 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.509 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.5 p90 -65.59 127.94 33.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.635 179.688 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.16 161.52 28.32 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.235 -179.944 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 tt -162.21 143.24 3.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.732 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.494 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 44.1 t -150.32 157.24 42.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.127 0.489 . . . . 0.0 111.519 -179.143 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 71.2 p -136.49 -7.66 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.695 179.413 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -60.19 139.69 57.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.605 179.883 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.2 p -63.48 -47.33 82.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.61 -179.356 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -52.48 -43.42 64.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.716 -179.224 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.465 ' HA ' HG22 ' A' ' 21' ' ' VAL . 67.0 t -72.15 -51.04 32.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.849 0.356 . . . . 0.0 110.71 179.832 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.74 -14.84 23.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.088 0.47 . . . . 0.0 110.135 179.449 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.2 m -92.3 -39.46 11.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.418 178.799 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -62.86 -40.66 98.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.423 -179.996 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.429 ' HB2' HG12 ' A' ' 76' ' ' ILE . 65.8 m-85 -88.25 8.2 28.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.467 179.426 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 58.54 27.06 15.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.506 179.539 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.726 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.6 mm -63.2 121.69 12.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.225 179.689 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.0 p -141.12 56.17 1.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.377 -179.965 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.37 44.37 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.579 179.847 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.651 ' HB2' HG21 ' A' ' 99' ' ' ILE . 28.4 m-20 51.31 43.85 29.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.297 0.57 . . . . 0.0 110.379 -179.846 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.726 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.3 m -69.13 153.28 43.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.076 -178.334 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.567 HG12 ' HA2' ' A' ' 37' ' ' GLY . 55.2 mt -119.14 116.41 50.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.92 177.88 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 72.4 m -104.85 130.1 53.04 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.833 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.648 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -107.92 100.74 10.07 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.583 178.102 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -95.16 121.65 37.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.488 179.808 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.555 HH12 HD12 ' A' ' 116' ' ' LEU . 5.0 mtm180 -105.05 88.04 2.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.545 -179.933 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 tp -27.11 -60.28 0.09 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.279 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.526 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.19 -79.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.361 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -78.3 2.57 18.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.818 -179.907 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 54.36 28.84 9.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.54 179.671 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.541 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 27.5 mm-40 -71.32 163.44 27.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.884 0.374 . . . . 0.0 110.882 179.876 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.443 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -150.02 88.48 1.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.668 179.76 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.648 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -78.45 117.79 19.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.897 179.879 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.77 93.55 5.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.882 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.499 HD21 HD13 ' A' ' 102' ' ' ILE . 4.0 tt -78.71 78.6 5.15 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.776 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 99' ' ' ILE . 28.8 mt-10 -79.73 -165.5 0.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.787 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.471 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.7 OUTLIER -44.83 -52.05 8.92 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.374 -179.377 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -46.06 -17.68 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.365 179.786 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 96' ' ' ASP . 28.6 m-20 -125.9 -13.8 6.26 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.523 -179.941 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.651 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.0 mm -90.85 -35.13 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.338 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.0 -39.0 58.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.362 -179.681 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.7 m -126.48 32.96 5.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.749 179.937 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.516 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.9 tp -58.37 143.71 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.681 -179.935 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 102' ' ' ILE . 23.3 m-20 -138.61 148.78 44.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.475 178.891 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.868 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.88 -37.14 13.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.061 0.458 . . . . 0.0 110.337 -179.888 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.6 m -61.76 -48.0 82.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.237 178.741 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -60.1 -62.38 1.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.26 -179.895 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.765 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.22 -56.44 6.7 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.013 0.435 . . . . 0.0 110.258 179.982 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.9 m -57.97 -31.25 66.72 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.815 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -70.32 -66.51 0.59 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.184 179.71 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -42.07 -43.96 3.43 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.295 179.351 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.486 HG12 HG21 ' A' ' 35' ' ' VAL . 95.1 mt -63.42 -55.05 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.381 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -54.01 -18.89 3.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.151 179.234 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.482 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.91 -35.81 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.944 -179.137 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.472 ' O ' HD21 ' A' ' 83' ' ' LEU . 14.9 m120 -125.17 31.78 5.53 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.472 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.1 p -83.84 36.54 0.56 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.037 0.446 . . . . 0.0 110.465 178.792 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.555 HD12 HH12 ' A' ' 85' ' ' ARG . 63.7 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.311 -179.565 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 10.3 pt-20 . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.513 0.197 . . . . 0.0 110.545 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 30.3 Cg_endo -64.26 148.99 91.06 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.584 2.19 . . . . 0.0 112.594 -179.373 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 17' ' ' TRP . 26.0 m -64.13 154.28 35.11 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.161 -179.39 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.416 ' N ' HG22 ' A' ' 16' ' ' THR . 5.6 m-90 -98.09 88.4 4.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.827 179.647 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.635 HD22 ' HA ' ' A' ' 24' ' ' ALA . 60.8 mt -88.33 77.01 8.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.057 0.456 . . . . 0.0 110.379 179.914 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.2 p -75.03 -7.09 52.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.32 -179.076 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -138.8 147.9 43.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.816 -179.576 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.598 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 47.9 t -54.93 -50.32 86.91 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.521 179.794 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.44 -44.49 42.0 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.944 1.762 . . . . 0.0 111.854 -179.956 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.86 -33.98 77.29 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.258 0.552 . . . . 0.0 110.4 -179.988 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.635 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -65.28 -58.55 5.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.127 179.371 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.5 mtp -61.24 -27.02 68.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.981 179.992 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 18.7 mt-10 -71.0 -49.88 40.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.654 0.264 . . . . 0.0 110.342 179.616 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.574 ' O ' HG22 ' A' ' 31' ' ' THR . 2.7 m-85 -60.16 -35.24 74.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.002 179.229 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 36' ' ' ILE . 49.0 mt -72.28 -38.36 61.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.926 178.526 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.3 -18.65 61.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.04 -179.823 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.08 26.63 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.04 -179.842 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.599 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.9 t -173.32 153.72 2.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.541 -179.623 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.523 ' HG3' HG13 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -63.3 -84.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.148 0.499 . . . . 0.0 110.903 179.532 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.544 HG13 HD11 ' A' ' 83' ' ' LEU . 13.0 t -87.7 134.21 28.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.663 -179.808 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.55 125.46 21.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 112.019 -179.162 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.444 HG11 HD11 ' A' ' 111' ' ' ILE . 53.5 t -115.21 127.87 72.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.955 178.544 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.532 HD12 HD11 ' A' ' 28' ' ' ILE . 23.5 mt -133.23 136.15 55.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.513 -177.27 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.595 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.58 98.8 1.99 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.49 179.797 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 11.7 m-85 -83.81 92.36 7.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.632 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.9 m-85 -113.42 141.59 46.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.451 -178.068 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.438 ' HG2' HD23 ' A' ' 71' ' ' LEU . 89.6 mt-30 -89.41 -6.99 56.07 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.712 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.499 ' O ' HG12 ' A' ' 44' ' ' ILE . 36.4 t70 -150.03 119.06 6.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.82 179.916 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.546 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.7 mt -88.36 44.97 1.24 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.11 0.481 . . . . 0.0 111.165 -179.605 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.409 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 8.5 mm-40 -135.99 10.85 3.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.21 179.317 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.839 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.7 pt -95.13 156.39 37.88 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.098 179.742 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.467 ' O ' HD12 ' A' ' 49' ' ' ILE . 76.4 Cg_exo -50.94 -29.79 28.31 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.712 2.274 . . . . 0.0 112.909 179.825 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.839 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -60.47 -36.11 77.48 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.052 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.661 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.2 t -64.49 -57.66 16.38 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.636 -178.926 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.9 Cg_exo -58.23 -37.93 93.21 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.712 1.608 . . . . 0.0 111.205 179.279 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.902 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.6 mt -64.34 -37.32 79.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.029 179.822 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 54' ' ' VAL . 39.7 tp -72.82 -52.92 12.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.905 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -54.8 -25.16 26.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.021 0.438 . . . . 0.0 109.966 178.791 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.7 t -81.71 -44.94 16.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.465 179.588 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.598 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.49 -26.31 67.83 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.159 0.504 . . . . 0.0 109.788 179.497 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.7 t -53.02 -49.65 48.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.121 179.513 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -74.47 -11.74 60.31 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.564 -179.949 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.3 mtpp -93.71 -17.9 22.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.291 179.936 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.559 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 65.2 m-85 -136.49 61.65 38.81 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.551 -179.74 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.61 -42.64 60.88 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.682 2.255 . . . . 0.0 111.67 179.174 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.29 -39.47 90.31 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.368 179.31 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.6 t -67.76 145.09 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.521 -0.34 . . . . 0.0 110.19 178.927 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.599 ' CB ' HG21 ' A' ' 31' ' ' THR . 22.6 t -82.71 96.79 8.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.03 0.443 . . . . 0.0 110.899 -179.716 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.485 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.9 p90 -63.98 129.53 40.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.05 179.888 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.97 161.57 28.73 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.01 179.697 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.404 HD11 HG13 ' A' ' 47' ' ' VAL . 4.4 tt -160.12 144.39 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.795 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.8 t -146.82 155.55 42.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.174 0.512 . . . . 0.0 111.733 -179.137 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 77.9 p -139.14 2.08 2.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.618 179.654 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -73.63 143.78 46.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.744 -179.893 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.2 p -64.91 -51.84 59.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.405 -179.578 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -49.23 -42.58 40.94 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.707 -179.472 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.573 ' HA ' HG22 ' A' ' 21' ' ' VAL . 77.7 t -71.77 -54.1 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.936 0.398 . . . . 0.0 110.714 179.973 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.438 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.63 -14.68 8.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.303 179.368 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.1 m -91.91 -40.95 10.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.261 178.966 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -60.69 -39.34 88.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.403 179.825 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.4 ' HB2' HG12 ' A' ' 76' ' ' ILE . 58.6 m-85 -91.9 10.61 28.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.723 179.398 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 58.26 22.37 9.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.662 179.128 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.674 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.9 mm -57.83 122.21 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.044 179.912 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.0 p -142.3 59.55 1.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.139 -179.912 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.3 44.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.725 179.989 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.65 ' HB2' HG21 ' A' ' 99' ' ' ILE . 42.1 m-20 51.77 42.83 30.21 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.192 0.52 . . . . 0.0 110.532 -179.9 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.674 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.8 m -69.02 153.83 43.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.677 -178.671 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.595 HG12 ' HA2' ' A' ' 37' ' ' GLY . 62.7 mt -120.83 118.28 55.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.941 178.268 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.481 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.4 m -106.55 134.31 49.88 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.998 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.65 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -111.42 105.08 13.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.129 178.716 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.3 t80 -99.31 119.91 38.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.446 179.543 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.466 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 4.6 mtm180 -101.74 79.98 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.809 -179.731 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 32' ' ' GLU . 11.5 tp -23.9 -59.35 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.108 -179.622 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.523 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.21 -63.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.264 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.49 3.72 54.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.061 0.457 . . . . 0.0 111.14 -179.694 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 51.37 30.02 5.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.947 179.422 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 7.0 mm-40 -77.53 153.5 33.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.505 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.401 HE22 ' HB3' ' A' ' 93' ' ' ASN . 22.6 tm0? -135.4 94.98 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.904 179.816 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.65 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -84.71 134.85 34.34 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.003 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.401 ' HB3' HE22 ' A' ' 91' ' ' GLN . 0.7 OUTLIER -117.26 101.31 8.33 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.824 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.602 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -85.93 78.19 9.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.794 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.453 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.1 mt-10 -80.4 -164.84 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.891 -176.877 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.522 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 23.7 t70 -51.26 -36.12 40.56 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.831 -179.381 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -55.77 -14.88 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.106 0.479 . . . . 0.0 110.21 179.448 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -131.5 -13.81 3.34 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.623 -179.806 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.65 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.8 mm -90.17 -35.45 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.594 0.235 . . . . 0.0 111.406 -179.496 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -49.62 -44.56 47.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.801 -179.98 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.3 m -124.74 41.14 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.358 179.498 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.602 HD13 HD21 ' A' ' 94' ' ' LEU . 7.8 tp -66.3 143.97 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.8 -179.618 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -138.45 149.59 45.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.581 178.72 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.902 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.61 -37.6 12.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.581 -179.788 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.5 m -61.6 -47.49 85.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.346 178.75 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -59.86 -61.39 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.249 -179.718 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.777 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.71 -55.8 10.36 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.924 0.392 . . . . 0.0 110.382 179.98 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.6 m -58.51 -30.18 66.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.88 179.901 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.551 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.9 tmt_? -70.54 -66.42 0.61 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.101 179.558 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -42.88 -44.4 4.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.274 179.34 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.444 HD11 HG11 ' A' ' 35' ' ' VAL . 96.6 mt -63.19 -54.75 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.287 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.408 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 32.8 tt0 -53.96 -19.66 5.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.224 179.191 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.551 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.7 -36.53 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.771 -179.155 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.464 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.0 m120 -123.71 30.01 6.35 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.183 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 96.6 p -82.83 37.13 0.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.165 0.507 . . . . 0.0 110.052 178.797 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.448 HD12 HH12 ' A' ' 85' ' ' ARG . 53.5 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.314 -179.329 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.7 pt-20 . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 110.52 -0.178 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 38.1 Cg_endo -66.43 144.48 73.68 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.53 2.153 . . . . 0.0 112.405 -179.614 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.6 m -63.41 153.58 34.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.671 -179.536 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -98.62 92.53 5.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 179.488 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 24' ' ' ALA . 43.5 mt -86.96 73.65 9.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.326 179.801 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.2 p -72.21 -5.37 35.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.118 -179.167 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -137.06 146.72 45.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.905 0.383 . . . . 0.0 111.604 -179.684 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 59.9 t -55.5 -49.81 90.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.61 179.883 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.8 Cg_endo -57.77 -46.17 28.29 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.923 1.749 . . . . 0.0 112.07 179.877 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.83 81.39 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.346 0.593 . . . . 0.0 110.239 -179.898 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.635 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -63.99 -58.53 6.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.023 179.524 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 21' ' ' VAL . 57.7 mtm -60.02 -25.76 65.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.065 179.891 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -71.97 -52.07 18.86 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.621 179.642 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -60.01 -30.2 69.0 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.33 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.564 HD11 HD12 ' A' ' 36' ' ' ILE . 48.0 mt -75.57 -38.69 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.121 178.201 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 -20.66 60.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.018 -179.851 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.78 31.85 1.33 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -179.929 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.507 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.7 t -170.43 151.78 3.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.45 -179.539 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.615 ' HG3' HG13 ' A' ' 87' ' ' VAL . 24.4 tt0 -70.18 -40.55 74.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.558 179.539 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.493 HG13 HD11 ' A' ' 83' ' ' LEU . 19.4 t -129.94 137.35 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.162 179.283 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.93 128.19 19.85 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.134 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.456 HG21 HG12 ' A' ' 111' ' ' ILE . 55.0 t -115.93 130.53 70.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.379 178.338 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.564 HD12 HD11 ' A' ' 28' ' ' ILE . 28.7 mt -136.19 135.92 49.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.305 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.585 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.39 96.86 1.73 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.559 179.722 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.489 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 13.6 m-85 -82.45 89.68 6.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.522 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -109.94 140.56 43.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.057 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -87.28 -6.51 58.51 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.661 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.9 t70 -151.58 122.42 7.54 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.755 179.837 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.505 ' HA ' HG21 ' A' ' 47' ' ' VAL . 97.1 mt -91.34 46.18 1.29 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.131 0.491 . . . . 0.0 111.208 -179.486 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -137.25 11.08 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.0 179.204 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.777 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.3 pt -94.21 156.13 39.23 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.133 179.923 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.45 ' O ' HD12 ' A' ' 49' ' ' ILE . 75.0 Cg_exo -51.16 -27.08 21.28 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.807 2.338 . . . . 0.0 113.057 179.666 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.777 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.67 -38.7 92.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.945 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.664 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -60.21 -56.67 33.15 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.734 -178.849 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.634 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.0 Cg_exo -58.42 -40.12 77.76 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.587 1.525 . . . . 0.0 111.37 179.597 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.898 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.9 mt -62.66 -34.92 67.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.092 179.874 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.62 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.2 tp -74.95 -52.77 10.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.845 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -54.26 -23.15 13.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.036 0.446 . . . . 0.0 109.932 178.781 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 75.6 m -84.15 -46.45 11.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.498 179.363 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.568 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.75 -26.18 63.72 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.374 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.5 t -51.69 -50.62 30.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.013 179.28 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -75.96 -8.59 57.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.934 -179.558 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -95.0 -19.25 20.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.177 179.581 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.585 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 63.9 m-85 -136.04 63.16 49.62 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.578 -179.734 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.87 -44.46 44.91 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.718 2.278 . . . . 0.0 111.553 178.988 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.24 -40.94 85.76 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.421 179.212 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.3 t -67.27 143.96 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.886 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.507 ' CB ' HG21 ' A' ' 31' ' ' THR . 42.2 t -82.34 99.56 9.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.083 0.468 . . . . 0.0 111.014 -179.591 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.533 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.9 p90 -66.71 123.96 21.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.0 179.787 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -143.74 162.81 27.7 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.063 179.979 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.403 HD11 HG13 ' A' ' 47' ' ' VAL . 4.4 tt -160.06 142.33 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.936 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.9 t -143.42 153.57 42.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.114 0.483 . . . . 0.0 111.843 -178.888 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 39' ' ' PHE . 75.3 p -138.34 1.16 2.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.589 179.598 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -73.38 145.95 45.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.7 t -66.76 -50.83 61.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.385 -179.569 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -50.1 -43.98 51.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.539 -179.392 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.556 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.1 t -71.04 -53.43 21.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.867 0.365 . . . . 0.0 110.799 179.885 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mp -58.74 -14.74 9.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.263 179.402 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.7 m -91.62 -42.96 9.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.427 179.062 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -60.36 -38.66 84.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.577 179.816 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.434 ' HB2' HG12 ' A' ' 76' ' ' ILE . 60.8 m-85 -91.39 11.17 24.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.697 179.647 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 56.19 24.41 8.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.705 179.289 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.672 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.3 mm -60.93 122.3 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.922 179.648 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.4 p -142.89 60.34 1.42 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.089 -179.959 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.29 45.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.499 179.88 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.646 ' HB2' HG21 ' A' ' 99' ' ' ILE . 30.5 m-20 50.52 43.81 27.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.158 0.504 . . . . 0.0 110.301 -179.773 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.672 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.7 m -69.56 153.61 43.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.653 -178.41 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.585 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.9 mt -120.71 116.61 50.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.004 177.993 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.489 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 71.4 m -106.18 132.57 52.09 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.837 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.626 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -108.32 102.6 11.7 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.798 178.291 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -97.39 123.64 41.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.885 0.374 . . . . 0.0 110.68 179.784 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.493 HH21 ' HB2' ' A' ' 88' ' ' ASP . 3.6 mtm180 -106.17 99.66 9.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.073 179.7 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.0 tp -43.28 -51.1 6.41 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.621 -179.38 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.615 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -42.59 -64.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.334 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.493 ' HB2' HH21 ' A' ' 85' ' ' ARG . 2.9 m-20 -98.29 18.09 17.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.59 -179.13 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.7 p30 43.63 29.49 0.28 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.022 179.207 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.48 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 7.5 mm-40 -75.02 156.38 36.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.37 . . . . 0.0 111.137 -179.946 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -139.93 89.78 2.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.687 179.574 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.626 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -78.03 142.38 38.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.65 179.574 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.22 111.25 15.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.355 0.598 . . . . 0.0 112.534 -179.108 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.66 HD21 HD13 ' A' ' 102' ' ' ILE . 3.6 tt -98.29 76.39 2.32 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.043 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.7 mt-10 -77.65 -166.29 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -176.697 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.539 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.6 t70 -50.54 -37.71 40.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.914 -179.218 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -56.46 -15.27 3.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.13 0.491 . . . . 0.0 110.461 179.791 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -128.66 -13.67 4.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.395 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.646 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.9 mm -89.63 -25.13 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.592 -179.31 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -51.9 -61.48 2.23 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.923 0.392 . . . . 0.0 110.653 179.846 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.8 m -112.89 38.94 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.471 179.649 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.66 HD13 HD21 ' A' ' 94' ' ' LEU . 7.7 tp -57.1 143.24 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.427 -179.832 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -136.05 149.81 48.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.823 178.873 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.898 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.25 -33.92 9.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.187 179.97 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 97.8 m -62.82 -50.6 70.33 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.245 178.73 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -58.33 -58.42 8.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.278 -179.614 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.781 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.93 -57.27 8.95 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.036 0.446 . . . . 0.0 110.32 179.977 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 64.9 m -57.82 -29.4 64.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.831 179.85 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.48 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.1 tmt_? -71.38 -64.88 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.239 179.786 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -43.44 -43.38 5.26 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.972 178.976 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.456 HG12 HG21 ' A' ' 35' ' ' VAL . 95.9 mt -63.68 -56.11 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.509 178.408 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.84 -16.7 2.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.283 0.563 . . . . 0.0 110.334 179.337 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.48 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -91.91 -34.99 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.738 -179.231 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.502 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.0 m120 -127.5 32.16 5.06 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.306 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 111' ' ' ILE . 91.0 p -83.94 36.08 0.55 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.201 0.524 . . . . 0.0 110.199 178.995 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.488 HD12 HH12 ' A' ' 85' ' ' ARG . 51.9 mt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.174 -179.443 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.502 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.581 0.229 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 40.0 Cg_endo -67.89 142.59 57.7 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.733 2.289 . . . . 0.0 112.533 -179.702 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 m -54.49 152.66 6.41 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.23 -179.977 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -103.11 79.66 1.77 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.066 0.46 . . . . 0.0 111.057 -179.79 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.678 HD22 ' HA ' ' A' ' 24' ' ' ALA . 46.6 mt -71.06 94.45 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.317 179.708 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.4 p -85.45 -12.93 50.72 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.871 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 5.4 m-20 -139.62 151.27 45.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.77 -179.471 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 30.0 t -52.89 -49.76 85.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.561 179.853 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.6 Cg_endo -57.42 -45.71 32.58 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.97 1.78 . . . . 0.0 112.043 179.912 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.22 -34.79 78.42 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.201 0.524 . . . . 0.0 110.279 -179.852 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.678 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.93 -59.46 4.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.147 179.406 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.6 mtm -60.75 -24.26 65.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.041 -179.994 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.4 -51.28 17.85 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.312 179.437 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.49 ' O ' HG22 ' A' ' 31' ' ' THR . 4.9 m-85 -59.62 -31.74 69.77 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.141 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 36' ' ' ILE . 49.4 mt -75.03 -41.25 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.271 178.444 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.28 -19.04 62.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.162 -179.788 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.59 27.82 2.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.146 -179.845 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.609 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.8 t -172.68 154.01 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.769 -179.629 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.591 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.0 tt0 -63.8 -73.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.747 179.911 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.569 HG13 HD11 ' A' ' 83' ' ' LEU . 21.6 t -100.68 137.86 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.656 179.87 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.94 126.1 18.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.987 0.422 . . . . 0.0 112.058 -179.27 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.458 HG21 HG12 ' A' ' 111' ' ' ILE . 50.0 t -114.7 130.63 68.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.518 178.413 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.541 HD12 HD11 ' A' ' 28' ' ' ILE . 24.0 mt -135.07 136.02 52.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.243 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.51 97.73 1.93 Allowed Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.465 179.787 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 10.3 m-85 -83.37 92.06 7.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.665 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.7 m-85 -112.92 138.66 49.44 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.093 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.542 ' HG2' HD23 ' A' ' 71' ' ' LEU . 86.4 mt-30 -85.25 -6.48 59.26 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.714 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.4 t70 -151.54 125.67 9.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.644 179.672 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.516 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.9 mt -93.83 44.06 1.12 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.004 0.43 . . . . 0.0 111.203 -179.535 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.3 mt-10 -133.56 9.63 3.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.865 178.962 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.75 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.2 pt -91.73 157.69 41.31 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.19 179.942 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.476 ' O ' HD12 ' A' ' 49' ' ' ILE . 77.9 Cg_exo -53.22 -26.08 32.51 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.845 2.363 . . . . 0.0 112.956 179.603 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.75 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.32 -38.87 92.58 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.916 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.694 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -60.26 -55.41 45.57 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -178.557 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -60.22 -39.47 68.14 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.882 1.721 . . . . 0.0 111.509 179.286 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.893 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.5 mt -63.88 -34.2 66.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.045 179.984 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 54' ' ' VAL . 50.1 tp -74.76 -52.27 11.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.823 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -53.44 -27.31 24.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.168 0.508 . . . . 0.0 109.765 178.618 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -80.25 -46.38 16.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.568 179.876 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.587 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.49 -25.8 64.74 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.406 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.1 t -53.53 -50.39 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.999 179.505 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -73.89 -11.51 60.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.617 179.911 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -93.3 -18.77 22.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.22 -179.863 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.6 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 63.0 m-85 -136.0 61.6 41.52 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.636 -179.682 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.37 -38.28 82.33 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.604 2.203 . . . . 0.0 111.506 179.167 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.16 -41.27 99.42 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.354 179.079 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.1 t -67.07 145.23 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.884 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.609 ' HB2' HG21 ' A' ' 31' ' ' THR . 36.0 t -82.41 96.57 8.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.959 0.409 . . . . 0.0 111.114 -179.696 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.502 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.9 p90 -63.87 127.16 30.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.982 179.763 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.54 162.71 28.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.054 179.78 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 tt -160.62 144.71 5.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.986 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 t -145.01 157.05 44.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.98 0.419 . . . . 0.0 111.81 -178.949 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 39' ' ' PHE . 76.5 p -141.92 1.41 1.47 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.593 179.649 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.7 144.15 45.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.624 179.93 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.5 p -65.28 -51.51 60.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.67 -179.439 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -49.67 -43.03 46.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.64 -179.386 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.463 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.3 t -71.72 -52.96 22.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.311 . . . . 0.0 110.748 179.981 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.542 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -59.14 -14.6 10.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.158 0.504 . . . . 0.0 110.273 179.371 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.4 m -91.84 -40.57 11.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.377 178.722 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -61.31 -39.99 92.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.232 179.822 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.425 ' HB2' HG12 ' A' ' 76' ' ' ILE . 37.4 m-85 -90.51 9.73 28.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.626 179.533 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 57.38 25.53 11.39 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.641 179.107 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.653 HD12 ' HB ' ' A' ' 80' ' ' THR . 36.9 mm -60.8 118.13 3.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.997 179.653 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.1 p -136.62 56.28 1.81 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.388 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.25 45.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.728 179.838 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.59 ' HB2' HG21 ' A' ' 99' ' ' ILE . 24.8 m-80 51.62 42.54 29.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.196 0.522 . . . . 0.0 110.474 179.93 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.653 ' HB ' HD12 ' A' ' 76' ' ' ILE . 89.3 m -68.24 153.07 44.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.646 -178.607 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.578 HG12 ' HA2' ' A' ' 37' ' ' GLY . 61.7 mt -119.33 118.65 58.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.054 177.988 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 81.5 m -107.62 135.7 48.62 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.787 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.652 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -110.41 105.47 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.104 178.552 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.3 t80 -98.9 123.09 42.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.851 0.357 . . . . 0.0 110.666 179.652 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.472 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.5 mtm180 -106.73 91.8 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.205 179.844 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tp -38.25 -50.74 1.46 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.711 -179.824 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.591 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -45.2 -59.78 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.435 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -99.98 17.08 21.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.328 -179.418 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 42.83 32.76 0.42 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.948 179.084 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 8.3 mm-40 -81.58 160.59 23.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 111.147 -179.823 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -146.75 91.45 2.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.362 179.564 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.652 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -80.07 149.22 30.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.875 179.7 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.6 124.62 41.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.315 0.579 . . . . 0.0 112.117 -179.366 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.602 HD21 HD13 ' A' ' 102' ' ' ILE . 3.8 tt -111.24 75.53 0.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.073 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.0 mt-10 -77.51 -165.62 0.63 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.395 -0.821 . . . . 0.0 113.208 -176.736 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.516 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.5 t70 -51.31 -36.74 43.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.968 -179.181 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -56.49 -14.82 3.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.152 0.501 . . . . 0.0 110.266 179.536 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -130.26 -13.94 3.88 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.554 -179.947 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.59 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.2 mm -90.7 -25.38 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.78 0.324 . . . . 0.0 111.34 -179.364 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.6 -52.2 62.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.691 179.993 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 81.1 p -119.66 36.57 4.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.511 179.811 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.602 HD13 HD21 ' A' ' 94' ' ' LEU . 7.5 tp -57.38 142.24 13.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.487 -179.853 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.45 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 25.0 m-20 -135.93 149.76 49.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.757 178.884 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.893 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.04 -37.06 14.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.03 0.443 . . . . 0.0 110.446 -179.77 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.8 m -62.52 -47.85 82.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.295 178.71 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.45 ' HD3' ' N ' ' A' ' 103' ' ' ASP . 59.3 mtpt -59.2 -60.23 4.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.087 -179.735 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.755 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.06 -55.98 10.45 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.931 0.396 . . . . 0.0 110.15 179.847 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.2 m -57.87 -30.19 65.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.814 179.794 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.49 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -70.61 -65.77 0.69 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.088 179.696 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -42.29 -44.78 3.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.076 179.053 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -62.66 -55.86 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.537 178.495 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -54.13 -18.31 3.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.444 179.326 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.49 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.87 -38.51 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.016 -179.057 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.445 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.5 m120 -123.35 29.59 6.61 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.348 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.5 p -82.11 50.32 1.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.116 0.484 . . . . 0.0 110.267 178.9 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 61.3 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.43 -179.44 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.626 0.251 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.8 Cg_endo -68.67 148.93 73.0 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.7 2.267 . . . . 0.0 112.677 -179.777 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 m -63.16 152.61 36.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.575 -179.668 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -98.8 97.46 8.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.812 179.706 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 24' ' ' ALA . 38.4 mt -96.37 71.57 2.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.641 179.964 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.9 p -71.39 -3.12 19.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.953 -179.171 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -140.14 147.68 40.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.934 0.397 . . . . 0.0 111.656 -179.991 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 24.9 t -56.49 -49.46 93.4 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.761 -179.896 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.51 -45.27 35.25 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.931 1.754 . . . . 0.0 111.963 179.954 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.38 -35.89 82.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.267 0.556 . . . . 0.0 110.344 -179.961 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.608 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.95 -57.91 8.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.185 179.427 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 64.4 mtp -61.75 -26.39 68.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.224 -179.952 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.48 -50.79 28.15 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.497 179.598 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.468 ' O ' HG22 ' A' ' 31' ' ' THR . 7.6 m-85 -60.24 -33.05 71.74 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.035 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.502 HD11 HD12 ' A' ' 36' ' ' ILE . 57.1 mt -72.72 -39.81 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.024 178.475 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.75 -19.33 62.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.99 -179.869 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.12 29.45 2.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.856 -179.975 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.583 HG21 ' CB ' ' A' ' 61' ' ' SER . 10.0 t -169.31 153.03 5.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.271 -179.722 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HG3' HG13 ' A' ' 87' ' ' VAL . 27.1 tt0 -72.4 -46.34 55.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.577 HG13 HD11 ' A' ' 83' ' ' LEU . 21.0 t -122.68 133.87 67.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.08 179.296 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.544 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.66 126.29 20.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.012 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.513 HG21 HG12 ' A' ' 111' ' ' ILE . 52.0 t -114.24 127.59 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.766 178.701 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.502 HD12 HD11 ' A' ' 28' ' ' ILE . 24.8 mt -133.03 136.73 54.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.391 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.604 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.91 96.92 1.7 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.544 179.972 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.6 m-85 -83.17 90.82 7.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.654 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.4 m-85 -111.56 139.34 47.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.184 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.453 ' HG2' HD23 ' A' ' 71' ' ' LEU . 89.6 mt-30 -85.42 -7.21 59.05 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.89 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.439 ' O ' HG12 ' A' ' 44' ' ' ILE . 36.6 t70 -150.67 125.68 9.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.667 179.768 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.604 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.2 mt -93.72 46.94 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.112 0.482 . . . . 0.0 111.373 -179.533 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 46.7 mt-10 -138.19 9.99 2.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.948 179.034 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.801 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.4 pt -93.06 156.28 40.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.064 179.848 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.465 ' O ' HD12 ' A' ' 49' ' ' ILE . 81.4 Cg_exo -50.96 -27.25 20.52 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.818 2.345 . . . . 0.0 113.214 -179.914 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.801 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.43 -38.25 90.39 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.916 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.69 HG23 HG13 ' A' ' 44' ' ' ILE . 3.0 t -60.45 -55.96 39.98 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.585 -178.742 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.6 -41.55 55.37 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.876 1.717 . . . . 0.0 111.4 179.487 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.883 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.2 mt -60.94 -35.58 66.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.247 179.983 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.2 tp -73.99 -52.28 13.26 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.957 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -54.44 -24.25 19.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.08 0.467 . . . . 0.0 109.824 178.831 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.3 m -82.55 -46.38 13.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.514 179.643 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.576 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.59 -26.41 65.4 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.107 0.48 . . . . 0.0 109.744 179.492 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.7 t -52.86 -50.02 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.194 179.498 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -75.83 -8.35 56.68 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.631 179.992 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -95.72 -19.04 19.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.133 179.743 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.562 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 71.9 m-85 -136.73 62.36 41.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.509 -179.617 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.87 -41.12 72.78 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.7 2.266 . . . . 0.0 111.538 179.09 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.58 -41.63 95.67 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.428 179.191 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.8 t -66.18 145.72 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.765 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.583 ' CB ' HG21 ' A' ' 31' ' ' THR . 40.3 t -83.11 97.34 8.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 111.035 -179.553 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.51 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 8.0 p90 -62.82 129.53 40.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.862 179.646 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.514 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -148.16 159.83 28.15 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.993 179.73 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.9 tt -161.83 140.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.882 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.9 t -145.15 159.2 43.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.146 0.498 . . . . 0.0 111.741 -178.872 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.455 HG21 ' HG ' ' A' ' 42' ' ' LEU . 79.7 p -140.29 -0.77 1.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.396 179.495 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -69.46 141.2 54.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.718 -179.786 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.2 t -64.3 -48.38 75.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.296 -179.78 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -49.96 -46.31 52.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.436 -179.639 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.52 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.5 t -69.44 -53.27 25.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.703 179.846 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.8 mp -58.27 -14.82 8.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.195 0.521 . . . . 0.0 110.317 179.462 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.2 m -90.66 -42.46 10.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.264 178.615 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -59.79 -40.76 89.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.629 -179.98 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.405 ' HB2' HG12 ' A' ' 76' ' ' ILE . 51.3 m-85 -90.6 11.04 23.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.831 179.602 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 56.8 26.24 11.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.438 179.326 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.683 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.5 mm -61.61 122.96 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.839 179.633 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.1 p -140.9 47.89 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.762 0.315 . . . . 0.0 111.51 -179.891 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.8 47.88 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.742 179.819 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.621 ' HB2' HG21 ' A' ' 99' ' ' ILE . 23.7 m-80 50.06 41.45 23.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.257 0.551 . . . . 0.0 110.271 -179.775 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.683 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.1 m -67.79 151.79 46.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.671 -178.515 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.604 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.3 mt -118.73 115.79 49.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.865 178.059 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.535 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.1 m -105.47 130.92 53.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.779 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.616 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.3 tp -107.66 99.84 9.29 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.843 178.455 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.5 t80 -92.31 122.93 35.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.364 179.633 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.462 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 6.1 mtm180 -105.24 85.66 2.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.867 0.365 . . . . 0.0 110.57 -179.915 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 tp -26.05 -59.61 0.08 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.12 -179.322 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.456 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.86 -71.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.261 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.71 13.41 8.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.333 -179.302 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 44.29 29.82 0.4 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.131 178.973 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 10.4 mm-40 -76.41 167.52 21.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.349 . . . . 0.0 110.79 179.825 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -154.26 95.23 1.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.623 179.724 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.616 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -80.55 110.71 16.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.065 -179.953 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -92.52 92.1 7.9 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.973 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.611 HD21 HD13 ' A' ' 102' ' ' ILE . 3.3 tt -77.92 78.11 4.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.753 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.449 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.8 mt-10 -79.05 -164.95 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.865 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.517 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 22.5 t70 -51.18 -37.61 47.56 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.905 -179.252 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -54.91 -14.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.213 0.53 . . . . 0.0 110.352 179.533 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -130.77 -13.99 3.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.753 -179.906 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.621 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.1 mm -89.84 -37.11 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.281 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -51.0 -39.77 56.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.885 0.374 . . . . 0.0 111.077 -179.874 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.9 p -126.92 36.03 4.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.645 179.939 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.611 HD13 HD21 ' A' ' 94' ' ' LEU . 7.9 tp -62.61 143.91 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.701 -179.666 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -137.74 147.34 44.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.364 178.856 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.883 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.85 -35.93 6.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.972 0.415 . . . . 0.0 110.333 -179.735 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 99.6 m -62.29 -48.31 80.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.266 178.646 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -60.0 -59.87 4.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.241 -179.709 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.776 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.03 -55.69 13.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.899 0.381 . . . . 0.0 110.275 -179.909 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.2 m -58.19 -29.93 66.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.687 179.702 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.51 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.6 tmt_? -71.39 -66.14 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.188 179.772 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -42.75 -43.4 3.93 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.12 179.286 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.513 HG12 HG21 ' A' ' 35' ' ' VAL . 90.2 mt -63.89 -55.23 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.549 178.409 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -55.14 -16.82 3.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.281 179.282 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.51 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -92.27 -34.7 6.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.767 -179.272 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' A' ' 85' ' ' ARG . 36.1 m120 -123.12 28.1 7.31 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.653 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.1 p -82.35 46.81 1.08 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.067 0.46 . . . . 0.0 110.502 179.278 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.455 HD12 HH12 ' A' ' 85' ' ' ARG . 70.2 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.212 -179.62 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.452 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 14.3 pt-20 . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 120.497 0.189 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 42.8 Cg_endo -69.57 144.05 53.77 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.656 2.237 . . . . 0.0 112.574 -179.675 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -59.45 151.32 24.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.346 -179.835 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -96.87 86.85 4.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.938 179.995 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.627 HD22 ' HA ' ' A' ' 24' ' ' ALA . 40.4 mt -83.58 74.47 10.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.488 179.929 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.8 p -74.4 0.54 14.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.048 -179.188 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.41 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 4.7 m-20 -143.88 147.44 34.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.996 0.427 . . . . 0.0 111.751 -179.863 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.608 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.1 t -55.67 -49.34 93.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.45 179.77 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.1 Cg_endo -58.44 -46.48 24.2 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.039 1.826 . . . . 0.0 111.977 179.799 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.16 -34.57 77.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.232 0.539 . . . . 0.0 110.169 -179.873 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.627 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.38 -58.06 7.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.973 179.535 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 33.1 mtt -61.86 -26.01 67.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.239 -179.898 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -71.89 -51.02 24.33 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 110.552 179.681 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.456 ' O ' HG22 ' A' ' 31' ' ' THR . 7.5 m-85 -60.59 -31.2 70.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.06 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.509 HD11 ' CD1' ' A' ' 36' ' ' ILE . 52.4 mt -75.22 -39.57 42.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.059 178.198 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 -18.59 61.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.109 -179.816 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.45 26.15 2.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.147 -179.947 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.727 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.9 t -171.35 155.87 4.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.608 -179.788 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.498 ' HG3' HG13 ' A' ' 87' ' ' VAL . 26.0 tt0 -67.92 -58.78 3.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.717 179.934 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 83' ' ' LEU . 13.6 t -111.17 138.33 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.67 127.44 18.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.961 0.41 . . . . 0.0 111.876 -179.526 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG21 HG12 ' A' ' 111' ' ' ILE . 47.0 t -116.01 128.58 73.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.748 178.732 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 21.5 mt -134.01 136.76 53.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.412 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.595 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.21 97.7 1.78 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.521 179.728 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.514 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.4 m-85 -83.43 91.32 7.34 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.482 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -111.57 142.06 44.36 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -177.945 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -88.96 -7.33 56.23 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.563 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.7 t70 -149.38 121.72 8.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.52 179.623 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.581 ' HA ' HG21 ' A' ' 47' ' ' VAL . 98.7 mt -91.7 46.84 1.31 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.18 0.514 . . . . 0.0 111.383 -179.293 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.424 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 47.4 mt-10 -137.54 7.09 2.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.002 178.964 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.827 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.3 pt -90.13 155.63 46.89 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.949 179.786 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.48 ' O ' HD12 ' A' ' 49' ' ' ILE . 84.3 Cg_exo -49.95 -29.38 21.09 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.729 2.286 . . . . 0.0 112.984 -179.953 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.827 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -61.25 -38.48 86.82 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.998 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.664 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.4 t -61.66 -57.49 24.38 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.569 -178.83 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.06 -38.77 85.4 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.765 1.644 . . . . 0.0 111.453 179.437 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.904 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.9 mt -63.66 -34.38 67.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.907 179.85 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.608 ' O ' HG23 ' A' ' 54' ' ' VAL . 46.6 tp -75.57 -53.02 9.29 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.836 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -54.06 -24.18 16.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.115 0.483 . . . . 0.0 109.977 178.876 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.6 t -84.08 -47.0 11.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.607 179.657 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.616 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.27 -25.84 62.25 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.504 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 50' ' ' LEU . 49.4 t -52.63 -49.15 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.166 179.483 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -76.61 -9.01 58.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.714 179.989 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -94.46 -19.16 20.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.047 179.601 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 58.4 m-85 -135.52 63.02 52.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.752 -179.795 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.79 -45.24 39.56 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.77 2.313 . . . . 0.0 111.636 179.206 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.63 -42.32 84.34 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.468 179.133 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.3 t -65.48 143.58 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.947 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.727 ' HB2' HG21 ' A' ' 31' ' ' THR . 41.7 t -82.33 97.11 8.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.02 0.438 . . . . 0.0 111.125 -179.627 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.515 ' HB3' HG22 ' A' ' 54' ' ' VAL . 6.5 p90 -62.85 128.81 37.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.897 179.658 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.69 160.28 28.32 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.106 179.98 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.8 tt -158.83 143.29 6.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.723 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.4 t -146.44 152.69 39.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.003 0.43 . . . . 0.0 111.776 -179.083 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 39' ' ' PHE . 71.4 p -136.99 -3.95 1.98 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.326 179.5 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.49 142.73 58.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.697 179.986 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.5 m -64.79 -50.44 66.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.428 -179.461 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -50.37 -43.82 54.49 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.671 -179.338 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.504 ' HA ' HG22 ' A' ' 21' ' ' VAL . 69.1 t -71.46 -52.39 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 -179.973 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.39 -15.14 14.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.15 0.5 . . . . 0.0 110.187 179.387 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.7 m -91.59 -40.02 11.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.296 178.795 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.423 ' ND1' HG11 ' A' ' 21' ' ' VAL . 4.7 t60 -61.32 -42.4 98.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.374 179.948 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.409 ' HB2' HG12 ' A' ' 76' ' ' ILE . 39.2 m-85 -88.51 9.31 24.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.695 179.528 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.9 t30 58.82 23.27 11.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.538 179.128 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.664 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.2 mm -56.81 120.83 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.975 179.852 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.6 p -140.31 58.71 1.57 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.344 -179.546 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.76 45.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.7 179.606 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.596 ' HB2' HG21 ' A' ' 99' ' ' ILE . 26.2 m-80 51.73 43.28 30.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.217 0.532 . . . . 0.0 110.422 -179.914 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.664 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.5 m -69.36 152.08 45.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.735 -178.539 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.595 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.0 mt -119.02 118.04 56.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.964 178.135 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 79.4 m -105.91 133.21 51.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.907 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.648 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -109.02 105.17 14.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.774 178.48 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -98.67 120.11 38.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.683 179.787 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.461 HH12 HD12 ' A' ' 116' ' ' LEU . 4.3 mtm180 -104.74 80.98 1.71 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.611 179.965 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 85' ' ' ARG . 7.1 tp -22.59 -58.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 O-C-N 124.009 0.818 . . . . 0.0 112.856 -179.683 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.498 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.09 -67.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.366 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -93.3 3.26 55.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.388 -179.227 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 50.48 37.7 16.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.68 179.682 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 6.6 mm-40 -86.15 134.09 33.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.709 179.952 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.48 95.04 4.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.998 0.427 . . . . 0.0 110.833 179.954 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.648 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -82.41 109.93 17.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.634 179.506 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -93.87 94.59 8.58 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.439 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.555 HD21 HD13 ' A' ' 102' ' ' ILE . 4.3 tt -78.66 77.61 5.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.438 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.5 mt-10 -78.88 -164.91 0.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.908 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.517 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.6 t70 -50.76 -38.43 47.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.148 -179.145 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.57 -14.69 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.227 0.537 . . . . 0.0 110.33 179.722 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -129.68 -13.83 4.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.63 -179.85 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.6 mm -91.08 -31.27 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 111.438 -179.5 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -53.28 -43.15 67.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.891 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.8 m -124.93 38.53 4.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.419 179.711 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.555 HD13 HD21 ' A' ' 94' ' ' LEU . 7.3 tp -63.93 142.52 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.67 -179.698 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -137.98 150.91 47.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.604 178.803 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.904 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.78 -37.37 18.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.002 0.43 . . . . 0.0 110.443 -179.859 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 94.6 m -61.97 -46.93 87.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.208 178.686 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -60.75 -61.14 2.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.415 -179.819 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.79 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.52 -55.16 11.79 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.979 0.418 . . . . 0.0 110.128 179.906 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.6 m -59.05 -30.98 68.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.912 179.832 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.491 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.2 tmt_? -70.53 -65.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.097 179.691 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -43.01 -42.7 3.92 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.306 179.411 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.441 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -64.65 -55.23 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.23 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -54.02 -18.23 3.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.201 179.305 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.491 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -90.06 -38.42 10.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.985 -179.077 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.464 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.7 m120 -122.77 30.54 6.4 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.432 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.0 p -83.14 44.03 0.91 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 110.15 178.727 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.461 HD12 HH12 ' A' ' 85' ' ' ARG . 57.7 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.404 -179.328 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.492 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.3 pt-20 . . . . . 0 CA--C 1.53 0.203 0 CA-C-O 120.513 0.197 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 54.0 Cg_endo -69.9 149.65 66.28 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.636 2.224 . . . . 0.0 112.753 -179.686 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 m -71.55 155.89 40.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.509 -179.622 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -100.05 88.9 3.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.073 179.827 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 24' ' ' ALA . 35.1 mt -82.73 71.78 9.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.375 179.781 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.5 p -70.21 -5.18 25.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.07 -178.892 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -135.81 147.36 48.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 111.416 -179.76 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.606 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 15.6 t -58.27 -48.99 96.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.367 179.915 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.0 Cg_endo -58.45 -43.83 42.71 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.899 1.733 . . . . 0.0 111.839 179.45 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.5 -37.22 86.79 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.291 0.567 . . . . 0.0 110.261 179.811 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.595 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -62.03 -54.89 35.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.049 179.45 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 38.3 mtt -62.48 -29.91 70.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.28 -179.928 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -69.18 -49.01 60.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.658 0.266 . . . . 0.0 110.517 -179.959 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -62.26 -32.82 73.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.851 179.253 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.52 HD11 HD12 ' A' ' 36' ' ' ILE . 48.1 mt -74.16 -36.15 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.156 0.503 . . . . 0.0 109.821 178.05 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.45 -18.57 60.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.21 27.57 2.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.185 -179.823 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.764 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.2 t -171.16 155.95 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.608 -179.761 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.535 ' HG3' HG13 ' A' ' 87' ' ' VAL . 24.4 tt0 -71.26 -46.87 59.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.597 179.755 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.488 HG13 HD11 ' A' ' 83' ' ' LEU . 19.1 t -121.68 137.6 54.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.361 179.555 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.06 128.45 20.03 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.154 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 83' ' ' LEU . 43.5 t -116.22 129.61 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.467 178.463 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.52 HD12 HD11 ' A' ' 28' ' ' ILE . 28.0 mt -136.46 136.15 48.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.226 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.63 96.71 1.77 Allowed Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.482 179.686 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.487 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 40.0 m-85 -82.71 89.67 6.78 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.277 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.1 m-85 -108.44 146.55 32.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.603 -178.031 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -94.48 -1.8 52.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.947 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.515 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.6 t70 -156.87 118.16 3.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.582 179.876 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.506 ' HA ' HG21 ' A' ' 47' ' ' VAL . 90.9 mt -87.28 44.78 1.21 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.117 0.485 . . . . 0.0 111.291 -179.351 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.1 mt-10 -136.61 13.09 3.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.078 179.255 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.833 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.4 pt -96.97 156.23 36.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.19 179.928 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 86.2 Cg_exo -49.57 -31.36 24.27 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.745 2.297 . . . . 0.0 112.851 179.657 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.833 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -59.38 -37.21 77.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.312 -179.107 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.706 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.9 t -61.89 -58.55 17.29 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.591 -178.917 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.706 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 37.0 Cg_exo -58.38 -40.54 74.23 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.777 1.651 . . . . 0.0 111.291 179.342 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.96 HG23 ' HA ' ' A' ' 104' ' ' ALA . 8.6 mt -61.02 -36.3 71.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.899 179.712 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 54' ' ' VAL . 47.6 tp -74.01 -52.37 12.96 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.942 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -54.13 -23.06 12.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.061 0.458 . . . . 0.0 109.876 178.824 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.9 m -83.08 -47.57 11.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.357 179.329 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.562 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.11 -26.4 62.56 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.272 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.0 t -51.67 -51.38 27.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.091 179.512 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -74.3 -12.09 60.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.688 -179.852 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 28.7 mtpp -92.46 -17.61 24.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.27 -179.96 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 52.6 m-85 -137.92 62.91 36.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.535 -179.799 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.67 -43.82 54.53 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.601 2.2 . . . . 0.0 111.618 179.065 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.58 -38.92 83.84 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.417 179.305 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 13.0 t -68.74 144.67 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.861 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.764 ' HB2' HG21 ' A' ' 31' ' ' THR . 42.3 t -81.68 98.77 8.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.047 0.451 . . . . 0.0 110.79 180.0 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.49 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.6 p90 -66.95 122.42 17.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.016 179.856 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.466 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -141.87 163.91 26.87 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.159 179.997 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -162.12 143.08 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.924 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.487 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 43.8 t -148.54 158.81 44.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 111.777 -179.094 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.505 HG21 ' HG ' ' A' ' 42' ' ' LEU . 64.6 p -138.93 -5.42 1.49 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.898 179.548 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.69 140.02 58.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.722 179.948 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.3 m -63.52 -48.16 78.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.824 -179.308 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -51.23 -44.27 61.64 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.241 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.498 ' HA ' HG22 ' A' ' 21' ' ' VAL . 54.2 t -70.75 -53.47 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.85 0.357 . . . . 0.0 110.726 179.804 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.93 -14.91 10.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.234 179.475 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.9 m -91.74 -39.87 11.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.299 178.848 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.437 ' ND1' HG11 ' A' ' 21' ' ' VAL . 5.2 t60 -61.21 -39.93 92.06 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.329 179.902 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.407 ' HB2' HG12 ' A' ' 76' ' ' ILE . 88.0 m-85 -91.86 12.26 22.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.919 179.557 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 56.67 25.43 10.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.6 179.23 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.698 HG23 ' HB ' ' A' ' 80' ' ' THR . 41.7 mm -61.77 120.51 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.968 179.653 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.5 p -140.95 57.17 1.56 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.272 179.982 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.89 45.08 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.552 179.824 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.603 ' HB2' HG21 ' A' ' 99' ' ' ILE . 26.8 m-20 50.25 43.47 26.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.255 0.55 . . . . 0.0 110.248 -179.817 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.698 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.2 m -68.99 151.25 46.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.785 -178.627 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.578 HG12 ' HA2' ' A' ' 37' ' ' GLY . 72.0 mt -117.76 115.38 48.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.851 177.931 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.478 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 80.1 m -103.76 130.5 51.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.755 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.663 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -107.78 101.65 10.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.613 178.231 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.4 t80 -95.86 123.03 39.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.478 179.806 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.504 HH12 HD12 ' A' ' 116' ' ' LEU . 4.8 mtm180 -105.72 87.23 2.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.841 -179.7 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 tp -26.29 -60.68 0.08 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.903 -179.383 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.535 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.76 -79.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.433 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -79.2 3.33 18.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.96 0.409 . . . . 0.0 110.993 -179.891 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 52.21 32.8 11.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.691 179.561 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 10.4 mm-40 -76.39 161.45 28.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.695 179.83 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -145.03 93.95 2.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.627 179.788 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.663 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.1 mm? -83.43 118.6 23.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.789 179.74 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -99.86 94.54 6.36 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.756 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.63 HD21 HD13 ' A' ' 102' ' ' ILE . 3.4 tt -79.2 77.93 5.7 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.672 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.8 mt-10 -79.76 -164.33 0.64 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -176.843 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.517 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.0 t70 -50.78 -37.65 43.54 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.971 -179.379 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.21 -15.92 2.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.226 0.536 . . . . 0.0 110.338 179.76 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -129.63 -14.07 4.17 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.645 -179.92 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.603 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.6 mm -89.89 -24.8 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.77 0.319 . . . . 0.0 111.268 -179.3 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.66 -57.45 11.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.4 p -114.56 35.52 4.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.325 179.661 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.63 HD13 HD21 ' A' ' 94' ' ' LEU . 7.6 tp -57.78 146.85 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.485 -179.844 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.442 ' HA ' ' CD1' ' A' ' 49' ' ' ILE . 9.5 t70 -139.3 164.84 28.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.674 178.605 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.96 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -62.49 -35.97 81.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.111 0.481 . . . . 0.0 110.061 -179.616 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 83.4 m -65.42 -44.88 86.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.199 178.743 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -61.06 -58.46 8.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.952 -179.713 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.733 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.3 -54.32 27.24 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.037 0.446 . . . . 0.0 109.975 179.556 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.4 m -59.02 -29.93 67.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.847 179.795 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.504 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -71.06 -66.03 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.056 179.697 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -43.2 -43.87 4.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.223 179.38 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.416 HG12 HG21 ' A' ' 35' ' ' VAL . 96.4 mt -62.97 -54.23 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.225 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.418 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 33.4 tt0 -54.59 -19.63 6.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.159 179.226 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.504 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.27 -34.5 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.79 -178.985 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.411 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.5 m120 -124.86 29.56 6.15 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.329 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 111' ' ' ILE . 88.2 p -83.54 45.25 1.04 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.115 0.483 . . . . 0.0 110.111 178.996 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.504 HD12 HH12 ' A' ' 85' ' ' ARG . 69.9 mt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.35 -179.344 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.503 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.7 pt-20 . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.503 0.192 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 39.2 Cg_endo -67.7 142.72 59.19 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.597 2.198 . . . . 0.0 112.623 -179.901 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.4 m -63.12 153.47 34.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.809 -179.686 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.89 89.91 5.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.167 179.886 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.599 HD22 ' HA ' ' A' ' 24' ' ' ALA . 41.2 mt -84.78 72.57 10.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.298 179.613 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.1 p -71.9 -2.02 16.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.176 -179.043 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -139.27 147.42 41.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.987 0.423 . . . . 0.0 111.573 -179.797 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 29.6 t -57.24 -49.52 93.42 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.449 179.913 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.66 -44.82 33.58 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.901 1.734 . . . . 0.0 111.998 179.723 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.25 83.19 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.332 0.587 . . . . 0.0 110.203 179.824 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.599 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.65 -57.51 10.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.157 179.548 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 31.4 mtt -61.89 -26.83 68.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.225 -179.923 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -70.44 -50.38 38.92 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.477 179.786 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -61.68 -31.17 71.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.182 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.507 HD11 HD12 ' A' ' 36' ' ' ILE . 52.7 mt -74.62 -37.67 43.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.967 178.056 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.41 -17.59 61.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.972 -179.747 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.56 28.69 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.122 -179.929 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.726 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.1 t -168.89 153.89 6.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.572 -179.681 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.577 ' HG3' HG13 ' A' ' 87' ' ' VAL . 20.8 tt0 -70.91 -42.73 69.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.498 179.6 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.547 HG13 HD11 ' A' ' 83' ' ' LEU . 22.1 t -127.0 137.05 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.278 179.414 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.78 128.37 21.46 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.173 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.479 HG21 HG12 ' A' ' 111' ' ' ILE . 46.1 t -116.25 130.53 70.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.496 178.473 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.507 HD12 HD11 ' A' ' 28' ' ' ILE . 29.3 mt -136.42 136.81 48.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.232 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.22 99.01 2.05 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.528 179.716 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.7 m-85 -85.35 93.97 8.84 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.657 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 9.1 m-85 -114.38 143.77 44.37 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.125 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.407 ' HG2' HD23 ' A' ' 71' ' ' LEU . 95.9 mt-30 -91.17 -3.51 56.96 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.913 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 44' ' ' ILE . 37.1 t70 -154.27 122.33 6.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.689 -1.142 . . . . 0.0 109.465 179.845 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.493 ' HA ' HG21 ' A' ' 47' ' ' VAL . 91.6 mt -91.9 47.18 1.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 0.0 111.276 -179.486 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.9 mt-10 -136.51 11.13 3.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.792 178.977 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.739 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.1 pt -93.6 159.06 35.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.437 -179.915 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.486 ' O ' HD12 ' A' ' 49' ' ' ILE . 69.3 Cg_exo -54.59 -23.66 33.26 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.99 2.46 . . . . 0.0 112.925 179.556 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.739 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -67.11 -38.8 86.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.823 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.694 HG23 HG13 ' A' ' 44' ' ' ILE . 2.5 t -59.13 -54.72 53.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -178.787 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.1 Cg_exo -61.29 -43.53 28.19 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.066 1.844 . . . . 0.0 111.499 179.225 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.878 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -59.89 -34.01 54.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.148 179.981 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.63 ' O ' HG23 ' A' ' 54' ' ' VAL . 50.1 tp -75.48 -51.5 12.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.167 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -53.96 -25.23 19.66 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.994 0.426 . . . . 0.0 109.936 178.793 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 t -83.09 -47.45 11.64 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.625 179.764 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.625 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -57.76 -26.37 61.78 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.376 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 50' ' ' LEU . 51.2 t -51.89 -49.87 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.048 179.451 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -75.45 -12.74 60.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.641 179.952 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -91.5 -17.24 26.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.325 180.0 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.574 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 46.3 m-85 -138.97 63.11 29.66 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.432 -179.877 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.03 -47.67 26.28 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.756 2.304 . . . . 0.0 111.766 179.315 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.71 -41.14 57.17 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.395 179.275 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.6 t -66.23 143.13 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.781 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.726 ' HB2' HG21 ' A' ' 31' ' ' THR . 42.0 t -81.06 97.42 7.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.984 0.421 . . . . 0.0 110.903 -179.786 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.496 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.6 p90 -65.61 123.58 20.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.822 179.699 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.451 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -143.09 163.8 27.33 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.109 179.996 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -161.02 141.95 3.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.897 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.2 t -145.33 155.6 43.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.046 0.45 . . . . 0.0 111.708 -178.993 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.44 HG21 ' HG ' ' A' ' 42' ' ' LEU . 57.1 p -137.99 -3.25 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.807 179.652 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.73 139.81 55.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.425 179.976 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -62.24 -47.4 84.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.68 -179.313 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -50.73 -46.94 59.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.486 -179.217 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.51 ' HA ' HG22 ' A' ' 21' ' ' VAL . 75.3 t -69.6 -51.87 37.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.767 0.318 . . . . 0.0 110.756 179.92 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.407 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -59.36 -14.57 12.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.033 0.444 . . . . 0.0 110.219 179.466 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.3 m -92.63 -40.75 10.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.429 178.776 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -62.65 -35.55 79.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 -179.922 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.443 ' HB2' HG12 ' A' ' 76' ' ' ILE . 44.8 m-85 -94.11 10.36 34.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.754 179.544 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 57.27 24.3 9.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.683 179.422 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.671 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.0 mm -61.31 120.2 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.032 179.767 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.5 p -139.94 55.91 1.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 111.397 -179.926 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.9 44.19 0.02 OUTLIER Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.515 179.86 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.622 ' HB2' HG21 ' A' ' 99' ' ' ILE . 30.8 m-80 52.14 41.9 30.32 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.178 0.513 . . . . 0.0 110.437 -179.646 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.671 ' HB ' HG23 ' A' ' 76' ' ' ILE . 88.2 m -67.77 152.68 45.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.628 -178.564 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.591 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.5 mt -119.58 118.57 57.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.951 178.006 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.3 m -107.5 133.89 51.32 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -177.855 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.638 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.2 tp -109.73 102.55 11.35 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.794 178.262 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -96.93 122.64 40.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.791 0.329 . . . . 0.0 110.77 179.755 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.523 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 4.7 mtm180 -104.61 100.43 10.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.138 0.494 . . . . 0.0 109.971 179.582 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -43.78 -52.01 6.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.872 -179.156 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.577 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -42.82 -65.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.154 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.21 18.95 12.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.652 -179.322 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 p30 42.93 31.1 0.3 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.941 179.332 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.523 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 8.8 mm-40 -75.91 159.5 30.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 0.0 110.974 -179.923 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -146.42 85.44 1.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.65 179.798 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.638 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -75.04 144.84 42.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.224 179.996 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -121.93 124.83 44.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.351 0.596 . . . . 0.0 111.792 -179.643 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.656 HD21 HD13 ' A' ' 102' ' ' ILE . 3.7 tt -112.09 76.03 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.273 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.439 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.0 mt-10 -77.91 -165.41 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.752 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.495 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -46.45 -51.22 15.59 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.556 -179.11 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -47.23 -17.87 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.923 0.392 . . . . 0.0 110.899 179.764 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 96' ' ' ASP . 9.4 m-20 -124.84 -13.94 6.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.414 -179.91 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.622 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.3 mm -92.23 -42.74 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.264 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -50.78 -34.76 28.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.021 179.812 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.5 t -127.66 37.69 4.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.371 179.622 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.656 HD13 HD21 ' A' ' 94' ' ' LEU . 8.7 tp -67.6 144.72 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.779 -179.607 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -138.64 147.87 43.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.345 178.542 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.878 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.71 -37.44 8.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.962 0.41 . . . . 0.0 110.579 -179.722 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.5 m -62.32 -48.45 79.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.322 178.88 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -58.39 -58.4 8.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.311 -179.677 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.761 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.77 -56.59 11.36 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.057 0.456 . . . . 0.0 110.271 179.902 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.4 m -57.71 -29.41 64.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.762 179.796 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.526 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.2 tmt_? -71.44 -65.65 0.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.247 179.83 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -42.89 -42.77 3.81 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.033 179.231 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.479 HG12 HG21 ' A' ' 35' ' ' VAL . 95.5 mt -63.92 -55.3 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.494 178.377 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -54.96 -17.71 4.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.253 0.549 . . . . 0.0 110.332 179.333 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.526 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.77 -36.81 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.84 -179.29 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -123.64 30.12 6.33 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.527 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.8 p -82.58 51.33 1.84 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.085 0.469 . . . . 0.0 109.959 178.741 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 85' ' ' ARG . 55.3 mt . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.295 -179.208 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 46.6 Cg_endo -68.71 146.87 68.15 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.348 2.032 . . . . 0.0 112.811 -179.168 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.6 m -67.75 152.4 45.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.443 -179.623 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -95.81 85.88 4.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.813 179.87 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.3 mt -81.75 71.24 8.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.63 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.0 p -71.43 0.14 8.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.034 -179.266 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -142.56 147.43 35.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.965 0.412 . . . . 0.0 111.705 -179.701 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.594 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.2 t -56.86 -50.35 88.61 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.443 179.881 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.2 Cg_endo -58.39 -44.48 37.65 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.975 1.783 . . . . 0.0 111.93 179.916 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.26 83.28 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.291 0.567 . . . . 0.0 110.18 179.953 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.69 -57.42 10.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.053 179.435 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.2 mtm -61.39 -26.78 68.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.013 -179.903 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -71.47 -50.66 29.44 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.484 179.738 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -60.65 -31.67 70.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.058 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.489 HD11 HD12 ' A' ' 36' ' ' ILE . 49.9 mt -73.17 -38.03 53.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.809 178.236 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.06 -19.7 61.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.998 179.857 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.14 31.01 1.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.471 -179.715 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.695 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.8 t -171.26 153.25 3.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.333 -179.853 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.615 ' HG3' HG13 ' A' ' 87' ' ' VAL . 27.6 tt0 -71.62 -37.46 70.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.651 179.63 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.579 HG13 HD11 ' A' ' 83' ' ' LEU . 26.9 t -131.53 136.81 56.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.229 179.408 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.02 127.12 19.49 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.252 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 111' ' ' ILE . 50.8 t -114.58 130.6 68.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.427 178.304 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.489 HD12 HD11 ' A' ' 28' ' ' ILE . 28.2 mt -136.09 135.66 50.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.439 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.574 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.54 99.13 2.12 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.404 179.46 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 13.9 m-85 -85.39 93.28 8.7 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.631 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -112.8 142.06 45.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.492 -177.958 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.458 ' HG2' HD23 ' A' ' 71' ' ' LEU . 47.7 mt-30 -90.87 1.69 56.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.767 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.8 t70 -159.36 122.22 3.59 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.585 179.895 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.554 ' HA ' HG21 ' A' ' 47' ' ' VAL . 90.1 mt -92.38 47.67 1.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.185 0.517 . . . . 0.0 111.417 -179.32 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 47.5 mt-10 -138.0 7.47 2.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.913 178.868 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.822 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.8 pt -90.93 155.91 44.75 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.159 179.824 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.455 ' O ' HD12 ' A' ' 49' ' ' ILE . 86.5 Cg_exo -51.11 -26.71 20.01 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.862 2.374 . . . . 0.0 113.214 179.733 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.822 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.51 -36.22 83.48 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.842 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.65 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -62.98 -55.92 33.29 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.494 -178.854 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.641 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.1 Cg_exo -58.75 -39.62 80.31 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.807 1.672 . . . . 0.0 111.407 179.34 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 8.3 mt -63.35 -37.59 79.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.137 179.986 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.608 ' O ' HG23 ' A' ' 54' ' ' VAL . 41.9 tp -71.87 -51.76 20.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.844 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -55.49 -22.0 19.0 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.507 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -85.09 -44.17 13.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.581 179.494 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.582 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -62.12 -25.56 67.8 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.33 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 50' ' ' LEU . 52.9 t -52.87 -46.97 52.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.928 179.436 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -77.62 -11.65 59.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.705 -179.729 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -93.72 -18.09 22.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.347 -179.85 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.586 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 66.4 m-85 -137.34 62.39 37.29 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.569 -179.775 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.52 -42.53 61.07 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.632 2.221 . . . . 0.0 111.636 179.033 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.95 -40.96 94.02 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.521 179.227 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.2 t -66.93 143.27 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 178.8 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.695 ' HB2' HG21 ' A' ' 31' ' ' THR . 48.4 t -80.58 98.08 7.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.134 0.492 . . . . 0.0 110.99 -179.681 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.52 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.6 p90 -66.11 125.57 25.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.78 179.67 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.48 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -144.39 161.91 27.94 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.99 179.902 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.412 HD11 HG13 ' A' ' 47' ' ' VAL . 5.0 tt -159.54 144.17 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.803 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.3 t -150.29 154.37 37.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.218 0.532 . . . . 0.0 111.811 -178.993 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.489 HG21 ' HG ' ' A' ' 42' ' ' LEU . 75.2 p -135.21 -2.64 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.474 179.464 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.05 141.36 57.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.717 -179.875 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.3 p -64.57 -49.93 69.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.509 -179.569 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -49.6 -45.02 47.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.492 -179.371 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.539 ' HA ' HG22 ' A' ' 21' ' ' VAL . 69.0 t -70.52 -53.19 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.877 0.37 . . . . 0.0 110.734 179.853 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.458 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.25 -14.71 7.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.193 179.406 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.4 m -91.59 -41.85 10.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.333 178.889 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -61.25 -35.48 77.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.449 179.679 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.424 ' HB2' HG12 ' A' ' 76' ' ' ILE . 45.4 m-85 -94.61 9.31 39.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.759 179.452 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.3 t30 57.65 23.19 9.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.671 178.787 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.679 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.6 mm -58.13 120.78 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.157 179.856 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.3 p -139.23 57.34 1.66 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.403 -179.632 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.82 46.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.75 179.754 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.612 ' HB2' HG21 ' A' ' 99' ' ' ILE . 21.8 m-80 50.62 42.52 27.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.188 0.518 . . . . 0.0 110.293 -179.868 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.679 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.4 m -69.0 152.26 45.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.665 -178.352 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.583 HG21 HD21 ' A' ' 107' ' ' LEU . 66.0 mt -119.18 116.42 50.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.952 178.01 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.4 m -105.34 135.23 47.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.816 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.638 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -109.64 98.78 8.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.916 178.377 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -92.45 120.11 32.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.541 179.816 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.508 HH12 HD12 ' A' ' 116' ' ' LEU . 5.1 mtm180 -103.74 103.84 13.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.399 . . . . 0.0 110.108 179.706 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.5 tp -45.1 -56.32 4.82 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.831 -179.182 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.615 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.03 -76.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.175 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -82.5 5.9 19.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.047 -179.754 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 52.3 36.58 20.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.425 179.779 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 7.3 mm-40 -81.61 167.19 19.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.959 179.833 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -150.73 89.53 1.56 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.575 179.621 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.638 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.8 mm? -74.49 148.09 41.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.877 179.735 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.5 114.62 18.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.3 0.571 . . . . 0.0 112.165 -179.512 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.6 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -103.52 77.88 1.54 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.154 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.2 mt-10 -80.55 -164.4 0.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.91 -176.775 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 17.7 t70 -50.62 -36.25 34.31 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.068 -179.319 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -56.04 -14.7 2.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.313 0.578 . . . . 0.0 110.254 179.63 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -132.33 -13.67 3.03 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.768 -179.909 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.612 HG21 ' HB2' ' A' ' 79' ' ' ASN . 26.2 mm -89.69 -31.54 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.7 0.286 . . . . 0.0 111.269 -179.555 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -53.78 -43.04 68.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.0 110.707 179.815 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.5 p -125.74 38.83 4.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.393 179.738 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.6 HD13 HD21 ' A' ' 94' ' ' LEU . 7.7 tp -63.56 142.93 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.653 -179.835 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -137.25 148.46 46.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.505 178.836 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.53 -34.89 8.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.193 0.52 . . . . 0.0 110.274 -179.989 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.2 m -63.47 -48.1 79.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.35 178.774 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -60.3 -60.74 3.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.266 -179.71 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.745 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.68 -55.36 11.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.029 0.442 . . . . 0.0 110.239 179.898 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 65.8 m -58.92 -30.86 68.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.87 179.948 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.49 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.2 tmt_? -70.85 -65.81 0.69 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.146 179.724 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -42.87 -44.23 4.42 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.232 179.355 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.475 HG12 HG21 ' A' ' 35' ' ' VAL . 95.4 mt -62.89 -55.08 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.175 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.447 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 7.8 tp10 -54.1 -17.97 3.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.294 179.178 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.49 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -91.09 -34.9 6.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.031 -179.097 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.467 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.6 m120 -124.78 28.79 6.39 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.408 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 94.3 p -82.47 43.88 0.85 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.076 0.465 . . . . 0.0 110.346 179.157 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.508 HD12 HH12 ' A' ' 85' ' ' ARG . 59.2 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.392 -179.279 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.8 pt-20 . . . . . 0 CA--C 1.53 0.19 0 CA-C-O 120.404 0.145 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 32.5 Cg_endo -64.89 139.11 60.64 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.549 2.166 . . . . 0.0 112.502 -179.655 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -54.84 153.49 6.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.824 -179.368 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -98.18 92.18 5.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.976 179.78 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.614 HD22 ' HA ' ' A' ' 24' ' ' ALA . 50.9 mt -92.42 72.07 5.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.448 179.77 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.8 p -73.79 -0.99 17.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.889 -179.299 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -140.51 146.78 38.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.393 . . . . 0.0 111.626 -179.953 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 48.4 t -56.29 -49.96 90.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.494 179.862 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.4 Cg_endo -57.5 -46.15 29.36 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.896 1.73 . . . . 0.0 111.773 179.842 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.98 76.9 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.269 0.557 . . . . 0.0 110.259 -179.822 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.614 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.87 -58.68 5.55 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.104 179.342 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 46.7 mtm -61.3 -26.3 67.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.209 -179.943 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.0 mt-10 -72.06 -51.42 21.72 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.687 0.28 . . . . 0.0 110.612 179.806 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.575 ' O ' HG22 ' A' ' 31' ' ' THR . 6.2 m-85 -59.69 -34.64 73.14 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.106 179.249 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 36' ' ' ILE . 49.3 mt -72.89 -38.49 56.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.844 178.293 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.65 -17.46 61.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.005 -179.826 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.61 26.04 5.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.307 -179.9 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 27' ' ' PHE . 8.8 t -172.78 152.06 2.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.597 -179.77 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.724 ' HG3' HG13 ' A' ' 87' ' ' VAL . 1.2 mp0 -59.67 -90.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.252 0.548 . . . . 0.0 110.948 179.32 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.547 HG13 HD11 ' A' ' 83' ' ' LEU . 11.4 t -85.41 133.12 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.715 -179.321 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -137.57 124.4 21.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.873 -178.977 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.428 HG21 HG12 ' A' ' 111' ' ' ILE . 52.3 t -112.75 129.71 67.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.845 178.736 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.521 HD12 HD11 ' A' ' 28' ' ' ILE . 25.2 mt -134.66 135.56 53.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.646 -177.249 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.54 98.06 1.97 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.41 179.859 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.526 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.9 m-85 -83.24 90.06 7.06 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.725 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.4 m-85 -110.29 139.74 45.16 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.0 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -87.36 -5.91 58.69 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.764 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.488 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.2 t70 -152.59 120.85 6.28 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.583 -179.924 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.484 ' HA ' HG21 ' A' ' 47' ' ' VAL . 99.3 mt -89.81 45.58 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.047 0.451 . . . . 0.0 111.513 -179.187 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.4 mt-10 -136.85 11.05 3.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.09 178.97 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.734 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.2 pt -92.77 157.22 39.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.27 179.815 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.487 ' O ' HD12 ' A' ' 49' ' ' ILE . 70.9 Cg_exo -51.67 -25.93 21.61 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.853 2.368 . . . . 0.0 113.004 179.547 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.734 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.41 -37.9 88.34 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.853 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.684 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -61.12 -54.92 49.16 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -178.73 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.614 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 35.2 Cg_exo -61.05 -38.81 65.11 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.951 1.767 . . . . 0.0 111.508 179.202 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.879 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -64.76 -34.58 71.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.025 -179.954 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.617 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.1 tp -74.3 -52.13 13.17 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.879 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -53.11 -26.36 16.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.173 0.511 . . . . 0.0 109.681 178.618 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 t -80.93 -47.55 13.55 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.778 179.867 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.587 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.72 -26.32 63.81 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.443 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 50' ' ' LEU . 56.0 t -52.36 -49.43 42.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.019 179.624 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -77.57 -11.44 59.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.75 -179.815 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -91.3 -18.74 23.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.01 179.807 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 50.3 m-85 -135.92 63.2 50.6 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.267 -179.818 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.03 -43.86 49.6 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.629 2.219 . . . . 0.0 111.692 179.252 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.6 -40.94 88.8 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.367 179.086 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.1 t -66.45 144.48 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.913 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.567 ' CB ' HG21 ' A' ' 31' ' ' THR . 31.0 t -83.73 98.98 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.059 0.457 . . . . 0.0 110.987 -179.581 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.491 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.4 p90 -64.39 128.84 37.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.053 179.875 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.62 161.65 28.7 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.137 179.762 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 15' ' ' PRO . 4.2 tt -159.32 141.89 5.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.679 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.1 t -141.73 154.55 45.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.971 0.415 . . . . 0.0 111.489 -178.974 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 39' ' ' PHE . 68.9 p -139.96 -2.44 1.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.875 179.894 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -72.15 143.06 49.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.754 -179.939 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.8 p -63.19 -49.67 73.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.533 -179.493 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -49.97 -44.37 50.71 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.69 -179.381 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.566 ' HA ' HG22 ' A' ' 21' ' ' VAL . 79.6 t -70.54 -52.83 25.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.925 0.393 . . . . 0.0 110.723 179.797 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.19 -14.55 11.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.223 179.422 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.7 m -91.53 -41.89 10.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.264 178.871 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -59.78 -39.92 86.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.498 179.723 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -92.11 13.75 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.987 179.675 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.4 m120 55.32 24.19 6.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.598 179.433 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.66 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.1 mm -59.73 119.23 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.886 179.747 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -139.51 57.59 1.64 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.199 -179.948 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.2 45.06 0.02 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.515 179.828 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.555 ' HB2' HG21 ' A' ' 99' ' ' ILE . 24.9 m-80 51.42 42.16 28.99 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.292 0.567 . . . . 0.0 110.406 -179.859 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.66 ' HB ' HG23 ' A' ' 76' ' ' ILE . 97.9 m -67.86 152.86 44.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.605 -178.621 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.591 HG12 ' HA2' ' A' ' 37' ' ' GLY . 66.1 mt -119.41 117.26 53.43 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.14 178.161 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.526 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.1 m -106.13 135.99 46.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.837 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.626 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -110.64 104.49 13.18 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.132 178.546 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -97.46 120.1 37.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.76 179.76 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.567 HH12 HD12 ' A' ' 116' ' ' LEU . 5.6 mtm180 -103.39 88.83 3.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.563 -179.739 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tp -38.61 -49.46 1.54 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.637 -179.791 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.724 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -42.48 -52.38 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 111.431 -179.88 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -108.59 9.39 27.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.62 179.821 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 85' ' ' ARG . 17.0 t-20 47.89 35.55 5.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.519 -179.834 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 8.0 mm-40 -83.05 163.8 20.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.648 179.566 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.2 94.14 2.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 179.761 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.626 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -80.94 146.16 30.9 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.338 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.75 106.31 9.96 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.927 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.619 HD21 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -91.79 77.42 5.54 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.663 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' HG12 ' A' ' 99' ' ' ILE . 24.4 mt-10 -79.19 -165.09 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.767 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.472 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -45.25 -51.46 10.75 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.569 -179.331 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -47.04 -17.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.901 0.382 . . . . 0.0 111.215 179.88 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -125.52 -13.85 6.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.575 -179.968 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.555 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.3 mm -90.88 -41.32 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.729 -179.381 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -49.05 -40.41 31.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.4 p -126.03 41.87 3.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.684 179.839 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.619 HD13 HD21 ' A' ' 94' ' ' LEU . 7.5 tp -69.31 142.54 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.663 -179.581 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -135.6 147.76 48.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.237 178.597 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.879 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.45 -36.14 6.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.593 -179.608 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.8 m -63.22 -47.45 82.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.562 178.822 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -59.5 -59.3 5.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.206 -179.743 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.741 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.02 -54.59 19.13 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.898 0.38 . . . . 0.0 110.22 179.712 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.3 m -59.38 -30.15 68.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.504 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.1 tmt_? -70.84 -65.59 0.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.191 179.651 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -43.48 -44.23 5.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.908 179.363 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.428 HG12 HG21 ' A' ' 35' ' ' VAL . 96.8 mt -62.34 -54.96 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.437 178.257 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -54.8 -18.9 5.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.213 179.358 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.504 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.91 -35.72 8.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.937 -179.094 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.451 ' O ' HD21 ' A' ' 83' ' ' LEU . 18.0 m120 -125.3 29.82 5.97 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.397 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 96.8 p -81.99 38.3 0.52 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.971 0.415 . . . . 0.0 110.487 179.048 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.567 HD12 HH12 ' A' ' 85' ' ' ARG . 58.6 mt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.114 -179.705 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.443 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.3 pt-20 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.403 0.144 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.2 Cg_endo -66.25 143.49 70.98 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.532 2.155 . . . . 0.0 112.712 -179.429 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.4 m -59.3 154.17 17.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.427 -179.614 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -102.14 97.06 7.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.935 -179.987 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.604 HD13 ' HA ' ' A' ' 24' ' ' ALA . 39.2 mt -95.17 76.81 3.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.432 179.958 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.0 p -74.09 -4.34 34.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.142 -179.085 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -139.02 147.32 41.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.92 0.39 . . . . 0.0 111.595 -179.669 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.2 t -55.97 -50.24 88.42 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.36 179.969 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.95 -44.25 41.63 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 121.88 1.72 . . . . 0.0 111.736 179.992 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.76 78.82 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.321 0.582 . . . . 0.0 110.22 179.995 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.604 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -64.51 -58.66 5.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.093 179.483 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.2 mtp -61.7 -25.83 67.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 19.1 mt-10 -71.34 -51.5 23.9 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.738 0.304 . . . . 0.0 110.474 179.591 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.583 ' O ' HG22 ' A' ' 31' ' ' THR . 7.0 m-85 -59.27 -35.68 74.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.97 179.317 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 36' ' ' ILE . 46.9 mt -71.13 -39.56 74.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.904 178.305 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.98 -17.98 62.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.994 -179.906 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.78 24.95 5.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.186 -179.862 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.59 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.3 t -169.95 152.76 4.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.416 -179.92 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.587 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.5 tt0 -61.23 -82.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.898 -179.888 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.554 HG13 HD11 ' A' ' 83' ' ' LEU . 21.9 t -94.63 138.16 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.48 179.964 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.99 126.84 20.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.946 0.403 . . . . 0.0 111.989 -179.173 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.445 HG21 HG12 ' A' ' 111' ' ' ILE . 45.1 t -113.65 128.11 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.789 178.445 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.541 HD12 HD11 ' A' ' 28' ' ' ILE . 32.0 mt -133.0 134.68 57.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.658 -177.053 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.536 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.3 100.25 2.31 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.347 179.614 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 4.4 m-85 -84.76 93.19 8.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.8 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.2 m-85 -114.5 141.45 47.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.103 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.496 ' HG2' HD23 ' A' ' 71' ' ' LEU . 74.0 mt-30 -88.89 -7.8 55.43 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.706 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 44' ' ' ILE . 25.4 t70 -150.2 120.95 7.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.667 -1.152 . . . . 0.0 109.66 179.688 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.476 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.6 mt -90.17 45.33 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.006 0.432 . . . . 0.0 111.536 -179.197 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.7 mt-10 -135.42 11.84 3.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.083 178.976 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.696 HG13 HG23 ' A' ' 47' ' ' VAL . 4.9 pt -93.18 158.93 36.43 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.508 ' O ' HD12 ' A' ' 49' ' ' ILE . 68.8 Cg_exo -54.15 -25.66 38.58 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.743 2.295 . . . . 0.0 112.791 179.462 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.673 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.29 -38.33 89.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.456 -178.804 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.696 HG23 HG13 ' A' ' 44' ' ' ILE . 2.1 t -60.34 -56.45 35.24 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.704 -178.788 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.4 -41.11 61.19 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.812 1.675 . . . . 0.0 111.401 179.561 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.87 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.6 mt -61.64 -34.87 63.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.992 179.781 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.7 tp -74.19 -53.39 9.93 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 178.809 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -53.47 -24.52 13.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.004 0.431 . . . . 0.0 109.887 178.911 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.9 m -82.74 -45.93 13.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.499 179.421 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.552 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.25 -25.84 64.39 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.407 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.0 t -52.84 -49.98 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.823 179.312 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -75.73 -11.45 60.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.813 -179.867 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -92.64 -18.26 23.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.145 179.937 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.592 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 68.1 m-85 -135.56 62.34 48.44 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.396 -179.739 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.7 -43.32 51.78 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.727 2.284 . . . . 0.0 111.552 179.0 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.72 -38.11 86.61 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.52 179.294 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.0 t -70.05 144.4 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.955 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.59 ' CB ' HG21 ' A' ' 31' ' ' THR . 42.9 t -83.83 99.32 10.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.006 0.431 . . . . 0.0 111.042 -179.672 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.478 ' HB3' HG22 ' A' ' 54' ' ' VAL . 7.7 p90 -62.57 131.25 48.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.151 179.915 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -150.06 161.69 28.97 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.121 179.712 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -162.85 142.63 2.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.995 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.8 t -144.37 155.97 44.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.041 0.448 . . . . 0.0 111.652 -179.059 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 39' ' ' PHE . 67.7 p -139.03 3.1 2.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.842 179.666 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.75 143.11 44.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.784 -179.972 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.9 t -64.48 -50.47 67.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.496 -179.426 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.76 -43.57 48.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.514 -179.413 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.534 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.1 t -71.51 -53.02 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.811 0.339 . . . . 0.0 110.756 179.987 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.496 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -58.86 -14.51 9.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.233 179.315 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 76.1 m -91.48 -40.98 11.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.294 178.641 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -60.49 -40.22 90.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.45 179.847 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -91.45 11.86 22.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.853 179.644 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 56.04 25.74 9.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.596 179.551 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.665 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.0 mm -59.78 119.42 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.839 179.597 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.4 p -138.49 58.88 1.65 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.235 -179.549 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.11 48.22 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.709 179.664 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.616 ' HB2' HG21 ' A' ' 99' ' ' ILE . 36.3 m-20 49.52 43.4 23.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.103 0.478 . . . . 0.0 110.461 -179.945 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.665 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.1 m -68.62 152.63 45.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.621 -178.677 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.536 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.4 mt -118.81 119.14 60.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.07 178.065 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 83.6 m -108.55 134.62 51.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.038 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.63 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -106.71 103.99 13.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.608 178.438 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -97.33 119.72 36.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.867 0.365 . . . . 0.0 111.199 -179.886 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.485 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 3.2 mtm180 -105.24 95.93 6.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.407 -179.95 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 1.6 tp -43.19 -54.55 4.43 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.782 -179.622 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.587 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.1 -59.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.03 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -97.86 3.62 49.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.446 -179.346 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 85' ' ' ARG . 38.2 t30 51.58 47.08 25.5 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.259 0.552 . . . . 0.0 110.834 -179.818 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.485 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 10.2 mm-40 -97.23 158.67 15.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.715 -179.894 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -140.96 92.34 2.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.934 179.809 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.63 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.5 mm? -80.8 143.42 32.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.258 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -120.97 123.06 41.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.281 0.562 . . . . 0.0 112.439 -179.363 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.632 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -111.09 76.34 0.97 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.126 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.44 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.3 mt-10 -78.13 -164.58 0.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.364 -0.834 . . . . 0.0 113.137 -176.669 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.53 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 12.5 t70 -50.94 -37.2 42.83 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.98 -179.113 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.74 -14.98 2.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.106 0.479 . . . . 0.0 110.304 179.639 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -130.6 -13.8 3.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.585 179.776 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.616 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.7 mm -90.48 -24.95 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.76 0.314 . . . . 0.0 111.195 -179.538 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -57.18 -52.02 66.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.993 0.425 . . . . 0.0 110.611 179.843 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.5 m -117.73 35.6 4.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.348 179.537 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.632 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -58.09 140.6 16.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.437 -179.619 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -135.69 149.97 49.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.424 178.644 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.87 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.02 -34.55 9.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.019 0.437 . . . . 0.0 110.479 -179.844 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.9 m -64.79 -48.24 75.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.452 178.844 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -59.99 -57.33 13.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.226 -179.794 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.763 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -51.75 -55.89 17.08 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.132 0.491 . . . . 0.0 110.001 179.662 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.9 m -58.0 -30.24 65.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.917 179.866 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.444 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.8 tmt_? -70.37 -65.81 0.68 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.275 179.66 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -42.98 -43.9 4.39 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.141 179.277 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.445 HG12 HG21 ' A' ' 35' ' ' VAL . 88.8 mt -62.29 -55.55 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.208 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -54.6 -18.33 4.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.451 179.319 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.444 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.74 -36.64 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.079 -178.873 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.486 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.0 m120 -124.22 28.79 6.6 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.574 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.9 p -81.04 42.84 0.67 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.928 0.394 . . . . 0.0 110.462 179.21 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.442 HD12 ' NH1' ' A' ' 85' ' ' ARG . 62.3 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.189 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.761 0.315 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.56 133.19 59.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.161 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -136.7 -3.0 2.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.87 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -103.27 -164.26 1.06 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.995 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.9 p -57.14 164.3 1.76 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.4 m 55.28 76.89 0.24 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.957 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -87.43 -20.99 25.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.796 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.32 153.66 9.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.548 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.85 130.4 32.8 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.54 2.16 . . . . 0.0 112.266 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.54 98.8 2.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.618 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -169.1 -75.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.688 0.28 . . . . 0.0 110.697 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.73 -80.4 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.52 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.534 ' HG3' HG12 ' A' ' 54' ' ' VAL . 11.2 pt20 -164.23 142.61 7.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.882 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.483 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.0 pt-20 -129.83 158.15 74.59 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.76 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.506 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.9 Cg_endo -65.46 145.27 82.29 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.617 2.211 . . . . 0.0 112.706 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 m -62.27 154.14 28.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.912 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -97.42 92.82 6.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.811 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.596 HD22 ' HA ' ' A' ' 24' ' ' ALA . 42.9 mt -91.84 71.23 5.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.513 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.2 p -72.93 -0.8 14.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.103 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -139.7 147.28 40.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 111.488 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 45.2 t -56.81 -49.93 91.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.518 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.05 -45.44 31.97 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.926 1.751 . . . . 0.0 111.786 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.29 80.12 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.195 0.521 . . . . 0.0 110.19 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.596 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.77 -59.83 4.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.063 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.3 mtm -60.59 -25.54 66.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.144 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 21.8 mt-10 -71.6 -51.22 24.41 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.495 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.498 ' O ' HG22 ' A' ' 31' ' ' THR . 10.4 m-85 -61.06 -30.21 70.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.575 HD11 HD12 ' A' ' 36' ' ' ILE . 48.6 mt -75.79 -36.96 34.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.965 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.36 -19.48 59.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.248 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.14 28.1 2.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.655 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.1 t -171.16 153.15 3.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.46 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.503 ' HG3' HG13 ' A' ' 87' ' ' VAL . 23.3 tt0 -65.36 -65.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.773 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.509 HG13 HD11 ' A' ' 83' ' ' LEU . 18.1 t -106.1 137.82 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.638 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.536 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.3 125.92 17.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.476 HG21 HG12 ' A' ' 111' ' ' ILE . 53.9 t -114.56 128.75 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.641 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.575 HD12 HD11 ' A' ' 28' ' ' ILE . 29.9 mt -134.49 137.89 50.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.558 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.11 97.79 1.72 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.427 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.469 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.8 m-85 -83.27 91.85 7.37 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.1 m-85 -111.45 143.3 42.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.469 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -90.46 -6.22 55.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.0 t70 -151.95 121.86 7.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.614 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.514 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.7 mt -90.51 45.76 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.999 0.428 . . . . 0.0 111.515 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 36.9 mt-10 -136.59 8.98 3.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.094 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.741 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.8 pt -90.66 156.86 44.75 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.162 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.487 ' O ' HD12 ' A' ' 49' ' ' ILE . 79.6 Cg_exo -51.0 -27.75 22.2 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.837 2.358 . . . . 0.0 112.923 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.741 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.46 -38.57 91.67 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.703 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -60.46 -56.7 32.66 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.802 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.644 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -59.39 -40.88 63.46 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.671 1.581 . . . . 0.0 111.441 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -61.82 -35.59 68.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.145 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.603 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.4 tp -74.65 -52.56 11.37 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -54.83 -24.27 22.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.071 0.463 . . . . 0.0 109.977 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 m -83.03 -45.27 14.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.623 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.614 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.59 -26.28 66.85 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.2 0.524 . . . . 0.0 109.619 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -51.25 -47.71 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.226 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -77.43 -12.97 60.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.913 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -91.23 -17.52 25.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.171 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.576 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 47.8 m-85 -137.99 62.64 34.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.567 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.84 -42.58 65.34 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.677 2.251 . . . . 0.0 111.661 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.93 -37.79 80.84 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.381 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.7 t -70.34 144.34 13.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.655 ' HB2' HG21 ' A' ' 31' ' ' THR . 46.7 t -82.26 98.46 8.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.948 0.404 . . . . 0.0 111.094 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.506 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -65.21 127.37 31.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.066 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.27 160.44 28.18 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.159 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 tt -160.37 144.16 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.469 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 37.3 t -148.48 159.11 44.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.5 . . . . 0.0 111.768 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.468 HG21 ' HG ' ' A' ' 42' ' ' LEU . 67.8 p -140.99 4.82 1.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.656 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -74.43 141.56 45.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.672 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.2 t -64.32 -51.11 65.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.448 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -49.88 -41.94 46.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.61 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.543 ' HA ' HG22 ' A' ' 21' ' ' VAL . 56.5 t -72.08 -53.99 18.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.831 0.348 . . . . 0.0 110.762 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -58.78 -14.69 9.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.091 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.0 m -90.54 -42.45 10.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.093 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -59.73 -37.76 79.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.356 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.431 ' HB2' HG12 ' A' ' 76' ' ' ILE . 79.6 m-85 -93.67 12.01 26.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.807 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 55.7 23.75 6.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.64 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.703 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.3 mm -59.78 121.59 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.221 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.4 p -142.48 58.7 1.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.011 0.434 . . . . 0.0 111.05 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.04 43.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.658 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.556 ' HB2' HG21 ' A' ' 99' ' ' ILE . 24.2 m-80 52.07 43.23 30.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.296 0.569 . . . . 0.0 110.448 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.703 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.2 m -68.61 151.86 46.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.741 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.558 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.1 mt -118.43 116.63 51.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.025 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 72.0 m -105.28 130.3 53.44 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.606 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -107.8 103.51 12.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.771 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.0 t80 -97.51 124.37 41.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.529 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.534 HH12 HD12 ' A' ' 116' ' ' LEU . 4.5 mtm180 -106.8 82.85 1.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.967 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 85' ' ' ARG . 6.0 tp -24.99 -60.04 0.06 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.087 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.503 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.52 -70.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.134 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.03 2.08 50.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.05 0.452 . . . . 0.0 110.959 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 m120 53.76 34.85 19.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.632 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 11.8 mm-40 -81.17 163.93 22.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.746 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.09 98.58 2.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.824 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.606 HD23 ' HG ' ' A' ' 83' ' ' LEU . 1.8 mm? -88.37 117.08 27.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.784 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -97.85 94.08 6.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.545 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -77.65 77.42 4.17 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.4 mt-10 -78.4 -164.49 0.57 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.516 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 16.3 t70 -51.27 -39.02 55.86 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.096 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.26 -14.67 1.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.103 0.477 . . . . 0.0 110.346 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -129.22 -13.85 4.4 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.674 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.556 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.4 mm -90.29 -31.0 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.607 0.242 . . . . 0.0 111.563 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -55.21 -39.37 69.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.19 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.8 p -128.03 37.07 4.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.506 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.545 HD13 HD21 ' A' ' 94' ' ' LEU . 6.6 tp -62.77 142.78 16.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.423 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -137.34 150.53 47.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.642 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.881 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.42 -36.2 14.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.036 0.446 . . . . 0.0 110.367 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.8 m -63.29 -48.7 77.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.398 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -59.08 -58.59 7.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.281 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.49 -56.22 12.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.883 0.373 . . . . 0.0 110.227 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.7 m -58.39 -29.65 66.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.792 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.493 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -71.24 -66.39 0.62 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.094 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -42.57 -42.45 3.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.146 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.476 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -64.12 -56.27 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.562 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -53.43 -19.87 4.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.328 0.585 . . . . 0.0 110.267 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.493 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.22 -37.04 10.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.915 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.435 ' OD1' ' HG ' ' A' ' 92' ' ' LEU . 16.7 m120 -123.3 30.95 6.12 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.0 p -83.35 41.7 0.78 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.02 0.438 . . . . 0.0 110.169 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.534 HD12 HH12 ' A' ' 85' ' ' ARG . 64.6 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.249 -0.882 . . . . 0.0 111.374 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.737 0.303 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.4 t 57.3 84.04 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -155.69 -41.47 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.989 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -125.43 18.48 8.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.6 m -101.43 25.11 8.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.947 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.2 m -98.56 -10.17 23.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.921 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.85 101.72 8.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.979 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.59 -160.87 9.29 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.473 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.08 -70.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.548 2.165 . . . . 0.0 112.24 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.95 -130.21 43.22 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.645 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -169.87 -59.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.67 0.272 . . . . 0.0 110.77 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.64 104.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.371 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.608 ' HG3' HG12 ' A' ' 54' ' ' VAL . 20.6 pt20 -55.96 154.19 7.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.222 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.515 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.5 pt-20 -126.57 160.23 59.43 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.651 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 37.2 Cg_endo -66.16 143.9 73.18 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.464 2.109 . . . . 0.0 112.668 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 m -62.0 154.41 26.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.422 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -98.99 90.13 4.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.068 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.633 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.7 mt -86.8 74.14 9.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.312 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.8 p -74.05 -5.28 40.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.971 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -137.56 147.2 44.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.888 0.375 . . . . 0.0 111.555 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.2 t -56.76 -50.03 90.35 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.448 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.8 Cg_endo -57.56 -44.08 45.09 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.911 1.741 . . . . 0.0 111.83 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.36 83.9 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.172 0.51 . . . . 0.0 110.228 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.633 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.52 -58.73 6.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.169 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 64.5 mtp -60.36 -26.37 66.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.148 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -71.45 -51.34 24.36 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.672 0.273 . . . . 0.0 110.569 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.546 ' O ' HG22 ' A' ' 31' ' ' THR . 10.9 m-85 -60.37 -32.86 71.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.909 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.49 HD11 ' CD1' ' A' ' 36' ' ' ILE . 54.7 mt -73.71 -38.75 51.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.108 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.98 -19.86 60.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.055 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.8 25.57 3.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.638 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.0 t -168.85 152.2 5.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.514 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HG2' HG22 ' A' ' 87' ' ' VAL . 21.9 tt0 -63.82 -74.04 0.11 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.744 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.549 HG13 HD11 ' A' ' 83' ' ' LEU . 17.9 t -98.25 136.32 29.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.452 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.84 125.37 19.19 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.437 HG21 HG12 ' A' ' 111' ' ' ILE . 56.0 t -115.15 131.13 68.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.688 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 21.5 mt -136.58 138.51 46.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.604 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.74 97.02 1.55 Allowed Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.583 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 11.5 m-85 -83.32 89.8 7.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -109.48 137.92 46.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.455 -178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.481 ' HG2' HD23 ' A' ' 71' ' ' LEU . 94.2 mt-30 -83.85 -6.21 59.38 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.442 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 37.5 t70 -151.69 124.96 8.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.605 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.564 ' HA ' HG21 ' A' ' 47' ' ' VAL . 91.7 mt -93.67 47.14 1.21 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.175 0.512 . . . . 0.0 111.246 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.442 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 6.8 mm-40 -138.81 10.77 2.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.98 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.819 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.4 pt -94.08 156.67 38.84 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.06 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.503 ' O ' HD12 ' A' ' 49' ' ' ILE . 77.8 Cg_exo -50.6 -29.15 24.21 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.774 2.316 . . . . 0.0 113.064 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.819 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.4 -36.65 82.97 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.656 HG23 HG13 ' A' ' 44' ' ' ILE . 2.5 t -63.09 -57.19 22.17 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.72 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.653 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.3 Cg_exo -59.64 -36.1 93.2 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.776 1.651 . . . . 0.0 111.284 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -66.04 -36.31 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.034 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.595 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.5 tp -72.96 -52.19 15.47 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -55.19 -23.03 19.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.892 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.3 t -84.27 -44.17 14.12 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.364 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.576 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.57 -25.39 67.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.21 0.529 . . . . 0.0 109.613 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.608 HG12 ' HG3' ' A' ' 13' ' ' GLN . 55.0 t -52.91 -51.18 39.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.171 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -74.31 -10.6 59.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.662 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.1 mtpp -93.88 -18.94 21.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.186 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.623 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 56.7 m-85 -135.38 61.99 47.64 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.55 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.94 -41.69 62.19 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.687 2.258 . . . . 0.0 111.653 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.12 96.51 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.59 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.623 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.8 t -65.76 144.87 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.638 ' HB2' HG21 ' A' ' 31' ' ' THR . 48.2 t -82.4 97.49 8.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.167 0.508 . . . . 0.0 110.81 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.499 ' HB3' HG22 ' A' ' 54' ' ' VAL . 4.8 p90 -65.21 126.5 28.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.105 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.507 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.98 161.59 28.29 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.139 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -157.92 140.33 5.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.831 0.348 . . . . 0.0 110.082 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.3 t -141.03 155.22 46.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.499 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 39' ' ' PHE . 77.1 p -141.31 -7.19 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.753 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.63 143.57 56.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.709 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 m -62.71 -50.82 69.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.26 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -48.19 -48.56 34.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.687 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HA ' HG22 ' A' ' 21' ' ' VAL . 84.2 t -68.1 -53.4 29.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.82 0.343 . . . . 0.0 110.986 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.481 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -57.78 -14.76 6.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.43 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.9 m -91.24 -42.85 10.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.417 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -59.37 -43.65 92.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.644 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -87.61 12.98 11.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.803 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 54.45 26.9 7.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.536 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.699 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.6 mm -61.08 123.33 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.842 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.6 p -143.57 60.43 1.39 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.935 0.398 . . . . 0.0 111.448 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.82 44.14 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.512 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.594 ' HB2' HG21 ' A' ' 99' ' ' ILE . 19.0 m-80 52.54 43.19 31.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.269 0.557 . . . . 0.0 110.337 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.699 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.1 m -69.01 153.09 44.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.701 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.604 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.4 mt -119.58 117.68 54.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.792 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.506 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.8 m -106.93 134.12 50.55 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.662 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -110.13 105.03 13.97 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.138 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.9 t80 -98.53 122.07 41.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 6.1 mtm180 -104.45 82.12 1.88 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.71 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tp -24.47 -62.0 0.05 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.415 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.87 -63.49 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.97 2.33 55.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.082 0.468 . . . . 0.0 110.713 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.3 m120 53.48 25.28 4.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.667 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.549 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 14.2 mm-40 -68.94 158.09 35.36 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.81 0.338 . . . . 0.0 110.806 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -143.07 90.42 2.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.742 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.662 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -79.92 141.41 36.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.48 96.14 4.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.524 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -82.0 77.77 8.78 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.451 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.5 mt-10 -79.13 -165.25 0.73 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.525 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 13.8 t70 -50.9 -37.63 44.93 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.836 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -55.6 -14.74 2.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.044 0.449 . . . . 0.0 110.406 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -129.93 -14.0 4.03 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.356 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.594 HG21 ' HB2' ' A' ' 79' ' ' ASN . 21.4 mm -90.03 -23.0 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.899 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.56 -51.72 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.658 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 83.2 p -121.21 38.57 4.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.258 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.524 HD13 HD21 ' A' ' 94' ' ' LEU . 6.6 tp -59.41 142.78 14.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.529 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -137.24 150.29 47.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.647 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.89 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.87 -37.11 13.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 110.447 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -63.27 -47.96 80.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.374 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -59.08 -59.67 5.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.113 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.752 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -49.76 -55.31 14.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.094 0.474 . . . . 0.0 110.152 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.7 m -59.08 -28.72 66.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.781 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.474 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -72.11 -65.77 0.73 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.012 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -42.86 -43.79 4.22 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.03 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.437 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -63.23 -56.62 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.585 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -52.56 -20.97 3.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.201 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.474 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -86.15 -39.03 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.953 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.419 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.6 m120 -121.03 29.59 7.28 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 111' ' ' ILE . 80.4 p -82.78 49.49 1.51 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.021 0.439 . . . . 0.0 110.246 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.526 HD12 HH12 ' A' ' 85' ' ' ARG . 72.6 mt . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.29 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.811 0.339 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.6 m -105.7 -40.36 5.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.343 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 51.66 85.66 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -94.66 -57.61 2.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.102 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.7 t -93.61 30.75 1.69 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.952 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.3 m 56.41 71.41 0.57 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.085 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -84.68 6.82 22.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.695 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.28 -171.2 27.12 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.623 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -61.85 -33.62 84.12 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.511 2.141 . . . . 0.0 112.396 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.99 56.35 0.21 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.323 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.73 -49.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 0.0 110.516 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 64.19 -78.17 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.689 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.534 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.7 pt20 -156.15 131.61 9.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.877 0.37 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.427 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.7 pt-20 -114.21 156.44 44.24 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.787 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 31.6 Cg_endo -64.73 142.48 76.84 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.666 2.244 . . . . 0.0 112.398 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.3 m -57.68 152.86 14.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.612 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -99.55 94.22 6.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.962 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.65 HD22 ' HA ' ' A' ' 24' ' ' ALA . 42.6 mt -90.37 72.92 7.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.366 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 76.4 p -70.06 -8.04 46.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.185 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 3.7 m-20 -138.55 147.45 43.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.153 0.502 . . . . 0.0 111.729 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.608 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.8 t -54.32 -49.5 90.16 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.861 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.59 -45.31 34.57 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.018 1.812 . . . . 0.0 112.059 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.96 -36.5 84.18 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.233 0.539 . . . . 0.0 110.295 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.65 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.53 -58.71 6.6 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.106 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 69.6 mtp -60.15 -27.57 67.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.18 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 25.0 mt-10 -71.25 -50.34 33.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.803 0.335 . . . . 0.0 110.671 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.53 ' O ' HG22 ' A' ' 31' ' ' THR . 7.2 m-85 -59.98 -32.63 71.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.042 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 36' ' ' ILE . 44.0 mt -74.84 -38.81 44.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.047 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.45 -19.61 61.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.158 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.53 25.96 4.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.379 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.656 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.0 t -170.09 151.14 3.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.387 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.515 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.7 tt0 -62.0 -72.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.774 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.525 HG13 HD11 ' A' ' 83' ' ' LEU . 20.7 t -100.78 138.12 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.812 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.16 128.41 20.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.675 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG21 HG12 ' A' ' 111' ' ' ILE . 47.6 t -116.69 128.74 73.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.701 178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.521 HD12 HD11 ' A' ' 28' ' ' ILE . 22.4 mt -134.09 135.9 54.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.615 -177.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.9 99.41 2.05 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.255 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.495 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.8 m-85 -84.77 92.73 8.3 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.575 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.0 m-85 -112.14 139.26 47.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.431 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.491 ' HG2' HD23 ' A' ' 71' ' ' LEU . 74.4 mt-30 -85.81 -8.0 58.38 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.6 t70 -149.96 123.28 8.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.656 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.551 ' HA ' HG21 ' A' ' 47' ' ' VAL . 98.7 mt -92.28 46.97 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.134 0.492 . . . . 0.0 111.321 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 40.7 mt-10 -137.75 9.18 2.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.981 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.81 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.7 pt -92.84 156.54 40.63 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.271 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.489 ' O ' HD12 ' A' ' 49' ' ' ILE . 83.2 Cg_exo -50.54 -28.93 23.19 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.836 2.358 . . . . 0.0 113.162 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.81 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.07 -38.65 89.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.642 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -61.53 -56.69 30.82 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.76 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -59.34 -37.9 87.81 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.746 1.631 . . . . 0.0 111.322 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.869 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.5 mt -64.42 -35.25 73.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.992 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.602 ' O ' HG23 ' A' ' 54' ' ' VAL . 46.8 tp -73.6 -52.77 12.29 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -54.21 -24.72 19.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.07 0.462 . . . . 0.0 109.795 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 t -82.85 -44.37 15.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.631 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.598 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.42 -25.95 67.54 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.244 0.545 . . . . 0.0 109.653 179.261 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 50' ' ' LEU . 56.3 t -52.15 -50.01 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.848 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -74.43 -12.62 60.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.816 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -91.93 -18.41 23.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.294 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.612 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 45.1 m-85 -135.92 62.47 46.89 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.496 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.07 -45.46 38.84 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.82 2.347 . . . . 0.0 111.61 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.07 -41.81 79.09 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.476 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.612 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.5 t -65.97 144.22 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.656 ' HB2' HG21 ' A' ' 31' ' ' THR . 37.6 t -82.41 98.03 8.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.916 0.389 . . . . 0.0 110.896 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.501 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 7.9 p90 -62.65 129.38 40.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.781 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.37 160.66 28.43 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.14 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.417 HD11 HG13 ' A' ' 47' ' ' VAL . 4.6 tt -159.38 141.7 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.8 t -145.19 151.71 38.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.104 0.478 . . . . 0.0 111.686 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 39' ' ' PHE . 81.1 p -135.59 -4.89 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.515 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.41 146.22 55.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.791 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.8 t -66.84 -52.12 47.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.474 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -49.71 -43.56 47.66 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.551 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.502 ' HA ' HG22 ' A' ' 21' ' ' VAL . 77.3 t -70.58 -54.07 19.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.91 0.386 . . . . 0.0 110.695 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.491 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -58.75 -14.67 9.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.357 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.4 m -92.29 -39.96 11.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.316 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -61.95 -39.29 91.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.398 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.411 ' HB2' HG12 ' A' ' 76' ' ' ILE . 41.2 m-85 -91.12 10.76 25.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 57.53 25.0 10.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.502 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.668 HG23 ' HB ' ' A' ' 80' ' ' THR . 36.0 mm -60.52 121.44 8.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.055 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.2 p -141.86 59.16 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.36 45.27 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.666 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.615 ' HB2' HG21 ' A' ' 99' ' ' ILE . 28.4 m-80 52.17 42.89 30.92 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.282 0.563 . . . . 0.0 110.557 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.668 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.1 m -69.28 152.6 44.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.681 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.565 HG12 ' HA2' ' A' ' 37' ' ' GLY . 68.2 mt -119.45 118.8 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.095 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.495 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 83.9 m -107.79 133.55 52.02 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.651 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -108.29 104.24 13.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.778 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.2 t80 -97.76 123.41 41.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.479 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.531 HH12 HD12 ' A' ' 116' ' ' LEU . 5.7 mtm180 -106.83 82.91 1.76 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.957 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 tp -26.01 -59.1 0.08 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.04 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.515 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.55 -70.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 O-C-N 123.413 0.446 . . . . 0.0 112.069 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -87.52 2.51 50.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.739 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 52.07 37.88 22.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.17 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.493 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 8.4 mm-40 -82.36 158.19 23.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.618 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -140.11 91.95 2.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.86 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.651 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -81.62 133.81 35.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.491 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.06 116.11 28.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.334 0.588 . . . . 0.0 112.317 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.553 HD21 HD13 ' A' ' 102' ' ' ILE . 3.7 tt -102.39 77.19 1.62 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -79.64 -164.84 0.7 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -176.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.518 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 21.2 t70 -50.52 -36.59 34.82 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.101 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -56.67 -14.51 3.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.151 0.501 . . . . 0.0 110.311 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -131.07 -13.93 3.49 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.593 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.615 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.7 mm -90.07 -30.97 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.774 0.321 . . . . 0.0 111.246 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -54.47 -41.58 69.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.511 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.1 m -126.82 38.64 4.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.569 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.553 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -64.31 142.44 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.608 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -136.55 149.47 48.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.321 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.869 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.41 -35.92 9.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.092 0.472 . . . . 0.0 110.416 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 98.8 m -62.7 -49.11 76.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.413 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -59.1 -58.28 9.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.411 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.746 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.67 -56.69 10.72 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.107 0.479 . . . . 0.0 110.027 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.6 m -58.06 -28.68 64.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.746 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.483 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.1 tmt_? -71.96 -65.58 0.75 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.062 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -43.05 -42.78 4.04 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.084 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.422 HG12 HG21 ' A' ' 35' ' ' VAL . 96.1 mt -64.46 -55.44 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.551 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.79 -17.21 3.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.232 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.483 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -90.77 -37.01 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.0 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.409 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.7 m120 -124.47 29.95 6.16 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.6 p -81.95 47.07 1.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.074 0.464 . . . . 0.0 110.197 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.531 HD12 HH12 ' A' ' 85' ' ' ARG . 51.2 mt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.171 -0.919 . . . . 0.0 111.353 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.838 0.351 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.9 t 58.45 87.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.268 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -85.04 -63.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.999 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -131.33 -71.83 0.56 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.091 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.0 m -154.77 -177.58 6.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.229 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 p -85.84 -61.72 1.69 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.656 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.7 t70 56.31 82.2 0.11 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.111 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.99 -165.92 36.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.632 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.98 -39.69 59.3 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.741 2.294 . . . . 0.0 112.53 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.89 171.85 22.11 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.636 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.92 -62.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.8 0.333 . . . . 0.0 110.429 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.45 106.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.586 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.566 ' HG3' HG12 ' A' ' 54' ' ' VAL . 9.5 pt20 -50.52 155.63 1.04 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.264 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.497 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 -128.1 159.3 67.66 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 32.2 Cg_endo -65.51 144.91 81.0 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.653 2.236 . . . . 0.0 112.538 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.7 m -62.23 154.13 28.45 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.359 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -99.69 95.57 7.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.136 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 24' ' ' ALA . 44.7 mt -93.13 71.3 4.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.327 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.4 p -71.75 -0.07 10.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.289 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -141.37 147.62 38.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.939 0.4 . . . . 0.0 111.592 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 23.2 t -57.28 -49.73 92.2 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.499 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.0 Cg_endo -58.71 -42.5 52.97 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.975 1.784 . . . . 0.0 111.879 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.91 -34.91 78.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.195 0.521 . . . . 0.0 110.533 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.602 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -65.06 -57.01 9.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.184 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 61.0 mtm -62.87 -28.6 70.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.075 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 9.9 mt-10 -69.88 -47.77 61.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.718 0.294 . . . . 0.0 110.5 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.567 ' O ' HG22 ' A' ' 31' ' ' THR . 0.4 OUTLIER -60.08 -42.35 94.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.346 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.539 HD11 HD12 ' A' ' 36' ' ' ILE . 51.0 mt -65.36 -40.12 87.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.23 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.61 -15.52 61.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.786 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.45 24.86 6.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.13 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.629 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.5 t -171.69 155.02 3.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.515 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.53 ' HG3' HG13 ' A' ' 87' ' ' VAL . 20.7 tt0 -64.76 -79.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.876 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.519 HG13 HD11 ' A' ' 83' ' ' LEU . 17.0 t -93.5 135.14 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.411 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.96 125.51 20.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.026 0.441 . . . . 0.0 112.138 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG21 HG12 ' A' ' 111' ' ' ILE . 52.4 t -114.48 127.66 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.799 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.539 HD12 HD11 ' A' ' 28' ' ' ILE . 23.7 mt -133.18 137.2 53.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.401 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.54 98.61 1.88 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.455 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 6.1 m-85 -83.83 90.22 7.32 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.0 m-85 -109.32 139.09 44.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.377 -178.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.426 ' HG2' HD23 ' A' ' 71' ' ' LEU . 54.1 mt-30 -86.06 -8.57 57.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.485 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.4 t70 -149.84 121.7 8.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.623 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.567 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.3 mt -89.55 44.85 1.23 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.066 0.46 . . . . 0.0 111.35 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.7 mt-10 -135.94 10.52 3.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.028 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.1 pt -94.34 156.77 38.39 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.288 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' O ' HD12 ' A' ' 49' ' ' ILE . 73.4 Cg_exo -51.19 -28.58 26.21 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.794 2.33 . . . . 0.0 112.899 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.795 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -61.89 -38.89 90.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.315 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.678 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -60.97 -57.28 27.5 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.681 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.66 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -58.98 -40.27 72.88 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.767 1.644 . . . . 0.0 111.387 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.892 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -61.77 -35.77 69.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.007 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.596 ' O ' HG23 ' A' ' 54' ' ' VAL . 42.1 tp -73.52 -53.11 11.35 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 14.7 m-70 -53.58 -24.44 13.73 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.1 m -82.49 -46.18 13.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.621 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.585 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.7 -26.1 65.33 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 50' ' ' LEU . 58.7 t -53.08 -47.28 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.942 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -77.46 -10.5 59.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.647 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -94.1 -19.68 20.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.16 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.57 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 64.4 m-85 -136.44 62.66 44.57 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.525 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.26 -42.37 60.46 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.653 2.235 . . . . 0.0 111.624 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.72 -39.39 91.17 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.32 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.3 t -67.67 144.11 14.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.629 ' HB2' HG21 ' A' ' 31' ' ' THR . 33.7 t -81.89 98.8 8.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 111.015 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.493 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 8.3 p90 -64.88 128.64 36.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.905 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.74 160.87 28.44 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.987 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.43 HD11 HG13 ' A' ' 47' ' ' VAL . 4.8 tt -160.75 141.82 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.1 t -146.94 155.87 42.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.952 0.406 . . . . 0.0 111.769 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 39' ' ' PHE . 82.5 p -137.64 -8.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.681 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.77 141.8 56.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.669 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.4 m -64.68 -49.53 70.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.126 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -50.19 -44.48 53.02 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.411 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.486 ' HA ' HG22 ' A' ' 21' ' ' VAL . 77.2 t -70.53 -53.78 21.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.831 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.426 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.0 mp -58.38 -14.63 8.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.261 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.4 m -91.73 -40.63 11.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.205 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -61.87 -36.17 80.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.486 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.43 ' HB2' HG12 ' A' ' 76' ' ' ILE . 32.4 m-85 -94.16 10.67 32.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.73 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 57.51 23.66 9.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.64 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.665 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.2 mm -59.89 120.05 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.245 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.9 p -139.39 55.85 1.68 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.174 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.19 45.7 0.02 OUTLIER Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.634 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.624 ' HB2' HG21 ' A' ' 99' ' ' ILE . 21.8 m-80 51.28 43.27 29.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.252 0.549 . . . . 0.0 110.504 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.665 ' HB ' HG23 ' A' ' 76' ' ' ILE . 98.0 m -69.17 151.27 46.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.569 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.581 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.3 mt -117.45 118.95 60.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.223 -0.898 . . . . 0.0 108.821 178.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.513 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.4 m -107.26 133.23 52.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.654 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -109.41 103.38 12.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.966 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.9 t80 -96.34 120.88 37.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.56 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.504 HH12 HD12 ' A' ' 116' ' ' LEU . 5.2 mtm180 -104.06 80.63 1.75 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.808 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 8.6 tp -25.18 -58.2 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.028 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.53 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.84 -62.88 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.314 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -95.05 15.45 18.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.783 0.325 . . . . 0.0 111.301 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 44.7 27.94 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.104 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.495 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.4 mm-40 -75.98 156.78 33.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.834 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.7 tm0? -144.26 90.68 2.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.774 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.654 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -77.52 142.19 39.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.4 91.99 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.573 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -78.34 79.36 4.78 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -79.5 -165.49 0.8 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.8 t70 -50.37 -39.86 47.86 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.48 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.14 -15.12 1.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.167 0.508 . . . . 0.0 110.295 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -127.95 -13.79 5.11 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.461 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.624 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.4 mm -90.16 -33.45 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.543 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -50.11 -53.64 26.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 110.544 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.6 m -114.97 38.55 3.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.436 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.579 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.3 tp -62.0 142.88 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 111.448 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -137.96 149.57 46.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.848 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.892 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.92 -35.89 11.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.034 0.445 . . . . 0.0 110.36 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 95.6 m -62.97 -47.83 81.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.293 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -60.2 -60.29 4.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.126 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.738 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.06 -56.02 10.31 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.995 0.426 . . . . 0.0 110.131 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.0 m -58.23 -30.76 66.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.999 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.5 ' HD3' HD13 ' A' ' 113' ' ' ILE . 1.7 tmt_? -69.85 -66.02 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.052 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -42.86 -43.83 4.23 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.218 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.459 HG12 HG21 ' A' ' 35' ' ' VAL . 95.3 mt -62.92 -54.89 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -54.57 -18.68 4.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.267 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.5 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.79 -35.24 7.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.944 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.472 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.3 m120 -126.03 30.91 5.55 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.2 p -83.44 38.32 0.61 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.995 0.426 . . . . 0.0 110.423 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.504 HD12 HH12 ' A' ' 85' ' ' ARG . 72.0 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.386 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.721 0.296 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.13 133.89 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.895 0.379 . . . . 0.0 111.198 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.08 -175.71 3.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.599 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -60.46 -78.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.703 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.6 p 45.41 62.83 2.0 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.38 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.8 p -142.77 -19.46 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.067 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.72 174.68 7.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.01 175.28 15.15 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.545 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.27 119.16 5.69 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.622 2.215 . . . . 0.0 112.454 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.08 147.15 3.73 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.638 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.42 -23.53 0.24 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.91 0.386 . . . . 0.0 110.289 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.24 95.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.467 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.609 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.7 pt20 -50.17 152.97 1.56 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.362 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.48 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.4 pt-20 -122.6 158.77 55.59 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.579 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 30.8 Cg_endo -64.26 145.77 89.2 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.536 2.158 . . . . 0.0 112.518 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.2 m -61.05 153.92 24.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.581 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -99.97 89.61 4.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.709 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 35.4 mt -87.72 76.8 8.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.56 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.0 p -74.6 -4.95 40.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.049 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -141.48 148.31 39.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.952 0.406 . . . . 0.0 111.821 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 12.6 t -54.63 -49.97 88.25 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.583 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.0 Cg_endo -57.81 -44.15 43.2 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.005 1.804 . . . . 0.0 112.127 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.98 -37.54 87.81 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.206 0.527 . . . . 0.0 110.263 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.69 -56.54 16.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.016 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.6 mtm -61.86 -26.76 68.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.056 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -71.72 -50.59 28.9 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.642 0.258 . . . . 0.0 110.602 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.539 ' O ' HG22 ' A' ' 31' ' ' THR . 11.4 m-85 -60.83 -32.17 71.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.105 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.527 HD11 HD12 ' A' ' 36' ' ' ILE . 53.4 mt -75.29 -39.06 41.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.03 0.443 . . . . 0.0 110.075 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.51 -18.46 61.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.143 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.1 25.39 4.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.261 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.628 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.0 t -169.57 154.24 5.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.689 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.545 ' HG3' HG13 ' A' ' 87' ' ' VAL . 18.9 tt0 -65.13 -72.58 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.878 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.524 HG13 HD11 ' A' ' 83' ' ' LEU . 15.7 t -99.45 137.13 27.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.672 0.272 . . . . 0.0 110.657 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.58 125.35 16.97 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.024 0.44 . . . . 0.0 112.019 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.467 HG22 ' HB2' ' A' ' 83' ' ' LEU . 56.0 t -114.88 129.64 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.902 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.527 HD12 HD11 ' A' ' 28' ' ' ILE . 21.6 mt -135.21 136.8 51.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.468 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.0 99.78 2.1 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.543 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 6.4 m-85 -85.4 93.93 8.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.4 m-85 -113.38 143.37 44.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -92.64 -1.16 57.1 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.52 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.3 t70 -156.89 115.53 3.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.479 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.592 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.2 mt -85.47 44.14 1.08 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.11 0.481 . . . . 0.0 111.233 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.425 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 17.5 mm-40 -135.29 12.74 3.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.46 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.797 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.8 pt -96.57 156.37 36.79 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.176 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.492 ' O ' HD12 ' A' ' 49' ' ' ILE . 87.6 Cg_exo -50.95 -27.24 20.41 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.837 2.358 . . . . 0.0 113.048 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.797 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.15 -37.12 86.31 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.672 HG23 HG13 ' A' ' 44' ' ' ILE . 2.7 t -62.13 -56.1 34.47 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.939 -0.305 . . . . 0.0 111.682 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.8 Cg_exo -59.79 -40.25 65.4 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.735 1.623 . . . . 0.0 111.461 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.869 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -61.83 -37.2 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.086 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.579 ' O ' HG23 ' A' ' 54' ' ' VAL . 37.6 tp -72.13 -53.19 13.5 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -54.92 -21.02 10.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.085 0.469 . . . . 0.0 109.815 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.7 t -85.38 -44.87 12.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.496 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.582 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.28 -26.55 67.85 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.609 HG12 ' HG3' ' A' ' 13' ' ' GLN . 54.5 t -51.89 -50.0 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.069 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -74.54 -13.41 60.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.685 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -91.13 -18.7 24.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.288 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.654 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 48.8 m-85 -135.4 62.06 47.84 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.436 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.18 -36.77 78.62 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.494 2.129 . . . . 0.0 111.493 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.44 -39.77 98.09 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.518 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.654 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.5 t -67.72 145.23 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.628 ' HB2' HG21 ' A' ' 31' ' ' THR . 36.9 t -82.7 96.28 8.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.099 0.476 . . . . 0.0 110.795 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.504 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.8 p90 -64.05 130.83 45.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.187 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.494 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -149.87 162.3 29.11 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.008 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.5 tt -160.47 147.1 5.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.9 t -153.11 157.55 40.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.17 0.509 . . . . 0.0 111.697 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.436 HG21 ' HG ' ' A' ' 42' ' ' LEU . 69.9 p -138.03 -3.39 1.8 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.444 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -63.95 143.36 57.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.679 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.0 p -66.22 -52.08 51.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.53 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -50.2 -43.46 52.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.592 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.477 HG22 ' HA ' ' A' ' 21' ' ' VAL . 60.4 t -70.53 -52.5 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.934 0.397 . . . . 0.0 110.563 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.96 -14.52 16.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.47 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.6 m -92.13 -41.53 10.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.204 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -60.1 -41.3 92.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.451 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.401 ' HB2' HG12 ' A' ' 76' ' ' ILE . 36.3 m-85 -89.02 11.98 16.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.81 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 55.95 28.81 13.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.483 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.68 HG23 ' HB ' ' A' ' 80' ' ' THR . 34.9 mm -65.5 118.65 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.079 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.7 p -139.75 51.96 1.72 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.193 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.87 44.42 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.567 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.643 ' HB2' HG21 ' A' ' 99' ' ' ILE . 39.2 m-20 51.42 42.29 29.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.364 0.602 . . . . 0.0 110.137 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.68 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.4 m -68.55 153.36 43.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.93 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.591 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.3 mt -119.93 118.06 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.867 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.2 m -106.75 132.8 52.31 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.624 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -110.42 104.72 13.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.039 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.0 t80 -97.54 123.94 41.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.447 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.533 HH12 HD12 ' A' ' 116' ' ' LEU . 4.8 mtm180 -106.12 81.08 1.58 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.708 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ARG . 8.9 tp -24.28 -59.86 0.05 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.113 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.545 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.8 -63.3 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -93.77 2.57 56.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.995 0.426 . . . . 0.0 111.077 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 54.12 30.7 12.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.718 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.9 mm-40 -78.32 164.07 25.17 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.706 0.288 . . . . 0.0 110.648 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.99 98.74 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.624 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -86.81 115.37 24.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.742 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -96.67 93.61 6.83 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.563 HD21 HD13 ' A' ' 102' ' ' ILE . 4.1 tt -78.67 78.92 5.11 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -80.51 -165.44 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.501 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.17 -50.35 11.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.675 -179.316 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -47.59 -16.5 0.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.941 0.4 . . . . 0.0 111.209 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 96' ' ' ASP . 19.3 m-20 -127.27 -13.73 5.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.467 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.643 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.2 mm -91.36 -40.73 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -50.35 -37.36 36.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.349 . . . . 0.0 111.076 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.2 p -127.11 38.58 4.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.48 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.563 HD13 HD21 ' A' ' 94' ' ' LEU . 7.5 tp -67.11 143.76 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.616 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -137.93 148.39 45.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.32 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.869 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.8 -36.48 7.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.026 0.441 . . . . 0.0 110.445 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.3 m -62.57 -49.4 75.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.413 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -58.2 -59.07 5.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.365 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.732 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.64 -55.67 15.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.015 0.436 . . . . 0.0 110.146 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 65.5 m -58.42 -28.76 65.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.763 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.556 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -72.12 -67.21 0.56 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.094 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -42.85 -40.23 2.82 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.34 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.416 HG12 HG21 ' A' ' 35' ' ' VAL . 96.6 mt -66.45 -54.97 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -53.96 -18.84 3.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.324 0.583 . . . . 0.0 110.285 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.556 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.5 mp -90.1 -38.6 11.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.899 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.493 ' OD1' HG22 ' A' ' 113' ' ' ILE . 28.2 m120 -118.36 28.13 8.53 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -82.39 47.63 1.18 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 110.08 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.533 HD12 HH12 ' A' ' 85' ' ' ARG . 52.1 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.252 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.874 0.369 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.5 m -122.43 149.4 25.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.269 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -135.73 -72.4 0.46 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.023 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -66.84 98.78 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.893 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.6 p -73.15 124.31 25.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.8 m -75.19 -48.75 22.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -146.98 -61.37 0.29 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 124.36 -72.84 0.42 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.748 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.93 127.63 26.9 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.595 2.197 . . . . 0.0 112.478 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.28 108.76 0.41 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.602 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.98 -77.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.749 0.309 . . . . 0.0 110.793 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.75 96.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.662 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.521 ' HG3' ' CG1' ' A' ' 54' ' ' VAL . 2.4 pt20 -171.22 177.33 3.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.472 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.9 pt-20 -126.59 157.97 69.2 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.128 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.511 ' HD3' HG21 ' A' ' 54' ' ' VAL . 47.4 Cg_endo -68.66 150.59 74.65 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.855 2.37 . . . . 0.0 112.592 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.423 HG21 ' CZ ' ' A' ' 27' ' ' PHE . 8.4 m -73.18 154.23 40.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.38 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -97.53 91.16 5.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.166 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.591 HD13 ' HA ' ' A' ' 24' ' ' ALA . 30.7 mt -85.02 73.14 10.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.237 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.9 p -68.85 -6.72 28.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.421 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -138.25 147.4 43.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.931 0.396 . . . . 0.0 111.937 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 33.2 t -54.0 -49.68 88.39 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.685 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.7 Cg_endo -58.05 -46.15 27.48 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.962 1.775 . . . . 0.0 112.131 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.55 -35.33 80.13 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.115 0.483 . . . . 0.0 110.409 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.591 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -64.17 -59.64 4.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.006 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.9 mtm -61.51 -24.91 66.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.025 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 17.8 mt-10 -71.68 -50.33 31.47 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.749 0.309 . . . . 0.0 110.169 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.511 ' O ' HG22 ' A' ' 31' ' ' THR . 6.3 m-85 -60.04 -33.24 71.76 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.569 HD11 HD12 ' A' ' 36' ' ' ILE . 50.0 mt -72.49 -38.98 61.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.038 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.22 -18.33 60.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.239 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.75 27.18 3.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.288 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.762 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.6 t -170.8 150.77 3.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.426 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.505 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.0 tt0 -62.67 -63.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.953 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.504 HG13 HD11 ' A' ' 83' ' ' LEU . 21.8 t -108.18 138.32 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.591 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.37 125.75 18.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.993 0.425 . . . . 0.0 111.991 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.442 HG21 HG12 ' A' ' 111' ' ' ILE . 51.4 t -114.38 129.79 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 28' ' ' ILE . 39.3 mt -135.45 138.12 48.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.56 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.07 96.84 1.5 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.478 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.463 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 37.1 m-85 -83.04 90.45 7.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.646 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 13.6 m-85 -108.51 142.04 39.52 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -87.93 -5.97 58.28 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.477 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.8 t70 -154.49 123.48 6.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.747 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.554 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.3 mt -91.22 46.33 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.13 0.49 . . . . 0.0 111.293 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 32.5 mt-10 -137.57 11.4 2.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.972 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.813 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.6 pt -95.61 156.42 37.46 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.158 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.475 ' O ' HD12 ' A' ' 49' ' ' ILE . 82.0 Cg_exo -50.18 -28.47 19.97 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.848 2.365 . . . . 0.0 113.145 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.813 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.03 -37.05 85.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.67 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.6 t -62.39 -56.31 31.69 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.67 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.7 Cg_exo -60.04 -37.25 85.92 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 121.923 1.749 . . . . 0.0 111.49 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.7 mt -65.65 -35.9 76.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.112 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 54' ' ' VAL . 45.9 tp -73.23 -50.46 22.28 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -54.95 -26.12 34.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.124 0.487 . . . . 0.0 109.78 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.3 t -81.13 -46.97 14.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.625 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.585 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.28 -26.53 65.03 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.52 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 50' ' ' LEU . 47.0 t -52.19 -48.15 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.225 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -77.06 -11.89 59.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 28.8 mtpp -92.17 -18.47 23.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.176 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.59 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 56.5 m-85 -136.13 62.45 45.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.439 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.43 -43.09 56.94 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.701 2.267 . . . . 0.0 111.842 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.79 -39.44 91.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.57 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.8 t -67.35 145.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.762 ' HB2' HG21 ' A' ' 31' ' ' THR . 23.9 t -83.04 97.7 8.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.104 0.478 . . . . 0.0 110.826 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.502 ' HB3' HG22 ' A' ' 54' ' ' VAL . 5.0 p90 -64.73 125.17 23.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.965 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -143.56 162.42 27.67 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.146 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -163.08 142.77 2.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.463 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 42.5 t -149.56 156.3 41.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.12 0.486 . . . . 0.0 111.711 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.52 HG21 ' HG ' ' A' ' 42' ' ' LEU . 75.8 p -136.55 -1.54 2.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.459 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -68.08 139.97 56.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.72 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.7 p -62.34 -48.95 77.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.461 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -49.44 -47.38 48.22 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.574 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.498 ' HA ' HG22 ' A' ' 21' ' ' VAL . 71.5 t -69.01 -53.96 22.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.985 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.86 -14.88 6.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.134 0.492 . . . . 0.0 110.225 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.5 m -90.49 -41.6 11.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.32 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -60.77 -37.87 83.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.475 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.431 ' HB2' HG12 ' A' ' 76' ' ' ILE . 60.0 m-85 -92.88 10.11 32.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.815 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 56.76 25.97 10.86 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.51 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.705 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.3 mm -61.31 123.88 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.353 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.1 p -143.08 60.01 1.41 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.174 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.15 44.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.733 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.646 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 24.0 m-80 51.87 43.99 29.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.23 0.538 . . . . 0.0 110.506 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.705 ' HB ' HG23 ' A' ' 76' ' ' ILE . 90.1 m -69.32 150.94 46.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.744 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.56 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.2 mt -117.23 115.81 49.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.202 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.427 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 71.0 m -104.04 133.16 49.45 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.663 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -108.87 101.3 10.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.028 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.9 t80 -95.32 121.26 36.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.555 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.455 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 4.3 mtm180 -104.56 84.12 2.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.752 0.311 . . . . 0.0 110.897 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tp -26.26 -59.02 0.08 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.505 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.39 -72.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 O-C-N 123.428 0.455 . . . . 0.0 112.009 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.85 3.6 40.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.152 0.501 . . . . 0.0 110.655 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.5 t30 52.72 31.94 11.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.344 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 16.7 mm-40 -75.11 158.78 32.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.582 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -140.48 90.77 2.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.663 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -77.52 142.92 38.81 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -124.39 108.86 12.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.167 0.508 . . . . 0.0 112.343 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.553 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -96.54 77.86 2.95 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.6 mt-10 -79.0 -165.21 0.71 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.528 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.3 t70 -51.17 -36.6 41.93 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.02 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.15 -14.77 2.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.061 0.458 . . . . 0.0 110.437 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -130.88 -14.17 3.55 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.639 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.588 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.0 mm -89.07 -29.49 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.705 0.288 . . . . 0.0 111.271 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -55.7 -47.94 75.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.659 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.9 t -118.81 36.06 4.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.514 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.553 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -62.2 142.76 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.513 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -137.87 149.07 45.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.57 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.1 -37.24 9.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.013 0.435 . . . . 0.0 110.441 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 98.9 m -62.87 -48.45 78.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.256 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.09 -57.85 11.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.29 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.779 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.96 -56.22 13.45 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.052 0.453 . . . . 0.0 110.275 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.8 m -58.15 -29.47 65.6 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.887 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.501 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.3 tmt_? -71.58 -64.68 0.88 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.331 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -43.03 -45.8 5.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.932 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.442 HG12 HG21 ' A' ' 35' ' ' VAL . 96.4 mt -61.2 -55.75 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.506 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -54.34 -18.07 3.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.39 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.501 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.25 -37.23 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.04 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.448 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.5 m120 -124.81 30.35 5.95 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.5 p -83.13 48.98 1.45 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.049 0.452 . . . . 0.0 110.139 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.409 HD12 ' NH1' ' A' ' 85' ' ' ARG . 61.2 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.357 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.823 0.345 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -100.54 165.99 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.858 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -136.17 126.36 26.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.978 0.418 . . . . 0.0 111.13 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -63.73 -45.0 91.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.584 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 85.3 p 45.47 60.92 2.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.338 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.3 t -105.45 82.01 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.817 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -133.1 111.72 11.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.51 -94.53 0.17 Allowed Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.471 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.78 103.32 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.401 2.068 . . . . 0.0 112.269 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.49 -115.21 0.32 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.528 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.48 -47.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.446 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.04 -84.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.558 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.536 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.8 pt20 -133.11 143.85 49.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.368 . . . . 0.0 110.871 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.2 pt-20 -129.63 158.15 74.36 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.775 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 36.7 Cg_endo -67.22 143.8 66.13 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.512 2.142 . . . . 0.0 112.578 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 m -61.09 154.43 22.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.457 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -100.56 88.51 3.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.886 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 24' ' ' ALA . 59.8 mt -83.19 71.99 10.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.414 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.5 p -70.56 -1.51 11.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.377 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -143.27 147.03 34.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.986 0.422 . . . . 0.0 111.829 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.0 t -54.75 -49.17 93.04 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.561 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.57 -47.46 18.92 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.835 1.69 . . . . 0.0 111.84 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.29 -32.57 73.31 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.182 0.515 . . . . 0.0 110.174 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.611 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.85 -61.38 2.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.027 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.4 mmt -59.73 -25.04 64.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.302 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -73.1 -52.19 15.2 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.669 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.46 ' O ' HG22 ' A' ' 31' ' ' THR . 5.6 m-85 -58.74 -32.55 69.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.523 HD11 ' CD1' ' A' ' 36' ' ' ILE . 50.8 mt -74.76 -41.13 47.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.287 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.66 -15.27 62.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.14 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.85 26.81 4.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.132 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.674 HG21 ' HB2' ' A' ' 61' ' ' SER . 7.6 t -172.11 154.77 3.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.644 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HG2' HG22 ' A' ' 87' ' ' VAL . 10.9 tt0 -64.13 -76.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.842 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.551 HG13 HD11 ' A' ' 83' ' ' LEU . 16.9 t -96.6 136.1 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.59 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.68 125.67 19.77 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.472 HG21 HG12 ' A' ' 111' ' ' ILE . 52.6 t -115.32 131.67 66.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.755 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.523 ' CD1' HD11 ' A' ' 28' ' ' ILE . 20.6 mt -137.04 139.97 43.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.385 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.59 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.96 97.99 1.67 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.592 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.472 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 44.5 m-85 -84.6 93.12 8.31 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.613 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.1 m-85 -113.15 141.22 47.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -86.53 -8.84 57.21 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.494 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.0 t70 -149.82 123.17 9.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.813 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.554 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.5 mt -91.89 46.36 1.27 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.062 0.458 . . . . 0.0 111.326 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -135.18 9.62 3.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.848 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.723 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.0 pt -91.98 158.01 40.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.343 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' HD12 ' A' ' 49' ' ' ILE . 76.5 Cg_exo -53.24 -24.91 28.23 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.961 2.441 . . . . 0.0 113.015 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.723 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -66.1 -37.22 85.22 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.705 HG23 HG13 ' A' ' 44' ' ' ILE . 2.9 t -61.02 -55.2 46.86 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.616 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.658 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.2 Cg_exo -60.88 -42.41 37.92 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.035 1.824 . . . . 0.0 111.565 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.891 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -61.15 -35.28 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.251 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.61 ' O ' HG23 ' A' ' 54' ' ' VAL . 51.9 tp -74.15 -51.63 14.98 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -54.09 -26.75 28.68 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.9 m -80.84 -46.62 15.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.565 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.634 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.75 -25.28 64.74 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.195 0.521 . . . . 0.0 109.7 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 50' ' ' LEU . 49.5 t -53.12 -46.52 55.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.937 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -79.16 -9.16 59.49 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.808 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -94.61 -19.08 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.225 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.579 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 52.4 m-85 -136.95 63.02 43.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.419 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.68 -44.55 46.85 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.744 2.296 . . . . 0.0 111.71 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.33 -40.67 77.19 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.523 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.7 t -66.93 143.12 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.674 ' HB2' HG21 ' A' ' 31' ' ' THR . 22.1 t -80.92 96.31 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.403 . . . . 0.0 111.054 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.526 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.7 p90 -65.58 125.46 25.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.912 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -144.71 163.82 27.88 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.01 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 tt -161.81 144.11 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.452 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.9 t -150.1 157.38 43.06 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.041 0.448 . . . . 0.0 111.498 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.462 HG21 ' HG ' ' A' ' 42' ' ' LEU . 75.2 p -138.1 -2.99 1.81 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.644 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -64.06 142.2 58.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.631 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.2 t -65.29 -51.17 62.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.447 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -50.26 -41.97 51.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.5 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.508 ' HA ' HG22 ' A' ' 21' ' ' VAL . 65.4 t -71.91 -53.99 18.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 0.0 110.763 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp -59.07 -14.54 10.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.169 0.509 . . . . 0.0 110.21 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.9 m -92.49 -39.22 11.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.302 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -62.31 -40.95 98.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.445 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.433 ' HB2' HG12 ' A' ' 76' ' ' ILE . 90.5 m-85 -89.17 11.9 17.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.591 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 57.4 24.23 9.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.567 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.689 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.9 mm -61.0 119.9 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.9 p -138.23 52.66 1.83 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.421 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.95 48.15 0.01 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.799 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.624 ' HB2' HG21 ' A' ' 99' ' ' ILE . 21.4 m-80 49.71 43.69 24.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.119 0.485 . . . . 0.0 110.477 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.689 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.5 m -69.55 153.3 43.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.838 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.59 HG12 ' HA2' ' A' ' 37' ' ' GLY . 56.0 mt -118.83 119.41 60.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.84 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.472 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 75.5 m -108.2 135.4 49.59 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.595 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -112.85 105.65 13.8 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.196 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.9 t80 -98.33 122.06 41.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.315 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.472 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 5.4 mtm180 -104.29 81.12 1.78 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.757 0.313 . . . . 0.0 110.894 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 85' ' ' ARG . 9.4 tp -25.18 -56.72 0.06 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.809 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.507 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.58 -68.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.991 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -91.16 13.63 16.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.057 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 43.99 30.88 0.45 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.161 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 7.6 mm-40 -78.02 160.8 27.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.323 . . . . 0.0 110.674 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.81 95.14 2.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.974 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.595 HD23 ' HG ' ' A' ' 83' ' ' LEU . 1.8 mm? -83.02 143.2 30.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -123.82 93.68 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.548 HD21 HD13 ' A' ' 102' ' ' ILE . 4.9 tt -76.91 77.86 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.5 mt-10 -78.55 -165.7 0.75 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 19.0 t70 -51.2 -35.44 36.47 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.695 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.29 -17.4 4.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.237 0.541 . . . . 0.0 110.24 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -128.73 -13.87 4.65 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.668 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.624 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.4 mm -88.69 -32.08 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 120.593 0.235 . . . . 0.0 111.591 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.6 -36.23 64.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.103 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.6 m -132.41 38.56 3.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.465 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.548 HD13 HD21 ' A' ' 94' ' ' LEU . 7.0 tp -63.05 142.48 16.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.687 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -136.12 149.03 48.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.349 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.891 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.36 -37.54 11.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.982 0.42 . . . . 0.0 110.641 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.4 m -61.74 -47.17 86.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.363 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -59.95 -60.46 3.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.27 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.767 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.72 -56.04 9.72 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.03 0.443 . . . . 0.0 110.303 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.7 m -58.28 -30.97 67.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.914 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.501 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.7 tmt_? -69.95 -65.8 0.68 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.235 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -42.87 -45.02 4.77 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.164 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.472 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -61.55 -55.03 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -54.79 -18.62 4.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.395 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.501 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.88 -36.47 8.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.875 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.443 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.2 m120 -124.88 30.43 5.91 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.4 p -83.21 42.05 0.79 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.972 0.415 . . . . 0.0 110.286 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.461 HD12 ' NH1' ' A' ' 85' ' ' ARG . 81.5 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.382 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.743 0.306 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.29 17.85 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.321 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 55.55 46.86 22.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.129 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 55.91 84.24 0.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.075 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.4 p -60.09 124.81 21.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.78 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.0 t -98.58 104.3 16.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.987 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -109.49 -11.76 14.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.845 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.05 154.32 9.28 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.475 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.2 -33.14 95.07 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.642 2.228 . . . . 0.0 112.41 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.91 -136.97 4.34 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.49 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.3 -51.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.791 0.329 . . . . 0.0 110.653 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . . . 60.3 -83.8 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.534 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.528 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.8 pt20 -129.81 142.7 50.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.351 . . . . 0.0 110.891 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.0 pt-20 -125.09 157.76 65.86 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.984 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.0 Cg_endo -66.09 143.53 72.16 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.7 2.267 . . . . 0.0 112.504 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.0 m -58.38 149.49 24.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.65 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -97.34 85.76 3.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.627 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.621 HD22 ' HA ' ' A' ' 24' ' ' ALA . 39.0 mt -82.14 73.22 9.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.546 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.5 p -71.77 -2.06 16.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.339 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -141.5 147.35 37.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 111.696 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.598 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 58.6 t -55.37 -49.92 89.73 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.602 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.7 Cg_endo -57.85 -45.26 33.89 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.849 1.699 . . . . 0.0 112.066 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.54 78.4 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.132 0.491 . . . . 0.0 110.416 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.621 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.6 -59.24 4.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.98 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 60.4 mtp -60.99 -26.54 67.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.04 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 18.7 mt-10 -71.25 -49.27 44.91 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.657 0.265 . . . . 0.0 110.333 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.549 ' O ' HG22 ' A' ' 31' ' ' THR . 4.3 m-85 -60.34 -34.27 73.59 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.584 HD11 HD12 ' A' ' 36' ' ' ILE . 51.4 mt -72.96 -38.31 55.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.292 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.17 -17.9 60.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.09 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.86 27.27 4.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.287 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.62 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.3 t -169.49 152.37 4.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.453 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.598 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.5 tt0 -64.65 -64.97 0.74 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.912 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.527 HG13 HD11 ' A' ' 83' ' ' LEU . 21.8 t -108.33 137.4 40.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.491 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.87 126.99 21.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.945 0.403 . . . . 0.0 112.031 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.458 HG21 HG12 ' A' ' 111' ' ' ILE . 42.9 t -115.47 127.58 73.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.593 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.584 HD12 HD11 ' A' ' 28' ' ' ILE . 32.2 mt -134.15 138.78 49.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.572 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.568 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.49 98.42 1.69 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.562 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.446 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.0 m-85 -84.98 92.77 8.41 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.4 m-85 -111.56 147.48 35.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.541 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.417 ' HG2' HD23 ' A' ' 71' ' ' LEU . 89.0 mt-30 -94.51 -9.89 33.94 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.531 ' O ' HG12 ' A' ' 44' ' ' ILE . 37.5 t70 -147.17 117.41 7.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.397 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.572 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.3 mt -87.35 45.26 1.25 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.127 0.489 . . . . 0.0 111.506 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.1 mt-10 -136.13 10.88 3.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.114 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.806 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.5 pt -94.29 155.04 40.27 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.132 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.484 ' O ' HD12 ' A' ' 49' ' ' ILE . 88.2 Cg_exo -48.88 -28.51 13.32 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.936 2.424 . . . . 0.0 113.091 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.806 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.9 -37.9 88.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.677 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.9 t -61.38 -56.35 34.52 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.604 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.677 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.2 Cg_exo -60.86 -41.87 42.14 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.822 1.682 . . . . 0.0 111.416 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.884 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -60.4 -34.94 59.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.038 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.61 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.8 tp -73.92 -52.39 13.06 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -52.79 -27.1 16.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.065 0.46 . . . . 0.0 109.772 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.6 m -80.12 -46.84 15.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.722 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.575 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.11 -26.04 64.34 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.194 0.521 . . . . 0.0 109.639 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.2 t -52.83 -51.12 39.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.89 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.413 ' OE1' ' HB3' ' A' ' 12' ' ' ALA . 7.7 mt-30 -75.24 -10.42 59.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.75 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.2 mtpp -93.51 -18.25 22.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.253 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.607 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 55.3 m-85 -136.81 62.53 41.5 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.488 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.65 -41.14 70.82 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.592 2.195 . . . . 0.0 111.627 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.72 -39.44 93.59 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.321 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.607 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -69.12 144.25 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.62 ' HB2' HG21 ' A' ' 31' ' ' THR . 41.3 t -81.96 98.29 8.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.985 0.421 . . . . 0.0 111.013 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.479 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.2 p90 -63.53 128.92 37.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.854 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.509 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.15 161.36 28.46 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.261 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.9 tt -162.6 145.12 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.446 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.0 t -152.46 157.72 41.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.195 0.522 . . . . 0.0 111.787 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.457 HG21 ' HG ' ' A' ' 42' ' ' LEU . 67.5 p -138.03 -3.39 1.8 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.626 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.4 139.73 58.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.415 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.4 m -63.69 -49.09 74.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.54 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -50.57 -41.14 53.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.489 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.582 ' HA ' HG22 ' A' ' 21' ' ' VAL . 56.6 t -73.49 -54.98 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 110.685 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.417 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.0 mp -57.66 -14.52 5.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.367 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 83.2 m -92.44 -42.33 9.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.286 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -60.53 -34.76 74.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.59 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' HB2' HG12 ' A' ' 76' ' ' ILE . 96.7 m-85 -95.88 10.17 38.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.693 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.0 m120 56.63 27.43 12.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.755 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.711 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.6 mm -63.87 122.23 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.867 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.5 p -141.72 54.77 1.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.911 0.386 . . . . 0.0 111.322 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.49 44.03 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.753 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.593 ' HB2' HG21 ' A' ' 99' ' ' ILE . 19.8 m-80 51.79 41.97 29.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.338 0.589 . . . . 0.0 110.251 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.711 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.8 m -67.64 151.55 47.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.703 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.568 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.3 mt -118.28 116.22 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.869 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 73.0 m -104.14 129.94 51.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.644 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.2 tp -107.01 100.34 9.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.507 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.6 t80 -94.67 122.81 37.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.532 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.7 mtm180 -107.13 92.78 4.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.363 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 tp -37.81 -53.52 1.28 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.009 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.598 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.59 -58.22 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -102.84 9.64 38.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.002 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 85' ' ' ARG . 16.0 t-20 47.2 34.44 3.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.423 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.532 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 15.8 mm-40 -77.48 159.46 29.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.87 91.21 2.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.914 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.644 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.5 mm? -81.97 115.27 21.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.847 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.81 98.63 9.41 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.499 HD21 HD13 ' A' ' 102' ' ' ILE . 4.3 tt -83.77 77.63 9.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.461 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.3 mt-10 -77.87 -165.64 0.67 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.548 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 20.6 t70 -51.21 -37.89 49.28 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.117 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -55.55 -15.18 2.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.059 0.457 . . . . 0.0 110.437 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -128.38 -14.2 4.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.394 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.593 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.7 mm -90.18 -29.26 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.889 0.376 . . . . 0.0 111.321 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -56.13 -38.05 70.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 85.4 p -129.98 36.07 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.582 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.2 tp -62.05 141.98 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.597 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -136.89 150.34 48.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.533 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.884 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.74 -37.72 13.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.903 0.382 . . . . 0.0 110.584 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -62.73 -47.94 81.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.303 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -58.8 -60.27 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.199 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.765 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.13 -56.58 8.72 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.965 0.412 . . . . 0.0 110.191 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.7 m -58.07 -28.87 64.95 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.947 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.51 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.2 tmt_? -72.42 -67.0 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.077 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -42.37 -41.36 2.83 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.103 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 35' ' ' VAL . 96.6 mt -65.49 -55.68 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -53.27 -18.68 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.187 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.51 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.5 mp -89.99 -39.38 12.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.918 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.449 ' OD1' HG22 ' A' ' 113' ' ' ILE . 26.3 m120 -116.39 26.77 9.66 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 78.7 p -81.56 52.59 1.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.174 0.511 . . . . 0.0 110.216 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.447 HD12 HH12 ' A' ' 85' ' ' ARG . 70.8 mt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.032 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.777 0.322 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -155.24 -30.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -93.79 130.82 39.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.763 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 4' ' ' LYS . 13.8 mptt -94.5 162.8 13.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.0 p -139.91 17.97 2.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.0 p -89.8 -43.83 10.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.98 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -148.48 89.14 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.011 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -107.19 -163.08 21.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.487 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.47 98.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.587 2.191 . . . . 0.0 112.33 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.32 79.02 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.462 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.75 -65.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 13' ' ' GLN . . . 54.81 53.07 11.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.271 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.447 ' OE1' HG12 ' A' ' 54' ' ' VAL . 3.7 pt20 47.37 173.26 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.846 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.483 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 -165.54 159.4 13.67 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.488 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 53.6 Cg_endo -69.46 136.34 33.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.365 2.044 . . . . 0.0 112.685 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.9 m -60.7 152.43 26.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.676 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -94.01 98.54 11.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.94 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.1 mt -93.05 70.71 4.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.265 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.9 p -70.54 -2.15 13.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.165 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -139.7 146.87 40.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.021 0.439 . . . . 0.0 111.64 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 43.4 t -56.82 -50.08 90.1 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.396 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.41 -43.89 42.46 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.945 1.763 . . . . 0.0 111.878 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.28 -36.99 85.91 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.223 0.535 . . . . 0.0 110.305 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.602 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.84 -57.07 12.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.04 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 62.1 mtp -62.59 -26.74 68.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.117 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.32 -50.76 35.91 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.726 0.298 . . . . 0.0 110.464 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.478 ' O ' HG22 ' A' ' 31' ' ' THR . 12.2 m-85 -61.46 -32.54 72.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.513 HD11 HD12 ' A' ' 36' ' ' ILE . 47.7 mt -72.9 -36.86 52.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.836 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.7 -20.33 59.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.022 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.94 28.33 1.86 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.162 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.75 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.8 t -172.3 154.63 3.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.475 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.545 ' HG3' HG13 ' A' ' 87' ' ' VAL . 30.1 tt0 -68.0 -59.9 2.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.012 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.529 HG13 HD11 ' A' ' 83' ' ' LEU . 20.6 t -110.26 138.26 38.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.495 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.78 127.16 17.73 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.453 HG21 HG12 ' A' ' 111' ' ' ILE . 48.6 t -116.05 130.3 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.586 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.513 HD12 HD11 ' A' ' 28' ' ' ILE . 25.4 mt -135.94 137.59 48.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.456 -177.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.94 99.43 2.05 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.443 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 10.8 m-85 -85.67 93.99 8.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.4 m-85 -115.09 141.48 47.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -88.95 -2.24 58.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.465 ' O ' HG12 ' A' ' 44' ' ' ILE . 25.1 t70 -155.81 123.06 5.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.636 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.55 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.6 mt -92.62 46.15 1.23 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.136 0.493 . . . . 0.0 111.475 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.417 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 38.3 mt-10 -135.19 8.06 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.921 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.755 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.0 pt -90.82 155.51 45.32 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.186 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.506 ' O ' HD12 ' A' ' 49' ' ' ILE . 77.2 Cg_exo -50.75 -27.12 19.17 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.87 2.38 . . . . 0.0 112.942 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.755 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.6 -37.86 88.94 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.673 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -61.88 -56.0 36.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.773 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.5 Cg_exo -60.47 -37.01 84.08 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 121.9 1.733 . . . . 0.0 111.435 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.875 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -65.75 -35.43 75.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.941 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.4 tp -74.31 -51.85 13.98 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -55.86 -22.21 24.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.979 0.419 . . . . 0.0 109.922 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.6 t -85.59 -44.63 12.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.372 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.615 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.24 -26.03 67.47 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.226 0.536 . . . . 0.0 109.593 179.337 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 50' ' ' LEU . 44.9 t -51.61 -48.98 35.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.009 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -74.44 -14.84 60.9 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.566 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -90.35 -17.71 26.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.357 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.583 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 65.6 m-85 -137.14 61.82 35.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.699 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.47 -43.52 56.85 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.645 2.23 . . . . 0.0 111.611 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.58 -42.29 90.2 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.422 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.583 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.1 t -65.97 141.71 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.75 ' HB2' HG21 ' A' ' 31' ' ' THR . 41.2 t -78.37 97.71 5.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.081 0.467 . . . . 0.0 110.816 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.496 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.5 p90 -67.9 124.64 23.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.914 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.459 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -143.51 164.13 27.41 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.041 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.7 tt -161.2 142.14 3.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 t -147.23 153.35 39.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.161 0.505 . . . . 0.0 111.794 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.457 HG21 ' HG ' ' A' ' 42' ' ' LEU . 77.8 p -135.05 2.73 3.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.432 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.84 140.67 49.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.705 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.0 t -64.03 -49.97 70.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.531 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -50.76 -44.46 58.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.602 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.556 ' HA ' HG22 ' A' ' 21' ' ' VAL . 54.5 t -70.24 -52.1 33.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.891 0.377 . . . . 0.0 110.598 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.52 -15.08 15.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.253 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.1 m -90.93 -41.23 11.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.32 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -61.63 -37.84 85.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.389 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.41 ' HB2' HG12 ' A' ' 76' ' ' ILE . 45.3 m-85 -92.08 11.69 24.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.805 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 56.02 23.03 6.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.689 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.671 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.7 mm -57.94 117.28 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.83 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.1 p -136.51 56.4 1.81 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.387 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.28 46.32 0.02 OUTLIER Glycine 0 C--N 1.329 0.174 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.628 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.595 ' HB2' HG21 ' A' ' 99' ' ' ILE . 16.4 m-80 51.43 43.62 29.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.162 0.506 . . . . 0.0 110.277 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.671 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.3 m -69.08 154.75 41.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.675 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.592 HG12 ' HA2' ' A' ' 37' ' ' GLY . 52.9 mt -120.65 117.55 53.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.817 178.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.513 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.2 m -106.7 135.9 47.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.674 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -112.85 101.64 9.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.064 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.6 t80 -95.05 125.18 39.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.772 0.32 . . . . 0.0 110.334 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.519 HH12 HD12 ' A' ' 116' ' ' LEU . 5.3 mtm180 -107.75 83.65 1.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.825 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 85' ' ' ARG . 9.0 tp -24.67 -59.15 0.06 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.789 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.545 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.85 -77.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 O-C-N 123.5 0.5 . . . . 0.0 112.127 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.55 4.32 21.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.636 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.2 m120 53.8 31.43 13.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.522 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.1 mm-40 -74.46 161.49 29.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -145.94 86.91 1.73 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.862 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.674 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -74.25 144.84 44.47 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -128.25 98.28 5.03 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.528 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -84.64 78.28 9.88 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.0 mt-10 -79.02 -165.61 0.78 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.518 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.8 t70 -50.23 -38.62 41.43 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.03 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -55.06 -14.9 1.74 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.119 0.485 . . . . 0.0 110.492 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -130.1 -13.94 3.96 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.664 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.595 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.5 mm -88.49 -31.86 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.636 0.255 . . . . 0.0 111.614 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -56.43 -35.29 67.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.952 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.5 m -130.31 39.77 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.558 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.528 HD13 HD21 ' A' ' 94' ' ' LEU . 7.2 tp -68.25 142.08 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.754 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -136.04 149.69 48.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.391 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.875 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.63 -35.87 10.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.127 0.489 . . . . 0.0 110.445 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.8 m -62.59 -48.61 78.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.42 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -59.4 -59.76 4.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.256 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.775 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.34 -55.48 12.72 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 110.301 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.5 m -58.92 -30.59 67.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.999 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.494 ' HD3' HD13 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -70.83 -66.25 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.138 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -43.15 -43.58 4.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.119 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.453 HG12 HG21 ' A' ' 35' ' ' VAL . 96.8 mt -63.8 -55.43 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -54.12 -17.59 2.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.129 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.494 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -90.69 -37.22 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.01 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.448 ' O ' HD21 ' A' ' 83' ' ' LEU . 14.9 m120 -122.63 29.96 6.67 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 98.7 p -83.26 40.55 0.72 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.091 0.472 . . . . 0.0 110.1 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.519 HD12 HH12 ' A' ' 85' ' ' ARG . 58.2 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.422 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.821 0.344 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.0 p -155.94 143.6 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.93 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -124.37 103.71 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.993 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -135.32 127.37 29.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.735 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.4 m -75.14 87.84 2.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.9 p -162.42 37.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.21 -57.59 3.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.802 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -113.72 177.44 17.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.578 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.07 -58.78 1.02 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.584 2.19 . . . . 0.0 112.253 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.66 -118.37 0.54 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.374 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.541 ' HB1' HE21 ' A' ' 13' ' ' GLN . . . -167.98 -68.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.638 0.256 . . . . 0.0 110.787 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.438 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . . . 59.35 100.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.315 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.541 HE21 ' HB1' ' A' ' 11' ' ' ALA . 9.0 pt20 -168.98 172.28 7.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.977 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 -118.29 158.45 46.55 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.084 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 45.0 Cg_endo -69.7 148.15 64.8 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.773 2.315 . . . . 0.0 112.756 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 m -66.25 150.13 49.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.527 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -96.51 90.64 5.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.999 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 37.1 mt -86.12 71.49 10.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.567 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.8 p -70.68 -1.96 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.081 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -141.57 147.07 37.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.919 0.39 . . . . 0.0 111.7 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 59.3 t -55.79 -49.85 90.52 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.491 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.4 Cg_endo -57.55 -44.91 37.65 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.89 1.727 . . . . 0.0 111.937 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.84 -34.46 78.43 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.226 0.536 . . . . 0.0 110.353 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.46 -59.41 4.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.174 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.1 mtm -61.48 -26.96 68.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.049 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -70.77 -49.26 48.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.638 0.256 . . . . 0.0 110.51 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.465 ' O ' HG22 ' A' ' 31' ' ' THR . 6.2 m-85 -61.48 -32.88 72.91 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.49 HD11 ' CD1' ' A' ' 36' ' ' ILE . 42.8 mt -72.08 -37.99 61.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.828 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.76 -23.62 61.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.837 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.93 32.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.138 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.615 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.8 t -173.47 151.31 1.94 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.346 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.521 ' HG3' HG13 ' A' ' 87' ' ' VAL . 30.0 tt0 -68.31 -53.45 24.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.749 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.509 HG13 HD11 ' A' ' 83' ' ' LEU . 21.5 t -116.58 139.83 41.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.413 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.15 126.78 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.488 HG21 HG12 ' A' ' 111' ' ' ILE . 43.7 t -115.61 125.99 73.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.404 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.49 ' CD1' HD11 ' A' ' 28' ' ' ILE . 28.2 mt -131.39 136.26 57.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -177.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.597 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.08 98.33 1.88 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.267 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.5 m-85 -84.12 93.27 8.1 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -113.62 142.88 45.45 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.42 ' HG2' HD23 ' A' ' 71' ' ' LEU . 74.0 mt-30 -90.47 -9.25 48.08 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.514 ' O ' HG12 ' A' ' 44' ' ' ILE . 30.2 t70 -147.72 119.28 7.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.55 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.536 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.3 mt -88.9 45.49 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.096 0.474 . . . . 0.0 111.413 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.433 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.9 mt-10 -135.65 7.94 3.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.107 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.731 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.5 pt -89.87 157.03 46.69 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.158 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' HD12 ' A' ' 49' ' ' ILE . 74.0 Cg_exo -51.84 -25.98 22.86 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.792 2.328 . . . . 0.0 112.824 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.731 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.87 -39.04 92.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 44' ' ' ILE . 2.1 t -60.38 -55.12 48.26 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.608 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.4 Cg_exo -60.56 -42.0 43.56 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.879 1.719 . . . . 0.0 111.371 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.898 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -60.62 -35.45 63.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.046 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.605 ' O ' HG23 ' A' ' 54' ' ' VAL . 50.9 tp -73.81 -50.09 22.15 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -55.81 -25.27 40.71 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.8 m -81.56 -45.77 15.4 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.595 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.609 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.22 -25.82 67.32 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.114 0.483 . . . . 0.0 109.748 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 50' ' ' LEU . 42.8 t -52.16 -47.77 43.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.084 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' A' ' 12' ' ' ALA . 36.5 mt-30 -76.94 -14.29 59.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.668 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -90.8 -16.58 28.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.389 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.671 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 34.3 m-85 -136.99 61.42 34.52 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.606 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.39 -39.56 81.25 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.636 2.224 . . . . 0.0 111.592 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.98 -41.16 99.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.519 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.9 t -67.12 145.23 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.615 ' CB ' HG21 ' A' ' 31' ' ' THR . 46.6 t -82.31 96.56 7.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.984 0.421 . . . . 0.0 110.999 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.496 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 4.7 p90 -62.1 128.24 35.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.612 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.5 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.2 161.46 28.32 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.826 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.407 HD11 HG13 ' A' ' 47' ' ' VAL . 5.5 tt -164.02 140.73 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.2 t -144.45 159.33 42.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.227 0.537 . . . . 0.0 111.959 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 39' ' ' PHE . 76.2 p -141.18 -0.0 1.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.314 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -71.28 144.4 50.01 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.602 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.8 p -65.66 -50.96 63.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.392 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -49.96 -41.8 47.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.616 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.563 ' HA ' HG22 ' A' ' 21' ' ' VAL . 70.9 t -72.45 -54.08 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.841 0.353 . . . . 0.0 110.712 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.42 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.3 mp -59.0 -14.74 10.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.35 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.6 m -91.67 -42.0 10.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.258 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -60.52 -38.97 86.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.356 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.413 ' HB2' HG12 ' A' ' 76' ' ' ILE . 43.6 m-85 -91.15 9.61 30.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.763 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.8 m120 57.24 24.68 10.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.592 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.673 HG23 ' HB ' ' A' ' 80' ' ' THR . 42.0 mm -59.27 125.24 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.9 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.0 p -143.86 60.31 1.37 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.529 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.87 45.51 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.542 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.616 ' HB2' HG21 ' A' ' 99' ' ' ILE . 29.6 m-80 51.63 41.87 29.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.236 0.541 . . . . 0.0 110.385 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.673 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.2 m -67.65 152.22 45.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.747 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.597 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.1 mt -119.56 116.83 51.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.835 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.497 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 71.2 m -106.31 136.58 45.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.655 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -109.73 100.91 9.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.196 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.5 t80 -92.99 119.88 32.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.434 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.471 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.5 mtm180 -104.25 85.21 2.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.973 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 tp -26.97 -61.28 0.09 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.521 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.1 -76.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 O-C-N 123.525 0.516 . . . . 0.0 112.056 -179.42 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.48 3.12 25.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.098 0.475 . . . . 0.0 110.533 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.405 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 12.3 t30 52.65 31.84 10.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.299 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 19.6 mm-40 -75.28 165.96 24.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.533 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -149.68 87.55 1.5 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.655 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -72.04 147.22 47.04 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.85 105.72 8.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.292 0.568 . . . . 0.0 112.302 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.561 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -94.05 76.45 4.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.0 mt-10 -77.61 -165.88 0.68 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.492 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.63 -51.9 11.51 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.524 -179.368 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -47.28 -17.56 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.868 0.366 . . . . 0.0 111.301 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -124.39 -13.92 7.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.423 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.616 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.8 mm -91.48 -40.25 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -51.71 -30.38 22.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.821 0.343 . . . . 0.0 111.29 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m -134.67 39.98 2.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.079 0.466 . . . . 0.0 110.395 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.561 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -68.48 143.93 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.712 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.409 ' H ' ' HD3' ' A' ' 106' ' ' LYS . 23.7 m-20 -136.32 147.89 47.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.437 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.898 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.69 -38.69 10.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.017 0.437 . . . . 0.0 110.542 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 98.8 m -59.51 -49.32 78.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.323 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 103' ' ' ASP . 51.1 mtpt -57.87 -62.6 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.274 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.76 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -46.64 -57.53 4.71 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.945 0.403 . . . . 0.0 110.446 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.9 m -57.74 -29.88 65.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.931 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.509 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.0 tmt_? -71.4 -65.85 0.7 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.237 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -42.64 -43.61 3.9 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.993 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.488 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -63.25 -55.98 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.617 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -54.15 -18.36 3.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.362 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.509 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.91 -37.47 10.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.84 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.478 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.6 m120 -125.45 31.21 5.6 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 98.2 p -83.9 44.51 1.0 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.122 0.487 . . . . 0.0 110.074 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.443 HD12 HH12 ' A' ' 85' ' ' ARG . 65.4 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.352 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.701 0.286 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p -141.78 133.66 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.187 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -105.31 -9.59 17.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.846 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -78.49 152.98 31.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.976 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -95.54 120.23 35.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.4 m -146.01 122.2 10.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.101 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -120.62 96.64 5.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.776 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 110.06 -94.19 0.79 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.362 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.72 134.09 52.04 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.451 2.101 . . . . 0.0 112.239 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.34 -78.36 0.18 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.701 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.42 -41.9 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.864 0.364 . . . . 0.0 110.35 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.53 -83.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.72 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.499 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.7 pt20 -139.9 142.37 36.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.863 0.363 . . . . 0.0 110.963 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.2 pt-20 -128.09 157.87 72.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.798 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.484 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 36.3 Cg_endo -67.13 140.55 54.34 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.444 2.096 . . . . 0.0 112.494 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.0 m -54.8 152.03 7.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.748 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -98.98 87.11 3.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.079 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.618 HD22 ' HA ' ' A' ' 24' ' ' ALA . 45.8 mt -84.85 72.57 10.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.344 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.0 p -71.67 0.19 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.445 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -144.67 148.29 34.07 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.752 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 45.2 t -55.3 -49.57 91.62 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.528 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.28 -46.53 24.38 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.922 1.748 . . . . 0.0 111.9 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.88 -33.06 74.84 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.11 0.481 . . . . 0.0 110.324 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.618 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -65.83 -59.03 4.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.939 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.6 mtm -61.0 -25.39 66.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.054 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.4 mt-10 -72.97 -52.01 16.18 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.684 0.278 . . . . 0.0 110.499 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.502 ' O ' HG22 ' A' ' 31' ' ' THR . 4.0 m-85 -58.49 -33.78 70.19 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.558 HD11 HD12 ' A' ' 36' ' ' ILE . 57.9 mt -73.84 -40.76 53.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.261 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.98 -15.22 62.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.174 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.29 23.74 7.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.643 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.4 t -169.88 153.68 4.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.737 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.7 tt0 -63.35 -74.95 0.09 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.816 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.548 HG13 HD11 ' A' ' 83' ' ' LEU . 15.7 t -97.75 135.9 30.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.784 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.512 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.91 124.07 16.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.948 0.404 . . . . 0.0 111.904 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 111' ' ' ILE . 45.8 t -112.44 130.38 66.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.785 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 28' ' ' ILE . 29.1 mt -135.75 138.63 47.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.611 -177.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.551 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.03 98.13 1.77 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.543 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.476 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 35.9 m-85 -83.84 91.63 7.59 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.3 m-85 -111.75 141.08 45.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.3 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.429 ' HG2' HD23 ' A' ' 71' ' ' LEU . 88.2 mt-30 -86.08 -10.19 55.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 44' ' ' ILE . 9.8 t70 -148.53 129.35 14.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.561 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.501 ' HA ' HG21 ' A' ' 47' ' ' VAL . 90.1 mt -96.97 48.4 1.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.077 0.465 . . . . 0.0 111.475 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -137.9 7.29 2.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.771 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.713 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.7 pt -88.58 159.2 47.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.129 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.481 ' O ' HD12 ' A' ' 49' ' ' ILE . 54.4 Cg_exo -54.47 -24.91 37.86 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.864 2.376 . . . . 0.0 112.816 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.713 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.9 -39.01 90.22 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.702 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -59.34 -55.08 49.8 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.3 Cg_exo -60.37 -41.84 46.45 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.01 1.807 . . . . 0.0 111.505 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.892 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.5 mt -61.68 -34.42 62.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.103 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.614 ' O ' HG23 ' A' ' 54' ' ' VAL . 52.0 tp -75.09 -51.85 12.49 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -54.32 -24.92 21.15 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -82.08 -46.13 14.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.593 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.609 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.43 -25.52 66.03 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.9 t -52.39 -48.18 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.081 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -78.11 -9.96 59.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.83 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -93.9 -19.15 21.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.304 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.608 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 51.3 m-85 -135.83 62.91 49.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.56 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.82 -43.9 48.48 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.829 2.352 . . . . 0.0 111.644 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.08 -40.71 91.86 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.497 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.3 t -67.57 142.51 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.643 ' HB2' HG21 ' A' ' 31' ' ' THR . 32.2 t -81.44 97.68 7.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.055 0.455 . . . . 0.0 110.976 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.484 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.6 p90 -65.03 128.14 34.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.786 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.84 163.0 28.6 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.8 -0.715 . . . . 0.0 111.937 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 tt -161.68 144.26 3.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.476 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 40.7 t -148.52 156.33 42.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.131 0.491 . . . . 0.0 111.581 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.471 HG21 ' HG ' ' A' ' 42' ' ' LEU . 69.6 p -138.24 5.93 2.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.783 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -76.2 141.19 41.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.632 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.9 t -63.77 -50.35 69.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.396 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -49.68 -43.29 47.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.405 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.544 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.0 t -71.14 -54.16 18.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.841 0.353 . . . . 0.0 110.745 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.429 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -58.23 -14.82 7.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.118 0.485 . . . . 0.0 110.211 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.4 m -91.17 -40.55 11.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.161 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -61.75 -33.02 73.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.149 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.432 ' HB2' HG12 ' A' ' 76' ' ' ILE . 68.2 m-85 -97.35 9.15 43.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.959 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 58.88 22.78 10.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.506 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.709 HD12 ' HB ' ' A' ' 80' ' ' THR . 41.0 mm -59.13 125.61 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.266 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.6 p -144.44 58.69 1.33 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.29 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.57 43.94 0.02 OUTLIER Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.664 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.617 ' HB2' HG21 ' A' ' 99' ' ' ILE . 32.5 m-20 52.37 44.75 29.55 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.285 0.564 . . . . 0.0 110.435 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.709 ' HB ' HD12 ' A' ' 76' ' ' ILE . 89.8 m -69.96 152.31 44.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.913 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.551 HG12 ' HA2' ' A' ' 37' ' ' GLY . 59.5 mt -117.72 116.99 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-N 115.496 -0.775 . . . . 0.0 108.979 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.436 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 75.7 m -106.22 133.65 50.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.631 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -110.34 105.41 14.42 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.077 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.2 t80 -97.22 122.12 39.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.697 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.491 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.3 mtm180 -105.04 81.94 1.79 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 110.552 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.7 tp -25.71 -58.73 0.07 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.026 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.539 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -44.26 -57.25 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.136 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.59 13.52 33.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.592 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 43.8 28.81 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.301 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 15.9 mm-40 -77.79 156.98 30.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.745 0.307 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.83 95.33 2.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.567 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.631 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -84.9 116.14 23.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.959 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.18 108.89 21.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.586 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -95.01 77.62 3.55 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.436 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.4 mt-10 -78.72 -165.09 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.531 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 17.2 t70 -50.26 -39.9 46.4 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.249 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -53.91 -15.88 1.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.132 0.492 . . . . 0.0 110.229 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -128.96 -13.68 4.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.58 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.617 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.5 mm -91.01 -40.04 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -51.55 -33.82 33.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.935 0.398 . . . . 0.0 111.044 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.1 m -131.39 40.0 3.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.372 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.586 HD13 HD21 ' A' ' 94' ' ' LEU . 8.0 tp -68.89 144.91 13.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.658 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -138.59 146.95 42.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.257 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.892 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.09 -36.17 5.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.967 0.413 . . . . 0.0 110.694 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 100.0 m -62.24 -48.18 81.1 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.489 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -59.32 -61.29 2.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.055 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.752 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.91 -55.88 8.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.974 0.416 . . . . 0.0 110.332 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.9 m -58.44 -30.61 67.04 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.922 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.536 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.7 tmt_? -71.06 -66.08 0.66 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.245 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -42.98 -41.9 3.56 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.243 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.475 HG12 HG21 ' A' ' 35' ' ' VAL . 97.0 mt -65.11 -55.14 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -53.94 -18.85 3.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.14 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.536 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.75 -37.95 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.827 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.485 ' OD1' HG22 ' A' ' 113' ' ' ILE . 31.6 m120 -119.86 28.6 8.02 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.8 p -82.81 48.0 1.28 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.075 0.464 . . . . 0.0 110.484 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.43 HD12 ' NH1' ' A' ' 85' ' ' ARG . 78.1 mt . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.246 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.747 0.308 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.84 151.76 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.151 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 56.8 84.2 0.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -157.98 139.66 13.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.6 m -96.68 46.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.717 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.7 m -139.39 -46.41 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -100.49 97.36 8.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.94 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.07 -173.04 27.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.455 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.25 104.75 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.527 2.151 . . . . 0.0 112.175 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.87 55.02 0.58 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.437 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.73 -46.82 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.976 0.417 . . . . 0.0 110.571 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.37 -83.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.673 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.496 ' HG3' HG12 ' A' ' 54' ' ' VAL . 10.5 pt20 -139.72 154.63 47.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.485 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 -140.88 159.28 62.8 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 49.9 Cg_endo -70.37 144.91 52.15 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.664 2.243 . . . . 0.0 112.762 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.3 m -63.46 150.7 43.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.631 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -96.26 97.86 9.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.015 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 54.9 mt -92.93 70.91 4.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.318 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.8 p -71.74 -2.25 16.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.136 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -139.32 146.7 40.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.058 0.456 . . . . 0.0 111.509 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 13.1 t -56.43 -50.42 87.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.471 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.74 -45.28 34.19 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.831 1.688 . . . . 0.0 111.856 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.31 79.87 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.198 0.523 . . . . 0.0 110.309 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.07 -59.26 4.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.988 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.1 mtm -60.63 -25.39 66.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.202 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 26.3 mt-10 -73.38 -51.39 17.51 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.728 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.546 ' O ' HG22 ' A' ' 31' ' ' THR . 9.1 m-85 -60.04 -31.67 70.18 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.561 HD11 HD12 ' A' ' 36' ' ' ILE . 48.8 mt -75.21 -39.85 43.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.127 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.58 -18.14 61.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.266 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.33 24.97 5.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.31 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.631 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.2 t -168.44 152.75 6.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.677 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.533 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.5 tt0 -62.82 -77.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.895 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.561 HG13 HD11 ' A' ' 83' ' ' LEU . 19.5 t -95.73 135.27 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.397 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.565 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.76 125.77 21.23 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.457 HG22 ' HB2' ' A' ' 83' ' ' LEU . 49.3 t -115.41 129.73 71.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.789 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.561 HD12 HD11 ' A' ' 28' ' ' ILE . 23.0 mt -135.45 137.19 50.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.446 -177.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.77 96.91 1.63 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.294 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.508 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 19.5 m-85 -82.51 89.02 6.61 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -107.44 137.71 44.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.473 ' HG2' HD23 ' A' ' 71' ' ' LEU . 90.8 mt-30 -83.83 -5.0 59.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.432 ' O ' HG12 ' A' ' 44' ' ' ILE . 27.0 t70 -155.41 127.71 7.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.529 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.562 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.5 mt -95.34 46.91 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 111.68 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.425 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.8 mt-10 -135.85 5.08 3.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.612 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.809 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.2 pt -88.84 157.39 48.95 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.296 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' HD12 ' A' ' 49' ' ' ILE . 74.6 Cg_exo -52.8 -27.96 36.53 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.914 2.409 . . . . 0.0 112.958 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.809 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.27 -37.21 84.6 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.654 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.2 t -62.21 -56.94 26.4 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.525 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.654 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.8 Cg_exo -58.64 -40.9 69.34 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.758 1.639 . . . . 0.0 111.448 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.888 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.8 mt -61.37 -37.16 77.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.572 ' O ' HG23 ' A' ' 54' ' ' VAL . 37.9 tp -73.46 -53.82 9.74 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -53.1 -23.25 7.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.098 0.475 . . . . 0.0 110.081 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.2 m -83.92 -45.5 13.12 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.467 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.596 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.03 -25.2 65.13 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.8 t -52.33 -48.05 45.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.992 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -77.85 -11.17 59.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.797 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -93.08 -17.91 23.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.235 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.587 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 57.0 m-85 -137.57 62.53 36.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.558 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.63 -42.73 60.43 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.612 2.208 . . . . 0.0 111.708 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.76 -40.49 92.93 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.509 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.587 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.7 t -66.57 143.9 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.631 ' HB2' HG21 ' A' ' 31' ' ' THR . 30.5 t -81.42 97.12 7.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 0.0 110.994 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.472 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.8 p90 -64.82 127.13 30.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.965 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.481 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.09 162.84 28.39 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.029 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.415 HD11 HG13 ' A' ' 47' ' ' VAL . 4.6 tt -160.96 142.36 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.2 t -145.5 154.04 41.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.983 0.421 . . . . 0.0 111.691 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.452 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.4 p -137.52 -4.41 1.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.884 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.42 142.84 56.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.771 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.2 t -64.5 -50.58 66.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.511 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -49.02 -45.45 42.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.658 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 21' ' ' VAL . 77.8 t -70.59 -52.4 29.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.917 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.473 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -59.05 -14.85 10.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.122 0.487 . . . . 0.0 110.135 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.1 m -91.17 -41.38 11.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.394 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -60.97 -40.07 92.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.455 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.415 ' HB2' HG12 ' A' ' 76' ' ' ILE . 64.3 m-85 -90.24 11.82 20.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.576 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.6 m120 55.98 24.17 7.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.494 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.675 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.9 mm -60.83 120.08 5.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.4 p -138.68 52.37 1.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.419 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.27 46.49 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.64 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.605 ' HB2' HG21 ' A' ' 99' ' ' ILE . 28.3 m-80 50.77 42.01 27.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.177 0.513 . . . . 0.0 110.29 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.675 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.3 m -68.07 150.38 48.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.68 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.584 HG12 ' HA2' ' A' ' 37' ' ' GLY . 69.4 mt -116.79 116.94 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.984 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.508 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.4 m -106.64 132.14 52.98 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.652 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -109.08 105.37 14.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.979 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.5 t80 -98.62 121.07 40.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.498 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.532 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.1 mtm180 -102.85 80.71 1.91 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.711 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 6.1 tp -25.11 -58.46 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.533 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.35 -59.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.199 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -97.11 2.9 51.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.045 0.45 . . . . 0.0 110.82 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 52.77 32.58 12.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.817 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 13.0 mm-40 -77.93 156.99 29.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.663 0.268 . . . . 0.0 110.805 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 91' ' ' GLN . 1.1 tm0? -140.18 96.23 3.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.601 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.652 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -88.13 114.47 24.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.804 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -97.65 99.69 11.07 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.605 HD21 HD13 ' A' ' 102' ' ' ILE . 4.4 tt -84.24 77.45 9.97 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.2 mt-10 -78.11 -165.61 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -176.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.72 -49.9 14.25 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.548 -179.515 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -48.5 -15.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.929 0.395 . . . . 0.0 111.291 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 96' ' ' ASP . 22.1 m-20 -127.33 -13.9 5.45 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.498 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.605 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.9 mm -90.67 -37.24 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -49.04 -49.31 41.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.334 . . . . 0.0 111.127 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.0 m -118.0 35.6 4.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.778 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.605 HD13 HD21 ' A' ' 94' ' ' LEU . 8.1 tp -60.78 145.17 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.46 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -138.41 149.22 45.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.48 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.888 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.4 -36.22 14.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.035 0.445 . . . . 0.0 110.377 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.0 m -62.06 -49.62 75.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.286 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -58.18 -60.39 3.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.376 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.709 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -49.19 -55.99 10.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.964 0.411 . . . . 0.0 110.378 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.6 m -58.57 -28.87 65.94 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.726 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.527 ' NH1' HD11 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -72.25 -66.64 0.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.188 179.761 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -43.56 -41.99 4.81 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.065 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.407 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -64.72 -55.94 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.423 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 43.1 tt0 -52.95 -19.13 2.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.294 0.569 . . . . 0.0 110.265 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.527 HD11 ' NH1' ' A' ' 109' ' ' ARG . 1.4 mp -90.11 -38.56 11.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.062 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.486 ' OD1' HG22 ' A' ' 113' ' ' ILE . 28.9 m120 -117.72 27.12 9.23 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.2 p -81.32 50.12 1.39 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.083 0.468 . . . . 0.0 110.152 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.507 HD12 HH12 ' A' ' 85' ' ' ARG . 56.4 mt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.345 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.714 0.292 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.8 p -144.77 139.72 23.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.105 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -107.48 154.85 20.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.449 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 5.7 ttpm? 59.06 95.43 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.938 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.6 p -62.61 146.3 52.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.063 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.6 m -87.41 87.41 7.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.7 t70 62.07 -83.11 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.12 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.79 172.03 45.09 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.603 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.56 -176.75 0.26 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.739 2.293 . . . . 0.0 112.372 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.34 -119.5 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.509 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.25 -72.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.709 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.51 -81.58 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.527 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.531 ' HG3' HG12 ' A' ' 54' ' ' VAL . 9.1 pt20 -155.97 142.57 18.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.632 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.49 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 16.6 pt-20 -134.27 158.56 74.98 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.96 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 38.1 Cg_endo -66.65 145.17 75.01 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.635 2.223 . . . . 0.0 112.564 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 17' ' ' TRP . 11.5 m -62.22 155.78 23.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.911 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.408 ' N ' HG22 ' A' ' 16' ' ' THR . 12.1 m-90 -99.53 86.94 3.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.719 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 24' ' ' ALA . 44.1 mt -83.04 73.83 10.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.047 0.451 . . . . 0.0 110.61 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.0 p -72.19 -0.82 12.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.356 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -143.0 148.26 36.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.917 0.389 . . . . 0.0 111.535 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.594 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 32.8 t -56.77 -50.52 87.52 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.434 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.61 -44.76 38.73 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.939 1.76 . . . . 0.0 111.832 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.33 -36.5 83.89 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.334 0.588 . . . . 0.0 110.183 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.609 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.91 -59.12 4.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.91 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.6 mtp -60.19 -24.98 65.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.095 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -72.57 -52.52 15.18 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.775 0.321 . . . . 0.0 110.558 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.479 ' O ' HG22 ' A' ' 31' ' ' THR . 13.0 m-85 -59.34 -31.41 69.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.519 HD11 HD12 ' A' ' 36' ' ' ILE . 55.3 mt -74.52 -39.37 47.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.175 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.29 -20.77 61.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.147 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.64 28.69 2.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.032 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.635 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.9 t -170.11 152.43 4.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.425 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.551 ' HG3' HG13 ' A' ' 87' ' ' VAL . 26.0 tt0 -66.76 -61.73 1.81 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.526 HG13 HD11 ' A' ' 83' ' ' LEU . 17.2 t -109.33 136.98 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.438 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.506 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.91 127.75 20.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.014 0.435 . . . . 0.0 112.116 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.435 ' C ' HG13 ' A' ' 36' ' ' ILE . 50.6 t -116.46 131.19 69.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.615 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.519 HD12 HD11 ' A' ' 28' ' ' ILE . 22.1 mt -136.45 135.34 49.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -177.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -97.32 98.03 2.06 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.539 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.524 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.9 m-85 -84.43 93.48 8.3 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.0 m-85 -114.3 142.14 46.69 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -89.97 -0.94 57.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' O ' HG12 ' A' ' 44' ' ' ILE . 37.8 t70 -156.26 122.47 5.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.707 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.52 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.1 mt -92.32 46.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.159 0.504 . . . . 0.0 111.293 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.435 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.5 mt-10 -136.91 7.5 2.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.005 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.779 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.7 pt -89.46 158.45 45.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.014 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.519 ' O ' HD12 ' A' ' 49' ' ' ILE . 66.1 Cg_exo -53.32 -26.23 33.97 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.781 2.321 . . . . 0.0 112.896 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.779 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.92 -37.64 88.32 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 44' ' ' ILE . 2.1 t -61.54 -55.66 40.63 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.616 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 36.6 Cg_exo -61.24 -37.82 70.72 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.067 1.845 . . . . 0.0 111.519 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.878 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.5 mt -65.24 -34.86 73.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.014 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.59 ' O ' HG23 ' A' ' 54' ' ' VAL . 45.4 tp -73.27 -52.34 14.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -52.81 -26.31 14.09 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -80.29 -47.59 14.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.7 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.566 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.8 -25.93 63.61 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.136 0.493 . . . . 0.0 109.684 179.6 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.2 t -53.23 -48.35 55.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.967 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.92 -10.06 59.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.635 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -94.1 -18.88 21.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.212 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.608 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 59.9 m-85 -136.82 62.84 43.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.526 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.8 -41.61 68.89 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.748 2.298 . . . . 0.0 111.369 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.61 -39.38 93.25 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.375 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.9 t -68.55 144.33 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.635 ' HB2' HG21 ' A' ' 31' ' ' THR . 39.5 t -81.88 98.07 8.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.075 0.464 . . . . 0.0 111.043 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.5 ' HB3' HG22 ' A' ' 54' ' ' VAL . 5.3 p90 -65.06 125.55 25.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.028 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.03 162.11 28.12 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.998 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.415 HD11 HG13 ' A' ' 47' ' ' VAL . 4.4 tt -161.19 145.49 4.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.0 t -151.02 158.08 43.68 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.173 0.511 . . . . 0.0 111.857 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.462 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.3 p -138.53 -0.61 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.375 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.06 143.85 56.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.779 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.6 t -67.49 -50.95 56.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.437 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 2.4 mp0 -50.77 -42.39 57.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.355 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HA ' HG22 ' A' ' 21' ' ' VAL . 63.6 t -70.91 -53.85 20.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 120.914 0.387 . . . . 0.0 110.731 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 mp -58.8 -15.42 12.24 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.425 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.0 m -90.4 -40.56 11.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.074 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -60.27 -40.13 89.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.386 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -92.56 14.57 16.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 54.0 25.83 5.82 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.638 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.693 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.6 mm -61.43 120.78 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.175 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.3 p -140.69 56.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.075 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.68 45.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.64 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 29.8 m-80 51.29 43.62 29.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.192 0.52 . . . . 0.0 110.539 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.693 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.8 m -70.21 152.79 43.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.544 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.582 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.8 mt -119.11 117.88 55.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.524 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 70.7 m -105.56 133.37 50.42 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.592 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.3 tp -109.89 104.77 13.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.905 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.0 t80 -98.4 124.21 42.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.459 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.516 HH12 HD12 ' A' ' 116' ' ' LEU . 4.9 mtm180 -106.32 83.29 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.85 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 tp -25.48 -59.4 0.07 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.024 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.551 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.75 -67.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 123.505 0.503 . . . . 0.0 112.305 -179.324 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.06 4.96 51.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.935 0.398 . . . . 0.0 111.012 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.8 m120 53.78 29.21 9.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.636 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.469 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.7 mm-40 -74.27 159.89 31.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.682 0.277 . . . . 0.0 110.882 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.1 95.18 2.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.867 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.592 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -84.35 135.73 34.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.414 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -114.07 96.01 5.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.628 HD21 HD13 ' A' ' 102' ' ' ILE . 4.1 tt -79.44 79.38 5.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.451 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.0 mt-10 -82.34 -162.89 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.653 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.587 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 5.1 m-20 -50.62 -39.39 50.17 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.091 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.43 -15.09 0.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.265 0.555 . . . . 0.0 110.112 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.423 ' N ' ' C ' ' A' ' 96' ' ' ASP . 42.9 m-20 -132.11 -13.45 3.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.566 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.587 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 27.7 mm -91.5 -39.41 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -47.52 -42.52 23.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.909 0.385 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.8 t -129.69 44.39 2.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.28 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.628 HD13 HD21 ' A' ' 94' ' ' LEU . 6.7 tp -67.1 144.37 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.584 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.414 ' N ' HG13 ' A' ' 102' ' ' ILE . 9.5 m-20 -136.98 149.04 47.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.35 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.878 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.88 -34.63 9.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.052 0.453 . . . . 0.0 110.408 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.2 m -63.88 -48.02 78.34 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.537 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -59.73 -57.41 13.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.308 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.723 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.7 -54.99 22.21 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.039 0.447 . . . . 0.0 110.064 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.0 m -59.5 -28.67 67.25 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.775 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.511 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -72.07 -67.06 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.142 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -43.05 -43.14 4.2 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.196 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.431 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -63.69 -54.64 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.81 -19.56 6.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.248 0.547 . . . . 0.0 110.301 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.511 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.41 -37.03 9.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.814 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.404 ' O ' HD21 ' A' ' 83' ' ' LEU . 17.2 m120 -122.84 29.86 6.66 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 83.6 p -82.95 47.36 1.21 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.14 0.495 . . . . 0.0 109.846 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.516 HD12 HH12 ' A' ' 85' ' ' ARG . 53.2 mt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.265 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.901 0.381 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.8 p -156.99 142.95 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.165 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -133.6 127.94 34.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -80.55 121.99 26.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.3 p -163.73 156.65 18.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.024 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.5 t -147.93 -4.84 0.48 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.811 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -165.62 131.82 2.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.789 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.93 -87.57 1.71 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.522 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.87 99.34 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.492 2.128 . . . . 0.0 112.371 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.82 75.51 0.2 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.475 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.71 -71.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.664 0.269 . . . . 0.0 110.636 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.43 -81.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.57 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.534 ' HG3' HG12 ' A' ' 54' ' ' VAL . 9.9 pt20 -130.52 159.68 36.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.908 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.9 pt-20 -143.85 157.35 58.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.083 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.466 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 53.6 Cg_endo -70.18 141.14 42.78 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.569 2.179 . . . . 0.0 112.415 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 m -62.33 151.88 35.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.497 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.67 88.8 4.74 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.007 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.606 HD22 ' HA ' ' A' ' 24' ' ' ALA . 44.1 mt -80.73 71.79 7.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.372 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.7 p -69.65 -6.07 28.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.236 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -138.68 147.18 42.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.005 0.431 . . . . 0.0 111.764 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.613 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.2 t -54.66 -49.38 91.66 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.561 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.33 -47.31 22.8 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.985 1.79 . . . . 0.0 112.009 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.12 -34.4 77.54 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.24 0.543 . . . . 0.0 110.281 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.31 -59.48 4.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.207 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.8 mtm -60.67 -26.07 66.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.105 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -70.91 -51.0 28.78 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.771 0.32 . . . . 0.0 110.493 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.412 ' O ' HG22 ' A' ' 31' ' ' THR . 7.9 m-85 -60.64 -31.97 71.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.852 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.528 HD11 HD12 ' A' ' 36' ' ' ILE . 49.7 mt -73.96 -36.52 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.037 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.93 -20.94 59.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.815 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.19 30.98 1.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.579 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.8 t -169.72 151.48 4.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.388 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.644 ' HG3' HG13 ' A' ' 87' ' ' VAL . 31.2 tt0 -72.17 -40.76 67.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.632 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 83' ' ' LEU . 20.5 t -129.7 130.96 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.893 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -135.64 128.67 31.54 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 83' ' ' LEU . 41.2 t -116.5 128.03 73.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.532 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.528 HD12 HD11 ' A' ' 28' ' ' ILE . 26.2 mt -134.02 137.19 52.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.607 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.33 96.29 1.66 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.638 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.0 m-85 -82.68 89.24 6.72 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.0 m-85 -108.98 140.35 42.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -88.43 -1.91 58.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.6 t70 -156.85 124.04 5.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.621 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.7 mt -93.4 47.34 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.152 0.501 . . . . 0.0 111.408 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 37.0 mt-10 -137.07 6.88 2.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.841 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.832 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.4 pt -90.24 156.55 46.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.177 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.516 ' O ' HD12 ' A' ' 49' ' ' ILE . 71.2 Cg_exo -51.5 -26.14 21.15 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.858 2.372 . . . . 0.0 113.255 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.832 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.01 -35.72 82.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.626 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.3 t -64.12 -55.14 34.06 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.66 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.0 Cg_exo -60.93 -37.74 74.72 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.987 1.791 . . . . 0.0 111.321 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.88 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.6 mt -65.58 -36.45 77.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.921 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.626 ' O ' HG23 ' A' ' 54' ' ' VAL . 51.3 tp -71.98 -51.61 21.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -53.89 -24.53 16.38 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.9 t -82.66 -46.63 13.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.641 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.576 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.31 -25.44 64.16 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.403 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.2 t -52.92 -50.01 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.036 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -76.73 -9.53 58.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.76 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.3 mtpp -93.79 -19.28 21.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.121 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.621 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 59.5 m-85 -135.66 62.9 50.92 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.511 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.42 -40.42 71.27 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.724 2.283 . . . . 0.0 111.733 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.29 -41.51 98.39 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.539 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.4 t -65.56 147.06 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.579 ' CB ' HG21 ' A' ' 31' ' ' THR . 36.0 t -84.27 96.75 9.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.997 0.427 . . . . 0.0 110.839 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.466 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.2 p90 -65.24 121.83 15.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.216 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.458 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -141.37 163.32 26.8 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.118 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -161.68 143.3 3.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.5 t -146.97 157.81 43.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.139 0.495 . . . . 0.0 111.753 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.461 HG21 ' HG ' ' A' ' 42' ' ' LEU . 76.8 p -140.67 3.53 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.63 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -74.74 142.36 44.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.593 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.3 t -64.31 -49.05 73.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.45 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -50.66 -45.3 57.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.494 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.502 ' HA ' HG22 ' A' ' 21' ' ' VAL . 74.3 t -70.15 -53.21 24.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.86 0.362 . . . . 0.0 110.772 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.55 -15.04 9.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.25 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.4 m -91.72 -41.28 10.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.457 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -61.57 -36.23 80.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.579 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -94.2 9.76 36.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.947 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.0 t30 60.28 20.39 9.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.667 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.701 HG23 ' HB ' ' A' ' 80' ' ' THR . 36.7 mm -56.88 123.21 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.097 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.3 p -143.37 60.5 1.4 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.26 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.59 45.9 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.633 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 29.8 m-80 51.41 43.38 29.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.181 0.515 . . . . 0.0 110.403 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.701 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.7 m -69.55 150.63 46.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.716 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.607 HG12 ' HA2' ' A' ' 37' ' ' GLY . 57.3 mt -117.23 118.28 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.076 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.4 m -107.94 131.42 54.56 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.571 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.1 tp -107.54 103.47 12.8 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.622 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.3 t80 -97.73 119.27 36.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.872 0.368 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.511 HH12 HD12 ' A' ' 116' ' ' LEU . 4.3 mtm180 -101.44 98.41 8.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.028 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.0 tp -43.28 -52.38 5.77 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.907 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.644 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.59 -62.18 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.548 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.427 ' HB2' HH21 ' A' ' 85' ' ' ARG . 6.2 m-20 -99.3 9.5 43.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.426 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 85' ' ' ARG . 85.7 m-20 50.26 32.75 6.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.747 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 11.7 mm-40 -78.23 162.98 26.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.718 0.294 . . . . 0.0 111.006 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.96 98.06 2.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.66 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.571 HD23 ' HG ' ' A' ' 83' ' ' LEU . 1.7 mm? -88.14 123.85 33.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.664 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -103.21 98.12 8.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 102' ' ' ILE . 4.7 tt -82.05 77.0 8.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.2 mt-10 -78.04 -165.53 0.67 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.5 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.5 OUTLIER -45.56 -52.43 10.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.279 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -46.01 -18.33 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.874 0.369 . . . . 0.0 111.198 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 96' ' ' ASP . 14.8 m-20 -124.78 -13.94 6.84 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.348 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.576 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.1 mm -90.72 -42.39 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -49.74 -33.41 16.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.9 t -129.58 37.81 3.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.492 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.541 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.0 tp -66.61 143.66 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.541 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -138.59 148.5 44.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.32 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.88 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.13 -36.75 8.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 110.349 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 100.0 m -62.43 -47.12 85.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.423 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -61.3 -58.44 8.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.4 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.773 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.83 -55.35 17.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.946 0.403 . . . . 0.0 110.169 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.5 m -58.71 -31.23 68.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.975 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.552 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.1 tmt_? -70.57 -66.28 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.267 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -43.29 -43.01 4.7 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.331 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.45 HG12 HG21 ' A' ' 35' ' ' VAL . 96.7 mt -63.1 -55.01 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -53.84 -22.26 9.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.374 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.552 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -85.27 -38.59 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.889 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.502 ' OD1' HG22 ' A' ' 113' ' ' ILE . 30.8 m120 -118.29 27.73 8.78 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.4 p -80.82 46.18 0.87 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.026 0.441 . . . . 0.0 110.278 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.511 HD12 HH12 ' A' ' 85' ' ' ARG . 48.4 mt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.138 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.873 0.368 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.499 HG23 ' HG3' ' A' ' 3' ' ' GLU . 24.3 m -103.32 -15.82 7.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.09 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.499 ' HG3' HG23 ' A' ' 2' ' ' VAL . 40.9 mt-10 -137.53 -66.32 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.762 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm 64.14 144.31 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.242 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.2 t 61.98 176.09 0.13 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.161 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.4 t -66.24 -71.91 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -145.14 147.37 32.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.851 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.91 -83.87 0.05 OUTLIER Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.57 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.17 118.15 4.98 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.543 2.162 . . . . 0.0 112.388 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.73 162.45 10.83 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.547 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.95 -72.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.709 0.29 . . . . 0.0 110.618 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.1 106.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.75 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.546 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.5 pt20 -59.5 165.85 2.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.099 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.5 pt-20 -133.21 157.9 77.09 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.761 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 31.5 Cg_endo -64.67 152.0 83.54 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.642 2.228 . . . . 0.0 112.778 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 17' ' ' TRP . 39.8 m -68.34 154.24 42.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.605 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.41 ' N ' HG22 ' A' ' 16' ' ' THR . 92.8 m95 -99.44 92.2 5.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.898 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.606 HD22 ' HA ' ' A' ' 24' ' ' ALA . 55.8 mt -91.41 70.98 6.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.702 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.2 p -72.6 -1.4 15.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.908 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -140.71 147.03 38.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 111.782 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.2 t -56.22 -50.21 88.79 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.567 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.1 Cg_endo -57.98 -45.29 33.17 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.924 1.75 . . . . 0.0 111.802 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.92 -34.11 77.23 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.25 0.547 . . . . 0.0 110.408 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.55 -58.8 5.37 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.947 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.6 mtp -60.14 -27.53 67.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.194 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 27.9 mt-10 -72.08 -51.04 23.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.707 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.498 ' O ' HG22 ' A' ' 31' ' ' THR . 6.0 m-85 -59.5 -32.76 70.58 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.544 HD11 HD12 ' A' ' 36' ' ' ILE . 42.4 mt -74.79 -38.85 45.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.97 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.52 -18.91 61.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.215 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.49 27.03 3.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.311 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.722 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.4 t -171.86 155.2 3.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.491 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.572 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.3 tt0 -64.79 -73.81 0.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.531 HG13 HD11 ' A' ' 83' ' ' LEU . 21.1 t -99.23 139.1 21.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.568 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.02 127.96 19.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 111' ' ' ILE . 49.9 t -116.68 129.23 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.59 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.544 HD12 HD11 ' A' ' 28' ' ' ILE . 20.7 mt -135.02 137.87 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.466 -177.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.11 97.17 1.63 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.593 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.479 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 42.0 m-85 -83.13 89.92 7.0 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -108.28 143.13 37.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.351 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -89.87 -6.6 55.65 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.507 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.6 t70 -151.62 119.81 6.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.584 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.493 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.9 mt -88.69 45.39 1.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.218 0.532 . . . . 0.0 111.127 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 10.2 mm-40 -136.33 12.04 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.248 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.823 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.1 pt -97.04 157.8 34.4 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.426 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.502 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 79.9 Cg_exo -51.11 -30.8 33.26 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.723 2.282 . . . . 0.0 112.886 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.823 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -59.59 -38.51 81.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.401 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.669 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.3 t -61.02 -58.02 22.18 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.569 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.669 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 35.8 Cg_exo -58.31 -40.25 77.23 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.784 1.656 . . . . 0.0 111.435 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.979 HG23 ' HA ' ' A' ' 104' ' ' ALA . 9.8 mt -61.7 -35.96 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 54' ' ' VAL . 46.3 tp -73.89 -53.58 9.85 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -54.34 -24.09 17.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.007 0.432 . . . . 0.0 109.915 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.5 t -83.22 -43.78 15.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.558 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.59 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.85 -25.66 67.66 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.3 t -53.1 -48.53 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.095 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -75.24 -11.65 60.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.58 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -93.44 -18.49 22.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.27 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.622 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 44.9 m-85 -135.99 63.08 49.61 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.643 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.94 -44.21 50.47 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.731 2.287 . . . . 0.0 111.654 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.6 -41.69 89.67 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.473 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 14.3 t -65.64 144.7 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.722 ' HB2' HG21 ' A' ' 31' ' ' THR . 36.2 t -82.06 96.26 7.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.02 0.438 . . . . 0.0 111.012 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.485 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.6 p90 -62.6 129.3 39.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.735 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.522 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -148.13 161.36 28.58 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.058 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.438 HD11 HG13 ' A' ' 47' ' ' VAL . 5.2 tt -160.84 143.06 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.479 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 32.4 t -150.46 158.25 43.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 111.793 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.46 HG21 ' HG ' ' A' ' 42' ' ' LEU . 82.7 p -138.69 -2.72 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.642 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.402 ' O ' HD13 ' A' ' 71' ' ' LEU . 16.6 t70 -62.64 143.12 57.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.662 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.0 m -67.29 -52.57 39.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.23 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 2.6 mp0 -49.83 -40.71 42.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.409 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.523 ' HA ' HG22 ' A' ' 21' ' ' VAL . 54.9 t -72.54 -55.08 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 67' ' ' ASP . 6.3 mp -57.98 -14.29 6.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.248 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.3 m -92.41 -40.49 10.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.214 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -61.84 -35.04 77.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.224 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.43 ' HB2' HG12 ' A' ' 76' ' ' ILE . 86.9 m-85 -95.12 9.68 38.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.695 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t30 58.6 24.28 11.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.454 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.719 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.2 mm -61.28 124.19 15.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.3 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.1 p -143.68 59.49 1.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.195 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.78 44.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.706 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.632 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 26.3 m-80 52.31 44.63 29.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.188 0.518 . . . . 0.0 110.639 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.719 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.3 m -69.55 152.14 45.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.63 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.571 HG21 HD21 ' A' ' 107' ' ' LEU . 60.5 mt -118.46 115.58 48.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.07 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 77.4 m -103.4 133.25 48.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.663 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -108.71 101.54 10.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.853 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.2 t80 -95.31 121.86 37.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.568 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.478 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 4.6 mtm180 -106.6 82.04 1.67 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.908 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.422 ' HG ' ' N ' ' A' ' 87' ' ' VAL . 4.8 tp -25.46 -61.78 0.07 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.572 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.76 -54.84 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -103.84 3.97 34.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.92 0.391 . . . . 0.0 111.21 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 51.57 31.31 7.5 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.57 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 9.7 mm-40 -77.83 157.62 29.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.491 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.13 95.89 2.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.997 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.663 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -84.31 112.3 20.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.586 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -95.8 96.05 8.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.589 HD21 HD13 ' A' ' 102' ' ' ILE . 3.8 tt -81.73 78.93 8.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.5 mt-10 -79.8 -165.01 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.527 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.6 t70 -50.66 -37.41 40.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.988 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -55.25 -14.79 1.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.204 0.526 . . . . 0.0 110.428 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -130.74 -13.94 3.64 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.546 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.571 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 23.8 mm -89.5 -29.01 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.709 0.29 . . . . 0.0 111.413 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -52.93 -52.34 58.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.811 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.2 m -117.51 37.25 3.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.488 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.589 HD13 HD21 ' A' ' 94' ' ' LEU . 7.8 tp -61.36 147.56 10.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.596 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.449 ' HA ' ' CD1' ' A' ' 49' ' ' ILE . 4.3 t70 -140.83 161.08 38.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.621 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.979 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -58.95 -35.04 72.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.091 0.472 . . . . 0.0 110.17 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 94.0 m -65.34 -46.71 79.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.407 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -59.96 -57.15 14.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.983 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.78 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.81 -54.87 24.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.117 0.484 . . . . 0.0 110.109 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.7 m -59.18 -29.3 67.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.704 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.483 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.6 tmt_? -71.97 -66.21 0.67 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.213 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -42.86 -43.85 4.24 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.154 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.475 HG12 HG21 ' A' ' 35' ' ' VAL . 82.8 mt -63.06 -55.05 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.465 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -54.76 -17.93 4.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.14 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.483 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.96 -35.26 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.923 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.442 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.4 m120 -125.44 30.31 5.81 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 95.5 p -84.03 51.49 2.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.066 0.46 . . . . 0.0 110.25 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.448 HD12 ' NH1' ' A' ' 85' ' ' ARG . 82.0 mt . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.421 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.764 0.316 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p -81.75 -23.68 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 110.946 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.02 -46.14 78.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.959 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -137.35 118.74 14.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.842 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.0 p -143.7 136.99 27.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.9 m -127.56 -38.98 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -116.48 -64.16 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.73 -173.75 45.56 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.437 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.95 115.58 2.23 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.688 2.259 . . . . 0.0 112.467 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.36 164.41 40.25 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.681 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.02 -63.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.75 0.309 . . . . 0.0 110.509 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.21 -82.08 0.02 OUTLIER 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.712 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.434 ' HG3' HG12 ' A' ' 54' ' ' VAL . 29.8 pt20 -140.16 147.19 39.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.117 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.504 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.0 pt-20 -131.74 159.36 72.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.638 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.1 Cg_endo -65.81 143.09 72.33 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.574 2.182 . . . . 0.0 112.672 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.5 m -63.53 153.22 36.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.676 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -96.97 93.0 6.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.012 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.603 HD13 ' HA ' ' A' ' 24' ' ' ALA . 39.4 mt -87.34 70.84 10.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.128 0.49 . . . . 0.0 110.234 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.4 p -69.9 -3.12 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.161 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -139.01 147.43 42.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.909 0.385 . . . . 0.0 111.65 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 42.1 t -56.43 -49.95 90.5 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.485 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.64 -46.0 29.87 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.974 1.783 . . . . 0.0 111.867 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.85 81.64 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.178 0.513 . . . . 0.0 110.112 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -62.54 -60.13 3.96 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.002 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 44.7 mtm -60.36 -25.82 66.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.278 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -70.92 -51.66 24.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.704 0.288 . . . . 0.0 110.418 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.407 ' O ' HG22 ' A' ' 31' ' ' THR . 13.9 m-85 -60.6 -30.79 70.04 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.526 HD11 HD12 ' A' ' 36' ' ' ILE . 53.2 mt -74.38 -37.52 45.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.023 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.93 -19.67 60.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.16 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.53 30.96 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.079 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.694 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.2 t -172.35 152.97 2.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.426 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.511 ' HG3' HG13 ' A' ' 87' ' ' VAL . 26.8 tt0 -68.88 -47.07 66.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.77 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.494 HG13 HD11 ' A' ' 83' ' ' LEU . 18.5 t -122.22 139.48 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.432 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.512 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -143.13 125.95 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.529 HG21 HG12 ' A' ' 111' ' ' ILE . 49.5 t -114.39 128.77 71.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.424 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 28' ' ' ILE . 29.2 mt -134.88 137.57 50.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.421 -177.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.23 96.41 1.6 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.587 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.449 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.7 m-85 -82.89 91.27 7.08 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -111.03 144.35 40.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.453 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.453 ' HG2' HD23 ' A' ' 71' ' ' LEU . 45.8 mt-30 -92.98 -2.55 55.66 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.484 ' O ' HG12 ' A' ' 44' ' ' ILE . 28.6 t70 -155.97 117.13 3.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.582 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.484 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.2 mt -87.31 45.5 1.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.116 0.484 . . . . 0.0 111.604 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 38.6 mt-10 -134.59 10.76 3.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.037 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.688 HG13 HG23 ' A' ' 47' ' ' VAL . 7.2 pt -92.31 161.33 33.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.293 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.498 ' O ' HD12 ' A' ' 49' ' ' ILE . 50.1 Cg_exo -56.81 -26.52 66.97 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.739 2.293 . . . . 0.0 112.369 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.673 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.67 -37.78 88.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.482 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.688 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -61.23 -56.66 32.04 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.642 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.87 -38.61 78.4 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.864 1.709 . . . . 0.0 111.423 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.864 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.6 mt -64.12 -35.09 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.869 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 54' ' ' VAL . 49.7 tp -74.03 -52.47 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -55.53 -23.2 25.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.036 0.446 . . . . 0.0 109.853 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.6 t -83.78 -44.73 14.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.445 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.614 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.6 -25.77 67.55 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -52.79 -49.5 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.036 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.408 ' HA ' HE21 ' A' ' 13' ' ' GLN . 8.3 mt-30 -74.41 -11.67 60.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.7 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -93.38 -19.04 21.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.305 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.555 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 54.8 m-85 -137.16 61.99 36.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.399 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.73 -42.16 68.46 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.684 2.256 . . . . 0.0 111.615 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.86 -39.84 88.84 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.212 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.555 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.5 t -67.71 143.37 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.694 ' HB2' HG21 ' A' ' 31' ' ' THR . 47.1 t -80.14 98.37 7.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.022 0.439 . . . . 0.0 110.967 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.51 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.3 p90 -65.99 124.73 23.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.968 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.47 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -143.71 162.01 27.73 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.171 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -161.8 142.73 3.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.449 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 41.0 t -149.04 156.51 42.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.194 0.521 . . . . 0.0 111.809 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 68.2 p -137.15 3.05 2.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.481 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.413 ' O ' HD13 ' A' ' 71' ' ' LEU . 17.7 t70 -69.92 142.97 52.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.685 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.9 m -67.34 -50.92 58.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.351 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -51.11 -40.94 59.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.364 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.531 ' HA ' HG22 ' A' ' 21' ' ' VAL . 53.7 t -72.48 -54.68 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.358 . . . . 0.0 110.539 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -58.41 -14.64 8.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.099 0.476 . . . . 0.0 110.255 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.5 m -91.78 -40.35 11.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.239 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -62.08 -34.36 76.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.267 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.415 ' HB2' HG12 ' A' ' 76' ' ' ILE . 84.9 m-85 -96.63 10.88 37.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.72 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 56.01 26.65 10.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.867 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.716 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.1 mm -62.7 122.19 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.4 p -141.8 59.16 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 111.259 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.52 44.65 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.521 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.609 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 23.2 m-80 51.48 44.18 29.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.141 0.496 . . . . 0.0 110.635 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.716 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.0 m -69.72 151.67 45.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.836 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.565 HG12 ' HA2' ' A' ' 37' ' ' GLY . 55.8 mt -117.6 116.74 52.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.813 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 74.8 m -104.28 132.79 50.14 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.643 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -109.63 101.98 10.85 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.866 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -96.38 122.78 39.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.538 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.479 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 4.0 mtm180 -106.31 86.37 2.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.857 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.1 tp -27.05 -60.54 0.09 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.511 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.91 -73.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 123.434 0.459 . . . . 0.0 112.149 -179.273 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -83.51 2.89 34.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.014 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.9 m120 53.75 30.07 10.6 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.42 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.479 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 8.0 mm-40 -74.46 159.25 32.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.805 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -144.16 93.31 2.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.823 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.643 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -80.91 141.83 34.16 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -122.85 92.81 3.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.643 HD21 HD13 ' A' ' 102' ' ' ILE . 4.0 tt -76.99 77.43 3.54 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.444 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.2 mt-10 -79.08 -164.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.508 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 23.7 t70 -51.66 -36.38 46.08 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.915 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.68 -14.65 3.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.282 0.563 . . . . 0.0 110.244 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -130.65 -13.83 3.7 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.694 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.578 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.1 mm -89.94 -30.0 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.727 0.298 . . . . 0.0 111.294 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -52.12 -48.52 64.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.746 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.9 t -123.78 42.08 3.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.414 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.643 HD13 HD21 ' A' ' 94' ' ' LEU . 7.9 tp -63.46 143.14 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.545 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -136.03 150.56 49.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.487 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.864 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.07 -33.85 12.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.034 0.445 . . . . 0.0 110.26 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.3 m -65.35 -47.31 76.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.438 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -60.05 -56.34 22.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.149 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.793 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -52.36 -57.14 10.72 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.959 0.409 . . . . 0.0 109.905 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 61.4 m -56.87 -28.91 62.42 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.869 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.474 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.7 tmt_? -71.04 -66.88 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.954 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -42.3 -41.17 2.7 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.156 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.529 HG12 HG21 ' A' ' 35' ' ' VAL . 76.8 mt -64.91 -55.77 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -54.24 -18.01 3.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.253 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.474 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.5 mp -92.56 -34.58 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.12 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.486 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.0 m120 -128.31 32.69 4.83 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 93.8 p -85.17 41.84 0.9 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.164 0.507 . . . . 0.0 109.918 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 85' ' ' ARG . 49.9 mt . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.527 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.402 ' HG3' HG13 ' A' ' 2' ' ' VAL . 10.2 pt-20 . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.402 HG13 ' HG3' ' A' ' 1' ' ' GLU . 27.7 m -118.17 20.83 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.167 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 58.55 34.2 23.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.153 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt 60.51 -85.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.284 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.9 p 47.48 80.05 0.06 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.27 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.1 m -99.37 31.12 3.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.964 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.44 -47.46 17.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.39 -104.57 0.26 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.603 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.11 -67.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.489 2.126 . . . . 0.0 112.315 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.13 81.01 0.13 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.504 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' A' ' 55' ' ' GLN . . . -164.42 -67.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.345 . . . . 0.0 110.647 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.527 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . . . 59.42 94.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.454 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.522 ' HG3' ' CG1' ' A' ' 54' ' ' VAL . 7.0 pt20 -170.48 166.74 8.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.627 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 -114.63 158.5 40.11 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.249 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.48 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.7 Cg_endo -68.23 155.38 69.58 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.768 2.312 . . . . 0.0 112.741 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.7 m -70.71 151.61 44.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.416 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -96.79 86.36 4.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.755 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.0 mt -83.34 71.52 10.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.619 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 76.8 p -69.21 -6.2 27.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.288 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -140.05 146.97 39.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.993 0.425 . . . . 0.0 111.791 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.615 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.5 t -54.34 -49.74 88.82 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.632 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.8 Cg_endo -56.58 -46.46 29.81 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.984 1.789 . . . . 0.0 112.082 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.23 -34.47 78.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.173 0.511 . . . . 0.0 110.288 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.61 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.88 -58.88 5.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.081 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 61.3 mtp -61.39 -27.16 68.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.189 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.5 mt-10 -70.64 -49.89 42.7 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.772 0.32 . . . . 0.0 110.386 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 31' ' ' THR . 5.9 m-85 -60.5 -33.14 72.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.846 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.527 HD11 ' CD1' ' A' ' 36' ' ' ILE . 46.0 mt -73.86 -37.66 48.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.127 178.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.66 -20.75 60.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.128 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.1 29.77 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.059 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.638 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.9 t -171.25 150.86 3.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.333 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.527 ' HG3' HG13 ' A' ' 87' ' ' VAL . 25.1 tt0 -64.58 -63.32 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.91 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.484 HG13 HD11 ' A' ' 83' ' ' LEU . 21.4 t -108.04 141.9 22.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.592 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -144.08 126.52 15.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.021 0.439 . . . . 0.0 112.109 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.468 HG21 HG12 ' A' ' 111' ' ' ILE . 47.8 t -115.47 127.53 73.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.622 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.527 ' CD1' HD11 ' A' ' 28' ' ' ILE . 26.7 mt -133.71 136.4 54.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.728 -177.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.498 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.71 97.69 1.82 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.347 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.443 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 38.8 m-85 -83.49 89.67 7.11 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -108.35 141.3 40.36 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.448 ' HG2' HD23 ' A' ' 71' ' ' LEU . 77.0 mt-30 -89.62 -2.69 58.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.522 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.9 t70 -155.37 117.51 4.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.581 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.512 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.3 mt -86.99 43.67 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.054 0.454 . . . . 0.0 111.343 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.1 mt-10 -134.61 13.14 3.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.121 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.825 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.0 pt -96.92 157.62 34.78 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.266 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.473 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 76.4 Cg_exo -51.6 -28.67 29.82 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.834 2.356 . . . . 0.0 112.888 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.825 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -61.95 -37.58 85.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.668 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.7 t -61.33 -56.77 30.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.606 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.668 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 39.5 Cg_exo -57.52 -42.4 61.37 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 121.742 1.628 . . . . 0.0 111.125 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.908 HG23 ' HA ' ' A' ' 104' ' ' ALA . 11.8 mt -60.0 -37.71 73.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.215 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.596 ' O ' HG23 ' A' ' 54' ' ' VAL . 47.2 tp -73.32 -51.71 16.53 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -54.8 -24.37 22.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.087 0.47 . . . . 0.0 109.858 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.3 m -83.84 -44.59 14.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.585 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.591 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.68 -25.91 66.72 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.372 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 50' ' ' LEU . 45.2 t -51.99 -47.0 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.898 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.527 ' NE2' ' HA ' ' A' ' 12' ' ' ALA . 30.7 mt-30 -78.89 -13.47 59.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.712 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -90.89 -17.09 27.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.308 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.61 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 44.0 m-85 -137.95 62.93 35.89 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.558 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.18 -44.4 49.21 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.703 2.269 . . . . 0.0 111.754 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.86 -37.16 76.46 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.515 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.61 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 17.2 t -70.18 143.6 14.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.638 ' HB2' HG21 ' A' ' 31' ' ' THR . 45.6 t -81.37 97.94 7.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 110.886 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.481 ' HB3' HG22 ' A' ' 54' ' ' VAL . 4.9 p90 -64.18 129.2 39.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.828 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.538 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.51 161.06 28.46 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.128 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -161.26 145.69 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.407 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 40.1 t -154.06 159.53 41.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.069 0.461 . . . . 0.0 111.727 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.481 HG21 ' HG ' ' A' ' 42' ' ' LEU . 58.3 p -138.84 -7.66 1.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.693 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.06 141.45 55.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.706 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.0 p -64.39 -50.11 68.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.38 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -49.81 -44.46 49.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.543 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.539 ' HA ' HG22 ' A' ' 21' ' ' VAL . 70.6 t -70.05 -54.61 18.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.956 0.408 . . . . 0.0 110.674 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.448 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.1 mp -58.38 -14.42 7.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.437 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.1 m -91.3 -42.01 10.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.339 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -60.26 -37.38 80.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.367 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.424 ' HB2' HG12 ' A' ' 76' ' ' ILE . 83.0 m-85 -93.72 12.49 25.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.979 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 55.64 26.77 9.63 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.674 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.692 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.0 mm -64.16 123.5 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.174 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.7 p -142.16 58.35 1.47 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.286 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.42 ' HA3' ' OD1' ' A' ' 96' ' ' ASP . . . 152.7 44.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.947 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 27.4 m-80 52.61 42.53 31.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.244 0.545 . . . . 0.0 110.492 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.692 ' HB ' HG23 ' A' ' 76' ' ' ILE . 90.1 m -68.83 151.34 46.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.43 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.542 HG21 HD21 ' A' ' 107' ' ' LEU . 62.2 mt -117.13 116.76 53.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.199 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.443 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 74.2 m -105.45 133.83 49.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.611 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.2 tp -109.59 103.39 12.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.971 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.4 t80 -96.47 124.44 40.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.693 0.283 . . . . 0.0 110.749 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.466 ' NH1' HD12 ' A' ' 116' ' ' LEU . 3.5 mtm180 -107.95 85.52 2.13 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.11 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 tp -27.13 -60.57 0.09 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.527 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -35.84 -68.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 123.574 0.546 . . . . 0.0 112.289 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -89.77 3.65 52.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.165 0.507 . . . . 0.0 110.715 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.4 t30 51.85 37.37 20.48 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.986 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 11.0 mm-40 -81.84 159.06 23.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.563 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -140.9 90.83 2.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.667 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.611 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.8 mm? -77.75 141.87 39.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.61 116.84 26.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.253 0.549 . . . . 0.0 112.023 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.626 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -104.32 77.94 1.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -80.61 -164.27 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.827 -177.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.621 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 7.2 m-20 -49.74 -41.1 43.05 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.294 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -52.17 -15.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.256 0.55 . . . . 0.0 110.143 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.417 ' N ' ' C ' ' A' ' 96' ' ' ASP . 36.2 m-20 -130.86 -13.38 3.64 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.321 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.621 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 26.8 mm -90.96 -42.13 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.488 ' HG3' ' HB3' ' A' ' 96' ' ' ASP . 43.4 mt-10 -48.49 -37.96 18.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.936 0.398 . . . . 0.0 111.055 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.5 p -130.43 45.16 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.375 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.626 HD13 HD21 ' A' ' 94' ' ' LEU . 8.6 tp -71.95 145.17 12.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.785 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -138.61 149.4 45.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.649 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.908 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.0 -36.47 12.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.018 0.437 . . . . 0.0 110.609 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.4 m -61.53 -48.61 80.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.202 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 102' ' ' ILE . 28.9 mtpp -59.05 -60.68 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.149 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.779 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.41 -55.93 9.53 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.953 0.406 . . . . 0.0 110.315 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.8 m -58.08 -30.38 66.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.787 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.502 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.2 tmt_? -71.03 -65.91 0.68 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.209 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -43.17 -44.06 4.93 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.921 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.468 HG12 HG21 ' A' ' 35' ' ' VAL . 96.4 mt -62.61 -56.41 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.445 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.86 -18.39 3.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.316 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.502 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.95 -37.25 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.925 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -123.64 29.01 6.72 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 98.2 p -83.04 51.6 1.98 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.217 0.532 . . . . 0.0 109.915 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.466 HD12 ' NH1' ' A' ' 85' ' ' ARG . 68.1 mt . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.397 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.449 ' HG3' HG13 ' A' ' 2' ' ' VAL . 11.2 pt-20 . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.721 0.296 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.449 HG13 ' HG3' ' A' ' 1' ' ' GLU . 14.8 m -110.65 11.66 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.371 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -89.04 -59.67 2.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.503 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -128.25 21.8 6.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.612 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.2 m 59.4 33.84 22.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.852 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.4 m -84.94 138.42 32.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -138.96 -27.99 0.81 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.961 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.46 -170.86 45.95 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.716 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -52.0 106.32 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.675 2.25 . . . . 0.0 112.491 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.76 -171.29 35.94 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.64 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 55' ' ' GLN . . . -170.85 -61.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 110.516 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.84 93.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.519 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.471 ' HG3' ' CG1' ' A' ' 54' ' ' VAL . 5.3 pt20 -171.44 165.52 6.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.554 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.474 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 -116.03 157.71 44.32 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-O 120.779 0.323 . . . . 0.0 111.339 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 31.8 Cg_endo -66.0 152.79 80.44 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.967 2.444 . . . . 0.0 112.794 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.44 HG22 ' N ' ' A' ' 17' ' ' TRP . 18.8 m -69.36 157.16 37.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.825 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.44 ' N ' HG22 ' A' ' 16' ' ' THR . 8.4 m-90 -99.52 92.91 5.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.962 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.0 mt -91.62 72.69 5.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.359 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 p -71.24 -5.38 31.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.334 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -137.46 147.4 45.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.935 0.398 . . . . 0.0 111.72 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.598 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 48.9 t -56.05 -50.05 89.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.568 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.8 Cg_endo -57.91 -45.4 32.74 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.896 1.731 . . . . 0.0 112.027 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.52 -36.08 82.59 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.259 0.552 . . . . 0.0 110.439 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.608 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.82 -59.32 4.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.952 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.4 mtm -60.05 -25.45 65.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.076 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -72.12 -51.46 21.34 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.39 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 31' ' ' THR . 9.0 m-85 -59.75 -30.45 68.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.555 HD11 HD12 ' A' ' 36' ' ' ILE . 49.3 mt -75.78 -40.43 39.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.242 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.51 -21.47 61.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.243 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.76 27.32 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.292 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.677 HG21 ' HB2' ' A' ' 61' ' ' SER . 7.7 t -170.86 155.66 4.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.578 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.462 ' HG3' HG13 ' A' ' 87' ' ' VAL . 25.5 tt0 -68.08 -62.31 1.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.51 HG13 HD11 ' A' ' 83' ' ' LEU . 16.6 t -108.56 137.78 38.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.715 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.13 127.49 18.8 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.468 HG21 HG12 ' A' ' 111' ' ' ILE . 47.6 t -116.39 130.06 71.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.7 178.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.555 HD12 HD11 ' A' ' 28' ' ' ILE . 25.7 mt -136.11 136.91 49.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.597 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.76 99.51 2.08 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.476 -0.783 . . . . 0.0 112.586 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.519 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.6 m-85 -86.07 92.72 8.8 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -112.29 142.01 45.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.47 ' HG2' HD23 ' A' ' 71' ' ' LEU . 46.6 mt-30 -90.61 -0.78 57.8 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 44' ' ' ILE . 30.1 t70 -156.51 121.17 4.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.453 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.535 ' HA ' HG21 ' A' ' 47' ' ' VAL . 96.8 mt -92.13 46.49 1.27 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.057 0.456 . . . . 0.0 111.554 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 39.9 mt-10 -136.24 7.21 3.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.952 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.797 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.0 pt -89.27 157.07 48.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.164 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.501 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.7 Cg_exo -51.72 -27.02 25.05 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.828 2.352 . . . . 0.0 113.034 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.797 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.75 -37.38 87.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.668 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -62.0 -55.96 36.16 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 121.044 -0.263 . . . . 0.0 111.707 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.644 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -60.12 -37.93 80.49 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.103 1.868 . . . . 0.0 111.486 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.88 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.7 mt -65.31 -35.82 76.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.18 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.585 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.4 tp -73.42 -50.45 21.69 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -54.52 -24.68 21.73 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -82.4 -46.68 13.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.798 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.581 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.15 -26.0 64.37 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 50' ' ' LEU . 48.6 t -52.72 -49.11 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.213 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 31.3 mt-30 -77.89 -9.01 58.85 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.571 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.3 mtpp -94.7 -18.92 20.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.235 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.606 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 54.3 m-85 -137.57 63.19 39.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.36 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.13 -41.32 72.91 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.713 2.275 . . . . 0.0 111.575 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.43 -42.72 95.91 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.283 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.3 t -64.87 142.94 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.677 ' HB2' HG21 ' A' ' 31' ' ' THR . 25.2 t -80.37 96.44 6.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.13 0.49 . . . . 0.0 110.943 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.52 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.1 p90 -65.97 125.87 26.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.912 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.55 163.03 28.26 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.983 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -160.02 141.9 4.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.7 t -145.36 158.87 43.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.117 0.484 . . . . 0.0 111.594 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 39' ' ' PHE . 69.0 p -141.37 -6.2 1.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.823 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.71 142.21 58.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.686 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.0 t -63.35 -48.45 77.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.665 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -49.7 -47.18 50.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.577 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.5 t -69.6 -52.66 30.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.779 0.323 . . . . 0.0 110.85 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.47 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.38 -14.71 8.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.084 0.469 . . . . 0.0 110.304 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.5 m -91.0 -42.48 10.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.396 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -60.21 -38.53 83.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.469 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -91.64 9.7 31.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.7 t30 58.82 21.88 9.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.397 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.668 HD12 ' HB ' ' A' ' 80' ' ' THR . 36.0 mm -57.78 117.91 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.047 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.2 p -137.34 48.68 2.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.467 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 162.69 48.1 0.02 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.426 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 24.2 m-80 49.22 42.38 21.52 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.321 0.582 . . . . 0.0 110.313 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.668 ' HB ' HD12 ' A' ' 76' ' ' ILE . 92.8 m -68.15 152.41 45.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.687 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.597 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.3 mt -119.36 118.82 58.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.979 178.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.519 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 79.7 m -106.97 133.11 52.12 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.663 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -109.46 103.44 12.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.8 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.5 t80 -97.51 123.44 41.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.763 0.316 . . . . 0.0 110.713 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.463 ' NH1' HD12 ' A' ' 116' ' ' LEU . 4.1 mtm180 -106.62 84.2 1.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.741 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 85' ' ' ARG . 5.9 tp -24.96 -60.33 0.06 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.95 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.462 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.16 -73.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 O-C-N 123.488 0.493 . . . . 0.0 112.255 -179.277 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -84.13 0.85 46.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.988 0.423 . . . . 0.0 111.053 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.9 m120 54.0 36.68 25.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.566 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 13.2 mm-40 -82.78 158.14 22.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.736 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.4 96.49 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.632 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.663 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -85.15 114.17 22.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.817 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.72 100.41 11.79 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -85.24 76.96 10.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.413 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.2 mt-10 -77.49 -165.66 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.485 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.91 -51.63 12.88 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.383 -179.363 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -47.49 -17.35 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 96' ' ' ASP . 14.8 m-20 -124.79 -14.16 6.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.506 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.577 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.8 mm -90.11 -38.37 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -49.05 -46.15 43.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 110.942 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -118.96 39.29 3.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.617 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.54 HD13 HD21 ' A' ' 94' ' ' LEU . 7.8 tp -65.95 143.84 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 111.201 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -139.38 148.4 42.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.557 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.88 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.99 -37.8 9.71 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 110.372 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.6 m -61.62 -48.79 79.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.262 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -58.41 -60.75 3.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.279 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.744 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.41 -56.74 7.38 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.873 0.368 . . . . 0.0 110.208 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.2 m -57.75 -30.08 65.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.865 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.503 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -71.17 -65.68 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.196 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -43.05 -42.57 3.95 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.014 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.468 HG12 HG21 ' A' ' 35' ' ' VAL . 97.3 mt -63.5 -55.74 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -54.38 -18.55 4.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.32 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.503 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.63 -35.04 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.953 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.44 ' O ' HD21 ' A' ' 83' ' ' LEU . 17.8 m120 -126.4 30.98 5.47 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 91.6 p -83.89 42.34 0.85 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.017 0.437 . . . . 0.0 110.267 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.463 HD12 ' NH1' ' A' ' 85' ' ' ARG . 77.5 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.365 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.762 0.315 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.595 HG22 ' HG3' ' A' ' 3' ' ' GLU . 12.6 p -99.46 148.66 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.058 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.595 ' HG3' HG22 ' A' ' 2' ' ' VAL . 46.2 mt-10 56.48 78.6 0.2 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.106 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -103.37 -32.36 9.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.709 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.3 p -113.3 23.16 13.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.7 t -142.25 40.57 1.62 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -147.24 146.12 29.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -132.25 -173.99 13.49 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.408 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.14 -56.32 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.517 2.145 . . . . 0.0 112.283 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.8 82.5 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.334 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.35 -68.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 110.576 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.61 -80.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.45 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.462 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.4 pt20 -141.78 163.25 33.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.473 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.2 pt-20 -141.93 158.24 62.56 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.803 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.523 ' HD3' HG21 ' A' ' 54' ' ' VAL . 23.7 Cg_endo -63.71 147.76 92.45 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.552 2.168 . . . . 0.0 112.764 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 17' ' ' TRP . 19.9 m -61.4 155.12 22.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.581 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.406 ' N ' HG22 ' A' ' 16' ' ' THR . 9.1 m-90 -98.48 91.71 5.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.877 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 24' ' ' ALA . 43.3 mt -92.49 76.49 5.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.005 0.431 . . . . 0.0 110.471 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.8 p -74.71 -6.32 48.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.123 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -139.83 148.46 42.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.005 0.431 . . . . 0.0 111.743 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.61 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 19.6 t -54.43 -49.44 90.77 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.832 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.11 -47.31 23.36 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.087 1.858 . . . . 0.0 112.135 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.84 -35.64 80.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.217 0.532 . . . . 0.0 110.211 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.84 -59.6 4.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.105 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 59.0 mtm -60.8 -24.39 65.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.041 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -72.47 -52.22 16.78 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.704 0.288 . . . . 0.0 110.527 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.404 ' O ' HG22 ' A' ' 31' ' ' THR . 10.5 m-85 -59.69 -30.35 68.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 36' ' ' ILE . 50.0 mt -75.1 -39.01 43.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.18 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.96 -18.89 60.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.161 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.28 28.46 2.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.209 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.651 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.8 t -170.08 152.24 4.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.351 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.524 ' HG3' HG13 ' A' ' 87' ' ' VAL . 23.8 tt0 -68.32 -48.19 65.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.516 HG13 HD11 ' A' ' 83' ' ' LEU . 15.7 t -121.83 134.96 63.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.523 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.94 127.95 22.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 111.948 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.456 HG21 HG12 ' A' ' 111' ' ' ILE . 51.9 t -116.56 127.68 74.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.725 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.532 HD12 HD11 ' A' ' 28' ' ' ILE . 23.5 mt -133.24 137.13 53.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.69 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.53 99.75 2.05 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.405 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.6 m-85 -85.38 94.23 8.92 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.8 m-85 -113.89 141.63 47.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -89.35 -3.61 58.4 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.471 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.0 t70 -154.12 121.52 5.78 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.614 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.565 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.1 mt -90.9 47.28 1.4 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.081 0.467 . . . . 0.0 111.184 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 37.3 mt-10 -138.45 8.42 2.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.113 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.821 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.6 pt -91.68 156.45 42.88 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.256 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.481 ' O ' HD12 ' A' ' 49' ' ' ILE . 81.4 Cg_exo -50.74 -27.16 19.22 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.781 2.321 . . . . 0.0 113.112 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.821 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.28 -36.99 85.9 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.671 HG23 HG13 ' A' ' 44' ' ' ILE . 2.6 t -62.47 -55.4 39.82 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.703 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.2 Cg_exo -60.46 -38.63 72.39 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.985 1.79 . . . . 0.0 111.376 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.864 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.3 mt -64.93 -35.47 75.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.09 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.4 tp -73.17 -51.74 16.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 16.1 m80 -53.58 -26.7 22.73 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.154 0.502 . . . . 0.0 109.656 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.9 t -80.85 -47.1 14.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.709 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.58 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.05 -26.08 64.3 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.186 0.517 . . . . 0.0 109.608 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.1 t -53.4 -48.26 57.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.034 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -77.88 -8.52 58.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.671 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -95.25 -18.65 20.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.171 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.595 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 57.8 m-85 -136.66 63.22 45.85 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.484 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.37 -43.18 55.98 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.699 2.266 . . . . 0.0 111.465 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.0 -40.77 91.79 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.377 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.4 t -66.6 144.5 14.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.651 ' HB2' HG21 ' A' ' 31' ' ' THR . 33.0 t -83.08 96.28 8.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 110.865 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.475 ' HB3' HG22 ' A' ' 54' ' ' VAL . 7.4 p90 -63.07 130.8 46.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.937 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -149.71 161.33 28.8 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.023 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.4 tt -160.53 143.23 4.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.756 0.313 . . . . 0.0 110.207 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -146.41 160.15 42.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.215 0.531 . . . . 0.0 111.716 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.434 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.6 p -142.0 -1.95 1.2 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.562 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.03 144.78 52.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -64.9 -50.75 65.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.499 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -48.74 -46.94 41.69 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.588 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.455 ' HA ' HG22 ' A' ' 21' ' ' VAL . 75.1 t -68.84 -53.3 27.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.805 0.336 . . . . 0.0 110.88 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -58.61 -14.5 8.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.289 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.9 m -91.53 -40.56 11.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.19 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -60.91 -39.65 90.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.466 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.417 ' HB2' HG12 ' A' ' 76' ' ' ILE . 42.3 m-85 -92.24 11.62 25.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.809 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 55.34 28.57 11.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.221 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.646 HG23 ' HB ' ' A' ' 80' ' ' THR . 36.1 mm -62.44 119.2 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.076 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.5 p -140.13 58.27 1.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.17 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.31 44.56 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.433 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.583 ' HB2' HG21 ' A' ' 99' ' ' ILE . 26.1 m-80 51.65 43.36 29.91 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.183 0.516 . . . . 0.0 110.304 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.646 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.9 m -68.67 154.03 42.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.657 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.592 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.5 mt -120.94 118.81 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.034 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.509 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 81.6 m -107.6 134.62 50.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.658 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -110.69 104.68 13.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.989 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.2 t80 -98.81 122.6 42.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.788 0.328 . . . . 0.0 110.582 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.526 HH12 HD12 ' A' ' 116' ' ' LEU . 3.6 mtm180 -106.05 87.76 2.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.727 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.41 ' HB3' ' HA ' ' A' ' 32' ' ' GLU . 8.7 tp -26.93 -59.85 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.439 -0.8 . . . . 0.0 113.059 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.524 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -35.4 -80.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 O-C-N 123.542 0.526 . . . . 0.0 112.331 -179.43 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.436 ' HB2' HH21 ' A' ' 85' ' ' ARG . 2.7 m-20 -78.67 1.6 22.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.787 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 m120 55.91 33.25 21.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.421 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 19.7 mm-40 -77.11 159.69 29.6 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.833 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.17 91.61 2.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.757 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.658 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -77.63 143.52 38.17 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -124.92 96.93 5.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.536 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -83.44 79.17 9.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.9 mt-10 -80.61 -164.53 0.73 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.479 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.99 -49.69 15.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.604 -179.32 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -48.23 -16.6 0.1 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.773 0.321 . . . . 0.0 111.158 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -127.19 -13.94 5.52 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.556 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.583 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.2 mm -89.81 -33.15 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.729 0.299 . . . . 0.0 111.611 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -55.45 -42.03 73.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.968 0.413 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.4 m -122.53 35.16 4.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.697 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.536 HD13 HD21 ' A' ' 94' ' ' LEU . 7.0 tp -62.97 142.18 17.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.118 0.485 . . . . 0.0 111.496 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -137.45 148.3 46.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.437 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.864 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.02 -36.83 8.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.95 0.405 . . . . 0.0 110.513 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -62.68 -47.14 84.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.286 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.68 -61.47 2.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.11 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.82 -55.31 10.0 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.049 0.452 . . . . 0.0 110.201 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 63.5 m -58.88 -30.47 67.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.794 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.2 tmt_? -71.3 -66.35 0.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.045 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -42.01 -43.33 3.14 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.141 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.456 HG12 HG21 ' A' ' 35' ' ' VAL . 93.3 mt -63.57 -56.14 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.439 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 41.2 tt0 -53.01 -19.2 2.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.31 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.482 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.24 -38.88 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.902 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.416 ' O ' HD21 ' A' ' 83' ' ' LEU . 17.1 m120 -121.24 29.21 7.4 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 82.8 p -82.25 44.95 0.9 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.043 0.449 . . . . 0.0 110.039 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.526 HD12 HH12 ' A' ' 85' ' ' ARG . 55.3 mt . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.245 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.936 0.398 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.5 p -90.13 -36.58 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.265 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 52.15 82.84 0.06 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.905 0.383 . . . . 0.0 110.839 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -79.59 -19.54 49.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.235 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.6 p -148.42 97.27 2.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.125 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.5 m -75.45 122.33 23.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.615 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -91.33 -7.6 50.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.044 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.43 98.98 2.58 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.492 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.87 142.86 90.17 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.471 2.114 . . . . 0.0 112.142 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.36 64.03 0.24 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.637 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.05 -65.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.722 0.296 . . . . 0.0 110.711 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.2 -82.61 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.48 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.483 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.2 pt20 -148.99 146.99 28.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.832 0.349 . . . . 0.0 111.101 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 -133.06 158.34 76.07 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.542 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.484 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 33.8 Cg_endo -65.5 139.96 61.1 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.532 2.155 . . . . 0.0 112.588 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 17' ' ' TRP . 20.4 m -55.26 155.09 5.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.872 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.401 ' N ' HG22 ' A' ' 16' ' ' THR . 76.1 m95 -100.29 90.58 4.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.866 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.606 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.5 mt -88.83 73.72 8.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.59 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.5 p -73.56 -0.35 14.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.239 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -143.8 147.73 34.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.98 0.419 . . . . 0.0 111.591 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 31.0 t -55.6 -50.18 88.4 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.573 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.6 Cg_endo -57.83 -44.75 37.87 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.054 1.836 . . . . 0.0 111.886 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.23 -35.63 81.45 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.15 0.5 . . . . 0.0 110.351 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.93 -59.09 4.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.98 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.3 mtm -60.4 -26.73 66.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.173 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 20.2 mt-10 -71.65 -50.31 31.81 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.687 0.279 . . . . 0.0 110.658 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.569 ' O ' HG22 ' A' ' 31' ' ' THR . 9.9 m-85 -60.33 -34.27 73.58 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.564 HD11 HD12 ' A' ' 36' ' ' ILE . 47.7 mt -72.97 -38.57 56.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.032 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.97 -17.3 61.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.971 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.84 25.64 5.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.174 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.605 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.8 t -170.3 152.63 4.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.622 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.595 ' HG3' HG13 ' A' ' 87' ' ' VAL . 15.6 tt0 -61.88 -80.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.595 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.534 HG13 HD11 ' A' ' 83' ' ' LEU . 20.1 t -94.39 136.68 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.619 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.65 126.25 20.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.053 0.454 . . . . 0.0 111.883 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.501 HG21 HG12 ' A' ' 111' ' ' ILE . 47.1 t -115.07 128.02 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.752 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.564 HD12 HD11 ' A' ' 28' ' ' ILE . 23.1 mt -134.65 137.53 51.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.428 -177.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.538 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.66 98.48 1.85 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.347 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.465 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 37.7 m-85 -83.4 90.82 7.23 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.614 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 13.4 m-85 -109.16 141.77 40.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.537 -178.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -88.77 -7.58 55.97 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' O ' HG12 ' A' ' 44' ' ' ILE . 27.7 t70 -151.22 121.79 7.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.641 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.549 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.0 mt -90.49 46.04 1.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.108 0.48 . . . . 0.0 111.393 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 40.0 mt-10 -136.7 11.07 3.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.041 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.817 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.7 pt -95.7 155.52 38.42 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.311 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.472 ' O ' HD12 ' A' ' 49' ' ' ILE . 84.7 Cg_exo -49.75 -28.59 17.91 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.833 2.355 . . . . 0.0 113.089 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.817 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.54 -37.24 85.33 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.664 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.5 t -62.58 -56.31 31.0 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.615 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.9 Cg_exo -59.4 -39.87 72.67 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.89 1.727 . . . . 0.0 111.187 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.927 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.5 mt -63.2 -36.07 74.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.064 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.623 ' O ' HG23 ' A' ' 54' ' ' VAL . 52.0 tp -71.97 -51.42 22.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -54.94 -25.72 31.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 p -80.99 -45.2 16.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.599 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.605 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.95 -25.9 67.87 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.4 t -53.2 -49.88 49.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.913 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -75.63 -9.18 58.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.716 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -95.26 -18.99 20.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.286 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.563 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 62.4 m-85 -136.1 62.3 44.81 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.566 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.0 -45.82 36.35 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.893 2.395 . . . . 0.0 111.742 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.5 -40.3 69.08 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.403 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.7 t -67.3 143.61 15.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.605 ' HB2' HG21 ' A' ' 31' ' ' THR . 39.8 t -81.8 96.55 7.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.948 0.404 . . . . 0.0 110.965 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.484 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.6 p90 -63.82 129.67 41.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.983 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -149.14 162.3 28.94 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.143 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 15' ' ' PRO . 4.7 tt -160.26 145.39 5.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.465 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 30.9 t -151.02 155.55 39.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.229 0.538 . . . . 0.0 111.787 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.476 HG21 ' HG ' ' A' ' 42' ' ' LEU . 66.8 p -135.95 -3.56 2.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.398 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.73 139.74 58.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.505 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.0 m -64.61 -51.95 60.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.258 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -49.53 -41.53 41.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.543 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.541 ' HA ' HG22 ' A' ' 21' ' ' VAL . 59.8 t -71.77 -55.32 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.731 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.27 -14.63 7.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.365 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 79.5 m -91.98 -40.9 10.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.312 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -61.63 -36.46 80.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.326 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.432 ' HB2' HG12 ' A' ' 76' ' ' ILE . 90.1 m-85 -93.87 12.07 27.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.793 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 57.47 22.96 8.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.716 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.709 HD12 ' HB ' ' A' ' 80' ' ' THR . 40.8 mm -60.64 122.3 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.104 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.2 p -141.99 58.58 1.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.205 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.77 44.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.741 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.631 ' HB2' HG21 ' A' ' 99' ' ' ILE . 21.2 m-80 52.8 43.16 31.8 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.115 0.483 . . . . 0.0 110.739 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.709 ' HB ' HD12 ' A' ' 76' ' ' ILE . 94.8 m -68.77 151.03 47.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.65 -178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.591 HG21 HD21 ' A' ' 107' ' ' LEU . 67.2 mt -117.32 116.12 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.986 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 76.9 m -104.11 133.65 48.69 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.665 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -109.43 102.55 11.42 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.941 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.4 t80 -97.5 121.76 39.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.771 0.32 . . . . 0.0 110.762 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.516 HH12 HD12 ' A' ' 116' ' ' LEU . 3.0 mtm180 -105.76 91.75 3.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.123 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 tp -38.55 -50.69 1.59 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.611 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.595 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.36 -63.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.796 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.412 ' HB2' HH21 ' A' ' 85' ' ' ARG . 9.2 m-20 -96.52 8.54 43.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.04 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 m120 51.86 31.97 9.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.615 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 20.3 mm-40 -78.82 160.82 27.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.809 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -146.92 91.49 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.911 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.665 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -78.42 144.65 35.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.03 99.33 6.07 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.598 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -85.29 78.31 9.81 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.454 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.4 mt-10 -78.46 -165.6 0.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.564 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.7 t70 -51.7 -35.4 42.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.004 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -56.87 -14.92 3.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.248 0.547 . . . . 0.0 110.327 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -129.94 -14.01 4.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.481 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.631 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.3 mm -89.48 -32.58 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 120.781 0.324 . . . . 0.0 111.267 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -51.7 -45.19 63.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.2 p -124.56 37.09 4.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.573 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.598 HD13 HD21 ' A' ' 94' ' ' LEU . 7.6 tp -60.6 143.18 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.787 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -137.53 149.51 46.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.523 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.927 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.08 -38.33 11.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 110.593 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.2 m -61.74 -47.78 83.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.488 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -59.02 -59.62 5.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.273 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.727 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.97 -56.52 10.34 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.08 0.467 . . . . 0.0 110.23 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 55.1 m -57.59 -30.64 65.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.844 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.9 tmt_? -70.01 -65.73 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.073 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -42.5 -44.49 4.1 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.034 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.501 HG12 HG21 ' A' ' 35' ' ' VAL . 83.3 mt -61.83 -55.78 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.453 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -54.39 -18.1 3.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.512 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.475 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.48 -36.65 8.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.929 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.472 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.2 m120 -125.88 31.47 5.47 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.5 p -83.33 40.55 0.72 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.036 0.446 . . . . 0.0 110.307 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.516 HD12 HH12 ' A' ' 85' ' ' ARG . 59.5 mt . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.266 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 120.744 0.307 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -144.13 -22.63 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.987 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -60.38 -62.46 1.85 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.964 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -94.3 55.66 2.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.828 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -75.35 84.19 2.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.8 m -150.32 25.78 0.79 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 57.85 72.74 0.5 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.015 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.29 92.33 0.54 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.543 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.92 147.4 89.23 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.762 2.308 . . . . 0.0 112.226 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.32 102.22 0.46 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.488 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.409 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . -159.93 -21.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.824 0.345 . . . . 0.0 110.857 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.409 ' H ' ' H ' ' A' ' 11' ' ' ALA . . . -39.98 98.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.655 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.578 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.7 pt20 -47.88 140.87 6.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.229 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.3 pt-20 -110.42 157.2 38.85 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.733 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.516 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.5 Cg_endo -66.35 146.23 80.0 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.666 2.244 . . . . 0.0 112.463 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.9 m -61.35 153.61 26.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.792 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -100.34 92.57 5.24 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.754 179.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' ' 24' ' ' ALA . 47.3 mt -91.03 71.15 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.714 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.3 p -72.75 2.26 6.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.044 -179.209 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -143.75 146.61 33.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.841 0.353 . . . . 0.0 111.559 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 43.7 t -55.94 -50.2 88.61 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.577 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.1 Cg_endo -58.37 -45.85 28.25 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.873 1.716 . . . . 0.0 111.895 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.06 -34.32 77.34 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 110.29 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.642 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -65.42 -59.24 4.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.044 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.8 mtm -61.08 -24.2 66.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.021 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.5 mt-10 -73.91 -52.19 13.7 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.661 0.267 . . . . 0.0 110.544 179.592 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.497 ' O ' HG22 ' A' ' 31' ' ' THR . 8.2 m-85 -58.83 -31.7 68.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.558 HD11 HD12 ' A' ' 36' ' ' ILE . 49.0 mt -75.05 -40.64 45.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.938 178.074 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.16 -16.9 62.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.096 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.89 24.3 5.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.266 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.599 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.0 t -170.77 153.7 4.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.618 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.502 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.6 tt0 -63.51 -75.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.552 HG13 HD11 ' A' ' 83' ' ' LEU . 18.2 t -96.97 136.63 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.817 0.341 . . . . 0.0 110.701 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.96 124.25 16.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.79 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.489 HG11 HD11 ' A' ' 111' ' ' ILE . 51.6 t -112.49 128.87 68.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.796 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 28' ' ' ILE . 29.3 mt -134.2 137.33 52.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.21 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.554 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.62 97.22 1.68 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.199 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.473 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 41.9 m-85 -82.9 90.83 7.01 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.5 m-85 -109.91 140.63 43.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.41 -178.106 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.453 ' HG2' HD23 ' A' ' 71' ' ' LEU . 47.8 mt-30 -87.45 -9.3 55.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.459 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 17.7 t70 -148.91 123.43 9.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.53 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.499 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.8 mt -92.2 47.14 1.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.974 0.416 . . . . 0.0 111.599 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.9 mt-10 -137.94 10.47 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.113 178.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.72 HG13 HG23 ' A' ' 47' ' ' VAL . 4.1 pt -91.84 159.04 38.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.155 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.496 ' O ' HD12 ' A' ' 49' ' ' ILE . 75.4 Cg_exo -53.93 -25.41 35.71 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.693 2.262 . . . . 0.0 112.858 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.677 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.28 -41.4 94.23 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.72 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -56.67 -55.6 41.4 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.64 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.6 Cg_exo -61.01 -42.23 38.33 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.572 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.874 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.8 mt -60.34 -33.65 54.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.097 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.61 ' O ' HG23 ' A' ' 54' ' ' VAL . 46.7 tp -75.36 -52.7 10.17 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -52.57 -27.42 16.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.1 0.476 . . . . 0.0 109.763 178.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -79.76 -49.07 12.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.624 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.593 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -57.08 -26.46 60.43 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.528 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.6 t -51.67 -49.79 33.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.838 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -74.77 -16.31 60.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.679 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -88.01 -16.18 34.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.246 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.635 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 50.8 m-85 -137.56 62.43 35.99 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.447 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.52 -43.6 53.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.705 2.27 . . . . 0.0 111.671 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.8 -41.49 94.04 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.645 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.635 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 13.1 t -65.75 145.07 14.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.599 ' HB2' HG21 ' A' ' 31' ' ' THR . 36.8 t -83.64 98.27 9.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 111.016 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.516 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.3 p90 -63.86 129.07 38.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.089 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.469 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -147.39 161.17 28.46 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.071 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -161.61 144.99 4.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.473 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 37.1 t -149.57 159.14 44.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.121 0.486 . . . . 0.0 111.777 -179.124 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.465 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.3 p -139.97 -1.87 1.55 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.546 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.59 138.91 55.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.74 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 61.2 m -61.58 -51.61 67.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.672 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -48.21 -44.08 32.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.695 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.545 ' HA ' HG22 ' A' ' 21' ' ' VAL . 76.1 t -70.7 -54.96 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.908 0.385 . . . . 0.0 110.769 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.2 mp -57.59 -14.57 5.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.2 179.37 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.6 m -91.2 -41.15 11.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.144 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -59.71 -40.22 87.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.455 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.42 ' HB2' HG12 ' A' ' 76' ' ' ILE . 97.5 m-85 -93.33 15.07 16.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.725 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.7 m120 53.87 25.45 5.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.791 179.142 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.694 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.2 mm -60.33 121.41 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.002 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.9 p -140.97 57.86 1.55 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.491 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.3 44.58 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.637 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.617 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 19.5 m-80 51.97 44.09 29.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.247 0.546 . . . . 0.0 110.37 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.694 ' HB ' HG23 ' A' ' 76' ' ' ILE . 91.9 m -69.14 152.79 44.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.676 -178.624 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.554 HG12 ' HA2' ' A' ' 37' ' ' GLY . 66.1 mt -118.89 116.75 52.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.998 177.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.472 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 74.7 m -106.45 133.02 51.79 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.628 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -107.49 103.99 13.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.899 178.405 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -97.05 120.37 37.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.789 0.328 . . . . 0.0 110.694 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.496 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 5.3 mtm180 -104.18 82.22 1.93 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.719 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ARG . 7.2 tp -25.19 -59.66 0.06 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.41 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.502 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.73 -64.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.295 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -93.27 3.83 54.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.922 0.391 . . . . 0.0 110.959 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 49.56 36.59 10.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.526 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 6.3 mm-40 -83.57 157.08 22.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.5 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.18 96.06 3.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.724 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.628 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -84.71 111.55 19.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.048 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.35 115.41 27.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.262 0.553 . . . . 0.0 112.308 -178.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.581 HD21 HD13 ' A' ' 102' ' ' ILE . 3.1 tt -102.61 76.84 1.56 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.156 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.5 mt-10 -78.2 -165.08 0.62 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.621 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.524 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 22.6 t70 -50.48 -38.89 46.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.174 -179.16 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -54.89 -14.62 1.52 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.142 0.496 . . . . 0.0 110.343 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -130.42 -13.81 3.82 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.721 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.563 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.1 mm -90.8 -35.1 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.701 0.286 . . . . 0.0 111.435 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.77 -43.46 65.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.914 0.388 . . . . 0.0 110.758 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.7 m -122.34 40.33 3.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.518 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.581 HD13 HD21 ' A' ' 94' ' ' LEU . 7.6 tp -67.32 143.43 15.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.687 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -138.37 148.31 44.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.536 178.568 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.874 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.14 -36.8 8.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.984 0.421 . . . . 0.0 110.449 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.2 m -62.07 -49.83 74.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.249 178.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -57.6 -60.96 2.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.227 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.761 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.69 -56.52 8.32 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.912 0.387 . . . . 0.0 110.44 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.7 m -58.66 -29.99 66.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.974 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.553 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.2 tmt_? -71.08 -65.33 0.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.138 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -43.44 -44.58 5.9 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.044 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.489 HD11 HG11 ' A' ' 35' ' ' VAL . 96.8 mt -62.6 -55.39 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.512 178.365 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.41 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 37.6 tt0 -54.36 -18.73 4.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.266 0.555 . . . . 0.0 110.305 179.392 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.553 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.44 -37.02 9.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.907 -179.136 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.48 ' O ' HD21 ' A' ' 83' ' ' LEU . 17.7 m120 -124.48 30.38 6.03 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 97.9 p -83.08 44.29 0.93 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.055 0.455 . . . . 0.0 110.091 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.418 HD12 HH12 ' A' ' 85' ' ' ARG . 44.4 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.33 -179.445 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.859 0.361 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.6 m -115.85 -12.57 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.332 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.23 173.81 8.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.19 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.8 tttm 62.2 -83.16 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.121 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.6 t -158.44 -81.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.771 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.0 m 52.41 83.93 0.06 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.199 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -81.28 -84.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.959 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.412 ' HA2' ' HD3' ' A' ' 9' ' ' PRO . . . 70.04 137.8 0.12 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.692 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.412 ' HD3' ' HA2' ' A' ' 8' ' ' GLY . 35.6 Cg_exo -60.35 107.48 0.42 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.507 2.138 . . . . 0.0 112.25 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.21 -169.87 32.68 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.458 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.2 -71.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.781 0.325 . . . . 0.0 110.781 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.11 107.33 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.502 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.622 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.3 pt20 -62.04 160.08 13.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.394 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.497 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.0 pt-20 -128.98 159.57 68.01 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.621 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 46.0 Cg_endo -68.51 142.57 54.3 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.531 2.154 . . . . 0.0 112.619 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.6 m -63.33 152.26 38.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.51 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 12.7 m0 -96.53 89.51 5.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.005 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 24' ' ' ALA . 54.7 mt -83.4 71.28 10.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.056 0.455 . . . . 0.0 110.39 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.6 p -71.07 -1.83 13.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.096 -179.099 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -141.42 147.28 37.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.892 0.377 . . . . 0.0 111.673 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.1 t -57.33 -49.68 92.51 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.364 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.11 -43.76 45.08 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.939 1.759 . . . . 0.0 111.743 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.23 -34.85 79.34 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.2 0.524 . . . . 0.0 110.361 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.624 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.68 -58.65 5.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.954 179.286 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 59.4 mtm -60.6 -27.64 67.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.135 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -71.36 -50.68 29.81 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.756 0.312 . . . . 0.0 110.677 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.534 ' O ' HG22 ' A' ' 31' ' ' THR . 4.0 m-85 -59.47 -34.77 72.96 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.246 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.555 HD11 HD12 ' A' ' 36' ' ' ILE . 48.4 mt -73.07 -39.38 57.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.103 178.519 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.26 -18.85 61.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.081 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.3 24.26 3.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.252 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.709 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.0 t -170.78 155.09 4.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.546 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.547 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.8 tt0 -65.53 -73.25 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG13 HD11 ' A' ' 83' ' ' LEU . 17.9 t -98.66 137.37 26.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.743 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.455 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.19 128.07 19.43 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.234 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.444 HG21 HG12 ' A' ' 111' ' ' ILE . 54.6 t -115.37 131.38 67.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.43 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.555 HD12 HD11 ' A' ' 28' ' ' ILE . 23.1 mt -136.55 136.17 48.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.377 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.64 98.16 1.89 Allowed Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.505 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.49 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.9 m-85 -83.34 89.73 7.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.0 m-85 -109.59 137.88 46.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.497 -178.018 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.449 ' HG2' HD23 ' A' ' 71' ' ' LEU . 48.8 mt-30 -85.18 -4.49 59.18 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.449 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 12.0 t70 -153.63 126.4 8.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.561 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.543 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.1 mt -95.48 48.21 1.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.112 0.482 . . . . 0.0 111.369 -179.355 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.449 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 45.2 mt-10 -137.98 8.65 2.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.808 178.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.812 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.8 pt -91.94 157.17 41.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.247 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.503 ' O ' HD12 ' A' ' 49' ' ' ILE . 76.3 Cg_exo -52.23 -26.03 25.49 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.915 2.41 . . . . 0.0 113.058 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.812 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.19 -36.06 83.0 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.655 HG23 HG13 ' A' ' 44' ' ' ILE . 2.5 t -62.78 -55.75 35.55 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.741 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.644 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.0 Cg_exo -60.83 -39.43 62.28 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.03 1.82 . . . . 0.0 111.471 179.381 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -63.45 -36.7 77.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.062 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.6 ' O ' HG23 ' A' ' 54' ' ' VAL . 42.8 tp -71.89 -51.95 19.73 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -53.21 -26.31 17.15 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.338 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.6 t -80.01 -47.55 14.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.656 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.562 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.17 -26.11 64.5 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.429 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.622 HG12 ' HG3' ' A' ' 13' ' ' GLN . 54.7 t -53.11 -49.43 50.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.834 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -76.08 -10.59 59.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.626 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -93.69 -18.94 21.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.374 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 67.5 m-85 -135.96 62.21 45.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.589 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.9 -41.14 64.87 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.693 2.262 . . . . 0.0 111.568 179.114 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.14 -41.58 96.69 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.293 179.15 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.1 t -66.1 143.77 15.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.709 ' HB2' HG21 ' A' ' 31' ' ' THR . 33.3 t -81.5 99.3 8.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.039 0.447 . . . . 0.0 110.844 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.479 ' HB3' HG22 ' A' ' 54' ' ' VAL . 3.9 p90 -65.61 126.76 29.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.987 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.95 162.73 28.35 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.318 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -160.89 141.34 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.1 t -144.29 151.78 39.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.107 0.48 . . . . 0.0 111.655 -179.044 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.432 HG21 ' HG ' ' A' ' 42' ' ' LEU . 81.6 p -135.57 -0.5 2.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.772 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.59 145.99 50.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.918 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.0 t -67.66 -50.58 57.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.466 -179.424 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -50.45 -44.05 55.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.363 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.536 ' HA ' HG22 ' A' ' 21' ' ' VAL . 58.4 t -70.83 -53.45 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.736 0.303 . . . . 0.0 110.604 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.449 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.4 -14.72 8.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.147 0.498 . . . . 0.0 110.459 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.0 m -92.56 -40.68 10.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.466 178.675 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -61.88 -35.33 78.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.497 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.421 ' HB2' HG12 ' A' ' 76' ' ' ILE . 41.9 m-85 -95.55 12.88 28.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.872 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 56.93 23.65 8.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.691 179.236 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.681 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.2 mm -61.08 121.13 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.092 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.2 p -141.02 57.86 1.55 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.378 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.51 46.49 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.536 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.585 ' HB2' HG21 ' A' ' 99' ' ' ILE . 23.3 m-80 51.29 42.94 29.5 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.253 0.549 . . . . 0.0 110.406 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.681 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.0 m -68.93 152.39 45.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.65 -178.568 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.578 HG12 ' HA2' ' A' ' 37' ' ' GLY . 68.1 mt -119.32 118.53 57.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.241 178.163 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.49 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.9 m -107.34 134.04 50.98 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.658 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -107.62 103.05 12.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.716 178.183 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.1 t80 -95.87 120.26 35.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.869 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.567 HH12 HD12 ' A' ' 116' ' ' LEU . 3.9 mtm180 -106.09 82.19 1.73 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.872 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.5 tp -25.11 -58.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.219 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.547 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.08 -60.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.375 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -100.77 4.77 43.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.128 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 54.08 26.01 6.11 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.373 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 13.9 mm-40 -70.61 155.18 41.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.822 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.86 95.06 2.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.445 179.391 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.658 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -84.36 111.55 19.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.224 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.7 118.08 30.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.37 0.605 . . . . 0.0 112.253 -179.13 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.515 HD21 HD13 ' A' ' 102' ' ' ILE . 4.3 tt -105.56 77.6 1.29 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.131 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.7 mt-10 -79.69 -163.84 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.905 -176.543 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.7 t70 -51.11 -35.71 36.7 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.925 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.415 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 12.9 pt-20 -56.18 -14.57 2.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.091 0.472 . . . . 0.0 110.192 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.415 ' OD2' ' HG3' ' A' ' 97' ' ' GLU . 35.5 m-20 -132.46 -14.05 2.94 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.573 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.4 mm -89.86 -33.96 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.718 0.294 . . . . 0.0 111.402 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -54.54 -34.23 61.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.753 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.5 p -133.06 40.25 3.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.341 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.517 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.6 tp -66.07 143.57 15.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.597 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.404 ' N ' HG13 ' A' ' 102' ' ' ILE . 9.3 m-20 -138.62 148.56 44.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.5 178.591 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.91 -35.57 6.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.102 0.477 . . . . 0.0 110.342 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.2 m -63.33 -49.63 73.17 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.358 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -58.61 -59.66 5.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.131 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.7 -55.92 12.07 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.963 0.411 . . . . 0.0 110.317 179.875 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.2 m -58.66 -28.93 66.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.785 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.555 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -71.58 -65.69 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.169 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -42.91 -43.97 4.35 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.913 179.106 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.444 HG12 HG21 ' A' ' 35' ' ' VAL . 94.6 mt -62.96 -55.93 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.571 178.314 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.31 -17.81 3.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.555 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.83 -36.84 8.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.98 -179.194 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.413 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.3 m120 -124.37 30.02 6.16 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 81.2 p -82.38 47.69 1.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.013 0.435 . . . . 0.0 110.315 179.058 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.567 HD12 HH12 ' A' ' 85' ' ' ARG . 63.1 mt . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.297 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.775 0.321 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.423 HG23 ' HG3' ' A' ' 3' ' ' GLU . 22.6 m -97.74 -2.41 10.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 2' ' ' VAL . 44.5 mt-10 -139.52 29.24 2.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.821 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -137.64 -56.31 0.68 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.748 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.7 m -117.91 136.9 53.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.686 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.3 m -111.2 -48.62 3.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -122.88 10.55 9.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.046 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.17 97.6 0.33 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -61.89 120.0 7.39 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.579 2.186 . . . . 0.0 112.163 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.88 -130.18 2.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.617 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.57 -72.36 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.739 0.304 . . . . 0.0 110.715 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.436 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . . . 57.69 96.89 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.673 179.341 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.502 ' HG3' ' CG1' ' A' ' 54' ' ' VAL . 2.3 pt20 -172.83 170.28 4.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.964 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.47 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 -117.26 157.96 45.78 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.0 Cg_endo -67.83 148.25 76.54 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.878 2.385 . . . . 0.0 112.6 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.3 m -64.64 153.99 37.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.54 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -98.84 89.37 4.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.005 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 24' ' ' ALA . 50.1 mt -86.86 74.14 9.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.603 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.9 p -71.82 -1.25 13.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.266 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -143.52 148.73 36.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.868 0.366 . . . . 0.0 111.863 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.592 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 20.4 t -56.86 -50.66 86.78 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.407 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.52 -43.45 50.97 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.944 1.763 . . . . 0.0 111.884 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.61 -35.47 80.9 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.222 0.534 . . . . 0.0 110.299 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.61 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.26 -58.2 7.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.868 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.7 mtm -60.25 -28.56 68.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.005 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -70.57 -48.9 53.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.794 0.331 . . . . 0.0 110.568 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 31' ' ' THR . 4.5 m-85 -60.75 -33.64 73.24 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.999 179.311 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.6 HD11 HD12 ' A' ' 36' ' ' ILE . 38.1 mt -73.55 -39.6 54.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.003 178.568 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.33 -19.16 62.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.177 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.32 26.45 3.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.253 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.648 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.0 t -172.8 154.28 2.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.705 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.526 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.3 tt0 -63.65 -79.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.711 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.53 HG13 HD11 ' A' ' 83' ' ' LEU . 16.0 t -92.88 139.03 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.661 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.45 122.99 14.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 0.0 111.716 -179.45 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.554 HG21 HG12 ' A' ' 111' ' ' ILE . 55.1 t -112.03 128.34 68.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.755 178.449 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.6 HD12 HD11 ' A' ' 28' ' ' ILE . 38.4 mt -134.08 137.59 51.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.604 -177.015 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.544 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.75 98.26 1.82 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.217 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.467 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 35.8 m-85 -84.17 91.88 7.8 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.8 m-85 -111.78 143.76 42.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.356 -178.085 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -89.31 -8.07 54.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.447 ' O ' HG12 ' A' ' 44' ' ' ILE . 13.4 t70 -149.79 124.57 9.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.618 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.547 ' HA ' HG21 ' A' ' 47' ' ' VAL . 90.6 mt -93.18 46.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.055 0.455 . . . . 0.0 111.511 -179.239 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 37.1 mt-10 -136.98 8.93 3.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.917 178.851 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.78 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.2 pt -91.81 155.56 43.37 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.4 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.489 ' O ' HD12 ' A' ' 49' ' ' ILE . 83.8 Cg_exo -50.42 -26.61 16.53 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.877 2.385 . . . . 0.0 112.964 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.78 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.48 -38.52 91.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -179.028 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.691 HG23 HG13 ' A' ' 44' ' ' ILE . 2.8 t -60.0 -55.91 40.83 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.817 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.663 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.7 Cg_exo -60.67 -41.59 45.93 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.081 1.854 . . . . 0.0 111.545 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.871 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.8 mt -61.12 -35.17 63.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.973 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.614 ' O ' HG23 ' A' ' 54' ' ' VAL . 50.4 tp -74.57 -49.47 21.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.06 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -55.14 -25.83 34.63 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.635 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -81.84 -47.34 12.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.69 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.584 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.48 -26.38 63.35 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.455 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 50' ' ' LEU . 41.9 t -52.82 -48.01 50.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.123 179.395 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.436 ' NE2' ' HA ' ' A' ' 12' ' ' ALA . 38.5 mt-30 -77.97 -11.88 59.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.4 mtpp -92.23 -17.86 24.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.312 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.608 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 62.4 m-85 -136.5 62.36 42.52 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.453 -179.651 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.33 -42.12 62.38 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.79 2.327 . . . . 0.0 111.677 179.137 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.9 -40.59 95.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.443 179.233 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.4 t -67.22 142.6 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.648 ' HB2' HG21 ' A' ' 31' ' ' THR . 28.7 t -81.17 98.46 8.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.049 0.452 . . . . 0.0 110.877 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.521 ' HB3' HG22 ' A' ' 54' ' ' VAL . 4.6 p90 -66.04 129.44 39.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.015 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.32 161.98 28.57 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.003 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -160.93 143.93 4.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.467 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 34.1 t -149.79 158.3 44.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.1 0.476 . . . . 0.0 111.693 -179.165 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.518 HG21 ' HG ' ' A' ' 42' ' ' LEU . 77.5 p -139.86 2.53 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.668 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -72.18 134.51 45.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.428 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.1 t -57.86 -49.29 77.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.435 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -50.21 -43.49 52.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.695 -179.378 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.57 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.9 t -71.35 -53.2 21.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.967 0.413 . . . . 0.0 110.69 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 76' ' ' ILE . 6.6 mp -59.31 -14.34 11.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.176 179.362 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.5 m -92.02 -41.24 10.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.251 178.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -60.68 -38.51 85.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.434 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.41 ' HB2' HG12 ' A' ' 76' ' ' ILE . 60.1 m-85 -92.61 10.46 30.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.766 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.9 t30 58.95 23.01 11.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.626 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.718 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.0 mm -60.23 123.34 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.022 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.5 p -143.62 60.05 1.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.028 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.86 43.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.572 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.612 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 30.0 m-80 52.09 43.57 30.35 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.109 0.48 . . . . 0.0 110.43 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.718 ' HB ' HG23 ' A' ' 76' ' ' ILE . 88.5 m -68.41 152.67 45.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.655 -178.636 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.579 HG21 HD21 ' A' ' 107' ' ' LEU . 62.2 mt -118.46 115.53 48.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 78.3 m -103.63 135.14 45.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -177.742 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.631 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -110.72 105.61 14.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.125 178.519 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.7 t80 -99.41 118.94 37.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.996 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.456 HH12 HD12 ' A' ' 116' ' ' LEU . 3.3 mtm180 -103.29 80.69 1.86 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.789 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 85' ' ' ARG . 6.6 tp -24.33 -59.65 0.05 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.935 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.526 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.79 -62.48 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.302 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -96.87 3.3 52.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.0 0.428 . . . . 0.0 111.065 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 51.77 32.07 9.01 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.526 179.471 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.9 mm-40 -80.03 137.5 36.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.614 179.656 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.02 93.31 4.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.028 0.442 . . . . 0.0 110.86 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.631 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -81.16 141.39 34.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.361 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -121.86 115.18 22.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.322 0.582 . . . . 0.0 112.343 -179.425 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.533 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -99.57 74.88 1.91 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.5 mt-10 -76.38 -166.03 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -176.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.474 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.4 OUTLIER -46.01 -51.7 13.1 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.418 -179.278 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -47.15 -15.83 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.275 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 96' ' ' ASP . 30.5 m-20 -127.02 -14.03 5.6 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.351 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.546 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.4 mm -91.59 -40.48 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -46.18 -42.85 14.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 t -124.45 41.36 3.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.491 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.533 HD13 HD21 ' A' ' 94' ' ' LEU . 7.3 tp -66.86 143.6 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.712 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -137.22 149.54 47.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.486 178.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.871 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.23 -36.77 14.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.379 . . . . 0.0 110.461 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 99.5 m -62.27 -48.42 79.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.236 178.711 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -58.86 -59.34 5.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.188 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.2 -56.39 11.25 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.05 0.452 . . . . 0.0 110.182 -179.96 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.6 m -58.05 -28.8 64.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.744 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.498 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.9 tmt_? -71.6 -66.05 0.68 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.967 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -42.13 -45.52 4.03 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.865 179.105 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.554 HG12 HG21 ' A' ' 35' ' ' VAL . 82.1 mt -61.33 -56.86 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.593 178.521 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -53.82 -18.07 2.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.336 179.393 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.498 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.43 -37.16 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.215 -179.042 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.458 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.6 m120 -124.62 29.63 6.21 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 99.8 p -82.9 49.11 1.45 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.996 0.427 . . . . 0.0 110.316 179.055 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.456 HD12 HH12 ' A' ' 85' ' ' ARG . 73.7 mt . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.355 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.861 0.362 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.2 m -99.44 -43.37 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.093 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -172.51 92.17 0.11 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.777 179.921 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.8 tttt 55.71 90.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.094 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 85.3 p -161.19 114.0 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.004 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.4 m -130.98 24.75 4.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.995 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -110.54 -40.43 4.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.846 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.93 152.78 6.02 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.48 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.84 107.34 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.546 2.164 . . . . 0.0 112.13 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.76 165.62 25.87 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.612 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.07 -61.74 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.74 0.305 . . . . 0.0 110.676 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 13' ' ' GLN . . . 53.89 83.26 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.102 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.489 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.5 pt20 48.27 117.29 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.919 0.762 . . . . 0.0 112.287 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.519 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.9 pt-20 -114.25 159.54 36.14 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.649 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 31.4 Cg_endo -65.0 139.76 62.89 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.487 2.124 . . . . 0.0 112.526 -179.534 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 17' ' ' TRP . 19.2 m -57.18 154.34 10.34 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.003 -179.399 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.401 ' N ' HG22 ' A' ' 16' ' ' THR . 10.4 m-90 -98.21 94.11 6.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.902 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.617 HD13 ' HA ' ' A' ' 24' ' ' ALA . 51.3 mt -90.07 70.01 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.27 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.2 p -68.82 -2.6 9.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.246 -178.91 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -142.61 147.53 35.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.997 0.427 . . . . 0.0 111.645 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.7 t -55.29 -50.01 89.11 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.638 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.6 Cg_endo -57.06 -46.87 25.86 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.958 1.772 . . . . 0.0 111.924 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.8 -34.62 77.66 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.193 0.52 . . . . 0.0 110.113 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -64.13 -59.26 4.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.054 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.4 mtp -60.62 -25.19 66.09 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.183 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -72.26 -50.82 24.3 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.571 179.601 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 31' ' ' THR . 12.0 m-85 -61.72 -29.48 70.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.047 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.516 HD11 HD12 ' A' ' 36' ' ' ILE . 50.2 mt -76.11 -37.48 33.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.068 178.217 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.79 -19.54 60.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.115 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.41 30.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.197 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.613 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.7 t -170.97 153.53 3.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.314 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.615 ' HG3' HG13 ' A' ' 87' ' ' VAL . 27.5 tt0 -70.18 -46.29 64.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.793 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.508 HG13 HD11 ' A' ' 83' ' ' LEU . 21.1 t -124.53 135.22 64.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.286 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.507 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.56 127.47 22.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.163 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.503 HG21 HG12 ' A' ' 111' ' ' ILE . 49.2 t -115.66 128.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.465 178.511 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.516 HD12 HD11 ' A' ' 28' ' ' ILE . 22.2 mt -134.64 138.41 49.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.556 -177.322 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.575 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.87 97.06 1.64 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.378 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.477 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 39.3 m-85 -82.95 91.96 7.24 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.0 m-85 -112.0 145.21 40.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.181 0.515 . . . . 0.0 112.378 -178.188 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.479 ' HG2' HD23 ' A' ' 71' ' ' LEU . 46.2 mt-30 -93.17 -0.99 56.75 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.8 t70 -156.58 123.85 5.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.564 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.549 ' HA ' HG21 ' A' ' 47' ' ' VAL . 84.0 mt -93.75 47.5 1.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.204 0.526 . . . . 0.0 111.505 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 45.4 mt-10 -137.38 7.27 2.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.729 178.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.808 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.0 pt -89.68 156.55 47.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.027 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.509 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.1 Cg_exo -52.16 -24.19 19.62 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.876 2.384 . . . . 0.0 113.007 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.808 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -67.32 -35.99 80.56 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.706 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.673 HG23 HG13 ' A' ' 44' ' ' ILE . 2.6 t -61.9 -54.97 45.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.667 -178.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.6 Cg_exo -61.44 -40.28 49.48 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.999 1.799 . . . . 0.0 111.445 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.868 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.3 mt -63.11 -35.92 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.19 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.624 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.9 tp -73.06 -50.26 23.99 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -54.82 -25.37 27.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.198 0.523 . . . . 0.0 109.598 178.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.9 t -80.98 -47.23 13.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.547 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.556 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.23 -27.17 65.51 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.541 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.6 t -51.71 -50.91 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.021 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.423 ' NE2' ' HB3' ' A' ' 12' ' ' ALA . 36.0 mt-30 -74.68 -12.35 60.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.722 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -91.81 -17.34 25.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.215 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.619 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.0 m-85 -138.15 63.37 36.23 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.568 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.07 -41.11 74.19 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.652 2.235 . . . . 0.0 111.58 179.021 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.3 -41.83 97.05 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.35 179.124 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.6 t -65.76 144.69 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.613 ' HB2' HG21 ' A' ' 31' ' ' THR . 47.5 t -82.35 97.23 8.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.026 0.441 . . . . 0.0 111.006 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.493 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -64.45 126.64 28.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.724 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.476 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.1 161.84 28.33 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.169 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' A' ' 15' ' ' PRO . 4.3 tt -161.03 143.02 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.477 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 35.6 t -147.25 153.52 39.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.071 0.462 . . . . 0.0 111.805 -179.061 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.483 HG21 ' HG ' ' A' ' 42' ' ' LEU . 64.4 p -135.62 5.73 3.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.371 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.27 140.34 44.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.738 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.8 m -62.94 -52.78 61.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.378 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -47.7 -44.73 27.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.614 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.509 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.0 t -70.05 -55.29 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.832 0.348 . . . . 0.0 110.991 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.479 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -57.39 -14.84 5.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.25 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.4 m -90.48 -41.43 11.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.246 178.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -60.1 -39.42 86.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.392 179.804 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -92.93 12.99 21.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.959 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.3 m120 55.15 24.28 6.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.623 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.709 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.4 mm -60.16 120.43 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.97 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.5 p -142.05 55.67 1.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.942 0.401 . . . . 0.0 111.109 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.44 42.37 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.432 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.625 ' HB2' HG21 ' A' ' 99' ' ' ILE . 35.6 m-20 52.24 43.37 30.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.232 0.539 . . . . 0.0 110.364 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.709 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.6 m -68.95 151.11 46.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.87 -178.427 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.575 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.0 mt -117.8 115.47 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.911 177.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.458 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 78.3 m -103.82 132.57 49.95 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.665 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.3 tp -109.07 103.68 12.74 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.803 178.312 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.6 t80 -98.73 122.15 41.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.821 0.343 . . . . 0.0 110.79 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.481 HH21 ' HB2' ' A' ' 88' ' ' ASP . 2.8 mtm180 -105.04 98.72 8.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.036 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.3 tp -41.9 -52.71 4.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.882 -179.533 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.615 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.7 -71.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.385 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.481 ' HB2' HH21 ' A' ' 85' ' ' ARG . 11.2 m-20 -88.33 6.01 39.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.041 -179.665 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 52.49 35.89 18.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.387 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 7.3 mm-40 -81.46 161.66 23.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.817 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -146.05 92.81 2.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.92 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.665 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -79.39 144.23 34.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.181 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -124.56 95.49 4.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.025 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.579 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -81.0 77.78 7.88 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.639 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.5 mt-10 -78.8 -165.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.514 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 25.5 t70 -51.01 -36.47 39.57 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.932 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -56.27 -14.61 2.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.183 0.516 . . . . 0.0 110.361 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -130.68 -13.95 3.67 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.592 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.625 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.0 mm -89.49 -32.71 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.754 0.311 . . . . 0.0 111.373 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -50.36 -47.98 55.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.728 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -122.05 38.31 4.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.609 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.579 HD13 HD21 ' A' ' 94' ' ' LEU . 7.0 tp -61.07 143.44 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.653 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.404 ' N ' HG13 ' A' ' 102' ' ' ILE . 19.1 m-20 -137.12 147.91 46.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.473 178.605 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.868 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.1 -35.26 6.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.99 0.424 . . . . 0.0 110.45 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -63.91 -48.68 75.62 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.423 178.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -58.98 -58.58 8.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.115 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.733 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.49 -55.78 14.47 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.998 0.428 . . . . 0.0 110.134 179.901 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.1 m -58.31 -28.98 65.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.823 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.7 tmt_? -72.65 -65.88 0.73 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.222 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -42.92 -42.82 3.86 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.04 179.112 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.503 HG12 HG21 ' A' ' 35' ' ' VAL . 92.2 mt -64.18 -56.63 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.576 178.371 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -52.33 -22.16 4.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.367 0.604 . . . . 0.0 110.211 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.475 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -85.17 -37.88 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.93 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.436 ' O ' HD21 ' A' ' 83' ' ' LEU . 17.7 m120 -123.64 30.78 6.1 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.312 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 111' ' ' ILE . 87.4 p -83.5 39.58 0.68 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.18 0.514 . . . . 0.0 110.066 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.7 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.291 -179.453 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.518 0.199 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.5 m 34.94 61.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.09 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.07 -27.77 65.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.978 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -63.79 144.24 57.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.5 m -141.75 -26.61 0.67 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.792 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 56.5 m -153.86 107.22 2.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -110.55 108.44 18.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -129.86 -176.06 14.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.384 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.26 130.86 42.44 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.555 2.17 . . . . 0.0 112.426 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.62 59.56 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.462 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.9 -51.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.823 0.344 . . . . 0.0 110.447 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.52 -82.28 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.632 179.585 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.532 ' HG3' HG12 ' A' ' 54' ' ' VAL . 11.1 pt20 -161.66 139.94 9.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.89 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.1 pt-20 -121.68 158.3 54.58 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.739 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.495 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.9 Cg_endo -66.3 140.71 59.53 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.55 2.167 . . . . 0.0 112.465 -179.701 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 m -56.46 150.5 15.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.666 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -96.27 93.36 6.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.98 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 24' ' ' ALA . 54.2 mt -90.7 72.93 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.511 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.7 p -74.96 2.11 11.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.065 -179.21 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -144.67 147.54 33.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 0.0 111.595 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.589 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 39.7 t -56.48 -50.21 89.08 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.622 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.96 -44.92 35.82 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 121.876 1.717 . . . . 0.0 111.797 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.85 -36.22 83.2 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.169 0.509 . . . . 0.0 110.33 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.61 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.21 -59.4 4.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.148 179.377 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 65.8 mtp -60.97 -25.19 66.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.139 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 21.3 mt-10 -72.59 -51.98 17.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.719 0.295 . . . . 0.0 110.648 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.507 ' O ' HG22 ' A' ' 31' ' ' THR . 12.5 m-85 -59.94 -31.87 70.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.935 179.368 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.572 HD11 HD12 ' A' ' 36' ' ' ILE . 50.7 mt -75.27 -38.8 41.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.938 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.61 -19.0 61.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.232 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.76 26.18 3.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.243 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.0 t -170.62 153.75 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.611 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.529 ' HG3' HG13 ' A' ' 87' ' ' VAL . 18.2 tt0 -64.5 -73.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.574 HG13 HD11 ' A' ' 83' ' ' LEU . 19.7 t -98.13 137.81 24.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.613 179.787 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.18 125.65 16.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.937 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 111' ' ' ILE . 55.0 t -114.07 130.16 68.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.85 178.558 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.572 HD12 HD11 ' A' ' 28' ' ' ILE . 27.0 mt -135.53 137.78 49.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.625 -177.264 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.24 98.08 1.75 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.587 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.523 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.0 m-85 -84.3 91.84 7.85 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.4 m-85 -110.84 143.87 40.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.287 -178.191 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -91.51 -3.3 56.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.522 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.6 t70 -154.8 118.46 4.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.596 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.494 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.8 mt -87.96 44.78 1.22 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.01 0.433 . . . . 0.0 111.329 -179.318 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 31.3 mt-10 -135.28 10.11 3.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.128 179.054 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.73 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.3 pt -92.77 157.57 39.4 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.477 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.462 ' O ' HD12 ' A' ' 49' ' ' ILE . 71.8 Cg_exo -52.22 -27.5 30.43 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.908 2.405 . . . . 0.0 112.898 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.73 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.36 -39.95 95.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.701 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -58.57 -56.89 30.92 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -178.633 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -58.87 -40.29 73.4 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.783 1.655 . . . . 0.0 111.438 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.874 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -61.85 -35.34 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.936 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.586 ' O ' HG23 ' A' ' 54' ' ' VAL . 39.7 tp -75.03 -54.67 6.76 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -52.68 -23.69 7.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.0 0.429 . . . . 0.0 109.947 178.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -84.22 -46.08 12.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.557 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.606 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.0 -25.26 63.48 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.318 0.58 . . . . 0.0 109.457 179.433 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.3 t -51.57 -50.49 29.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.121 179.352 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -76.08 -9.48 58.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.874 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -93.13 -19.74 21.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.998 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.9 m-85 -135.84 63.79 53.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.506 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.61 -43.2 57.05 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.707 2.272 . . . . 0.0 111.576 179.229 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.42 -42.29 93.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.337 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -65.27 143.77 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.67 ' HB2' HG21 ' A' ' 31' ' ' THR . 38.2 t -82.28 98.12 8.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 111.092 -179.627 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.495 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.4 p90 -65.37 128.35 35.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.927 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.485 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.83 161.84 28.62 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.025 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.419 HD11 HG13 ' A' ' 47' ' ' VAL . 4.7 tt -160.18 144.3 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 t -148.48 158.72 44.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.191 0.519 . . . . 0.0 111.865 -178.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 39' ' ' PHE . 72.5 p -141.49 1.03 1.53 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.585 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.02 144.97 52.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.663 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.4 m -66.67 -53.4 34.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.344 -179.522 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 2.2 mp0 -48.71 -42.95 36.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.511 -179.684 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.522 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.8 t -70.56 -56.12 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.051 0.453 . . . . 0.0 110.648 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.49 -15.08 3.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.315 179.477 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.5 m -90.87 -41.23 11.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.304 178.745 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -61.33 -31.91 71.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.251 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -100.02 12.39 37.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.274 179.63 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.7 m120 55.95 22.05 5.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.595 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.666 HG23 ' HB ' ' A' ' 80' ' ' THR . 32.4 mm -58.96 118.99 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.152 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.6 p -142.16 55.81 1.46 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.085 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.82 42.41 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.355 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.591 ' HB2' HG21 ' A' ' 99' ' ' ILE . 23.8 m-80 53.17 42.19 32.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.256 0.55 . . . . 0.0 110.203 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.666 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.9 m -67.93 151.77 46.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.864 -178.497 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.581 HG12 ' HA2' ' A' ' 37' ' ' GLY . 66.4 mt -118.95 115.79 49.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.88 177.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.523 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.4 m -105.34 132.65 51.26 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.656 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -108.34 103.91 13.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.925 178.327 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.5 t80 -97.36 123.58 41.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.847 0.356 . . . . 0.0 110.579 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.487 HH12 HD12 ' A' ' 116' ' ' LEU . 4.5 mtm180 -106.36 81.23 1.58 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.705 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 85' ' ' ARG . 4.6 tp -24.13 -59.76 0.05 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.06 -179.537 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.529 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.03 -61.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.064 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.9 4.29 49.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.953 0.406 . . . . 0.0 111.19 -179.428 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.9 m120 53.21 28.24 6.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.81 179.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.0 mm-40 -74.13 159.29 32.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.578 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -144.19 96.8 2.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.827 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.656 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.1 mm? -85.32 111.57 20.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.058 179.635 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -93.87 101.36 13.44 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.634 HD21 HD13 ' A' ' 102' ' ' ILE . 3.4 tt -86.72 75.82 9.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.656 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.0 mt-10 -77.1 -166.1 0.66 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -176.805 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.48 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -46.11 -50.67 15.13 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.398 -179.388 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -47.73 -16.3 0.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.976 0.417 . . . . 0.0 111.285 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.41 ' N ' ' C ' ' A' ' 96' ' ' ASP . 43.0 m-20 -126.38 -13.91 5.98 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.465 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.591 HG21 ' HB2' ' A' ' 79' ' ' ASN . 20.9 mm -91.46 -32.21 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -48.84 -59.31 3.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.962 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.6 p -110.72 36.28 3.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.585 179.623 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.634 HD13 HD21 ' A' ' 94' ' ' LEU . 8.7 tp -56.91 144.66 8.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.438 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.413 ' H ' ' HD3' ' A' ' 106' ' ' LYS . 21.7 m-20 -138.5 148.75 44.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.721 179.072 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.874 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.18 -36.72 14.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.029 0.442 . . . . 0.0 110.491 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 96.6 m -61.46 -49.07 78.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.174 178.724 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.413 ' HD3' ' H ' ' A' ' 103' ' ' ASP . 55.9 mtpt -58.1 -61.45 2.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.148 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.79 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.21 -56.54 7.69 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.903 0.382 . . . . 0.0 110.511 -179.849 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 56.6 m -58.31 -29.85 66.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.918 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.508 ' NH1' HD11 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -71.29 -64.7 0.86 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.252 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -44.52 -43.01 7.64 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.079 179.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.475 HG12 HG21 ' A' ' 35' ' ' VAL . 95.9 mt -63.76 -56.43 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.639 178.464 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -53.23 -19.39 3.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.179 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.508 HD11 ' NH1' ' A' ' 109' ' ' ARG . 1.3 mp -88.56 -37.75 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.07 -179.075 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.429 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.6 m120 -122.4 30.03 6.7 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.6 p -82.35 43.74 0.83 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.123 0.487 . . . . 0.0 110.152 178.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.487 HD12 HH12 ' A' ' 85' ' ' ARG . 49.5 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.408 -179.224 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.82 0.343 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.2 m -89.62 3.11 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.472 -179.881 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.09 136.23 57.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.967 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.6 mttp 58.64 -169.42 0.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.422 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.5 m -65.11 -26.21 68.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.264 -179.682 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.8 t 67.71 -75.21 0.06 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.162 -179.768 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.8 t70 63.47 107.24 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.99 0.424 . . . . 0.0 111.272 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.56 179.09 40.7 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.36 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -57.23 98.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.59 2.193 . . . . 0.0 112.186 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.89 58.66 0.51 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.706 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.39 -69.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.779 0.324 . . . . 0.0 110.795 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 13' ' ' GLN . . . 55.15 81.12 0.12 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.156 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.506 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.2 pt20 46.02 115.89 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 O-C-N 123.905 0.753 . . . . 0.0 112.66 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.9 pt-20 -111.46 157.84 38.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.687 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.503 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.7 Cg_endo -66.89 141.65 59.58 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.423 2.082 . . . . 0.0 112.173 -179.792 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.6 m -56.42 152.31 11.67 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.495 -179.547 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -99.79 85.67 3.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.062 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.603 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.7 mt -81.89 74.61 8.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.453 179.84 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.7 p -74.14 -1.96 22.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.98 -178.959 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -140.11 147.02 39.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.422 . . . . 0.0 111.643 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 32.2 t -56.09 -50.05 89.62 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.534 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.4 Cg_endo -58.74 -45.33 29.94 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.808 1.672 . . . . 0.0 111.718 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.54 -33.82 76.42 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.25 0.547 . . . . 0.0 110.169 179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.93 -59.11 4.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.006 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.8 mtp -60.6 -26.02 66.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.182 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.3 mt-10 -72.86 -50.97 20.66 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.708 0.289 . . . . 0.0 110.642 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.486 ' O ' HG22 ' A' ' 31' ' ' THR . 7.8 m-85 -59.92 -32.2 70.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.854 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 36' ' ' ILE . 47.6 mt -75.08 -40.5 44.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.08 0.466 . . . . 0.0 110.111 178.312 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -18.7 62.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.207 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.48 25.41 3.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.206 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.635 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.7 t -171.0 155.1 4.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.744 -179.788 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.522 ' HG3' HG13 ' A' ' 87' ' ' VAL . 18.4 tt0 -64.61 -77.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.824 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.584 HG13 HD11 ' A' ' 83' ' ' LEU . 20.2 t -95.93 136.97 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.731 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.516 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.41 126.04 17.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.942 0.401 . . . . 0.0 112.074 -179.124 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.421 HG21 HG12 ' A' ' 111' ' ' ILE . 53.9 t -114.53 131.01 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.836 178.539 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.559 HD12 HD11 ' A' ' 28' ' ' ILE . 27.9 mt -135.97 135.39 50.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.274 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.593 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.58 98.06 1.97 Allowed Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.619 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 10.8 m-85 -84.17 91.73 7.77 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.606 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.0 m-85 -112.08 137.98 49.37 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.128 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -83.21 -7.03 59.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.459 ' O ' HG12 ' A' ' 44' ' ' ILE . 7.2 t70 -152.03 125.6 8.89 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.654 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.551 ' HA ' HG21 ' A' ' 47' ' ' VAL . 96.0 mt -93.23 43.27 1.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.039 0.447 . . . . 0.0 111.407 -179.645 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -132.55 14.79 4.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.828 178.932 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.6 pt -99.08 157.77 33.48 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.197 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.477 ' O ' HD12 ' A' ' 49' ' ' ILE . 74.1 Cg_exo -52.99 -26.98 33.88 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.9 2.4 . . . . 0.0 112.956 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.781 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.77 -38.25 89.86 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.017 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.672 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.35 -56.4 34.2 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.629 -178.826 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.2 Cg_exo -59.64 -41.23 57.98 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.942 1.762 . . . . 0.0 111.372 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -61.16 -35.87 68.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.054 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.594 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.8 tp -73.68 -52.06 14.58 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 178.784 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -53.58 -25.18 16.2 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.705 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -81.76 -46.82 13.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.505 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.558 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.16 -25.81 64.24 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.357 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.7 t -53.06 -47.69 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.948 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.412 ' HA ' ' OE1' ' A' ' 13' ' ' GLN . 8.9 mt-30 -77.99 -11.62 59.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.714 -179.802 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -92.73 -17.77 23.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.155 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.618 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.3 m-85 -137.14 62.63 39.85 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.605 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.37 -39.46 81.47 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.517 2.145 . . . . 0.0 111.466 178.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.65 -39.42 96.55 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.458 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.1 t -68.58 144.09 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.067 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.635 ' HB2' HG21 ' A' ' 31' ' ' THR . 35.7 t -81.29 98.08 7.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 110.916 -179.754 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.503 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.2 p90 -65.16 127.52 32.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.77 162.88 28.57 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.212 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -160.68 143.71 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.774 0.321 . . . . 0.0 110.155 179.889 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.3 t -146.91 154.17 40.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.041 0.448 . . . . 0.0 111.512 -179.255 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.457 HG21 ' HG ' ' A' ' 42' ' ' LEU . 81.9 p -137.73 -4.75 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.71 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.35 144.49 55.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.831 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -64.35 -51.49 63.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.46 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -48.6 -45.26 37.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.656 -179.517 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.533 ' HA ' HG22 ' A' ' 21' ' ' VAL . 74.5 t -70.15 -53.47 23.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.829 0.347 . . . . 0.0 110.724 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.71 -14.32 8.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.351 179.416 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.2 m -91.91 -41.68 10.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.274 178.717 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -60.09 -39.62 86.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.414 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.42 ' HB2' HG12 ' A' ' 76' ' ' ILE . 59.0 m-85 -91.74 11.95 22.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.787 179.606 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 55.79 26.23 9.32 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.542 179.222 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.682 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.0 mm -61.89 122.06 11.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.226 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.6 p -140.83 58.2 1.55 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.311 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.87 46.77 0.02 OUTLIER Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.89 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.626 ' HB2' HG21 ' A' ' 99' ' ' ILE . 30.2 m-80 50.57 43.0 27.53 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.229 0.538 . . . . 0.0 110.543 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.682 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.6 m -69.17 152.57 44.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.686 -178.612 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.593 HG12 ' HA2' ' A' ' 37' ' ' GLY . 60.6 mt -118.9 118.34 57.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.107 178.189 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.9 m -107.89 134.07 51.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.651 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -109.53 104.73 13.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.085 178.544 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.4 t80 -97.3 122.61 40.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.464 179.555 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.583 HH12 HD12 ' A' ' 116' ' ' LEU . 5.6 mtm180 -106.85 82.71 1.74 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.928 0.394 . . . . 0.0 110.835 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tp -25.67 -60.03 0.07 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.127 -179.404 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.522 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.25 -58.75 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.852 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -98.83 13.28 32.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.758 0.313 . . . . 0.0 111.37 -179.177 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.2 p30 43.55 30.95 0.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.017 178.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.536 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 28.2 mm-40 -77.47 157.16 30.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.835 0.35 . . . . 0.0 110.916 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -142.26 94.48 2.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.676 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.651 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -85.25 121.69 28.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.637 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -105.16 103.77 13.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.767 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.555 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -89.63 78.67 6.96 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.817 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.1 mt-10 -79.81 -165.87 0.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.81 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.491 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.1 -51.06 10.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.7 -179.311 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -46.56 -18.88 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.857 0.361 . . . . 0.0 111.088 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 96' ' ' ASP . 16.2 m-20 -124.73 -13.82 6.89 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.488 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.626 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.7 mm -90.59 -40.61 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.363 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -49.08 -40.91 33.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.342 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.3 t -123.68 36.41 4.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.449 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.58 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 8.1 tp -63.14 144.68 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.475 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -139.69 147.88 41.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.475 178.756 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.11 -37.84 10.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.984 0.421 . . . . 0.0 110.554 -179.571 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -61.43 -47.55 85.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.311 178.647 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -60.12 -60.83 3.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.215 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.763 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.0 -55.56 11.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.329 -179.999 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.0 m -58.45 -30.49 66.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.732 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.443 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.5 tmt_? -70.4 -66.55 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.128 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -42.62 -45.16 4.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.169 179.454 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.421 HG12 HG21 ' A' ' 35' ' ' VAL . 96.4 mt -62.41 -54.76 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.306 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.41 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 40.8 tt0 -54.6 -18.78 4.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.426 179.397 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.443 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.62 -37.43 10.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.79 -178.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.419 ' O ' HD21 ' A' ' 83' ' ' LEU . 19.9 m120 -122.96 29.36 6.82 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.387 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 78.9 p -82.65 50.85 1.75 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.118 0.485 . . . . 0.0 110.092 178.824 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.583 HD12 HH12 ' A' ' 85' ' ' ARG . 57.0 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.278 -0.867 . . . . 0.0 111.374 -179.251 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.91 0.386 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.5 m -86.21 174.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.867 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 57.63 93.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.979 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -81.12 -71.27 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.998 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.2 t -105.63 130.81 53.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.052 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.8 t -126.27 146.04 50.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.698 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -106.88 101.42 10.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.067 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.22 -160.5 54.06 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.54 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.82 -39.42 91.22 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.64 2.226 . . . . 0.0 112.413 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.25 -83.46 0.35 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.426 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.99 -45.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.87 0.367 . . . . 0.0 110.445 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.65 -83.59 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.695 179.388 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.482 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.8 pt20 -140.65 146.83 38.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 111.034 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.1 pt-20 -131.78 157.77 77.28 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.714 179.902 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.7 Cg_endo -65.37 145.21 82.68 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.618 2.212 . . . . 0.0 112.48 -179.569 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 17' ' ' TRP . 21.8 m -61.76 155.36 23.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.74 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.414 ' N ' HG22 ' A' ' 16' ' ' THR . 7.4 m-90 -99.1 91.46 5.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.077 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.628 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.8 mt -87.97 74.19 8.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.415 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.7 p -73.02 -3.18 24.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.156 -178.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -141.31 148.28 39.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.865 0.364 . . . . 0.0 111.643 -179.721 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.609 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.9 t -56.54 -50.28 88.7 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.407 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -57.34 -44.04 46.6 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 121.97 1.78 . . . . 0.0 111.866 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.24 -36.91 85.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.206 0.527 . . . . 0.0 110.184 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.628 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.87 -59.05 5.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.026 179.499 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.0 mtp -60.55 -27.19 67.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.212 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 19.8 mt-10 -70.66 -49.29 48.87 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.746 0.308 . . . . 0.0 110.547 179.843 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.57 ' O ' HG22 ' A' ' 31' ' ' THR . 9.5 m-85 -61.52 -34.16 75.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.243 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 36' ' ' ILE . 50.0 mt -72.99 -37.06 52.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.126 0.488 . . . . 0.0 109.939 178.345 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.01 -19.43 60.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.959 -179.849 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.61 23.95 4.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.297 -179.651 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.674 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.1 t -169.96 153.33 4.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.518 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.542 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.2 tt0 -63.92 -80.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.669 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.544 HG13 HD11 ' A' ' 83' ' ' LEU . 16.9 t -91.86 134.15 31.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.489 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.43 126.06 22.11 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.195 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.474 HG21 HG12 ' A' ' 111' ' ' ILE . 48.9 t -114.21 129.13 70.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.811 178.546 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.559 HD12 HD11 ' A' ' 28' ' ' ILE . 24.2 mt -135.59 137.17 49.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.439 -177.524 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.527 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.61 98.71 1.89 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.427 179.734 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.48 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 45.7 m-85 -84.62 93.05 8.3 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.302 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.2 m-85 -112.33 145.86 39.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.351 -177.986 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -93.81 -4.95 49.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.516 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.1 t70 -152.68 118.39 5.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.599 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.518 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.4 mt -88.15 45.8 1.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 111.336 -179.295 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 45.4 mt-10 -136.03 9.06 3.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.125 179.161 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.779 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.7 pt -92.27 157.52 40.48 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.152 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.49 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.3 Cg_exo -52.53 -27.94 34.36 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.855 2.37 . . . . 0.0 112.865 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.779 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.47 -37.79 87.29 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.936 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.684 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.51 -57.35 25.63 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.654 -178.833 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.659 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -59.39 -38.97 80.94 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.794 1.663 . . . . 0.0 111.37 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -63.26 -35.19 71.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.89 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.7 tp -74.61 -53.35 9.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.73 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -54.64 -21.81 11.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.009 0.433 . . . . 0.0 110.04 178.874 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 t -85.89 -45.01 11.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.491 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.583 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.31 -25.83 66.07 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.296 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.4 t -52.39 -49.92 40.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.999 179.286 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -74.91 -9.59 58.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.721 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.1 mtpp -94.83 -19.35 20.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.09 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.569 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 70.4 m-85 -135.96 63.03 49.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.476 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.4 -43.15 56.36 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.629 2.219 . . . . 0.0 111.632 179.145 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.89 -42.66 92.43 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.338 179.188 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.8 t -64.47 145.27 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.815 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.674 ' HB2' HG21 ' A' ' 31' ' ' THR . 29.9 t -83.15 98.94 9.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.033 0.444 . . . . 0.0 111.072 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.52 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.0 p90 -66.47 126.66 29.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.1 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.55 161.34 28.37 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.145 179.645 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.416 HD11 HG13 ' A' ' 47' ' ' VAL . 4.9 tt -159.98 144.01 5.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.474 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 31.1 t -148.05 159.52 43.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.006 0.431 . . . . 0.0 111.705 -179.306 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 50.6 p -140.46 -2.56 1.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.086 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.43 141.11 55.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.744 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.0 m -62.99 -50.91 68.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.553 -179.417 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -48.95 -44.61 40.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.638 -179.37 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.517 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.3 t -70.01 -54.4 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.909 0.385 . . . . 0.0 110.766 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -57.97 -14.51 6.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.303 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 76.4 m -91.62 -40.14 11.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.227 178.659 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -60.68 -39.67 89.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.38 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.411 ' HB2' HG12 ' A' ' 76' ' ' ILE . 93.0 m-85 -93.09 13.88 19.58 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.444 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 m120 54.8 26.2 7.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.582 179.519 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.717 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.6 mm -61.19 120.7 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.01 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.5 p -140.74 58.28 1.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.323 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.47 44.26 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.643 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.603 ' HB2' HG21 ' A' ' 99' ' ' ILE . 35.2 m-20 51.75 43.49 29.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.284 0.564 . . . . 0.0 110.353 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.717 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.4 m -68.66 152.28 45.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.786 -178.646 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.527 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.2 mt -119.21 115.68 48.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.97 177.898 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.48 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 72.5 m -104.11 131.03 51.81 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.722 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.658 ' HG ' HD23 ' A' ' 92' ' ' LEU . 1.9 tp -106.96 102.16 11.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.492 177.906 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.1 t80 -95.73 119.68 34.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.806 -179.883 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.475 HH12 HD12 ' A' ' 116' ' ' LEU . 4.4 mtm180 -102.97 80.86 1.91 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.673 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 85' ' ' ARG . 4.7 tp -24.87 -59.14 0.06 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.351 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.542 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.13 -62.51 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.088 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -95.35 2.88 54.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.087 0.47 . . . . 0.0 110.797 -179.677 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 52.42 33.13 12.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.445 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 12.7 mm-40 -79.37 158.2 27.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.84 99.1 3.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.953 0.406 . . . . 0.0 110.885 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.658 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -87.59 107.6 18.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.747 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -90.89 95.12 9.96 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.572 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.572 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -79.6 76.98 6.22 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.594 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.3 mt-10 -78.46 -165.44 0.7 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -176.811 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.483 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -46.03 -50.02 15.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.484 -179.233 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -47.83 -17.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.963 0.411 . . . . 0.0 110.943 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 96' ' ' ASP . 13.7 m-20 -125.65 -13.67 6.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.392 -179.735 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.603 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.1 mm -91.87 -46.31 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.559 0.219 . . . . 0.0 111.561 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -48.82 -31.05 6.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.913 0.387 . . . . 0.0 110.739 179.783 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 57.0 m -131.25 45.55 2.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.072 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.572 HD13 HD21 ' A' ' 94' ' ' LEU . 8.1 tp -78.61 146.39 8.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.79 -179.452 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.427 ' N ' HG13 ' A' ' 102' ' ' ILE . 6.1 m-20 -141.37 148.8 40.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.266 178.616 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.13 -37.36 9.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 110.593 -179.598 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -61.44 -49.2 77.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.401 178.722 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -58.66 -60.47 3.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.151 -179.685 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.802 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.93 -55.72 10.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.006 0.432 . . . . 0.0 110.264 -179.954 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.3 m -58.35 -29.57 66.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.819 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.515 ' HD3' HD13 ' A' ' 113' ' ' ILE . 1.7 tmt_? -72.15 -66.56 0.63 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.184 179.713 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -42.05 -44.12 3.46 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.05 179.147 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.474 HG12 HG21 ' A' ' 35' ' ' VAL . 96.7 mt -62.5 -55.02 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.517 178.386 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -55.25 -17.85 5.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.325 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.515 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -91.01 -36.0 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.856 -179.185 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.449 ' OD1' HG22 ' A' ' 113' ' ' ILE . 30.4 m120 -119.33 26.4 9.46 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.9 p -79.92 46.12 0.77 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.044 0.449 . . . . 0.0 110.306 178.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.475 HD12 HH12 ' A' ' 85' ' ' ARG . 57.0 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.413 -179.336 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.777 0.322 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.621 HG22 ' HG2' ' A' ' 3' ' ' GLU . 11.5 p -87.84 141.28 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.051 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.621 ' HG2' HG22 ' A' ' 2' ' ' VAL . 15.8 mm-40 60.6 -84.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.354 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.482 ' HA ' ' HE3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -88.34 -174.2 4.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.185 -179.687 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.3 m -83.81 -165.51 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 t -64.56 -61.75 2.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -149.24 -36.87 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.141 179.768 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.45 -163.89 24.14 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.644 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.65 143.92 98.12 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.665 2.243 . . . . 0.0 112.318 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.24 110.78 3.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.598 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.87 -24.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.924 0.392 . . . . 0.0 110.592 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.498 ' HB1' ' NE2' ' A' ' 55' ' ' GLN . . . -53.66 92.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.31 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.589 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.6 pt20 -50.31 155.88 0.94 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.537 179.893 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.47 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.3 pt-20 -124.67 158.63 61.49 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.369 179.641 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.482 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.4 Cg_endo -65.48 142.62 72.56 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.421 2.081 . . . . 0.0 112.611 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.5 m -60.76 151.45 29.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.695 -179.595 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -95.17 92.01 6.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.083 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.631 HD22 ' HA ' ' A' ' 24' ' ' ALA . 65.2 mt -88.72 77.64 7.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.411 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.6 p -77.26 -3.19 38.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.023 -179.113 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -141.69 147.33 37.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.948 0.404 . . . . 0.0 111.774 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 22.1 t -55.22 -50.02 88.98 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.633 179.875 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.89 -45.82 30.17 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.939 1.759 . . . . 0.0 111.793 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.23 -33.99 76.69 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.205 0.526 . . . . 0.0 110.149 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.631 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.52 -59.39 4.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.116 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 47.3 mtm -61.1 -26.33 67.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.131 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.9 mt-10 -71.23 -52.07 21.08 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.702 0.286 . . . . 0.0 110.437 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -59.79 -30.71 69.08 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.122 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.504 HD11 HD12 ' A' ' 36' ' ' ILE . 47.2 mt -74.59 -37.81 44.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.965 178.188 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.6 -18.56 61.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.813 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.89 27.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.057 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.617 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.7 t -169.05 156.65 7.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.328 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.623 ' HG3' HG13 ' A' ' 87' ' ' VAL . 27.6 tt0 -75.56 -37.2 60.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.657 179.617 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.545 HG13 HD11 ' A' ' 83' ' ' LEU . 18.7 t -132.29 131.45 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.291 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -137.25 128.27 27.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.032 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.471 HG21 HG12 ' A' ' 111' ' ' ILE . 52.7 t -116.03 127.92 73.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.692 178.39 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.504 HD12 HD11 ' A' ' 28' ' ' ILE . 20.6 mt -133.79 137.08 53.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.781 -177.251 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.85 96.29 1.61 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.371 179.726 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.0 m-85 -81.51 88.55 6.17 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.524 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -108.43 142.57 38.59 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.194 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -90.29 -8.97 49.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.804 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.497 ' O ' HG12 ' A' ' 44' ' ' ILE . 15.6 t70 -148.54 119.28 7.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.521 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.555 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.5 mt -89.06 45.17 1.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.131 0.491 . . . . 0.0 111.588 -179.279 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.5 mt-10 -135.31 8.28 3.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.069 178.939 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.841 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.5 pt -92.19 156.09 42.24 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.169 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.518 ' O ' HD12 ' A' ' 49' ' ' ILE . 86.3 Cg_exo -49.78 -31.32 25.62 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.794 2.329 . . . . 0.0 112.807 179.684 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.841 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -59.14 -37.38 77.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.29 -178.914 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.696 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.5 t -62.28 -58.3 18.17 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.578 -178.912 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.696 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.5 Cg_exo -58.97 -40.94 66.69 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.697 1.598 . . . . 0.0 111.272 179.187 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.947 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -60.46 -35.5 63.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.738 179.66 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.583 ' O ' HG23 ' A' ' 54' ' ' VAL . 49.0 tp -74.3 -53.75 9.06 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -53.83 -24.03 14.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.105 0.479 . . . . 0.0 109.946 178.823 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.0 m -82.97 -45.11 14.51 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.342 179.551 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.61 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.58 -26.41 66.94 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.368 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.589 HG12 ' HG3' ' A' ' 13' ' ' GLN . 62.3 t -53.16 -50.7 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.976 179.518 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.498 ' NE2' ' HB1' ' A' ' 12' ' ' ALA . 34.5 mt-30 -73.23 -10.97 60.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.617 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -93.96 -19.42 20.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.295 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.592 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 54.2 m-85 -135.88 61.79 43.38 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.472 -179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.02 -40.5 76.26 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.565 2.176 . . . . 0.0 111.415 179.175 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.17 -43.0 95.56 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.357 178.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.1 t -65.02 146.08 13.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 178.86 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.617 ' HB2' HG21 ' A' ' 31' ' ' THR . 37.5 t -83.1 95.73 8.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.053 0.454 . . . . 0.0 111.054 -179.61 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.482 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.8 p90 -61.42 128.9 38.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.75 179.49 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -148.84 160.98 28.58 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.251 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.5 tt -159.47 143.54 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.696 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.4 t -147.28 155.29 41.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.154 0.502 . . . . 0.0 111.833 -178.93 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 39' ' ' PHE . 81.4 p -138.77 -0.31 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.587 179.561 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -68.61 141.98 55.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.571 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 t -65.12 -51.34 61.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.411 -179.494 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -50.91 -42.05 59.05 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.551 -179.377 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HA ' HG22 ' A' ' 21' ' ' VAL . 57.4 t -71.15 -53.39 21.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.92 0.39 . . . . 0.0 110.596 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.05 -15.43 13.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.324 179.429 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.4 m -91.24 -40.6 11.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.359 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -61.13 -38.22 85.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.345 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -93.25 14.28 18.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.682 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 54.45 23.32 4.41 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.643 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.707 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.6 mm -57.72 120.05 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.961 179.754 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.2 p -139.01 57.36 1.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.492 -179.618 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.36 49.3 0.02 OUTLIER Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.738 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.598 ' HB2' HG21 ' A' ' 99' ' ' ILE . 34.3 m-20 48.17 43.68 18.79 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.207 0.527 . . . . 0.0 110.292 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.707 ' HB ' HG23 ' A' ' 76' ' ' ILE . 97.2 m -69.34 151.53 46.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.737 -178.373 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.581 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.9 mt -118.27 117.0 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.835 178.12 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.516 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.1 m -106.05 130.93 53.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.824 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.634 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -107.23 104.19 13.75 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.525 177.952 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.2 t80 -98.7 121.1 40.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.798 0.332 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.538 HH12 HD12 ' A' ' 116' ' ' LEU . 3.8 mtm180 -104.38 98.45 8.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.094 179.711 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tp -42.07 -50.46 4.7 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.783 -179.389 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.623 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.86 -65.21 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.516 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.442 ' HB2' HH21 ' A' ' 85' ' ' ARG . 9.7 m-20 -99.01 10.57 41.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.562 -179.315 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 85' ' ' ARG . 78.1 m-20 49.66 34.27 7.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.509 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 8.2 mm-40 -78.02 157.69 29.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.122 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -142.34 97.2 3.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.808 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.634 HD23 ' HG ' ' A' ' 83' ' ' LEU . 1.9 mm? -88.06 113.52 23.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.767 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -95.84 96.91 9.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.817 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.572 HD21 HD13 ' A' ' 102' ' ' ILE . 4.1 tt -80.98 78.76 7.77 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.626 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.0 mt-10 -80.77 -163.79 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.762 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.497 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 17.4 t70 -50.66 -37.7 42.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.047 -179.2 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -55.34 -14.93 2.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.118 0.485 . . . . 0.0 110.393 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -131.14 -13.76 3.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.605 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.598 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.8 mm -89.63 -32.98 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.612 0.244 . . . . 0.0 111.379 -179.376 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -51.51 -49.38 62.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.704 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.3 m -117.79 38.14 3.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.526 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.592 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.2 tp -63.93 147.0 12.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.645 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.465 ' N ' HG13 ' A' ' 102' ' ' ILE . 11.5 t70 -141.09 165.24 28.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.685 178.574 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.947 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -62.12 -35.57 79.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.144 0.497 . . . . 0.0 109.691 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -64.66 -47.5 78.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.222 178.705 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -59.31 -59.37 5.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.177 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.76 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.21 -55.62 14.49 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.937 0.399 . . . . 0.0 110.132 179.656 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.5 m -58.85 -28.65 66.29 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.82 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.549 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.9 tmt_? -71.93 -66.45 0.64 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.185 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -42.9 -43.71 4.22 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.166 179.177 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.471 HG12 HG21 ' A' ' 35' ' ' VAL . 95.4 mt -63.38 -54.69 29.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.551 178.452 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -54.52 -19.36 5.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.23 179.261 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.549 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -87.89 -37.67 10.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.939 -179.109 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -121.76 29.39 7.16 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.601 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 81.1 p -81.65 44.97 0.85 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.11 0.481 . . . . 0.0 110.232 178.959 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.538 HD12 HH12 ' A' ' 85' ' ' ARG . 52.6 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.185 -179.398 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.775 0.321 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.8 m -101.38 19.14 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.219 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -99.33 124.53 44.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.96 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 4' ' ' LYS . 11.4 mmpt? 55.72 42.85 28.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.992 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.1 t -149.05 30.23 0.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.687 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.6 m -146.81 87.67 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.995 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -121.13 -172.33 2.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.86 -152.82 33.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.279 -179.828 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -56.93 104.36 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.508 2.139 . . . . 0.0 112.062 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.33 110.2 3.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.546 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.78 -74.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.621 0.248 . . . . 0.0 110.779 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.0 -80.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.269 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.487 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.5 pt20 -167.23 148.0 5.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.482 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.7 pt-20 -131.87 158.4 75.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.985 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.499 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 38.8 Cg_endo -66.76 142.85 65.07 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.592 2.195 . . . . 0.0 112.389 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.3 m -61.81 152.87 30.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.765 -179.315 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.51 94.91 7.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.866 179.699 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.621 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.8 mt -90.52 71.48 6.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.373 179.855 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.0 p -70.92 -5.04 27.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.945 -179.23 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -137.53 146.49 44.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.007 0.432 . . . . 0.0 111.656 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.615 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.9 t -56.12 -49.17 94.7 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.377 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -58.11 -46.46 25.35 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.936 1.757 . . . . 0.0 111.869 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.68 -34.85 77.96 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.344 0.592 . . . . 0.0 110.251 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.621 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.8 -59.84 4.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.113 179.399 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 30.6 mtt -60.7 -25.88 66.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.207 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 31.3 mt-10 -71.27 -51.13 26.2 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.373 179.639 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -60.66 -30.32 69.83 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.159 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.517 HD11 HD12 ' A' ' 36' ' ' ILE . 45.6 mt -76.22 -37.01 31.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.96 178.15 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.02 -23.08 61.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.813 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.13 31.65 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.923 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.506 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.9 t -170.22 151.25 3.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.337 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.522 ' HG3' HG13 ' A' ' 87' ' ' VAL . 23.3 tt0 -70.73 -50.36 37.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.58 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.528 HG13 HD11 ' A' ' 83' ' ' LEU . 19.1 t -119.7 136.34 57.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.359 179.262 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.56 128.55 20.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.013 0.435 . . . . 0.0 112.119 -178.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG21 HG12 ' A' ' 111' ' ' ILE . 47.1 t -115.5 128.81 72.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.672 178.469 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.517 HD12 HD11 ' A' ' 28' ' ' ILE . 23.8 mt -135.03 136.08 52.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -177.306 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.58 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.48 97.24 1.78 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.455 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.4 m-85 -83.39 90.98 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.9 m-85 -110.5 142.71 41.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.037 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.456 ' HG2' HD23 ' A' ' 71' ' ' LEU . 50.8 mt-30 -91.04 -0.96 57.85 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.803 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.498 ' O ' HG12 ' A' ' 44' ' ' ILE . 26.6 t70 -157.59 119.39 3.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.571 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.495 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.2 mt -89.15 45.4 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.087 0.47 . . . . 0.0 111.386 -179.262 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.1 mt-10 -134.66 12.04 3.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.01 179.094 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.741 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.5 pt -95.53 158.29 34.75 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.483 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.487 ' O ' HD12 ' A' ' 49' ' ' ILE . 73.4 Cg_exo -52.73 -28.65 38.84 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.853 2.369 . . . . 0.0 112.721 179.42 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.741 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -61.63 -38.09 86.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.012 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.692 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.05 -57.69 24.48 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.681 -178.724 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.675 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.5 Cg_exo -59.46 -39.49 75.53 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.775 1.65 . . . . 0.0 111.431 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.7 mt -62.5 -36.06 73.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.008 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.586 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.1 tp -74.8 -54.07 7.99 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.852 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -53.45 -23.63 10.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.952 0.406 . . . . 0.0 110.025 178.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 t -84.27 -45.54 12.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.474 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.605 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.33 -25.6 64.31 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.342 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.2 t -51.89 -49.08 38.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.265 179.391 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -76.76 -9.08 58.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.738 -179.82 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -94.94 -18.71 20.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.156 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.569 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.4 m-85 -136.86 63.21 44.49 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.368 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.55 -46.12 35.46 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.643 2.229 . . . . 0.0 111.643 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.82 -42.87 69.97 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.392 179.038 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -65.03 144.28 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.781 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.506 ' CB ' HG21 ' A' ' 31' ' ' THR . 46.8 t -82.35 98.79 9.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.078 0.466 . . . . 0.0 111.159 -179.554 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.499 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.1 p90 -65.35 126.72 29.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.009 179.728 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.504 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.73 161.98 28.46 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.187 179.861 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -160.57 143.3 4.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.2 t -146.18 156.67 43.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.183 0.516 . . . . 0.0 111.675 -179.066 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.449 HG21 ' HG ' ' A' ' 42' ' ' LEU . 52.2 p -139.17 -3.63 1.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.589 179.548 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.44 140.46 57.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.401 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.4 t -64.63 -47.64 77.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.68 -179.31 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -51.77 -43.68 63.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.73 -0.213 . . . . 0.0 111.554 -179.307 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.527 ' HA ' HG22 ' A' ' 21' ' ' VAL . 79.7 t -71.75 -52.37 25.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.722 0.296 . . . . 0.0 110.513 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.456 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -58.48 -15.0 9.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.24 179.271 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.7 m -92.61 -40.52 10.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.429 178.789 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -62.41 -33.08 74.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.428 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.414 ' HB2' HG12 ' A' ' 76' ' ' ILE . 28.7 m-85 -97.07 9.81 41.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.864 179.507 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.6 t30 60.1 20.7 9.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.569 178.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.674 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.9 mm -58.36 117.92 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 179.818 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.9 p -138.38 56.78 1.71 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.283 179.951 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.22 45.45 0.02 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.677 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 17.6 m-80 51.26 43.11 29.47 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.243 0.545 . . . . 0.0 110.398 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.674 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.5 m -69.05 151.08 46.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.673 -178.573 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.58 HG12 ' HA2' ' A' ' 37' ' ' GLY . 70.9 mt -118.32 116.8 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.882 178.045 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.5 m -105.89 130.88 53.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.808 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.612 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -105.37 99.73 9.33 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.389 177.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.1 t80 -92.63 121.85 34.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.583 179.854 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.504 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.0 mtm180 -106.41 85.56 2.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.83 -179.684 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.9 tp -26.51 -60.2 0.08 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.365 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.522 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.94 -71.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 O-C-N 123.448 0.467 . . . . 0.0 112.092 -179.161 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.04 5.32 41.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 110.687 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 51.12 33.44 9.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.148 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.504 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 14.1 mm-40 -75.64 164.77 25.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.727 179.535 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.79 89.01 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.836 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.612 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.6 mm? -76.6 111.71 12.38 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.544 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -94.48 97.53 10.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.488 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.548 HD21 HD13 ' A' ' 102' ' ' ILE . 4.4 tt -82.93 77.29 9.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.593 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.448 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.2 mt-10 -78.91 -165.12 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.785 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.512 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 19.4 t70 -51.67 -35.42 42.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.686 -179.291 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -56.57 -15.19 3.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.225 0.536 . . . . 0.0 110.24 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -130.33 -13.99 3.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.779 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.57 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.4 mm -89.44 -29.59 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.684 0.278 . . . . 0.0 111.514 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.52 -38.38 69.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.855 0.36 . . . . 0.0 110.961 -179.801 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.8 t -129.78 38.74 3.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.319 179.685 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.548 HD13 HD21 ' A' ' 94' ' ' LEU . 6.8 tp -64.02 141.74 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.559 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -137.24 149.81 47.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.531 178.786 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.889 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.67 -37.31 12.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.923 0.392 . . . . 0.0 110.337 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -61.88 -49.09 77.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.147 178.69 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -58.65 -61.31 2.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.23 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.73 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.18 -57.34 6.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 110.35 179.908 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.3 m -57.06 -30.38 64.23 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.8 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.506 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -70.91 -65.72 0.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.186 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -42.82 -40.91 3.05 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.044 179.277 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.459 HG12 HG21 ' A' ' 35' ' ' VAL . 96.2 mt -65.9 -56.29 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.247 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -53.21 -18.26 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.325 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.506 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -90.31 -39.5 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.87 -179.108 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.454 ' OD1' HG22 ' A' ' 113' ' ' ILE . 33.0 m120 -118.72 28.73 8.13 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.775 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.3 p -82.22 50.26 1.56 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.023 0.44 . . . . 0.0 110.35 179.224 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.495 HD12 HH12 ' A' ' 85' ' ' ARG . 67.2 mt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.265 -179.618 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.906 0.384 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.501 HG23 ' HG3' ' A' ' 3' ' ' GLU . 27.5 m -104.99 -10.33 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.178 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.501 ' HG3' HG23 ' A' ' 2' ' ' VAL . 46.2 mt-10 -120.67 146.69 46.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.0 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -135.12 16.94 3.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.718 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 t -126.51 117.93 23.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.967 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.5 m -69.07 103.86 1.98 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.821 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -65.22 147.0 54.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.96 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.56 -75.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.516 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.16 130.36 32.06 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.671 2.248 . . . . 0.0 112.353 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.0 158.36 19.59 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.282 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.27 -32.39 0.05 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.951 0.405 . . . . 0.0 110.782 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.17 -30.69 62.57 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.996 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.484 ' HG3' HG12 ' A' ' 54' ' ' VAL . 11.5 pt20 -173.45 145.91 1.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.687 -179.848 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.7 pt-20 -133.05 158.7 75.16 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.062 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 37.7 Cg_endo -67.78 145.44 69.08 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.739 2.293 . . . . 0.0 112.559 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -64.14 153.35 38.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.554 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -98.13 95.02 7.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.799 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 24' ' ' ALA . 44.7 mt -91.45 71.91 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.357 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.2 p -70.84 -4.28 23.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.169 -179.157 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -139.46 147.34 41.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.378 . . . . 0.0 111.661 -179.717 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 35.3 t -55.64 -49.69 91.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.559 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.68 -46.39 27.18 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.917 1.745 . . . . 0.0 112.053 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.79 81.45 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.176 0.513 . . . . 0.0 110.2 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.608 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.55 -58.84 5.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.121 179.328 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.6 mtp -60.37 -25.54 65.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.157 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -72.61 -51.16 20.82 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.608 179.637 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.4 ' O ' HG22 ' A' ' 31' ' ' THR . 8.5 m-85 -60.63 -30.73 70.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.199 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.511 HD11 HD12 ' A' ' 36' ' ' ILE . 53.4 mt -75.79 -37.96 36.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.052 178.417 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.85 -17.08 60.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.285 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.42 26.62 3.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.078 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.7 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.2 t -167.86 153.09 6.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.54 -179.652 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.592 ' HG3' HG13 ' A' ' 87' ' ' VAL . 25.0 tt0 -66.79 -52.31 45.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.89 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.539 HG13 HD11 ' A' ' 83' ' ' LEU . 22.4 t -119.83 137.39 53.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.322 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.71 128.55 21.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.193 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG21 HG12 ' A' ' 111' ' ' ILE . 52.1 t -116.61 131.76 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.572 178.511 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.511 HD12 HD11 ' A' ' 28' ' ' ILE . 21.0 mt -136.62 136.73 48.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.487 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.593 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.34 97.53 1.83 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.549 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.1 m-85 -83.7 92.49 7.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.6 m-85 -112.95 140.44 47.76 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.166 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.457 ' HG2' HD23 ' A' ' 71' ' ' LEU . 51.7 mt-30 -88.93 0.33 56.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.718 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 44' ' ' ILE . 24.8 t70 -157.96 120.72 3.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.66 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.499 ' HA ' HG21 ' A' ' 47' ' ' VAL . 91.7 mt -90.62 46.53 1.34 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 111.428 -179.307 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.447 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 36.8 mt-10 -136.95 9.72 3.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 179.122 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.779 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.3 pt -92.97 157.01 39.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.313 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.471 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.4 Cg_exo -52.01 -25.26 21.75 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.943 2.429 . . . . 0.0 113.022 179.719 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.779 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.44 -38.59 90.3 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.669 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -59.95 -55.59 44.01 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.583 -178.776 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.632 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.96 -41.31 54.38 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.928 1.752 . . . . 0.0 111.502 179.218 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.3 mt -61.57 -34.6 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.208 179.83 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 54' ' ' VAL . 45.8 tp -73.93 -52.71 12.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.968 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -53.03 -26.96 17.39 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.576 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.9 m -80.07 -46.45 16.51 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.621 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.565 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.75 -25.99 65.31 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.446 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.8 t -53.1 -49.37 50.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.718 179.368 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -76.23 -9.7 58.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.666 -179.855 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -94.92 -17.8 21.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.116 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.566 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 68.3 m-85 -138.35 63.01 33.56 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.441 -179.845 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.01 -43.56 56.02 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.623 2.215 . . . . 0.0 111.651 179.145 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.23 -40.83 85.4 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.239 179.041 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.3 t -66.19 142.99 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.845 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.7 ' HB2' HG21 ' A' ' 31' ' ' THR . 42.1 t -80.79 96.8 7.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.959 0.409 . . . . 0.0 110.957 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.475 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.9 p90 -62.59 126.94 29.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.836 179.582 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.495 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.16 161.76 28.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.256 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.8 tt -161.24 142.24 3.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.749 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -147.59 154.14 40.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.1 0.476 . . . . 0.0 111.803 -178.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.454 HG21 ' HG ' ' A' ' 42' ' ' LEU . 68.4 p -135.57 -2.08 2.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.534 179.529 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.408 ' O ' HD13 ' A' ' 71' ' ' LEU . 23.9 t70 -67.18 142.48 56.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.717 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.1 m -65.95 -49.85 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.664 -179.461 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -50.47 -43.24 55.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.436 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.496 ' HA ' HG22 ' A' ' 21' ' ' VAL . 76.2 t -71.45 -53.21 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.668 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.457 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -58.52 -14.63 8.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.222 179.371 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 78.4 m -91.89 -41.2 10.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.252 178.749 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -61.22 -34.86 75.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.318 179.703 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 76' ' ' ILE . 47.7 m-85 -96.01 11.91 32.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.854 179.516 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 56.05 22.74 6.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.646 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.674 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.5 mm -59.03 120.21 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.951 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.1 p -140.7 55.2 1.59 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.333 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.75 45.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.458 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.618 ' HB2' HG21 ' A' ' 99' ' ' ILE . 22.2 m-80 50.71 43.43 27.92 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.15 0.5 . . . . 0.0 110.44 -179.826 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.674 ' HB ' HG23 ' A' ' 76' ' ' ILE . 98.0 m -69.61 152.31 44.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.77 -178.495 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.625 HG21 HD21 ' A' ' 107' ' ' LEU . 62.8 mt -118.8 118.17 56.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.892 178.075 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.2 m -106.81 134.78 49.44 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.634 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -110.79 103.36 11.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.788 178.227 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -96.96 123.0 40.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.525 179.802 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.539 HH12 HD12 ' A' ' 116' ' ' LEU . 5.5 mtm180 -106.07 96.33 6.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.051 0.453 . . . . 0.0 110.187 179.803 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.4 tp -40.45 -50.2 2.88 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.558 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.592 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -44.66 -68.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.85 0.357 . . . . 0.0 111.908 -179.627 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.447 ' HB2' HH21 ' A' ' 85' ' ' ARG . 17.7 m-20 -92.85 17.76 10.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.442 -179.424 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.9 p30 43.11 31.3 0.34 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.043 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.511 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 13.7 mm-40 -76.59 162.48 27.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.824 0.345 . . . . 0.0 111.14 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.01 87.1 1.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.967 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.634 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -76.05 144.64 40.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.304 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -125.35 99.31 6.0 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.074 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.617 HD21 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -84.11 78.01 9.84 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.597 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.3 mt-10 -79.66 -165.79 0.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.787 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.476 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.6 OUTLIER -44.47 -52.58 7.76 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.618 -179.255 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.402 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 12.8 pt-20 -46.82 -17.06 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.51 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' OD2' ' HG3' ' A' ' 97' ' ' GLU . 36.5 m-20 -125.76 -13.98 6.3 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.41 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.618 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.6 mm -89.73 -35.41 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.112 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -48.25 -55.39 10.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.852 -179.833 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.1 p -114.08 39.31 2.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.539 179.462 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.617 HD13 HD21 ' A' ' 94' ' ' LEU . 8.2 tp -61.14 142.57 15.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.515 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -134.92 149.76 50.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.572 178.785 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.89 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.32 -32.96 12.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.11 0.481 . . . . 0.0 110.102 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -63.9 -49.08 74.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.352 178.691 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 102' ' ' ILE . 29.7 mtpp -59.04 -59.84 4.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.278 -179.806 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.755 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.19 -56.19 12.09 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.071 0.462 . . . . 0.0 110.076 179.848 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.3 m -58.21 -28.86 65.21 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.776 179.769 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.459 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.4 tmt_? -71.35 -67.11 0.54 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.079 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -42.24 -43.34 3.38 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.158 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.459 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -64.35 -55.47 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.702 178.416 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -52.89 -22.9 6.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.481 0.658 . . . . 0.0 110.112 179.259 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.459 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -85.66 -36.96 11.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.009 -179.054 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.473 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.7 m120 -124.84 31.87 5.56 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.054 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 111' ' ' ILE . 89.1 p -83.6 36.93 0.56 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.189 0.518 . . . . 0.0 110.213 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.539 HD12 HH12 ' A' ' 85' ' ' ARG . 51.7 mt . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.212 -179.517 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.6 m -90.84 148.16 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.093 -179.926 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -136.75 -42.49 0.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.974 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -76.42 -68.21 0.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.697 179.946 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.5 p -109.26 162.02 14.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.825 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.2 t -121.64 120.32 34.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.177 -179.702 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.9 t70 55.21 84.78 0.07 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.124 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -107.99 158.51 14.83 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.457 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.97 96.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.53 2.153 . . . . 0.0 112.409 179.992 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.87 -87.07 0.11 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.299 179.827 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.04 -81.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.571 0.224 . . . . 0.0 110.59 179.783 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.16 104.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.507 179.678 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.652 ' HG3' HG12 ' A' ' 54' ' ' VAL . 24.9 pt20 -51.47 139.24 20.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.076 -179.986 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.508 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 -111.19 159.67 31.93 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.859 -179.958 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 29.4 Cg_endo -64.32 154.0 73.63 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.63 2.22 . . . . 0.0 112.525 -179.718 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -67.94 153.06 44.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.42 -179.765 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.99 84.15 2.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.727 179.696 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 46.8 mt -81.73 72.21 8.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.633 -179.723 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.1 p -70.63 -2.94 15.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.09 -179.013 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -142.27 147.63 36.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.083 0.468 . . . . 0.0 111.804 -179.603 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 60.6 t -55.47 -49.99 89.39 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.824 -179.999 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.3 Cg_endo -58.32 -44.84 34.97 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.035 1.823 . . . . 0.0 111.82 -179.899 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.23 -34.55 78.37 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.33 0.586 . . . . 0.0 110.229 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.2 -59.18 5.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.929 179.262 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 34.0 mtt -60.23 -27.82 67.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.244 -179.967 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -70.21 -49.88 45.72 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 110.603 179.807 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.531 ' O ' HG22 ' A' ' 31' ' ' THR . 6.6 m-85 -61.13 -32.95 72.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.892 179.237 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.526 HD11 ' CD1' ' A' ' 36' ' ' ILE . 48.4 mt -75.0 -37.35 40.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.034 178.478 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.32 -18.27 60.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.131 -179.705 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.2 27.31 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.131 -179.896 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.718 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.9 t -174.31 154.91 2.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.602 -179.873 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.492 ' HG3' HG13 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -64.58 -82.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.016 0.436 . . . . 0.0 110.719 179.556 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.561 HG13 HD11 ' A' ' 83' ' ' LEU . 18.1 t -89.6 134.34 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.758 -179.53 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.46 124.71 20.37 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.061 -179.216 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.524 HG21 HG12 ' A' ' 111' ' ' ILE . 46.4 t -113.61 128.16 70.61 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.921 178.702 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.526 ' CD1' HD11 ' A' ' 28' ' ' ILE . 26.8 mt -133.63 138.48 50.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.457 -177.289 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.68 95.9 1.41 Allowed Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.381 179.801 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.519 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 36.3 m-85 -81.99 89.33 6.39 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.294 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 13.6 m-85 -107.59 140.57 40.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.615 -177.769 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -88.9 -5.62 57.87 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.081 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.486 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.3 t70 -154.53 121.73 5.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.656 179.851 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.522 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.0 mt -90.04 45.29 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.014 0.435 . . . . 0.0 111.449 -179.354 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.441 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 11.1 mm-40 -134.83 11.78 3.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.068 179.245 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.734 HD12 ' HB3' ' A' ' 46' ' ' ALA . 4.0 pt -94.89 158.92 34.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.286 -179.955 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.511 ' O ' HD12 ' A' ' 49' ' ' ILE . 62.4 Cg_exo -54.86 -25.38 43.12 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.843 2.362 . . . . 0.0 112.803 179.497 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.734 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.43 -35.64 81.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.705 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.707 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -63.51 -55.87 31.33 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.648 -178.776 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 38.0 Cg_exo -60.84 -34.49 91.29 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.999 1.8 . . . . 0.0 111.598 179.65 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.843 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -69.38 -35.35 66.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.635 ' O ' HG23 ' A' ' 54' ' ' VAL . 36.7 tp -73.61 -50.41 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.471 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -55.74 -20.32 14.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.304 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -84.43 -49.67 8.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.567 179.29 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.699 ' HG2' HD13 ' A' ' 107' ' ' LEU . 2.9 ppp? -57.67 -25.36 60.13 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.099 0.476 . . . . 0.0 109.91 179.556 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.652 HG12 ' HG3' ' A' ' 13' ' ' GLN . 55.0 t -52.87 -46.55 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.991 179.51 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -80.05 -9.85 59.73 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.533 -179.848 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.495 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 27.8 mtpp -93.55 -19.0 21.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.239 -179.963 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.618 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 70.8 m-85 -137.17 62.57 39.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.468 -179.291 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.64 -36.47 71.98 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.535 2.157 . . . . 0.0 111.366 179.025 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.85 -42.05 99.75 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.818 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.1 t -65.95 144.95 14.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.799 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.718 ' HB2' HG21 ' A' ' 31' ' ' THR . 46.7 t -83.24 98.82 9.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.108 0.48 . . . . 0.0 110.974 -179.613 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.496 ' HB3' HG22 ' A' ' 54' ' ' VAL . 6.4 p90 -64.8 129.05 38.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.025 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.502 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.1 161.46 28.46 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.087 179.862 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -162.25 144.07 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.823 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.519 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 44.8 t -149.77 155.61 40.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.144 0.497 . . . . 0.0 111.673 -179.262 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 70.2 p -136.94 0.03 2.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.39 179.281 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -69.53 138.91 53.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.506 179.841 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.4 p -63.14 -48.26 79.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.529 -179.459 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -49.98 -46.78 52.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.615 0.245 . . . . 0.0 111.571 -179.411 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.571 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.4 t -69.02 -53.96 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -58.32 -15.05 8.85 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.258 179.478 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.2 m -91.67 -39.23 11.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.362 179.041 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -62.84 -39.04 93.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.468 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -92.15 12.62 21.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.627 179.312 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 55.86 25.2 8.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.535 179.363 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.697 HG23 ' HB ' ' A' ' 80' ' ' THR . 42.1 mm -60.84 122.68 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.48 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.2 p -142.8 59.68 1.43 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.248 -179.824 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.29 43.46 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.571 179.856 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 24.6 m-80 52.41 44.26 30.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.177 0.513 . . . . 0.0 110.569 -179.821 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.697 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.6 m -69.71 151.34 45.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.404 -0.817 . . . . 0.0 112.804 -178.568 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.565 HG12 ' HA2' ' A' ' 37' ' ' GLY . 57.1 mt -116.85 116.6 52.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.132 178.155 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 74.4 m -104.56 135.27 46.29 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.95 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.626 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -112.07 102.58 10.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.296 178.822 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.2 t80 -96.03 119.67 34.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.448 179.547 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.514 HH12 HD12 ' A' ' 116' ' ' LEU . 5.6 mtm180 -103.49 81.39 1.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.958 -179.421 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 32' ' ' GLU . 11.6 tp -25.35 -58.73 0.06 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.026 -179.369 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.492 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.42 -72.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.408 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -83.44 3.69 30.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.009 0.433 . . . . 0.0 110.542 179.944 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 52.06 32.7 10.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.639 179.725 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.474 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 7.1 mm-40 -78.26 162.1 26.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.688 179.737 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -146.45 91.67 2.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.026 179.926 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.626 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -79.09 146.06 33.45 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.378 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -127.28 93.21 3.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.018 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.49 HD21 HD13 ' A' ' 102' ' ' ILE . 4.4 tt -79.01 77.69 5.46 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.689 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.6 mt-10 -78.18 -166.24 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.801 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.54 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.8 t70 -51.12 -36.74 42.1 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.86 -179.369 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.428 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 10.3 pt-20 -55.82 -14.75 2.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.193 0.521 . . . . 0.0 110.477 179.551 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.428 ' OD2' ' HG3' ' A' ' 97' ' ' GLU . 23.7 m-20 -130.12 -13.75 3.97 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.537 179.881 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 79' ' ' ASN . 19.6 mm -89.27 -29.96 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.316 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -55.16 -45.28 75.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 111.134 -179.804 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.6 m -121.74 37.66 4.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.454 179.774 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.7 tp -62.35 144.69 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.43 -179.842 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.422 ' N ' HG13 ' A' ' 102' ' ' ILE . 21.6 m-20 -139.9 150.09 44.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.73 178.881 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.843 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.56 -39.79 11.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.916 0.389 . . . . 0.0 110.617 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.1 m -61.89 -47.57 84.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.64 178.846 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -59.03 -57.09 14.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.366 -179.521 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.813 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.7 -57.34 9.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.966 0.412 . . . . 0.0 110.011 179.832 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.2 m -56.7 -29.62 62.61 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.98 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.488 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -70.69 -65.25 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.189 179.739 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -43.2 -43.61 4.77 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.938 179.167 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.556 HD11 HD22 ' A' ' 107' ' ' LEU . 26.0 mt -62.13 -56.32 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.438 178.249 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -53.87 -19.38 4.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.29 179.401 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.488 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.63 -35.71 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.956 -179.154 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.457 ' O ' HD21 ' A' ' 83' ' ' LEU . 17.2 m120 -126.6 31.25 5.38 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.463 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 111' ' ' ILE . 88.6 p -84.56 45.98 1.19 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.242 0.544 . . . . 0.0 110.071 178.848 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.514 HD12 HH12 ' A' ' 85' ' ' ARG . 55.5 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.455 -179.163 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 p -61.92 145.89 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.046 179.868 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -153.18 92.78 1.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.926 179.911 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -96.0 20.11 10.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.593 179.86 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.7 t 61.61 -86.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.264 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.0 t -146.43 141.29 26.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.85 0.357 . . . . 0.0 110.801 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.03 63.02 6.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.948 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.17 95.5 0.24 Allowed Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.414 179.976 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.38 142.97 92.83 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.639 2.226 . . . . 0.0 112.233 -179.836 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.85 51.58 1.63 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.591 179.972 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.0 -60.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 0.0 110.673 179.926 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.15 -81.77 0.02 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.489 179.655 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.563 ' HG3' HG12 ' A' ' 54' ' ' VAL . 26.2 pt20 -143.18 135.99 27.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 111.049 179.889 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 -121.78 158.45 54.42 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.81 -179.723 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 38.0 Cg_endo -67.18 142.14 59.86 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.595 2.197 . . . . 0.0 112.473 -179.753 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.0 m -56.28 152.95 10.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.52 -179.874 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -99.84 83.07 2.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.856 179.852 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 24' ' ' ALA . 36.9 mt -80.87 73.24 7.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.527 -179.905 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.0 p -72.8 -4.75 33.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.937 -179.191 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -136.65 147.11 46.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.382 . . . . 0.0 111.65 -179.72 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 24.1 t -56.33 -49.81 91.22 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.493 -179.985 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.82 -46.04 29.02 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.849 1.699 . . . . 0.0 111.934 179.994 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.37 -35.44 80.42 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.211 0.529 . . . . 0.0 110.277 -179.944 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.595 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -63.49 -58.93 5.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.097 179.562 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 60.3 mtp -59.82 -27.31 66.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.103 -179.986 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -71.2 -50.44 33.02 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.661 0.267 . . . . 0.0 110.778 179.777 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -60.99 -31.89 71.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.976 179.283 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.526 HD11 HD12 ' A' ' 36' ' ' ILE . 47.2 mt -73.93 -37.26 47.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.883 178.269 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.92 -18.73 60.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.018 -179.882 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.12 29.61 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.642 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.9 t -169.49 152.23 4.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.389 -179.736 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.632 ' HG3' HG13 ' A' ' 87' ' ' VAL . 31.3 tt0 -70.33 -41.45 73.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.765 179.913 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.515 HG13 HD11 ' A' ' 83' ' ' LEU . 19.6 t -128.95 134.11 64.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.182 179.324 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.11 128.91 26.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 112.154 -179.052 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.448 HG21 HG12 ' A' ' 111' ' ' ILE . 43.3 t -116.92 127.14 74.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.502 178.325 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 28' ' ' ILE . 23.4 mt -133.25 136.16 55.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.45 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.603 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.12 97.38 1.83 Allowed Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.562 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.5 m-85 -83.57 91.69 7.48 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.408 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.2 m-85 -111.89 138.32 48.67 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.023 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -85.06 -9.5 57.91 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.87 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.463 ' O ' HG12 ' A' ' 44' ' ' ILE . 15.8 t70 -150.4 119.56 6.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.745 179.716 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.506 ' HA ' HG21 ' A' ' 47' ' ' VAL . 96.4 mt -87.89 44.06 1.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.023 0.44 . . . . 0.0 111.562 -179.153 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.417 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 36.8 mt-10 -131.97 11.52 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.237 0.541 . . . . 0.0 109.972 179.134 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.682 HG13 HG23 ' A' ' 47' ' ' VAL . 8.5 pt -93.96 161.61 29.38 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.517 -179.657 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.482 ' O ' HD12 ' A' ' 49' ' ' ILE . 51.6 Cg_exo -57.04 -25.22 62.09 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.843 2.362 . . . . 0.0 112.538 179.202 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.628 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.14 -38.77 91.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.478 -178.763 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 44' ' ' ILE . 2.1 t -59.81 -55.41 45.96 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -178.717 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.5 Cg_exo -60.88 -41.63 43.85 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.026 1.817 . . . . 0.0 111.567 179.199 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.879 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -61.72 -34.2 61.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.149 -179.998 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.1 tp -74.98 -51.89 12.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.785 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -53.6 -26.0 19.9 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.094 0.473 . . . . 0.0 109.808 178.607 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 t -82.17 -46.39 13.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.642 179.6 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.578 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.67 -25.84 63.21 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.358 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 50' ' ' LEU . 52.5 t -52.29 -46.05 44.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.827 179.34 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.448 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 29.5 mt-30 -80.76 -10.12 59.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.735 -179.795 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -93.55 -17.12 23.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.153 179.837 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 49.3 m-85 -139.38 63.89 29.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.505 -179.854 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.78 -45.1 42.92 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.719 2.279 . . . . 0.0 111.713 179.052 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.23 -40.76 76.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.293 179.252 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.6 t -66.86 143.97 15.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.69 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.642 ' CB ' HG21 ' A' ' 31' ' ' THR . 42.2 t -82.42 97.96 8.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.987 0.422 . . . . 0.0 111.045 -179.633 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.483 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -64.2 127.24 30.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.722 179.71 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.501 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.82 162.7 28.56 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.133 179.887 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 tt -160.82 145.12 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.913 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 t -149.82 152.82 35.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.004 0.431 . . . . 0.0 111.597 -179.157 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 39' ' ' PHE . 81.7 p -135.87 -1.45 2.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.622 179.569 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.61 143.32 56.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.77 -179.918 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 81.7 p -65.7 -49.59 67.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.103 -179.556 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -50.79 -45.87 59.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.458 -179.352 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.496 ' HA ' HG22 ' A' ' 21' ' ' VAL . 62.3 t -69.48 -53.17 26.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.733 0.301 . . . . 0.0 110.737 179.935 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -58.55 -15.17 10.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.283 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.4 m -90.39 -40.97 11.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.223 178.63 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -60.67 -40.49 92.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.45 179.841 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.407 ' HB2' HG12 ' A' ' 76' ' ' ILE . 46.1 m-85 -90.51 11.44 21.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 179.605 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 55.96 25.1 8.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.482 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.672 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.7 mm -60.67 119.74 5.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 179.797 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.6 p -140.35 57.76 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.242 179.98 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.76 42.97 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.601 179.82 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.578 ' HB2' HG21 ' A' ' 99' ' ' ILE . 25.9 m-80 52.67 42.38 31.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.194 0.521 . . . . 0.0 110.255 -179.726 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.672 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.9 m -68.74 152.83 44.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.806 -178.529 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.603 HG12 ' HA2' ' A' ' 37' ' ' GLY . 71.4 mt -119.76 117.54 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.979 178.206 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.5 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 72.4 m -105.75 130.42 53.75 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.871 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.642 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -106.49 101.16 10.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.619 178.036 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.7 t80 -95.89 120.51 36.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.769 0.319 . . . . 0.0 110.706 -179.954 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.6 HH12 HD12 ' A' ' 116' ' ' LEU . 5.0 mtm180 -103.24 97.95 7.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.045 179.881 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 tp -41.67 -51.79 3.99 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.598 -179.464 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.632 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -44.5 -65.67 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.395 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.46 ' HB2' HH21 ' A' ' 85' ' ' ARG . 7.6 m-20 -95.53 17.31 14.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.69 -178.977 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.4 p30 42.38 32.64 0.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.036 179.227 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 25.3 mm-40 -78.99 161.69 26.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.855 0.36 . . . . 0.0 111.33 -179.876 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -147.23 96.45 2.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.52 179.497 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.642 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.1 mm? -86.66 120.3 27.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.942 179.817 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.95 98.72 9.16 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.679 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.573 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -83.43 77.71 9.77 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.721 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.6 mt-10 -78.99 -164.7 0.64 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.801 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.526 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.8 t70 -51.39 -36.4 43.25 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.254 -179.175 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -56.95 -14.69 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.148 0.499 . . . . 0.0 110.265 179.558 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -129.64 -13.64 4.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.577 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.578 HG21 ' HB2' ' A' ' 79' ' ' ASN . 21.4 mm -91.24 -29.27 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.519 -179.492 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -51.7 -51.89 52.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 56.0 m -121.27 39.98 3.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.506 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.573 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -60.67 142.01 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.557 -179.704 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.445 ' H ' ' HD3' ' A' ' 106' ' ' LYS . 17.4 m-20 -134.25 150.71 51.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.428 178.752 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.879 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.74 -35.86 23.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.065 0.46 . . . . 0.0 110.4 179.993 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.6 m -62.4 -46.08 90.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.237 178.739 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.51 ' HZ3' HD12 ' A' ' 102' ' ' ILE . 8.3 mtpm? -60.97 -60.76 3.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.179 -179.79 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.79 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.48 -55.45 10.93 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.958 0.409 . . . . 0.0 110.04 179.844 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.9 m -58.51 -30.81 67.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.92 179.715 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -70.94 -65.71 0.7 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.195 179.677 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -42.91 -43.31 4.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.06 179.303 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.448 HG12 HG21 ' A' ' 35' ' ' VAL . 96.6 mt -63.28 -55.87 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.174 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.13 -18.42 3.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.305 179.259 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.469 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.41 -36.39 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.69 -179.305 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.475 ' O ' HD21 ' A' ' 83' ' ' LEU . 18.3 m120 -126.29 32.97 5.11 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.547 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.2 p -84.57 38.35 0.68 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.058 0.456 . . . . 0.0 110.243 178.801 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.6 HD12 HH12 ' A' ' 85' ' ' ARG . 58.6 mt . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.085 -0.959 . . . . 0.0 111.28 -179.445 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.5 p -108.0 142.45 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.191 -179.956 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -154.56 -31.7 0.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.004 179.842 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -57.38 130.51 46.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.091 -179.961 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 85.1 p 47.99 83.24 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.447 179.914 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.0 m -90.67 52.5 2.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 179.883 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -135.44 39.79 2.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.28 113.5 0.56 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.341 -179.969 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -56.13 101.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.419 2.079 . . . . 0.0 112.437 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.91 -133.66 11.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.693 179.802 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.01 -59.36 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 110.608 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.497 ' HB1' ' NE2' ' A' ' 55' ' ' GLN . . . 60.43 106.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.542 179.673 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.617 ' HG3' HG12 ' A' ' 54' ' ' VAL . 8.3 pt20 -54.38 163.97 0.77 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.525 179.95 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.491 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.8 pt-20 -138.98 159.08 68.4 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.476 179.79 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 42.6 Cg_endo -67.24 147.74 79.11 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.569 2.18 . . . . 0.0 112.628 -179.251 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.5 m -69.39 154.06 42.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.662 -179.494 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -97.16 87.73 4.28 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.251 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.1 mt -81.6 70.05 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.066 179.473 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.6 p -67.85 -0.44 4.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.626 -178.654 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 7.8 m-20 -145.9 147.83 32.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 111.65 -179.887 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.608 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.0 t -54.29 -49.83 88.21 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.504 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.6 Cg_endo -56.81 -47.53 22.96 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.07 1.847 . . . . 0.0 112.195 179.94 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.62 78.08 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.202 0.525 . . . . 0.0 110.508 -179.701 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.17 -58.7 5.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.169 179.355 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 68.3 mtp -60.98 -27.21 68.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.065 -179.861 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 25.0 mt-10 -71.33 -50.48 31.94 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.735 0.303 . . . . 0.0 110.596 179.777 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.564 ' O ' HG22 ' A' ' 31' ' ' THR . 7.5 m-85 -59.74 -34.59 73.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.904 179.303 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.576 HD11 HD12 ' A' ' 36' ' ' ILE . 44.3 mt -72.62 -37.78 57.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.946 178.288 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.56 -17.67 61.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.989 -179.768 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.1 26.41 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.222 -179.671 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.613 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.0 t -169.88 151.75 4.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.557 -179.881 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.564 ' HG3' HG13 ' A' ' 87' ' ' VAL . 15.6 tt0 -62.78 -76.42 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.598 179.751 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG13 HD11 ' A' ' 83' ' ' LEU . 16.0 t -96.49 138.71 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.459 179.538 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.59 124.11 15.85 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.991 0.424 . . . . 0.0 112.003 -179.26 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.431 HG11 HD11 ' A' ' 111' ' ' ILE . 50.0 t -112.62 129.85 67.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.435 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 28' ' ' ILE . 34.7 mt -135.74 137.13 49.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.041 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.91 96.69 1.66 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.461 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.451 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.1 m-85 -82.97 90.56 7.01 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.233 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.1 m-85 -110.23 145.82 36.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.363 -178.148 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.444 ' HG2' HD23 ' A' ' 71' ' ' LEU . 93.2 mt-30 -92.36 -6.5 50.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.839 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.514 ' O ' HG12 ' A' ' 44' ' ' ILE . 36.6 t70 -151.87 121.93 7.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.555 179.822 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.584 ' HA ' HG21 ' A' ' 47' ' ' VAL . 87.9 mt -90.57 46.49 1.34 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.158 0.504 . . . . 0.0 111.331 -179.319 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.438 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 38.9 mt-10 -135.68 7.11 3.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.937 178.977 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.754 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.1 pt -89.54 157.64 46.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.26 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.484 ' O ' HD12 ' A' ' 49' ' ' ILE . 70.6 Cg_exo -53.4 -26.05 33.99 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.92 2.413 . . . . 0.0 112.911 179.665 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.754 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.08 -36.95 85.95 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.977 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.72 HG23 HG13 ' A' ' 44' ' ' ILE . 3.2 t -60.99 -56.65 32.86 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.549 -178.915 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.68 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.2 Cg_exo -59.82 -41.26 56.06 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 121.754 1.636 . . . . 0.0 111.407 179.635 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -61.29 -35.6 67.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.027 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.1 tp -72.98 -53.78 10.32 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.809 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -53.71 -24.6 15.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.086 0.47 . . . . 0.0 109.848 178.748 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -82.07 -45.57 15.06 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.623 179.615 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.605 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.83 -26.18 67.15 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.082 0.468 . . . . 0.0 109.74 179.582 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.617 HG12 ' HG3' ' A' ' 13' ' ' GLN . 61.1 t -52.76 -49.65 45.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.843 179.492 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.497 ' NE2' ' HB1' ' A' ' 12' ' ' ALA . 33.3 mt-30 -75.04 -9.41 58.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.637 -179.708 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -95.14 -18.67 20.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.059 179.586 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.586 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 64.3 m-85 -135.92 62.85 48.93 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.285 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.8 -42.51 62.82 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.701 2.267 . . . . 0.0 111.64 179.137 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.25 -37.23 86.26 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.657 179.147 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.2 t -69.89 144.8 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.121 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.613 ' CB ' HG21 ' A' ' 31' ' ' THR . 35.4 t -82.53 98.81 9.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.095 0.474 . . . . 0.0 110.932 -179.902 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.493 ' HB3' HG22 ' A' ' 54' ' ' VAL . 5.4 p90 -65.23 126.29 27.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.205 179.976 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.479 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.24 161.23 28.16 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.276 179.809 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -161.64 144.18 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.451 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.8 t -149.47 157.85 43.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.171 0.51 . . . . 0.0 111.845 -179.28 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.501 HG21 ' HG ' ' A' ' 42' ' ' LEU . 57.9 p -138.57 -0.24 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.481 179.488 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.25 137.13 54.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.343 -179.907 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.0 m -61.59 -50.7 71.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.501 -179.341 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -50.28 -40.91 49.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.568 -179.558 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.512 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.2 t -72.05 -54.93 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.028 0.442 . . . . 0.0 110.73 179.846 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.444 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.2 mp -58.38 -14.64 8.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.291 179.324 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.5 m -91.18 -41.72 10.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.178 178.719 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -59.9 -40.64 89.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.462 179.833 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 76' ' ' ILE . 89.9 m-85 -90.43 9.15 30.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.794 179.444 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 58.73 24.71 12.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.604 179.429 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.748 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.8 mm -60.97 119.62 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.986 179.53 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.0 p -138.55 56.04 1.72 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.262 -179.941 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.09 45.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.594 179.849 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.636 ' HB2' HG21 ' A' ' 99' ' ' ILE . 25.7 m-20 50.15 43.44 25.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.162 0.506 . . . . 0.0 110.397 -179.828 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.748 ' HB ' HG23 ' A' ' 76' ' ' ILE . 88.5 m -68.42 151.97 46.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.786 -178.665 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.581 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.9 mt -118.21 115.65 48.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.219 178.032 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 72.1 m -103.85 133.49 48.75 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -177.819 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.657 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -109.22 104.6 13.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.979 178.392 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.7 t80 -98.62 121.11 40.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.643 179.8 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.503 HH12 HD12 ' A' ' 116' ' ' LEU . 4.4 mtm180 -103.94 81.34 1.85 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.906 -179.726 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 7.2 tp -25.26 -59.63 0.06 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -179.455 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.564 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.53 -57.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.338 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -98.3 3.42 48.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.636 -179.735 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.2 t30 53.11 21.2 2.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.586 179.654 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 12.6 mm-40 -67.34 154.12 42.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.659 179.596 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -138.05 89.3 2.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.507 179.314 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.657 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -78.0 141.79 38.68 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.378 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.92 109.27 14.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.218 0.532 . . . . 0.0 112.401 -178.929 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.606 HD21 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -94.7 76.43 3.71 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.875 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 99' ' ' ILE . 24.0 mt-10 -77.39 -165.31 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -176.857 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.473 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.3 OUTLIER -46.52 -51.05 16.22 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.575 -179.191 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -48.15 -15.24 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.967 0.413 . . . . 0.0 111.262 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.413 ' N ' ' C ' ' A' ' 96' ' ' ASP . 17.0 m-20 -126.98 -13.66 5.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.367 179.792 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.636 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.5 mm -91.87 -38.97 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.479 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -50.43 -47.42 56.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.967 0.413 . . . . 0.0 110.71 179.74 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.8 m -116.61 38.83 3.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.507 179.89 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.606 HD13 HD21 ' A' ' 94' ' ' LEU . 8.5 tp -67.21 144.86 14.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.593 -179.541 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -139.44 148.83 43.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.321 178.48 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.887 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.37 -36.84 10.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.104 0.478 . . . . 0.0 110.444 -179.713 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.9 m -63.05 -47.55 82.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.342 178.977 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -59.81 -58.93 6.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.313 -179.694 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.764 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.23 -55.44 15.29 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.002 0.43 . . . . 0.0 110.117 179.869 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.2 m -58.39 -29.53 66.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.809 179.796 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.499 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -71.3 -66.11 0.66 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.225 179.609 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -42.82 -44.04 4.28 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.122 179.274 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.431 HD11 HG11 ' A' ' 35' ' ' VAL . 96.2 mt -62.92 -55.36 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.529 178.293 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -54.32 -18.41 4.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.374 179.223 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.499 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.0 -36.89 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.862 -179.059 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.5 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.0 m120 -125.37 31.03 5.65 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.464 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 97.1 p -82.62 37.76 0.53 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.076 0.465 . . . . 0.0 110.142 178.869 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.503 HD12 HH12 ' A' ' 85' ' ' ARG . 59.0 mt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.188 -179.425 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.547 ' HG3' HG12 ' A' ' 2' ' ' VAL . 13.5 tp10 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.804 0.335 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.547 HG12 ' HG3' ' A' ' 1' ' ' GLU . 7.2 p -170.33 -41.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.191 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 51.25 70.72 0.5 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.986 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -160.59 101.55 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 -179.782 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.1 p -130.12 143.19 50.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.778 179.827 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.9 m -137.53 -63.05 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.035 -179.935 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 57.39 76.91 0.3 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.022 -179.893 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.75 -72.05 0.83 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.462 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -59.81 141.33 96.57 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.462 2.108 . . . . 0.0 112.196 179.704 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.86 49.29 3.58 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.579 -179.96 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.55 -75.9 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.92 107.7 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.357 179.748 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.557 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.9 pt20 -58.81 164.45 2.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.503 -179.712 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.48 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.1 pt-20 -134.91 159.55 71.69 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.109 179.789 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 37.9 Cg_endo -66.83 145.68 75.62 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.308 2.005 . . . . 0.0 112.756 -179.541 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.4 m -62.54 147.52 48.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.524 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -92.99 84.3 4.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.739 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.62 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.4 mt -81.77 76.21 8.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.638 -179.913 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.8 p -76.02 -4.17 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.856 -179.255 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -139.37 147.28 41.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.994 0.426 . . . . 0.0 111.61 -179.738 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 44.2 t -55.76 -50.33 87.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.59 179.891 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.33 -45.11 37.01 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.986 1.791 . . . . 0.0 111.939 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.03 82.73 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.262 0.553 . . . . 0.0 110.285 -179.881 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.62 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.55 -59.0 5.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.05 179.513 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 59.7 mtm -60.41 -27.02 67.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.148 -179.928 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -70.98 -50.79 30.45 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.72 0.295 . . . . 0.0 110.571 179.594 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.415 ' O ' HG22 ' A' ' 31' ' ' THR . 9.9 m-85 -60.26 -31.42 70.2 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.197 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 36' ' ' ILE . 47.7 mt -74.18 -39.07 49.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.077 178.196 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.45 -19.71 60.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.071 -179.899 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.25 30.0 1.78 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.576 HG21 ' CB ' ' A' ' 61' ' ' SER . 10.0 t -169.85 154.34 5.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.42 -179.593 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.631 ' HG3' HG13 ' A' ' 87' ' ' VAL . 24.8 tt0 -71.8 -43.46 65.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.683 179.861 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG13 HD11 ' A' ' 83' ' ' LEU . 19.1 t -127.47 137.4 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.225 179.418 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.67 129.75 22.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.947 0.403 . . . . 0.0 112.062 -179.061 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.431 HG11 HD11 ' A' ' 111' ' ' ILE . 42.3 t -117.45 128.26 74.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.571 178.536 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.541 HD12 HD11 ' A' ' 28' ' ' ILE . 22.8 mt -133.66 136.18 54.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.47 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.585 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.81 95.97 1.57 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.517 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.6 m-85 -82.6 89.65 6.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.523 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.7 m-85 -108.55 139.24 43.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.538 -178.181 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.432 ' HG2' HD23 ' A' ' 71' ' ' LEU . 47.4 mt-30 -85.94 -4.52 59.19 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.915 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.4 t70 -153.95 122.05 6.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.619 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.632 ' HA ' HG21 ' A' ' 47' ' ' VAL . 97.9 mt -91.17 47.37 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.147 0.499 . . . . 0.0 111.375 -179.331 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.423 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.4 mt-10 -138.85 8.67 2.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.941 179.073 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.841 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.2 pt -92.91 154.45 41.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.061 179.753 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.504 ' O ' HD12 ' A' ' 49' ' ' ILE . 87.0 Cg_exo -48.24 -29.75 13.5 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.004 2.469 . . . . 0.0 113.242 179.82 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.841 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.37 -36.7 83.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.911 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.665 HG23 HG13 ' A' ' 44' ' ' ILE . 2.7 t -63.18 -56.62 26.18 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.747 -178.801 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.656 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.3 Cg_exo -59.86 -36.92 89.2 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.789 1.659 . . . . 0.0 111.42 179.534 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.6 mt -64.83 -36.52 77.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.909 179.73 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.593 ' O ' HG23 ' A' ' 54' ' ' VAL . 42.9 tp -72.46 -53.36 12.37 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.749 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -53.86 -22.26 9.45 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.072 0.463 . . . . 0.0 109.824 178.765 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -85.36 -44.83 12.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.555 179.668 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.593 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.92 -25.55 66.84 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.369 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.7 t -53.24 -49.41 52.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.988 179.411 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -75.09 -9.41 58.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.686 -179.885 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -95.23 -20.25 19.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.309 179.788 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.599 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 61.1 m-85 -134.69 61.12 46.38 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.508 -179.603 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.74 -40.17 74.83 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.506 2.137 . . . . 0.0 111.45 179.176 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.04 -40.85 96.05 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.764 -0.732 . . . . 0.0 111.449 178.963 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.3 t -67.65 144.58 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.798 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.576 ' CB ' HG21 ' A' ' 31' ' ' THR . 38.7 t -81.43 96.5 7.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.085 0.469 . . . . 0.0 111.157 -179.624 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.455 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.7 p90 -62.28 129.45 40.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.962 179.732 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.514 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -148.51 161.48 28.65 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.079 179.716 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.431 HD11 HG13 ' A' ' 47' ' ' VAL . 5.2 tt -160.53 143.07 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.813 0.34 . . . . 0.0 110.178 179.862 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.6 t -146.44 157.98 43.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.971 0.415 . . . . 0.0 111.678 -179.035 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.457 HG21 ' HG ' ' A' ' 42' ' ' LEU . 67.5 p -141.07 -8.78 1.01 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.766 179.804 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -64.48 142.79 58.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.789 -179.882 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.6 m -64.03 -47.74 79.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.567 -179.495 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -51.14 -46.09 61.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.514 -179.269 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.556 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.7 t -70.34 -51.54 37.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.812 0.339 . . . . 0.0 110.73 179.806 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.432 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -59.3 -14.63 12.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.187 179.371 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.0 m -91.97 -41.17 10.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.297 178.657 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -60.3 -41.99 94.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.657 179.933 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.417 ' HB2' HG12 ' A' ' 76' ' ' ILE . 51.2 m-85 -89.21 11.29 19.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.798 179.587 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 56.41 27.72 12.5 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.597 179.45 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.683 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.4 mm -62.67 124.3 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.961 179.755 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.1 p -142.78 59.31 1.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.444 -179.782 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.83 46.39 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.687 179.697 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 30.1 m-80 51.91 43.15 30.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.059 0.457 . . . . 0.0 110.469 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.683 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.8 m -68.87 152.01 45.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.661 -178.522 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.585 HG12 ' HA2' ' A' ' 37' ' ' GLY . 61.2 mt -118.97 116.28 50.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.906 177.985 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.509 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 72.8 m -106.15 132.67 51.95 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.83 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.668 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.1 tp -108.64 103.54 12.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.838 178.413 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -97.95 123.94 42.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.823 0.344 . . . . 0.0 110.863 179.992 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.51 HH21 ' HB2' ' A' ' 88' ' ' ASP . 2.3 mtm180 -107.35 100.81 10.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.092 179.833 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.9 tp -44.37 -52.69 7.49 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.687 -179.203 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.631 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.22 -64.33 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.015 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' HB2' HH21 ' A' ' 85' ' ' ARG . 5.8 m-20 -97.01 17.13 17.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.605 -179.044 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 42.37 32.31 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.152 179.128 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.493 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 5.8 mm-40 -79.05 159.85 27.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.944 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.35 92.31 2.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.95 179.656 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.668 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -78.58 140.24 38.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.453 179.257 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.08 100.79 7.16 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.477 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.537 HD21 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -87.16 77.04 9.15 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.819 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.9 mt-10 -79.0 -164.85 0.66 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -176.93 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.496 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -46.38 -49.62 17.67 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.452 -179.369 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -47.62 -18.25 0.13 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.852 0.358 . . . . 0.0 111.165 179.762 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -125.29 -13.83 6.59 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.574 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.567 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.9 mm -90.44 -28.77 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.682 0.277 . . . . 0.0 111.475 -179.451 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -53.96 -48.87 69.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 82.5 p -119.61 36.72 4.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.435 179.783 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.537 HD13 HD21 ' A' ' 94' ' ' LEU . 6.2 tp -60.55 142.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.425 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.412 ' N ' HG13 ' A' ' 102' ' ' ILE . 24.6 m-20 -138.55 150.46 46.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.665 178.883 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.889 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.2 -37.25 15.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.968 0.413 . . . . 0.0 110.348 -179.632 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.4 m -62.11 -47.72 83.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.437 178.803 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -60.69 -60.78 3.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.169 -179.682 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.743 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -47.98 -55.84 9.06 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.923 0.392 . . . . 0.0 110.125 179.977 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.8 m -58.49 -31.62 68.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.523 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -70.39 -65.73 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.398 179.847 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -42.93 -43.62 4.22 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.014 179.282 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.431 HD11 HG11 ' A' ' 35' ' ' VAL . 96.1 mt -63.47 -55.84 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.529 178.167 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -53.41 -18.75 2.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.336 179.282 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.523 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.16 -37.84 11.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.833 -179.359 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.478 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.4 m120 -123.55 30.92 6.07 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.821 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 111' ' ' ILE . 90.2 p -84.28 39.46 0.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.078 0.466 . . . . 0.0 110.282 179.013 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.481 HD12 ' NH1' ' A' ' 85' ' ' ARG . 77.3 mt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.146 -0.931 . . . . 0.0 111.29 -179.679 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.862 0.363 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.4 m -92.82 5.68 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.421 -179.807 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.592 ' HG2' ' HG3' ' A' ' 4' ' ' LYS . 38.8 tt0 -126.96 149.7 49.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.699 179.874 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.592 ' HG3' ' HG2' ' A' ' 3' ' ' GLU . 54.5 mtpt 58.71 34.44 23.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 -179.763 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.3 t -139.4 83.23 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.013 -179.837 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.2 t -115.1 -3.77 12.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 179.987 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -87.44 -52.54 5.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.975 -179.975 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.57 163.58 19.25 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.477 -179.898 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.35 172.35 1.95 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.725 2.283 . . . . 0.0 112.385 179.952 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.83 148.21 9.54 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.644 179.94 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.96 -67.12 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.682 0.277 . . . . 0.0 110.836 179.906 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.493 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . . . 59.88 105.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.58 179.429 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.518 ' HG3' HG12 ' A' ' 54' ' ' VAL . 6.1 pt20 -169.68 172.78 6.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.883 -179.727 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.498 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.8 pt-20 -121.76 158.81 53.38 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.176 -179.371 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 45.7 Cg_endo -69.47 143.74 53.26 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.831 2.354 . . . . 0.0 112.622 -179.701 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.7 m -63.37 151.29 41.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.544 -179.61 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -94.55 94.42 8.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.96 -179.934 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.647 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.6 mt -88.77 73.89 8.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.299 179.64 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.0 p -72.4 0.51 9.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.306 -178.927 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -145.63 148.56 33.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.928 0.394 . . . . 0.0 111.862 -179.78 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 57.6 t -56.06 -50.26 88.38 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.448 179.815 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.5 Cg_endo -58.23 -45.1 33.4 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.826 1.684 . . . . 0.0 112.035 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.59 81.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.257 0.551 . . . . 0.0 110.35 -179.927 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.647 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.09 -59.59 4.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.98 179.391 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.8 mtm -60.48 -25.94 66.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.156 -179.972 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 21.3 mt-10 -71.83 -49.94 34.06 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.695 0.283 . . . . 0.0 110.414 179.657 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.455 ' O ' HG22 ' A' ' 31' ' ' THR . 0.2 OUTLIER -60.06 -33.37 71.97 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.079 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.558 HD11 HD12 ' A' ' 36' ' ' ILE . 50.4 mt -72.33 -39.01 62.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.105 178.627 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.05 -21.33 60.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.994 -179.856 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.93 31.87 1.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.939 -179.878 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.566 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.1 t -170.8 151.29 3.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.328 -179.621 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.476 ' HG3' HG13 ' A' ' 87' ' ' VAL . 30.0 tt0 -68.27 -52.76 30.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.598 179.652 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.479 HG13 HD11 ' A' ' 83' ' ' LEU . 19.4 t -118.27 137.61 51.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.174 179.329 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.9 126.23 18.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.055 0.455 . . . . 0.0 112.191 -179.031 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.527 HG21 HG12 ' A' ' 111' ' ' ILE . 49.2 t -115.22 127.85 72.63 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.521 178.338 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 28' ' ' ILE . 32.6 mt -134.17 138.3 50.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.642 -177.165 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.555 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.4 97.54 1.66 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.45 179.773 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.463 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 39.3 m-85 -83.82 92.43 7.76 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.224 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -112.49 139.32 48.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.485 -178.003 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.459 ' HG2' HD23 ' A' ' 71' ' ' LEU . 78.6 mt-30 -87.68 -3.22 58.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.691 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.431 ' O ' HG12 ' A' ' 44' ' ' ILE . 22.2 t70 -153.72 124.39 7.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.511 179.922 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.572 ' HA ' HG21 ' A' ' 47' ' ' VAL . 96.0 mt -94.92 47.34 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 0.0 111.528 -179.436 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 33.8 mt-10 -136.33 5.88 3.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.7 178.845 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.809 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.1 pt -88.46 156.31 50.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.083 179.884 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.507 ' O ' HD12 ' A' ' 49' ' ' ILE . 75.2 Cg_exo -51.78 -27.09 25.76 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.85 2.367 . . . . 0.0 113.078 179.797 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.809 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.7 -37.67 88.21 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.78 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.66 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -62.22 -56.15 33.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.752 -178.692 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.5 Cg_exo -60.13 -36.03 90.29 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.804 1.67 . . . . 0.0 111.488 179.65 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.876 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.3 mt -67.1 -34.81 71.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.995 -179.937 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.58 ' O ' HG23 ' A' ' 54' ' ' VAL . 44.6 tp -74.44 -50.98 16.23 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.893 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -55.29 -22.8 20.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.03 0.443 . . . . 0.0 109.994 178.77 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.8 m -84.89 -45.44 12.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.455 179.36 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.583 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.48 -25.62 64.59 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.198 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 50' ' ' LEU . 45.6 t -52.77 -47.75 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.119 179.329 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.493 ' NE2' ' HA ' ' A' ' 12' ' ' ALA . 35.9 mt-30 -78.31 -8.96 59.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.656 -179.855 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -94.51 -19.36 20.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.277 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.604 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 61.0 m-85 -136.03 62.88 48.38 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.623 -179.79 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.2 -43.35 53.91 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.689 2.259 . . . . 0.0 111.634 179.019 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.5 -42.03 93.72 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.413 179.355 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.7 t -65.31 144.53 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 178.876 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.566 ' CB ' HG21 ' A' ' 31' ' ' THR . 33.9 t -81.94 96.97 7.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.012 0.434 . . . . 0.0 110.95 -179.83 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.488 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.8 p90 -64.3 127.34 31.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.785 179.692 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.478 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.99 160.67 28.19 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.061 179.807 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.434 HD11 HG13 ' A' ' 47' ' ' VAL . 5.0 tt -160.98 142.59 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.788 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.463 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.9 t -147.78 158.77 44.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.218 0.532 . . . . 0.0 111.646 -179.094 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.446 HG21 ' HG ' ' A' ' 42' ' ' LEU . 76.3 p -139.49 -2.35 1.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.568 179.619 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -66.79 140.52 57.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.703 -179.977 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.6 m -63.98 -49.91 70.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.444 -179.465 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -50.3 -42.7 52.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.605 -179.458 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.584 ' HA ' HG22 ' A' ' 21' ' ' VAL . 58.9 t -71.92 -54.02 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.344 . . . . 0.0 110.791 179.832 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.459 HD23 ' HG2' ' A' ' 40' ' ' GLN . 5.9 mp -58.29 -14.61 7.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.339 179.331 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.7 m -91.78 -41.51 10.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.333 178.789 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -60.69 -39.64 89.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.496 179.78 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.445 ' HB2' HG12 ' A' ' 76' ' ' ILE . 61.0 m-85 -90.17 9.92 26.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.754 179.567 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.0 m120 57.71 25.28 11.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.672 179.386 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.69 HG23 ' HB ' ' A' ' 80' ' ' THR . 42.1 mm -61.73 121.77 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.149 179.805 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.1 p -140.63 58.42 1.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 0.0 111.184 -179.935 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.65 45.04 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.623 179.791 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.571 ' HB2' HG21 ' A' ' 99' ' ' ILE . 25.9 m-80 51.07 44.17 28.74 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.125 0.488 . . . . 0.0 110.476 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.69 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.7 m -69.53 152.65 44.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.632 -178.688 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.555 HG12 ' HA2' ' A' ' 37' ' ' GLY . 58.9 mt -118.62 116.4 51.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.428 -0.805 . . . . 0.0 108.982 178.04 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.434 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 75.6 m -104.35 132.68 50.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -177.723 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.669 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -110.94 102.66 11.13 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.982 178.434 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.2 t80 -96.59 125.25 40.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.7 0.286 . . . . 0.0 110.392 179.723 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.6 mtm180 -107.63 85.8 2.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.034 -179.536 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.6 tp -27.42 -61.93 0.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.253 -179.286 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.476 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.29 -64.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.154 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -90.99 13.77 15.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.781 0.324 . . . . 0.0 111.32 -179.314 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 43.68 29.1 0.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.086 178.985 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.513 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 20.6 mm-40 -75.94 160.94 29.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.78 179.85 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.57 84.68 1.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.695 179.778 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.669 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -71.48 145.08 49.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.565 179.662 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -127.32 93.44 3.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.23 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.568 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -78.84 78.31 5.28 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.609 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.8 mt-10 -79.63 -164.35 0.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -176.915 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.504 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 22.7 t70 -51.09 -38.36 51.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.093 -179.246 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -55.22 -14.98 1.97 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.202 0.525 . . . . 0.0 110.213 179.552 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -129.82 -13.89 4.1 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.73 -179.716 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.571 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.2 mm -90.32 -30.04 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 111.294 -179.652 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.45 -33.73 68.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.6 m -133.68 39.64 3.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 179.816 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.568 HD13 HD21 ' A' ' 94' ' ' LEU . 7.1 tp -66.64 143.33 15.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.726 -179.676 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -138.33 148.93 45.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.421 178.857 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.876 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.71 -36.68 11.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.094 0.473 . . . . 0.0 110.508 -179.719 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.7 m -62.38 -46.79 87.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.27 178.785 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -61.16 -59.38 5.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.224 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.772 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.52 -54.4 18.14 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.995 0.426 . . . . 0.0 110.109 179.852 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.9 m -58.88 -31.1 68.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.761 179.765 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.468 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.6 tmt_? -71.0 -65.62 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.297 179.768 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -43.19 -43.57 4.74 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.147 179.34 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.527 HG12 HG21 ' A' ' 35' ' ' VAL . 85.2 mt -63.22 -55.24 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.259 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -54.84 -18.16 4.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.219 0.533 . . . . 0.0 110.203 179.305 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.468 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.59 -35.15 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.821 -179.302 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.471 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.5 m120 -127.03 31.2 5.31 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.369 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 111' ' ' ILE . 89.1 p -84.42 36.48 0.59 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.034 0.445 . . . . 0.0 110.253 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.464 HD12 ' NH1' ' A' ' 85' ' ' ARG . 70.5 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.309 -179.46 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.69 0.281 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.53 HG23 ' HG2' ' A' ' 3' ' ' GLU . 35.1 m -133.52 -18.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 179.967 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.53 ' HG2' HG23 ' A' ' 2' ' ' VAL . 7.1 pt-20 -149.07 99.31 2.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.039 0.447 . . . . 0.0 111.088 179.886 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -164.36 -42.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.757 179.856 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 93.5 p 51.23 -166.76 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.193 -179.953 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.3 t 58.98 34.2 23.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.847 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -108.32 -42.81 4.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.827 179.772 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.15 -165.06 13.66 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.314 179.937 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.24 179.83 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.506 2.137 . . . . 0.0 112.287 179.989 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.88 -105.34 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.482 179.946 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -174.42 -44.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.929 0.395 . . . . 0.0 110.257 179.933 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.11 -80.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.841 179.431 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.555 ' HG3' HG12 ' A' ' 54' ' ' VAL . 11.2 pt20 -140.29 141.91 35.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.874 0.369 . . . . 0.0 110.981 179.937 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 14.4 pt-20 -127.94 159.53 66.12 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.421 179.858 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 35.5 Cg_endo -65.95 144.7 77.54 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.548 2.165 . . . . 0.0 112.798 -179.196 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.6 m -62.9 150.18 42.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.602 -179.602 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -94.31 97.77 10.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.903 179.697 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.616 HD22 ' HA ' ' A' ' 24' ' ' ALA . 59.6 mt -95.44 70.99 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.072 0.463 . . . . 0.0 110.632 179.882 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 p -68.68 -8.18 40.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.225 -178.885 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -137.12 150.28 47.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.979 0.419 . . . . 0.0 111.933 -179.421 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 20.9 t -58.49 -49.78 91.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.617 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -57.81 -43.26 51.14 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.91 1.74 . . . . 0.0 111.873 179.865 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.39 -36.99 85.64 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.196 0.522 . . . . 0.0 110.277 179.921 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.39 -57.37 11.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.028 179.262 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 65.4 mtp -62.08 -27.22 68.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.253 -179.941 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -70.28 -51.36 31.07 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.73 0.3 . . . . 0.0 110.381 179.747 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.446 ' O ' HG22 ' A' ' 31' ' ' THR . 8.4 m-85 -59.92 -33.18 71.53 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.147 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.51 HD11 HD12 ' A' ' 36' ' ' ILE . 52.9 mt -71.81 -38.24 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.907 178.241 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.06 -18.75 61.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.929 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.24 28.95 3.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.249 -179.824 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.589 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.8 t -168.58 151.55 5.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 -179.701 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.607 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.7 tt0 -68.86 -49.64 56.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.03 -179.968 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 83' ' ' LEU . 23.4 t -122.29 135.19 63.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.12 179.31 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.29 125.85 22.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.996 0.427 . . . . 0.0 112.022 -178.862 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.489 HG21 HG12 ' A' ' 111' ' ' ILE . 48.0 t -114.26 127.15 71.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.558 178.355 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.51 HD12 HD11 ' A' ' 28' ' ' ILE . 33.9 mt -132.95 139.36 49.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.735 -177.062 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.513 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.54 100.14 1.94 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.121 179.596 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.461 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 40.1 m-85 -86.84 94.56 9.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.387 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.4 m-85 -114.06 142.24 46.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.503 -177.898 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -88.32 -6.03 57.98 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.72 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' O ' HG12 ' A' ' 44' ' ' ILE . 9.6 t70 -151.4 125.75 9.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.618 179.606 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.647 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.2 mt -95.24 47.83 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.032 0.444 . . . . 0.0 111.502 -179.526 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -137.72 7.14 2.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.718 178.869 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.813 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.2 pt -90.51 155.41 46.12 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.194 179.939 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.494 ' O ' HD12 ' A' ' 49' ' ' ILE . 78.3 Cg_exo -50.38 -27.32 18.04 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.881 2.387 . . . . 0.0 113.246 -179.881 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.813 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.56 -37.52 87.84 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.892 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.708 HG23 HG13 ' A' ' 44' ' ' ILE . 3.1 t -61.79 -56.0 36.54 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.572 -178.895 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.663 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.4 Cg_exo -60.16 -39.44 68.97 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.833 1.689 . . . . 0.0 111.533 179.508 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.2 mt -62.99 -36.7 76.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.035 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.2 tp -72.43 -52.68 14.84 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.021 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -54.69 -22.28 13.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.037 0.446 . . . . 0.0 109.943 178.774 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.4 m -85.48 -44.12 12.99 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.494 179.501 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.609 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.52 -24.93 66.94 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.378 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.5 t -51.74 -47.22 39.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.962 179.319 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -77.43 -13.04 60.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.837 -179.776 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -91.45 -18.27 24.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.014 179.897 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.589 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.3 m-85 -137.22 62.74 39.88 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.466 -179.836 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.56 -45.15 43.11 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.643 2.228 . . . . 0.0 111.734 179.231 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.2 -42.86 83.43 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.545 179.148 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.1 t -64.29 144.51 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.667 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.589 ' CB ' HG21 ' A' ' 31' ' ' THR . 37.7 t -82.3 97.43 8.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.036 0.446 . . . . 0.0 111.137 -179.68 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.487 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.6 p90 -64.49 128.13 34.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.607 179.579 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.87 160.76 28.32 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.022 179.901 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -159.97 143.29 5.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.428 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 41.6 t -150.09 157.25 42.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.048 0.451 . . . . 0.0 111.558 -179.181 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.458 HG21 ' HG ' ' A' ' 42' ' ' LEU . 82.7 p -137.82 -3.33 1.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.619 179.777 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -65.55 139.72 58.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.627 -179.835 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.2 t -61.58 -50.39 72.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.209 -179.633 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -48.69 -47.77 40.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.665 -179.391 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.558 ' HA ' HG22 ' A' ' 21' ' ' VAL . 64.9 t -67.87 -55.02 18.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.772 0.32 . . . . 0.0 110.73 179.818 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 mp -56.86 -14.8 3.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.351 179.397 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.7 m -91.0 -41.75 10.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.281 178.764 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -60.82 -35.94 77.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.616 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.409 ' HB2' HG12 ' A' ' 76' ' ' ILE . 84.7 m-85 -95.88 14.25 24.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.805 179.621 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 55.49 25.11 7.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.771 179.067 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.685 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.4 mm -62.67 121.82 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.883 0.373 . . . . 0.0 111.243 179.981 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.5 p -142.46 59.28 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.117 179.959 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.28 44.93 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.586 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.645 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 29.2 m-80 51.79 43.83 29.76 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.222 0.534 . . . . 0.0 110.609 -179.944 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.685 ' HB ' HG23 ' A' ' 76' ' ' ILE . 87.5 m -69.31 151.65 45.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.55 -178.642 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.57 HG21 HD21 ' A' ' 107' ' ' LEU . 54.6 mt -117.7 117.54 55.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.158 177.931 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.461 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 71.2 m -108.06 133.2 52.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.566 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.649 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -108.55 104.96 14.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.752 178.268 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -98.95 120.84 40.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.881 0.372 . . . . 0.0 110.892 179.77 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.519 HH12 HD12 ' A' ' 116' ' ' LEU . 3.7 mtm180 -104.43 100.49 10.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.123 179.82 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.6 tp -43.78 -55.11 4.67 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.017 -179.362 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.607 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.3 -62.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.171 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -98.31 8.14 45.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.167 -179.618 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 85' ' ' ARG . 19.7 t-20 48.69 38.03 10.73 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.023 -179.914 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 7.1 mm-40 -82.25 160.72 22.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.765 179.691 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.2 94.3 2.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 179.462 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.649 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -81.94 139.51 34.56 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.291 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -120.28 114.55 22.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.315 0.578 . . . . 0.0 112.294 -179.385 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.483 HD21 HD13 ' A' ' 102' ' ' ILE . 3.8 tt -100.23 75.75 1.84 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.9 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' O ' HG12 ' A' ' 99' ' ' ILE . 22.5 mt-10 -76.98 -166.41 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.146 -176.785 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.483 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.4 OUTLIER -45.92 -51.21 13.61 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.249 -179.334 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -46.98 -17.02 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.286 179.653 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.406 ' N ' ' C ' ' A' ' 96' ' ' ASP . 10.8 m-20 -126.22 -14.17 6.01 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.551 -179.999 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.552 HG21 ' HB2' ' A' ' 79' ' ' ASN . 21.7 mm -90.91 -26.19 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.624 -179.322 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -58.18 -35.48 71.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.868 0.366 . . . . 0.0 110.971 -179.81 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.3 m -132.52 39.49 3.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.526 179.964 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.519 HG21 ' HB2' ' A' ' 46' ' ' ALA . 6.2 tp -64.16 142.07 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.438 -179.86 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -136.74 148.36 47.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.593 178.846 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.89 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.39 -35.57 5.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.034 0.445 . . . . 0.0 110.391 179.961 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -63.67 -49.02 74.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.441 178.891 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -59.2 -58.7 7.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.179 -179.88 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.721 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.18 -55.84 13.52 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.091 0.472 . . . . 0.0 109.966 179.881 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.0 m -58.39 -29.13 65.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.9 179.726 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.489 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -71.48 -66.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.172 179.588 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -42.59 -42.58 3.45 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.07 179.132 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.489 HG12 HG21 ' A' ' 35' ' ' VAL . 95.5 mt -64.28 -55.77 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.503 178.346 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.28 -18.62 4.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.319 179.41 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.489 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.32 -37.28 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.934 -179.023 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.404 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.1 m120 -122.44 28.75 7.25 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.595 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.1 p -82.3 52.85 2.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.09 0.472 . . . . 0.0 110.184 178.884 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.519 HD12 HH12 ' A' ' 85' ' ' ARG . 67.9 mt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.125 -179.344 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.783 0.325 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.462 HG23 ' HG2' ' A' ' 3' ' ' GLU . 20.3 m -137.5 -23.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 2' ' ' VAL . 21.8 mm-40 -124.96 27.14 6.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.064 179.946 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -131.14 54.14 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.799 179.875 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.6 m -143.6 20.14 1.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.971 179.976 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.9 m -148.0 -56.91 0.23 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.858 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.95 134.85 54.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.071 -179.888 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.73 -162.13 13.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.348 -179.912 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -51.66 111.91 0.7 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.631 2.221 . . . . 0.0 112.348 179.781 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.13 -160.63 36.71 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.548 -179.761 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . -161.22 -24.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.028 0.442 . . . . 0.0 110.593 -179.917 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' A' ' 11' ' ' ALA . . . -49.78 -30.06 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.35 179.986 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.525 ' HG3' HG12 ' A' ' 54' ' ' VAL . 10.3 pt20 -168.36 153.19 6.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.204 -179.735 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.467 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.4 pt-20 -143.93 158.28 56.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.476 179.949 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HD3' HG21 ' A' ' 54' ' ' VAL . 42.0 Cg_endo -67.77 139.9 49.38 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.492 2.128 . . . . 0.0 112.535 -179.397 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.5 m -59.35 154.67 16.23 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.831 -179.52 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -97.11 90.6 5.21 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.023 -179.927 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 24' ' ' ALA . 51.5 mt -88.01 74.53 8.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.233 179.643 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.8 p -75.83 2.62 11.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.214 -179.167 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 9.7 m-20 -145.2 147.69 32.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 111.612 -179.813 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.3 t -56.47 -49.29 94.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.516 179.896 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 17.7 Cg_endo -59.39 -43.8 37.74 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.841 1.694 . . . . 0.0 111.975 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.18 -34.95 79.59 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.191 0.519 . . . . 0.0 110.317 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.619 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.93 -59.05 4.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.051 179.396 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 46.3 mtm -61.42 -27.17 68.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.16 -179.964 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.0 mt-10 -70.05 -49.77 47.85 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.756 0.312 . . . . 0.0 110.512 179.774 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.597 ' O ' HG22 ' A' ' 31' ' ' THR . 6.6 m-85 -61.42 -35.36 77.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.981 179.2 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.512 HD11 HD12 ' A' ' 36' ' ' ILE . 48.7 mt -71.19 -35.98 60.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.213 0.53 . . . . 0.0 109.802 178.324 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.7 -19.36 60.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.927 -179.915 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.17 25.49 4.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.211 -179.736 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.644 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.9 t -170.68 153.56 4.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.633 -179.8 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.514 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.3 tt0 -64.37 -80.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.727 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.571 HG13 HD11 ' A' ' 83' ' ' LEU . 19.6 t -92.14 135.0 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.498 179.693 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.6 126.12 21.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.035 0.445 . . . . 0.0 112.11 -179.107 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.431 HG21 HG12 ' A' ' 111' ' ' ILE . 45.6 t -114.76 130.93 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.71 178.51 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.512 HD12 HD11 ' A' ' 28' ' ' ILE . 25.9 mt -135.88 137.54 48.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.544 -177.385 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.585 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.39 97.68 1.76 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.519 179.907 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.5 m-85 -82.85 90.91 6.99 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.632 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.6 m-85 -110.85 138.64 47.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.224 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -84.59 -8.69 58.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.824 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.3 t70 -150.37 125.87 10.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.738 179.794 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.515 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.0 mt -93.41 46.68 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.422 . . . . 0.0 111.325 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.6 mt-10 -137.26 11.37 3.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.929 179.036 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.767 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.5 pt -94.03 158.1 36.74 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.014 179.984 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.505 ' O ' HD12 ' A' ' 49' ' ' ILE . 78.0 Cg_exo -53.47 -25.08 30.67 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.709 2.273 . . . . 0.0 112.93 179.951 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.767 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.53 -37.68 87.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.758 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.683 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -61.28 -55.45 43.51 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -178.754 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.2 Cg_exo -60.95 -40.41 52.89 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.045 1.83 . . . . 0.0 111.367 179.405 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.877 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -63.0 -33.79 62.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.042 179.973 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.62 ' O ' HG23 ' A' ' 54' ' ' VAL . 42.9 tp -75.26 -51.85 12.3 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.842 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -53.56 -25.85 18.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.218 0.532 . . . . 0.0 109.837 178.541 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 t -81.88 -47.53 12.66 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.589 179.895 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.613 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.14 -26.44 62.68 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.517 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 50' ' ' LEU . 52.6 t -51.68 -47.54 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.016 179.306 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -78.54 -11.88 59.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.681 -179.891 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 28.4 mtpp -92.12 -16.41 26.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.226 179.764 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.598 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 55.4 m-85 -138.71 63.18 31.72 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.478 -179.883 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.8 -44.47 47.92 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.636 2.224 . . . . 0.0 111.643 179.085 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.53 -38.85 82.94 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.542 179.209 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.0 t -68.76 144.28 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.175 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.644 ' HB2' HG21 ' A' ' 31' ' ' THR . 23.2 t -82.53 96.5 8.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.106 0.479 . . . . 0.0 110.816 -179.65 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.501 ' HB3' HG22 ' A' ' 54' ' ' VAL . 4.0 p90 -64.07 125.75 25.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.074 179.69 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.66 162.05 28.25 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.16 179.908 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.5 tt -158.16 142.19 6.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.811 0.339 . . . . 0.0 110.223 179.62 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.8 t -142.73 154.69 44.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.136 0.493 . . . . 0.0 111.706 -179.036 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.442 HG21 ' HG ' ' A' ' 42' ' ' LEU . 71.3 p -140.16 1.86 1.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.534 179.503 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -74.24 139.86 44.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.658 -179.786 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.3 m -62.17 -50.77 70.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.296 -179.694 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -49.65 -44.63 47.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.588 -179.449 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.498 ' HA ' HG22 ' A' ' 21' ' ' VAL . 67.6 t -69.8 -53.94 21.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.859 0.361 . . . . 0.0 110.687 179.856 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp -57.95 -15.43 8.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.396 179.385 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 86.4 m -89.81 -42.5 11.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.212 178.748 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -59.72 -36.92 77.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.45 179.694 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.412 ' HB2' HG12 ' A' ' 76' ' ' ILE . 65.4 m-85 -94.86 12.31 28.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.11 179.638 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.7 m120 57.29 20.77 6.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.67 179.063 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.654 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.3 mm -57.49 120.66 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.951 179.637 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.1 p -140.62 53.8 1.61 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.865 0.364 . . . . 0.0 111.312 -179.957 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.43 46.15 0.01 OUTLIER Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.68 179.839 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.62 ' HB2' HG21 ' A' ' 99' ' ' ILE . 23.3 m-80 51.2 42.54 28.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.186 0.517 . . . . 0.0 110.404 -179.85 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.654 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.3 m -68.35 152.82 44.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.557 -178.658 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.585 HG12 ' HA2' ' A' ' 37' ' ' GLY . 60.7 mt -119.43 118.53 57.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.035 178.195 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.477 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 65.6 m -107.57 137.08 46.24 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.695 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.643 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -111.47 103.49 11.85 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.092 178.702 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -96.65 117.96 32.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.664 179.644 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.467 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 4.5 mtm180 -101.94 81.37 2.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.761 -179.863 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 5.6 tp -25.05 -60.98 0.06 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.327 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.514 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.46 -62.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.137 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -94.43 1.07 55.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.011 0.434 . . . . 0.0 111.045 -179.5 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 51.13 38.81 21.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.313 179.684 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 6.3 mm-40 -87.52 157.54 19.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.574 179.658 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.03 101.51 4.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.938 179.735 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.643 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -90.4 115.81 27.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.704 179.319 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.79 111.27 23.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.734 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.554 HD21 HD13 ' A' ' 102' ' ' ILE . 5.4 tt -97.6 77.61 2.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.723 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.4 mt-10 -79.12 -164.74 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -176.786 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -45.66 -50.97 12.96 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.515 -179.173 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -46.55 -17.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.008 0.432 . . . . 0.0 111.128 179.747 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.414 ' N ' ' C ' ' A' ' 96' ' ' ASP . 17.0 m-20 -126.79 -13.78 5.77 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.484 180.0 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.62 HG21 ' HB2' ' A' ' 79' ' ' ASN . 27.4 mm -91.32 -42.11 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.464 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -51.9 -30.74 25.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.907 0.384 . . . . 0.0 111.052 179.935 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.5 m -131.36 36.09 3.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.277 179.68 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.7 tp -65.66 143.91 15.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.583 -179.818 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.411 ' N ' HG13 ' A' ' 102' ' ' ILE . 16.2 m-20 -139.2 147.58 41.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.39 178.719 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.877 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.71 -37.11 7.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 110.307 -179.829 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.1 m -61.83 -48.37 80.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.357 178.677 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -59.9 -61.23 2.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.367 -179.842 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.736 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.85 -55.89 8.75 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 110.386 179.894 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -58.75 -31.75 68.62 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.991 179.909 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.535 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.3 tmt_? -69.86 -65.32 0.74 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.308 179.777 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -43.59 -44.17 6.06 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.168 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.431 HG12 HG21 ' A' ' 35' ' ' VAL . 96.7 mt -62.29 -55.36 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.197 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.43 -19.04 4.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.522 179.31 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.535 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -87.29 -36.79 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.796 -179.294 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.446 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.9 m120 -124.91 29.86 6.05 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.784 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.8 p -82.67 46.73 1.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.121 0.486 . . . . 0.0 110.329 179.166 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 63.1 mt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.316 -179.379 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.809 0.337 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.9 m -80.01 162.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.305 -179.925 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -131.33 110.27 10.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.803 -179.912 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER 56.47 68.64 0.83 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 -179.76 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.8 t -118.03 39.86 3.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.867 -179.829 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.3 t 56.73 62.48 2.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.917 -179.954 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -88.15 -21.2 24.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.822 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.89 169.92 24.23 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.339 179.944 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.7 121.85 10.27 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.64 2.227 . . . . 0.0 112.229 179.942 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.94 28.4 1.42 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.578 -179.832 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.59 -24.94 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.026 0.441 . . . . 0.0 110.514 179.774 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 13' ' ' GLN . . . -62.89 84.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.024 179.811 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.52 ' HG3' HG12 ' A' ' 54' ' ' VAL . 5.1 pt20 44.84 114.62 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.85 0.719 . . . . 0.0 112.63 -179.872 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 -110.35 158.03 36.47 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.798 -179.748 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.9 Cg_endo -67.91 140.86 51.73 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.654 2.236 . . . . 0.0 112.407 -179.712 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 17' ' ' TRP . 23.2 m -55.1 155.0 5.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.892 -179.409 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.4 ' N ' HG22 ' A' ' 16' ' ' THR . 91.4 m95 -100.57 92.26 5.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.876 179.725 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.609 HD13 ' HA ' ' A' ' 24' ' ' ALA . 55.4 mt -90.2 73.41 7.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.433 -179.893 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.5 p -74.36 0.85 13.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.288 -178.858 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -143.49 147.17 34.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.729 -179.678 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.586 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 19.9 t -55.2 -51.01 83.3 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.413 179.973 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.02 -44.18 41.91 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.905 1.737 . . . . 0.0 112.012 179.805 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.94 79.21 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.284 0.564 . . . . 0.0 110.35 -179.883 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.609 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -65.19 -58.48 5.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.984 179.515 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.7 mtm -61.28 -25.18 66.93 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.88 179.892 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -71.51 -51.68 22.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.357 179.613 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.574 ' O ' HG22 ' A' ' 31' ' ' THR . 0.3 OUTLIER -60.01 -33.82 72.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.929 179.282 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.533 HD11 HD12 ' A' ' 36' ' ' ILE . 51.6 mt -73.42 -37.99 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.951 178.492 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.17 -18.35 60.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.905 -179.933 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.4 24.73 4.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.19 -179.871 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.656 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.9 t -169.71 153.08 4.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.695 -179.792 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.528 ' HG3' HG13 ' A' ' 87' ' ' VAL . 18.2 tt0 -64.12 -77.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.609 179.774 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 83' ' ' LEU . 21.5 t -95.53 133.84 35.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.418 179.668 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.559 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -137.47 124.9 21.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.254 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.438 HG11 HD11 ' A' ' 111' ' ' ILE . 55.0 t -114.07 128.32 71.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.723 178.464 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.533 HD12 HD11 ' A' ' 28' ' ' ILE . 27.3 mt -135.05 138.53 48.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.534 -177.345 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.57 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.66 98.79 1.9 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.272 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.451 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 37.1 m-85 -84.23 91.02 7.63 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.291 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -110.72 142.54 42.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.646 -178.065 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -86.63 -8.08 57.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.887 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -151.53 131.11 13.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.605 179.745 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.636 ' HA ' HG21 ' A' ' 47' ' ' VAL . 84.4 mt -97.75 47.58 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.109 0.48 . . . . 0.0 111.621 -179.539 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -137.09 5.22 2.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.689 178.773 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.811 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.6 pt -88.27 155.72 51.64 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.094 179.766 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.488 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.3 Cg_exo -50.95 -29.06 25.94 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.89 2.393 . . . . 0.0 113.126 179.886 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.811 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.04 -37.44 84.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.831 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.709 HG23 HG13 ' A' ' 44' ' ' ILE . 3.2 t -61.9 -57.21 25.48 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.659 -178.787 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.693 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.3 Cg_exo -59.07 -38.57 86.51 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.759 1.639 . . . . 0.0 111.52 179.589 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -63.33 -36.48 76.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.047 179.936 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.5 tp -73.98 -53.23 10.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.77 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -54.2 -22.59 11.86 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.816 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.2 t -85.32 -43.66 13.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.435 179.516 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.585 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.44 -24.85 66.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.253 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -51.97 -46.69 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.89 179.236 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -77.58 -12.6 59.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.905 -179.74 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -92.19 -18.16 23.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.332 -179.978 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 52.5 m-85 -137.37 63.31 41.45 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.547 -179.692 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.64 -46.43 33.41 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.71 2.274 . . . . 0.0 111.77 178.939 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.9 -42.08 78.59 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.658 179.328 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.9 t -64.27 146.61 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.87 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.656 ' HB2' HG21 ' A' ' 31' ' ' THR . 32.8 t -83.51 97.48 9.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.964 0.411 . . . . 0.0 110.924 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.51 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.2 p90 -66.02 126.17 27.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.49 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.32 161.62 28.35 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.195 179.81 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -159.07 144.36 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.993 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.451 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 29.4 t -149.18 155.86 41.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.12 0.486 . . . . 0.0 111.762 -179.214 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.513 HG21 ' HG ' ' A' ' 42' ' ' LEU . 76.6 p -137.09 -0.8 2.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.613 179.387 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.92 136.33 53.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.566 -179.927 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 59.5 m -61.52 -48.66 80.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.577 -179.634 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -51.51 -41.27 60.88 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.51 -179.435 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.45 ' HA ' HG22 ' A' ' 21' ' ' VAL . 55.4 t -72.6 -53.61 18.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.915 0.388 . . . . 0.0 110.439 179.835 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.64 -14.56 8.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.23 179.261 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.2 m -91.84 -42.12 10.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.385 178.85 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -60.39 -39.49 87.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.422 ' HB2' HG12 ' A' ' 76' ' ' ILE . 88.5 m-85 -90.06 11.02 21.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.651 179.595 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.8 m120 58.03 24.97 11.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.52 179.373 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.747 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.9 mm -62.8 124.17 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.875 179.458 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.8 p -142.32 58.95 1.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.437 -179.887 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.09 45.3 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.823 179.854 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 26.8 m-80 52.04 44.03 29.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.174 0.511 . . . . 0.0 110.613 -179.86 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.747 ' HB ' HG23 ' A' ' 76' ' ' ILE . 86.6 m -69.16 154.22 42.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.533 -178.763 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.609 HG21 HD21 ' A' ' 107' ' ' LEU . 60.5 mt -119.72 117.8 55.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.16 178.156 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 72.8 m -106.99 134.68 49.78 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -177.787 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.635 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -110.78 103.79 12.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.663 178.17 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -97.93 118.03 33.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.634 179.909 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.543 HH12 HD12 ' A' ' 116' ' ' LEU . 4.5 mtm180 -101.22 80.08 2.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.462 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' ARG . 5.1 tp -23.91 -60.51 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.36 -0.836 . . . . 0.0 113.249 -179.417 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.528 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.97 -61.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.01 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -95.34 3.31 54.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.41 . . . . 0.0 111.034 -179.506 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 53.19 29.24 8.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.802 179.357 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.5 mm-40 -75.47 153.13 37.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.538 0.209 . . . . 0.0 110.643 179.721 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.54 95.98 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.718 179.858 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.635 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -87.44 114.53 24.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.976 179.917 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.39 110.53 23.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.087 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.566 HD21 HD13 ' A' ' 102' ' ' ILE . 4.3 tt -96.16 78.81 3.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.014 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.441 ' O ' HG12 ' A' ' 99' ' ' ILE . 30.6 mt-10 -78.78 -165.17 0.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -176.383 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.526 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 30.2 t70 -51.46 -35.28 39.03 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.951 -179.178 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -56.68 -15.33 4.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.206 0.527 . . . . 0.0 110.261 179.482 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -130.11 -14.09 3.93 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.531 179.923 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.572 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.9 mm -90.0 -27.67 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.789 0.328 . . . . 0.0 111.263 -179.517 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -57.13 -37.43 71.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.782 -179.862 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.5 m -131.95 38.17 3.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.562 179.673 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.566 HD13 HD21 ' A' ' 94' ' ' LEU . 7.6 tp -63.61 144.61 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.575 -179.602 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -138.37 149.64 45.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.45 178.603 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.887 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.73 -35.0 9.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.111 0.481 . . . . 0.0 110.48 -179.673 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.5 m -63.01 -48.53 78.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.49 178.761 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 102' ' ' ILE . 54.3 mtpt -59.66 -59.17 5.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.182 -179.703 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.739 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.1 -55.45 14.89 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.988 0.423 . . . . 0.0 110.18 -179.994 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.6 m -58.72 -29.48 66.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.714 179.836 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.519 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -71.11 -66.2 0.65 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.068 179.724 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -42.71 -44.73 4.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.057 179.275 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.438 HD11 HG11 ' A' ' 35' ' ' VAL . 96.5 mt -62.65 -55.2 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.535 178.387 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -54.37 -18.69 4.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.253 179.357 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.519 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.09 -36.21 8.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.898 -179.137 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.431 ' O ' HD21 ' A' ' 83' ' ' LEU . 19.0 m120 -125.35 30.33 5.83 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.3 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.1 p -83.53 48.48 1.42 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.135 0.493 . . . . 0.0 110.145 178.922 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.543 HD12 HH12 ' A' ' 85' ' ' ARG . 60.9 mt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.36 -179.362 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.785 0.326 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.48 131.75 70.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.038 -179.995 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -171.73 164.93 6.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.833 -179.896 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -89.29 50.58 1.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.83 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.1 m -156.74 130.03 8.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.922 -179.987 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 t -139.01 125.28 20.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.804 -179.982 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -142.37 26.73 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 -179.968 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.24 -166.02 29.97 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.572 -179.866 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.92 -173.55 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.647 2.231 . . . . 0.0 112.473 -179.939 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.54 -122.8 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.682 -179.931 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.04 -69.2 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.683 0.277 . . . . 0.0 110.6 -179.811 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.475 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . . . 57.32 99.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.367 179.687 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.505 ' HG3' ' CG1' ' A' ' 54' ' ' VAL . 5.4 pt20 -167.31 -179.93 4.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.825 -179.366 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.1 pt-20 -128.92 157.01 77.0 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.135 -179.542 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 36.4 Cg_endo -67.08 142.93 63.36 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.934 2.423 . . . . 0.0 112.827 -179.514 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.8 m -59.68 153.77 19.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.624 -179.838 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -98.53 97.5 8.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.129 -179.849 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 24' ' ' ALA . 46.8 mt -95.21 76.46 3.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.361 179.769 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.9 p -75.17 -2.49 28.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.297 -178.736 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -142.16 147.36 36.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.919 0.39 . . . . 0.0 111.727 -179.814 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 36.1 t -54.3 -49.5 90.14 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.663 179.983 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.07 -46.97 22.3 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.949 1.766 . . . . 0.0 112.147 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.92 -34.68 77.94 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.186 0.517 . . . . 0.0 110.388 -179.81 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.619 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.84 -59.97 3.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.122 179.389 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 67.5 mtp -60.4 -25.98 66.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.215 -179.897 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 25.1 mt-10 -73.07 -51.73 16.97 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 120.652 0.263 . . . . 0.0 110.675 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.499 ' O ' HG22 ' A' ' 31' ' ' THR . 7.0 m-85 -58.44 -33.35 69.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.117 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.556 HD11 HD12 ' A' ' 36' ' ' ILE . 45.0 mt -72.35 -40.04 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.901 178.104 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.81 -17.77 62.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.06 179.948 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.64 27.92 2.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.231 -179.828 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.639 HG21 ' HB2' ' A' ' 61' ' ' SER . 7.8 t -173.16 155.49 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.579 -179.626 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.551 ' HG3' HG13 ' A' ' 87' ' ' VAL . 19.6 tt0 -65.31 -76.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.681 179.838 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.537 HG13 HD11 ' A' ' 83' ' ' LEU . 21.0 t -95.38 137.98 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.42 179.661 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.545 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.97 125.94 18.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.039 0.447 . . . . 0.0 112.021 -179.142 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.504 HG21 HG12 ' A' ' 111' ' ' ILE . 51.6 t -115.57 129.53 71.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.828 178.526 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.556 HD12 HD11 ' A' ' 28' ' ' ILE . 26.5 mt -135.02 135.72 52.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.624 -177.341 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.4 99.81 2.24 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.335 179.633 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 11.7 m-85 -84.63 92.57 8.19 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.725 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 9.7 m-85 -114.69 142.67 46.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.309 -178.217 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -90.06 -8.64 50.98 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.7 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.494 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.5 t70 -148.12 118.96 7.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.742 179.761 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.501 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.9 mt -88.4 44.85 1.23 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.114 0.483 . . . . 0.0 111.516 -179.268 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 39.1 mt-10 -133.82 6.96 3.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.124 178.953 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.694 HG13 HG23 ' A' ' 47' ' ' VAL . 5.6 pt -88.14 159.48 47.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.191 179.89 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' HD12 ' A' ' 49' ' ' ILE . 54.3 Cg_exo -54.91 -26.07 46.95 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.763 2.308 . . . . 0.0 112.689 179.429 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.656 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.41 -38.7 91.94 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.883 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.694 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -59.69 -55.58 44.33 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.723 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.647 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.1 Cg_exo -59.75 -41.27 56.59 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.052 1.835 . . . . 0.0 111.403 179.185 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.905 HG23 ' HA ' ' A' ' 104' ' ' ALA . 8.9 mt -61.97 -35.01 65.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.194 -179.906 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 54' ' ' VAL . 47.2 tp -74.75 -50.93 15.59 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.959 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -54.98 -26.0 33.7 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.398 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -81.42 -46.12 15.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.734 179.859 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.58 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.21 -26.15 66.15 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.38 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 50' ' ' LEU . 47.7 t -53.87 -48.44 62.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.162 179.541 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.475 ' NE2' ' HA ' ' A' ' 12' ' ' ALA . 34.0 mt-30 -76.83 -9.35 58.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.588 -179.898 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -94.82 -19.56 20.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 179.719 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.599 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 73.4 m-85 -135.04 62.11 50.43 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.609 -179.548 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.4 -40.35 71.33 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.57 2.18 . . . . 0.0 111.379 178.996 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.42 -42.5 97.54 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.323 179.068 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.9 t -65.49 144.83 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.084 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.639 ' HB2' HG21 ' A' ' 31' ' ' THR . 24.1 t -82.65 96.6 8.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.095 0.474 . . . . 0.0 110.967 -179.554 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.54 ' HB3' HG22 ' A' ' 54' ' ' VAL . 5.2 p90 -64.28 129.39 39.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.106 179.805 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.83 161.98 28.8 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.097 179.667 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -160.99 143.03 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.808 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.1 t -145.67 155.66 43.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.109 0.481 . . . . 0.0 111.917 -178.935 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 78.8 p -138.89 6.16 2.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.655 179.505 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.09 144.42 40.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.706 -179.925 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -65.64 -54.39 28.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.384 -179.547 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -49.04 -40.0 29.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.631 -179.364 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.576 ' HA ' HG22 ' A' ' 21' ' ' VAL . 68.3 t -72.37 -55.27 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.857 0.361 . . . . 0.0 110.603 179.69 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.3 -14.78 8.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.517 179.461 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.6 m -89.22 -48.04 7.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.721 179.101 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -59.03 -33.58 70.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.57 179.837 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 76' ' ' ILE . 40.7 m-85 -92.82 8.24 40.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.547 179.235 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 57.32 23.69 9.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.632 179.51 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.697 HG23 ' HB ' ' A' ' 80' ' ' THR . 34.3 mm -61.22 120.9 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.012 179.652 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.8 p -141.3 58.43 1.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.308 179.825 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.32 42.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.533 179.815 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.601 ' HB2' HG21 ' A' ' 99' ' ' ILE . 39.9 m-20 52.77 42.43 31.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.267 0.556 . . . . 0.0 110.151 -179.669 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.697 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.4 m -67.97 154.36 41.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.682 -178.472 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.588 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.5 mt -120.32 116.95 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.271 178.271 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.7 m -105.93 137.09 44.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.857 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.668 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -112.98 105.68 13.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.253 178.671 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.2 t80 -98.18 123.08 42.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.682 0.277 . . . . 0.0 110.415 179.413 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.552 HH12 HD12 ' A' ' 116' ' ' LEU . 5.7 mtm180 -105.59 82.38 1.8 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.801 0.334 . . . . 0.0 110.875 -179.698 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 7.2 tp -26.29 -59.28 0.08 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.432 -0.803 . . . . 0.0 113.103 -179.287 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.551 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.21 -56.27 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.128 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -99.93 13.27 34.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.734 0.302 . . . . 0.0 111.386 -179.353 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 45.2 24.39 0.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.218 179.234 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.516 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 15.9 mm-40 -72.02 157.73 37.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.768 0.318 . . . . 0.0 110.77 179.794 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -143.6 85.44 1.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.67 179.667 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.668 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -72.78 147.96 45.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.947 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.69 114.41 16.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.309 0.576 . . . . 0.0 112.285 -179.562 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.617 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -101.83 76.33 1.62 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.93 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.444 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.8 mt-10 -75.82 -166.75 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -176.692 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.554 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.6 t70 -50.91 -38.67 51.47 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.057 -179.093 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -55.51 -14.9 2.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.164 0.506 . . . . 0.0 110.525 179.794 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -128.45 -13.67 4.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.47 -179.988 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.601 HG21 ' HB2' ' A' ' 79' ' ' ASN . 21.2 mm -89.47 -23.79 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.71 -179.33 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -53.65 -66.46 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 110.684 179.807 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.8 t -105.77 34.3 3.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.622 179.782 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.617 HD13 HD21 ' A' ' 94' ' ' LEU . 7.5 tp -53.99 142.04 8.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.224 -179.947 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -135.61 151.06 49.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.676 178.967 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.905 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.42 -34.97 17.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.981 0.42 . . . . 0.0 110.446 -179.883 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 95.0 m -63.1 -48.16 79.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.287 178.774 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -59.79 -60.44 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.252 -179.815 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.767 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -49.36 -55.62 12.32 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.074 0.464 . . . . 0.0 110.237 179.785 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.2 m -58.32 -30.57 66.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.872 179.735 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.516 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -70.15 -66.19 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.118 179.771 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -43.43 -44.73 5.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.059 179.355 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.504 HG12 HG21 ' A' ' 35' ' ' VAL . 95.5 mt -61.88 -54.63 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.367 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -55.51 -19.15 8.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.4 179.48 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.516 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -87.69 -36.61 9.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.88 -179.009 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -122.15 27.27 8.09 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.44 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.6 p -81.33 51.68 1.68 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.988 0.423 . . . . 0.0 110.362 178.886 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.552 HD12 HH12 ' A' ' 85' ' ' ARG . 71.1 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.401 -179.469 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.775 0.321 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.75 164.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.098 179.986 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -146.12 148.8 32.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 179.924 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -107.0 126.02 51.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.946 -179.952 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -148.09 92.92 2.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 179.91 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.1 p -110.4 137.23 48.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.027 -179.848 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -108.66 144.2 36.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.738 179.867 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.12 179.08 35.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.547 -179.831 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.09 135.81 64.96 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.666 2.244 . . . . 0.0 112.317 179.939 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.19 147.09 2.52 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.528 -179.927 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.05 -70.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.733 0.301 . . . . 0.0 110.729 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.2 106.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.212 179.836 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.564 ' HG3' HG12 ' A' ' 54' ' ' VAL . 26.2 pt20 -51.25 148.35 4.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.265 -179.788 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.516 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 -122.77 159.5 53.11 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.735 -179.748 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 30.5 Cg_endo -64.18 143.69 84.59 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.699 2.266 . . . . 0.0 112.603 -179.709 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.0 m -61.71 152.41 31.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.552 -179.776 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -98.18 92.55 5.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 40.2 mt -87.71 72.55 9.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.258 -179.905 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.4 p -69.07 -3.98 15.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.251 -178.922 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -141.39 149.58 41.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.993 0.425 . . . . 0.0 111.792 -179.569 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 25.3 t -57.03 -49.12 95.81 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.626 179.753 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.7 Cg_endo -58.93 -43.73 41.04 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.956 1.771 . . . . 0.0 111.909 179.865 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.16 -35.3 80.67 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 110.143 179.831 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.43 -56.97 11.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.091 179.361 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 33.8 mtt -62.53 -27.72 69.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.171 -179.961 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -69.94 -49.61 50.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.686 0.279 . . . . 0.0 110.449 179.723 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.01 -32.56 73.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.84 179.071 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.526 HD11 HD12 ' A' ' 36' ' ' ILE . 54.3 mt -72.47 -37.65 57.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.833 178.161 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 -20.81 60.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.706 -179.958 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.17 28.96 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.153 -179.873 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.557 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.9 t -169.1 155.38 6.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.33 -179.798 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.526 ' HG3' HG13 ' A' ' 87' ' ' VAL . 29.2 tt0 -75.98 -33.91 59.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.254 179.481 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.474 HG13 HD11 ' A' ' 83' ' ' LEU . 17.1 t -133.37 136.3 54.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.125 179.273 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.59 125.24 16.85 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.117 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.486 HG21 HG12 ' A' ' 111' ' ' ILE . 53.4 t -113.18 127.63 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.449 178.234 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 28' ' ' ILE . 35.7 mt -133.87 139.41 48.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.62 -176.86 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.89 97.59 1.53 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.459 179.848 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.494 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 36.9 m-85 -84.84 94.37 8.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.322 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.576 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 9.9 m-85 -114.32 146.12 40.91 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.092 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -93.77 -6.45 46.01 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.082 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.476 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.7 t70 -151.98 113.94 4.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.511 179.855 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.498 ' HA ' HG21 ' A' ' 47' ' ' VAL . 89.0 mt -84.19 43.63 0.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.026 0.441 . . . . 0.0 111.549 -179.166 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.446 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.5 mt-10 -132.24 11.38 4.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.999 179.11 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.677 HG13 HG23 ' A' ' 47' ' ' VAL . 9.6 pt -91.78 161.89 32.62 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.336 179.969 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.501 ' O ' HD12 ' A' ' 49' ' ' ILE . 51.3 Cg_exo -57.73 -23.93 60.6 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.737 2.291 . . . . 0.0 112.587 179.047 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.604 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -66.36 -39.18 88.99 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.812 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.677 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -58.6 -55.1 49.38 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -178.681 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.8 Cg_exo -61.57 -42.46 33.01 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.971 1.781 . . . . 0.0 111.648 179.287 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.868 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -60.67 -34.33 58.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.236 -179.991 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.623 ' O ' HG23 ' A' ' 54' ' ' VAL . 51.3 tp -74.37 -51.67 14.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.138 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -53.55 -25.89 18.94 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.541 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 m -80.56 -49.79 10.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.606 179.686 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.578 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -56.43 -27.17 55.87 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.174 0.511 . . . . 0.0 109.666 179.551 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.2 t -53.27 -49.97 49.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.726 179.481 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -75.17 -8.66 57.2 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.583 -179.76 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -95.81 -19.14 19.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.203 179.613 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.624 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 63.4 m-85 -135.65 62.61 49.4 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.503 -179.796 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.65 -41.44 61.42 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.613 2.209 . . . . 0.0 111.658 179.094 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.37 -41.78 97.13 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.511 179.167 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.0 t -66.03 144.07 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.882 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.557 ' CB ' HG21 ' A' ' 31' ' ' THR . 47.4 t -82.07 99.32 9.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.08 0.467 . . . . 0.0 111.001 -179.773 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.509 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.5 p90 -65.59 127.94 33.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.635 179.688 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.16 161.52 28.32 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.235 -179.944 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 tt -162.21 143.24 3.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.732 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.494 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 44.1 t -150.32 157.24 42.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.127 0.489 . . . . 0.0 111.519 -179.143 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 71.2 p -136.49 -7.66 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.695 179.413 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -60.19 139.69 57.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.605 179.883 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.2 p -63.48 -47.33 82.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.61 -179.356 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -52.48 -43.42 64.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.716 -179.224 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.465 ' HA ' HG22 ' A' ' 21' ' ' VAL . 67.0 t -72.15 -51.04 32.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.849 0.356 . . . . 0.0 110.71 179.832 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.74 -14.84 23.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.088 0.47 . . . . 0.0 110.135 179.449 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.2 m -92.3 -39.46 11.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.418 178.799 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -62.86 -40.66 98.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.423 -179.996 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.429 ' HB2' HG12 ' A' ' 76' ' ' ILE . 65.8 m-85 -88.25 8.2 28.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.467 179.426 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 58.54 27.06 15.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.506 179.539 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.726 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.6 mm -63.2 121.69 12.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.225 179.689 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.0 p -141.12 56.17 1.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.377 -179.965 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.37 44.37 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.579 179.847 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.651 ' HB2' HG21 ' A' ' 99' ' ' ILE . 28.4 m-20 51.31 43.85 29.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.297 0.57 . . . . 0.0 110.379 -179.846 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.726 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.3 m -69.13 153.28 43.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.076 -178.334 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.567 HG12 ' HA2' ' A' ' 37' ' ' GLY . 55.2 mt -119.14 116.41 50.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.92 177.88 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 72.4 m -104.85 130.1 53.04 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.833 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.648 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -107.92 100.74 10.07 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.583 178.102 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -95.16 121.65 37.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.488 179.808 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.555 HH12 HD12 ' A' ' 116' ' ' LEU . 5.0 mtm180 -105.05 88.04 2.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.545 -179.933 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 tp -27.11 -60.28 0.09 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.279 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.526 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.19 -79.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.361 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -78.3 2.57 18.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.818 -179.907 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 54.36 28.84 9.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.54 179.671 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.541 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 27.5 mm-40 -71.32 163.44 27.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.884 0.374 . . . . 0.0 110.882 179.876 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.443 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -150.02 88.48 1.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.668 179.76 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.648 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -78.45 117.79 19.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.897 179.879 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.77 93.55 5.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.882 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.499 HD21 HD13 ' A' ' 102' ' ' ILE . 4.0 tt -78.71 78.6 5.15 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.776 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 99' ' ' ILE . 28.8 mt-10 -79.73 -165.5 0.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.787 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.471 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.7 OUTLIER -44.83 -52.05 8.92 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.374 -179.377 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -46.06 -17.68 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.365 179.786 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 96' ' ' ASP . 28.6 m-20 -125.9 -13.8 6.26 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.523 -179.941 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.651 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.0 mm -90.85 -35.13 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.338 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.0 -39.0 58.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.362 -179.681 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.7 m -126.48 32.96 5.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.749 179.937 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.516 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.9 tp -58.37 143.71 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.681 -179.935 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 102' ' ' ILE . 23.3 m-20 -138.61 148.78 44.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.475 178.891 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.868 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.88 -37.14 13.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.061 0.458 . . . . 0.0 110.337 -179.888 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.6 m -61.76 -48.0 82.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.237 178.741 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -60.1 -62.38 1.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.26 -179.895 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.765 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.22 -56.44 6.7 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.013 0.435 . . . . 0.0 110.258 179.982 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.9 m -57.97 -31.25 66.72 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.815 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -70.32 -66.51 0.59 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.184 179.71 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -42.07 -43.96 3.43 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.295 179.351 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.486 HG12 HG21 ' A' ' 35' ' ' VAL . 95.1 mt -63.42 -55.05 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.381 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -54.01 -18.89 3.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.151 179.234 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.482 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.91 -35.81 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.944 -179.137 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.472 ' O ' HD21 ' A' ' 83' ' ' LEU . 14.9 m120 -125.17 31.78 5.53 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.472 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.1 p -83.84 36.54 0.56 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.037 0.446 . . . . 0.0 110.465 178.792 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.555 HD12 HH12 ' A' ' 85' ' ' ARG . 63.7 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.311 -179.565 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.735 0.302 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.36 -21.86 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.311 -179.839 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -94.84 149.28 21.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.803 179.846 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -126.87 25.17 6.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.947 -179.841 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 t -75.84 136.87 40.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.776 179.915 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.2 m -134.65 -60.62 0.78 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.123 -179.805 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.29 100.26 2.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.114 -179.839 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.37 177.93 41.21 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.425 179.831 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.57 -41.27 66.19 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.419 2.079 . . . . 0.0 112.134 179.903 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.69 -97.1 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.295 179.866 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.22 -65.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.707 0.289 . . . . 0.0 110.74 -179.955 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.55 104.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.48 179.699 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.554 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.5 pt20 -56.59 164.97 1.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.297 179.947 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 10.3 pt-20 -134.94 157.4 77.14 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.545 179.919 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 30.3 Cg_endo -64.26 148.99 91.06 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.584 2.19 . . . . 0.0 112.594 -179.373 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 17' ' ' TRP . 26.0 m -64.13 154.28 35.11 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.161 -179.39 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.416 ' N ' HG22 ' A' ' 16' ' ' THR . 5.6 m-90 -98.09 88.4 4.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.827 179.647 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.635 HD22 ' HA ' ' A' ' 24' ' ' ALA . 60.8 mt -88.33 77.01 8.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.057 0.456 . . . . 0.0 110.379 179.914 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.2 p -75.03 -7.09 52.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.32 -179.076 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -138.8 147.9 43.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.816 -179.576 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.598 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 47.9 t -54.93 -50.32 86.91 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.521 179.794 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.44 -44.49 42.0 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.944 1.762 . . . . 0.0 111.854 -179.956 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.86 -33.98 77.29 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.258 0.552 . . . . 0.0 110.4 -179.988 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.635 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -65.28 -58.55 5.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.127 179.371 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.5 mtp -61.24 -27.02 68.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.981 179.992 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 18.7 mt-10 -71.0 -49.88 40.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.654 0.264 . . . . 0.0 110.342 179.616 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.574 ' O ' HG22 ' A' ' 31' ' ' THR . 2.7 m-85 -60.16 -35.24 74.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.002 179.229 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 36' ' ' ILE . 49.0 mt -72.28 -38.36 61.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.926 178.526 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.3 -18.65 61.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.04 -179.823 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.08 26.63 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.04 -179.842 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.599 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.9 t -173.32 153.72 2.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.541 -179.623 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.523 ' HG3' HG13 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -63.3 -84.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.148 0.499 . . . . 0.0 110.903 179.532 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.544 HG13 HD11 ' A' ' 83' ' ' LEU . 13.0 t -87.7 134.21 28.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.663 -179.808 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.55 125.46 21.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 112.019 -179.162 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.444 HG11 HD11 ' A' ' 111' ' ' ILE . 53.5 t -115.21 127.87 72.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.955 178.544 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.532 HD12 HD11 ' A' ' 28' ' ' ILE . 23.5 mt -133.23 136.15 55.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.513 -177.27 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.595 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.58 98.8 1.99 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.49 179.797 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 11.7 m-85 -83.81 92.36 7.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.632 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.9 m-85 -113.42 141.59 46.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.451 -178.068 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.438 ' HG2' HD23 ' A' ' 71' ' ' LEU . 89.6 mt-30 -89.41 -6.99 56.07 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.712 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.499 ' O ' HG12 ' A' ' 44' ' ' ILE . 36.4 t70 -150.03 119.06 6.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.82 179.916 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.546 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.7 mt -88.36 44.97 1.24 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.11 0.481 . . . . 0.0 111.165 -179.605 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.409 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 8.5 mm-40 -135.99 10.85 3.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.21 179.317 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.839 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.7 pt -95.13 156.39 37.88 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.098 179.742 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.467 ' O ' HD12 ' A' ' 49' ' ' ILE . 76.4 Cg_exo -50.94 -29.79 28.31 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.712 2.274 . . . . 0.0 112.909 179.825 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.839 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -60.47 -36.11 77.48 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.052 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.661 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.2 t -64.49 -57.66 16.38 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.636 -178.926 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.9 Cg_exo -58.23 -37.93 93.21 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.712 1.608 . . . . 0.0 111.205 179.279 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.902 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.6 mt -64.34 -37.32 79.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.029 179.822 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 54' ' ' VAL . 39.7 tp -72.82 -52.92 12.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.905 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -54.8 -25.16 26.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.021 0.438 . . . . 0.0 109.966 178.791 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.7 t -81.71 -44.94 16.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.465 179.588 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.598 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.49 -26.31 67.83 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.159 0.504 . . . . 0.0 109.788 179.497 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.7 t -53.02 -49.65 48.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.121 179.513 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -74.47 -11.74 60.31 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.564 -179.949 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.3 mtpp -93.71 -17.9 22.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.291 179.936 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.559 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 65.2 m-85 -136.49 61.65 38.81 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.551 -179.74 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.61 -42.64 60.88 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.682 2.255 . . . . 0.0 111.67 179.174 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.29 -39.47 90.31 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.368 179.31 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.6 t -67.76 145.09 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.521 -0.34 . . . . 0.0 110.19 178.927 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.599 ' CB ' HG21 ' A' ' 31' ' ' THR . 22.6 t -82.71 96.79 8.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.03 0.443 . . . . 0.0 110.899 -179.716 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.485 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.9 p90 -63.98 129.53 40.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.05 179.888 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.97 161.57 28.73 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.01 179.697 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.404 HD11 HG13 ' A' ' 47' ' ' VAL . 4.4 tt -160.12 144.39 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.795 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.8 t -146.82 155.55 42.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.174 0.512 . . . . 0.0 111.733 -179.137 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 77.9 p -139.14 2.08 2.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.618 179.654 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -73.63 143.78 46.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.744 -179.893 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.2 p -64.91 -51.84 59.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.405 -179.578 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -49.23 -42.58 40.94 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.707 -179.472 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.573 ' HA ' HG22 ' A' ' 21' ' ' VAL . 77.7 t -71.77 -54.1 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.936 0.398 . . . . 0.0 110.714 179.973 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.438 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.63 -14.68 8.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.303 179.368 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.1 m -91.91 -40.95 10.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.261 178.966 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -60.69 -39.34 88.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.403 179.825 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.4 ' HB2' HG12 ' A' ' 76' ' ' ILE . 58.6 m-85 -91.9 10.61 28.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.723 179.398 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 58.26 22.37 9.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.662 179.128 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.674 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.9 mm -57.83 122.21 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.044 179.912 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.0 p -142.3 59.55 1.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.139 -179.912 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.3 44.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.725 179.989 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.65 ' HB2' HG21 ' A' ' 99' ' ' ILE . 42.1 m-20 51.77 42.83 30.21 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.192 0.52 . . . . 0.0 110.532 -179.9 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.674 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.8 m -69.02 153.83 43.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.677 -178.671 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.595 HG12 ' HA2' ' A' ' 37' ' ' GLY . 62.7 mt -120.83 118.28 55.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.941 178.268 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.481 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.4 m -106.55 134.31 49.88 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.998 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.65 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -111.42 105.08 13.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.129 178.716 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.3 t80 -99.31 119.91 38.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.446 179.543 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.466 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 4.6 mtm180 -101.74 79.98 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.809 -179.731 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 32' ' ' GLU . 11.5 tp -23.9 -59.35 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.108 -179.622 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.523 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.21 -63.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.264 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.49 3.72 54.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.061 0.457 . . . . 0.0 111.14 -179.694 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 51.37 30.02 5.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.947 179.422 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 7.0 mm-40 -77.53 153.5 33.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.505 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.401 HE22 ' HB3' ' A' ' 93' ' ' ASN . 22.6 tm0? -135.4 94.98 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.904 179.816 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.65 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -84.71 134.85 34.34 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.003 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.401 ' HB3' HE22 ' A' ' 91' ' ' GLN . 0.7 OUTLIER -117.26 101.31 8.33 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.824 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.602 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -85.93 78.19 9.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.794 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.453 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.1 mt-10 -80.4 -164.84 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.891 -176.877 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.522 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 23.7 t70 -51.26 -36.12 40.56 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.831 -179.381 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -55.77 -14.88 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.106 0.479 . . . . 0.0 110.21 179.448 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -131.5 -13.81 3.34 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.623 -179.806 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.65 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.8 mm -90.17 -35.45 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.594 0.235 . . . . 0.0 111.406 -179.496 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -49.62 -44.56 47.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.801 -179.98 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.3 m -124.74 41.14 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.358 179.498 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.602 HD13 HD21 ' A' ' 94' ' ' LEU . 7.8 tp -66.3 143.97 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.8 -179.618 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -138.45 149.59 45.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.581 178.72 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.902 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.61 -37.6 12.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.581 -179.788 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.5 m -61.6 -47.49 85.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.346 178.75 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -59.86 -61.39 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.249 -179.718 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.777 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.71 -55.8 10.36 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.924 0.392 . . . . 0.0 110.382 179.98 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.6 m -58.51 -30.18 66.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.88 179.901 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.551 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.9 tmt_? -70.54 -66.42 0.61 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.101 179.558 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -42.88 -44.4 4.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.274 179.34 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.444 HD11 HG11 ' A' ' 35' ' ' VAL . 96.6 mt -63.19 -54.75 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.287 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.408 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 32.8 tt0 -53.96 -19.66 5.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.224 179.191 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.551 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.7 -36.53 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.771 -179.155 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.464 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.0 m120 -123.71 30.01 6.35 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.183 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 96.6 p -82.83 37.13 0.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.165 0.507 . . . . 0.0 110.052 178.797 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.448 HD12 HH12 ' A' ' 85' ' ' ARG . 53.5 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.314 -179.329 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.841 0.353 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.2 p -130.43 135.61 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 -179.939 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -79.54 -179.75 7.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.773 179.963 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -57.24 -74.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.826 179.994 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.3 m 52.02 40.43 28.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.192 179.679 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.9 p -168.88 153.81 5.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.911 0.386 . . . . 0.0 110.949 179.953 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -155.32 130.2 9.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.859 179.766 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.74 -165.3 25.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.474 -179.924 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.27 -37.76 81.09 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.591 2.194 . . . . 0.0 112.449 -179.996 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.09 23.11 0.49 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.464 179.985 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.11 -66.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.85 0.357 . . . . 0.0 110.286 -179.946 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 13' ' ' GLN . . . 52.24 54.27 11.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.748 179.232 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.526 ' HG3' HG12 ' A' ' 54' ' ' VAL . 11.3 pt20 45.82 117.43 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.707 0.803 . . . . 0.0 112.844 179.727 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.7 pt-20 -116.25 158.15 43.57 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.52 179.774 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 38.1 Cg_endo -66.43 144.48 73.68 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.53 2.153 . . . . 0.0 112.405 -179.614 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.6 m -63.41 153.58 34.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.671 -179.536 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -98.62 92.53 5.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 179.488 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 24' ' ' ALA . 43.5 mt -86.96 73.65 9.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.326 179.801 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.2 p -72.21 -5.37 35.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.118 -179.167 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -137.06 146.72 45.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.905 0.383 . . . . 0.0 111.604 -179.684 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 59.9 t -55.5 -49.81 90.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.61 179.883 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.8 Cg_endo -57.77 -46.17 28.29 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.923 1.749 . . . . 0.0 112.07 179.877 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.83 81.39 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.346 0.593 . . . . 0.0 110.239 -179.898 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.635 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -63.99 -58.53 6.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.023 179.524 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 21' ' ' VAL . 57.7 mtm -60.02 -25.76 65.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.065 179.891 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -71.97 -52.07 18.86 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.621 179.642 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -60.01 -30.2 69.0 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.33 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.564 HD11 HD12 ' A' ' 36' ' ' ILE . 48.0 mt -75.57 -38.69 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.121 178.201 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 -20.66 60.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.018 -179.851 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.78 31.85 1.33 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -179.929 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.507 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.7 t -170.43 151.78 3.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.45 -179.539 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.615 ' HG3' HG13 ' A' ' 87' ' ' VAL . 24.4 tt0 -70.18 -40.55 74.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.558 179.539 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.493 HG13 HD11 ' A' ' 83' ' ' LEU . 19.4 t -129.94 137.35 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.162 179.283 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.93 128.19 19.85 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.134 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.456 HG21 HG12 ' A' ' 111' ' ' ILE . 55.0 t -115.93 130.53 70.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.379 178.338 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.564 HD12 HD11 ' A' ' 28' ' ' ILE . 28.7 mt -136.19 135.92 49.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.305 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.585 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.39 96.86 1.73 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.559 179.722 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.489 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 13.6 m-85 -82.45 89.68 6.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.522 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -109.94 140.56 43.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.057 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -87.28 -6.51 58.51 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.661 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.9 t70 -151.58 122.42 7.54 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.755 179.837 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.505 ' HA ' HG21 ' A' ' 47' ' ' VAL . 97.1 mt -91.34 46.18 1.29 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.131 0.491 . . . . 0.0 111.208 -179.486 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -137.25 11.08 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.0 179.204 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.777 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.3 pt -94.21 156.13 39.23 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.133 179.923 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.45 ' O ' HD12 ' A' ' 49' ' ' ILE . 75.0 Cg_exo -51.16 -27.08 21.28 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.807 2.338 . . . . 0.0 113.057 179.666 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.777 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.67 -38.7 92.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.945 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.664 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -60.21 -56.67 33.15 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.734 -178.849 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.634 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.0 Cg_exo -58.42 -40.12 77.76 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.587 1.525 . . . . 0.0 111.37 179.597 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.898 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.9 mt -62.66 -34.92 67.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.092 179.874 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.62 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.2 tp -74.95 -52.77 10.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.845 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -54.26 -23.15 13.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.036 0.446 . . . . 0.0 109.932 178.781 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 75.6 m -84.15 -46.45 11.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.498 179.363 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.568 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.75 -26.18 63.72 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.374 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.5 t -51.69 -50.62 30.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.013 179.28 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -75.96 -8.59 57.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.934 -179.558 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -95.0 -19.25 20.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.177 179.581 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.585 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 63.9 m-85 -136.04 63.16 49.62 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.578 -179.734 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.87 -44.46 44.91 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.718 2.278 . . . . 0.0 111.553 178.988 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.24 -40.94 85.76 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.421 179.212 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.3 t -67.27 143.96 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.886 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.507 ' CB ' HG21 ' A' ' 31' ' ' THR . 42.2 t -82.34 99.56 9.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.083 0.468 . . . . 0.0 111.014 -179.591 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.533 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.9 p90 -66.71 123.96 21.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.0 179.787 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -143.74 162.81 27.7 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.063 179.979 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.403 HD11 HG13 ' A' ' 47' ' ' VAL . 4.4 tt -160.06 142.33 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.936 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.9 t -143.42 153.57 42.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.114 0.483 . . . . 0.0 111.843 -178.888 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 39' ' ' PHE . 75.3 p -138.34 1.16 2.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.589 179.598 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -73.38 145.95 45.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.7 t -66.76 -50.83 61.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.385 -179.569 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -50.1 -43.98 51.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.539 -179.392 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.556 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.1 t -71.04 -53.43 21.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.867 0.365 . . . . 0.0 110.799 179.885 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mp -58.74 -14.74 9.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.263 179.402 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.7 m -91.62 -42.96 9.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.427 179.062 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -60.36 -38.66 84.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.577 179.816 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.434 ' HB2' HG12 ' A' ' 76' ' ' ILE . 60.8 m-85 -91.39 11.17 24.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.697 179.647 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 56.19 24.41 8.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.705 179.289 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.672 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.3 mm -60.93 122.3 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.922 179.648 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.4 p -142.89 60.34 1.42 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.089 -179.959 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.29 45.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.499 179.88 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.646 ' HB2' HG21 ' A' ' 99' ' ' ILE . 30.5 m-20 50.52 43.81 27.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.158 0.504 . . . . 0.0 110.301 -179.773 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.672 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.7 m -69.56 153.61 43.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.653 -178.41 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.585 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.9 mt -120.71 116.61 50.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.004 177.993 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.489 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 71.4 m -106.18 132.57 52.09 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.837 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.626 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -108.32 102.6 11.7 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.798 178.291 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -97.39 123.64 41.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.885 0.374 . . . . 0.0 110.68 179.784 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.493 HH21 ' HB2' ' A' ' 88' ' ' ASP . 3.6 mtm180 -106.17 99.66 9.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.073 179.7 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.0 tp -43.28 -51.1 6.41 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.621 -179.38 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.615 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -42.59 -64.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.334 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.493 ' HB2' HH21 ' A' ' 85' ' ' ARG . 2.9 m-20 -98.29 18.09 17.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.59 -179.13 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.7 p30 43.63 29.49 0.28 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.022 179.207 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.48 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 7.5 mm-40 -75.02 156.38 36.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.37 . . . . 0.0 111.137 -179.946 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -139.93 89.78 2.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.687 179.574 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.626 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -78.03 142.38 38.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.65 179.574 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.22 111.25 15.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.355 0.598 . . . . 0.0 112.534 -179.108 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.66 HD21 HD13 ' A' ' 102' ' ' ILE . 3.6 tt -98.29 76.39 2.32 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.043 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.7 mt-10 -77.65 -166.29 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -176.697 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.539 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.6 t70 -50.54 -37.71 40.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.914 -179.218 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -56.46 -15.27 3.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.13 0.491 . . . . 0.0 110.461 179.791 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -128.66 -13.67 4.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.395 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.646 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.9 mm -89.63 -25.13 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.592 -179.31 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -51.9 -61.48 2.23 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.923 0.392 . . . . 0.0 110.653 179.846 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.8 m -112.89 38.94 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.471 179.649 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.66 HD13 HD21 ' A' ' 94' ' ' LEU . 7.7 tp -57.1 143.24 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.427 -179.832 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -136.05 149.81 48.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.823 178.873 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.898 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.25 -33.92 9.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.187 179.97 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 97.8 m -62.82 -50.6 70.33 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.245 178.73 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -58.33 -58.42 8.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.278 -179.614 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.781 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.93 -57.27 8.95 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.036 0.446 . . . . 0.0 110.32 179.977 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 64.9 m -57.82 -29.4 64.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.831 179.85 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.48 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.1 tmt_? -71.38 -64.88 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.239 179.786 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -43.44 -43.38 5.26 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.972 178.976 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.456 HG12 HG21 ' A' ' 35' ' ' VAL . 95.9 mt -63.68 -56.11 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.509 178.408 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.84 -16.7 2.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.283 0.563 . . . . 0.0 110.334 179.337 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.48 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -91.91 -34.99 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.738 -179.231 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.502 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.0 m120 -127.5 32.16 5.06 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.306 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 111' ' ' ILE . 91.0 p -83.94 36.08 0.55 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.201 0.524 . . . . 0.0 110.199 178.995 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.488 HD12 HH12 ' A' ' 85' ' ' ARG . 51.9 mt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.174 -179.443 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.891 0.376 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.455 HG13 ' HG3' ' A' ' 3' ' ' GLU . 8.4 p -137.92 -31.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.15 -179.911 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.455 ' HG3' HG13 ' A' ' 2' ' ' VAL . 47.8 mt-10 -137.56 -68.41 0.47 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.074 -179.796 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -155.2 153.59 30.94 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.927 -179.741 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.1 t 61.79 173.54 0.12 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.109 179.944 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.2 m -144.51 90.44 2.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.932 179.943 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 58.42 89.41 0.05 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.096 -179.94 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.34 159.38 27.71 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.503 179.977 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.35 100.45 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.541 2.161 . . . . 0.0 112.28 179.932 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.37 132.04 0.43 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.632 179.923 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.5 -24.56 0.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.843 0.354 . . . . 0.0 110.585 179.944 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.92 94.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.113 179.856 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.622 ' HG3' HG12 ' A' ' 54' ' ' VAL . 22.2 pt20 -44.03 136.46 3.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.213 179.931 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.502 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 -108.85 159.21 31.87 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.146 -179.548 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 40.0 Cg_endo -67.89 142.59 57.7 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.733 2.289 . . . . 0.0 112.533 -179.702 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 m -54.49 152.66 6.41 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.23 -179.977 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -103.11 79.66 1.77 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.066 0.46 . . . . 0.0 111.057 -179.79 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.678 HD22 ' HA ' ' A' ' 24' ' ' ALA . 46.6 mt -71.06 94.45 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.317 179.708 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.4 p -85.45 -12.93 50.72 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.871 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 5.4 m-20 -139.62 151.27 45.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.77 -179.471 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 30.0 t -52.89 -49.76 85.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.561 179.853 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.6 Cg_endo -57.42 -45.71 32.58 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.97 1.78 . . . . 0.0 112.043 179.912 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.22 -34.79 78.42 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.201 0.524 . . . . 0.0 110.279 -179.852 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.678 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.93 -59.46 4.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.147 179.406 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.6 mtm -60.75 -24.26 65.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.041 -179.994 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.4 -51.28 17.85 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.312 179.437 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.49 ' O ' HG22 ' A' ' 31' ' ' THR . 4.9 m-85 -59.62 -31.74 69.77 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.141 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 36' ' ' ILE . 49.4 mt -75.03 -41.25 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.271 178.444 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.28 -19.04 62.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.162 -179.788 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.59 27.82 2.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.146 -179.845 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.609 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.8 t -172.68 154.01 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.769 -179.629 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.591 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.0 tt0 -63.8 -73.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.747 179.911 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.569 HG13 HD11 ' A' ' 83' ' ' LEU . 21.6 t -100.68 137.86 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.656 179.87 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.94 126.1 18.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.987 0.422 . . . . 0.0 112.058 -179.27 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.458 HG21 HG12 ' A' ' 111' ' ' ILE . 50.0 t -114.7 130.63 68.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.518 178.413 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.541 HD12 HD11 ' A' ' 28' ' ' ILE . 24.0 mt -135.07 136.02 52.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.243 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.51 97.73 1.93 Allowed Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.465 179.787 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 10.3 m-85 -83.37 92.06 7.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.665 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.7 m-85 -112.92 138.66 49.44 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.093 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.542 ' HG2' HD23 ' A' ' 71' ' ' LEU . 86.4 mt-30 -85.25 -6.48 59.26 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.714 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.4 t70 -151.54 125.67 9.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.644 179.672 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.516 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.9 mt -93.83 44.06 1.12 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.004 0.43 . . . . 0.0 111.203 -179.535 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.3 mt-10 -133.56 9.63 3.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.865 178.962 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.75 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.2 pt -91.73 157.69 41.31 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.19 179.942 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.476 ' O ' HD12 ' A' ' 49' ' ' ILE . 77.9 Cg_exo -53.22 -26.08 32.51 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.845 2.363 . . . . 0.0 112.956 179.603 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.75 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.32 -38.87 92.58 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.916 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.694 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -60.26 -55.41 45.57 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -178.557 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -60.22 -39.47 68.14 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.882 1.721 . . . . 0.0 111.509 179.286 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.893 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.5 mt -63.88 -34.2 66.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.045 179.984 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 54' ' ' VAL . 50.1 tp -74.76 -52.27 11.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.823 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -53.44 -27.31 24.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.168 0.508 . . . . 0.0 109.765 178.618 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -80.25 -46.38 16.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.568 179.876 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.587 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.49 -25.8 64.74 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.406 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.622 HG12 ' HG3' ' A' ' 13' ' ' GLN . 54.1 t -53.53 -50.39 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.999 179.505 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -73.89 -11.51 60.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.617 179.911 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -93.3 -18.77 22.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.22 -179.863 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.6 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 63.0 m-85 -136.0 61.6 41.52 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.636 -179.682 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.37 -38.28 82.33 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.604 2.203 . . . . 0.0 111.506 179.167 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.16 -41.27 99.42 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.354 179.079 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.1 t -67.07 145.23 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.884 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.609 ' HB2' HG21 ' A' ' 31' ' ' THR . 36.0 t -82.41 96.57 8.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.959 0.409 . . . . 0.0 111.114 -179.696 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.502 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.9 p90 -63.87 127.16 30.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.982 179.763 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.54 162.71 28.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.054 179.78 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 tt -160.62 144.71 5.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.986 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 t -145.01 157.05 44.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.98 0.419 . . . . 0.0 111.81 -178.949 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 39' ' ' PHE . 76.5 p -141.92 1.41 1.47 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.593 179.649 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.7 144.15 45.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.624 179.93 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.5 p -65.28 -51.51 60.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.67 -179.439 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -49.67 -43.03 46.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.64 -179.386 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.463 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.3 t -71.72 -52.96 22.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.311 . . . . 0.0 110.748 179.981 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.542 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -59.14 -14.6 10.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.158 0.504 . . . . 0.0 110.273 179.371 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.4 m -91.84 -40.57 11.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.377 178.722 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -61.31 -39.99 92.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.232 179.822 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.425 ' HB2' HG12 ' A' ' 76' ' ' ILE . 37.4 m-85 -90.51 9.73 28.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.626 179.533 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 57.38 25.53 11.39 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.641 179.107 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.653 HD12 ' HB ' ' A' ' 80' ' ' THR . 36.9 mm -60.8 118.13 3.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.997 179.653 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.1 p -136.62 56.28 1.81 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.388 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.25 45.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.728 179.838 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.59 ' HB2' HG21 ' A' ' 99' ' ' ILE . 24.8 m-80 51.62 42.54 29.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.196 0.522 . . . . 0.0 110.474 179.93 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.653 ' HB ' HD12 ' A' ' 76' ' ' ILE . 89.3 m -68.24 153.07 44.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.646 -178.607 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.578 HG12 ' HA2' ' A' ' 37' ' ' GLY . 61.7 mt -119.33 118.65 58.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.054 177.988 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 81.5 m -107.62 135.7 48.62 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.787 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.652 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -110.41 105.47 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.104 178.552 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.3 t80 -98.9 123.09 42.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.851 0.357 . . . . 0.0 110.666 179.652 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.472 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.5 mtm180 -106.73 91.8 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.205 179.844 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tp -38.25 -50.74 1.46 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.711 -179.824 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.591 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -45.2 -59.78 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.435 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -99.98 17.08 21.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.328 -179.418 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 42.83 32.76 0.42 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.948 179.084 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 8.3 mm-40 -81.58 160.59 23.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 111.147 -179.823 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -146.75 91.45 2.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.362 179.564 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.652 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -80.07 149.22 30.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.875 179.7 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.6 124.62 41.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.315 0.579 . . . . 0.0 112.117 -179.366 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.602 HD21 HD13 ' A' ' 102' ' ' ILE . 3.8 tt -111.24 75.53 0.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.073 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.0 mt-10 -77.51 -165.62 0.63 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.395 -0.821 . . . . 0.0 113.208 -176.736 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.516 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.5 t70 -51.31 -36.74 43.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.968 -179.181 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -56.49 -14.82 3.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.152 0.501 . . . . 0.0 110.266 179.536 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -130.26 -13.94 3.88 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.554 -179.947 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.59 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.2 mm -90.7 -25.38 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.78 0.324 . . . . 0.0 111.34 -179.364 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.6 -52.2 62.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.691 179.993 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 81.1 p -119.66 36.57 4.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.511 179.811 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.602 HD13 HD21 ' A' ' 94' ' ' LEU . 7.5 tp -57.38 142.24 13.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.487 -179.853 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.45 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 25.0 m-20 -135.93 149.76 49.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.757 178.884 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.893 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.04 -37.06 14.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.03 0.443 . . . . 0.0 110.446 -179.77 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.8 m -62.52 -47.85 82.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.295 178.71 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.45 ' HD3' ' N ' ' A' ' 103' ' ' ASP . 59.3 mtpt -59.2 -60.23 4.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.087 -179.735 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.755 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.06 -55.98 10.45 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.931 0.396 . . . . 0.0 110.15 179.847 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.2 m -57.87 -30.19 65.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.814 179.794 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.49 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -70.61 -65.77 0.69 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.088 179.696 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -42.29 -44.78 3.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.076 179.053 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -62.66 -55.86 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.537 178.495 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -54.13 -18.31 3.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.444 179.326 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.49 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.87 -38.51 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.016 -179.057 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.445 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.5 m120 -123.35 29.59 6.61 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.348 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.5 p -82.11 50.32 1.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.116 0.484 . . . . 0.0 110.267 178.9 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 61.3 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.43 -179.44 . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.42 ' HG3' HG23 ' A' ' 2' ' ' VAL . 10.6 tp10 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.654 0.264 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.42 HG23 ' HG3' ' A' ' 1' ' ' GLU . 48.8 t 61.77 -83.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.544 179.96 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 58.71 94.22 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.855 -179.95 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -92.73 11.84 25.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.243 -179.748 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.4 m -68.95 129.74 40.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.67 179.767 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.8 p -85.76 -20.07 29.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.122 -179.836 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -126.38 103.57 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.88 0.372 . . . . 0.0 110.985 179.904 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.99 148.98 48.71 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.458 -179.948 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.94 -39.86 88.36 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.494 2.129 . . . . 0.0 112.361 -179.863 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.1 -177.75 16.81 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.729 179.757 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.1 -73.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.638 0.256 . . . . 0.0 110.73 179.951 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.53 93.9 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.407 179.506 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.55 ' HG3' HG12 ' A' ' 54' ' ' VAL . 7.3 pt20 -170.09 161.02 8.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.817 -179.793 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 -107.74 158.37 33.58 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.04 -179.622 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.8 Cg_endo -68.67 148.93 73.0 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.7 2.267 . . . . 0.0 112.677 -179.777 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 m -63.16 152.61 36.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.575 -179.668 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -98.8 97.46 8.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.812 179.706 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 24' ' ' ALA . 38.4 mt -96.37 71.57 2.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.641 179.964 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.9 p -71.39 -3.12 19.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.953 -179.171 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -140.14 147.68 40.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.934 0.397 . . . . 0.0 111.656 -179.991 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 24.9 t -56.49 -49.46 93.4 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.761 -179.896 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.51 -45.27 35.25 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.931 1.754 . . . . 0.0 111.963 179.954 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.38 -35.89 82.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.267 0.556 . . . . 0.0 110.344 -179.961 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.608 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.95 -57.91 8.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.185 179.427 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 64.4 mtp -61.75 -26.39 68.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.224 -179.952 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.48 -50.79 28.15 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.497 179.598 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.468 ' O ' HG22 ' A' ' 31' ' ' THR . 7.6 m-85 -60.24 -33.05 71.74 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.035 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.502 HD11 HD12 ' A' ' 36' ' ' ILE . 57.1 mt -72.72 -39.81 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.024 178.475 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.75 -19.33 62.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.99 -179.869 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.12 29.45 2.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.856 -179.975 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.583 HG21 ' CB ' ' A' ' 61' ' ' SER . 10.0 t -169.31 153.03 5.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.271 -179.722 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HG3' HG13 ' A' ' 87' ' ' VAL . 27.1 tt0 -72.4 -46.34 55.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.577 HG13 HD11 ' A' ' 83' ' ' LEU . 21.0 t -122.68 133.87 67.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.08 179.296 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.544 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.66 126.29 20.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.012 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.513 HG21 HG12 ' A' ' 111' ' ' ILE . 52.0 t -114.24 127.59 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.766 178.701 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.502 HD12 HD11 ' A' ' 28' ' ' ILE . 24.8 mt -133.03 136.73 54.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.391 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.604 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.91 96.92 1.7 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.544 179.972 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.6 m-85 -83.17 90.82 7.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.654 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.4 m-85 -111.56 139.34 47.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.184 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.453 ' HG2' HD23 ' A' ' 71' ' ' LEU . 89.6 mt-30 -85.42 -7.21 59.05 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.89 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.439 ' O ' HG12 ' A' ' 44' ' ' ILE . 36.6 t70 -150.67 125.68 9.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.667 179.768 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.604 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.2 mt -93.72 46.94 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.112 0.482 . . . . 0.0 111.373 -179.533 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 46.7 mt-10 -138.19 9.99 2.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.948 179.034 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.801 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.4 pt -93.06 156.28 40.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.064 179.848 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.465 ' O ' HD12 ' A' ' 49' ' ' ILE . 81.4 Cg_exo -50.96 -27.25 20.52 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.818 2.345 . . . . 0.0 113.214 -179.914 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.801 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.43 -38.25 90.39 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.916 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.69 HG23 HG13 ' A' ' 44' ' ' ILE . 3.0 t -60.45 -55.96 39.98 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.585 -178.742 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.6 -41.55 55.37 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.876 1.717 . . . . 0.0 111.4 179.487 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.883 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.2 mt -60.94 -35.58 66.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.247 179.983 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.2 tp -73.99 -52.28 13.26 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.957 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -54.44 -24.25 19.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.08 0.467 . . . . 0.0 109.824 178.831 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.3 m -82.55 -46.38 13.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.514 179.643 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.576 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.59 -26.41 65.4 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.107 0.48 . . . . 0.0 109.744 179.492 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.7 t -52.86 -50.02 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.194 179.498 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -75.83 -8.35 56.68 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.631 179.992 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -95.72 -19.04 19.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.133 179.743 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.562 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 71.9 m-85 -136.73 62.36 41.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.509 -179.617 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.87 -41.12 72.78 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.7 2.266 . . . . 0.0 111.538 179.09 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.58 -41.63 95.67 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.428 179.191 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.8 t -66.18 145.72 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.765 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.583 ' CB ' HG21 ' A' ' 31' ' ' THR . 40.3 t -83.11 97.34 8.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 111.035 -179.553 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.51 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 8.0 p90 -62.82 129.53 40.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.862 179.646 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.514 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -148.16 159.83 28.15 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.993 179.73 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.9 tt -161.83 140.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.882 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.9 t -145.15 159.2 43.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.146 0.498 . . . . 0.0 111.741 -178.872 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.455 HG21 ' HG ' ' A' ' 42' ' ' LEU . 79.7 p -140.29 -0.77 1.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.396 179.495 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -69.46 141.2 54.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.718 -179.786 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.2 t -64.3 -48.38 75.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.296 -179.78 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -49.96 -46.31 52.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.436 -179.639 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.52 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.5 t -69.44 -53.27 25.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.703 179.846 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.8 mp -58.27 -14.82 8.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.195 0.521 . . . . 0.0 110.317 179.462 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.2 m -90.66 -42.46 10.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.264 178.615 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -59.79 -40.76 89.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.629 -179.98 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.405 ' HB2' HG12 ' A' ' 76' ' ' ILE . 51.3 m-85 -90.6 11.04 23.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.831 179.602 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 56.8 26.24 11.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.438 179.326 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.683 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.5 mm -61.61 122.96 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.839 179.633 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.1 p -140.9 47.89 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.762 0.315 . . . . 0.0 111.51 -179.891 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.8 47.88 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.742 179.819 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.621 ' HB2' HG21 ' A' ' 99' ' ' ILE . 23.7 m-80 50.06 41.45 23.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.257 0.551 . . . . 0.0 110.271 -179.775 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.683 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.1 m -67.79 151.79 46.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.671 -178.515 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.604 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.3 mt -118.73 115.79 49.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.865 178.059 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.535 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.1 m -105.47 130.92 53.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.779 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.616 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.3 tp -107.66 99.84 9.29 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.843 178.455 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.5 t80 -92.31 122.93 35.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.364 179.633 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.462 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 6.1 mtm180 -105.24 85.66 2.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.867 0.365 . . . . 0.0 110.57 -179.915 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 tp -26.05 -59.61 0.08 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.12 -179.322 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.456 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.86 -71.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.261 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.71 13.41 8.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.333 -179.302 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 44.29 29.82 0.4 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.131 178.973 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 10.4 mm-40 -76.41 167.52 21.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.349 . . . . 0.0 110.79 179.825 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -154.26 95.23 1.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.623 179.724 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.616 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -80.55 110.71 16.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.065 -179.953 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -92.52 92.1 7.9 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.973 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.611 HD21 HD13 ' A' ' 102' ' ' ILE . 3.3 tt -77.92 78.11 4.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.753 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.449 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.8 mt-10 -79.05 -164.95 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.865 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.517 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 22.5 t70 -51.18 -37.61 47.56 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.905 -179.252 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -54.91 -14.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.213 0.53 . . . . 0.0 110.352 179.533 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -130.77 -13.99 3.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.753 -179.906 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.621 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.1 mm -89.84 -37.11 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.281 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -51.0 -39.77 56.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.885 0.374 . . . . 0.0 111.077 -179.874 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.9 p -126.92 36.03 4.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.645 179.939 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.611 HD13 HD21 ' A' ' 94' ' ' LEU . 7.9 tp -62.61 143.91 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.701 -179.666 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -137.74 147.34 44.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.364 178.856 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.883 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.85 -35.93 6.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.972 0.415 . . . . 0.0 110.333 -179.735 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 99.6 m -62.29 -48.31 80.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.266 178.646 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -60.0 -59.87 4.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.241 -179.709 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.776 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.03 -55.69 13.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.899 0.381 . . . . 0.0 110.275 -179.909 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.2 m -58.19 -29.93 66.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.687 179.702 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.51 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.6 tmt_? -71.39 -66.14 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.188 179.772 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -42.75 -43.4 3.93 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.12 179.286 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.513 HG12 HG21 ' A' ' 35' ' ' VAL . 90.2 mt -63.89 -55.23 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.549 178.409 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -55.14 -16.82 3.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.281 179.282 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.51 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -92.27 -34.7 6.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.767 -179.272 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' A' ' 85' ' ' ARG . 36.1 m120 -123.12 28.1 7.31 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.653 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.1 p -82.35 46.81 1.08 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.067 0.46 . . . . 0.0 110.502 179.278 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.455 HD12 HH12 ' A' ' 85' ' ' ARG . 70.2 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.212 -179.62 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.807 0.337 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.4 m -116.78 20.05 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.853 179.757 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -88.94 10.62 20.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.758 179.98 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -137.96 -173.8 3.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.164 -179.758 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.6 m 55.66 38.95 30.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.104 179.934 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.0 m -135.28 -65.66 0.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 57.2 89.35 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -101.93 -79.94 1.44 Allowed Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.7 -179.918 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.72 118.18 4.91 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.569 2.179 . . . . 0.0 112.353 -179.994 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.9 154.34 16.69 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.485 -179.995 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.16 -71.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.757 0.313 . . . . 0.0 110.575 -180.0 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.91 95.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.485 179.543 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.525 ' HG3' HG12 ' A' ' 54' ' ' VAL . 6.6 pt20 -170.08 161.51 8.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.62 -179.707 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.452 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 14.3 pt-20 -110.12 157.81 36.9 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.984 -179.458 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 42.8 Cg_endo -69.57 144.05 53.77 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.656 2.237 . . . . 0.0 112.574 -179.675 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -59.45 151.32 24.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.346 -179.835 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -96.87 86.85 4.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.938 179.995 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.627 HD22 ' HA ' ' A' ' 24' ' ' ALA . 40.4 mt -83.58 74.47 10.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.488 179.929 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.8 p -74.4 0.54 14.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.048 -179.188 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.41 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 4.7 m-20 -143.88 147.44 34.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.996 0.427 . . . . 0.0 111.751 -179.863 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.608 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.1 t -55.67 -49.34 93.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.45 179.77 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.1 Cg_endo -58.44 -46.48 24.2 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.039 1.826 . . . . 0.0 111.977 179.799 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.16 -34.57 77.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.232 0.539 . . . . 0.0 110.169 -179.873 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.627 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.38 -58.06 7.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.973 179.535 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 33.1 mtt -61.86 -26.01 67.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.239 -179.898 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -71.89 -51.02 24.33 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 110.552 179.681 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.456 ' O ' HG22 ' A' ' 31' ' ' THR . 7.5 m-85 -60.59 -31.2 70.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.06 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.509 HD11 ' CD1' ' A' ' 36' ' ' ILE . 52.4 mt -75.22 -39.57 42.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.059 178.198 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 -18.59 61.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.109 -179.816 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.45 26.15 2.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.147 -179.947 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.727 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.9 t -171.35 155.87 4.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.608 -179.788 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.498 ' HG3' HG13 ' A' ' 87' ' ' VAL . 26.0 tt0 -67.92 -58.78 3.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.717 179.934 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 83' ' ' LEU . 13.6 t -111.17 138.33 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.67 127.44 18.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.961 0.41 . . . . 0.0 111.876 -179.526 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG21 HG12 ' A' ' 111' ' ' ILE . 47.0 t -116.01 128.58 73.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.748 178.732 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 21.5 mt -134.01 136.76 53.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.412 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.595 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.21 97.7 1.78 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.521 179.728 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.514 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.4 m-85 -83.43 91.32 7.34 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.482 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -111.57 142.06 44.36 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -177.945 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -88.96 -7.33 56.23 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.563 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.7 t70 -149.38 121.72 8.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.52 179.623 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.581 ' HA ' HG21 ' A' ' 47' ' ' VAL . 98.7 mt -91.7 46.84 1.31 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.18 0.514 . . . . 0.0 111.383 -179.293 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.424 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 47.4 mt-10 -137.54 7.09 2.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.002 178.964 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.827 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.3 pt -90.13 155.63 46.89 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.949 179.786 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.48 ' O ' HD12 ' A' ' 49' ' ' ILE . 84.3 Cg_exo -49.95 -29.38 21.09 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.729 2.286 . . . . 0.0 112.984 -179.953 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.827 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -61.25 -38.48 86.82 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.998 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.664 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.4 t -61.66 -57.49 24.38 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.569 -178.83 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.06 -38.77 85.4 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.765 1.644 . . . . 0.0 111.453 179.437 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.904 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.9 mt -63.66 -34.38 67.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.907 179.85 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.608 ' O ' HG23 ' A' ' 54' ' ' VAL . 46.6 tp -75.57 -53.02 9.29 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.836 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -54.06 -24.18 16.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.115 0.483 . . . . 0.0 109.977 178.876 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.6 t -84.08 -47.0 11.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.607 179.657 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.616 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.27 -25.84 62.25 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.504 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 50' ' ' LEU . 49.4 t -52.63 -49.15 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.166 179.483 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -76.61 -9.01 58.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.714 179.989 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -94.46 -19.16 20.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.047 179.601 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 58.4 m-85 -135.52 63.02 52.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.752 -179.795 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.79 -45.24 39.56 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.77 2.313 . . . . 0.0 111.636 179.206 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.63 -42.32 84.34 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.468 179.133 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.3 t -65.48 143.58 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.947 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.727 ' HB2' HG21 ' A' ' 31' ' ' THR . 41.7 t -82.33 97.11 8.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.02 0.438 . . . . 0.0 111.125 -179.627 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.515 ' HB3' HG22 ' A' ' 54' ' ' VAL . 6.5 p90 -62.85 128.81 37.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.897 179.658 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.69 160.28 28.32 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.106 179.98 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.8 tt -158.83 143.29 6.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.723 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.4 t -146.44 152.69 39.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.003 0.43 . . . . 0.0 111.776 -179.083 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 39' ' ' PHE . 71.4 p -136.99 -3.95 1.98 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.326 179.5 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.49 142.73 58.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.697 179.986 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.5 m -64.79 -50.44 66.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.428 -179.461 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -50.37 -43.82 54.49 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.671 -179.338 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.504 ' HA ' HG22 ' A' ' 21' ' ' VAL . 69.1 t -71.46 -52.39 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 -179.973 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.39 -15.14 14.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.15 0.5 . . . . 0.0 110.187 179.387 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.7 m -91.59 -40.02 11.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.296 178.795 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.423 ' ND1' HG11 ' A' ' 21' ' ' VAL . 4.7 t60 -61.32 -42.4 98.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.374 179.948 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.409 ' HB2' HG12 ' A' ' 76' ' ' ILE . 39.2 m-85 -88.51 9.31 24.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.695 179.528 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.9 t30 58.82 23.27 11.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.538 179.128 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.664 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.2 mm -56.81 120.83 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.975 179.852 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.6 p -140.31 58.71 1.57 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.344 -179.546 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.76 45.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.7 179.606 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.596 ' HB2' HG21 ' A' ' 99' ' ' ILE . 26.2 m-80 51.73 43.28 30.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.217 0.532 . . . . 0.0 110.422 -179.914 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.664 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.5 m -69.36 152.08 45.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.735 -178.539 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.595 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.0 mt -119.02 118.04 56.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.964 178.135 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 79.4 m -105.91 133.21 51.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.907 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.648 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -109.02 105.17 14.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.774 178.48 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -98.67 120.11 38.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.683 179.787 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.461 HH12 HD12 ' A' ' 116' ' ' LEU . 4.3 mtm180 -104.74 80.98 1.71 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.611 179.965 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 85' ' ' ARG . 7.1 tp -22.59 -58.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 O-C-N 124.009 0.818 . . . . 0.0 112.856 -179.683 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.498 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.09 -67.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.366 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -93.3 3.26 55.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.388 -179.227 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 50.48 37.7 16.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.68 179.682 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 6.6 mm-40 -86.15 134.09 33.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.709 179.952 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.48 95.04 4.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.998 0.427 . . . . 0.0 110.833 179.954 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.648 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -82.41 109.93 17.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.634 179.506 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -93.87 94.59 8.58 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.439 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.555 HD21 HD13 ' A' ' 102' ' ' ILE . 4.3 tt -78.66 77.61 5.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.438 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.5 mt-10 -78.88 -164.91 0.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.908 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.517 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.6 t70 -50.76 -38.43 47.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.148 -179.145 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.57 -14.69 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.227 0.537 . . . . 0.0 110.33 179.722 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -129.68 -13.83 4.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.63 -179.85 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.6 mm -91.08 -31.27 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 111.438 -179.5 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -53.28 -43.15 67.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.891 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.8 m -124.93 38.53 4.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.419 179.711 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.555 HD13 HD21 ' A' ' 94' ' ' LEU . 7.3 tp -63.93 142.52 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.67 -179.698 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -137.98 150.91 47.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.604 178.803 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.904 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.78 -37.37 18.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.002 0.43 . . . . 0.0 110.443 -179.859 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 94.6 m -61.97 -46.93 87.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.208 178.686 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -60.75 -61.14 2.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.415 -179.819 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.79 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.52 -55.16 11.79 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.979 0.418 . . . . 0.0 110.128 179.906 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.6 m -59.05 -30.98 68.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.912 179.832 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.491 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.2 tmt_? -70.53 -65.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.097 179.691 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -43.01 -42.7 3.92 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.306 179.411 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.441 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -64.65 -55.23 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.23 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -54.02 -18.23 3.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.201 179.305 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.491 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -90.06 -38.42 10.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.985 -179.077 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.464 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.7 m120 -122.77 30.54 6.4 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.432 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.0 p -83.14 44.03 0.91 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 110.15 178.727 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.461 HD12 HH12 ' A' ' 85' ' ' ARG . 57.7 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.404 -179.328 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.8 0.333 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 t 55.72 72.72 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.175 -179.945 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -145.27 138.26 26.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.851 -179.967 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 80.1 tttt 55.9 47.46 20.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.727 -179.887 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.0 t -120.69 2.51 10.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.91 -179.996 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.3 p -96.36 2.91 53.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.043 -179.93 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.7 t70 57.64 88.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.196 179.88 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' A' ' 9' ' ' PRO . . . -157.77 135.82 4.53 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.284 179.804 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.429 ' HD3' ' HA2' ' A' ' 8' ' ' GLY . 28.6 Cg_exo -62.03 -20.59 70.16 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.4 2.066 . . . . 0.0 112.28 -179.865 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.61 119.02 4.96 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.444 179.972 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.31 -70.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 0.0 110.653 -179.982 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.05 -82.02 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.642 179.751 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.512 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.3 pt20 -151.39 170.64 19.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.043 -179.637 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.492 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.3 pt-20 -147.33 159.44 42.02 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 -179.775 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 54.0 Cg_endo -69.9 149.65 66.28 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.636 2.224 . . . . 0.0 112.753 -179.686 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 m -71.55 155.89 40.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.509 -179.622 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -100.05 88.9 3.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.073 179.827 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 24' ' ' ALA . 35.1 mt -82.73 71.78 9.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.375 179.781 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.5 p -70.21 -5.18 25.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.07 -178.892 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -135.81 147.36 48.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 111.416 -179.76 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.606 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 15.6 t -58.27 -48.99 96.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.367 179.915 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.0 Cg_endo -58.45 -43.83 42.71 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.899 1.733 . . . . 0.0 111.839 179.45 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.5 -37.22 86.79 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.291 0.567 . . . . 0.0 110.261 179.811 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.595 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -62.03 -54.89 35.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.049 179.45 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 38.3 mtt -62.48 -29.91 70.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.28 -179.928 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -69.18 -49.01 60.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.658 0.266 . . . . 0.0 110.517 -179.959 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -62.26 -32.82 73.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.851 179.253 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.52 HD11 HD12 ' A' ' 36' ' ' ILE . 48.1 mt -74.16 -36.15 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.156 0.503 . . . . 0.0 109.821 178.05 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.45 -18.57 60.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.21 27.57 2.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.185 -179.823 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.764 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.2 t -171.16 155.95 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.608 -179.761 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.535 ' HG3' HG13 ' A' ' 87' ' ' VAL . 24.4 tt0 -71.26 -46.87 59.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.597 179.755 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.488 HG13 HD11 ' A' ' 83' ' ' LEU . 19.1 t -121.68 137.6 54.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.361 179.555 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.06 128.45 20.03 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.154 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 83' ' ' LEU . 43.5 t -116.22 129.61 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.467 178.463 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.52 HD12 HD11 ' A' ' 28' ' ' ILE . 28.0 mt -136.46 136.15 48.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.226 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.63 96.71 1.77 Allowed Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.482 179.686 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.487 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 40.0 m-85 -82.71 89.67 6.78 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.277 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.1 m-85 -108.44 146.55 32.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.603 -178.031 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -94.48 -1.8 52.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.947 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.515 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.6 t70 -156.87 118.16 3.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.582 179.876 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.506 ' HA ' HG21 ' A' ' 47' ' ' VAL . 90.9 mt -87.28 44.78 1.21 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.117 0.485 . . . . 0.0 111.291 -179.351 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.1 mt-10 -136.61 13.09 3.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.078 179.255 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.833 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.4 pt -96.97 156.23 36.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.19 179.928 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 86.2 Cg_exo -49.57 -31.36 24.27 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.745 2.297 . . . . 0.0 112.851 179.657 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.833 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -59.38 -37.21 77.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.312 -179.107 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.706 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.9 t -61.89 -58.55 17.29 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.591 -178.917 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.706 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 37.0 Cg_exo -58.38 -40.54 74.23 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.777 1.651 . . . . 0.0 111.291 179.342 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.96 HG23 ' HA ' ' A' ' 104' ' ' ALA . 8.6 mt -61.02 -36.3 71.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.899 179.712 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 54' ' ' VAL . 47.6 tp -74.01 -52.37 12.96 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.942 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -54.13 -23.06 12.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.061 0.458 . . . . 0.0 109.876 178.824 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.9 m -83.08 -47.57 11.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.357 179.329 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.562 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.11 -26.4 62.56 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.272 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.0 t -51.67 -51.38 27.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.091 179.512 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -74.3 -12.09 60.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.688 -179.852 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 28.7 mtpp -92.46 -17.61 24.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.27 -179.96 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 52.6 m-85 -137.92 62.91 36.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.535 -179.799 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.67 -43.82 54.53 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.601 2.2 . . . . 0.0 111.618 179.065 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.58 -38.92 83.84 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.417 179.305 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 13.0 t -68.74 144.67 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.861 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.764 ' HB2' HG21 ' A' ' 31' ' ' THR . 42.3 t -81.68 98.77 8.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.047 0.451 . . . . 0.0 110.79 180.0 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.49 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.6 p90 -66.95 122.42 17.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.016 179.856 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.466 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -141.87 163.91 26.87 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.159 179.997 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -162.12 143.08 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.924 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.487 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 43.8 t -148.54 158.81 44.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 111.777 -179.094 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.505 HG21 ' HG ' ' A' ' 42' ' ' LEU . 64.6 p -138.93 -5.42 1.49 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.898 179.548 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.69 140.02 58.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.722 179.948 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.3 m -63.52 -48.16 78.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.824 -179.308 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -51.23 -44.27 61.64 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.241 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.498 ' HA ' HG22 ' A' ' 21' ' ' VAL . 54.2 t -70.75 -53.47 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.85 0.357 . . . . 0.0 110.726 179.804 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.93 -14.91 10.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.234 179.475 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.9 m -91.74 -39.87 11.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.299 178.848 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.437 ' ND1' HG11 ' A' ' 21' ' ' VAL . 5.2 t60 -61.21 -39.93 92.06 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.329 179.902 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.407 ' HB2' HG12 ' A' ' 76' ' ' ILE . 88.0 m-85 -91.86 12.26 22.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.919 179.557 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 56.67 25.43 10.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.6 179.23 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.698 HG23 ' HB ' ' A' ' 80' ' ' THR . 41.7 mm -61.77 120.51 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.968 179.653 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.5 p -140.95 57.17 1.56 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.272 179.982 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.89 45.08 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.552 179.824 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.603 ' HB2' HG21 ' A' ' 99' ' ' ILE . 26.8 m-20 50.25 43.47 26.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.255 0.55 . . . . 0.0 110.248 -179.817 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.698 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.2 m -68.99 151.25 46.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.785 -178.627 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.578 HG12 ' HA2' ' A' ' 37' ' ' GLY . 72.0 mt -117.76 115.38 48.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.851 177.931 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.478 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 80.1 m -103.76 130.5 51.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.755 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.663 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -107.78 101.65 10.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.613 178.231 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.4 t80 -95.86 123.03 39.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.478 179.806 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.504 HH12 HD12 ' A' ' 116' ' ' LEU . 4.8 mtm180 -105.72 87.23 2.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.841 -179.7 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 tp -26.29 -60.68 0.08 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.903 -179.383 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.535 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.76 -79.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.433 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -79.2 3.33 18.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.96 0.409 . . . . 0.0 110.993 -179.891 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 52.21 32.8 11.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.691 179.561 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 10.4 mm-40 -76.39 161.45 28.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.695 179.83 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -145.03 93.95 2.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.627 179.788 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.663 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.1 mm? -83.43 118.6 23.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.789 179.74 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -99.86 94.54 6.36 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.756 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.63 HD21 HD13 ' A' ' 102' ' ' ILE . 3.4 tt -79.2 77.93 5.7 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.672 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.8 mt-10 -79.76 -164.33 0.64 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -176.843 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.517 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.0 t70 -50.78 -37.65 43.54 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.971 -179.379 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.21 -15.92 2.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.226 0.536 . . . . 0.0 110.338 179.76 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -129.63 -14.07 4.17 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.645 -179.92 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.603 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.6 mm -89.89 -24.8 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.77 0.319 . . . . 0.0 111.268 -179.3 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.66 -57.45 11.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.4 p -114.56 35.52 4.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.325 179.661 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.63 HD13 HD21 ' A' ' 94' ' ' LEU . 7.6 tp -57.78 146.85 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.485 -179.844 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.442 ' HA ' ' CD1' ' A' ' 49' ' ' ILE . 9.5 t70 -139.3 164.84 28.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.674 178.605 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.96 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -62.49 -35.97 81.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.111 0.481 . . . . 0.0 110.061 -179.616 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 83.4 m -65.42 -44.88 86.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.199 178.743 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -61.06 -58.46 8.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.952 -179.713 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.733 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.3 -54.32 27.24 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.037 0.446 . . . . 0.0 109.975 179.556 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.4 m -59.02 -29.93 67.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.847 179.795 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.504 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -71.06 -66.03 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.056 179.697 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -43.2 -43.87 4.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.223 179.38 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.416 HG12 HG21 ' A' ' 35' ' ' VAL . 96.4 mt -62.97 -54.23 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.225 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.418 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 33.4 tt0 -54.59 -19.63 6.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.159 179.226 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.504 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.27 -34.5 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.79 -178.985 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.411 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.5 m120 -124.86 29.56 6.15 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.329 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 111' ' ' ILE . 88.2 p -83.54 45.25 1.04 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.115 0.483 . . . . 0.0 110.111 178.996 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.504 HD12 HH12 ' A' ' 85' ' ' ARG . 69.9 mt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.35 -179.344 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.879 0.371 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.7 p -159.84 -30.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.226 -179.965 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -107.83 9.14 28.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.872 179.963 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -113.62 13.82 18.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.984 -179.873 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.1 p -90.74 106.81 18.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.936 -179.759 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 t -83.17 85.15 7.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.765 179.918 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.09 -59.04 2.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.74 116.98 0.06 OUTLIER Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.627 179.902 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.28 108.37 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.47 2.114 . . . . 0.0 112.19 179.861 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.57 -96.28 0.16 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.452 -179.953 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.88 -72.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.534 0.207 . . . . 0.0 110.828 179.882 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.3 103.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.596 179.848 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.639 ' HG3' HG12 ' A' ' 54' ' ' VAL . 22.6 pt20 -53.37 141.06 25.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.092 -179.913 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.503 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.7 pt-20 -113.98 160.33 32.71 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.939 -179.784 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 39.2 Cg_endo -67.7 142.72 59.19 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.597 2.198 . . . . 0.0 112.623 -179.901 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.4 m -63.12 153.47 34.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.809 -179.686 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.89 89.91 5.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.167 179.886 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.599 HD22 ' HA ' ' A' ' 24' ' ' ALA . 41.2 mt -84.78 72.57 10.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.298 179.613 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.1 p -71.9 -2.02 16.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.176 -179.043 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -139.27 147.42 41.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.987 0.423 . . . . 0.0 111.573 -179.797 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 29.6 t -57.24 -49.52 93.42 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.449 179.913 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.66 -44.82 33.58 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.901 1.734 . . . . 0.0 111.998 179.723 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.25 83.19 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.332 0.587 . . . . 0.0 110.203 179.824 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.599 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.65 -57.51 10.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.157 179.548 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 31.4 mtt -61.89 -26.83 68.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.225 -179.923 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -70.44 -50.38 38.92 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.477 179.786 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -61.68 -31.17 71.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.182 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.507 HD11 HD12 ' A' ' 36' ' ' ILE . 52.7 mt -74.62 -37.67 43.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.967 178.056 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.41 -17.59 61.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.972 -179.747 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.56 28.69 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.122 -179.929 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.726 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.1 t -168.89 153.89 6.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.572 -179.681 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.577 ' HG3' HG13 ' A' ' 87' ' ' VAL . 20.8 tt0 -70.91 -42.73 69.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.498 179.6 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.547 HG13 HD11 ' A' ' 83' ' ' LEU . 22.1 t -127.0 137.05 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.278 179.414 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.78 128.37 21.46 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.173 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.479 HG21 HG12 ' A' ' 111' ' ' ILE . 46.1 t -116.25 130.53 70.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.496 178.473 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.507 HD12 HD11 ' A' ' 28' ' ' ILE . 29.3 mt -136.42 136.81 48.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.232 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.22 99.01 2.05 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.528 179.716 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.7 m-85 -85.35 93.97 8.84 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.657 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 9.1 m-85 -114.38 143.77 44.37 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.125 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.407 ' HG2' HD23 ' A' ' 71' ' ' LEU . 95.9 mt-30 -91.17 -3.51 56.96 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.913 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 44' ' ' ILE . 37.1 t70 -154.27 122.33 6.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.689 -1.142 . . . . 0.0 109.465 179.845 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.493 ' HA ' HG21 ' A' ' 47' ' ' VAL . 91.6 mt -91.9 47.18 1.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 0.0 111.276 -179.486 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.9 mt-10 -136.51 11.13 3.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.792 178.977 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.739 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.1 pt -93.6 159.06 35.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.437 -179.915 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' O ' HD12 ' A' ' 49' ' ' ILE . 69.3 Cg_exo -54.59 -23.66 33.26 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.99 2.46 . . . . 0.0 112.925 179.556 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.739 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -67.11 -38.8 86.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.823 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.694 HG23 HG13 ' A' ' 44' ' ' ILE . 2.5 t -59.13 -54.72 53.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -178.787 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.1 Cg_exo -61.29 -43.53 28.19 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.066 1.844 . . . . 0.0 111.499 179.225 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.878 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -59.89 -34.01 54.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.148 179.981 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.63 ' O ' HG23 ' A' ' 54' ' ' VAL . 50.1 tp -75.48 -51.5 12.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.167 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -53.96 -25.23 19.66 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.994 0.426 . . . . 0.0 109.936 178.793 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 t -83.09 -47.45 11.64 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.625 179.764 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.625 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -57.76 -26.37 61.78 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.376 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.639 HG12 ' HG3' ' A' ' 13' ' ' GLN . 51.2 t -51.89 -49.87 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.048 179.451 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -75.45 -12.74 60.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.641 179.952 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -91.5 -17.24 26.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.325 180.0 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.574 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 46.3 m-85 -138.97 63.11 29.66 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.432 -179.877 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.03 -47.67 26.28 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.756 2.304 . . . . 0.0 111.766 179.315 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.71 -41.14 57.17 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.395 179.275 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.6 t -66.23 143.13 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.781 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.726 ' HB2' HG21 ' A' ' 31' ' ' THR . 42.0 t -81.06 97.42 7.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.984 0.421 . . . . 0.0 110.903 -179.786 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.496 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.6 p90 -65.61 123.58 20.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.822 179.699 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.451 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -143.09 163.8 27.33 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.109 179.996 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -161.02 141.95 3.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.897 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.2 t -145.33 155.6 43.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.046 0.45 . . . . 0.0 111.708 -178.993 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.44 HG21 ' HG ' ' A' ' 42' ' ' LEU . 57.1 p -137.99 -3.25 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.807 179.652 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.73 139.81 55.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.425 179.976 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -62.24 -47.4 84.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.68 -179.313 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -50.73 -46.94 59.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.486 -179.217 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.51 ' HA ' HG22 ' A' ' 21' ' ' VAL . 75.3 t -69.6 -51.87 37.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.767 0.318 . . . . 0.0 110.756 179.92 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.407 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -59.36 -14.57 12.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.033 0.444 . . . . 0.0 110.219 179.466 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.3 m -92.63 -40.75 10.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.429 178.776 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -62.65 -35.55 79.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 -179.922 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.443 ' HB2' HG12 ' A' ' 76' ' ' ILE . 44.8 m-85 -94.11 10.36 34.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.754 179.544 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 57.27 24.3 9.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.683 179.422 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.671 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.0 mm -61.31 120.2 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.032 179.767 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.5 p -139.94 55.91 1.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 111.397 -179.926 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.9 44.19 0.02 OUTLIER Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.515 179.86 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.622 ' HB2' HG21 ' A' ' 99' ' ' ILE . 30.8 m-80 52.14 41.9 30.32 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.178 0.513 . . . . 0.0 110.437 -179.646 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.671 ' HB ' HG23 ' A' ' 76' ' ' ILE . 88.2 m -67.77 152.68 45.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.628 -178.564 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.591 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.5 mt -119.58 118.57 57.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.951 178.006 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.3 m -107.5 133.89 51.32 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -177.855 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.638 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.2 tp -109.73 102.55 11.35 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.794 178.262 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -96.93 122.64 40.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.791 0.329 . . . . 0.0 110.77 179.755 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.523 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 4.7 mtm180 -104.61 100.43 10.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.138 0.494 . . . . 0.0 109.971 179.582 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -43.78 -52.01 6.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.872 -179.156 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.577 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -42.82 -65.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.154 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.21 18.95 12.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.652 -179.322 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 p30 42.93 31.1 0.3 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.941 179.332 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.523 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 8.8 mm-40 -75.91 159.5 30.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 0.0 110.974 -179.923 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -146.42 85.44 1.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.65 179.798 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.638 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -75.04 144.84 42.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.224 179.996 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -121.93 124.83 44.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.351 0.596 . . . . 0.0 111.792 -179.643 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.656 HD21 HD13 ' A' ' 102' ' ' ILE . 3.7 tt -112.09 76.03 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.273 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.0 mt-10 -77.91 -165.41 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.752 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.495 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -46.45 -51.22 15.59 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.556 -179.11 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -47.23 -17.87 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.923 0.392 . . . . 0.0 110.899 179.764 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 96' ' ' ASP . 9.4 m-20 -124.84 -13.94 6.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.414 -179.91 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.622 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.3 mm -92.23 -42.74 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.264 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -50.78 -34.76 28.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.021 179.812 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.5 t -127.66 37.69 4.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.371 179.622 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.656 HD13 HD21 ' A' ' 94' ' ' LEU . 8.7 tp -67.6 144.72 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.779 -179.607 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -138.64 147.87 43.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.345 178.542 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.878 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.71 -37.44 8.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.962 0.41 . . . . 0.0 110.579 -179.722 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.5 m -62.32 -48.45 79.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.322 178.88 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -58.39 -58.4 8.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.311 -179.677 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.761 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.77 -56.59 11.36 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.057 0.456 . . . . 0.0 110.271 179.902 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.4 m -57.71 -29.41 64.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.762 179.796 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.526 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.2 tmt_? -71.44 -65.65 0.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.247 179.83 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -42.89 -42.77 3.81 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.033 179.231 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.479 HG12 HG21 ' A' ' 35' ' ' VAL . 95.5 mt -63.92 -55.3 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.494 178.377 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -54.96 -17.71 4.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.253 0.549 . . . . 0.0 110.332 179.333 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.526 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.77 -36.81 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.84 -179.29 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -123.64 30.12 6.33 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.527 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.8 p -82.58 51.33 1.84 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.085 0.469 . . . . 0.0 109.959 178.741 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 85' ' ' ARG . 55.3 mt . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.295 -179.208 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.681 0.277 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.8 t 55.4 77.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 -179.937 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -121.06 72.14 0.97 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.012 -179.872 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -88.22 -25.1 23.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 179.91 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.0 t -166.62 43.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.927 179.889 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.0 t -143.36 115.99 8.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.843 179.939 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -82.1 -20.03 38.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.855 -179.875 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.37 165.22 28.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.625 -179.988 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.16 -45.33 19.63 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.623 2.215 . . . . 0.0 112.192 179.856 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.37 160.12 13.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.646 -179.883 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.56 -63.63 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.83 0.347 . . . . 0.0 110.56 -179.957 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.537 ' HB3' ' NE2' ' A' ' 55' ' ' GLN . . . 55.39 89.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.75 179.62 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 12' ' ' ALA . 4.8 pt20 48.14 170.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.961 179.689 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 -164.14 160.17 16.54 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.2 -179.862 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 46.6 Cg_endo -68.71 146.87 68.15 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.348 2.032 . . . . 0.0 112.811 -179.168 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.6 m -67.75 152.4 45.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.443 -179.623 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -95.81 85.88 4.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.813 179.87 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.3 mt -81.75 71.24 8.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.63 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.0 p -71.43 0.14 8.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.034 -179.266 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -142.56 147.43 35.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.965 0.412 . . . . 0.0 111.705 -179.701 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.594 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.2 t -56.86 -50.35 88.61 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.443 179.881 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.2 Cg_endo -58.39 -44.48 37.65 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.975 1.783 . . . . 0.0 111.93 179.916 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.26 83.28 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.291 0.567 . . . . 0.0 110.18 179.953 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.69 -57.42 10.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.053 179.435 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.2 mtm -61.39 -26.78 68.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.013 -179.903 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -71.47 -50.66 29.44 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.484 179.738 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -60.65 -31.67 70.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.058 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.489 HD11 HD12 ' A' ' 36' ' ' ILE . 49.9 mt -73.17 -38.03 53.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.809 178.236 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.06 -19.7 61.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.998 179.857 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.14 31.01 1.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.471 -179.715 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.695 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.8 t -171.26 153.25 3.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.333 -179.853 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.615 ' HG3' HG13 ' A' ' 87' ' ' VAL . 27.6 tt0 -71.62 -37.46 70.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.651 179.63 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.579 HG13 HD11 ' A' ' 83' ' ' LEU . 26.9 t -131.53 136.81 56.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.229 179.408 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.02 127.12 19.49 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.252 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 111' ' ' ILE . 50.8 t -114.58 130.6 68.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.427 178.304 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.489 HD12 HD11 ' A' ' 28' ' ' ILE . 28.2 mt -136.09 135.66 50.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.439 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.574 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.54 99.13 2.12 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.404 179.46 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 13.9 m-85 -85.39 93.28 8.7 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.631 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -112.8 142.06 45.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.492 -177.958 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.458 ' HG2' HD23 ' A' ' 71' ' ' LEU . 47.7 mt-30 -90.87 1.69 56.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.767 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.8 t70 -159.36 122.22 3.59 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.585 179.895 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.554 ' HA ' HG21 ' A' ' 47' ' ' VAL . 90.1 mt -92.38 47.67 1.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.185 0.517 . . . . 0.0 111.417 -179.32 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 47.5 mt-10 -138.0 7.47 2.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.913 178.868 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.822 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.8 pt -90.93 155.91 44.75 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.159 179.824 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.455 ' O ' HD12 ' A' ' 49' ' ' ILE . 86.5 Cg_exo -51.11 -26.71 20.01 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.862 2.374 . . . . 0.0 113.214 179.733 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.822 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.51 -36.22 83.48 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.842 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.65 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -62.98 -55.92 33.29 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.494 -178.854 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.641 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.1 Cg_exo -58.75 -39.62 80.31 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.807 1.672 . . . . 0.0 111.407 179.34 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 8.3 mt -63.35 -37.59 79.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.137 179.986 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.608 ' O ' HG23 ' A' ' 54' ' ' VAL . 41.9 tp -71.87 -51.76 20.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.844 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -55.49 -22.0 19.0 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.507 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -85.09 -44.17 13.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.581 179.494 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.582 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -62.12 -25.56 67.8 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.33 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 50' ' ' LEU . 52.9 t -52.87 -46.97 52.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.928 179.436 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.537 ' NE2' ' HB3' ' A' ' 12' ' ' ALA . 27.7 mt-30 -77.62 -11.65 59.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.705 -179.729 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -93.72 -18.09 22.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.347 -179.85 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.586 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 66.4 m-85 -137.34 62.39 37.29 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.569 -179.775 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.52 -42.53 61.07 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.632 2.221 . . . . 0.0 111.636 179.033 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.95 -40.96 94.02 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.521 179.227 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.2 t -66.93 143.27 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 178.8 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.695 ' HB2' HG21 ' A' ' 31' ' ' THR . 48.4 t -80.58 98.08 7.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.134 0.492 . . . . 0.0 110.99 -179.681 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.52 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.6 p90 -66.11 125.57 25.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.78 179.67 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.48 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -144.39 161.91 27.94 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.99 179.902 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.412 HD11 HG13 ' A' ' 47' ' ' VAL . 5.0 tt -159.54 144.17 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.803 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.3 t -150.29 154.37 37.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.218 0.532 . . . . 0.0 111.811 -178.993 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.489 HG21 ' HG ' ' A' ' 42' ' ' LEU . 75.2 p -135.21 -2.64 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.474 179.464 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.05 141.36 57.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.717 -179.875 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.3 p -64.57 -49.93 69.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.509 -179.569 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -49.6 -45.02 47.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.492 -179.371 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.539 ' HA ' HG22 ' A' ' 21' ' ' VAL . 69.0 t -70.52 -53.19 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.877 0.37 . . . . 0.0 110.734 179.853 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.458 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.25 -14.71 7.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.193 179.406 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.4 m -91.59 -41.85 10.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.333 178.889 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -61.25 -35.48 77.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.449 179.679 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.424 ' HB2' HG12 ' A' ' 76' ' ' ILE . 45.4 m-85 -94.61 9.31 39.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.759 179.452 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.3 t30 57.65 23.19 9.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.671 178.787 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.679 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.6 mm -58.13 120.78 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.157 179.856 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.3 p -139.23 57.34 1.66 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.403 -179.632 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.82 46.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.75 179.754 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.612 ' HB2' HG21 ' A' ' 99' ' ' ILE . 21.8 m-80 50.62 42.52 27.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.188 0.518 . . . . 0.0 110.293 -179.868 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.679 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.4 m -69.0 152.26 45.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.665 -178.352 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.583 HG21 HD21 ' A' ' 107' ' ' LEU . 66.0 mt -119.18 116.42 50.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.952 178.01 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.4 m -105.34 135.23 47.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.816 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.638 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -109.64 98.78 8.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.916 178.377 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -92.45 120.11 32.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.541 179.816 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.508 HH12 HD12 ' A' ' 116' ' ' LEU . 5.1 mtm180 -103.74 103.84 13.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.399 . . . . 0.0 110.108 179.706 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.5 tp -45.1 -56.32 4.82 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.831 -179.182 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.615 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.03 -76.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.175 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -82.5 5.9 19.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.047 -179.754 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 52.3 36.58 20.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.425 179.779 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 7.3 mm-40 -81.61 167.19 19.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.959 179.833 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -150.73 89.53 1.56 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.575 179.621 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.638 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.8 mm? -74.49 148.09 41.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.877 179.735 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.5 114.62 18.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.3 0.571 . . . . 0.0 112.165 -179.512 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.6 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -103.52 77.88 1.54 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.154 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.2 mt-10 -80.55 -164.4 0.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.91 -176.775 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 17.7 t70 -50.62 -36.25 34.31 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.068 -179.319 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -56.04 -14.7 2.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.313 0.578 . . . . 0.0 110.254 179.63 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -132.33 -13.67 3.03 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.768 -179.909 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.612 HG21 ' HB2' ' A' ' 79' ' ' ASN . 26.2 mm -89.69 -31.54 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.7 0.286 . . . . 0.0 111.269 -179.555 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -53.78 -43.04 68.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.0 110.707 179.815 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.5 p -125.74 38.83 4.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.393 179.738 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.6 HD13 HD21 ' A' ' 94' ' ' LEU . 7.7 tp -63.56 142.93 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.653 -179.835 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -137.25 148.46 46.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.505 178.836 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.53 -34.89 8.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.193 0.52 . . . . 0.0 110.274 -179.989 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.2 m -63.47 -48.1 79.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.35 178.774 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -60.3 -60.74 3.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.266 -179.71 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.745 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.68 -55.36 11.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.029 0.442 . . . . 0.0 110.239 179.898 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 65.8 m -58.92 -30.86 68.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.87 179.948 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.49 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.2 tmt_? -70.85 -65.81 0.69 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.146 179.724 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -42.87 -44.23 4.42 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.232 179.355 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.475 HG12 HG21 ' A' ' 35' ' ' VAL . 95.4 mt -62.89 -55.08 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.175 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.447 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 7.8 tp10 -54.1 -17.97 3.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.294 179.178 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.49 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -91.09 -34.9 6.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.031 -179.097 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.467 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.6 m120 -124.78 28.79 6.39 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.408 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 94.3 p -82.47 43.88 0.85 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.076 0.465 . . . . 0.0 110.346 179.157 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.508 HD12 HH12 ' A' ' 85' ' ' ARG . 59.2 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.392 -179.279 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.867 0.365 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.3 m -107.26 158.37 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.087 -179.891 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -135.52 -65.44 0.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.731 -179.913 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 63.85 151.53 0.04 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.362 179.709 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.4 t -78.4 95.97 5.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.033 -179.915 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.6 m -136.91 -55.79 0.72 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -68.78 164.26 22.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.911 179.996 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.61 -161.66 28.41 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.56 -179.93 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.19 131.26 37.98 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.582 2.188 . . . . 0.0 112.314 179.839 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.47 -77.67 0.24 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.613 179.976 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.73 -45.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.001 0.429 . . . . 0.0 110.429 -179.945 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.35 -84.04 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.954 179.093 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.516 ' HG3' HG12 ' A' ' 54' ' ' VAL . 11.5 pt20 -133.16 138.12 46.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.106 -179.929 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.8 pt-20 -122.15 156.29 60.31 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.62 179.905 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 32.5 Cg_endo -64.89 139.11 60.64 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.549 2.166 . . . . 0.0 112.502 -179.655 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -54.84 153.49 6.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.824 -179.368 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -98.18 92.18 5.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.976 179.78 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.614 HD22 ' HA ' ' A' ' 24' ' ' ALA . 50.9 mt -92.42 72.07 5.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.448 179.77 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.8 p -73.79 -0.99 17.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.889 -179.299 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -140.51 146.78 38.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.393 . . . . 0.0 111.626 -179.953 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 48.4 t -56.29 -49.96 90.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.494 179.862 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.4 Cg_endo -57.5 -46.15 29.36 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.896 1.73 . . . . 0.0 111.773 179.842 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.98 76.9 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.269 0.557 . . . . 0.0 110.259 -179.822 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.614 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.87 -58.68 5.55 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.104 179.342 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 46.7 mtm -61.3 -26.3 67.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.209 -179.943 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.0 mt-10 -72.06 -51.42 21.72 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.687 0.28 . . . . 0.0 110.612 179.806 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.575 ' O ' HG22 ' A' ' 31' ' ' THR . 6.2 m-85 -59.69 -34.64 73.14 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.106 179.249 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 36' ' ' ILE . 49.3 mt -72.89 -38.49 56.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.844 178.293 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.65 -17.46 61.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.005 -179.826 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.61 26.04 5.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.307 -179.9 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 27' ' ' PHE . 8.8 t -172.78 152.06 2.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.597 -179.77 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.724 ' HG3' HG13 ' A' ' 87' ' ' VAL . 1.2 mp0 -59.67 -90.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.252 0.548 . . . . 0.0 110.948 179.32 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.547 HG13 HD11 ' A' ' 83' ' ' LEU . 11.4 t -85.41 133.12 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.715 -179.321 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -137.57 124.4 21.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.873 -178.977 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.428 HG21 HG12 ' A' ' 111' ' ' ILE . 52.3 t -112.75 129.71 67.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.845 178.736 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.521 HD12 HD11 ' A' ' 28' ' ' ILE . 25.2 mt -134.66 135.56 53.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.646 -177.249 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.54 98.06 1.97 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.41 179.859 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.526 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.9 m-85 -83.24 90.06 7.06 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.725 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.4 m-85 -110.29 139.74 45.16 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.0 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -87.36 -5.91 58.69 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.764 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.488 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.2 t70 -152.59 120.85 6.28 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.583 -179.924 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.484 ' HA ' HG21 ' A' ' 47' ' ' VAL . 99.3 mt -89.81 45.58 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.047 0.451 . . . . 0.0 111.513 -179.187 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.4 mt-10 -136.85 11.05 3.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.09 178.97 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.734 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.2 pt -92.77 157.22 39.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.27 179.815 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.487 ' O ' HD12 ' A' ' 49' ' ' ILE . 70.9 Cg_exo -51.67 -25.93 21.61 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.853 2.368 . . . . 0.0 113.004 179.547 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.734 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.41 -37.9 88.34 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.853 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.684 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -61.12 -54.92 49.16 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -178.73 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.614 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 35.2 Cg_exo -61.05 -38.81 65.11 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.951 1.767 . . . . 0.0 111.508 179.202 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.879 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -64.76 -34.58 71.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.025 -179.954 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.617 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.1 tp -74.3 -52.13 13.17 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.879 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -53.11 -26.36 16.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.173 0.511 . . . . 0.0 109.681 178.618 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 t -80.93 -47.55 13.55 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.778 179.867 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.587 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.72 -26.32 63.81 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.443 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 50' ' ' LEU . 56.0 t -52.36 -49.43 42.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.019 179.624 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -77.57 -11.44 59.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.75 -179.815 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -91.3 -18.74 23.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.01 179.807 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 50.3 m-85 -135.92 63.2 50.6 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.267 -179.818 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.03 -43.86 49.6 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.629 2.219 . . . . 0.0 111.692 179.252 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.6 -40.94 88.8 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.367 179.086 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.1 t -66.45 144.48 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.913 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.567 ' CB ' HG21 ' A' ' 31' ' ' THR . 31.0 t -83.73 98.98 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.059 0.457 . . . . 0.0 110.987 -179.581 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.491 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.4 p90 -64.39 128.84 37.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.053 179.875 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.62 161.65 28.7 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.137 179.762 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 15' ' ' PRO . 4.2 tt -159.32 141.89 5.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.679 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.1 t -141.73 154.55 45.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.971 0.415 . . . . 0.0 111.489 -178.974 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 39' ' ' PHE . 68.9 p -139.96 -2.44 1.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.875 179.894 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -72.15 143.06 49.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.754 -179.939 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.8 p -63.19 -49.67 73.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.533 -179.493 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -49.97 -44.37 50.71 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.69 -179.381 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.566 ' HA ' HG22 ' A' ' 21' ' ' VAL . 79.6 t -70.54 -52.83 25.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.925 0.393 . . . . 0.0 110.723 179.797 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.19 -14.55 11.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.223 179.422 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.7 m -91.53 -41.89 10.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.264 178.871 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -59.78 -39.92 86.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.498 179.723 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -92.11 13.75 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.987 179.675 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.4 m120 55.32 24.19 6.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.598 179.433 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.66 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.1 mm -59.73 119.23 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.886 179.747 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -139.51 57.59 1.64 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.199 -179.948 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.2 45.06 0.02 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.515 179.828 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.555 ' HB2' HG21 ' A' ' 99' ' ' ILE . 24.9 m-80 51.42 42.16 28.99 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.292 0.567 . . . . 0.0 110.406 -179.859 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.66 ' HB ' HG23 ' A' ' 76' ' ' ILE . 97.9 m -67.86 152.86 44.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.605 -178.621 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.591 HG12 ' HA2' ' A' ' 37' ' ' GLY . 66.1 mt -119.41 117.26 53.43 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.14 178.161 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.526 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.1 m -106.13 135.99 46.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.837 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.626 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -110.64 104.49 13.18 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.132 178.546 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -97.46 120.1 37.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.76 179.76 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.567 HH12 HD12 ' A' ' 116' ' ' LEU . 5.6 mtm180 -103.39 88.83 3.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.563 -179.739 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tp -38.61 -49.46 1.54 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.637 -179.791 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.724 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -42.48 -52.38 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 111.431 -179.88 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -108.59 9.39 27.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.62 179.821 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 85' ' ' ARG . 17.0 t-20 47.89 35.55 5.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.519 -179.834 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 8.0 mm-40 -83.05 163.8 20.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.648 179.566 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.2 94.14 2.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 179.761 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.626 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -80.94 146.16 30.9 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.338 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.75 106.31 9.96 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.927 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.619 HD21 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -91.79 77.42 5.54 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.663 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' HG12 ' A' ' 99' ' ' ILE . 24.4 mt-10 -79.19 -165.09 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.767 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.472 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -45.25 -51.46 10.75 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.569 -179.331 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -47.04 -17.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.901 0.382 . . . . 0.0 111.215 179.88 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -125.52 -13.85 6.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.575 -179.968 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.555 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.3 mm -90.88 -41.32 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.729 -179.381 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -49.05 -40.41 31.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.4 p -126.03 41.87 3.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.684 179.839 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.619 HD13 HD21 ' A' ' 94' ' ' LEU . 7.5 tp -69.31 142.54 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.663 -179.581 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -135.6 147.76 48.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.237 178.597 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.879 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.45 -36.14 6.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.593 -179.608 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.8 m -63.22 -47.45 82.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.562 178.822 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -59.5 -59.3 5.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.206 -179.743 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.741 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.02 -54.59 19.13 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.898 0.38 . . . . 0.0 110.22 179.712 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.3 m -59.38 -30.15 68.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.504 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.1 tmt_? -70.84 -65.59 0.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.191 179.651 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -43.48 -44.23 5.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.908 179.363 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.428 HG12 HG21 ' A' ' 35' ' ' VAL . 96.8 mt -62.34 -54.96 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.437 178.257 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -54.8 -18.9 5.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.213 179.358 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.504 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.91 -35.72 8.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.937 -179.094 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.451 ' O ' HD21 ' A' ' 83' ' ' LEU . 18.0 m120 -125.3 29.82 5.97 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.397 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 96.8 p -81.99 38.3 0.52 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.971 0.415 . . . . 0.0 110.487 179.048 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.567 HD12 HH12 ' A' ' 85' ' ' ARG . 58.6 mt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.114 -179.705 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.763 0.316 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.3 m -66.77 140.78 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.121 -179.934 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -74.16 89.63 2.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.917 -179.861 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -163.72 32.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.561 179.862 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.2 m 64.56 127.58 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.279 -179.969 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -134.94 81.9 1.93 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.986 -179.953 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 61.63 -84.35 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.271 179.778 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.37 -161.38 10.68 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.669 -179.81 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.32 148.96 84.05 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.762 2.308 . . . . 0.0 112.507 -179.806 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.72 148.67 17.08 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.434 179.928 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.33 -54.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.786 0.326 . . . . 0.0 110.681 -179.9 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.62 -84.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.67 179.527 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.495 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.7 pt20 -162.35 135.16 5.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.859 0.361 . . . . 0.0 111.31 -179.985 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.443 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.3 pt-20 -120.13 157.71 52.43 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.625 179.895 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.2 Cg_endo -66.25 143.49 70.98 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.532 2.155 . . . . 0.0 112.712 -179.429 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.4 m -59.3 154.17 17.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.427 -179.614 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -102.14 97.06 7.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.935 -179.987 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.604 HD13 ' HA ' ' A' ' 24' ' ' ALA . 39.2 mt -95.17 76.81 3.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.432 179.958 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.0 p -74.09 -4.34 34.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.142 -179.085 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -139.02 147.32 41.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.92 0.39 . . . . 0.0 111.595 -179.669 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.2 t -55.97 -50.24 88.42 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.36 179.969 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.95 -44.25 41.63 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 121.88 1.72 . . . . 0.0 111.736 179.992 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.76 78.82 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.321 0.582 . . . . 0.0 110.22 179.995 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.604 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -64.51 -58.66 5.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.093 179.483 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.2 mtp -61.7 -25.83 67.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 19.1 mt-10 -71.34 -51.5 23.9 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.738 0.304 . . . . 0.0 110.474 179.591 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.583 ' O ' HG22 ' A' ' 31' ' ' THR . 7.0 m-85 -59.27 -35.68 74.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.97 179.317 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 36' ' ' ILE . 46.9 mt -71.13 -39.56 74.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.904 178.305 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.98 -17.98 62.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.994 -179.906 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.78 24.95 5.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.186 -179.862 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.59 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.3 t -169.95 152.76 4.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.416 -179.92 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.587 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.5 tt0 -61.23 -82.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.898 -179.888 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.554 HG13 HD11 ' A' ' 83' ' ' LEU . 21.9 t -94.63 138.16 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.48 179.964 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.99 126.84 20.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.946 0.403 . . . . 0.0 111.989 -179.173 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.445 HG21 HG12 ' A' ' 111' ' ' ILE . 45.1 t -113.65 128.11 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.789 178.445 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.541 HD12 HD11 ' A' ' 28' ' ' ILE . 32.0 mt -133.0 134.68 57.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.658 -177.053 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.536 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.3 100.25 2.31 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.347 179.614 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 4.4 m-85 -84.76 93.19 8.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.8 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.2 m-85 -114.5 141.45 47.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.103 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.496 ' HG2' HD23 ' A' ' 71' ' ' LEU . 74.0 mt-30 -88.89 -7.8 55.43 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.706 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 44' ' ' ILE . 25.4 t70 -150.2 120.95 7.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.667 -1.152 . . . . 0.0 109.66 179.688 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.476 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.6 mt -90.17 45.33 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.006 0.432 . . . . 0.0 111.536 -179.197 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.7 mt-10 -135.42 11.84 3.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.083 178.976 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.696 HG13 HG23 ' A' ' 47' ' ' VAL . 4.9 pt -93.18 158.93 36.43 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.508 ' O ' HD12 ' A' ' 49' ' ' ILE . 68.8 Cg_exo -54.15 -25.66 38.58 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.743 2.295 . . . . 0.0 112.791 179.462 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.673 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.29 -38.33 89.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.456 -178.804 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.696 HG23 HG13 ' A' ' 44' ' ' ILE . 2.1 t -60.34 -56.45 35.24 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.704 -178.788 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.4 -41.11 61.19 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.812 1.675 . . . . 0.0 111.401 179.561 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.87 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.6 mt -61.64 -34.87 63.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.992 179.781 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.7 tp -74.19 -53.39 9.93 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 178.809 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -53.47 -24.52 13.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.004 0.431 . . . . 0.0 109.887 178.911 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.9 m -82.74 -45.93 13.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.499 179.421 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.552 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.25 -25.84 64.39 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.407 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.0 t -52.84 -49.98 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.823 179.312 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -75.73 -11.45 60.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.813 -179.867 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -92.64 -18.26 23.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.145 179.937 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.592 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 68.1 m-85 -135.56 62.34 48.44 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.396 -179.739 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.7 -43.32 51.78 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.727 2.284 . . . . 0.0 111.552 179.0 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.72 -38.11 86.61 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.52 179.294 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.0 t -70.05 144.4 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.955 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.59 ' CB ' HG21 ' A' ' 31' ' ' THR . 42.9 t -83.83 99.32 10.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.006 0.431 . . . . 0.0 111.042 -179.672 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.478 ' HB3' HG22 ' A' ' 54' ' ' VAL . 7.7 p90 -62.57 131.25 48.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.151 179.915 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -150.06 161.69 28.97 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.121 179.712 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -162.85 142.63 2.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.995 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.8 t -144.37 155.97 44.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.041 0.448 . . . . 0.0 111.652 -179.059 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 39' ' ' PHE . 67.7 p -139.03 3.1 2.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.842 179.666 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.75 143.11 44.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.784 -179.972 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.9 t -64.48 -50.47 67.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.496 -179.426 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.76 -43.57 48.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.514 -179.413 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.534 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.1 t -71.51 -53.02 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.811 0.339 . . . . 0.0 110.756 179.987 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.496 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -58.86 -14.51 9.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.233 179.315 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 76.1 m -91.48 -40.98 11.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.294 178.641 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -60.49 -40.22 90.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.45 179.847 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -91.45 11.86 22.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.853 179.644 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 56.04 25.74 9.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.596 179.551 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.665 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.0 mm -59.78 119.42 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.839 179.597 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.4 p -138.49 58.88 1.65 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.235 -179.549 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.11 48.22 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.709 179.664 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.616 ' HB2' HG21 ' A' ' 99' ' ' ILE . 36.3 m-20 49.52 43.4 23.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.103 0.478 . . . . 0.0 110.461 -179.945 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.665 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.1 m -68.62 152.63 45.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.621 -178.677 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.536 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.4 mt -118.81 119.14 60.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.07 178.065 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 83.6 m -108.55 134.62 51.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.038 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.63 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -106.71 103.99 13.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.608 178.438 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -97.33 119.72 36.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.867 0.365 . . . . 0.0 111.199 -179.886 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.485 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 3.2 mtm180 -105.24 95.93 6.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.407 -179.95 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 1.6 tp -43.19 -54.55 4.43 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.782 -179.622 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.587 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.1 -59.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.03 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -97.86 3.62 49.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.446 -179.346 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 85' ' ' ARG . 38.2 t30 51.58 47.08 25.5 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.259 0.552 . . . . 0.0 110.834 -179.818 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.485 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 10.2 mm-40 -97.23 158.67 15.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.715 -179.894 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -140.96 92.34 2.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.934 179.809 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.63 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.5 mm? -80.8 143.42 32.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.258 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -120.97 123.06 41.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.281 0.562 . . . . 0.0 112.439 -179.363 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.632 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -111.09 76.34 0.97 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.126 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.44 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.3 mt-10 -78.13 -164.58 0.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.364 -0.834 . . . . 0.0 113.137 -176.669 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.53 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 12.5 t70 -50.94 -37.2 42.83 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.98 -179.113 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.74 -14.98 2.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.106 0.479 . . . . 0.0 110.304 179.639 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -130.6 -13.8 3.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.585 179.776 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.616 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.7 mm -90.48 -24.95 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.76 0.314 . . . . 0.0 111.195 -179.538 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -57.18 -52.02 66.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.993 0.425 . . . . 0.0 110.611 179.843 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.5 m -117.73 35.6 4.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.348 179.537 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.632 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -58.09 140.6 16.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.437 -179.619 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -135.69 149.97 49.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.424 178.644 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.87 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.02 -34.55 9.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.019 0.437 . . . . 0.0 110.479 -179.844 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.9 m -64.79 -48.24 75.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.452 178.844 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -59.99 -57.33 13.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.226 -179.794 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.763 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -51.75 -55.89 17.08 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.132 0.491 . . . . 0.0 110.001 179.662 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.9 m -58.0 -30.24 65.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.917 179.866 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.444 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.8 tmt_? -70.37 -65.81 0.68 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.275 179.66 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -42.98 -43.9 4.39 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.141 179.277 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.445 HG12 HG21 ' A' ' 35' ' ' VAL . 88.8 mt -62.29 -55.55 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.208 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -54.6 -18.33 4.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.451 179.319 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.444 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.74 -36.64 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.079 -178.873 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.486 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.0 m120 -124.22 28.79 6.6 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.574 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.9 p -81.04 42.84 0.67 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.928 0.394 . . . . 0.0 110.462 179.21 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.442 HD12 ' NH1' ' A' ' 85' ' ' ARG . 62.3 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.189 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.483 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.0 pt-20 . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.536 0.207 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.506 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.9 Cg_endo -65.46 145.27 82.29 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.617 2.211 . . . . 0.0 112.706 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 m -62.27 154.14 28.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.912 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -97.42 92.82 6.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.811 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.596 HD22 ' HA ' ' A' ' 24' ' ' ALA . 42.9 mt -91.84 71.23 5.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.513 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.2 p -72.93 -0.8 14.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.103 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -139.7 147.28 40.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 111.488 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 45.2 t -56.81 -49.93 91.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.518 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.05 -45.44 31.97 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.926 1.751 . . . . 0.0 111.786 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.29 80.12 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.195 0.521 . . . . 0.0 110.19 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.596 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.77 -59.83 4.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.063 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.3 mtm -60.59 -25.54 66.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.144 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 21.8 mt-10 -71.6 -51.22 24.41 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.495 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.498 ' O ' HG22 ' A' ' 31' ' ' THR . 10.4 m-85 -61.06 -30.21 70.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.575 HD11 HD12 ' A' ' 36' ' ' ILE . 48.6 mt -75.79 -36.96 34.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.965 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.36 -19.48 59.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.248 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.14 28.1 2.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.655 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.1 t -171.16 153.15 3.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.46 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.503 ' HG3' HG13 ' A' ' 87' ' ' VAL . 23.3 tt0 -65.36 -65.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.773 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.509 HG13 HD11 ' A' ' 83' ' ' LEU . 18.1 t -106.1 137.82 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.638 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.536 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.3 125.92 17.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.476 HG21 HG12 ' A' ' 111' ' ' ILE . 53.9 t -114.56 128.75 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.641 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.575 HD12 HD11 ' A' ' 28' ' ' ILE . 29.9 mt -134.49 137.89 50.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.558 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.11 97.79 1.72 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.427 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.469 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.8 m-85 -83.27 91.85 7.37 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.1 m-85 -111.45 143.3 42.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.469 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.486 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 48.6 mt-30 -90.46 -6.22 55.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.0 t70 -151.95 121.86 7.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.614 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.514 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.7 mt -90.51 45.76 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.999 0.428 . . . . 0.0 111.515 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 36.9 mt-10 -136.59 8.98 3.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.094 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.741 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.8 pt -90.66 156.86 44.75 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.162 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.487 ' O ' HD12 ' A' ' 49' ' ' ILE . 79.6 Cg_exo -51.0 -27.75 22.2 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.837 2.358 . . . . 0.0 112.923 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.741 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.46 -38.57 91.67 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.703 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -60.46 -56.7 32.66 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.802 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.644 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -59.39 -40.88 63.46 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.671 1.581 . . . . 0.0 111.441 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -61.82 -35.59 68.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.145 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.603 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.4 tp -74.65 -52.56 11.37 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -54.83 -24.27 22.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.071 0.463 . . . . 0.0 109.977 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 m -83.03 -45.27 14.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.623 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.614 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.59 -26.28 66.85 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.2 0.524 . . . . 0.0 109.619 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -51.25 -47.71 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.226 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -77.43 -12.97 60.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.913 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -91.23 -17.52 25.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.171 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.576 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 47.8 m-85 -137.99 62.64 34.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.567 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.84 -42.58 65.34 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.677 2.251 . . . . 0.0 111.661 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.93 -37.79 80.84 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.381 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.7 t -70.34 144.34 13.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.655 ' HB2' HG21 ' A' ' 31' ' ' THR . 46.7 t -82.26 98.46 8.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.948 0.404 . . . . 0.0 111.094 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.506 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -65.21 127.37 31.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.066 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.27 160.44 28.18 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.159 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 tt -160.37 144.16 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.469 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 37.3 t -148.48 159.11 44.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.5 . . . . 0.0 111.768 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.468 HG21 ' HG ' ' A' ' 42' ' ' LEU . 67.8 p -140.99 4.82 1.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.656 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -74.43 141.56 45.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.672 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.2 t -64.32 -51.11 65.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.448 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -49.88 -41.94 46.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.61 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.543 ' HA ' HG22 ' A' ' 21' ' ' VAL . 56.5 t -72.08 -53.99 18.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.831 0.348 . . . . 0.0 110.762 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -58.78 -14.69 9.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.091 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.0 m -90.54 -42.45 10.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.093 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -59.73 -37.76 79.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.356 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.431 ' HB2' HG12 ' A' ' 76' ' ' ILE . 79.6 m-85 -93.67 12.01 26.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.807 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.9 m120 55.7 23.75 6.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.64 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.703 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.3 mm -59.78 121.59 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.221 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.4 p -142.48 58.7 1.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.011 0.434 . . . . 0.0 111.05 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.04 43.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.658 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.556 ' HB2' HG21 ' A' ' 99' ' ' ILE . 14.2 m120 52.07 43.23 30.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.296 0.569 . . . . 0.0 110.448 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.703 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.2 m -68.61 151.86 46.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.741 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.558 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.1 mt -118.43 116.63 51.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.025 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 72.0 m -105.28 130.3 53.44 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.606 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -107.8 103.51 12.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.771 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.0 t80 -97.51 124.37 41.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.529 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.534 HH12 HD12 ' A' ' 116' ' ' LEU . 4.5 mtm180 -106.8 82.85 1.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.967 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 85' ' ' ARG . 6.0 tp -24.99 -60.04 0.06 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.087 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.503 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.52 -70.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.03 2.08 50.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.05 0.452 . . . . 0.0 110.959 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 m120 53.76 34.85 19.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.632 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 11.8 mm-40 -81.17 163.93 22.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.746 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.09 98.58 2.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.824 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.606 HD23 ' HG ' ' A' ' 83' ' ' LEU . 1.8 mm? -88.37 117.08 27.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.784 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -97.85 94.08 6.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.545 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -77.65 77.42 4.17 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.4 mt-10 -78.4 -164.49 0.57 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.516 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 16.3 t70 -51.27 -39.02 55.86 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.096 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.26 -14.67 1.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.103 0.477 . . . . 0.0 110.346 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -129.22 -13.85 4.4 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.674 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.556 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.4 mm -90.29 -31.0 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.607 0.242 . . . . 0.0 111.563 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -55.21 -39.37 69.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.19 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.8 p -128.03 37.07 4.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.506 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.545 HD13 HD21 ' A' ' 94' ' ' LEU . 6.6 tp -62.77 142.78 16.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.423 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -137.34 150.53 47.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.642 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.881 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.42 -36.2 14.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.036 0.446 . . . . 0.0 110.367 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.8 m -63.29 -48.7 77.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.398 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -59.08 -58.59 7.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.281 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.49 -56.22 12.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.883 0.373 . . . . 0.0 110.227 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.7 m -58.39 -29.65 66.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.792 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.493 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -71.24 -66.39 0.62 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.094 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -42.57 -42.45 3.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.146 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.476 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -64.12 -56.27 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.562 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -53.43 -19.87 4.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.328 0.585 . . . . 0.0 110.267 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.493 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.22 -37.04 10.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.915 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.435 ' OD1' ' HG ' ' A' ' 92' ' ' LEU . 16.7 m120 -123.3 30.95 6.12 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.0 p -83.35 41.7 0.78 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.02 0.438 . . . . 0.0 110.169 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.534 HD12 HH12 ' A' ' 85' ' ' ARG . 64.6 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.249 -0.882 . . . . 0.0 111.374 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.515 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.5 pt-20 . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 110.651 -0.129 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 37.2 Cg_endo -66.16 143.9 73.18 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.464 2.109 . . . . 0.0 112.668 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 m -62.0 154.41 26.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.422 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -98.99 90.13 4.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.068 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.633 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.7 mt -86.8 74.14 9.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.312 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.8 p -74.05 -5.28 40.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.971 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -137.56 147.2 44.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.888 0.375 . . . . 0.0 111.555 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.2 t -56.76 -50.03 90.35 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.448 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.8 Cg_endo -57.56 -44.08 45.09 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.911 1.741 . . . . 0.0 111.83 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.36 83.9 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.172 0.51 . . . . 0.0 110.228 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.633 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.52 -58.73 6.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.169 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 64.5 mtp -60.36 -26.37 66.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.148 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -71.45 -51.34 24.36 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.672 0.273 . . . . 0.0 110.569 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.546 ' O ' HG22 ' A' ' 31' ' ' THR . 10.9 m-85 -60.37 -32.86 71.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.909 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.49 HD11 ' CD1' ' A' ' 36' ' ' ILE . 54.7 mt -73.71 -38.75 51.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.108 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.98 -19.86 60.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.055 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.8 25.57 3.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.638 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.0 t -168.85 152.2 5.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.514 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HG2' HG22 ' A' ' 87' ' ' VAL . 21.9 tt0 -63.82 -74.04 0.11 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.744 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.549 HG13 HD11 ' A' ' 83' ' ' LEU . 17.9 t -98.25 136.32 29.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.452 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.84 125.37 19.19 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.437 HG21 HG12 ' A' ' 111' ' ' ILE . 56.0 t -115.15 131.13 68.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.688 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 21.5 mt -136.58 138.51 46.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.604 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.74 97.02 1.55 Allowed Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.583 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 11.5 m-85 -83.32 89.8 7.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -109.48 137.92 46.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.455 -178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.481 ' HG2' HD23 ' A' ' 71' ' ' LEU . 24.7 mt-30 -83.85 -6.21 59.38 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.442 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 37.5 t70 -151.69 124.96 8.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.605 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.564 ' HA ' HG21 ' A' ' 47' ' ' VAL . 91.7 mt -93.67 47.14 1.21 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.175 0.512 . . . . 0.0 111.246 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.442 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 6.8 mm-40 -138.81 10.77 2.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.98 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.819 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.4 pt -94.08 156.67 38.84 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.06 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.503 ' O ' HD12 ' A' ' 49' ' ' ILE . 77.8 Cg_exo -50.6 -29.15 24.21 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.774 2.316 . . . . 0.0 113.064 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.819 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.4 -36.65 82.97 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.656 HG23 HG13 ' A' ' 44' ' ' ILE . 2.5 t -63.09 -57.19 22.17 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.72 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.653 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.3 Cg_exo -59.64 -36.1 93.2 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.776 1.651 . . . . 0.0 111.284 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -66.04 -36.31 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.034 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.595 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.5 tp -72.96 -52.19 15.47 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -55.19 -23.03 19.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.892 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.3 t -84.27 -44.17 14.12 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.364 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.576 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.57 -25.39 67.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.21 0.529 . . . . 0.0 109.613 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -52.91 -51.18 39.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.171 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -74.31 -10.6 59.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.662 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.1 mtpp -93.88 -18.94 21.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.186 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.623 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 56.7 m-85 -135.38 61.99 47.64 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.55 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.94 -41.69 62.19 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.687 2.258 . . . . 0.0 111.653 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.12 96.51 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.59 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.623 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.8 t -65.76 144.87 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.638 ' HB2' HG21 ' A' ' 31' ' ' THR . 48.2 t -82.4 97.49 8.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.167 0.508 . . . . 0.0 110.81 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.499 ' HB3' HG22 ' A' ' 54' ' ' VAL . 4.8 p90 -65.21 126.5 28.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.105 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.507 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.98 161.59 28.29 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.139 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -157.92 140.33 5.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.831 0.348 . . . . 0.0 110.082 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.3 t -141.03 155.22 46.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.499 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 39' ' ' PHE . 77.1 p -141.31 -7.19 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.753 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.63 143.57 56.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.709 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 m -62.71 -50.82 69.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.26 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -48.19 -48.56 34.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.687 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HA ' HG22 ' A' ' 21' ' ' VAL . 84.2 t -68.1 -53.4 29.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.82 0.343 . . . . 0.0 110.986 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.481 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -57.78 -14.76 6.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.43 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.9 m -91.24 -42.85 10.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.417 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -59.37 -43.65 92.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.644 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -87.61 12.98 11.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.803 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 54.45 26.9 7.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.536 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.699 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.6 mm -61.08 123.33 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.842 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.6 p -143.57 60.43 1.39 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.935 0.398 . . . . 0.0 111.448 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.82 44.14 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.512 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.594 ' HB2' HG21 ' A' ' 99' ' ' ILE . 12.1 m120 52.54 43.19 31.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.269 0.557 . . . . 0.0 110.337 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.699 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.1 m -69.01 153.09 44.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.701 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.604 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.4 mt -119.58 117.68 54.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.792 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.506 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.8 m -106.93 134.12 50.55 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.662 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -110.13 105.03 13.97 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.138 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.9 t80 -98.53 122.07 41.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 6.1 mtm180 -104.45 82.12 1.88 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.71 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tp -24.47 -62.0 0.05 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.415 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.87 -63.49 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.97 2.33 55.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.082 0.468 . . . . 0.0 110.713 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.3 m120 53.48 25.28 4.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.667 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.549 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 14.2 mm-40 -68.94 158.09 35.36 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.81 0.338 . . . . 0.0 110.806 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -143.07 90.42 2.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.742 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.662 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -79.92 141.41 36.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.48 96.14 4.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.524 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -82.0 77.77 8.78 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.451 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.5 mt-10 -79.13 -165.25 0.73 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.525 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 13.8 t70 -50.9 -37.63 44.93 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.836 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -55.6 -14.74 2.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.044 0.449 . . . . 0.0 110.406 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -129.93 -14.0 4.03 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.356 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.594 HG21 ' HB2' ' A' ' 79' ' ' ASN . 21.4 mm -90.03 -23.0 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.899 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.56 -51.72 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.658 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 83.2 p -121.21 38.57 4.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.258 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.524 HD13 HD21 ' A' ' 94' ' ' LEU . 6.6 tp -59.41 142.78 14.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.529 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -137.24 150.29 47.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.647 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.89 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.87 -37.11 13.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 110.447 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -63.27 -47.96 80.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.374 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -59.08 -59.67 5.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.113 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.752 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -49.76 -55.31 14.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.094 0.474 . . . . 0.0 110.152 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.7 m -59.08 -28.72 66.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.781 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.474 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -72.11 -65.77 0.73 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.012 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -42.86 -43.79 4.22 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.03 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.437 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -63.23 -56.62 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.585 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -52.56 -20.97 3.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.201 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.474 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -86.15 -39.03 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.953 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.599 HD22 ' HG ' ' A' ' 92' ' ' LEU . 90.2 m-20 -121.03 29.59 7.28 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 111' ' ' ILE . 80.4 p -82.78 49.49 1.51 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.021 0.439 . . . . 0.0 110.246 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.526 HD12 HH12 ' A' ' 85' ' ' ARG . 72.6 mt . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.29 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.427 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.7 pt-20 . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.406 0.146 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 31.6 Cg_endo -64.73 142.48 76.84 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.666 2.244 . . . . 0.0 112.398 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.3 m -57.68 152.86 14.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.612 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -99.55 94.22 6.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.962 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.65 HD22 ' HA ' ' A' ' 24' ' ' ALA . 42.6 mt -90.37 72.92 7.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.366 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 76.4 p -70.06 -8.04 46.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.185 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 3.7 m-20 -138.55 147.45 43.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.153 0.502 . . . . 0.0 111.729 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.608 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.8 t -54.32 -49.5 90.16 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.861 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.59 -45.31 34.57 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.018 1.812 . . . . 0.0 112.059 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.96 -36.5 84.18 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.233 0.539 . . . . 0.0 110.295 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.65 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.53 -58.71 6.6 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.106 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 69.6 mtp -60.15 -27.57 67.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.18 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 25.0 mt-10 -71.25 -50.34 33.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.803 0.335 . . . . 0.0 110.671 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.53 ' O ' HG22 ' A' ' 31' ' ' THR . 7.2 m-85 -59.98 -32.63 71.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.042 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 36' ' ' ILE . 44.0 mt -74.84 -38.81 44.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.047 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.45 -19.61 61.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.158 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.53 25.96 4.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.379 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.656 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.0 t -170.09 151.14 3.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.387 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.515 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.7 tt0 -62.0 -72.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.774 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.525 HG13 HD11 ' A' ' 83' ' ' LEU . 20.7 t -100.78 138.12 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.812 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.16 128.41 20.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.675 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG21 HG12 ' A' ' 111' ' ' ILE . 47.6 t -116.69 128.74 73.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.701 178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.521 HD12 HD11 ' A' ' 28' ' ' ILE . 22.4 mt -134.09 135.9 54.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.615 -177.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.9 99.41 2.05 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.255 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.495 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.8 m-85 -84.77 92.73 8.3 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.575 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.0 m-85 -112.14 139.26 47.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.431 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.491 ' HG2' HD23 ' A' ' 71' ' ' LEU . 74.4 mt-30 -85.81 -8.0 58.38 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.6 t70 -149.96 123.28 8.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.656 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.551 ' HA ' HG21 ' A' ' 47' ' ' VAL . 98.7 mt -92.28 46.97 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.134 0.492 . . . . 0.0 111.321 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 40.7 mt-10 -137.75 9.18 2.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.981 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.81 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.7 pt -92.84 156.54 40.63 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.271 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.489 ' O ' HD12 ' A' ' 49' ' ' ILE . 83.2 Cg_exo -50.54 -28.93 23.19 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.836 2.358 . . . . 0.0 113.162 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.81 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.07 -38.65 89.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.642 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -61.53 -56.69 30.82 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.76 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -59.34 -37.9 87.81 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.746 1.631 . . . . 0.0 111.322 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.869 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.5 mt -64.42 -35.25 73.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.992 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.602 ' O ' HG23 ' A' ' 54' ' ' VAL . 46.8 tp -73.6 -52.77 12.29 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -54.21 -24.72 19.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.07 0.462 . . . . 0.0 109.795 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 t -82.85 -44.37 15.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.631 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.598 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.42 -25.95 67.54 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.244 0.545 . . . . 0.0 109.653 179.261 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 50' ' ' LEU . 56.3 t -52.15 -50.01 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.848 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -74.43 -12.62 60.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.816 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -91.93 -18.41 23.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.294 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.612 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 45.1 m-85 -135.92 62.47 46.89 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.496 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.07 -45.46 38.84 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.82 2.347 . . . . 0.0 111.61 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.07 -41.81 79.09 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.476 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.612 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.5 t -65.97 144.22 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.656 ' HB2' HG21 ' A' ' 31' ' ' THR . 37.6 t -82.41 98.03 8.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.916 0.389 . . . . 0.0 110.896 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.501 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 7.9 p90 -62.65 129.38 40.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.781 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.37 160.66 28.43 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.14 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.417 HD11 HG13 ' A' ' 47' ' ' VAL . 4.6 tt -159.38 141.7 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.8 t -145.19 151.71 38.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.104 0.478 . . . . 0.0 111.686 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 39' ' ' PHE . 81.1 p -135.59 -4.89 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.515 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.41 146.22 55.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.791 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.8 t -66.84 -52.12 47.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.474 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -49.71 -43.56 47.66 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.551 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.502 ' HA ' HG22 ' A' ' 21' ' ' VAL . 77.3 t -70.58 -54.07 19.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.91 0.386 . . . . 0.0 110.695 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.491 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -58.75 -14.67 9.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.357 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.4 m -92.29 -39.96 11.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.316 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -61.95 -39.29 91.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.398 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.411 ' HB2' HG12 ' A' ' 76' ' ' ILE . 41.2 m-85 -91.12 10.76 25.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.8 m120 57.53 25.0 10.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.502 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.668 HG23 ' HB ' ' A' ' 80' ' ' THR . 36.0 mm -60.52 121.44 8.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.055 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.2 p -141.86 59.16 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.36 45.27 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.666 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.615 ' HB2' HG21 ' A' ' 99' ' ' ILE . 15.3 m120 52.17 42.89 30.92 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.282 0.563 . . . . 0.0 110.557 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.668 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.1 m -69.28 152.6 44.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.681 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.565 HG12 ' HA2' ' A' ' 37' ' ' GLY . 68.2 mt -119.45 118.8 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.095 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.495 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 83.9 m -107.79 133.55 52.02 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.651 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -108.29 104.24 13.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.778 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.2 t80 -97.76 123.41 41.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.479 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.531 HH12 HD12 ' A' ' 116' ' ' LEU . 5.7 mtm180 -106.83 82.91 1.76 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.957 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 tp -26.01 -59.1 0.08 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.04 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.515 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.55 -70.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 O-C-N 123.413 0.446 . . . . 0.0 112.069 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -87.52 2.51 50.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.739 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 52.07 37.88 22.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.17 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.493 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 8.4 mm-40 -82.36 158.19 23.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.618 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -140.11 91.95 2.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.86 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.651 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -81.62 133.81 35.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.491 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.06 116.11 28.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.334 0.588 . . . . 0.0 112.317 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.553 HD21 HD13 ' A' ' 102' ' ' ILE . 3.7 tt -102.39 77.19 1.62 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -79.64 -164.84 0.7 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -176.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.518 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 21.2 t70 -50.52 -36.59 34.82 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.101 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -56.67 -14.51 3.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.151 0.501 . . . . 0.0 110.311 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -131.07 -13.93 3.49 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.593 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.615 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.7 mm -90.07 -30.97 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.774 0.321 . . . . 0.0 111.246 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -54.47 -41.58 69.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.511 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.1 m -126.82 38.64 4.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.569 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.553 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -64.31 142.44 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.608 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -136.55 149.47 48.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.321 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.869 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.41 -35.92 9.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.092 0.472 . . . . 0.0 110.416 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 98.8 m -62.7 -49.11 76.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.413 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -59.1 -58.28 9.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.411 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.746 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.67 -56.69 10.72 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.107 0.479 . . . . 0.0 110.027 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.6 m -58.06 -28.68 64.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.746 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.483 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.1 tmt_? -71.96 -65.58 0.75 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.062 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -43.05 -42.78 4.04 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.084 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.422 HG12 HG21 ' A' ' 35' ' ' VAL . 96.1 mt -64.46 -55.44 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.551 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.79 -17.21 3.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.232 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.483 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -90.77 -37.01 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.0 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.581 HD22 ' HG ' ' A' ' 92' ' ' LEU . 93.3 m-20 -124.47 29.95 6.16 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.6 p -81.95 47.07 1.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.074 0.464 . . . . 0.0 110.197 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.531 HD12 HH12 ' A' ' 85' ' ' ARG . 51.2 mt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.171 -0.919 . . . . 0.0 111.353 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.497 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 . . . . . 0 CA--C 1.532 0.254 0 CA-C-O 120.431 0.157 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 32.2 Cg_endo -65.51 144.91 81.0 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.653 2.236 . . . . 0.0 112.538 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.7 m -62.23 154.13 28.45 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.359 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -99.69 95.57 7.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.136 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 24' ' ' ALA . 44.7 mt -93.13 71.3 4.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.327 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.4 p -71.75 -0.07 10.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.289 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -141.37 147.62 38.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.939 0.4 . . . . 0.0 111.592 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 23.2 t -57.28 -49.73 92.2 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.499 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.0 Cg_endo -58.71 -42.5 52.97 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.975 1.784 . . . . 0.0 111.879 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.91 -34.91 78.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.195 0.521 . . . . 0.0 110.533 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.602 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -65.06 -57.01 9.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.184 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 61.0 mtm -62.87 -28.6 70.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.075 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 9.9 mt-10 -69.88 -47.77 61.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.718 0.294 . . . . 0.0 110.5 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.567 ' O ' HG22 ' A' ' 31' ' ' THR . 0.4 OUTLIER -60.08 -42.35 94.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.539 HD11 HD12 ' A' ' 36' ' ' ILE . 51.0 mt -65.36 -40.12 87.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.23 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.61 -15.52 61.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.786 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.45 24.86 6.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.13 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.629 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.5 t -171.69 155.02 3.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.515 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.53 ' HG3' HG13 ' A' ' 87' ' ' VAL . 20.7 tt0 -64.76 -79.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.876 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.519 HG13 HD11 ' A' ' 83' ' ' LEU . 17.0 t -93.5 135.14 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.411 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.96 125.51 20.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.026 0.441 . . . . 0.0 112.138 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.459 HG21 HG12 ' A' ' 111' ' ' ILE . 52.4 t -114.48 127.66 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.799 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.539 HD12 HD11 ' A' ' 28' ' ' ILE . 23.7 mt -133.18 137.2 53.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.401 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.54 98.61 1.88 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.455 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 6.1 m-85 -83.83 90.22 7.32 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.0 m-85 -109.32 139.09 44.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.377 -178.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.426 ' HG2' HD23 ' A' ' 71' ' ' LEU . 54.1 mt-30 -86.06 -8.57 57.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.485 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.4 t70 -149.84 121.7 8.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.623 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.567 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.3 mt -89.55 44.85 1.23 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.066 0.46 . . . . 0.0 111.35 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.408 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.7 mt-10 -135.94 10.52 3.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.028 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.1 pt -94.34 156.77 38.39 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.288 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.486 ' O ' HD12 ' A' ' 49' ' ' ILE . 73.4 Cg_exo -51.19 -28.58 26.21 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.794 2.33 . . . . 0.0 112.899 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.795 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -61.89 -38.89 90.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.315 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.678 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -60.97 -57.28 27.5 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.681 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.66 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -58.98 -40.27 72.88 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.767 1.644 . . . . 0.0 111.387 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.892 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -61.77 -35.77 69.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.007 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.596 ' O ' HG23 ' A' ' 54' ' ' VAL . 42.1 tp -73.52 -53.11 11.35 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 14.7 m-70 -53.58 -24.44 13.73 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.1 m -82.49 -46.18 13.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.621 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.585 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.7 -26.1 65.33 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 50' ' ' LEU . 58.7 t -53.08 -47.28 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.942 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -77.46 -10.5 59.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.647 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -94.1 -19.68 20.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.16 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.57 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 64.4 m-85 -136.44 62.66 44.57 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.525 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.26 -42.37 60.46 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.653 2.235 . . . . 0.0 111.624 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.72 -39.39 91.17 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.32 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.3 t -67.67 144.11 14.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.629 ' HB2' HG21 ' A' ' 31' ' ' THR . 33.7 t -81.89 98.8 8.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 111.015 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.493 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 8.3 p90 -64.88 128.64 36.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.905 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.74 160.87 28.44 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.987 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.43 HD11 HG13 ' A' ' 47' ' ' VAL . 4.8 tt -160.75 141.82 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.1 t -146.94 155.87 42.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.952 0.406 . . . . 0.0 111.769 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 39' ' ' PHE . 82.5 p -137.64 -8.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.681 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.77 141.8 56.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.669 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.4 m -64.68 -49.53 70.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.126 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -50.19 -44.48 53.02 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.411 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.486 ' HA ' HG22 ' A' ' 21' ' ' VAL . 77.2 t -70.53 -53.78 21.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.831 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.426 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.0 mp -58.38 -14.63 8.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.261 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.4 m -91.73 -40.63 11.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.205 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -61.87 -36.17 80.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.486 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.43 ' HB2' HG12 ' A' ' 76' ' ' ILE . 32.4 m-85 -94.16 10.67 32.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.73 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 57.51 23.66 9.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.64 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.665 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.2 mm -59.89 120.05 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.245 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.9 p -139.39 55.85 1.68 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.174 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.19 45.7 0.02 OUTLIER Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.634 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.624 ' HB2' HG21 ' A' ' 99' ' ' ILE . 21.8 m-80 51.28 43.27 29.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.252 0.549 . . . . 0.0 110.504 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.665 ' HB ' HG23 ' A' ' 76' ' ' ILE . 98.0 m -69.17 151.27 46.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.569 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.581 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.3 mt -117.45 118.95 60.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.223 -0.898 . . . . 0.0 108.821 178.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.513 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.4 m -107.26 133.23 52.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.654 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -109.41 103.38 12.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.966 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.9 t80 -96.34 120.88 37.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.56 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.504 HH12 HD12 ' A' ' 116' ' ' LEU . 5.2 mtm180 -104.06 80.63 1.75 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.808 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 8.6 tp -25.18 -58.2 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.028 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.53 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.84 -62.88 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.314 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -95.05 15.45 18.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.783 0.325 . . . . 0.0 111.301 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 44.7 27.94 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.104 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.495 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.4 mm-40 -75.98 156.78 33.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.834 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.412 ' HB3' HE21 ' A' ' 91' ' ' GLN . 0.8 OUTLIER -144.26 90.68 2.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.774 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.654 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -77.52 142.19 39.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.4 91.99 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.573 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -78.34 79.36 4.78 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -79.5 -165.49 0.8 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.8 t70 -50.37 -39.86 47.86 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.48 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.14 -15.12 1.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.167 0.508 . . . . 0.0 110.295 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -127.95 -13.79 5.11 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.461 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.624 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.4 mm -90.16 -33.45 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.543 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -50.11 -53.64 26.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 110.544 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.6 m -114.97 38.55 3.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.436 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.579 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.3 tp -62.0 142.88 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 111.448 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -137.96 149.57 46.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.848 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.892 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.92 -35.89 11.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.034 0.445 . . . . 0.0 110.36 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 95.6 m -62.97 -47.83 81.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.293 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -60.2 -60.29 4.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.126 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.738 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.06 -56.02 10.31 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.995 0.426 . . . . 0.0 110.131 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.0 m -58.23 -30.76 66.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.999 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.5 ' HD3' HD13 ' A' ' 113' ' ' ILE . 1.7 tmt_? -69.85 -66.02 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.052 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -42.86 -43.83 4.23 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.218 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.459 HG12 HG21 ' A' ' 35' ' ' VAL . 95.3 mt -62.92 -54.89 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -54.57 -18.68 4.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.267 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.5 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.79 -35.24 7.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.944 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.601 HD22 ' HG ' ' A' ' 92' ' ' LEU . 87.6 m-20 -126.03 30.91 5.55 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.2 p -83.44 38.32 0.61 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.995 0.426 . . . . 0.0 110.423 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.504 HD12 HH12 ' A' ' 85' ' ' ARG . 72.0 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.386 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.48 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.4 pt-20 . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 30.8 Cg_endo -64.26 145.77 89.2 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.536 2.158 . . . . 0.0 112.518 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.2 m -61.05 153.92 24.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.581 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -99.97 89.61 4.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.709 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 35.4 mt -87.72 76.8 8.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.56 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.0 p -74.6 -4.95 40.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.049 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -141.48 148.31 39.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.952 0.406 . . . . 0.0 111.821 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 12.6 t -54.63 -49.97 88.25 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.583 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.0 Cg_endo -57.81 -44.15 43.2 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.005 1.804 . . . . 0.0 112.127 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.98 -37.54 87.81 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.206 0.527 . . . . 0.0 110.263 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.69 -56.54 16.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.016 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.6 mtm -61.86 -26.76 68.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.056 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -71.72 -50.59 28.9 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.642 0.258 . . . . 0.0 110.602 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.539 ' O ' HG22 ' A' ' 31' ' ' THR . 11.4 m-85 -60.83 -32.17 71.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.105 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.527 HD11 HD12 ' A' ' 36' ' ' ILE . 53.4 mt -75.29 -39.06 41.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.03 0.443 . . . . 0.0 110.075 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.51 -18.46 61.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.143 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.1 25.39 4.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.261 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.628 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.0 t -169.57 154.24 5.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.689 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.545 ' HG3' HG13 ' A' ' 87' ' ' VAL . 18.9 tt0 -65.13 -72.58 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.878 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.524 HG13 HD11 ' A' ' 83' ' ' LEU . 15.7 t -99.45 137.13 27.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.672 0.272 . . . . 0.0 110.657 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.58 125.35 16.97 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.024 0.44 . . . . 0.0 112.019 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.467 HG22 ' HB2' ' A' ' 83' ' ' LEU . 56.0 t -114.88 129.64 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.902 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.527 HD12 HD11 ' A' ' 28' ' ' ILE . 21.6 mt -135.21 136.8 51.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.468 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.0 99.78 2.1 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.543 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 6.4 m-85 -85.4 93.93 8.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.4 m-85 -113.38 143.37 44.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -92.64 -1.16 57.1 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.52 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.3 t70 -156.89 115.53 3.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.479 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.592 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.2 mt -85.47 44.14 1.08 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.11 0.481 . . . . 0.0 111.233 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.425 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 17.5 mm-40 -135.29 12.74 3.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.46 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.797 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.8 pt -96.57 156.37 36.79 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.176 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.492 ' O ' HD12 ' A' ' 49' ' ' ILE . 87.6 Cg_exo -50.95 -27.24 20.41 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.837 2.358 . . . . 0.0 113.048 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.797 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.15 -37.12 86.31 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.672 HG23 HG13 ' A' ' 44' ' ' ILE . 2.7 t -62.13 -56.1 34.47 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.939 -0.305 . . . . 0.0 111.682 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.8 Cg_exo -59.79 -40.25 65.4 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.735 1.623 . . . . 0.0 111.461 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.869 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -61.83 -37.2 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.086 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.579 ' O ' HG23 ' A' ' 54' ' ' VAL . 37.6 tp -72.13 -53.19 13.5 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -54.92 -21.02 10.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.085 0.469 . . . . 0.0 109.815 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.7 t -85.38 -44.87 12.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.496 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.582 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.28 -26.55 67.85 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.5 t -51.89 -50.0 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.069 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -74.54 -13.41 60.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.685 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -91.13 -18.7 24.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.288 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.654 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 48.8 m-85 -135.4 62.06 47.84 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.436 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.18 -36.77 78.62 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.494 2.129 . . . . 0.0 111.493 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.44 -39.77 98.09 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.518 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.654 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.5 t -67.72 145.23 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.628 ' HB2' HG21 ' A' ' 31' ' ' THR . 36.9 t -82.7 96.28 8.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.099 0.476 . . . . 0.0 110.795 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.504 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.8 p90 -64.05 130.83 45.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.187 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.494 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -149.87 162.3 29.11 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.008 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.5 tt -160.47 147.1 5.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.9 t -153.11 157.55 40.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.17 0.509 . . . . 0.0 111.697 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.436 HG21 ' HG ' ' A' ' 42' ' ' LEU . 69.9 p -138.03 -3.39 1.8 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.444 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -63.95 143.36 57.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.679 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.0 p -66.22 -52.08 51.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.53 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -50.2 -43.46 52.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.592 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.477 HG22 ' HA ' ' A' ' 21' ' ' VAL . 60.4 t -70.53 -52.5 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.934 0.397 . . . . 0.0 110.563 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.96 -14.52 16.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.47 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.6 m -92.13 -41.53 10.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.204 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -60.1 -41.3 92.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.451 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.401 ' HB2' HG12 ' A' ' 76' ' ' ILE . 36.3 m-85 -89.02 11.98 16.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.81 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 55.95 28.81 13.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.483 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.68 HG23 ' HB ' ' A' ' 80' ' ' THR . 34.9 mm -65.5 118.65 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.079 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.7 p -139.75 51.96 1.72 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.193 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.87 44.42 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.567 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.643 ' HB2' HG21 ' A' ' 99' ' ' ILE . 39.2 m-20 51.42 42.29 29.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.364 0.602 . . . . 0.0 110.137 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.68 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.4 m -68.55 153.36 43.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.93 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.591 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.3 mt -119.93 118.06 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.867 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.2 m -106.75 132.8 52.31 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.624 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -110.42 104.72 13.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.039 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.0 t80 -97.54 123.94 41.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.447 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.533 HH12 HD12 ' A' ' 116' ' ' LEU . 4.8 mtm180 -106.12 81.08 1.58 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.708 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ARG . 8.9 tp -24.28 -59.86 0.05 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.113 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.545 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.8 -63.3 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -93.77 2.57 56.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.995 0.426 . . . . 0.0 111.077 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 54.12 30.7 12.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.718 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.9 mm-40 -78.32 164.07 25.17 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.706 0.288 . . . . 0.0 110.648 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.99 98.74 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.624 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -86.81 115.37 24.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.742 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -96.67 93.61 6.83 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.563 HD21 HD13 ' A' ' 102' ' ' ILE . 4.1 tt -78.67 78.92 5.11 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -80.51 -165.44 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.501 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.17 -50.35 11.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.675 -179.316 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -47.59 -16.5 0.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.941 0.4 . . . . 0.0 111.209 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 96' ' ' ASP . 19.3 m-20 -127.27 -13.73 5.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.467 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.643 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.2 mm -91.36 -40.73 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -50.35 -37.36 36.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.349 . . . . 0.0 111.076 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.2 p -127.11 38.58 4.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.48 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.563 HD13 HD21 ' A' ' 94' ' ' LEU . 7.5 tp -67.11 143.76 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.616 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -137.93 148.39 45.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.32 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.869 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.8 -36.48 7.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.026 0.441 . . . . 0.0 110.445 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.3 m -62.57 -49.4 75.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.413 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -58.2 -59.07 5.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.365 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.732 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.64 -55.67 15.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.015 0.436 . . . . 0.0 110.146 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 65.5 m -58.42 -28.76 65.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.763 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.556 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -72.12 -67.21 0.56 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.094 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -42.85 -40.23 2.82 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.34 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.416 HG12 HG21 ' A' ' 35' ' ' VAL . 96.6 mt -66.45 -54.97 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -53.96 -18.84 3.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.324 0.583 . . . . 0.0 110.285 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.556 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.5 mp -90.1 -38.6 11.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.899 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.493 ' OD1' HG22 ' A' ' 113' ' ' ILE . 28.2 m120 -118.36 28.13 8.53 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -82.39 47.63 1.18 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 110.08 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.533 HD12 HH12 ' A' ' 85' ' ' ARG . 52.1 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.252 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.472 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.9 pt-20 . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 120.543 0.211 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.511 ' HD3' HG21 ' A' ' 54' ' ' VAL . 47.4 Cg_endo -68.66 150.59 74.65 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.855 2.37 . . . . 0.0 112.592 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.423 HG21 ' CZ ' ' A' ' 27' ' ' PHE . 8.4 m -73.18 154.23 40.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.38 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -97.53 91.16 5.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.166 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.591 HD13 ' HA ' ' A' ' 24' ' ' ALA . 30.7 mt -85.02 73.14 10.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.237 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.9 p -68.85 -6.72 28.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.421 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -138.25 147.4 43.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.931 0.396 . . . . 0.0 111.937 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 33.2 t -54.0 -49.68 88.39 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.685 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.7 Cg_endo -58.05 -46.15 27.48 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.962 1.775 . . . . 0.0 112.131 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.55 -35.33 80.13 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.115 0.483 . . . . 0.0 110.409 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.591 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -64.17 -59.64 4.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.006 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.9 mtm -61.51 -24.91 66.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.025 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 17.8 mt-10 -71.68 -50.33 31.47 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.749 0.309 . . . . 0.0 110.169 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.511 ' O ' HG22 ' A' ' 31' ' ' THR . 6.3 m-85 -60.04 -33.24 71.76 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.569 HD11 HD12 ' A' ' 36' ' ' ILE . 50.0 mt -72.49 -38.98 61.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.038 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.22 -18.33 60.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.239 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.75 27.18 3.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.288 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.762 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.6 t -170.8 150.77 3.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.426 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.505 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.0 tt0 -62.67 -63.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.953 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.504 HG13 HD11 ' A' ' 83' ' ' LEU . 21.8 t -108.18 138.32 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.591 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.37 125.75 18.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.993 0.425 . . . . 0.0 111.991 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.442 HG21 HG12 ' A' ' 111' ' ' ILE . 51.4 t -114.38 129.79 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 28' ' ' ILE . 39.3 mt -135.45 138.12 48.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.56 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.07 96.84 1.5 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.478 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.463 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 37.1 m-85 -83.04 90.45 7.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.646 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 13.6 m-85 -108.51 142.04 39.52 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -87.93 -5.97 58.28 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.477 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.8 t70 -154.49 123.48 6.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.747 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.554 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.3 mt -91.22 46.33 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.13 0.49 . . . . 0.0 111.293 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 32.5 mt-10 -137.57 11.4 2.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.972 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.813 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.6 pt -95.61 156.42 37.46 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.158 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.475 ' O ' HD12 ' A' ' 49' ' ' ILE . 82.0 Cg_exo -50.18 -28.47 19.97 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.848 2.365 . . . . 0.0 113.145 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.813 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.03 -37.05 85.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.67 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.6 t -62.39 -56.31 31.69 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.67 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.7 Cg_exo -60.04 -37.25 85.92 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 121.923 1.749 . . . . 0.0 111.49 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.7 mt -65.65 -35.9 76.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.112 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 54' ' ' VAL . 45.9 tp -73.23 -50.46 22.28 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -54.95 -26.12 34.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.124 0.487 . . . . 0.0 109.78 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.3 t -81.13 -46.97 14.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.625 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.585 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.28 -26.53 65.03 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 50' ' ' LEU . 47.0 t -52.19 -48.15 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.225 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -77.06 -11.89 59.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 28.8 mtpp -92.17 -18.47 23.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.176 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.59 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 56.5 m-85 -136.13 62.45 45.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.439 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.43 -43.09 56.94 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.701 2.267 . . . . 0.0 111.842 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.79 -39.44 91.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.57 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.8 t -67.35 145.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.762 ' HB2' HG21 ' A' ' 31' ' ' THR . 23.9 t -83.04 97.7 8.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.104 0.478 . . . . 0.0 110.826 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.502 ' HB3' HG22 ' A' ' 54' ' ' VAL . 5.0 p90 -64.73 125.17 23.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.965 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -143.56 162.42 27.67 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.146 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -163.08 142.77 2.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.463 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 42.5 t -149.56 156.3 41.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.12 0.486 . . . . 0.0 111.711 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.52 HG21 ' HG ' ' A' ' 42' ' ' LEU . 75.8 p -136.55 -1.54 2.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.459 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -68.08 139.97 56.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.72 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.7 p -62.34 -48.95 77.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.461 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -49.44 -47.38 48.22 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.574 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.498 ' HA ' HG22 ' A' ' 21' ' ' VAL . 71.5 t -69.01 -53.96 22.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.985 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.86 -14.88 6.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.134 0.492 . . . . 0.0 110.225 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.5 m -90.49 -41.6 11.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.32 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -60.77 -37.87 83.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.475 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.431 ' HB2' HG12 ' A' ' 76' ' ' ILE . 60.0 m-85 -92.88 10.11 32.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.815 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 56.76 25.97 10.86 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.51 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.705 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.3 mm -61.31 123.88 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.353 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.1 p -143.08 60.01 1.41 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.174 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.15 44.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.733 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.646 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 24.0 m-80 51.87 43.99 29.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.23 0.538 . . . . 0.0 110.506 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.705 ' HB ' HG23 ' A' ' 76' ' ' ILE . 90.1 m -69.32 150.94 46.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.744 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.56 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.2 mt -117.23 115.81 49.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.202 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.427 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 71.0 m -104.04 133.16 49.45 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.663 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -108.87 101.3 10.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.028 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.9 t80 -95.32 121.26 36.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.555 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.455 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 4.3 mtm180 -104.56 84.12 2.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.752 0.311 . . . . 0.0 110.897 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tp -26.26 -59.02 0.08 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.505 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.39 -72.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 O-C-N 123.428 0.455 . . . . 0.0 112.009 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.85 3.6 40.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.152 0.501 . . . . 0.0 110.655 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.5 t30 52.72 31.94 11.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.344 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 16.7 mm-40 -75.11 158.78 32.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.582 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -140.48 90.77 2.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.663 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -77.52 142.92 38.81 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -124.39 108.86 12.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.167 0.508 . . . . 0.0 112.343 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.553 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -96.54 77.86 2.95 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.6 mt-10 -79.0 -165.21 0.71 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.528 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.3 t70 -51.17 -36.6 41.93 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.02 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.15 -14.77 2.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.061 0.458 . . . . 0.0 110.437 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -130.88 -14.17 3.55 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.639 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.588 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.0 mm -89.07 -29.49 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.705 0.288 . . . . 0.0 111.271 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -55.7 -47.94 75.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.659 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.9 t -118.81 36.06 4.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.514 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.553 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -62.2 142.76 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.513 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -137.87 149.07 45.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.57 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.1 -37.24 9.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.013 0.435 . . . . 0.0 110.441 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 98.9 m -62.87 -48.45 78.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.256 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.09 -57.85 11.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.29 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.779 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.96 -56.22 13.45 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.052 0.453 . . . . 0.0 110.275 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.8 m -58.15 -29.47 65.6 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.887 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.501 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.3 tmt_? -71.58 -64.68 0.88 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.331 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -43.03 -45.8 5.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.932 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.442 HG12 HG21 ' A' ' 35' ' ' VAL . 96.4 mt -61.2 -55.75 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.506 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -54.34 -18.07 3.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.39 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.501 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.25 -37.23 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.04 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.568 HD22 ' HG ' ' A' ' 92' ' ' LEU . 90.5 m-20 -124.81 30.35 5.95 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.5 p -83.13 48.98 1.45 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.049 0.452 . . . . 0.0 110.139 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.409 HD12 ' NH1' ' A' ' 85' ' ' ARG . 61.2 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.357 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.2 pt-20 . . . . . 0 CA--C 1.531 0.232 0 CA-C-O 120.511 0.196 . . . . 0.0 110.775 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 36.7 Cg_endo -67.22 143.8 66.13 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.512 2.142 . . . . 0.0 112.578 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 m -61.09 154.43 22.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.457 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -100.56 88.51 3.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.886 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 24' ' ' ALA . 59.8 mt -83.19 71.99 10.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.414 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.5 p -70.56 -1.51 11.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.377 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -143.27 147.03 34.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.986 0.422 . . . . 0.0 111.829 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.0 t -54.75 -49.17 93.04 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.561 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.57 -47.46 18.92 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.835 1.69 . . . . 0.0 111.84 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.29 -32.57 73.31 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.182 0.515 . . . . 0.0 110.174 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.611 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.85 -61.38 2.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.027 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.4 mmt -59.73 -25.04 64.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.302 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -73.1 -52.19 15.2 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.669 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.46 ' O ' HG22 ' A' ' 31' ' ' THR . 5.6 m-85 -58.74 -32.55 69.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.523 HD11 ' CD1' ' A' ' 36' ' ' ILE . 50.8 mt -74.76 -41.13 47.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.287 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.66 -15.27 62.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.14 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.85 26.81 4.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.132 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.674 HG21 ' HB2' ' A' ' 61' ' ' SER . 7.6 t -172.11 154.77 3.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.644 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HG2' HG22 ' A' ' 87' ' ' VAL . 10.9 tt0 -64.13 -76.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.842 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.551 HG13 HD11 ' A' ' 83' ' ' LEU . 16.9 t -96.6 136.1 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.59 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.68 125.67 19.77 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.472 HG21 HG12 ' A' ' 111' ' ' ILE . 52.6 t -115.32 131.67 66.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.755 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.523 ' CD1' HD11 ' A' ' 28' ' ' ILE . 20.6 mt -137.04 139.97 43.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.385 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.59 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.96 97.99 1.67 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.592 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.472 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 44.5 m-85 -84.6 93.12 8.31 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.613 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.1 m-85 -113.15 141.22 47.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.492 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 95.2 mt-30 -86.53 -8.84 57.21 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.494 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.0 t70 -149.82 123.17 9.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.813 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.554 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.5 mt -91.89 46.36 1.27 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.062 0.458 . . . . 0.0 111.326 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -135.18 9.62 3.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.848 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.723 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.0 pt -91.98 158.01 40.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.343 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' HD12 ' A' ' 49' ' ' ILE . 76.5 Cg_exo -53.24 -24.91 28.23 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.961 2.441 . . . . 0.0 113.015 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.723 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -66.1 -37.22 85.22 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.705 HG23 HG13 ' A' ' 44' ' ' ILE . 2.9 t -61.02 -55.2 46.86 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.616 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.658 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.2 Cg_exo -60.88 -42.41 37.92 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.035 1.824 . . . . 0.0 111.565 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.891 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -61.15 -35.28 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.251 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.61 ' O ' HG23 ' A' ' 54' ' ' VAL . 51.9 tp -74.15 -51.63 14.98 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -54.09 -26.75 28.68 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.9 m -80.84 -46.62 15.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.565 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.634 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.75 -25.28 64.74 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.195 0.521 . . . . 0.0 109.7 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 50' ' ' LEU . 49.5 t -53.12 -46.52 55.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.937 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -79.16 -9.16 59.49 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.808 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -94.61 -19.08 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.225 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.579 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 52.4 m-85 -136.95 63.02 43.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.419 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.68 -44.55 46.85 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.744 2.296 . . . . 0.0 111.71 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.33 -40.67 77.19 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.523 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.7 t -66.93 143.12 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.674 ' HB2' HG21 ' A' ' 31' ' ' THR . 22.1 t -80.92 96.31 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.403 . . . . 0.0 111.054 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.526 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.7 p90 -65.58 125.46 25.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.912 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -144.71 163.82 27.88 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.01 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 tt -161.81 144.11 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.452 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.9 t -150.1 157.38 43.06 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.041 0.448 . . . . 0.0 111.498 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.462 HG21 ' HG ' ' A' ' 42' ' ' LEU . 75.2 p -138.1 -2.99 1.81 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.644 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -64.06 142.2 58.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.631 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.2 t -65.29 -51.17 62.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.447 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -50.26 -41.97 51.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.5 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.508 ' HA ' HG22 ' A' ' 21' ' ' VAL . 65.4 t -71.91 -53.99 18.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 0.0 110.763 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp -59.07 -14.54 10.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.169 0.509 . . . . 0.0 110.21 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.9 m -92.49 -39.22 11.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.302 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -62.31 -40.95 98.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.445 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.433 ' HB2' HG12 ' A' ' 76' ' ' ILE . 90.5 m-85 -89.17 11.9 17.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.591 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 57.4 24.23 9.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.567 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.689 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.9 mm -61.0 119.9 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.9 p -138.23 52.66 1.83 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.421 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.95 48.15 0.01 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.799 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.624 ' HB2' HG21 ' A' ' 99' ' ' ILE . 12.6 m120 49.71 43.69 24.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.119 0.485 . . . . 0.0 110.477 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.689 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.5 m -69.55 153.3 43.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.838 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.59 HG12 ' HA2' ' A' ' 37' ' ' GLY . 56.0 mt -118.83 119.41 60.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.84 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.472 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 75.5 m -108.2 135.4 49.59 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.595 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -112.85 105.65 13.8 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.196 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.9 t80 -98.33 122.06 41.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.315 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.472 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 5.4 mtm180 -104.29 81.12 1.78 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.757 0.313 . . . . 0.0 110.894 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 85' ' ' ARG . 9.4 tp -25.18 -56.72 0.06 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.809 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.507 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.58 -68.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.991 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -91.16 13.63 16.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.057 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.6 p30 43.99 30.88 0.45 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.161 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 7.6 mm-40 -78.02 160.8 27.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.323 . . . . 0.0 110.674 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.81 95.14 2.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.974 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.595 HD23 ' HG ' ' A' ' 83' ' ' LEU . 1.8 mm? -83.02 143.2 30.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -123.82 93.68 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.548 HD21 HD13 ' A' ' 102' ' ' ILE . 4.9 tt -76.91 77.86 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.5 mt-10 -78.55 -165.7 0.75 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 19.0 t70 -51.2 -35.44 36.47 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.695 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.29 -17.4 4.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.237 0.541 . . . . 0.0 110.24 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -128.73 -13.87 4.65 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.668 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.624 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.4 mm -88.69 -32.08 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 120.593 0.235 . . . . 0.0 111.591 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.6 -36.23 64.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.103 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.6 m -132.41 38.56 3.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.465 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.548 HD13 HD21 ' A' ' 94' ' ' LEU . 7.0 tp -63.05 142.48 16.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.687 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -136.12 149.03 48.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.349 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.891 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.36 -37.54 11.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.982 0.42 . . . . 0.0 110.641 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.4 m -61.74 -47.17 86.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.363 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -59.95 -60.46 3.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.27 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.767 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.72 -56.04 9.72 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.03 0.443 . . . . 0.0 110.303 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.7 m -58.28 -30.97 67.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.914 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.501 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.7 tmt_? -69.95 -65.8 0.68 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.235 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -42.87 -45.02 4.77 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.164 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.472 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -61.55 -55.03 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -54.79 -18.62 4.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.395 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.501 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.88 -36.47 8.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.875 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.443 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.2 m120 -124.88 30.43 5.91 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.4 p -83.21 42.05 0.79 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.972 0.415 . . . . 0.0 110.286 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.461 HD12 ' NH1' ' A' ' 85' ' ' ARG . 81.5 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.382 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.0 pt-20 . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.546 0.212 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.0 Cg_endo -66.09 143.53 72.16 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.7 2.267 . . . . 0.0 112.504 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.0 m -58.38 149.49 24.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.65 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -97.34 85.76 3.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.627 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.621 HD22 ' HA ' ' A' ' 24' ' ' ALA . 39.0 mt -82.14 73.22 9.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.546 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.5 p -71.77 -2.06 16.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.339 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -141.5 147.35 37.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 111.696 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.598 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 58.6 t -55.37 -49.92 89.73 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.602 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.7 Cg_endo -57.85 -45.26 33.89 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.849 1.699 . . . . 0.0 112.066 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.54 78.4 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.132 0.491 . . . . 0.0 110.416 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.621 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.6 -59.24 4.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.98 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 60.4 mtp -60.99 -26.54 67.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.04 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 18.7 mt-10 -71.25 -49.27 44.91 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.657 0.265 . . . . 0.0 110.333 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.549 ' O ' HG22 ' A' ' 31' ' ' THR . 4.3 m-85 -60.34 -34.27 73.59 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.584 HD11 HD12 ' A' ' 36' ' ' ILE . 51.4 mt -72.96 -38.31 55.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.292 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.17 -17.9 60.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.09 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.86 27.27 4.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.287 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.62 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.3 t -169.49 152.37 4.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.453 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.598 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.5 tt0 -64.65 -64.97 0.74 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.912 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.527 HG13 HD11 ' A' ' 83' ' ' LEU . 21.8 t -108.33 137.4 40.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.491 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.87 126.99 21.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.945 0.403 . . . . 0.0 112.031 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.458 HG21 HG12 ' A' ' 111' ' ' ILE . 42.9 t -115.47 127.58 73.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.593 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.584 HD12 HD11 ' A' ' 28' ' ' ILE . 32.2 mt -134.15 138.78 49.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.572 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.568 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.49 98.42 1.69 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.562 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.446 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.0 m-85 -84.98 92.77 8.41 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.4 m-85 -111.56 147.48 35.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.541 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.552 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 23.9 mt-30 -94.51 -9.89 33.94 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.531 ' O ' HG12 ' A' ' 44' ' ' ILE . 37.5 t70 -147.17 117.41 7.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.397 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.572 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.3 mt -87.35 45.26 1.25 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.127 0.489 . . . . 0.0 111.506 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.1 mt-10 -136.13 10.88 3.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.114 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.806 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.5 pt -94.29 155.04 40.27 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.132 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.484 ' O ' HD12 ' A' ' 49' ' ' ILE . 88.2 Cg_exo -48.88 -28.51 13.32 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.936 2.424 . . . . 0.0 113.091 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.806 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.9 -37.9 88.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.677 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.9 t -61.38 -56.35 34.52 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.604 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.677 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.2 Cg_exo -60.86 -41.87 42.14 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.822 1.682 . . . . 0.0 111.416 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.884 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -60.4 -34.94 59.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.038 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.61 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.8 tp -73.92 -52.39 13.06 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -52.79 -27.1 16.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.065 0.46 . . . . 0.0 109.772 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.6 m -80.12 -46.84 15.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.722 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.575 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.11 -26.04 64.34 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.194 0.521 . . . . 0.0 109.639 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.2 t -52.83 -51.12 39.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.89 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -75.24 -10.42 59.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.75 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.2 mtpp -93.51 -18.25 22.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.253 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.607 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 55.3 m-85 -136.81 62.53 41.5 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.488 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.65 -41.14 70.82 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.592 2.195 . . . . 0.0 111.627 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.72 -39.44 93.59 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.321 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.607 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -69.12 144.25 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.62 ' HB2' HG21 ' A' ' 31' ' ' THR . 41.3 t -81.96 98.29 8.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.985 0.421 . . . . 0.0 111.013 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.479 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.2 p90 -63.53 128.92 37.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.854 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.509 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.15 161.36 28.46 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.261 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.9 tt -162.6 145.12 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.446 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.0 t -152.46 157.72 41.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.195 0.522 . . . . 0.0 111.787 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.457 HG21 ' HG ' ' A' ' 42' ' ' LEU . 67.5 p -138.03 -3.39 1.8 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.626 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.4 139.73 58.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.415 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.4 m -63.69 -49.09 74.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.54 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -50.57 -41.14 53.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.489 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.582 ' HA ' HG22 ' A' ' 21' ' ' VAL . 56.6 t -73.49 -54.98 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 110.685 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.417 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.0 mp -57.66 -14.52 5.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.367 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 83.2 m -92.44 -42.33 9.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.286 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -60.53 -34.76 74.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.59 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.437 ' HB2' HG12 ' A' ' 76' ' ' ILE . 96.7 m-85 -95.88 10.17 38.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.693 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.0 m120 56.63 27.43 12.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.755 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.711 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.6 mm -63.87 122.23 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.867 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.5 p -141.72 54.77 1.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.911 0.386 . . . . 0.0 111.322 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.49 44.03 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.753 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.593 ' HB2' HG21 ' A' ' 99' ' ' ILE . 12.4 m120 51.79 41.97 29.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.338 0.589 . . . . 0.0 110.251 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.711 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.8 m -67.64 151.55 47.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.703 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.568 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.3 mt -118.28 116.22 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.869 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 73.0 m -104.14 129.94 51.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.644 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.2 tp -107.01 100.34 9.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.507 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.6 t80 -94.67 122.81 37.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.532 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.7 mtm180 -107.13 92.78 4.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.363 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 tp -37.81 -53.52 1.28 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.009 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.598 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.59 -58.22 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -102.84 9.64 38.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.002 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 85' ' ' ARG . 16.0 t-20 47.2 34.44 3.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.423 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.532 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 15.8 mm-40 -77.48 159.46 29.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.403 HE21 ' HD1' ' A' ' 74' ' ' TYR . 1.3 tm0? -141.87 91.21 2.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.914 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.644 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.5 mm? -81.97 115.27 21.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.847 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -99.81 98.63 9.41 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.499 HD21 HD13 ' A' ' 102' ' ' ILE . 4.3 tt -83.77 77.63 9.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.461 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.3 mt-10 -77.87 -165.64 0.67 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.548 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 20.6 t70 -51.21 -37.89 49.28 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.117 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -55.55 -15.18 2.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.059 0.457 . . . . 0.0 110.437 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -128.38 -14.2 4.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.394 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.593 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.7 mm -90.18 -29.26 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.889 0.376 . . . . 0.0 111.321 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -56.13 -38.05 70.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 85.4 p -129.98 36.07 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.582 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.2 tp -62.05 141.98 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.597 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -136.89 150.34 48.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.533 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.884 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.74 -37.72 13.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.903 0.382 . . . . 0.0 110.584 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -62.73 -47.94 81.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.303 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -58.8 -60.27 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.199 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.765 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.13 -56.58 8.72 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.965 0.412 . . . . 0.0 110.191 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.7 m -58.07 -28.87 64.95 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.947 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.51 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.2 tmt_? -72.42 -67.0 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.077 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -42.37 -41.36 2.83 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.103 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 35' ' ' VAL . 96.6 mt -65.49 -55.68 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -53.27 -18.68 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.187 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.596 HG22 ' ND2' ' A' ' 114' ' ' ASN . 1.5 mp -89.99 -39.38 12.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.918 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.596 ' ND2' HG22 ' A' ' 113' ' ' ILE . 49.4 m-80 -116.39 26.77 9.66 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 78.7 p -81.56 52.59 1.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.174 0.511 . . . . 0.0 110.216 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.447 HD12 HH12 ' A' ' 85' ' ' ARG . 70.8 mt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.032 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.483 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 . . . . . 0 CA--C 1.532 0.251 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 53.6 Cg_endo -69.46 136.34 33.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.365 2.044 . . . . 0.0 112.685 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.9 m -60.7 152.43 26.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.676 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -94.01 98.54 11.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.94 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.1 mt -93.05 70.71 4.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.265 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.9 p -70.54 -2.15 13.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.165 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -139.7 146.87 40.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.021 0.439 . . . . 0.0 111.64 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 43.4 t -56.82 -50.08 90.1 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.396 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.41 -43.89 42.46 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.945 1.763 . . . . 0.0 111.878 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.28 -36.99 85.91 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.223 0.535 . . . . 0.0 110.305 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.602 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.84 -57.07 12.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.04 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 62.1 mtp -62.59 -26.74 68.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.117 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.32 -50.76 35.91 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.726 0.298 . . . . 0.0 110.464 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.478 ' O ' HG22 ' A' ' 31' ' ' THR . 12.2 m-85 -61.46 -32.54 72.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.513 HD11 HD12 ' A' ' 36' ' ' ILE . 47.7 mt -72.9 -36.86 52.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.836 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.7 -20.33 59.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.022 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.94 28.33 1.86 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.162 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.75 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.8 t -172.3 154.63 3.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.475 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.545 ' HG3' HG13 ' A' ' 87' ' ' VAL . 30.1 tt0 -68.0 -59.9 2.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.012 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.529 HG13 HD11 ' A' ' 83' ' ' LEU . 20.6 t -110.26 138.26 38.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.495 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.78 127.16 17.73 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.453 HG21 HG12 ' A' ' 111' ' ' ILE . 48.6 t -116.05 130.3 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.586 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.513 HD12 HD11 ' A' ' 28' ' ' ILE . 25.4 mt -135.94 137.59 48.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.456 -177.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.94 99.43 2.05 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.443 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 10.8 m-85 -85.67 93.99 8.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.4 m-85 -115.09 141.48 47.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.449 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 48.5 mt-30 -88.95 -2.24 58.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.465 ' O ' HG12 ' A' ' 44' ' ' ILE . 25.1 t70 -155.81 123.06 5.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.636 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.55 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.6 mt -92.62 46.15 1.23 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.136 0.493 . . . . 0.0 111.475 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.417 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 38.3 mt-10 -135.19 8.06 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.921 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.755 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.0 pt -90.82 155.51 45.32 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.186 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.506 ' O ' HD12 ' A' ' 49' ' ' ILE . 77.2 Cg_exo -50.75 -27.12 19.17 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.87 2.38 . . . . 0.0 112.942 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.755 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.6 -37.86 88.94 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.673 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -61.88 -56.0 36.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.773 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.5 Cg_exo -60.47 -37.01 84.08 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 121.9 1.733 . . . . 0.0 111.435 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.875 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -65.75 -35.43 75.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.941 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.4 tp -74.31 -51.85 13.98 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -55.86 -22.21 24.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.979 0.419 . . . . 0.0 109.922 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.6 t -85.59 -44.63 12.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.372 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.615 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.24 -26.03 67.47 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.226 0.536 . . . . 0.0 109.593 179.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 50' ' ' LEU . 44.9 t -51.61 -48.98 35.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.009 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -74.44 -14.84 60.9 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.566 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -90.35 -17.71 26.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.357 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.583 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 65.6 m-85 -137.14 61.82 35.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.699 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.47 -43.52 56.85 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.645 2.23 . . . . 0.0 111.611 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.58 -42.29 90.2 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.422 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.583 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.1 t -65.97 141.71 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.75 ' HB2' HG21 ' A' ' 31' ' ' THR . 41.2 t -78.37 97.71 5.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.081 0.467 . . . . 0.0 110.816 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.496 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.5 p90 -67.9 124.64 23.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.914 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.459 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -143.51 164.13 27.41 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.041 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.7 tt -161.2 142.14 3.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 t -147.23 153.35 39.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.161 0.505 . . . . 0.0 111.794 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.457 HG21 ' HG ' ' A' ' 42' ' ' LEU . 77.8 p -135.05 2.73 3.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.432 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.84 140.67 49.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.705 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.0 t -64.03 -49.97 70.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.531 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -50.76 -44.46 58.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.602 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.556 ' HA ' HG22 ' A' ' 21' ' ' VAL . 54.5 t -70.24 -52.1 33.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.891 0.377 . . . . 0.0 110.598 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.52 -15.08 15.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.253 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.1 m -90.93 -41.23 11.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.32 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -61.63 -37.84 85.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.389 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.41 ' HB2' HG12 ' A' ' 76' ' ' ILE . 45.3 m-85 -92.08 11.69 24.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.805 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 56.02 23.03 6.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.689 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.671 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.7 mm -57.94 117.28 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.83 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.1 p -136.51 56.4 1.81 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.387 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.28 46.32 0.02 OUTLIER Glycine 0 C--N 1.329 0.174 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.628 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.595 ' HB2' HG21 ' A' ' 99' ' ' ILE . 11.3 m120 51.43 43.62 29.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.162 0.506 . . . . 0.0 110.277 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.671 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.3 m -69.08 154.75 41.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.675 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.592 HG12 ' HA2' ' A' ' 37' ' ' GLY . 52.9 mt -120.65 117.55 53.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.817 178.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.513 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.2 m -106.7 135.9 47.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.674 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -112.85 101.64 9.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.064 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.6 t80 -95.05 125.18 39.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.772 0.32 . . . . 0.0 110.334 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.519 HH12 HD12 ' A' ' 116' ' ' LEU . 5.3 mtm180 -107.75 83.65 1.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.825 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 85' ' ' ARG . 9.0 tp -24.67 -59.15 0.06 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.789 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.545 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.85 -77.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 O-C-N 123.5 0.5 . . . . 0.0 112.127 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.55 4.32 21.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.636 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.2 m120 53.8 31.43 13.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.522 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.1 mm-40 -74.46 161.49 29.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -145.94 86.91 1.73 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.862 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.674 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -74.25 144.84 44.47 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -128.25 98.28 5.03 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.528 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -84.64 78.28 9.88 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.0 mt-10 -79.02 -165.61 0.78 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.518 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.8 t70 -50.23 -38.62 41.43 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.03 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -55.06 -14.9 1.74 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.119 0.485 . . . . 0.0 110.492 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -130.1 -13.94 3.96 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.664 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.595 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.5 mm -88.49 -31.86 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.636 0.255 . . . . 0.0 111.614 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -56.43 -35.29 67.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.952 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.5 m -130.31 39.77 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.558 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.528 HD13 HD21 ' A' ' 94' ' ' LEU . 7.2 tp -68.25 142.08 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.754 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -136.04 149.69 48.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.391 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.875 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.63 -35.87 10.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.127 0.489 . . . . 0.0 110.445 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.8 m -62.59 -48.61 78.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.42 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -59.4 -59.76 4.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.256 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.775 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.34 -55.48 12.72 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 110.301 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.5 m -58.92 -30.59 67.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.999 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.494 ' HD3' HD13 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -70.83 -66.25 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.138 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -43.15 -43.58 4.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.119 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.453 HG12 HG21 ' A' ' 35' ' ' VAL . 96.8 mt -63.8 -55.43 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -54.12 -17.59 2.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.129 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.494 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -90.69 -37.22 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.01 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.448 ' O ' HD21 ' A' ' 83' ' ' LEU . 14.9 m120 -122.63 29.96 6.67 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 98.7 p -83.26 40.55 0.72 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.091 0.472 . . . . 0.0 110.1 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.519 HD12 HH12 ' A' ' 85' ' ' ARG . 58.2 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.422 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.595 0.236 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 45.0 Cg_endo -69.7 148.15 64.8 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.773 2.315 . . . . 0.0 112.756 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 m -66.25 150.13 49.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.527 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -96.51 90.64 5.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.999 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 37.1 mt -86.12 71.49 10.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.567 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.8 p -70.68 -1.96 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.081 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -141.57 147.07 37.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.919 0.39 . . . . 0.0 111.7 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 59.3 t -55.79 -49.85 90.52 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.491 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.4 Cg_endo -57.55 -44.91 37.65 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.89 1.727 . . . . 0.0 111.937 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.84 -34.46 78.43 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.226 0.536 . . . . 0.0 110.353 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.46 -59.41 4.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.174 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.1 mtm -61.48 -26.96 68.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.049 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -70.77 -49.26 48.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.638 0.256 . . . . 0.0 110.51 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.465 ' O ' HG22 ' A' ' 31' ' ' THR . 6.2 m-85 -61.48 -32.88 72.91 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.49 HD11 ' CD1' ' A' ' 36' ' ' ILE . 42.8 mt -72.08 -37.99 61.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.828 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.76 -23.62 61.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.837 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.93 32.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.138 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.615 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.8 t -173.47 151.31 1.94 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.346 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.521 ' HG3' HG13 ' A' ' 87' ' ' VAL . 30.0 tt0 -68.31 -53.45 24.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.749 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.509 HG13 HD11 ' A' ' 83' ' ' LEU . 21.5 t -116.58 139.83 41.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.413 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.15 126.78 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.488 HG21 HG12 ' A' ' 111' ' ' ILE . 43.7 t -115.61 125.99 73.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.404 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.49 ' CD1' HD11 ' A' ' 28' ' ' ILE . 28.2 mt -131.39 136.26 57.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -177.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.597 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.08 98.33 1.88 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.267 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.5 m-85 -84.12 93.27 8.1 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -113.62 142.88 45.45 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.42 ' HG2' HD23 ' A' ' 71' ' ' LEU . 23.4 mt-30 -90.47 -9.25 48.08 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.514 ' O ' HG12 ' A' ' 44' ' ' ILE . 30.2 t70 -147.72 119.28 7.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.55 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.536 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.3 mt -88.9 45.49 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.096 0.474 . . . . 0.0 111.413 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.433 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.9 mt-10 -135.65 7.94 3.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.107 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.731 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.5 pt -89.87 157.03 46.69 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.158 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' HD12 ' A' ' 49' ' ' ILE . 74.0 Cg_exo -51.84 -25.98 22.86 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.792 2.328 . . . . 0.0 112.824 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.731 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.87 -39.04 92.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 44' ' ' ILE . 2.1 t -60.38 -55.12 48.26 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.608 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.4 Cg_exo -60.56 -42.0 43.56 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.879 1.719 . . . . 0.0 111.371 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.898 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -60.62 -35.45 63.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.046 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.605 ' O ' HG23 ' A' ' 54' ' ' VAL . 50.9 tp -73.81 -50.09 22.15 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -55.81 -25.27 40.71 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.8 m -81.56 -45.77 15.4 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.595 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.609 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.22 -25.82 67.32 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.114 0.483 . . . . 0.0 109.748 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 50' ' ' LEU . 42.8 t -52.16 -47.77 43.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.084 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -76.94 -14.29 59.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.668 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -90.8 -16.58 28.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.389 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.671 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 34.3 m-85 -136.99 61.42 34.52 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.606 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.39 -39.56 81.25 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.636 2.224 . . . . 0.0 111.592 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.98 -41.16 99.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.519 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.9 t -67.12 145.23 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.615 ' CB ' HG21 ' A' ' 31' ' ' THR . 46.6 t -82.31 96.56 7.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.984 0.421 . . . . 0.0 110.999 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.496 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 4.7 p90 -62.1 128.24 35.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.612 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.5 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.2 161.46 28.32 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.826 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.407 HD11 HG13 ' A' ' 47' ' ' VAL . 5.5 tt -164.02 140.73 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.2 t -144.45 159.33 42.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.227 0.537 . . . . 0.0 111.959 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 39' ' ' PHE . 76.2 p -141.18 -0.0 1.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.314 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -71.28 144.4 50.01 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.602 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.8 p -65.66 -50.96 63.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.392 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -49.96 -41.8 47.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.616 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.563 ' HA ' HG22 ' A' ' 21' ' ' VAL . 70.9 t -72.45 -54.08 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.841 0.353 . . . . 0.0 110.712 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.42 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.3 mp -59.0 -14.74 10.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.35 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.6 m -91.67 -42.0 10.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.258 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -60.52 -38.97 86.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.356 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.413 ' HB2' HG12 ' A' ' 76' ' ' ILE . 43.6 m-85 -91.15 9.61 30.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.763 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.8 m120 57.24 24.68 10.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.592 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.673 HG23 ' HB ' ' A' ' 80' ' ' THR . 42.0 mm -59.27 125.24 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.9 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.0 p -143.86 60.31 1.37 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.529 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.87 45.51 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.542 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.616 ' HB2' HG21 ' A' ' 99' ' ' ILE . 29.6 m-80 51.63 41.87 29.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.236 0.541 . . . . 0.0 110.385 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.673 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.2 m -67.65 152.22 45.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.747 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.597 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.1 mt -119.56 116.83 51.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.835 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.497 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 71.2 m -106.31 136.58 45.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.655 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -109.73 100.91 9.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.196 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.5 t80 -92.99 119.88 32.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.434 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.471 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.5 mtm180 -104.25 85.21 2.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.973 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 tp -26.97 -61.28 0.09 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.521 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.1 -76.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 O-C-N 123.525 0.516 . . . . 0.0 112.056 -179.42 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.48 3.12 25.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.098 0.475 . . . . 0.0 110.533 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.405 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 12.3 t30 52.65 31.84 10.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.299 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 19.6 mm-40 -75.28 165.96 24.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.533 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -149.68 87.55 1.5 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.655 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -72.04 147.22 47.04 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.85 105.72 8.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.292 0.568 . . . . 0.0 112.302 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.561 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -94.05 76.45 4.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.0 mt-10 -77.61 -165.88 0.68 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.492 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.63 -51.9 11.51 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.524 -179.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -47.28 -17.56 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.868 0.366 . . . . 0.0 111.301 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -124.39 -13.92 7.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.423 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.616 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.8 mm -91.48 -40.25 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -51.71 -30.38 22.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.821 0.343 . . . . 0.0 111.29 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m -134.67 39.98 2.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.079 0.466 . . . . 0.0 110.395 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.561 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -68.48 143.93 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.712 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.409 ' H ' ' HD3' ' A' ' 106' ' ' LYS . 23.7 m-20 -136.32 147.89 47.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.437 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.898 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.69 -38.69 10.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.017 0.437 . . . . 0.0 110.542 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 98.8 m -59.51 -49.32 78.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.323 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 103' ' ' ASP . 51.1 mtpt -57.87 -62.6 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.274 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.76 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -46.64 -57.53 4.71 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.945 0.403 . . . . 0.0 110.446 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.9 m -57.74 -29.88 65.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.931 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.509 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.0 tmt_? -71.4 -65.85 0.7 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.237 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -42.64 -43.61 3.9 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.993 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.488 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -63.25 -55.98 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.617 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -54.15 -18.36 3.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.362 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.509 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.91 -37.47 10.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.84 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.478 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.6 m120 -125.45 31.21 5.6 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 98.2 p -83.9 44.51 1.0 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.122 0.487 . . . . 0.0 110.074 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.443 HD12 HH12 ' A' ' 85' ' ' ARG . 65.4 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.352 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.2 pt-20 . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.358 0.123 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.484 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 36.3 Cg_endo -67.13 140.55 54.34 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.444 2.096 . . . . 0.0 112.494 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.0 m -54.8 152.03 7.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.748 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -98.98 87.11 3.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.079 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.618 HD22 ' HA ' ' A' ' 24' ' ' ALA . 45.8 mt -84.85 72.57 10.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.344 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.0 p -71.67 0.19 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.445 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -144.67 148.29 34.07 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.752 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 45.2 t -55.3 -49.57 91.62 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.528 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.28 -46.53 24.38 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.922 1.748 . . . . 0.0 111.9 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.88 -33.06 74.84 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.11 0.481 . . . . 0.0 110.324 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.618 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -65.83 -59.03 4.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.939 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.6 mtm -61.0 -25.39 66.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.054 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.4 mt-10 -72.97 -52.01 16.18 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.684 0.278 . . . . 0.0 110.499 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.502 ' O ' HG22 ' A' ' 31' ' ' THR . 4.0 m-85 -58.49 -33.78 70.19 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.558 HD11 HD12 ' A' ' 36' ' ' ILE . 57.9 mt -73.84 -40.76 53.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.261 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.98 -15.22 62.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.174 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.29 23.74 7.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.643 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.4 t -169.88 153.68 4.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.737 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.7 tt0 -63.35 -74.95 0.09 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.816 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.548 HG13 HD11 ' A' ' 83' ' ' LEU . 15.7 t -97.75 135.9 30.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.784 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.512 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.91 124.07 16.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.948 0.404 . . . . 0.0 111.904 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 111' ' ' ILE . 45.8 t -112.44 130.38 66.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.785 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 28' ' ' ILE . 29.1 mt -135.75 138.63 47.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.611 -177.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.551 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.03 98.13 1.77 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.543 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.476 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 35.9 m-85 -83.84 91.63 7.59 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.3 m-85 -111.75 141.08 45.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.3 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.429 ' HG2' HD23 ' A' ' 71' ' ' LEU . 88.2 mt-30 -86.08 -10.19 55.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 44' ' ' ILE . 9.8 t70 -148.53 129.35 14.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.561 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.501 ' HA ' HG21 ' A' ' 47' ' ' VAL . 90.1 mt -96.97 48.4 1.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.077 0.465 . . . . 0.0 111.475 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -137.9 7.29 2.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.771 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.713 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.7 pt -88.58 159.2 47.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.129 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.481 ' O ' HD12 ' A' ' 49' ' ' ILE . 54.4 Cg_exo -54.47 -24.91 37.86 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.864 2.376 . . . . 0.0 112.816 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.713 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.9 -39.01 90.22 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.702 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -59.34 -55.08 49.8 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.3 Cg_exo -60.37 -41.84 46.45 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.01 1.807 . . . . 0.0 111.505 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.892 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.5 mt -61.68 -34.42 62.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.103 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.614 ' O ' HG23 ' A' ' 54' ' ' VAL . 52.0 tp -75.09 -51.85 12.49 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -54.32 -24.92 21.15 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -82.08 -46.13 14.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.593 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.609 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.43 -25.52 66.03 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.9 t -52.39 -48.18 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.081 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -78.11 -9.96 59.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.83 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -93.9 -19.15 21.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.304 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.608 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 51.3 m-85 -135.83 62.91 49.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.56 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.82 -43.9 48.48 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.829 2.352 . . . . 0.0 111.644 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.08 -40.71 91.86 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.497 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.3 t -67.57 142.51 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.643 ' HB2' HG21 ' A' ' 31' ' ' THR . 32.2 t -81.44 97.68 7.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.055 0.455 . . . . 0.0 110.976 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.484 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.6 p90 -65.03 128.14 34.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.786 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.84 163.0 28.6 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.8 -0.715 . . . . 0.0 111.937 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 tt -161.68 144.26 3.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.476 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 40.7 t -148.52 156.33 42.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.131 0.491 . . . . 0.0 111.581 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.471 HG21 ' HG ' ' A' ' 42' ' ' LEU . 69.6 p -138.24 5.93 2.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.783 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -76.2 141.19 41.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.632 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.9 t -63.77 -50.35 69.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.396 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -49.68 -43.29 47.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.405 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.544 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.0 t -71.14 -54.16 18.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.841 0.353 . . . . 0.0 110.745 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.429 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -58.23 -14.82 7.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.118 0.485 . . . . 0.0 110.211 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.4 m -91.17 -40.55 11.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.161 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -61.75 -33.02 73.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.149 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.432 ' HB2' HG12 ' A' ' 76' ' ' ILE . 68.2 m-85 -97.35 9.15 43.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.959 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 58.88 22.78 10.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.506 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.709 HD12 ' HB ' ' A' ' 80' ' ' THR . 41.0 mm -59.13 125.61 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.266 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.6 p -144.44 58.69 1.33 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.29 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.57 43.94 0.02 OUTLIER Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.664 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.617 ' HB2' HG21 ' A' ' 99' ' ' ILE . 32.5 m-20 52.37 44.75 29.55 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.285 0.564 . . . . 0.0 110.435 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.709 ' HB ' HD12 ' A' ' 76' ' ' ILE . 89.8 m -69.96 152.31 44.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.913 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.551 HG12 ' HA2' ' A' ' 37' ' ' GLY . 59.5 mt -117.72 116.99 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-N 115.496 -0.775 . . . . 0.0 108.979 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.436 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 75.7 m -106.22 133.65 50.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.631 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -110.34 105.41 14.42 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.077 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.2 t80 -97.22 122.12 39.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.697 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.491 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.3 mtm180 -105.04 81.94 1.79 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 110.552 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.7 tp -25.71 -58.73 0.07 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.026 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.539 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -44.26 -57.25 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.59 13.52 33.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.592 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 43.8 28.81 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.301 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 15.9 mm-40 -77.79 156.98 30.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.745 0.307 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.417 HE22 ' HB3' ' A' ' 93' ' ' ASN . 1.1 tm0? -141.83 95.33 2.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.567 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.631 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -84.9 116.14 23.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.959 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.417 ' HB3' HE22 ' A' ' 91' ' ' GLN . 0.9 OUTLIER -98.18 108.89 21.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.094 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.586 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -95.01 77.62 3.55 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.436 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.4 mt-10 -78.72 -165.09 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.531 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 17.2 t70 -50.26 -39.9 46.4 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.249 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -53.91 -15.88 1.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.132 0.492 . . . . 0.0 110.229 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -128.96 -13.68 4.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.58 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.617 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.5 mm -91.01 -40.04 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -51.55 -33.82 33.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.935 0.398 . . . . 0.0 111.044 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.1 m -131.39 40.0 3.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.372 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.586 HD13 HD21 ' A' ' 94' ' ' LEU . 8.0 tp -68.89 144.91 13.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.658 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -138.59 146.95 42.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.257 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.892 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.09 -36.17 5.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.967 0.413 . . . . 0.0 110.694 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 100.0 m -62.24 -48.18 81.1 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.489 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -59.32 -61.29 2.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.055 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.752 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.91 -55.88 8.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.974 0.416 . . . . 0.0 110.332 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.9 m -58.44 -30.61 67.04 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.922 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.536 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.7 tmt_? -71.06 -66.08 0.66 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.245 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -42.98 -41.9 3.56 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.243 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.475 HG12 HG21 ' A' ' 35' ' ' VAL . 97.0 mt -65.11 -55.14 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -53.94 -18.85 3.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.14 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.536 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.75 -37.95 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.827 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.485 ' OD1' HG22 ' A' ' 113' ' ' ILE . 31.6 m120 -119.86 28.6 8.02 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.8 p -82.81 48.0 1.28 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.075 0.464 . . . . 0.0 110.484 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.43 HD12 ' NH1' ' A' ' 85' ' ' ARG . 78.1 mt . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.246 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.485 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.48 0.181 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 49.9 Cg_endo -70.37 144.91 52.15 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.664 2.243 . . . . 0.0 112.762 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.3 m -63.46 150.7 43.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.631 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -96.26 97.86 9.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.015 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 54.9 mt -92.93 70.91 4.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.318 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.8 p -71.74 -2.25 16.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.136 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -139.32 146.7 40.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.058 0.456 . . . . 0.0 111.509 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 13.1 t -56.43 -50.42 87.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.471 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.74 -45.28 34.19 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.831 1.688 . . . . 0.0 111.856 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.31 79.87 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.198 0.523 . . . . 0.0 110.309 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.07 -59.26 4.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.988 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.1 mtm -60.63 -25.39 66.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.202 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 26.3 mt-10 -73.38 -51.39 17.51 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.728 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.546 ' O ' HG22 ' A' ' 31' ' ' THR . 9.1 m-85 -60.04 -31.67 70.18 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.561 HD11 HD12 ' A' ' 36' ' ' ILE . 48.8 mt -75.21 -39.85 43.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.127 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.58 -18.14 61.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.266 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.33 24.97 5.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.31 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.631 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.2 t -168.44 152.75 6.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.677 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.533 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.5 tt0 -62.82 -77.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.895 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.561 HG13 HD11 ' A' ' 83' ' ' LEU . 19.5 t -95.73 135.27 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.397 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.565 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.76 125.77 21.23 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.457 HG22 ' HB2' ' A' ' 83' ' ' LEU . 49.3 t -115.41 129.73 71.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.789 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.561 HD12 HD11 ' A' ' 28' ' ' ILE . 23.0 mt -135.45 137.19 50.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.446 -177.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.77 96.91 1.63 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.294 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.508 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 19.5 m-85 -82.51 89.02 6.61 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -107.44 137.71 44.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.473 ' HG2' HD23 ' A' ' 71' ' ' LEU . 21.9 mt-30 -83.83 -5.0 59.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.432 ' O ' HG12 ' A' ' 44' ' ' ILE . 27.0 t70 -155.41 127.71 7.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.529 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.562 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.5 mt -95.34 46.91 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 111.68 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.425 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.8 mt-10 -135.85 5.08 3.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.612 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.809 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.2 pt -88.84 157.39 48.95 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.296 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' HD12 ' A' ' 49' ' ' ILE . 74.6 Cg_exo -52.8 -27.96 36.53 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.914 2.409 . . . . 0.0 112.958 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.809 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.27 -37.21 84.6 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.654 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.2 t -62.21 -56.94 26.4 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.525 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.654 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.8 Cg_exo -58.64 -40.9 69.34 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.758 1.639 . . . . 0.0 111.448 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.888 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.8 mt -61.37 -37.16 77.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.572 ' O ' HG23 ' A' ' 54' ' ' VAL . 37.9 tp -73.46 -53.82 9.74 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -53.1 -23.25 7.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.098 0.475 . . . . 0.0 110.081 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.2 m -83.92 -45.5 13.12 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.467 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.596 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.03 -25.2 65.13 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.8 t -52.33 -48.05 45.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.992 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -77.85 -11.17 59.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.797 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -93.08 -17.91 23.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.235 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.587 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 57.0 m-85 -137.57 62.53 36.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.558 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.63 -42.73 60.43 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.612 2.208 . . . . 0.0 111.708 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.76 -40.49 92.93 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.509 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.587 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.7 t -66.57 143.9 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.631 ' HB2' HG21 ' A' ' 31' ' ' THR . 30.5 t -81.42 97.12 7.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 0.0 110.994 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.472 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.8 p90 -64.82 127.13 30.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.965 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.481 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.09 162.84 28.39 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.029 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.415 HD11 HG13 ' A' ' 47' ' ' VAL . 4.6 tt -160.96 142.36 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.2 t -145.5 154.04 41.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.983 0.421 . . . . 0.0 111.691 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.452 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.4 p -137.52 -4.41 1.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.884 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.42 142.84 56.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.771 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.2 t -64.5 -50.58 66.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.511 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -49.02 -45.45 42.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.658 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 21' ' ' VAL . 77.8 t -70.59 -52.4 29.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.917 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.473 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -59.05 -14.85 10.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.122 0.487 . . . . 0.0 110.135 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.1 m -91.17 -41.38 11.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.394 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -60.97 -40.07 92.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.455 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.415 ' HB2' HG12 ' A' ' 76' ' ' ILE . 64.3 m-85 -90.24 11.82 20.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.576 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.6 m120 55.98 24.17 7.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.494 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.675 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.9 mm -60.83 120.08 5.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.4 p -138.68 52.37 1.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.419 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.27 46.49 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.64 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.605 ' HB2' HG21 ' A' ' 99' ' ' ILE . 28.3 m-80 50.77 42.01 27.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.177 0.513 . . . . 0.0 110.29 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.675 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.3 m -68.07 150.38 48.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.68 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.584 HG12 ' HA2' ' A' ' 37' ' ' GLY . 69.4 mt -116.79 116.94 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.984 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.508 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.4 m -106.64 132.14 52.98 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.652 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -109.08 105.37 14.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.979 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.5 t80 -98.62 121.07 40.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.498 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.532 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.1 mtm180 -102.85 80.71 1.91 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.711 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 6.1 tp -25.11 -58.46 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.533 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.35 -59.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.199 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -97.11 2.9 51.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.045 0.45 . . . . 0.0 110.82 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 52.77 32.58 12.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.817 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 13.0 mm-40 -77.93 156.99 29.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.663 0.268 . . . . 0.0 110.805 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 91' ' ' GLN . 1.1 tm0? -140.18 96.23 3.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.601 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.652 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -88.13 114.47 24.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.804 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -97.65 99.69 11.07 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.605 HD21 HD13 ' A' ' 102' ' ' ILE . 4.4 tt -84.24 77.45 9.97 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.2 mt-10 -78.11 -165.61 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -176.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.72 -49.9 14.25 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.548 -179.515 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -48.5 -15.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.929 0.395 . . . . 0.0 111.291 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 96' ' ' ASP . 22.1 m-20 -127.33 -13.9 5.45 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.498 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.605 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.9 mm -90.67 -37.24 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -49.04 -49.31 41.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.334 . . . . 0.0 111.127 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.0 m -118.0 35.6 4.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.778 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.605 HD13 HD21 ' A' ' 94' ' ' LEU . 8.1 tp -60.78 145.17 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.46 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -138.41 149.22 45.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.48 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.888 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.4 -36.22 14.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.035 0.445 . . . . 0.0 110.377 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.0 m -62.06 -49.62 75.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.286 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -58.18 -60.39 3.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.376 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.709 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -49.19 -55.99 10.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.964 0.411 . . . . 0.0 110.378 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.6 m -58.57 -28.87 65.94 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.726 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.527 ' NH1' HD11 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -72.25 -66.64 0.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.188 179.761 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -43.56 -41.99 4.81 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.065 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.407 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -64.72 -55.94 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.423 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 43.1 tt0 -52.95 -19.13 2.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.294 0.569 . . . . 0.0 110.265 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.527 HD11 ' NH1' ' A' ' 109' ' ' ARG . 1.4 mp -90.11 -38.56 11.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.062 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.486 ' OD1' HG22 ' A' ' 113' ' ' ILE . 28.9 m120 -117.72 27.12 9.23 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.2 p -81.32 50.12 1.39 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.083 0.468 . . . . 0.0 110.152 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.507 HD12 HH12 ' A' ' 85' ' ' ARG . 56.4 mt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.345 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.49 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 16.6 pt-20 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.521 0.201 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 38.1 Cg_endo -66.65 145.17 75.01 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.635 2.223 . . . . 0.0 112.564 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 17' ' ' TRP . 11.5 m -62.22 155.78 23.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.911 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.408 ' N ' HG22 ' A' ' 16' ' ' THR . 12.1 m-90 -99.53 86.94 3.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.719 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 24' ' ' ALA . 44.1 mt -83.04 73.83 10.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.047 0.451 . . . . 0.0 110.61 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.0 p -72.19 -0.82 12.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.356 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -143.0 148.26 36.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.917 0.389 . . . . 0.0 111.535 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.594 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 32.8 t -56.77 -50.52 87.52 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.434 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.61 -44.76 38.73 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.939 1.76 . . . . 0.0 111.832 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.33 -36.5 83.89 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.334 0.588 . . . . 0.0 110.183 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.609 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.91 -59.12 4.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.91 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.6 mtp -60.19 -24.98 65.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.095 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -72.57 -52.52 15.18 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.775 0.321 . . . . 0.0 110.558 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.479 ' O ' HG22 ' A' ' 31' ' ' THR . 13.0 m-85 -59.34 -31.41 69.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.519 HD11 HD12 ' A' ' 36' ' ' ILE . 55.3 mt -74.52 -39.37 47.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.175 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.29 -20.77 61.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.147 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.64 28.69 2.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.032 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.635 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.9 t -170.11 152.43 4.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.425 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.551 ' HG3' HG13 ' A' ' 87' ' ' VAL . 26.0 tt0 -66.76 -61.73 1.81 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.526 HG13 HD11 ' A' ' 83' ' ' LEU . 17.2 t -109.33 136.98 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.438 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.506 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.91 127.75 20.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.014 0.435 . . . . 0.0 112.116 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.435 ' C ' HG13 ' A' ' 36' ' ' ILE . 50.6 t -116.46 131.19 69.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.615 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.519 HD12 HD11 ' A' ' 28' ' ' ILE . 22.1 mt -136.45 135.34 49.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -177.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -97.32 98.03 2.06 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.539 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.524 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.9 m-85 -84.43 93.48 8.3 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.0 m-85 -114.3 142.14 46.69 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -89.97 -0.94 57.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' O ' HG12 ' A' ' 44' ' ' ILE . 37.8 t70 -156.26 122.47 5.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.707 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.52 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.1 mt -92.32 46.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.159 0.504 . . . . 0.0 111.293 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.435 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.5 mt-10 -136.91 7.5 2.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.005 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.779 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.7 pt -89.46 158.45 45.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.014 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.519 ' O ' HD12 ' A' ' 49' ' ' ILE . 66.1 Cg_exo -53.32 -26.23 33.97 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.781 2.321 . . . . 0.0 112.896 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.779 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.92 -37.64 88.32 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 44' ' ' ILE . 2.1 t -61.54 -55.66 40.63 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.616 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 36.6 Cg_exo -61.24 -37.82 70.72 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.067 1.845 . . . . 0.0 111.519 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.878 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.5 mt -65.24 -34.86 73.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.014 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.59 ' O ' HG23 ' A' ' 54' ' ' VAL . 45.4 tp -73.27 -52.34 14.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -52.81 -26.31 14.09 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -80.29 -47.59 14.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.7 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.566 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.8 -25.93 63.61 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.136 0.493 . . . . 0.0 109.684 179.6 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.2 t -53.23 -48.35 55.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.967 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.92 -10.06 59.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.635 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -94.1 -18.88 21.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.212 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.608 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 59.9 m-85 -136.82 62.84 43.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.526 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.8 -41.61 68.89 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.748 2.298 . . . . 0.0 111.369 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.61 -39.38 93.25 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.375 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.9 t -68.55 144.33 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.635 ' HB2' HG21 ' A' ' 31' ' ' THR . 39.5 t -81.88 98.07 8.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.075 0.464 . . . . 0.0 111.043 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.5 ' HB3' HG22 ' A' ' 54' ' ' VAL . 5.3 p90 -65.06 125.55 25.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.028 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.03 162.11 28.12 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.998 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.415 HD11 HG13 ' A' ' 47' ' ' VAL . 4.4 tt -161.19 145.49 4.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.0 t -151.02 158.08 43.68 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.173 0.511 . . . . 0.0 111.857 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.462 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.3 p -138.53 -0.61 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.375 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.06 143.85 56.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.779 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.6 t -67.49 -50.95 56.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.437 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 2.4 mp0 -50.77 -42.39 57.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.355 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HA ' HG22 ' A' ' 21' ' ' VAL . 63.6 t -70.91 -53.85 20.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 120.914 0.387 . . . . 0.0 110.731 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 mp -58.8 -15.42 12.24 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.425 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.0 m -90.4 -40.56 11.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.074 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -60.27 -40.13 89.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.386 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -92.56 14.57 16.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 54.0 25.83 5.82 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.638 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.693 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.6 mm -61.43 120.78 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.175 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.3 p -140.69 56.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.075 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.68 45.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.64 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 29.8 m-80 51.29 43.62 29.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.192 0.52 . . . . 0.0 110.539 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.693 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.8 m -70.21 152.79 43.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.544 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.582 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.8 mt -119.11 117.88 55.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.524 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 70.7 m -105.56 133.37 50.42 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.592 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.3 tp -109.89 104.77 13.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.905 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.0 t80 -98.4 124.21 42.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.459 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.516 HH12 HD12 ' A' ' 116' ' ' LEU . 4.9 mtm180 -106.32 83.29 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.85 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 tp -25.48 -59.4 0.07 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.024 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.551 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.75 -67.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 123.505 0.503 . . . . 0.0 112.305 -179.324 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.06 4.96 51.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.935 0.398 . . . . 0.0 111.012 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.8 m120 53.78 29.21 9.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.636 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.469 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.7 mm-40 -74.27 159.89 31.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.682 0.277 . . . . 0.0 110.882 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -146.1 95.18 2.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.867 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.629 ' HG ' HD22 ' A' ' 114' ' ' ASN . 2.0 mm? -84.35 135.73 34.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.414 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -114.07 96.01 5.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.628 HD21 HD13 ' A' ' 102' ' ' ILE . 4.1 tt -79.44 79.38 5.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.451 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.0 mt-10 -82.34 -162.89 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.653 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.587 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 5.1 m-20 -50.62 -39.39 50.17 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.091 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.43 -15.09 0.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.265 0.555 . . . . 0.0 110.112 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.423 ' N ' ' C ' ' A' ' 96' ' ' ASP . 42.9 m-20 -132.11 -13.45 3.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.566 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.587 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 27.7 mm -91.5 -39.41 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -47.52 -42.52 23.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.909 0.385 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.8 t -129.69 44.39 2.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.28 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.628 HD13 HD21 ' A' ' 94' ' ' LEU . 6.7 tp -67.1 144.37 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.584 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.414 ' N ' HG13 ' A' ' 102' ' ' ILE . 9.5 m-20 -136.98 149.04 47.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.35 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.878 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.88 -34.63 9.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.052 0.453 . . . . 0.0 110.408 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.2 m -63.88 -48.02 78.34 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.537 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -59.73 -57.41 13.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.308 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.723 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.7 -54.99 22.21 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.039 0.447 . . . . 0.0 110.064 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.0 m -59.5 -28.67 67.25 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.775 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.511 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -72.07 -67.06 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.142 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -43.05 -43.14 4.2 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.196 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.431 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -63.69 -54.64 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.81 -19.56 6.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.248 0.547 . . . . 0.0 110.301 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.511 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.41 -37.03 9.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.814 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.629 HD22 ' HG ' ' A' ' 92' ' ' LEU . 90.8 m-20 -122.84 29.86 6.66 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 83.6 p -82.95 47.36 1.21 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.14 0.495 . . . . 0.0 109.846 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.516 HD12 HH12 ' A' ' 85' ' ' ARG . 53.2 mt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.265 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.9 pt-20 . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.424 0.154 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.466 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 53.6 Cg_endo -70.18 141.14 42.78 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.569 2.179 . . . . 0.0 112.415 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 m -62.33 151.88 35.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.497 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.67 88.8 4.74 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.007 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.606 HD22 ' HA ' ' A' ' 24' ' ' ALA . 44.1 mt -80.73 71.79 7.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.372 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.7 p -69.65 -6.07 28.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.236 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -138.68 147.18 42.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.005 0.431 . . . . 0.0 111.764 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.613 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.2 t -54.66 -49.38 91.66 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.561 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.33 -47.31 22.8 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.985 1.79 . . . . 0.0 112.009 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.12 -34.4 77.54 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.24 0.543 . . . . 0.0 110.281 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.31 -59.48 4.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.207 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.8 mtm -60.67 -26.07 66.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.105 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -70.91 -51.0 28.78 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.771 0.32 . . . . 0.0 110.493 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.412 ' O ' HG22 ' A' ' 31' ' ' THR . 7.9 m-85 -60.64 -31.97 71.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.852 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.528 HD11 HD12 ' A' ' 36' ' ' ILE . 49.7 mt -73.96 -36.52 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.037 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.93 -20.94 59.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.815 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.19 30.98 1.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.579 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.8 t -169.72 151.48 4.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.388 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.644 ' HG3' HG13 ' A' ' 87' ' ' VAL . 31.2 tt0 -72.17 -40.76 67.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.632 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 83' ' ' LEU . 20.5 t -129.7 130.96 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.893 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -135.64 128.67 31.54 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 83' ' ' LEU . 41.2 t -116.5 128.03 73.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.532 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.528 HD12 HD11 ' A' ' 28' ' ' ILE . 26.2 mt -134.02 137.19 52.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.607 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.33 96.29 1.66 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.638 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.0 m-85 -82.68 89.24 6.72 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.0 m-85 -108.98 140.35 42.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -88.43 -1.91 58.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.6 t70 -156.85 124.04 5.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.621 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.7 mt -93.4 47.34 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.152 0.501 . . . . 0.0 111.408 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 37.0 mt-10 -137.07 6.88 2.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.841 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.832 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.4 pt -90.24 156.55 46.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.177 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.516 ' O ' HD12 ' A' ' 49' ' ' ILE . 71.2 Cg_exo -51.5 -26.14 21.15 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.858 2.372 . . . . 0.0 113.255 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.832 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.01 -35.72 82.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.626 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.3 t -64.12 -55.14 34.06 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.66 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.0 Cg_exo -60.93 -37.74 74.72 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.987 1.791 . . . . 0.0 111.321 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.88 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.6 mt -65.58 -36.45 77.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.921 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.626 ' O ' HG23 ' A' ' 54' ' ' VAL . 51.3 tp -71.98 -51.61 21.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -53.89 -24.53 16.38 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.9 t -82.66 -46.63 13.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.641 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.576 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.31 -25.44 64.16 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.403 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.2 t -52.92 -50.01 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.036 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -76.73 -9.53 58.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.76 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.3 mtpp -93.79 -19.28 21.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.121 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.621 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 59.5 m-85 -135.66 62.9 50.92 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.511 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.42 -40.42 71.27 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.724 2.283 . . . . 0.0 111.733 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.29 -41.51 98.39 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.539 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.4 t -65.56 147.06 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.579 ' CB ' HG21 ' A' ' 31' ' ' THR . 36.0 t -84.27 96.75 9.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.997 0.427 . . . . 0.0 110.839 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.466 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.2 p90 -65.24 121.83 15.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.216 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.458 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -141.37 163.32 26.8 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.118 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -161.68 143.3 3.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.5 t -146.97 157.81 43.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.139 0.495 . . . . 0.0 111.753 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.461 HG21 ' HG ' ' A' ' 42' ' ' LEU . 76.8 p -140.67 3.53 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.63 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -74.74 142.36 44.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.593 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.3 t -64.31 -49.05 73.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.45 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -50.66 -45.3 57.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.494 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.502 ' HA ' HG22 ' A' ' 21' ' ' VAL . 74.3 t -70.15 -53.21 24.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.86 0.362 . . . . 0.0 110.772 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.55 -15.04 9.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.25 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.4 m -91.72 -41.28 10.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.457 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -61.57 -36.23 80.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.579 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -94.2 9.76 36.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.947 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.0 t30 60.28 20.39 9.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.667 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.701 HG23 ' HB ' ' A' ' 80' ' ' THR . 36.7 mm -56.88 123.21 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.097 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.3 p -143.37 60.5 1.4 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.26 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.59 45.9 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.633 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 29.8 m-80 51.41 43.38 29.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.181 0.515 . . . . 0.0 110.403 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.701 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.7 m -69.55 150.63 46.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.716 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.607 HG12 ' HA2' ' A' ' 37' ' ' GLY . 57.3 mt -117.23 118.28 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.076 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.4 m -107.94 131.42 54.56 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.571 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.1 tp -107.54 103.47 12.8 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.622 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.3 t80 -97.73 119.27 36.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.872 0.368 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.511 HH12 HD12 ' A' ' 116' ' ' LEU . 4.3 mtm180 -101.44 98.41 8.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.028 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.0 tp -43.28 -52.38 5.77 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.907 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.644 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.59 -62.18 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.548 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.427 ' HB2' HH21 ' A' ' 85' ' ' ARG . 6.2 m-20 -99.3 9.5 43.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.426 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 85' ' ' ARG . 18.5 m120 50.26 32.75 6.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.747 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.491 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 11.7 mm-40 -78.23 162.98 26.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.718 0.294 . . . . 0.0 111.006 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.96 98.06 2.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.66 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.571 HD23 ' HG ' ' A' ' 83' ' ' LEU . 1.7 mm? -88.14 123.85 33.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.664 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -103.21 98.12 8.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 102' ' ' ILE . 4.7 tt -82.05 77.0 8.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.2 mt-10 -78.04 -165.53 0.67 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.5 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.5 OUTLIER -45.56 -52.43 10.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.279 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -46.01 -18.33 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.874 0.369 . . . . 0.0 111.198 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 96' ' ' ASP . 14.8 m-20 -124.78 -13.94 6.84 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.348 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.576 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.1 mm -90.72 -42.39 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -49.74 -33.41 16.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.9 t -129.58 37.81 3.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.492 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.541 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.0 tp -66.61 143.66 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.541 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -138.59 148.5 44.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.32 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.88 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.13 -36.75 8.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 110.349 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 100.0 m -62.43 -47.12 85.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.423 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -61.3 -58.44 8.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.4 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.773 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.83 -55.35 17.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.946 0.403 . . . . 0.0 110.169 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.5 m -58.71 -31.23 68.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.975 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.552 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.1 tmt_? -70.57 -66.28 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.267 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -43.29 -43.01 4.7 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.331 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.45 HG12 HG21 ' A' ' 35' ' ' VAL . 96.7 mt -63.1 -55.01 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -53.84 -22.26 9.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.374 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.552 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -85.27 -38.59 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.889 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.502 ' OD1' HG22 ' A' ' 113' ' ' ILE . 30.8 m120 -118.29 27.73 8.78 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.4 p -80.82 46.18 0.87 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.026 0.441 . . . . 0.0 110.278 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.511 HD12 HH12 ' A' ' 85' ' ' ARG . 48.4 mt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.138 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.5 pt-20 . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 120.389 0.138 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 31.5 Cg_endo -64.67 152.0 83.54 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.642 2.228 . . . . 0.0 112.778 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 17' ' ' TRP . 39.8 m -68.34 154.24 42.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.605 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.41 ' N ' HG22 ' A' ' 16' ' ' THR . 92.8 m95 -99.44 92.2 5.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.898 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.606 HD22 ' HA ' ' A' ' 24' ' ' ALA . 55.8 mt -91.41 70.98 6.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.702 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.2 p -72.6 -1.4 15.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.908 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -140.71 147.03 38.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 111.782 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.2 t -56.22 -50.21 88.79 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.567 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.1 Cg_endo -57.98 -45.29 33.17 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.924 1.75 . . . . 0.0 111.802 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.92 -34.11 77.23 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.25 0.547 . . . . 0.0 110.408 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.55 -58.8 5.37 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.947 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.6 mtp -60.14 -27.53 67.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.194 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 27.9 mt-10 -72.08 -51.04 23.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.707 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.498 ' O ' HG22 ' A' ' 31' ' ' THR . 6.0 m-85 -59.5 -32.76 70.58 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.544 HD11 HD12 ' A' ' 36' ' ' ILE . 42.4 mt -74.79 -38.85 45.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.97 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.52 -18.91 61.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.215 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.49 27.03 3.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.311 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.722 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.4 t -171.86 155.2 3.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.491 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.572 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.3 tt0 -64.79 -73.81 0.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.531 HG13 HD11 ' A' ' 83' ' ' LEU . 21.1 t -99.23 139.1 21.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.568 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.02 127.96 19.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 111' ' ' ILE . 49.9 t -116.68 129.23 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.59 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.544 HD12 HD11 ' A' ' 28' ' ' ILE . 20.7 mt -135.02 137.87 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.466 -177.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.11 97.17 1.63 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.593 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.479 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 42.0 m-85 -83.13 89.92 7.0 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -108.28 143.13 37.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.351 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -89.87 -6.6 55.65 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.507 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.6 t70 -151.62 119.81 6.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.584 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.493 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.9 mt -88.69 45.39 1.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.218 0.532 . . . . 0.0 111.127 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 10.2 mm-40 -136.33 12.04 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.248 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.823 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.1 pt -97.04 157.8 34.4 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.426 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.502 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 79.9 Cg_exo -51.11 -30.8 33.26 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.723 2.282 . . . . 0.0 112.886 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.823 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -59.59 -38.51 81.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.401 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.669 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.3 t -61.02 -58.02 22.18 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.569 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.669 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 35.8 Cg_exo -58.31 -40.25 77.23 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.784 1.656 . . . . 0.0 111.435 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.979 HG23 ' HA ' ' A' ' 104' ' ' ALA . 9.8 mt -61.7 -35.96 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 54' ' ' VAL . 46.3 tp -73.89 -53.58 9.85 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -54.34 -24.09 17.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.007 0.432 . . . . 0.0 109.915 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.5 t -83.22 -43.78 15.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.558 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.59 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.85 -25.66 67.66 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.3 t -53.1 -48.53 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.095 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -75.24 -11.65 60.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.58 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -93.44 -18.49 22.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.27 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.622 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 44.9 m-85 -135.99 63.08 49.61 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.643 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.94 -44.21 50.47 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.731 2.287 . . . . 0.0 111.654 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.6 -41.69 89.67 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.473 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 14.3 t -65.64 144.7 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.722 ' HB2' HG21 ' A' ' 31' ' ' THR . 36.2 t -82.06 96.26 7.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.02 0.438 . . . . 0.0 111.012 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.485 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.6 p90 -62.6 129.3 39.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.735 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.522 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -148.13 161.36 28.58 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.058 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.438 HD11 HG13 ' A' ' 47' ' ' VAL . 5.2 tt -160.84 143.06 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.479 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 32.4 t -150.46 158.25 43.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 111.793 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.46 HG21 ' HG ' ' A' ' 42' ' ' LEU . 82.7 p -138.69 -2.72 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.642 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.402 ' O ' HD13 ' A' ' 71' ' ' LEU . 16.6 t70 -62.64 143.12 57.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.662 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.0 m -67.29 -52.57 39.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.23 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 2.6 mp0 -49.83 -40.71 42.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.409 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.523 ' HA ' HG22 ' A' ' 21' ' ' VAL . 54.9 t -72.54 -55.08 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 67' ' ' ASP . 6.3 mp -57.98 -14.29 6.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.248 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.3 m -92.41 -40.49 10.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.214 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -61.84 -35.04 77.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.224 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.43 ' HB2' HG12 ' A' ' 76' ' ' ILE . 86.9 m-85 -95.12 9.68 38.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.695 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t30 58.6 24.28 11.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.454 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.719 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.2 mm -61.28 124.19 15.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.3 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.1 p -143.68 59.49 1.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.195 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.78 44.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.706 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.632 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 26.3 m-80 52.31 44.63 29.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.188 0.518 . . . . 0.0 110.639 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.719 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.3 m -69.55 152.14 45.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.63 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.571 HG21 HD21 ' A' ' 107' ' ' LEU . 60.5 mt -118.46 115.58 48.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.07 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 77.4 m -103.4 133.25 48.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.663 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -108.71 101.54 10.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.853 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.2 t80 -95.31 121.86 37.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.568 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.478 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 4.6 mtm180 -106.6 82.04 1.67 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.908 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.422 ' HG ' ' N ' ' A' ' 87' ' ' VAL . 4.8 tp -25.46 -61.78 0.07 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.572 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.76 -54.84 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -103.84 3.97 34.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.92 0.391 . . . . 0.0 111.21 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 51.57 31.31 7.5 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.57 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 9.7 mm-40 -77.83 157.62 29.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.491 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.13 95.89 2.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.997 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.663 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -84.31 112.3 20.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.586 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.561 ' ND2' ' H ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -95.8 96.05 8.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.589 HD21 HD13 ' A' ' 102' ' ' ILE . 3.8 tt -81.73 78.93 8.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.5 mt-10 -79.8 -165.01 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.527 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.6 t70 -50.66 -37.41 40.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.988 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -55.25 -14.79 1.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.204 0.526 . . . . 0.0 110.428 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -130.74 -13.94 3.64 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.546 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.571 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 23.8 mm -89.5 -29.01 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.709 0.29 . . . . 0.0 111.413 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -52.93 -52.34 58.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.811 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.2 m -117.51 37.25 3.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.488 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.589 HD13 HD21 ' A' ' 94' ' ' LEU . 7.8 tp -61.36 147.56 10.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.596 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.449 ' HA ' ' CD1' ' A' ' 49' ' ' ILE . 4.3 t70 -140.83 161.08 38.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.621 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.979 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -58.95 -35.04 72.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.091 0.472 . . . . 0.0 110.17 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 94.0 m -65.34 -46.71 79.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.407 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -59.96 -57.15 14.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.983 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.78 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.81 -54.87 24.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.117 0.484 . . . . 0.0 110.109 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.7 m -59.18 -29.3 67.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.704 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.483 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.6 tmt_? -71.97 -66.21 0.67 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.213 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -42.86 -43.85 4.24 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.154 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.475 HG12 HG21 ' A' ' 35' ' ' VAL . 82.8 mt -63.06 -55.05 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.465 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -54.76 -17.93 4.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.14 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.483 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.96 -35.26 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.923 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.617 HD22 ' HG ' ' A' ' 92' ' ' LEU . 88.0 m-20 -125.44 30.31 5.81 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 95.5 p -84.03 51.49 2.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.066 0.46 . . . . 0.0 110.25 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.448 HD12 ' NH1' ' A' ' 85' ' ' ARG . 82.0 mt . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.421 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.504 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.0 pt-20 . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.402 0.144 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.1 Cg_endo -65.81 143.09 72.33 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.574 2.182 . . . . 0.0 112.672 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.5 m -63.53 153.22 36.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.676 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -96.97 93.0 6.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.012 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.603 HD13 ' HA ' ' A' ' 24' ' ' ALA . 39.4 mt -87.34 70.84 10.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.128 0.49 . . . . 0.0 110.234 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.4 p -69.9 -3.12 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.161 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -139.01 147.43 42.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.909 0.385 . . . . 0.0 111.65 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 42.1 t -56.43 -49.95 90.5 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.485 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.64 -46.0 29.87 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.974 1.783 . . . . 0.0 111.867 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.85 81.64 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.178 0.513 . . . . 0.0 110.112 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -62.54 -60.13 3.96 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.002 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 44.7 mtm -60.36 -25.82 66.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.278 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -70.92 -51.66 24.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.704 0.288 . . . . 0.0 110.418 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.407 ' O ' HG22 ' A' ' 31' ' ' THR . 13.9 m-85 -60.6 -30.79 70.04 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.526 HD11 HD12 ' A' ' 36' ' ' ILE . 53.2 mt -74.38 -37.52 45.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.023 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.93 -19.67 60.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.16 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.53 30.96 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.079 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.694 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.2 t -172.35 152.97 2.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.426 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.511 ' HG3' HG13 ' A' ' 87' ' ' VAL . 26.8 tt0 -68.88 -47.07 66.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.77 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.494 HG13 HD11 ' A' ' 83' ' ' LEU . 18.5 t -122.22 139.48 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.432 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.512 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -143.13 125.95 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.529 HG21 HG12 ' A' ' 111' ' ' ILE . 49.5 t -114.39 128.77 71.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.424 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 28' ' ' ILE . 29.2 mt -134.88 137.57 50.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.421 -177.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.23 96.41 1.6 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.587 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.449 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.7 m-85 -82.89 91.27 7.08 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.633 ' HB3' HD22 ' A' ' 79' ' ' ASN . 11.5 m-85 -111.03 144.35 40.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.453 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.525 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 45.8 mt-30 -92.98 -2.55 55.66 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.484 ' O ' HG12 ' A' ' 44' ' ' ILE . 28.6 t70 -155.97 117.13 3.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.582 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.484 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.2 mt -87.31 45.5 1.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.116 0.484 . . . . 0.0 111.604 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.403 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 38.6 mt-10 -134.59 10.76 3.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.037 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.688 HG13 HG23 ' A' ' 47' ' ' VAL . 7.2 pt -92.31 161.33 33.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.293 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.498 ' O ' HD12 ' A' ' 49' ' ' ILE . 50.1 Cg_exo -56.81 -26.52 66.97 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.739 2.293 . . . . 0.0 112.369 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.673 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.67 -37.78 88.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.482 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.688 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -61.23 -56.66 32.04 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.642 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.87 -38.61 78.4 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.864 1.709 . . . . 0.0 111.423 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.864 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.6 mt -64.12 -35.09 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.869 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 54' ' ' VAL . 49.7 tp -74.03 -52.47 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -55.53 -23.2 25.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.036 0.446 . . . . 0.0 109.853 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.6 t -83.78 -44.73 14.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.445 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.614 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.6 -25.77 67.55 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -52.79 -49.5 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.036 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -74.41 -11.67 60.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.7 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -93.38 -19.04 21.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.305 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.555 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 54.8 m-85 -137.16 61.99 36.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.399 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.73 -42.16 68.46 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.684 2.256 . . . . 0.0 111.615 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.86 -39.84 88.84 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.212 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.555 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.5 t -67.71 143.37 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.694 ' HB2' HG21 ' A' ' 31' ' ' THR . 47.1 t -80.14 98.37 7.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.022 0.439 . . . . 0.0 110.967 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.51 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.3 p90 -65.99 124.73 23.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.968 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.47 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -143.71 162.01 27.73 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.171 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -161.8 142.73 3.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.449 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 41.0 t -149.04 156.51 42.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.194 0.521 . . . . 0.0 111.809 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 68.2 p -137.15 3.05 2.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.481 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.413 ' O ' HD13 ' A' ' 71' ' ' LEU . 17.7 t70 -69.92 142.97 52.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.685 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.9 m -67.34 -50.92 58.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.351 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -51.11 -40.94 59.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.364 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.531 ' HA ' HG22 ' A' ' 21' ' ' VAL . 53.7 t -72.48 -54.68 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.358 . . . . 0.0 110.539 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -58.41 -14.64 8.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.099 0.476 . . . . 0.0 110.255 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.5 m -91.78 -40.35 11.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.239 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -62.08 -34.36 76.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.267 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.415 ' HB2' HG12 ' A' ' 76' ' ' ILE . 84.9 m-85 -96.63 10.88 37.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.72 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 56.01 26.65 10.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.867 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.716 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.1 mm -62.7 122.19 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.4 p -141.8 59.16 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 111.259 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.52 44.65 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.521 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.633 HD22 ' HB3' ' A' ' 39' ' ' PHE . 13.8 m120 51.48 44.18 29.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.141 0.496 . . . . 0.0 110.635 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.716 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.0 m -69.72 151.67 45.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.836 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.565 HG12 ' HA2' ' A' ' 37' ' ' GLY . 55.8 mt -117.6 116.74 52.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.813 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 74.8 m -104.28 132.79 50.14 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.643 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -109.63 101.98 10.85 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.866 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -96.38 122.78 39.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.538 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.479 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 4.0 mtm180 -106.31 86.37 2.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.857 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.1 tp -27.05 -60.54 0.09 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.511 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.91 -73.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 123.434 0.459 . . . . 0.0 112.149 -179.273 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -83.51 2.89 34.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.014 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.9 m120 53.75 30.07 10.6 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.42 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.479 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 8.0 mm-40 -74.46 159.25 32.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.805 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -144.16 93.31 2.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.823 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.643 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -80.91 141.83 34.16 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -122.85 92.81 3.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.643 HD21 HD13 ' A' ' 102' ' ' ILE . 4.0 tt -76.99 77.43 3.54 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.444 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.2 mt-10 -79.08 -164.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.508 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 23.7 t70 -51.66 -36.38 46.08 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.915 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.68 -14.65 3.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.282 0.563 . . . . 0.0 110.244 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -130.65 -13.83 3.7 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.694 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.578 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.1 mm -89.94 -30.0 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.727 0.298 . . . . 0.0 111.294 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -52.12 -48.52 64.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.746 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.9 t -123.78 42.08 3.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.414 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.643 HD13 HD21 ' A' ' 94' ' ' LEU . 7.9 tp -63.46 143.14 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.545 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -136.03 150.56 49.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.487 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.864 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.07 -33.85 12.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.034 0.445 . . . . 0.0 110.26 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.3 m -65.35 -47.31 76.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.438 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -60.05 -56.34 22.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.149 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.793 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -52.36 -57.14 10.72 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.959 0.409 . . . . 0.0 109.905 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 61.4 m -56.87 -28.91 62.42 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.869 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.474 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.7 tmt_? -71.04 -66.88 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.954 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -42.3 -41.17 2.7 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.156 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.529 HG12 HG21 ' A' ' 35' ' ' VAL . 76.8 mt -64.91 -55.77 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -54.24 -18.01 3.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.253 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.474 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.5 mp -92.56 -34.58 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.12 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.629 HD22 ' HG ' ' A' ' 92' ' ' LEU . 85.5 m-20 -128.31 32.69 4.83 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 93.8 p -85.17 41.84 0.9 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.164 0.507 . . . . 0.0 109.918 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 85' ' ' ARG . 49.9 mt . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.527 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 . . . . . 0 CA--C 1.531 0.245 0 CA-C-O 120.631 0.253 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.48 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.7 Cg_endo -68.23 155.38 69.58 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.768 2.312 . . . . 0.0 112.741 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.7 m -70.71 151.61 44.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.416 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -96.79 86.36 4.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.755 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.0 mt -83.34 71.52 10.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.619 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 76.8 p -69.21 -6.2 27.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.288 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -140.05 146.97 39.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.993 0.425 . . . . 0.0 111.791 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.615 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.5 t -54.34 -49.74 88.82 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.632 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.8 Cg_endo -56.58 -46.46 29.81 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.984 1.789 . . . . 0.0 112.082 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.23 -34.47 78.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.173 0.511 . . . . 0.0 110.288 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.61 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.88 -58.88 5.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.081 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 61.3 mtp -61.39 -27.16 68.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.189 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.5 mt-10 -70.64 -49.89 42.7 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.772 0.32 . . . . 0.0 110.386 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 31' ' ' THR . 5.9 m-85 -60.5 -33.14 72.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.846 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.527 HD11 ' CD1' ' A' ' 36' ' ' ILE . 46.0 mt -73.86 -37.66 48.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.127 178.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.66 -20.75 60.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.128 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.1 29.77 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.059 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.638 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.9 t -171.25 150.86 3.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.333 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.527 ' HG3' HG13 ' A' ' 87' ' ' VAL . 25.1 tt0 -64.58 -63.32 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.91 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.484 HG13 HD11 ' A' ' 83' ' ' LEU . 21.4 t -108.04 141.9 22.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.592 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -144.08 126.52 15.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.021 0.439 . . . . 0.0 112.109 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.468 HG21 HG12 ' A' ' 111' ' ' ILE . 47.8 t -115.47 127.53 73.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.622 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.527 ' CD1' HD11 ' A' ' 28' ' ' ILE . 26.7 mt -133.71 136.4 54.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.728 -177.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.498 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.71 97.69 1.82 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.347 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.443 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 38.8 m-85 -83.49 89.67 7.11 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -108.35 141.3 40.36 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.448 ' HG2' HD23 ' A' ' 71' ' ' LEU . 24.8 mt-30 -89.62 -2.69 58.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.522 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.9 t70 -155.37 117.51 4.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.581 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.512 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.3 mt -86.99 43.67 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.054 0.454 . . . . 0.0 111.343 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.1 mt-10 -134.61 13.14 3.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.121 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.825 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.0 pt -96.92 157.62 34.78 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.266 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.473 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 76.4 Cg_exo -51.6 -28.67 29.82 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.834 2.356 . . . . 0.0 112.888 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.825 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -61.95 -37.58 85.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.668 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.7 t -61.33 -56.77 30.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.606 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.668 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 39.5 Cg_exo -57.52 -42.4 61.37 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 121.742 1.628 . . . . 0.0 111.125 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.908 HG23 ' HA ' ' A' ' 104' ' ' ALA . 11.8 mt -60.0 -37.71 73.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.215 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.596 ' O ' HG23 ' A' ' 54' ' ' VAL . 47.2 tp -73.32 -51.71 16.53 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -54.8 -24.37 22.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.087 0.47 . . . . 0.0 109.858 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.3 m -83.84 -44.59 14.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.585 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.591 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.68 -25.91 66.72 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.372 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 50' ' ' LEU . 45.2 t -51.99 -47.0 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.898 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -78.89 -13.47 59.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.712 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -90.89 -17.09 27.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.308 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.61 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 44.0 m-85 -137.95 62.93 35.89 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.558 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.18 -44.4 49.21 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.703 2.269 . . . . 0.0 111.754 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.86 -37.16 76.46 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.515 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.61 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 17.2 t -70.18 143.6 14.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.638 ' HB2' HG21 ' A' ' 31' ' ' THR . 45.6 t -81.37 97.94 7.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 110.886 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.481 ' HB3' HG22 ' A' ' 54' ' ' VAL . 4.9 p90 -64.18 129.2 39.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.828 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.538 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.51 161.06 28.46 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.128 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -161.26 145.69 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.407 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 40.1 t -154.06 159.53 41.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.069 0.461 . . . . 0.0 111.727 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.481 HG21 ' HG ' ' A' ' 42' ' ' LEU . 58.3 p -138.84 -7.66 1.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.693 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.06 141.45 55.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.706 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.0 p -64.39 -50.11 68.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.38 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -49.81 -44.46 49.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.543 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.539 ' HA ' HG22 ' A' ' 21' ' ' VAL . 70.6 t -70.05 -54.61 18.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.956 0.408 . . . . 0.0 110.674 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.448 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.1 mp -58.38 -14.42 7.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.437 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.1 m -91.3 -42.01 10.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.339 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -60.26 -37.38 80.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.367 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.424 ' HB2' HG12 ' A' ' 76' ' ' ILE . 83.0 m-85 -93.72 12.49 25.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.979 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 55.64 26.77 9.63 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.674 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.692 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.0 mm -64.16 123.5 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.174 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.7 p -142.16 58.35 1.47 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.286 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.42 ' HA3' ' OD1' ' A' ' 96' ' ' ASP . . . 152.7 44.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.947 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 27.4 m-80 52.61 42.53 31.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.244 0.545 . . . . 0.0 110.492 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.692 ' HB ' HG23 ' A' ' 76' ' ' ILE . 90.1 m -68.83 151.34 46.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.43 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.542 HG21 HD21 ' A' ' 107' ' ' LEU . 62.2 mt -117.13 116.76 53.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.199 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.443 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 74.2 m -105.45 133.83 49.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.611 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.2 tp -109.59 103.39 12.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.971 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.4 t80 -96.47 124.44 40.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.693 0.283 . . . . 0.0 110.749 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.466 ' NH1' HD12 ' A' ' 116' ' ' LEU . 3.5 mtm180 -107.95 85.52 2.13 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.11 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 tp -27.13 -60.57 0.09 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.527 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -35.84 -68.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 123.574 0.546 . . . . 0.0 112.289 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -89.77 3.65 52.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.165 0.507 . . . . 0.0 110.715 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.4 t30 51.85 37.37 20.48 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.986 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 11.0 mm-40 -81.84 159.06 23.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.563 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -140.9 90.83 2.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.667 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.611 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.8 mm? -77.75 141.87 39.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.61 116.84 26.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.253 0.549 . . . . 0.0 112.023 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.626 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -104.32 77.94 1.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -80.61 -164.27 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.827 -177.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.621 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 7.2 m-20 -49.74 -41.1 43.05 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.294 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -52.17 -15.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.256 0.55 . . . . 0.0 110.143 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.417 ' N ' ' C ' ' A' ' 96' ' ' ASP . 36.2 m-20 -130.86 -13.38 3.64 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.321 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.621 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 26.8 mm -90.96 -42.13 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.488 ' HG3' ' HB3' ' A' ' 96' ' ' ASP . 43.4 mt-10 -48.49 -37.96 18.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.936 0.398 . . . . 0.0 111.055 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.5 p -130.43 45.16 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.375 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.626 HD13 HD21 ' A' ' 94' ' ' LEU . 8.6 tp -71.95 145.17 12.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.785 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -138.61 149.4 45.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.649 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.908 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.0 -36.47 12.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.018 0.437 . . . . 0.0 110.609 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.4 m -61.53 -48.61 80.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.202 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 102' ' ' ILE . 28.9 mtpp -59.05 -60.68 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.149 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.779 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.41 -55.93 9.53 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.953 0.406 . . . . 0.0 110.315 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.8 m -58.08 -30.38 66.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.787 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.502 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.2 tmt_? -71.03 -65.91 0.68 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.209 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -43.17 -44.06 4.93 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.921 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.468 HG12 HG21 ' A' ' 35' ' ' VAL . 96.4 mt -62.61 -56.41 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.445 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.86 -18.39 3.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.316 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.502 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.95 -37.25 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.925 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -123.64 29.01 6.72 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 98.2 p -83.04 51.6 1.98 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.217 0.532 . . . . 0.0 109.915 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.466 HD12 ' NH1' ' A' ' 85' ' ' ARG . 68.1 mt . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.397 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.474 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.779 0.323 . . . . 0.0 111.339 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 31.8 Cg_endo -66.0 152.79 80.44 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.967 2.444 . . . . 0.0 112.794 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.44 HG22 ' N ' ' A' ' 17' ' ' TRP . 18.8 m -69.36 157.16 37.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.825 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.44 ' N ' HG22 ' A' ' 16' ' ' THR . 8.4 m-90 -99.52 92.91 5.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.962 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.0 mt -91.62 72.69 5.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.359 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 p -71.24 -5.38 31.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.334 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -137.46 147.4 45.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.935 0.398 . . . . 0.0 111.72 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.598 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 48.9 t -56.05 -50.05 89.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.568 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.8 Cg_endo -57.91 -45.4 32.74 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.896 1.731 . . . . 0.0 112.027 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.52 -36.08 82.59 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.259 0.552 . . . . 0.0 110.439 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.608 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.82 -59.32 4.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.952 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.4 mtm -60.05 -25.45 65.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.076 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -72.12 -51.46 21.34 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.39 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 31' ' ' THR . 9.0 m-85 -59.75 -30.45 68.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.555 HD11 HD12 ' A' ' 36' ' ' ILE . 49.3 mt -75.78 -40.43 39.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.242 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.51 -21.47 61.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.243 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.76 27.32 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.292 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.677 HG21 ' HB2' ' A' ' 61' ' ' SER . 7.7 t -170.86 155.66 4.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.578 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.462 ' HG3' HG13 ' A' ' 87' ' ' VAL . 25.5 tt0 -68.08 -62.31 1.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.51 HG13 HD11 ' A' ' 83' ' ' LEU . 16.6 t -108.56 137.78 38.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.715 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.13 127.49 18.8 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.468 HG21 HG12 ' A' ' 111' ' ' ILE . 47.6 t -116.39 130.06 71.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.7 178.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.555 HD12 HD11 ' A' ' 28' ' ' ILE . 25.7 mt -136.11 136.91 49.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.597 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.76 99.51 2.08 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.476 -0.783 . . . . 0.0 112.586 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.519 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.6 m-85 -86.07 92.72 8.8 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -112.29 142.01 45.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.47 ' HG2' HD23 ' A' ' 71' ' ' LEU . 46.6 mt-30 -90.61 -0.78 57.8 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 44' ' ' ILE . 30.1 t70 -156.51 121.17 4.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.453 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.535 ' HA ' HG21 ' A' ' 47' ' ' VAL . 96.8 mt -92.13 46.49 1.27 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.057 0.456 . . . . 0.0 111.554 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 39.9 mt-10 -136.24 7.21 3.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.952 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.797 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.0 pt -89.27 157.07 48.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.164 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.501 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.7 Cg_exo -51.72 -27.02 25.05 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.828 2.352 . . . . 0.0 113.034 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.797 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.75 -37.38 87.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.668 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -62.0 -55.96 36.16 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 121.044 -0.263 . . . . 0.0 111.707 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.644 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -60.12 -37.93 80.49 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.103 1.868 . . . . 0.0 111.486 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.88 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.7 mt -65.31 -35.82 76.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.18 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.585 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.4 tp -73.42 -50.45 21.69 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -54.52 -24.68 21.73 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -82.4 -46.68 13.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.798 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.581 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.15 -26.0 64.37 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 50' ' ' LEU . 48.6 t -52.72 -49.11 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.213 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -77.89 -9.01 58.85 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.571 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.3 mtpp -94.7 -18.92 20.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.235 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.606 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 54.3 m-85 -137.57 63.19 39.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.36 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.13 -41.32 72.91 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.713 2.275 . . . . 0.0 111.575 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.43 -42.72 95.91 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.283 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.3 t -64.87 142.94 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.677 ' HB2' HG21 ' A' ' 31' ' ' THR . 25.2 t -80.37 96.44 6.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.13 0.49 . . . . 0.0 110.943 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.52 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.1 p90 -65.97 125.87 26.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.912 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.55 163.03 28.26 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.983 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -160.02 141.9 4.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.7 t -145.36 158.87 43.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.117 0.484 . . . . 0.0 111.594 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 39' ' ' PHE . 69.0 p -141.37 -6.2 1.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.823 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.71 142.21 58.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.686 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.0 t -63.35 -48.45 77.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.665 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -49.7 -47.18 50.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.577 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.5 t -69.6 -52.66 30.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.779 0.323 . . . . 0.0 110.85 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.47 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.38 -14.71 8.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.084 0.469 . . . . 0.0 110.304 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.5 m -91.0 -42.48 10.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.396 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -60.21 -38.53 83.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.469 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -91.64 9.7 31.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 58.82 21.88 9.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.397 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.668 HD12 ' HB ' ' A' ' 80' ' ' THR . 36.0 mm -57.78 117.91 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.047 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.2 p -137.34 48.68 2.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.467 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 162.69 48.1 0.02 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.426 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 24.2 m-80 49.22 42.38 21.52 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.321 0.582 . . . . 0.0 110.313 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.668 ' HB ' HD12 ' A' ' 76' ' ' ILE . 92.8 m -68.15 152.41 45.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.687 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.597 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.3 mt -119.36 118.82 58.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.979 178.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.519 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 79.7 m -106.97 133.11 52.12 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.663 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -109.46 103.44 12.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.8 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.5 t80 -97.51 123.44 41.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.763 0.316 . . . . 0.0 110.713 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.463 ' NH1' HD12 ' A' ' 116' ' ' LEU . 4.1 mtm180 -106.62 84.2 1.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.741 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 85' ' ' ARG . 5.9 tp -24.96 -60.33 0.06 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.95 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.462 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.16 -73.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 O-C-N 123.488 0.493 . . . . 0.0 112.255 -179.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -84.13 0.85 46.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.988 0.423 . . . . 0.0 111.053 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.9 m120 54.0 36.68 25.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.566 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 13.2 mm-40 -82.78 158.14 22.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.736 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.4 96.49 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.632 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.663 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -85.15 114.17 22.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.817 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.72 100.41 11.79 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -85.24 76.96 10.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.413 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.2 mt-10 -77.49 -165.66 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.485 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.91 -51.63 12.88 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.383 -179.363 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -47.49 -17.35 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 96' ' ' ASP . 14.8 m-20 -124.79 -14.16 6.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.506 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.577 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.8 mm -90.11 -38.37 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -49.05 -46.15 43.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 110.942 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -118.96 39.29 3.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.617 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.54 HD13 HD21 ' A' ' 94' ' ' LEU . 7.8 tp -65.95 143.84 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 111.201 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -139.38 148.4 42.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.557 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.88 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.99 -37.8 9.71 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 110.372 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.6 m -61.62 -48.79 79.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.262 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -58.41 -60.75 3.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.279 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.744 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.41 -56.74 7.38 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.873 0.368 . . . . 0.0 110.208 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.2 m -57.75 -30.08 65.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.865 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.503 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -71.17 -65.68 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.196 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -43.05 -42.57 3.95 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.014 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.468 HG12 HG21 ' A' ' 35' ' ' VAL . 97.3 mt -63.5 -55.74 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -54.38 -18.55 4.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.32 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.503 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.63 -35.04 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.953 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.645 HD22 ' HG ' ' A' ' 92' ' ' LEU . 88.2 m-20 -126.4 30.98 5.47 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 91.6 p -83.89 42.34 0.85 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.017 0.437 . . . . 0.0 110.267 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.463 HD12 ' NH1' ' A' ' 85' ' ' ARG . 77.5 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.365 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.473 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.2 pt-20 . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 120.476 0.179 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.523 ' HD3' HG21 ' A' ' 54' ' ' VAL . 23.7 Cg_endo -63.71 147.76 92.45 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.552 2.168 . . . . 0.0 112.764 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 17' ' ' TRP . 19.9 m -61.4 155.12 22.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.581 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.406 ' N ' HG22 ' A' ' 16' ' ' THR . 9.1 m-90 -98.48 91.71 5.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.877 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 24' ' ' ALA . 43.3 mt -92.49 76.49 5.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.005 0.431 . . . . 0.0 110.471 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.8 p -74.71 -6.32 48.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.123 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -139.83 148.46 42.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.005 0.431 . . . . 0.0 111.743 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.61 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 19.6 t -54.43 -49.44 90.77 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.832 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.11 -47.31 23.36 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.087 1.858 . . . . 0.0 112.135 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.84 -35.64 80.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.217 0.532 . . . . 0.0 110.211 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.84 -59.6 4.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.105 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 59.0 mtm -60.8 -24.39 65.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.041 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -72.47 -52.22 16.78 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.704 0.288 . . . . 0.0 110.527 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.404 ' O ' HG22 ' A' ' 31' ' ' THR . 10.5 m-85 -59.69 -30.35 68.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 36' ' ' ILE . 50.0 mt -75.1 -39.01 43.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.18 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.96 -18.89 60.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.161 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.28 28.46 2.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.209 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.651 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.8 t -170.08 152.24 4.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.351 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.524 ' HG3' HG13 ' A' ' 87' ' ' VAL . 23.8 tt0 -68.32 -48.19 65.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.516 HG13 HD11 ' A' ' 83' ' ' LEU . 15.7 t -121.83 134.96 63.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.523 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.94 127.95 22.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 111.948 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.456 HG21 HG12 ' A' ' 111' ' ' ILE . 51.9 t -116.56 127.68 74.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.725 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.532 HD12 HD11 ' A' ' 28' ' ' ILE . 23.5 mt -133.24 137.13 53.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.69 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.53 99.75 2.05 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.405 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.6 m-85 -85.38 94.23 8.92 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.8 m-85 -113.89 141.63 47.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -89.35 -3.61 58.4 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.471 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.0 t70 -154.12 121.52 5.78 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.614 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.565 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.1 mt -90.9 47.28 1.4 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.081 0.467 . . . . 0.0 111.184 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 37.3 mt-10 -138.45 8.42 2.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.113 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.821 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.6 pt -91.68 156.45 42.88 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.256 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.481 ' O ' HD12 ' A' ' 49' ' ' ILE . 81.4 Cg_exo -50.74 -27.16 19.22 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.781 2.321 . . . . 0.0 113.112 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.821 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.28 -36.99 85.9 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.671 HG23 HG13 ' A' ' 44' ' ' ILE . 2.6 t -62.47 -55.4 39.82 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.703 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.2 Cg_exo -60.46 -38.63 72.39 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.985 1.79 . . . . 0.0 111.376 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.864 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.3 mt -64.93 -35.47 75.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.09 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.4 tp -73.17 -51.74 16.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 16.1 m80 -53.58 -26.7 22.73 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.154 0.502 . . . . 0.0 109.656 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.9 t -80.85 -47.1 14.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.709 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.58 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.05 -26.08 64.3 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.186 0.517 . . . . 0.0 109.608 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.1 t -53.4 -48.26 57.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.034 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -77.88 -8.52 58.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.671 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -95.25 -18.65 20.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.171 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.595 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 57.8 m-85 -136.66 63.22 45.85 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.484 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.37 -43.18 55.98 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.699 2.266 . . . . 0.0 111.465 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.0 -40.77 91.79 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.377 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.4 t -66.6 144.5 14.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.651 ' HB2' HG21 ' A' ' 31' ' ' THR . 33.0 t -83.08 96.28 8.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 110.865 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.475 ' HB3' HG22 ' A' ' 54' ' ' VAL . 7.4 p90 -63.07 130.8 46.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.937 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -149.71 161.33 28.8 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.023 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.4 tt -160.53 143.23 4.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.756 0.313 . . . . 0.0 110.207 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -146.41 160.15 42.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.215 0.531 . . . . 0.0 111.716 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.434 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.6 p -142.0 -1.95 1.2 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.562 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.03 144.78 52.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -64.9 -50.75 65.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.499 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -48.74 -46.94 41.69 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.588 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.455 ' HA ' HG22 ' A' ' 21' ' ' VAL . 75.1 t -68.84 -53.3 27.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.805 0.336 . . . . 0.0 110.88 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -58.61 -14.5 8.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.289 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.9 m -91.53 -40.56 11.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.19 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -60.91 -39.65 90.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.466 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.417 ' HB2' HG12 ' A' ' 76' ' ' ILE . 42.3 m-85 -92.24 11.62 25.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.809 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 55.34 28.57 11.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.221 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.646 HG23 ' HB ' ' A' ' 80' ' ' THR . 36.1 mm -62.44 119.2 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.076 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.5 p -140.13 58.27 1.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.17 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.31 44.56 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.433 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.583 ' HB2' HG21 ' A' ' 99' ' ' ILE . 26.1 m-80 51.65 43.36 29.91 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.183 0.516 . . . . 0.0 110.304 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.646 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.9 m -68.67 154.03 42.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.657 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.592 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.5 mt -120.94 118.81 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.034 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.509 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 81.6 m -107.6 134.62 50.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.658 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -110.69 104.68 13.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.989 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.2 t80 -98.81 122.6 42.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.788 0.328 . . . . 0.0 110.582 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.526 HH12 HD12 ' A' ' 116' ' ' LEU . 3.6 mtm180 -106.05 87.76 2.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.727 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.41 ' HB3' ' HA ' ' A' ' 32' ' ' GLU . 8.7 tp -26.93 -59.85 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.439 -0.8 . . . . 0.0 113.059 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.524 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -35.4 -80.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 O-C-N 123.542 0.526 . . . . 0.0 112.331 -179.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.436 ' HB2' HH21 ' A' ' 85' ' ' ARG . 2.7 m-20 -78.67 1.6 22.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.787 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 m120 55.91 33.25 21.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.421 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 19.7 mm-40 -77.11 159.69 29.6 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.833 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -144.17 91.61 2.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.757 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.658 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -77.63 143.52 38.17 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -124.92 96.93 5.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.536 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -83.44 79.17 9.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.9 mt-10 -80.61 -164.53 0.73 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.479 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.99 -49.69 15.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.604 -179.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -48.23 -16.6 0.1 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.773 0.321 . . . . 0.0 111.158 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -127.19 -13.94 5.52 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.556 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.583 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.2 mm -89.81 -33.15 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.729 0.299 . . . . 0.0 111.611 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -55.45 -42.03 73.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.968 0.413 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.4 m -122.53 35.16 4.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.697 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.536 HD13 HD21 ' A' ' 94' ' ' LEU . 7.0 tp -62.97 142.18 17.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.118 0.485 . . . . 0.0 111.496 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -137.45 148.3 46.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.437 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.864 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.02 -36.83 8.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.95 0.405 . . . . 0.0 110.513 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -62.68 -47.14 84.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.286 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.68 -61.47 2.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.11 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.82 -55.31 10.0 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.049 0.452 . . . . 0.0 110.201 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 63.5 m -58.88 -30.47 67.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.794 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.2 tmt_? -71.3 -66.35 0.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.045 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -42.01 -43.33 3.14 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.141 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.456 HG12 HG21 ' A' ' 35' ' ' VAL . 93.3 mt -63.57 -56.14 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.439 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 41.2 tt0 -53.01 -19.2 2.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.31 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.482 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.24 -38.88 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.902 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.62 HD22 ' HG ' ' A' ' 92' ' ' LEU . 88.7 m-20 -121.24 29.21 7.4 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 82.8 p -82.25 44.95 0.9 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.043 0.449 . . . . 0.0 110.039 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.526 HD12 HH12 ' A' ' 85' ' ' ARG . 55.3 mt . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.245 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 120.496 0.189 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.484 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 33.8 Cg_endo -65.5 139.96 61.1 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.532 2.155 . . . . 0.0 112.588 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 17' ' ' TRP . 20.4 m -55.26 155.09 5.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.872 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.401 ' N ' HG22 ' A' ' 16' ' ' THR . 76.1 m95 -100.29 90.58 4.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.866 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.606 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.5 mt -88.83 73.72 8.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.59 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.5 p -73.56 -0.35 14.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.239 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -143.8 147.73 34.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.98 0.419 . . . . 0.0 111.591 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 31.0 t -55.6 -50.18 88.4 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.573 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.6 Cg_endo -57.83 -44.75 37.87 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.054 1.836 . . . . 0.0 111.886 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.23 -35.63 81.45 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.15 0.5 . . . . 0.0 110.351 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.93 -59.09 4.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.98 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.3 mtm -60.4 -26.73 66.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.173 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 20.2 mt-10 -71.65 -50.31 31.81 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.687 0.279 . . . . 0.0 110.658 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.569 ' O ' HG22 ' A' ' 31' ' ' THR . 9.9 m-85 -60.33 -34.27 73.58 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.564 HD11 HD12 ' A' ' 36' ' ' ILE . 47.7 mt -72.97 -38.57 56.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.032 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.97 -17.3 61.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.971 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.84 25.64 5.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.174 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.605 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.8 t -170.3 152.63 4.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.622 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.595 ' HG3' HG13 ' A' ' 87' ' ' VAL . 15.6 tt0 -61.88 -80.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.595 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.534 HG13 HD11 ' A' ' 83' ' ' LEU . 20.1 t -94.39 136.68 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.619 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.65 126.25 20.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.053 0.454 . . . . 0.0 111.883 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.501 HG21 HG12 ' A' ' 111' ' ' ILE . 47.1 t -115.07 128.02 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.752 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.564 HD12 HD11 ' A' ' 28' ' ' ILE . 23.1 mt -134.65 137.53 51.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.428 -177.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.538 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.66 98.48 1.85 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.347 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.465 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 37.7 m-85 -83.4 90.82 7.23 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.614 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 13.4 m-85 -109.16 141.77 40.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.537 -178.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.493 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 28.4 mt-30 -88.77 -7.58 55.97 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.479 ' O ' HG12 ' A' ' 44' ' ' ILE . 27.7 t70 -151.22 121.79 7.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.641 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.549 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.0 mt -90.49 46.04 1.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.108 0.48 . . . . 0.0 111.393 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 40.0 mt-10 -136.7 11.07 3.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.041 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.817 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.7 pt -95.7 155.52 38.42 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.311 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.472 ' O ' HD12 ' A' ' 49' ' ' ILE . 84.7 Cg_exo -49.75 -28.59 17.91 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.833 2.355 . . . . 0.0 113.089 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.817 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.54 -37.24 85.33 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.664 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.5 t -62.58 -56.31 31.0 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.615 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.9 Cg_exo -59.4 -39.87 72.67 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.89 1.727 . . . . 0.0 111.187 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.927 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.5 mt -63.2 -36.07 74.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.064 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.623 ' O ' HG23 ' A' ' 54' ' ' VAL . 52.0 tp -71.97 -51.42 22.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -54.94 -25.72 31.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 p -80.99 -45.2 16.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.599 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.605 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.95 -25.9 67.87 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.4 t -53.2 -49.88 49.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.913 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -75.63 -9.18 58.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.716 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -95.26 -18.99 20.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.286 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.563 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 62.4 m-85 -136.1 62.3 44.81 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.566 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.0 -45.82 36.35 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.893 2.395 . . . . 0.0 111.742 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.5 -40.3 69.08 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.403 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.7 t -67.3 143.61 15.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.605 ' HB2' HG21 ' A' ' 31' ' ' THR . 39.8 t -81.8 96.55 7.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.948 0.404 . . . . 0.0 110.965 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.484 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.6 p90 -63.82 129.67 41.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.983 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -149.14 162.3 28.94 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.143 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 15' ' ' PRO . 4.7 tt -160.26 145.39 5.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.465 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 30.9 t -151.02 155.55 39.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.229 0.538 . . . . 0.0 111.787 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.476 HG21 ' HG ' ' A' ' 42' ' ' LEU . 66.8 p -135.95 -3.56 2.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.398 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.73 139.74 58.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.505 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.0 m -64.61 -51.95 60.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.258 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -49.53 -41.53 41.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.543 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.541 ' HA ' HG22 ' A' ' 21' ' ' VAL . 59.8 t -71.77 -55.32 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.731 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.27 -14.63 7.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.365 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 79.5 m -91.98 -40.9 10.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.312 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -61.63 -36.46 80.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.326 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.432 ' HB2' HG12 ' A' ' 76' ' ' ILE . 90.1 m-85 -93.87 12.07 27.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.793 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 57.47 22.96 8.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.716 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.709 HD12 ' HB ' ' A' ' 80' ' ' THR . 40.8 mm -60.64 122.3 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.104 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.2 p -141.99 58.58 1.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.205 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.77 44.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.741 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.631 ' HB2' HG21 ' A' ' 99' ' ' ILE . 13.4 m120 52.8 43.16 31.8 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.115 0.483 . . . . 0.0 110.739 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.709 ' HB ' HD12 ' A' ' 76' ' ' ILE . 94.8 m -68.77 151.03 47.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.65 -178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.591 HG21 HD21 ' A' ' 107' ' ' LEU . 67.2 mt -117.32 116.12 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.986 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 76.9 m -104.11 133.65 48.69 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.665 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -109.43 102.55 11.42 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.941 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.4 t80 -97.5 121.76 39.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.771 0.32 . . . . 0.0 110.762 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.516 HH12 HD12 ' A' ' 116' ' ' LEU . 3.0 mtm180 -105.76 91.75 3.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.123 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 tp -38.55 -50.69 1.59 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.611 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.595 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.36 -63.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.796 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.412 ' HB2' HH21 ' A' ' 85' ' ' ARG . 9.2 m-20 -96.52 8.54 43.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.04 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 m120 51.86 31.97 9.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.615 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 20.3 mm-40 -78.82 160.82 27.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.809 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.92 91.49 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.911 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.665 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -78.42 144.65 35.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.03 99.33 6.07 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.598 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -85.29 78.31 9.81 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.454 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.4 mt-10 -78.46 -165.6 0.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.564 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.7 t70 -51.7 -35.4 42.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.004 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -56.87 -14.92 3.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.248 0.547 . . . . 0.0 110.327 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -129.94 -14.01 4.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.481 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.631 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.3 mm -89.48 -32.58 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 120.781 0.324 . . . . 0.0 111.267 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -51.7 -45.19 63.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.2 p -124.56 37.09 4.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.573 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.598 HD13 HD21 ' A' ' 94' ' ' LEU . 7.6 tp -60.6 143.18 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.787 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -137.53 149.51 46.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.523 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.927 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.08 -38.33 11.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 110.593 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.2 m -61.74 -47.78 83.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.488 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -59.02 -59.62 5.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.273 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.727 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.97 -56.52 10.34 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.08 0.467 . . . . 0.0 110.23 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 55.1 m -57.59 -30.64 65.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.844 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.9 tmt_? -70.01 -65.73 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.073 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -42.5 -44.49 4.1 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.034 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.501 HG12 HG21 ' A' ' 35' ' ' VAL . 83.3 mt -61.83 -55.78 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.453 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -54.39 -18.1 3.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.512 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.475 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.48 -36.65 8.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.929 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.621 HD22 ' HG ' ' A' ' 92' ' ' LEU . 90.4 m-20 -125.88 31.47 5.47 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.5 p -83.33 40.55 0.72 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.036 0.446 . . . . 0.0 110.307 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.516 HD12 HH12 ' A' ' 85' ' ' ARG . 59.5 mt . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.266 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.3 pt-20 . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.571 0.224 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.516 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.5 Cg_endo -66.35 146.23 80.0 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.666 2.244 . . . . 0.0 112.463 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.9 m -61.35 153.61 26.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.792 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -100.34 92.57 5.24 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.754 179.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' ' 24' ' ' ALA . 47.3 mt -91.03 71.15 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.714 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.3 p -72.75 2.26 6.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.044 -179.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -143.75 146.61 33.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.841 0.353 . . . . 0.0 111.559 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 43.7 t -55.94 -50.2 88.61 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.577 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.1 Cg_endo -58.37 -45.85 28.25 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.873 1.716 . . . . 0.0 111.895 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.06 -34.32 77.34 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 110.29 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.642 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -65.42 -59.24 4.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.044 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.8 mtm -61.08 -24.2 66.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.021 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.5 mt-10 -73.91 -52.19 13.7 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.661 0.267 . . . . 0.0 110.544 179.592 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.497 ' O ' HG22 ' A' ' 31' ' ' THR . 8.2 m-85 -58.83 -31.7 68.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.558 HD11 HD12 ' A' ' 36' ' ' ILE . 49.0 mt -75.05 -40.64 45.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.938 178.074 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.16 -16.9 62.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.096 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.89 24.3 5.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.266 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.599 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.0 t -170.77 153.7 4.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.618 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.502 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.6 tt0 -63.51 -75.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.552 HG13 HD11 ' A' ' 83' ' ' LEU . 18.2 t -96.97 136.63 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.817 0.341 . . . . 0.0 110.701 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.96 124.25 16.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.79 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.489 HG11 HD11 ' A' ' 111' ' ' ILE . 51.6 t -112.49 128.87 68.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.796 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 28' ' ' ILE . 29.3 mt -134.2 137.33 52.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.554 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.62 97.22 1.68 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.199 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.473 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 41.9 m-85 -82.9 90.83 7.01 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.5 m-85 -109.91 140.63 43.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.41 -178.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.48 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 47.8 mt-30 -87.45 -9.3 55.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.459 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 17.7 t70 -148.91 123.43 9.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.53 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.499 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.8 mt -92.2 47.14 1.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.974 0.416 . . . . 0.0 111.599 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.9 mt-10 -137.94 10.47 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.113 178.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.72 HG13 HG23 ' A' ' 47' ' ' VAL . 4.1 pt -91.84 159.04 38.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.155 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.496 ' O ' HD12 ' A' ' 49' ' ' ILE . 75.4 Cg_exo -53.93 -25.41 35.71 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.693 2.262 . . . . 0.0 112.858 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.677 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.28 -41.4 94.23 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.72 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -56.67 -55.6 41.4 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.6 Cg_exo -61.01 -42.23 38.33 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.572 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.874 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.8 mt -60.34 -33.65 54.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.097 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.61 ' O ' HG23 ' A' ' 54' ' ' VAL . 46.7 tp -75.36 -52.7 10.17 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -52.57 -27.42 16.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.1 0.476 . . . . 0.0 109.763 178.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -79.76 -49.07 12.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.624 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.593 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -57.08 -26.46 60.43 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.528 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.6 t -51.67 -49.79 33.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.838 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -74.77 -16.31 60.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.679 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -88.01 -16.18 34.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.246 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.635 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 50.8 m-85 -137.56 62.43 35.99 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.447 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.52 -43.6 53.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.705 2.27 . . . . 0.0 111.671 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.8 -41.49 94.04 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.645 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.635 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 13.1 t -65.75 145.07 14.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.599 ' HB2' HG21 ' A' ' 31' ' ' THR . 36.8 t -83.64 98.27 9.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 111.016 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.516 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.3 p90 -63.86 129.07 38.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.089 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.469 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -147.39 161.17 28.46 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.071 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -161.61 144.99 4.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.473 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 37.1 t -149.57 159.14 44.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.121 0.486 . . . . 0.0 111.777 -179.124 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.465 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.3 p -139.97 -1.87 1.55 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.546 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.59 138.91 55.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.74 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 61.2 m -61.58 -51.61 67.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.672 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -48.21 -44.08 32.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.695 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.545 ' HA ' HG22 ' A' ' 21' ' ' VAL . 76.1 t -70.7 -54.96 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.908 0.385 . . . . 0.0 110.769 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.2 mp -57.59 -14.57 5.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.2 179.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.6 m -91.2 -41.15 11.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.144 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -59.71 -40.22 87.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.455 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.42 ' HB2' HG12 ' A' ' 76' ' ' ILE . 97.5 m-85 -93.33 15.07 16.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.725 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.7 m120 53.87 25.45 5.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.791 179.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.694 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.2 mm -60.33 121.41 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.002 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.9 p -140.97 57.86 1.55 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.491 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.3 44.58 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.637 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.617 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 12.5 m120 51.97 44.09 29.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.247 0.546 . . . . 0.0 110.37 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.694 ' HB ' HG23 ' A' ' 76' ' ' ILE . 91.9 m -69.14 152.79 44.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.676 -178.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.554 HG12 ' HA2' ' A' ' 37' ' ' GLY . 66.1 mt -118.89 116.75 52.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.998 177.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.472 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 74.7 m -106.45 133.02 51.79 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.628 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -107.49 103.99 13.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.899 178.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -97.05 120.37 37.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.789 0.328 . . . . 0.0 110.694 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.496 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 5.3 mtm180 -104.18 82.22 1.93 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.719 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ARG . 7.2 tp -25.19 -59.66 0.06 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.41 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.502 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.73 -64.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.295 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -93.27 3.83 54.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.922 0.391 . . . . 0.0 110.959 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 49.56 36.59 10.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.526 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 6.3 mm-40 -83.57 157.08 22.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.5 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.18 96.06 3.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.724 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.628 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -84.71 111.55 19.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.048 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.35 115.41 27.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.262 0.553 . . . . 0.0 112.308 -178.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.581 HD21 HD13 ' A' ' 102' ' ' ILE . 3.1 tt -102.61 76.84 1.56 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.5 mt-10 -78.2 -165.08 0.62 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.524 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 22.6 t70 -50.48 -38.89 46.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.174 -179.16 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -54.89 -14.62 1.52 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.142 0.496 . . . . 0.0 110.343 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -130.42 -13.81 3.82 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.721 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.563 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.1 mm -90.8 -35.1 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.701 0.286 . . . . 0.0 111.435 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.77 -43.46 65.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.914 0.388 . . . . 0.0 110.758 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.7 m -122.34 40.33 3.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.518 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.581 HD13 HD21 ' A' ' 94' ' ' LEU . 7.6 tp -67.32 143.43 15.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.687 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -138.37 148.31 44.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.536 178.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.874 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.14 -36.8 8.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.984 0.421 . . . . 0.0 110.449 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.2 m -62.07 -49.83 74.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.249 178.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -57.6 -60.96 2.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.227 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.761 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.69 -56.52 8.32 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.912 0.387 . . . . 0.0 110.44 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.7 m -58.66 -29.99 66.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.974 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.553 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.2 tmt_? -71.08 -65.33 0.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.138 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -43.44 -44.58 5.9 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.044 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.489 HD11 HG11 ' A' ' 35' ' ' VAL . 96.8 mt -62.6 -55.39 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.512 178.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.41 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 37.6 tt0 -54.36 -18.73 4.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.266 0.555 . . . . 0.0 110.305 179.392 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.553 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.44 -37.02 9.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.907 -179.136 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.561 HD22 ' HG ' ' A' ' 92' ' ' LEU . 89.6 m-20 -124.48 30.38 6.03 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 97.9 p -83.08 44.29 0.93 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.055 0.455 . . . . 0.0 110.091 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.418 HD12 HH12 ' A' ' 85' ' ' ARG . 44.4 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.33 -179.445 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.497 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.0 pt-20 . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 46.0 Cg_endo -68.51 142.57 54.3 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.531 2.154 . . . . 0.0 112.619 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.6 m -63.33 152.26 38.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.51 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 12.7 m0 -96.53 89.51 5.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.005 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 24' ' ' ALA . 54.7 mt -83.4 71.28 10.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.056 0.455 . . . . 0.0 110.39 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.6 p -71.07 -1.83 13.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.096 -179.099 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -141.42 147.28 37.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.892 0.377 . . . . 0.0 111.673 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.1 t -57.33 -49.68 92.51 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.364 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.11 -43.76 45.08 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.939 1.759 . . . . 0.0 111.743 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.23 -34.85 79.34 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.2 0.524 . . . . 0.0 110.361 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.624 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.68 -58.65 5.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.954 179.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 59.4 mtm -60.6 -27.64 67.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.135 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -71.36 -50.68 29.81 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.756 0.312 . . . . 0.0 110.677 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.534 ' O ' HG22 ' A' ' 31' ' ' THR . 4.0 m-85 -59.47 -34.77 72.96 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.246 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.555 HD11 HD12 ' A' ' 36' ' ' ILE . 48.4 mt -73.07 -39.38 57.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.103 178.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.26 -18.85 61.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.081 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.3 24.26 3.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.252 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.709 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.0 t -170.78 155.09 4.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.546 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.547 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.8 tt0 -65.53 -73.25 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG13 HD11 ' A' ' 83' ' ' LEU . 17.9 t -98.66 137.37 26.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.743 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.455 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.19 128.07 19.43 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.234 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.444 HG21 HG12 ' A' ' 111' ' ' ILE . 54.6 t -115.37 131.38 67.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.43 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.555 HD12 HD11 ' A' ' 28' ' ' ILE . 23.1 mt -136.55 136.17 48.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.64 98.16 1.89 Allowed Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.505 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.49 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.9 m-85 -83.34 89.73 7.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.595 ' HB3' HD22 ' A' ' 79' ' ' ASN . 11.0 m-85 -109.59 137.88 46.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.497 -178.018 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.449 ' HG2' HD23 ' A' ' 71' ' ' LEU . 48.8 mt-30 -85.18 -4.49 59.18 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.449 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 12.0 t70 -153.63 126.4 8.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.561 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.543 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.1 mt -95.48 48.21 1.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.112 0.482 . . . . 0.0 111.369 -179.355 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.449 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 45.2 mt-10 -137.98 8.65 2.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.808 178.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.812 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.8 pt -91.94 157.17 41.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.247 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.503 ' O ' HD12 ' A' ' 49' ' ' ILE . 76.3 Cg_exo -52.23 -26.03 25.49 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.915 2.41 . . . . 0.0 113.058 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.812 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.19 -36.06 83.0 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.655 HG23 HG13 ' A' ' 44' ' ' ILE . 2.5 t -62.78 -55.75 35.55 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.644 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.0 Cg_exo -60.83 -39.43 62.28 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.03 1.82 . . . . 0.0 111.471 179.381 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -63.45 -36.7 77.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.062 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.6 ' O ' HG23 ' A' ' 54' ' ' VAL . 42.8 tp -71.89 -51.95 19.73 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -53.21 -26.31 17.15 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.6 t -80.01 -47.55 14.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.656 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.562 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.17 -26.11 64.5 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.429 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.7 t -53.11 -49.43 50.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.834 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -76.08 -10.59 59.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.626 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -93.69 -18.94 21.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.374 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 67.5 m-85 -135.96 62.21 45.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.589 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.9 -41.14 64.87 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.693 2.262 . . . . 0.0 111.568 179.114 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.14 -41.58 96.69 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.293 179.15 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.1 t -66.1 143.77 15.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.709 ' HB2' HG21 ' A' ' 31' ' ' THR . 33.3 t -81.5 99.3 8.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.039 0.447 . . . . 0.0 110.844 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.479 ' HB3' HG22 ' A' ' 54' ' ' VAL . 3.9 p90 -65.61 126.76 29.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.987 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.491 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.95 162.73 28.35 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.318 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -160.89 141.34 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.1 t -144.29 151.78 39.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.107 0.48 . . . . 0.0 111.655 -179.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.432 HG21 ' HG ' ' A' ' 42' ' ' LEU . 81.6 p -135.57 -0.5 2.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.772 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.59 145.99 50.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.918 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.0 t -67.66 -50.58 57.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.466 -179.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -50.45 -44.05 55.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.363 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.536 ' HA ' HG22 ' A' ' 21' ' ' VAL . 58.4 t -70.83 -53.45 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.736 0.303 . . . . 0.0 110.604 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.449 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.4 -14.72 8.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.147 0.498 . . . . 0.0 110.459 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.0 m -92.56 -40.68 10.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.466 178.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -61.88 -35.33 78.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.497 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.421 ' HB2' HG12 ' A' ' 76' ' ' ILE . 41.9 m-85 -95.55 12.88 28.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.872 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.599 ' N ' HD22 ' A' ' 75' ' ' ASN . 0.8 OUTLIER 56.93 23.65 8.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.691 179.236 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.681 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.2 mm -61.08 121.13 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.092 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.2 p -141.02 57.86 1.55 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.378 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.51 46.49 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.536 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.595 HD22 ' HB3' ' A' ' 39' ' ' PHE . 14.0 m120 51.29 42.94 29.5 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.253 0.549 . . . . 0.0 110.406 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.681 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.0 m -68.93 152.39 45.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.65 -178.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.578 HG12 ' HA2' ' A' ' 37' ' ' GLY . 68.1 mt -119.32 118.53 57.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.241 178.163 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.49 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.9 m -107.34 134.04 50.98 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.658 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -107.62 103.05 12.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.716 178.183 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.1 t80 -95.87 120.26 35.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.869 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.567 HH12 HD12 ' A' ' 116' ' ' LEU . 3.9 mtm180 -106.09 82.19 1.73 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.872 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.5 tp -25.11 -58.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.219 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.547 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.08 -60.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.375 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -100.77 4.77 43.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.128 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 54.08 26.01 6.11 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.373 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 13.9 mm-40 -70.61 155.18 41.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.822 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.86 95.06 2.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.445 179.391 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.658 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -84.36 111.55 19.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.224 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.7 118.08 30.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.37 0.605 . . . . 0.0 112.253 -179.13 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.515 HD21 HD13 ' A' ' 102' ' ' ILE . 4.3 tt -105.56 77.6 1.29 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.7 mt-10 -79.69 -163.84 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.905 -176.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.7 t70 -51.11 -35.71 36.7 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.925 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.415 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 12.9 pt-20 -56.18 -14.57 2.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.091 0.472 . . . . 0.0 110.192 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.415 ' OD2' ' HG3' ' A' ' 97' ' ' GLU . 35.5 m-20 -132.46 -14.05 2.94 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.573 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.4 mm -89.86 -33.96 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.718 0.294 . . . . 0.0 111.402 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -54.54 -34.23 61.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.753 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.5 p -133.06 40.25 3.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.341 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.517 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.6 tp -66.07 143.57 15.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.597 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.404 ' N ' HG13 ' A' ' 102' ' ' ILE . 9.3 m-20 -138.62 148.56 44.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.5 178.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.91 -35.57 6.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.102 0.477 . . . . 0.0 110.342 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.2 m -63.33 -49.63 73.17 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.358 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -58.61 -59.66 5.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.131 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.7 -55.92 12.07 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.963 0.411 . . . . 0.0 110.317 179.875 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.2 m -58.66 -28.93 66.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.785 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.555 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -71.58 -65.69 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.169 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -42.91 -43.97 4.35 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.913 179.106 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.444 HG12 HG21 ' A' ' 35' ' ' VAL . 94.6 mt -62.96 -55.93 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.571 178.314 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.31 -17.81 3.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.555 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.83 -36.84 8.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.98 -179.194 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.413 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.3 m120 -124.37 30.02 6.16 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 81.2 p -82.38 47.69 1.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.013 0.435 . . . . 0.0 110.315 179.058 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.567 HD12 HH12 ' A' ' 85' ' ' ARG . 63.1 mt . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.297 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.47 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 120.525 0.202 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.0 Cg_endo -67.83 148.25 76.54 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.878 2.385 . . . . 0.0 112.6 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.3 m -64.64 153.99 37.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.54 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -98.84 89.37 4.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.005 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 24' ' ' ALA . 50.1 mt -86.86 74.14 9.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.603 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.9 p -71.82 -1.25 13.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.266 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -143.52 148.73 36.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.868 0.366 . . . . 0.0 111.863 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.592 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 20.4 t -56.86 -50.66 86.78 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.407 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.52 -43.45 50.97 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.944 1.763 . . . . 0.0 111.884 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.61 -35.47 80.9 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.222 0.534 . . . . 0.0 110.299 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.61 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.26 -58.2 7.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.868 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.7 mtm -60.25 -28.56 68.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.005 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -70.57 -48.9 53.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.794 0.331 . . . . 0.0 110.568 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 31' ' ' THR . 4.5 m-85 -60.75 -33.64 73.24 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.999 179.311 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.6 HD11 HD12 ' A' ' 36' ' ' ILE . 38.1 mt -73.55 -39.6 54.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.003 178.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.33 -19.16 62.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.177 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.32 26.45 3.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.253 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.648 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.0 t -172.8 154.28 2.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.705 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.526 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.3 tt0 -63.65 -79.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.711 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.53 HG13 HD11 ' A' ' 83' ' ' LEU . 16.0 t -92.88 139.03 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.661 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.45 122.99 14.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 0.0 111.716 -179.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.554 HG21 HG12 ' A' ' 111' ' ' ILE . 55.1 t -112.03 128.34 68.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.755 178.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.6 HD12 HD11 ' A' ' 28' ' ' ILE . 38.4 mt -134.08 137.59 51.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.604 -177.015 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.544 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.75 98.26 1.82 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.217 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.467 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 35.8 m-85 -84.17 91.88 7.8 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.8 m-85 -111.78 143.76 42.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.356 -178.085 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -89.31 -8.07 54.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.447 ' O ' HG12 ' A' ' 44' ' ' ILE . 13.4 t70 -149.79 124.57 9.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.618 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.547 ' HA ' HG21 ' A' ' 47' ' ' VAL . 90.6 mt -93.18 46.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.055 0.455 . . . . 0.0 111.511 -179.239 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 37.1 mt-10 -136.98 8.93 3.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.917 178.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.78 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.2 pt -91.81 155.56 43.37 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.4 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.489 ' O ' HD12 ' A' ' 49' ' ' ILE . 83.8 Cg_exo -50.42 -26.61 16.53 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.877 2.385 . . . . 0.0 112.964 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.78 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.48 -38.52 91.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -179.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.691 HG23 HG13 ' A' ' 44' ' ' ILE . 2.8 t -60.0 -55.91 40.83 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.663 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.7 Cg_exo -60.67 -41.59 45.93 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.081 1.854 . . . . 0.0 111.545 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.871 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.8 mt -61.12 -35.17 63.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.973 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.614 ' O ' HG23 ' A' ' 54' ' ' VAL . 50.4 tp -74.57 -49.47 21.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.06 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -55.14 -25.83 34.63 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -81.84 -47.34 12.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.69 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.584 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.48 -26.38 63.35 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.455 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 50' ' ' LEU . 41.9 t -52.82 -48.01 50.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.123 179.395 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -77.97 -11.88 59.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.4 mtpp -92.23 -17.86 24.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.312 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.608 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 62.4 m-85 -136.5 62.36 42.52 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.453 -179.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.33 -42.12 62.38 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.79 2.327 . . . . 0.0 111.677 179.137 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.9 -40.59 95.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.443 179.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.4 t -67.22 142.6 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.648 ' HB2' HG21 ' A' ' 31' ' ' THR . 28.7 t -81.17 98.46 8.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.049 0.452 . . . . 0.0 110.877 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.521 ' HB3' HG22 ' A' ' 54' ' ' VAL . 4.6 p90 -66.04 129.44 39.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.015 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.32 161.98 28.57 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.003 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -160.93 143.93 4.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.467 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 34.1 t -149.79 158.3 44.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.1 0.476 . . . . 0.0 111.693 -179.165 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.518 HG21 ' HG ' ' A' ' 42' ' ' LEU . 77.5 p -139.86 2.53 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.668 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -72.18 134.51 45.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.428 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.1 t -57.86 -49.29 77.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.435 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -50.21 -43.49 52.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.695 -179.378 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.57 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.9 t -71.35 -53.2 21.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.967 0.413 . . . . 0.0 110.69 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 76' ' ' ILE . 6.6 mp -59.31 -14.34 11.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.176 179.362 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.5 m -92.02 -41.24 10.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.251 178.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -60.68 -38.51 85.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.434 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.41 ' HB2' HG12 ' A' ' 76' ' ' ILE . 60.1 m-85 -92.61 10.46 30.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.766 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.9 t30 58.95 23.01 11.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.626 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.718 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.0 mm -60.23 123.34 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.022 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.5 p -143.62 60.05 1.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.028 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.86 43.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.572 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.612 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 30.0 m-80 52.09 43.57 30.35 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.109 0.48 . . . . 0.0 110.43 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.718 ' HB ' HG23 ' A' ' 76' ' ' ILE . 88.5 m -68.41 152.67 45.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.655 -178.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.579 HG21 HD21 ' A' ' 107' ' ' LEU . 62.2 mt -118.46 115.53 48.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 78.3 m -103.63 135.14 45.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -177.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.631 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -110.72 105.61 14.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.125 178.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.7 t80 -99.41 118.94 37.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.996 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.456 HH12 HD12 ' A' ' 116' ' ' LEU . 3.3 mtm180 -103.29 80.69 1.86 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.789 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 85' ' ' ARG . 6.6 tp -24.33 -59.65 0.05 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.935 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.526 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.79 -62.48 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.302 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -96.87 3.3 52.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.0 0.428 . . . . 0.0 111.065 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 51.77 32.07 9.01 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.526 179.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.9 mm-40 -80.03 137.5 36.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.614 179.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.02 93.31 4.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.028 0.442 . . . . 0.0 110.86 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.631 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -81.16 141.39 34.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.361 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -121.86 115.18 22.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.322 0.582 . . . . 0.0 112.343 -179.425 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.533 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -99.57 74.88 1.91 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.42 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.5 mt-10 -76.38 -166.03 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -176.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.474 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.4 OUTLIER -46.01 -51.7 13.1 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.418 -179.278 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -47.15 -15.83 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.275 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 96' ' ' ASP . 30.5 m-20 -127.02 -14.03 5.6 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.351 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.546 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.4 mm -91.59 -40.48 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -46.18 -42.85 14.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 t -124.45 41.36 3.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.491 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.533 HD13 HD21 ' A' ' 94' ' ' LEU . 7.3 tp -66.86 143.6 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.712 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -137.22 149.54 47.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.486 178.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.871 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.23 -36.77 14.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.379 . . . . 0.0 110.461 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 99.5 m -62.27 -48.42 79.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.236 178.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -58.86 -59.34 5.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.188 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.2 -56.39 11.25 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.05 0.452 . . . . 0.0 110.182 -179.96 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.6 m -58.05 -28.8 64.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.744 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.498 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.9 tmt_? -71.6 -66.05 0.68 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.967 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -42.13 -45.52 4.03 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.865 179.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.554 HG12 HG21 ' A' ' 35' ' ' VAL . 82.1 mt -61.33 -56.86 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.593 178.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -53.82 -18.07 2.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.336 179.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.498 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.43 -37.16 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.215 -179.042 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.616 HD22 ' HG ' ' A' ' 92' ' ' LEU . 82.9 m-20 -124.62 29.63 6.21 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 99.8 p -82.9 49.11 1.45 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.996 0.427 . . . . 0.0 110.316 179.055 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.456 HD12 HH12 ' A' ' 85' ' ' ARG . 73.7 mt . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.355 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.519 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.9 pt-20 . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.423 0.154 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 31.4 Cg_endo -65.0 139.76 62.89 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.487 2.124 . . . . 0.0 112.526 -179.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 17' ' ' TRP . 19.2 m -57.18 154.34 10.34 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.003 -179.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.401 ' N ' HG22 ' A' ' 16' ' ' THR . 10.4 m-90 -98.21 94.11 6.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.902 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.617 HD13 ' HA ' ' A' ' 24' ' ' ALA . 51.3 mt -90.07 70.01 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.27 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.2 p -68.82 -2.6 9.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.246 -178.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -142.61 147.53 35.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.997 0.427 . . . . 0.0 111.645 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.7 t -55.29 -50.01 89.11 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.638 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.6 Cg_endo -57.06 -46.87 25.86 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.958 1.772 . . . . 0.0 111.924 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.8 -34.62 77.66 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.193 0.52 . . . . 0.0 110.113 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -64.13 -59.26 4.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.054 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.4 mtp -60.62 -25.19 66.09 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.183 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -72.26 -50.82 24.3 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.571 179.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 31' ' ' THR . 12.0 m-85 -61.72 -29.48 70.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.047 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.516 HD11 HD12 ' A' ' 36' ' ' ILE . 50.2 mt -76.11 -37.48 33.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.068 178.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.79 -19.54 60.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.115 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.41 30.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.197 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.613 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.7 t -170.97 153.53 3.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.314 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.615 ' HG3' HG13 ' A' ' 87' ' ' VAL . 27.5 tt0 -70.18 -46.29 64.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.793 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.508 HG13 HD11 ' A' ' 83' ' ' LEU . 21.1 t -124.53 135.22 64.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.286 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.507 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.56 127.47 22.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.163 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.503 HG21 HG12 ' A' ' 111' ' ' ILE . 49.2 t -115.66 128.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.465 178.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.516 HD12 HD11 ' A' ' 28' ' ' ILE . 22.2 mt -134.64 138.41 49.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.556 -177.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.575 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.87 97.06 1.64 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.378 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.477 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 39.3 m-85 -82.95 91.96 7.24 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.0 m-85 -112.0 145.21 40.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.181 0.515 . . . . 0.0 112.378 -178.188 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.479 ' HG2' HD23 ' A' ' 71' ' ' LEU . 46.2 mt-30 -93.17 -0.99 56.75 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.8 t70 -156.58 123.85 5.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.564 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.549 ' HA ' HG21 ' A' ' 47' ' ' VAL . 84.0 mt -93.75 47.5 1.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.204 0.526 . . . . 0.0 111.505 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 45.4 mt-10 -137.38 7.27 2.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.729 178.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.808 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.0 pt -89.68 156.55 47.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.027 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.509 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.1 Cg_exo -52.16 -24.19 19.62 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.876 2.384 . . . . 0.0 113.007 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.808 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -67.32 -35.99 80.56 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.673 HG23 HG13 ' A' ' 44' ' ' ILE . 2.6 t -61.9 -54.97 45.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.667 -178.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.6 Cg_exo -61.44 -40.28 49.48 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.999 1.799 . . . . 0.0 111.445 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.868 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.3 mt -63.11 -35.92 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.19 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.624 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.9 tp -73.06 -50.26 23.99 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -54.82 -25.37 27.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.198 0.523 . . . . 0.0 109.598 178.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.9 t -80.98 -47.23 13.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.547 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.556 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.23 -27.17 65.51 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.541 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.6 t -51.71 -50.91 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.021 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -74.68 -12.35 60.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.722 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -91.81 -17.34 25.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.215 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.619 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.0 m-85 -138.15 63.37 36.23 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.568 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.07 -41.11 74.19 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.652 2.235 . . . . 0.0 111.58 179.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.3 -41.83 97.05 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.35 179.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.6 t -65.76 144.69 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.613 ' HB2' HG21 ' A' ' 31' ' ' THR . 47.5 t -82.35 97.23 8.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.026 0.441 . . . . 0.0 111.006 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.493 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -64.45 126.64 28.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.724 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.476 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.1 161.84 28.33 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.169 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' A' ' 15' ' ' PRO . 4.3 tt -161.03 143.02 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.477 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 35.6 t -147.25 153.52 39.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.071 0.462 . . . . 0.0 111.805 -179.061 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.483 HG21 ' HG ' ' A' ' 42' ' ' LEU . 64.4 p -135.62 5.73 3.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.371 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.27 140.34 44.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.738 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.8 m -62.94 -52.78 61.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.378 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -47.7 -44.73 27.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.614 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.509 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.0 t -70.05 -55.29 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.832 0.348 . . . . 0.0 110.991 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.479 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -57.39 -14.84 5.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.25 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.4 m -90.48 -41.43 11.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.246 178.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -60.1 -39.42 86.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.392 179.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -92.93 12.99 21.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.959 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.3 m120 55.15 24.28 6.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.623 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.709 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.4 mm -60.16 120.43 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.97 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.5 p -142.05 55.67 1.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.942 0.401 . . . . 0.0 111.109 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.44 42.37 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.432 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.625 ' HB2' HG21 ' A' ' 99' ' ' ILE . 35.6 m-20 52.24 43.37 30.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.232 0.539 . . . . 0.0 110.364 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.709 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.6 m -68.95 151.11 46.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.87 -178.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.575 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.0 mt -117.8 115.47 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.911 177.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.458 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 78.3 m -103.82 132.57 49.95 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.665 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.3 tp -109.07 103.68 12.74 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.803 178.312 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.6 t80 -98.73 122.15 41.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.821 0.343 . . . . 0.0 110.79 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.481 HH21 ' HB2' ' A' ' 88' ' ' ASP . 2.8 mtm180 -105.04 98.72 8.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.036 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.3 tp -41.9 -52.71 4.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.882 -179.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.615 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.7 -71.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.385 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.481 ' HB2' HH21 ' A' ' 85' ' ' ARG . 11.2 m-20 -88.33 6.01 39.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.041 -179.665 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 52.49 35.89 18.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.387 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 7.3 mm-40 -81.46 161.66 23.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.817 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -146.05 92.81 2.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.92 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.665 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -79.39 144.23 34.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.181 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -124.56 95.49 4.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.025 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.579 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -81.0 77.78 7.88 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.639 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.5 mt-10 -78.8 -165.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.514 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 25.5 t70 -51.01 -36.47 39.57 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.932 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -56.27 -14.61 2.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.183 0.516 . . . . 0.0 110.361 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -130.68 -13.95 3.67 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.592 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.625 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.0 mm -89.49 -32.71 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.754 0.311 . . . . 0.0 111.373 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -50.36 -47.98 55.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.728 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -122.05 38.31 4.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.609 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.579 HD13 HD21 ' A' ' 94' ' ' LEU . 7.0 tp -61.07 143.44 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.653 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.404 ' N ' HG13 ' A' ' 102' ' ' ILE . 19.1 m-20 -137.12 147.91 46.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.473 178.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.868 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.1 -35.26 6.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.99 0.424 . . . . 0.0 110.45 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -63.91 -48.68 75.62 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.423 178.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -58.98 -58.58 8.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.115 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.733 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.49 -55.78 14.47 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.998 0.428 . . . . 0.0 110.134 179.901 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.1 m -58.31 -28.98 65.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.823 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.7 tmt_? -72.65 -65.88 0.73 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.222 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -42.92 -42.82 3.86 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.04 179.112 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.503 HG12 HG21 ' A' ' 35' ' ' VAL . 92.2 mt -64.18 -56.63 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.576 178.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -52.33 -22.16 4.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.367 0.604 . . . . 0.0 110.211 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.475 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -85.17 -37.88 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.93 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.618 HD22 ' HG ' ' A' ' 92' ' ' LEU . 88.9 m-20 -123.64 30.78 6.1 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.312 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 111' ' ' ILE . 87.4 p -83.5 39.58 0.68 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.18 0.514 . . . . 0.0 110.066 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.7 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.291 -179.453 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.1 pt-20 . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 120.426 0.155 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.495 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.9 Cg_endo -66.3 140.71 59.53 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.55 2.167 . . . . 0.0 112.465 -179.701 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 m -56.46 150.5 15.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.666 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -96.27 93.36 6.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.98 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 24' ' ' ALA . 54.2 mt -90.7 72.93 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.511 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.7 p -74.96 2.11 11.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.065 -179.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -144.67 147.54 33.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 0.0 111.595 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.589 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 39.7 t -56.48 -50.21 89.08 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.622 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.96 -44.92 35.82 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 121.876 1.717 . . . . 0.0 111.797 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.85 -36.22 83.2 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.169 0.509 . . . . 0.0 110.33 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.61 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.21 -59.4 4.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.148 179.377 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 65.8 mtp -60.97 -25.19 66.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.139 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 21.3 mt-10 -72.59 -51.98 17.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.719 0.295 . . . . 0.0 110.648 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.507 ' O ' HG22 ' A' ' 31' ' ' THR . 12.5 m-85 -59.94 -31.87 70.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.935 179.368 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.572 HD11 HD12 ' A' ' 36' ' ' ILE . 50.7 mt -75.27 -38.8 41.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.938 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.61 -19.0 61.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.232 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.76 26.18 3.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.243 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.0 t -170.62 153.75 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.611 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.529 ' HG3' HG13 ' A' ' 87' ' ' VAL . 18.2 tt0 -64.5 -73.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.574 HG13 HD11 ' A' ' 83' ' ' LEU . 19.7 t -98.13 137.81 24.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.613 179.787 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.18 125.65 16.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.937 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 111' ' ' ILE . 55.0 t -114.07 130.16 68.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.85 178.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.572 HD12 HD11 ' A' ' 28' ' ' ILE . 27.0 mt -135.53 137.78 49.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.625 -177.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.24 98.08 1.75 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.587 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.523 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.0 m-85 -84.3 91.84 7.85 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.595 ' HB3' HD22 ' A' ' 79' ' ' ASN . 11.4 m-85 -110.84 143.87 40.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.287 -178.191 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.478 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 49.9 mt-30 -91.51 -3.3 56.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.522 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.6 t70 -154.8 118.46 4.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.596 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.494 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.8 mt -87.96 44.78 1.22 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.01 0.433 . . . . 0.0 111.329 -179.318 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 31.3 mt-10 -135.28 10.11 3.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.128 179.054 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.73 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.3 pt -92.77 157.57 39.4 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.477 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.462 ' O ' HD12 ' A' ' 49' ' ' ILE . 71.8 Cg_exo -52.22 -27.5 30.43 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.908 2.405 . . . . 0.0 112.898 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.73 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.36 -39.95 95.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.701 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -58.57 -56.89 30.92 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -178.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -58.87 -40.29 73.4 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.783 1.655 . . . . 0.0 111.438 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.874 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -61.85 -35.34 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.936 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.586 ' O ' HG23 ' A' ' 54' ' ' VAL . 39.7 tp -75.03 -54.67 6.76 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -52.68 -23.69 7.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.0 0.429 . . . . 0.0 109.947 178.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -84.22 -46.08 12.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.557 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.606 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.0 -25.26 63.48 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.318 0.58 . . . . 0.0 109.457 179.433 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.3 t -51.57 -50.49 29.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.121 179.352 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -76.08 -9.48 58.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.874 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -93.13 -19.74 21.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.998 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.9 m-85 -135.84 63.79 53.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.506 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.61 -43.2 57.05 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.707 2.272 . . . . 0.0 111.576 179.229 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.42 -42.29 93.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.337 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -65.27 143.77 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.67 ' HB2' HG21 ' A' ' 31' ' ' THR . 38.2 t -82.28 98.12 8.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 111.092 -179.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.495 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.4 p90 -65.37 128.35 35.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.927 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.485 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.83 161.84 28.62 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.025 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.419 HD11 HG13 ' A' ' 47' ' ' VAL . 4.7 tt -160.18 144.3 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 t -148.48 158.72 44.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.191 0.519 . . . . 0.0 111.865 -178.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 39' ' ' PHE . 72.5 p -141.49 1.03 1.53 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.585 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.02 144.97 52.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.663 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.4 m -66.67 -53.4 34.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.344 -179.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 2.2 mp0 -48.71 -42.95 36.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.511 -179.684 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.522 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.8 t -70.56 -56.12 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.051 0.453 . . . . 0.0 110.648 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.49 -15.08 3.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.315 179.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.5 m -90.87 -41.23 11.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.304 178.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -61.33 -31.91 71.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.251 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -100.02 12.39 37.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.274 179.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.7 m120 55.95 22.05 5.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.595 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.666 HG23 ' HB ' ' A' ' 80' ' ' THR . 32.4 mm -58.96 118.99 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.152 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.6 p -142.16 55.81 1.46 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.085 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.82 42.41 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.355 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.595 HD22 ' HB3' ' A' ' 39' ' ' PHE . 14.1 m120 53.17 42.19 32.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.256 0.55 . . . . 0.0 110.203 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.666 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.9 m -67.93 151.77 46.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.864 -178.497 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.581 HG12 ' HA2' ' A' ' 37' ' ' GLY . 66.4 mt -118.95 115.79 49.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.88 177.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.523 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.4 m -105.34 132.65 51.26 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.656 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -108.34 103.91 13.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.925 178.327 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.5 t80 -97.36 123.58 41.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.847 0.356 . . . . 0.0 110.579 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.487 HH12 HD12 ' A' ' 116' ' ' LEU . 4.5 mtm180 -106.36 81.23 1.58 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.705 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 85' ' ' ARG . 4.6 tp -24.13 -59.76 0.05 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.06 -179.537 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.529 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.03 -61.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.064 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.9 4.29 49.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.953 0.406 . . . . 0.0 111.19 -179.428 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.9 m120 53.21 28.24 6.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.81 179.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.0 mm-40 -74.13 159.29 32.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.578 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -144.19 96.8 2.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.827 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.656 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.1 mm? -85.32 111.57 20.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.058 179.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -93.87 101.36 13.44 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.634 HD21 HD13 ' A' ' 102' ' ' ILE . 3.4 tt -86.72 75.82 9.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.0 mt-10 -77.1 -166.1 0.66 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -176.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.48 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -46.11 -50.67 15.13 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.398 -179.388 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -47.73 -16.3 0.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.976 0.417 . . . . 0.0 111.285 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.41 ' N ' ' C ' ' A' ' 96' ' ' ASP . 43.0 m-20 -126.38 -13.91 5.98 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.465 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.591 HG21 ' HB2' ' A' ' 79' ' ' ASN . 20.9 mm -91.46 -32.21 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -48.84 -59.31 3.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.962 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.6 p -110.72 36.28 3.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.585 179.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.634 HD13 HD21 ' A' ' 94' ' ' LEU . 8.7 tp -56.91 144.66 8.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.438 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.413 ' H ' ' HD3' ' A' ' 106' ' ' LYS . 21.7 m-20 -138.5 148.75 44.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.721 179.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.874 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.18 -36.72 14.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.029 0.442 . . . . 0.0 110.491 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 96.6 m -61.46 -49.07 78.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.174 178.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.413 ' HD3' ' H ' ' A' ' 103' ' ' ASP . 55.9 mtpt -58.1 -61.45 2.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.148 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.79 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.21 -56.54 7.69 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.903 0.382 . . . . 0.0 110.511 -179.849 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 56.6 m -58.31 -29.85 66.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.918 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.508 ' NH1' HD11 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -71.29 -64.7 0.86 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.252 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -44.52 -43.01 7.64 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.079 179.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.475 HG12 HG21 ' A' ' 35' ' ' VAL . 95.9 mt -63.76 -56.43 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.639 178.464 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -53.23 -19.39 3.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.179 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.508 HD11 ' NH1' ' A' ' 109' ' ' ARG . 1.3 mp -88.56 -37.75 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.07 -179.075 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.429 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.6 m120 -122.4 30.03 6.7 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.6 p -82.35 43.74 0.83 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.123 0.487 . . . . 0.0 110.152 178.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.487 HD12 HH12 ' A' ' 85' ' ' ARG . 49.5 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.408 -179.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.9 pt-20 . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 110.687 -0.116 . . . . 0.0 110.687 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.503 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.7 Cg_endo -66.89 141.65 59.58 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.423 2.082 . . . . 0.0 112.173 -179.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.6 m -56.42 152.31 11.67 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.495 -179.547 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -99.79 85.67 3.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.062 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.603 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.7 mt -81.89 74.61 8.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.453 179.84 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.7 p -74.14 -1.96 22.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.98 -178.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -140.11 147.02 39.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.422 . . . . 0.0 111.643 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 32.2 t -56.09 -50.05 89.62 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.534 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.4 Cg_endo -58.74 -45.33 29.94 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.808 1.672 . . . . 0.0 111.718 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.54 -33.82 76.42 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.25 0.547 . . . . 0.0 110.169 179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.93 -59.11 4.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.006 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.8 mtp -60.6 -26.02 66.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.182 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.3 mt-10 -72.86 -50.97 20.66 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.708 0.289 . . . . 0.0 110.642 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.486 ' O ' HG22 ' A' ' 31' ' ' THR . 7.8 m-85 -59.92 -32.2 70.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.854 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 36' ' ' ILE . 47.6 mt -75.08 -40.5 44.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.08 0.466 . . . . 0.0 110.111 178.312 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -18.7 62.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.207 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.48 25.41 3.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.206 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.635 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.7 t -171.0 155.1 4.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.744 -179.788 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.522 ' HG3' HG13 ' A' ' 87' ' ' VAL . 18.4 tt0 -64.61 -77.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.824 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.584 HG13 HD11 ' A' ' 83' ' ' LEU . 20.2 t -95.93 136.97 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.731 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.516 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.41 126.04 17.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.942 0.401 . . . . 0.0 112.074 -179.124 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.421 HG21 HG12 ' A' ' 111' ' ' ILE . 53.9 t -114.53 131.01 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.836 178.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.559 HD12 HD11 ' A' ' 28' ' ' ILE . 27.9 mt -135.97 135.39 50.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.274 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.593 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.58 98.06 1.97 Allowed Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.619 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 10.8 m-85 -84.17 91.73 7.77 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.606 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.0 m-85 -112.08 137.98 49.37 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.128 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -83.21 -7.03 59.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.459 ' O ' HG12 ' A' ' 44' ' ' ILE . 7.2 t70 -152.03 125.6 8.89 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.654 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.551 ' HA ' HG21 ' A' ' 47' ' ' VAL . 96.0 mt -93.23 43.27 1.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.039 0.447 . . . . 0.0 111.407 -179.645 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -132.55 14.79 4.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.828 178.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.6 pt -99.08 157.77 33.48 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.197 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.477 ' O ' HD12 ' A' ' 49' ' ' ILE . 74.1 Cg_exo -52.99 -26.98 33.88 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.9 2.4 . . . . 0.0 112.956 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.781 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.77 -38.25 89.86 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.017 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.672 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.35 -56.4 34.2 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.629 -178.826 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.2 Cg_exo -59.64 -41.23 57.98 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.942 1.762 . . . . 0.0 111.372 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -61.16 -35.87 68.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.054 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.594 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.8 tp -73.68 -52.06 14.58 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 178.784 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -53.58 -25.18 16.2 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.705 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -81.76 -46.82 13.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.505 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.558 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.16 -25.81 64.24 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.357 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.7 t -53.06 -47.69 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.948 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -77.99 -11.62 59.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.714 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -92.73 -17.77 23.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.155 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.618 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.3 m-85 -137.14 62.63 39.85 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.605 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.37 -39.46 81.47 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.517 2.145 . . . . 0.0 111.466 178.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.65 -39.42 96.55 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.458 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.1 t -68.58 144.09 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.067 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.635 ' HB2' HG21 ' A' ' 31' ' ' THR . 35.7 t -81.29 98.08 7.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 110.916 -179.754 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.503 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.2 p90 -65.16 127.52 32.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.77 162.88 28.57 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.212 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -160.68 143.71 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.774 0.321 . . . . 0.0 110.155 179.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.3 t -146.91 154.17 40.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.041 0.448 . . . . 0.0 111.512 -179.255 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.457 HG21 ' HG ' ' A' ' 42' ' ' LEU . 81.9 p -137.73 -4.75 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.71 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.35 144.49 55.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.831 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -64.35 -51.49 63.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.46 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -48.6 -45.26 37.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.656 -179.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.533 ' HA ' HG22 ' A' ' 21' ' ' VAL . 74.5 t -70.15 -53.47 23.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.829 0.347 . . . . 0.0 110.724 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.71 -14.32 8.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.351 179.416 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.2 m -91.91 -41.68 10.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.274 178.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -60.09 -39.62 86.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.414 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.42 ' HB2' HG12 ' A' ' 76' ' ' ILE . 59.0 m-85 -91.74 11.95 22.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.787 179.606 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 55.79 26.23 9.32 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.542 179.222 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.682 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.0 mm -61.89 122.06 11.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.226 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.6 p -140.83 58.2 1.55 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.311 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.87 46.77 0.02 OUTLIER Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.89 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.626 ' HB2' HG21 ' A' ' 99' ' ' ILE . 30.2 m-80 50.57 43.0 27.53 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.229 0.538 . . . . 0.0 110.543 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.682 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.6 m -69.17 152.57 44.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.686 -178.612 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.593 HG12 ' HA2' ' A' ' 37' ' ' GLY . 60.6 mt -118.9 118.34 57.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.107 178.189 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.9 m -107.89 134.07 51.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.651 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -109.53 104.73 13.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.085 178.544 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.4 t80 -97.3 122.61 40.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.464 179.555 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.583 HH12 HD12 ' A' ' 116' ' ' LEU . 5.6 mtm180 -106.85 82.71 1.74 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.928 0.394 . . . . 0.0 110.835 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tp -25.67 -60.03 0.07 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.127 -179.404 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.522 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.25 -58.75 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.852 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -98.83 13.28 32.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.758 0.313 . . . . 0.0 111.37 -179.177 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.2 p30 43.55 30.95 0.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.017 178.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.536 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 28.2 mm-40 -77.47 157.16 30.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.835 0.35 . . . . 0.0 110.916 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.469 HE22 ' HB3' ' A' ' 93' ' ' ASN . 1.2 tm0? -142.26 94.48 2.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.676 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.651 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -85.25 121.69 28.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.637 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.576 ' ND2' ' H ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -105.16 103.77 13.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.767 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.555 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -89.63 78.67 6.96 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.1 mt-10 -79.81 -165.87 0.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.81 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.491 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.1 -51.06 10.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.7 -179.311 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -46.56 -18.88 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.857 0.361 . . . . 0.0 111.088 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 96' ' ' ASP . 16.2 m-20 -124.73 -13.82 6.89 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.488 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.626 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.7 mm -90.59 -40.61 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.363 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -49.08 -40.91 33.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.342 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.3 t -123.68 36.41 4.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.449 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.58 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 8.1 tp -63.14 144.68 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.475 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -139.69 147.88 41.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.475 178.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.11 -37.84 10.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.984 0.421 . . . . 0.0 110.554 -179.571 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -61.43 -47.55 85.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.311 178.647 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -60.12 -60.83 3.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.215 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.763 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.0 -55.56 11.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.329 -179.999 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.0 m -58.45 -30.49 66.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.732 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.443 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.5 tmt_? -70.4 -66.55 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.128 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -42.62 -45.16 4.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.169 179.454 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.421 HG12 HG21 ' A' ' 35' ' ' VAL . 96.4 mt -62.41 -54.76 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.306 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.41 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 40.8 tt0 -54.6 -18.78 4.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.426 179.397 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.443 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.62 -37.43 10.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.79 -178.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.584 HD22 ' HG ' ' A' ' 92' ' ' LEU . 89.1 m-20 -122.96 29.36 6.82 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.387 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 78.9 p -82.65 50.85 1.75 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.118 0.485 . . . . 0.0 110.092 178.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.583 HD12 HH12 ' A' ' 85' ' ' ARG . 57.0 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.278 -0.867 . . . . 0.0 111.374 -179.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.1 pt-20 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.405 0.145 . . . . 0.0 110.714 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.7 Cg_endo -65.37 145.21 82.68 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.618 2.212 . . . . 0.0 112.48 -179.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 17' ' ' TRP . 21.8 m -61.76 155.36 23.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.74 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.414 ' N ' HG22 ' A' ' 16' ' ' THR . 7.4 m-90 -99.1 91.46 5.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.077 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.628 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.8 mt -87.97 74.19 8.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.415 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.7 p -73.02 -3.18 24.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.156 -178.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -141.31 148.28 39.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.865 0.364 . . . . 0.0 111.643 -179.721 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.609 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.9 t -56.54 -50.28 88.7 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.407 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -57.34 -44.04 46.6 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 121.97 1.78 . . . . 0.0 111.866 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.24 -36.91 85.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.206 0.527 . . . . 0.0 110.184 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.628 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.87 -59.05 5.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.026 179.499 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.0 mtp -60.55 -27.19 67.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.212 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 19.8 mt-10 -70.66 -49.29 48.87 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.746 0.308 . . . . 0.0 110.547 179.843 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.57 ' O ' HG22 ' A' ' 31' ' ' THR . 9.5 m-85 -61.52 -34.16 75.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.243 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 36' ' ' ILE . 50.0 mt -72.99 -37.06 52.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.126 0.488 . . . . 0.0 109.939 178.345 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.01 -19.43 60.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.959 -179.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.61 23.95 4.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.297 -179.651 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.674 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.1 t -169.96 153.33 4.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.518 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.542 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.2 tt0 -63.92 -80.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.669 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.544 HG13 HD11 ' A' ' 83' ' ' LEU . 16.9 t -91.86 134.15 31.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.489 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.43 126.06 22.11 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.195 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.474 HG21 HG12 ' A' ' 111' ' ' ILE . 48.9 t -114.21 129.13 70.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.811 178.546 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.559 HD12 HD11 ' A' ' 28' ' ' ILE . 24.2 mt -135.59 137.17 49.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.439 -177.524 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.527 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.61 98.71 1.89 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.427 179.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.48 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 45.7 m-85 -84.62 93.05 8.3 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.302 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.2 m-85 -112.33 145.86 39.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.351 -177.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -93.81 -4.95 49.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.516 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.1 t70 -152.68 118.39 5.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.599 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.518 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.4 mt -88.15 45.8 1.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 111.336 -179.295 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 45.4 mt-10 -136.03 9.06 3.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.125 179.161 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.779 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.7 pt -92.27 157.52 40.48 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.152 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.49 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.3 Cg_exo -52.53 -27.94 34.36 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.855 2.37 . . . . 0.0 112.865 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.779 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.47 -37.79 87.29 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.936 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.684 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.51 -57.35 25.63 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.654 -178.833 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.659 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -59.39 -38.97 80.94 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.794 1.663 . . . . 0.0 111.37 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -63.26 -35.19 71.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.89 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.7 tp -74.61 -53.35 9.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.73 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -54.64 -21.81 11.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.009 0.433 . . . . 0.0 110.04 178.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 t -85.89 -45.01 11.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.491 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.583 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.31 -25.83 66.07 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.296 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.4 t -52.39 -49.92 40.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.999 179.286 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -74.91 -9.59 58.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.721 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.1 mtpp -94.83 -19.35 20.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.09 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.569 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 70.4 m-85 -135.96 63.03 49.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.476 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.4 -43.15 56.36 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.629 2.219 . . . . 0.0 111.632 179.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.89 -42.66 92.43 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.338 179.188 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.8 t -64.47 145.27 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.674 ' HB2' HG21 ' A' ' 31' ' ' THR . 29.9 t -83.15 98.94 9.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.033 0.444 . . . . 0.0 111.072 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.52 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.0 p90 -66.47 126.66 29.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.1 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.55 161.34 28.37 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.145 179.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.416 HD11 HG13 ' A' ' 47' ' ' VAL . 4.9 tt -159.98 144.01 5.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.474 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 31.1 t -148.05 159.52 43.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.006 0.431 . . . . 0.0 111.705 -179.306 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 50.6 p -140.46 -2.56 1.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.086 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.43 141.11 55.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.744 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.0 m -62.99 -50.91 68.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.553 -179.417 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -48.95 -44.61 40.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.638 -179.37 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.517 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.3 t -70.01 -54.4 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.909 0.385 . . . . 0.0 110.766 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -57.97 -14.51 6.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.303 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 76.4 m -91.62 -40.14 11.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.227 178.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -60.68 -39.67 89.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.38 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.411 ' HB2' HG12 ' A' ' 76' ' ' ILE . 93.0 m-85 -93.09 13.88 19.58 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.444 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 m120 54.8 26.2 7.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.582 179.519 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.717 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.6 mm -61.19 120.7 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.01 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.5 p -140.74 58.28 1.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.323 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.47 44.26 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.643 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.603 ' HB2' HG21 ' A' ' 99' ' ' ILE . 35.2 m-20 51.75 43.49 29.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.284 0.564 . . . . 0.0 110.353 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.717 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.4 m -68.66 152.28 45.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.786 -178.646 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.527 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.2 mt -119.21 115.68 48.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.97 177.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.48 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 72.5 m -104.11 131.03 51.81 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.722 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.658 ' HG ' HD23 ' A' ' 92' ' ' LEU . 1.9 tp -106.96 102.16 11.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.492 177.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.1 t80 -95.73 119.68 34.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.806 -179.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.475 HH12 HD12 ' A' ' 116' ' ' LEU . 4.4 mtm180 -102.97 80.86 1.91 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.673 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 85' ' ' ARG . 4.7 tp -24.87 -59.14 0.06 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.351 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.542 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.13 -62.51 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.088 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -95.35 2.88 54.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.087 0.47 . . . . 0.0 110.797 -179.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 52.42 33.13 12.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.445 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 12.7 mm-40 -79.37 158.2 27.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.84 99.1 3.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.953 0.406 . . . . 0.0 110.885 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.658 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -87.59 107.6 18.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.747 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -90.89 95.12 9.96 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.572 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.572 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -79.6 76.98 6.22 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.3 mt-10 -78.46 -165.44 0.7 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -176.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.483 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -46.03 -50.02 15.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.484 -179.233 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -47.83 -17.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.963 0.411 . . . . 0.0 110.943 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 96' ' ' ASP . 13.7 m-20 -125.65 -13.67 6.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.392 -179.735 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.603 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.1 mm -91.87 -46.31 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.559 0.219 . . . . 0.0 111.561 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -48.82 -31.05 6.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.913 0.387 . . . . 0.0 110.739 179.783 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 57.0 m -131.25 45.55 2.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.072 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.572 HD13 HD21 ' A' ' 94' ' ' LEU . 8.1 tp -78.61 146.39 8.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.79 -179.452 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.427 ' N ' HG13 ' A' ' 102' ' ' ILE . 6.1 m-20 -141.37 148.8 40.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.266 178.616 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.13 -37.36 9.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 110.593 -179.598 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -61.44 -49.2 77.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.401 178.722 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -58.66 -60.47 3.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.151 -179.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.802 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.93 -55.72 10.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.006 0.432 . . . . 0.0 110.264 -179.954 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.3 m -58.35 -29.57 66.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.819 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.515 ' HD3' HD13 ' A' ' 113' ' ' ILE . 1.7 tmt_? -72.15 -66.56 0.63 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.184 179.713 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -42.05 -44.12 3.46 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.05 179.147 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.474 HG12 HG21 ' A' ' 35' ' ' VAL . 96.7 mt -62.5 -55.02 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.517 178.386 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -55.25 -17.85 5.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.325 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.599 HG22 ' ND2' ' A' ' 114' ' ' ASN . 1.4 mp -91.01 -36.0 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.856 -179.185 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.599 ' ND2' HG22 ' A' ' 113' ' ' ILE . 61.7 m-80 -119.33 26.4 9.46 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.9 p -79.92 46.12 0.77 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.044 0.449 . . . . 0.0 110.306 178.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.475 HD12 HH12 ' A' ' 85' ' ' ARG . 57.0 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.413 -179.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.47 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.3 pt-20 . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.482 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.4 Cg_endo -65.48 142.62 72.56 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.421 2.081 . . . . 0.0 112.611 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.5 m -60.76 151.45 29.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.695 -179.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -95.17 92.01 6.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.083 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.631 HD22 ' HA ' ' A' ' 24' ' ' ALA . 65.2 mt -88.72 77.64 7.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.411 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.6 p -77.26 -3.19 38.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.023 -179.113 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -141.69 147.33 37.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.948 0.404 . . . . 0.0 111.774 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 22.1 t -55.22 -50.02 88.98 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.633 179.875 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.89 -45.82 30.17 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.939 1.759 . . . . 0.0 111.793 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.23 -33.99 76.69 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.205 0.526 . . . . 0.0 110.149 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.631 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.52 -59.39 4.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.116 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 47.3 mtm -61.1 -26.33 67.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.131 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.9 mt-10 -71.23 -52.07 21.08 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.702 0.286 . . . . 0.0 110.437 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -59.79 -30.71 69.08 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.122 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.504 HD11 HD12 ' A' ' 36' ' ' ILE . 47.2 mt -74.59 -37.81 44.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.965 178.188 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.6 -18.56 61.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.813 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.89 27.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.057 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.617 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.7 t -169.05 156.65 7.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.328 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.623 ' HG3' HG13 ' A' ' 87' ' ' VAL . 27.6 tt0 -75.56 -37.2 60.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.657 179.617 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.545 HG13 HD11 ' A' ' 83' ' ' LEU . 18.7 t -132.29 131.45 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.291 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -137.25 128.27 27.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.032 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.471 HG21 HG12 ' A' ' 111' ' ' ILE . 52.7 t -116.03 127.92 73.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.692 178.39 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.504 HD12 HD11 ' A' ' 28' ' ' ILE . 20.6 mt -133.79 137.08 53.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.781 -177.251 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.85 96.29 1.61 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.371 179.726 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.0 m-85 -81.51 88.55 6.17 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.524 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -108.43 142.57 38.59 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.194 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -90.29 -8.97 49.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.497 ' O ' HG12 ' A' ' 44' ' ' ILE . 15.6 t70 -148.54 119.28 7.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.521 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.555 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.5 mt -89.06 45.17 1.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.131 0.491 . . . . 0.0 111.588 -179.279 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.5 mt-10 -135.31 8.28 3.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.069 178.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.841 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.5 pt -92.19 156.09 42.24 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.169 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.518 ' O ' HD12 ' A' ' 49' ' ' ILE . 86.3 Cg_exo -49.78 -31.32 25.62 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.794 2.329 . . . . 0.0 112.807 179.684 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.841 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -59.14 -37.38 77.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.29 -178.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.696 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.5 t -62.28 -58.3 18.17 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.578 -178.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.696 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.5 Cg_exo -58.97 -40.94 66.69 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.697 1.598 . . . . 0.0 111.272 179.187 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.947 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -60.46 -35.5 63.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.738 179.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.583 ' O ' HG23 ' A' ' 54' ' ' VAL . 49.0 tp -74.3 -53.75 9.06 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -53.83 -24.03 14.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.105 0.479 . . . . 0.0 109.946 178.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.0 m -82.97 -45.11 14.51 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.342 179.551 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.61 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.58 -26.41 66.94 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.368 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 50' ' ' LEU . 62.3 t -53.16 -50.7 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.976 179.518 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -73.23 -10.97 60.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.617 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -93.96 -19.42 20.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.295 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.592 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 54.2 m-85 -135.88 61.79 43.38 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.472 -179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.02 -40.5 76.26 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.565 2.176 . . . . 0.0 111.415 179.175 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.17 -43.0 95.56 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.357 178.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.1 t -65.02 146.08 13.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 178.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.617 ' HB2' HG21 ' A' ' 31' ' ' THR . 37.5 t -83.1 95.73 8.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.053 0.454 . . . . 0.0 111.054 -179.61 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.482 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.8 p90 -61.42 128.9 38.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.75 179.49 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.496 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -148.84 160.98 28.58 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.251 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.5 tt -159.47 143.54 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.696 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.4 t -147.28 155.29 41.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.154 0.502 . . . . 0.0 111.833 -178.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 39' ' ' PHE . 81.4 p -138.77 -0.31 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.587 179.561 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -68.61 141.98 55.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.571 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 t -65.12 -51.34 61.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.411 -179.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -50.91 -42.05 59.05 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.551 -179.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HA ' HG22 ' A' ' 21' ' ' VAL . 57.4 t -71.15 -53.39 21.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.92 0.39 . . . . 0.0 110.596 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.05 -15.43 13.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.324 179.429 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.4 m -91.24 -40.6 11.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.359 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -61.13 -38.22 85.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.345 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -93.25 14.28 18.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.682 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 54.45 23.32 4.41 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.643 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.707 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.6 mm -57.72 120.05 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.961 179.754 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.2 p -139.01 57.36 1.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.492 -179.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.36 49.3 0.02 OUTLIER Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.738 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.598 ' HB2' HG21 ' A' ' 99' ' ' ILE . 34.3 m-20 48.17 43.68 18.79 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.207 0.527 . . . . 0.0 110.292 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.707 ' HB ' HG23 ' A' ' 76' ' ' ILE . 97.2 m -69.34 151.53 46.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.737 -178.373 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.581 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.9 mt -118.27 117.0 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.835 178.12 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.516 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.1 m -106.05 130.93 53.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.824 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.634 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -107.23 104.19 13.75 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.525 177.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.2 t80 -98.7 121.1 40.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.798 0.332 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.538 HH12 HD12 ' A' ' 116' ' ' LEU . 3.8 mtm180 -104.38 98.45 8.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.094 179.711 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tp -42.07 -50.46 4.7 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.783 -179.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.623 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.86 -65.21 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.516 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.442 ' HB2' HH21 ' A' ' 85' ' ' ARG . 9.7 m-20 -99.01 10.57 41.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.562 -179.315 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 85' ' ' ARG . 78.1 m-20 49.66 34.27 7.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.509 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 8.2 mm-40 -78.02 157.69 29.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.122 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -142.34 97.2 3.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.808 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.634 HD23 ' HG ' ' A' ' 83' ' ' LEU . 1.9 mm? -88.06 113.52 23.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.767 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -95.84 96.91 9.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.572 HD21 HD13 ' A' ' 102' ' ' ILE . 4.1 tt -80.98 78.76 7.77 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.626 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.0 mt-10 -80.77 -163.79 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.762 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.497 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 17.4 t70 -50.66 -37.7 42.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.047 -179.2 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -55.34 -14.93 2.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.118 0.485 . . . . 0.0 110.393 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -131.14 -13.76 3.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.605 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.598 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.8 mm -89.63 -32.98 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.612 0.244 . . . . 0.0 111.379 -179.376 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -51.51 -49.38 62.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.704 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.3 m -117.79 38.14 3.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.526 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.592 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.2 tp -63.93 147.0 12.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.645 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.465 ' N ' HG13 ' A' ' 102' ' ' ILE . 11.5 t70 -141.09 165.24 28.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.685 178.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.947 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -62.12 -35.57 79.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.144 0.497 . . . . 0.0 109.691 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -64.66 -47.5 78.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.222 178.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -59.31 -59.37 5.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.177 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.76 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.21 -55.62 14.49 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.937 0.399 . . . . 0.0 110.132 179.656 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.5 m -58.85 -28.65 66.29 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.82 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.549 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.9 tmt_? -71.93 -66.45 0.64 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.185 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -42.9 -43.71 4.22 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.166 179.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.471 HG12 HG21 ' A' ' 35' ' ' VAL . 95.4 mt -63.38 -54.69 29.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.551 178.452 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -54.52 -19.36 5.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.23 179.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.549 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -87.89 -37.67 10.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.939 -179.109 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -121.76 29.39 7.16 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.601 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 81.1 p -81.65 44.97 0.85 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.11 0.481 . . . . 0.0 110.232 178.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.538 HD12 HH12 ' A' ' 85' ' ' ARG . 52.6 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.185 -179.398 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.482 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.7 pt-20 . . . . . 0 CA--C 1.53 0.201 0 CA-C-O 120.5 0.19 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.499 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 38.8 Cg_endo -66.76 142.85 65.07 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.592 2.195 . . . . 0.0 112.389 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.3 m -61.81 152.87 30.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.765 -179.315 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.51 94.91 7.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.866 179.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.621 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.8 mt -90.52 71.48 6.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.373 179.855 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.0 p -70.92 -5.04 27.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.945 -179.23 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -137.53 146.49 44.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.007 0.432 . . . . 0.0 111.656 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.615 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.9 t -56.12 -49.17 94.7 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.377 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -58.11 -46.46 25.35 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.936 1.757 . . . . 0.0 111.869 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.68 -34.85 77.96 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.344 0.592 . . . . 0.0 110.251 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.621 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.8 -59.84 4.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.113 179.399 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 30.6 mtt -60.7 -25.88 66.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.207 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 31.3 mt-10 -71.27 -51.13 26.2 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.373 179.639 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -60.66 -30.32 69.83 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.159 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.517 HD11 HD12 ' A' ' 36' ' ' ILE . 45.6 mt -76.22 -37.01 31.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.96 178.15 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.02 -23.08 61.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.813 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.13 31.65 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.923 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.506 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.9 t -170.22 151.25 3.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.337 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.522 ' HG3' HG13 ' A' ' 87' ' ' VAL . 23.3 tt0 -70.73 -50.36 37.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.58 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.528 HG13 HD11 ' A' ' 83' ' ' LEU . 19.1 t -119.7 136.34 57.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.359 179.262 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.56 128.55 20.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.013 0.435 . . . . 0.0 112.119 -178.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.459 HG21 HG12 ' A' ' 111' ' ' ILE . 47.1 t -115.5 128.81 72.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.672 178.469 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.517 HD12 HD11 ' A' ' 28' ' ' ILE . 23.8 mt -135.03 136.08 52.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -177.306 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.58 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.48 97.24 1.78 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.455 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.4 m-85 -83.39 90.98 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.9 m-85 -110.5 142.71 41.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.037 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.463 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 50.8 mt-30 -91.04 -0.96 57.85 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.498 ' O ' HG12 ' A' ' 44' ' ' ILE . 26.6 t70 -157.59 119.39 3.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.571 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.495 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.2 mt -89.15 45.4 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.087 0.47 . . . . 0.0 111.386 -179.262 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.1 mt-10 -134.66 12.04 3.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.01 179.094 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.741 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.5 pt -95.53 158.29 34.75 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.483 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.487 ' O ' HD12 ' A' ' 49' ' ' ILE . 73.4 Cg_exo -52.73 -28.65 38.84 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.853 2.369 . . . . 0.0 112.721 179.42 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.741 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -61.63 -38.09 86.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.012 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.692 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.05 -57.69 24.48 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.681 -178.724 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.675 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.5 Cg_exo -59.46 -39.49 75.53 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.775 1.65 . . . . 0.0 111.431 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.7 mt -62.5 -36.06 73.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.008 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.586 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.1 tp -74.8 -54.07 7.99 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -53.45 -23.63 10.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.952 0.406 . . . . 0.0 110.025 178.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 t -84.27 -45.54 12.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.474 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.605 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.33 -25.6 64.31 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.342 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.2 t -51.89 -49.08 38.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.265 179.391 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -76.76 -9.08 58.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.738 -179.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -94.94 -18.71 20.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.156 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.569 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.4 m-85 -136.86 63.21 44.49 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.368 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.55 -46.12 35.46 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.643 2.229 . . . . 0.0 111.643 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.82 -42.87 69.97 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.392 179.038 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -65.03 144.28 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.781 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.506 ' CB ' HG21 ' A' ' 31' ' ' THR . 46.8 t -82.35 98.79 9.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.078 0.466 . . . . 0.0 111.159 -179.554 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.499 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.1 p90 -65.35 126.72 29.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.009 179.728 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.504 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.73 161.98 28.46 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.187 179.861 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -160.57 143.3 4.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.2 t -146.18 156.67 43.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.183 0.516 . . . . 0.0 111.675 -179.066 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.449 HG21 ' HG ' ' A' ' 42' ' ' LEU . 52.2 p -139.17 -3.63 1.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.589 179.548 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.44 140.46 57.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.401 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.4 t -64.63 -47.64 77.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.68 -179.31 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -51.77 -43.68 63.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.73 -0.213 . . . . 0.0 111.554 -179.307 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.527 ' HA ' HG22 ' A' ' 21' ' ' VAL . 79.7 t -71.75 -52.37 25.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.722 0.296 . . . . 0.0 110.513 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.456 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -58.48 -15.0 9.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.24 179.271 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.7 m -92.61 -40.52 10.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.429 178.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -62.41 -33.08 74.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.428 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.414 ' HB2' HG12 ' A' ' 76' ' ' ILE . 28.7 m-85 -97.07 9.81 41.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.864 179.507 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.413 ' HA ' HD22 ' A' ' 75' ' ' ASN . 2.1 t-20 60.1 20.7 9.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.569 178.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.674 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.9 mm -58.36 117.92 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 179.818 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.9 p -138.38 56.78 1.71 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.283 179.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.22 45.45 0.02 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.677 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 12.2 m120 51.26 43.11 29.47 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.243 0.545 . . . . 0.0 110.398 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.674 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.5 m -69.05 151.08 46.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.673 -178.573 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.58 HG12 ' HA2' ' A' ' 37' ' ' GLY . 70.9 mt -118.32 116.8 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.882 178.045 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.5 m -105.89 130.88 53.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.808 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.612 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -105.37 99.73 9.33 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.389 177.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.1 t80 -92.63 121.85 34.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.583 179.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.504 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.0 mtm180 -106.41 85.56 2.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.83 -179.684 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.9 tp -26.51 -60.2 0.08 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.365 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.522 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.94 -71.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 O-C-N 123.448 0.467 . . . . 0.0 112.092 -179.161 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.04 5.32 41.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 110.687 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 51.12 33.44 9.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.148 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.504 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 14.1 mm-40 -75.64 164.77 25.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.727 179.535 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.79 89.01 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.836 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.612 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.6 mm? -76.6 111.71 12.38 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.544 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -94.48 97.53 10.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.488 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.548 HD21 HD13 ' A' ' 102' ' ' ILE . 4.4 tt -82.93 77.29 9.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.593 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.448 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.2 mt-10 -78.91 -165.12 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.512 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 19.4 t70 -51.67 -35.42 42.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.686 -179.291 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -56.57 -15.19 3.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.225 0.536 . . . . 0.0 110.24 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -130.33 -13.99 3.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.779 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.57 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.4 mm -89.44 -29.59 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.684 0.278 . . . . 0.0 111.514 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.52 -38.38 69.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.855 0.36 . . . . 0.0 110.961 -179.801 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.8 t -129.78 38.74 3.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.319 179.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.548 HD13 HD21 ' A' ' 94' ' ' LEU . 6.8 tp -64.02 141.74 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.559 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -137.24 149.81 47.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.531 178.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.889 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.67 -37.31 12.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.923 0.392 . . . . 0.0 110.337 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -61.88 -49.09 77.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.147 178.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -58.65 -61.31 2.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.23 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.73 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.18 -57.34 6.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 110.35 179.908 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.3 m -57.06 -30.38 64.23 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.8 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.506 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -70.91 -65.72 0.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.186 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -42.82 -40.91 3.05 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.044 179.277 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.459 HG12 HG21 ' A' ' 35' ' ' VAL . 96.2 mt -65.9 -56.29 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.247 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -53.21 -18.26 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.325 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.591 HG22 ' ND2' ' A' ' 114' ' ' ASN . 1.4 mp -90.31 -39.5 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.87 -179.108 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.591 ' ND2' HG22 ' A' ' 113' ' ' ILE . 67.8 m-80 -118.72 28.73 8.13 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.775 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.3 p -82.22 50.26 1.56 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.023 0.44 . . . . 0.0 110.35 179.224 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.495 HD12 HH12 ' A' ' 85' ' ' ARG . 67.2 mt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.265 -179.618 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.7 pt-20 . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.495 0.188 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 37.7 Cg_endo -67.78 145.44 69.08 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.739 2.293 . . . . 0.0 112.559 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -64.14 153.35 38.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.554 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -98.13 95.02 7.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.799 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 24' ' ' ALA . 44.7 mt -91.45 71.91 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.357 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.2 p -70.84 -4.28 23.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.169 -179.157 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -139.46 147.34 41.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.378 . . . . 0.0 111.661 -179.717 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 35.3 t -55.64 -49.69 91.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.559 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.68 -46.39 27.18 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.917 1.745 . . . . 0.0 112.053 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.79 81.45 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.176 0.513 . . . . 0.0 110.2 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.608 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.55 -58.84 5.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.121 179.328 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.6 mtp -60.37 -25.54 65.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.157 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -72.61 -51.16 20.82 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.608 179.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.4 ' O ' HG22 ' A' ' 31' ' ' THR . 8.5 m-85 -60.63 -30.73 70.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.199 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.511 HD11 HD12 ' A' ' 36' ' ' ILE . 53.4 mt -75.79 -37.96 36.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.052 178.417 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.85 -17.08 60.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.285 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.42 26.62 3.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.078 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.7 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.2 t -167.86 153.09 6.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.54 -179.652 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.592 ' HG3' HG13 ' A' ' 87' ' ' VAL . 25.0 tt0 -66.79 -52.31 45.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.89 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.539 HG13 HD11 ' A' ' 83' ' ' LEU . 22.4 t -119.83 137.39 53.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.322 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.71 128.55 21.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.193 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.459 HG21 HG12 ' A' ' 111' ' ' ILE . 52.1 t -116.61 131.76 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.572 178.511 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.511 HD12 HD11 ' A' ' 28' ' ' ILE . 21.0 mt -136.62 136.73 48.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.487 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.593 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.34 97.53 1.83 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.549 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.1 m-85 -83.7 92.49 7.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.6 m-85 -112.95 140.44 47.76 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.166 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.467 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 51.7 mt-30 -88.93 0.33 56.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 44' ' ' ILE . 24.8 t70 -157.96 120.72 3.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.66 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.499 ' HA ' HG21 ' A' ' 47' ' ' VAL . 91.7 mt -90.62 46.53 1.34 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 111.428 -179.307 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.447 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 36.8 mt-10 -136.95 9.72 3.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 179.122 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.779 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.3 pt -92.97 157.01 39.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.313 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.471 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.4 Cg_exo -52.01 -25.26 21.75 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.943 2.429 . . . . 0.0 113.022 179.719 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.779 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.44 -38.59 90.3 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.669 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -59.95 -55.59 44.01 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.583 -178.776 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.632 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.96 -41.31 54.38 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.928 1.752 . . . . 0.0 111.502 179.218 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.3 mt -61.57 -34.6 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.208 179.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 54' ' ' VAL . 45.8 tp -73.93 -52.71 12.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -53.03 -26.96 17.39 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.9 m -80.07 -46.45 16.51 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.621 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.565 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.75 -25.99 65.31 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.446 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.8 t -53.1 -49.37 50.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.718 179.368 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -76.23 -9.7 58.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.666 -179.855 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -94.92 -17.8 21.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.116 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.566 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 68.3 m-85 -138.35 63.01 33.56 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.441 -179.845 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.01 -43.56 56.02 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.623 2.215 . . . . 0.0 111.651 179.145 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.23 -40.83 85.4 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.239 179.041 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.3 t -66.19 142.99 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.845 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.7 ' HB2' HG21 ' A' ' 31' ' ' THR . 42.1 t -80.79 96.8 7.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.959 0.409 . . . . 0.0 110.957 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.475 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.9 p90 -62.59 126.94 29.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.836 179.582 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.495 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.16 161.76 28.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.256 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.8 tt -161.24 142.24 3.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -147.59 154.14 40.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.1 0.476 . . . . 0.0 111.803 -178.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.454 HG21 ' HG ' ' A' ' 42' ' ' LEU . 68.4 p -135.57 -2.08 2.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.534 179.529 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.408 ' O ' HD13 ' A' ' 71' ' ' LEU . 23.9 t70 -67.18 142.48 56.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.717 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.1 m -65.95 -49.85 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.664 -179.461 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -50.47 -43.24 55.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.436 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.496 ' HA ' HG22 ' A' ' 21' ' ' VAL . 76.2 t -71.45 -53.21 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.668 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.457 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -58.52 -14.63 8.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.222 179.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 78.4 m -91.89 -41.2 10.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.252 178.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -61.22 -34.86 75.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.318 179.703 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 76' ' ' ILE . 47.7 m-85 -96.01 11.91 32.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.854 179.516 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 56.05 22.74 6.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.646 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.674 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.5 mm -59.03 120.21 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.951 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.1 p -140.7 55.2 1.59 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.333 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.75 45.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.458 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.618 ' HB2' HG21 ' A' ' 99' ' ' ILE . 13.1 m120 50.71 43.43 27.92 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.15 0.5 . . . . 0.0 110.44 -179.826 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.674 ' HB ' HG23 ' A' ' 76' ' ' ILE . 98.0 m -69.61 152.31 44.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.77 -178.495 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.625 HG21 HD21 ' A' ' 107' ' ' LEU . 62.8 mt -118.8 118.17 56.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.892 178.075 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.2 m -106.81 134.78 49.44 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.634 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -110.79 103.36 11.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.788 178.227 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -96.96 123.0 40.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.525 179.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.539 HH12 HD12 ' A' ' 116' ' ' LEU . 5.5 mtm180 -106.07 96.33 6.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.051 0.453 . . . . 0.0 110.187 179.803 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.4 tp -40.45 -50.2 2.88 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.558 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.592 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -44.66 -68.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.85 0.357 . . . . 0.0 111.908 -179.627 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.447 ' HB2' HH21 ' A' ' 85' ' ' ARG . 17.7 m-20 -92.85 17.76 10.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.442 -179.424 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.9 p30 43.11 31.3 0.34 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.043 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.511 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 13.7 mm-40 -76.59 162.48 27.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.824 0.345 . . . . 0.0 111.14 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -149.01 87.1 1.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.967 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.634 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -76.05 144.64 40.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.304 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -125.35 99.31 6.0 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.074 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.617 HD21 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -84.11 78.01 9.84 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.597 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.421 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.3 mt-10 -79.66 -165.79 0.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.476 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.6 OUTLIER -44.47 -52.58 7.76 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.618 -179.255 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.402 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 12.8 pt-20 -46.82 -17.06 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.51 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' OD2' ' HG3' ' A' ' 97' ' ' GLU . 36.5 m-20 -125.76 -13.98 6.3 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.41 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.618 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.6 mm -89.73 -35.41 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.112 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -48.25 -55.39 10.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.852 -179.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.1 p -114.08 39.31 2.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.539 179.462 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.617 HD13 HD21 ' A' ' 94' ' ' LEU . 8.2 tp -61.14 142.57 15.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.515 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -134.92 149.76 50.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.572 178.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.89 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.32 -32.96 12.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.11 0.481 . . . . 0.0 110.102 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -63.9 -49.08 74.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.352 178.691 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 102' ' ' ILE . 29.7 mtpp -59.04 -59.84 4.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.278 -179.806 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.755 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.19 -56.19 12.09 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.071 0.462 . . . . 0.0 110.076 179.848 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.3 m -58.21 -28.86 65.21 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.776 179.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.459 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.4 tmt_? -71.35 -67.11 0.54 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.079 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -42.24 -43.34 3.38 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.158 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.459 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -64.35 -55.47 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.702 178.416 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -52.89 -22.9 6.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.481 0.658 . . . . 0.0 110.112 179.259 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.459 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -85.66 -36.96 11.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.009 -179.054 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.473 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.7 m120 -124.84 31.87 5.56 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.054 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 111' ' ' ILE . 89.1 p -83.6 36.93 0.56 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.189 0.518 . . . . 0.0 110.213 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.539 HD12 HH12 ' A' ' 85' ' ' ARG . 51.7 mt . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.212 -179.517 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.508 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 . . . . . 0 CA--C 1.532 0.259 0 CA-C-O 120.395 0.141 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 29.4 Cg_endo -64.32 154.0 73.63 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.63 2.22 . . . . 0.0 112.525 -179.718 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -67.94 153.06 44.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.42 -179.765 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.99 84.15 2.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.727 179.696 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 46.8 mt -81.73 72.21 8.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.633 -179.723 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.1 p -70.63 -2.94 15.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.09 -179.013 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -142.27 147.63 36.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.083 0.468 . . . . 0.0 111.804 -179.603 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 60.6 t -55.47 -49.99 89.39 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.824 -179.999 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.3 Cg_endo -58.32 -44.84 34.97 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.035 1.823 . . . . 0.0 111.82 -179.899 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.23 -34.55 78.37 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.33 0.586 . . . . 0.0 110.229 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.2 -59.18 5.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.929 179.262 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 34.0 mtt -60.23 -27.82 67.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.244 -179.967 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -70.21 -49.88 45.72 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 110.603 179.807 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.531 ' O ' HG22 ' A' ' 31' ' ' THR . 6.6 m-85 -61.13 -32.95 72.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.892 179.237 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.526 HD11 ' CD1' ' A' ' 36' ' ' ILE . 48.4 mt -75.0 -37.35 40.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.034 178.478 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.32 -18.27 60.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.131 -179.705 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.2 27.31 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.131 -179.896 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.718 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.9 t -174.31 154.91 2.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.602 -179.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.492 ' HG3' HG13 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -64.58 -82.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.016 0.436 . . . . 0.0 110.719 179.556 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.561 HG13 HD11 ' A' ' 83' ' ' LEU . 18.1 t -89.6 134.34 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.758 -179.53 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.46 124.71 20.37 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.061 -179.216 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.524 HG21 HG12 ' A' ' 111' ' ' ILE . 46.4 t -113.61 128.16 70.61 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.921 178.702 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.526 ' CD1' HD11 ' A' ' 28' ' ' ILE . 26.8 mt -133.63 138.48 50.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.457 -177.289 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.68 95.9 1.41 Allowed Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.381 179.801 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.519 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 36.3 m-85 -81.99 89.33 6.39 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.294 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 13.6 m-85 -107.59 140.57 40.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.615 -177.769 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -88.9 -5.62 57.87 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.081 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.486 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.3 t70 -154.53 121.73 5.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.656 179.851 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.522 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.0 mt -90.04 45.29 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.014 0.435 . . . . 0.0 111.449 -179.354 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.441 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 11.1 mm-40 -134.83 11.78 3.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.068 179.245 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.734 HD12 ' HB3' ' A' ' 46' ' ' ALA . 4.0 pt -94.89 158.92 34.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.286 -179.955 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.511 ' O ' HD12 ' A' ' 49' ' ' ILE . 62.4 Cg_exo -54.86 -25.38 43.12 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.843 2.362 . . . . 0.0 112.803 179.497 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.734 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.43 -35.64 81.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.705 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.707 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -63.51 -55.87 31.33 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.648 -178.776 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 38.0 Cg_exo -60.84 -34.49 91.29 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.999 1.8 . . . . 0.0 111.598 179.65 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.843 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -69.38 -35.35 66.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.635 ' O ' HG23 ' A' ' 54' ' ' VAL . 36.7 tp -73.61 -50.41 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.471 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -55.74 -20.32 14.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.304 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -84.43 -49.67 8.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.567 179.29 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.699 ' HG2' HD13 ' A' ' 107' ' ' LEU . 2.9 ppp? -57.67 -25.36 60.13 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.099 0.476 . . . . 0.0 109.91 179.556 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -52.87 -46.55 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.991 179.51 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -80.05 -9.85 59.73 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.533 -179.848 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.495 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 27.8 mtpp -93.55 -19.0 21.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.239 -179.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.618 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 70.8 m-85 -137.17 62.57 39.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.468 -179.291 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.64 -36.47 71.98 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.535 2.157 . . . . 0.0 111.366 179.025 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.85 -42.05 99.75 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.818 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.1 t -65.95 144.95 14.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.799 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.718 ' HB2' HG21 ' A' ' 31' ' ' THR . 46.7 t -83.24 98.82 9.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.108 0.48 . . . . 0.0 110.974 -179.613 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.496 ' HB3' HG22 ' A' ' 54' ' ' VAL . 6.4 p90 -64.8 129.05 38.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.025 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.502 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.1 161.46 28.46 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.087 179.862 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -162.25 144.07 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.823 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.519 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 44.8 t -149.77 155.61 40.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.144 0.497 . . . . 0.0 111.673 -179.262 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 70.2 p -136.94 0.03 2.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.39 179.281 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -69.53 138.91 53.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.506 179.841 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.4 p -63.14 -48.26 79.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.529 -179.459 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -49.98 -46.78 52.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.615 0.245 . . . . 0.0 111.571 -179.411 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.571 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.4 t -69.02 -53.96 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -58.32 -15.05 8.85 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.258 179.478 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.2 m -91.67 -39.23 11.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.362 179.041 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -62.84 -39.04 93.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.468 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -92.15 12.62 21.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.627 179.312 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 55.86 25.2 8.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.535 179.363 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.697 HG23 ' HB ' ' A' ' 80' ' ' THR . 42.1 mm -60.84 122.68 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.48 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.2 p -142.8 59.68 1.43 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.248 -179.824 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.29 43.46 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.571 179.856 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 24.6 m-80 52.41 44.26 30.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.177 0.513 . . . . 0.0 110.569 -179.821 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.697 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.6 m -69.71 151.34 45.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.404 -0.817 . . . . 0.0 112.804 -178.568 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.565 HG12 ' HA2' ' A' ' 37' ' ' GLY . 57.1 mt -116.85 116.6 52.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.132 178.155 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 74.4 m -104.56 135.27 46.29 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.626 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -112.07 102.58 10.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.296 178.822 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.2 t80 -96.03 119.67 34.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.448 179.547 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.514 HH12 HD12 ' A' ' 116' ' ' LEU . 5.6 mtm180 -103.49 81.39 1.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.958 -179.421 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 32' ' ' GLU . 11.6 tp -25.35 -58.73 0.06 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.026 -179.369 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.492 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.42 -72.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.408 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -83.44 3.69 30.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.009 0.433 . . . . 0.0 110.542 179.944 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 52.06 32.7 10.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.639 179.725 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.474 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 7.1 mm-40 -78.26 162.1 26.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.688 179.737 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -146.45 91.67 2.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.026 179.926 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.626 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -79.09 146.06 33.45 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.378 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -127.28 93.21 3.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.018 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.49 HD21 HD13 ' A' ' 102' ' ' ILE . 4.4 tt -79.01 77.69 5.46 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.689 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.6 mt-10 -78.18 -166.24 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.801 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.54 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.8 t70 -51.12 -36.74 42.1 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.86 -179.369 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.428 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 10.3 pt-20 -55.82 -14.75 2.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.193 0.521 . . . . 0.0 110.477 179.551 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.428 ' OD2' ' HG3' ' A' ' 97' ' ' GLU . 23.7 m-20 -130.12 -13.75 3.97 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.537 179.881 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 79' ' ' ASN . 19.6 mm -89.27 -29.96 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.316 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -55.16 -45.28 75.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 111.134 -179.804 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.6 m -121.74 37.66 4.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.454 179.774 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.7 tp -62.35 144.69 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.43 -179.842 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.422 ' N ' HG13 ' A' ' 102' ' ' ILE . 21.6 m-20 -139.9 150.09 44.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.73 178.881 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.843 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.56 -39.79 11.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.916 0.389 . . . . 0.0 110.617 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.1 m -61.89 -47.57 84.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.64 178.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -59.03 -57.09 14.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.366 -179.521 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.813 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.7 -57.34 9.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.966 0.412 . . . . 0.0 110.011 179.832 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.2 m -56.7 -29.62 62.61 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.98 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.488 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -70.69 -65.25 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.189 179.739 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -43.2 -43.61 4.77 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.938 179.167 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.556 HD11 HD22 ' A' ' 107' ' ' LEU . 26.0 mt -62.13 -56.32 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.438 178.249 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -53.87 -19.38 4.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.29 179.401 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.488 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.63 -35.71 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.956 -179.154 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.598 HD22 ' HG ' ' A' ' 92' ' ' LEU . 87.8 m-20 -126.6 31.25 5.38 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.463 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 111' ' ' ILE . 88.6 p -84.56 45.98 1.19 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.242 0.544 . . . . 0.0 110.071 178.848 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.514 HD12 HH12 ' A' ' 85' ' ' ARG . 55.5 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.455 -179.163 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 120.525 0.203 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 38.0 Cg_endo -67.18 142.14 59.86 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.595 2.197 . . . . 0.0 112.473 -179.753 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.0 m -56.28 152.95 10.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.52 -179.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -99.84 83.07 2.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.856 179.852 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 24' ' ' ALA . 36.9 mt -80.87 73.24 7.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.527 -179.905 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.0 p -72.8 -4.75 33.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.937 -179.191 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -136.65 147.11 46.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.382 . . . . 0.0 111.65 -179.72 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 24.1 t -56.33 -49.81 91.22 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.493 -179.985 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.82 -46.04 29.02 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.849 1.699 . . . . 0.0 111.934 179.994 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.37 -35.44 80.42 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.211 0.529 . . . . 0.0 110.277 -179.944 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.595 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -63.49 -58.93 5.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.097 179.562 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 60.3 mtp -59.82 -27.31 66.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.103 -179.986 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -71.2 -50.44 33.02 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.661 0.267 . . . . 0.0 110.778 179.777 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -60.99 -31.89 71.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.976 179.283 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.526 HD11 HD12 ' A' ' 36' ' ' ILE . 47.2 mt -73.93 -37.26 47.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.883 178.269 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.92 -18.73 60.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.018 -179.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.12 29.61 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.642 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.9 t -169.49 152.23 4.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.389 -179.736 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.632 ' HG3' HG13 ' A' ' 87' ' ' VAL . 31.3 tt0 -70.33 -41.45 73.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.765 179.913 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.515 HG13 HD11 ' A' ' 83' ' ' LEU . 19.6 t -128.95 134.11 64.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.182 179.324 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.11 128.91 26.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 112.154 -179.052 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.448 HG21 HG12 ' A' ' 111' ' ' ILE . 43.3 t -116.92 127.14 74.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.502 178.325 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 28' ' ' ILE . 23.4 mt -133.25 136.16 55.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.45 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.603 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.12 97.38 1.83 Allowed Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.562 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.5 m-85 -83.57 91.69 7.48 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.408 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.2 m-85 -111.89 138.32 48.67 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.023 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.478 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 48.3 mt-30 -85.06 -9.5 57.91 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.87 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.463 ' O ' HG12 ' A' ' 44' ' ' ILE . 15.8 t70 -150.4 119.56 6.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.745 179.716 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.506 ' HA ' HG21 ' A' ' 47' ' ' VAL . 96.4 mt -87.89 44.06 1.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.023 0.44 . . . . 0.0 111.562 -179.153 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.417 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 36.8 mt-10 -131.97 11.52 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.237 0.541 . . . . 0.0 109.972 179.134 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.682 HG13 HG23 ' A' ' 47' ' ' VAL . 8.5 pt -93.96 161.61 29.38 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.517 -179.657 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.482 ' O ' HD12 ' A' ' 49' ' ' ILE . 51.6 Cg_exo -57.04 -25.22 62.09 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.843 2.362 . . . . 0.0 112.538 179.202 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.628 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.14 -38.77 91.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.478 -178.763 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 44' ' ' ILE . 2.1 t -59.81 -55.41 45.96 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -178.717 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.5 Cg_exo -60.88 -41.63 43.85 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.026 1.817 . . . . 0.0 111.567 179.199 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.879 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -61.72 -34.2 61.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.149 -179.998 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.1 tp -74.98 -51.89 12.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.785 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -53.6 -26.0 19.9 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.094 0.473 . . . . 0.0 109.808 178.607 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 t -82.17 -46.39 13.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.642 179.6 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.578 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.67 -25.84 63.21 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.358 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 50' ' ' LEU . 52.5 t -52.29 -46.05 44.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.827 179.34 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -80.76 -10.12 59.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.735 -179.795 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -93.55 -17.12 23.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.153 179.837 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 49.3 m-85 -139.38 63.89 29.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.505 -179.854 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.78 -45.1 42.92 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.719 2.279 . . . . 0.0 111.713 179.052 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.23 -40.76 76.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.293 179.252 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.6 t -66.86 143.97 15.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.69 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.642 ' CB ' HG21 ' A' ' 31' ' ' THR . 42.2 t -82.42 97.96 8.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.987 0.422 . . . . 0.0 111.045 -179.633 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.483 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -64.2 127.24 30.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.722 179.71 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.501 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.82 162.7 28.56 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.133 179.887 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 tt -160.82 145.12 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.913 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 t -149.82 152.82 35.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.004 0.431 . . . . 0.0 111.597 -179.157 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 39' ' ' PHE . 81.7 p -135.87 -1.45 2.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.622 179.569 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.61 143.32 56.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.77 -179.918 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 81.7 p -65.7 -49.59 67.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.103 -179.556 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -50.79 -45.87 59.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.458 -179.352 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.496 ' HA ' HG22 ' A' ' 21' ' ' VAL . 62.3 t -69.48 -53.17 26.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.733 0.301 . . . . 0.0 110.737 179.935 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -58.55 -15.17 10.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.283 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.4 m -90.39 -40.97 11.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.223 178.63 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -60.67 -40.49 92.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.45 179.841 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.407 ' HB2' HG12 ' A' ' 76' ' ' ILE . 46.1 m-85 -90.51 11.44 21.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 179.605 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 55.96 25.1 8.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.482 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.672 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.7 mm -60.67 119.74 5.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 179.797 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.6 p -140.35 57.76 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.242 179.98 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.76 42.97 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.601 179.82 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.578 ' HB2' HG21 ' A' ' 99' ' ' ILE . 14.4 m120 52.67 42.38 31.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.194 0.521 . . . . 0.0 110.255 -179.726 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.672 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.9 m -68.74 152.83 44.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.806 -178.529 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.603 HG12 ' HA2' ' A' ' 37' ' ' GLY . 71.4 mt -119.76 117.54 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.979 178.206 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.5 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 72.4 m -105.75 130.42 53.75 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.871 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.642 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -106.49 101.16 10.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.619 178.036 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.7 t80 -95.89 120.51 36.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.769 0.319 . . . . 0.0 110.706 -179.954 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.6 HH12 HD12 ' A' ' 116' ' ' LEU . 5.0 mtm180 -103.24 97.95 7.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.045 179.881 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 tp -41.67 -51.79 3.99 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.598 -179.464 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.632 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -44.5 -65.67 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.395 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.46 ' HB2' HH21 ' A' ' 85' ' ' ARG . 7.6 m-20 -95.53 17.31 14.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.69 -178.977 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.4 p30 42.38 32.64 0.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.036 179.227 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 25.3 mm-40 -78.99 161.69 26.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.855 0.36 . . . . 0.0 111.33 -179.876 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -147.23 96.45 2.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.52 179.497 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.642 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.1 mm? -86.66 120.3 27.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.942 179.817 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.95 98.72 9.16 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.679 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.573 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -83.43 77.71 9.77 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.721 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.6 mt-10 -78.99 -164.7 0.64 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.801 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.526 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.8 t70 -51.39 -36.4 43.25 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.254 -179.175 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -56.95 -14.69 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.148 0.499 . . . . 0.0 110.265 179.558 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -129.64 -13.64 4.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.577 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.578 HG21 ' HB2' ' A' ' 79' ' ' ASN . 21.4 mm -91.24 -29.27 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.519 -179.492 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -51.7 -51.89 52.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 56.0 m -121.27 39.98 3.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.506 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.573 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -60.67 142.01 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.557 -179.704 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.445 ' H ' ' HD3' ' A' ' 106' ' ' LYS . 17.4 m-20 -134.25 150.71 51.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.428 178.752 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.879 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.74 -35.86 23.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.065 0.46 . . . . 0.0 110.4 179.993 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.6 m -62.4 -46.08 90.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.237 178.739 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.51 ' HZ3' HD12 ' A' ' 102' ' ' ILE . 8.3 mtpm? -60.97 -60.76 3.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.179 -179.79 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.79 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.48 -55.45 10.93 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.958 0.409 . . . . 0.0 110.04 179.844 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.9 m -58.51 -30.81 67.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.92 179.715 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -70.94 -65.71 0.7 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.195 179.677 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -42.91 -43.31 4.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.06 179.303 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.448 HG12 HG21 ' A' ' 35' ' ' VAL . 96.6 mt -63.28 -55.87 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.174 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.13 -18.42 3.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.305 179.259 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.469 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.41 -36.39 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.69 -179.305 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.636 HD22 ' HG ' ' A' ' 92' ' ' LEU . 91.7 m-20 -126.29 32.97 5.11 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.547 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.2 p -84.57 38.35 0.68 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.058 0.456 . . . . 0.0 110.243 178.801 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.6 HD12 HH12 ' A' ' 85' ' ' ARG . 58.6 mt . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.085 -0.959 . . . . 0.0 111.28 -179.445 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.491 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.8 pt-20 . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 42.6 Cg_endo -67.24 147.74 79.11 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.569 2.18 . . . . 0.0 112.628 -179.251 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.5 m -69.39 154.06 42.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.662 -179.494 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -97.16 87.73 4.28 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.251 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.1 mt -81.6 70.05 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.066 179.473 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.6 p -67.85 -0.44 4.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.626 -178.654 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 7.8 m-20 -145.9 147.83 32.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 111.65 -179.887 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.608 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.0 t -54.29 -49.83 88.21 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.504 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.6 Cg_endo -56.81 -47.53 22.96 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.07 1.847 . . . . 0.0 112.195 179.94 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.62 78.08 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.202 0.525 . . . . 0.0 110.508 -179.701 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.17 -58.7 5.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.169 179.355 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 68.3 mtp -60.98 -27.21 68.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.065 -179.861 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 25.0 mt-10 -71.33 -50.48 31.94 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.735 0.303 . . . . 0.0 110.596 179.777 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.564 ' O ' HG22 ' A' ' 31' ' ' THR . 7.5 m-85 -59.74 -34.59 73.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.904 179.303 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.576 HD11 HD12 ' A' ' 36' ' ' ILE . 44.3 mt -72.62 -37.78 57.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.946 178.288 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.56 -17.67 61.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.989 -179.768 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.1 26.41 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.222 -179.671 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.613 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.0 t -169.88 151.75 4.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.557 -179.881 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.564 ' HG3' HG13 ' A' ' 87' ' ' VAL . 15.6 tt0 -62.78 -76.42 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.598 179.751 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG13 HD11 ' A' ' 83' ' ' LEU . 16.0 t -96.49 138.71 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.459 179.538 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.59 124.11 15.85 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.991 0.424 . . . . 0.0 112.003 -179.26 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.431 HG11 HD11 ' A' ' 111' ' ' ILE . 50.0 t -112.62 129.85 67.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.435 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 28' ' ' ILE . 34.7 mt -135.74 137.13 49.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.041 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.91 96.69 1.66 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.461 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.451 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.1 m-85 -82.97 90.56 7.01 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.233 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.1 m-85 -110.23 145.82 36.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.363 -178.148 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.444 ' HG2' HD23 ' A' ' 71' ' ' LEU . 93.2 mt-30 -92.36 -6.5 50.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.839 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.514 ' O ' HG12 ' A' ' 44' ' ' ILE . 36.6 t70 -151.87 121.93 7.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.555 179.822 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.584 ' HA ' HG21 ' A' ' 47' ' ' VAL . 87.9 mt -90.57 46.49 1.34 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.158 0.504 . . . . 0.0 111.331 -179.319 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.438 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 38.9 mt-10 -135.68 7.11 3.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.937 178.977 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.754 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.1 pt -89.54 157.64 46.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.26 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.484 ' O ' HD12 ' A' ' 49' ' ' ILE . 70.6 Cg_exo -53.4 -26.05 33.99 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.92 2.413 . . . . 0.0 112.911 179.665 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.754 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.08 -36.95 85.95 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.977 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.72 HG23 HG13 ' A' ' 44' ' ' ILE . 3.2 t -60.99 -56.65 32.86 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.549 -178.915 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.68 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.2 Cg_exo -59.82 -41.26 56.06 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 121.754 1.636 . . . . 0.0 111.407 179.635 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -61.29 -35.6 67.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.027 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.1 tp -72.98 -53.78 10.32 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.809 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -53.71 -24.6 15.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.086 0.47 . . . . 0.0 109.848 178.748 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -82.07 -45.57 15.06 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.623 179.615 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.605 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.83 -26.18 67.15 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.082 0.468 . . . . 0.0 109.74 179.582 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 50' ' ' LEU . 61.1 t -52.76 -49.65 45.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.843 179.492 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -75.04 -9.41 58.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.637 -179.708 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -95.14 -18.67 20.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.059 179.586 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.586 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 64.3 m-85 -135.92 62.85 48.93 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.285 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.8 -42.51 62.82 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.701 2.267 . . . . 0.0 111.64 179.137 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.25 -37.23 86.26 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.657 179.147 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.2 t -69.89 144.8 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.121 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.613 ' CB ' HG21 ' A' ' 31' ' ' THR . 35.4 t -82.53 98.81 9.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.095 0.474 . . . . 0.0 110.932 -179.902 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.493 ' HB3' HG22 ' A' ' 54' ' ' VAL . 5.4 p90 -65.23 126.29 27.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.205 179.976 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.479 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.24 161.23 28.16 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.276 179.809 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -161.64 144.18 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.451 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.8 t -149.47 157.85 43.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.171 0.51 . . . . 0.0 111.845 -179.28 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.501 HG21 ' HG ' ' A' ' 42' ' ' LEU . 57.9 p -138.57 -0.24 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.481 179.488 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.25 137.13 54.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.343 -179.907 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.0 m -61.59 -50.7 71.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.501 -179.341 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -50.28 -40.91 49.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.568 -179.558 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.512 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.2 t -72.05 -54.93 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.028 0.442 . . . . 0.0 110.73 179.846 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.444 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.2 mp -58.38 -14.64 8.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.291 179.324 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.5 m -91.18 -41.72 10.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.178 178.719 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -59.9 -40.64 89.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.462 179.833 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 76' ' ' ILE . 89.9 m-85 -90.43 9.15 30.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.794 179.444 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 58.73 24.71 12.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.604 179.429 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.748 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.8 mm -60.97 119.62 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.986 179.53 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.0 p -138.55 56.04 1.72 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.262 -179.941 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.09 45.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.594 179.849 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.636 ' HB2' HG21 ' A' ' 99' ' ' ILE . 25.7 m-20 50.15 43.44 25.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.162 0.506 . . . . 0.0 110.397 -179.828 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.748 ' HB ' HG23 ' A' ' 76' ' ' ILE . 88.5 m -68.42 151.97 46.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.786 -178.665 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.581 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.9 mt -118.21 115.65 48.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.219 178.032 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 72.1 m -103.85 133.49 48.75 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -177.819 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.657 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -109.22 104.6 13.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.979 178.392 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.7 t80 -98.62 121.11 40.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.643 179.8 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.503 HH12 HD12 ' A' ' 116' ' ' LEU . 4.4 mtm180 -103.94 81.34 1.85 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.906 -179.726 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 7.2 tp -25.26 -59.63 0.06 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -179.455 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.564 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.53 -57.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.338 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -98.3 3.42 48.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.636 -179.735 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.2 t30 53.11 21.2 2.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.586 179.654 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 12.6 mm-40 -67.34 154.12 42.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.659 179.596 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -138.05 89.3 2.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.507 179.314 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.657 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -78.0 141.79 38.68 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.378 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.92 109.27 14.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.218 0.532 . . . . 0.0 112.401 -178.929 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.606 HD21 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -94.7 76.43 3.71 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.875 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 99' ' ' ILE . 24.0 mt-10 -77.39 -165.31 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -176.857 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.473 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.3 OUTLIER -46.52 -51.05 16.22 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.575 -179.191 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -48.15 -15.24 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.967 0.413 . . . . 0.0 111.262 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.413 ' N ' ' C ' ' A' ' 96' ' ' ASP . 17.0 m-20 -126.98 -13.66 5.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.367 179.792 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.636 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.5 mm -91.87 -38.97 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.479 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -50.43 -47.42 56.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.967 0.413 . . . . 0.0 110.71 179.74 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.8 m -116.61 38.83 3.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.507 179.89 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.606 HD13 HD21 ' A' ' 94' ' ' LEU . 8.5 tp -67.21 144.86 14.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.593 -179.541 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -139.44 148.83 43.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.321 178.48 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.887 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.37 -36.84 10.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.104 0.478 . . . . 0.0 110.444 -179.713 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.9 m -63.05 -47.55 82.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.342 178.977 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -59.81 -58.93 6.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.313 -179.694 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.764 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.23 -55.44 15.29 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.002 0.43 . . . . 0.0 110.117 179.869 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.2 m -58.39 -29.53 66.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.809 179.796 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.499 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -71.3 -66.11 0.66 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.225 179.609 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -42.82 -44.04 4.28 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.122 179.274 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.431 HD11 HG11 ' A' ' 35' ' ' VAL . 96.2 mt -62.92 -55.36 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.529 178.293 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -54.32 -18.41 4.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.374 179.223 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.499 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.0 -36.89 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.862 -179.059 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.5 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.0 m120 -125.37 31.03 5.65 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.464 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 97.1 p -82.62 37.76 0.53 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.076 0.465 . . . . 0.0 110.142 178.869 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.503 HD12 HH12 ' A' ' 85' ' ' ARG . 59.0 mt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.188 -179.425 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.48 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.1 pt-20 . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 37.9 Cg_endo -66.83 145.68 75.62 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.308 2.005 . . . . 0.0 112.756 -179.541 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.4 m -62.54 147.52 48.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.524 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -92.99 84.3 4.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.739 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.62 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.4 mt -81.77 76.21 8.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.638 -179.913 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.8 p -76.02 -4.17 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.856 -179.255 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -139.37 147.28 41.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.994 0.426 . . . . 0.0 111.61 -179.738 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 44.2 t -55.76 -50.33 87.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.59 179.891 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.33 -45.11 37.01 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.986 1.791 . . . . 0.0 111.939 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.03 82.73 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.262 0.553 . . . . 0.0 110.285 -179.881 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.62 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.55 -59.0 5.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.05 179.513 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 59.7 mtm -60.41 -27.02 67.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.148 -179.928 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -70.98 -50.79 30.45 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.72 0.295 . . . . 0.0 110.571 179.594 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.415 ' O ' HG22 ' A' ' 31' ' ' THR . 9.9 m-85 -60.26 -31.42 70.2 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.197 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 36' ' ' ILE . 47.7 mt -74.18 -39.07 49.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.077 178.196 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.45 -19.71 60.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.071 -179.899 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.25 30.0 1.78 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.576 HG21 ' CB ' ' A' ' 61' ' ' SER . 10.0 t -169.85 154.34 5.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.42 -179.593 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.631 ' HG3' HG13 ' A' ' 87' ' ' VAL . 24.8 tt0 -71.8 -43.46 65.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.683 179.861 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG13 HD11 ' A' ' 83' ' ' LEU . 19.1 t -127.47 137.4 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.225 179.418 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.67 129.75 22.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.947 0.403 . . . . 0.0 112.062 -179.061 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.431 HG11 HD11 ' A' ' 111' ' ' ILE . 42.3 t -117.45 128.26 74.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.571 178.536 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.541 HD12 HD11 ' A' ' 28' ' ' ILE . 22.8 mt -133.66 136.18 54.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.47 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.585 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.81 95.97 1.57 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.517 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.6 m-85 -82.6 89.65 6.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.523 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.7 m-85 -108.55 139.24 43.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.538 -178.181 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.432 ' HG2' HD23 ' A' ' 71' ' ' LEU . 47.4 mt-30 -85.94 -4.52 59.19 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.915 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.4 t70 -153.95 122.05 6.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.619 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.632 ' HA ' HG21 ' A' ' 47' ' ' VAL . 97.9 mt -91.17 47.37 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.147 0.499 . . . . 0.0 111.375 -179.331 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.423 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.4 mt-10 -138.85 8.67 2.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.941 179.073 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.841 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.2 pt -92.91 154.45 41.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.061 179.753 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.504 ' O ' HD12 ' A' ' 49' ' ' ILE . 87.0 Cg_exo -48.24 -29.75 13.5 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.004 2.469 . . . . 0.0 113.242 179.82 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.841 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.37 -36.7 83.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.911 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.665 HG23 HG13 ' A' ' 44' ' ' ILE . 2.7 t -63.18 -56.62 26.18 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.747 -178.801 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.656 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.3 Cg_exo -59.86 -36.92 89.2 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.789 1.659 . . . . 0.0 111.42 179.534 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.6 mt -64.83 -36.52 77.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.909 179.73 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.593 ' O ' HG23 ' A' ' 54' ' ' VAL . 42.9 tp -72.46 -53.36 12.37 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.749 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -53.86 -22.26 9.45 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.072 0.463 . . . . 0.0 109.824 178.765 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -85.36 -44.83 12.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.555 179.668 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.593 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.92 -25.55 66.84 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.369 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.7 t -53.24 -49.41 52.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.988 179.411 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -75.09 -9.41 58.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.686 -179.885 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -95.23 -20.25 19.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.309 179.788 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.599 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 61.1 m-85 -134.69 61.12 46.38 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.508 -179.603 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.74 -40.17 74.83 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.506 2.137 . . . . 0.0 111.45 179.176 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.04 -40.85 96.05 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.764 -0.732 . . . . 0.0 111.449 178.963 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.3 t -67.65 144.58 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.798 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.576 ' CB ' HG21 ' A' ' 31' ' ' THR . 38.7 t -81.43 96.5 7.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.085 0.469 . . . . 0.0 111.157 -179.624 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.455 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.7 p90 -62.28 129.45 40.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.962 179.732 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.514 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -148.51 161.48 28.65 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.079 179.716 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.431 HD11 HG13 ' A' ' 47' ' ' VAL . 5.2 tt -160.53 143.07 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.813 0.34 . . . . 0.0 110.178 179.862 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.6 t -146.44 157.98 43.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.971 0.415 . . . . 0.0 111.678 -179.035 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.457 HG21 ' HG ' ' A' ' 42' ' ' LEU . 67.5 p -141.07 -8.78 1.01 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.766 179.804 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -64.48 142.79 58.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.789 -179.882 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.6 m -64.03 -47.74 79.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.567 -179.495 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -51.14 -46.09 61.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.514 -179.269 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.556 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.7 t -70.34 -51.54 37.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.812 0.339 . . . . 0.0 110.73 179.806 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.432 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -59.3 -14.63 12.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.187 179.371 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.0 m -91.97 -41.17 10.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.297 178.657 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -60.3 -41.99 94.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.657 179.933 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.417 ' HB2' HG12 ' A' ' 76' ' ' ILE . 51.2 m-85 -89.21 11.29 19.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.798 179.587 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 56.41 27.72 12.5 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.597 179.45 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.683 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.4 mm -62.67 124.3 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.961 179.755 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.1 p -142.78 59.31 1.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.444 -179.782 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.83 46.39 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.687 179.697 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 30.1 m-80 51.91 43.15 30.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.059 0.457 . . . . 0.0 110.469 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.683 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.8 m -68.87 152.01 45.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.661 -178.522 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.585 HG12 ' HA2' ' A' ' 37' ' ' GLY . 61.2 mt -118.97 116.28 50.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.906 177.985 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.509 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 72.8 m -106.15 132.67 51.95 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.83 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.668 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.1 tp -108.64 103.54 12.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.838 178.413 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -97.95 123.94 42.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.823 0.344 . . . . 0.0 110.863 179.992 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.51 HH21 ' HB2' ' A' ' 88' ' ' ASP . 2.3 mtm180 -107.35 100.81 10.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.092 179.833 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.9 tp -44.37 -52.69 7.49 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.687 -179.203 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.631 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.22 -64.33 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.015 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' HB2' HH21 ' A' ' 85' ' ' ARG . 5.8 m-20 -97.01 17.13 17.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.605 -179.044 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.9 p30 42.37 32.31 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.152 179.128 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.493 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 5.8 mm-40 -79.05 159.85 27.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.944 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.35 92.31 2.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.95 179.656 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.668 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -78.58 140.24 38.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.453 179.257 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.08 100.79 7.16 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.477 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.537 HD21 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -87.16 77.04 9.15 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.819 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.9 mt-10 -79.0 -164.85 0.66 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -176.93 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.496 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -46.38 -49.62 17.67 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.452 -179.369 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -47.62 -18.25 0.13 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.852 0.358 . . . . 0.0 111.165 179.762 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -125.29 -13.83 6.59 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.574 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.567 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.9 mm -90.44 -28.77 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.682 0.277 . . . . 0.0 111.475 -179.451 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -53.96 -48.87 69.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 82.5 p -119.61 36.72 4.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.435 179.783 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.537 HD13 HD21 ' A' ' 94' ' ' LEU . 6.2 tp -60.55 142.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.425 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.412 ' N ' HG13 ' A' ' 102' ' ' ILE . 24.6 m-20 -138.55 150.46 46.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.665 178.883 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.889 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.2 -37.25 15.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.968 0.413 . . . . 0.0 110.348 -179.632 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.4 m -62.11 -47.72 83.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.437 178.803 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -60.69 -60.78 3.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.169 -179.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.743 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -47.98 -55.84 9.06 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.923 0.392 . . . . 0.0 110.125 179.977 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.8 m -58.49 -31.62 68.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.523 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -70.39 -65.73 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.398 179.847 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -42.93 -43.62 4.22 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.014 179.282 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.431 HD11 HG11 ' A' ' 35' ' ' VAL . 96.1 mt -63.47 -55.84 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.529 178.167 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -53.41 -18.75 2.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.336 179.282 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.523 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.16 -37.84 11.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.833 -179.359 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.478 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.4 m120 -123.55 30.92 6.07 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.821 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 111' ' ' ILE . 90.2 p -84.28 39.46 0.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.078 0.466 . . . . 0.0 110.282 179.013 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.481 HD12 ' NH1' ' A' ' 85' ' ' ARG . 77.3 mt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.146 -0.931 . . . . 0.0 111.29 -179.679 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.498 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.8 pt-20 . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.611 0.243 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 45.7 Cg_endo -69.47 143.74 53.26 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.831 2.354 . . . . 0.0 112.622 -179.701 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.7 m -63.37 151.29 41.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.544 -179.61 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -94.55 94.42 8.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.96 -179.934 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.647 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.6 mt -88.77 73.89 8.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.299 179.64 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.0 p -72.4 0.51 9.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.306 -178.927 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -145.63 148.56 33.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.928 0.394 . . . . 0.0 111.862 -179.78 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 57.6 t -56.06 -50.26 88.38 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.448 179.815 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.5 Cg_endo -58.23 -45.1 33.4 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.826 1.684 . . . . 0.0 112.035 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.59 81.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.257 0.551 . . . . 0.0 110.35 -179.927 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.647 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.09 -59.59 4.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.98 179.391 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.8 mtm -60.48 -25.94 66.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.156 -179.972 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 21.3 mt-10 -71.83 -49.94 34.06 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.695 0.283 . . . . 0.0 110.414 179.657 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.455 ' O ' HG22 ' A' ' 31' ' ' THR . 0.2 OUTLIER -60.06 -33.37 71.97 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.079 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.558 HD11 HD12 ' A' ' 36' ' ' ILE . 50.4 mt -72.33 -39.01 62.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.105 178.627 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.05 -21.33 60.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.994 -179.856 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.93 31.87 1.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.939 -179.878 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.566 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.1 t -170.8 151.29 3.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.328 -179.621 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.476 ' HG3' HG13 ' A' ' 87' ' ' VAL . 30.0 tt0 -68.27 -52.76 30.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.598 179.652 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.479 HG13 HD11 ' A' ' 83' ' ' LEU . 19.4 t -118.27 137.61 51.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.174 179.329 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.9 126.23 18.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.055 0.455 . . . . 0.0 112.191 -179.031 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.527 HG21 HG12 ' A' ' 111' ' ' ILE . 49.2 t -115.22 127.85 72.63 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.521 178.338 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 28' ' ' ILE . 32.6 mt -134.17 138.3 50.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.642 -177.165 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.555 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.4 97.54 1.66 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.45 179.773 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.463 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 39.3 m-85 -83.82 92.43 7.76 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.224 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.555 ' HB3' HD22 ' A' ' 79' ' ' ASN . 11.7 m-85 -112.49 139.32 48.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.485 -178.003 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.459 ' HG2' HD23 ' A' ' 71' ' ' LEU . 78.6 mt-30 -87.68 -3.22 58.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.691 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.431 ' O ' HG12 ' A' ' 44' ' ' ILE . 22.2 t70 -153.72 124.39 7.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.511 179.922 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.572 ' HA ' HG21 ' A' ' 47' ' ' VAL . 96.0 mt -94.92 47.34 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 0.0 111.528 -179.436 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 33.8 mt-10 -136.33 5.88 3.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.7 178.845 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.809 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.1 pt -88.46 156.31 50.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.083 179.884 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.507 ' O ' HD12 ' A' ' 49' ' ' ILE . 75.2 Cg_exo -51.78 -27.09 25.76 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.85 2.367 . . . . 0.0 113.078 179.797 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.809 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.7 -37.67 88.21 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.78 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.66 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -62.22 -56.15 33.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.752 -178.692 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.5 Cg_exo -60.13 -36.03 90.29 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.804 1.67 . . . . 0.0 111.488 179.65 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.876 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.3 mt -67.1 -34.81 71.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.995 -179.937 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.58 ' O ' HG23 ' A' ' 54' ' ' VAL . 44.6 tp -74.44 -50.98 16.23 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.893 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -55.29 -22.8 20.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.03 0.443 . . . . 0.0 109.994 178.77 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.8 m -84.89 -45.44 12.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.455 179.36 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.583 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.48 -25.62 64.59 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.198 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 50' ' ' LEU . 45.6 t -52.77 -47.75 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.119 179.329 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -78.31 -8.96 59.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.656 -179.855 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -94.51 -19.36 20.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.277 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.604 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 61.0 m-85 -136.03 62.88 48.38 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.623 -179.79 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.2 -43.35 53.91 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.689 2.259 . . . . 0.0 111.634 179.019 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.5 -42.03 93.72 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.413 179.355 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.7 t -65.31 144.53 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 178.876 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.566 ' CB ' HG21 ' A' ' 31' ' ' THR . 33.9 t -81.94 96.97 7.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.012 0.434 . . . . 0.0 110.95 -179.83 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.488 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.8 p90 -64.3 127.34 31.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.785 179.692 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.478 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.99 160.67 28.19 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.061 179.807 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.434 HD11 HG13 ' A' ' 47' ' ' VAL . 5.0 tt -160.98 142.59 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.788 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.463 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.9 t -147.78 158.77 44.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.218 0.532 . . . . 0.0 111.646 -179.094 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.446 HG21 ' HG ' ' A' ' 42' ' ' LEU . 76.3 p -139.49 -2.35 1.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.568 179.619 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -66.79 140.52 57.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.703 -179.977 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.6 m -63.98 -49.91 70.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.444 -179.465 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -50.3 -42.7 52.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.605 -179.458 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.584 ' HA ' HG22 ' A' ' 21' ' ' VAL . 58.9 t -71.92 -54.02 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.344 . . . . 0.0 110.791 179.832 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.459 HD23 ' HG2' ' A' ' 40' ' ' GLN . 5.9 mp -58.29 -14.61 7.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.339 179.331 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.7 m -91.78 -41.51 10.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.333 178.789 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -60.69 -39.64 89.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.496 179.78 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.445 ' HB2' HG12 ' A' ' 76' ' ' ILE . 61.0 m-85 -90.17 9.92 26.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.754 179.567 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.0 m120 57.71 25.28 11.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.672 179.386 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.69 HG23 ' HB ' ' A' ' 80' ' ' THR . 42.1 mm -61.73 121.77 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.149 179.805 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.1 p -140.63 58.42 1.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 0.0 111.184 -179.935 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.65 45.04 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.623 179.791 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.571 ' HB2' HG21 ' A' ' 99' ' ' ILE . 14.4 m120 51.07 44.17 28.74 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.125 0.488 . . . . 0.0 110.476 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.69 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.7 m -69.53 152.65 44.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.632 -178.688 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.555 HG12 ' HA2' ' A' ' 37' ' ' GLY . 58.9 mt -118.62 116.4 51.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.428 -0.805 . . . . 0.0 108.982 178.04 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.434 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 75.6 m -104.35 132.68 50.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -177.723 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.669 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -110.94 102.66 11.13 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.982 178.434 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.2 t80 -96.59 125.25 40.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.7 0.286 . . . . 0.0 110.392 179.723 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.6 mtm180 -107.63 85.8 2.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.034 -179.536 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.6 tp -27.42 -61.93 0.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.253 -179.286 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.476 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.29 -64.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.154 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -90.99 13.77 15.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.781 0.324 . . . . 0.0 111.32 -179.314 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 43.68 29.1 0.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.086 178.985 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.513 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 20.6 mm-40 -75.94 160.94 29.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.78 179.85 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -147.57 84.68 1.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.695 179.778 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.669 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -71.48 145.08 49.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.565 179.662 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -127.32 93.44 3.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.23 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.568 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -78.84 78.31 5.28 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.609 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.8 mt-10 -79.63 -164.35 0.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -176.915 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.504 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 22.7 t70 -51.09 -38.36 51.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.093 -179.246 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -55.22 -14.98 1.97 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.202 0.525 . . . . 0.0 110.213 179.552 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -129.82 -13.89 4.1 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.73 -179.716 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.571 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.2 mm -90.32 -30.04 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 111.294 -179.652 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.45 -33.73 68.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.6 m -133.68 39.64 3.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 179.816 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.568 HD13 HD21 ' A' ' 94' ' ' LEU . 7.1 tp -66.64 143.33 15.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.726 -179.676 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -138.33 148.93 45.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.421 178.857 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.876 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.71 -36.68 11.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.094 0.473 . . . . 0.0 110.508 -179.719 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.7 m -62.38 -46.79 87.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.27 178.785 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -61.16 -59.38 5.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.224 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.772 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.52 -54.4 18.14 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.995 0.426 . . . . 0.0 110.109 179.852 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.9 m -58.88 -31.1 68.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.761 179.765 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.468 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.6 tmt_? -71.0 -65.62 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.297 179.768 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -43.19 -43.57 4.74 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.147 179.34 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.527 HG12 HG21 ' A' ' 35' ' ' VAL . 85.2 mt -63.22 -55.24 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.259 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -54.84 -18.16 4.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.219 0.533 . . . . 0.0 110.203 179.305 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.468 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.59 -35.15 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.821 -179.302 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.62 HD22 ' HG ' ' A' ' 92' ' ' LEU . 89.6 m-20 -127.03 31.2 5.31 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.369 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 111' ' ' ILE . 89.1 p -84.42 36.48 0.59 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.034 0.445 . . . . 0.0 110.253 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.464 HD12 ' NH1' ' A' ' 85' ' ' ARG . 70.5 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.309 -179.46 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 14.4 pt-20 . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 35.5 Cg_endo -65.95 144.7 77.54 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.548 2.165 . . . . 0.0 112.798 -179.196 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.6 m -62.9 150.18 42.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.602 -179.602 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -94.31 97.77 10.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.903 179.697 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.616 HD22 ' HA ' ' A' ' 24' ' ' ALA . 59.6 mt -95.44 70.99 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.072 0.463 . . . . 0.0 110.632 179.882 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 p -68.68 -8.18 40.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.225 -178.885 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -137.12 150.28 47.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.979 0.419 . . . . 0.0 111.933 -179.421 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 20.9 t -58.49 -49.78 91.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.617 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -57.81 -43.26 51.14 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.91 1.74 . . . . 0.0 111.873 179.865 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.39 -36.99 85.64 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.196 0.522 . . . . 0.0 110.277 179.921 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.39 -57.37 11.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.028 179.262 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 65.4 mtp -62.08 -27.22 68.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.253 -179.941 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -70.28 -51.36 31.07 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.73 0.3 . . . . 0.0 110.381 179.747 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.446 ' O ' HG22 ' A' ' 31' ' ' THR . 8.4 m-85 -59.92 -33.18 71.53 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.147 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.51 HD11 HD12 ' A' ' 36' ' ' ILE . 52.9 mt -71.81 -38.24 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.907 178.241 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.06 -18.75 61.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.929 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.24 28.95 3.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.249 -179.824 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.589 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.8 t -168.58 151.55 5.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 -179.701 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.607 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.7 tt0 -68.86 -49.64 56.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.03 -179.968 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 83' ' ' LEU . 23.4 t -122.29 135.19 63.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.12 179.31 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.29 125.85 22.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.996 0.427 . . . . 0.0 112.022 -178.862 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.489 HG21 HG12 ' A' ' 111' ' ' ILE . 48.0 t -114.26 127.15 71.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.558 178.355 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.51 HD12 HD11 ' A' ' 28' ' ' ILE . 33.9 mt -132.95 139.36 49.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.735 -177.062 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.513 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.54 100.14 1.94 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.121 179.596 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.461 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 40.1 m-85 -86.84 94.56 9.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.387 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.4 m-85 -114.06 142.24 46.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.503 -177.898 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -88.32 -6.03 57.98 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.72 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' O ' HG12 ' A' ' 44' ' ' ILE . 9.6 t70 -151.4 125.75 9.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.618 179.606 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.647 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.2 mt -95.24 47.83 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.032 0.444 . . . . 0.0 111.502 -179.526 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -137.72 7.14 2.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.718 178.869 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.813 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.2 pt -90.51 155.41 46.12 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.194 179.939 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.494 ' O ' HD12 ' A' ' 49' ' ' ILE . 78.3 Cg_exo -50.38 -27.32 18.04 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.881 2.387 . . . . 0.0 113.246 -179.881 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.813 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.56 -37.52 87.84 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.892 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.708 HG23 HG13 ' A' ' 44' ' ' ILE . 3.1 t -61.79 -56.0 36.54 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.572 -178.895 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.663 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.4 Cg_exo -60.16 -39.44 68.97 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.833 1.689 . . . . 0.0 111.533 179.508 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.2 mt -62.99 -36.7 76.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.035 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.2 tp -72.43 -52.68 14.84 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.021 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -54.69 -22.28 13.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.037 0.446 . . . . 0.0 109.943 178.774 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.4 m -85.48 -44.12 12.99 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.494 179.501 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.609 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.52 -24.93 66.94 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.378 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.5 t -51.74 -47.22 39.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.962 179.319 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -77.43 -13.04 60.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.837 -179.776 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -91.45 -18.27 24.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.014 179.897 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.589 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.3 m-85 -137.22 62.74 39.88 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.466 -179.836 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.56 -45.15 43.11 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.643 2.228 . . . . 0.0 111.734 179.231 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.2 -42.86 83.43 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.545 179.148 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.1 t -64.29 144.51 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.667 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.589 ' CB ' HG21 ' A' ' 31' ' ' THR . 37.7 t -82.3 97.43 8.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.036 0.446 . . . . 0.0 111.137 -179.68 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.487 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.6 p90 -64.49 128.13 34.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.607 179.579 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.87 160.76 28.32 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.022 179.901 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -159.97 143.29 5.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.428 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 41.6 t -150.09 157.25 42.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.048 0.451 . . . . 0.0 111.558 -179.181 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.458 HG21 ' HG ' ' A' ' 42' ' ' LEU . 82.7 p -137.82 -3.33 1.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.619 179.777 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -65.55 139.72 58.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.627 -179.835 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.2 t -61.58 -50.39 72.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.209 -179.633 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -48.69 -47.77 40.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.665 -179.391 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.558 ' HA ' HG22 ' A' ' 21' ' ' VAL . 64.9 t -67.87 -55.02 18.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.772 0.32 . . . . 0.0 110.73 179.818 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 mp -56.86 -14.8 3.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.351 179.397 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.7 m -91.0 -41.75 10.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.281 178.764 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -60.82 -35.94 77.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.616 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.409 ' HB2' HG12 ' A' ' 76' ' ' ILE . 84.7 m-85 -95.88 14.25 24.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.805 179.621 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 55.49 25.11 7.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.771 179.067 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.685 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.4 mm -62.67 121.82 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.883 0.373 . . . . 0.0 111.243 179.981 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.5 p -142.46 59.28 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.117 179.959 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.28 44.93 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.586 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.645 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 29.2 m-80 51.79 43.83 29.76 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.222 0.534 . . . . 0.0 110.609 -179.944 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.685 ' HB ' HG23 ' A' ' 76' ' ' ILE . 87.5 m -69.31 151.65 45.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.55 -178.642 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.57 HG21 HD21 ' A' ' 107' ' ' LEU . 54.6 mt -117.7 117.54 55.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.158 177.931 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.461 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 71.2 m -108.06 133.2 52.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.566 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.649 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -108.55 104.96 14.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.752 178.268 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -98.95 120.84 40.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.881 0.372 . . . . 0.0 110.892 179.77 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.519 HH12 HD12 ' A' ' 116' ' ' LEU . 3.7 mtm180 -104.43 100.49 10.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.123 179.82 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.6 tp -43.78 -55.11 4.67 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.017 -179.362 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.607 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.3 -62.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.171 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -98.31 8.14 45.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.167 -179.618 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 85' ' ' ARG . 19.7 t-20 48.69 38.03 10.73 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.023 -179.914 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 7.1 mm-40 -82.25 160.72 22.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.765 179.691 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.2 94.3 2.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 179.462 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.649 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -81.94 139.51 34.56 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.291 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -120.28 114.55 22.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.315 0.578 . . . . 0.0 112.294 -179.385 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.483 HD21 HD13 ' A' ' 102' ' ' ILE . 3.8 tt -100.23 75.75 1.84 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.9 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.421 ' O ' HG12 ' A' ' 99' ' ' ILE . 22.5 mt-10 -76.98 -166.41 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.146 -176.785 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.483 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.4 OUTLIER -45.92 -51.21 13.61 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.249 -179.334 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -46.98 -17.02 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.286 179.653 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.406 ' N ' ' C ' ' A' ' 96' ' ' ASP . 10.8 m-20 -126.22 -14.17 6.01 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.551 -179.999 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.552 HG21 ' HB2' ' A' ' 79' ' ' ASN . 21.7 mm -90.91 -26.19 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.624 -179.322 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -58.18 -35.48 71.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.868 0.366 . . . . 0.0 110.971 -179.81 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.3 m -132.52 39.49 3.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.526 179.964 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.519 HG21 ' HB2' ' A' ' 46' ' ' ALA . 6.2 tp -64.16 142.07 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.438 -179.86 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -136.74 148.36 47.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.593 178.846 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.89 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.39 -35.57 5.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.034 0.445 . . . . 0.0 110.391 179.961 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -63.67 -49.02 74.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.441 178.891 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -59.2 -58.7 7.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.179 -179.88 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.721 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.18 -55.84 13.52 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.091 0.472 . . . . 0.0 109.966 179.881 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.0 m -58.39 -29.13 65.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.9 179.726 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.489 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -71.48 -66.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.172 179.588 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -42.59 -42.58 3.45 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.07 179.132 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.489 HG12 HG21 ' A' ' 35' ' ' VAL . 95.5 mt -64.28 -55.77 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.503 178.346 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.28 -18.62 4.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.319 179.41 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.489 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.32 -37.28 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.934 -179.023 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.404 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.1 m120 -122.44 28.75 7.25 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.595 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.1 p -82.3 52.85 2.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.09 0.472 . . . . 0.0 110.184 178.884 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.519 HD12 HH12 ' A' ' 85' ' ' ARG . 67.9 mt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.125 -179.344 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.467 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.4 pt-20 . . . . . 0 CA--C 1.53 0.191 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HD3' HG21 ' A' ' 54' ' ' VAL . 42.0 Cg_endo -67.77 139.9 49.38 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.492 2.128 . . . . 0.0 112.535 -179.397 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.5 m -59.35 154.67 16.23 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.831 -179.52 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -97.11 90.6 5.21 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.023 -179.927 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 24' ' ' ALA . 51.5 mt -88.01 74.53 8.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.233 179.643 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.8 p -75.83 2.62 11.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.214 -179.167 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 9.7 m-20 -145.2 147.69 32.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 111.612 -179.813 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.3 t -56.47 -49.29 94.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.516 179.896 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 17.7 Cg_endo -59.39 -43.8 37.74 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.841 1.694 . . . . 0.0 111.975 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.18 -34.95 79.59 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.191 0.519 . . . . 0.0 110.317 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.619 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.93 -59.05 4.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.051 179.396 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 46.3 mtm -61.42 -27.17 68.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.16 -179.964 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.0 mt-10 -70.05 -49.77 47.85 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.756 0.312 . . . . 0.0 110.512 179.774 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.597 ' O ' HG22 ' A' ' 31' ' ' THR . 6.6 m-85 -61.42 -35.36 77.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.981 179.2 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.512 HD11 HD12 ' A' ' 36' ' ' ILE . 48.7 mt -71.19 -35.98 60.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.213 0.53 . . . . 0.0 109.802 178.324 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.7 -19.36 60.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.927 -179.915 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.17 25.49 4.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.211 -179.736 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.644 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.9 t -170.68 153.56 4.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.633 -179.8 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.514 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.3 tt0 -64.37 -80.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.727 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.571 HG13 HD11 ' A' ' 83' ' ' LEU . 19.6 t -92.14 135.0 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.498 179.693 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.6 126.12 21.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.035 0.445 . . . . 0.0 112.11 -179.107 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.431 HG21 HG12 ' A' ' 111' ' ' ILE . 45.6 t -114.76 130.93 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.71 178.51 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.512 HD12 HD11 ' A' ' 28' ' ' ILE . 25.9 mt -135.88 137.54 48.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.544 -177.385 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.585 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.39 97.68 1.76 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.519 179.907 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.5 m-85 -82.85 90.91 6.99 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.632 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.6 m-85 -110.85 138.64 47.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.224 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.475 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 78.6 mt-30 -84.59 -8.69 58.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.824 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.3 t70 -150.37 125.87 10.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.738 179.794 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.515 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.0 mt -93.41 46.68 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.422 . . . . 0.0 111.325 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.6 mt-10 -137.26 11.37 3.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.929 179.036 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.767 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.5 pt -94.03 158.1 36.74 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.014 179.984 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.505 ' O ' HD12 ' A' ' 49' ' ' ILE . 78.0 Cg_exo -53.47 -25.08 30.67 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.709 2.273 . . . . 0.0 112.93 179.951 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.767 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.53 -37.68 87.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.758 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.683 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -61.28 -55.45 43.51 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -178.754 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.2 Cg_exo -60.95 -40.41 52.89 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.045 1.83 . . . . 0.0 111.367 179.405 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.877 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -63.0 -33.79 62.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.042 179.973 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.62 ' O ' HG23 ' A' ' 54' ' ' VAL . 42.9 tp -75.26 -51.85 12.3 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.842 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -53.56 -25.85 18.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.218 0.532 . . . . 0.0 109.837 178.541 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 t -81.88 -47.53 12.66 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.589 179.895 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.613 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.14 -26.44 62.68 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.517 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 50' ' ' LEU . 52.6 t -51.68 -47.54 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.016 179.306 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -78.54 -11.88 59.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.681 -179.891 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 28.4 mtpp -92.12 -16.41 26.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.226 179.764 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.598 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 55.4 m-85 -138.71 63.18 31.72 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.478 -179.883 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.8 -44.47 47.92 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.636 2.224 . . . . 0.0 111.643 179.085 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.53 -38.85 82.94 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.542 179.209 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.0 t -68.76 144.28 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.175 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.644 ' HB2' HG21 ' A' ' 31' ' ' THR . 23.2 t -82.53 96.5 8.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.106 0.479 . . . . 0.0 110.816 -179.65 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.501 ' HB3' HG22 ' A' ' 54' ' ' VAL . 4.0 p90 -64.07 125.75 25.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.074 179.69 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.66 162.05 28.25 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.16 179.908 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.5 tt -158.16 142.19 6.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.811 0.339 . . . . 0.0 110.223 179.62 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.8 t -142.73 154.69 44.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.136 0.493 . . . . 0.0 111.706 -179.036 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.442 HG21 ' HG ' ' A' ' 42' ' ' LEU . 71.3 p -140.16 1.86 1.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.534 179.503 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -74.24 139.86 44.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.658 -179.786 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.3 m -62.17 -50.77 70.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.296 -179.694 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -49.65 -44.63 47.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.588 -179.449 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.498 ' HA ' HG22 ' A' ' 21' ' ' VAL . 67.6 t -69.8 -53.94 21.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.859 0.361 . . . . 0.0 110.687 179.856 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp -57.95 -15.43 8.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.396 179.385 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 86.4 m -89.81 -42.5 11.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.212 178.748 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -59.72 -36.92 77.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.45 179.694 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.412 ' HB2' HG12 ' A' ' 76' ' ' ILE . 65.4 m-85 -94.86 12.31 28.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.11 179.638 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.7 m120 57.29 20.77 6.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.67 179.063 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.654 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.3 mm -57.49 120.66 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.951 179.637 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.1 p -140.62 53.8 1.61 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.865 0.364 . . . . 0.0 111.312 -179.957 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.43 46.15 0.01 OUTLIER Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.68 179.839 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.62 ' HB2' HG21 ' A' ' 99' ' ' ILE . 13.6 m120 51.2 42.54 28.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.186 0.517 . . . . 0.0 110.404 -179.85 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.654 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.3 m -68.35 152.82 44.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.557 -178.658 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.585 HG12 ' HA2' ' A' ' 37' ' ' GLY . 60.7 mt -119.43 118.53 57.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.035 178.195 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.477 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 65.6 m -107.57 137.08 46.24 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.695 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.643 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -111.47 103.49 11.85 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.092 178.702 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -96.65 117.96 32.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.664 179.644 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.467 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 4.5 mtm180 -101.94 81.37 2.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.761 -179.863 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 5.6 tp -25.05 -60.98 0.06 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.327 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.514 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.46 -62.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.137 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -94.43 1.07 55.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.011 0.434 . . . . 0.0 111.045 -179.5 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 51.13 38.81 21.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.313 179.684 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 6.3 mm-40 -87.52 157.54 19.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.574 179.658 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.03 101.51 4.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.938 179.735 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.643 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -90.4 115.81 27.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.704 179.319 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.79 111.27 23.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.734 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.554 HD21 HD13 ' A' ' 102' ' ' ILE . 5.4 tt -97.6 77.61 2.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.723 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.4 mt-10 -79.12 -164.74 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -176.786 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -45.66 -50.97 12.96 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.515 -179.173 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -46.55 -17.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.008 0.432 . . . . 0.0 111.128 179.747 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.414 ' N ' ' C ' ' A' ' 96' ' ' ASP . 17.0 m-20 -126.79 -13.78 5.77 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.484 180.0 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.62 HG21 ' HB2' ' A' ' 79' ' ' ASN . 27.4 mm -91.32 -42.11 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.464 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -51.9 -30.74 25.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.907 0.384 . . . . 0.0 111.052 179.935 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.5 m -131.36 36.09 3.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.277 179.68 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.7 tp -65.66 143.91 15.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.583 -179.818 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.411 ' N ' HG13 ' A' ' 102' ' ' ILE . 16.2 m-20 -139.2 147.58 41.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.39 178.719 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.877 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.71 -37.11 7.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 110.307 -179.829 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.1 m -61.83 -48.37 80.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.357 178.677 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -59.9 -61.23 2.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.367 -179.842 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.736 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.85 -55.89 8.75 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 110.386 179.894 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -58.75 -31.75 68.62 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.991 179.909 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.535 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.3 tmt_? -69.86 -65.32 0.74 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.308 179.777 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -43.59 -44.17 6.06 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.168 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.431 HG12 HG21 ' A' ' 35' ' ' VAL . 96.7 mt -62.29 -55.36 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.197 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.43 -19.04 4.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.522 179.31 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.535 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -87.29 -36.79 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.796 -179.294 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.446 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.9 m120 -124.91 29.86 6.05 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.784 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.8 p -82.67 46.73 1.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.121 0.486 . . . . 0.0 110.329 179.166 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 63.1 mt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.316 -179.379 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.57 0.224 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.9 Cg_endo -67.91 140.86 51.73 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.654 2.236 . . . . 0.0 112.407 -179.712 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 17' ' ' TRP . 23.2 m -55.1 155.0 5.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.892 -179.409 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.4 ' N ' HG22 ' A' ' 16' ' ' THR . 91.4 m95 -100.57 92.26 5.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.876 179.725 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.609 HD13 ' HA ' ' A' ' 24' ' ' ALA . 55.4 mt -90.2 73.41 7.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.433 -179.893 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.5 p -74.36 0.85 13.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.288 -178.858 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -143.49 147.17 34.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.729 -179.678 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.586 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 19.9 t -55.2 -51.01 83.3 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.413 179.973 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.02 -44.18 41.91 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.905 1.737 . . . . 0.0 112.012 179.805 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.94 79.21 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.284 0.564 . . . . 0.0 110.35 -179.883 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.609 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -65.19 -58.48 5.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.984 179.515 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.7 mtm -61.28 -25.18 66.93 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.88 179.892 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -71.51 -51.68 22.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.357 179.613 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.574 ' O ' HG22 ' A' ' 31' ' ' THR . 0.3 OUTLIER -60.01 -33.82 72.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.929 179.282 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.533 HD11 HD12 ' A' ' 36' ' ' ILE . 51.6 mt -73.42 -37.99 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.951 178.492 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.17 -18.35 60.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.905 -179.933 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.4 24.73 4.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.19 -179.871 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.656 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.9 t -169.71 153.08 4.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.695 -179.792 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.528 ' HG3' HG13 ' A' ' 87' ' ' VAL . 18.2 tt0 -64.12 -77.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.609 179.774 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 83' ' ' LEU . 21.5 t -95.53 133.84 35.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.418 179.668 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.559 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -137.47 124.9 21.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.254 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.438 HG11 HD11 ' A' ' 111' ' ' ILE . 55.0 t -114.07 128.32 71.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.723 178.464 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.533 HD12 HD11 ' A' ' 28' ' ' ILE . 27.3 mt -135.05 138.53 48.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.534 -177.345 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.57 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.66 98.79 1.9 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.272 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.451 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 37.1 m-85 -84.23 91.02 7.63 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.291 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -110.72 142.54 42.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.646 -178.065 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -86.63 -8.08 57.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.887 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -151.53 131.11 13.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.605 179.745 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.636 ' HA ' HG21 ' A' ' 47' ' ' VAL . 84.4 mt -97.75 47.58 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.109 0.48 . . . . 0.0 111.621 -179.539 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -137.09 5.22 2.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.689 178.773 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.811 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.6 pt -88.27 155.72 51.64 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.094 179.766 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.488 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.3 Cg_exo -50.95 -29.06 25.94 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.89 2.393 . . . . 0.0 113.126 179.886 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.811 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.04 -37.44 84.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.831 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.709 HG23 HG13 ' A' ' 44' ' ' ILE . 3.2 t -61.9 -57.21 25.48 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.659 -178.787 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.693 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.3 Cg_exo -59.07 -38.57 86.51 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.759 1.639 . . . . 0.0 111.52 179.589 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -63.33 -36.48 76.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.047 179.936 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.5 tp -73.98 -53.23 10.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.77 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -54.2 -22.59 11.86 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.816 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.2 t -85.32 -43.66 13.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.435 179.516 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.585 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.44 -24.85 66.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.253 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -51.97 -46.69 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.89 179.236 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -77.58 -12.6 59.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.905 -179.74 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -92.19 -18.16 23.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.332 -179.978 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 52.5 m-85 -137.37 63.31 41.45 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.547 -179.692 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.64 -46.43 33.41 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.71 2.274 . . . . 0.0 111.77 178.939 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.9 -42.08 78.59 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.658 179.328 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.9 t -64.27 146.61 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.87 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.656 ' HB2' HG21 ' A' ' 31' ' ' THR . 32.8 t -83.51 97.48 9.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.964 0.411 . . . . 0.0 110.924 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.51 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.2 p90 -66.02 126.17 27.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.49 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.32 161.62 28.35 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.195 179.81 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -159.07 144.36 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.993 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.451 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 29.4 t -149.18 155.86 41.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.12 0.486 . . . . 0.0 111.762 -179.214 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.513 HG21 ' HG ' ' A' ' 42' ' ' LEU . 76.6 p -137.09 -0.8 2.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.613 179.387 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.92 136.33 53.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.566 -179.927 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 59.5 m -61.52 -48.66 80.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.577 -179.634 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -51.51 -41.27 60.88 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.51 -179.435 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.45 ' HA ' HG22 ' A' ' 21' ' ' VAL . 55.4 t -72.6 -53.61 18.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.915 0.388 . . . . 0.0 110.439 179.835 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.64 -14.56 8.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.23 179.261 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.2 m -91.84 -42.12 10.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.385 178.85 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -60.39 -39.49 87.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.422 ' HB2' HG12 ' A' ' 76' ' ' ILE . 88.5 m-85 -90.06 11.02 21.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.651 179.595 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.8 m120 58.03 24.97 11.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.52 179.373 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.747 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.9 mm -62.8 124.17 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.875 179.458 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.8 p -142.32 58.95 1.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.437 -179.887 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.09 45.3 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.823 179.854 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 26.8 m-80 52.04 44.03 29.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.174 0.511 . . . . 0.0 110.613 -179.86 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.747 ' HB ' HG23 ' A' ' 76' ' ' ILE . 86.6 m -69.16 154.22 42.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.533 -178.763 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.609 HG21 HD21 ' A' ' 107' ' ' LEU . 60.5 mt -119.72 117.8 55.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.16 178.156 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 72.8 m -106.99 134.68 49.78 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -177.787 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.635 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -110.78 103.79 12.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.663 178.17 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -97.93 118.03 33.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.634 179.909 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.543 HH12 HD12 ' A' ' 116' ' ' LEU . 4.5 mtm180 -101.22 80.08 2.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.462 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' ARG . 5.1 tp -23.91 -60.51 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.36 -0.836 . . . . 0.0 113.249 -179.417 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.528 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.97 -61.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.01 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -95.34 3.31 54.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.41 . . . . 0.0 111.034 -179.506 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 53.19 29.24 8.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.802 179.357 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.5 mm-40 -75.47 153.13 37.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.538 0.209 . . . . 0.0 110.643 179.721 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.54 95.98 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.718 179.858 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.635 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -87.44 114.53 24.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.976 179.917 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.39 110.53 23.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.087 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.566 HD21 HD13 ' A' ' 102' ' ' ILE . 4.3 tt -96.16 78.81 3.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.014 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.441 ' O ' HG12 ' A' ' 99' ' ' ILE . 30.6 mt-10 -78.78 -165.17 0.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -176.383 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.526 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 30.2 t70 -51.46 -35.28 39.03 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.951 -179.178 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -56.68 -15.33 4.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.206 0.527 . . . . 0.0 110.261 179.482 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -130.11 -14.09 3.93 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.531 179.923 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.572 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.9 mm -90.0 -27.67 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.789 0.328 . . . . 0.0 111.263 -179.517 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -57.13 -37.43 71.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.782 -179.862 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.5 m -131.95 38.17 3.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.562 179.673 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.566 HD13 HD21 ' A' ' 94' ' ' LEU . 7.6 tp -63.61 144.61 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.575 -179.602 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -138.37 149.64 45.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.45 178.603 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.887 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.73 -35.0 9.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.111 0.481 . . . . 0.0 110.48 -179.673 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.5 m -63.01 -48.53 78.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.49 178.761 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 102' ' ' ILE . 54.3 mtpt -59.66 -59.17 5.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.182 -179.703 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.739 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.1 -55.45 14.89 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.988 0.423 . . . . 0.0 110.18 -179.994 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.6 m -58.72 -29.48 66.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.714 179.836 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.519 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -71.11 -66.2 0.65 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.068 179.724 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -42.71 -44.73 4.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.057 179.275 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.438 HD11 HG11 ' A' ' 35' ' ' VAL . 96.5 mt -62.65 -55.2 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.535 178.387 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -54.37 -18.69 4.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.253 179.357 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.519 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.09 -36.21 8.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.898 -179.137 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.617 HD22 ' HG ' ' A' ' 92' ' ' LEU . 90.2 m-20 -125.35 30.33 5.83 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.3 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.1 p -83.53 48.48 1.42 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.135 0.493 . . . . 0.0 110.145 178.922 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.543 HD12 HH12 ' A' ' 85' ' ' ARG . 60.9 mt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.36 -179.362 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.1 pt-20 . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 120.625 0.25 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 36.4 Cg_endo -67.08 142.93 63.36 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.934 2.423 . . . . 0.0 112.827 -179.514 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.8 m -59.68 153.77 19.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.624 -179.838 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -98.53 97.5 8.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.129 -179.849 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 24' ' ' ALA . 46.8 mt -95.21 76.46 3.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.361 179.769 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.9 p -75.17 -2.49 28.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.297 -178.736 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -142.16 147.36 36.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.919 0.39 . . . . 0.0 111.727 -179.814 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 36.1 t -54.3 -49.5 90.14 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.663 179.983 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.07 -46.97 22.3 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.949 1.766 . . . . 0.0 112.147 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.92 -34.68 77.94 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.186 0.517 . . . . 0.0 110.388 -179.81 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.619 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.84 -59.97 3.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.122 179.389 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 67.5 mtp -60.4 -25.98 66.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.215 -179.897 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 25.1 mt-10 -73.07 -51.73 16.97 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 120.652 0.263 . . . . 0.0 110.675 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.499 ' O ' HG22 ' A' ' 31' ' ' THR . 7.0 m-85 -58.44 -33.35 69.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.117 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.556 HD11 HD12 ' A' ' 36' ' ' ILE . 45.0 mt -72.35 -40.04 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.901 178.104 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.81 -17.77 62.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.06 179.948 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.64 27.92 2.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.231 -179.828 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.639 HG21 ' HB2' ' A' ' 61' ' ' SER . 7.8 t -173.16 155.49 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.579 -179.626 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.551 ' HG3' HG13 ' A' ' 87' ' ' VAL . 19.6 tt0 -65.31 -76.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.681 179.838 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.537 HG13 HD11 ' A' ' 83' ' ' LEU . 21.0 t -95.38 137.98 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.42 179.661 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.545 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.97 125.94 18.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.039 0.447 . . . . 0.0 112.021 -179.142 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.504 HG21 HG12 ' A' ' 111' ' ' ILE . 51.6 t -115.57 129.53 71.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.828 178.526 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.556 HD12 HD11 ' A' ' 28' ' ' ILE . 26.5 mt -135.02 135.72 52.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.624 -177.341 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.4 99.81 2.24 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.335 179.633 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 11.7 m-85 -84.63 92.57 8.19 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.725 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 9.7 m-85 -114.69 142.67 46.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.309 -178.217 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -90.06 -8.64 50.98 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.7 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.494 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.5 t70 -148.12 118.96 7.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.742 179.761 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.501 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.9 mt -88.4 44.85 1.23 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.114 0.483 . . . . 0.0 111.516 -179.268 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.408 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 39.1 mt-10 -133.82 6.96 3.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.124 178.953 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.694 HG13 HG23 ' A' ' 47' ' ' VAL . 5.6 pt -88.14 159.48 47.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.191 179.89 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' HD12 ' A' ' 49' ' ' ILE . 54.3 Cg_exo -54.91 -26.07 46.95 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.763 2.308 . . . . 0.0 112.689 179.429 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.656 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.41 -38.7 91.94 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.883 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.694 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -59.69 -55.58 44.33 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.723 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.647 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.1 Cg_exo -59.75 -41.27 56.59 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.052 1.835 . . . . 0.0 111.403 179.185 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.905 HG23 ' HA ' ' A' ' 104' ' ' ALA . 8.9 mt -61.97 -35.01 65.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.194 -179.906 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 54' ' ' VAL . 47.2 tp -74.75 -50.93 15.59 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.959 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -54.98 -26.0 33.7 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.398 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -81.42 -46.12 15.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.734 179.859 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.58 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.21 -26.15 66.15 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.38 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 50' ' ' LEU . 47.7 t -53.87 -48.44 62.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.162 179.541 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -76.83 -9.35 58.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.588 -179.898 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -94.82 -19.56 20.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 179.719 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.599 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 73.4 m-85 -135.04 62.11 50.43 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.609 -179.548 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.4 -40.35 71.33 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.57 2.18 . . . . 0.0 111.379 178.996 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.42 -42.5 97.54 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.323 179.068 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.9 t -65.49 144.83 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.084 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.639 ' HB2' HG21 ' A' ' 31' ' ' THR . 24.1 t -82.65 96.6 8.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.095 0.474 . . . . 0.0 110.967 -179.554 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.54 ' HB3' HG22 ' A' ' 54' ' ' VAL . 5.2 p90 -64.28 129.39 39.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.106 179.805 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.83 161.98 28.8 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.097 179.667 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -160.99 143.03 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.808 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.1 t -145.67 155.66 43.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.109 0.481 . . . . 0.0 111.917 -178.935 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 78.8 p -138.89 6.16 2.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.655 179.505 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.09 144.42 40.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.706 -179.925 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -65.64 -54.39 28.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.384 -179.547 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -49.04 -40.0 29.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.631 -179.364 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.576 ' HA ' HG22 ' A' ' 21' ' ' VAL . 68.3 t -72.37 -55.27 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.857 0.361 . . . . 0.0 110.603 179.69 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.3 -14.78 8.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.517 179.461 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.6 m -89.22 -48.04 7.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.721 179.101 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -59.03 -33.58 70.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.57 179.837 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 76' ' ' ILE . 40.7 m-85 -92.82 8.24 40.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.547 179.235 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 57.32 23.69 9.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.632 179.51 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.697 HG23 ' HB ' ' A' ' 80' ' ' THR . 34.3 mm -61.22 120.9 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.012 179.652 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.8 p -141.3 58.43 1.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.308 179.825 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.32 42.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.533 179.815 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.601 ' HB2' HG21 ' A' ' 99' ' ' ILE . 39.9 m-20 52.77 42.43 31.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.267 0.556 . . . . 0.0 110.151 -179.669 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.697 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.4 m -67.97 154.36 41.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.682 -178.472 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.588 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.5 mt -120.32 116.95 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.271 178.271 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.7 m -105.93 137.09 44.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.857 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.668 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -112.98 105.68 13.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.253 178.671 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.2 t80 -98.18 123.08 42.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.682 0.277 . . . . 0.0 110.415 179.413 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.552 HH12 HD12 ' A' ' 116' ' ' LEU . 5.7 mtm180 -105.59 82.38 1.8 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.801 0.334 . . . . 0.0 110.875 -179.698 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 7.2 tp -26.29 -59.28 0.08 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.432 -0.803 . . . . 0.0 113.103 -179.287 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.551 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.21 -56.27 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.128 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -99.93 13.27 34.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.734 0.302 . . . . 0.0 111.386 -179.353 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 45.2 24.39 0.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.218 179.234 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.516 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 15.9 mm-40 -72.02 157.73 37.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.768 0.318 . . . . 0.0 110.77 179.794 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -143.6 85.44 1.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.67 179.667 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.668 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -72.78 147.96 45.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.947 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.69 114.41 16.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.309 0.576 . . . . 0.0 112.285 -179.562 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.617 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -101.83 76.33 1.62 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.93 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.444 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.8 mt-10 -75.82 -166.75 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -176.692 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.554 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.6 t70 -50.91 -38.67 51.47 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.057 -179.093 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -55.51 -14.9 2.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.164 0.506 . . . . 0.0 110.525 179.794 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -128.45 -13.67 4.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.47 -179.988 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.601 HG21 ' HB2' ' A' ' 79' ' ' ASN . 21.2 mm -89.47 -23.79 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.71 -179.33 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -53.65 -66.46 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 110.684 179.807 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.8 t -105.77 34.3 3.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.622 179.782 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.617 HD13 HD21 ' A' ' 94' ' ' LEU . 7.5 tp -53.99 142.04 8.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.224 -179.947 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -135.61 151.06 49.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.676 178.967 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.905 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.42 -34.97 17.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.981 0.42 . . . . 0.0 110.446 -179.883 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 95.0 m -63.1 -48.16 79.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.287 178.774 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -59.79 -60.44 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.252 -179.815 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.767 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -49.36 -55.62 12.32 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.074 0.464 . . . . 0.0 110.237 179.785 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.2 m -58.32 -30.57 66.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.872 179.735 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.516 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -70.15 -66.19 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.118 179.771 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -43.43 -44.73 5.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.059 179.355 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.504 HG12 HG21 ' A' ' 35' ' ' VAL . 95.5 mt -61.88 -54.63 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.367 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -55.51 -19.15 8.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.4 179.48 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.516 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -87.69 -36.61 9.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.88 -179.009 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.615 HD22 ' HG ' ' A' ' 92' ' ' LEU . 85.1 m-20 -122.15 27.27 8.09 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.44 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.6 p -81.33 51.68 1.68 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.988 0.423 . . . . 0.0 110.362 178.886 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.552 HD12 HH12 ' A' ' 85' ' ' ARG . 71.1 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.401 -179.469 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.516 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.427 0.156 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 30.5 Cg_endo -64.18 143.69 84.59 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.699 2.266 . . . . 0.0 112.603 -179.709 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.0 m -61.71 152.41 31.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.552 -179.776 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -98.18 92.55 5.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 40.2 mt -87.71 72.55 9.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.258 -179.905 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.4 p -69.07 -3.98 15.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.251 -178.922 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -141.39 149.58 41.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.993 0.425 . . . . 0.0 111.792 -179.569 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 25.3 t -57.03 -49.12 95.81 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.626 179.753 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.7 Cg_endo -58.93 -43.73 41.04 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.956 1.771 . . . . 0.0 111.909 179.865 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.16 -35.3 80.67 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 110.143 179.831 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.43 -56.97 11.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.091 179.361 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 33.8 mtt -62.53 -27.72 69.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.171 -179.961 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -69.94 -49.61 50.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.686 0.279 . . . . 0.0 110.449 179.723 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.01 -32.56 73.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.84 179.071 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.526 HD11 HD12 ' A' ' 36' ' ' ILE . 54.3 mt -72.47 -37.65 57.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.833 178.161 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 -20.81 60.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.706 -179.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.17 28.96 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.153 -179.873 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.557 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.9 t -169.1 155.38 6.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.33 -179.798 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.526 ' HG3' HG13 ' A' ' 87' ' ' VAL . 29.2 tt0 -75.98 -33.91 59.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.254 179.481 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.474 HG13 HD11 ' A' ' 83' ' ' LEU . 17.1 t -133.37 136.3 54.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.125 179.273 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.59 125.24 16.85 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.117 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.486 HG21 HG12 ' A' ' 111' ' ' ILE . 53.4 t -113.18 127.63 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.449 178.234 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 28' ' ' ILE . 35.7 mt -133.87 139.41 48.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.62 -176.86 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.89 97.59 1.53 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.459 179.848 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.494 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 36.9 m-85 -84.84 94.37 8.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.322 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.576 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 9.9 m-85 -114.32 146.12 40.91 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.092 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.673 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 52.4 mt-30 -93.77 -6.45 46.01 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.082 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.476 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.7 t70 -151.98 113.94 4.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.511 179.855 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.498 ' HA ' HG21 ' A' ' 47' ' ' VAL . 89.0 mt -84.19 43.63 0.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.026 0.441 . . . . 0.0 111.549 -179.166 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.446 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.5 mt-10 -132.24 11.38 4.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.999 179.11 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.677 HG13 HG23 ' A' ' 47' ' ' VAL . 9.6 pt -91.78 161.89 32.62 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.336 179.969 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.501 ' O ' HD12 ' A' ' 49' ' ' ILE . 51.3 Cg_exo -57.73 -23.93 60.6 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.737 2.291 . . . . 0.0 112.587 179.047 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.604 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -66.36 -39.18 88.99 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.812 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.677 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -58.6 -55.1 49.38 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -178.681 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.8 Cg_exo -61.57 -42.46 33.01 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.971 1.781 . . . . 0.0 111.648 179.287 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.868 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -60.67 -34.33 58.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.236 -179.991 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.623 ' O ' HG23 ' A' ' 54' ' ' VAL . 51.3 tp -74.37 -51.67 14.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.138 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -53.55 -25.89 18.94 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.541 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 m -80.56 -49.79 10.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.606 179.686 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.578 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -56.43 -27.17 55.87 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.174 0.511 . . . . 0.0 109.666 179.551 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.2 t -53.27 -49.97 49.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.726 179.481 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -75.17 -8.66 57.2 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.583 -179.76 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -95.81 -19.14 19.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.203 179.613 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.624 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 63.4 m-85 -135.65 62.61 49.4 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.503 -179.796 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.65 -41.44 61.42 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.613 2.209 . . . . 0.0 111.658 179.094 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.37 -41.78 97.13 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.511 179.167 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.0 t -66.03 144.07 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.882 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.557 ' CB ' HG21 ' A' ' 31' ' ' THR . 47.4 t -82.07 99.32 9.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.08 0.467 . . . . 0.0 111.001 -179.773 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.509 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.5 p90 -65.59 127.94 33.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.635 179.688 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.16 161.52 28.32 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.235 -179.944 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 tt -162.21 143.24 3.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.732 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.494 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 44.1 t -150.32 157.24 42.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.127 0.489 . . . . 0.0 111.519 -179.143 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 71.2 p -136.49 -7.66 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.695 179.413 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -60.19 139.69 57.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.605 179.883 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.2 p -63.48 -47.33 82.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.61 -179.356 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -52.48 -43.42 64.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.716 -179.224 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.465 ' HA ' HG22 ' A' ' 21' ' ' VAL . 67.0 t -72.15 -51.04 32.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.849 0.356 . . . . 0.0 110.71 179.832 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.74 -14.84 23.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.088 0.47 . . . . 0.0 110.135 179.449 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.2 m -92.3 -39.46 11.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.418 178.799 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -62.86 -40.66 98.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.423 -179.996 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.429 ' HB2' HG12 ' A' ' 76' ' ' ILE . 65.8 m-85 -88.25 8.2 28.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.467 179.426 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 58.54 27.06 15.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.506 179.539 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.726 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.6 mm -63.2 121.69 12.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.225 179.689 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.0 p -141.12 56.17 1.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.377 -179.965 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.37 44.37 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.579 179.847 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.673 ' ND2' ' H ' ' A' ' 40' ' ' GLN . 6.8 m120 51.31 43.85 29.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.297 0.57 . . . . 0.0 110.379 -179.846 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.726 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.3 m -69.13 153.28 43.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.076 -178.334 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.567 HG12 ' HA2' ' A' ' 37' ' ' GLY . 55.2 mt -119.14 116.41 50.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.92 177.88 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 72.4 m -104.85 130.1 53.04 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.833 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.648 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -107.92 100.74 10.07 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.583 178.102 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -95.16 121.65 37.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.488 179.808 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.555 HH12 HD12 ' A' ' 116' ' ' LEU . 5.0 mtm180 -105.05 88.04 2.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.545 -179.933 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 tp -27.11 -60.28 0.09 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.279 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.526 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.19 -79.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.361 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -78.3 2.57 18.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.818 -179.907 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 54.36 28.84 9.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.54 179.671 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.541 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 27.5 mm-40 -71.32 163.44 27.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.884 0.374 . . . . 0.0 110.882 179.876 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.443 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -150.02 88.48 1.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.668 179.76 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.648 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -78.45 117.79 19.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.897 179.879 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.77 93.55 5.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.882 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.499 HD21 HD13 ' A' ' 102' ' ' ILE . 4.0 tt -78.71 78.6 5.15 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.776 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 99' ' ' ILE . 28.8 mt-10 -79.73 -165.5 0.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.787 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.471 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.7 OUTLIER -44.83 -52.05 8.92 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.374 -179.377 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -46.06 -17.68 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.365 179.786 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 96' ' ' ASP . 28.6 m-20 -125.9 -13.8 6.26 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.523 -179.941 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.651 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.0 mm -90.85 -35.13 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.338 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.0 -39.0 58.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.362 -179.681 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.7 m -126.48 32.96 5.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.749 179.937 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.516 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.9 tp -58.37 143.71 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.681 -179.935 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 102' ' ' ILE . 23.3 m-20 -138.61 148.78 44.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.475 178.891 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.868 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.88 -37.14 13.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.061 0.458 . . . . 0.0 110.337 -179.888 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.6 m -61.76 -48.0 82.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.237 178.741 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -60.1 -62.38 1.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.26 -179.895 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.765 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.22 -56.44 6.7 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.013 0.435 . . . . 0.0 110.258 179.982 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.9 m -57.97 -31.25 66.72 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.815 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -70.32 -66.51 0.59 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.184 179.71 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -42.07 -43.96 3.43 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.295 179.351 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.486 HG12 HG21 ' A' ' 35' ' ' VAL . 95.1 mt -63.42 -55.05 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.381 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -54.01 -18.89 3.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.151 179.234 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.482 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.91 -35.81 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.944 -179.137 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.472 ' O ' HD21 ' A' ' 83' ' ' LEU . 14.9 m120 -125.17 31.78 5.53 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.472 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.1 p -83.84 36.54 0.56 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.037 0.446 . . . . 0.0 110.465 178.792 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.555 HD12 HH12 ' A' ' 85' ' ' ARG . 63.7 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.311 -179.565 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 10.3 pt-20 . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.513 0.197 . . . . 0.0 110.545 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 30.3 Cg_endo -64.26 148.99 91.06 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.584 2.19 . . . . 0.0 112.594 -179.373 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 17' ' ' TRP . 26.0 m -64.13 154.28 35.11 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.161 -179.39 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.416 ' N ' HG22 ' A' ' 16' ' ' THR . 5.6 m-90 -98.09 88.4 4.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.827 179.647 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.635 HD22 ' HA ' ' A' ' 24' ' ' ALA . 60.8 mt -88.33 77.01 8.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.057 0.456 . . . . 0.0 110.379 179.914 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.2 p -75.03 -7.09 52.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.32 -179.076 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -138.8 147.9 43.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.816 -179.576 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.598 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 47.9 t -54.93 -50.32 86.91 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.521 179.794 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.44 -44.49 42.0 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.944 1.762 . . . . 0.0 111.854 -179.956 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.86 -33.98 77.29 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.258 0.552 . . . . 0.0 110.4 -179.988 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.635 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -65.28 -58.55 5.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.127 179.371 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.5 mtp -61.24 -27.02 68.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.981 179.992 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 18.7 mt-10 -71.0 -49.88 40.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.654 0.264 . . . . 0.0 110.342 179.616 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.574 ' O ' HG22 ' A' ' 31' ' ' THR . 2.7 m-85 -60.16 -35.24 74.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.002 179.229 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 36' ' ' ILE . 49.0 mt -72.28 -38.36 61.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.926 178.526 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.3 -18.65 61.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.04 -179.823 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.08 26.63 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.04 -179.842 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.599 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.9 t -173.32 153.72 2.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.541 -179.623 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.523 ' HG3' HG13 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -63.3 -84.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.148 0.499 . . . . 0.0 110.903 179.532 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.544 HG13 HD11 ' A' ' 83' ' ' LEU . 13.0 t -87.7 134.21 28.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.663 -179.808 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.55 125.46 21.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 112.019 -179.162 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.444 HG11 HD11 ' A' ' 111' ' ' ILE . 53.5 t -115.21 127.87 72.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.955 178.544 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.532 HD12 HD11 ' A' ' 28' ' ' ILE . 23.5 mt -133.23 136.15 55.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.513 -177.27 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.595 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.58 98.8 1.99 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.49 179.797 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 11.7 m-85 -83.81 92.36 7.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.632 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.9 m-85 -113.42 141.59 46.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.451 -178.068 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.438 ' HG2' HD23 ' A' ' 71' ' ' LEU . 25.3 mt-30 -89.41 -6.99 56.07 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.712 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.499 ' O ' HG12 ' A' ' 44' ' ' ILE . 36.4 t70 -150.03 119.06 6.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.82 179.916 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.546 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.7 mt -88.36 44.97 1.24 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.11 0.481 . . . . 0.0 111.165 -179.605 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.409 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 8.5 mm-40 -135.99 10.85 3.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.21 179.317 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.839 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.7 pt -95.13 156.39 37.88 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.098 179.742 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.467 ' O ' HD12 ' A' ' 49' ' ' ILE . 76.4 Cg_exo -50.94 -29.79 28.31 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.712 2.274 . . . . 0.0 112.909 179.825 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.839 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -60.47 -36.11 77.48 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.052 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.661 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.2 t -64.49 -57.66 16.38 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.636 -178.926 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.9 Cg_exo -58.23 -37.93 93.21 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.712 1.608 . . . . 0.0 111.205 179.279 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.902 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.6 mt -64.34 -37.32 79.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.029 179.822 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 54' ' ' VAL . 39.7 tp -72.82 -52.92 12.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.905 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -54.8 -25.16 26.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.021 0.438 . . . . 0.0 109.966 178.791 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.7 t -81.71 -44.94 16.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.465 179.588 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.598 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.49 -26.31 67.83 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.159 0.504 . . . . 0.0 109.788 179.497 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.7 t -53.02 -49.65 48.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.121 179.513 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -74.47 -11.74 60.31 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.564 -179.949 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.3 mtpp -93.71 -17.9 22.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.291 179.936 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.559 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 65.2 m-85 -136.49 61.65 38.81 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.551 -179.74 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.61 -42.64 60.88 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.682 2.255 . . . . 0.0 111.67 179.174 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.29 -39.47 90.31 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.368 179.31 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.6 t -67.76 145.09 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.521 -0.34 . . . . 0.0 110.19 178.927 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.599 ' CB ' HG21 ' A' ' 31' ' ' THR . 22.6 t -82.71 96.79 8.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.03 0.443 . . . . 0.0 110.899 -179.716 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.485 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.9 p90 -63.98 129.53 40.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.05 179.888 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.97 161.57 28.73 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.01 179.697 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.404 HD11 HG13 ' A' ' 47' ' ' VAL . 4.4 tt -160.12 144.39 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.795 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.8 t -146.82 155.55 42.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.174 0.512 . . . . 0.0 111.733 -179.137 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 77.9 p -139.14 2.08 2.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.618 179.654 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -73.63 143.78 46.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.744 -179.893 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.2 p -64.91 -51.84 59.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.405 -179.578 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -49.23 -42.58 40.94 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.707 -179.472 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.573 ' HA ' HG22 ' A' ' 21' ' ' VAL . 77.7 t -71.77 -54.1 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.936 0.398 . . . . 0.0 110.714 179.973 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.438 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.63 -14.68 8.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.303 179.368 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.1 m -91.91 -40.95 10.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.261 178.966 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -60.69 -39.34 88.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.403 179.825 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.4 ' HB2' HG12 ' A' ' 76' ' ' ILE . 58.6 m-85 -91.9 10.61 28.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.723 179.398 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 58.26 22.37 9.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.662 179.128 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.674 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.9 mm -57.83 122.21 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.044 179.912 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.0 p -142.3 59.55 1.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.139 -179.912 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.3 44.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.725 179.989 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.65 ' HB2' HG21 ' A' ' 99' ' ' ILE . 42.1 m-20 51.77 42.83 30.21 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.192 0.52 . . . . 0.0 110.532 -179.9 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.674 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.8 m -69.02 153.83 43.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.677 -178.671 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.595 HG12 ' HA2' ' A' ' 37' ' ' GLY . 62.7 mt -120.83 118.28 55.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.941 178.268 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.481 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.4 m -106.55 134.31 49.88 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.998 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.65 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -111.42 105.08 13.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.129 178.716 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.3 t80 -99.31 119.91 38.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.446 179.543 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.466 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 4.6 mtm180 -101.74 79.98 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.809 -179.731 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 32' ' ' GLU . 11.5 tp -23.9 -59.35 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.108 -179.622 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.523 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.21 -63.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.264 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.49 3.72 54.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.061 0.457 . . . . 0.0 111.14 -179.694 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 51.37 30.02 5.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.947 179.422 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 7.0 mm-40 -77.53 153.5 33.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.505 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.401 HE22 ' HB3' ' A' ' 93' ' ' ASN . 22.6 tm0? -135.4 94.98 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.904 179.816 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.65 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -84.71 134.85 34.34 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.003 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.401 ' HB3' HE22 ' A' ' 91' ' ' GLN . 0.7 OUTLIER -117.26 101.31 8.33 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.824 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.602 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -85.93 78.19 9.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.794 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.453 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.1 mt-10 -80.4 -164.84 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.891 -176.877 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.522 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 23.7 t70 -51.26 -36.12 40.56 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.831 -179.381 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -55.77 -14.88 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.106 0.479 . . . . 0.0 110.21 179.448 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -131.5 -13.81 3.34 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.623 -179.806 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.65 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.8 mm -90.17 -35.45 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.594 0.235 . . . . 0.0 111.406 -179.496 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -49.62 -44.56 47.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.801 -179.98 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.3 m -124.74 41.14 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.358 179.498 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.602 HD13 HD21 ' A' ' 94' ' ' LEU . 7.8 tp -66.3 143.97 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.8 -179.618 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -138.45 149.59 45.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.581 178.72 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.902 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.61 -37.6 12.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.581 -179.788 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.5 m -61.6 -47.49 85.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.346 178.75 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -59.86 -61.39 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.249 -179.718 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.777 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.71 -55.8 10.36 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.924 0.392 . . . . 0.0 110.382 179.98 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.6 m -58.51 -30.18 66.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.88 179.901 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.551 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.9 tmt_? -70.54 -66.42 0.61 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.101 179.558 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -42.88 -44.4 4.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.274 179.34 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.444 HD11 HG11 ' A' ' 35' ' ' VAL . 96.6 mt -63.19 -54.75 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.287 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.408 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 32.8 tt0 -53.96 -19.66 5.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.224 179.191 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.551 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.7 -36.53 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.771 -179.155 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.612 HD22 ' HG ' ' A' ' 92' ' ' LEU . 88.9 m-20 -123.71 30.01 6.35 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.183 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 96.6 p -82.83 37.13 0.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.165 0.507 . . . . 0.0 110.052 178.797 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.448 HD12 HH12 ' A' ' 85' ' ' ARG . 53.5 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.314 -179.329 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.7 pt-20 . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 110.52 -0.178 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 38.1 Cg_endo -66.43 144.48 73.68 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.53 2.153 . . . . 0.0 112.405 -179.614 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.6 m -63.41 153.58 34.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.671 -179.536 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -98.62 92.53 5.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 179.488 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 24' ' ' ALA . 43.5 mt -86.96 73.65 9.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.326 179.801 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.2 p -72.21 -5.37 35.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.118 -179.167 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -137.06 146.72 45.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.905 0.383 . . . . 0.0 111.604 -179.684 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 59.9 t -55.5 -49.81 90.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.61 179.883 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.8 Cg_endo -57.77 -46.17 28.29 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.923 1.749 . . . . 0.0 112.07 179.877 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.83 81.39 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.346 0.593 . . . . 0.0 110.239 -179.898 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.635 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -63.99 -58.53 6.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.023 179.524 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 21' ' ' VAL . 57.7 mtm -60.02 -25.76 65.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.065 179.891 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -71.97 -52.07 18.86 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.621 179.642 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -60.01 -30.2 69.0 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.33 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.564 HD11 HD12 ' A' ' 36' ' ' ILE . 48.0 mt -75.57 -38.69 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.121 178.201 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 -20.66 60.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.018 -179.851 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.78 31.85 1.33 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -179.929 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.507 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.7 t -170.43 151.78 3.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.45 -179.539 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.615 ' HG3' HG13 ' A' ' 87' ' ' VAL . 24.4 tt0 -70.18 -40.55 74.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.558 179.539 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.493 HG13 HD11 ' A' ' 83' ' ' LEU . 19.4 t -129.94 137.35 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.162 179.283 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.93 128.19 19.85 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.134 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.456 HG21 HG12 ' A' ' 111' ' ' ILE . 55.0 t -115.93 130.53 70.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.379 178.338 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.564 HD12 HD11 ' A' ' 28' ' ' ILE . 28.7 mt -136.19 135.92 49.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.305 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.585 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.39 96.86 1.73 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.559 179.722 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.489 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 13.6 m-85 -82.45 89.68 6.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.522 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -109.94 140.56 43.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.057 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -87.28 -6.51 58.51 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.661 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.9 t70 -151.58 122.42 7.54 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.755 179.837 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.505 ' HA ' HG21 ' A' ' 47' ' ' VAL . 97.1 mt -91.34 46.18 1.29 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.131 0.491 . . . . 0.0 111.208 -179.486 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -137.25 11.08 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.0 179.204 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.777 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.3 pt -94.21 156.13 39.23 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.133 179.923 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.45 ' O ' HD12 ' A' ' 49' ' ' ILE . 75.0 Cg_exo -51.16 -27.08 21.28 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.807 2.338 . . . . 0.0 113.057 179.666 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.777 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.67 -38.7 92.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.945 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.664 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -60.21 -56.67 33.15 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.734 -178.849 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.634 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.0 Cg_exo -58.42 -40.12 77.76 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.587 1.525 . . . . 0.0 111.37 179.597 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.898 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.9 mt -62.66 -34.92 67.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.092 179.874 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.62 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.2 tp -74.95 -52.77 10.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.845 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -54.26 -23.15 13.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.036 0.446 . . . . 0.0 109.932 178.781 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 75.6 m -84.15 -46.45 11.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.498 179.363 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.568 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.75 -26.18 63.72 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.374 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.5 t -51.69 -50.62 30.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.013 179.28 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -75.96 -8.59 57.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.934 -179.558 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -95.0 -19.25 20.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.177 179.581 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.585 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 63.9 m-85 -136.04 63.16 49.62 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.578 -179.734 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.87 -44.46 44.91 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.718 2.278 . . . . 0.0 111.553 178.988 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.24 -40.94 85.76 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.421 179.212 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.3 t -67.27 143.96 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.886 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.507 ' CB ' HG21 ' A' ' 31' ' ' THR . 42.2 t -82.34 99.56 9.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.083 0.468 . . . . 0.0 111.014 -179.591 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.533 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.9 p90 -66.71 123.96 21.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.0 179.787 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -143.74 162.81 27.7 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.063 179.979 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.403 HD11 HG13 ' A' ' 47' ' ' VAL . 4.4 tt -160.06 142.33 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.936 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.9 t -143.42 153.57 42.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.114 0.483 . . . . 0.0 111.843 -178.888 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 39' ' ' PHE . 75.3 p -138.34 1.16 2.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.589 179.598 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -73.38 145.95 45.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.7 t -66.76 -50.83 61.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.385 -179.569 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -50.1 -43.98 51.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.539 -179.392 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.556 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.1 t -71.04 -53.43 21.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.867 0.365 . . . . 0.0 110.799 179.885 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mp -58.74 -14.74 9.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.263 179.402 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.7 m -91.62 -42.96 9.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.427 179.062 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -60.36 -38.66 84.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.577 179.816 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.434 ' HB2' HG12 ' A' ' 76' ' ' ILE . 60.8 m-85 -91.39 11.17 24.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.697 179.647 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 56.19 24.41 8.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.705 179.289 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.672 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.3 mm -60.93 122.3 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.922 179.648 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.4 p -142.89 60.34 1.42 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.089 -179.959 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.29 45.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.499 179.88 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.646 ' HB2' HG21 ' A' ' 99' ' ' ILE . 30.5 m-20 50.52 43.81 27.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.158 0.504 . . . . 0.0 110.301 -179.773 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.672 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.7 m -69.56 153.61 43.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.653 -178.41 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.585 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.9 mt -120.71 116.61 50.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.004 177.993 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.489 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 71.4 m -106.18 132.57 52.09 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.837 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.626 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -108.32 102.6 11.7 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.798 178.291 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -97.39 123.64 41.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.885 0.374 . . . . 0.0 110.68 179.784 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.493 HH21 ' HB2' ' A' ' 88' ' ' ASP . 3.6 mtm180 -106.17 99.66 9.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.073 179.7 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.0 tp -43.28 -51.1 6.41 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.621 -179.38 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.615 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -42.59 -64.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.334 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.493 ' HB2' HH21 ' A' ' 85' ' ' ARG . 2.9 m-20 -98.29 18.09 17.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.59 -179.13 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.7 p30 43.63 29.49 0.28 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.022 179.207 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.48 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 7.5 mm-40 -75.02 156.38 36.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.37 . . . . 0.0 111.137 -179.946 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.446 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.8 OUTLIER -139.93 89.78 2.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.687 179.574 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.626 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -78.03 142.38 38.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.65 179.574 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.22 111.25 15.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.355 0.598 . . . . 0.0 112.534 -179.108 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.66 HD21 HD13 ' A' ' 102' ' ' ILE . 3.6 tt -98.29 76.39 2.32 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.043 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.7 mt-10 -77.65 -166.29 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -176.697 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.539 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.6 t70 -50.54 -37.71 40.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.914 -179.218 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -56.46 -15.27 3.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.13 0.491 . . . . 0.0 110.461 179.791 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -128.66 -13.67 4.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.395 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.646 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.9 mm -89.63 -25.13 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.592 -179.31 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -51.9 -61.48 2.23 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.923 0.392 . . . . 0.0 110.653 179.846 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.8 m -112.89 38.94 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.471 179.649 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.66 HD13 HD21 ' A' ' 94' ' ' LEU . 7.7 tp -57.1 143.24 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.427 -179.832 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -136.05 149.81 48.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.823 178.873 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.898 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.25 -33.92 9.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.187 179.97 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 97.8 m -62.82 -50.6 70.33 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.245 178.73 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -58.33 -58.42 8.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.278 -179.614 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.781 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.93 -57.27 8.95 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.036 0.446 . . . . 0.0 110.32 179.977 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 64.9 m -57.82 -29.4 64.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.831 179.85 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.48 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.1 tmt_? -71.38 -64.88 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.239 179.786 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -43.44 -43.38 5.26 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.972 178.976 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.456 HG12 HG21 ' A' ' 35' ' ' VAL . 95.9 mt -63.68 -56.11 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.509 178.408 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.84 -16.7 2.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.283 0.563 . . . . 0.0 110.334 179.337 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.48 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -91.91 -34.99 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.738 -179.231 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.616 HD22 ' HG ' ' A' ' 92' ' ' LEU . 88.4 m-20 -127.5 32.16 5.06 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.306 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 111' ' ' ILE . 91.0 p -83.94 36.08 0.55 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.201 0.524 . . . . 0.0 110.199 178.995 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.488 HD12 HH12 ' A' ' 85' ' ' ARG . 51.9 mt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.174 -179.443 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.502 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.581 0.229 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 40.0 Cg_endo -67.89 142.59 57.7 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.733 2.289 . . . . 0.0 112.533 -179.702 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 m -54.49 152.66 6.41 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.23 -179.977 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -103.11 79.66 1.77 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.066 0.46 . . . . 0.0 111.057 -179.79 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.678 HD22 ' HA ' ' A' ' 24' ' ' ALA . 46.6 mt -71.06 94.45 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.317 179.708 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.4 p -85.45 -12.93 50.72 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.871 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 5.4 m-20 -139.62 151.27 45.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.77 -179.471 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 30.0 t -52.89 -49.76 85.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.561 179.853 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.6 Cg_endo -57.42 -45.71 32.58 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.97 1.78 . . . . 0.0 112.043 179.912 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.22 -34.79 78.42 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.201 0.524 . . . . 0.0 110.279 -179.852 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.678 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.93 -59.46 4.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.147 179.406 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.6 mtm -60.75 -24.26 65.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.041 -179.994 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.4 -51.28 17.85 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.312 179.437 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.49 ' O ' HG22 ' A' ' 31' ' ' THR . 4.9 m-85 -59.62 -31.74 69.77 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.141 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 36' ' ' ILE . 49.4 mt -75.03 -41.25 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.271 178.444 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.28 -19.04 62.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.162 -179.788 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.59 27.82 2.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.146 -179.845 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.609 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.8 t -172.68 154.01 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.769 -179.629 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.591 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.0 tt0 -63.8 -73.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.747 179.911 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.569 HG13 HD11 ' A' ' 83' ' ' LEU . 21.6 t -100.68 137.86 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.656 179.87 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.94 126.1 18.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.987 0.422 . . . . 0.0 112.058 -179.27 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.458 HG21 HG12 ' A' ' 111' ' ' ILE . 50.0 t -114.7 130.63 68.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.518 178.413 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.541 HD12 HD11 ' A' ' 28' ' ' ILE . 24.0 mt -135.07 136.02 52.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.243 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.51 97.73 1.93 Allowed Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.465 179.787 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 10.3 m-85 -83.37 92.06 7.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.665 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.7 m-85 -112.92 138.66 49.44 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.093 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.542 ' HG2' HD23 ' A' ' 71' ' ' LEU . 22.9 mt-30 -85.25 -6.48 59.26 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.714 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.4 t70 -151.54 125.67 9.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.644 179.672 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.516 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.9 mt -93.83 44.06 1.12 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.004 0.43 . . . . 0.0 111.203 -179.535 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.3 mt-10 -133.56 9.63 3.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.865 178.962 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.75 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.2 pt -91.73 157.69 41.31 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.19 179.942 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.476 ' O ' HD12 ' A' ' 49' ' ' ILE . 77.9 Cg_exo -53.22 -26.08 32.51 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.845 2.363 . . . . 0.0 112.956 179.603 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.75 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.32 -38.87 92.58 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.916 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.694 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -60.26 -55.41 45.57 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -178.557 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -60.22 -39.47 68.14 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.882 1.721 . . . . 0.0 111.509 179.286 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.893 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.5 mt -63.88 -34.2 66.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.045 179.984 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 54' ' ' VAL . 50.1 tp -74.76 -52.27 11.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.823 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -53.44 -27.31 24.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.168 0.508 . . . . 0.0 109.765 178.618 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -80.25 -46.38 16.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.568 179.876 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.587 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.49 -25.8 64.74 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.406 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.1 t -53.53 -50.39 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.999 179.505 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -73.89 -11.51 60.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.617 179.911 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -93.3 -18.77 22.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.22 -179.863 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.6 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 63.0 m-85 -136.0 61.6 41.52 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.636 -179.682 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.37 -38.28 82.33 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.604 2.203 . . . . 0.0 111.506 179.167 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.16 -41.27 99.42 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.354 179.079 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.1 t -67.07 145.23 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.884 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.609 ' HB2' HG21 ' A' ' 31' ' ' THR . 36.0 t -82.41 96.57 8.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.959 0.409 . . . . 0.0 111.114 -179.696 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.502 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.9 p90 -63.87 127.16 30.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.982 179.763 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.54 162.71 28.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.054 179.78 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 tt -160.62 144.71 5.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.986 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 t -145.01 157.05 44.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.98 0.419 . . . . 0.0 111.81 -178.949 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 39' ' ' PHE . 76.5 p -141.92 1.41 1.47 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.593 179.649 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.7 144.15 45.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.624 179.93 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.5 p -65.28 -51.51 60.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.67 -179.439 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -49.67 -43.03 46.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.64 -179.386 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.463 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.3 t -71.72 -52.96 22.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.311 . . . . 0.0 110.748 179.981 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.542 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -59.14 -14.6 10.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.158 0.504 . . . . 0.0 110.273 179.371 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.4 m -91.84 -40.57 11.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.377 178.722 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -61.31 -39.99 92.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.232 179.822 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.425 ' HB2' HG12 ' A' ' 76' ' ' ILE . 37.4 m-85 -90.51 9.73 28.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.626 179.533 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 m120 57.38 25.53 11.39 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.641 179.107 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.653 HD12 ' HB ' ' A' ' 80' ' ' THR . 36.9 mm -60.8 118.13 3.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.997 179.653 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.1 p -136.62 56.28 1.81 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.388 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.25 45.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.728 179.838 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.59 ' HB2' HG21 ' A' ' 99' ' ' ILE . 14.0 m120 51.62 42.54 29.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.196 0.522 . . . . 0.0 110.474 179.93 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.653 ' HB ' HD12 ' A' ' 76' ' ' ILE . 89.3 m -68.24 153.07 44.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.646 -178.607 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.578 HG12 ' HA2' ' A' ' 37' ' ' GLY . 61.7 mt -119.33 118.65 58.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.054 177.988 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 81.5 m -107.62 135.7 48.62 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.787 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.652 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -110.41 105.47 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.104 178.552 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.3 t80 -98.9 123.09 42.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.851 0.357 . . . . 0.0 110.666 179.652 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.472 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.5 mtm180 -106.73 91.8 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.205 179.844 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tp -38.25 -50.74 1.46 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.711 -179.824 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.591 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -45.2 -59.78 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.435 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -99.98 17.08 21.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.328 -179.418 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.2 p30 42.83 32.76 0.42 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.948 179.084 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 8.3 mm-40 -81.58 160.59 23.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 111.147 -179.823 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.75 91.45 2.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.362 179.564 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.652 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -80.07 149.22 30.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.875 179.7 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.6 124.62 41.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.315 0.579 . . . . 0.0 112.117 -179.366 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.602 HD21 HD13 ' A' ' 102' ' ' ILE . 3.8 tt -111.24 75.53 0.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.073 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.0 mt-10 -77.51 -165.62 0.63 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.395 -0.821 . . . . 0.0 113.208 -176.736 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.516 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.5 t70 -51.31 -36.74 43.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.968 -179.181 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -56.49 -14.82 3.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.152 0.501 . . . . 0.0 110.266 179.536 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -130.26 -13.94 3.88 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.554 -179.947 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.59 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.2 mm -90.7 -25.38 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.78 0.324 . . . . 0.0 111.34 -179.364 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.6 -52.2 62.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.691 179.993 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 81.1 p -119.66 36.57 4.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.511 179.811 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.602 HD13 HD21 ' A' ' 94' ' ' LEU . 7.5 tp -57.38 142.24 13.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.487 -179.853 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.45 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 25.0 m-20 -135.93 149.76 49.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.757 178.884 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.893 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.04 -37.06 14.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.03 0.443 . . . . 0.0 110.446 -179.77 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.8 m -62.52 -47.85 82.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.295 178.71 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.45 ' HD3' ' N ' ' A' ' 103' ' ' ASP . 59.3 mtpt -59.2 -60.23 4.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.087 -179.735 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.755 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.06 -55.98 10.45 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.931 0.396 . . . . 0.0 110.15 179.847 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.2 m -57.87 -30.19 65.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.814 179.794 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.49 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -70.61 -65.77 0.69 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.088 179.696 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -42.29 -44.78 3.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.076 179.053 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -62.66 -55.86 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.537 178.495 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -54.13 -18.31 3.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.444 179.326 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.49 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.87 -38.51 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.016 -179.057 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.596 HD22 ' HG ' ' A' ' 92' ' ' LEU . 90.4 m-20 -123.35 29.59 6.61 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.348 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.5 p -82.11 50.32 1.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.116 0.484 . . . . 0.0 110.267 178.9 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 61.3 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.43 -179.44 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.626 0.251 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.8 Cg_endo -68.67 148.93 73.0 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.7 2.267 . . . . 0.0 112.677 -179.777 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 m -63.16 152.61 36.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.575 -179.668 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -98.8 97.46 8.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.812 179.706 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 24' ' ' ALA . 38.4 mt -96.37 71.57 2.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.641 179.964 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.9 p -71.39 -3.12 19.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.953 -179.171 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -140.14 147.68 40.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.934 0.397 . . . . 0.0 111.656 -179.991 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 24.9 t -56.49 -49.46 93.4 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.761 -179.896 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.51 -45.27 35.25 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.931 1.754 . . . . 0.0 111.963 179.954 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.38 -35.89 82.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.267 0.556 . . . . 0.0 110.344 -179.961 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.608 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.95 -57.91 8.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.185 179.427 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 64.4 mtp -61.75 -26.39 68.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.224 -179.952 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.48 -50.79 28.15 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.497 179.598 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.468 ' O ' HG22 ' A' ' 31' ' ' THR . 7.6 m-85 -60.24 -33.05 71.74 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.035 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.502 HD11 HD12 ' A' ' 36' ' ' ILE . 57.1 mt -72.72 -39.81 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.024 178.475 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.75 -19.33 62.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.99 -179.869 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.12 29.45 2.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.856 -179.975 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.583 HG21 ' CB ' ' A' ' 61' ' ' SER . 10.0 t -169.31 153.03 5.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.271 -179.722 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HG3' HG13 ' A' ' 87' ' ' VAL . 27.1 tt0 -72.4 -46.34 55.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.577 HG13 HD11 ' A' ' 83' ' ' LEU . 21.0 t -122.68 133.87 67.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.08 179.296 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.544 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.66 126.29 20.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.012 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.513 HG21 HG12 ' A' ' 111' ' ' ILE . 52.0 t -114.24 127.59 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.766 178.701 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.502 HD12 HD11 ' A' ' 28' ' ' ILE . 24.8 mt -133.03 136.73 54.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.391 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.604 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.91 96.92 1.7 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.544 179.972 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.6 m-85 -83.17 90.82 7.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.654 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.4 m-85 -111.56 139.34 47.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.184 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.453 ' HG2' HD23 ' A' ' 71' ' ' LEU . 89.6 mt-30 -85.42 -7.21 59.05 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.89 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.439 ' O ' HG12 ' A' ' 44' ' ' ILE . 36.6 t70 -150.67 125.68 9.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.667 179.768 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.604 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.2 mt -93.72 46.94 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.112 0.482 . . . . 0.0 111.373 -179.533 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 46.7 mt-10 -138.19 9.99 2.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.948 179.034 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.801 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.4 pt -93.06 156.28 40.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.064 179.848 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.465 ' O ' HD12 ' A' ' 49' ' ' ILE . 81.4 Cg_exo -50.96 -27.25 20.52 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.818 2.345 . . . . 0.0 113.214 -179.914 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.801 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.43 -38.25 90.39 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.916 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.69 HG23 HG13 ' A' ' 44' ' ' ILE . 3.0 t -60.45 -55.96 39.98 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.585 -178.742 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.6 -41.55 55.37 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.876 1.717 . . . . 0.0 111.4 179.487 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.883 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.2 mt -60.94 -35.58 66.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.247 179.983 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.2 tp -73.99 -52.28 13.26 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.957 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -54.44 -24.25 19.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.08 0.467 . . . . 0.0 109.824 178.831 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.3 m -82.55 -46.38 13.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.514 179.643 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.576 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.59 -26.41 65.4 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.107 0.48 . . . . 0.0 109.744 179.492 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.7 t -52.86 -50.02 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.194 179.498 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -75.83 -8.35 56.68 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.631 179.992 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -95.72 -19.04 19.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.133 179.743 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.562 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 71.9 m-85 -136.73 62.36 41.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.509 -179.617 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.87 -41.12 72.78 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.7 2.266 . . . . 0.0 111.538 179.09 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.58 -41.63 95.67 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.428 179.191 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.8 t -66.18 145.72 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.765 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.583 ' CB ' HG21 ' A' ' 31' ' ' THR . 40.3 t -83.11 97.34 8.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 111.035 -179.553 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.51 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 8.0 p90 -62.82 129.53 40.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.862 179.646 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.514 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -148.16 159.83 28.15 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.993 179.73 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.9 tt -161.83 140.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.882 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.9 t -145.15 159.2 43.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.146 0.498 . . . . 0.0 111.741 -178.872 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.455 HG21 ' HG ' ' A' ' 42' ' ' LEU . 79.7 p -140.29 -0.77 1.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.396 179.495 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -69.46 141.2 54.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.718 -179.786 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.2 t -64.3 -48.38 75.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.296 -179.78 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -49.96 -46.31 52.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.436 -179.639 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.52 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.5 t -69.44 -53.27 25.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.703 179.846 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.8 mp -58.27 -14.82 8.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.195 0.521 . . . . 0.0 110.317 179.462 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.2 m -90.66 -42.46 10.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.264 178.615 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -59.79 -40.76 89.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.629 -179.98 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.405 ' HB2' HG12 ' A' ' 76' ' ' ILE . 51.3 m-85 -90.6 11.04 23.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.831 179.602 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 56.8 26.24 11.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.438 179.326 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.683 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.5 mm -61.61 122.96 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.839 179.633 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.1 p -140.9 47.89 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.762 0.315 . . . . 0.0 111.51 -179.891 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.8 47.88 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.742 179.819 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.621 ' HB2' HG21 ' A' ' 99' ' ' ILE . 13.9 m120 50.06 41.45 23.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.257 0.551 . . . . 0.0 110.271 -179.775 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.683 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.1 m -67.79 151.79 46.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.671 -178.515 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.604 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.3 mt -118.73 115.79 49.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.865 178.059 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.535 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.1 m -105.47 130.92 53.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.779 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.616 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.3 tp -107.66 99.84 9.29 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.843 178.455 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.5 t80 -92.31 122.93 35.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.364 179.633 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.462 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 6.1 mtm180 -105.24 85.66 2.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.867 0.365 . . . . 0.0 110.57 -179.915 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 tp -26.05 -59.61 0.08 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.12 -179.322 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.456 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.86 -71.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.261 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.71 13.41 8.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.333 -179.302 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.29 29.82 0.4 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.131 178.973 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 10.4 mm-40 -76.41 167.52 21.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.349 . . . . 0.0 110.79 179.825 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -154.26 95.23 1.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.623 179.724 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.616 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -80.55 110.71 16.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.065 -179.953 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -92.52 92.1 7.9 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.973 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.611 HD21 HD13 ' A' ' 102' ' ' ILE . 3.3 tt -77.92 78.11 4.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.753 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.449 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.8 mt-10 -79.05 -164.95 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.865 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.517 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 22.5 t70 -51.18 -37.61 47.56 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.905 -179.252 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -54.91 -14.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.213 0.53 . . . . 0.0 110.352 179.533 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -130.77 -13.99 3.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.753 -179.906 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.621 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.1 mm -89.84 -37.11 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.281 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -51.0 -39.77 56.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.885 0.374 . . . . 0.0 111.077 -179.874 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.9 p -126.92 36.03 4.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.645 179.939 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.611 HD13 HD21 ' A' ' 94' ' ' LEU . 7.9 tp -62.61 143.91 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.701 -179.666 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -137.74 147.34 44.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.364 178.856 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.883 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.85 -35.93 6.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.972 0.415 . . . . 0.0 110.333 -179.735 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 99.6 m -62.29 -48.31 80.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.266 178.646 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -60.0 -59.87 4.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.241 -179.709 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.776 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.03 -55.69 13.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.899 0.381 . . . . 0.0 110.275 -179.909 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.2 m -58.19 -29.93 66.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.687 179.702 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.51 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.6 tmt_? -71.39 -66.14 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.188 179.772 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -42.75 -43.4 3.93 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.12 179.286 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.513 HG12 HG21 ' A' ' 35' ' ' VAL . 90.2 mt -63.89 -55.23 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.549 178.409 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -55.14 -16.82 3.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.281 179.282 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.51 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -92.27 -34.7 6.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.767 -179.272 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' A' ' 85' ' ' ARG . 36.1 m120 -123.12 28.1 7.31 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.653 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.1 p -82.35 46.81 1.08 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.067 0.46 . . . . 0.0 110.502 179.278 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.455 HD12 HH12 ' A' ' 85' ' ' ARG . 70.2 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.212 -179.62 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.452 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 14.3 pt-20 . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 120.497 0.189 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 42.8 Cg_endo -69.57 144.05 53.77 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.656 2.237 . . . . 0.0 112.574 -179.675 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -59.45 151.32 24.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.346 -179.835 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -96.87 86.85 4.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.938 179.995 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.627 HD22 ' HA ' ' A' ' 24' ' ' ALA . 40.4 mt -83.58 74.47 10.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.488 179.929 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.8 p -74.4 0.54 14.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.048 -179.188 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.41 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 4.7 m-20 -143.88 147.44 34.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.996 0.427 . . . . 0.0 111.751 -179.863 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.608 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.1 t -55.67 -49.34 93.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.45 179.77 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.1 Cg_endo -58.44 -46.48 24.2 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.039 1.826 . . . . 0.0 111.977 179.799 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.16 -34.57 77.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.232 0.539 . . . . 0.0 110.169 -179.873 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.627 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.38 -58.06 7.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.973 179.535 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 33.1 mtt -61.86 -26.01 67.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.239 -179.898 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -71.89 -51.02 24.33 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 110.552 179.681 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.456 ' O ' HG22 ' A' ' 31' ' ' THR . 7.5 m-85 -60.59 -31.2 70.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.06 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.509 HD11 ' CD1' ' A' ' 36' ' ' ILE . 52.4 mt -75.22 -39.57 42.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.059 178.198 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 -18.59 61.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.109 -179.816 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.45 26.15 2.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.147 -179.947 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.727 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.9 t -171.35 155.87 4.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.608 -179.788 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.498 ' HG3' HG13 ' A' ' 87' ' ' VAL . 26.0 tt0 -67.92 -58.78 3.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.717 179.934 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 83' ' ' LEU . 13.6 t -111.17 138.33 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.67 127.44 18.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.961 0.41 . . . . 0.0 111.876 -179.526 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG21 HG12 ' A' ' 111' ' ' ILE . 47.0 t -116.01 128.58 73.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.748 178.732 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 21.5 mt -134.01 136.76 53.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.412 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.595 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.21 97.7 1.78 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.521 179.728 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.514 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.4 m-85 -83.43 91.32 7.34 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.482 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -111.57 142.06 44.36 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -177.945 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.502 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 76.6 mt-30 -88.96 -7.33 56.23 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.563 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.7 t70 -149.38 121.72 8.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.52 179.623 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.581 ' HA ' HG21 ' A' ' 47' ' ' VAL . 98.7 mt -91.7 46.84 1.31 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.18 0.514 . . . . 0.0 111.383 -179.293 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.424 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 47.4 mt-10 -137.54 7.09 2.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.002 178.964 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.827 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.3 pt -90.13 155.63 46.89 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.949 179.786 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.48 ' O ' HD12 ' A' ' 49' ' ' ILE . 84.3 Cg_exo -49.95 -29.38 21.09 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.729 2.286 . . . . 0.0 112.984 -179.953 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.827 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -61.25 -38.48 86.82 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.998 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.664 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.4 t -61.66 -57.49 24.38 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.569 -178.83 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.06 -38.77 85.4 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.765 1.644 . . . . 0.0 111.453 179.437 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.904 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.9 mt -63.66 -34.38 67.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.907 179.85 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.608 ' O ' HG23 ' A' ' 54' ' ' VAL . 46.6 tp -75.57 -53.02 9.29 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.836 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -54.06 -24.18 16.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.115 0.483 . . . . 0.0 109.977 178.876 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.6 t -84.08 -47.0 11.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.607 179.657 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.616 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.27 -25.84 62.25 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.504 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 50' ' ' LEU . 49.4 t -52.63 -49.15 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.166 179.483 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -76.61 -9.01 58.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.714 179.989 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -94.46 -19.16 20.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.047 179.601 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 58.4 m-85 -135.52 63.02 52.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.752 -179.795 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.79 -45.24 39.56 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.77 2.313 . . . . 0.0 111.636 179.206 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.63 -42.32 84.34 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.468 179.133 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.3 t -65.48 143.58 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.947 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.727 ' HB2' HG21 ' A' ' 31' ' ' THR . 41.7 t -82.33 97.11 8.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.02 0.438 . . . . 0.0 111.125 -179.627 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.515 ' HB3' HG22 ' A' ' 54' ' ' VAL . 6.5 p90 -62.85 128.81 37.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.897 179.658 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.69 160.28 28.32 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.106 179.98 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.8 tt -158.83 143.29 6.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.723 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.4 t -146.44 152.69 39.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.003 0.43 . . . . 0.0 111.776 -179.083 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 39' ' ' PHE . 71.4 p -136.99 -3.95 1.98 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.326 179.5 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.49 142.73 58.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.697 179.986 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.5 m -64.79 -50.44 66.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.428 -179.461 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -50.37 -43.82 54.49 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.671 -179.338 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.504 ' HA ' HG22 ' A' ' 21' ' ' VAL . 69.1 t -71.46 -52.39 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 -179.973 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.39 -15.14 14.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.15 0.5 . . . . 0.0 110.187 179.387 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.7 m -91.59 -40.02 11.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.296 178.795 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.423 ' ND1' HG11 ' A' ' 21' ' ' VAL . 4.7 t60 -61.32 -42.4 98.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.374 179.948 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.409 ' HB2' HG12 ' A' ' 76' ' ' ILE . 39.2 m-85 -88.51 9.31 24.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.695 179.528 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 58.82 23.27 11.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.538 179.128 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.664 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.2 mm -56.81 120.83 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.975 179.852 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.6 p -140.31 58.71 1.57 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.344 -179.546 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.76 45.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.7 179.606 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.596 ' HB2' HG21 ' A' ' 99' ' ' ILE . 14.5 m120 51.73 43.28 30.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.217 0.532 . . . . 0.0 110.422 -179.914 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.664 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.5 m -69.36 152.08 45.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.735 -178.539 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.595 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.0 mt -119.02 118.04 56.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.964 178.135 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 79.4 m -105.91 133.21 51.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.907 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.648 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -109.02 105.17 14.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.774 178.48 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -98.67 120.11 38.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.683 179.787 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.461 HH12 HD12 ' A' ' 116' ' ' LEU . 4.3 mtm180 -104.74 80.98 1.71 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.611 179.965 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 85' ' ' ARG . 7.1 tp -22.59 -58.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 O-C-N 124.009 0.818 . . . . 0.0 112.856 -179.683 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.498 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.09 -67.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.366 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -93.3 3.26 55.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.388 -179.227 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 50.48 37.7 16.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.68 179.682 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 6.6 mm-40 -86.15 134.09 33.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.709 179.952 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.48 95.04 4.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.998 0.427 . . . . 0.0 110.833 179.954 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.648 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -82.41 109.93 17.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.634 179.506 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -93.87 94.59 8.58 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.439 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.555 HD21 HD13 ' A' ' 102' ' ' ILE . 4.3 tt -78.66 77.61 5.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.438 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.5 mt-10 -78.88 -164.91 0.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.908 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.517 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.6 t70 -50.76 -38.43 47.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.148 -179.145 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.57 -14.69 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.227 0.537 . . . . 0.0 110.33 179.722 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -129.68 -13.83 4.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.63 -179.85 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.6 mm -91.08 -31.27 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 111.438 -179.5 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -53.28 -43.15 67.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.891 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.8 m -124.93 38.53 4.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.419 179.711 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.555 HD13 HD21 ' A' ' 94' ' ' LEU . 7.3 tp -63.93 142.52 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.67 -179.698 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -137.98 150.91 47.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.604 178.803 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.904 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.78 -37.37 18.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.002 0.43 . . . . 0.0 110.443 -179.859 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 94.6 m -61.97 -46.93 87.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.208 178.686 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -60.75 -61.14 2.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.415 -179.819 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.79 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.52 -55.16 11.79 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.979 0.418 . . . . 0.0 110.128 179.906 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.6 m -59.05 -30.98 68.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.912 179.832 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.491 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.2 tmt_? -70.53 -65.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.097 179.691 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -43.01 -42.7 3.92 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.306 179.411 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.441 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -64.65 -55.23 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.23 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -54.02 -18.23 3.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.201 179.305 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.491 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -90.06 -38.42 10.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.985 -179.077 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.632 HD22 ' HG ' ' A' ' 92' ' ' LEU . 90.2 m-20 -122.77 30.54 6.4 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.432 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.0 p -83.14 44.03 0.91 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 110.15 178.727 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.461 HD12 HH12 ' A' ' 85' ' ' ARG . 57.7 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.404 -179.328 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.492 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.3 pt-20 . . . . . 0 CA--C 1.53 0.203 0 CA-C-O 120.513 0.197 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 54.0 Cg_endo -69.9 149.65 66.28 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.636 2.224 . . . . 0.0 112.753 -179.686 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 m -71.55 155.89 40.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.509 -179.622 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -100.05 88.9 3.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.073 179.827 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 24' ' ' ALA . 35.1 mt -82.73 71.78 9.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.375 179.781 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.5 p -70.21 -5.18 25.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.07 -178.892 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -135.81 147.36 48.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 111.416 -179.76 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.606 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 15.6 t -58.27 -48.99 96.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.367 179.915 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.0 Cg_endo -58.45 -43.83 42.71 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.899 1.733 . . . . 0.0 111.839 179.45 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.5 -37.22 86.79 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.291 0.567 . . . . 0.0 110.261 179.811 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.595 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -62.03 -54.89 35.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.049 179.45 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 38.3 mtt -62.48 -29.91 70.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.28 -179.928 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -69.18 -49.01 60.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.658 0.266 . . . . 0.0 110.517 -179.959 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -62.26 -32.82 73.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.851 179.253 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.52 HD11 HD12 ' A' ' 36' ' ' ILE . 48.1 mt -74.16 -36.15 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.156 0.503 . . . . 0.0 109.821 178.05 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.45 -18.57 60.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.21 27.57 2.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.185 -179.823 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.764 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.2 t -171.16 155.95 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.608 -179.761 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.535 ' HG3' HG13 ' A' ' 87' ' ' VAL . 24.4 tt0 -71.26 -46.87 59.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.597 179.755 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.488 HG13 HD11 ' A' ' 83' ' ' LEU . 19.1 t -121.68 137.6 54.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.361 179.555 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.06 128.45 20.03 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.154 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 83' ' ' LEU . 43.5 t -116.22 129.61 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.467 178.463 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.52 HD12 HD11 ' A' ' 28' ' ' ILE . 28.0 mt -136.46 136.15 48.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.226 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.63 96.71 1.77 Allowed Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.482 179.686 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.487 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 40.0 m-85 -82.71 89.67 6.78 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.277 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.1 m-85 -108.44 146.55 32.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.603 -178.031 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -94.48 -1.8 52.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.947 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.515 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.6 t70 -156.87 118.16 3.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.582 179.876 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.506 ' HA ' HG21 ' A' ' 47' ' ' VAL . 90.9 mt -87.28 44.78 1.21 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.117 0.485 . . . . 0.0 111.291 -179.351 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.1 mt-10 -136.61 13.09 3.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.078 179.255 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.833 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.4 pt -96.97 156.23 36.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.19 179.928 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 86.2 Cg_exo -49.57 -31.36 24.27 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.745 2.297 . . . . 0.0 112.851 179.657 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.833 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -59.38 -37.21 77.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.312 -179.107 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.706 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.9 t -61.89 -58.55 17.29 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.591 -178.917 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.706 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 37.0 Cg_exo -58.38 -40.54 74.23 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.777 1.651 . . . . 0.0 111.291 179.342 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.96 HG23 ' HA ' ' A' ' 104' ' ' ALA . 8.6 mt -61.02 -36.3 71.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.899 179.712 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 54' ' ' VAL . 47.6 tp -74.01 -52.37 12.96 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.942 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -54.13 -23.06 12.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.061 0.458 . . . . 0.0 109.876 178.824 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.9 m -83.08 -47.57 11.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.357 179.329 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.562 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.11 -26.4 62.56 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.272 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.0 t -51.67 -51.38 27.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.091 179.512 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -74.3 -12.09 60.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.688 -179.852 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 28.7 mtpp -92.46 -17.61 24.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.27 -179.96 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 52.6 m-85 -137.92 62.91 36.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.535 -179.799 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.67 -43.82 54.53 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.601 2.2 . . . . 0.0 111.618 179.065 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.58 -38.92 83.84 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.417 179.305 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 13.0 t -68.74 144.67 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.861 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.764 ' HB2' HG21 ' A' ' 31' ' ' THR . 42.3 t -81.68 98.77 8.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.047 0.451 . . . . 0.0 110.79 180.0 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.49 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.6 p90 -66.95 122.42 17.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.016 179.856 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.466 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -141.87 163.91 26.87 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.159 179.997 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -162.12 143.08 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.924 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.487 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 43.8 t -148.54 158.81 44.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 111.777 -179.094 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.505 HG21 ' HG ' ' A' ' 42' ' ' LEU . 64.6 p -138.93 -5.42 1.49 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.898 179.548 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.69 140.02 58.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.722 179.948 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.3 m -63.52 -48.16 78.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.824 -179.308 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -51.23 -44.27 61.64 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.241 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.498 ' HA ' HG22 ' A' ' 21' ' ' VAL . 54.2 t -70.75 -53.47 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.85 0.357 . . . . 0.0 110.726 179.804 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.93 -14.91 10.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.234 179.475 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.9 m -91.74 -39.87 11.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.299 178.848 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.437 ' ND1' HG11 ' A' ' 21' ' ' VAL . 5.2 t60 -61.21 -39.93 92.06 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.329 179.902 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.407 ' HB2' HG12 ' A' ' 76' ' ' ILE . 88.0 m-85 -91.86 12.26 22.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.919 179.557 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 56.67 25.43 10.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.6 179.23 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.698 HG23 ' HB ' ' A' ' 80' ' ' THR . 41.7 mm -61.77 120.51 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.968 179.653 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.5 p -140.95 57.17 1.56 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.272 179.982 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.89 45.08 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.552 179.824 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.603 ' HB2' HG21 ' A' ' 99' ' ' ILE . 26.8 m-20 50.25 43.47 26.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.255 0.55 . . . . 0.0 110.248 -179.817 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.698 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.2 m -68.99 151.25 46.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.785 -178.627 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.578 HG12 ' HA2' ' A' ' 37' ' ' GLY . 72.0 mt -117.76 115.38 48.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.851 177.931 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.478 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 80.1 m -103.76 130.5 51.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.755 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.663 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -107.78 101.65 10.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.613 178.231 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.4 t80 -95.86 123.03 39.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.478 179.806 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.504 HH12 HD12 ' A' ' 116' ' ' LEU . 4.8 mtm180 -105.72 87.23 2.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.841 -179.7 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 tp -26.29 -60.68 0.08 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.903 -179.383 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.535 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.76 -79.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.433 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -79.2 3.33 18.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.96 0.409 . . . . 0.0 110.993 -179.891 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 52.21 32.8 11.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.691 179.561 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 10.4 mm-40 -76.39 161.45 28.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.695 179.83 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.537 HE22 ' HB3' ' A' ' 93' ' ' ASN . 1.1 tm0? -145.03 93.95 2.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.627 179.788 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.663 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.1 mm? -83.43 118.6 23.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.789 179.74 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.537 ' HB3' HE22 ' A' ' 91' ' ' GLN . 1.3 p-10 -99.86 94.54 6.36 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.756 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.63 HD21 HD13 ' A' ' 102' ' ' ILE . 3.4 tt -79.2 77.93 5.7 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.672 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.8 mt-10 -79.76 -164.33 0.64 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -176.843 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.517 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.0 t70 -50.78 -37.65 43.54 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.971 -179.379 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.21 -15.92 2.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.226 0.536 . . . . 0.0 110.338 179.76 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -129.63 -14.07 4.17 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.645 -179.92 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.603 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.6 mm -89.89 -24.8 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.77 0.319 . . . . 0.0 111.268 -179.3 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.66 -57.45 11.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.4 p -114.56 35.52 4.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.325 179.661 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.63 HD13 HD21 ' A' ' 94' ' ' LEU . 7.6 tp -57.78 146.85 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.485 -179.844 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.442 ' HA ' ' CD1' ' A' ' 49' ' ' ILE . 9.5 t70 -139.3 164.84 28.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.674 178.605 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.96 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -62.49 -35.97 81.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.111 0.481 . . . . 0.0 110.061 -179.616 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 83.4 m -65.42 -44.88 86.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.199 178.743 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -61.06 -58.46 8.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.952 -179.713 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.733 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.3 -54.32 27.24 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.037 0.446 . . . . 0.0 109.975 179.556 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.4 m -59.02 -29.93 67.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.847 179.795 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.504 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -71.06 -66.03 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.056 179.697 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -43.2 -43.87 4.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.223 179.38 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.416 HG12 HG21 ' A' ' 35' ' ' VAL . 96.4 mt -62.97 -54.23 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.225 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.418 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 33.4 tt0 -54.59 -19.63 6.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.159 179.226 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.504 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.27 -34.5 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.79 -178.985 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.641 HD22 ' HG ' ' A' ' 92' ' ' LEU . 89.4 m-20 -124.86 29.56 6.15 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.329 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 111' ' ' ILE . 88.2 p -83.54 45.25 1.04 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.115 0.483 . . . . 0.0 110.111 178.996 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.504 HD12 HH12 ' A' ' 85' ' ' ARG . 69.9 mt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.35 -179.344 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.503 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.7 pt-20 . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.503 0.192 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 39.2 Cg_endo -67.7 142.72 59.19 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.597 2.198 . . . . 0.0 112.623 -179.901 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.4 m -63.12 153.47 34.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.809 -179.686 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.89 89.91 5.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.167 179.886 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.599 HD22 ' HA ' ' A' ' 24' ' ' ALA . 41.2 mt -84.78 72.57 10.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.298 179.613 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.1 p -71.9 -2.02 16.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.176 -179.043 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -139.27 147.42 41.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.987 0.423 . . . . 0.0 111.573 -179.797 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 29.6 t -57.24 -49.52 93.42 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.449 179.913 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.66 -44.82 33.58 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.901 1.734 . . . . 0.0 111.998 179.723 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.25 83.19 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.332 0.587 . . . . 0.0 110.203 179.824 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.599 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.65 -57.51 10.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.157 179.548 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 31.4 mtt -61.89 -26.83 68.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.225 -179.923 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -70.44 -50.38 38.92 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.477 179.786 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -61.68 -31.17 71.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.182 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.507 HD11 HD12 ' A' ' 36' ' ' ILE . 52.7 mt -74.62 -37.67 43.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.967 178.056 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.41 -17.59 61.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.972 -179.747 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.56 28.69 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.122 -179.929 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.726 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.1 t -168.89 153.89 6.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.572 -179.681 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.577 ' HG3' HG13 ' A' ' 87' ' ' VAL . 20.8 tt0 -70.91 -42.73 69.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.498 179.6 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.547 HG13 HD11 ' A' ' 83' ' ' LEU . 22.1 t -127.0 137.05 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.278 179.414 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.78 128.37 21.46 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.173 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.479 HG21 HG12 ' A' ' 111' ' ' ILE . 46.1 t -116.25 130.53 70.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.496 178.473 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.507 HD12 HD11 ' A' ' 28' ' ' ILE . 29.3 mt -136.42 136.81 48.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.232 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.22 99.01 2.05 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.528 179.716 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.7 m-85 -85.35 93.97 8.84 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.657 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 9.1 m-85 -114.38 143.77 44.37 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.125 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.407 ' HG2' HD23 ' A' ' 71' ' ' LEU . 95.9 mt-30 -91.17 -3.51 56.96 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.913 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 44' ' ' ILE . 37.1 t70 -154.27 122.33 6.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.689 -1.142 . . . . 0.0 109.465 179.845 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.493 ' HA ' HG21 ' A' ' 47' ' ' VAL . 91.6 mt -91.9 47.18 1.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 0.0 111.276 -179.486 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.9 mt-10 -136.51 11.13 3.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.792 178.977 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.739 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.1 pt -93.6 159.06 35.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.437 -179.915 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.486 ' O ' HD12 ' A' ' 49' ' ' ILE . 69.3 Cg_exo -54.59 -23.66 33.26 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.99 2.46 . . . . 0.0 112.925 179.556 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.739 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -67.11 -38.8 86.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.823 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.694 HG23 HG13 ' A' ' 44' ' ' ILE . 2.5 t -59.13 -54.72 53.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -178.787 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.1 Cg_exo -61.29 -43.53 28.19 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.066 1.844 . . . . 0.0 111.499 179.225 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.878 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -59.89 -34.01 54.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.148 179.981 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.63 ' O ' HG23 ' A' ' 54' ' ' VAL . 50.1 tp -75.48 -51.5 12.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.167 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -53.96 -25.23 19.66 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.994 0.426 . . . . 0.0 109.936 178.793 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 t -83.09 -47.45 11.64 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.625 179.764 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.625 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -57.76 -26.37 61.78 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.376 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 50' ' ' LEU . 51.2 t -51.89 -49.87 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.048 179.451 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -75.45 -12.74 60.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.641 179.952 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -91.5 -17.24 26.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.325 180.0 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.574 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 46.3 m-85 -138.97 63.11 29.66 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.432 -179.877 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.03 -47.67 26.28 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.756 2.304 . . . . 0.0 111.766 179.315 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.71 -41.14 57.17 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.395 179.275 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.6 t -66.23 143.13 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.781 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.726 ' HB2' HG21 ' A' ' 31' ' ' THR . 42.0 t -81.06 97.42 7.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.984 0.421 . . . . 0.0 110.903 -179.786 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.496 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.6 p90 -65.61 123.58 20.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.822 179.699 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.451 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -143.09 163.8 27.33 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.109 179.996 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -161.02 141.95 3.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.897 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.2 t -145.33 155.6 43.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.046 0.45 . . . . 0.0 111.708 -178.993 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.44 HG21 ' HG ' ' A' ' 42' ' ' LEU . 57.1 p -137.99 -3.25 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.807 179.652 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.73 139.81 55.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.425 179.976 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -62.24 -47.4 84.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.68 -179.313 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -50.73 -46.94 59.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.486 -179.217 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.51 ' HA ' HG22 ' A' ' 21' ' ' VAL . 75.3 t -69.6 -51.87 37.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.767 0.318 . . . . 0.0 110.756 179.92 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.407 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -59.36 -14.57 12.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.033 0.444 . . . . 0.0 110.219 179.466 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.3 m -92.63 -40.75 10.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.429 178.776 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -62.65 -35.55 79.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 -179.922 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.443 ' HB2' HG12 ' A' ' 76' ' ' ILE . 44.8 m-85 -94.11 10.36 34.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.754 179.544 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 57.27 24.3 9.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.683 179.422 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.671 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.0 mm -61.31 120.2 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.032 179.767 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.5 p -139.94 55.91 1.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 111.397 -179.926 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.9 44.19 0.02 OUTLIER Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.515 179.86 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.622 ' HB2' HG21 ' A' ' 99' ' ' ILE . 30.8 m-80 52.14 41.9 30.32 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.178 0.513 . . . . 0.0 110.437 -179.646 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.671 ' HB ' HG23 ' A' ' 76' ' ' ILE . 88.2 m -67.77 152.68 45.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.628 -178.564 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.591 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.5 mt -119.58 118.57 57.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.951 178.006 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.3 m -107.5 133.89 51.32 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -177.855 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.638 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.2 tp -109.73 102.55 11.35 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.794 178.262 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -96.93 122.64 40.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.791 0.329 . . . . 0.0 110.77 179.755 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.523 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 4.7 mtm180 -104.61 100.43 10.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.138 0.494 . . . . 0.0 109.971 179.582 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -43.78 -52.01 6.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.872 -179.156 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.577 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -42.82 -65.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.154 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.21 18.95 12.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.652 -179.322 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 p30 42.93 31.1 0.3 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.941 179.332 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.523 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 8.8 mm-40 -75.91 159.5 30.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 0.0 110.974 -179.923 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -146.42 85.44 1.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.65 179.798 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.638 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -75.04 144.84 42.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.224 179.996 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -121.93 124.83 44.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.351 0.596 . . . . 0.0 111.792 -179.643 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.656 HD21 HD13 ' A' ' 102' ' ' ILE . 3.7 tt -112.09 76.03 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.273 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.439 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.0 mt-10 -77.91 -165.41 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.752 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.495 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -46.45 -51.22 15.59 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.556 -179.11 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -47.23 -17.87 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.923 0.392 . . . . 0.0 110.899 179.764 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 96' ' ' ASP . 9.4 m-20 -124.84 -13.94 6.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.414 -179.91 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.622 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.3 mm -92.23 -42.74 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.264 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -50.78 -34.76 28.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.021 179.812 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.5 t -127.66 37.69 4.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.371 179.622 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.656 HD13 HD21 ' A' ' 94' ' ' LEU . 8.7 tp -67.6 144.72 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.779 -179.607 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -138.64 147.87 43.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.345 178.542 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.878 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.71 -37.44 8.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.962 0.41 . . . . 0.0 110.579 -179.722 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.5 m -62.32 -48.45 79.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.322 178.88 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -58.39 -58.4 8.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.311 -179.677 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.761 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.77 -56.59 11.36 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.057 0.456 . . . . 0.0 110.271 179.902 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.4 m -57.71 -29.41 64.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.762 179.796 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.526 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.2 tmt_? -71.44 -65.65 0.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.247 179.83 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -42.89 -42.77 3.81 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.033 179.231 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.479 HG12 HG21 ' A' ' 35' ' ' VAL . 95.5 mt -63.92 -55.3 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.494 178.377 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -54.96 -17.71 4.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.253 0.549 . . . . 0.0 110.332 179.333 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.526 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.77 -36.81 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.84 -179.29 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -123.64 30.12 6.33 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.527 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.8 p -82.58 51.33 1.84 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.085 0.469 . . . . 0.0 109.959 178.741 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 85' ' ' ARG . 55.3 mt . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.295 -179.208 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 46.6 Cg_endo -68.71 146.87 68.15 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.348 2.032 . . . . 0.0 112.811 -179.168 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.6 m -67.75 152.4 45.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.443 -179.623 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -95.81 85.88 4.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.813 179.87 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.3 mt -81.75 71.24 8.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.63 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.0 p -71.43 0.14 8.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.034 -179.266 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -142.56 147.43 35.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.965 0.412 . . . . 0.0 111.705 -179.701 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.594 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.2 t -56.86 -50.35 88.61 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.443 179.881 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.2 Cg_endo -58.39 -44.48 37.65 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.975 1.783 . . . . 0.0 111.93 179.916 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.26 83.28 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.291 0.567 . . . . 0.0 110.18 179.953 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.69 -57.42 10.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.053 179.435 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.2 mtm -61.39 -26.78 68.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.013 -179.903 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -71.47 -50.66 29.44 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.484 179.738 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -60.65 -31.67 70.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.058 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.489 HD11 HD12 ' A' ' 36' ' ' ILE . 49.9 mt -73.17 -38.03 53.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.809 178.236 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.06 -19.7 61.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.998 179.857 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.14 31.01 1.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.471 -179.715 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.695 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.8 t -171.26 153.25 3.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.333 -179.853 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.615 ' HG3' HG13 ' A' ' 87' ' ' VAL . 27.6 tt0 -71.62 -37.46 70.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.651 179.63 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.579 HG13 HD11 ' A' ' 83' ' ' LEU . 26.9 t -131.53 136.81 56.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.229 179.408 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.02 127.12 19.49 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.252 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 111' ' ' ILE . 50.8 t -114.58 130.6 68.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.427 178.304 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.489 HD12 HD11 ' A' ' 28' ' ' ILE . 28.2 mt -136.09 135.66 50.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.439 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.574 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.54 99.13 2.12 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.404 179.46 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 13.9 m-85 -85.39 93.28 8.7 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.631 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -112.8 142.06 45.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.492 -177.958 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.458 ' HG2' HD23 ' A' ' 71' ' ' LEU . 47.7 mt-30 -90.87 1.69 56.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.767 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.8 t70 -159.36 122.22 3.59 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.585 179.895 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.554 ' HA ' HG21 ' A' ' 47' ' ' VAL . 90.1 mt -92.38 47.67 1.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.185 0.517 . . . . 0.0 111.417 -179.32 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 47.5 mt-10 -138.0 7.47 2.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.913 178.868 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.822 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.8 pt -90.93 155.91 44.75 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.159 179.824 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.455 ' O ' HD12 ' A' ' 49' ' ' ILE . 86.5 Cg_exo -51.11 -26.71 20.01 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.862 2.374 . . . . 0.0 113.214 179.733 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.822 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.51 -36.22 83.48 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.842 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.65 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -62.98 -55.92 33.29 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.494 -178.854 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.641 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.1 Cg_exo -58.75 -39.62 80.31 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.807 1.672 . . . . 0.0 111.407 179.34 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 8.3 mt -63.35 -37.59 79.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.137 179.986 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.608 ' O ' HG23 ' A' ' 54' ' ' VAL . 41.9 tp -71.87 -51.76 20.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.844 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -55.49 -22.0 19.0 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.507 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -85.09 -44.17 13.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.581 179.494 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.582 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -62.12 -25.56 67.8 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.33 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 50' ' ' LEU . 52.9 t -52.87 -46.97 52.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.928 179.436 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -77.62 -11.65 59.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.705 -179.729 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -93.72 -18.09 22.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.347 -179.85 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.586 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 66.4 m-85 -137.34 62.39 37.29 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.569 -179.775 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.52 -42.53 61.07 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.632 2.221 . . . . 0.0 111.636 179.033 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.95 -40.96 94.02 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.521 179.227 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.2 t -66.93 143.27 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 178.8 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.695 ' HB2' HG21 ' A' ' 31' ' ' THR . 48.4 t -80.58 98.08 7.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.134 0.492 . . . . 0.0 110.99 -179.681 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.52 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.6 p90 -66.11 125.57 25.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.78 179.67 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.48 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -144.39 161.91 27.94 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.99 179.902 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.412 HD11 HG13 ' A' ' 47' ' ' VAL . 5.0 tt -159.54 144.17 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.803 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.3 t -150.29 154.37 37.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.218 0.532 . . . . 0.0 111.811 -178.993 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.489 HG21 ' HG ' ' A' ' 42' ' ' LEU . 75.2 p -135.21 -2.64 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.474 179.464 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.05 141.36 57.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.717 -179.875 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.3 p -64.57 -49.93 69.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.509 -179.569 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -49.6 -45.02 47.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.492 -179.371 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.539 ' HA ' HG22 ' A' ' 21' ' ' VAL . 69.0 t -70.52 -53.19 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.877 0.37 . . . . 0.0 110.734 179.853 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.458 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.25 -14.71 7.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.193 179.406 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.4 m -91.59 -41.85 10.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.333 178.889 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -61.25 -35.48 77.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.449 179.679 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.424 ' HB2' HG12 ' A' ' 76' ' ' ILE . 45.4 m-85 -94.61 9.31 39.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.759 179.452 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.3 t30 57.65 23.19 9.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.671 178.787 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.679 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.6 mm -58.13 120.78 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.157 179.856 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.3 p -139.23 57.34 1.66 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.403 -179.632 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.82 46.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.75 179.754 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.612 ' HB2' HG21 ' A' ' 99' ' ' ILE . 13.1 m120 50.62 42.52 27.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.188 0.518 . . . . 0.0 110.293 -179.868 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.679 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.4 m -69.0 152.26 45.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.665 -178.352 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.583 HG21 HD21 ' A' ' 107' ' ' LEU . 66.0 mt -119.18 116.42 50.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.952 178.01 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.4 m -105.34 135.23 47.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.816 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.638 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -109.64 98.78 8.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.916 178.377 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -92.45 120.11 32.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.541 179.816 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.508 HH12 HD12 ' A' ' 116' ' ' LEU . 5.1 mtm180 -103.74 103.84 13.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.399 . . . . 0.0 110.108 179.706 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.5 tp -45.1 -56.32 4.82 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.831 -179.182 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.615 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.03 -76.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.175 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -82.5 5.9 19.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.047 -179.754 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 52.3 36.58 20.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.425 179.779 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 7.3 mm-40 -81.61 167.19 19.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.959 179.833 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -150.73 89.53 1.56 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.575 179.621 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.638 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.8 mm? -74.49 148.09 41.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.877 179.735 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.5 114.62 18.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.3 0.571 . . . . 0.0 112.165 -179.512 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.6 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -103.52 77.88 1.54 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.154 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.2 mt-10 -80.55 -164.4 0.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.91 -176.775 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 17.7 t70 -50.62 -36.25 34.31 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.068 -179.319 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -56.04 -14.7 2.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.313 0.578 . . . . 0.0 110.254 179.63 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -132.33 -13.67 3.03 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.768 -179.909 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.612 HG21 ' HB2' ' A' ' 79' ' ' ASN . 26.2 mm -89.69 -31.54 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.7 0.286 . . . . 0.0 111.269 -179.555 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -53.78 -43.04 68.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.0 110.707 179.815 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.5 p -125.74 38.83 4.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.393 179.738 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.6 HD13 HD21 ' A' ' 94' ' ' LEU . 7.7 tp -63.56 142.93 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.653 -179.835 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -137.25 148.46 46.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.505 178.836 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.53 -34.89 8.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.193 0.52 . . . . 0.0 110.274 -179.989 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.2 m -63.47 -48.1 79.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.35 178.774 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -60.3 -60.74 3.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.266 -179.71 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.745 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.68 -55.36 11.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.029 0.442 . . . . 0.0 110.239 179.898 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 65.8 m -58.92 -30.86 68.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.87 179.948 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.49 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.2 tmt_? -70.85 -65.81 0.69 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.146 179.724 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -42.87 -44.23 4.42 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.232 179.355 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.475 HG12 HG21 ' A' ' 35' ' ' VAL . 95.4 mt -62.89 -55.08 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.175 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.447 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 7.8 tp10 -54.1 -17.97 3.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.294 179.178 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.49 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -91.09 -34.9 6.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.031 -179.097 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.595 HD22 ' HG ' ' A' ' 92' ' ' LEU . 83.7 m-20 -124.78 28.79 6.39 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.408 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 94.3 p -82.47 43.88 0.85 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.076 0.465 . . . . 0.0 110.346 179.157 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.508 HD12 HH12 ' A' ' 85' ' ' ARG . 59.2 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.392 -179.279 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.8 pt-20 . . . . . 0 CA--C 1.53 0.19 0 CA-C-O 120.404 0.145 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 32.5 Cg_endo -64.89 139.11 60.64 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.549 2.166 . . . . 0.0 112.502 -179.655 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -54.84 153.49 6.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.824 -179.368 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -98.18 92.18 5.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.976 179.78 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.614 HD22 ' HA ' ' A' ' 24' ' ' ALA . 50.9 mt -92.42 72.07 5.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.448 179.77 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.8 p -73.79 -0.99 17.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.889 -179.299 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -140.51 146.78 38.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.393 . . . . 0.0 111.626 -179.953 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 48.4 t -56.29 -49.96 90.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.494 179.862 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.4 Cg_endo -57.5 -46.15 29.36 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.896 1.73 . . . . 0.0 111.773 179.842 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.98 76.9 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.269 0.557 . . . . 0.0 110.259 -179.822 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.614 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.87 -58.68 5.55 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.104 179.342 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 46.7 mtm -61.3 -26.3 67.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.209 -179.943 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.0 mt-10 -72.06 -51.42 21.72 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.687 0.28 . . . . 0.0 110.612 179.806 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.575 ' O ' HG22 ' A' ' 31' ' ' THR . 6.2 m-85 -59.69 -34.64 73.14 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.106 179.249 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 36' ' ' ILE . 49.3 mt -72.89 -38.49 56.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.844 178.293 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.65 -17.46 61.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.005 -179.826 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.61 26.04 5.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.307 -179.9 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 27' ' ' PHE . 8.8 t -172.78 152.06 2.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.597 -179.77 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.724 ' HG3' HG13 ' A' ' 87' ' ' VAL . 1.2 mp0 -59.67 -90.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.252 0.548 . . . . 0.0 110.948 179.32 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.547 HG13 HD11 ' A' ' 83' ' ' LEU . 11.4 t -85.41 133.12 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.715 -179.321 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -137.57 124.4 21.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.873 -178.977 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.428 HG21 HG12 ' A' ' 111' ' ' ILE . 52.3 t -112.75 129.71 67.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.845 178.736 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.521 HD12 HD11 ' A' ' 28' ' ' ILE . 25.2 mt -134.66 135.56 53.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.646 -177.249 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.54 98.06 1.97 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.41 179.859 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.526 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.9 m-85 -83.24 90.06 7.06 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.725 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.4 m-85 -110.29 139.74 45.16 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.0 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -87.36 -5.91 58.69 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.764 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.488 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.2 t70 -152.59 120.85 6.28 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.583 -179.924 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.484 ' HA ' HG21 ' A' ' 47' ' ' VAL . 99.3 mt -89.81 45.58 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.047 0.451 . . . . 0.0 111.513 -179.187 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.4 mt-10 -136.85 11.05 3.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.09 178.97 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.734 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.2 pt -92.77 157.22 39.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.27 179.815 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.487 ' O ' HD12 ' A' ' 49' ' ' ILE . 70.9 Cg_exo -51.67 -25.93 21.61 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.853 2.368 . . . . 0.0 113.004 179.547 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.734 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.41 -37.9 88.34 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.853 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.684 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -61.12 -54.92 49.16 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -178.73 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.614 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 35.2 Cg_exo -61.05 -38.81 65.11 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.951 1.767 . . . . 0.0 111.508 179.202 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.879 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -64.76 -34.58 71.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.025 -179.954 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.617 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.1 tp -74.3 -52.13 13.17 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.879 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -53.11 -26.36 16.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.173 0.511 . . . . 0.0 109.681 178.618 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 t -80.93 -47.55 13.55 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.778 179.867 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.587 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.72 -26.32 63.81 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.443 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 50' ' ' LEU . 56.0 t -52.36 -49.43 42.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.019 179.624 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -77.57 -11.44 59.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.75 -179.815 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -91.3 -18.74 23.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.01 179.807 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 50.3 m-85 -135.92 63.2 50.6 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.267 -179.818 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.03 -43.86 49.6 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.629 2.219 . . . . 0.0 111.692 179.252 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.6 -40.94 88.8 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.367 179.086 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.1 t -66.45 144.48 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.913 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.567 ' CB ' HG21 ' A' ' 31' ' ' THR . 31.0 t -83.73 98.98 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.059 0.457 . . . . 0.0 110.987 -179.581 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.491 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.4 p90 -64.39 128.84 37.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.053 179.875 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.62 161.65 28.7 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.137 179.762 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 15' ' ' PRO . 4.2 tt -159.32 141.89 5.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.679 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.1 t -141.73 154.55 45.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.971 0.415 . . . . 0.0 111.489 -178.974 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 39' ' ' PHE . 68.9 p -139.96 -2.44 1.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.875 179.894 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -72.15 143.06 49.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.754 -179.939 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.8 p -63.19 -49.67 73.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.533 -179.493 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -49.97 -44.37 50.71 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.69 -179.381 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.566 ' HA ' HG22 ' A' ' 21' ' ' VAL . 79.6 t -70.54 -52.83 25.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.925 0.393 . . . . 0.0 110.723 179.797 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.19 -14.55 11.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.223 179.422 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.7 m -91.53 -41.89 10.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.264 178.871 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -59.78 -39.92 86.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.498 179.723 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -92.11 13.75 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.987 179.675 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.4 m120 55.32 24.19 6.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.598 179.433 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.66 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.1 mm -59.73 119.23 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.886 179.747 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -139.51 57.59 1.64 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.199 -179.948 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.2 45.06 0.02 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.515 179.828 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.555 ' HB2' HG21 ' A' ' 99' ' ' ILE . 24.9 m-80 51.42 42.16 28.99 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.292 0.567 . . . . 0.0 110.406 -179.859 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.66 ' HB ' HG23 ' A' ' 76' ' ' ILE . 97.9 m -67.86 152.86 44.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.605 -178.621 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.591 HG12 ' HA2' ' A' ' 37' ' ' GLY . 66.1 mt -119.41 117.26 53.43 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.14 178.161 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.526 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.1 m -106.13 135.99 46.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.837 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.626 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -110.64 104.49 13.18 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.132 178.546 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -97.46 120.1 37.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.76 179.76 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.567 HH12 HD12 ' A' ' 116' ' ' LEU . 5.6 mtm180 -103.39 88.83 3.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.563 -179.739 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tp -38.61 -49.46 1.54 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.637 -179.791 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.724 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -42.48 -52.38 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 111.431 -179.88 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -108.59 9.39 27.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.62 179.821 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 85' ' ' ARG . 17.0 t-20 47.89 35.55 5.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.519 -179.834 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 8.0 mm-40 -83.05 163.8 20.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.648 179.566 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -147.2 94.14 2.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 179.761 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.626 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -80.94 146.16 30.9 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.338 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.75 106.31 9.96 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.927 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.619 HD21 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -91.79 77.42 5.54 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.663 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' HG12 ' A' ' 99' ' ' ILE . 24.4 mt-10 -79.19 -165.09 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.767 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.472 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -45.25 -51.46 10.75 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.569 -179.331 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -47.04 -17.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.901 0.382 . . . . 0.0 111.215 179.88 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -125.52 -13.85 6.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.575 -179.968 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.555 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.3 mm -90.88 -41.32 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.729 -179.381 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -49.05 -40.41 31.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.4 p -126.03 41.87 3.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.684 179.839 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.619 HD13 HD21 ' A' ' 94' ' ' LEU . 7.5 tp -69.31 142.54 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.663 -179.581 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -135.6 147.76 48.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.237 178.597 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.879 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.45 -36.14 6.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.593 -179.608 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.8 m -63.22 -47.45 82.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.562 178.822 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -59.5 -59.3 5.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.206 -179.743 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.741 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.02 -54.59 19.13 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.898 0.38 . . . . 0.0 110.22 179.712 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.3 m -59.38 -30.15 68.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.504 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.1 tmt_? -70.84 -65.59 0.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.191 179.651 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -43.48 -44.23 5.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.908 179.363 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.428 HG12 HG21 ' A' ' 35' ' ' VAL . 96.8 mt -62.34 -54.96 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.437 178.257 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -54.8 -18.9 5.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.213 179.358 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.504 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.91 -35.72 8.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.937 -179.094 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.603 HD22 ' HG ' ' A' ' 92' ' ' LEU . 87.3 m-20 -125.3 29.82 5.97 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.397 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 96.8 p -81.99 38.3 0.52 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.971 0.415 . . . . 0.0 110.487 179.048 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.567 HD12 HH12 ' A' ' 85' ' ' ARG . 58.6 mt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.114 -179.705 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.443 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.3 pt-20 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.403 0.144 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.2 Cg_endo -66.25 143.49 70.98 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.532 2.155 . . . . 0.0 112.712 -179.429 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.4 m -59.3 154.17 17.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.427 -179.614 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -102.14 97.06 7.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.935 -179.987 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.604 HD13 ' HA ' ' A' ' 24' ' ' ALA . 39.2 mt -95.17 76.81 3.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.432 179.958 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.0 p -74.09 -4.34 34.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.142 -179.085 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -139.02 147.32 41.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.92 0.39 . . . . 0.0 111.595 -179.669 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.2 t -55.97 -50.24 88.42 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.36 179.969 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.95 -44.25 41.63 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 121.88 1.72 . . . . 0.0 111.736 179.992 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.76 78.82 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.321 0.582 . . . . 0.0 110.22 179.995 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.604 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -64.51 -58.66 5.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.093 179.483 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.2 mtp -61.7 -25.83 67.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 19.1 mt-10 -71.34 -51.5 23.9 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.738 0.304 . . . . 0.0 110.474 179.591 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.583 ' O ' HG22 ' A' ' 31' ' ' THR . 7.0 m-85 -59.27 -35.68 74.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.97 179.317 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 36' ' ' ILE . 46.9 mt -71.13 -39.56 74.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.904 178.305 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.98 -17.98 62.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.994 -179.906 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.78 24.95 5.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.186 -179.862 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.59 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.3 t -169.95 152.76 4.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.416 -179.92 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.587 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.5 tt0 -61.23 -82.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.898 -179.888 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.554 HG13 HD11 ' A' ' 83' ' ' LEU . 21.9 t -94.63 138.16 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.48 179.964 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.99 126.84 20.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.946 0.403 . . . . 0.0 111.989 -179.173 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.445 HG21 HG12 ' A' ' 111' ' ' ILE . 45.1 t -113.65 128.11 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.789 178.445 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.541 HD12 HD11 ' A' ' 28' ' ' ILE . 32.0 mt -133.0 134.68 57.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.658 -177.053 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.536 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.3 100.25 2.31 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.347 179.614 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 4.4 m-85 -84.76 93.19 8.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.8 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.2 m-85 -114.5 141.45 47.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.103 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.496 ' HG2' HD23 ' A' ' 71' ' ' LEU . 74.0 mt-30 -88.89 -7.8 55.43 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.706 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 44' ' ' ILE . 25.4 t70 -150.2 120.95 7.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.667 -1.152 . . . . 0.0 109.66 179.688 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.476 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.6 mt -90.17 45.33 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.006 0.432 . . . . 0.0 111.536 -179.197 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.7 mt-10 -135.42 11.84 3.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.083 178.976 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.696 HG13 HG23 ' A' ' 47' ' ' VAL . 4.9 pt -93.18 158.93 36.43 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.508 ' O ' HD12 ' A' ' 49' ' ' ILE . 68.8 Cg_exo -54.15 -25.66 38.58 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.743 2.295 . . . . 0.0 112.791 179.462 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.673 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.29 -38.33 89.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.456 -178.804 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.696 HG23 HG13 ' A' ' 44' ' ' ILE . 2.1 t -60.34 -56.45 35.24 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.704 -178.788 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.4 -41.11 61.19 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.812 1.675 . . . . 0.0 111.401 179.561 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.87 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.6 mt -61.64 -34.87 63.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.992 179.781 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.7 tp -74.19 -53.39 9.93 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 178.809 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -53.47 -24.52 13.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.004 0.431 . . . . 0.0 109.887 178.911 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.9 m -82.74 -45.93 13.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.499 179.421 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.552 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.25 -25.84 64.39 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.407 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.0 t -52.84 -49.98 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.823 179.312 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -75.73 -11.45 60.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.813 -179.867 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -92.64 -18.26 23.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.145 179.937 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.592 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 68.1 m-85 -135.56 62.34 48.44 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.396 -179.739 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.7 -43.32 51.78 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.727 2.284 . . . . 0.0 111.552 179.0 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.72 -38.11 86.61 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.52 179.294 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.0 t -70.05 144.4 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.955 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.59 ' CB ' HG21 ' A' ' 31' ' ' THR . 42.9 t -83.83 99.32 10.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.006 0.431 . . . . 0.0 111.042 -179.672 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.478 ' HB3' HG22 ' A' ' 54' ' ' VAL . 7.7 p90 -62.57 131.25 48.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.151 179.915 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -150.06 161.69 28.97 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.121 179.712 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -162.85 142.63 2.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.995 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.8 t -144.37 155.97 44.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.041 0.448 . . . . 0.0 111.652 -179.059 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 39' ' ' PHE . 67.7 p -139.03 3.1 2.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.842 179.666 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.75 143.11 44.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.784 -179.972 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.9 t -64.48 -50.47 67.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.496 -179.426 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.76 -43.57 48.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.514 -179.413 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.534 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.1 t -71.51 -53.02 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.811 0.339 . . . . 0.0 110.756 179.987 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.496 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -58.86 -14.51 9.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.233 179.315 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 76.1 m -91.48 -40.98 11.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.294 178.641 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -60.49 -40.22 90.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.45 179.847 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -91.45 11.86 22.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.853 179.644 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 56.04 25.74 9.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.596 179.551 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.665 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.0 mm -59.78 119.42 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.839 179.597 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.4 p -138.49 58.88 1.65 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.235 -179.549 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.11 48.22 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.709 179.664 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.616 ' HB2' HG21 ' A' ' 99' ' ' ILE . 36.3 m-20 49.52 43.4 23.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.103 0.478 . . . . 0.0 110.461 -179.945 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.665 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.1 m -68.62 152.63 45.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.621 -178.677 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.536 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.4 mt -118.81 119.14 60.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.07 178.065 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 83.6 m -108.55 134.62 51.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.038 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.63 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -106.71 103.99 13.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.608 178.438 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -97.33 119.72 36.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.867 0.365 . . . . 0.0 111.199 -179.886 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.485 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 3.2 mtm180 -105.24 95.93 6.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.407 -179.95 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 1.6 tp -43.19 -54.55 4.43 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.782 -179.622 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.587 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.1 -59.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.03 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -97.86 3.62 49.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.446 -179.346 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 85' ' ' ARG . 38.2 t30 51.58 47.08 25.5 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.259 0.552 . . . . 0.0 110.834 -179.818 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.485 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 10.2 mm-40 -97.23 158.67 15.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.715 -179.894 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -140.96 92.34 2.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.934 179.809 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.63 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.5 mm? -80.8 143.42 32.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.258 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -120.97 123.06 41.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.281 0.562 . . . . 0.0 112.439 -179.363 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.632 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -111.09 76.34 0.97 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.126 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.44 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.3 mt-10 -78.13 -164.58 0.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.364 -0.834 . . . . 0.0 113.137 -176.669 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.53 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 12.5 t70 -50.94 -37.2 42.83 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.98 -179.113 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.74 -14.98 2.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.106 0.479 . . . . 0.0 110.304 179.639 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -130.6 -13.8 3.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.585 179.776 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.616 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.7 mm -90.48 -24.95 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.76 0.314 . . . . 0.0 111.195 -179.538 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -57.18 -52.02 66.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.993 0.425 . . . . 0.0 110.611 179.843 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.5 m -117.73 35.6 4.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.348 179.537 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.632 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -58.09 140.6 16.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.437 -179.619 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -135.69 149.97 49.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.424 178.644 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.87 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.02 -34.55 9.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.019 0.437 . . . . 0.0 110.479 -179.844 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.9 m -64.79 -48.24 75.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.452 178.844 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -59.99 -57.33 13.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.226 -179.794 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.763 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -51.75 -55.89 17.08 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.132 0.491 . . . . 0.0 110.001 179.662 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.9 m -58.0 -30.24 65.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.917 179.866 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.444 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.8 tmt_? -70.37 -65.81 0.68 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.275 179.66 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -42.98 -43.9 4.39 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.141 179.277 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.445 HG12 HG21 ' A' ' 35' ' ' VAL . 88.8 mt -62.29 -55.55 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.208 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -54.6 -18.33 4.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.451 179.319 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.444 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.74 -36.64 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.079 -178.873 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.486 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.0 m120 -124.22 28.79 6.6 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.574 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.9 p -81.04 42.84 0.67 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.928 0.394 . . . . 0.0 110.462 179.21 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.442 HD12 ' NH1' ' A' ' 85' ' ' ARG . 62.3 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.189 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.761 0.315 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.56 133.19 59.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.161 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -136.7 -3.0 2.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.87 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -103.27 -164.26 1.06 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.995 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.9 p -57.14 164.3 1.76 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.4 m 55.28 76.89 0.24 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.957 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -87.43 -20.99 25.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.796 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.32 153.66 9.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.548 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.85 130.4 32.8 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.54 2.16 . . . . 0.0 112.266 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.54 98.8 2.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.618 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -169.1 -75.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.688 0.28 . . . . 0.0 110.697 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.73 -80.4 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.52 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.534 ' HG3' HG12 ' A' ' 54' ' ' VAL . 11.2 pt20 -164.23 142.61 7.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.882 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.483 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.0 pt-20 -129.83 158.15 74.59 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.76 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.506 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.9 Cg_endo -65.46 145.27 82.29 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.617 2.211 . . . . 0.0 112.706 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 m -62.27 154.14 28.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.912 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -97.42 92.82 6.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.811 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.596 HD22 ' HA ' ' A' ' 24' ' ' ALA . 42.9 mt -91.84 71.23 5.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.513 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.2 p -72.93 -0.8 14.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.103 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -139.7 147.28 40.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 111.488 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 45.2 t -56.81 -49.93 91.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.518 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.05 -45.44 31.97 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.926 1.751 . . . . 0.0 111.786 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.29 80.12 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.195 0.521 . . . . 0.0 110.19 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.596 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.77 -59.83 4.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.063 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.3 mtm -60.59 -25.54 66.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.144 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 21.8 mt-10 -71.6 -51.22 24.41 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.495 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.498 ' O ' HG22 ' A' ' 31' ' ' THR . 10.4 m-85 -61.06 -30.21 70.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.575 HD11 HD12 ' A' ' 36' ' ' ILE . 48.6 mt -75.79 -36.96 34.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.965 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.36 -19.48 59.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.248 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.14 28.1 2.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.655 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.1 t -171.16 153.15 3.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.46 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.503 ' HG3' HG13 ' A' ' 87' ' ' VAL . 23.3 tt0 -65.36 -65.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.773 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.509 HG13 HD11 ' A' ' 83' ' ' LEU . 18.1 t -106.1 137.82 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.638 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.536 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.3 125.92 17.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.476 HG21 HG12 ' A' ' 111' ' ' ILE . 53.9 t -114.56 128.75 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.641 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.575 HD12 HD11 ' A' ' 28' ' ' ILE . 29.9 mt -134.49 137.89 50.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.558 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.11 97.79 1.72 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.427 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.469 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.8 m-85 -83.27 91.85 7.37 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.1 m-85 -111.45 143.3 42.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.469 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.486 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 48.6 mt-30 -90.46 -6.22 55.13 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.0 t70 -151.95 121.86 7.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.614 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.514 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.7 mt -90.51 45.76 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.999 0.428 . . . . 0.0 111.515 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 36.9 mt-10 -136.59 8.98 3.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.094 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.741 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.8 pt -90.66 156.86 44.75 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.162 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.487 ' O ' HD12 ' A' ' 49' ' ' ILE . 79.6 Cg_exo -51.0 -27.75 22.2 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.837 2.358 . . . . 0.0 112.923 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.741 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.46 -38.57 91.67 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.703 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -60.46 -56.7 32.66 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.802 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.644 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -59.39 -40.88 63.46 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.671 1.581 . . . . 0.0 111.441 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -61.82 -35.59 68.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.145 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.603 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.4 tp -74.65 -52.56 11.37 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -54.83 -24.27 22.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.071 0.463 . . . . 0.0 109.977 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 m -83.03 -45.27 14.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.623 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.614 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.59 -26.28 66.85 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.2 0.524 . . . . 0.0 109.619 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -51.25 -47.71 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.226 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -77.43 -12.97 60.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.913 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -91.23 -17.52 25.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.171 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.576 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 47.8 m-85 -137.99 62.64 34.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.567 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.84 -42.58 65.34 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.677 2.251 . . . . 0.0 111.661 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.93 -37.79 80.84 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.381 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.7 t -70.34 144.34 13.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.655 ' HB2' HG21 ' A' ' 31' ' ' THR . 46.7 t -82.26 98.46 8.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.948 0.404 . . . . 0.0 111.094 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.506 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -65.21 127.37 31.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.066 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.27 160.44 28.18 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.159 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 tt -160.37 144.16 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.469 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 37.3 t -148.48 159.11 44.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.5 . . . . 0.0 111.768 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.468 HG21 ' HG ' ' A' ' 42' ' ' LEU . 67.8 p -140.99 4.82 1.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.656 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -74.43 141.56 45.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.672 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.2 t -64.32 -51.11 65.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.448 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -49.88 -41.94 46.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.61 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.543 ' HA ' HG22 ' A' ' 21' ' ' VAL . 56.5 t -72.08 -53.99 18.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.831 0.348 . . . . 0.0 110.762 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -58.78 -14.69 9.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.091 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.0 m -90.54 -42.45 10.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.093 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -59.73 -37.76 79.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.356 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.431 ' HB2' HG12 ' A' ' 76' ' ' ILE . 79.6 m-85 -93.67 12.01 26.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.807 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.9 m120 55.7 23.75 6.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.64 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.703 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.3 mm -59.78 121.59 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.221 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.4 p -142.48 58.7 1.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.011 0.434 . . . . 0.0 111.05 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.04 43.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.658 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.556 ' HB2' HG21 ' A' ' 99' ' ' ILE . 14.2 m120 52.07 43.23 30.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.296 0.569 . . . . 0.0 110.448 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.703 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.2 m -68.61 151.86 46.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.741 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.558 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.1 mt -118.43 116.63 51.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.025 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 72.0 m -105.28 130.3 53.44 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.606 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -107.8 103.51 12.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.771 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.0 t80 -97.51 124.37 41.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.529 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.534 HH12 HD12 ' A' ' 116' ' ' LEU . 4.5 mtm180 -106.8 82.85 1.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.967 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 85' ' ' ARG . 6.0 tp -24.99 -60.04 0.06 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.087 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.503 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.52 -70.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.03 2.08 50.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.05 0.452 . . . . 0.0 110.959 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 m120 53.76 34.85 19.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.632 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 11.8 mm-40 -81.17 163.93 22.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.746 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.09 98.58 2.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.824 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.606 HD23 ' HG ' ' A' ' 83' ' ' LEU . 1.8 mm? -88.37 117.08 27.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.784 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -97.85 94.08 6.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.545 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -77.65 77.42 4.17 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.4 mt-10 -78.4 -164.49 0.57 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.516 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 16.3 t70 -51.27 -39.02 55.86 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.096 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.26 -14.67 1.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.103 0.477 . . . . 0.0 110.346 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -129.22 -13.85 4.4 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.674 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.556 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.4 mm -90.29 -31.0 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.607 0.242 . . . . 0.0 111.563 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -55.21 -39.37 69.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.19 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.8 p -128.03 37.07 4.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.506 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.545 HD13 HD21 ' A' ' 94' ' ' LEU . 6.6 tp -62.77 142.78 16.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.423 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -137.34 150.53 47.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.642 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.881 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.42 -36.2 14.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.036 0.446 . . . . 0.0 110.367 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.8 m -63.29 -48.7 77.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.398 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -59.08 -58.59 7.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.281 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.49 -56.22 12.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.883 0.373 . . . . 0.0 110.227 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.7 m -58.39 -29.65 66.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.792 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.493 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -71.24 -66.39 0.62 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.094 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -42.57 -42.45 3.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.146 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.476 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -64.12 -56.27 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.562 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -53.43 -19.87 4.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.328 0.585 . . . . 0.0 110.267 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.493 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.22 -37.04 10.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.915 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.435 ' OD1' ' HG ' ' A' ' 92' ' ' LEU . 16.7 m120 -123.3 30.95 6.12 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.0 p -83.35 41.7 0.78 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.02 0.438 . . . . 0.0 110.169 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.534 HD12 HH12 ' A' ' 85' ' ' ARG . 64.6 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.249 -0.882 . . . . 0.0 111.374 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.737 0.303 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.4 t 57.3 84.04 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -155.69 -41.47 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.989 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -125.43 18.48 8.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.6 m -101.43 25.11 8.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.947 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.2 m -98.56 -10.17 23.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.921 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.85 101.72 8.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.979 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.59 -160.87 9.29 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.473 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.08 -70.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.548 2.165 . . . . 0.0 112.24 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.95 -130.21 43.22 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.645 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -169.87 -59.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.67 0.272 . . . . 0.0 110.77 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.64 104.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.371 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.608 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.2 pt20 -55.96 154.19 7.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.222 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.515 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.5 pt-20 -126.57 160.23 59.43 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.651 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 37.2 Cg_endo -66.16 143.9 73.18 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.464 2.109 . . . . 0.0 112.668 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 m -62.0 154.41 26.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.422 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -98.99 90.13 4.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.068 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.633 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.7 mt -86.8 74.14 9.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.312 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.8 p -74.05 -5.28 40.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.971 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -137.56 147.2 44.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.888 0.375 . . . . 0.0 111.555 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.2 t -56.76 -50.03 90.35 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.448 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.8 Cg_endo -57.56 -44.08 45.09 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.911 1.741 . . . . 0.0 111.83 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.36 83.9 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.172 0.51 . . . . 0.0 110.228 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.633 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.52 -58.73 6.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.169 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 64.5 mtp -60.36 -26.37 66.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.148 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -71.45 -51.34 24.36 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.672 0.273 . . . . 0.0 110.569 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.546 ' O ' HG22 ' A' ' 31' ' ' THR . 10.9 m-85 -60.37 -32.86 71.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.909 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.49 HD11 ' CD1' ' A' ' 36' ' ' ILE . 54.7 mt -73.71 -38.75 51.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.108 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.98 -19.86 60.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.055 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.8 25.57 3.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.638 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.0 t -168.85 152.2 5.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.514 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HG2' HG22 ' A' ' 87' ' ' VAL . 21.9 tt0 -63.82 -74.04 0.11 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.744 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.549 HG13 HD11 ' A' ' 83' ' ' LEU . 17.9 t -98.25 136.32 29.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.452 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.84 125.37 19.19 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.437 HG21 HG12 ' A' ' 111' ' ' ILE . 56.0 t -115.15 131.13 68.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.688 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 21.5 mt -136.58 138.51 46.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.604 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.74 97.02 1.55 Allowed Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.583 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 11.5 m-85 -83.32 89.8 7.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -109.48 137.92 46.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.455 -178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.481 ' HG2' HD23 ' A' ' 71' ' ' LEU . 24.7 mt-30 -83.85 -6.21 59.38 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.442 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 37.5 t70 -151.69 124.96 8.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.605 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.564 ' HA ' HG21 ' A' ' 47' ' ' VAL . 91.7 mt -93.67 47.14 1.21 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.175 0.512 . . . . 0.0 111.246 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.442 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 6.8 mm-40 -138.81 10.77 2.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.98 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.819 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.4 pt -94.08 156.67 38.84 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.06 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.503 ' O ' HD12 ' A' ' 49' ' ' ILE . 77.8 Cg_exo -50.6 -29.15 24.21 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.774 2.316 . . . . 0.0 113.064 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.819 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.4 -36.65 82.97 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.656 HG23 HG13 ' A' ' 44' ' ' ILE . 2.5 t -63.09 -57.19 22.17 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.72 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.653 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.3 Cg_exo -59.64 -36.1 93.2 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.776 1.651 . . . . 0.0 111.284 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -66.04 -36.31 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.034 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.595 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.5 tp -72.96 -52.19 15.47 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -55.19 -23.03 19.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.892 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.3 t -84.27 -44.17 14.12 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.364 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.576 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.57 -25.39 67.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.21 0.529 . . . . 0.0 109.613 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.608 HG12 ' HG3' ' A' ' 13' ' ' GLN . 55.0 t -52.91 -51.18 39.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.171 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -74.31 -10.6 59.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.662 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.1 mtpp -93.88 -18.94 21.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.186 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.623 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 56.7 m-85 -135.38 61.99 47.64 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.55 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.94 -41.69 62.19 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.687 2.258 . . . . 0.0 111.653 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.12 96.51 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.59 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.623 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.8 t -65.76 144.87 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.638 ' HB2' HG21 ' A' ' 31' ' ' THR . 48.2 t -82.4 97.49 8.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.167 0.508 . . . . 0.0 110.81 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.499 ' HB3' HG22 ' A' ' 54' ' ' VAL . 4.8 p90 -65.21 126.5 28.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.105 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.507 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.98 161.59 28.29 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.139 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -157.92 140.33 5.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.831 0.348 . . . . 0.0 110.082 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.3 t -141.03 155.22 46.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.499 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 39' ' ' PHE . 77.1 p -141.31 -7.19 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.753 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.63 143.57 56.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.709 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 m -62.71 -50.82 69.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.26 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -48.19 -48.56 34.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.687 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HA ' HG22 ' A' ' 21' ' ' VAL . 84.2 t -68.1 -53.4 29.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.82 0.343 . . . . 0.0 110.986 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.481 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -57.78 -14.76 6.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.43 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.9 m -91.24 -42.85 10.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.417 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -59.37 -43.65 92.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.644 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -87.61 12.98 11.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.803 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 54.45 26.9 7.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.536 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.699 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.6 mm -61.08 123.33 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.842 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.6 p -143.57 60.43 1.39 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.935 0.398 . . . . 0.0 111.448 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.82 44.14 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.512 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.594 ' HB2' HG21 ' A' ' 99' ' ' ILE . 12.1 m120 52.54 43.19 31.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.269 0.557 . . . . 0.0 110.337 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.699 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.1 m -69.01 153.09 44.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.701 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.604 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.4 mt -119.58 117.68 54.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.792 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.506 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.8 m -106.93 134.12 50.55 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.662 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -110.13 105.03 13.97 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.138 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.9 t80 -98.53 122.07 41.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 6.1 mtm180 -104.45 82.12 1.88 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.71 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tp -24.47 -62.0 0.05 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.415 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.87 -63.49 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.97 2.33 55.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.082 0.468 . . . . 0.0 110.713 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.3 m120 53.48 25.28 4.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.667 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.549 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 14.2 mm-40 -68.94 158.09 35.36 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.81 0.338 . . . . 0.0 110.806 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -143.07 90.42 2.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.742 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.662 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -79.92 141.41 36.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.48 96.14 4.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.524 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -82.0 77.77 8.78 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.451 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.5 mt-10 -79.13 -165.25 0.73 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.525 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 13.8 t70 -50.9 -37.63 44.93 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.836 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -55.6 -14.74 2.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.044 0.449 . . . . 0.0 110.406 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -129.93 -14.0 4.03 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.356 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.594 HG21 ' HB2' ' A' ' 79' ' ' ASN . 21.4 mm -90.03 -23.0 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.899 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.56 -51.72 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.658 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 83.2 p -121.21 38.57 4.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.258 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.524 HD13 HD21 ' A' ' 94' ' ' LEU . 6.6 tp -59.41 142.78 14.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.529 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -137.24 150.29 47.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.647 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.89 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.87 -37.11 13.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 110.447 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -63.27 -47.96 80.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.374 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -59.08 -59.67 5.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.113 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.752 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -49.76 -55.31 14.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.094 0.474 . . . . 0.0 110.152 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.7 m -59.08 -28.72 66.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.781 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.474 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -72.11 -65.77 0.73 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.012 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -42.86 -43.79 4.22 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.03 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.437 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -63.23 -56.62 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.585 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -52.56 -20.97 3.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.201 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.474 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -86.15 -39.03 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.953 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.599 HD22 ' HG ' ' A' ' 92' ' ' LEU . 90.2 m-20 -121.03 29.59 7.28 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 111' ' ' ILE . 80.4 p -82.78 49.49 1.51 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.021 0.439 . . . . 0.0 110.246 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.526 HD12 HH12 ' A' ' 85' ' ' ARG . 72.6 mt . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.29 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.811 0.339 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.6 m -105.7 -40.36 5.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.343 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 51.66 85.66 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -94.66 -57.61 2.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.102 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.7 t -93.61 30.75 1.69 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.952 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.3 m 56.41 71.41 0.57 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.085 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -84.68 6.82 22.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.695 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.28 -171.2 27.12 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.623 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -61.85 -33.62 84.12 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.511 2.141 . . . . 0.0 112.396 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.99 56.35 0.21 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.323 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.73 -49.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 0.0 110.516 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 64.19 -78.17 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.689 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.534 ' HG3' HG12 ' A' ' 54' ' ' VAL . 12.9 pt20 -156.15 131.61 9.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.877 0.37 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.427 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.7 pt-20 -114.21 156.44 44.24 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.787 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 31.6 Cg_endo -64.73 142.48 76.84 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.666 2.244 . . . . 0.0 112.398 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.3 m -57.68 152.86 14.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.612 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -99.55 94.22 6.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.962 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.65 HD22 ' HA ' ' A' ' 24' ' ' ALA . 42.6 mt -90.37 72.92 7.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.366 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 76.4 p -70.06 -8.04 46.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.185 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 3.7 m-20 -138.55 147.45 43.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.153 0.502 . . . . 0.0 111.729 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.608 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.8 t -54.32 -49.5 90.16 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.861 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.59 -45.31 34.57 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.018 1.812 . . . . 0.0 112.059 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.96 -36.5 84.18 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.233 0.539 . . . . 0.0 110.295 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.65 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.53 -58.71 6.6 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.106 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 69.6 mtp -60.15 -27.57 67.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.18 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 25.0 mt-10 -71.25 -50.34 33.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.803 0.335 . . . . 0.0 110.671 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.53 ' O ' HG22 ' A' ' 31' ' ' THR . 7.2 m-85 -59.98 -32.63 71.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.042 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 36' ' ' ILE . 44.0 mt -74.84 -38.81 44.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.047 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.45 -19.61 61.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.158 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.53 25.96 4.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.379 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.656 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.0 t -170.09 151.14 3.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.387 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.515 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.7 tt0 -62.0 -72.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.774 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.525 HG13 HD11 ' A' ' 83' ' ' LEU . 20.7 t -100.78 138.12 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.812 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.16 128.41 20.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.675 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG21 HG12 ' A' ' 111' ' ' ILE . 47.6 t -116.69 128.74 73.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.701 178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.521 HD12 HD11 ' A' ' 28' ' ' ILE . 22.4 mt -134.09 135.9 54.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.615 -177.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.9 99.41 2.05 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.255 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.495 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.8 m-85 -84.77 92.73 8.3 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.575 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.0 m-85 -112.14 139.26 47.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.431 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.491 ' HG2' HD23 ' A' ' 71' ' ' LEU . 74.4 mt-30 -85.81 -8.0 58.38 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.6 t70 -149.96 123.28 8.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.656 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.551 ' HA ' HG21 ' A' ' 47' ' ' VAL . 98.7 mt -92.28 46.97 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.134 0.492 . . . . 0.0 111.321 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 40.7 mt-10 -137.75 9.18 2.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.981 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.81 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.7 pt -92.84 156.54 40.63 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.271 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.489 ' O ' HD12 ' A' ' 49' ' ' ILE . 83.2 Cg_exo -50.54 -28.93 23.19 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.836 2.358 . . . . 0.0 113.162 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.81 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.07 -38.65 89.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.642 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -61.53 -56.69 30.82 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.76 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -59.34 -37.9 87.81 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.746 1.631 . . . . 0.0 111.322 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.869 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.5 mt -64.42 -35.25 73.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.992 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.602 ' O ' HG23 ' A' ' 54' ' ' VAL . 46.8 tp -73.6 -52.77 12.29 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -54.21 -24.72 19.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.07 0.462 . . . . 0.0 109.795 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 t -82.85 -44.37 15.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.631 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.598 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.42 -25.95 67.54 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.244 0.545 . . . . 0.0 109.653 179.261 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 50' ' ' LEU . 56.3 t -52.15 -50.01 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.848 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.452 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 8.6 mt-30 -74.43 -12.62 60.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.816 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -91.93 -18.41 23.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.294 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.612 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 45.1 m-85 -135.92 62.47 46.89 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.496 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.07 -45.46 38.84 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.82 2.347 . . . . 0.0 111.61 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.07 -41.81 79.09 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.476 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.612 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.5 t -65.97 144.22 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.656 ' HB2' HG21 ' A' ' 31' ' ' THR . 37.6 t -82.41 98.03 8.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.916 0.389 . . . . 0.0 110.896 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.501 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 7.9 p90 -62.65 129.38 40.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.781 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.37 160.66 28.43 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.14 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.417 HD11 HG13 ' A' ' 47' ' ' VAL . 4.6 tt -159.38 141.7 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.8 t -145.19 151.71 38.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.104 0.478 . . . . 0.0 111.686 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 39' ' ' PHE . 81.1 p -135.59 -4.89 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.515 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.41 146.22 55.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.791 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.8 t -66.84 -52.12 47.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.474 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -49.71 -43.56 47.66 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.551 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.502 ' HA ' HG22 ' A' ' 21' ' ' VAL . 77.3 t -70.58 -54.07 19.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.91 0.386 . . . . 0.0 110.695 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.491 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -58.75 -14.67 9.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.357 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.4 m -92.29 -39.96 11.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.316 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -61.95 -39.29 91.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.398 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.411 ' HB2' HG12 ' A' ' 76' ' ' ILE . 41.2 m-85 -91.12 10.76 25.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.8 m120 57.53 25.0 10.98 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.502 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.668 HG23 ' HB ' ' A' ' 80' ' ' THR . 36.0 mm -60.52 121.44 8.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.055 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.2 p -141.86 59.16 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.36 45.27 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.666 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.615 ' HB2' HG21 ' A' ' 99' ' ' ILE . 15.3 m120 52.17 42.89 30.92 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.282 0.563 . . . . 0.0 110.557 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.668 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.1 m -69.28 152.6 44.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.681 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.565 HG12 ' HA2' ' A' ' 37' ' ' GLY . 68.2 mt -119.45 118.8 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.095 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.495 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 83.9 m -107.79 133.55 52.02 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.651 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -108.29 104.24 13.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.778 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.2 t80 -97.76 123.41 41.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.479 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.531 HH12 HD12 ' A' ' 116' ' ' LEU . 5.7 mtm180 -106.83 82.91 1.76 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.957 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 tp -26.01 -59.1 0.08 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.04 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.515 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.55 -70.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 O-C-N 123.413 0.446 . . . . 0.0 112.069 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -87.52 2.51 50.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.739 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 52.07 37.88 22.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.17 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.493 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 8.4 mm-40 -82.36 158.19 23.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.618 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -140.11 91.95 2.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.86 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.651 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -81.62 133.81 35.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.491 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.06 116.11 28.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.334 0.588 . . . . 0.0 112.317 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.553 HD21 HD13 ' A' ' 102' ' ' ILE . 3.7 tt -102.39 77.19 1.62 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -79.64 -164.84 0.7 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -176.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.518 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 21.2 t70 -50.52 -36.59 34.82 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.101 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -56.67 -14.51 3.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.151 0.501 . . . . 0.0 110.311 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -131.07 -13.93 3.49 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.593 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.615 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.7 mm -90.07 -30.97 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.774 0.321 . . . . 0.0 111.246 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -54.47 -41.58 69.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.511 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.1 m -126.82 38.64 4.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.569 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.553 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -64.31 142.44 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.608 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -136.55 149.47 48.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.321 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.869 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.41 -35.92 9.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.092 0.472 . . . . 0.0 110.416 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 98.8 m -62.7 -49.11 76.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.413 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -59.1 -58.28 9.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.411 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.746 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.67 -56.69 10.72 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.107 0.479 . . . . 0.0 110.027 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.6 m -58.06 -28.68 64.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.746 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.483 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.1 tmt_? -71.96 -65.58 0.75 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.062 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -43.05 -42.78 4.04 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.084 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.422 HG12 HG21 ' A' ' 35' ' ' VAL . 96.1 mt -64.46 -55.44 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.551 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.79 -17.21 3.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.232 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.483 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -90.77 -37.01 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.0 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.581 HD22 ' HG ' ' A' ' 92' ' ' LEU . 93.3 m-20 -124.47 29.95 6.16 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.6 p -81.95 47.07 1.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.074 0.464 . . . . 0.0 110.197 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.531 HD12 HH12 ' A' ' 85' ' ' ARG . 51.2 mt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.171 -0.919 . . . . 0.0 111.353 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.838 0.351 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.9 t 58.45 87.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.268 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -85.04 -63.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.999 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -131.33 -71.83 0.56 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.091 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.0 m -154.77 -177.58 6.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.229 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 p -85.84 -61.72 1.69 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.656 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.7 t70 56.31 82.2 0.11 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.111 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.99 -165.92 36.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.632 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.98 -39.69 59.3 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.741 2.294 . . . . 0.0 112.53 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.89 171.85 22.11 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.636 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.92 -62.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.8 0.333 . . . . 0.0 110.429 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.532 ' HB1' ' NE2' ' A' ' 55' ' ' GLN . . . 60.45 106.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.586 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.566 ' HG3' HG12 ' A' ' 54' ' ' VAL . 16.4 pt20 -50.52 155.63 1.04 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.264 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.497 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 -128.1 159.3 67.66 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 32.2 Cg_endo -65.51 144.91 81.0 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.653 2.236 . . . . 0.0 112.538 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.7 m -62.23 154.13 28.45 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.359 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -99.69 95.57 7.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.136 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 24' ' ' ALA . 44.7 mt -93.13 71.3 4.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.327 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.4 p -71.75 -0.07 10.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.289 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -141.37 147.62 38.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.939 0.4 . . . . 0.0 111.592 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 23.2 t -57.28 -49.73 92.2 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.499 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.0 Cg_endo -58.71 -42.5 52.97 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.975 1.784 . . . . 0.0 111.879 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.91 -34.91 78.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.195 0.521 . . . . 0.0 110.533 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.602 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -65.06 -57.01 9.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.184 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 61.0 mtm -62.87 -28.6 70.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.075 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 9.9 mt-10 -69.88 -47.77 61.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.718 0.294 . . . . 0.0 110.5 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.567 ' O ' HG22 ' A' ' 31' ' ' THR . 0.4 OUTLIER -60.08 -42.35 94.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.539 HD11 HD12 ' A' ' 36' ' ' ILE . 51.0 mt -65.36 -40.12 87.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.23 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.61 -15.52 61.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.786 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.45 24.86 6.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.13 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.629 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.5 t -171.69 155.02 3.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.515 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.53 ' HG3' HG13 ' A' ' 87' ' ' VAL . 20.7 tt0 -64.76 -79.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.876 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.519 HG13 HD11 ' A' ' 83' ' ' LEU . 17.0 t -93.5 135.14 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.411 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.96 125.51 20.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.026 0.441 . . . . 0.0 112.138 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG21 HG12 ' A' ' 111' ' ' ILE . 52.4 t -114.48 127.66 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.799 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.539 HD12 HD11 ' A' ' 28' ' ' ILE . 23.7 mt -133.18 137.2 53.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.401 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.54 98.61 1.88 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.455 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 6.1 m-85 -83.83 90.22 7.32 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.0 m-85 -109.32 139.09 44.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.377 -178.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.426 ' HG2' HD23 ' A' ' 71' ' ' LEU . 54.1 mt-30 -86.06 -8.57 57.82 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.485 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.4 t70 -149.84 121.7 8.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.623 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.567 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.3 mt -89.55 44.85 1.23 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.066 0.46 . . . . 0.0 111.35 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.7 mt-10 -135.94 10.52 3.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.028 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.1 pt -94.34 156.77 38.39 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.288 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' O ' HD12 ' A' ' 49' ' ' ILE . 73.4 Cg_exo -51.19 -28.58 26.21 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.794 2.33 . . . . 0.0 112.899 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.795 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -61.89 -38.89 90.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.315 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.678 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -60.97 -57.28 27.5 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.681 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.66 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -58.98 -40.27 72.88 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.767 1.644 . . . . 0.0 111.387 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.892 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -61.77 -35.77 69.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.007 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.596 ' O ' HG23 ' A' ' 54' ' ' VAL . 42.1 tp -73.52 -53.11 11.35 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 14.7 m-70 -53.58 -24.44 13.73 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.1 m -82.49 -46.18 13.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.621 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.585 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.7 -26.1 65.33 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 50' ' ' LEU . 58.7 t -53.08 -47.28 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.942 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.532 ' NE2' ' HB1' ' A' ' 12' ' ' ALA . 22.6 mt-30 -77.46 -10.5 59.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.647 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -94.1 -19.68 20.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.16 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.57 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 64.4 m-85 -136.44 62.66 44.57 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.525 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.26 -42.37 60.46 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.653 2.235 . . . . 0.0 111.624 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.72 -39.39 91.17 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.32 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.3 t -67.67 144.11 14.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.629 ' HB2' HG21 ' A' ' 31' ' ' THR . 33.7 t -81.89 98.8 8.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 111.015 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.493 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 8.3 p90 -64.88 128.64 36.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.905 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.74 160.87 28.44 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.987 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.43 HD11 HG13 ' A' ' 47' ' ' VAL . 4.8 tt -160.75 141.82 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.1 t -146.94 155.87 42.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.952 0.406 . . . . 0.0 111.769 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 39' ' ' PHE . 82.5 p -137.64 -8.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.681 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.77 141.8 56.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.669 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.4 m -64.68 -49.53 70.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.126 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -50.19 -44.48 53.02 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.411 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.486 ' HA ' HG22 ' A' ' 21' ' ' VAL . 77.2 t -70.53 -53.78 21.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.831 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.426 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.0 mp -58.38 -14.63 8.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.261 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.4 m -91.73 -40.63 11.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.205 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -61.87 -36.17 80.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.486 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.43 ' HB2' HG12 ' A' ' 76' ' ' ILE . 32.4 m-85 -94.16 10.67 32.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.73 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 57.51 23.66 9.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.64 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.665 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.2 mm -59.89 120.05 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.245 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.9 p -139.39 55.85 1.68 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.174 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.19 45.7 0.02 OUTLIER Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.634 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.624 ' HB2' HG21 ' A' ' 99' ' ' ILE . 21.8 m-80 51.28 43.27 29.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.252 0.549 . . . . 0.0 110.504 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.665 ' HB ' HG23 ' A' ' 76' ' ' ILE . 98.0 m -69.17 151.27 46.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.569 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.581 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.3 mt -117.45 118.95 60.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.223 -0.898 . . . . 0.0 108.821 178.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.513 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.4 m -107.26 133.23 52.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.654 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -109.41 103.38 12.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.966 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.9 t80 -96.34 120.88 37.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.56 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.504 HH12 HD12 ' A' ' 116' ' ' LEU . 5.2 mtm180 -104.06 80.63 1.75 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.808 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 8.6 tp -25.18 -58.2 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.028 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.53 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.84 -62.88 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.314 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -95.05 15.45 18.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.783 0.325 . . . . 0.0 111.301 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 44.7 27.94 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.104 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.495 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.4 mm-40 -75.98 156.78 33.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.834 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.412 ' HB3' HE21 ' A' ' 91' ' ' GLN . 0.8 OUTLIER -144.26 90.68 2.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.774 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.654 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -77.52 142.19 39.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.4 91.99 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.573 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -78.34 79.36 4.78 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -79.5 -165.49 0.8 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.8 t70 -50.37 -39.86 47.86 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.48 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.14 -15.12 1.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.167 0.508 . . . . 0.0 110.295 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -127.95 -13.79 5.11 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.461 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.624 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.4 mm -90.16 -33.45 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.543 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -50.11 -53.64 26.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 110.544 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.6 m -114.97 38.55 3.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.436 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.579 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.3 tp -62.0 142.88 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 111.448 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -137.96 149.57 46.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.848 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.892 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.92 -35.89 11.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.034 0.445 . . . . 0.0 110.36 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 95.6 m -62.97 -47.83 81.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.293 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -60.2 -60.29 4.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.126 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.738 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.06 -56.02 10.31 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.995 0.426 . . . . 0.0 110.131 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.0 m -58.23 -30.76 66.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.999 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.5 ' HD3' HD13 ' A' ' 113' ' ' ILE . 1.7 tmt_? -69.85 -66.02 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.052 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -42.86 -43.83 4.23 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.218 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.459 HG12 HG21 ' A' ' 35' ' ' VAL . 95.3 mt -62.92 -54.89 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -54.57 -18.68 4.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.267 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.5 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.79 -35.24 7.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.944 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.601 HD22 ' HG ' ' A' ' 92' ' ' LEU . 87.6 m-20 -126.03 30.91 5.55 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.2 p -83.44 38.32 0.61 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.995 0.426 . . . . 0.0 110.423 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.504 HD12 HH12 ' A' ' 85' ' ' ARG . 72.0 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.386 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.721 0.296 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.13 133.89 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.895 0.379 . . . . 0.0 111.198 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.08 -175.71 3.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.599 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -60.46 -78.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.703 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.6 p 45.41 62.83 2.0 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.38 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.8 p -142.77 -19.46 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.067 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.72 174.68 7.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.01 175.28 15.15 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.545 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.27 119.16 5.69 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.622 2.215 . . . . 0.0 112.454 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.08 147.15 3.73 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.638 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.42 -23.53 0.24 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.91 0.386 . . . . 0.0 110.289 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.24 95.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.467 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.609 ' HG3' HG12 ' A' ' 54' ' ' VAL . 12.1 pt20 -50.17 152.97 1.56 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.362 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.48 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.4 pt-20 -122.6 158.77 55.59 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.579 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 30.8 Cg_endo -64.26 145.77 89.2 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.536 2.158 . . . . 0.0 112.518 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.2 m -61.05 153.92 24.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.581 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -99.97 89.61 4.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.709 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 35.4 mt -87.72 76.8 8.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.56 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.0 p -74.6 -4.95 40.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.049 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -141.48 148.31 39.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.952 0.406 . . . . 0.0 111.821 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 12.6 t -54.63 -49.97 88.25 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.583 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.0 Cg_endo -57.81 -44.15 43.2 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.005 1.804 . . . . 0.0 112.127 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.98 -37.54 87.81 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.206 0.527 . . . . 0.0 110.263 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.69 -56.54 16.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.016 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.6 mtm -61.86 -26.76 68.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.056 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -71.72 -50.59 28.9 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.642 0.258 . . . . 0.0 110.602 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.539 ' O ' HG22 ' A' ' 31' ' ' THR . 11.4 m-85 -60.83 -32.17 71.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.105 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.527 HD11 HD12 ' A' ' 36' ' ' ILE . 53.4 mt -75.29 -39.06 41.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.03 0.443 . . . . 0.0 110.075 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.51 -18.46 61.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.143 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.1 25.39 4.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.261 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.628 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.0 t -169.57 154.24 5.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.689 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.545 ' HG3' HG13 ' A' ' 87' ' ' VAL . 18.9 tt0 -65.13 -72.58 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.878 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.524 HG13 HD11 ' A' ' 83' ' ' LEU . 15.7 t -99.45 137.13 27.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.672 0.272 . . . . 0.0 110.657 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.58 125.35 16.97 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.024 0.44 . . . . 0.0 112.019 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.467 HG22 ' HB2' ' A' ' 83' ' ' LEU . 56.0 t -114.88 129.64 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.902 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.527 HD12 HD11 ' A' ' 28' ' ' ILE . 21.6 mt -135.21 136.8 51.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.468 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.0 99.78 2.1 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.543 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 6.4 m-85 -85.4 93.93 8.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.4 m-85 -113.38 143.37 44.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -92.64 -1.16 57.1 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.52 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.3 t70 -156.89 115.53 3.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.479 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.592 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.2 mt -85.47 44.14 1.08 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.11 0.481 . . . . 0.0 111.233 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.425 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 17.5 mm-40 -135.29 12.74 3.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.46 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.797 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.8 pt -96.57 156.37 36.79 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.176 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.492 ' O ' HD12 ' A' ' 49' ' ' ILE . 87.6 Cg_exo -50.95 -27.24 20.41 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.837 2.358 . . . . 0.0 113.048 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.797 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.15 -37.12 86.31 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.672 HG23 HG13 ' A' ' 44' ' ' ILE . 2.7 t -62.13 -56.1 34.47 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.939 -0.305 . . . . 0.0 111.682 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.8 Cg_exo -59.79 -40.25 65.4 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.735 1.623 . . . . 0.0 111.461 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.869 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -61.83 -37.2 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.086 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.579 ' O ' HG23 ' A' ' 54' ' ' VAL . 37.6 tp -72.13 -53.19 13.5 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -54.92 -21.02 10.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.085 0.469 . . . . 0.0 109.815 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.7 t -85.38 -44.87 12.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.496 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.582 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.28 -26.55 67.85 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.609 HG12 ' HG3' ' A' ' 13' ' ' GLN . 54.5 t -51.89 -50.0 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.069 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -74.54 -13.41 60.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.685 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -91.13 -18.7 24.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.288 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.654 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 48.8 m-85 -135.4 62.06 47.84 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.436 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.18 -36.77 78.62 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.494 2.129 . . . . 0.0 111.493 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.44 -39.77 98.09 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.518 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.654 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.5 t -67.72 145.23 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.628 ' HB2' HG21 ' A' ' 31' ' ' THR . 36.9 t -82.7 96.28 8.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.099 0.476 . . . . 0.0 110.795 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.504 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.8 p90 -64.05 130.83 45.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.187 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.494 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -149.87 162.3 29.11 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.008 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.5 tt -160.47 147.1 5.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.9 t -153.11 157.55 40.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.17 0.509 . . . . 0.0 111.697 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.436 HG21 ' HG ' ' A' ' 42' ' ' LEU . 69.9 p -138.03 -3.39 1.8 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.444 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -63.95 143.36 57.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.679 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.0 p -66.22 -52.08 51.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.53 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -50.2 -43.46 52.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.592 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.477 HG22 ' HA ' ' A' ' 21' ' ' VAL . 60.4 t -70.53 -52.5 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.934 0.397 . . . . 0.0 110.563 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.96 -14.52 16.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.47 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.6 m -92.13 -41.53 10.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.204 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -60.1 -41.3 92.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.451 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.401 ' HB2' HG12 ' A' ' 76' ' ' ILE . 36.3 m-85 -89.02 11.98 16.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.81 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 55.95 28.81 13.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.483 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.68 HG23 ' HB ' ' A' ' 80' ' ' THR . 34.9 mm -65.5 118.65 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.079 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.7 p -139.75 51.96 1.72 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.193 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.87 44.42 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.567 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.643 ' HB2' HG21 ' A' ' 99' ' ' ILE . 39.2 m-20 51.42 42.29 29.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.364 0.602 . . . . 0.0 110.137 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.68 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.4 m -68.55 153.36 43.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.93 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.591 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.3 mt -119.93 118.06 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.867 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.2 m -106.75 132.8 52.31 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.624 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -110.42 104.72 13.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.039 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.0 t80 -97.54 123.94 41.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.447 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.533 HH12 HD12 ' A' ' 116' ' ' LEU . 4.8 mtm180 -106.12 81.08 1.58 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.708 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ARG . 8.9 tp -24.28 -59.86 0.05 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.113 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.545 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.8 -63.3 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -93.77 2.57 56.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.995 0.426 . . . . 0.0 111.077 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 54.12 30.7 12.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.718 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.9 mm-40 -78.32 164.07 25.17 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.706 0.288 . . . . 0.0 110.648 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.99 98.74 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.624 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -86.81 115.37 24.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.742 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -96.67 93.61 6.83 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.563 HD21 HD13 ' A' ' 102' ' ' ILE . 4.1 tt -78.67 78.92 5.11 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -80.51 -165.44 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.501 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.17 -50.35 11.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.675 -179.316 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -47.59 -16.5 0.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.941 0.4 . . . . 0.0 111.209 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 96' ' ' ASP . 19.3 m-20 -127.27 -13.73 5.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.467 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.643 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.2 mm -91.36 -40.73 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -50.35 -37.36 36.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.349 . . . . 0.0 111.076 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.2 p -127.11 38.58 4.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.48 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.563 HD13 HD21 ' A' ' 94' ' ' LEU . 7.5 tp -67.11 143.76 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.616 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -137.93 148.39 45.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.32 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.869 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.8 -36.48 7.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.026 0.441 . . . . 0.0 110.445 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.3 m -62.57 -49.4 75.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.413 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -58.2 -59.07 5.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.365 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.732 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.64 -55.67 15.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.015 0.436 . . . . 0.0 110.146 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 65.5 m -58.42 -28.76 65.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.763 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.556 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -72.12 -67.21 0.56 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.094 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -42.85 -40.23 2.82 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.34 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.416 HG12 HG21 ' A' ' 35' ' ' VAL . 96.6 mt -66.45 -54.97 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -53.96 -18.84 3.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.324 0.583 . . . . 0.0 110.285 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.556 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.5 mp -90.1 -38.6 11.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.899 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.493 ' OD1' HG22 ' A' ' 113' ' ' ILE . 28.2 m120 -118.36 28.13 8.53 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -82.39 47.63 1.18 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 110.08 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.533 HD12 HH12 ' A' ' 85' ' ' ARG . 52.1 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.252 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.874 0.369 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.5 m -122.43 149.4 25.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.269 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -135.73 -72.4 0.46 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.023 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -66.84 98.78 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.893 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.6 p -73.15 124.31 25.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.8 m -75.19 -48.75 22.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -146.98 -61.37 0.29 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 124.36 -72.84 0.42 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.748 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.93 127.63 26.9 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.595 2.197 . . . . 0.0 112.478 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.28 108.76 0.41 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.602 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.579 ' HB1' HE21 ' A' ' 13' ' ' GLN . . . -168.98 -77.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.749 0.309 . . . . 0.0 110.793 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.75 96.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.662 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.579 HE21 ' HB1' ' A' ' 11' ' ' ALA . 8.5 pt20 -171.22 177.33 3.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.472 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.9 pt-20 -126.59 157.97 69.2 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.128 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.511 ' HD3' HG21 ' A' ' 54' ' ' VAL . 47.4 Cg_endo -68.66 150.59 74.65 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.855 2.37 . . . . 0.0 112.592 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.423 HG21 ' CZ ' ' A' ' 27' ' ' PHE . 8.4 m -73.18 154.23 40.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.38 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -97.53 91.16 5.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.166 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.591 HD13 ' HA ' ' A' ' 24' ' ' ALA . 30.7 mt -85.02 73.14 10.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.237 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.9 p -68.85 -6.72 28.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.421 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -138.25 147.4 43.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.931 0.396 . . . . 0.0 111.937 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 33.2 t -54.0 -49.68 88.39 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.685 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.7 Cg_endo -58.05 -46.15 27.48 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.962 1.775 . . . . 0.0 112.131 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.55 -35.33 80.13 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.115 0.483 . . . . 0.0 110.409 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.591 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -64.17 -59.64 4.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.006 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.9 mtm -61.51 -24.91 66.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.025 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 17.8 mt-10 -71.68 -50.33 31.47 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.749 0.309 . . . . 0.0 110.169 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.511 ' O ' HG22 ' A' ' 31' ' ' THR . 6.3 m-85 -60.04 -33.24 71.76 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.569 HD11 HD12 ' A' ' 36' ' ' ILE . 50.0 mt -72.49 -38.98 61.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.038 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.22 -18.33 60.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.239 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.75 27.18 3.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.288 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.762 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.6 t -170.8 150.77 3.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.426 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.505 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.0 tt0 -62.67 -63.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.953 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.504 HG13 HD11 ' A' ' 83' ' ' LEU . 21.8 t -108.18 138.32 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.591 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.37 125.75 18.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.993 0.425 . . . . 0.0 111.991 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.442 HG21 HG12 ' A' ' 111' ' ' ILE . 51.4 t -114.38 129.79 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 28' ' ' ILE . 39.3 mt -135.45 138.12 48.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.56 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.07 96.84 1.5 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.478 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.463 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 37.1 m-85 -83.04 90.45 7.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.646 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 13.6 m-85 -108.51 142.04 39.52 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -87.93 -5.97 58.28 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.477 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.8 t70 -154.49 123.48 6.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.747 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.554 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.3 mt -91.22 46.33 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.13 0.49 . . . . 0.0 111.293 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 32.5 mt-10 -137.57 11.4 2.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.972 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.813 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.6 pt -95.61 156.42 37.46 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.158 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.475 ' O ' HD12 ' A' ' 49' ' ' ILE . 82.0 Cg_exo -50.18 -28.47 19.97 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.848 2.365 . . . . 0.0 113.145 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.813 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.03 -37.05 85.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.67 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.6 t -62.39 -56.31 31.69 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.67 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.7 Cg_exo -60.04 -37.25 85.92 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 121.923 1.749 . . . . 0.0 111.49 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.7 mt -65.65 -35.9 76.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.112 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 54' ' ' VAL . 45.9 tp -73.23 -50.46 22.28 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -54.95 -26.12 34.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.124 0.487 . . . . 0.0 109.78 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.3 t -81.13 -46.97 14.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.625 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.585 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.28 -26.53 65.03 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 50' ' ' LEU . 47.0 t -52.19 -48.15 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.225 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -77.06 -11.89 59.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 28.8 mtpp -92.17 -18.47 23.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.176 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.59 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 56.5 m-85 -136.13 62.45 45.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.439 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.43 -43.09 56.94 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.701 2.267 . . . . 0.0 111.842 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.79 -39.44 91.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.57 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.8 t -67.35 145.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.762 ' HB2' HG21 ' A' ' 31' ' ' THR . 23.9 t -83.04 97.7 8.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.104 0.478 . . . . 0.0 110.826 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.502 ' HB3' HG22 ' A' ' 54' ' ' VAL . 5.0 p90 -64.73 125.17 23.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.965 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -143.56 162.42 27.67 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.146 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -163.08 142.77 2.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.463 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 42.5 t -149.56 156.3 41.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.12 0.486 . . . . 0.0 111.711 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.52 HG21 ' HG ' ' A' ' 42' ' ' LEU . 75.8 p -136.55 -1.54 2.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.459 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -68.08 139.97 56.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.72 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.7 p -62.34 -48.95 77.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.461 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -49.44 -47.38 48.22 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.574 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.498 ' HA ' HG22 ' A' ' 21' ' ' VAL . 71.5 t -69.01 -53.96 22.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.985 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.86 -14.88 6.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.134 0.492 . . . . 0.0 110.225 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.5 m -90.49 -41.6 11.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.32 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -60.77 -37.87 83.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.475 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.431 ' HB2' HG12 ' A' ' 76' ' ' ILE . 60.0 m-85 -92.88 10.11 32.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.815 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 56.76 25.97 10.86 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.51 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.705 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.3 mm -61.31 123.88 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.353 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.1 p -143.08 60.01 1.41 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.174 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.15 44.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.733 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.646 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 24.0 m-80 51.87 43.99 29.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.23 0.538 . . . . 0.0 110.506 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.705 ' HB ' HG23 ' A' ' 76' ' ' ILE . 90.1 m -69.32 150.94 46.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.744 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.56 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.2 mt -117.23 115.81 49.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.202 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.427 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 71.0 m -104.04 133.16 49.45 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.663 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -108.87 101.3 10.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.028 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.9 t80 -95.32 121.26 36.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.555 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.455 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 4.3 mtm180 -104.56 84.12 2.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.752 0.311 . . . . 0.0 110.897 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tp -26.26 -59.02 0.08 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.505 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.39 -72.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 O-C-N 123.428 0.455 . . . . 0.0 112.009 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.85 3.6 40.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.152 0.501 . . . . 0.0 110.655 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.5 t30 52.72 31.94 11.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.344 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 16.7 mm-40 -75.11 158.78 32.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.582 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -140.48 90.77 2.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.663 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -77.52 142.92 38.81 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -124.39 108.86 12.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.167 0.508 . . . . 0.0 112.343 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.553 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -96.54 77.86 2.95 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.6 mt-10 -79.0 -165.21 0.71 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.528 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.3 t70 -51.17 -36.6 41.93 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.02 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.15 -14.77 2.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.061 0.458 . . . . 0.0 110.437 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -130.88 -14.17 3.55 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.639 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.588 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.0 mm -89.07 -29.49 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.705 0.288 . . . . 0.0 111.271 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -55.7 -47.94 75.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.659 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.9 t -118.81 36.06 4.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.514 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.553 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -62.2 142.76 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.513 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -137.87 149.07 45.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.57 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.1 -37.24 9.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.013 0.435 . . . . 0.0 110.441 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 98.9 m -62.87 -48.45 78.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.256 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -59.09 -57.85 11.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.29 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.779 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.96 -56.22 13.45 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.052 0.453 . . . . 0.0 110.275 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.8 m -58.15 -29.47 65.6 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.887 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.501 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.3 tmt_? -71.58 -64.68 0.88 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.331 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -43.03 -45.8 5.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.932 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.442 HG12 HG21 ' A' ' 35' ' ' VAL . 96.4 mt -61.2 -55.75 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.506 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -54.34 -18.07 3.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.39 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.501 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.25 -37.23 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.04 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.568 HD22 ' HG ' ' A' ' 92' ' ' LEU . 90.5 m-20 -124.81 30.35 5.95 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.5 p -83.13 48.98 1.45 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.049 0.452 . . . . 0.0 110.139 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.409 HD12 ' NH1' ' A' ' 85' ' ' ARG . 61.2 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.357 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.823 0.345 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -100.54 165.99 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.858 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -136.17 126.36 26.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.978 0.418 . . . . 0.0 111.13 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -63.73 -45.0 91.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.584 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 85.3 p 45.47 60.92 2.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.338 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.3 t -105.45 82.01 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.817 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -133.1 111.72 11.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.51 -94.53 0.17 Allowed Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.471 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.78 103.32 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.401 2.068 . . . . 0.0 112.269 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.49 -115.21 0.32 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.528 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.48 -47.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.446 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.04 -84.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.558 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.536 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.8 pt20 -133.11 143.85 49.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.368 . . . . 0.0 110.871 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.2 pt-20 -129.63 158.15 74.36 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.775 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 36.7 Cg_endo -67.22 143.8 66.13 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.512 2.142 . . . . 0.0 112.578 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 m -61.09 154.43 22.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.457 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -100.56 88.51 3.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.886 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 24' ' ' ALA . 59.8 mt -83.19 71.99 10.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.414 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.5 p -70.56 -1.51 11.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.377 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -143.27 147.03 34.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.986 0.422 . . . . 0.0 111.829 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.0 t -54.75 -49.17 93.04 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.561 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.57 -47.46 18.92 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.835 1.69 . . . . 0.0 111.84 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.29 -32.57 73.31 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.182 0.515 . . . . 0.0 110.174 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.611 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.85 -61.38 2.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.027 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.4 mmt -59.73 -25.04 64.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.302 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -73.1 -52.19 15.2 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.669 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.46 ' O ' HG22 ' A' ' 31' ' ' THR . 5.6 m-85 -58.74 -32.55 69.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.523 HD11 ' CD1' ' A' ' 36' ' ' ILE . 50.8 mt -74.76 -41.13 47.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.287 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.66 -15.27 62.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.14 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.85 26.81 4.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.132 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.674 HG21 ' HB2' ' A' ' 61' ' ' SER . 7.6 t -172.11 154.77 3.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.644 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HG2' HG22 ' A' ' 87' ' ' VAL . 10.9 tt0 -64.13 -76.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.842 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.551 HG13 HD11 ' A' ' 83' ' ' LEU . 16.9 t -96.6 136.1 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.59 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.68 125.67 19.77 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.472 HG21 HG12 ' A' ' 111' ' ' ILE . 52.6 t -115.32 131.67 66.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.755 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.523 ' CD1' HD11 ' A' ' 28' ' ' ILE . 20.6 mt -137.04 139.97 43.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.385 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.59 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.96 97.99 1.67 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.592 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.472 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 44.5 m-85 -84.6 93.12 8.31 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.613 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.1 m-85 -113.15 141.22 47.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.492 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 95.2 mt-30 -86.53 -8.84 57.21 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.494 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.0 t70 -149.82 123.17 9.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.813 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.554 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.5 mt -91.89 46.36 1.27 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.062 0.458 . . . . 0.0 111.326 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -135.18 9.62 3.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.848 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.723 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.0 pt -91.98 158.01 40.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.343 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' HD12 ' A' ' 49' ' ' ILE . 76.5 Cg_exo -53.24 -24.91 28.23 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.961 2.441 . . . . 0.0 113.015 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.723 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -66.1 -37.22 85.22 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.705 HG23 HG13 ' A' ' 44' ' ' ILE . 2.9 t -61.02 -55.2 46.86 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.616 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.658 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.2 Cg_exo -60.88 -42.41 37.92 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.035 1.824 . . . . 0.0 111.565 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.891 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -61.15 -35.28 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.251 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.61 ' O ' HG23 ' A' ' 54' ' ' VAL . 51.9 tp -74.15 -51.63 14.98 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -54.09 -26.75 28.68 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.9 m -80.84 -46.62 15.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.565 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.634 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.75 -25.28 64.74 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.195 0.521 . . . . 0.0 109.7 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 50' ' ' LEU . 49.5 t -53.12 -46.52 55.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.937 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -79.16 -9.16 59.49 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.808 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -94.61 -19.08 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.225 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.579 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 52.4 m-85 -136.95 63.02 43.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.419 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.68 -44.55 46.85 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.744 2.296 . . . . 0.0 111.71 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.33 -40.67 77.19 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.523 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.7 t -66.93 143.12 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.674 ' HB2' HG21 ' A' ' 31' ' ' THR . 22.1 t -80.92 96.31 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.403 . . . . 0.0 111.054 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.526 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.7 p90 -65.58 125.46 25.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.912 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -144.71 163.82 27.88 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.01 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 tt -161.81 144.11 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.452 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.9 t -150.1 157.38 43.06 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.041 0.448 . . . . 0.0 111.498 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.462 HG21 ' HG ' ' A' ' 42' ' ' LEU . 75.2 p -138.1 -2.99 1.81 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.644 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -64.06 142.2 58.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.631 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.2 t -65.29 -51.17 62.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.447 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -50.26 -41.97 51.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.5 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.508 ' HA ' HG22 ' A' ' 21' ' ' VAL . 65.4 t -71.91 -53.99 18.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 0.0 110.763 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp -59.07 -14.54 10.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.169 0.509 . . . . 0.0 110.21 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.9 m -92.49 -39.22 11.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.302 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -62.31 -40.95 98.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.445 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.433 ' HB2' HG12 ' A' ' 76' ' ' ILE . 90.5 m-85 -89.17 11.9 17.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.591 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 57.4 24.23 9.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.567 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.689 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.9 mm -61.0 119.9 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.9 p -138.23 52.66 1.83 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.421 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.95 48.15 0.01 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.799 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.624 ' HB2' HG21 ' A' ' 99' ' ' ILE . 12.6 m120 49.71 43.69 24.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.119 0.485 . . . . 0.0 110.477 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.689 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.5 m -69.55 153.3 43.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.838 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.59 HG12 ' HA2' ' A' ' 37' ' ' GLY . 56.0 mt -118.83 119.41 60.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.84 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.472 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 75.5 m -108.2 135.4 49.59 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.595 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -112.85 105.65 13.8 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.196 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.9 t80 -98.33 122.06 41.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.315 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.472 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 5.4 mtm180 -104.29 81.12 1.78 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.757 0.313 . . . . 0.0 110.894 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 85' ' ' ARG . 9.4 tp -25.18 -56.72 0.06 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.809 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.507 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.58 -68.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.991 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -91.16 13.63 16.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.057 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.6 p30 43.99 30.88 0.45 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.161 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 7.6 mm-40 -78.02 160.8 27.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.323 . . . . 0.0 110.674 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.81 95.14 2.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.974 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.595 HD23 ' HG ' ' A' ' 83' ' ' LEU . 1.8 mm? -83.02 143.2 30.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -123.82 93.68 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.548 HD21 HD13 ' A' ' 102' ' ' ILE . 4.9 tt -76.91 77.86 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.5 mt-10 -78.55 -165.7 0.75 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 19.0 t70 -51.2 -35.44 36.47 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.695 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.29 -17.4 4.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.237 0.541 . . . . 0.0 110.24 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -128.73 -13.87 4.65 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.668 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.624 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.4 mm -88.69 -32.08 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 120.593 0.235 . . . . 0.0 111.591 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.6 -36.23 64.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.103 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.6 m -132.41 38.56 3.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.465 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.548 HD13 HD21 ' A' ' 94' ' ' LEU . 7.0 tp -63.05 142.48 16.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.687 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -136.12 149.03 48.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.349 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.891 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.36 -37.54 11.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.982 0.42 . . . . 0.0 110.641 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.4 m -61.74 -47.17 86.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.363 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -59.95 -60.46 3.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.27 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.767 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.72 -56.04 9.72 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.03 0.443 . . . . 0.0 110.303 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.7 m -58.28 -30.97 67.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.914 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.501 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.7 tmt_? -69.95 -65.8 0.68 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.235 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -42.87 -45.02 4.77 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.164 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.472 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -61.55 -55.03 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -54.79 -18.62 4.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.395 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.501 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.88 -36.47 8.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.875 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.443 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.2 m120 -124.88 30.43 5.91 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.4 p -83.21 42.05 0.79 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.972 0.415 . . . . 0.0 110.286 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.461 HD12 ' NH1' ' A' ' 85' ' ' ARG . 81.5 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.382 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.743 0.306 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.29 17.85 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.321 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 55.55 46.86 22.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.129 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 55.91 84.24 0.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.075 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.4 p -60.09 124.81 21.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.78 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.0 t -98.58 104.3 16.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.987 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -109.49 -11.76 14.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.845 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.05 154.32 9.28 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.475 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.2 -33.14 95.07 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.642 2.228 . . . . 0.0 112.41 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.91 -136.97 4.34 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.49 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.3 -51.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.791 0.329 . . . . 0.0 110.653 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . . . 60.3 -83.8 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.534 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.593 HE21 HG12 ' A' ' 54' ' ' VAL . 13.7 pt20 -129.81 142.7 50.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.351 . . . . 0.0 110.891 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.0 pt-20 -125.09 157.76 65.86 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.984 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.0 Cg_endo -66.09 143.53 72.16 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.7 2.267 . . . . 0.0 112.504 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.0 m -58.38 149.49 24.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.65 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -97.34 85.76 3.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.627 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.621 HD22 ' HA ' ' A' ' 24' ' ' ALA . 39.0 mt -82.14 73.22 9.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.546 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.5 p -71.77 -2.06 16.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.339 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -141.5 147.35 37.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 111.696 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.598 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 58.6 t -55.37 -49.92 89.73 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.602 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.7 Cg_endo -57.85 -45.26 33.89 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.849 1.699 . . . . 0.0 112.066 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.54 78.4 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.132 0.491 . . . . 0.0 110.416 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.621 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.6 -59.24 4.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.98 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 60.4 mtp -60.99 -26.54 67.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.04 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 18.7 mt-10 -71.25 -49.27 44.91 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.657 0.265 . . . . 0.0 110.333 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.549 ' O ' HG22 ' A' ' 31' ' ' THR . 4.3 m-85 -60.34 -34.27 73.59 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.584 HD11 HD12 ' A' ' 36' ' ' ILE . 51.4 mt -72.96 -38.31 55.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.292 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.17 -17.9 60.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.09 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.86 27.27 4.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.287 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.62 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.3 t -169.49 152.37 4.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.453 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.598 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.5 tt0 -64.65 -64.97 0.74 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.912 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.527 HG13 HD11 ' A' ' 83' ' ' LEU . 21.8 t -108.33 137.4 40.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.491 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.87 126.99 21.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.945 0.403 . . . . 0.0 112.031 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.458 HG21 HG12 ' A' ' 111' ' ' ILE . 42.9 t -115.47 127.58 73.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.593 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.584 HD12 HD11 ' A' ' 28' ' ' ILE . 32.2 mt -134.15 138.78 49.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.572 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.568 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.49 98.42 1.69 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.562 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.446 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.0 m-85 -84.98 92.77 8.41 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.4 m-85 -111.56 147.48 35.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.541 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.552 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 23.9 mt-30 -94.51 -9.89 33.94 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.531 ' O ' HG12 ' A' ' 44' ' ' ILE . 37.5 t70 -147.17 117.41 7.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.397 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.572 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.3 mt -87.35 45.26 1.25 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.127 0.489 . . . . 0.0 111.506 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.1 mt-10 -136.13 10.88 3.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.114 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.806 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.5 pt -94.29 155.04 40.27 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.132 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.484 ' O ' HD12 ' A' ' 49' ' ' ILE . 88.2 Cg_exo -48.88 -28.51 13.32 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.936 2.424 . . . . 0.0 113.091 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.806 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.9 -37.9 88.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.677 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.9 t -61.38 -56.35 34.52 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.604 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.677 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.2 Cg_exo -60.86 -41.87 42.14 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.822 1.682 . . . . 0.0 111.416 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.884 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -60.4 -34.94 59.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.038 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.61 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.8 tp -73.92 -52.39 13.06 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -52.79 -27.1 16.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.065 0.46 . . . . 0.0 109.772 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.6 m -80.12 -46.84 15.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.722 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.575 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.11 -26.04 64.34 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.194 0.521 . . . . 0.0 109.639 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.2 t -52.83 -51.12 39.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.89 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.413 ' OE1' ' HB3' ' A' ' 12' ' ' ALA . 7.7 mt-30 -75.24 -10.42 59.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.75 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.2 mtpp -93.51 -18.25 22.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.253 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.607 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 55.3 m-85 -136.81 62.53 41.5 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.488 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.65 -41.14 70.82 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.592 2.195 . . . . 0.0 111.627 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.72 -39.44 93.59 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.321 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.607 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -69.12 144.25 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.62 ' HB2' HG21 ' A' ' 31' ' ' THR . 41.3 t -81.96 98.29 8.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.985 0.421 . . . . 0.0 111.013 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.479 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.2 p90 -63.53 128.92 37.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.854 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.509 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.15 161.36 28.46 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.261 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.9 tt -162.6 145.12 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.446 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.0 t -152.46 157.72 41.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.195 0.522 . . . . 0.0 111.787 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.457 HG21 ' HG ' ' A' ' 42' ' ' LEU . 67.5 p -138.03 -3.39 1.8 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.626 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.4 139.73 58.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.415 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.4 m -63.69 -49.09 74.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.54 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -50.57 -41.14 53.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.489 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.582 ' HA ' HG22 ' A' ' 21' ' ' VAL . 56.6 t -73.49 -54.98 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 110.685 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.417 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.0 mp -57.66 -14.52 5.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.367 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 83.2 m -92.44 -42.33 9.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.286 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -60.53 -34.76 74.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.59 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' HB2' HG12 ' A' ' 76' ' ' ILE . 96.7 m-85 -95.88 10.17 38.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.693 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.0 m120 56.63 27.43 12.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.755 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.711 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.6 mm -63.87 122.23 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.867 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.5 p -141.72 54.77 1.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.911 0.386 . . . . 0.0 111.322 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.49 44.03 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.753 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.593 ' HB2' HG21 ' A' ' 99' ' ' ILE . 12.4 m120 51.79 41.97 29.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.338 0.589 . . . . 0.0 110.251 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.711 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.8 m -67.64 151.55 47.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.703 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.568 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.3 mt -118.28 116.22 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.869 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 73.0 m -104.14 129.94 51.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.644 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.2 tp -107.01 100.34 9.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.507 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.6 t80 -94.67 122.81 37.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.532 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.7 mtm180 -107.13 92.78 4.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.363 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 tp -37.81 -53.52 1.28 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.009 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.598 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.59 -58.22 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -102.84 9.64 38.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.002 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 85' ' ' ARG . 16.0 t-20 47.2 34.44 3.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.423 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.532 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 15.8 mm-40 -77.48 159.46 29.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.403 HE21 ' HD1' ' A' ' 74' ' ' TYR . 1.3 tm0? -141.87 91.21 2.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.914 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.644 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.5 mm? -81.97 115.27 21.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.847 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -99.81 98.63 9.41 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.499 HD21 HD13 ' A' ' 102' ' ' ILE . 4.3 tt -83.77 77.63 9.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.461 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.3 mt-10 -77.87 -165.64 0.67 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.548 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 20.6 t70 -51.21 -37.89 49.28 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.117 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -55.55 -15.18 2.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.059 0.457 . . . . 0.0 110.437 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -128.38 -14.2 4.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.394 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.593 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.7 mm -90.18 -29.26 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.889 0.376 . . . . 0.0 111.321 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -56.13 -38.05 70.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 85.4 p -129.98 36.07 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.582 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.2 tp -62.05 141.98 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.597 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -136.89 150.34 48.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.533 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.884 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.74 -37.72 13.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.903 0.382 . . . . 0.0 110.584 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -62.73 -47.94 81.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.303 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -58.8 -60.27 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.199 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.765 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.13 -56.58 8.72 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.965 0.412 . . . . 0.0 110.191 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.7 m -58.07 -28.87 64.95 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.947 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.51 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.2 tmt_? -72.42 -67.0 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.077 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -42.37 -41.36 2.83 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.103 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 35' ' ' VAL . 96.6 mt -65.49 -55.68 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -53.27 -18.68 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.187 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.596 HG22 ' ND2' ' A' ' 114' ' ' ASN . 1.5 mp -89.99 -39.38 12.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.918 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.596 ' ND2' HG22 ' A' ' 113' ' ' ILE . 49.4 m-80 -116.39 26.77 9.66 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 78.7 p -81.56 52.59 1.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.174 0.511 . . . . 0.0 110.216 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.447 HD12 HH12 ' A' ' 85' ' ' ARG . 70.8 mt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.032 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.777 0.322 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -155.24 -30.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -93.79 130.82 39.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.763 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 4' ' ' LYS . 13.8 mptt -94.5 162.8 13.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.0 p -139.91 17.97 2.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.0 p -89.8 -43.83 10.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.98 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -148.48 89.14 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.011 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -107.19 -163.08 21.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.487 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.47 98.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.587 2.191 . . . . 0.0 112.33 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.32 79.02 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.462 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.75 -65.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 13' ' ' GLN . . . 54.81 53.07 11.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.271 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.447 ' OE1' HG12 ' A' ' 54' ' ' VAL . 3.7 pt20 47.37 173.26 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.846 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.483 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 -165.54 159.4 13.67 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.488 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 53.6 Cg_endo -69.46 136.34 33.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.365 2.044 . . . . 0.0 112.685 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.9 m -60.7 152.43 26.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.676 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -94.01 98.54 11.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.94 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.1 mt -93.05 70.71 4.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.265 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.9 p -70.54 -2.15 13.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.165 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -139.7 146.87 40.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.021 0.439 . . . . 0.0 111.64 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 43.4 t -56.82 -50.08 90.1 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.396 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.41 -43.89 42.46 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.945 1.763 . . . . 0.0 111.878 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.28 -36.99 85.91 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.223 0.535 . . . . 0.0 110.305 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.602 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.84 -57.07 12.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.04 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 62.1 mtp -62.59 -26.74 68.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.117 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.32 -50.76 35.91 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.726 0.298 . . . . 0.0 110.464 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.478 ' O ' HG22 ' A' ' 31' ' ' THR . 12.2 m-85 -61.46 -32.54 72.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.513 HD11 HD12 ' A' ' 36' ' ' ILE . 47.7 mt -72.9 -36.86 52.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.836 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.7 -20.33 59.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.022 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.94 28.33 1.86 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.162 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.75 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.8 t -172.3 154.63 3.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.475 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.545 ' HG3' HG13 ' A' ' 87' ' ' VAL . 30.1 tt0 -68.0 -59.9 2.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.012 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.529 HG13 HD11 ' A' ' 83' ' ' LEU . 20.6 t -110.26 138.26 38.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.495 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.78 127.16 17.73 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.453 HG21 HG12 ' A' ' 111' ' ' ILE . 48.6 t -116.05 130.3 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.586 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.513 HD12 HD11 ' A' ' 28' ' ' ILE . 25.4 mt -135.94 137.59 48.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.456 -177.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.94 99.43 2.05 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.443 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 10.8 m-85 -85.67 93.99 8.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.4 m-85 -115.09 141.48 47.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.449 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 48.5 mt-30 -88.95 -2.24 58.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.465 ' O ' HG12 ' A' ' 44' ' ' ILE . 25.1 t70 -155.81 123.06 5.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.636 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.55 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.6 mt -92.62 46.15 1.23 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.136 0.493 . . . . 0.0 111.475 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.417 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 38.3 mt-10 -135.19 8.06 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.921 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.755 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.0 pt -90.82 155.51 45.32 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.186 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.506 ' O ' HD12 ' A' ' 49' ' ' ILE . 77.2 Cg_exo -50.75 -27.12 19.17 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.87 2.38 . . . . 0.0 112.942 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.755 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.6 -37.86 88.94 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.673 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -61.88 -56.0 36.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.773 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.5 Cg_exo -60.47 -37.01 84.08 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 121.9 1.733 . . . . 0.0 111.435 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.875 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -65.75 -35.43 75.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.941 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.4 tp -74.31 -51.85 13.98 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -55.86 -22.21 24.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.979 0.419 . . . . 0.0 109.922 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.6 t -85.59 -44.63 12.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.372 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.615 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.24 -26.03 67.47 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.226 0.536 . . . . 0.0 109.593 179.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 50' ' ' LEU . 44.9 t -51.61 -48.98 35.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.009 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -74.44 -14.84 60.9 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.566 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -90.35 -17.71 26.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.357 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.583 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 65.6 m-85 -137.14 61.82 35.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.699 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.47 -43.52 56.85 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.645 2.23 . . . . 0.0 111.611 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.58 -42.29 90.2 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.422 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.583 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.1 t -65.97 141.71 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.75 ' HB2' HG21 ' A' ' 31' ' ' THR . 41.2 t -78.37 97.71 5.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.081 0.467 . . . . 0.0 110.816 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.496 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.5 p90 -67.9 124.64 23.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.914 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.459 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -143.51 164.13 27.41 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.041 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.7 tt -161.2 142.14 3.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 t -147.23 153.35 39.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.161 0.505 . . . . 0.0 111.794 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.457 HG21 ' HG ' ' A' ' 42' ' ' LEU . 77.8 p -135.05 2.73 3.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.432 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.84 140.67 49.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.705 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.0 t -64.03 -49.97 70.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.531 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -50.76 -44.46 58.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.602 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.556 ' HA ' HG22 ' A' ' 21' ' ' VAL . 54.5 t -70.24 -52.1 33.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.891 0.377 . . . . 0.0 110.598 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.52 -15.08 15.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.253 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.1 m -90.93 -41.23 11.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.32 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -61.63 -37.84 85.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.389 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.41 ' HB2' HG12 ' A' ' 76' ' ' ILE . 45.3 m-85 -92.08 11.69 24.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.805 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 56.02 23.03 6.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.689 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.671 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.7 mm -57.94 117.28 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.83 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.1 p -136.51 56.4 1.81 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.387 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.28 46.32 0.02 OUTLIER Glycine 0 C--N 1.329 0.174 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.628 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.595 ' HB2' HG21 ' A' ' 99' ' ' ILE . 11.3 m120 51.43 43.62 29.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.162 0.506 . . . . 0.0 110.277 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.671 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.3 m -69.08 154.75 41.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.675 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.592 HG12 ' HA2' ' A' ' 37' ' ' GLY . 52.9 mt -120.65 117.55 53.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.817 178.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.513 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.2 m -106.7 135.9 47.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.674 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -112.85 101.64 9.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.064 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.6 t80 -95.05 125.18 39.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.772 0.32 . . . . 0.0 110.334 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.519 HH12 HD12 ' A' ' 116' ' ' LEU . 5.3 mtm180 -107.75 83.65 1.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.825 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 85' ' ' ARG . 9.0 tp -24.67 -59.15 0.06 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.789 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.545 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.85 -77.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 O-C-N 123.5 0.5 . . . . 0.0 112.127 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.55 4.32 21.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.636 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.2 m120 53.8 31.43 13.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.522 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.1 mm-40 -74.46 161.49 29.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -145.94 86.91 1.73 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.862 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.674 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -74.25 144.84 44.47 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -128.25 98.28 5.03 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.528 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -84.64 78.28 9.88 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.0 mt-10 -79.02 -165.61 0.78 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.518 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.8 t70 -50.23 -38.62 41.43 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.03 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -55.06 -14.9 1.74 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.119 0.485 . . . . 0.0 110.492 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -130.1 -13.94 3.96 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.664 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.595 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.5 mm -88.49 -31.86 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.636 0.255 . . . . 0.0 111.614 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -56.43 -35.29 67.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.952 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.5 m -130.31 39.77 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.558 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.528 HD13 HD21 ' A' ' 94' ' ' LEU . 7.2 tp -68.25 142.08 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.754 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -136.04 149.69 48.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.391 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.875 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.63 -35.87 10.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.127 0.489 . . . . 0.0 110.445 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.8 m -62.59 -48.61 78.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.42 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -59.4 -59.76 4.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.256 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.775 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.34 -55.48 12.72 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 110.301 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.5 m -58.92 -30.59 67.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.999 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.494 ' HD3' HD13 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -70.83 -66.25 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.138 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -43.15 -43.58 4.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.119 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.453 HG12 HG21 ' A' ' 35' ' ' VAL . 96.8 mt -63.8 -55.43 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -54.12 -17.59 2.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.129 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.494 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -90.69 -37.22 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.01 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.448 ' O ' HD21 ' A' ' 83' ' ' LEU . 14.9 m120 -122.63 29.96 6.67 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 98.7 p -83.26 40.55 0.72 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.091 0.472 . . . . 0.0 110.1 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.519 HD12 HH12 ' A' ' 85' ' ' ARG . 58.2 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.422 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.821 0.344 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.0 p -155.94 143.6 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.93 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -124.37 103.71 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.993 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -135.32 127.37 29.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.735 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.4 m -75.14 87.84 2.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.9 p -162.42 37.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.21 -57.59 3.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.802 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -113.72 177.44 17.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.578 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.07 -58.78 1.02 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.584 2.19 . . . . 0.0 112.253 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.66 -118.37 0.54 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.374 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.541 ' HB1' HE21 ' A' ' 13' ' ' GLN . . . -167.98 -68.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.638 0.256 . . . . 0.0 110.787 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.438 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . . . 59.35 100.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.315 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.541 HE21 ' HB1' ' A' ' 11' ' ' ALA . 9.0 pt20 -168.98 172.28 7.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.977 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 -118.29 158.45 46.55 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.084 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 45.0 Cg_endo -69.7 148.15 64.8 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.773 2.315 . . . . 0.0 112.756 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 m -66.25 150.13 49.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.527 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -96.51 90.64 5.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.999 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 37.1 mt -86.12 71.49 10.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.567 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.8 p -70.68 -1.96 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.081 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -141.57 147.07 37.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.919 0.39 . . . . 0.0 111.7 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 59.3 t -55.79 -49.85 90.52 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.491 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.4 Cg_endo -57.55 -44.91 37.65 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.89 1.727 . . . . 0.0 111.937 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.84 -34.46 78.43 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.226 0.536 . . . . 0.0 110.353 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.46 -59.41 4.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.174 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.1 mtm -61.48 -26.96 68.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.049 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -70.77 -49.26 48.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.638 0.256 . . . . 0.0 110.51 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.465 ' O ' HG22 ' A' ' 31' ' ' THR . 6.2 m-85 -61.48 -32.88 72.91 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.49 HD11 ' CD1' ' A' ' 36' ' ' ILE . 42.8 mt -72.08 -37.99 61.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.828 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.76 -23.62 61.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.837 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.93 32.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.138 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.615 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.8 t -173.47 151.31 1.94 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.346 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.521 ' HG3' HG13 ' A' ' 87' ' ' VAL . 30.0 tt0 -68.31 -53.45 24.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.749 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.509 HG13 HD11 ' A' ' 83' ' ' LEU . 21.5 t -116.58 139.83 41.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.413 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.15 126.78 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.488 HG21 HG12 ' A' ' 111' ' ' ILE . 43.7 t -115.61 125.99 73.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.404 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.49 ' CD1' HD11 ' A' ' 28' ' ' ILE . 28.2 mt -131.39 136.26 57.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -177.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.597 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.08 98.33 1.88 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.267 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.5 m-85 -84.12 93.27 8.1 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -113.62 142.88 45.45 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.42 ' HG2' HD23 ' A' ' 71' ' ' LEU . 23.4 mt-30 -90.47 -9.25 48.08 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.514 ' O ' HG12 ' A' ' 44' ' ' ILE . 30.2 t70 -147.72 119.28 7.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.55 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.536 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.3 mt -88.9 45.49 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.096 0.474 . . . . 0.0 111.413 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.433 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.9 mt-10 -135.65 7.94 3.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.107 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.731 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.5 pt -89.87 157.03 46.69 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.158 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' HD12 ' A' ' 49' ' ' ILE . 74.0 Cg_exo -51.84 -25.98 22.86 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.792 2.328 . . . . 0.0 112.824 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.731 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.87 -39.04 92.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 44' ' ' ILE . 2.1 t -60.38 -55.12 48.26 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.608 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.4 Cg_exo -60.56 -42.0 43.56 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.879 1.719 . . . . 0.0 111.371 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.898 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -60.62 -35.45 63.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.046 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.605 ' O ' HG23 ' A' ' 54' ' ' VAL . 50.9 tp -73.81 -50.09 22.15 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -55.81 -25.27 40.71 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.8 m -81.56 -45.77 15.4 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.595 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.609 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.22 -25.82 67.32 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.114 0.483 . . . . 0.0 109.748 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 50' ' ' LEU . 42.8 t -52.16 -47.77 43.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.084 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' A' ' 12' ' ' ALA . 36.5 mt-30 -76.94 -14.29 59.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.668 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -90.8 -16.58 28.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.389 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.671 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 34.3 m-85 -136.99 61.42 34.52 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.606 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.39 -39.56 81.25 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.636 2.224 . . . . 0.0 111.592 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.98 -41.16 99.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.519 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.9 t -67.12 145.23 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.615 ' CB ' HG21 ' A' ' 31' ' ' THR . 46.6 t -82.31 96.56 7.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.984 0.421 . . . . 0.0 110.999 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.496 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 4.7 p90 -62.1 128.24 35.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.612 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.5 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.2 161.46 28.32 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.826 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.407 HD11 HG13 ' A' ' 47' ' ' VAL . 5.5 tt -164.02 140.73 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.2 t -144.45 159.33 42.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.227 0.537 . . . . 0.0 111.959 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 39' ' ' PHE . 76.2 p -141.18 -0.0 1.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.314 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -71.28 144.4 50.01 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.602 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.8 p -65.66 -50.96 63.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.392 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -49.96 -41.8 47.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.616 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.563 ' HA ' HG22 ' A' ' 21' ' ' VAL . 70.9 t -72.45 -54.08 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.841 0.353 . . . . 0.0 110.712 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.42 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.3 mp -59.0 -14.74 10.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.35 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.6 m -91.67 -42.0 10.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.258 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -60.52 -38.97 86.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.356 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.413 ' HB2' HG12 ' A' ' 76' ' ' ILE . 43.6 m-85 -91.15 9.61 30.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.763 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.8 m120 57.24 24.68 10.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.592 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.673 HG23 ' HB ' ' A' ' 80' ' ' THR . 42.0 mm -59.27 125.24 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.9 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.0 p -143.86 60.31 1.37 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.529 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.87 45.51 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.542 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.616 ' HB2' HG21 ' A' ' 99' ' ' ILE . 29.6 m-80 51.63 41.87 29.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.236 0.541 . . . . 0.0 110.385 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.673 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.2 m -67.65 152.22 45.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.747 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.597 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.1 mt -119.56 116.83 51.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.835 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.497 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 71.2 m -106.31 136.58 45.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.655 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -109.73 100.91 9.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.196 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.5 t80 -92.99 119.88 32.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.434 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.471 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.5 mtm180 -104.25 85.21 2.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.973 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 tp -26.97 -61.28 0.09 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.521 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.1 -76.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 O-C-N 123.525 0.516 . . . . 0.0 112.056 -179.42 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.48 3.12 25.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.098 0.475 . . . . 0.0 110.533 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.405 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 12.3 t30 52.65 31.84 10.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.299 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 19.6 mm-40 -75.28 165.96 24.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.533 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -149.68 87.55 1.5 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.655 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -72.04 147.22 47.04 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.85 105.72 8.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.292 0.568 . . . . 0.0 112.302 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.561 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -94.05 76.45 4.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.0 mt-10 -77.61 -165.88 0.68 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.492 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.63 -51.9 11.51 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.524 -179.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -47.28 -17.56 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.868 0.366 . . . . 0.0 111.301 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -124.39 -13.92 7.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.423 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.616 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.8 mm -91.48 -40.25 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -51.71 -30.38 22.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.821 0.343 . . . . 0.0 111.29 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m -134.67 39.98 2.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.079 0.466 . . . . 0.0 110.395 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.561 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -68.48 143.93 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.712 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.409 ' H ' ' HD3' ' A' ' 106' ' ' LYS . 23.7 m-20 -136.32 147.89 47.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.437 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.898 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.69 -38.69 10.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.017 0.437 . . . . 0.0 110.542 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 98.8 m -59.51 -49.32 78.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.323 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 103' ' ' ASP . 51.1 mtpt -57.87 -62.6 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.274 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.76 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -46.64 -57.53 4.71 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.945 0.403 . . . . 0.0 110.446 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.9 m -57.74 -29.88 65.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.931 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.509 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.0 tmt_? -71.4 -65.85 0.7 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.237 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -42.64 -43.61 3.9 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.993 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.488 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -63.25 -55.98 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.617 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -54.15 -18.36 3.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.362 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.509 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.91 -37.47 10.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.84 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.478 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.6 m120 -125.45 31.21 5.6 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 98.2 p -83.9 44.51 1.0 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.122 0.487 . . . . 0.0 110.074 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.443 HD12 HH12 ' A' ' 85' ' ' ARG . 65.4 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.352 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.701 0.286 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p -141.78 133.66 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.187 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -105.31 -9.59 17.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.846 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -78.49 152.98 31.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.976 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -95.54 120.23 35.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.4 m -146.01 122.2 10.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.101 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -120.62 96.64 5.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.776 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 110.06 -94.19 0.79 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.362 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.72 134.09 52.04 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.451 2.101 . . . . 0.0 112.239 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.34 -78.36 0.18 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.701 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.42 -41.9 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.864 0.364 . . . . 0.0 110.35 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.53 -83.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.72 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.499 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.7 pt20 -139.9 142.37 36.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.863 0.363 . . . . 0.0 110.963 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.2 pt-20 -128.09 157.87 72.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.798 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.484 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 36.3 Cg_endo -67.13 140.55 54.34 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.444 2.096 . . . . 0.0 112.494 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.0 m -54.8 152.03 7.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.748 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -98.98 87.11 3.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.079 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.618 HD22 ' HA ' ' A' ' 24' ' ' ALA . 45.8 mt -84.85 72.57 10.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.344 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.0 p -71.67 0.19 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.445 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -144.67 148.29 34.07 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.752 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 45.2 t -55.3 -49.57 91.62 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.528 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.28 -46.53 24.38 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.922 1.748 . . . . 0.0 111.9 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.88 -33.06 74.84 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.11 0.481 . . . . 0.0 110.324 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.618 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -65.83 -59.03 4.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.939 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.6 mtm -61.0 -25.39 66.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.054 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.4 mt-10 -72.97 -52.01 16.18 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.684 0.278 . . . . 0.0 110.499 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.502 ' O ' HG22 ' A' ' 31' ' ' THR . 4.0 m-85 -58.49 -33.78 70.19 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.558 HD11 HD12 ' A' ' 36' ' ' ILE . 57.9 mt -73.84 -40.76 53.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.261 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.98 -15.22 62.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.174 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.29 23.74 7.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.643 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.4 t -169.88 153.68 4.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.737 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.7 tt0 -63.35 -74.95 0.09 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.816 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.548 HG13 HD11 ' A' ' 83' ' ' LEU . 15.7 t -97.75 135.9 30.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.784 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.512 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.91 124.07 16.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.948 0.404 . . . . 0.0 111.904 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 111' ' ' ILE . 45.8 t -112.44 130.38 66.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.785 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 28' ' ' ILE . 29.1 mt -135.75 138.63 47.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.611 -177.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.551 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.03 98.13 1.77 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.543 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.476 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 35.9 m-85 -83.84 91.63 7.59 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.3 m-85 -111.75 141.08 45.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.3 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.429 ' HG2' HD23 ' A' ' 71' ' ' LEU . 88.2 mt-30 -86.08 -10.19 55.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 44' ' ' ILE . 9.8 t70 -148.53 129.35 14.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.561 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.501 ' HA ' HG21 ' A' ' 47' ' ' VAL . 90.1 mt -96.97 48.4 1.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.077 0.465 . . . . 0.0 111.475 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -137.9 7.29 2.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.771 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.713 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.7 pt -88.58 159.2 47.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.129 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.481 ' O ' HD12 ' A' ' 49' ' ' ILE . 54.4 Cg_exo -54.47 -24.91 37.86 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.864 2.376 . . . . 0.0 112.816 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.713 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.9 -39.01 90.22 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.702 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -59.34 -55.08 49.8 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.3 Cg_exo -60.37 -41.84 46.45 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.01 1.807 . . . . 0.0 111.505 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.892 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.5 mt -61.68 -34.42 62.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.103 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.614 ' O ' HG23 ' A' ' 54' ' ' VAL . 52.0 tp -75.09 -51.85 12.49 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -54.32 -24.92 21.15 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -82.08 -46.13 14.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.593 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.609 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.43 -25.52 66.03 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.9 t -52.39 -48.18 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.081 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -78.11 -9.96 59.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.83 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -93.9 -19.15 21.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.304 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.608 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 51.3 m-85 -135.83 62.91 49.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.56 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.82 -43.9 48.48 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.829 2.352 . . . . 0.0 111.644 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.08 -40.71 91.86 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.497 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.3 t -67.57 142.51 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.643 ' HB2' HG21 ' A' ' 31' ' ' THR . 32.2 t -81.44 97.68 7.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.055 0.455 . . . . 0.0 110.976 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.484 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.6 p90 -65.03 128.14 34.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.786 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.84 163.0 28.6 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.8 -0.715 . . . . 0.0 111.937 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 tt -161.68 144.26 3.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.476 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 40.7 t -148.52 156.33 42.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.131 0.491 . . . . 0.0 111.581 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.471 HG21 ' HG ' ' A' ' 42' ' ' LEU . 69.6 p -138.24 5.93 2.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.783 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -76.2 141.19 41.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.632 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.9 t -63.77 -50.35 69.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.396 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -49.68 -43.29 47.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.405 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.544 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.0 t -71.14 -54.16 18.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.841 0.353 . . . . 0.0 110.745 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.429 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -58.23 -14.82 7.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.118 0.485 . . . . 0.0 110.211 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.4 m -91.17 -40.55 11.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.161 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -61.75 -33.02 73.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.149 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.432 ' HB2' HG12 ' A' ' 76' ' ' ILE . 68.2 m-85 -97.35 9.15 43.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.959 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 58.88 22.78 10.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.506 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.709 HD12 ' HB ' ' A' ' 80' ' ' THR . 41.0 mm -59.13 125.61 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.266 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.6 p -144.44 58.69 1.33 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.29 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.57 43.94 0.02 OUTLIER Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.664 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.617 ' HB2' HG21 ' A' ' 99' ' ' ILE . 32.5 m-20 52.37 44.75 29.55 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.285 0.564 . . . . 0.0 110.435 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.709 ' HB ' HD12 ' A' ' 76' ' ' ILE . 89.8 m -69.96 152.31 44.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.913 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.551 HG12 ' HA2' ' A' ' 37' ' ' GLY . 59.5 mt -117.72 116.99 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-N 115.496 -0.775 . . . . 0.0 108.979 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.436 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 75.7 m -106.22 133.65 50.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.631 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -110.34 105.41 14.42 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.077 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.2 t80 -97.22 122.12 39.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.697 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.491 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.3 mtm180 -105.04 81.94 1.79 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 110.552 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.7 tp -25.71 -58.73 0.07 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.026 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.539 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -44.26 -57.25 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.59 13.52 33.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.592 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 43.8 28.81 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.301 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 15.9 mm-40 -77.79 156.98 30.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.745 0.307 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.417 HE22 ' HB3' ' A' ' 93' ' ' ASN . 1.1 tm0? -141.83 95.33 2.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.567 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.631 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -84.9 116.14 23.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.959 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.417 ' HB3' HE22 ' A' ' 91' ' ' GLN . 0.9 OUTLIER -98.18 108.89 21.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.094 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.586 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -95.01 77.62 3.55 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.436 ' O ' HG12 ' A' ' 99' ' ' ILE . 29.4 mt-10 -78.72 -165.09 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.531 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 17.2 t70 -50.26 -39.9 46.4 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.249 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -53.91 -15.88 1.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.132 0.492 . . . . 0.0 110.229 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -128.96 -13.68 4.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.58 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.617 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.5 mm -91.01 -40.04 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -51.55 -33.82 33.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.935 0.398 . . . . 0.0 111.044 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.1 m -131.39 40.0 3.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.372 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.586 HD13 HD21 ' A' ' 94' ' ' LEU . 8.0 tp -68.89 144.91 13.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.658 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -138.59 146.95 42.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.257 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.892 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.09 -36.17 5.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.967 0.413 . . . . 0.0 110.694 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 100.0 m -62.24 -48.18 81.1 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.489 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -59.32 -61.29 2.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.055 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.752 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.91 -55.88 8.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.974 0.416 . . . . 0.0 110.332 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.9 m -58.44 -30.61 67.04 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.922 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.536 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.7 tmt_? -71.06 -66.08 0.66 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.245 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -42.98 -41.9 3.56 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.243 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.475 HG12 HG21 ' A' ' 35' ' ' VAL . 97.0 mt -65.11 -55.14 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -53.94 -18.85 3.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.14 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.536 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.75 -37.95 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.827 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.485 ' OD1' HG22 ' A' ' 113' ' ' ILE . 31.6 m120 -119.86 28.6 8.02 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.8 p -82.81 48.0 1.28 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.075 0.464 . . . . 0.0 110.484 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.43 HD12 ' NH1' ' A' ' 85' ' ' ARG . 78.1 mt . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.246 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.747 0.308 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.84 151.76 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.151 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 56.8 84.2 0.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -157.98 139.66 13.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.6 m -96.68 46.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.717 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.7 m -139.39 -46.41 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -100.49 97.36 8.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.94 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.07 -173.04 27.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.455 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.25 104.75 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.527 2.151 . . . . 0.0 112.175 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.87 55.02 0.58 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.437 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.73 -46.82 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.976 0.417 . . . . 0.0 110.571 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.447 ' HB3' ' NE2' ' A' ' 55' ' ' GLN . . . 61.37 -83.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.673 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.496 ' HG3' HG12 ' A' ' 54' ' ' VAL . 10.5 pt20 -139.72 154.63 47.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.485 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 -140.88 159.28 62.8 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 49.9 Cg_endo -70.37 144.91 52.15 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.664 2.243 . . . . 0.0 112.762 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.3 m -63.46 150.7 43.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.631 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -96.26 97.86 9.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.015 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 54.9 mt -92.93 70.91 4.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.318 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.8 p -71.74 -2.25 16.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.136 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -139.32 146.7 40.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.058 0.456 . . . . 0.0 111.509 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 13.1 t -56.43 -50.42 87.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.471 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.74 -45.28 34.19 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.831 1.688 . . . . 0.0 111.856 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.31 79.87 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.198 0.523 . . . . 0.0 110.309 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.07 -59.26 4.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.988 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.1 mtm -60.63 -25.39 66.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.202 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 26.3 mt-10 -73.38 -51.39 17.51 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.728 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.546 ' O ' HG22 ' A' ' 31' ' ' THR . 9.1 m-85 -60.04 -31.67 70.18 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.561 HD11 HD12 ' A' ' 36' ' ' ILE . 48.8 mt -75.21 -39.85 43.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.127 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.58 -18.14 61.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.266 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.33 24.97 5.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.31 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.631 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.2 t -168.44 152.75 6.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.677 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.533 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.5 tt0 -62.82 -77.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.895 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.561 HG13 HD11 ' A' ' 83' ' ' LEU . 19.5 t -95.73 135.27 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.397 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.565 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.76 125.77 21.23 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.457 HG22 ' HB2' ' A' ' 83' ' ' LEU . 49.3 t -115.41 129.73 71.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.789 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.561 HD12 HD11 ' A' ' 28' ' ' ILE . 23.0 mt -135.45 137.19 50.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.446 -177.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.77 96.91 1.63 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.294 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.508 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 19.5 m-85 -82.51 89.02 6.61 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -107.44 137.71 44.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.473 ' HG2' HD23 ' A' ' 71' ' ' LEU . 21.9 mt-30 -83.83 -5.0 59.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.432 ' O ' HG12 ' A' ' 44' ' ' ILE . 27.0 t70 -155.41 127.71 7.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.529 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.562 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.5 mt -95.34 46.91 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 111.68 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.425 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.8 mt-10 -135.85 5.08 3.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.612 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.809 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.2 pt -88.84 157.39 48.95 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.296 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' HD12 ' A' ' 49' ' ' ILE . 74.6 Cg_exo -52.8 -27.96 36.53 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.914 2.409 . . . . 0.0 112.958 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.809 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.27 -37.21 84.6 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.654 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.2 t -62.21 -56.94 26.4 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.525 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.654 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.8 Cg_exo -58.64 -40.9 69.34 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.758 1.639 . . . . 0.0 111.448 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.888 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.8 mt -61.37 -37.16 77.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.572 ' O ' HG23 ' A' ' 54' ' ' VAL . 37.9 tp -73.46 -53.82 9.74 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -53.1 -23.25 7.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.098 0.475 . . . . 0.0 110.081 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.2 m -83.92 -45.5 13.12 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.467 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.596 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.03 -25.2 65.13 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.8 t -52.33 -48.05 45.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.992 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.447 ' NE2' ' HB3' ' A' ' 12' ' ' ALA . 38.7 mt-30 -77.85 -11.17 59.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.797 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -93.08 -17.91 23.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.235 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.587 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 57.0 m-85 -137.57 62.53 36.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.558 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.63 -42.73 60.43 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.612 2.208 . . . . 0.0 111.708 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.76 -40.49 92.93 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.509 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.587 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.7 t -66.57 143.9 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.631 ' HB2' HG21 ' A' ' 31' ' ' THR . 30.5 t -81.42 97.12 7.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 0.0 110.994 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.472 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.8 p90 -64.82 127.13 30.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.965 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.481 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.09 162.84 28.39 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.029 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.415 HD11 HG13 ' A' ' 47' ' ' VAL . 4.6 tt -160.96 142.36 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.2 t -145.5 154.04 41.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.983 0.421 . . . . 0.0 111.691 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.452 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.4 p -137.52 -4.41 1.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.884 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.42 142.84 56.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.771 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.2 t -64.5 -50.58 66.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.511 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -49.02 -45.45 42.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.658 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 21' ' ' VAL . 77.8 t -70.59 -52.4 29.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.917 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.473 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -59.05 -14.85 10.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.122 0.487 . . . . 0.0 110.135 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.1 m -91.17 -41.38 11.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.394 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -60.97 -40.07 92.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.455 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.415 ' HB2' HG12 ' A' ' 76' ' ' ILE . 64.3 m-85 -90.24 11.82 20.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.576 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.6 m120 55.98 24.17 7.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.494 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.675 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.9 mm -60.83 120.08 5.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.4 p -138.68 52.37 1.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.419 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.27 46.49 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.64 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.605 ' HB2' HG21 ' A' ' 99' ' ' ILE . 28.3 m-80 50.77 42.01 27.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.177 0.513 . . . . 0.0 110.29 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.675 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.3 m -68.07 150.38 48.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.68 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.584 HG12 ' HA2' ' A' ' 37' ' ' GLY . 69.4 mt -116.79 116.94 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.984 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.508 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.4 m -106.64 132.14 52.98 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.652 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -109.08 105.37 14.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.979 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.5 t80 -98.62 121.07 40.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.498 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.532 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.1 mtm180 -102.85 80.71 1.91 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.711 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 6.1 tp -25.11 -58.46 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.533 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.35 -59.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.199 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -97.11 2.9 51.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.045 0.45 . . . . 0.0 110.82 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 52.77 32.58 12.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.817 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 13.0 mm-40 -77.93 156.99 29.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.663 0.268 . . . . 0.0 110.805 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 91' ' ' GLN . 1.1 tm0? -140.18 96.23 3.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.601 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.652 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -88.13 114.47 24.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.804 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -97.65 99.69 11.07 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.605 HD21 HD13 ' A' ' 102' ' ' ILE . 4.4 tt -84.24 77.45 9.97 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.2 mt-10 -78.11 -165.61 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -176.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.72 -49.9 14.25 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.548 -179.515 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -48.5 -15.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.929 0.395 . . . . 0.0 111.291 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 96' ' ' ASP . 22.1 m-20 -127.33 -13.9 5.45 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.498 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.605 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.9 mm -90.67 -37.24 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -49.04 -49.31 41.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.334 . . . . 0.0 111.127 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.0 m -118.0 35.6 4.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.778 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.605 HD13 HD21 ' A' ' 94' ' ' LEU . 8.1 tp -60.78 145.17 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.46 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -138.41 149.22 45.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.48 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.888 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.4 -36.22 14.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.035 0.445 . . . . 0.0 110.377 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.0 m -62.06 -49.62 75.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.286 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -58.18 -60.39 3.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.376 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.709 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -49.19 -55.99 10.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.964 0.411 . . . . 0.0 110.378 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.6 m -58.57 -28.87 65.94 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.726 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.527 ' NH1' HD11 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -72.25 -66.64 0.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.188 179.761 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -43.56 -41.99 4.81 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.065 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.407 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -64.72 -55.94 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.423 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 43.1 tt0 -52.95 -19.13 2.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.294 0.569 . . . . 0.0 110.265 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.527 HD11 ' NH1' ' A' ' 109' ' ' ARG . 1.4 mp -90.11 -38.56 11.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.062 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.486 ' OD1' HG22 ' A' ' 113' ' ' ILE . 28.9 m120 -117.72 27.12 9.23 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.2 p -81.32 50.12 1.39 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.083 0.468 . . . . 0.0 110.152 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.507 HD12 HH12 ' A' ' 85' ' ' ARG . 56.4 mt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.345 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.714 0.292 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.8 p -144.77 139.72 23.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.105 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -107.48 154.85 20.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.449 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 5.7 ttpm? 59.06 95.43 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.938 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.6 p -62.61 146.3 52.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.063 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.6 m -87.41 87.41 7.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.7 t70 62.07 -83.11 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.12 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.79 172.03 45.09 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.603 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.56 -176.75 0.26 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.739 2.293 . . . . 0.0 112.372 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.34 -119.5 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.509 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.25 -72.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.709 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.51 -81.58 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.527 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.531 ' HG3' HG12 ' A' ' 54' ' ' VAL . 16.5 pt20 -155.97 142.57 18.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.632 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.49 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 16.6 pt-20 -134.27 158.56 74.98 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.96 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 38.1 Cg_endo -66.65 145.17 75.01 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.635 2.223 . . . . 0.0 112.564 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 17' ' ' TRP . 11.5 m -62.22 155.78 23.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.911 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.408 ' N ' HG22 ' A' ' 16' ' ' THR . 12.1 m-90 -99.53 86.94 3.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.719 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 24' ' ' ALA . 44.1 mt -83.04 73.83 10.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.047 0.451 . . . . 0.0 110.61 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.0 p -72.19 -0.82 12.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.356 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -143.0 148.26 36.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.917 0.389 . . . . 0.0 111.535 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.594 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 32.8 t -56.77 -50.52 87.52 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.434 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.61 -44.76 38.73 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.939 1.76 . . . . 0.0 111.832 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.33 -36.5 83.89 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.334 0.588 . . . . 0.0 110.183 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.609 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.91 -59.12 4.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.91 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.6 mtp -60.19 -24.98 65.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.095 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -72.57 -52.52 15.18 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.775 0.321 . . . . 0.0 110.558 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.479 ' O ' HG22 ' A' ' 31' ' ' THR . 13.0 m-85 -59.34 -31.41 69.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.519 HD11 HD12 ' A' ' 36' ' ' ILE . 55.3 mt -74.52 -39.37 47.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.175 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.29 -20.77 61.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.147 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.64 28.69 2.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.032 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.635 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.9 t -170.11 152.43 4.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.425 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.551 ' HG3' HG13 ' A' ' 87' ' ' VAL . 26.0 tt0 -66.76 -61.73 1.81 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.526 HG13 HD11 ' A' ' 83' ' ' LEU . 17.2 t -109.33 136.98 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.438 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.506 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.91 127.75 20.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.014 0.435 . . . . 0.0 112.116 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.435 ' C ' HG13 ' A' ' 36' ' ' ILE . 50.6 t -116.46 131.19 69.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.615 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.519 HD12 HD11 ' A' ' 28' ' ' ILE . 22.1 mt -136.45 135.34 49.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -177.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -97.32 98.03 2.06 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.539 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.524 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.9 m-85 -84.43 93.48 8.3 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.0 m-85 -114.3 142.14 46.69 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -89.97 -0.94 57.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' O ' HG12 ' A' ' 44' ' ' ILE . 37.8 t70 -156.26 122.47 5.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.707 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.52 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.1 mt -92.32 46.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.159 0.504 . . . . 0.0 111.293 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.435 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.5 mt-10 -136.91 7.5 2.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.005 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.779 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.7 pt -89.46 158.45 45.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.014 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.519 ' O ' HD12 ' A' ' 49' ' ' ILE . 66.1 Cg_exo -53.32 -26.23 33.97 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.781 2.321 . . . . 0.0 112.896 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.779 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.92 -37.64 88.32 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 44' ' ' ILE . 2.1 t -61.54 -55.66 40.63 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.616 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 36.6 Cg_exo -61.24 -37.82 70.72 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.067 1.845 . . . . 0.0 111.519 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.878 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.5 mt -65.24 -34.86 73.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.014 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.59 ' O ' HG23 ' A' ' 54' ' ' VAL . 45.4 tp -73.27 -52.34 14.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -52.81 -26.31 14.09 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -80.29 -47.59 14.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.7 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.566 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.8 -25.93 63.61 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.136 0.493 . . . . 0.0 109.684 179.6 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.2 t -53.23 -48.35 55.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.967 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.92 -10.06 59.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.635 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -94.1 -18.88 21.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.212 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.608 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 59.9 m-85 -136.82 62.84 43.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.526 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.8 -41.61 68.89 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.748 2.298 . . . . 0.0 111.369 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.61 -39.38 93.25 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.375 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.9 t -68.55 144.33 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.635 ' HB2' HG21 ' A' ' 31' ' ' THR . 39.5 t -81.88 98.07 8.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.075 0.464 . . . . 0.0 111.043 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.5 ' HB3' HG22 ' A' ' 54' ' ' VAL . 5.3 p90 -65.06 125.55 25.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.028 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.03 162.11 28.12 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.998 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.415 HD11 HG13 ' A' ' 47' ' ' VAL . 4.4 tt -161.19 145.49 4.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.0 t -151.02 158.08 43.68 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.173 0.511 . . . . 0.0 111.857 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.462 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.3 p -138.53 -0.61 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.375 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.06 143.85 56.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.779 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.6 t -67.49 -50.95 56.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.437 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 2.4 mp0 -50.77 -42.39 57.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.355 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HA ' HG22 ' A' ' 21' ' ' VAL . 63.6 t -70.91 -53.85 20.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 120.914 0.387 . . . . 0.0 110.731 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 mp -58.8 -15.42 12.24 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.425 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.0 m -90.4 -40.56 11.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.074 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -60.27 -40.13 89.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.386 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -92.56 14.57 16.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 54.0 25.83 5.82 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.638 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.693 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.6 mm -61.43 120.78 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.175 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.3 p -140.69 56.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.075 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.68 45.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.64 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 29.8 m-80 51.29 43.62 29.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.192 0.52 . . . . 0.0 110.539 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.693 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.8 m -70.21 152.79 43.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.544 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.582 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.8 mt -119.11 117.88 55.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.524 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 70.7 m -105.56 133.37 50.42 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.592 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.3 tp -109.89 104.77 13.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.905 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.0 t80 -98.4 124.21 42.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.459 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.516 HH12 HD12 ' A' ' 116' ' ' LEU . 4.9 mtm180 -106.32 83.29 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.85 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 tp -25.48 -59.4 0.07 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.024 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.551 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.75 -67.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 123.505 0.503 . . . . 0.0 112.305 -179.324 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.06 4.96 51.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.935 0.398 . . . . 0.0 111.012 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.8 m120 53.78 29.21 9.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.636 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.469 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 11.7 mm-40 -74.27 159.89 31.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.682 0.277 . . . . 0.0 110.882 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -146.1 95.18 2.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.867 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.629 ' HG ' HD22 ' A' ' 114' ' ' ASN . 2.0 mm? -84.35 135.73 34.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.414 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -114.07 96.01 5.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.628 HD21 HD13 ' A' ' 102' ' ' ILE . 4.1 tt -79.44 79.38 5.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.451 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.0 mt-10 -82.34 -162.89 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.653 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.587 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 5.1 m-20 -50.62 -39.39 50.17 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.091 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.43 -15.09 0.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.265 0.555 . . . . 0.0 110.112 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.423 ' N ' ' C ' ' A' ' 96' ' ' ASP . 42.9 m-20 -132.11 -13.45 3.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.566 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.587 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 27.7 mm -91.5 -39.41 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -47.52 -42.52 23.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.909 0.385 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.8 t -129.69 44.39 2.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.28 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.628 HD13 HD21 ' A' ' 94' ' ' LEU . 6.7 tp -67.1 144.37 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.584 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.414 ' N ' HG13 ' A' ' 102' ' ' ILE . 9.5 m-20 -136.98 149.04 47.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.35 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.878 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.88 -34.63 9.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.052 0.453 . . . . 0.0 110.408 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.2 m -63.88 -48.02 78.34 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.537 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -59.73 -57.41 13.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.308 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.723 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.7 -54.99 22.21 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.039 0.447 . . . . 0.0 110.064 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.0 m -59.5 -28.67 67.25 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.775 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.511 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -72.07 -67.06 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.142 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -43.05 -43.14 4.2 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.196 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.431 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -63.69 -54.64 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.81 -19.56 6.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.248 0.547 . . . . 0.0 110.301 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.511 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.41 -37.03 9.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.814 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.629 HD22 ' HG ' ' A' ' 92' ' ' LEU . 90.8 m-20 -122.84 29.86 6.66 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 83.6 p -82.95 47.36 1.21 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.14 0.495 . . . . 0.0 109.846 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.516 HD12 HH12 ' A' ' 85' ' ' ARG . 53.2 mt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.265 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.901 0.381 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.8 p -156.99 142.95 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.165 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -133.6 127.94 34.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -80.55 121.99 26.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.3 p -163.73 156.65 18.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.024 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.5 t -147.93 -4.84 0.48 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.811 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -165.62 131.82 2.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.789 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.93 -87.57 1.71 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.522 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.87 99.34 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.492 2.128 . . . . 0.0 112.371 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.82 75.51 0.2 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.475 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.71 -71.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.664 0.269 . . . . 0.0 110.636 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.43 -81.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.57 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.534 ' HG3' HG12 ' A' ' 54' ' ' VAL . 9.9 pt20 -130.52 159.68 36.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.908 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.9 pt-20 -143.85 157.35 58.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.083 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.466 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 53.6 Cg_endo -70.18 141.14 42.78 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.569 2.179 . . . . 0.0 112.415 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 m -62.33 151.88 35.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.497 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.67 88.8 4.74 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.007 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.606 HD22 ' HA ' ' A' ' 24' ' ' ALA . 44.1 mt -80.73 71.79 7.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.372 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.7 p -69.65 -6.07 28.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.236 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -138.68 147.18 42.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.005 0.431 . . . . 0.0 111.764 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.613 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.2 t -54.66 -49.38 91.66 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.561 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.33 -47.31 22.8 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.985 1.79 . . . . 0.0 112.009 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.12 -34.4 77.54 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.24 0.543 . . . . 0.0 110.281 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.31 -59.48 4.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.207 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.8 mtm -60.67 -26.07 66.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.105 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -70.91 -51.0 28.78 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.771 0.32 . . . . 0.0 110.493 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.412 ' O ' HG22 ' A' ' 31' ' ' THR . 7.9 m-85 -60.64 -31.97 71.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.852 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.528 HD11 HD12 ' A' ' 36' ' ' ILE . 49.7 mt -73.96 -36.52 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.037 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.93 -20.94 59.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.815 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.19 30.98 1.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.579 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.8 t -169.72 151.48 4.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.388 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.644 ' HG3' HG13 ' A' ' 87' ' ' VAL . 31.2 tt0 -72.17 -40.76 67.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.632 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 83' ' ' LEU . 20.5 t -129.7 130.96 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.893 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -135.64 128.67 31.54 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 83' ' ' LEU . 41.2 t -116.5 128.03 73.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.532 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.528 HD12 HD11 ' A' ' 28' ' ' ILE . 26.2 mt -134.02 137.19 52.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.607 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.33 96.29 1.66 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.638 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.0 m-85 -82.68 89.24 6.72 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.0 m-85 -108.98 140.35 42.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -88.43 -1.91 58.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.6 t70 -156.85 124.04 5.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.621 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.7 mt -93.4 47.34 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.152 0.501 . . . . 0.0 111.408 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 37.0 mt-10 -137.07 6.88 2.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.841 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.832 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.4 pt -90.24 156.55 46.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.177 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.516 ' O ' HD12 ' A' ' 49' ' ' ILE . 71.2 Cg_exo -51.5 -26.14 21.15 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.858 2.372 . . . . 0.0 113.255 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.832 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.01 -35.72 82.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.626 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.3 t -64.12 -55.14 34.06 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.66 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.0 Cg_exo -60.93 -37.74 74.72 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.987 1.791 . . . . 0.0 111.321 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.88 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.6 mt -65.58 -36.45 77.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.921 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.626 ' O ' HG23 ' A' ' 54' ' ' VAL . 51.3 tp -71.98 -51.61 21.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -53.89 -24.53 16.38 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.9 t -82.66 -46.63 13.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.641 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.576 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.31 -25.44 64.16 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.403 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.2 t -52.92 -50.01 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.036 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -76.73 -9.53 58.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.76 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.3 mtpp -93.79 -19.28 21.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.121 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.621 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 59.5 m-85 -135.66 62.9 50.92 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.511 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.42 -40.42 71.27 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.724 2.283 . . . . 0.0 111.733 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.29 -41.51 98.39 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.539 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.4 t -65.56 147.06 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.579 ' CB ' HG21 ' A' ' 31' ' ' THR . 36.0 t -84.27 96.75 9.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.997 0.427 . . . . 0.0 110.839 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.466 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.2 p90 -65.24 121.83 15.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.216 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.458 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -141.37 163.32 26.8 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.118 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -161.68 143.3 3.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.5 t -146.97 157.81 43.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.139 0.495 . . . . 0.0 111.753 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.461 HG21 ' HG ' ' A' ' 42' ' ' LEU . 76.8 p -140.67 3.53 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.63 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -74.74 142.36 44.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.593 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.3 t -64.31 -49.05 73.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.45 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -50.66 -45.3 57.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.494 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.502 ' HA ' HG22 ' A' ' 21' ' ' VAL . 74.3 t -70.15 -53.21 24.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.86 0.362 . . . . 0.0 110.772 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.55 -15.04 9.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.25 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.4 m -91.72 -41.28 10.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.457 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -61.57 -36.23 80.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.579 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -94.2 9.76 36.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.947 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.0 t30 60.28 20.39 9.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.667 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.701 HG23 ' HB ' ' A' ' 80' ' ' THR . 36.7 mm -56.88 123.21 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.097 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.3 p -143.37 60.5 1.4 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.26 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.59 45.9 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.633 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 29.8 m-80 51.41 43.38 29.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.181 0.515 . . . . 0.0 110.403 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.701 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.7 m -69.55 150.63 46.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.716 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.607 HG12 ' HA2' ' A' ' 37' ' ' GLY . 57.3 mt -117.23 118.28 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.076 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.4 m -107.94 131.42 54.56 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.571 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.1 tp -107.54 103.47 12.8 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.622 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.3 t80 -97.73 119.27 36.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.872 0.368 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.511 HH12 HD12 ' A' ' 116' ' ' LEU . 4.3 mtm180 -101.44 98.41 8.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.028 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.0 tp -43.28 -52.38 5.77 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.907 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.644 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.59 -62.18 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.548 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.427 ' HB2' HH21 ' A' ' 85' ' ' ARG . 6.2 m-20 -99.3 9.5 43.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.426 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 85' ' ' ARG . 18.5 m120 50.26 32.75 6.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.747 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 11.7 mm-40 -78.23 162.98 26.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.718 0.294 . . . . 0.0 111.006 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.96 98.06 2.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.66 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.571 HD23 ' HG ' ' A' ' 83' ' ' LEU . 1.7 mm? -88.14 123.85 33.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.664 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -103.21 98.12 8.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 102' ' ' ILE . 4.7 tt -82.05 77.0 8.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.2 mt-10 -78.04 -165.53 0.67 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.5 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.5 OUTLIER -45.56 -52.43 10.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.279 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -46.01 -18.33 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.874 0.369 . . . . 0.0 111.198 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 96' ' ' ASP . 14.8 m-20 -124.78 -13.94 6.84 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.348 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.576 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.1 mm -90.72 -42.39 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -49.74 -33.41 16.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.9 t -129.58 37.81 3.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.492 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.541 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.0 tp -66.61 143.66 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.541 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -138.59 148.5 44.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.32 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.88 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.13 -36.75 8.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 110.349 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 100.0 m -62.43 -47.12 85.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.423 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -61.3 -58.44 8.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.4 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.773 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.83 -55.35 17.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.946 0.403 . . . . 0.0 110.169 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.5 m -58.71 -31.23 68.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.975 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.552 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.1 tmt_? -70.57 -66.28 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.267 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -43.29 -43.01 4.7 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.331 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.45 HG12 HG21 ' A' ' 35' ' ' VAL . 96.7 mt -63.1 -55.01 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -53.84 -22.26 9.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.374 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.552 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -85.27 -38.59 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.889 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.502 ' OD1' HG22 ' A' ' 113' ' ' ILE . 30.8 m120 -118.29 27.73 8.78 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.4 p -80.82 46.18 0.87 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.026 0.441 . . . . 0.0 110.278 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.511 HD12 HH12 ' A' ' 85' ' ' ARG . 48.4 mt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.138 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.873 0.368 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.499 HG23 ' HG3' ' A' ' 3' ' ' GLU . 24.3 m -103.32 -15.82 7.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.09 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.499 ' HG3' HG23 ' A' ' 2' ' ' VAL . 40.9 mt-10 -137.53 -66.32 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.762 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm 64.14 144.31 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.242 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.2 t 61.98 176.09 0.13 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.161 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.4 t -66.24 -71.91 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -145.14 147.37 32.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.851 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.91 -83.87 0.05 OUTLIER Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.57 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.17 118.15 4.98 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.543 2.162 . . . . 0.0 112.388 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.73 162.45 10.83 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.547 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.95 -72.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.709 0.29 . . . . 0.0 110.618 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.44 ' HB1' ' NE2' ' A' ' 55' ' ' GLN . . . 59.1 106.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.75 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.566 HE21 HG12 ' A' ' 54' ' ' VAL . 11.6 pt20 -59.5 165.85 2.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.099 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.5 pt-20 -133.21 157.9 77.09 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.761 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 31.5 Cg_endo -64.67 152.0 83.54 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.642 2.228 . . . . 0.0 112.778 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 17' ' ' TRP . 39.8 m -68.34 154.24 42.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.605 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.41 ' N ' HG22 ' A' ' 16' ' ' THR . 92.8 m95 -99.44 92.2 5.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.898 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.606 HD22 ' HA ' ' A' ' 24' ' ' ALA . 55.8 mt -91.41 70.98 6.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.702 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.2 p -72.6 -1.4 15.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.908 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -140.71 147.03 38.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 111.782 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.2 t -56.22 -50.21 88.79 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.567 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.1 Cg_endo -57.98 -45.29 33.17 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.924 1.75 . . . . 0.0 111.802 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.92 -34.11 77.23 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.25 0.547 . . . . 0.0 110.408 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.55 -58.8 5.37 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.947 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.6 mtp -60.14 -27.53 67.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.194 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 27.9 mt-10 -72.08 -51.04 23.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.707 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.498 ' O ' HG22 ' A' ' 31' ' ' THR . 6.0 m-85 -59.5 -32.76 70.58 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.544 HD11 HD12 ' A' ' 36' ' ' ILE . 42.4 mt -74.79 -38.85 45.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.97 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.52 -18.91 61.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.215 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.49 27.03 3.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.311 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.722 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.4 t -171.86 155.2 3.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.491 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.572 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.3 tt0 -64.79 -73.81 0.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.531 HG13 HD11 ' A' ' 83' ' ' LEU . 21.1 t -99.23 139.1 21.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.568 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.02 127.96 19.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 111' ' ' ILE . 49.9 t -116.68 129.23 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.59 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.544 HD12 HD11 ' A' ' 28' ' ' ILE . 20.7 mt -135.02 137.87 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.466 -177.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.11 97.17 1.63 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.593 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.479 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 42.0 m-85 -83.13 89.92 7.0 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -108.28 143.13 37.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.351 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -89.87 -6.6 55.65 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.507 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.6 t70 -151.62 119.81 6.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.584 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.493 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.9 mt -88.69 45.39 1.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.218 0.532 . . . . 0.0 111.127 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 10.2 mm-40 -136.33 12.04 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.248 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.823 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.1 pt -97.04 157.8 34.4 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.426 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.502 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 79.9 Cg_exo -51.11 -30.8 33.26 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.723 2.282 . . . . 0.0 112.886 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.823 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -59.59 -38.51 81.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.401 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.669 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.3 t -61.02 -58.02 22.18 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.569 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.669 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 35.8 Cg_exo -58.31 -40.25 77.23 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.784 1.656 . . . . 0.0 111.435 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.979 HG23 ' HA ' ' A' ' 104' ' ' ALA . 9.8 mt -61.7 -35.96 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 54' ' ' VAL . 46.3 tp -73.89 -53.58 9.85 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -54.34 -24.09 17.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.007 0.432 . . . . 0.0 109.915 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.5 t -83.22 -43.78 15.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.558 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.59 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.85 -25.66 67.66 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.3 t -53.1 -48.53 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.095 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.44 ' NE2' ' HB1' ' A' ' 12' ' ' ALA . 29.3 mt-30 -75.24 -11.65 60.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.58 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -93.44 -18.49 22.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.27 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.622 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 44.9 m-85 -135.99 63.08 49.61 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.643 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.94 -44.21 50.47 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.731 2.287 . . . . 0.0 111.654 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.6 -41.69 89.67 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.473 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 14.3 t -65.64 144.7 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.722 ' HB2' HG21 ' A' ' 31' ' ' THR . 36.2 t -82.06 96.26 7.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.02 0.438 . . . . 0.0 111.012 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.485 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.6 p90 -62.6 129.3 39.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.735 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.522 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -148.13 161.36 28.58 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.058 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.438 HD11 HG13 ' A' ' 47' ' ' VAL . 5.2 tt -160.84 143.06 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.479 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 32.4 t -150.46 158.25 43.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 111.793 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.46 HG21 ' HG ' ' A' ' 42' ' ' LEU . 82.7 p -138.69 -2.72 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.642 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.402 ' O ' HD13 ' A' ' 71' ' ' LEU . 16.6 t70 -62.64 143.12 57.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.662 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.0 m -67.29 -52.57 39.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.23 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 2.6 mp0 -49.83 -40.71 42.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.409 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.523 ' HA ' HG22 ' A' ' 21' ' ' VAL . 54.9 t -72.54 -55.08 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 67' ' ' ASP . 6.3 mp -57.98 -14.29 6.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.248 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.3 m -92.41 -40.49 10.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.214 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -61.84 -35.04 77.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.224 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.43 ' HB2' HG12 ' A' ' 76' ' ' ILE . 86.9 m-85 -95.12 9.68 38.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.695 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t30 58.6 24.28 11.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.454 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.719 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.2 mm -61.28 124.19 15.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.3 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.1 p -143.68 59.49 1.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.195 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.78 44.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.706 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.632 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 26.3 m-80 52.31 44.63 29.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.188 0.518 . . . . 0.0 110.639 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.719 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.3 m -69.55 152.14 45.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.63 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.571 HG21 HD21 ' A' ' 107' ' ' LEU . 60.5 mt -118.46 115.58 48.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.07 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 77.4 m -103.4 133.25 48.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.663 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -108.71 101.54 10.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.853 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.2 t80 -95.31 121.86 37.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.568 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.478 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 4.6 mtm180 -106.6 82.04 1.67 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.908 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.422 ' HG ' ' N ' ' A' ' 87' ' ' VAL . 4.8 tp -25.46 -61.78 0.07 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.572 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.76 -54.84 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -103.84 3.97 34.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.92 0.391 . . . . 0.0 111.21 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 51.57 31.31 7.5 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.57 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 9.7 mm-40 -77.83 157.62 29.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.491 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.13 95.89 2.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.997 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.663 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -84.31 112.3 20.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.586 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.561 ' ND2' ' H ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -95.8 96.05 8.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.589 HD21 HD13 ' A' ' 102' ' ' ILE . 3.8 tt -81.73 78.93 8.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.5 mt-10 -79.8 -165.01 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -176.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.527 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.6 t70 -50.66 -37.41 40.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.988 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -55.25 -14.79 1.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.204 0.526 . . . . 0.0 110.428 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -130.74 -13.94 3.64 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.546 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.571 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 23.8 mm -89.5 -29.01 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.709 0.29 . . . . 0.0 111.413 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -52.93 -52.34 58.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.811 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.2 m -117.51 37.25 3.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.488 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.589 HD13 HD21 ' A' ' 94' ' ' LEU . 7.8 tp -61.36 147.56 10.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.596 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.449 ' HA ' ' CD1' ' A' ' 49' ' ' ILE . 4.3 t70 -140.83 161.08 38.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.621 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.979 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -58.95 -35.04 72.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.091 0.472 . . . . 0.0 110.17 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 94.0 m -65.34 -46.71 79.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.407 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -59.96 -57.15 14.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.983 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.78 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.81 -54.87 24.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.117 0.484 . . . . 0.0 110.109 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.7 m -59.18 -29.3 67.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.704 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.483 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.6 tmt_? -71.97 -66.21 0.67 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.213 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -42.86 -43.85 4.24 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.154 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.475 HG12 HG21 ' A' ' 35' ' ' VAL . 82.8 mt -63.06 -55.05 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.465 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -54.76 -17.93 4.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.14 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.483 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.96 -35.26 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.923 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.617 HD22 ' HG ' ' A' ' 92' ' ' LEU . 88.0 m-20 -125.44 30.31 5.81 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 95.5 p -84.03 51.49 2.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.066 0.46 . . . . 0.0 110.25 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.448 HD12 ' NH1' ' A' ' 85' ' ' ARG . 82.0 mt . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.421 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.764 0.316 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p -81.75 -23.68 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 110.946 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.02 -46.14 78.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.959 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -137.35 118.74 14.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.842 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.0 p -143.7 136.99 27.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.9 m -127.56 -38.98 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -116.48 -64.16 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.73 -173.75 45.56 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.437 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.95 115.58 2.23 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.688 2.259 . . . . 0.0 112.467 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.36 164.41 40.25 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.681 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.02 -63.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.75 0.309 . . . . 0.0 110.509 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.53 ' HB3' ' NE2' ' A' ' 55' ' ' GLN . . . 61.21 -82.08 0.02 OUTLIER 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.712 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.434 ' HG3' HG12 ' A' ' 54' ' ' VAL . 29.8 pt20 -140.16 147.19 39.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.117 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.504 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.0 pt-20 -131.74 159.36 72.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.638 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.1 Cg_endo -65.81 143.09 72.33 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.574 2.182 . . . . 0.0 112.672 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.5 m -63.53 153.22 36.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.676 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -96.97 93.0 6.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.012 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.603 HD13 ' HA ' ' A' ' 24' ' ' ALA . 39.4 mt -87.34 70.84 10.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.128 0.49 . . . . 0.0 110.234 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.4 p -69.9 -3.12 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.161 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -139.01 147.43 42.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.909 0.385 . . . . 0.0 111.65 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 42.1 t -56.43 -49.95 90.5 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.485 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.64 -46.0 29.87 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.974 1.783 . . . . 0.0 111.867 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.85 81.64 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.178 0.513 . . . . 0.0 110.112 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -62.54 -60.13 3.96 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.002 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 44.7 mtm -60.36 -25.82 66.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.278 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -70.92 -51.66 24.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.704 0.288 . . . . 0.0 110.418 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.407 ' O ' HG22 ' A' ' 31' ' ' THR . 13.9 m-85 -60.6 -30.79 70.04 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.526 HD11 HD12 ' A' ' 36' ' ' ILE . 53.2 mt -74.38 -37.52 45.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.023 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.93 -19.67 60.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.16 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.53 30.96 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.079 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.694 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.2 t -172.35 152.97 2.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.426 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.511 ' HG3' HG13 ' A' ' 87' ' ' VAL . 26.8 tt0 -68.88 -47.07 66.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.77 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.494 HG13 HD11 ' A' ' 83' ' ' LEU . 18.5 t -122.22 139.48 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.432 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.512 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -143.13 125.95 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.529 HG21 HG12 ' A' ' 111' ' ' ILE . 49.5 t -114.39 128.77 71.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.424 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 28' ' ' ILE . 29.2 mt -134.88 137.57 50.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.421 -177.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.23 96.41 1.6 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.587 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.449 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.7 m-85 -82.89 91.27 7.08 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.633 ' HB3' HD22 ' A' ' 79' ' ' ASN . 11.5 m-85 -111.03 144.35 40.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.453 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.525 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 45.8 mt-30 -92.98 -2.55 55.66 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.484 ' O ' HG12 ' A' ' 44' ' ' ILE . 28.6 t70 -155.97 117.13 3.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.582 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.484 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.2 mt -87.31 45.5 1.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.116 0.484 . . . . 0.0 111.604 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 38.6 mt-10 -134.59 10.76 3.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.037 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.688 HG13 HG23 ' A' ' 47' ' ' VAL . 7.2 pt -92.31 161.33 33.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.293 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.498 ' O ' HD12 ' A' ' 49' ' ' ILE . 50.1 Cg_exo -56.81 -26.52 66.97 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.739 2.293 . . . . 0.0 112.369 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.673 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.67 -37.78 88.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.482 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.688 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -61.23 -56.66 32.04 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.642 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.87 -38.61 78.4 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.864 1.709 . . . . 0.0 111.423 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.864 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.6 mt -64.12 -35.09 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.869 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 54' ' ' VAL . 49.7 tp -74.03 -52.47 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -55.53 -23.2 25.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.036 0.446 . . . . 0.0 109.853 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.6 t -83.78 -44.73 14.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.445 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.614 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.6 -25.77 67.55 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -52.79 -49.5 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.036 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.53 ' NE2' ' HB3' ' A' ' 12' ' ' ALA . 41.3 mt-30 -74.41 -11.67 60.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.7 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -93.38 -19.04 21.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.305 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.555 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 54.8 m-85 -137.16 61.99 36.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.399 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.73 -42.16 68.46 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.684 2.256 . . . . 0.0 111.615 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.86 -39.84 88.84 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.212 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.555 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.5 t -67.71 143.37 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.694 ' HB2' HG21 ' A' ' 31' ' ' THR . 47.1 t -80.14 98.37 7.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.022 0.439 . . . . 0.0 110.967 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.51 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.3 p90 -65.99 124.73 23.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.968 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.47 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -143.71 162.01 27.73 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.171 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -161.8 142.73 3.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.449 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 41.0 t -149.04 156.51 42.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.194 0.521 . . . . 0.0 111.809 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 68.2 p -137.15 3.05 2.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.481 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.413 ' O ' HD13 ' A' ' 71' ' ' LEU . 17.7 t70 -69.92 142.97 52.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.685 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.9 m -67.34 -50.92 58.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.351 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -51.11 -40.94 59.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.364 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.531 ' HA ' HG22 ' A' ' 21' ' ' VAL . 53.7 t -72.48 -54.68 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.358 . . . . 0.0 110.539 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -58.41 -14.64 8.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.099 0.476 . . . . 0.0 110.255 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.5 m -91.78 -40.35 11.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.239 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -62.08 -34.36 76.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.267 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.415 ' HB2' HG12 ' A' ' 76' ' ' ILE . 84.9 m-85 -96.63 10.88 37.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.72 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 56.01 26.65 10.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.867 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.716 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.1 mm -62.7 122.19 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.4 p -141.8 59.16 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 111.259 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.52 44.65 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.521 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.633 HD22 ' HB3' ' A' ' 39' ' ' PHE . 13.8 m120 51.48 44.18 29.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.141 0.496 . . . . 0.0 110.635 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.716 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.0 m -69.72 151.67 45.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.836 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.565 HG12 ' HA2' ' A' ' 37' ' ' GLY . 55.8 mt -117.6 116.74 52.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.813 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 74.8 m -104.28 132.79 50.14 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.643 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -109.63 101.98 10.85 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.866 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -96.38 122.78 39.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.538 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.479 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 4.0 mtm180 -106.31 86.37 2.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.857 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.1 tp -27.05 -60.54 0.09 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.511 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.91 -73.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 123.434 0.459 . . . . 0.0 112.149 -179.273 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -83.51 2.89 34.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.014 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.9 m120 53.75 30.07 10.6 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.42 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.479 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 8.0 mm-40 -74.46 159.25 32.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.805 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -144.16 93.31 2.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.823 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.643 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -80.91 141.83 34.16 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -122.85 92.81 3.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.643 HD21 HD13 ' A' ' 102' ' ' ILE . 4.0 tt -76.99 77.43 3.54 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.444 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.2 mt-10 -79.08 -164.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.508 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 23.7 t70 -51.66 -36.38 46.08 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.915 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.68 -14.65 3.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.282 0.563 . . . . 0.0 110.244 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -130.65 -13.83 3.7 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.694 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.578 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.1 mm -89.94 -30.0 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.727 0.298 . . . . 0.0 111.294 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -52.12 -48.52 64.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.746 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.9 t -123.78 42.08 3.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.414 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.643 HD13 HD21 ' A' ' 94' ' ' LEU . 7.9 tp -63.46 143.14 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.545 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -136.03 150.56 49.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.487 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.864 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.07 -33.85 12.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.034 0.445 . . . . 0.0 110.26 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.3 m -65.35 -47.31 76.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.438 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -60.05 -56.34 22.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.149 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.793 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -52.36 -57.14 10.72 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.959 0.409 . . . . 0.0 109.905 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 61.4 m -56.87 -28.91 62.42 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.869 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.474 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.7 tmt_? -71.04 -66.88 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.954 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -42.3 -41.17 2.7 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.156 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.529 HG12 HG21 ' A' ' 35' ' ' VAL . 76.8 mt -64.91 -55.77 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -54.24 -18.01 3.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.253 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.474 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.5 mp -92.56 -34.58 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.12 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.629 HD22 ' HG ' ' A' ' 92' ' ' LEU . 85.5 m-20 -128.31 32.69 4.83 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 93.8 p -85.17 41.84 0.9 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.164 0.507 . . . . 0.0 109.918 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 85' ' ' ARG . 49.9 mt . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.527 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.402 ' HG3' HG13 ' A' ' 2' ' ' VAL . 10.2 pt-20 . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.402 HG13 ' HG3' ' A' ' 1' ' ' GLU . 27.7 m -118.17 20.83 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.167 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 58.55 34.2 23.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.153 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt 60.51 -85.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.284 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.9 p 47.48 80.05 0.06 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.27 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.1 m -99.37 31.12 3.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.964 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.44 -47.46 17.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.39 -104.57 0.26 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.603 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.11 -67.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.489 2.126 . . . . 0.0 112.315 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.13 81.01 0.13 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.504 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' A' ' 55' ' ' GLN . . . -164.42 -67.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.345 . . . . 0.0 110.647 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.527 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . . . 59.42 94.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.454 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.522 ' HG3' ' CG1' ' A' ' 54' ' ' VAL . 1.3 pt20 -170.48 166.74 8.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.627 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 -114.63 158.5 40.11 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.249 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.48 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.7 Cg_endo -68.23 155.38 69.58 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.768 2.312 . . . . 0.0 112.741 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.7 m -70.71 151.61 44.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.416 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -96.79 86.36 4.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.755 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.0 mt -83.34 71.52 10.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.619 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 76.8 p -69.21 -6.2 27.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.288 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -140.05 146.97 39.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.993 0.425 . . . . 0.0 111.791 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.615 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.5 t -54.34 -49.74 88.82 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.632 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.8 Cg_endo -56.58 -46.46 29.81 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.984 1.789 . . . . 0.0 112.082 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.23 -34.47 78.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.173 0.511 . . . . 0.0 110.288 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.61 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.88 -58.88 5.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.081 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 61.3 mtp -61.39 -27.16 68.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.189 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.5 mt-10 -70.64 -49.89 42.7 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.772 0.32 . . . . 0.0 110.386 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 31' ' ' THR . 5.9 m-85 -60.5 -33.14 72.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.846 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.527 HD11 ' CD1' ' A' ' 36' ' ' ILE . 46.0 mt -73.86 -37.66 48.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.127 178.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.66 -20.75 60.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.128 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.1 29.77 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.059 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.638 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.9 t -171.25 150.86 3.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.333 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.527 ' HG3' HG13 ' A' ' 87' ' ' VAL . 25.1 tt0 -64.58 -63.32 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.91 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.484 HG13 HD11 ' A' ' 83' ' ' LEU . 21.4 t -108.04 141.9 22.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.592 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -144.08 126.52 15.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.021 0.439 . . . . 0.0 112.109 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.468 HG21 HG12 ' A' ' 111' ' ' ILE . 47.8 t -115.47 127.53 73.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.622 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.527 ' CD1' HD11 ' A' ' 28' ' ' ILE . 26.7 mt -133.71 136.4 54.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.728 -177.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.498 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.71 97.69 1.82 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.347 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.443 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 38.8 m-85 -83.49 89.67 7.11 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -108.35 141.3 40.36 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.448 ' HG2' HD23 ' A' ' 71' ' ' LEU . 24.8 mt-30 -89.62 -2.69 58.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.522 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.9 t70 -155.37 117.51 4.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.581 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.512 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.3 mt -86.99 43.67 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.054 0.454 . . . . 0.0 111.343 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.1 mt-10 -134.61 13.14 3.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.121 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.825 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.0 pt -96.92 157.62 34.78 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.266 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.473 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 76.4 Cg_exo -51.6 -28.67 29.82 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.834 2.356 . . . . 0.0 112.888 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.825 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -61.95 -37.58 85.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.668 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.7 t -61.33 -56.77 30.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.606 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.668 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 39.5 Cg_exo -57.52 -42.4 61.37 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 121.742 1.628 . . . . 0.0 111.125 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.908 HG23 ' HA ' ' A' ' 104' ' ' ALA . 11.8 mt -60.0 -37.71 73.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.215 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.596 ' O ' HG23 ' A' ' 54' ' ' VAL . 47.2 tp -73.32 -51.71 16.53 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -54.8 -24.37 22.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.087 0.47 . . . . 0.0 109.858 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.3 m -83.84 -44.59 14.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.585 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.591 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.68 -25.91 66.72 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.372 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 50' ' ' LEU . 45.2 t -51.99 -47.0 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.898 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.527 ' NE2' ' HA ' ' A' ' 12' ' ' ALA . 30.7 mt-30 -78.89 -13.47 59.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.712 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -90.89 -17.09 27.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.308 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.61 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 44.0 m-85 -137.95 62.93 35.89 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.558 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.18 -44.4 49.21 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.703 2.269 . . . . 0.0 111.754 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.86 -37.16 76.46 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.515 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.61 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 17.2 t -70.18 143.6 14.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.638 ' HB2' HG21 ' A' ' 31' ' ' THR . 45.6 t -81.37 97.94 7.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 110.886 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.481 ' HB3' HG22 ' A' ' 54' ' ' VAL . 4.9 p90 -64.18 129.2 39.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.828 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.538 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.51 161.06 28.46 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.128 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -161.26 145.69 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.407 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 40.1 t -154.06 159.53 41.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.069 0.461 . . . . 0.0 111.727 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.481 HG21 ' HG ' ' A' ' 42' ' ' LEU . 58.3 p -138.84 -7.66 1.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.693 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.06 141.45 55.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.706 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.0 p -64.39 -50.11 68.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.38 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -49.81 -44.46 49.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.543 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.539 ' HA ' HG22 ' A' ' 21' ' ' VAL . 70.6 t -70.05 -54.61 18.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.956 0.408 . . . . 0.0 110.674 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.448 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.1 mp -58.38 -14.42 7.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.437 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.1 m -91.3 -42.01 10.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.339 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -60.26 -37.38 80.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.367 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.424 ' HB2' HG12 ' A' ' 76' ' ' ILE . 83.0 m-85 -93.72 12.49 25.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.979 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 55.64 26.77 9.63 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.674 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.692 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.0 mm -64.16 123.5 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.174 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.7 p -142.16 58.35 1.47 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.286 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.42 ' HA3' ' OD1' ' A' ' 96' ' ' ASP . . . 152.7 44.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.947 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 27.4 m-80 52.61 42.53 31.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.244 0.545 . . . . 0.0 110.492 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.692 ' HB ' HG23 ' A' ' 76' ' ' ILE . 90.1 m -68.83 151.34 46.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.43 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.542 HG21 HD21 ' A' ' 107' ' ' LEU . 62.2 mt -117.13 116.76 53.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.199 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.443 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 74.2 m -105.45 133.83 49.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.611 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.2 tp -109.59 103.39 12.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.971 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.4 t80 -96.47 124.44 40.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.693 0.283 . . . . 0.0 110.749 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.466 ' NH1' HD12 ' A' ' 116' ' ' LEU . 3.5 mtm180 -107.95 85.52 2.13 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.11 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 tp -27.13 -60.57 0.09 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.527 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -35.84 -68.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 123.574 0.546 . . . . 0.0 112.289 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -89.77 3.65 52.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.165 0.507 . . . . 0.0 110.715 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.4 t30 51.85 37.37 20.48 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.986 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 11.0 mm-40 -81.84 159.06 23.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.563 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -140.9 90.83 2.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.667 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.611 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.8 mm? -77.75 141.87 39.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.61 116.84 26.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.253 0.549 . . . . 0.0 112.023 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.626 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -104.32 77.94 1.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 mt-10 -80.61 -164.27 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.827 -177.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.621 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 7.2 m-20 -49.74 -41.1 43.05 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.294 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -52.17 -15.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.256 0.55 . . . . 0.0 110.143 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.417 ' N ' ' C ' ' A' ' 96' ' ' ASP . 36.2 m-20 -130.86 -13.38 3.64 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.321 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.621 ' HB ' ' HA ' ' A' ' 96' ' ' ASP . 26.8 mm -90.96 -42.13 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.488 ' HG3' ' HB3' ' A' ' 96' ' ' ASP . 43.4 mt-10 -48.49 -37.96 18.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.936 0.398 . . . . 0.0 111.055 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.5 p -130.43 45.16 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.375 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.626 HD13 HD21 ' A' ' 94' ' ' LEU . 8.6 tp -71.95 145.17 12.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.785 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -138.61 149.4 45.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.649 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.908 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.0 -36.47 12.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.018 0.437 . . . . 0.0 110.609 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.4 m -61.53 -48.61 80.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.202 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 102' ' ' ILE . 28.9 mtpp -59.05 -60.68 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.149 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.779 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.41 -55.93 9.53 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.953 0.406 . . . . 0.0 110.315 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.8 m -58.08 -30.38 66.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.787 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.502 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.2 tmt_? -71.03 -65.91 0.68 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.209 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -43.17 -44.06 4.93 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.921 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.468 HG12 HG21 ' A' ' 35' ' ' VAL . 96.4 mt -62.61 -56.41 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.445 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.86 -18.39 3.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.316 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.502 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.95 -37.25 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.925 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -123.64 29.01 6.72 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 98.2 p -83.04 51.6 1.98 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.217 0.532 . . . . 0.0 109.915 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.466 HD12 ' NH1' ' A' ' 85' ' ' ARG . 68.1 mt . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.397 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.449 ' HG3' HG13 ' A' ' 2' ' ' VAL . 11.2 pt-20 . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.721 0.296 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.449 HG13 ' HG3' ' A' ' 1' ' ' GLU . 14.8 m -110.65 11.66 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.371 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -89.04 -59.67 2.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.503 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -128.25 21.8 6.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.612 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.2 m 59.4 33.84 22.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.852 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.4 m -84.94 138.42 32.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -138.96 -27.99 0.81 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.961 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.46 -170.86 45.95 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.716 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -52.0 106.32 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.675 2.25 . . . . 0.0 112.491 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.76 -171.29 35.94 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.64 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 55' ' ' GLN . . . -170.85 -61.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 110.516 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.84 93.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.519 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.471 ' HG3' ' CG1' ' A' ' 54' ' ' VAL . 3.7 pt20 -171.44 165.52 6.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.554 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.474 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 -116.03 157.71 44.32 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-O 120.779 0.323 . . . . 0.0 111.339 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 31.8 Cg_endo -66.0 152.79 80.44 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.967 2.444 . . . . 0.0 112.794 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.44 HG22 ' N ' ' A' ' 17' ' ' TRP . 18.8 m -69.36 157.16 37.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.825 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.44 ' N ' HG22 ' A' ' 16' ' ' THR . 8.4 m-90 -99.52 92.91 5.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.962 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.0 mt -91.62 72.69 5.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.359 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 p -71.24 -5.38 31.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.334 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -137.46 147.4 45.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.935 0.398 . . . . 0.0 111.72 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.598 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 48.9 t -56.05 -50.05 89.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.568 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.8 Cg_endo -57.91 -45.4 32.74 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.896 1.731 . . . . 0.0 112.027 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.52 -36.08 82.59 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.259 0.552 . . . . 0.0 110.439 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.608 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.82 -59.32 4.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.952 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.4 mtm -60.05 -25.45 65.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.076 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -72.12 -51.46 21.34 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.39 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 31' ' ' THR . 9.0 m-85 -59.75 -30.45 68.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.555 HD11 HD12 ' A' ' 36' ' ' ILE . 49.3 mt -75.78 -40.43 39.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.242 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.51 -21.47 61.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.243 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.76 27.32 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.292 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.677 HG21 ' HB2' ' A' ' 61' ' ' SER . 7.7 t -170.86 155.66 4.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.578 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.462 ' HG3' HG13 ' A' ' 87' ' ' VAL . 25.5 tt0 -68.08 -62.31 1.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.51 HG13 HD11 ' A' ' 83' ' ' LEU . 16.6 t -108.56 137.78 38.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.715 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.13 127.49 18.8 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.468 HG21 HG12 ' A' ' 111' ' ' ILE . 47.6 t -116.39 130.06 71.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.7 178.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.555 HD12 HD11 ' A' ' 28' ' ' ILE . 25.7 mt -136.11 136.91 49.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.597 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.76 99.51 2.08 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.476 -0.783 . . . . 0.0 112.586 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.519 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.6 m-85 -86.07 92.72 8.8 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -112.29 142.01 45.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.47 ' HG2' HD23 ' A' ' 71' ' ' LEU . 46.6 mt-30 -90.61 -0.78 57.8 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 44' ' ' ILE . 30.1 t70 -156.51 121.17 4.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.453 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.535 ' HA ' HG21 ' A' ' 47' ' ' VAL . 96.8 mt -92.13 46.49 1.27 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.057 0.456 . . . . 0.0 111.554 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 39.9 mt-10 -136.24 7.21 3.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.952 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.797 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.0 pt -89.27 157.07 48.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.164 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.501 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.7 Cg_exo -51.72 -27.02 25.05 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.828 2.352 . . . . 0.0 113.034 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.797 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.75 -37.38 87.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.668 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -62.0 -55.96 36.16 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 121.044 -0.263 . . . . 0.0 111.707 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.644 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -60.12 -37.93 80.49 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.103 1.868 . . . . 0.0 111.486 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.88 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.7 mt -65.31 -35.82 76.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.18 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.585 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.4 tp -73.42 -50.45 21.69 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -54.52 -24.68 21.73 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -82.4 -46.68 13.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.798 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.581 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.15 -26.0 64.37 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 50' ' ' LEU . 48.6 t -52.72 -49.11 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.213 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 7.4 mt-30 -77.89 -9.01 58.85 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.571 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.3 mtpp -94.7 -18.92 20.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.235 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.606 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 54.3 m-85 -137.57 63.19 39.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.36 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.13 -41.32 72.91 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.713 2.275 . . . . 0.0 111.575 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.43 -42.72 95.91 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.283 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.3 t -64.87 142.94 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.677 ' HB2' HG21 ' A' ' 31' ' ' THR . 25.2 t -80.37 96.44 6.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.13 0.49 . . . . 0.0 110.943 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.52 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.1 p90 -65.97 125.87 26.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.912 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.55 163.03 28.26 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.983 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -160.02 141.9 4.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.7 t -145.36 158.87 43.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.117 0.484 . . . . 0.0 111.594 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 39' ' ' PHE . 69.0 p -141.37 -6.2 1.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.823 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.71 142.21 58.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.686 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.0 t -63.35 -48.45 77.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.665 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -49.7 -47.18 50.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.577 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.5 t -69.6 -52.66 30.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.779 0.323 . . . . 0.0 110.85 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.47 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.38 -14.71 8.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.084 0.469 . . . . 0.0 110.304 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.5 m -91.0 -42.48 10.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.396 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -60.21 -38.53 83.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.469 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -91.64 9.7 31.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 58.82 21.88 9.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.397 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.668 HD12 ' HB ' ' A' ' 80' ' ' THR . 36.0 mm -57.78 117.91 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.047 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.2 p -137.34 48.68 2.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.467 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 162.69 48.1 0.02 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.426 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 24.2 m-80 49.22 42.38 21.52 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.321 0.582 . . . . 0.0 110.313 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.668 ' HB ' HD12 ' A' ' 76' ' ' ILE . 92.8 m -68.15 152.41 45.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.687 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.597 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.3 mt -119.36 118.82 58.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.979 178.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.519 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 79.7 m -106.97 133.11 52.12 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.663 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -109.46 103.44 12.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.8 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.5 t80 -97.51 123.44 41.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.763 0.316 . . . . 0.0 110.713 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.463 ' NH1' HD12 ' A' ' 116' ' ' LEU . 4.1 mtm180 -106.62 84.2 1.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.741 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 85' ' ' ARG . 5.9 tp -24.96 -60.33 0.06 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.95 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.462 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.16 -73.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 O-C-N 123.488 0.493 . . . . 0.0 112.255 -179.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -84.13 0.85 46.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.988 0.423 . . . . 0.0 111.053 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.9 m120 54.0 36.68 25.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.566 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 13.2 mm-40 -82.78 158.14 22.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.736 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.4 96.49 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.632 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.663 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -85.15 114.17 22.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.817 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.72 100.41 11.79 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -85.24 76.96 10.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.413 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.2 mt-10 -77.49 -165.66 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.485 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.91 -51.63 12.88 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.383 -179.363 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -47.49 -17.35 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 96' ' ' ASP . 14.8 m-20 -124.79 -14.16 6.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.506 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.577 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.8 mm -90.11 -38.37 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -49.05 -46.15 43.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 110.942 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -118.96 39.29 3.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.617 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.54 HD13 HD21 ' A' ' 94' ' ' LEU . 7.8 tp -65.95 143.84 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 111.201 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -139.38 148.4 42.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.557 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.88 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.99 -37.8 9.71 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 110.372 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.6 m -61.62 -48.79 79.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.262 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -58.41 -60.75 3.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.279 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.744 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.41 -56.74 7.38 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.873 0.368 . . . . 0.0 110.208 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.2 m -57.75 -30.08 65.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.865 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.503 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -71.17 -65.68 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.196 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -43.05 -42.57 3.95 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.014 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.468 HG12 HG21 ' A' ' 35' ' ' VAL . 97.3 mt -63.5 -55.74 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -54.38 -18.55 4.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.32 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.503 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.63 -35.04 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.953 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.645 HD22 ' HG ' ' A' ' 92' ' ' LEU . 88.2 m-20 -126.4 30.98 5.47 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 91.6 p -83.89 42.34 0.85 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.017 0.437 . . . . 0.0 110.267 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.463 HD12 ' NH1' ' A' ' 85' ' ' ARG . 77.5 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.365 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.762 0.315 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.595 HG22 ' HG3' ' A' ' 3' ' ' GLU . 12.6 p -99.46 148.66 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.058 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.595 ' HG3' HG22 ' A' ' 2' ' ' VAL . 46.2 mt-10 56.48 78.6 0.2 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.106 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -103.37 -32.36 9.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.709 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.3 p -113.3 23.16 13.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.7 t -142.25 40.57 1.62 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -147.24 146.12 29.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -132.25 -173.99 13.49 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.408 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.14 -56.32 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.517 2.145 . . . . 0.0 112.283 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.8 82.5 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.334 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.35 -68.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 110.576 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.61 -80.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.45 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.462 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.4 pt20 -141.78 163.25 33.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.473 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.2 pt-20 -141.93 158.24 62.56 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.803 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.523 ' HD3' HG21 ' A' ' 54' ' ' VAL . 23.7 Cg_endo -63.71 147.76 92.45 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.552 2.168 . . . . 0.0 112.764 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 17' ' ' TRP . 19.9 m -61.4 155.12 22.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.581 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.406 ' N ' HG22 ' A' ' 16' ' ' THR . 9.1 m-90 -98.48 91.71 5.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.877 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 24' ' ' ALA . 43.3 mt -92.49 76.49 5.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.005 0.431 . . . . 0.0 110.471 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.8 p -74.71 -6.32 48.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.123 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -139.83 148.46 42.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.005 0.431 . . . . 0.0 111.743 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.61 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 19.6 t -54.43 -49.44 90.77 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.832 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.11 -47.31 23.36 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.087 1.858 . . . . 0.0 112.135 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.84 -35.64 80.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.217 0.532 . . . . 0.0 110.211 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.84 -59.6 4.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.105 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 59.0 mtm -60.8 -24.39 65.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.041 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -72.47 -52.22 16.78 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.704 0.288 . . . . 0.0 110.527 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.404 ' O ' HG22 ' A' ' 31' ' ' THR . 10.5 m-85 -59.69 -30.35 68.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 36' ' ' ILE . 50.0 mt -75.1 -39.01 43.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.18 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.96 -18.89 60.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.161 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.28 28.46 2.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.209 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.651 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.8 t -170.08 152.24 4.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.351 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.524 ' HG3' HG13 ' A' ' 87' ' ' VAL . 23.8 tt0 -68.32 -48.19 65.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.516 HG13 HD11 ' A' ' 83' ' ' LEU . 15.7 t -121.83 134.96 63.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.523 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.94 127.95 22.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 111.948 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.456 HG21 HG12 ' A' ' 111' ' ' ILE . 51.9 t -116.56 127.68 74.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.725 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.532 HD12 HD11 ' A' ' 28' ' ' ILE . 23.5 mt -133.24 137.13 53.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.69 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.53 99.75 2.05 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.405 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.6 m-85 -85.38 94.23 8.92 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.8 m-85 -113.89 141.63 47.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -89.35 -3.61 58.4 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.471 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.0 t70 -154.12 121.52 5.78 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.614 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.565 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.1 mt -90.9 47.28 1.4 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.081 0.467 . . . . 0.0 111.184 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 37.3 mt-10 -138.45 8.42 2.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.113 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.821 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.6 pt -91.68 156.45 42.88 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.256 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.481 ' O ' HD12 ' A' ' 49' ' ' ILE . 81.4 Cg_exo -50.74 -27.16 19.22 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.781 2.321 . . . . 0.0 113.112 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.821 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.28 -36.99 85.9 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.671 HG23 HG13 ' A' ' 44' ' ' ILE . 2.6 t -62.47 -55.4 39.82 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.703 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.2 Cg_exo -60.46 -38.63 72.39 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.985 1.79 . . . . 0.0 111.376 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.864 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.3 mt -64.93 -35.47 75.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.09 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.4 tp -73.17 -51.74 16.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 16.1 m80 -53.58 -26.7 22.73 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.154 0.502 . . . . 0.0 109.656 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.9 t -80.85 -47.1 14.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.709 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.58 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.05 -26.08 64.3 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.186 0.517 . . . . 0.0 109.608 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.1 t -53.4 -48.26 57.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.034 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -77.88 -8.52 58.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.671 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -95.25 -18.65 20.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.171 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.595 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 57.8 m-85 -136.66 63.22 45.85 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.484 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.37 -43.18 55.98 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.699 2.266 . . . . 0.0 111.465 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.0 -40.77 91.79 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.377 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.4 t -66.6 144.5 14.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.651 ' HB2' HG21 ' A' ' 31' ' ' THR . 33.0 t -83.08 96.28 8.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 110.865 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.475 ' HB3' HG22 ' A' ' 54' ' ' VAL . 7.4 p90 -63.07 130.8 46.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.937 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -149.71 161.33 28.8 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.023 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.4 tt -160.53 143.23 4.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.756 0.313 . . . . 0.0 110.207 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -146.41 160.15 42.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.215 0.531 . . . . 0.0 111.716 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.434 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.6 p -142.0 -1.95 1.2 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.562 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.03 144.78 52.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -64.9 -50.75 65.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.499 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -48.74 -46.94 41.69 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.588 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.455 ' HA ' HG22 ' A' ' 21' ' ' VAL . 75.1 t -68.84 -53.3 27.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.805 0.336 . . . . 0.0 110.88 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -58.61 -14.5 8.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.289 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.9 m -91.53 -40.56 11.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.19 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -60.91 -39.65 90.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.466 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.417 ' HB2' HG12 ' A' ' 76' ' ' ILE . 42.3 m-85 -92.24 11.62 25.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.809 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 55.34 28.57 11.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.221 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.646 HG23 ' HB ' ' A' ' 80' ' ' THR . 36.1 mm -62.44 119.2 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.076 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.5 p -140.13 58.27 1.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.17 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.31 44.56 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.433 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.583 ' HB2' HG21 ' A' ' 99' ' ' ILE . 26.1 m-80 51.65 43.36 29.91 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.183 0.516 . . . . 0.0 110.304 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.646 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.9 m -68.67 154.03 42.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.657 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.592 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.5 mt -120.94 118.81 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.034 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.509 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 81.6 m -107.6 134.62 50.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.658 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -110.69 104.68 13.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.989 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.2 t80 -98.81 122.6 42.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.788 0.328 . . . . 0.0 110.582 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.526 HH12 HD12 ' A' ' 116' ' ' LEU . 3.6 mtm180 -106.05 87.76 2.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.727 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.41 ' HB3' ' HA ' ' A' ' 32' ' ' GLU . 8.7 tp -26.93 -59.85 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.439 -0.8 . . . . 0.0 113.059 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.524 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -35.4 -80.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 O-C-N 123.542 0.526 . . . . 0.0 112.331 -179.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.436 ' HB2' HH21 ' A' ' 85' ' ' ARG . 2.7 m-20 -78.67 1.6 22.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.787 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 m120 55.91 33.25 21.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.421 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 19.7 mm-40 -77.11 159.69 29.6 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.833 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -144.17 91.61 2.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.757 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.658 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -77.63 143.52 38.17 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -124.92 96.93 5.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.536 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -83.44 79.17 9.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.9 mt-10 -80.61 -164.53 0.73 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.479 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.99 -49.69 15.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.604 -179.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -48.23 -16.6 0.1 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.773 0.321 . . . . 0.0 111.158 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -127.19 -13.94 5.52 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.556 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.583 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.2 mm -89.81 -33.15 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.729 0.299 . . . . 0.0 111.611 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -55.45 -42.03 73.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.968 0.413 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.4 m -122.53 35.16 4.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.697 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.536 HD13 HD21 ' A' ' 94' ' ' LEU . 7.0 tp -62.97 142.18 17.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.118 0.485 . . . . 0.0 111.496 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -137.45 148.3 46.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.437 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.864 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.02 -36.83 8.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.95 0.405 . . . . 0.0 110.513 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -62.68 -47.14 84.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.286 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -60.68 -61.47 2.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.11 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.82 -55.31 10.0 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.049 0.452 . . . . 0.0 110.201 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 63.5 m -58.88 -30.47 67.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.794 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.2 tmt_? -71.3 -66.35 0.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.045 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -42.01 -43.33 3.14 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.141 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.456 HG12 HG21 ' A' ' 35' ' ' VAL . 93.3 mt -63.57 -56.14 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.439 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 41.2 tt0 -53.01 -19.2 2.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.31 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.482 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.24 -38.88 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.902 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.62 HD22 ' HG ' ' A' ' 92' ' ' LEU . 88.7 m-20 -121.24 29.21 7.4 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 82.8 p -82.25 44.95 0.9 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.043 0.449 . . . . 0.0 110.039 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.526 HD12 HH12 ' A' ' 85' ' ' ARG . 55.3 mt . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.245 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.936 0.398 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.5 p -90.13 -36.58 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.265 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 52.15 82.84 0.06 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.905 0.383 . . . . 0.0 110.839 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -79.59 -19.54 49.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.235 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.6 p -148.42 97.27 2.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.125 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.5 m -75.45 122.33 23.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.615 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -91.33 -7.6 50.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.044 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.43 98.98 2.58 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.492 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.87 142.86 90.17 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.471 2.114 . . . . 0.0 112.142 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.36 64.03 0.24 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.637 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.05 -65.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.722 0.296 . . . . 0.0 110.711 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.2 -82.61 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.48 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.483 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.2 pt20 -148.99 146.99 28.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.832 0.349 . . . . 0.0 111.101 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 -133.06 158.34 76.07 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.542 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.484 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 33.8 Cg_endo -65.5 139.96 61.1 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.532 2.155 . . . . 0.0 112.588 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 17' ' ' TRP . 20.4 m -55.26 155.09 5.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.872 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.401 ' N ' HG22 ' A' ' 16' ' ' THR . 76.1 m95 -100.29 90.58 4.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.866 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.606 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.5 mt -88.83 73.72 8.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.59 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.5 p -73.56 -0.35 14.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.239 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -143.8 147.73 34.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.98 0.419 . . . . 0.0 111.591 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 31.0 t -55.6 -50.18 88.4 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.573 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.6 Cg_endo -57.83 -44.75 37.87 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.054 1.836 . . . . 0.0 111.886 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.23 -35.63 81.45 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.15 0.5 . . . . 0.0 110.351 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.93 -59.09 4.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.98 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.3 mtm -60.4 -26.73 66.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.173 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 20.2 mt-10 -71.65 -50.31 31.81 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.687 0.279 . . . . 0.0 110.658 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.569 ' O ' HG22 ' A' ' 31' ' ' THR . 9.9 m-85 -60.33 -34.27 73.58 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.564 HD11 HD12 ' A' ' 36' ' ' ILE . 47.7 mt -72.97 -38.57 56.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.032 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.97 -17.3 61.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.971 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.84 25.64 5.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.174 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.605 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.8 t -170.3 152.63 4.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.622 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.595 ' HG3' HG13 ' A' ' 87' ' ' VAL . 15.6 tt0 -61.88 -80.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.595 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.534 HG13 HD11 ' A' ' 83' ' ' LEU . 20.1 t -94.39 136.68 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.619 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.65 126.25 20.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.053 0.454 . . . . 0.0 111.883 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.501 HG21 HG12 ' A' ' 111' ' ' ILE . 47.1 t -115.07 128.02 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.752 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.564 HD12 HD11 ' A' ' 28' ' ' ILE . 23.1 mt -134.65 137.53 51.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.428 -177.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.538 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.66 98.48 1.85 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.347 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.465 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 37.7 m-85 -83.4 90.82 7.23 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.614 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 13.4 m-85 -109.16 141.77 40.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.537 -178.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.493 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 28.4 mt-30 -88.77 -7.58 55.97 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' O ' HG12 ' A' ' 44' ' ' ILE . 27.7 t70 -151.22 121.79 7.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.641 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.549 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.0 mt -90.49 46.04 1.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.108 0.48 . . . . 0.0 111.393 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 40.0 mt-10 -136.7 11.07 3.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.041 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.817 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.7 pt -95.7 155.52 38.42 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.311 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.472 ' O ' HD12 ' A' ' 49' ' ' ILE . 84.7 Cg_exo -49.75 -28.59 17.91 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.833 2.355 . . . . 0.0 113.089 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.817 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.54 -37.24 85.33 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.664 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.5 t -62.58 -56.31 31.0 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.615 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.9 Cg_exo -59.4 -39.87 72.67 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.89 1.727 . . . . 0.0 111.187 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.927 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.5 mt -63.2 -36.07 74.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.064 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.623 ' O ' HG23 ' A' ' 54' ' ' VAL . 52.0 tp -71.97 -51.42 22.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -54.94 -25.72 31.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 p -80.99 -45.2 16.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.599 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.605 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.95 -25.9 67.87 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.4 t -53.2 -49.88 49.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.913 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -75.63 -9.18 58.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.716 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -95.26 -18.99 20.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.286 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.563 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 62.4 m-85 -136.1 62.3 44.81 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.566 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.0 -45.82 36.35 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.893 2.395 . . . . 0.0 111.742 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.5 -40.3 69.08 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.403 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.7 t -67.3 143.61 15.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.605 ' HB2' HG21 ' A' ' 31' ' ' THR . 39.8 t -81.8 96.55 7.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.948 0.404 . . . . 0.0 110.965 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.484 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.6 p90 -63.82 129.67 41.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.983 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -149.14 162.3 28.94 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.143 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 15' ' ' PRO . 4.7 tt -160.26 145.39 5.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.465 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 30.9 t -151.02 155.55 39.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.229 0.538 . . . . 0.0 111.787 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.476 HG21 ' HG ' ' A' ' 42' ' ' LEU . 66.8 p -135.95 -3.56 2.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.398 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.73 139.74 58.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.505 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.0 m -64.61 -51.95 60.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.258 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -49.53 -41.53 41.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.543 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.541 ' HA ' HG22 ' A' ' 21' ' ' VAL . 59.8 t -71.77 -55.32 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.731 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.27 -14.63 7.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.365 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 79.5 m -91.98 -40.9 10.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.312 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -61.63 -36.46 80.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.326 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.432 ' HB2' HG12 ' A' ' 76' ' ' ILE . 90.1 m-85 -93.87 12.07 27.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.793 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 57.47 22.96 8.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.716 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.709 HD12 ' HB ' ' A' ' 80' ' ' THR . 40.8 mm -60.64 122.3 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.104 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.2 p -141.99 58.58 1.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.205 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.77 44.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.741 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.631 ' HB2' HG21 ' A' ' 99' ' ' ILE . 13.4 m120 52.8 43.16 31.8 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.115 0.483 . . . . 0.0 110.739 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.709 ' HB ' HD12 ' A' ' 76' ' ' ILE . 94.8 m -68.77 151.03 47.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.65 -178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.591 HG21 HD21 ' A' ' 107' ' ' LEU . 67.2 mt -117.32 116.12 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.986 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 76.9 m -104.11 133.65 48.69 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.665 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -109.43 102.55 11.42 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.941 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.4 t80 -97.5 121.76 39.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.771 0.32 . . . . 0.0 110.762 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.516 HH12 HD12 ' A' ' 116' ' ' LEU . 3.0 mtm180 -105.76 91.75 3.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.123 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 tp -38.55 -50.69 1.59 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.611 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.595 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.36 -63.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.796 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.412 ' HB2' HH21 ' A' ' 85' ' ' ARG . 9.2 m-20 -96.52 8.54 43.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.04 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 m120 51.86 31.97 9.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.615 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 20.3 mm-40 -78.82 160.82 27.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.809 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.92 91.49 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.911 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.665 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -78.42 144.65 35.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.03 99.33 6.07 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.598 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -85.29 78.31 9.81 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.454 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.4 mt-10 -78.46 -165.6 0.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.564 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.7 t70 -51.7 -35.4 42.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.004 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -56.87 -14.92 3.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.248 0.547 . . . . 0.0 110.327 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -129.94 -14.01 4.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.481 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.631 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.3 mm -89.48 -32.58 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 120.781 0.324 . . . . 0.0 111.267 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -51.7 -45.19 63.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.2 p -124.56 37.09 4.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.573 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.598 HD13 HD21 ' A' ' 94' ' ' LEU . 7.6 tp -60.6 143.18 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.787 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -137.53 149.51 46.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.523 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.927 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.08 -38.33 11.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 110.593 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.2 m -61.74 -47.78 83.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.488 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -59.02 -59.62 5.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.273 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.727 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.97 -56.52 10.34 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.08 0.467 . . . . 0.0 110.23 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 55.1 m -57.59 -30.64 65.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.844 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.9 tmt_? -70.01 -65.73 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.073 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -42.5 -44.49 4.1 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.034 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.501 HG12 HG21 ' A' ' 35' ' ' VAL . 83.3 mt -61.83 -55.78 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.453 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -54.39 -18.1 3.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.512 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.475 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.48 -36.65 8.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.929 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.621 HD22 ' HG ' ' A' ' 92' ' ' LEU . 90.4 m-20 -125.88 31.47 5.47 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.5 p -83.33 40.55 0.72 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.036 0.446 . . . . 0.0 110.307 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.516 HD12 HH12 ' A' ' 85' ' ' ARG . 59.5 mt . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.266 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 120.744 0.307 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -144.13 -22.63 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.987 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -60.38 -62.46 1.85 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.964 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -94.3 55.66 2.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.828 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -75.35 84.19 2.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.8 m -150.32 25.78 0.79 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 57.85 72.74 0.5 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.015 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.29 92.33 0.54 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.543 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.92 147.4 89.23 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.762 2.308 . . . . 0.0 112.226 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.32 102.22 0.46 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.488 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.409 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . -159.93 -21.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.824 0.345 . . . . 0.0 110.857 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.409 ' H ' ' H ' ' A' ' 11' ' ' ALA . . . -39.98 98.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.655 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.578 ' HG3' HG12 ' A' ' 54' ' ' VAL . 10.5 pt20 -47.88 140.87 6.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.229 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.3 pt-20 -110.42 157.2 38.85 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.733 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.516 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.5 Cg_endo -66.35 146.23 80.0 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.666 2.244 . . . . 0.0 112.463 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.9 m -61.35 153.61 26.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.792 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -100.34 92.57 5.24 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.754 179.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' ' 24' ' ' ALA . 47.3 mt -91.03 71.15 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.714 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.3 p -72.75 2.26 6.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.044 -179.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -143.75 146.61 33.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.841 0.353 . . . . 0.0 111.559 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 43.7 t -55.94 -50.2 88.61 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.577 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.1 Cg_endo -58.37 -45.85 28.25 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.873 1.716 . . . . 0.0 111.895 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.06 -34.32 77.34 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 110.29 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.642 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -65.42 -59.24 4.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.044 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.8 mtm -61.08 -24.2 66.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.021 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.5 mt-10 -73.91 -52.19 13.7 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.661 0.267 . . . . 0.0 110.544 179.592 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.497 ' O ' HG22 ' A' ' 31' ' ' THR . 8.2 m-85 -58.83 -31.7 68.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.558 HD11 HD12 ' A' ' 36' ' ' ILE . 49.0 mt -75.05 -40.64 45.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.938 178.074 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.16 -16.9 62.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.096 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.89 24.3 5.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.266 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.599 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.0 t -170.77 153.7 4.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.618 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.502 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.6 tt0 -63.51 -75.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.552 HG13 HD11 ' A' ' 83' ' ' LEU . 18.2 t -96.97 136.63 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.817 0.341 . . . . 0.0 110.701 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.96 124.25 16.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.79 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.489 HG11 HD11 ' A' ' 111' ' ' ILE . 51.6 t -112.49 128.87 68.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.796 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 28' ' ' ILE . 29.3 mt -134.2 137.33 52.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.554 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.62 97.22 1.68 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.199 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.473 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 41.9 m-85 -82.9 90.83 7.01 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.5 m-85 -109.91 140.63 43.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.41 -178.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.48 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 47.8 mt-30 -87.45 -9.3 55.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.459 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 17.7 t70 -148.91 123.43 9.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.53 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.499 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.8 mt -92.2 47.14 1.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.974 0.416 . . . . 0.0 111.599 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.9 mt-10 -137.94 10.47 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.113 178.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.72 HG13 HG23 ' A' ' 47' ' ' VAL . 4.1 pt -91.84 159.04 38.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.155 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.496 ' O ' HD12 ' A' ' 49' ' ' ILE . 75.4 Cg_exo -53.93 -25.41 35.71 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.693 2.262 . . . . 0.0 112.858 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.677 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.28 -41.4 94.23 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.72 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -56.67 -55.6 41.4 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.6 Cg_exo -61.01 -42.23 38.33 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.572 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.874 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.8 mt -60.34 -33.65 54.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.097 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.61 ' O ' HG23 ' A' ' 54' ' ' VAL . 46.7 tp -75.36 -52.7 10.17 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -52.57 -27.42 16.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.1 0.476 . . . . 0.0 109.763 178.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -79.76 -49.07 12.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.624 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.593 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -57.08 -26.46 60.43 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.528 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.6 t -51.67 -49.79 33.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.838 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -74.77 -16.31 60.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.679 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -88.01 -16.18 34.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.246 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.635 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 50.8 m-85 -137.56 62.43 35.99 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.447 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.52 -43.6 53.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.705 2.27 . . . . 0.0 111.671 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.8 -41.49 94.04 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.645 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.635 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 13.1 t -65.75 145.07 14.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.599 ' HB2' HG21 ' A' ' 31' ' ' THR . 36.8 t -83.64 98.27 9.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 111.016 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.516 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.3 p90 -63.86 129.07 38.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.089 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.469 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -147.39 161.17 28.46 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.071 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -161.61 144.99 4.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.473 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 37.1 t -149.57 159.14 44.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.121 0.486 . . . . 0.0 111.777 -179.124 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.465 HG21 ' HG ' ' A' ' 42' ' ' LEU . 74.3 p -139.97 -1.87 1.55 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.546 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.59 138.91 55.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.74 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 61.2 m -61.58 -51.61 67.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.672 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -48.21 -44.08 32.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.695 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.545 ' HA ' HG22 ' A' ' 21' ' ' VAL . 76.1 t -70.7 -54.96 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.908 0.385 . . . . 0.0 110.769 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.2 mp -57.59 -14.57 5.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.2 179.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.6 m -91.2 -41.15 11.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.144 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -59.71 -40.22 87.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.455 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.42 ' HB2' HG12 ' A' ' 76' ' ' ILE . 97.5 m-85 -93.33 15.07 16.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.725 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.7 m120 53.87 25.45 5.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.791 179.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.694 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.2 mm -60.33 121.41 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.002 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.9 p -140.97 57.86 1.55 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.491 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.3 44.58 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.637 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.617 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 12.5 m120 51.97 44.09 29.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.247 0.546 . . . . 0.0 110.37 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.694 ' HB ' HG23 ' A' ' 76' ' ' ILE . 91.9 m -69.14 152.79 44.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.676 -178.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.554 HG12 ' HA2' ' A' ' 37' ' ' GLY . 66.1 mt -118.89 116.75 52.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.113 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.998 177.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.472 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 74.7 m -106.45 133.02 51.79 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.628 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -107.49 103.99 13.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.899 178.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -97.05 120.37 37.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.789 0.328 . . . . 0.0 110.694 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.496 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 5.3 mtm180 -104.18 82.22 1.93 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.719 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ARG . 7.2 tp -25.19 -59.66 0.06 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.41 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.502 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.73 -64.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.295 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -93.27 3.83 54.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.922 0.391 . . . . 0.0 110.959 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 49.56 36.59 10.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.526 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 6.3 mm-40 -83.57 157.08 22.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.5 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.18 96.06 3.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.724 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.628 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -84.71 111.55 19.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.048 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.35 115.41 27.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.262 0.553 . . . . 0.0 112.308 -178.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.581 HD21 HD13 ' A' ' 102' ' ' ILE . 3.1 tt -102.61 76.84 1.56 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.5 mt-10 -78.2 -165.08 0.62 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.524 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 22.6 t70 -50.48 -38.89 46.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.174 -179.16 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -54.89 -14.62 1.52 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.142 0.496 . . . . 0.0 110.343 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -130.42 -13.81 3.82 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.721 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.563 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.1 mm -90.8 -35.1 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.701 0.286 . . . . 0.0 111.435 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.77 -43.46 65.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.914 0.388 . . . . 0.0 110.758 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.7 m -122.34 40.33 3.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.518 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.581 HD13 HD21 ' A' ' 94' ' ' LEU . 7.6 tp -67.32 143.43 15.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.687 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -138.37 148.31 44.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.536 178.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.874 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.14 -36.8 8.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.984 0.421 . . . . 0.0 110.449 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.2 m -62.07 -49.83 74.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.249 178.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -57.6 -60.96 2.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.227 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.761 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.69 -56.52 8.32 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.912 0.387 . . . . 0.0 110.44 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.7 m -58.66 -29.99 66.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.974 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.553 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.2 tmt_? -71.08 -65.33 0.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.138 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -43.44 -44.58 5.9 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.044 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.489 HD11 HG11 ' A' ' 35' ' ' VAL . 96.8 mt -62.6 -55.39 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.512 178.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.41 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 37.6 tt0 -54.36 -18.73 4.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.266 0.555 . . . . 0.0 110.305 179.392 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.553 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.44 -37.02 9.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.907 -179.136 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.561 HD22 ' HG ' ' A' ' 92' ' ' LEU . 89.6 m-20 -124.48 30.38 6.03 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 97.9 p -83.08 44.29 0.93 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.055 0.455 . . . . 0.0 110.091 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.418 HD12 HH12 ' A' ' 85' ' ' ARG . 44.4 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.33 -179.445 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.859 0.361 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.6 m -115.85 -12.57 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.332 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.23 173.81 8.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.19 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.8 tttm 62.2 -83.16 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.121 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.6 t -158.44 -81.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.771 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.0 m 52.41 83.93 0.06 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.199 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -81.28 -84.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.959 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.412 ' HA2' ' HD3' ' A' ' 9' ' ' PRO . . . 70.04 137.8 0.12 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.692 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.412 ' HD3' ' HA2' ' A' ' 8' ' ' GLY . 35.6 Cg_exo -60.35 107.48 0.42 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.507 2.138 . . . . 0.0 112.25 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.21 -169.87 32.68 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.458 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.2 -71.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.781 0.325 . . . . 0.0 110.781 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.11 107.33 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.502 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.622 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.3 pt20 -62.04 160.08 13.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.394 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.497 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.0 pt-20 -128.98 159.57 68.01 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.621 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 46.0 Cg_endo -68.51 142.57 54.3 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.531 2.154 . . . . 0.0 112.619 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.6 m -63.33 152.26 38.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.51 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 12.7 m0 -96.53 89.51 5.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.005 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 24' ' ' ALA . 54.7 mt -83.4 71.28 10.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.056 0.455 . . . . 0.0 110.39 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.6 p -71.07 -1.83 13.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.096 -179.099 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -141.42 147.28 37.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.892 0.377 . . . . 0.0 111.673 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.1 t -57.33 -49.68 92.51 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.364 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.11 -43.76 45.08 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.939 1.759 . . . . 0.0 111.743 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.23 -34.85 79.34 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.2 0.524 . . . . 0.0 110.361 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.624 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.68 -58.65 5.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.954 179.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 59.4 mtm -60.6 -27.64 67.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.135 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -71.36 -50.68 29.81 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.756 0.312 . . . . 0.0 110.677 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.534 ' O ' HG22 ' A' ' 31' ' ' THR . 4.0 m-85 -59.47 -34.77 72.96 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.246 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.555 HD11 HD12 ' A' ' 36' ' ' ILE . 48.4 mt -73.07 -39.38 57.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.103 178.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.26 -18.85 61.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.081 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.3 24.26 3.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.252 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.709 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.0 t -170.78 155.09 4.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.546 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.547 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.8 tt0 -65.53 -73.25 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG13 HD11 ' A' ' 83' ' ' LEU . 17.9 t -98.66 137.37 26.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.743 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.455 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.19 128.07 19.43 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.234 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.444 HG21 HG12 ' A' ' 111' ' ' ILE . 54.6 t -115.37 131.38 67.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.43 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.555 HD12 HD11 ' A' ' 28' ' ' ILE . 23.1 mt -136.55 136.17 48.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.64 98.16 1.89 Allowed Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.505 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.49 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.9 m-85 -83.34 89.73 7.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.595 ' HB3' HD22 ' A' ' 79' ' ' ASN . 11.0 m-85 -109.59 137.88 46.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.497 -178.018 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.449 ' HG2' HD23 ' A' ' 71' ' ' LEU . 48.8 mt-30 -85.18 -4.49 59.18 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.449 ' OD2' ' HB2' ' A' ' 43' ' ' GLU . 12.0 t70 -153.63 126.4 8.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.561 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.543 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.1 mt -95.48 48.21 1.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.112 0.482 . . . . 0.0 111.369 -179.355 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.449 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 45.2 mt-10 -137.98 8.65 2.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.808 178.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.812 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.8 pt -91.94 157.17 41.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.247 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.503 ' O ' HD12 ' A' ' 49' ' ' ILE . 76.3 Cg_exo -52.23 -26.03 25.49 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.915 2.41 . . . . 0.0 113.058 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.812 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.19 -36.06 83.0 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.655 HG23 HG13 ' A' ' 44' ' ' ILE . 2.5 t -62.78 -55.75 35.55 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -178.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.644 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.0 Cg_exo -60.83 -39.43 62.28 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.03 1.82 . . . . 0.0 111.471 179.381 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -63.45 -36.7 77.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.062 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.6 ' O ' HG23 ' A' ' 54' ' ' VAL . 42.8 tp -71.89 -51.95 19.73 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -53.21 -26.31 17.15 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.6 t -80.01 -47.55 14.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.656 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.562 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.17 -26.11 64.5 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.429 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.622 HG12 ' HG3' ' A' ' 13' ' ' GLN . 54.7 t -53.11 -49.43 50.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.834 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -76.08 -10.59 59.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.626 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -93.69 -18.94 21.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.374 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 67.5 m-85 -135.96 62.21 45.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.589 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.9 -41.14 64.87 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.693 2.262 . . . . 0.0 111.568 179.114 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.14 -41.58 96.69 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.293 179.15 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.1 t -66.1 143.77 15.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.709 ' HB2' HG21 ' A' ' 31' ' ' THR . 33.3 t -81.5 99.3 8.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.039 0.447 . . . . 0.0 110.844 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.479 ' HB3' HG22 ' A' ' 54' ' ' VAL . 3.9 p90 -65.61 126.76 29.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.987 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.95 162.73 28.35 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.318 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -160.89 141.34 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.1 t -144.29 151.78 39.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.107 0.48 . . . . 0.0 111.655 -179.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.432 HG21 ' HG ' ' A' ' 42' ' ' LEU . 81.6 p -135.57 -0.5 2.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.772 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.59 145.99 50.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.918 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.0 t -67.66 -50.58 57.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.466 -179.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -50.45 -44.05 55.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.363 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.536 ' HA ' HG22 ' A' ' 21' ' ' VAL . 58.4 t -70.83 -53.45 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.736 0.303 . . . . 0.0 110.604 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.449 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.4 -14.72 8.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.147 0.498 . . . . 0.0 110.459 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.0 m -92.56 -40.68 10.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.466 178.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -61.88 -35.33 78.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.497 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.421 ' HB2' HG12 ' A' ' 76' ' ' ILE . 41.9 m-85 -95.55 12.88 28.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.872 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.599 ' N ' HD22 ' A' ' 75' ' ' ASN . 0.8 OUTLIER 56.93 23.65 8.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.691 179.236 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.681 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.2 mm -61.08 121.13 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.092 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.2 p -141.02 57.86 1.55 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.378 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.51 46.49 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.536 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.595 HD22 ' HB3' ' A' ' 39' ' ' PHE . 14.0 m120 51.29 42.94 29.5 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.253 0.549 . . . . 0.0 110.406 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.681 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.0 m -68.93 152.39 45.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.65 -178.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.578 HG12 ' HA2' ' A' ' 37' ' ' GLY . 68.1 mt -119.32 118.53 57.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.241 178.163 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.49 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.9 m -107.34 134.04 50.98 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.658 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -107.62 103.05 12.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.716 178.183 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.1 t80 -95.87 120.26 35.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.869 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.567 HH12 HD12 ' A' ' 116' ' ' LEU . 3.9 mtm180 -106.09 82.19 1.73 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.872 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.5 tp -25.11 -58.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.219 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.547 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.08 -60.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.375 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -100.77 4.77 43.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.128 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 54.08 26.01 6.11 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.373 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 13.9 mm-40 -70.61 155.18 41.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.822 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.86 95.06 2.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.445 179.391 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.658 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -84.36 111.55 19.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.224 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.7 118.08 30.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.37 0.605 . . . . 0.0 112.253 -179.13 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.515 HD21 HD13 ' A' ' 102' ' ' ILE . 4.3 tt -105.56 77.6 1.29 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.7 mt-10 -79.69 -163.84 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.905 -176.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.7 t70 -51.11 -35.71 36.7 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.925 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.415 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 12.9 pt-20 -56.18 -14.57 2.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.091 0.472 . . . . 0.0 110.192 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.415 ' OD2' ' HG3' ' A' ' 97' ' ' GLU . 35.5 m-20 -132.46 -14.05 2.94 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.573 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.4 mm -89.86 -33.96 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.718 0.294 . . . . 0.0 111.402 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -54.54 -34.23 61.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.753 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.5 p -133.06 40.25 3.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.341 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.517 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.6 tp -66.07 143.57 15.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.597 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.404 ' N ' HG13 ' A' ' 102' ' ' ILE . 9.3 m-20 -138.62 148.56 44.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.5 178.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.91 -35.57 6.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.102 0.477 . . . . 0.0 110.342 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.2 m -63.33 -49.63 73.17 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.358 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -58.61 -59.66 5.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.131 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.7 -55.92 12.07 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.963 0.411 . . . . 0.0 110.317 179.875 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.2 m -58.66 -28.93 66.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.785 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.555 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -71.58 -65.69 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.169 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -42.91 -43.97 4.35 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.913 179.106 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.444 HG12 HG21 ' A' ' 35' ' ' VAL . 94.6 mt -62.96 -55.93 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.571 178.314 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.31 -17.81 3.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.555 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.83 -36.84 8.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.98 -179.194 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.413 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.3 m120 -124.37 30.02 6.16 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 81.2 p -82.38 47.69 1.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.013 0.435 . . . . 0.0 110.315 179.058 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.567 HD12 HH12 ' A' ' 85' ' ' ARG . 63.1 mt . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.297 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.775 0.321 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.423 HG23 ' HG3' ' A' ' 3' ' ' GLU . 22.6 m -97.74 -2.41 10.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 2' ' ' VAL . 44.5 mt-10 -139.52 29.24 2.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.821 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -137.64 -56.31 0.68 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.748 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.7 m -117.91 136.9 53.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.686 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.3 m -111.2 -48.62 3.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -122.88 10.55 9.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.046 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.17 97.6 0.33 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -61.89 120.0 7.39 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.579 2.186 . . . . 0.0 112.163 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.88 -130.18 2.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.617 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.706 ' HB1' HE21 ' A' ' 13' ' ' GLN . . . -162.57 -72.36 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.739 0.304 . . . . 0.0 110.715 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.436 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . . . 57.69 96.89 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.673 179.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.706 HE21 ' HB1' ' A' ' 11' ' ' ALA . 7.6 pt20 -172.83 170.28 4.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.964 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.47 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 -117.26 157.96 45.78 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.0 Cg_endo -67.83 148.25 76.54 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.878 2.385 . . . . 0.0 112.6 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.3 m -64.64 153.99 37.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.54 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -98.84 89.37 4.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.005 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 24' ' ' ALA . 50.1 mt -86.86 74.14 9.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.603 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.9 p -71.82 -1.25 13.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.266 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -143.52 148.73 36.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.868 0.366 . . . . 0.0 111.863 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.592 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 20.4 t -56.86 -50.66 86.78 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.407 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.52 -43.45 50.97 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.944 1.763 . . . . 0.0 111.884 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.61 -35.47 80.9 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.222 0.534 . . . . 0.0 110.299 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.61 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.26 -58.2 7.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.868 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.7 mtm -60.25 -28.56 68.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.005 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -70.57 -48.9 53.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.794 0.331 . . . . 0.0 110.568 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 31' ' ' THR . 4.5 m-85 -60.75 -33.64 73.24 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.999 179.311 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.6 HD11 HD12 ' A' ' 36' ' ' ILE . 38.1 mt -73.55 -39.6 54.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.003 178.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.33 -19.16 62.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.177 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.32 26.45 3.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.253 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.648 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.0 t -172.8 154.28 2.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.705 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.526 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.3 tt0 -63.65 -79.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.711 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.53 HG13 HD11 ' A' ' 83' ' ' LEU . 16.0 t -92.88 139.03 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.661 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.45 122.99 14.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 0.0 111.716 -179.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.554 HG21 HG12 ' A' ' 111' ' ' ILE . 55.1 t -112.03 128.34 68.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.755 178.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.6 HD12 HD11 ' A' ' 28' ' ' ILE . 38.4 mt -134.08 137.59 51.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.604 -177.015 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.544 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.75 98.26 1.82 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.217 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.467 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 35.8 m-85 -84.17 91.88 7.8 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.8 m-85 -111.78 143.76 42.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.356 -178.085 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -89.31 -8.07 54.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.447 ' O ' HG12 ' A' ' 44' ' ' ILE . 13.4 t70 -149.79 124.57 9.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.618 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.547 ' HA ' HG21 ' A' ' 47' ' ' VAL . 90.6 mt -93.18 46.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.055 0.455 . . . . 0.0 111.511 -179.239 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 37.1 mt-10 -136.98 8.93 3.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.917 178.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.78 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.2 pt -91.81 155.56 43.37 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.4 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.489 ' O ' HD12 ' A' ' 49' ' ' ILE . 83.8 Cg_exo -50.42 -26.61 16.53 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.877 2.385 . . . . 0.0 112.964 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.78 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.48 -38.52 91.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -179.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.691 HG23 HG13 ' A' ' 44' ' ' ILE . 2.8 t -60.0 -55.91 40.83 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.663 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.7 Cg_exo -60.67 -41.59 45.93 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.081 1.854 . . . . 0.0 111.545 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.871 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.8 mt -61.12 -35.17 63.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.973 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.614 ' O ' HG23 ' A' ' 54' ' ' VAL . 50.4 tp -74.57 -49.47 21.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.06 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -55.14 -25.83 34.63 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -81.84 -47.34 12.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.69 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.584 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.48 -26.38 63.35 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.455 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 50' ' ' LEU . 41.9 t -52.82 -48.01 50.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.123 179.395 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.436 ' NE2' ' HA ' ' A' ' 12' ' ' ALA . 38.5 mt-30 -77.97 -11.88 59.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.4 mtpp -92.23 -17.86 24.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.312 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.608 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 62.4 m-85 -136.5 62.36 42.52 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.453 -179.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.33 -42.12 62.38 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.79 2.327 . . . . 0.0 111.677 179.137 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.9 -40.59 95.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.443 179.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.4 t -67.22 142.6 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.648 ' HB2' HG21 ' A' ' 31' ' ' THR . 28.7 t -81.17 98.46 8.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.049 0.452 . . . . 0.0 110.877 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.521 ' HB3' HG22 ' A' ' 54' ' ' VAL . 4.6 p90 -66.04 129.44 39.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.015 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.32 161.98 28.57 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.003 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -160.93 143.93 4.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.467 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 34.1 t -149.79 158.3 44.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.1 0.476 . . . . 0.0 111.693 -179.165 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.518 HG21 ' HG ' ' A' ' 42' ' ' LEU . 77.5 p -139.86 2.53 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.668 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -72.18 134.51 45.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.428 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.1 t -57.86 -49.29 77.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.435 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -50.21 -43.49 52.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.695 -179.378 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.57 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.9 t -71.35 -53.2 21.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.967 0.413 . . . . 0.0 110.69 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 76' ' ' ILE . 6.6 mp -59.31 -14.34 11.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.176 179.362 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.5 m -92.02 -41.24 10.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.251 178.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -60.68 -38.51 85.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.434 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.41 ' HB2' HG12 ' A' ' 76' ' ' ILE . 60.1 m-85 -92.61 10.46 30.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.766 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.9 t30 58.95 23.01 11.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.626 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.718 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.0 mm -60.23 123.34 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.022 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.5 p -143.62 60.05 1.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.028 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.86 43.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.572 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.612 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 30.0 m-80 52.09 43.57 30.35 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.109 0.48 . . . . 0.0 110.43 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.718 ' HB ' HG23 ' A' ' 76' ' ' ILE . 88.5 m -68.41 152.67 45.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.655 -178.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.579 HG21 HD21 ' A' ' 107' ' ' LEU . 62.2 mt -118.46 115.53 48.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 78.3 m -103.63 135.14 45.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -177.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.631 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -110.72 105.61 14.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.125 178.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.7 t80 -99.41 118.94 37.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.996 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.456 HH12 HD12 ' A' ' 116' ' ' LEU . 3.3 mtm180 -103.29 80.69 1.86 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.789 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 85' ' ' ARG . 6.6 tp -24.33 -59.65 0.05 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.935 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.526 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.79 -62.48 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.302 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -96.87 3.3 52.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.0 0.428 . . . . 0.0 111.065 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 51.77 32.07 9.01 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.526 179.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.9 mm-40 -80.03 137.5 36.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.614 179.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.02 93.31 4.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.028 0.442 . . . . 0.0 110.86 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.631 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -81.16 141.39 34.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.361 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -121.86 115.18 22.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.322 0.582 . . . . 0.0 112.343 -179.425 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.533 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -99.57 74.88 1.91 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.5 mt-10 -76.38 -166.03 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -176.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.474 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.4 OUTLIER -46.01 -51.7 13.1 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.418 -179.278 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -47.15 -15.83 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.275 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 96' ' ' ASP . 30.5 m-20 -127.02 -14.03 5.6 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.351 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.546 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.4 mm -91.59 -40.48 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -46.18 -42.85 14.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 t -124.45 41.36 3.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.491 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.533 HD13 HD21 ' A' ' 94' ' ' LEU . 7.3 tp -66.86 143.6 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.712 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -137.22 149.54 47.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.486 178.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.871 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.23 -36.77 14.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.379 . . . . 0.0 110.461 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 99.5 m -62.27 -48.42 79.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.236 178.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -58.86 -59.34 5.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.188 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.2 -56.39 11.25 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.05 0.452 . . . . 0.0 110.182 -179.96 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.6 m -58.05 -28.8 64.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.744 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.498 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.9 tmt_? -71.6 -66.05 0.68 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.967 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -42.13 -45.52 4.03 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.865 179.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.554 HG12 HG21 ' A' ' 35' ' ' VAL . 82.1 mt -61.33 -56.86 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.593 178.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -53.82 -18.07 2.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.336 179.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.498 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.43 -37.16 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.215 -179.042 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.616 HD22 ' HG ' ' A' ' 92' ' ' LEU . 82.9 m-20 -124.62 29.63 6.21 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 99.8 p -82.9 49.11 1.45 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.996 0.427 . . . . 0.0 110.316 179.055 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.456 HD12 HH12 ' A' ' 85' ' ' ARG . 73.7 mt . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.355 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.861 0.362 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.2 m -99.44 -43.37 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.093 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -172.51 92.17 0.11 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.777 179.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.8 tttt 55.71 90.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.094 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 85.3 p -161.19 114.0 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.004 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.4 m -130.98 24.75 4.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.995 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -110.54 -40.43 4.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.846 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.93 152.78 6.02 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.48 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.84 107.34 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.546 2.164 . . . . 0.0 112.13 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.76 165.62 25.87 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.612 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.07 -61.74 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.74 0.305 . . . . 0.0 110.676 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 13' ' ' GLN . . . 53.89 83.26 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.102 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.489 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.5 pt20 48.27 117.29 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.919 0.762 . . . . 0.0 112.287 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.519 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.9 pt-20 -114.25 159.54 36.14 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.649 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 31.4 Cg_endo -65.0 139.76 62.89 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.487 2.124 . . . . 0.0 112.526 -179.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 17' ' ' TRP . 19.2 m -57.18 154.34 10.34 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.003 -179.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.401 ' N ' HG22 ' A' ' 16' ' ' THR . 10.4 m-90 -98.21 94.11 6.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.902 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.617 HD13 ' HA ' ' A' ' 24' ' ' ALA . 51.3 mt -90.07 70.01 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.27 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.2 p -68.82 -2.6 9.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.246 -178.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -142.61 147.53 35.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.997 0.427 . . . . 0.0 111.645 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.7 t -55.29 -50.01 89.11 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.638 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.6 Cg_endo -57.06 -46.87 25.86 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.958 1.772 . . . . 0.0 111.924 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.8 -34.62 77.66 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.193 0.52 . . . . 0.0 110.113 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -64.13 -59.26 4.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.054 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.4 mtp -60.62 -25.19 66.09 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.183 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -72.26 -50.82 24.3 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.571 179.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 31' ' ' THR . 12.0 m-85 -61.72 -29.48 70.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.047 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.516 HD11 HD12 ' A' ' 36' ' ' ILE . 50.2 mt -76.11 -37.48 33.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.068 178.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.79 -19.54 60.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.115 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.41 30.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.197 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.613 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.7 t -170.97 153.53 3.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.314 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.615 ' HG3' HG13 ' A' ' 87' ' ' VAL . 27.5 tt0 -70.18 -46.29 64.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.793 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.508 HG13 HD11 ' A' ' 83' ' ' LEU . 21.1 t -124.53 135.22 64.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.286 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.507 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.56 127.47 22.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.163 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.503 HG21 HG12 ' A' ' 111' ' ' ILE . 49.2 t -115.66 128.73 72.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.465 178.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.516 HD12 HD11 ' A' ' 28' ' ' ILE . 22.2 mt -134.64 138.41 49.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.556 -177.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.575 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.87 97.06 1.64 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.378 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.477 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 39.3 m-85 -82.95 91.96 7.24 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.0 m-85 -112.0 145.21 40.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.181 0.515 . . . . 0.0 112.378 -178.188 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.479 ' HG2' HD23 ' A' ' 71' ' ' LEU . 46.2 mt-30 -93.17 -0.99 56.75 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.8 t70 -156.58 123.85 5.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.564 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.549 ' HA ' HG21 ' A' ' 47' ' ' VAL . 84.0 mt -93.75 47.5 1.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.204 0.526 . . . . 0.0 111.505 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 45.4 mt-10 -137.38 7.27 2.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.729 178.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.808 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.0 pt -89.68 156.55 47.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.027 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.509 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.1 Cg_exo -52.16 -24.19 19.62 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.876 2.384 . . . . 0.0 113.007 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.808 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -67.32 -35.99 80.56 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.673 HG23 HG13 ' A' ' 44' ' ' ILE . 2.6 t -61.9 -54.97 45.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.667 -178.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 34.6 Cg_exo -61.44 -40.28 49.48 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.999 1.799 . . . . 0.0 111.445 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.868 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.3 mt -63.11 -35.92 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.19 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.624 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.9 tp -73.06 -50.26 23.99 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -54.82 -25.37 27.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.198 0.523 . . . . 0.0 109.598 178.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.9 t -80.98 -47.23 13.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.547 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.556 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.23 -27.17 65.51 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.541 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.6 t -51.71 -50.91 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.021 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.423 ' NE2' ' HB3' ' A' ' 12' ' ' ALA . 36.0 mt-30 -74.68 -12.35 60.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.722 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -91.81 -17.34 25.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.215 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.619 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.0 m-85 -138.15 63.37 36.23 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.568 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.07 -41.11 74.19 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.652 2.235 . . . . 0.0 111.58 179.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.3 -41.83 97.05 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.35 179.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.6 t -65.76 144.69 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.613 ' HB2' HG21 ' A' ' 31' ' ' THR . 47.5 t -82.35 97.23 8.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.026 0.441 . . . . 0.0 111.006 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.493 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -64.45 126.64 28.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.724 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.476 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.1 161.84 28.33 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.169 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' A' ' 15' ' ' PRO . 4.3 tt -161.03 143.02 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.477 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 35.6 t -147.25 153.52 39.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.071 0.462 . . . . 0.0 111.805 -179.061 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.483 HG21 ' HG ' ' A' ' 42' ' ' LEU . 64.4 p -135.62 5.73 3.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.371 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.27 140.34 44.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.738 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.8 m -62.94 -52.78 61.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.378 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -47.7 -44.73 27.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.614 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.509 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.0 t -70.05 -55.29 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.832 0.348 . . . . 0.0 110.991 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.479 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -57.39 -14.84 5.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.25 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.4 m -90.48 -41.43 11.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.246 178.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -60.1 -39.42 86.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.392 179.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -92.93 12.99 21.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.959 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.3 m120 55.15 24.28 6.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.623 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.709 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.4 mm -60.16 120.43 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.97 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.5 p -142.05 55.67 1.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.942 0.401 . . . . 0.0 111.109 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.44 42.37 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.432 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.625 ' HB2' HG21 ' A' ' 99' ' ' ILE . 35.6 m-20 52.24 43.37 30.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.232 0.539 . . . . 0.0 110.364 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.709 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.6 m -68.95 151.11 46.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.87 -178.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.575 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.0 mt -117.8 115.47 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.911 177.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.458 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 78.3 m -103.82 132.57 49.95 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.665 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.3 tp -109.07 103.68 12.74 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.803 178.312 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.6 t80 -98.73 122.15 41.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.821 0.343 . . . . 0.0 110.79 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.481 HH21 ' HB2' ' A' ' 88' ' ' ASP . 2.8 mtm180 -105.04 98.72 8.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.036 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.3 tp -41.9 -52.71 4.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.882 -179.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.615 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.7 -71.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.385 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.481 ' HB2' HH21 ' A' ' 85' ' ' ARG . 11.2 m-20 -88.33 6.01 39.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.041 -179.665 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 52.49 35.89 18.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.387 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 7.3 mm-40 -81.46 161.66 23.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.817 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -146.05 92.81 2.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.92 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.665 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -79.39 144.23 34.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.181 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -124.56 95.49 4.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.025 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.579 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -81.0 77.78 7.88 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.639 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.5 mt-10 -78.8 -165.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.514 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 25.5 t70 -51.01 -36.47 39.57 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.932 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -56.27 -14.61 2.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.183 0.516 . . . . 0.0 110.361 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -130.68 -13.95 3.67 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.592 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.625 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.0 mm -89.49 -32.71 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.754 0.311 . . . . 0.0 111.373 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -50.36 -47.98 55.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.728 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -122.05 38.31 4.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.609 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.579 HD13 HD21 ' A' ' 94' ' ' LEU . 7.0 tp -61.07 143.44 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.653 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.404 ' N ' HG13 ' A' ' 102' ' ' ILE . 19.1 m-20 -137.12 147.91 46.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.473 178.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.868 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.1 -35.26 6.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.99 0.424 . . . . 0.0 110.45 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -63.91 -48.68 75.62 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.423 178.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -58.98 -58.58 8.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.115 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.733 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.49 -55.78 14.47 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.998 0.428 . . . . 0.0 110.134 179.901 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.1 m -58.31 -28.98 65.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.823 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.7 tmt_? -72.65 -65.88 0.73 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.222 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -42.92 -42.82 3.86 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.04 179.112 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.503 HG12 HG21 ' A' ' 35' ' ' VAL . 92.2 mt -64.18 -56.63 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.576 178.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -52.33 -22.16 4.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.367 0.604 . . . . 0.0 110.211 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.475 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -85.17 -37.88 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.93 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.618 HD22 ' HG ' ' A' ' 92' ' ' LEU . 88.9 m-20 -123.64 30.78 6.1 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.312 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 111' ' ' ILE . 87.4 p -83.5 39.58 0.68 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.18 0.514 . . . . 0.0 110.066 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.7 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.291 -179.453 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.518 0.199 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.5 m 34.94 61.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.09 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.07 -27.77 65.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.978 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -63.79 144.24 57.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.5 m -141.75 -26.61 0.67 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.792 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 56.5 m -153.86 107.22 2.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -110.55 108.44 18.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -129.86 -176.06 14.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.384 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.26 130.86 42.44 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.555 2.17 . . . . 0.0 112.426 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.62 59.56 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.462 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.9 -51.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.823 0.344 . . . . 0.0 110.447 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.52 -82.28 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.632 179.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.532 ' HG3' HG12 ' A' ' 54' ' ' VAL . 11.1 pt20 -161.66 139.94 9.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.89 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.1 pt-20 -121.68 158.3 54.58 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.739 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.495 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.9 Cg_endo -66.3 140.71 59.53 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.55 2.167 . . . . 0.0 112.465 -179.701 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 m -56.46 150.5 15.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.666 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -96.27 93.36 6.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.98 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 24' ' ' ALA . 54.2 mt -90.7 72.93 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.511 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.7 p -74.96 2.11 11.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.065 -179.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -144.67 147.54 33.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 0.0 111.595 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.589 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 39.7 t -56.48 -50.21 89.08 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.622 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.96 -44.92 35.82 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 121.876 1.717 . . . . 0.0 111.797 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.85 -36.22 83.2 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.169 0.509 . . . . 0.0 110.33 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.61 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.21 -59.4 4.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.148 179.377 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 65.8 mtp -60.97 -25.19 66.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.139 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 21.3 mt-10 -72.59 -51.98 17.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.719 0.295 . . . . 0.0 110.648 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.507 ' O ' HG22 ' A' ' 31' ' ' THR . 12.5 m-85 -59.94 -31.87 70.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.935 179.368 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.572 HD11 HD12 ' A' ' 36' ' ' ILE . 50.7 mt -75.27 -38.8 41.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.938 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.61 -19.0 61.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.232 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.76 26.18 3.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.243 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.0 t -170.62 153.75 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.611 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.529 ' HG3' HG13 ' A' ' 87' ' ' VAL . 18.2 tt0 -64.5 -73.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.574 HG13 HD11 ' A' ' 83' ' ' LEU . 19.7 t -98.13 137.81 24.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.613 179.787 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.18 125.65 16.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.937 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 111' ' ' ILE . 55.0 t -114.07 130.16 68.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.85 178.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.572 HD12 HD11 ' A' ' 28' ' ' ILE . 27.0 mt -135.53 137.78 49.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.625 -177.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.24 98.08 1.75 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.587 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.523 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.0 m-85 -84.3 91.84 7.85 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.595 ' HB3' HD22 ' A' ' 79' ' ' ASN . 11.4 m-85 -110.84 143.87 40.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.287 -178.191 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.478 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 49.9 mt-30 -91.51 -3.3 56.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.522 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.6 t70 -154.8 118.46 4.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.596 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.494 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.8 mt -87.96 44.78 1.22 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.01 0.433 . . . . 0.0 111.329 -179.318 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 31.3 mt-10 -135.28 10.11 3.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.128 179.054 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.73 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.3 pt -92.77 157.57 39.4 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.477 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.462 ' O ' HD12 ' A' ' 49' ' ' ILE . 71.8 Cg_exo -52.22 -27.5 30.43 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.908 2.405 . . . . 0.0 112.898 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.73 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.36 -39.95 95.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.701 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -58.57 -56.89 30.92 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -178.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -58.87 -40.29 73.4 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.783 1.655 . . . . 0.0 111.438 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.874 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -61.85 -35.34 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.936 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.586 ' O ' HG23 ' A' ' 54' ' ' VAL . 39.7 tp -75.03 -54.67 6.76 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -52.68 -23.69 7.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.0 0.429 . . . . 0.0 109.947 178.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -84.22 -46.08 12.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.557 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.606 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.0 -25.26 63.48 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.318 0.58 . . . . 0.0 109.457 179.433 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.3 t -51.57 -50.49 29.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.121 179.352 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -76.08 -9.48 58.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.874 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -93.13 -19.74 21.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.998 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.9 m-85 -135.84 63.79 53.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.506 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.61 -43.2 57.05 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.707 2.272 . . . . 0.0 111.576 179.229 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.42 -42.29 93.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.337 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -65.27 143.77 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.67 ' HB2' HG21 ' A' ' 31' ' ' THR . 38.2 t -82.28 98.12 8.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 111.092 -179.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.495 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.4 p90 -65.37 128.35 35.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.927 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.485 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.83 161.84 28.62 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.025 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.419 HD11 HG13 ' A' ' 47' ' ' VAL . 4.7 tt -160.18 144.3 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 t -148.48 158.72 44.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.191 0.519 . . . . 0.0 111.865 -178.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 39' ' ' PHE . 72.5 p -141.49 1.03 1.53 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.585 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.02 144.97 52.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.663 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.4 m -66.67 -53.4 34.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.344 -179.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 2.2 mp0 -48.71 -42.95 36.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.511 -179.684 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.522 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.8 t -70.56 -56.12 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.051 0.453 . . . . 0.0 110.648 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.49 -15.08 3.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.315 179.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.5 m -90.87 -41.23 11.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.304 178.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -61.33 -31.91 71.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.251 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -100.02 12.39 37.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.274 179.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.7 m120 55.95 22.05 5.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.595 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.666 HG23 ' HB ' ' A' ' 80' ' ' THR . 32.4 mm -58.96 118.99 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.152 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.6 p -142.16 55.81 1.46 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.085 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.82 42.41 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.355 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.595 HD22 ' HB3' ' A' ' 39' ' ' PHE . 14.1 m120 53.17 42.19 32.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.256 0.55 . . . . 0.0 110.203 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.666 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.9 m -67.93 151.77 46.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.864 -178.497 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.581 HG12 ' HA2' ' A' ' 37' ' ' GLY . 66.4 mt -118.95 115.79 49.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.88 177.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.523 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.4 m -105.34 132.65 51.26 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.656 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -108.34 103.91 13.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.925 178.327 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.5 t80 -97.36 123.58 41.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.847 0.356 . . . . 0.0 110.579 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.487 HH12 HD12 ' A' ' 116' ' ' LEU . 4.5 mtm180 -106.36 81.23 1.58 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.705 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 85' ' ' ARG . 4.6 tp -24.13 -59.76 0.05 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.06 -179.537 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.529 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.03 -61.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.064 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.9 4.29 49.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.953 0.406 . . . . 0.0 111.19 -179.428 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.9 m120 53.21 28.24 6.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.81 179.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.0 mm-40 -74.13 159.29 32.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.578 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -144.19 96.8 2.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.827 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.656 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.1 mm? -85.32 111.57 20.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.058 179.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -93.87 101.36 13.44 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.634 HD21 HD13 ' A' ' 102' ' ' ILE . 3.4 tt -86.72 75.82 9.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.0 mt-10 -77.1 -166.1 0.66 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -176.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.48 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -46.11 -50.67 15.13 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.398 -179.388 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -47.73 -16.3 0.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.976 0.417 . . . . 0.0 111.285 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.41 ' N ' ' C ' ' A' ' 96' ' ' ASP . 43.0 m-20 -126.38 -13.91 5.98 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.465 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.591 HG21 ' HB2' ' A' ' 79' ' ' ASN . 20.9 mm -91.46 -32.21 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -48.84 -59.31 3.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.962 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.6 p -110.72 36.28 3.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.585 179.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.634 HD13 HD21 ' A' ' 94' ' ' LEU . 8.7 tp -56.91 144.66 8.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.438 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.413 ' H ' ' HD3' ' A' ' 106' ' ' LYS . 21.7 m-20 -138.5 148.75 44.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.721 179.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.874 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.18 -36.72 14.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.029 0.442 . . . . 0.0 110.491 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 96.6 m -61.46 -49.07 78.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.174 178.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.413 ' HD3' ' H ' ' A' ' 103' ' ' ASP . 55.9 mtpt -58.1 -61.45 2.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.148 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.79 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.21 -56.54 7.69 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.903 0.382 . . . . 0.0 110.511 -179.849 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 56.6 m -58.31 -29.85 66.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.918 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.508 ' NH1' HD11 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -71.29 -64.7 0.86 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.252 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -44.52 -43.01 7.64 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.079 179.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.475 HG12 HG21 ' A' ' 35' ' ' VAL . 95.9 mt -63.76 -56.43 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.639 178.464 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -53.23 -19.39 3.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.179 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.508 HD11 ' NH1' ' A' ' 109' ' ' ARG . 1.3 mp -88.56 -37.75 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.07 -179.075 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.429 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.6 m120 -122.4 30.03 6.7 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.6 p -82.35 43.74 0.83 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.123 0.487 . . . . 0.0 110.152 178.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.487 HD12 HH12 ' A' ' 85' ' ' ARG . 49.5 mt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.408 -179.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.82 0.343 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.2 m -89.62 3.11 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.472 -179.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.09 136.23 57.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.967 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.6 mttp 58.64 -169.42 0.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.422 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.5 m -65.11 -26.21 68.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.264 -179.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.8 t 67.71 -75.21 0.06 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.162 -179.768 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.8 t70 63.47 107.24 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.99 0.424 . . . . 0.0 111.272 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.56 179.09 40.7 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.36 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -57.23 98.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.59 2.193 . . . . 0.0 112.186 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.89 58.66 0.51 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.706 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.39 -69.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.779 0.324 . . . . 0.0 110.795 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 13' ' ' GLN . . . 55.15 81.12 0.12 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.156 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.506 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.2 pt20 46.02 115.89 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 O-C-N 123.905 0.753 . . . . 0.0 112.66 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.9 pt-20 -111.46 157.84 38.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.687 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.503 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.7 Cg_endo -66.89 141.65 59.58 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.423 2.082 . . . . 0.0 112.173 -179.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.6 m -56.42 152.31 11.67 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.495 -179.547 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -99.79 85.67 3.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.062 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.603 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.7 mt -81.89 74.61 8.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.453 179.84 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.7 p -74.14 -1.96 22.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.98 -178.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -140.11 147.02 39.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.422 . . . . 0.0 111.643 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.587 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 32.2 t -56.09 -50.05 89.62 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.534 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.4 Cg_endo -58.74 -45.33 29.94 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.808 1.672 . . . . 0.0 111.718 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.54 -33.82 76.42 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.25 0.547 . . . . 0.0 110.169 179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.93 -59.11 4.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.006 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.8 mtp -60.6 -26.02 66.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.182 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.3 mt-10 -72.86 -50.97 20.66 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.708 0.289 . . . . 0.0 110.642 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.486 ' O ' HG22 ' A' ' 31' ' ' THR . 7.8 m-85 -59.92 -32.2 70.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.854 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 36' ' ' ILE . 47.6 mt -75.08 -40.5 44.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.08 0.466 . . . . 0.0 110.111 178.312 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -18.7 62.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.207 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.48 25.41 3.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.206 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.635 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.7 t -171.0 155.1 4.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.744 -179.788 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.522 ' HG3' HG13 ' A' ' 87' ' ' VAL . 18.4 tt0 -64.61 -77.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.824 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.584 HG13 HD11 ' A' ' 83' ' ' LEU . 20.2 t -95.93 136.97 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.731 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.516 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.41 126.04 17.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.942 0.401 . . . . 0.0 112.074 -179.124 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.421 HG21 HG12 ' A' ' 111' ' ' ILE . 53.9 t -114.53 131.01 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.836 178.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.559 HD12 HD11 ' A' ' 28' ' ' ILE . 27.9 mt -135.97 135.39 50.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.274 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.593 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.58 98.06 1.97 Allowed Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.619 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 10.8 m-85 -84.17 91.73 7.77 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.606 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.0 m-85 -112.08 137.98 49.37 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.128 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -83.21 -7.03 59.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.459 ' O ' HG12 ' A' ' 44' ' ' ILE . 7.2 t70 -152.03 125.6 8.89 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.654 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.551 ' HA ' HG21 ' A' ' 47' ' ' VAL . 96.0 mt -93.23 43.27 1.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.039 0.447 . . . . 0.0 111.407 -179.645 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -132.55 14.79 4.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.828 178.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.6 pt -99.08 157.77 33.48 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.197 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.477 ' O ' HD12 ' A' ' 49' ' ' ILE . 74.1 Cg_exo -52.99 -26.98 33.88 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.9 2.4 . . . . 0.0 112.956 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.781 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.77 -38.25 89.86 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.017 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.672 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.35 -56.4 34.2 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.629 -178.826 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.2 Cg_exo -59.64 -41.23 57.98 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.942 1.762 . . . . 0.0 111.372 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -61.16 -35.87 68.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.054 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.594 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.8 tp -73.68 -52.06 14.58 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 178.784 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -53.58 -25.18 16.2 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.705 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -81.76 -46.82 13.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.505 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.558 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.16 -25.81 64.24 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.357 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.7 t -53.06 -47.69 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.948 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.412 ' HA ' ' OE1' ' A' ' 13' ' ' GLN . 8.9 mt-30 -77.99 -11.62 59.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.714 -179.802 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -92.73 -17.77 23.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.155 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.618 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.3 m-85 -137.14 62.63 39.85 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.605 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.37 -39.46 81.47 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.517 2.145 . . . . 0.0 111.466 178.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.65 -39.42 96.55 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.458 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.1 t -68.58 144.09 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.067 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.635 ' HB2' HG21 ' A' ' 31' ' ' THR . 35.7 t -81.29 98.08 7.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 110.916 -179.754 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.503 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.2 p90 -65.16 127.52 32.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.77 162.88 28.57 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.212 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -160.68 143.71 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.774 0.321 . . . . 0.0 110.155 179.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.3 t -146.91 154.17 40.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.041 0.448 . . . . 0.0 111.512 -179.255 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.457 HG21 ' HG ' ' A' ' 42' ' ' LEU . 81.9 p -137.73 -4.75 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.71 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.35 144.49 55.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.831 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -64.35 -51.49 63.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.46 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -48.6 -45.26 37.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.656 -179.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.533 ' HA ' HG22 ' A' ' 21' ' ' VAL . 74.5 t -70.15 -53.47 23.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.829 0.347 . . . . 0.0 110.724 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.71 -14.32 8.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.351 179.416 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.2 m -91.91 -41.68 10.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.274 178.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -60.09 -39.62 86.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.414 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.42 ' HB2' HG12 ' A' ' 76' ' ' ILE . 59.0 m-85 -91.74 11.95 22.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.787 179.606 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 55.79 26.23 9.32 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.542 179.222 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.682 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.0 mm -61.89 122.06 11.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.226 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.6 p -140.83 58.2 1.55 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.311 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.87 46.77 0.02 OUTLIER Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.89 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.626 ' HB2' HG21 ' A' ' 99' ' ' ILE . 30.2 m-80 50.57 43.0 27.53 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.229 0.538 . . . . 0.0 110.543 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.682 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.6 m -69.17 152.57 44.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.686 -178.612 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.593 HG12 ' HA2' ' A' ' 37' ' ' GLY . 60.6 mt -118.9 118.34 57.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.107 178.189 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.9 m -107.89 134.07 51.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.651 ' HG ' HD23 ' A' ' 92' ' ' LEU . 3.0 tp -109.53 104.73 13.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.085 178.544 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.4 t80 -97.3 122.61 40.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.464 179.555 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.583 HH12 HD12 ' A' ' 116' ' ' LEU . 5.6 mtm180 -106.85 82.71 1.74 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.928 0.394 . . . . 0.0 110.835 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tp -25.67 -60.03 0.07 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.127 -179.404 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.522 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.25 -58.75 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.852 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -98.83 13.28 32.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.758 0.313 . . . . 0.0 111.37 -179.177 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.2 p30 43.55 30.95 0.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.017 178.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.536 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 28.2 mm-40 -77.47 157.16 30.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.835 0.35 . . . . 0.0 110.916 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.469 HE22 ' HB3' ' A' ' 93' ' ' ASN . 1.2 tm0? -142.26 94.48 2.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.676 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.651 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -85.25 121.69 28.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.637 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.576 ' ND2' ' H ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -105.16 103.77 13.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.767 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.555 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -89.63 78.67 6.96 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.1 mt-10 -79.81 -165.87 0.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.81 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.491 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -45.1 -51.06 10.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.7 -179.311 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -46.56 -18.88 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.857 0.361 . . . . 0.0 111.088 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 96' ' ' ASP . 16.2 m-20 -124.73 -13.82 6.89 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.488 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.626 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.7 mm -90.59 -40.61 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.363 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -49.08 -40.91 33.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.342 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.3 t -123.68 36.41 4.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.449 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.58 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 8.1 tp -63.14 144.68 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.475 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -139.69 147.88 41.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.475 178.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.11 -37.84 10.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.984 0.421 . . . . 0.0 110.554 -179.571 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -61.43 -47.55 85.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.311 178.647 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -60.12 -60.83 3.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.215 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.763 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.0 -55.56 11.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.329 -179.999 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.0 m -58.45 -30.49 66.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.732 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.443 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.5 tmt_? -70.4 -66.55 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.128 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -42.62 -45.16 4.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.169 179.454 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.421 HG12 HG21 ' A' ' 35' ' ' VAL . 96.4 mt -62.41 -54.76 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.306 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.41 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 40.8 tt0 -54.6 -18.78 4.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.426 179.397 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.443 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.62 -37.43 10.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.79 -178.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.584 HD22 ' HG ' ' A' ' 92' ' ' LEU . 89.1 m-20 -122.96 29.36 6.82 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.387 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 78.9 p -82.65 50.85 1.75 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.118 0.485 . . . . 0.0 110.092 178.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.583 HD12 HH12 ' A' ' 85' ' ' ARG . 57.0 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.278 -0.867 . . . . 0.0 111.374 -179.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.91 0.386 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.5 m -86.21 174.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.867 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 57.63 93.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.979 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -81.12 -71.27 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.998 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.2 t -105.63 130.81 53.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.052 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.8 t -126.27 146.04 50.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.698 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -106.88 101.42 10.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.067 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.22 -160.5 54.06 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.54 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.82 -39.42 91.22 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.64 2.226 . . . . 0.0 112.413 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.25 -83.46 0.35 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.426 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.99 -45.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.87 0.367 . . . . 0.0 110.445 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.65 -83.59 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.695 179.388 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.482 ' HG3' HG12 ' A' ' 54' ' ' VAL . 28.4 pt20 -140.65 146.83 38.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 111.034 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.1 pt-20 -131.78 157.77 77.28 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.714 179.902 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.7 Cg_endo -65.37 145.21 82.68 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.618 2.212 . . . . 0.0 112.48 -179.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 17' ' ' TRP . 21.8 m -61.76 155.36 23.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.74 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.414 ' N ' HG22 ' A' ' 16' ' ' THR . 7.4 m-90 -99.1 91.46 5.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.077 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.628 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.8 mt -87.97 74.19 8.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.415 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.7 p -73.02 -3.18 24.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.156 -178.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -141.31 148.28 39.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.865 0.364 . . . . 0.0 111.643 -179.721 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.609 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.9 t -56.54 -50.28 88.7 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.407 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -57.34 -44.04 46.6 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 121.97 1.78 . . . . 0.0 111.866 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.24 -36.91 85.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.206 0.527 . . . . 0.0 110.184 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.628 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.87 -59.05 5.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.026 179.499 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.0 mtp -60.55 -27.19 67.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.212 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 19.8 mt-10 -70.66 -49.29 48.87 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.746 0.308 . . . . 0.0 110.547 179.843 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.57 ' O ' HG22 ' A' ' 31' ' ' THR . 9.5 m-85 -61.52 -34.16 75.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.243 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 36' ' ' ILE . 50.0 mt -72.99 -37.06 52.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.126 0.488 . . . . 0.0 109.939 178.345 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.01 -19.43 60.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.959 -179.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.61 23.95 4.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.297 -179.651 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.674 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.1 t -169.96 153.33 4.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.518 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.542 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.2 tt0 -63.92 -80.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.669 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.544 HG13 HD11 ' A' ' 83' ' ' LEU . 16.9 t -91.86 134.15 31.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.489 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.43 126.06 22.11 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.195 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.474 HG21 HG12 ' A' ' 111' ' ' ILE . 48.9 t -114.21 129.13 70.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.811 178.546 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.559 HD12 HD11 ' A' ' 28' ' ' ILE . 24.2 mt -135.59 137.17 49.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.439 -177.524 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.527 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.61 98.71 1.89 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.427 179.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.48 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 45.7 m-85 -84.62 93.05 8.3 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.302 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.2 m-85 -112.33 145.86 39.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.351 -177.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -93.81 -4.95 49.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.516 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.1 t70 -152.68 118.39 5.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.599 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.518 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.4 mt -88.15 45.8 1.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 111.336 -179.295 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 45.4 mt-10 -136.03 9.06 3.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.125 179.161 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.779 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.7 pt -92.27 157.52 40.48 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.152 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.49 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.3 Cg_exo -52.53 -27.94 34.36 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.855 2.37 . . . . 0.0 112.865 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.779 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.47 -37.79 87.29 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.936 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.684 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.51 -57.35 25.63 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.654 -178.833 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.659 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -59.39 -38.97 80.94 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.794 1.663 . . . . 0.0 111.37 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -63.26 -35.19 71.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.89 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.7 tp -74.61 -53.35 9.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.73 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -54.64 -21.81 11.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.009 0.433 . . . . 0.0 110.04 178.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 t -85.89 -45.01 11.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.491 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.583 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.31 -25.83 66.07 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.296 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.4 t -52.39 -49.92 40.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.999 179.286 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.457 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 31.3 mt-30 -74.91 -9.59 58.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.721 -179.877 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.1 mtpp -94.83 -19.35 20.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.09 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.569 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 70.4 m-85 -135.96 63.03 49.61 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.476 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.4 -43.15 56.36 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.629 2.219 . . . . 0.0 111.632 179.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.89 -42.66 92.43 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.338 179.188 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.8 t -64.47 145.27 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.674 ' HB2' HG21 ' A' ' 31' ' ' THR . 29.9 t -83.15 98.94 9.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.033 0.444 . . . . 0.0 111.072 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.52 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.0 p90 -66.47 126.66 29.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.1 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.55 161.34 28.37 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.145 179.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.416 HD11 HG13 ' A' ' 47' ' ' VAL . 4.9 tt -159.98 144.01 5.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.474 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 31.1 t -148.05 159.52 43.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.006 0.431 . . . . 0.0 111.705 -179.306 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 50.6 p -140.46 -2.56 1.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.086 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.43 141.11 55.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.744 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.0 m -62.99 -50.91 68.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.553 -179.417 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -48.95 -44.61 40.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.638 -179.37 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.517 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.3 t -70.01 -54.4 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.909 0.385 . . . . 0.0 110.766 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -57.97 -14.51 6.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.303 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 76.4 m -91.62 -40.14 11.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.227 178.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -60.68 -39.67 89.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.38 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.411 ' HB2' HG12 ' A' ' 76' ' ' ILE . 93.0 m-85 -93.09 13.88 19.58 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.444 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 m120 54.8 26.2 7.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.582 179.519 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.717 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.6 mm -61.19 120.7 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.01 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.5 p -140.74 58.28 1.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.323 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.47 44.26 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.643 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.603 ' HB2' HG21 ' A' ' 99' ' ' ILE . 35.2 m-20 51.75 43.49 29.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.284 0.564 . . . . 0.0 110.353 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.717 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.4 m -68.66 152.28 45.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.786 -178.646 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.527 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.2 mt -119.21 115.68 48.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.97 177.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.48 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 72.5 m -104.11 131.03 51.81 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.722 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.658 ' HG ' HD23 ' A' ' 92' ' ' LEU . 1.9 tp -106.96 102.16 11.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.492 177.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.1 t80 -95.73 119.68 34.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.806 -179.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.475 HH12 HD12 ' A' ' 116' ' ' LEU . 4.4 mtm180 -102.97 80.86 1.91 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.673 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 85' ' ' ARG . 4.7 tp -24.87 -59.14 0.06 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.351 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.542 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.13 -62.51 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.088 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -95.35 2.88 54.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.087 0.47 . . . . 0.0 110.797 -179.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 52.42 33.13 12.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.445 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 12.7 mm-40 -79.37 158.2 27.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.84 99.1 3.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.953 0.406 . . . . 0.0 110.885 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.658 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -87.59 107.6 18.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.747 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -90.89 95.12 9.96 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.572 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.572 HD21 HD13 ' A' ' 102' ' ' ILE . 4.6 tt -79.6 76.98 6.22 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.3 mt-10 -78.46 -165.44 0.7 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -176.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.483 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -46.03 -50.02 15.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.484 -179.233 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -47.83 -17.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.963 0.411 . . . . 0.0 110.943 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 96' ' ' ASP . 13.7 m-20 -125.65 -13.67 6.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.392 -179.735 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.603 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.1 mm -91.87 -46.31 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.559 0.219 . . . . 0.0 111.561 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -48.82 -31.05 6.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.913 0.387 . . . . 0.0 110.739 179.783 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 57.0 m -131.25 45.55 2.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.072 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.572 HD13 HD21 ' A' ' 94' ' ' LEU . 8.1 tp -78.61 146.39 8.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.79 -179.452 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.427 ' N ' HG13 ' A' ' 102' ' ' ILE . 6.1 m-20 -141.37 148.8 40.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.266 178.616 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.13 -37.36 9.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 110.593 -179.598 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -61.44 -49.2 77.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.401 178.722 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -58.66 -60.47 3.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.151 -179.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.802 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.93 -55.72 10.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.006 0.432 . . . . 0.0 110.264 -179.954 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.3 m -58.35 -29.57 66.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.819 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.515 ' HD3' HD13 ' A' ' 113' ' ' ILE . 1.7 tmt_? -72.15 -66.56 0.63 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.184 179.713 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -42.05 -44.12 3.46 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.05 179.147 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.474 HG12 HG21 ' A' ' 35' ' ' VAL . 96.7 mt -62.5 -55.02 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.517 178.386 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -55.25 -17.85 5.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.325 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.599 HG22 ' ND2' ' A' ' 114' ' ' ASN . 1.4 mp -91.01 -36.0 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.856 -179.185 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.599 ' ND2' HG22 ' A' ' 113' ' ' ILE . 61.7 m-80 -119.33 26.4 9.46 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.9 p -79.92 46.12 0.77 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.044 0.449 . . . . 0.0 110.306 178.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.475 HD12 HH12 ' A' ' 85' ' ' ARG . 57.0 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.413 -179.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.777 0.322 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.621 HG22 ' HG2' ' A' ' 3' ' ' GLU . 11.5 p -87.84 141.28 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.051 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.621 ' HG2' HG22 ' A' ' 2' ' ' VAL . 15.8 mm-40 60.6 -84.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.354 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.482 ' HA ' ' HE3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -88.34 -174.2 4.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.185 -179.687 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.3 m -83.81 -165.51 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 t -64.56 -61.75 2.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -149.24 -36.87 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.141 179.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.45 -163.89 24.14 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.644 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.65 143.92 98.12 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.665 2.243 . . . . 0.0 112.318 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.24 110.78 3.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.598 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.87 -24.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.924 0.392 . . . . 0.0 110.592 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.498 ' HB1' ' NE2' ' A' ' 55' ' ' GLN . . . -53.66 92.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.31 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.589 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.6 pt20 -50.31 155.88 0.94 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.537 179.893 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.47 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.3 pt-20 -124.67 158.63 61.49 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.369 179.641 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.482 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 35.4 Cg_endo -65.48 142.62 72.56 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.421 2.081 . . . . 0.0 112.611 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.5 m -60.76 151.45 29.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.695 -179.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -95.17 92.01 6.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.083 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.631 HD22 ' HA ' ' A' ' 24' ' ' ALA . 65.2 mt -88.72 77.64 7.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.411 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.6 p -77.26 -3.19 38.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.023 -179.113 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -141.69 147.33 37.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.948 0.404 . . . . 0.0 111.774 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 22.1 t -55.22 -50.02 88.98 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.633 179.875 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.89 -45.82 30.17 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.939 1.759 . . . . 0.0 111.793 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.23 -33.99 76.69 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.205 0.526 . . . . 0.0 110.149 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.631 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.52 -59.39 4.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.116 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 47.3 mtm -61.1 -26.33 67.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.131 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 22.9 mt-10 -71.23 -52.07 21.08 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.702 0.286 . . . . 0.0 110.437 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -59.79 -30.71 69.08 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.122 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.504 HD11 HD12 ' A' ' 36' ' ' ILE . 47.2 mt -74.59 -37.81 44.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.965 178.188 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.6 -18.56 61.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.813 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.89 27.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.057 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.617 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.7 t -169.05 156.65 7.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.328 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.623 ' HG3' HG13 ' A' ' 87' ' ' VAL . 27.6 tt0 -75.56 -37.2 60.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.657 179.617 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.545 HG13 HD11 ' A' ' 83' ' ' LEU . 18.7 t -132.29 131.45 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.291 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -137.25 128.27 27.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.032 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.471 HG21 HG12 ' A' ' 111' ' ' ILE . 52.7 t -116.03 127.92 73.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.692 178.39 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.504 HD12 HD11 ' A' ' 28' ' ' ILE . 20.6 mt -133.79 137.08 53.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.781 -177.251 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.85 96.29 1.61 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.371 179.726 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.0 m-85 -81.51 88.55 6.17 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.524 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -108.43 142.57 38.59 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.194 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -90.29 -8.97 49.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.497 ' O ' HG12 ' A' ' 44' ' ' ILE . 15.6 t70 -148.54 119.28 7.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.521 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.555 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.5 mt -89.06 45.17 1.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.131 0.491 . . . . 0.0 111.588 -179.279 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.5 mt-10 -135.31 8.28 3.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.069 178.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.841 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.5 pt -92.19 156.09 42.24 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.169 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.518 ' O ' HD12 ' A' ' 49' ' ' ILE . 86.3 Cg_exo -49.78 -31.32 25.62 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.794 2.329 . . . . 0.0 112.807 179.684 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.841 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -59.14 -37.38 77.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.29 -178.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.696 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.5 t -62.28 -58.3 18.17 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.578 -178.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.696 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.5 Cg_exo -58.97 -40.94 66.69 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.697 1.598 . . . . 0.0 111.272 179.187 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.947 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -60.46 -35.5 63.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.738 179.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.583 ' O ' HG23 ' A' ' 54' ' ' VAL . 49.0 tp -74.3 -53.75 9.06 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -53.83 -24.03 14.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.105 0.479 . . . . 0.0 109.946 178.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.0 m -82.97 -45.11 14.51 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.342 179.551 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.61 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.58 -26.41 66.94 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.368 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.589 HG12 ' HG3' ' A' ' 13' ' ' GLN . 62.3 t -53.16 -50.7 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.976 179.518 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.498 ' NE2' ' HB1' ' A' ' 12' ' ' ALA . 34.5 mt-30 -73.23 -10.97 60.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.617 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -93.96 -19.42 20.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.295 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.592 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 54.2 m-85 -135.88 61.79 43.38 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.472 -179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.02 -40.5 76.26 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.565 2.176 . . . . 0.0 111.415 179.175 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.17 -43.0 95.56 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.357 178.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.1 t -65.02 146.08 13.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 178.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.617 ' HB2' HG21 ' A' ' 31' ' ' THR . 37.5 t -83.1 95.73 8.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.053 0.454 . . . . 0.0 111.054 -179.61 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.482 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.8 p90 -61.42 128.9 38.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.75 179.49 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -148.84 160.98 28.58 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.251 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.5 tt -159.47 143.54 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.696 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.4 t -147.28 155.29 41.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.154 0.502 . . . . 0.0 111.833 -178.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 39' ' ' PHE . 81.4 p -138.77 -0.31 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.587 179.561 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -68.61 141.98 55.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.571 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 t -65.12 -51.34 61.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.411 -179.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -50.91 -42.05 59.05 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.551 -179.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HA ' HG22 ' A' ' 21' ' ' VAL . 57.4 t -71.15 -53.39 21.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.92 0.39 . . . . 0.0 110.596 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.05 -15.43 13.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.324 179.429 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.4 m -91.24 -40.6 11.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.359 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -61.13 -38.22 85.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.345 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -93.25 14.28 18.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.682 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 54.45 23.32 4.41 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.643 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.707 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.6 mm -57.72 120.05 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.961 179.754 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.2 p -139.01 57.36 1.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.492 -179.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.36 49.3 0.02 OUTLIER Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.738 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.598 ' HB2' HG21 ' A' ' 99' ' ' ILE . 34.3 m-20 48.17 43.68 18.79 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.207 0.527 . . . . 0.0 110.292 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.707 ' HB ' HG23 ' A' ' 76' ' ' ILE . 97.2 m -69.34 151.53 46.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.737 -178.373 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.581 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.9 mt -118.27 117.0 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.835 178.12 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.516 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.1 m -106.05 130.93 53.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.824 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.634 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -107.23 104.19 13.75 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.525 177.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.2 t80 -98.7 121.1 40.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.798 0.332 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.538 HH12 HD12 ' A' ' 116' ' ' LEU . 3.8 mtm180 -104.38 98.45 8.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.094 179.711 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tp -42.07 -50.46 4.7 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.783 -179.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.623 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.86 -65.21 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.516 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.442 ' HB2' HH21 ' A' ' 85' ' ' ARG . 9.7 m-20 -99.01 10.57 41.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.562 -179.315 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 85' ' ' ARG . 78.1 m-20 49.66 34.27 7.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.509 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 8.2 mm-40 -78.02 157.69 29.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.122 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -142.34 97.2 3.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.808 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.634 HD23 ' HG ' ' A' ' 83' ' ' LEU . 1.9 mm? -88.06 113.52 23.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.767 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -95.84 96.91 9.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.572 HD21 HD13 ' A' ' 102' ' ' ILE . 4.1 tt -80.98 78.76 7.77 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.626 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.0 mt-10 -80.77 -163.79 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.762 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.497 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 17.4 t70 -50.66 -37.7 42.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.047 -179.2 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -55.34 -14.93 2.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.118 0.485 . . . . 0.0 110.393 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -131.14 -13.76 3.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.605 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.598 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.8 mm -89.63 -32.98 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.612 0.244 . . . . 0.0 111.379 -179.376 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -51.51 -49.38 62.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.704 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.3 m -117.79 38.14 3.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.526 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.592 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 7.2 tp -63.93 147.0 12.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.645 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.465 ' N ' HG13 ' A' ' 102' ' ' ILE . 11.5 t70 -141.09 165.24 28.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.685 178.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.947 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -62.12 -35.57 79.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.144 0.497 . . . . 0.0 109.691 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.9 m -64.66 -47.5 78.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.222 178.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -59.31 -59.37 5.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.177 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.76 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.21 -55.62 14.49 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.937 0.399 . . . . 0.0 110.132 179.656 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.5 m -58.85 -28.65 66.29 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.82 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.549 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.9 tmt_? -71.93 -66.45 0.64 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.185 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -42.9 -43.71 4.22 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.166 179.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.471 HG12 HG21 ' A' ' 35' ' ' VAL . 95.4 mt -63.38 -54.69 29.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.551 178.452 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -54.52 -19.36 5.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.23 179.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.549 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -87.89 -37.67 10.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.939 -179.109 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -121.76 29.39 7.16 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.601 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 81.1 p -81.65 44.97 0.85 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.11 0.481 . . . . 0.0 110.232 178.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.538 HD12 HH12 ' A' ' 85' ' ' ARG . 52.6 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.185 -179.398 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.775 0.321 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.8 m -101.38 19.14 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.219 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -99.33 124.53 44.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.96 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 4' ' ' LYS . 11.4 mmpt? 55.72 42.85 28.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.992 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.1 t -149.05 30.23 0.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.687 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.6 m -146.81 87.67 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.995 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -121.13 -172.33 2.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.86 -152.82 33.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.279 -179.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -56.93 104.36 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.508 2.139 . . . . 0.0 112.062 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.33 110.2 3.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.546 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.78 -74.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.621 0.248 . . . . 0.0 110.779 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.0 -80.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.269 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.487 ' HG3' HG12 ' A' ' 54' ' ' VAL . 27.7 pt20 -167.23 148.0 5.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.482 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.7 pt-20 -131.87 158.4 75.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.985 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.499 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 38.8 Cg_endo -66.76 142.85 65.07 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.592 2.195 . . . . 0.0 112.389 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.3 m -61.81 152.87 30.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.765 -179.315 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.51 94.91 7.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.866 179.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.621 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.8 mt -90.52 71.48 6.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.373 179.855 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.0 p -70.92 -5.04 27.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.945 -179.23 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -137.53 146.49 44.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.007 0.432 . . . . 0.0 111.656 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.615 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.9 t -56.12 -49.17 94.7 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.377 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -58.11 -46.46 25.35 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.936 1.757 . . . . 0.0 111.869 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.68 -34.85 77.96 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.344 0.592 . . . . 0.0 110.251 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.621 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.8 -59.84 4.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.113 179.399 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 30.6 mtt -60.7 -25.88 66.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.207 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 31.3 mt-10 -71.27 -51.13 26.2 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.373 179.639 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -60.66 -30.32 69.83 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.159 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.517 HD11 HD12 ' A' ' 36' ' ' ILE . 45.6 mt -76.22 -37.01 31.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.96 178.15 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.02 -23.08 61.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.813 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.13 31.65 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.923 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.506 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.9 t -170.22 151.25 3.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.337 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.522 ' HG3' HG13 ' A' ' 87' ' ' VAL . 23.3 tt0 -70.73 -50.36 37.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.58 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.528 HG13 HD11 ' A' ' 83' ' ' LEU . 19.1 t -119.7 136.34 57.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.359 179.262 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.56 128.55 20.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.013 0.435 . . . . 0.0 112.119 -178.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG21 HG12 ' A' ' 111' ' ' ILE . 47.1 t -115.5 128.81 72.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.672 178.469 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.517 HD12 HD11 ' A' ' 28' ' ' ILE . 23.8 mt -135.03 136.08 52.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -177.306 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.58 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.48 97.24 1.78 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.455 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.4 m-85 -83.39 90.98 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.9 m-85 -110.5 142.71 41.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.037 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.463 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 50.8 mt-30 -91.04 -0.96 57.85 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.498 ' O ' HG12 ' A' ' 44' ' ' ILE . 26.6 t70 -157.59 119.39 3.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.571 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.495 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.2 mt -89.15 45.4 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.087 0.47 . . . . 0.0 111.386 -179.262 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.1 mt-10 -134.66 12.04 3.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.01 179.094 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.741 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.5 pt -95.53 158.29 34.75 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.483 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.487 ' O ' HD12 ' A' ' 49' ' ' ILE . 73.4 Cg_exo -52.73 -28.65 38.84 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.853 2.369 . . . . 0.0 112.721 179.42 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.741 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -61.63 -38.09 86.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.012 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.692 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -61.05 -57.69 24.48 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.681 -178.724 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.675 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.5 Cg_exo -59.46 -39.49 75.53 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.775 1.65 . . . . 0.0 111.431 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.7 mt -62.5 -36.06 73.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.008 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.586 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.1 tp -74.8 -54.07 7.99 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -53.45 -23.63 10.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.952 0.406 . . . . 0.0 110.025 178.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 t -84.27 -45.54 12.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.474 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.605 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.33 -25.6 64.31 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.342 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.2 t -51.89 -49.08 38.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.265 179.391 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.479 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 38.1 mt-30 -76.76 -9.08 58.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.738 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -94.94 -18.71 20.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.156 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.569 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.4 m-85 -136.86 63.21 44.49 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.368 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.55 -46.12 35.46 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.643 2.229 . . . . 0.0 111.643 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.82 -42.87 69.97 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.392 179.038 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -65.03 144.28 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.781 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.506 ' CB ' HG21 ' A' ' 31' ' ' THR . 46.8 t -82.35 98.79 9.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.078 0.466 . . . . 0.0 111.159 -179.554 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.499 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.1 p90 -65.35 126.72 29.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.009 179.728 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.504 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.73 161.98 28.46 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.187 179.861 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -160.57 143.3 4.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.2 t -146.18 156.67 43.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.183 0.516 . . . . 0.0 111.675 -179.066 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.449 HG21 ' HG ' ' A' ' 42' ' ' LEU . 52.2 p -139.17 -3.63 1.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.589 179.548 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.44 140.46 57.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.401 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.4 t -64.63 -47.64 77.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.68 -179.31 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -51.77 -43.68 63.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.73 -0.213 . . . . 0.0 111.554 -179.307 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.527 ' HA ' HG22 ' A' ' 21' ' ' VAL . 79.7 t -71.75 -52.37 25.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.722 0.296 . . . . 0.0 110.513 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.456 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -58.48 -15.0 9.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.24 179.271 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.7 m -92.61 -40.52 10.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.429 178.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -62.41 -33.08 74.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.428 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.414 ' HB2' HG12 ' A' ' 76' ' ' ILE . 28.7 m-85 -97.07 9.81 41.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.864 179.507 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.413 ' HA ' HD22 ' A' ' 75' ' ' ASN . 2.1 t-20 60.1 20.7 9.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.569 178.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.674 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.9 mm -58.36 117.92 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 179.818 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.9 p -138.38 56.78 1.71 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.283 179.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.22 45.45 0.02 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.677 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 12.2 m120 51.26 43.11 29.47 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.243 0.545 . . . . 0.0 110.398 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.674 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.5 m -69.05 151.08 46.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.673 -178.573 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.58 HG12 ' HA2' ' A' ' 37' ' ' GLY . 70.9 mt -118.32 116.8 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.882 178.045 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.5 m -105.89 130.88 53.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.808 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.612 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -105.37 99.73 9.33 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.389 177.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.1 t80 -92.63 121.85 34.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.583 179.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.504 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.0 mtm180 -106.41 85.56 2.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.83 -179.684 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.9 tp -26.51 -60.2 0.08 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.365 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.522 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -36.94 -71.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 O-C-N 123.448 0.467 . . . . 0.0 112.092 -179.161 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.04 5.32 41.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 110.687 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 51.12 33.44 9.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.148 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.504 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 14.1 mm-40 -75.64 164.77 25.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.727 179.535 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.79 89.01 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.836 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.612 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.6 mm? -76.6 111.71 12.38 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.544 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -94.48 97.53 10.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.488 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.548 HD21 HD13 ' A' ' 102' ' ' ILE . 4.4 tt -82.93 77.29 9.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.593 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.448 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.2 mt-10 -78.91 -165.12 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.512 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 19.4 t70 -51.67 -35.42 42.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.686 -179.291 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -56.57 -15.19 3.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.225 0.536 . . . . 0.0 110.24 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -130.33 -13.99 3.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.779 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.57 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.4 mm -89.44 -29.59 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.684 0.278 . . . . 0.0 111.514 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.52 -38.38 69.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.855 0.36 . . . . 0.0 110.961 -179.801 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.8 t -129.78 38.74 3.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.319 179.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.548 HD13 HD21 ' A' ' 94' ' ' LEU . 6.8 tp -64.02 141.74 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.559 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -137.24 149.81 47.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.531 178.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.889 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.67 -37.31 12.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.923 0.392 . . . . 0.0 110.337 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -61.88 -49.09 77.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.147 178.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -58.65 -61.31 2.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.23 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.73 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.18 -57.34 6.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 110.35 179.908 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.3 m -57.06 -30.38 64.23 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.8 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.506 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -70.91 -65.72 0.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.186 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -42.82 -40.91 3.05 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.044 179.277 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.459 HG12 HG21 ' A' ' 35' ' ' VAL . 96.2 mt -65.9 -56.29 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.247 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -53.21 -18.26 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.325 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.591 HG22 ' ND2' ' A' ' 114' ' ' ASN . 1.4 mp -90.31 -39.5 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.87 -179.108 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.591 ' ND2' HG22 ' A' ' 113' ' ' ILE . 67.8 m-80 -118.72 28.73 8.13 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.775 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.3 p -82.22 50.26 1.56 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.023 0.44 . . . . 0.0 110.35 179.224 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.495 HD12 HH12 ' A' ' 85' ' ' ARG . 67.2 mt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.265 -179.618 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.906 0.384 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.501 HG23 ' HG3' ' A' ' 3' ' ' GLU . 27.5 m -104.99 -10.33 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.178 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.501 ' HG3' HG23 ' A' ' 2' ' ' VAL . 46.2 mt-10 -120.67 146.69 46.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.0 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -135.12 16.94 3.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.718 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 t -126.51 117.93 23.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.967 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.5 m -69.07 103.86 1.98 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.821 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -65.22 147.0 54.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.96 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.56 -75.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.516 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.16 130.36 32.06 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.671 2.248 . . . . 0.0 112.353 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.0 158.36 19.59 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.282 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.27 -32.39 0.05 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.951 0.405 . . . . 0.0 110.782 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.17 -30.69 62.57 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.996 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.484 ' HG3' HG12 ' A' ' 54' ' ' VAL . 11.5 pt20 -173.45 145.91 1.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.687 -179.848 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 15.7 pt-20 -133.05 158.7 75.16 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.062 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 37.7 Cg_endo -67.78 145.44 69.08 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.739 2.293 . . . . 0.0 112.559 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 m -64.14 153.35 38.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.554 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -98.13 95.02 7.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.799 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 24' ' ' ALA . 44.7 mt -91.45 71.91 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.357 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.2 p -70.84 -4.28 23.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.169 -179.157 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -139.46 147.34 41.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.378 . . . . 0.0 111.661 -179.717 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 35.3 t -55.64 -49.69 91.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.559 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.68 -46.39 27.18 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.917 1.745 . . . . 0.0 112.053 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.79 81.45 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.176 0.513 . . . . 0.0 110.2 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.608 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.55 -58.84 5.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.121 179.328 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.6 mtp -60.37 -25.54 65.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.157 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -72.61 -51.16 20.82 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.608 179.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.4 ' O ' HG22 ' A' ' 31' ' ' THR . 8.5 m-85 -60.63 -30.73 70.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.199 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.511 HD11 HD12 ' A' ' 36' ' ' ILE . 53.4 mt -75.79 -37.96 36.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.052 178.417 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.85 -17.08 60.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.285 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.42 26.62 3.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.078 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.7 HG21 ' HB2' ' A' ' 61' ' ' SER . 10.2 t -167.86 153.09 6.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.54 -179.652 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.592 ' HG3' HG13 ' A' ' 87' ' ' VAL . 25.0 tt0 -66.79 -52.31 45.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.89 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.539 HG13 HD11 ' A' ' 83' ' ' LEU . 22.4 t -119.83 137.39 53.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.322 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.71 128.55 21.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.193 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG21 HG12 ' A' ' 111' ' ' ILE . 52.1 t -116.61 131.76 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.572 178.511 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.511 HD12 HD11 ' A' ' 28' ' ' ILE . 21.0 mt -136.62 136.73 48.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.487 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.593 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.34 97.53 1.83 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.549 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.1 m-85 -83.7 92.49 7.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.6 m-85 -112.95 140.44 47.76 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.166 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.467 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 51.7 mt-30 -88.93 0.33 56.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 44' ' ' ILE . 24.8 t70 -157.96 120.72 3.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.66 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.499 ' HA ' HG21 ' A' ' 47' ' ' VAL . 91.7 mt -90.62 46.53 1.34 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 111.428 -179.307 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.447 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 36.8 mt-10 -136.95 9.72 3.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 179.122 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.779 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.3 pt -92.97 157.01 39.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.313 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.471 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.4 Cg_exo -52.01 -25.26 21.75 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.943 2.429 . . . . 0.0 113.022 179.719 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.779 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.44 -38.59 90.3 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.669 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -59.95 -55.59 44.01 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.583 -178.776 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.632 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.96 -41.31 54.38 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.928 1.752 . . . . 0.0 111.502 179.218 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.3 mt -61.57 -34.6 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.208 179.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 54' ' ' VAL . 45.8 tp -73.93 -52.71 12.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -53.03 -26.96 17.39 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.9 m -80.07 -46.45 16.51 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.621 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.565 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.75 -25.99 65.31 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.446 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.8 t -53.1 -49.37 50.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.718 179.368 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -76.23 -9.7 58.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.666 -179.855 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -94.92 -17.8 21.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.116 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.566 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 68.3 m-85 -138.35 63.01 33.56 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.441 -179.845 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.01 -43.56 56.02 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.623 2.215 . . . . 0.0 111.651 179.145 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.23 -40.83 85.4 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.239 179.041 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.3 t -66.19 142.99 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.845 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.7 ' HB2' HG21 ' A' ' 31' ' ' THR . 42.1 t -80.79 96.8 7.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.959 0.409 . . . . 0.0 110.957 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.475 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.9 p90 -62.59 126.94 29.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.836 179.582 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.495 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.16 161.76 28.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.256 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.8 tt -161.24 142.24 3.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -147.59 154.14 40.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.1 0.476 . . . . 0.0 111.803 -178.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.454 HG21 ' HG ' ' A' ' 42' ' ' LEU . 68.4 p -135.57 -2.08 2.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.534 179.529 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.408 ' O ' HD13 ' A' ' 71' ' ' LEU . 23.9 t70 -67.18 142.48 56.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.717 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.1 m -65.95 -49.85 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.664 -179.461 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -50.47 -43.24 55.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.436 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.496 ' HA ' HG22 ' A' ' 21' ' ' VAL . 76.2 t -71.45 -53.21 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.668 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.457 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -58.52 -14.63 8.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.222 179.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 78.4 m -91.89 -41.2 10.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.252 178.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -61.22 -34.86 75.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.318 179.703 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 76' ' ' ILE . 47.7 m-85 -96.01 11.91 32.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.854 179.516 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 56.05 22.74 6.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.646 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.674 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.5 mm -59.03 120.21 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.951 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.1 p -140.7 55.2 1.59 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.333 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.75 45.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.458 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.618 ' HB2' HG21 ' A' ' 99' ' ' ILE . 13.1 m120 50.71 43.43 27.92 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.15 0.5 . . . . 0.0 110.44 -179.826 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.674 ' HB ' HG23 ' A' ' 76' ' ' ILE . 98.0 m -69.61 152.31 44.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.77 -178.495 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.625 HG21 HD21 ' A' ' 107' ' ' LEU . 62.8 mt -118.8 118.17 56.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.892 178.075 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.2 m -106.81 134.78 49.44 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.634 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -110.79 103.36 11.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.788 178.227 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -96.96 123.0 40.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.525 179.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.539 HH12 HD12 ' A' ' 116' ' ' LEU . 5.5 mtm180 -106.07 96.33 6.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.051 0.453 . . . . 0.0 110.187 179.803 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.4 tp -40.45 -50.2 2.88 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.558 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.592 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -44.66 -68.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.85 0.357 . . . . 0.0 111.908 -179.627 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.447 ' HB2' HH21 ' A' ' 85' ' ' ARG . 17.7 m-20 -92.85 17.76 10.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.442 -179.424 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.9 p30 43.11 31.3 0.34 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.043 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.511 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 13.7 mm-40 -76.59 162.48 27.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.824 0.345 . . . . 0.0 111.14 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -149.01 87.1 1.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.967 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.634 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -76.05 144.64 40.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.304 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -125.35 99.31 6.0 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.074 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.617 HD21 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -84.11 78.01 9.84 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.597 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.3 mt-10 -79.66 -165.79 0.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.476 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.6 OUTLIER -44.47 -52.58 7.76 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.618 -179.255 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.402 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 12.8 pt-20 -46.82 -17.06 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.51 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' OD2' ' HG3' ' A' ' 97' ' ' GLU . 36.5 m-20 -125.76 -13.98 6.3 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.41 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.618 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.6 mm -89.73 -35.41 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.112 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -48.25 -55.39 10.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.902 0.382 . . . . 0.0 110.852 -179.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.1 p -114.08 39.31 2.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.539 179.462 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.617 HD13 HD21 ' A' ' 94' ' ' LEU . 8.2 tp -61.14 142.57 15.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.515 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -134.92 149.76 50.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.572 178.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.89 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.32 -32.96 12.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.11 0.481 . . . . 0.0 110.102 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -63.9 -49.08 74.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.352 178.691 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 102' ' ' ILE . 29.7 mtpp -59.04 -59.84 4.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.278 -179.806 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.755 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.19 -56.19 12.09 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.071 0.462 . . . . 0.0 110.076 179.848 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.3 m -58.21 -28.86 65.21 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.776 179.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.459 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.4 tmt_? -71.35 -67.11 0.54 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.079 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -42.24 -43.34 3.38 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.158 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.459 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -64.35 -55.47 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.702 178.416 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -52.89 -22.9 6.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.481 0.658 . . . . 0.0 110.112 179.259 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.459 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -85.66 -36.96 11.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.009 -179.054 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.473 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.7 m120 -124.84 31.87 5.56 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.054 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 111' ' ' ILE . 89.1 p -83.6 36.93 0.56 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.189 0.518 . . . . 0.0 110.213 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.539 HD12 HH12 ' A' ' 85' ' ' ARG . 51.7 mt . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.212 -179.517 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.6 m -90.84 148.16 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.093 -179.926 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -136.75 -42.49 0.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.974 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -76.42 -68.21 0.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.697 179.946 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.5 p -109.26 162.02 14.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.825 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.2 t -121.64 120.32 34.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.177 -179.702 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.9 t70 55.21 84.78 0.07 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.124 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -107.99 158.51 14.83 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.457 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.97 96.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.53 2.153 . . . . 0.0 112.409 179.992 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.87 -87.07 0.11 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.299 179.827 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.04 -81.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.571 0.224 . . . . 0.0 110.59 179.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.16 104.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.507 179.678 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.652 ' HG3' HG12 ' A' ' 54' ' ' VAL . 24.9 pt20 -51.47 139.24 20.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.076 -179.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.508 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 -111.19 159.67 31.93 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.859 -179.958 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 29.4 Cg_endo -64.32 154.0 73.63 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.63 2.22 . . . . 0.0 112.525 -179.718 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -67.94 153.06 44.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.42 -179.765 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.99 84.15 2.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.727 179.696 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 46.8 mt -81.73 72.21 8.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.633 -179.723 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.1 p -70.63 -2.94 15.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.09 -179.013 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -142.27 147.63 36.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.083 0.468 . . . . 0.0 111.804 -179.603 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 60.6 t -55.47 -49.99 89.39 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.824 -179.999 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.3 Cg_endo -58.32 -44.84 34.97 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.035 1.823 . . . . 0.0 111.82 -179.899 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.23 -34.55 78.37 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.33 0.586 . . . . 0.0 110.229 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.2 -59.18 5.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.929 179.262 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 34.0 mtt -60.23 -27.82 67.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.244 -179.967 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -70.21 -49.88 45.72 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 110.603 179.807 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.531 ' O ' HG22 ' A' ' 31' ' ' THR . 6.6 m-85 -61.13 -32.95 72.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.892 179.237 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.526 HD11 ' CD1' ' A' ' 36' ' ' ILE . 48.4 mt -75.0 -37.35 40.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.034 178.478 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.32 -18.27 60.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.131 -179.705 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.2 27.31 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.131 -179.896 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.718 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.9 t -174.31 154.91 2.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.602 -179.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.492 ' HG3' HG13 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -64.58 -82.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.016 0.436 . . . . 0.0 110.719 179.556 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.561 HG13 HD11 ' A' ' 83' ' ' LEU . 18.1 t -89.6 134.34 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.758 -179.53 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.46 124.71 20.37 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.061 -179.216 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.524 HG21 HG12 ' A' ' 111' ' ' ILE . 46.4 t -113.61 128.16 70.61 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.921 178.702 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.526 ' CD1' HD11 ' A' ' 28' ' ' ILE . 26.8 mt -133.63 138.48 50.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.457 -177.289 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.68 95.9 1.41 Allowed Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.381 179.801 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.519 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 36.3 m-85 -81.99 89.33 6.39 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.294 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 13.6 m-85 -107.59 140.57 40.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.615 -177.769 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -88.9 -5.62 57.87 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.081 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.486 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.3 t70 -154.53 121.73 5.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.656 179.851 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.522 ' HA ' HG21 ' A' ' 47' ' ' VAL . 92.0 mt -90.04 45.29 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.014 0.435 . . . . 0.0 111.449 -179.354 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.441 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 11.1 mm-40 -134.83 11.78 3.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.068 179.245 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.734 HD12 ' HB3' ' A' ' 46' ' ' ALA . 4.0 pt -94.89 158.92 34.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.286 -179.955 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.511 ' O ' HD12 ' A' ' 49' ' ' ILE . 62.4 Cg_exo -54.86 -25.38 43.12 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.843 2.362 . . . . 0.0 112.803 179.497 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.734 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.43 -35.64 81.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.705 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.707 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -63.51 -55.87 31.33 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.648 -178.776 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 38.0 Cg_exo -60.84 -34.49 91.29 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.999 1.8 . . . . 0.0 111.598 179.65 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.843 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.4 mt -69.38 -35.35 66.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.635 ' O ' HG23 ' A' ' 54' ' ' VAL . 36.7 tp -73.61 -50.41 21.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.471 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -55.74 -20.32 14.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.304 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -84.43 -49.67 8.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.567 179.29 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.699 ' HG2' HD13 ' A' ' 107' ' ' LEU . 2.9 ppp? -57.67 -25.36 60.13 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.099 0.476 . . . . 0.0 109.91 179.556 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.652 HG12 ' HG3' ' A' ' 13' ' ' GLN . 55.0 t -52.87 -46.55 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.991 179.51 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -80.05 -9.85 59.73 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.533 -179.848 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.495 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 27.8 mtpp -93.55 -19.0 21.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.239 -179.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.618 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 70.8 m-85 -137.17 62.57 39.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.468 -179.291 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.64 -36.47 71.98 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.535 2.157 . . . . 0.0 111.366 179.025 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.85 -42.05 99.75 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.818 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.1 t -65.95 144.95 14.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.799 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.718 ' HB2' HG21 ' A' ' 31' ' ' THR . 46.7 t -83.24 98.82 9.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.108 0.48 . . . . 0.0 110.974 -179.613 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.496 ' HB3' HG22 ' A' ' 54' ' ' VAL . 6.4 p90 -64.8 129.05 38.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.025 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.502 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -147.1 161.46 28.46 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.087 179.862 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -162.25 144.07 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.823 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.519 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 44.8 t -149.77 155.61 40.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.144 0.497 . . . . 0.0 111.673 -179.262 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 70.2 p -136.94 0.03 2.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.39 179.281 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -69.53 138.91 53.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.506 179.841 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.4 p -63.14 -48.26 79.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.529 -179.459 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -49.98 -46.78 52.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.615 0.245 . . . . 0.0 111.571 -179.411 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.571 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.4 t -69.02 -53.96 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -58.32 -15.05 8.85 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.258 179.478 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.2 m -91.67 -39.23 11.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.362 179.041 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -62.84 -39.04 93.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.468 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -92.15 12.62 21.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.627 179.312 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 55.86 25.2 8.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.535 179.363 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.697 HG23 ' HB ' ' A' ' 80' ' ' THR . 42.1 mm -60.84 122.68 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.48 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.2 p -142.8 59.68 1.43 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.248 -179.824 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.29 43.46 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.571 179.856 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 24.6 m-80 52.41 44.26 30.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.177 0.513 . . . . 0.0 110.569 -179.821 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.697 ' HB ' HG23 ' A' ' 76' ' ' ILE . 95.6 m -69.71 151.34 45.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.404 -0.817 . . . . 0.0 112.804 -178.568 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.565 HG12 ' HA2' ' A' ' 37' ' ' GLY . 57.1 mt -116.85 116.6 52.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.132 178.155 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 74.4 m -104.56 135.27 46.29 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.626 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -112.07 102.58 10.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.296 178.822 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.2 t80 -96.03 119.67 34.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.448 179.547 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.514 HH12 HD12 ' A' ' 116' ' ' LEU . 5.6 mtm180 -103.49 81.39 1.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.958 -179.421 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 32' ' ' GLU . 11.6 tp -25.35 -58.73 0.06 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.026 -179.369 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.492 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.42 -72.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.408 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -83.44 3.69 30.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.009 0.433 . . . . 0.0 110.542 179.944 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 52.06 32.7 10.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.639 179.725 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.474 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 7.1 mm-40 -78.26 162.1 26.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.688 179.737 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -146.45 91.67 2.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.026 179.926 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.626 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -79.09 146.06 33.45 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.378 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -127.28 93.21 3.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.018 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.49 HD21 HD13 ' A' ' 102' ' ' ILE . 4.4 tt -79.01 77.69 5.46 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.689 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.6 mt-10 -78.18 -166.24 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.801 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.54 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.8 t70 -51.12 -36.74 42.1 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.86 -179.369 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.428 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 10.3 pt-20 -55.82 -14.75 2.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.193 0.521 . . . . 0.0 110.477 179.551 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.428 ' OD2' ' HG3' ' A' ' 97' ' ' GLU . 23.7 m-20 -130.12 -13.75 3.97 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.537 179.881 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 79' ' ' ASN . 19.6 mm -89.27 -29.96 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.316 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -55.16 -45.28 75.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 111.134 -179.804 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.6 m -121.74 37.66 4.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.454 179.774 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.7 tp -62.35 144.69 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.43 -179.842 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.422 ' N ' HG13 ' A' ' 102' ' ' ILE . 21.6 m-20 -139.9 150.09 44.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.73 178.881 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.843 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.56 -39.79 11.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.916 0.389 . . . . 0.0 110.617 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.1 m -61.89 -47.57 84.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.64 178.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -59.03 -57.09 14.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.366 -179.521 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.813 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.7 -57.34 9.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.966 0.412 . . . . 0.0 110.011 179.832 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.2 m -56.7 -29.62 62.61 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.98 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.488 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -70.69 -65.25 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.189 179.739 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -43.2 -43.61 4.77 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.938 179.167 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.556 HD11 HD22 ' A' ' 107' ' ' LEU . 26.0 mt -62.13 -56.32 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.438 178.249 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -53.87 -19.38 4.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.29 179.401 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.488 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.63 -35.71 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.956 -179.154 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.598 HD22 ' HG ' ' A' ' 92' ' ' LEU . 87.8 m-20 -126.6 31.25 5.38 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.463 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 111' ' ' ILE . 88.6 p -84.56 45.98 1.19 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.242 0.544 . . . . 0.0 110.071 178.848 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.514 HD12 HH12 ' A' ' 85' ' ' ARG . 55.5 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.455 -179.163 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 p -61.92 145.89 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.046 179.868 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -153.18 92.78 1.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.926 179.911 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -96.0 20.11 10.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.593 179.86 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.7 t 61.61 -86.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.264 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.0 t -146.43 141.29 26.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.85 0.357 . . . . 0.0 110.801 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.03 63.02 6.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.948 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.17 95.5 0.24 Allowed Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.414 179.976 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.38 142.97 92.83 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.639 2.226 . . . . 0.0 112.233 -179.836 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.85 51.58 1.63 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.591 179.972 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.0 -60.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 0.0 110.673 179.926 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.15 -81.77 0.02 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.489 179.655 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.563 ' HG3' HG12 ' A' ' 54' ' ' VAL . 26.2 pt20 -143.18 135.99 27.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 111.049 179.889 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.6 pt-20 -121.78 158.45 54.42 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.81 -179.723 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 38.0 Cg_endo -67.18 142.14 59.86 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.595 2.197 . . . . 0.0 112.473 -179.753 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.0 m -56.28 152.95 10.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.52 -179.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -99.84 83.07 2.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.856 179.852 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 24' ' ' ALA . 36.9 mt -80.87 73.24 7.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.527 -179.905 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.0 p -72.8 -4.75 33.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.937 -179.191 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -136.65 147.11 46.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.382 . . . . 0.0 111.65 -179.72 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 24.1 t -56.33 -49.81 91.22 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.493 -179.985 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.82 -46.04 29.02 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.849 1.699 . . . . 0.0 111.934 179.994 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.37 -35.44 80.42 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.211 0.529 . . . . 0.0 110.277 -179.944 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.595 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -63.49 -58.93 5.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.097 179.562 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 60.3 mtp -59.82 -27.31 66.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.103 -179.986 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -71.2 -50.44 33.02 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.661 0.267 . . . . 0.0 110.778 179.777 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -60.99 -31.89 71.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.976 179.283 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.526 HD11 HD12 ' A' ' 36' ' ' ILE . 47.2 mt -73.93 -37.26 47.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.883 178.269 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.92 -18.73 60.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.018 -179.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.12 29.61 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.642 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.9 t -169.49 152.23 4.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.389 -179.736 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.632 ' HG3' HG13 ' A' ' 87' ' ' VAL . 31.3 tt0 -70.33 -41.45 73.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.765 179.913 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.515 HG13 HD11 ' A' ' 83' ' ' LEU . 19.6 t -128.95 134.11 64.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.182 179.324 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.11 128.91 26.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 112.154 -179.052 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.448 HG21 HG12 ' A' ' 111' ' ' ILE . 43.3 t -116.92 127.14 74.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.502 178.325 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 28' ' ' ILE . 23.4 mt -133.25 136.16 55.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.45 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.603 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.12 97.38 1.83 Allowed Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.562 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.5 m-85 -83.57 91.69 7.48 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.408 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.2 m-85 -111.89 138.32 48.67 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.023 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.478 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 48.3 mt-30 -85.06 -9.5 57.91 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.87 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.463 ' O ' HG12 ' A' ' 44' ' ' ILE . 15.8 t70 -150.4 119.56 6.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.745 179.716 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.506 ' HA ' HG21 ' A' ' 47' ' ' VAL . 96.4 mt -87.89 44.06 1.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.023 0.44 . . . . 0.0 111.562 -179.153 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.417 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 36.8 mt-10 -131.97 11.52 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.237 0.541 . . . . 0.0 109.972 179.134 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.682 HG13 HG23 ' A' ' 47' ' ' VAL . 8.5 pt -93.96 161.61 29.38 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.517 -179.657 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.482 ' O ' HD12 ' A' ' 49' ' ' ILE . 51.6 Cg_exo -57.04 -25.22 62.09 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.843 2.362 . . . . 0.0 112.538 179.202 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.628 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.14 -38.77 91.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.478 -178.763 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 44' ' ' ILE . 2.1 t -59.81 -55.41 45.96 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -178.717 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.5 Cg_exo -60.88 -41.63 43.85 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.026 1.817 . . . . 0.0 111.567 179.199 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.879 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.9 mt -61.72 -34.2 61.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.149 -179.998 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.1 tp -74.98 -51.89 12.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.785 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -53.6 -26.0 19.9 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.094 0.473 . . . . 0.0 109.808 178.607 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 t -82.17 -46.39 13.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.642 179.6 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.578 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.67 -25.84 63.21 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.358 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 50' ' ' LEU . 52.5 t -52.29 -46.05 44.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.827 179.34 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.448 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 29.5 mt-30 -80.76 -10.12 59.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.735 -179.795 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -93.55 -17.12 23.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.153 179.837 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 49.3 m-85 -139.38 63.89 29.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.505 -179.854 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.78 -45.1 42.92 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.719 2.279 . . . . 0.0 111.713 179.052 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.23 -40.76 76.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.293 179.252 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.6 t -66.86 143.97 15.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.69 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.642 ' CB ' HG21 ' A' ' 31' ' ' THR . 42.2 t -82.42 97.96 8.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.987 0.422 . . . . 0.0 111.045 -179.633 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.483 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.4 p90 -64.2 127.24 30.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.722 179.71 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.501 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.82 162.7 28.56 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.133 179.887 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 tt -160.82 145.12 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.913 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 t -149.82 152.82 35.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.004 0.431 . . . . 0.0 111.597 -179.157 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 39' ' ' PHE . 81.7 p -135.87 -1.45 2.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.622 179.569 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.61 143.32 56.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.77 -179.918 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 81.7 p -65.7 -49.59 67.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.103 -179.556 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -50.79 -45.87 59.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.458 -179.352 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.496 ' HA ' HG22 ' A' ' 21' ' ' VAL . 62.3 t -69.48 -53.17 26.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.733 0.301 . . . . 0.0 110.737 179.935 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -58.55 -15.17 10.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.283 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.4 m -90.39 -40.97 11.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.223 178.63 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -60.67 -40.49 92.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.45 179.841 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.407 ' HB2' HG12 ' A' ' 76' ' ' ILE . 46.1 m-85 -90.51 11.44 21.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 179.605 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 55.96 25.1 8.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.482 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.672 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.7 mm -60.67 119.74 5.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 179.797 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.6 p -140.35 57.76 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.242 179.98 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.76 42.97 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.601 179.82 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.578 ' HB2' HG21 ' A' ' 99' ' ' ILE . 14.4 m120 52.67 42.38 31.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.194 0.521 . . . . 0.0 110.255 -179.726 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.672 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.9 m -68.74 152.83 44.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.806 -178.529 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.603 HG12 ' HA2' ' A' ' 37' ' ' GLY . 71.4 mt -119.76 117.54 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.979 178.206 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.5 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 72.4 m -105.75 130.42 53.75 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.871 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.642 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -106.49 101.16 10.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.619 178.036 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.7 t80 -95.89 120.51 36.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.769 0.319 . . . . 0.0 110.706 -179.954 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.6 HH12 HD12 ' A' ' 116' ' ' LEU . 5.0 mtm180 -103.24 97.95 7.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.045 179.881 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 tp -41.67 -51.79 3.99 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.598 -179.464 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.632 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -44.5 -65.67 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.395 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.46 ' HB2' HH21 ' A' ' 85' ' ' ARG . 7.6 m-20 -95.53 17.31 14.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.69 -178.977 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.4 p30 42.38 32.64 0.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.036 179.227 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 25.3 mm-40 -78.99 161.69 26.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.855 0.36 . . . . 0.0 111.33 -179.876 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -147.23 96.45 2.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.52 179.497 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.642 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.1 mm? -86.66 120.3 27.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.942 179.817 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.95 98.72 9.16 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.679 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.573 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -83.43 77.71 9.77 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.721 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.6 mt-10 -78.99 -164.7 0.64 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.801 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.526 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.8 t70 -51.39 -36.4 43.25 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.254 -179.175 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -56.95 -14.69 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.148 0.499 . . . . 0.0 110.265 179.558 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -129.64 -13.64 4.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.577 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.578 HG21 ' HB2' ' A' ' 79' ' ' ASN . 21.4 mm -91.24 -29.27 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.519 -179.492 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -51.7 -51.89 52.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 56.0 m -121.27 39.98 3.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.506 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.573 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -60.67 142.01 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.557 -179.704 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.445 ' H ' ' HD3' ' A' ' 106' ' ' LYS . 17.4 m-20 -134.25 150.71 51.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.428 178.752 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.879 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.74 -35.86 23.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.065 0.46 . . . . 0.0 110.4 179.993 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.6 m -62.4 -46.08 90.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.237 178.739 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.51 ' HZ3' HD12 ' A' ' 102' ' ' ILE . 8.3 mtpm? -60.97 -60.76 3.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.179 -179.79 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.79 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.48 -55.45 10.93 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.958 0.409 . . . . 0.0 110.04 179.844 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.9 m -58.51 -30.81 67.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.92 179.715 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -70.94 -65.71 0.7 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.195 179.677 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -42.91 -43.31 4.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.06 179.303 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.448 HG12 HG21 ' A' ' 35' ' ' VAL . 96.6 mt -63.28 -55.87 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.174 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.13 -18.42 3.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.305 179.259 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.469 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.41 -36.39 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.69 -179.305 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.636 HD22 ' HG ' ' A' ' 92' ' ' LEU . 91.7 m-20 -126.29 32.97 5.11 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.547 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.2 p -84.57 38.35 0.68 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.058 0.456 . . . . 0.0 110.243 178.801 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.6 HD12 HH12 ' A' ' 85' ' ' ARG . 58.6 mt . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.085 -0.959 . . . . 0.0 111.28 -179.445 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.5 p -108.0 142.45 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.191 -179.956 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -154.56 -31.7 0.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.004 179.842 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -57.38 130.51 46.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.091 -179.961 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 85.1 p 47.99 83.24 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.447 179.914 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.0 m -90.67 52.5 2.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 179.883 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -135.44 39.79 2.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.28 113.5 0.56 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.341 -179.969 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -56.13 101.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.419 2.079 . . . . 0.0 112.437 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.91 -133.66 11.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.693 179.802 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.01 -59.36 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 110.608 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.497 ' HB1' ' NE2' ' A' ' 55' ' ' GLN . . . 60.43 106.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.542 179.673 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.617 ' HG3' HG12 ' A' ' 54' ' ' VAL . 8.3 pt20 -54.38 163.97 0.77 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.525 179.95 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.491 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.8 pt-20 -138.98 159.08 68.4 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.476 179.79 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 42.6 Cg_endo -67.24 147.74 79.11 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.569 2.18 . . . . 0.0 112.628 -179.251 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.5 m -69.39 154.06 42.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.662 -179.494 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -97.16 87.73 4.28 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.251 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.1 mt -81.6 70.05 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.066 179.473 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.6 p -67.85 -0.44 4.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.626 -178.654 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 7.8 m-20 -145.9 147.83 32.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 111.65 -179.887 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.608 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 21.0 t -54.29 -49.83 88.21 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.504 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.6 Cg_endo -56.81 -47.53 22.96 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.07 1.847 . . . . 0.0 112.195 179.94 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.62 78.08 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.202 0.525 . . . . 0.0 110.508 -179.701 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.17 -58.7 5.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.169 179.355 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 68.3 mtp -60.98 -27.21 68.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.065 -179.861 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 25.0 mt-10 -71.33 -50.48 31.94 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.735 0.303 . . . . 0.0 110.596 179.777 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.564 ' O ' HG22 ' A' ' 31' ' ' THR . 7.5 m-85 -59.74 -34.59 73.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.904 179.303 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.576 HD11 HD12 ' A' ' 36' ' ' ILE . 44.3 mt -72.62 -37.78 57.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.946 178.288 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.56 -17.67 61.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.989 -179.768 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.1 26.41 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.222 -179.671 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.613 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.0 t -169.88 151.75 4.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.557 -179.881 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.564 ' HG3' HG13 ' A' ' 87' ' ' VAL . 15.6 tt0 -62.78 -76.42 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.598 179.751 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG13 HD11 ' A' ' 83' ' ' LEU . 16.0 t -96.49 138.71 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.459 179.538 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.59 124.11 15.85 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.991 0.424 . . . . 0.0 112.003 -179.26 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.431 HG11 HD11 ' A' ' 111' ' ' ILE . 50.0 t -112.62 129.85 67.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.435 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 28' ' ' ILE . 34.7 mt -135.74 137.13 49.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.041 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.91 96.69 1.66 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.461 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.451 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 38.1 m-85 -82.97 90.56 7.01 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.233 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.1 m-85 -110.23 145.82 36.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.363 -178.148 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.444 ' HG2' HD23 ' A' ' 71' ' ' LEU . 93.2 mt-30 -92.36 -6.5 50.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.839 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.514 ' O ' HG12 ' A' ' 44' ' ' ILE . 36.6 t70 -151.87 121.93 7.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.555 179.822 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.584 ' HA ' HG21 ' A' ' 47' ' ' VAL . 87.9 mt -90.57 46.49 1.34 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.158 0.504 . . . . 0.0 111.331 -179.319 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.438 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 38.9 mt-10 -135.68 7.11 3.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.937 178.977 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.754 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.1 pt -89.54 157.64 46.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.26 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.484 ' O ' HD12 ' A' ' 49' ' ' ILE . 70.6 Cg_exo -53.4 -26.05 33.99 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.92 2.413 . . . . 0.0 112.911 179.665 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.754 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.08 -36.95 85.95 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.977 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.72 HG23 HG13 ' A' ' 44' ' ' ILE . 3.2 t -60.99 -56.65 32.86 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.549 -178.915 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.68 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.2 Cg_exo -59.82 -41.26 56.06 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 121.754 1.636 . . . . 0.0 111.407 179.635 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.1 mt -61.29 -35.6 67.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.027 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.1 tp -72.98 -53.78 10.32 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.809 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -53.71 -24.6 15.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.086 0.47 . . . . 0.0 109.848 178.748 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -82.07 -45.57 15.06 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.623 179.615 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.605 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.83 -26.18 67.15 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.082 0.468 . . . . 0.0 109.74 179.582 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.617 HG12 ' HG3' ' A' ' 13' ' ' GLN . 61.1 t -52.76 -49.65 45.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.843 179.492 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.497 ' NE2' ' HB1' ' A' ' 12' ' ' ALA . 33.3 mt-30 -75.04 -9.41 58.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.637 -179.708 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -95.14 -18.67 20.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.059 179.586 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.586 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 64.3 m-85 -135.92 62.85 48.93 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.285 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.8 -42.51 62.82 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.701 2.267 . . . . 0.0 111.64 179.137 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.25 -37.23 86.26 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.657 179.147 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.2 t -69.89 144.8 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.121 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.613 ' CB ' HG21 ' A' ' 31' ' ' THR . 35.4 t -82.53 98.81 9.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.095 0.474 . . . . 0.0 110.932 -179.902 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.493 ' HB3' HG22 ' A' ' 54' ' ' VAL . 5.4 p90 -65.23 126.29 27.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.205 179.976 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.479 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.24 161.23 28.16 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.276 179.809 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -161.64 144.18 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.451 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.8 t -149.47 157.85 43.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.171 0.51 . . . . 0.0 111.845 -179.28 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.501 HG21 ' HG ' ' A' ' 42' ' ' LEU . 57.9 p -138.57 -0.24 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.481 179.488 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.25 137.13 54.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.343 -179.907 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.0 m -61.59 -50.7 71.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.501 -179.341 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -50.28 -40.91 49.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.568 -179.558 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.512 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.2 t -72.05 -54.93 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.028 0.442 . . . . 0.0 110.73 179.846 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.444 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.2 mp -58.38 -14.64 8.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.291 179.324 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.5 m -91.18 -41.72 10.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.178 178.719 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -59.9 -40.64 89.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.462 179.833 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 76' ' ' ILE . 89.9 m-85 -90.43 9.15 30.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.794 179.444 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 58.73 24.71 12.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.604 179.429 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.748 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.8 mm -60.97 119.62 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.986 179.53 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.0 p -138.55 56.04 1.72 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.262 -179.941 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.09 45.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.594 179.849 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.636 ' HB2' HG21 ' A' ' 99' ' ' ILE . 25.7 m-20 50.15 43.44 25.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.162 0.506 . . . . 0.0 110.397 -179.828 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.748 ' HB ' HG23 ' A' ' 76' ' ' ILE . 88.5 m -68.42 151.97 46.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.786 -178.665 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.581 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.9 mt -118.21 115.65 48.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.219 178.032 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 72.1 m -103.85 133.49 48.75 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -177.819 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.657 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -109.22 104.6 13.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.979 178.392 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.7 t80 -98.62 121.11 40.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.643 179.8 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.503 HH12 HD12 ' A' ' 116' ' ' LEU . 4.4 mtm180 -103.94 81.34 1.85 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.906 -179.726 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 7.2 tp -25.26 -59.63 0.06 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -179.455 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.564 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.53 -57.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.338 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -98.3 3.42 48.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.636 -179.735 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.2 t30 53.11 21.2 2.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.586 179.654 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 12.6 mm-40 -67.34 154.12 42.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.659 179.596 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -138.05 89.3 2.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.507 179.314 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.657 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -78.0 141.79 38.68 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.378 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.92 109.27 14.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.218 0.532 . . . . 0.0 112.401 -178.929 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.606 HD21 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -94.7 76.43 3.71 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.875 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 99' ' ' ILE . 24.0 mt-10 -77.39 -165.31 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -176.857 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.473 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.3 OUTLIER -46.52 -51.05 16.22 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.575 -179.191 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -48.15 -15.24 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.967 0.413 . . . . 0.0 111.262 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.413 ' N ' ' C ' ' A' ' 96' ' ' ASP . 17.0 m-20 -126.98 -13.66 5.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.367 179.792 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.636 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.5 mm -91.87 -38.97 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.479 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -50.43 -47.42 56.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.967 0.413 . . . . 0.0 110.71 179.74 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.8 m -116.61 38.83 3.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.507 179.89 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.606 HD13 HD21 ' A' ' 94' ' ' LEU . 8.5 tp -67.21 144.86 14.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.593 -179.541 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -139.44 148.83 43.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.321 178.48 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.887 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.37 -36.84 10.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.104 0.478 . . . . 0.0 110.444 -179.713 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.9 m -63.05 -47.55 82.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.342 178.977 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -59.81 -58.93 6.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.313 -179.694 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.764 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.23 -55.44 15.29 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.002 0.43 . . . . 0.0 110.117 179.869 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.2 m -58.39 -29.53 66.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.809 179.796 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.499 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -71.3 -66.11 0.66 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.225 179.609 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -42.82 -44.04 4.28 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.122 179.274 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.431 HD11 HG11 ' A' ' 35' ' ' VAL . 96.2 mt -62.92 -55.36 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.529 178.293 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -54.32 -18.41 4.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.374 179.223 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.499 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.0 -36.89 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.862 -179.059 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.5 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.0 m120 -125.37 31.03 5.65 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.464 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 97.1 p -82.62 37.76 0.53 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.076 0.465 . . . . 0.0 110.142 178.869 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.503 HD12 HH12 ' A' ' 85' ' ' ARG . 59.0 mt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.188 -179.425 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.547 ' HG3' HG12 ' A' ' 2' ' ' VAL . 13.5 tp10 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.804 0.335 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.547 HG12 ' HG3' ' A' ' 1' ' ' GLU . 7.2 p -170.33 -41.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.191 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 51.25 70.72 0.5 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.986 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -160.59 101.55 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 -179.782 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.1 p -130.12 143.19 50.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.778 179.827 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.9 m -137.53 -63.05 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.035 -179.935 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 57.39 76.91 0.3 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.022 -179.893 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.75 -72.05 0.83 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.462 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -59.81 141.33 96.57 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.462 2.108 . . . . 0.0 112.196 179.704 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.86 49.29 3.58 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.579 -179.96 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.55 -75.9 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.92 107.7 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.357 179.748 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.557 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.9 pt20 -58.81 164.45 2.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.503 -179.712 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.48 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.1 pt-20 -134.91 159.55 71.69 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.109 179.789 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 37.9 Cg_endo -66.83 145.68 75.62 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.308 2.005 . . . . 0.0 112.756 -179.541 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.4 m -62.54 147.52 48.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.524 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -92.99 84.3 4.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.739 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.62 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.4 mt -81.77 76.21 8.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.638 -179.913 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.8 p -76.02 -4.17 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.856 -179.255 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -139.37 147.28 41.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.994 0.426 . . . . 0.0 111.61 -179.738 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 44.2 t -55.76 -50.33 87.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.59 179.891 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -57.33 -45.11 37.01 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.986 1.791 . . . . 0.0 111.939 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.03 82.73 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.262 0.553 . . . . 0.0 110.285 -179.881 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.62 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.55 -59.0 5.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.05 179.513 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 59.7 mtm -60.41 -27.02 67.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.148 -179.928 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -70.98 -50.79 30.45 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.72 0.295 . . . . 0.0 110.571 179.594 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.415 ' O ' HG22 ' A' ' 31' ' ' THR . 9.9 m-85 -60.26 -31.42 70.2 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.197 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 36' ' ' ILE . 47.7 mt -74.18 -39.07 49.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.077 178.196 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.45 -19.71 60.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.071 -179.899 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.25 30.0 1.78 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.576 HG21 ' CB ' ' A' ' 61' ' ' SER . 10.0 t -169.85 154.34 5.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.42 -179.593 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.631 ' HG3' HG13 ' A' ' 87' ' ' VAL . 24.8 tt0 -71.8 -43.46 65.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.683 179.861 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG13 HD11 ' A' ' 83' ' ' LEU . 19.1 t -127.47 137.4 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.225 179.418 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.67 129.75 22.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.947 0.403 . . . . 0.0 112.062 -179.061 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.431 HG11 HD11 ' A' ' 111' ' ' ILE . 42.3 t -117.45 128.26 74.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.571 178.536 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.541 HD12 HD11 ' A' ' 28' ' ' ILE . 22.8 mt -133.66 136.18 54.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.47 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.585 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.81 95.97 1.57 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.517 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.6 m-85 -82.6 89.65 6.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.523 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.7 m-85 -108.55 139.24 43.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.538 -178.181 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.432 ' HG2' HD23 ' A' ' 71' ' ' LEU . 47.4 mt-30 -85.94 -4.52 59.19 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.915 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.4 t70 -153.95 122.05 6.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.619 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.632 ' HA ' HG21 ' A' ' 47' ' ' VAL . 97.9 mt -91.17 47.37 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.147 0.499 . . . . 0.0 111.375 -179.331 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.423 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.4 mt-10 -138.85 8.67 2.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.941 179.073 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.841 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.2 pt -92.91 154.45 41.91 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.061 179.753 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.504 ' O ' HD12 ' A' ' 49' ' ' ILE . 87.0 Cg_exo -48.24 -29.75 13.5 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.004 2.469 . . . . 0.0 113.242 179.82 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.841 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.37 -36.7 83.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.911 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.665 HG23 HG13 ' A' ' 44' ' ' ILE . 2.7 t -63.18 -56.62 26.18 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.747 -178.801 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.656 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.3 Cg_exo -59.86 -36.92 89.2 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.789 1.659 . . . . 0.0 111.42 179.534 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.6 mt -64.83 -36.52 77.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.909 179.73 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.593 ' O ' HG23 ' A' ' 54' ' ' VAL . 42.9 tp -72.46 -53.36 12.37 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.749 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -53.86 -22.26 9.45 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.072 0.463 . . . . 0.0 109.824 178.765 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -85.36 -44.83 12.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.555 179.668 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.593 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.92 -25.55 66.84 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.369 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.7 t -53.24 -49.41 52.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.988 179.411 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -75.09 -9.41 58.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.686 -179.885 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -95.23 -20.25 19.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.309 179.788 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.599 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 61.1 m-85 -134.69 61.12 46.38 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.508 -179.603 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.74 -40.17 74.83 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.506 2.137 . . . . 0.0 111.45 179.176 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.04 -40.85 96.05 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.764 -0.732 . . . . 0.0 111.449 178.963 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.3 t -67.65 144.58 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.798 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.576 ' CB ' HG21 ' A' ' 31' ' ' THR . 38.7 t -81.43 96.5 7.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.085 0.469 . . . . 0.0 111.157 -179.624 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.455 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.7 p90 -62.28 129.45 40.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.962 179.732 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.514 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -148.51 161.48 28.65 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.079 179.716 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.431 HD11 HG13 ' A' ' 47' ' ' VAL . 5.2 tt -160.53 143.07 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.813 0.34 . . . . 0.0 110.178 179.862 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.6 t -146.44 157.98 43.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.971 0.415 . . . . 0.0 111.678 -179.035 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.457 HG21 ' HG ' ' A' ' 42' ' ' LEU . 67.5 p -141.07 -8.78 1.01 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.766 179.804 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -64.48 142.79 58.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.789 -179.882 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.6 m -64.03 -47.74 79.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.567 -179.495 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -51.14 -46.09 61.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.514 -179.269 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.556 ' HA ' HG22 ' A' ' 21' ' ' VAL . 72.7 t -70.34 -51.54 37.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.812 0.339 . . . . 0.0 110.73 179.806 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.432 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -59.3 -14.63 12.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.187 179.371 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.0 m -91.97 -41.17 10.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.297 178.657 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -60.3 -41.99 94.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.657 179.933 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.417 ' HB2' HG12 ' A' ' 76' ' ' ILE . 51.2 m-85 -89.21 11.29 19.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.798 179.587 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 56.41 27.72 12.5 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.597 179.45 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.683 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.4 mm -62.67 124.3 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.961 179.755 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.1 p -142.78 59.31 1.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.444 -179.782 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.83 46.39 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.687 179.697 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 30.1 m-80 51.91 43.15 30.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.059 0.457 . . . . 0.0 110.469 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.683 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.8 m -68.87 152.01 45.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.661 -178.522 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.585 HG12 ' HA2' ' A' ' 37' ' ' GLY . 61.2 mt -118.97 116.28 50.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.906 177.985 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.509 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 72.8 m -106.15 132.67 51.95 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.83 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.668 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.1 tp -108.64 103.54 12.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.838 178.413 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -97.95 123.94 42.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.823 0.344 . . . . 0.0 110.863 179.992 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.51 HH21 ' HB2' ' A' ' 88' ' ' ASP . 2.3 mtm180 -107.35 100.81 10.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.092 179.833 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.9 tp -44.37 -52.69 7.49 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.687 -179.203 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.631 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.22 -64.33 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.015 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' HB2' HH21 ' A' ' 85' ' ' ARG . 5.8 m-20 -97.01 17.13 17.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.605 -179.044 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.9 p30 42.37 32.31 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.152 179.128 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.493 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 5.8 mm-40 -79.05 159.85 27.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.944 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.35 92.31 2.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.95 179.656 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.668 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.4 mm? -78.58 140.24 38.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.453 179.257 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.08 100.79 7.16 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.477 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.537 HD21 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -87.16 77.04 9.15 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.819 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.9 mt-10 -79.0 -164.85 0.66 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -176.93 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.496 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -46.38 -49.62 17.67 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.452 -179.369 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -47.62 -18.25 0.13 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.852 0.358 . . . . 0.0 111.165 179.762 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -125.29 -13.83 6.59 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.574 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.567 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.9 mm -90.44 -28.77 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.682 0.277 . . . . 0.0 111.475 -179.451 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -53.96 -48.87 69.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 82.5 p -119.61 36.72 4.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.435 179.783 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.537 HD13 HD21 ' A' ' 94' ' ' LEU . 6.2 tp -60.55 142.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.425 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.412 ' N ' HG13 ' A' ' 102' ' ' ILE . 24.6 m-20 -138.55 150.46 46.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.665 178.883 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.889 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.2 -37.25 15.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.968 0.413 . . . . 0.0 110.348 -179.632 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.4 m -62.11 -47.72 83.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.437 178.803 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -60.69 -60.78 3.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.169 -179.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.743 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -47.98 -55.84 9.06 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.923 0.392 . . . . 0.0 110.125 179.977 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.8 m -58.49 -31.62 68.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.523 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -70.39 -65.73 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.398 179.847 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -42.93 -43.62 4.22 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.014 179.282 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.431 HD11 HG11 ' A' ' 35' ' ' VAL . 96.1 mt -63.47 -55.84 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.529 178.167 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -53.41 -18.75 2.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.336 179.282 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.523 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.16 -37.84 11.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.833 -179.359 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.478 ' O ' HD21 ' A' ' 83' ' ' LEU . 15.4 m120 -123.55 30.92 6.07 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.821 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 111' ' ' ILE . 90.2 p -84.28 39.46 0.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.078 0.466 . . . . 0.0 110.282 179.013 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.481 HD12 ' NH1' ' A' ' 85' ' ' ARG . 77.3 mt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.146 -0.931 . . . . 0.0 111.29 -179.679 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.862 0.363 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.4 m -92.82 5.68 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.421 -179.807 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.592 ' HG2' ' HG3' ' A' ' 4' ' ' LYS . 38.8 tt0 -126.96 149.7 49.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.699 179.874 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.592 ' HG3' ' HG2' ' A' ' 3' ' ' GLU . 54.5 mtpt 58.71 34.44 23.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 -179.763 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.3 t -139.4 83.23 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.013 -179.837 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.2 t -115.1 -3.77 12.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 179.987 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -87.44 -52.54 5.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.975 -179.975 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.57 163.58 19.25 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.477 -179.898 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.35 172.35 1.95 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.725 2.283 . . . . 0.0 112.385 179.952 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.83 148.21 9.54 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.644 179.94 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.96 -67.12 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.682 0.277 . . . . 0.0 110.836 179.906 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.493 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . . . 59.88 105.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.58 179.429 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.518 ' HG3' HG12 ' A' ' 54' ' ' VAL . 1.1 pt20 -169.68 172.78 6.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.883 -179.727 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.498 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.8 pt-20 -121.76 158.81 53.38 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.176 -179.371 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 45.7 Cg_endo -69.47 143.74 53.26 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.831 2.354 . . . . 0.0 112.622 -179.701 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.7 m -63.37 151.29 41.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.544 -179.61 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -94.55 94.42 8.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.96 -179.934 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.647 HD22 ' HA ' ' A' ' 24' ' ' ALA . 48.6 mt -88.77 73.89 8.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.299 179.64 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.0 p -72.4 0.51 9.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.306 -178.927 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -145.63 148.56 33.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.928 0.394 . . . . 0.0 111.862 -179.78 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 57.6 t -56.06 -50.26 88.38 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.448 179.815 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.5 Cg_endo -58.23 -45.1 33.4 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.826 1.684 . . . . 0.0 112.035 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.59 81.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.257 0.551 . . . . 0.0 110.35 -179.927 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.647 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.09 -59.59 4.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.98 179.391 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.8 mtm -60.48 -25.94 66.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.156 -179.972 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 21.3 mt-10 -71.83 -49.94 34.06 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.695 0.283 . . . . 0.0 110.414 179.657 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.455 ' O ' HG22 ' A' ' 31' ' ' THR . 0.2 OUTLIER -60.06 -33.37 71.97 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.079 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.558 HD11 HD12 ' A' ' 36' ' ' ILE . 50.4 mt -72.33 -39.01 62.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.105 178.627 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.05 -21.33 60.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.994 -179.856 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.93 31.87 1.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.939 -179.878 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.566 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.1 t -170.8 151.29 3.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.328 -179.621 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.476 ' HG3' HG13 ' A' ' 87' ' ' VAL . 30.0 tt0 -68.27 -52.76 30.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.598 179.652 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.479 HG13 HD11 ' A' ' 83' ' ' LEU . 19.4 t -118.27 137.61 51.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.174 179.329 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.9 126.23 18.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.055 0.455 . . . . 0.0 112.191 -179.031 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.527 HG21 HG12 ' A' ' 111' ' ' ILE . 49.2 t -115.22 127.85 72.63 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.521 178.338 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 28' ' ' ILE . 32.6 mt -134.17 138.3 50.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.642 -177.165 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.555 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -101.4 97.54 1.66 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.45 179.773 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.463 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 39.3 m-85 -83.82 92.43 7.76 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.224 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.555 ' HB3' HD22 ' A' ' 79' ' ' ASN . 11.7 m-85 -112.49 139.32 48.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.485 -178.003 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.459 ' HG2' HD23 ' A' ' 71' ' ' LEU . 78.6 mt-30 -87.68 -3.22 58.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.691 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.431 ' O ' HG12 ' A' ' 44' ' ' ILE . 22.2 t70 -153.72 124.39 7.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.511 179.922 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.572 ' HA ' HG21 ' A' ' 47' ' ' VAL . 96.0 mt -94.92 47.34 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 0.0 111.528 -179.436 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 33.8 mt-10 -136.33 5.88 3.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.7 178.845 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.809 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.1 pt -88.46 156.31 50.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.083 179.884 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.507 ' O ' HD12 ' A' ' 49' ' ' ILE . 75.2 Cg_exo -51.78 -27.09 25.76 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.85 2.367 . . . . 0.0 113.078 179.797 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.809 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.7 -37.67 88.21 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.78 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.66 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -62.22 -56.15 33.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.752 -178.692 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.5 Cg_exo -60.13 -36.03 90.29 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.804 1.67 . . . . 0.0 111.488 179.65 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.876 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.3 mt -67.1 -34.81 71.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.995 -179.937 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.58 ' O ' HG23 ' A' ' 54' ' ' VAL . 44.6 tp -74.44 -50.98 16.23 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.893 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -55.29 -22.8 20.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.03 0.443 . . . . 0.0 109.994 178.77 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.8 m -84.89 -45.44 12.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.455 179.36 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.583 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.48 -25.62 64.59 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.198 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 50' ' ' LEU . 45.6 t -52.77 -47.75 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.119 179.329 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.493 ' NE2' ' HA ' ' A' ' 12' ' ' ALA . 35.9 mt-30 -78.31 -8.96 59.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.656 -179.855 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -94.51 -19.36 20.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.277 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.604 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 61.0 m-85 -136.03 62.88 48.38 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.623 -179.79 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.2 -43.35 53.91 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.689 2.259 . . . . 0.0 111.634 179.019 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.5 -42.03 93.72 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.413 179.355 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.7 t -65.31 144.53 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 178.876 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.566 ' CB ' HG21 ' A' ' 31' ' ' THR . 33.9 t -81.94 96.97 7.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.012 0.434 . . . . 0.0 110.95 -179.83 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.488 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.8 p90 -64.3 127.34 31.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.785 179.692 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.478 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -145.99 160.67 28.19 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.061 179.807 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.434 HD11 HG13 ' A' ' 47' ' ' VAL . 5.0 tt -160.98 142.59 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.788 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.463 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 39.9 t -147.78 158.77 44.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.218 0.532 . . . . 0.0 111.646 -179.094 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.446 HG21 ' HG ' ' A' ' 42' ' ' LEU . 76.3 p -139.49 -2.35 1.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.568 179.619 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -66.79 140.52 57.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.703 -179.977 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.6 m -63.98 -49.91 70.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.444 -179.465 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -50.3 -42.7 52.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.605 -179.458 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.584 ' HA ' HG22 ' A' ' 21' ' ' VAL . 58.9 t -71.92 -54.02 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.344 . . . . 0.0 110.791 179.832 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.459 HD23 ' HG2' ' A' ' 40' ' ' GLN . 5.9 mp -58.29 -14.61 7.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.339 179.331 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.7 m -91.78 -41.51 10.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.333 178.789 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -60.69 -39.64 89.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.496 179.78 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.445 ' HB2' HG12 ' A' ' 76' ' ' ILE . 61.0 m-85 -90.17 9.92 26.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.754 179.567 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.0 m120 57.71 25.28 11.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.672 179.386 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.69 HG23 ' HB ' ' A' ' 80' ' ' THR . 42.1 mm -61.73 121.77 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.149 179.805 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.1 p -140.63 58.42 1.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 0.0 111.184 -179.935 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.65 45.04 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.623 179.791 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.571 ' HB2' HG21 ' A' ' 99' ' ' ILE . 14.4 m120 51.07 44.17 28.74 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.125 0.488 . . . . 0.0 110.476 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.69 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.7 m -69.53 152.65 44.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.632 -178.688 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.555 HG12 ' HA2' ' A' ' 37' ' ' GLY . 58.9 mt -118.62 116.4 51.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.428 -0.805 . . . . 0.0 108.982 178.04 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.434 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 75.6 m -104.35 132.68 50.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -177.723 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.669 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -110.94 102.66 11.13 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.982 178.434 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 4.2 t80 -96.59 125.25 40.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.7 0.286 . . . . 0.0 110.392 179.723 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 5.6 mtm180 -107.63 85.8 2.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.034 -179.536 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.6 tp -27.42 -61.93 0.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.253 -179.286 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.476 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.29 -64.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.154 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -90.99 13.77 15.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.781 0.324 . . . . 0.0 111.32 -179.314 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 43.68 29.1 0.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.086 178.985 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.513 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 20.6 mm-40 -75.94 160.94 29.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.78 179.85 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -147.57 84.68 1.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.695 179.778 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.669 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -71.48 145.08 49.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.565 179.662 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -127.32 93.44 3.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.23 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.568 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -78.84 78.31 5.28 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.609 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' HG12 ' A' ' 99' ' ' ILE . 23.8 mt-10 -79.63 -164.35 0.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -176.915 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.504 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 22.7 t70 -51.09 -38.36 51.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.093 -179.246 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -55.22 -14.98 1.97 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.202 0.525 . . . . 0.0 110.213 179.552 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -129.82 -13.89 4.1 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.73 -179.716 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.571 HG21 ' HB2' ' A' ' 79' ' ' ASN . 24.2 mm -90.32 -30.04 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 111.294 -179.652 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.45 -33.73 68.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.6 m -133.68 39.64 3.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 179.816 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.568 HD13 HD21 ' A' ' 94' ' ' LEU . 7.1 tp -66.64 143.33 15.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.726 -179.676 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -138.33 148.93 45.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.421 178.857 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.876 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.71 -36.68 11.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.094 0.473 . . . . 0.0 110.508 -179.719 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.7 m -62.38 -46.79 87.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.27 178.785 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -61.16 -59.38 5.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.224 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.772 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.52 -54.4 18.14 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.995 0.426 . . . . 0.0 110.109 179.852 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.9 m -58.88 -31.1 68.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.761 179.765 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.468 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.6 tmt_? -71.0 -65.62 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.297 179.768 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -43.19 -43.57 4.74 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.147 179.34 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.527 HG12 HG21 ' A' ' 35' ' ' VAL . 85.2 mt -63.22 -55.24 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.259 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -54.84 -18.16 4.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.219 0.533 . . . . 0.0 110.203 179.305 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.468 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -89.59 -35.15 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.821 -179.302 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.62 HD22 ' HG ' ' A' ' 92' ' ' LEU . 89.6 m-20 -127.03 31.2 5.31 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.369 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 111' ' ' ILE . 89.1 p -84.42 36.48 0.59 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.034 0.445 . . . . 0.0 110.253 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.464 HD12 ' NH1' ' A' ' 85' ' ' ARG . 70.5 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.309 -179.46 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.69 0.281 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.53 HG23 ' HG2' ' A' ' 3' ' ' GLU . 35.1 m -133.52 -18.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 179.967 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.53 ' HG2' HG23 ' A' ' 2' ' ' VAL . 7.1 pt-20 -149.07 99.31 2.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.039 0.447 . . . . 0.0 111.088 179.886 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -164.36 -42.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.757 179.856 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 93.5 p 51.23 -166.76 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.193 -179.953 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.3 t 58.98 34.2 23.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.847 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -108.32 -42.81 4.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.827 179.772 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.15 -165.06 13.66 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.314 179.937 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.24 179.83 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.506 2.137 . . . . 0.0 112.287 179.989 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.88 -105.34 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.482 179.946 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -174.42 -44.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.929 0.395 . . . . 0.0 110.257 179.933 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.11 -80.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.841 179.431 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.555 ' HG3' HG12 ' A' ' 54' ' ' VAL . 11.2 pt20 -140.29 141.91 35.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.874 0.369 . . . . 0.0 110.981 179.937 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 14.4 pt-20 -127.94 159.53 66.12 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.421 179.858 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 35.5 Cg_endo -65.95 144.7 77.54 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.548 2.165 . . . . 0.0 112.798 -179.196 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.6 m -62.9 150.18 42.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.602 -179.602 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -94.31 97.77 10.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.903 179.697 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.616 HD22 ' HA ' ' A' ' 24' ' ' ALA . 59.6 mt -95.44 70.99 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.072 0.463 . . . . 0.0 110.632 179.882 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 p -68.68 -8.18 40.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.225 -178.885 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -137.12 150.28 47.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.979 0.419 . . . . 0.0 111.933 -179.421 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 20.9 t -58.49 -49.78 91.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.617 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -57.81 -43.26 51.14 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.91 1.74 . . . . 0.0 111.873 179.865 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.39 -36.99 85.64 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.196 0.522 . . . . 0.0 110.277 179.921 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.39 -57.37 11.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.028 179.262 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 65.4 mtp -62.08 -27.22 68.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.253 -179.941 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -70.28 -51.36 31.07 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.73 0.3 . . . . 0.0 110.381 179.747 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.446 ' O ' HG22 ' A' ' 31' ' ' THR . 8.4 m-85 -59.92 -33.18 71.53 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.147 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.51 HD11 HD12 ' A' ' 36' ' ' ILE . 52.9 mt -71.81 -38.24 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.907 178.241 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.06 -18.75 61.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.929 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.24 28.95 3.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.249 -179.824 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.589 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.8 t -168.58 151.55 5.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 -179.701 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.607 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.7 tt0 -68.86 -49.64 56.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.03 -179.968 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 83' ' ' LEU . 23.4 t -122.29 135.19 63.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.12 179.31 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.29 125.85 22.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.996 0.427 . . . . 0.0 112.022 -178.862 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.489 HG21 HG12 ' A' ' 111' ' ' ILE . 48.0 t -114.26 127.15 71.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.558 178.355 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.51 HD12 HD11 ' A' ' 28' ' ' ILE . 33.9 mt -132.95 139.36 49.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.735 -177.062 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.513 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.54 100.14 1.94 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.121 179.596 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.461 ' HE2' ' HB2' ' A' ' 82' ' ' CYS . 40.1 m-85 -86.84 94.56 9.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.387 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.4 m-85 -114.06 142.24 46.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.503 -177.898 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -88.32 -6.03 57.98 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.72 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' O ' HG12 ' A' ' 44' ' ' ILE . 9.6 t70 -151.4 125.75 9.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.618 179.606 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.647 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.2 mt -95.24 47.83 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.032 0.444 . . . . 0.0 111.502 -179.526 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -137.72 7.14 2.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.718 178.869 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.813 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.2 pt -90.51 155.41 46.12 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.194 179.939 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.494 ' O ' HD12 ' A' ' 49' ' ' ILE . 78.3 Cg_exo -50.38 -27.32 18.04 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.881 2.387 . . . . 0.0 113.246 -179.881 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.813 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.56 -37.52 87.84 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.892 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.708 HG23 HG13 ' A' ' 44' ' ' ILE . 3.1 t -61.79 -56.0 36.54 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.572 -178.895 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.663 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.4 Cg_exo -60.16 -39.44 68.97 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.833 1.689 . . . . 0.0 111.533 179.508 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.2 mt -62.99 -36.7 76.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.035 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.2 tp -72.43 -52.68 14.84 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.021 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -54.69 -22.28 13.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.037 0.446 . . . . 0.0 109.943 178.774 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.4 m -85.48 -44.12 12.99 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.494 179.501 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.609 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.52 -24.93 66.94 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.378 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.5 t -51.74 -47.22 39.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.962 179.319 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -77.43 -13.04 60.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.837 -179.776 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -91.45 -18.27 24.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.014 179.897 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.589 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 60.3 m-85 -137.22 62.74 39.88 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.466 -179.836 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.56 -45.15 43.11 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.643 2.228 . . . . 0.0 111.734 179.231 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.2 -42.86 83.43 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.545 179.148 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.1 t -64.29 144.51 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.667 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.589 ' CB ' HG21 ' A' ' 31' ' ' THR . 37.7 t -82.3 97.43 8.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.036 0.446 . . . . 0.0 111.137 -179.68 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.487 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.6 p90 -64.49 128.13 34.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.607 179.579 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.87 160.76 28.32 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.022 179.901 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -159.97 143.29 5.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.428 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 41.6 t -150.09 157.25 42.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.048 0.451 . . . . 0.0 111.558 -179.181 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.458 HG21 ' HG ' ' A' ' 42' ' ' LEU . 82.7 p -137.82 -3.33 1.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.619 179.777 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -65.55 139.72 58.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.627 -179.835 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.2 t -61.58 -50.39 72.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.209 -179.633 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -48.69 -47.77 40.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.665 -179.391 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.558 ' HA ' HG22 ' A' ' 21' ' ' VAL . 64.9 t -67.87 -55.02 18.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.772 0.32 . . . . 0.0 110.73 179.818 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 mp -56.86 -14.8 3.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.351 179.397 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.7 m -91.0 -41.75 10.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.281 178.764 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -60.82 -35.94 77.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.616 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.409 ' HB2' HG12 ' A' ' 76' ' ' ILE . 84.7 m-85 -95.88 14.25 24.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.805 179.621 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 55.49 25.11 7.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.771 179.067 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.685 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.4 mm -62.67 121.82 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.883 0.373 . . . . 0.0 111.243 179.981 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.5 p -142.46 59.28 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.117 179.959 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.28 44.93 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.586 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.645 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 29.2 m-80 51.79 43.83 29.76 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.222 0.534 . . . . 0.0 110.609 -179.944 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.685 ' HB ' HG23 ' A' ' 76' ' ' ILE . 87.5 m -69.31 151.65 45.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.55 -178.642 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.57 HG21 HD21 ' A' ' 107' ' ' LEU . 54.6 mt -117.7 117.54 55.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.158 177.931 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.461 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 71.2 m -108.06 133.2 52.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.566 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.649 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -108.55 104.96 14.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.752 178.268 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -98.95 120.84 40.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.881 0.372 . . . . 0.0 110.892 179.77 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.519 HH12 HD12 ' A' ' 116' ' ' LEU . 3.7 mtm180 -104.43 100.49 10.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.123 179.82 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.6 tp -43.78 -55.11 4.67 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.017 -179.362 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.607 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.3 -62.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.171 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -98.31 8.14 45.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.167 -179.618 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 85' ' ' ARG . 19.7 t-20 48.69 38.03 10.73 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.023 -179.914 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 7.1 mm-40 -82.25 160.72 22.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.765 179.691 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.2 94.3 2.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 179.462 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.649 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -81.94 139.51 34.56 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.291 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -120.28 114.55 22.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.315 0.578 . . . . 0.0 112.294 -179.385 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.483 HD21 HD13 ' A' ' 102' ' ' ILE . 3.8 tt -100.23 75.75 1.84 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.9 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' O ' HG12 ' A' ' 99' ' ' ILE . 22.5 mt-10 -76.98 -166.41 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.146 -176.785 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.483 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.4 OUTLIER -45.92 -51.21 13.61 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.249 -179.334 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -46.98 -17.02 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.286 179.653 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.406 ' N ' ' C ' ' A' ' 96' ' ' ASP . 10.8 m-20 -126.22 -14.17 6.01 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.551 -179.999 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.552 HG21 ' HB2' ' A' ' 79' ' ' ASN . 21.7 mm -90.91 -26.19 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.624 -179.322 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -58.18 -35.48 71.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.868 0.366 . . . . 0.0 110.971 -179.81 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.3 m -132.52 39.49 3.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.526 179.964 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.519 HG21 ' HB2' ' A' ' 46' ' ' ALA . 6.2 tp -64.16 142.07 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.438 -179.86 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -136.74 148.36 47.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.593 178.846 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.89 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.39 -35.57 5.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.034 0.445 . . . . 0.0 110.391 179.961 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -63.67 -49.02 74.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.441 178.891 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -59.2 -58.7 7.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.179 -179.88 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.721 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.18 -55.84 13.52 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.091 0.472 . . . . 0.0 109.966 179.881 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.0 m -58.39 -29.13 65.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.9 179.726 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.489 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -71.48 -66.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.172 179.588 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -42.59 -42.58 3.45 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.07 179.132 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.489 HG12 HG21 ' A' ' 35' ' ' VAL . 95.5 mt -64.28 -55.77 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.503 178.346 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.28 -18.62 4.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.319 179.41 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.489 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.32 -37.28 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.934 -179.023 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.404 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.1 m120 -122.44 28.75 7.25 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.595 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.1 p -82.3 52.85 2.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.09 0.472 . . . . 0.0 110.184 178.884 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.519 HD12 HH12 ' A' ' 85' ' ' ARG . 67.9 mt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.125 -179.344 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.783 0.325 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.462 HG23 ' HG2' ' A' ' 3' ' ' GLU . 20.3 m -137.5 -23.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 2' ' ' VAL . 21.8 mm-40 -124.96 27.14 6.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.064 179.946 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -131.14 54.14 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.799 179.875 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.6 m -143.6 20.14 1.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.971 179.976 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.9 m -148.0 -56.91 0.23 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.858 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.95 134.85 54.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.071 -179.888 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.73 -162.13 13.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.348 -179.912 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -51.66 111.91 0.7 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.631 2.221 . . . . 0.0 112.348 179.781 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.13 -160.63 36.71 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.548 -179.761 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' A' ' 12' ' ' ALA . . . -161.22 -24.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.028 0.442 . . . . 0.0 110.593 -179.917 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' A' ' 11' ' ' ALA . . . -49.78 -30.06 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.35 179.986 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.525 ' HG3' HG12 ' A' ' 54' ' ' VAL . 10.3 pt20 -168.36 153.19 6.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.204 -179.735 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.467 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.4 pt-20 -143.93 158.28 56.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.476 179.949 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HD3' HG21 ' A' ' 54' ' ' VAL . 42.0 Cg_endo -67.77 139.9 49.38 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.492 2.128 . . . . 0.0 112.535 -179.397 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.5 m -59.35 154.67 16.23 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.831 -179.52 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -97.11 90.6 5.21 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.023 -179.927 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 24' ' ' ALA . 51.5 mt -88.01 74.53 8.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.233 179.643 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.8 p -75.83 2.62 11.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.214 -179.167 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 9.7 m-20 -145.2 147.69 32.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 111.612 -179.813 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.3 t -56.47 -49.29 94.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.516 179.896 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 17.7 Cg_endo -59.39 -43.8 37.74 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.841 1.694 . . . . 0.0 111.975 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.18 -34.95 79.59 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.191 0.519 . . . . 0.0 110.317 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.619 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.93 -59.05 4.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.051 179.396 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 46.3 mtm -61.42 -27.17 68.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.16 -179.964 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.0 mt-10 -70.05 -49.77 47.85 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.756 0.312 . . . . 0.0 110.512 179.774 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.597 ' O ' HG22 ' A' ' 31' ' ' THR . 6.6 m-85 -61.42 -35.36 77.32 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.981 179.2 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.512 HD11 HD12 ' A' ' 36' ' ' ILE . 48.7 mt -71.19 -35.98 60.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.213 0.53 . . . . 0.0 109.802 178.324 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.7 -19.36 60.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.927 -179.915 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.17 25.49 4.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.211 -179.736 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.644 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.9 t -170.68 153.56 4.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.633 -179.8 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.514 ' HG3' HG13 ' A' ' 87' ' ' VAL . 21.3 tt0 -64.37 -80.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.727 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.571 HG13 HD11 ' A' ' 83' ' ' LEU . 19.6 t -92.14 135.0 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.498 179.693 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.6 126.12 21.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.035 0.445 . . . . 0.0 112.11 -179.107 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.431 HG21 HG12 ' A' ' 111' ' ' ILE . 45.6 t -114.76 130.93 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.71 178.51 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.512 HD12 HD11 ' A' ' 28' ' ' ILE . 25.9 mt -135.88 137.54 48.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.544 -177.385 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.585 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.39 97.68 1.76 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.519 179.907 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 12.5 m-85 -82.85 90.91 6.99 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.632 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.6 m-85 -110.85 138.64 47.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.224 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.475 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 78.6 mt-30 -84.59 -8.69 58.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.824 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.3 t70 -150.37 125.87 10.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.738 179.794 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.515 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.0 mt -93.41 46.68 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.422 . . . . 0.0 111.325 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.6 mt-10 -137.26 11.37 3.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.929 179.036 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.767 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.5 pt -94.03 158.1 36.74 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.014 179.984 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.505 ' O ' HD12 ' A' ' 49' ' ' ILE . 78.0 Cg_exo -53.47 -25.08 30.67 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.709 2.273 . . . . 0.0 112.93 179.951 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.767 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.53 -37.68 87.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.758 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.683 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -61.28 -55.45 43.51 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -178.754 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.2 Cg_exo -60.95 -40.41 52.89 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.045 1.83 . . . . 0.0 111.367 179.405 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.877 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -63.0 -33.79 62.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.042 179.973 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.62 ' O ' HG23 ' A' ' 54' ' ' VAL . 42.9 tp -75.26 -51.85 12.3 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.842 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -53.56 -25.85 18.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.218 0.532 . . . . 0.0 109.837 178.541 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 t -81.88 -47.53 12.66 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.589 179.895 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.613 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.14 -26.44 62.68 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.517 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 50' ' ' LEU . 52.6 t -51.68 -47.54 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.016 179.306 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -78.54 -11.88 59.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.681 -179.891 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 28.4 mtpp -92.12 -16.41 26.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.226 179.764 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.598 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 55.4 m-85 -138.71 63.18 31.72 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.478 -179.883 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.8 -44.47 47.92 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.636 2.224 . . . . 0.0 111.643 179.085 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.53 -38.85 82.94 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.542 179.209 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.0 t -68.76 144.28 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.175 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.644 ' HB2' HG21 ' A' ' 31' ' ' THR . 23.2 t -82.53 96.5 8.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.106 0.479 . . . . 0.0 110.816 -179.65 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.501 ' HB3' HG22 ' A' ' 54' ' ' VAL . 4.0 p90 -64.07 125.75 25.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.074 179.69 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -145.66 162.05 28.25 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.16 179.908 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.5 tt -158.16 142.19 6.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.811 0.339 . . . . 0.0 110.223 179.62 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.8 t -142.73 154.69 44.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.136 0.493 . . . . 0.0 111.706 -179.036 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.442 HG21 ' HG ' ' A' ' 42' ' ' LEU . 71.3 p -140.16 1.86 1.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.534 179.503 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -74.24 139.86 44.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.658 -179.786 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.3 m -62.17 -50.77 70.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.296 -179.694 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -49.65 -44.63 47.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.588 -179.449 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.498 ' HA ' HG22 ' A' ' 21' ' ' VAL . 67.6 t -69.8 -53.94 21.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.859 0.361 . . . . 0.0 110.687 179.856 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp -57.95 -15.43 8.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.396 179.385 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 86.4 m -89.81 -42.5 11.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.212 178.748 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -59.72 -36.92 77.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.45 179.694 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.412 ' HB2' HG12 ' A' ' 76' ' ' ILE . 65.4 m-85 -94.86 12.31 28.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.11 179.638 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.7 m120 57.29 20.77 6.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.67 179.063 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.654 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.3 mm -57.49 120.66 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.951 179.637 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.1 p -140.62 53.8 1.61 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.865 0.364 . . . . 0.0 111.312 -179.957 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.43 46.15 0.01 OUTLIER Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.68 179.839 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.62 ' HB2' HG21 ' A' ' 99' ' ' ILE . 13.6 m120 51.2 42.54 28.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.186 0.517 . . . . 0.0 110.404 -179.85 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.654 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.3 m -68.35 152.82 44.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.557 -178.658 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.585 HG12 ' HA2' ' A' ' 37' ' ' GLY . 60.7 mt -119.43 118.53 57.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.035 178.195 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.477 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 65.6 m -107.57 137.08 46.24 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.695 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.643 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.9 tp -111.47 103.49 11.85 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.092 178.702 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -96.65 117.96 32.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.664 179.644 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.467 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 4.5 mtm180 -101.94 81.37 2.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.761 -179.863 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 5.6 tp -25.05 -60.98 0.06 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.327 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.514 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.46 -62.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.137 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -94.43 1.07 55.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.011 0.434 . . . . 0.0 111.045 -179.5 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 51.13 38.81 21.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.313 179.684 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 6.3 mm-40 -87.52 157.54 19.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.574 179.658 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.03 101.51 4.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.938 179.735 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.643 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -90.4 115.81 27.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.704 179.319 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.79 111.27 23.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.734 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.554 HD21 HD13 ' A' ' 102' ' ' ILE . 5.4 tt -97.6 77.61 2.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.723 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.4 mt-10 -79.12 -164.74 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -176.786 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -45.66 -50.97 12.96 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.515 -179.173 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -46.55 -17.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.008 0.432 . . . . 0.0 111.128 179.747 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.414 ' N ' ' C ' ' A' ' 96' ' ' ASP . 17.0 m-20 -126.79 -13.78 5.77 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.484 180.0 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.62 HG21 ' HB2' ' A' ' 79' ' ' ASN . 27.4 mm -91.32 -42.11 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.464 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -51.9 -30.74 25.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.907 0.384 . . . . 0.0 111.052 179.935 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.5 m -131.36 36.09 3.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.277 179.68 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.7 tp -65.66 143.91 15.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.583 -179.818 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.411 ' N ' HG13 ' A' ' 102' ' ' ILE . 16.2 m-20 -139.2 147.58 41.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.39 178.719 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.877 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.71 -37.11 7.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 110.307 -179.829 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.1 m -61.83 -48.37 80.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.357 178.677 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -59.9 -61.23 2.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.367 -179.842 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.736 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.85 -55.89 8.75 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 110.386 179.894 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -58.75 -31.75 68.62 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.991 179.909 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.535 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.3 tmt_? -69.86 -65.32 0.74 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.308 179.777 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -43.59 -44.17 6.06 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.168 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.431 HG12 HG21 ' A' ' 35' ' ' VAL . 96.7 mt -62.29 -55.36 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.197 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.43 -19.04 4.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.522 179.31 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.535 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -87.29 -36.79 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.796 -179.294 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.446 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.9 m120 -124.91 29.86 6.05 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.784 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.8 p -82.67 46.73 1.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.121 0.486 . . . . 0.0 110.329 179.166 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 63.1 mt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.316 -179.379 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.809 0.337 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.9 m -80.01 162.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.305 -179.925 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -131.33 110.27 10.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.803 -179.912 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER 56.47 68.64 0.83 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 -179.76 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.8 t -118.03 39.86 3.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.867 -179.829 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.3 t 56.73 62.48 2.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.917 -179.954 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -88.15 -21.2 24.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.822 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.89 169.92 24.23 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.339 179.944 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.7 121.85 10.27 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.64 2.227 . . . . 0.0 112.229 179.942 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.94 28.4 1.42 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.578 -179.832 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.59 -24.94 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.026 0.441 . . . . 0.0 110.514 179.774 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 13' ' ' GLN . . . -62.89 84.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.024 179.811 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.52 ' HG3' HG12 ' A' ' 54' ' ' VAL . 30.0 pt20 44.84 114.62 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.85 0.719 . . . . 0.0 112.63 -179.872 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 -110.35 158.03 36.47 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.798 -179.748 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 37.9 Cg_endo -67.91 140.86 51.73 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.654 2.236 . . . . 0.0 112.407 -179.712 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 17' ' ' TRP . 23.2 m -55.1 155.0 5.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.892 -179.409 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.4 ' N ' HG22 ' A' ' 16' ' ' THR . 91.4 m95 -100.57 92.26 5.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.876 179.725 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.609 HD13 ' HA ' ' A' ' 24' ' ' ALA . 55.4 mt -90.2 73.41 7.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.433 -179.893 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.5 p -74.36 0.85 13.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.288 -178.858 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -143.49 147.17 34.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.729 -179.678 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.586 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 19.9 t -55.2 -51.01 83.3 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.413 179.973 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.2 Cg_endo -58.02 -44.18 41.91 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.905 1.737 . . . . 0.0 112.012 179.805 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.94 79.21 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.284 0.564 . . . . 0.0 110.35 -179.883 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.609 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -65.19 -58.48 5.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.984 179.515 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.7 mtm -61.28 -25.18 66.93 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.88 179.892 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -71.51 -51.68 22.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.357 179.613 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.574 ' O ' HG22 ' A' ' 31' ' ' THR . 0.3 OUTLIER -60.01 -33.82 72.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.929 179.282 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.533 HD11 HD12 ' A' ' 36' ' ' ILE . 51.6 mt -73.42 -37.99 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.951 178.492 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.17 -18.35 60.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.905 -179.933 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.4 24.73 4.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.19 -179.871 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.656 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.9 t -169.71 153.08 4.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.695 -179.792 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.528 ' HG3' HG13 ' A' ' 87' ' ' VAL . 18.2 tt0 -64.12 -77.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.609 179.774 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 83' ' ' LEU . 21.5 t -95.53 133.84 35.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.418 179.668 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.559 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -137.47 124.9 21.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.254 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.438 HG11 HD11 ' A' ' 111' ' ' ILE . 55.0 t -114.07 128.32 71.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.723 178.464 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.533 HD12 HD11 ' A' ' 28' ' ' ILE . 27.3 mt -135.05 138.53 48.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.534 -177.345 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.57 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.66 98.79 1.9 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.272 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.451 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 37.1 m-85 -84.23 91.02 7.63 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.291 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.5 m-85 -110.72 142.54 42.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.646 -178.065 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -86.63 -8.08 57.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.887 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -151.53 131.11 13.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.605 179.745 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.636 ' HA ' HG21 ' A' ' 47' ' ' VAL . 84.4 mt -97.75 47.58 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.109 0.48 . . . . 0.0 111.621 -179.539 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -137.09 5.22 2.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.689 178.773 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.811 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.6 pt -88.27 155.72 51.64 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.094 179.766 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.488 ' O ' HD12 ' A' ' 49' ' ' ILE . 72.3 Cg_exo -50.95 -29.06 25.94 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.89 2.393 . . . . 0.0 113.126 179.886 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.811 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -62.04 -37.44 84.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.831 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.709 HG23 HG13 ' A' ' 44' ' ' ILE . 3.2 t -61.9 -57.21 25.48 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.659 -178.787 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.693 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.3 Cg_exo -59.07 -38.57 86.51 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.759 1.639 . . . . 0.0 111.52 179.589 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -63.33 -36.48 76.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.047 179.936 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 54' ' ' VAL . 40.5 tp -73.98 -53.23 10.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.77 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -54.2 -22.59 11.86 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.816 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.2 t -85.32 -43.66 13.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.435 179.516 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.585 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.44 -24.85 66.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.253 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.0 t -51.97 -46.69 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.89 179.236 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.506 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 9.3 mt-30 -77.58 -12.6 59.98 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.905 -179.74 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -92.19 -18.16 23.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.332 -179.978 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 52.5 m-85 -137.37 63.31 41.45 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.547 -179.692 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.64 -46.43 33.41 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.71 2.274 . . . . 0.0 111.77 178.939 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.9 -42.08 78.59 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.658 179.328 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.9 t -64.27 146.61 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.87 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.656 ' HB2' HG21 ' A' ' 31' ' ' THR . 32.8 t -83.51 97.48 9.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.964 0.411 . . . . 0.0 110.924 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.51 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.2 p90 -66.02 126.17 27.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.49 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -146.32 161.62 28.35 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.195 179.81 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.6 tt -159.07 144.36 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.993 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.451 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 29.4 t -149.18 155.86 41.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.12 0.486 . . . . 0.0 111.762 -179.214 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.513 HG21 ' HG ' ' A' ' 42' ' ' LEU . 76.6 p -137.09 -0.8 2.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.613 179.387 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.92 136.33 53.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.566 -179.927 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 59.5 m -61.52 -48.66 80.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.577 -179.634 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -51.51 -41.27 60.88 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.51 -179.435 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.45 ' HA ' HG22 ' A' ' 21' ' ' VAL . 55.4 t -72.6 -53.61 18.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.915 0.388 . . . . 0.0 110.439 179.835 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.64 -14.56 8.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.23 179.261 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.2 m -91.84 -42.12 10.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.385 178.85 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -60.39 -39.49 87.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.422 ' HB2' HG12 ' A' ' 76' ' ' ILE . 88.5 m-85 -90.06 11.02 21.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.651 179.595 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.8 m120 58.03 24.97 11.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.52 179.373 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.747 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.9 mm -62.8 124.17 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.875 179.458 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.8 p -142.32 58.95 1.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.437 -179.887 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.09 45.3 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.823 179.854 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 26.8 m-80 52.04 44.03 29.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.174 0.511 . . . . 0.0 110.613 -179.86 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.747 ' HB ' HG23 ' A' ' 76' ' ' ILE . 86.6 m -69.16 154.22 42.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.533 -178.763 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.609 HG21 HD21 ' A' ' 107' ' ' LEU . 60.5 mt -119.72 117.8 55.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.16 178.156 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 72.8 m -106.99 134.68 49.78 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -177.787 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.635 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -110.78 103.79 12.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.663 178.17 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.3 t80 -97.93 118.03 33.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.634 179.909 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.543 HH12 HD12 ' A' ' 116' ' ' LEU . 4.5 mtm180 -101.22 80.08 2.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.462 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' ARG . 5.1 tp -23.91 -60.51 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.36 -0.836 . . . . 0.0 113.249 -179.417 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.528 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -39.97 -61.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.01 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -95.34 3.31 54.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.41 . . . . 0.0 111.034 -179.506 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 53.19 29.24 8.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.802 179.357 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 10.5 mm-40 -75.47 153.13 37.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.538 0.209 . . . . 0.0 110.643 179.721 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.54 95.98 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.718 179.858 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.635 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -87.44 114.53 24.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.976 179.917 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.39 110.53 23.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.087 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.566 HD21 HD13 ' A' ' 102' ' ' ILE . 4.3 tt -96.16 78.81 3.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.014 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.441 ' O ' HG12 ' A' ' 99' ' ' ILE . 30.6 mt-10 -78.78 -165.17 0.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -176.383 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.526 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 30.2 t70 -51.46 -35.28 39.03 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.951 -179.178 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -56.68 -15.33 4.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.206 0.527 . . . . 0.0 110.261 179.482 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -130.11 -14.09 3.93 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.531 179.923 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.572 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.9 mm -90.0 -27.67 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.789 0.328 . . . . 0.0 111.263 -179.517 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -57.13 -37.43 71.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.782 -179.862 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.5 m -131.95 38.17 3.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.562 179.673 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.566 HD13 HD21 ' A' ' 94' ' ' LEU . 7.6 tp -63.61 144.61 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.575 -179.602 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -138.37 149.64 45.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.45 178.603 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.887 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.73 -35.0 9.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.111 0.481 . . . . 0.0 110.48 -179.673 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.5 m -63.01 -48.53 78.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.49 178.761 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 102' ' ' ILE . 54.3 mtpt -59.66 -59.17 5.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.182 -179.703 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.739 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.1 -55.45 14.89 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.988 0.423 . . . . 0.0 110.18 -179.994 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.6 m -58.72 -29.48 66.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.714 179.836 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.519 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -71.11 -66.2 0.65 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.068 179.724 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -42.71 -44.73 4.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.057 179.275 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.438 HD11 HG11 ' A' ' 35' ' ' VAL . 96.5 mt -62.65 -55.2 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.535 178.387 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -54.37 -18.69 4.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.253 179.357 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.519 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.09 -36.21 8.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.898 -179.137 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.617 HD22 ' HG ' ' A' ' 92' ' ' LEU . 90.2 m-20 -125.35 30.33 5.83 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.3 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.1 p -83.53 48.48 1.42 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.135 0.493 . . . . 0.0 110.145 178.922 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.543 HD12 HH12 ' A' ' 85' ' ' ARG . 60.9 mt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.36 -179.362 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.785 0.326 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.48 131.75 70.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.038 -179.995 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -171.73 164.93 6.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.833 -179.896 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -89.29 50.58 1.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.83 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.1 m -156.74 130.03 8.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.922 -179.987 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 t -139.01 125.28 20.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.804 -179.982 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -142.37 26.73 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 -179.968 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.24 -166.02 29.97 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.572 -179.866 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.92 -173.55 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.647 2.231 . . . . 0.0 112.473 -179.939 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.54 -122.8 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.682 -179.931 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.04 -69.2 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.683 0.277 . . . . 0.0 110.6 -179.811 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.475 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . . . 57.32 99.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.367 179.687 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.505 ' HG3' ' CG1' ' A' ' 54' ' ' VAL . 0.6 OUTLIER -167.31 -179.93 4.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.825 -179.366 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.1 pt-20 -128.92 157.01 77.0 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.135 -179.542 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 36.4 Cg_endo -67.08 142.93 63.36 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.934 2.423 . . . . 0.0 112.827 -179.514 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.8 m -59.68 153.77 19.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.624 -179.838 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -98.53 97.5 8.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.129 -179.849 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 24' ' ' ALA . 46.8 mt -95.21 76.46 3.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.361 179.769 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.9 p -75.17 -2.49 28.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.297 -178.736 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -142.16 147.36 36.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.919 0.39 . . . . 0.0 111.727 -179.814 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 36.1 t -54.3 -49.5 90.14 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.663 179.983 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.07 -46.97 22.3 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.949 1.766 . . . . 0.0 112.147 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.92 -34.68 77.94 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.186 0.517 . . . . 0.0 110.388 -179.81 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.619 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.84 -59.97 3.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.122 179.389 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 67.5 mtp -60.4 -25.98 66.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.215 -179.897 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 25.1 mt-10 -73.07 -51.73 16.97 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 120.652 0.263 . . . . 0.0 110.675 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.499 ' O ' HG22 ' A' ' 31' ' ' THR . 7.0 m-85 -58.44 -33.35 69.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.117 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.556 HD11 HD12 ' A' ' 36' ' ' ILE . 45.0 mt -72.35 -40.04 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.901 178.104 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.81 -17.77 62.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.06 179.948 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.64 27.92 2.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.231 -179.828 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.639 HG21 ' HB2' ' A' ' 61' ' ' SER . 7.8 t -173.16 155.49 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.579 -179.626 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.551 ' HG3' HG13 ' A' ' 87' ' ' VAL . 19.6 tt0 -65.31 -76.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.681 179.838 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.537 HG13 HD11 ' A' ' 83' ' ' LEU . 21.0 t -95.38 137.98 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.42 179.661 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.545 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.97 125.94 18.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.039 0.447 . . . . 0.0 112.021 -179.142 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.504 HG21 HG12 ' A' ' 111' ' ' ILE . 51.6 t -115.57 129.53 71.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.828 178.526 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.556 HD12 HD11 ' A' ' 28' ' ' ILE . 26.5 mt -135.02 135.72 52.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.624 -177.341 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.4 99.81 2.24 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.335 179.633 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 11.7 m-85 -84.63 92.57 8.19 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.725 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 9.7 m-85 -114.69 142.67 46.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.309 -178.217 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -90.06 -8.64 50.98 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.7 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.494 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.5 t70 -148.12 118.96 7.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.742 179.761 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.501 ' HA ' HG21 ' A' ' 47' ' ' VAL . 93.9 mt -88.4 44.85 1.23 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.114 0.483 . . . . 0.0 111.516 -179.268 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 39.1 mt-10 -133.82 6.96 3.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.124 178.953 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.694 HG13 HG23 ' A' ' 47' ' ' VAL . 5.6 pt -88.14 159.48 47.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.191 179.89 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' HD12 ' A' ' 49' ' ' ILE . 54.3 Cg_exo -54.91 -26.07 46.95 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.763 2.308 . . . . 0.0 112.689 179.429 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.656 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.41 -38.7 91.94 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.883 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.694 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -59.69 -55.58 44.33 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.723 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.647 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.1 Cg_exo -59.75 -41.27 56.59 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.052 1.835 . . . . 0.0 111.403 179.185 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.905 HG23 ' HA ' ' A' ' 104' ' ' ALA . 8.9 mt -61.97 -35.01 65.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.194 -179.906 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 54' ' ' VAL . 47.2 tp -74.75 -50.93 15.59 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.959 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -54.98 -26.0 33.7 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.398 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 t -81.42 -46.12 15.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.734 179.859 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.58 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -60.21 -26.15 66.15 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.38 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 50' ' ' LEU . 47.7 t -53.87 -48.44 62.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.162 179.541 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.475 ' NE2' ' HA ' ' A' ' 12' ' ' ALA . 34.0 mt-30 -76.83 -9.35 58.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.588 -179.898 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -94.82 -19.56 20.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 179.719 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.599 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 73.4 m-85 -135.04 62.11 50.43 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.609 -179.548 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.4 -40.35 71.33 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.57 2.18 . . . . 0.0 111.379 178.996 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.42 -42.5 97.54 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.323 179.068 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.9 t -65.49 144.83 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.084 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.639 ' HB2' HG21 ' A' ' 31' ' ' THR . 24.1 t -82.65 96.6 8.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.095 0.474 . . . . 0.0 110.967 -179.554 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.54 ' HB3' HG22 ' A' ' 54' ' ' VAL . 5.2 p90 -64.28 129.39 39.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.106 179.805 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.83 161.98 28.8 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.097 179.667 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 tt -160.99 143.03 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.808 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.1 t -145.67 155.66 43.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.109 0.481 . . . . 0.0 111.917 -178.935 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 78.8 p -138.89 6.16 2.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.655 179.505 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.09 144.42 40.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.706 -179.925 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -65.64 -54.39 28.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.384 -179.547 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -49.04 -40.0 29.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.631 -179.364 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.576 ' HA ' HG22 ' A' ' 21' ' ' VAL . 68.3 t -72.37 -55.27 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.857 0.361 . . . . 0.0 110.603 179.69 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.3 -14.78 8.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.517 179.461 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.6 m -89.22 -48.04 7.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.721 179.101 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -59.03 -33.58 70.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.57 179.837 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 76' ' ' ILE . 40.7 m-85 -92.82 8.24 40.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.547 179.235 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 57.32 23.69 9.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.632 179.51 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.697 HG23 ' HB ' ' A' ' 80' ' ' THR . 34.3 mm -61.22 120.9 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.012 179.652 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.8 p -141.3 58.43 1.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.308 179.825 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.32 42.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.533 179.815 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.601 ' HB2' HG21 ' A' ' 99' ' ' ILE . 39.9 m-20 52.77 42.43 31.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.267 0.556 . . . . 0.0 110.151 -179.669 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.697 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.4 m -67.97 154.36 41.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.682 -178.472 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.588 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.5 mt -120.32 116.95 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.271 178.271 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.7 m -105.93 137.09 44.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.857 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.668 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -112.98 105.68 13.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.253 178.671 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.2 t80 -98.18 123.08 42.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.682 0.277 . . . . 0.0 110.415 179.413 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.552 HH12 HD12 ' A' ' 116' ' ' LEU . 5.7 mtm180 -105.59 82.38 1.8 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.801 0.334 . . . . 0.0 110.875 -179.698 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 7.2 tp -26.29 -59.28 0.08 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.432 -0.803 . . . . 0.0 113.103 -179.287 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.551 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.21 -56.27 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.128 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -99.93 13.27 34.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.734 0.302 . . . . 0.0 111.386 -179.353 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 45.2 24.39 0.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.218 179.234 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.516 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 15.9 mm-40 -72.02 157.73 37.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.768 0.318 . . . . 0.0 110.77 179.794 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -143.6 85.44 1.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.67 179.667 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.668 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -72.78 147.96 45.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.947 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.69 114.41 16.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.309 0.576 . . . . 0.0 112.285 -179.562 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.617 HD21 HD13 ' A' ' 102' ' ' ILE . 4.2 tt -101.83 76.33 1.62 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.93 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.444 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.8 mt-10 -75.82 -166.75 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -176.692 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.554 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.6 t70 -50.91 -38.67 51.47 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.057 -179.093 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -55.51 -14.9 2.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.164 0.506 . . . . 0.0 110.525 179.794 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -128.45 -13.67 4.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.47 -179.988 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.601 HG21 ' HB2' ' A' ' 79' ' ' ASN . 21.2 mm -89.47 -23.79 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.71 -179.33 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -53.65 -66.46 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 110.684 179.807 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.8 t -105.77 34.3 3.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.622 179.782 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.617 HD13 HD21 ' A' ' 94' ' ' LEU . 7.5 tp -53.99 142.04 8.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.224 -179.947 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -135.61 151.06 49.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.676 178.967 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.905 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -49.42 -34.97 17.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.981 0.42 . . . . 0.0 110.446 -179.883 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 95.0 m -63.1 -48.16 79.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.287 178.774 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -59.79 -60.44 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.252 -179.815 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.767 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -49.36 -55.62 12.32 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.074 0.464 . . . . 0.0 110.237 179.785 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.2 m -58.32 -30.57 66.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.872 179.735 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.516 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -70.15 -66.19 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.118 179.771 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -43.43 -44.73 5.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.059 179.355 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.504 HG12 HG21 ' A' ' 35' ' ' VAL . 95.5 mt -61.88 -54.63 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.367 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -55.51 -19.15 8.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.4 179.48 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.516 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -87.69 -36.61 9.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.88 -179.009 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.615 HD22 ' HG ' ' A' ' 92' ' ' LEU . 85.1 m-20 -122.15 27.27 8.09 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.44 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.6 p -81.33 51.68 1.68 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.988 0.423 . . . . 0.0 110.362 178.886 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.552 HD12 HH12 ' A' ' 85' ' ' ARG . 71.1 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.401 -179.469 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.775 0.321 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.75 164.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.098 179.986 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -146.12 148.8 32.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 179.924 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -107.0 126.02 51.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.946 -179.952 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -148.09 92.92 2.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 179.91 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.1 p -110.4 137.23 48.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.027 -179.848 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -108.66 144.2 36.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.738 179.867 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.12 179.08 35.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.547 -179.831 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.09 135.81 64.96 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.666 2.244 . . . . 0.0 112.317 179.939 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.19 147.09 2.52 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.528 -179.927 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.05 -70.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.733 0.301 . . . . 0.0 110.729 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.512 ' HB1' ' NE2' ' A' ' 55' ' ' GLN . . . 60.2 106.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.212 179.836 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.564 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.7 pt20 -51.25 148.35 4.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.265 -179.788 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.516 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 -122.77 159.5 53.11 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.735 -179.748 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 30.5 Cg_endo -64.18 143.69 84.59 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.699 2.266 . . . . 0.0 112.603 -179.709 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.0 m -61.71 152.41 31.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.552 -179.776 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -98.18 92.55 5.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 24' ' ' ALA . 40.2 mt -87.71 72.55 9.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.258 -179.905 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.4 p -69.07 -3.98 15.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.251 -178.922 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -141.39 149.58 41.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.993 0.425 . . . . 0.0 111.792 -179.569 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 25.3 t -57.03 -49.12 95.81 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.626 179.753 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.7 Cg_endo -58.93 -43.73 41.04 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.956 1.771 . . . . 0.0 111.909 179.865 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.16 -35.3 80.67 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 110.143 179.831 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.43 -56.97 11.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.091 179.361 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 33.8 mtt -62.53 -27.72 69.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.171 -179.961 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -69.94 -49.61 50.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.686 0.279 . . . . 0.0 110.449 179.723 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.01 -32.56 73.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.84 179.071 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.526 HD11 HD12 ' A' ' 36' ' ' ILE . 54.3 mt -72.47 -37.65 57.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.833 178.161 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 -20.81 60.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.706 -179.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.17 28.96 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.153 -179.873 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.557 HG21 ' CB ' ' A' ' 61' ' ' SER . 8.9 t -169.1 155.38 6.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.33 -179.798 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.526 ' HG3' HG13 ' A' ' 87' ' ' VAL . 29.2 tt0 -75.98 -33.91 59.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.254 179.481 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.474 HG13 HD11 ' A' ' 83' ' ' LEU . 17.1 t -133.37 136.3 54.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.125 179.273 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.59 125.24 16.85 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.117 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.486 HG21 HG12 ' A' ' 111' ' ' ILE . 53.4 t -113.18 127.63 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.449 178.234 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 28' ' ' ILE . 35.7 mt -133.87 139.41 48.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.62 -176.86 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -102.89 97.59 1.53 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.459 179.848 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.494 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 36.9 m-85 -84.84 94.37 8.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.322 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.576 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 9.9 m-85 -114.32 146.12 40.91 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.092 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.673 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 52.4 mt-30 -93.77 -6.45 46.01 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.082 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.476 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.7 t70 -151.98 113.94 4.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.511 179.855 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.498 ' HA ' HG21 ' A' ' 47' ' ' VAL . 89.0 mt -84.19 43.63 0.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.026 0.441 . . . . 0.0 111.549 -179.166 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.446 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 34.5 mt-10 -132.24 11.38 4.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.999 179.11 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.677 HG13 HG23 ' A' ' 47' ' ' VAL . 9.6 pt -91.78 161.89 32.62 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.336 179.969 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.501 ' O ' HD12 ' A' ' 49' ' ' ILE . 51.3 Cg_exo -57.73 -23.93 60.6 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.737 2.291 . . . . 0.0 112.587 179.047 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.604 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -66.36 -39.18 88.99 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.812 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.677 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -58.6 -55.1 49.38 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -178.681 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.8 Cg_exo -61.57 -42.46 33.01 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.971 1.781 . . . . 0.0 111.648 179.287 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.868 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -60.67 -34.33 58.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.236 -179.991 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.623 ' O ' HG23 ' A' ' 54' ' ' VAL . 51.3 tp -74.37 -51.67 14.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.138 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -53.55 -25.89 18.94 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.541 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 m -80.56 -49.79 10.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.606 179.686 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.578 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -56.43 -27.17 55.87 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.174 0.511 . . . . 0.0 109.666 179.551 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 50' ' ' LEU . 54.2 t -53.27 -49.97 49.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.726 179.481 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.512 ' NE2' ' HB1' ' A' ' 12' ' ' ALA . 27.2 mt-30 -75.17 -8.66 57.2 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.583 -179.76 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -95.81 -19.14 19.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.203 179.613 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.624 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 63.4 m-85 -135.65 62.61 49.4 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.503 -179.796 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.65 -41.44 61.42 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.613 2.209 . . . . 0.0 111.658 179.094 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.37 -41.78 97.13 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.511 179.167 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.0 t -66.03 144.07 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.882 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.557 ' CB ' HG21 ' A' ' 31' ' ' THR . 47.4 t -82.07 99.32 9.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.08 0.467 . . . . 0.0 111.001 -179.773 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.509 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 5.5 p90 -65.59 127.94 33.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.635 179.688 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.16 161.52 28.32 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.235 -179.944 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 tt -162.21 143.24 3.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.732 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.494 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 44.1 t -150.32 157.24 42.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.127 0.489 . . . . 0.0 111.519 -179.143 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 71.2 p -136.49 -7.66 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.695 179.413 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -60.19 139.69 57.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.605 179.883 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.2 p -63.48 -47.33 82.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.61 -179.356 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -52.48 -43.42 64.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.716 -179.224 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.465 ' HA ' HG22 ' A' ' 21' ' ' VAL . 67.0 t -72.15 -51.04 32.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.849 0.356 . . . . 0.0 110.71 179.832 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.74 -14.84 23.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.088 0.47 . . . . 0.0 110.135 179.449 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.2 m -92.3 -39.46 11.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.418 178.799 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -62.86 -40.66 98.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.423 -179.996 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.429 ' HB2' HG12 ' A' ' 76' ' ' ILE . 65.8 m-85 -88.25 8.2 28.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.467 179.426 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 58.54 27.06 15.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.506 179.539 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.726 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.6 mm -63.2 121.69 12.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.225 179.689 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.0 p -141.12 56.17 1.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.377 -179.965 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.37 44.37 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.579 179.847 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.673 ' ND2' ' H ' ' A' ' 40' ' ' GLN . 6.8 m120 51.31 43.85 29.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.297 0.57 . . . . 0.0 110.379 -179.846 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.726 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.3 m -69.13 153.28 43.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.076 -178.334 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.567 HG12 ' HA2' ' A' ' 37' ' ' GLY . 55.2 mt -119.14 116.41 50.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.92 177.88 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 72.4 m -104.85 130.1 53.04 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.833 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.648 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.8 tp -107.92 100.74 10.07 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.583 178.102 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -95.16 121.65 37.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.488 179.808 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.555 HH12 HD12 ' A' ' 116' ' ' LEU . 5.0 mtm180 -105.05 88.04 2.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.545 -179.933 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 tp -27.11 -60.28 0.09 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.279 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.526 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -38.19 -79.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.361 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -78.3 2.57 18.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.818 -179.907 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 54.36 28.84 9.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.54 179.671 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.541 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 27.5 mm-40 -71.32 163.44 27.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.884 0.374 . . . . 0.0 110.882 179.876 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.443 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -150.02 88.48 1.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.668 179.76 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.648 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -78.45 117.79 19.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.897 179.879 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.77 93.55 5.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.882 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.499 HD21 HD13 ' A' ' 102' ' ' ILE . 4.0 tt -78.71 78.6 5.15 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.776 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 99' ' ' ILE . 28.8 mt-10 -79.73 -165.5 0.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.787 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.471 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.7 OUTLIER -44.83 -52.05 8.92 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.374 -179.377 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -46.06 -17.68 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.365 179.786 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 96' ' ' ASP . 28.6 m-20 -125.9 -13.8 6.26 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.523 -179.941 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.651 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.0 mm -90.85 -35.13 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.338 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.0 -39.0 58.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.362 -179.681 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.7 m -126.48 32.96 5.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.749 179.937 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.516 ' HB ' ' HA ' ' A' ' 99' ' ' ILE . 6.9 tp -58.37 143.71 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.681 -179.935 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 102' ' ' ILE . 23.3 m-20 -138.61 148.78 44.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.475 178.891 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.868 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.88 -37.14 13.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.061 0.458 . . . . 0.0 110.337 -179.888 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.6 m -61.76 -48.0 82.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.237 178.741 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -60.1 -62.38 1.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.26 -179.895 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.765 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -47.22 -56.44 6.7 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.013 0.435 . . . . 0.0 110.258 179.982 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.9 m -57.97 -31.25 66.72 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.815 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.9 tmt_? -70.32 -66.51 0.59 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.184 179.71 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -42.07 -43.96 3.43 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.295 179.351 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.486 HG12 HG21 ' A' ' 35' ' ' VAL . 95.1 mt -63.42 -55.05 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.381 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -54.01 -18.89 3.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.151 179.234 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.482 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.91 -35.81 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.944 -179.137 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.472 ' O ' HD21 ' A' ' 83' ' ' LEU . 14.9 m120 -125.17 31.78 5.53 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.472 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 88.1 p -83.84 36.54 0.56 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.037 0.446 . . . . 0.0 110.465 178.792 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.555 HD12 HH12 ' A' ' 85' ' ' ARG . 63.7 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.311 -179.565 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.735 0.302 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.36 -21.86 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.311 -179.839 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -94.84 149.28 21.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.803 179.846 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -126.87 25.17 6.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.947 -179.841 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 t -75.84 136.87 40.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.776 179.915 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.2 m -134.65 -60.62 0.78 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.123 -179.805 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.29 100.26 2.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.114 -179.839 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.37 177.93 41.21 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.425 179.831 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.57 -41.27 66.19 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.419 2.079 . . . . 0.0 112.134 179.903 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.69 -97.1 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.295 179.866 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.22 -65.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.707 0.289 . . . . 0.0 110.74 -179.955 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.447 ' HB1' ' NE2' ' A' ' 55' ' ' GLN . . . 60.55 104.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.48 179.699 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.554 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.5 pt20 -56.59 164.97 1.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.297 179.947 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 10.3 pt-20 -134.94 157.4 77.14 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.545 179.919 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 30.3 Cg_endo -64.26 148.99 91.06 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.584 2.19 . . . . 0.0 112.594 -179.373 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 17' ' ' TRP . 26.0 m -64.13 154.28 35.11 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.161 -179.39 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.416 ' N ' HG22 ' A' ' 16' ' ' THR . 5.6 m-90 -98.09 88.4 4.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.827 179.647 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.635 HD22 ' HA ' ' A' ' 24' ' ' ALA . 60.8 mt -88.33 77.01 8.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.057 0.456 . . . . 0.0 110.379 179.914 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.2 p -75.03 -7.09 52.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.32 -179.076 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -138.8 147.9 43.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.816 -179.576 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.598 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 47.9 t -54.93 -50.32 86.91 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.521 179.794 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.44 -44.49 42.0 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.944 1.762 . . . . 0.0 111.854 -179.956 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.86 -33.98 77.29 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.258 0.552 . . . . 0.0 110.4 -179.988 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.635 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -65.28 -58.55 5.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.127 179.371 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.5 mtp -61.24 -27.02 68.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.981 179.992 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 18.7 mt-10 -71.0 -49.88 40.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.654 0.264 . . . . 0.0 110.342 179.616 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.574 ' O ' HG22 ' A' ' 31' ' ' THR . 2.7 m-85 -60.16 -35.24 74.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.002 179.229 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.532 HD11 HD12 ' A' ' 36' ' ' ILE . 49.0 mt -72.28 -38.36 61.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.926 178.526 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.3 -18.65 61.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.04 -179.823 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.08 26.63 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.04 -179.842 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.599 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.9 t -173.32 153.72 2.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.541 -179.623 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.523 ' HG3' HG13 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -63.3 -84.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.148 0.499 . . . . 0.0 110.903 179.532 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.544 HG13 HD11 ' A' ' 83' ' ' LEU . 13.0 t -87.7 134.21 28.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.663 -179.808 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -138.55 125.46 21.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 112.019 -179.162 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.444 HG11 HD11 ' A' ' 111' ' ' ILE . 53.5 t -115.21 127.87 72.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.955 178.544 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.532 HD12 HD11 ' A' ' 28' ' ' ILE . 23.5 mt -133.23 136.15 55.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.513 -177.27 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.595 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.58 98.8 1.99 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.49 179.797 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 11.7 m-85 -83.81 92.36 7.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.632 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.9 m-85 -113.42 141.59 46.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.451 -178.068 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.438 ' HG2' HD23 ' A' ' 71' ' ' LEU . 25.3 mt-30 -89.41 -6.99 56.07 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.712 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.499 ' O ' HG12 ' A' ' 44' ' ' ILE . 36.4 t70 -150.03 119.06 6.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.82 179.916 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.546 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.7 mt -88.36 44.97 1.24 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.11 0.481 . . . . 0.0 111.165 -179.605 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.409 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 8.5 mm-40 -135.99 10.85 3.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.21 179.317 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.839 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.7 pt -95.13 156.39 37.88 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.098 179.742 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.467 ' O ' HD12 ' A' ' 49' ' ' ILE . 76.4 Cg_exo -50.94 -29.79 28.31 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.712 2.274 . . . . 0.0 112.909 179.825 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.839 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -60.47 -36.11 77.48 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.052 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.661 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.2 t -64.49 -57.66 16.38 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.636 -178.926 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.9 Cg_exo -58.23 -37.93 93.21 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.712 1.608 . . . . 0.0 111.205 179.279 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.902 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.6 mt -64.34 -37.32 79.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.029 179.822 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 54' ' ' VAL . 39.7 tp -72.82 -52.92 12.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.905 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -54.8 -25.16 26.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.021 0.438 . . . . 0.0 109.966 178.791 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.7 t -81.71 -44.94 16.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.465 179.588 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.598 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -61.49 -26.31 67.83 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.159 0.504 . . . . 0.0 109.788 179.497 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.7 t -53.02 -49.65 48.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.121 179.513 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.447 ' NE2' ' HB1' ' A' ' 12' ' ' ALA . 29.0 mt-30 -74.47 -11.74 60.31 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.564 -179.949 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 29.3 mtpp -93.71 -17.9 22.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.291 179.936 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.559 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 65.2 m-85 -136.49 61.65 38.81 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.551 -179.74 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.61 -42.64 60.88 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.682 2.255 . . . . 0.0 111.67 179.174 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.29 -39.47 90.31 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.368 179.31 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 8.6 t -67.76 145.09 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.521 -0.34 . . . . 0.0 110.19 178.927 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.599 ' CB ' HG21 ' A' ' 31' ' ' THR . 22.6 t -82.71 96.79 8.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.03 0.443 . . . . 0.0 110.899 -179.716 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.485 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.9 p90 -63.98 129.53 40.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.05 179.888 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.97 161.57 28.73 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.01 179.697 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.404 HD11 HG13 ' A' ' 47' ' ' VAL . 4.4 tt -160.12 144.39 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.795 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.8 t -146.82 155.55 42.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.174 0.512 . . . . 0.0 111.733 -179.137 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 77.9 p -139.14 2.08 2.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.618 179.654 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -73.63 143.78 46.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.744 -179.893 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.2 p -64.91 -51.84 59.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.405 -179.578 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -49.23 -42.58 40.94 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.707 -179.472 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.573 ' HA ' HG22 ' A' ' 21' ' ' VAL . 77.7 t -71.77 -54.1 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.936 0.398 . . . . 0.0 110.714 179.973 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.438 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.63 -14.68 8.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.303 179.368 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.1 m -91.91 -40.95 10.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.261 178.966 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -60.69 -39.34 88.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.403 179.825 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.4 ' HB2' HG12 ' A' ' 76' ' ' ILE . 58.6 m-85 -91.9 10.61 28.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.723 179.398 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 58.26 22.37 9.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.662 179.128 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.674 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.9 mm -57.83 122.21 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.044 179.912 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.0 p -142.3 59.55 1.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.139 -179.912 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.3 44.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.725 179.989 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.65 ' HB2' HG21 ' A' ' 99' ' ' ILE . 42.1 m-20 51.77 42.83 30.21 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.192 0.52 . . . . 0.0 110.532 -179.9 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.674 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.8 m -69.02 153.83 43.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.677 -178.671 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.595 HG12 ' HA2' ' A' ' 37' ' ' GLY . 62.7 mt -120.83 118.28 55.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.941 178.268 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.481 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.4 m -106.55 134.31 49.88 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.998 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.65 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -111.42 105.08 13.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.129 178.716 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.3 t80 -99.31 119.91 38.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.446 179.543 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.466 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 4.6 mtm180 -101.74 79.98 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.809 -179.731 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 32' ' ' GLU . 11.5 tp -23.9 -59.35 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.108 -179.622 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.523 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.21 -63.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.264 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.49 3.72 54.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.061 0.457 . . . . 0.0 111.14 -179.694 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 51.37 30.02 5.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.947 179.422 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 7.0 mm-40 -77.53 153.5 33.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.505 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.401 HE22 ' HB3' ' A' ' 93' ' ' ASN . 22.6 tm0? -135.4 94.98 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.904 179.816 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.65 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.0 mm? -84.71 134.85 34.34 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.003 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.401 ' HB3' HE22 ' A' ' 91' ' ' GLN . 0.7 OUTLIER -117.26 101.31 8.33 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.824 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.602 HD21 HD13 ' A' ' 102' ' ' ILE . 3.9 tt -85.93 78.19 9.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.794 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.453 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.1 mt-10 -80.4 -164.84 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.891 -176.877 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.522 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 23.7 t70 -51.26 -36.12 40.56 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.831 -179.381 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -55.77 -14.88 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.106 0.479 . . . . 0.0 110.21 179.448 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -131.5 -13.81 3.34 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.623 -179.806 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.65 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.8 mm -90.17 -35.45 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.594 0.235 . . . . 0.0 111.406 -179.496 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -49.62 -44.56 47.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.801 -179.98 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.3 m -124.74 41.14 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.358 179.498 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.602 HD13 HD21 ' A' ' 94' ' ' LEU . 7.8 tp -66.3 143.97 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.8 -179.618 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -138.45 149.59 45.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.581 178.72 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.902 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.61 -37.6 12.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.581 -179.788 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.5 m -61.6 -47.49 85.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.346 178.75 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -59.86 -61.39 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.249 -179.718 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.777 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.71 -55.8 10.36 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.924 0.392 . . . . 0.0 110.382 179.98 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.6 m -58.51 -30.18 66.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.88 179.901 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.551 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.9 tmt_? -70.54 -66.42 0.61 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.101 179.558 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -42.88 -44.4 4.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.274 179.34 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.444 HD11 HG11 ' A' ' 35' ' ' VAL . 96.6 mt -63.19 -54.75 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.287 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.408 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 32.8 tt0 -53.96 -19.66 5.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.224 179.191 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.551 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.7 -36.53 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.771 -179.155 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.612 HD22 ' HG ' ' A' ' 92' ' ' LEU . 88.9 m-20 -123.71 30.01 6.35 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.183 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 96.6 p -82.83 37.13 0.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.165 0.507 . . . . 0.0 110.052 178.797 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.448 HD12 HH12 ' A' ' 85' ' ' ARG . 53.5 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.314 -179.329 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.841 0.353 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.2 p -130.43 135.61 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 -179.939 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -79.54 -179.75 7.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.773 179.963 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -57.24 -74.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.826 179.994 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.3 m 52.02 40.43 28.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.192 179.679 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.9 p -168.88 153.81 5.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.911 0.386 . . . . 0.0 110.949 179.953 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -155.32 130.2 9.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.859 179.766 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.74 -165.3 25.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.474 -179.924 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.27 -37.76 81.09 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.591 2.194 . . . . 0.0 112.449 -179.996 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.09 23.11 0.49 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.464 179.985 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.11 -66.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.85 0.357 . . . . 0.0 110.286 -179.946 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 13' ' ' GLN . . . 52.24 54.27 11.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.748 179.232 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.526 ' HG3' HG12 ' A' ' 54' ' ' VAL . 20.6 pt20 45.82 117.43 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.707 0.803 . . . . 0.0 112.844 179.727 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.7 pt-20 -116.25 158.15 43.57 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.52 179.774 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 38.1 Cg_endo -66.43 144.48 73.68 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.53 2.153 . . . . 0.0 112.405 -179.614 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.6 m -63.41 153.58 34.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.671 -179.536 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -98.62 92.53 5.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 179.488 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 24' ' ' ALA . 43.5 mt -86.96 73.65 9.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.326 179.801 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.2 p -72.21 -5.37 35.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.118 -179.167 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -137.06 146.72 45.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.905 0.383 . . . . 0.0 111.604 -179.684 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 59.9 t -55.5 -49.81 90.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.61 179.883 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.8 Cg_endo -57.77 -46.17 28.29 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.923 1.749 . . . . 0.0 112.07 179.877 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.83 81.39 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.346 0.593 . . . . 0.0 110.239 -179.898 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.635 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -63.99 -58.53 6.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.023 179.524 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 21' ' ' VAL . 57.7 mtm -60.02 -25.76 65.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.065 179.891 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -71.97 -52.07 18.86 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.621 179.642 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -60.01 -30.2 69.0 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.33 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.564 HD11 HD12 ' A' ' 36' ' ' ILE . 48.0 mt -75.57 -38.69 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.121 178.201 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 -20.66 60.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.018 -179.851 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.78 31.85 1.33 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -179.929 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.507 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.7 t -170.43 151.78 3.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.45 -179.539 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.615 ' HG3' HG13 ' A' ' 87' ' ' VAL . 24.4 tt0 -70.18 -40.55 74.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.558 179.539 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.493 HG13 HD11 ' A' ' 83' ' ' LEU . 19.4 t -129.94 137.35 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.162 179.283 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.93 128.19 19.85 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.134 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.456 HG21 HG12 ' A' ' 111' ' ' ILE . 55.0 t -115.93 130.53 70.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.379 178.338 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.564 HD12 HD11 ' A' ' 28' ' ' ILE . 28.7 mt -136.19 135.92 49.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.305 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.585 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.39 96.86 1.73 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.559 179.722 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.489 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 13.6 m-85 -82.45 89.68 6.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.522 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -109.94 140.56 43.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.057 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -87.28 -6.51 58.51 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.661 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.9 t70 -151.58 122.42 7.54 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.755 179.837 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.505 ' HA ' HG21 ' A' ' 47' ' ' VAL . 97.1 mt -91.34 46.18 1.29 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.131 0.491 . . . . 0.0 111.208 -179.486 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -137.25 11.08 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.0 179.204 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.777 HD12 ' HB3' ' A' ' 46' ' ' ALA . 2.3 pt -94.21 156.13 39.23 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.133 179.923 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.45 ' O ' HD12 ' A' ' 49' ' ' ILE . 75.0 Cg_exo -51.16 -27.08 21.28 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.807 2.338 . . . . 0.0 113.057 179.666 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.777 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -63.67 -38.7 92.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.945 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.664 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -60.21 -56.67 33.15 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.734 -178.849 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.634 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.0 Cg_exo -58.42 -40.12 77.76 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.587 1.525 . . . . 0.0 111.37 179.597 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.898 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.9 mt -62.66 -34.92 67.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.092 179.874 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.62 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.2 tp -74.95 -52.77 10.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.845 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -54.26 -23.15 13.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.036 0.446 . . . . 0.0 109.932 178.781 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 75.6 m -84.15 -46.45 11.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.498 179.363 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.568 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.75 -26.18 63.72 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.374 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.5 t -51.69 -50.62 30.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.013 179.28 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -75.96 -8.59 57.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.934 -179.558 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -95.0 -19.25 20.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.177 179.581 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.585 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 63.9 m-85 -136.04 63.16 49.62 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.578 -179.734 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.87 -44.46 44.91 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.718 2.278 . . . . 0.0 111.553 178.988 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.24 -40.94 85.76 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.421 179.212 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.3 t -67.27 143.96 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.886 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.507 ' CB ' HG21 ' A' ' 31' ' ' THR . 42.2 t -82.34 99.56 9.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.083 0.468 . . . . 0.0 111.014 -179.591 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.533 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.9 p90 -66.71 123.96 21.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.0 179.787 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -143.74 162.81 27.7 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.063 179.979 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.403 HD11 HG13 ' A' ' 47' ' ' VAL . 4.4 tt -160.06 142.33 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.936 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.9 t -143.42 153.57 42.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.114 0.483 . . . . 0.0 111.843 -178.888 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 39' ' ' PHE . 75.3 p -138.34 1.16 2.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.589 179.598 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -73.38 145.95 45.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.7 t -66.76 -50.83 61.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.385 -179.569 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -50.1 -43.98 51.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.539 -179.392 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.556 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.1 t -71.04 -53.43 21.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.867 0.365 . . . . 0.0 110.799 179.885 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mp -58.74 -14.74 9.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.263 179.402 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.7 m -91.62 -42.96 9.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.427 179.062 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -60.36 -38.66 84.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.577 179.816 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.434 ' HB2' HG12 ' A' ' 76' ' ' ILE . 60.8 m-85 -91.39 11.17 24.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.697 179.647 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 56.19 24.41 8.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.705 179.289 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.672 HG23 ' HB ' ' A' ' 80' ' ' THR . 39.3 mm -60.93 122.3 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.922 179.648 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.4 p -142.89 60.34 1.42 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.089 -179.959 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.29 45.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.499 179.88 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.646 ' HB2' HG21 ' A' ' 99' ' ' ILE . 30.5 m-20 50.52 43.81 27.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.158 0.504 . . . . 0.0 110.301 -179.773 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.672 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.7 m -69.56 153.61 43.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.653 -178.41 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.585 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.9 mt -120.71 116.61 50.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.004 177.993 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.489 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 71.4 m -106.18 132.57 52.09 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.837 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.626 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -108.32 102.6 11.7 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.798 178.291 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -97.39 123.64 41.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.885 0.374 . . . . 0.0 110.68 179.784 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.493 HH21 ' HB2' ' A' ' 88' ' ' ASP . 3.6 mtm180 -106.17 99.66 9.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.073 179.7 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.0 tp -43.28 -51.1 6.41 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.621 -179.38 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.615 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -42.59 -64.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.334 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.493 ' HB2' HH21 ' A' ' 85' ' ' ARG . 2.9 m-20 -98.29 18.09 17.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.59 -179.13 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.7 p30 43.63 29.49 0.28 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.022 179.207 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.48 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 7.5 mm-40 -75.02 156.38 36.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.37 . . . . 0.0 111.137 -179.946 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.446 HE21 ' HB3' ' A' ' 91' ' ' GLN . 0.8 OUTLIER -139.93 89.78 2.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.687 179.574 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.626 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.7 mm? -78.03 142.38 38.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.65 179.574 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.22 111.25 15.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.355 0.598 . . . . 0.0 112.534 -179.108 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.66 HD21 HD13 ' A' ' 102' ' ' ILE . 3.6 tt -98.29 76.39 2.32 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.043 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.7 mt-10 -77.65 -166.29 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -176.697 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.539 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 18.6 t70 -50.54 -37.71 40.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.914 -179.218 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -56.46 -15.27 3.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.13 0.491 . . . . 0.0 110.461 179.791 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -128.66 -13.67 4.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.395 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.646 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.9 mm -89.63 -25.13 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.592 -179.31 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -51.9 -61.48 2.23 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.923 0.392 . . . . 0.0 110.653 179.846 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.8 m -112.89 38.94 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.471 179.649 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.66 HD13 HD21 ' A' ' 94' ' ' LEU . 7.7 tp -57.1 143.24 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.427 -179.832 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -136.05 149.81 48.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.823 178.873 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.898 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.25 -33.92 9.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.187 179.97 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 97.8 m -62.82 -50.6 70.33 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.245 178.73 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -58.33 -58.42 8.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.278 -179.614 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.781 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.93 -57.27 8.95 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.036 0.446 . . . . 0.0 110.32 179.977 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 64.9 m -57.82 -29.4 64.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.831 179.85 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.48 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.1 tmt_? -71.38 -64.88 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.239 179.786 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -43.44 -43.38 5.26 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.972 178.976 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.456 HG12 HG21 ' A' ' 35' ' ' VAL . 95.9 mt -63.68 -56.11 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.509 178.408 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.84 -16.7 2.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.283 0.563 . . . . 0.0 110.334 179.337 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.48 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -91.91 -34.99 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.738 -179.231 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.616 HD22 ' HG ' ' A' ' 92' ' ' LEU . 88.4 m-20 -127.5 32.16 5.06 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.306 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 111' ' ' ILE . 91.0 p -83.94 36.08 0.55 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.201 0.524 . . . . 0.0 110.199 178.995 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.488 HD12 HH12 ' A' ' 85' ' ' ARG . 51.9 mt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.174 -179.443 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.891 0.376 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.455 HG13 ' HG3' ' A' ' 3' ' ' GLU . 8.4 p -137.92 -31.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.15 -179.911 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.455 ' HG3' HG13 ' A' ' 2' ' ' VAL . 47.8 mt-10 -137.56 -68.41 0.47 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.074 -179.796 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -155.2 153.59 30.94 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.927 -179.741 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.1 t 61.79 173.54 0.12 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.109 179.944 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.2 m -144.51 90.44 2.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.932 179.943 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 58.42 89.41 0.05 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.096 -179.94 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.34 159.38 27.71 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.503 179.977 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.35 100.45 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.541 2.161 . . . . 0.0 112.28 179.932 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.37 132.04 0.43 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.632 179.923 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.5 -24.56 0.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.843 0.354 . . . . 0.0 110.585 179.944 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.92 94.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.113 179.856 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.622 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.3 pt20 -44.03 136.46 3.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.213 179.931 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.502 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 -108.85 159.21 31.87 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.146 -179.548 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 40.0 Cg_endo -67.89 142.59 57.7 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.733 2.289 . . . . 0.0 112.533 -179.702 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 m -54.49 152.66 6.41 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.23 -179.977 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -103.11 79.66 1.77 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.066 0.46 . . . . 0.0 111.057 -179.79 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.678 HD22 ' HA ' ' A' ' 24' ' ' ALA . 46.6 mt -71.06 94.45 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.317 179.708 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.4 p -85.45 -12.93 50.72 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.871 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 5.4 m-20 -139.62 151.27 45.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.77 -179.471 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 30.0 t -52.89 -49.76 85.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.561 179.853 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.6 Cg_endo -57.42 -45.71 32.58 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.97 1.78 . . . . 0.0 112.043 179.912 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.22 -34.79 78.42 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.201 0.524 . . . . 0.0 110.279 -179.852 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.678 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.93 -59.46 4.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.147 179.406 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.6 mtm -60.75 -24.26 65.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.041 -179.994 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.4 -51.28 17.85 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.312 179.437 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.49 ' O ' HG22 ' A' ' 31' ' ' THR . 4.9 m-85 -59.62 -31.74 69.77 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.141 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 36' ' ' ILE . 49.4 mt -75.03 -41.25 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.271 178.444 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.28 -19.04 62.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.162 -179.788 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.59 27.82 2.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.146 -179.845 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.609 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.8 t -172.68 154.01 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.769 -179.629 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.591 ' HG3' HG13 ' A' ' 87' ' ' VAL . 22.0 tt0 -63.8 -73.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.747 179.911 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.569 HG13 HD11 ' A' ' 83' ' ' LEU . 21.6 t -100.68 137.86 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.656 179.87 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.94 126.1 18.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.987 0.422 . . . . 0.0 112.058 -179.27 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.458 HG21 HG12 ' A' ' 111' ' ' ILE . 50.0 t -114.7 130.63 68.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.518 178.413 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.541 HD12 HD11 ' A' ' 28' ' ' ILE . 24.0 mt -135.07 136.02 52.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.243 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.51 97.73 1.93 Allowed Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.465 179.787 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 10.3 m-85 -83.37 92.06 7.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.665 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.7 m-85 -112.92 138.66 49.44 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.093 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.542 ' HG2' HD23 ' A' ' 71' ' ' LEU . 22.9 mt-30 -85.25 -6.48 59.26 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.714 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 44' ' ' ILE . 38.4 t70 -151.54 125.67 9.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.644 179.672 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.516 ' HA ' HG21 ' A' ' 47' ' ' VAL . 94.9 mt -93.83 44.06 1.12 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.004 0.43 . . . . 0.0 111.203 -179.535 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 43.3 mt-10 -133.56 9.63 3.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.865 178.962 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.75 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.2 pt -91.73 157.69 41.31 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.19 179.942 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.476 ' O ' HD12 ' A' ' 49' ' ' ILE . 77.9 Cg_exo -53.22 -26.08 32.51 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.845 2.363 . . . . 0.0 112.956 179.603 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.75 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.32 -38.87 92.58 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.916 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.694 HG23 HG13 ' A' ' 44' ' ' ILE . 2.2 t -60.26 -55.41 45.57 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -178.557 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.6 Cg_exo -60.22 -39.47 68.14 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.882 1.721 . . . . 0.0 111.509 179.286 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.893 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.5 mt -63.88 -34.2 66.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.045 179.984 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.611 ' O ' HG23 ' A' ' 54' ' ' VAL . 50.1 tp -74.76 -52.27 11.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.823 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -53.44 -27.31 24.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.168 0.508 . . . . 0.0 109.765 178.618 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -80.25 -46.38 16.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.568 179.876 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.587 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.49 -25.8 64.74 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.406 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.622 HG12 ' HG3' ' A' ' 13' ' ' GLN . 54.1 t -53.53 -50.39 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.999 179.505 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -73.89 -11.51 60.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.617 179.911 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -93.3 -18.77 22.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.22 -179.863 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.6 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 63.0 m-85 -136.0 61.6 41.52 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.636 -179.682 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.37 -38.28 82.33 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.604 2.203 . . . . 0.0 111.506 179.167 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.16 -41.27 99.42 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.354 179.079 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.1 t -67.07 145.23 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.884 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.609 ' HB2' HG21 ' A' ' 31' ' ' THR . 36.0 t -82.41 96.57 8.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.959 0.409 . . . . 0.0 111.114 -179.696 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.502 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 4.9 p90 -63.87 127.16 30.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.982 179.763 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -146.54 162.71 28.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.054 179.78 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 tt -160.62 144.71 5.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.986 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 t -145.01 157.05 44.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.98 0.419 . . . . 0.0 111.81 -178.949 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 39' ' ' PHE . 76.5 p -141.92 1.41 1.47 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.593 179.649 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.7 144.15 45.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.624 179.93 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.5 p -65.28 -51.51 60.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.67 -179.439 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -49.67 -43.03 46.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.64 -179.386 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.463 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.3 t -71.72 -52.96 22.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.311 . . . . 0.0 110.748 179.981 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.542 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -59.14 -14.6 10.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.158 0.504 . . . . 0.0 110.273 179.371 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.4 m -91.84 -40.57 11.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.377 178.722 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -61.31 -39.99 92.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.232 179.822 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.425 ' HB2' HG12 ' A' ' 76' ' ' ILE . 37.4 m-85 -90.51 9.73 28.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.626 179.533 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 m120 57.38 25.53 11.39 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.641 179.107 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.653 HD12 ' HB ' ' A' ' 80' ' ' THR . 36.9 mm -60.8 118.13 3.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.997 179.653 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.1 p -136.62 56.28 1.81 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.388 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.25 45.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.728 179.838 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.59 ' HB2' HG21 ' A' ' 99' ' ' ILE . 14.0 m120 51.62 42.54 29.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.196 0.522 . . . . 0.0 110.474 179.93 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.653 ' HB ' HD12 ' A' ' 76' ' ' ILE . 89.3 m -68.24 153.07 44.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.646 -178.607 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.578 HG12 ' HA2' ' A' ' 37' ' ' GLY . 61.7 mt -119.33 118.65 58.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.054 177.988 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 81.5 m -107.62 135.7 48.62 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.787 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.652 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -110.41 105.47 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.104 178.552 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 3.3 t80 -98.9 123.09 42.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.851 0.357 . . . . 0.0 110.666 179.652 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.472 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 4.5 mtm180 -106.73 91.8 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.205 179.844 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tp -38.25 -50.74 1.46 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.711 -179.824 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.591 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -45.2 -59.78 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.435 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -99.98 17.08 21.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.328 -179.418 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.2 p30 42.83 32.76 0.42 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.948 179.084 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 8.3 mm-40 -81.58 160.59 23.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 111.147 -179.823 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.75 91.45 2.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.362 179.564 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.652 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -80.07 149.22 30.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.875 179.7 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.6 124.62 41.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.315 0.579 . . . . 0.0 112.117 -179.366 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.602 HD21 HD13 ' A' ' 102' ' ' ILE . 3.8 tt -111.24 75.53 0.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.073 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.0 mt-10 -77.51 -165.62 0.63 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.395 -0.821 . . . . 0.0 113.208 -176.736 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.516 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.5 t70 -51.31 -36.74 43.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.968 -179.181 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -56.49 -14.82 3.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.152 0.501 . . . . 0.0 110.266 179.536 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -130.26 -13.94 3.88 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.554 -179.947 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.59 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.2 mm -90.7 -25.38 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.78 0.324 . . . . 0.0 111.34 -179.364 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.6 -52.2 62.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.691 179.993 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 81.1 p -119.66 36.57 4.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.511 179.811 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.602 HD13 HD21 ' A' ' 94' ' ' LEU . 7.5 tp -57.38 142.24 13.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.487 -179.853 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.45 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 25.0 m-20 -135.93 149.76 49.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.757 178.884 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.893 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.04 -37.06 14.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.03 0.443 . . . . 0.0 110.446 -179.77 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.8 m -62.52 -47.85 82.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.295 178.71 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.45 ' HD3' ' N ' ' A' ' 103' ' ' ASP . 59.3 mtpt -59.2 -60.23 4.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.087 -179.735 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.755 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -49.06 -55.98 10.45 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.931 0.396 . . . . 0.0 110.15 179.847 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 54.2 m -57.87 -30.19 65.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.814 179.794 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.49 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.8 tmt_? -70.61 -65.77 0.69 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.088 179.696 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -42.29 -44.78 3.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.076 179.053 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 35' ' ' VAL . 96.5 mt -62.66 -55.86 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.537 178.495 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -54.13 -18.31 3.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.444 179.326 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.49 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.3 mp -88.87 -38.51 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.016 -179.057 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.596 HD22 ' HG ' ' A' ' 92' ' ' LEU . 90.4 m-20 -123.35 29.59 6.61 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.348 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.5 p -82.11 50.32 1.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.116 0.484 . . . . 0.0 110.267 178.9 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 61.3 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.43 -179.44 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.42 ' HG3' HG23 ' A' ' 2' ' ' VAL . 10.6 tp10 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.654 0.264 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.42 HG23 ' HG3' ' A' ' 1' ' ' GLU . 48.8 t 61.77 -83.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.544 179.96 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 58.71 94.22 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.855 -179.95 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -92.73 11.84 25.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.243 -179.748 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.4 m -68.95 129.74 40.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.67 179.767 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.8 p -85.76 -20.07 29.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.122 -179.836 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -126.38 103.57 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.88 0.372 . . . . 0.0 110.985 179.904 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.99 148.98 48.71 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.458 -179.948 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.94 -39.86 88.36 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.494 2.129 . . . . 0.0 112.361 -179.863 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.1 -177.75 16.81 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.729 179.757 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.1 -73.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.638 0.256 . . . . 0.0 110.73 179.951 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.53 93.9 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.407 179.506 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.55 ' HG3' HG12 ' A' ' 54' ' ' VAL . 7.3 pt20 -170.09 161.02 8.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.817 -179.793 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.5 pt-20 -107.74 158.37 33.58 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.04 -179.622 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.8 Cg_endo -68.67 148.93 73.0 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.7 2.267 . . . . 0.0 112.677 -179.777 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 m -63.16 152.61 36.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.575 -179.668 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -98.8 97.46 8.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.812 179.706 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 24' ' ' ALA . 38.4 mt -96.37 71.57 2.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.641 179.964 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.9 p -71.39 -3.12 19.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.953 -179.171 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -140.14 147.68 40.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.934 0.397 . . . . 0.0 111.656 -179.991 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 24.9 t -56.49 -49.46 93.4 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.761 -179.896 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -57.51 -45.27 35.25 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.931 1.754 . . . . 0.0 111.963 179.954 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.38 -35.89 82.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.267 0.556 . . . . 0.0 110.344 -179.961 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.608 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.95 -57.91 8.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.185 179.427 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 64.4 mtp -61.75 -26.39 68.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.224 -179.952 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.48 -50.79 28.15 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.497 179.598 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.468 ' O ' HG22 ' A' ' 31' ' ' THR . 7.6 m-85 -60.24 -33.05 71.74 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.035 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.502 HD11 HD12 ' A' ' 36' ' ' ILE . 57.1 mt -72.72 -39.81 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.024 178.475 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.75 -19.33 62.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.99 -179.869 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.12 29.45 2.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.856 -179.975 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.583 HG21 ' CB ' ' A' ' 61' ' ' SER . 10.0 t -169.31 153.03 5.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.271 -179.722 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HG3' HG13 ' A' ' 87' ' ' VAL . 27.1 tt0 -72.4 -46.34 55.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.577 HG13 HD11 ' A' ' 83' ' ' LEU . 21.0 t -122.68 133.87 67.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.08 179.296 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.544 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.66 126.29 20.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.012 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.513 HG21 HG12 ' A' ' 111' ' ' ILE . 52.0 t -114.24 127.59 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.766 178.701 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.502 HD12 HD11 ' A' ' 28' ' ' ILE . 24.8 mt -133.03 136.73 54.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.391 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.604 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.91 96.92 1.7 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.544 179.972 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 9.6 m-85 -83.17 90.82 7.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.654 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 10.4 m-85 -111.56 139.34 47.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.184 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.453 ' HG2' HD23 ' A' ' 71' ' ' LEU . 89.6 mt-30 -85.42 -7.21 59.05 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.89 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.439 ' O ' HG12 ' A' ' 44' ' ' ILE . 36.6 t70 -150.67 125.68 9.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.667 179.768 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.604 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.2 mt -93.72 46.94 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.112 0.482 . . . . 0.0 111.373 -179.533 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 46.7 mt-10 -138.19 9.99 2.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.948 179.034 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.801 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.4 pt -93.06 156.28 40.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.064 179.848 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.465 ' O ' HD12 ' A' ' 49' ' ' ILE . 81.4 Cg_exo -50.96 -27.25 20.52 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.818 2.345 . . . . 0.0 113.214 -179.914 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.801 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.43 -38.25 90.39 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.916 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.69 HG23 HG13 ' A' ' 44' ' ' ILE . 3.0 t -60.45 -55.96 39.98 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.585 -178.742 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.6 -41.55 55.37 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.876 1.717 . . . . 0.0 111.4 179.487 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.883 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.2 mt -60.94 -35.58 66.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.247 179.983 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.2 tp -73.99 -52.28 13.26 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.957 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -54.44 -24.25 19.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.08 0.467 . . . . 0.0 109.824 178.831 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.3 m -82.55 -46.38 13.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.514 179.643 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.576 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.59 -26.41 65.4 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.107 0.48 . . . . 0.0 109.744 179.492 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 50' ' ' LEU . 55.7 t -52.86 -50.02 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.194 179.498 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -75.83 -8.35 56.68 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.631 179.992 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -95.72 -19.04 19.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.133 179.743 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.562 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 71.9 m-85 -136.73 62.36 41.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.509 -179.617 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.87 -41.12 72.78 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.7 2.266 . . . . 0.0 111.538 179.09 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.58 -41.63 95.67 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.428 179.191 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 7.8 t -66.18 145.72 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.765 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.583 ' CB ' HG21 ' A' ' 31' ' ' THR . 40.3 t -83.11 97.34 8.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.989 0.423 . . . . 0.0 111.035 -179.553 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.51 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 8.0 p90 -62.82 129.53 40.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.862 179.646 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.514 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -148.16 159.83 28.15 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.993 179.73 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.9 tt -161.83 140.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.882 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.9 t -145.15 159.2 43.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.146 0.498 . . . . 0.0 111.741 -178.872 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.455 HG21 ' HG ' ' A' ' 42' ' ' LEU . 79.7 p -140.29 -0.77 1.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.396 179.495 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -69.46 141.2 54.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.718 -179.786 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.2 t -64.3 -48.38 75.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.296 -179.78 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -49.96 -46.31 52.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.436 -179.639 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.52 ' HA ' HG22 ' A' ' 21' ' ' VAL . 73.5 t -69.44 -53.27 25.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.703 179.846 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.8 mp -58.27 -14.82 8.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.195 0.521 . . . . 0.0 110.317 179.462 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.2 m -90.66 -42.46 10.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.264 178.615 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -59.79 -40.76 89.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.629 -179.98 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.405 ' HB2' HG12 ' A' ' 76' ' ' ILE . 51.3 m-85 -90.6 11.04 23.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.831 179.602 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 56.8 26.24 11.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.438 179.326 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.683 HG23 ' HB ' ' A' ' 80' ' ' THR . 35.5 mm -61.61 122.96 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.839 179.633 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.1 p -140.9 47.89 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.762 0.315 . . . . 0.0 111.51 -179.891 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.8 47.88 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.742 179.819 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.621 ' HB2' HG21 ' A' ' 99' ' ' ILE . 13.9 m120 50.06 41.45 23.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.257 0.551 . . . . 0.0 110.271 -179.775 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.683 ' HB ' HG23 ' A' ' 76' ' ' ILE . 94.1 m -67.79 151.79 46.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.671 -178.515 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.604 HG12 ' HA2' ' A' ' 37' ' ' GLY . 65.3 mt -118.73 115.79 49.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.865 178.059 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.535 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 74.1 m -105.47 130.92 53.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.779 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.616 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.3 tp -107.66 99.84 9.29 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.843 178.455 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 6.5 t80 -92.31 122.93 35.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.364 179.633 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.462 ' HG3' ' HB2' ' A' ' 90' ' ' GLU . 6.1 mtm180 -105.24 85.66 2.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.867 0.365 . . . . 0.0 110.57 -179.915 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 tp -26.05 -59.61 0.08 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.12 -179.322 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.456 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.86 -71.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.261 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.71 13.41 8.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.333 -179.302 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.3 p30 44.29 29.82 0.4 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.131 178.973 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 10.4 mm-40 -76.41 167.52 21.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.349 . . . . 0.0 110.79 179.825 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -154.26 95.23 1.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.623 179.724 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.616 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -80.55 110.71 16.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.065 -179.953 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -92.52 92.1 7.9 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.973 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.611 HD21 HD13 ' A' ' 102' ' ' ILE . 3.3 tt -77.92 78.11 4.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.753 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.449 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.8 mt-10 -79.05 -164.95 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.865 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.517 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 22.5 t70 -51.18 -37.61 47.56 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.905 -179.252 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -54.91 -14.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.213 0.53 . . . . 0.0 110.352 179.533 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -130.77 -13.99 3.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.753 -179.906 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.621 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.1 mm -89.84 -37.11 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.281 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -51.0 -39.77 56.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.885 0.374 . . . . 0.0 111.077 -179.874 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.9 p -126.92 36.03 4.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.645 179.939 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.611 HD13 HD21 ' A' ' 94' ' ' LEU . 7.9 tp -62.61 143.91 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.701 -179.666 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -137.74 147.34 44.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.364 178.856 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.883 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.85 -35.93 6.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.972 0.415 . . . . 0.0 110.333 -179.735 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 99.6 m -62.29 -48.31 80.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.266 178.646 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -60.0 -59.87 4.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.241 -179.709 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.776 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -50.03 -55.69 13.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.899 0.381 . . . . 0.0 110.275 -179.909 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.2 m -58.19 -29.93 66.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.687 179.702 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.51 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.6 tmt_? -71.39 -66.14 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.188 179.772 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -42.75 -43.4 3.93 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.12 179.286 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.513 HG12 HG21 ' A' ' 35' ' ' VAL . 90.2 mt -63.89 -55.23 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.549 178.409 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -55.14 -16.82 3.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.281 179.282 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.51 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -92.27 -34.7 6.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.767 -179.272 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' A' ' 85' ' ' ARG . 36.1 m120 -123.12 28.1 7.31 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.653 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 89.1 p -82.35 46.81 1.08 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.067 0.46 . . . . 0.0 110.502 179.278 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.455 HD12 HH12 ' A' ' 85' ' ' ARG . 70.2 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.212 -179.62 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.807 0.337 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.4 m -116.78 20.05 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.853 179.757 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -88.94 10.62 20.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.758 179.98 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -137.96 -173.8 3.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.164 -179.758 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.6 m 55.66 38.95 30.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.104 179.934 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.0 m -135.28 -65.66 0.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 57.2 89.35 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -101.93 -79.94 1.44 Allowed Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.7 -179.918 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.72 118.18 4.91 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.569 2.179 . . . . 0.0 112.353 -179.994 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.9 154.34 16.69 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.485 -179.995 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.16 -71.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.757 0.313 . . . . 0.0 110.575 -180.0 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.91 95.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.485 179.543 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.525 ' HG3' HG12 ' A' ' 54' ' ' VAL . 1.2 pt20 -170.08 161.51 8.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.62 -179.707 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.452 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 14.3 pt-20 -110.12 157.81 36.9 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.984 -179.458 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 42.8 Cg_endo -69.57 144.05 53.77 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.656 2.237 . . . . 0.0 112.574 -179.675 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -59.45 151.32 24.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.346 -179.835 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -96.87 86.85 4.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.938 179.995 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.627 HD22 ' HA ' ' A' ' 24' ' ' ALA . 40.4 mt -83.58 74.47 10.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.488 179.929 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.8 p -74.4 0.54 14.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.048 -179.188 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.41 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 4.7 m-20 -143.88 147.44 34.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.996 0.427 . . . . 0.0 111.751 -179.863 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.608 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.1 t -55.67 -49.34 93.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.45 179.77 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.1 Cg_endo -58.44 -46.48 24.2 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.039 1.826 . . . . 0.0 111.977 179.799 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.16 -34.57 77.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.232 0.539 . . . . 0.0 110.169 -179.873 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.627 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.38 -58.06 7.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.973 179.535 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 33.1 mtt -61.86 -26.01 67.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.239 -179.898 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -71.89 -51.02 24.33 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 110.552 179.681 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.456 ' O ' HG22 ' A' ' 31' ' ' THR . 7.5 m-85 -60.59 -31.2 70.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.06 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.509 HD11 ' CD1' ' A' ' 36' ' ' ILE . 52.4 mt -75.22 -39.57 42.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.059 178.198 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.15 -18.59 61.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.109 -179.816 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.45 26.15 2.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.147 -179.947 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.727 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.9 t -171.35 155.87 4.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.608 -179.788 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.498 ' HG3' HG13 ' A' ' 87' ' ' VAL . 26.0 tt0 -67.92 -58.78 3.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.717 179.934 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 83' ' ' LEU . 13.6 t -111.17 138.33 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.67 127.44 18.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.961 0.41 . . . . 0.0 111.876 -179.526 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG21 HG12 ' A' ' 111' ' ' ILE . 47.0 t -116.01 128.58 73.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.748 178.732 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 21.5 mt -134.01 136.76 53.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.412 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.595 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -100.21 97.7 1.78 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.521 179.728 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.514 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.4 m-85 -83.43 91.32 7.34 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.482 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.7 m-85 -111.57 142.06 44.36 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -177.945 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.502 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 76.6 mt-30 -88.96 -7.33 56.23 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.563 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 44' ' ' ILE . 33.7 t70 -149.38 121.72 8.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.52 179.623 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.581 ' HA ' HG21 ' A' ' 47' ' ' VAL . 98.7 mt -91.7 46.84 1.31 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.18 0.514 . . . . 0.0 111.383 -179.293 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.424 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 47.4 mt-10 -137.54 7.09 2.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.002 178.964 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.827 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.3 pt -90.13 155.63 46.89 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.949 179.786 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.48 ' O ' HD12 ' A' ' 49' ' ' ILE . 84.3 Cg_exo -49.95 -29.38 21.09 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.729 2.286 . . . . 0.0 112.984 -179.953 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.827 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -61.25 -38.48 86.82 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.998 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.664 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.4 t -61.66 -57.49 24.38 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.569 -178.83 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.06 -38.77 85.4 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.765 1.644 . . . . 0.0 111.453 179.437 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.904 HG23 ' HA ' ' A' ' 104' ' ' ALA . 7.9 mt -63.66 -34.38 67.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.907 179.85 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.608 ' O ' HG23 ' A' ' 54' ' ' VAL . 46.6 tp -75.57 -53.02 9.29 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.836 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -54.06 -24.18 16.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.115 0.483 . . . . 0.0 109.977 178.876 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.6 t -84.08 -47.0 11.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.607 179.657 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.616 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.27 -25.84 62.25 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.504 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 50' ' ' LEU . 49.4 t -52.63 -49.15 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.166 179.483 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -76.61 -9.01 58.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.714 179.989 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -94.46 -19.16 20.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.047 179.601 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 58.4 m-85 -135.52 63.02 52.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.752 -179.795 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.79 -45.24 39.56 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.77 2.313 . . . . 0.0 111.636 179.206 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.63 -42.32 84.34 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.468 179.133 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.3 t -65.48 143.58 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.947 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.727 ' HB2' HG21 ' A' ' 31' ' ' THR . 41.7 t -82.33 97.11 8.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.02 0.438 . . . . 0.0 111.125 -179.627 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.515 ' HB3' HG22 ' A' ' 54' ' ' VAL . 6.5 p90 -62.85 128.81 37.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.897 179.658 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.69 160.28 28.32 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.106 179.98 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.8 tt -158.83 143.29 6.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.723 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.4 t -146.44 152.69 39.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.003 0.43 . . . . 0.0 111.776 -179.083 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 39' ' ' PHE . 71.4 p -136.99 -3.95 1.98 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.326 179.5 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.49 142.73 58.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.697 179.986 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.5 m -64.79 -50.44 66.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.428 -179.461 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -50.37 -43.82 54.49 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.671 -179.338 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.504 ' HA ' HG22 ' A' ' 21' ' ' VAL . 69.1 t -71.46 -52.39 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 -179.973 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.39 -15.14 14.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.15 0.5 . . . . 0.0 110.187 179.387 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.7 m -91.59 -40.02 11.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.296 178.795 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.423 ' ND1' HG11 ' A' ' 21' ' ' VAL . 4.7 t60 -61.32 -42.4 98.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.374 179.948 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.409 ' HB2' HG12 ' A' ' 76' ' ' ILE . 39.2 m-85 -88.51 9.31 24.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.695 179.528 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 58.82 23.27 11.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.538 179.128 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.664 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.2 mm -56.81 120.83 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.975 179.852 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.6 p -140.31 58.71 1.57 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.344 -179.546 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.76 45.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.7 179.606 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.596 ' HB2' HG21 ' A' ' 99' ' ' ILE . 14.5 m120 51.73 43.28 30.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.217 0.532 . . . . 0.0 110.422 -179.914 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.664 ' HB ' HG23 ' A' ' 76' ' ' ILE . 96.5 m -69.36 152.08 45.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.735 -178.539 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.595 HG12 ' HA2' ' A' ' 37' ' ' GLY . 64.0 mt -119.02 118.04 56.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.964 178.135 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 79.4 m -105.91 133.21 51.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.907 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.648 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.7 tp -109.02 105.17 14.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.774 178.48 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -98.67 120.11 38.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.683 179.787 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.461 HH12 HD12 ' A' ' 116' ' ' LEU . 4.3 mtm180 -104.74 80.98 1.71 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.611 179.965 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 85' ' ' ARG . 7.1 tp -22.59 -58.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 O-C-N 124.009 0.818 . . . . 0.0 112.856 -179.683 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.498 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -41.09 -67.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.366 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -93.3 3.26 55.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.388 -179.227 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 50.48 37.7 16.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.68 179.682 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 6.6 mm-40 -86.15 134.09 33.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.709 179.952 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.48 95.04 4.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.998 0.427 . . . . 0.0 110.833 179.954 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.648 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.2 mm? -82.41 109.93 17.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.634 179.506 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -93.87 94.59 8.58 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.439 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.555 HD21 HD13 ' A' ' 102' ' ' ILE . 4.3 tt -78.66 77.61 5.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.438 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.5 mt-10 -78.88 -164.91 0.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.908 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.517 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 14.6 t70 -50.76 -38.43 47.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.148 -179.145 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.57 -14.69 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.227 0.537 . . . . 0.0 110.33 179.722 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -129.68 -13.83 4.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.63 -179.85 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.6 mm -91.08 -31.27 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 111.438 -179.5 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -53.28 -43.15 67.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.891 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.8 m -124.93 38.53 4.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.419 179.711 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.555 HD13 HD21 ' A' ' 94' ' ' LEU . 7.3 tp -63.93 142.52 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.67 -179.698 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -137.98 150.91 47.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.604 178.803 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.904 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.78 -37.37 18.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.002 0.43 . . . . 0.0 110.443 -179.859 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 94.6 m -61.97 -46.93 87.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.208 178.686 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -60.75 -61.14 2.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.415 -179.819 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.79 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -48.52 -55.16 11.79 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.979 0.418 . . . . 0.0 110.128 179.906 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.6 m -59.05 -30.98 68.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.912 179.832 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.491 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.2 tmt_? -70.53 -65.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.097 179.691 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -43.01 -42.7 3.92 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.306 179.411 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.441 HG12 HG21 ' A' ' 35' ' ' VAL . 96.3 mt -64.65 -55.23 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.23 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -54.02 -18.23 3.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.201 179.305 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.491 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -90.06 -38.42 10.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.985 -179.077 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.632 HD22 ' HG ' ' A' ' 92' ' ' LEU . 90.2 m-20 -122.77 30.54 6.4 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.432 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 90.0 p -83.14 44.03 0.91 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 110.15 178.727 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.461 HD12 HH12 ' A' ' 85' ' ' ARG . 57.7 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.404 -179.328 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.8 0.333 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 t 55.72 72.72 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.175 -179.945 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -145.27 138.26 26.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.851 -179.967 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 80.1 tttt 55.9 47.46 20.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.727 -179.887 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.0 t -120.69 2.51 10.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.91 -179.996 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.3 p -96.36 2.91 53.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.043 -179.93 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.7 t70 57.64 88.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.196 179.88 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' A' ' 9' ' ' PRO . . . -157.77 135.82 4.53 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.284 179.804 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.429 ' HD3' ' HA2' ' A' ' 8' ' ' GLY . 28.6 Cg_exo -62.03 -20.59 70.16 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.4 2.066 . . . . 0.0 112.28 -179.865 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.61 119.02 4.96 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.444 179.972 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.31 -70.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 0.0 110.653 -179.982 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.05 -82.02 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.642 179.751 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.512 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.3 pt20 -151.39 170.64 19.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.043 -179.637 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.492 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.3 pt-20 -147.33 159.44 42.02 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 -179.775 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 54.0 Cg_endo -69.9 149.65 66.28 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.636 2.224 . . . . 0.0 112.753 -179.686 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 m -71.55 155.89 40.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.509 -179.622 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -100.05 88.9 3.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.073 179.827 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 24' ' ' ALA . 35.1 mt -82.73 71.78 9.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.375 179.781 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.5 p -70.21 -5.18 25.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.07 -178.892 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -135.81 147.36 48.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 111.416 -179.76 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.606 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 15.6 t -58.27 -48.99 96.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.367 179.915 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.0 Cg_endo -58.45 -43.83 42.71 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.899 1.733 . . . . 0.0 111.839 179.45 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.5 -37.22 86.79 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.291 0.567 . . . . 0.0 110.261 179.811 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.595 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -62.03 -54.89 35.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.049 179.45 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 38.3 mtt -62.48 -29.91 70.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.28 -179.928 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -69.18 -49.01 60.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.658 0.266 . . . . 0.0 110.517 -179.959 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -62.26 -32.82 73.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.851 179.253 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.52 HD11 HD12 ' A' ' 36' ' ' ILE . 48.1 mt -74.16 -36.15 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.156 0.503 . . . . 0.0 109.821 178.05 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.45 -18.57 60.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.21 27.57 2.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.185 -179.823 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.764 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.2 t -171.16 155.95 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.608 -179.761 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.535 ' HG3' HG13 ' A' ' 87' ' ' VAL . 24.4 tt0 -71.26 -46.87 59.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.597 179.755 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.488 HG13 HD11 ' A' ' 83' ' ' LEU . 19.1 t -121.68 137.6 54.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.361 179.555 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -142.06 128.45 20.03 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.154 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 83' ' ' LEU . 43.5 t -116.22 129.61 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.467 178.463 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.52 HD12 HD11 ' A' ' 28' ' ' ILE . 28.0 mt -136.46 136.15 48.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.226 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.63 96.71 1.77 Allowed Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.482 179.686 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.487 ' HD1' ' HB3' ' A' ' 65' ' ' SER . 40.0 m-85 -82.71 89.67 6.78 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.277 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 12.1 m-85 -108.44 146.55 32.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.603 -178.031 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -94.48 -1.8 52.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.947 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.515 ' O ' HG12 ' A' ' 44' ' ' ILE . 35.6 t70 -156.87 118.16 3.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.582 179.876 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.506 ' HA ' HG21 ' A' ' 47' ' ' VAL . 90.9 mt -87.28 44.78 1.21 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.117 0.485 . . . . 0.0 111.291 -179.351 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.1 mt-10 -136.61 13.09 3.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.078 179.255 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.833 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.4 pt -96.97 156.23 36.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.19 179.928 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.499 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 86.2 Cg_exo -49.57 -31.36 24.27 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.745 2.297 . . . . 0.0 112.851 179.657 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.833 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -59.38 -37.21 77.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.312 -179.107 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.706 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.9 t -61.89 -58.55 17.29 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.591 -178.917 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.706 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 37.0 Cg_exo -58.38 -40.54 74.23 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.777 1.651 . . . . 0.0 111.291 179.342 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.96 HG23 ' HA ' ' A' ' 104' ' ' ALA . 8.6 mt -61.02 -36.3 71.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.899 179.712 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 54' ' ' VAL . 47.6 tp -74.01 -52.37 12.96 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.942 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -54.13 -23.06 12.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.061 0.458 . . . . 0.0 109.876 178.824 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.9 m -83.08 -47.57 11.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.357 179.329 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.562 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.11 -26.4 62.56 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.272 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.0 t -51.67 -51.38 27.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.091 179.512 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -74.3 -12.09 60.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.688 -179.852 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 53' ' ' MET . 28.7 mtpp -92.46 -17.61 24.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.27 -179.96 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 52.6 m-85 -137.92 62.91 36.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.535 -179.799 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.67 -43.82 54.53 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.601 2.2 . . . . 0.0 111.618 179.065 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.58 -38.92 83.84 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.417 179.305 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 13.0 t -68.74 144.67 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.861 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.764 ' HB2' HG21 ' A' ' 31' ' ' THR . 42.3 t -81.68 98.77 8.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.047 0.451 . . . . 0.0 110.79 180.0 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.49 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.6 p90 -66.95 122.42 17.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.016 179.856 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.466 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -141.87 163.91 26.87 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.159 179.997 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -162.12 143.08 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.924 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.487 ' HB3' ' HD1' ' A' ' 38' ' ' PHE . 43.8 t -148.54 158.81 44.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 111.777 -179.094 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.505 HG21 ' HG ' ' A' ' 42' ' ' LEU . 64.6 p -138.93 -5.42 1.49 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.898 179.548 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.69 140.02 58.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.722 179.948 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.3 m -63.52 -48.16 78.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.824 -179.308 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -51.23 -44.27 61.64 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.241 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.498 ' HA ' HG22 ' A' ' 21' ' ' VAL . 54.2 t -70.75 -53.47 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.85 0.357 . . . . 0.0 110.726 179.804 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.93 -14.91 10.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.234 179.475 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.9 m -91.74 -39.87 11.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.299 178.848 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.437 ' ND1' HG11 ' A' ' 21' ' ' VAL . 5.2 t60 -61.21 -39.93 92.06 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.329 179.902 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.407 ' HB2' HG12 ' A' ' 76' ' ' ILE . 88.0 m-85 -91.86 12.26 22.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.919 179.557 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 56.67 25.43 10.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.6 179.23 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.698 HG23 ' HB ' ' A' ' 80' ' ' THR . 41.7 mm -61.77 120.51 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.968 179.653 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.5 p -140.95 57.17 1.56 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.272 179.982 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.89 45.08 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.552 179.824 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.603 ' HB2' HG21 ' A' ' 99' ' ' ILE . 26.8 m-20 50.25 43.47 26.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.255 0.55 . . . . 0.0 110.248 -179.817 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.698 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.2 m -68.99 151.25 46.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.785 -178.627 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.578 HG12 ' HA2' ' A' ' 37' ' ' GLY . 72.0 mt -117.76 115.38 48.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.851 177.931 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.478 ' HB2' ' HE2' ' A' ' 38' ' ' PHE . 80.1 m -103.76 130.5 51.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.755 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.663 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.4 tp -107.78 101.65 10.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.613 178.231 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 5.4 t80 -95.86 123.03 39.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.478 179.806 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.504 HH12 HD12 ' A' ' 116' ' ' LEU . 4.8 mtm180 -105.72 87.23 2.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.841 -179.7 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 tp -26.29 -60.68 0.08 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.903 -179.383 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.535 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.76 -79.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.433 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -79.2 3.33 18.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.96 0.409 . . . . 0.0 110.993 -179.891 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 52.21 32.8 11.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.691 179.561 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 10.4 mm-40 -76.39 161.45 28.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.695 179.83 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.537 HE22 ' HB3' ' A' ' 93' ' ' ASN . 1.1 tm0? -145.03 93.95 2.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.627 179.788 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.663 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.1 mm? -83.43 118.6 23.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.789 179.74 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.537 ' HB3' HE22 ' A' ' 91' ' ' GLN . 1.3 p-10 -99.86 94.54 6.36 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.756 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.63 HD21 HD13 ' A' ' 102' ' ' ILE . 3.4 tt -79.2 77.93 5.7 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.672 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 99' ' ' ILE . 25.8 mt-10 -79.76 -164.33 0.64 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -176.843 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.517 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 15.0 t70 -50.78 -37.65 43.54 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.971 -179.379 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.21 -15.92 2.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.226 0.536 . . . . 0.0 110.338 179.76 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -129.63 -14.07 4.17 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.645 -179.92 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.603 HG21 ' HB2' ' A' ' 79' ' ' ASN . 22.6 mm -89.89 -24.8 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.77 0.319 . . . . 0.0 111.268 -179.3 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.66 -57.45 11.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.4 p -114.56 35.52 4.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.325 179.661 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.63 HD13 HD21 ' A' ' 94' ' ' LEU . 7.6 tp -57.78 146.85 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.485 -179.844 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.442 ' HA ' ' CD1' ' A' ' 49' ' ' ILE . 9.5 t70 -139.3 164.84 28.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.674 178.605 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.96 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -62.49 -35.97 81.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.111 0.481 . . . . 0.0 110.061 -179.616 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 83.4 m -65.42 -44.88 86.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.199 178.743 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -61.06 -58.46 8.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.952 -179.713 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.733 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.3 -54.32 27.24 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.037 0.446 . . . . 0.0 109.975 179.556 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.4 m -59.02 -29.93 67.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.847 179.795 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.504 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.0 tmt_? -71.06 -66.03 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.056 179.697 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -43.2 -43.87 4.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.223 179.38 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.416 HG12 HG21 ' A' ' 35' ' ' VAL . 96.4 mt -62.97 -54.23 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.225 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.418 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 33.4 tt0 -54.59 -19.63 6.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.159 179.226 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.504 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.27 -34.5 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.79 -178.985 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.641 HD22 ' HG ' ' A' ' 92' ' ' LEU . 89.4 m-20 -124.86 29.56 6.15 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.329 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 111' ' ' ILE . 88.2 p -83.54 45.25 1.04 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.115 0.483 . . . . 0.0 110.111 178.996 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.504 HD12 HH12 ' A' ' 85' ' ' ARG . 69.9 mt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.35 -179.344 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.879 0.371 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.7 p -159.84 -30.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.226 -179.965 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -107.83 9.14 28.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.872 179.963 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -113.62 13.82 18.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.984 -179.873 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.1 p -90.74 106.81 18.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.936 -179.759 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 t -83.17 85.15 7.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.765 179.918 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.09 -59.04 2.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.74 116.98 0.06 OUTLIER Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.627 179.902 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.28 108.37 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.47 2.114 . . . . 0.0 112.19 179.861 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.57 -96.28 0.16 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.452 -179.953 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.88 -72.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.534 0.207 . . . . 0.0 110.828 179.882 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.3 103.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.596 179.848 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.639 ' HG3' HG12 ' A' ' 54' ' ' VAL . 4.2 pt20 -53.37 141.06 25.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.092 -179.913 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.503 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 13.7 pt-20 -113.98 160.33 32.71 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.939 -179.784 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 39.2 Cg_endo -67.7 142.72 59.19 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.597 2.198 . . . . 0.0 112.623 -179.901 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.4 m -63.12 153.47 34.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.809 -179.686 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.89 89.91 5.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.167 179.886 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.599 HD22 ' HA ' ' A' ' 24' ' ' ALA . 41.2 mt -84.78 72.57 10.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.298 179.613 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.1 p -71.9 -2.02 16.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.176 -179.043 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -139.27 147.42 41.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.987 0.423 . . . . 0.0 111.573 -179.797 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 29.6 t -57.24 -49.52 93.42 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.449 179.913 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.9 Cg_endo -58.66 -44.82 33.58 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.901 1.734 . . . . 0.0 111.998 179.723 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.25 83.19 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.332 0.587 . . . . 0.0 110.203 179.824 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.599 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -62.65 -57.51 10.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.157 179.548 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 31.4 mtt -61.89 -26.83 68.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.225 -179.923 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -70.44 -50.38 38.92 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.477 179.786 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -61.68 -31.17 71.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.182 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.507 HD11 HD12 ' A' ' 36' ' ' ILE . 52.7 mt -74.62 -37.67 43.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.967 178.056 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.41 -17.59 61.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.972 -179.747 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.56 28.69 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.122 -179.929 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.726 HG21 ' HB2' ' A' ' 61' ' ' SER . 9.1 t -168.89 153.89 6.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.572 -179.681 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.577 ' HG3' HG13 ' A' ' 87' ' ' VAL . 20.8 tt0 -70.91 -42.73 69.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.498 179.6 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.547 HG13 HD11 ' A' ' 83' ' ' LEU . 22.1 t -127.0 137.05 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.278 179.414 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -140.78 128.37 21.46 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.173 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.479 HG21 HG12 ' A' ' 111' ' ' ILE . 46.1 t -116.25 130.53 70.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.496 178.473 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.507 HD12 HD11 ' A' ' 28' ' ' ILE . 29.3 mt -136.42 136.81 48.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.232 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -99.22 99.01 2.05 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.528 179.716 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.7 m-85 -85.35 93.97 8.84 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.657 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 9.1 m-85 -114.38 143.77 44.37 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.125 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.407 ' HG2' HD23 ' A' ' 71' ' ' LEU . 95.9 mt-30 -91.17 -3.51 56.96 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.913 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 44' ' ' ILE . 37.1 t70 -154.27 122.33 6.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.689 -1.142 . . . . 0.0 109.465 179.845 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.493 ' HA ' HG21 ' A' ' 47' ' ' VAL . 91.6 mt -91.9 47.18 1.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 0.0 111.276 -179.486 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.9 mt-10 -136.51 11.13 3.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.792 178.977 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.739 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.1 pt -93.6 159.06 35.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.437 -179.915 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' O ' HD12 ' A' ' 49' ' ' ILE . 69.3 Cg_exo -54.59 -23.66 33.26 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.99 2.46 . . . . 0.0 112.925 179.556 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.739 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -67.11 -38.8 86.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.823 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.694 HG23 HG13 ' A' ' 44' ' ' ILE . 2.5 t -59.13 -54.72 53.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -178.787 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 33.1 Cg_exo -61.29 -43.53 28.19 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.066 1.844 . . . . 0.0 111.499 179.225 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.878 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.6 mt -59.89 -34.01 54.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.148 179.981 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.63 ' O ' HG23 ' A' ' 54' ' ' VAL . 50.1 tp -75.48 -51.5 12.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.167 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -53.96 -25.23 19.66 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.994 0.426 . . . . 0.0 109.936 178.793 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 t -83.09 -47.45 11.64 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.625 179.764 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.625 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -57.76 -26.37 61.78 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.376 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.639 HG12 ' HG3' ' A' ' 13' ' ' GLN . 51.2 t -51.89 -49.87 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.048 179.451 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -75.45 -12.74 60.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.641 179.952 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -91.5 -17.24 26.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.325 180.0 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.574 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 46.3 m-85 -138.97 63.11 29.66 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.432 -179.877 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.03 -47.67 26.28 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.756 2.304 . . . . 0.0 111.766 179.315 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.71 -41.14 57.17 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.395 179.275 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 10.6 t -66.23 143.13 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.781 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.726 ' HB2' HG21 ' A' ' 31' ' ' THR . 42.0 t -81.06 97.42 7.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.984 0.421 . . . . 0.0 110.903 -179.786 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.496 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 3.6 p90 -65.61 123.58 20.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.822 179.699 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.451 ' HA3' HG12 ' A' ' 36' ' ' ILE . . . -143.09 163.8 27.33 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.109 179.996 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 tt -161.02 141.95 3.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.897 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.2 t -145.33 155.6 43.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.046 0.45 . . . . 0.0 111.708 -178.993 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.44 HG21 ' HG ' ' A' ' 42' ' ' LEU . 57.1 p -137.99 -3.25 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.807 179.652 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.73 139.81 55.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.425 179.976 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.6 p -62.24 -47.4 84.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.68 -179.313 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -50.73 -46.94 59.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.486 -179.217 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.51 ' HA ' HG22 ' A' ' 21' ' ' VAL . 75.3 t -69.6 -51.87 37.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.767 0.318 . . . . 0.0 110.756 179.92 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.407 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.6 mp -59.36 -14.57 12.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.033 0.444 . . . . 0.0 110.219 179.466 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.3 m -92.63 -40.75 10.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.429 178.776 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -62.65 -35.55 79.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 -179.922 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.443 ' HB2' HG12 ' A' ' 76' ' ' ILE . 44.8 m-85 -94.11 10.36 34.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.754 179.544 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 57.27 24.3 9.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.683 179.422 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.671 HG23 ' HB ' ' A' ' 80' ' ' THR . 38.0 mm -61.31 120.2 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.032 179.767 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.5 p -139.94 55.91 1.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 111.397 -179.926 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.9 44.19 0.02 OUTLIER Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.515 179.86 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.622 ' HB2' HG21 ' A' ' 99' ' ' ILE . 30.8 m-80 52.14 41.9 30.32 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.178 0.513 . . . . 0.0 110.437 -179.646 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.671 ' HB ' HG23 ' A' ' 76' ' ' ILE . 88.2 m -67.77 152.68 45.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.628 -178.564 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.591 HG12 ' HA2' ' A' ' 37' ' ' GLY . 63.5 mt -119.58 118.57 57.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.951 178.006 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 77.3 m -107.5 133.89 51.32 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -177.855 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.638 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.2 tp -109.73 102.55 11.35 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.794 178.262 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -96.93 122.64 40.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.791 0.329 . . . . 0.0 110.77 179.755 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.523 ' CZ ' ' HG3' ' A' ' 90' ' ' GLU . 4.7 mtm180 -104.61 100.43 10.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.138 0.494 . . . . 0.0 109.971 179.582 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -43.78 -52.01 6.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.872 -179.156 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.577 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -42.82 -65.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.154 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.21 18.95 12.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.652 -179.322 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 p30 42.93 31.1 0.3 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.941 179.332 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.523 ' HG3' ' CZ ' ' A' ' 85' ' ' ARG . 8.8 mm-40 -75.91 159.5 30.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 0.0 110.974 -179.923 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -146.42 85.44 1.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.65 179.798 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.638 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -75.04 144.84 42.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.224 179.996 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -121.93 124.83 44.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.351 0.596 . . . . 0.0 111.792 -179.643 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.656 HD21 HD13 ' A' ' 102' ' ' ILE . 3.7 tt -112.09 76.03 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.273 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' O ' HG12 ' A' ' 99' ' ' ILE . 26.0 mt-10 -77.91 -165.41 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.752 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.495 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -46.45 -51.22 15.59 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.556 -179.11 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -47.23 -17.87 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.923 0.392 . . . . 0.0 110.899 179.764 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 96' ' ' ASP . 9.4 m-20 -124.84 -13.94 6.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.414 -179.91 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.622 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.3 mm -92.23 -42.74 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.264 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -50.78 -34.76 28.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.021 179.812 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.5 t -127.66 37.69 4.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.371 179.622 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.656 HD13 HD21 ' A' ' 94' ' ' LEU . 8.7 tp -67.6 144.72 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.779 -179.607 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -138.64 147.87 43.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.345 178.542 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.878 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.71 -37.44 8.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.962 0.41 . . . . 0.0 110.579 -179.722 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.5 m -62.32 -48.45 79.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.322 178.88 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -58.39 -58.4 8.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.311 -179.677 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.761 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.77 -56.59 11.36 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.057 0.456 . . . . 0.0 110.271 179.902 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.4 m -57.71 -29.41 64.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.762 179.796 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.526 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.2 tmt_? -71.44 -65.65 0.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.247 179.83 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -42.89 -42.77 3.81 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.033 179.231 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.479 HG12 HG21 ' A' ' 35' ' ' VAL . 95.5 mt -63.92 -55.3 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.494 178.377 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -54.96 -17.71 4.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.253 0.549 . . . . 0.0 110.332 179.333 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.526 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.77 -36.81 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.84 -179.29 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -123.64 30.12 6.33 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.527 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 79.8 p -82.58 51.33 1.84 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.085 0.469 . . . . 0.0 109.959 178.741 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 85' ' ' ARG . 55.3 mt . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.295 -179.208 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.681 0.277 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.8 t 55.4 77.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 -179.937 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -121.06 72.14 0.97 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.012 -179.872 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -88.22 -25.1 23.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 179.91 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.0 t -166.62 43.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.927 179.889 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.0 t -143.36 115.99 8.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.843 179.939 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -82.1 -20.03 38.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.855 -179.875 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.37 165.22 28.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.625 -179.988 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.16 -45.33 19.63 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.623 2.215 . . . . 0.0 112.192 179.856 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.37 160.12 13.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.646 -179.883 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.56 -63.63 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.83 0.347 . . . . 0.0 110.56 -179.957 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.42 ' O ' ' HG2' ' A' ' 13' ' ' GLN . . . 55.39 89.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.75 179.62 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 12' ' ' ALA . 4.8 pt20 48.14 170.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.961 179.689 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.8 pt-20 -164.14 160.17 16.54 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.2 -179.862 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 14' ' ' GLU . 46.6 Cg_endo -68.71 146.87 68.15 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.348 2.032 . . . . 0.0 112.811 -179.168 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.6 m -67.75 152.4 45.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.443 -179.623 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -95.81 85.88 4.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.813 179.87 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 24' ' ' ALA . 49.3 mt -81.75 71.24 8.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.63 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.0 p -71.43 0.14 8.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.034 -179.266 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -142.56 147.43 35.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.965 0.412 . . . . 0.0 111.705 -179.701 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.594 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 40.2 t -56.86 -50.35 88.61 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.443 179.881 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 18.2 Cg_endo -58.39 -44.48 37.65 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.975 1.783 . . . . 0.0 111.93 179.916 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.26 83.28 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.291 0.567 . . . . 0.0 110.18 179.953 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.615 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -63.69 -57.42 10.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.053 179.435 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.2 mtm -61.39 -26.78 68.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.013 -179.903 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -71.47 -50.66 29.44 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.484 179.738 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -60.65 -31.67 70.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.058 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.489 HD11 HD12 ' A' ' 36' ' ' ILE . 49.9 mt -73.17 -38.03 53.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.809 178.236 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.06 -19.7 61.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.998 179.857 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.14 31.01 1.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.471 -179.715 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.695 HG21 ' HB2' ' A' ' 61' ' ' SER . 8.8 t -171.26 153.25 3.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.333 -179.853 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.615 ' HG3' HG13 ' A' ' 87' ' ' VAL . 27.6 tt0 -71.62 -37.46 70.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.651 179.63 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.579 HG13 HD11 ' A' ' 83' ' ' LEU . 26.9 t -131.53 136.81 56.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.229 179.408 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -141.02 127.12 19.49 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.252 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 111' ' ' ILE . 50.8 t -114.58 130.6 68.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.427 178.304 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.489 HD12 HD11 ' A' ' 28' ' ' ILE . 28.2 mt -136.09 135.66 50.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.439 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.574 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.54 99.13 2.12 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.404 179.46 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 13.9 m-85 -85.39 93.28 8.7 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.631 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.6 m-85 -112.8 142.06 45.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.492 -177.958 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.458 ' HG2' HD23 ' A' ' 71' ' ' LEU . 47.7 mt-30 -90.87 1.69 56.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.767 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.8 t70 -159.36 122.22 3.59 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.585 179.895 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.554 ' HA ' HG21 ' A' ' 47' ' ' VAL . 90.1 mt -92.38 47.67 1.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.185 0.517 . . . . 0.0 111.417 -179.32 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 47.5 mt-10 -138.0 7.47 2.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.913 178.868 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.822 HD12 ' HB3' ' A' ' 46' ' ' ALA . 1.8 pt -90.93 155.91 44.75 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.159 179.824 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.455 ' O ' HD12 ' A' ' 49' ' ' ILE . 86.5 Cg_exo -51.11 -26.71 20.01 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.862 2.374 . . . . 0.0 113.214 179.733 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.822 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -64.51 -36.22 83.48 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.842 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.65 HG23 HG13 ' A' ' 44' ' ' ILE . 2.4 t -62.98 -55.92 33.29 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.494 -178.854 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.641 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 32.1 Cg_exo -58.75 -39.62 80.31 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.807 1.672 . . . . 0.0 111.407 179.34 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 104' ' ' ALA . 8.3 mt -63.35 -37.59 79.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.137 179.986 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.608 ' O ' HG23 ' A' ' 54' ' ' VAL . 41.9 tp -71.87 -51.76 20.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.844 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -55.49 -22.0 19.0 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.507 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -85.09 -44.17 13.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.581 179.494 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.582 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -62.12 -25.56 67.8 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.33 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 50' ' ' LEU . 52.9 t -52.87 -46.97 52.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.928 179.436 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 13' ' ' GLN . 3.8 mt-30 -77.62 -11.65 59.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.705 -179.729 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -93.72 -18.09 22.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.347 -179.85 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.586 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 66.4 m-85 -137.34 62.39 37.29 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.569 -179.775 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.52 -42.53 61.07 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.632 2.221 . . . . 0.0 111.636 179.033 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.95 -40.96 94.02 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.521 179.227 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 9.2 t -66.93 143.27 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 178.8 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.695 ' HB2' HG21 ' A' ' 31' ' ' THR . 48.4 t -80.58 98.08 7.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.134 0.492 . . . . 0.0 110.99 -179.681 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.52 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.6 p90 -66.11 125.57 25.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.78 179.67 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.48 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -144.39 161.91 27.94 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.99 179.902 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.412 HD11 HG13 ' A' ' 47' ' ' VAL . 5.0 tt -159.54 144.17 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.803 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.3 t -150.29 154.37 37.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.218 0.532 . . . . 0.0 111.811 -178.993 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.489 HG21 ' HG ' ' A' ' 42' ' ' LEU . 75.2 p -135.21 -2.64 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.474 179.464 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.05 141.36 57.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.717 -179.875 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.3 p -64.57 -49.93 69.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.509 -179.569 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -49.6 -45.02 47.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.492 -179.371 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.539 ' HA ' HG22 ' A' ' 21' ' ' VAL . 69.0 t -70.52 -53.19 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.877 0.37 . . . . 0.0 110.734 179.853 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.458 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.5 mp -58.25 -14.71 7.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.193 179.406 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.4 m -91.59 -41.85 10.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.333 178.889 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -61.25 -35.48 77.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.449 179.679 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.424 ' HB2' HG12 ' A' ' 76' ' ' ILE . 45.4 m-85 -94.61 9.31 39.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.759 179.452 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.3 t30 57.65 23.19 9.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.671 178.787 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.679 HG23 ' HB ' ' A' ' 80' ' ' THR . 37.6 mm -58.13 120.78 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.157 179.856 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.3 p -139.23 57.34 1.66 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.403 -179.632 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.82 46.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.75 179.754 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.612 ' HB2' HG21 ' A' ' 99' ' ' ILE . 13.1 m120 50.62 42.52 27.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.188 0.518 . . . . 0.0 110.293 -179.868 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.679 ' HB ' HG23 ' A' ' 76' ' ' ILE . 93.4 m -69.0 152.26 45.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.665 -178.352 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.583 HG21 HD21 ' A' ' 107' ' ' LEU . 66.0 mt -119.18 116.42 50.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.952 178.01 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.4 m -105.34 135.23 47.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.816 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.638 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -109.64 98.78 8.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.916 178.377 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -92.45 120.11 32.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.541 179.816 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.508 HH12 HD12 ' A' ' 116' ' ' LEU . 5.1 mtm180 -103.74 103.84 13.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.399 . . . . 0.0 110.108 179.706 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.5 tp -45.1 -56.32 4.82 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.831 -179.182 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.615 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -37.03 -76.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.175 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -82.5 5.9 19.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.047 -179.754 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 52.3 36.58 20.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.425 179.779 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 7.3 mm-40 -81.61 167.19 19.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.959 179.833 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -150.73 89.53 1.56 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.575 179.621 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.638 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.8 mm? -74.49 148.09 41.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.877 179.735 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.5 114.62 18.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.3 0.571 . . . . 0.0 112.165 -179.512 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.6 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -103.52 77.88 1.54 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.154 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.2 mt-10 -80.55 -164.4 0.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.91 -176.775 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 17.7 t70 -50.62 -36.25 34.31 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.068 -179.319 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -56.04 -14.7 2.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.313 0.578 . . . . 0.0 110.254 179.63 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -132.33 -13.67 3.03 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.768 -179.909 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.612 HG21 ' HB2' ' A' ' 79' ' ' ASN . 26.2 mm -89.69 -31.54 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.7 0.286 . . . . 0.0 111.269 -179.555 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -53.78 -43.04 68.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.0 110.707 179.815 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.5 p -125.74 38.83 4.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.393 179.738 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.6 HD13 HD21 ' A' ' 94' ' ' LEU . 7.7 tp -63.56 142.93 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.653 -179.835 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -137.25 148.46 46.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.505 178.836 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.886 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -47.53 -34.89 8.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.193 0.52 . . . . 0.0 110.274 -179.989 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.2 m -63.47 -48.1 79.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.35 178.774 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -60.3 -60.74 3.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.266 -179.71 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.745 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -48.68 -55.36 11.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.029 0.442 . . . . 0.0 110.239 179.898 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 65.8 m -58.92 -30.86 68.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.87 179.948 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.49 ' HD3' HD13 ' A' ' 113' ' ' ILE . 3.2 tmt_? -70.85 -65.81 0.69 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.146 179.724 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -42.87 -44.23 4.42 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.232 179.355 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.475 HG12 HG21 ' A' ' 35' ' ' VAL . 95.4 mt -62.89 -55.08 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.175 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.447 ' HB2' ' HZ ' ' A' ' 57' ' ' PHE . 7.8 tp10 -54.1 -17.97 3.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.294 179.178 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.49 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -91.09 -34.9 6.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.031 -179.097 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.595 HD22 ' HG ' ' A' ' 92' ' ' LEU . 83.7 m-20 -124.78 28.79 6.39 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.408 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 94.3 p -82.47 43.88 0.85 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.076 0.465 . . . . 0.0 110.346 179.157 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.508 HD12 HH12 ' A' ' 85' ' ' ARG . 59.2 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.392 -179.279 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.867 0.365 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.3 m -107.26 158.37 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.087 -179.891 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -135.52 -65.44 0.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.731 -179.913 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 63.85 151.53 0.04 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.362 179.709 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.4 t -78.4 95.97 5.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.033 -179.915 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.6 m -136.91 -55.79 0.72 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -68.78 164.26 22.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.911 179.996 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.61 -161.66 28.41 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.56 -179.93 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.19 131.26 37.98 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.582 2.188 . . . . 0.0 112.314 179.839 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.47 -77.67 0.24 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.613 179.976 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.73 -45.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.001 0.429 . . . . 0.0 110.429 -179.945 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.35 -84.04 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.954 179.093 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.516 ' HG3' HG12 ' A' ' 54' ' ' VAL . 11.5 pt20 -133.16 138.12 46.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.106 -179.929 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 11.8 pt-20 -122.15 156.29 60.31 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.62 179.905 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HA ' ' HD1' ' A' ' 62' ' ' PHE . 32.5 Cg_endo -64.89 139.11 60.64 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.549 2.166 . . . . 0.0 112.502 -179.655 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -54.84 153.49 6.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.824 -179.368 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -98.18 92.18 5.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.976 179.78 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.614 HD22 ' HA ' ' A' ' 24' ' ' ALA . 50.9 mt -92.42 72.07 5.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.448 179.77 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.8 p -73.79 -0.99 17.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.889 -179.299 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -140.51 146.78 38.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.393 . . . . 0.0 111.626 -179.953 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 48.4 t -56.29 -49.96 90.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.494 179.862 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.4 Cg_endo -57.5 -46.15 29.36 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.896 1.73 . . . . 0.0 111.773 179.842 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.98 76.9 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.269 0.557 . . . . 0.0 110.259 -179.822 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.614 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -64.87 -58.68 5.55 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.104 179.342 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 46.7 mtm -61.3 -26.3 67.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.209 -179.943 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 23.0 mt-10 -72.06 -51.42 21.72 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.687 0.28 . . . . 0.0 110.612 179.806 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.575 ' O ' HG22 ' A' ' 31' ' ' THR . 6.2 m-85 -59.69 -34.64 73.14 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.106 179.249 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 36' ' ' ILE . 49.3 mt -72.89 -38.49 56.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.844 178.293 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.65 -17.46 61.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.005 -179.826 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.61 26.04 5.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.307 -179.9 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 27' ' ' PHE . 8.8 t -172.78 152.06 2.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.597 -179.77 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.724 ' HG3' HG13 ' A' ' 87' ' ' VAL . 1.2 mp0 -59.67 -90.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.252 0.548 . . . . 0.0 110.948 179.32 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.547 HG13 HD11 ' A' ' 83' ' ' LEU . 11.4 t -85.41 133.12 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.715 -179.321 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -137.57 124.4 21.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.873 -178.977 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.428 HG21 HG12 ' A' ' 111' ' ' ILE . 52.3 t -112.75 129.71 67.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.845 178.736 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.521 HD12 HD11 ' A' ' 28' ' ' ILE . 25.2 mt -134.66 135.56 53.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.646 -177.249 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.54 98.06 1.97 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.41 179.859 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.526 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 8.9 m-85 -83.24 90.06 7.06 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.725 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.4 m-85 -110.29 139.74 45.16 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.0 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -87.36 -5.91 58.69 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.764 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.488 ' O ' HG12 ' A' ' 44' ' ' ILE . 34.2 t70 -152.59 120.85 6.28 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.583 -179.924 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.484 ' HA ' HG21 ' A' ' 47' ' ' VAL . 99.3 mt -89.81 45.58 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.047 0.451 . . . . 0.0 111.513 -179.187 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 42.4 mt-10 -136.85 11.05 3.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.09 178.97 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.734 HD12 ' HB3' ' A' ' 46' ' ' ALA . 3.2 pt -92.77 157.22 39.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.27 179.815 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.487 ' O ' HD12 ' A' ' 49' ' ' ILE . 70.9 Cg_exo -51.67 -25.93 21.61 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.853 2.368 . . . . 0.0 113.004 179.547 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.734 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.41 -37.9 88.34 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.853 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.684 HG23 HG13 ' A' ' 44' ' ' ILE . 2.3 t -61.12 -54.92 49.16 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -178.73 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.614 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 35.2 Cg_exo -61.05 -38.81 65.11 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.951 1.767 . . . . 0.0 111.508 179.202 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.879 HG23 ' HA ' ' A' ' 104' ' ' ALA . 6.2 mt -64.76 -34.58 71.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.025 -179.954 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.617 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.1 tp -74.3 -52.13 13.17 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.879 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -53.11 -26.36 16.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.173 0.511 . . . . 0.0 109.681 178.618 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 t -80.93 -47.55 13.55 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.778 179.867 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.587 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -58.72 -26.32 63.81 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.443 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 50' ' ' LEU . 56.0 t -52.36 -49.43 42.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.019 179.624 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -77.57 -11.44 59.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.75 -179.815 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -91.3 -18.74 23.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.01 179.807 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 50.3 m-85 -135.92 63.2 50.6 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.267 -179.818 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.03 -43.86 49.6 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.629 2.219 . . . . 0.0 111.692 179.252 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.6 -40.94 88.8 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.367 179.086 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.1 t -66.45 144.48 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.913 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.567 ' CB ' HG21 ' A' ' 31' ' ' THR . 31.0 t -83.73 98.98 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.059 0.457 . . . . 0.0 110.987 -179.581 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.491 ' HD1' ' HA ' ' A' ' 15' ' ' PRO . 6.4 p90 -64.39 128.84 37.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.053 179.875 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -148.62 161.65 28.7 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.137 179.762 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 15' ' ' PRO . 4.2 tt -159.32 141.89 5.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.679 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.1 t -141.73 154.55 45.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.971 0.415 . . . . 0.0 111.489 -178.974 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 39' ' ' PHE . 68.9 p -139.96 -2.44 1.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.875 179.894 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -72.15 143.06 49.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.754 -179.939 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.8 p -63.19 -49.67 73.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.533 -179.493 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -49.97 -44.37 50.71 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.69 -179.381 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.566 ' HA ' HG22 ' A' ' 21' ' ' VAL . 79.6 t -70.54 -52.83 25.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.925 0.393 . . . . 0.0 110.723 179.797 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.19 -14.55 11.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.223 179.422 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.7 m -91.53 -41.89 10.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.264 178.871 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -59.78 -39.92 86.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.498 179.723 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -92.11 13.75 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.987 179.675 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.4 m120 55.32 24.19 6.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.598 179.433 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.66 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.1 mm -59.73 119.23 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.886 179.747 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -139.51 57.59 1.64 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.199 -179.948 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.2 45.06 0.02 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.515 179.828 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.555 ' HB2' HG21 ' A' ' 99' ' ' ILE . 24.9 m-80 51.42 42.16 28.99 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.292 0.567 . . . . 0.0 110.406 -179.859 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.66 ' HB ' HG23 ' A' ' 76' ' ' ILE . 97.9 m -67.86 152.86 44.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.605 -178.621 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.591 HG12 ' HA2' ' A' ' 37' ' ' GLY . 66.1 mt -119.41 117.26 53.43 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.14 178.161 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.526 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 73.1 m -106.13 135.99 46.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.837 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.626 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.6 tp -110.64 104.49 13.18 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.132 178.546 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 2.8 t80 -97.46 120.1 37.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.76 179.76 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.567 HH12 HD12 ' A' ' 116' ' ' LEU . 5.6 mtm180 -103.39 88.83 3.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.563 -179.739 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tp -38.61 -49.46 1.54 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.637 -179.791 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.724 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -42.48 -52.38 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 111.431 -179.88 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -108.59 9.39 27.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.62 179.821 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 85' ' ' ARG . 17.0 t-20 47.89 35.55 5.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.519 -179.834 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 8.0 mm-40 -83.05 163.8 20.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.648 179.566 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -147.2 94.14 2.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 179.761 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.626 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.3 mm? -80.94 146.16 30.9 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.338 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.75 106.31 9.96 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.927 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.619 HD21 HD13 ' A' ' 102' ' ' ILE . 4.8 tt -91.79 77.42 5.54 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.663 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' HG12 ' A' ' 99' ' ' ILE . 24.4 mt-10 -79.19 -165.09 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.767 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.472 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -45.25 -51.46 10.75 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.569 -179.331 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -47.04 -17.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.901 0.382 . . . . 0.0 111.215 179.88 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -125.52 -13.85 6.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.575 -179.968 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.555 HG21 ' HB2' ' A' ' 79' ' ' ASN . 23.3 mm -90.88 -41.32 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.729 -179.381 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -49.05 -40.41 31.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.4 p -126.03 41.87 3.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.684 179.839 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.619 HD13 HD21 ' A' ' 94' ' ' LEU . 7.5 tp -69.31 142.54 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.663 -179.581 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -135.6 147.76 48.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.237 178.597 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.879 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -46.45 -36.14 6.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.593 -179.608 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.8 m -63.22 -47.45 82.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.562 178.822 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -59.5 -59.3 5.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.206 -179.743 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.741 HD12 HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -50.02 -54.59 19.13 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.898 0.38 . . . . 0.0 110.22 179.712 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.3 m -59.38 -30.15 68.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.504 ' HD3' HD13 ' A' ' 113' ' ' ILE . 4.1 tmt_? -70.84 -65.59 0.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.191 179.651 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -43.48 -44.23 5.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.908 179.363 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.428 HG12 HG21 ' A' ' 35' ' ' VAL . 96.8 mt -62.34 -54.96 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.437 178.257 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -54.8 -18.9 5.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.213 179.358 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.504 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -88.91 -35.72 8.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.937 -179.094 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.603 HD22 ' HG ' ' A' ' 92' ' ' LEU . 87.3 m-20 -125.3 29.82 5.97 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.397 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 96.8 p -81.99 38.3 0.52 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.971 0.415 . . . . 0.0 110.487 179.048 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.567 HD12 HH12 ' A' ' 85' ' ' ARG . 58.6 mt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.114 -179.705 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.763 0.316 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.3 m -66.77 140.78 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.121 -179.934 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -74.16 89.63 2.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.917 -179.861 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -163.72 32.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.561 179.862 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.2 m 64.56 127.58 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.279 -179.969 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -134.94 81.9 1.93 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.986 -179.953 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 61.63 -84.35 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.271 179.778 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.37 -161.38 10.68 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.669 -179.81 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.32 148.96 84.05 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.762 2.308 . . . . 0.0 112.507 -179.806 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.72 148.67 17.08 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.434 179.928 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.33 -54.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.786 0.326 . . . . 0.0 110.681 -179.9 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.62 -84.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.67 179.527 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.495 ' HG3' HG12 ' A' ' 54' ' ' VAL . 28.1 pt20 -162.35 135.16 5.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.859 0.361 . . . . 0.0 111.31 -179.985 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.443 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 12.3 pt-20 -120.13 157.71 52.43 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.625 179.895 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HA ' ' HB2' ' A' ' 62' ' ' PHE . 37.2 Cg_endo -66.25 143.49 70.98 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.532 2.155 . . . . 0.0 112.712 -179.429 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.4 m -59.3 154.17 17.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.427 -179.614 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -102.14 97.06 7.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.935 -179.987 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.604 HD13 ' HA ' ' A' ' 24' ' ' ALA . 39.2 mt -95.17 76.81 3.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.432 179.958 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.0 p -74.09 -4.34 34.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.142 -179.085 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -139.02 147.32 41.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.92 0.39 . . . . 0.0 111.595 -179.669 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 26.2 t -55.97 -50.24 88.42 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.36 179.969 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 21' ' ' VAL . 19.5 Cg_endo -57.95 -44.25 41.63 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 121.88 1.72 . . . . 0.0 111.736 179.992 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.76 78.82 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.321 0.582 . . . . 0.0 110.22 179.995 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.604 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -64.51 -58.66 5.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.093 179.483 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.2 mtp -61.7 -25.83 67.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 22' ' ' PRO . 19.1 mt-10 -71.34 -51.5 23.9 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.738 0.304 . . . . 0.0 110.474 179.591 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.583 ' O ' HG22 ' A' ' 31' ' ' THR . 7.0 m-85 -59.27 -35.68 74.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.97 179.317 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 36' ' ' ILE . 46.9 mt -71.13 -39.56 74.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.904 178.305 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.98 -17.98 62.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.994 -179.906 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.78 24.95 5.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.186 -179.862 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.59 HG21 ' CB ' ' A' ' 61' ' ' SER . 9.3 t -169.95 152.76 4.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.416 -179.92 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.587 ' HG3' HG13 ' A' ' 87' ' ' VAL . 16.5 tt0 -61.23 -82.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.898 -179.888 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.554 HG13 HD11 ' A' ' 83' ' ' LEU . 21.9 t -94.63 138.16 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.48 179.964 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HA ' ' HB3' ' A' ' 61' ' ' SER . . . -139.99 126.84 20.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.946 0.403 . . . . 0.0 111.989 -179.173 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.445 HG21 HG12 ' A' ' 111' ' ' ILE . 45.1 t -113.65 128.11 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.789 178.445 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.541 HD12 HD11 ' A' ' 28' ' ' ILE . 32.0 mt -133.0 134.68 57.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.658 -177.053 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.536 ' HA2' HG12 ' A' ' 81' ' ' ILE . . . -98.3 100.25 2.31 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.347 179.614 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 82' ' ' CYS . 4.4 m-85 -84.76 93.19 8.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.8 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.2 m-85 -114.5 141.45 47.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.103 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.496 ' HG2' HD23 ' A' ' 71' ' ' LEU . 74.0 mt-30 -88.89 -7.8 55.43 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.706 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 44' ' ' ILE . 25.4 t70 -150.2 120.95 7.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.667 -1.152 . . . . 0.0 109.66 179.688 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.476 ' HA ' HG21 ' A' ' 47' ' ' VAL . 95.6 mt -90.17 45.33 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.006 0.432 . . . . 0.0 111.536 -179.197 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HB2' ' OD2' ' A' ' 41' ' ' ASP . 41.7 mt-10 -135.42 11.84 3.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.083 178.976 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.696 HG13 HG23 ' A' ' 47' ' ' VAL . 4.9 pt -93.18 158.93 36.43 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.508 ' O ' HD12 ' A' ' 49' ' ' ILE . 68.8 Cg_exo -54.15 -25.66 38.58 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.743 2.295 . . . . 0.0 112.791 179.462 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.673 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -65.29 -38.33 89.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.456 -178.804 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.696 HG23 HG13 ' A' ' 44' ' ' ILE . 2.1 t -60.34 -56.45 35.24 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.704 -178.788 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 31.4 Cg_exo -59.4 -41.11 61.19 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.812 1.675 . . . . 0.0 111.401 179.561 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.87 HG23 ' HA ' ' A' ' 104' ' ' ALA . 5.6 mt -61.64 -34.87 63.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.992 179.781 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.7 tp -74.19 -53.39 9.93 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 178.809 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -53.47 -24.52 13.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.004 0.431 . . . . 0.0 109.887 178.911 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.9 m -82.74 -45.93 13.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.499 179.421 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.552 ' HG2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -59.25 -25.84 64.39 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.407 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 50' ' ' LEU . 53.0 t -52.84 -49.98 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.823 179.312 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.474 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 7.6 mt-30 -75.73 -11.45 60.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.813 -179.867 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -92.64 -18.26 23.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.145 179.937 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.592 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 68.1 m-85 -135.56 62.34 48.44 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.396 -179.739 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.7 -43.32 51.78 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.727 2.284 . . . . 0.0 111.552 179.0 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.72 -38.11 86.61 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.52 179.294 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 12.0 t -70.05 144.4 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.955 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.59 ' CB ' HG21 ' A' ' 31' ' ' THR . 42.9 t -83.83 99.32 10.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.006 0.431 . . . . 0.0 111.042 -179.672 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.478 ' HB3' HG22 ' A' ' 54' ' ' VAL . 7.7 p90 -62.57 131.25 48.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.151 179.915 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 36' ' ' ILE . . . -150.06 161.69 28.97 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.121 179.712 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 tt -162.85 142.63 2.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.995 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.8 t -144.37 155.97 44.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.041 0.448 . . . . 0.0 111.652 -179.059 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 39' ' ' PHE . 67.7 p -139.03 3.1 2.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.842 179.666 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.75 143.11 44.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.784 -179.972 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.9 t -64.48 -50.47 67.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.496 -179.426 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.76 -43.57 48.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.514 -179.413 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.534 ' HA ' HG22 ' A' ' 21' ' ' VAL . 78.1 t -71.51 -53.02 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.811 0.339 . . . . 0.0 110.756 179.987 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.496 HD23 ' HG2' ' A' ' 40' ' ' GLN . 6.7 mp -58.86 -14.51 9.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.233 179.315 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 76.1 m -91.48 -40.98 11.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.294 178.641 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -60.49 -40.22 90.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.45 179.847 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -91.45 11.86 22.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.853 179.644 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 56.04 25.74 9.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.596 179.551 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.665 HG23 ' HB ' ' A' ' 80' ' ' THR . 40.0 mm -59.78 119.42 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.839 179.597 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.4 p -138.49 58.88 1.65 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.235 -179.549 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.11 48.22 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.709 179.664 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.616 ' HB2' HG21 ' A' ' 99' ' ' ILE . 36.3 m-20 49.52 43.4 23.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.103 0.478 . . . . 0.0 110.461 -179.945 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.665 ' HB ' HG23 ' A' ' 76' ' ' ILE . 92.1 m -68.62 152.63 45.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.621 -178.677 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.536 HG12 ' HA2' ' A' ' 37' ' ' GLY . 67.4 mt -118.81 119.14 60.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.07 178.065 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 83.6 m -108.55 134.62 51.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.038 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.63 ' HG ' HD23 ' A' ' 92' ' ' LEU . 2.5 tp -106.71 103.99 13.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.608 178.438 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -97.33 119.72 36.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.867 0.365 . . . . 0.0 111.199 -179.886 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.485 ' NH2' ' HG3' ' A' ' 90' ' ' GLU . 3.2 mtm180 -105.24 95.93 6.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.407 -179.95 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 1.6 tp -43.19 -54.55 4.43 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.782 -179.622 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.587 HG13 ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -40.1 -59.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.03 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -97.86 3.62 49.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.446 -179.346 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 85' ' ' ARG . 38.2 t30 51.58 47.08 25.5 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.259 0.552 . . . . 0.0 110.834 -179.818 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.485 ' HG3' ' NH2' ' A' ' 85' ' ' ARG . 10.2 mm-40 -97.23 158.67 15.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.715 -179.894 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -140.96 92.34 2.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.934 179.809 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.63 HD23 ' HG ' ' A' ' 83' ' ' LEU . 2.5 mm? -80.8 143.42 32.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.258 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -120.97 123.06 41.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.281 0.562 . . . . 0.0 112.439 -179.363 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.632 HD21 HD13 ' A' ' 102' ' ' ILE . 4.5 tt -111.09 76.34 0.97 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.126 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.44 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.3 mt-10 -78.13 -164.58 0.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.364 -0.834 . . . . 0.0 113.137 -176.669 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.53 ' HA ' ' HB ' ' A' ' 99' ' ' ILE . 12.5 t70 -50.94 -37.2 42.83 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.98 -179.113 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.74 -14.98 2.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.106 0.479 . . . . 0.0 110.304 179.639 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -130.6 -13.8 3.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.585 179.776 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.616 HG21 ' HB2' ' A' ' 79' ' ' ASN . 25.7 mm -90.48 -24.95 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.76 0.314 . . . . 0.0 111.195 -179.538 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -57.18 -52.02 66.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.993 0.425 . . . . 0.0 110.611 179.843 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.5 m -117.73 35.6 4.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.348 179.537 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.632 HD13 HD21 ' A' ' 94' ' ' LEU . 6.9 tp -58.09 140.6 16.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.437 -179.619 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -135.69 149.97 49.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.424 178.644 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.87 ' HA ' HG23 ' A' ' 49' ' ' ILE . . . -48.02 -34.55 9.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.019 0.437 . . . . 0.0 110.479 -179.844 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.9 m -64.79 -48.24 75.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.452 178.844 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -59.99 -57.33 13.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.226 -179.794 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.763 HD12 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -51.75 -55.89 17.08 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.132 0.491 . . . . 0.0 110.001 179.662 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.9 m -58.0 -30.24 65.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.917 179.866 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.444 ' HD3' HD13 ' A' ' 113' ' ' ILE . 2.8 tmt_? -70.37 -65.81 0.68 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.275 179.66 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -42.98 -43.9 4.39 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.141 179.277 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.445 HG12 HG21 ' A' ' 35' ' ' VAL . 88.8 mt -62.29 -55.55 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.208 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -54.6 -18.33 4.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.451 179.319 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.444 HD13 ' HD3' ' A' ' 109' ' ' ARG . 1.4 mp -89.74 -36.64 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.079 -178.873 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.486 ' O ' HD21 ' A' ' 83' ' ' LEU . 16.0 m120 -124.22 28.79 6.6 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.574 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.9 p -81.04 42.84 0.67 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.928 0.394 . . . . 0.0 110.462 179.21 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.442 HD12 ' NH1' ' A' ' 85' ' ' ARG . 62.3 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.189 -179.647 . . . . . . . . 1 1 . 1 stop_ save_